PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Beilharz, FL; Atkins, KJ; Duncum, AJF; Mundy, ME				Beilharz, Francesca L.; Atkins, Kelly J.; Duncum, Anna J. F.; Mundy, Matthew E.			Altering Visual Perception Abnormalities: A Marker for Body Image Concern	PLOS ONE			English	Article							DYSMORPHIC DISORDER; NAVON LETTERS; CONFIGURAL INFORMATION; PROCESSING ORIENTATION; FACE RECOGNITION; INVERSION; PRECEDENCE; BIAS; QUESTIONNAIRE; POPULATION	The body image concern (BIC) continuum ranges from a healthy and positive body image, to clinical diagnoses of abnormal body image, like body dysmorphic disorder (BDD). BDD and non-clinical, yet high-BIC participants have demonstrated a local visual processing bias, characterised by reduced inversion effects. To examine whether this bias is a potential marker of BDD, the visual processing of individuals across the entire BIC continuum was examined. Dysmorphic Concern Questionnaire (DCQ; quantified BIC) scores were expected to correlate with higher discrimination accuracy and faster reaction times of inverted stimuli, indicating reduced inversion effects (occurring due to increased local visual processing). Additionally, an induced global or local processing bias via Navon stimulus presentation was expected to alter these associations. Seventy-four participants completed the DCQ and upright-inverted face and body stimulus discrimination task. Moderate positive associations were revealed between DCQ scores and accuracy rates for inverted face and body stimuli, indicating a graded local bias accompanying increases in BIC. This relationship supports a local processing bias as a marker for BDD, which has significant assessment implications. Furthermore, a moderate negative relationship was found between DCQ score and inverted face accuracy after inducing global processing, indicating the processing bias can temporarily be reversed in high BIC individuals. Navon stimuli were successfully able to alter the visual processing of individuals across the BIC continuum, which has important implications for treating BDD.	[Mundy, Matthew E.] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia	Monash University; Monash University	Mundy, ME (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia.	matthew.mundy@monash.edu		Atkins, Kelly/0000-0003-0361-2494; Mundy, Matthew/0000-0002-7073-0047	Monash Institute of Cognitive and Clinical Neurosciences; School of Psychological Sciences, Monash University	Monash Institute of Cognitive and Clinical Neurosciences; School of Psychological Sciences, Monash University	Funding for this study was received from the Monash Institute of Cognitive and Clinical Neurosciences and School of Psychological Sciences, Monash University, recipient Dr. Matthew Mundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2010, PRES VERS 17 1; [Anonymous], 2011, MORPH PHOT VERS 3 16; [Anonymous], 2013, HUMANCAD VERS 2 5; Arienzo D, 2013, NEUROPSYCHOPHARMACOL, V38, P1130, DOI 10.1038/npp.2013.18; Basso M R, 1996, J Int Neuropsychol Soc, V2, P249; Bouvet L, 2011, ACTA PSYCHOL, V138, P329, DOI 10.1016/j.actpsy.2011.08.004; Buhlmann U, 2004, PSYCHIAT ANN, V34, P922, DOI 10.3928/0048-5713-20041201-14; Buhlmann U, 2007, BODY IMAGE, V4, P381, DOI 10.1016/j.bodyim.2007.06.004; Buhlmann U, 2014, COMPR PSYCHIAT, V55, P468, DOI 10.1016/j.comppsych.2013.09.011; Buhlmann U, 2010, PSYCHIAT RES, V178, P171, DOI 10.1016/j.psychres.2009.05.002; Callaghan GM, 2011, BODY IMAGE, V8, P267, DOI 10.1016/j.bodyim.2011.04.002; CASH TF, 1995, SEX ROLES, V33, P19, DOI 10.1007/BF01547933; Deckersbach T, 2000, J INT NEUROPSYCH SOC, V6, P673, DOI 10.1017/S1355617700666055; Dionne M., 2012, ENCY BODY IMAGE HUMA, P135; Duncum A. F. J., ADV COGNITI IN PRESS; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Feusne JD, 2009, PSYCHIAT RES-NEUROIM, V172, P161, DOI 10.1016/j.pscychresns.2008.12.003; Feusner J D, 2011, Psychol Med, V41, P2385, DOI 10.1017/S0033291711000572; Feusner JD, 2008, BODY IMAGE, V5, P3, DOI 10.1016/j.bodyim.2007.11.002; Feusner JD, 2007, ARCH GEN PSYCHIAT, V64, P1417, DOI 10.1001/archpsyc.64.12.1417; Feusner JD, 2010, J PSYCHIATR RES, V44, P1088, DOI 10.1016/j.jpsychires.2010.03.015; Feusner JD, 2010, PSYCHIAT ANN, V40, P349, DOI 10.3928/00485713-20100701-08; Feusner JD, 2010, ARCH GEN PSYCHIAT, V67, P197, DOI 10.1001/archgenpsychiatry.2009.190; Feusner JD, 2010, PSYCHIAT RES, V179, P318, DOI 10.1016/j.psychres.2009.01.016; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Friborg O, 2013, COMPR PSYCHIAT, V54, P1222, DOI 10.1016/j.comppsych.2013.05.004; Gable PA, 2013, BRAIN COGNITION, V83, P337, DOI 10.1016/j.bandc.2013.09.012; Gao ZF, 2011, ATTEN PERCEPT PSYCHO, V73, P1477, DOI 10.3758/s13414-011-0109-7; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Grant J.E., 2005, ANN CLIN PSYCHIATRY, V17, P205, DOI [10.1080/10401230500295313, DOI 10.1080/10401230500295313]; Greenberg JL, 2014, J PSYCHIATR RES, V57, P125, DOI 10.1016/j.jpsychires.2014.06.015; Grocholewski A, 2012, BODY IMAGE, V9, P261, DOI 10.1016/j.bodyim.2012.01.002; Hills PJ, 2008, EUR J COGN PSYCHOL, V20, P561, DOI 10.1080/09541440701728524; Hills PJ, 2007, PERCEPT MOTOR SKILL, V104, P501, DOI 10.2466/PMS.104.2.501-509; Hills PJ, 2009, J EXP PSYCHOL HUMAN, V35, P1427, DOI 10.1037/a0015788; Jefferies K, 2012, J OBSESS-COMPULS REL, V1, P175, DOI 10.1016/j.jocrd.2012.03.002; Jorgensen L, 2001, AUST NZ J PSYCHIAT, V35, P124, DOI 10.1046/j.1440-1614.2001.00860.x; Kerwin L, 2014, J PSYCHIATR RES, V57, P41, DOI 10.1016/j.jpsychires.2014.06.003; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Lewis MB, 2009, EXP PSYCHOL, V56, P258, DOI 10.1027/1618-3169.56.4.258; Littleton HL, 2005, BEHAV RES THER, V43, P229, DOI 10.1016/j.brat.2003.12.006; Luck AJ, 2002, BRIT MED J, V325, P755, DOI 10.1136/bmj.325.7367.755; Macrae CN, 2002, PSYCHOL SCI, V13, P194, DOI 10.1111/1467-9280.00436; Mancuso SG, 2010, AUST NZ J PSYCHIAT, V44, P535, DOI 10.3109/00048671003596055; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Minnebusch DA, 2009, NEUROSCI BIOBEHAV R, V33, P1133, DOI 10.1016/j.neubiorev.2009.05.008; Monzani B, 2013, PSYCHIAT RES, V210, P994, DOI 10.1016/j.psychres.2013.08.009; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Mundy ME, 2014, ADV COGN PSYCHOL, V10, DOI 10.5709/acp-0155-4; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Neumark-Sztainer D, 2002, ARCH PEDIAT ADOL MED, V156, P171, DOI 10.1001/archpedi.156.2.171; Neziroglu Fugen, 2006, Body Image, V3, P189, DOI 10.1016/j.bodyim.2006.03.001; O'Dea J.A., 2012, ENCY BODY IMAGE HUMA, VVol. 1, P141, DOI DOI 10.1016/B978-0-12-384925-0.00021-3; Oosthuizen P, 1998, AUST NZ J PSYCHIAT, V32, P129, DOI 10.3109/00048679809062719; Perfect TJ, 2008, Q J EXP PSYCHOL, V61, P1479, DOI 10.1080/17470210802034678; Perfect TJ, 2007, MEMORY, V15, P784, DOI 10.1080/09658210701654627; Phillips KA, 2008, AM J PSYCHIAT, V165, P1111, DOI 10.1176/appi.ajp.2008.08040500; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P73, DOI 10.1037/0096-1523.32.1.73; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Seitz K, 2002, J EXP CHILD PSYCHOL, V82, P367, DOI 10.1016/S0022-0965(02)00106-6; Silver J, 2010, SOC SCI MED, V70, P1641, DOI 10.1016/j.socscimed.2009.11.042; Stangier U, 2008, J ABNORM PSYCHOL, V117, P435, DOI 10.1037/0021-843X.117.2.435; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Weston NJ, 2005, PSYCHON B REV, V12, P1038, DOI 10.3758/BF03206440	66	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151933	10.1371/journal.pone.0151933	http://dx.doi.org/10.1371/journal.pone.0151933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003715	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400058
J	Hawkins, RXD; Goldstone, RL				Hawkins, Robert X. D.; Goldstone, Robert L.			The Formation of Social Conventions in Real-Time Environments	PLOS ONE			English	Article							COORDINATION; DYNAMICS; EMERGENCE; CONFLICT	Why are some behaviors governed by strong social conventions while others are not? We experimentally investigate two factors contributing to the formation of conventions in a game of impure coordination: the continuity of interaction within each round of play (simultaneous vs. real-time) and the stakes of the interaction (high vs. low differences between payoffs). To maximize efficiency and fairness in this game, players must coordinate on one of two equally advantageous equilibria. In agreement with other studies manipulating continuity of interaction, we find that players who were allowed to interact continuously within rounds achieved outcomes with greater efficiency and fairness than players who were forced to make simultaneous decisions. However, the stability of equilibria in the real-time condition varied systematically and dramatically with stakes: players converged on more stable patterns of behavior when stakes are high. To account for this result, we present a novel analysis of the dynamics of continuous interaction and signaling within rounds. We discuss this previously unconsidered interaction between within-trial and across-trial dynamics as a form of social canalization. When stakes are low in a real-time environment, players can satisfactorily coordinate 'on the fly', but when stakes are high there is increased pressure to establish and adhere to shared expectations that persist across rounds.	[Hawkins, Robert X. D.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Hawkins, Robert X. D.; Goldstone, Robert L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Stanford University; Indiana University System; Indiana University Bloomington	Hawkins, RXD (corresponding author), Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA.; Hawkins, RXD (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.	rxdh@stanford.edu			National Science Foundation; Stanford Graduate Fellowship; National Science Foundation Research and Evaluation on Education in Science and Engineering [0910218]	National Science Foundation(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); National Science Foundation Research and Evaluation on Education in Science and Engineering	This work was supported in part by a National Science Foundation Graduate Research Fellowship and Stanford Graduate Fellowship (to RXDH) and National Science Foundation Research and Evaluation on Education in Science and Engineering grant 0910218 (to RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CLARENDON LECT EC; Aumann Robert J., 1974, J MATH ECON, V1, P67, DOI 10.1016/0304-4068(74)90037-8; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Bicchieri C., 2005, GRAMMAR SOC NATURE D; Binmore K, 2005, NATURAL JUSTICE; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Caldwell CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043807; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; David Lewis, 1969, CONVENTION PHILOS ST; Frey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056416; Friedman D, 2012, AM ECON REV, V102, P337, DOI 10.1257/aer.102.1.337; GARROD S, 1994, COGNITION, V53, P181, DOI 10.1016/0010-0277(94)90048-5; GARROD S, 1987, COGNITION, V27, P181, DOI 10.1016/0010-0277(87)90018-7; Gintis H, 2015, REV BEHAV ECON, V2, P1, DOI 10.1561/105.00000016; Grice H.P, 1975, SYNTAX SEMANTICS, V3, P43; Hawkins RXD, 2015, BEHAV RES METHODS, V47, P966, DOI 10.3758/s13428-014-0515-6; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2005, ADV COMPLEX SYST, V8, P87, DOI 10.1142/S0219525905000361; Hinton G. E., 1987, Complex Systems, V1, P495; Jackson MO, 2014, P NATL ACAD SCI USA, V111, P10889, DOI 10.1073/pnas.1400826111; Koop GJ, 2011, JUDGM DECIS MAK, V6, P750; Lau SHP, 2008, THEOR DECIS, V65, P153, DOI 10.1007/s11238-008-9100-8; Oprea R, 2014, J ECON BEHAV ORGAN, V108, P212, DOI 10.1016/j.jebo.2014.09.012; Oprea R, 2011, J ECON THEORY, V146, P2206, DOI 10.1016/j.jet.2011.10.014; Rasmusen E, 2006, GAMES INFORM INTRO G; Schotter A, 2003, J POLIT ECON, V111, P498, DOI 10.1086/374187; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; van Doorn GS, 2014, J THEOR BIOL, V356, P1, DOI 10.1016/j.jtbi.2014.03.019; Vanderschraaf P, 2003, ERKENNTNIS, V59, P311, DOI 10.1023/A:1026046625024; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Weber RA, 2003, MANAGE SCI, V49, P400, DOI 10.1287/mnsc.49.4.400.14430	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151670	10.1371/journal.pone.0151670	http://dx.doi.org/10.1371/journal.pone.0151670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002729	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400036
J	Toderici, M; de la Morena-Barrio, ME; Padilla, J; Minano, A; Anton, AI; Iniesta, JA; Herranz, MT; Fernandez, N; Vicente, V; Corral, J				Toderici, Mara; Eugenia de la Morena-Barrio, Maria; Padilla, Jose; Minano, Antonia; Isabel Anton, Ana; Antonio Iniesta, Juan; Teresa Herranz, Maria; Fernandez, Nuria; Vicente, Vicente; Corral, Javier			Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; RISK-FACTORS; PROTEIN-S; III GENE; THROMBOSIS; EXPRESSION; REGIONS; MICE; SUPPLEMENTATION; THROMBOPHILIA	Antithrombin is a crucial anticoagulant serpin whose even moderate deficiency significantly increases the risk of thrombosis. Most cases with antithrombin deficiency carried genetic defects affecting exons or flanking regions of SERPINC1. We aimed to identify regulatory mutations inSERPINC1 through sequencing the promoter, intron 1 and 2 of this gene in 23 patients with antithrombin deficiency but without known genetic defects. Three cases with moderate antithrombin deficiency (63-78%) carried potential regulatory mutations. One located 200 bp before the initiation ATG and two in intron 1. These mutations disrupted two out of five potential vitamin D receptor elements (VDRE) identified in SERPINC1 with different software. One genetic defect, c.42-1060_-1057dupTTGA, was a new low prevalent polymorphism (MAF: 0.01) with functional consequences on plasma antithrombin levels. The relevance of the vitamin D pathway on the regulation of SERPINC1 was confirmed in a cell model. Incubation of HepG2 with paricalcitol, a vitamin D analog, increased dose-dependently the levels of SERPINC1transcripts and antithrombin released to the conditioned medium. This study shows further evidence of the transcriptional regulation of SERPINC1 by vitamin D and first describes the functional and pathological relevance of mutations affecting VDRE of this gene. Our study opens new perspectives in the search of new genetic defects involved in antithrombin deficiency and the risk of thrombosis as well as in the design of new antithrombotic treatments.	[Toderici, Mara; Eugenia de la Morena-Barrio, Maria; Padilla, Jose; Minano, Antonia; Isabel Anton, Ana; Vicente, Vicente; Corral, Javier] Univ Murcia, Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,IMIB Arrixaca, Murcia, Spain; [Antonio Iniesta, Juan] Hosp Univ Reina Sofia, Serv Neurol, Murcia, Spain; [Teresa Herranz, Maria] Hosp Univ Morales Meseguer, Serv Med Interna, Murcia, Spain; [Fernandez, Nuria] Hosp Univ Miguel Servet, Serv Hematol & Hemoterapia, Zaragoza, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Meseguer General University Hospital Morales; University of Murcia; Meseguer General University Hospital Morales; Miguel Servet University Hospital	de la Morena-Barrio, ME (corresponding author), Univ Murcia, Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,IMIB Arrixaca, Murcia, Spain.	uge2985@hotmail.com	Anton, Ana I. I/M-2962-2018; de la Morena-Barrio, ME/AAG-5103-2021; Vicente, Vicente/L-6185-2019	Anton, Ana I. I/0000-0003-1527-6096; de la Morena-Barrio, ME/0000-0001-7426-4947; Vicente, Vicente/0000-0002-4278-3264; Herranz, M. T./0000-0003-4194-4668; PADILLA RUIZ, JOSE/0000-0003-1599-7870; Corral, Javier/0000-0003-0288-1107				Aguila S, 2013, THROMB HAEMOSTASIS, V109, P556, DOI 10.1160/TH12-09-0707; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Anton AI, 2009, HAEMATOL-HEMATOL J, V94, P589, DOI 10.3324/haematol.2008.000604; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Blondon M, 2015, THROMB HAEMOSTASIS, V113, P999, DOI 10.1160/TH14-05-0478; BOCK SC, 1983, NUCLEIC ACIDS RES, V11, P8569, DOI 10.1093/nar/11.24.8569; Brodin EE, 2013, THROMB HAEMOSTASIS, V109, P885, DOI 10.1160/TH12-10-0728; Bucciarelli P, 2012, J THROMB HAEMOST, V10, P1783, DOI 10.1111/j.1538-7836.2012.04858.x; Caspers M, 2012, THROMB HAEMOSTASIS, V108, P247, DOI 10.1160/TH11-12-0875; CHOWDHURY V, 1993, BRIT J HAEMATOL, V84, P656, DOI 10.1111/j.1365-2141.1993.tb03142.x; CONLON MG, 1994, THROMB HAEMOSTASIS, V72, P551; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; de la Morena-Barrio ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064998; de la Morena-Barrio ME, 2012, THROMB HAEMOSTASIS, V107, P430, DOI 10.1160/TH11-10-0701; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FernandezRachubinski FA, 1996, J BIOL CHEM, V271, P29502, DOI 10.1074/jbc.271.46.29502; Folsom AR, 2014, J THROMB HAEMOST, V12, P1455, DOI 10.1111/jth.12665; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Hawa NS, 1996, BIOCHEM BIOPH RES CO, V228, P352, DOI 10.1006/bbrc.1996.1665; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Lindqvist PG, 2013, THROMB HAEMOSTASIS, V109, P787, DOI 10.1160/TH13-03-0235; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; Luxembourg B, 2011, THROMB HAEMOSTASIS, V105, P635, DOI 10.1160/TH10-08-0538; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mushunje A, 2004, J THROMB HAEMOST, V2, P2170, DOI 10.1111/j.1538-7836.2004.01047.x; Niessen RWLM, 1996, BIOCHEM J, V318, P263, DOI 10.1042/bj3180263; OCHOA A, 1989, NUCLEIC ACIDS RES, V17, P119, DOI 10.1093/nar/17.1.119; OLDS RJ, 1993, BIOCHEMISTRY-US, V32, P4216, DOI 10.1021/bi00067a008; Perry DJ, 1996, HUM MUTAT, V7, P7, DOI 10.1002/(SICI)1098-1004(1996)7:1<7::AID-HUMU2>3.3.CO;2-A; PROCHOWNIK EV, 1985, NATURE, V316, P845, DOI 10.1038/316845a0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sheffield WP, 1995, MOL BASIS THROMBOSIS, P355; Targher G, 2012, SEMIN THROMB HEMOST, V38, P114, DOI 10.1055/s-0031-1300957; TREMP GL, 1995, GENE, V156, P199, DOI 10.1016/0378-1119(95)00010-4; Vuckovic BA, 2015, AM J CLIN NUTR, V101, P606, DOI 10.3945/ajcn.114.095398	38	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152159	10.1371/journal.pone.0152159	http://dx.doi.org/10.1371/journal.pone.0152159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003919	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400088
J	Zhou, T; Li, CY; Zhao, WN; Wang, XR; Wang, FQ; Sha, JH				Zhou, Tao; Li, Chuyu; Zhao, Wene; Wang, Xinru; Wang, Fuqiang; Sha, Jiahao			MaxReport: An Enhanced Proteomic Result Reporting Tool for MaxQuant	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; QUANTIFICATION; GUIDELINES; COMPLEX	MaxQuant is a proteomic software widely used for large-scale tandem mass spectrometry data. We have designed and developed an enhanced result reporting tool for MaxQuant, named as MaxReport. This tool can optimize the results of MaxQuant and provide additional functions for result interpretation. MaxReport can generate report tables for protein N-terminal modifications. It also supports isobaric labelling based relative quantification at the protein, peptide or site level. To obtain an overview of the results, MaxReport performs general descriptive statistical analyses for both identification and quantification results. The output results of MaxReport are well organized and therefore helpful for proteomic users to better understand and share their data. The script of MaxReport, which is freely available at http://websdoor.net/bioinfo/maxreport/, is developed using Python code and is compatible across multiple systems including Windows and Linux.	[Zhou, Tao; Li, Chuyu; Wang, Xinru; Sha, Jiahao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Wene; Wang, Fuqiang] Nanjing Med Univ, Analyt & Testing Ctr, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Wang, XR (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.; Wang, FQ (corresponding author), Nanjing Med Univ, Analyt & Testing Ctr, Nanjing 210029, Jiangsu, Peoples R China.	xrwang@njmu.edu.cn; wangfq@njmu.edu.cn	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021; Zhou, Tao/H-1094-2013	Wang, Xin/0000-0002-4457-7376; Zhou, Tao/0000-0003-2219-6385; Wang, Fuqiang/0000-0002-7777-3541; Zhao, Wene/0000-0003-0497-5027	National Natural Science Foundation of China [31400727]; China Postdoctoral Science Foundation [2015M581836]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work was supported by the National Natural Science Foundation of China (no. 31400727). FW received the funding. The work was also supported by the China Postdoctoral Science Foundation (no. 2015M581836). TZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntzen MO, 2011, J PROTEOME RES, V10, P913, DOI 10.1021/pr1009977; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Gatto L, 2014, BBA-PROTEINS PROTEOM, V1844, P42, DOI 10.1016/j.bbapap.2013.04.032; Jones AR, 2008, MOL CELL PROTEOMICS, V7, P2067, DOI 10.1074/mcp.H800010-MCP200; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martinez-Bartolome S, 2013, J PROTEOMICS, V95, P84, DOI 10.1016/j.jprot.2013.02.026; Perkel JM, 2015, NATURE, V518, P125, DOI 10.1038/518125a; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Shao BB, 2015, J PROTEOMICS, V120, P35, DOI 10.1016/j.jprot.2015.02.015; Spudich GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-295; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Vaudel M, 2010, PROTEOMICS, V10, P650, DOI 10.1002/pmic.200900481; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang J, 2015, MOL CELL PROTEOMICS, V14, P1104, DOI 10.1074/mcp.M114.045468; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Wright JC, 2012, MOL CELL PROTEOMICS, V11, P478, DOI 10.1074/mcp.O111.014522; Zhou T, 2015, J PROTEOMICS; Zhou T, 2015, PROTEOMICS, V15, P1564, DOI 10.1002/pmic.201400248; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	23	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152067	10.1371/journal.pone.0152067	http://dx.doi.org/10.1371/journal.pone.0152067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003708	Green Published, gold			2022-12-27	WOS:000372697400072
J	Atif, M; Javaid, S; Farooqui, M; Sarwar, MR				Atif, Muhammad; Javaid, Sareema; Farooqui, Maryam; Sarwar, Muhammad Rehan			Rights and Responsibilities of Tuberculosis Patients, and the Global Fund: A Qualitative Study	PLOS ONE			English	Article							EXPERIENCES; AFRICA	Background Implementation of the Charter to protect patients' rights is an important criterion to achieve patient-centered approach and receive financial support from the Global Fund. Our study aims to explore the knowledge of tuberculosis (TB) patients about their rights and responsibilities at the Chest Disease Unit of the Bahawal Victoria Hospital, Bahawalpur, Pakistan. Methods This was a qualitative study. The data from purposefully selected TB patients was collected by in-depth interviews. Eligibility criteria included confirmed diagnosis of TB and enrollment in the TB program. A pilot tested interview protocol was based upon the objectives of the study, and was used uniformly in each interview to maintain the consistency. The sample size was limited by applying the saturation criteria. All interviews were audiotaped and transcribed verbatim. Inductive thematic content analysis was applied to analyze the data and draw conclusions. Results Out of the total 16 patients, four were female, and seven were illiterate. Eight patients were known cases of multi-drug resistant TB. Analysis of the data yielded seven themes; tuberculosis care services, moral support and stigmatization, dignity and privacy, complaints, fear of losing job, information sharing and compliance to the treatment plan, and contribution to eradicate TB. First five represented the rights section while latter two were related to the responsibilities section of the Charter. Conclusion Discriminatory access to TB care services and the right to privacy were two major concerns identified in this study. However, the respondents recognized their responsibilities as a TB patient. To ensure uninterrupted investment from the Global Fund, there is a need to implement fair TB care policies which support human rights-based approach.	[Atif, Muhammad; Javaid, Sareema; Sarwar, Muhammad Rehan] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan; [Farooqui, Maryam] Univ Teknol MARA, Fac Pharm, Bertam Campus, Kepala Batas, Penang, Malaysia	Islamia University of Bahawalpur	Atif, M (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.	muhammad.atif@iub.edu.pk		Farooqui, Maryam/0000-0002-3380-5855; Sarwar, Muhammad Rehan/0000-0003-4312-9157				Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; Behzadifar M, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.17(4)2015.20277; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Dodor E A, 2012, Ghana Med J, V46, P211; Guion LA., 2002, EDIS, V2002; Lewis CP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-190; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Murray EJ, 2013, HEALTH POLICY PLANN, V28, P410, DOI 10.1093/heapol/czs072; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rundi C, 2010, J HEALTH POPUL NUTR, V28, P114; Slagle T, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0034-7; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stop TB Partnership, 2015, TB HUM RIGHTS TASK F; The Global Fund, 2015, TUB HUM RIGHTS INFR; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR; *UNAIDS, 2010, NOND HIV RESP; UNAIDS and TB Care I, TB CAR PAT CTR APPR; United Nations Development Programme, 2015, FACTSH HUM RIGHTS 3; Vukovic DS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-284; WHO, 2014, GLOB TUB REP 2014; World Care Council, 2006, PAT CHART TUB CAR; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2006, THE STOP TB STRAT; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, PAK STOP TUB; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	28	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151321	10.1371/journal.pone.0151321	http://dx.doi.org/10.1371/journal.pone.0151321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26998830	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700031
J	Bourdier, T; Cordonnier, T; Kunstler, G; Piedallu, C; Lagarrigues, G; Courbaud, B				Bourdier, Thomas; Cordonnier, Thomas; Kunstler, Georges; Piedallu, Christian; Lagarrigues, Guillaume; Courbaud, Benoit			Tree Size Inequality Reduces Forest Productivity: An Analysis Combining Inventory Data for Ten European Species and a Light Competition Model	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; AREA INCREMENT MODEL; USE EFFICIENCY; PLANT DIVERSITY; STAND STRUCTURE; NORWAY SPRUCE; ASYMMETRIC COMPETITION; STRUCTURAL COMPLEXITY; CONIFEROUS FORESTS; GROWTH	Plant structural diversity is usually considered as beneficial for ecosystem functioning. For instance, numerous studies have reported positive species diversity-productivity relationships in plant communities. However, other aspects of structural diversity such as individual size inequality have been far less investigated. In forests, tree size inequality impacts directly tree growth and asymmetric competition, but consequences on forest productivity are still indeterminate. In addition, the effect of tree size inequality on productivity is likely to vary with species shade-tolerance, a key ecological characteristic controlling asymmetric competition and light resource acquisition. Using plot data from the French National Geographic Agency, we studied the response of stand productivity to size inequality for ten forest species differing in shade tolerance. We fitted a basal area stand production model that included abiotic factors, stand density, stand development stage and a tree size inequality index. Then, using a forest dynamics model we explored whether mechanisms of light interception and light use efficiency could explain the tree size inequality effect observed for three of the ten species studied. Size inequality negatively affected basal area increment for seven out of the ten species investigated. However, this effect was not related to the shade tolerance of these species. According to the model simulations, the negative tree size inequality effect could result both from reduced total stand light interception and reduced light use efficiency. Our results demonstrate that negative relationships between size inequality and productivity may be the rule in tree populations. The lack of effect of shade tolerance indicates compensatory mechanisms between effect on light availability and response to light availability. Such a pattern deserves further investigations for mixed forests where complementarity effects between species are involved. When studying the effect of structural diversity on ecosystem productivity, tree size inequality is a major facet that should be taken into account.	[Bourdier, Thomas; Cordonnier, Thomas; Kunstler, Georges; Lagarrigues, Guillaume; Courbaud, Benoit] Irstea, UR EMGR, Ctr Grenoble, 2 Rue Papeterie BP 76, F-38402 St Martin Dheres, France; [Bourdier, Thomas; Cordonnier, Thomas; Kunstler, Georges; Lagarrigues, Guillaume; Courbaud, Benoit] Univ Grenoble Alpes, F-38402 Grenoble, France; [Piedallu, Christian] AgroParisTech, UMR1092, ENGREF, LERFoB, 14 Rue Girardet,CS14216, FR-54042 Nancy, France	INRAE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); AgroParisTech	Bourdier, T (corresponding author), Irstea, UR EMGR, Ctr Grenoble, 2 Rue Papeterie BP 76, F-38402 St Martin Dheres, France.; Bourdier, T (corresponding author), Univ Grenoble Alpes, F-38402 Grenoble, France.	thomas.bourdier@irstea.fr	Kunstler, Georges/F-9179-2012; Cordonnier, Thomas/I-2586-2019	Kunstler, Georges/0000-0002-2544-1940; Cordonnier, Thomas/0000-0003-3684-4662	DIVCLIM (DEB); DISTIMACC (BGF) [Ecofor 2014-23]; Irstea; French Environment and Energy Management Agency (ADEME); French Forest National Office (ONF)	DIVCLIM (DEB); DISTIMACC (BGF); Irstea; French Environment and Energy Management Agency (ADEME); French Forest National Office (ONF)	This study was funded by the DIVCLIM (DEB) and DISTIMACC (BGF, no Ecofor 2014-23 http://bgf.gip-ecofor.org/) projects. Thomas Bourdier was funded by a research grant from Irstea and Guillaume Lagarrigues by the French Environment and Energy Management Agency (ADEME) and the French Forest National Office (ONF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann E, 1970, STUDIES ORGANIC PROD, P506; Bagnaresi U, 2002, FORESTRY, V75, P357, DOI 10.1093/forestry/75.4.357; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Binkley D, 2013, FOREST ECOL MANAG, V288, P5, DOI 10.1016/j.foreco.2011.11.002; Binkley D, 2010, FOREST ECOL MANAG, V259, P1704, DOI 10.1016/j.foreco.2009.05.037; Bugmann H, 1998, FOREST ECOL MANAG, V103, P247, DOI 10.1016/S0378-1127(97)00217-X; BUONGIORNO J, 1994, FOREST SCI, V40, P83; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Campoe OC, 2013, FOREST ECOL MANAG, V288, P43, DOI 10.1016/j.foreco.2012.05.026; Campoe OC, 2013, FOREST ECOL MANAG, V288, P14, DOI 10.1016/j.foreco.2012.07.035; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Caspersen JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028660; Cordonnier T, 2015, PERSPECT PLANT ECOL, V17, P107, DOI 10.1016/j.ppees.2015.01.001; Courbaud B, 2003, AGR FOREST METEOROL, V116, P1, DOI 10.1016/S0168-1923(02)00254-X; Damgaard C, 2000, ECOLOGY, V81, P1139, DOI 10.1890/0012-9658(2000)081[1139:DIIPSO]2.0.CO;2; De Boeck HJ, 2006, OIKOS, V113, P269, DOI 10.1111/j.2006.0030-1299.14257.x; Duduman G, 2011, FORESTRY, V84, P301, DOI 10.1093/forestry/cpr014; Forrester DI, 2014, FOREST ECOL MANAG, V328, P94, DOI 10.1016/j.foreco.2014.05.026; Gadow K, 2012, CONTINUOUS COVER FOR, DOI [10.1007/978-94-007-2202-6, DOI 10.1007/978-94-007-2202-6]; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gspaltl M, 2013, FOREST ECOL MANAG, V288, P49, DOI 10.1016/j.foreco.2011.11.044; Hardiman BS, 2011, ECOLOGY, V92, P1818, DOI 10.1890/10-2192.1; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Kelty M.J., 1992, ECOLOGY SILVICULTURE; Kiraly I, 2010, BIOL CONSERV, V143, P2063, DOI 10.1016/j.biocon.2010.05.014; Kunstler G, 2011, J ECOL, V99, P300, DOI 10.1111/j.1365-2745.2010.01751.x; Lafond V, 2015, ENVIRON MANAGE, V56, P1118, DOI 10.1007/s00267-015-0557-2; Lafond V, 2014, ANN FOREST SCI, V71, P173, DOI 10.1007/s13595-013-0291-y; Laurans M, 2014, FOREST ECOL MANAG, V329, P79, DOI 10.1016/j.foreco.2014.05.059; le Maire G, 2013, FOREST ECOL MANAG, V288, P31, DOI 10.1016/j.foreco.2012.03.005; Lei XD, 2009, CAN J FOREST RES, V39, P1835, DOI 10.1139/X09-089; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Liang JJ, 2007, FOREST ECOL MANAG, V243, P116, DOI 10.1016/j.foreco.2007.02.028; Liang JJ, 2005, CAN J FOREST RES, V35, P2368, DOI 10.1139/X05-137; Long JN, 2010, FORESTRY, V83, P121, DOI 10.1093/forestry/cpp033; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; Messier C, 1998, J VEG SCI, V9, P511, DOI 10.2307/3237266; Monserud RA, 1996, FOREST ECOL MANAG, V80, P57, DOI 10.1016/0378-1127(95)03638-5; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; O'Hara KL, 2007, FORESTRY, V80, P163, DOI 10.1093/forestry/cpl051; Oliver C.D., 1996, FOREST STAND DYNAMIC; Onoda Y, 2014, J ECOL, V102, P167, DOI 10.1111/1365-2745.12184; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Piedallu C, 2011, MAPPING SOIL WATER H; Piedallu C, 2008, AGR FOREST METEOROL, V148, P1696, DOI 10.1016/j.agrformet.2008.06.001; Piedallu C, 2013, GLOBAL ECOL BIOGEOGR, V22, P470, DOI 10.1111/geb.12012; Pokharel B, 2012, FORESTRY, V85, P255, DOI 10.1093/forestry/cpr070; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Pretzsch H, 2005, ECOL STUD-ANAL SYNTH, V176, P41; Pretzsch H., 2010, FOREST DYNAMICS GROW, P664, DOI DOI 10.1007/978-3-540-88307-4; Pretzsch H, 2010, CAN J FOREST RES, V40, P370, DOI 10.1139/X09-195; Ryan MG, 2010, FOREST ECOL MANAG, V259, P1695, DOI 10.1016/j.foreco.2010.01.013; Schutz JP, 2002, FORESTRY, V75, P329, DOI 10.1093/forestry/75.4.329; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Schwinning S, 1996, ANN BOT-LONDON, V77, P47, DOI 10.1006/anbo.1996.0006; Smith D.M., 1997, PRACTICE SILVICULTUR; Staudhammer CL, 2001, CAN J FOREST RES, V31, P1105, DOI 10.1139/x01-033; THOMAS SC, 1989, OECOLOGIA, V80, P349, DOI 10.1007/BF00379036; TURC L., 1961, Annales Agronomiques, V12, P13; Valbuena R., 2015, DISSERTATION FORESTA, V205, P1; Valbuena R, 2013, CAN J FOREST RES, V43, P1063, DOI 10.1139/cjfr-2013-0147; Valbuena R, 2012, FOREST ECOL MANAG, V276, P185, DOI 10.1016/j.foreco.2012.03.036; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Vallet P, 2006, FOREST ECOL MANAG, V229, P98, DOI 10.1016/j.foreco.2006.03.013; Vallet P, 2011, J VEG SCI, V22, P932, DOI 10.1111/j.1654-1103.2011.01288.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; ZEIDE B, 1985, FOREST ECOL MANAG, V13, P149, DOI 10.1016/0378-1127(85)90031-3; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	75	77	83	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151852	10.1371/journal.pone.0151852	http://dx.doi.org/10.1371/journal.pone.0151852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999820	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700073
J	Liu, JW; Zhao, L; Luo, LM; Liu, MM; Sun, Y; Su, X; Yu, XJ				Liu, Jian-Wei; Zhao, Li; Luo, Li-Mei; Liu, Miao-Miao; Sun, Yue; Su, Xiang; Yu, Xue-Jie			Molecular Evolution and Spatial Transmission of Severe Fever with Thrombocytopenia Syndrome Virus Based on Complete Genome Sequences	PLOS ONE			English	Article							HAEMAPHYSALIS-LONGICORNIS TICKS; HEMORRHAGIC-FEVER; SOUTH-KOREA; EBOLA-VIRUS; CHINA; PHLEBOVIRUS; INTERFERON; IDENTIFICATION; BUNYAVIRIDAE; REASSORTMENT	Severe fever with thrombocytopenia syndrome virus (SFTSV) was a novel tick-borne bunyavirus that caused hemorrhagic fever with a high fatality rate in East Asia. In this study we analyzed the complete genome sequences of 122 SFTSV strains to determine the phylogeny, evolution and reassortment of the virus. We revealed that the evolutionary rate of three genome segments were different, with highest in the S segment and lowest in the L segment. The SFTSV strains were phylogenetically classified into 5 lineages (A, B, C, D and E) with each genome segment. SFTSV strains from China were classified in all 5 lineages, strains from South Korea were classified into 3 lineages (A, D, and E), and all strains from Japan were classified in only linage E. Using the average evolutionary rate of the three genome segments, we found that the extant SFTSV originated 20-87 years ago in the Dabie Mountain area in central China. The viruses were then transmitted to other areas of China, Japan and South Korea. We also found that six SFTSV strains were reassortants. Selection pressure analysis suggested that SFTSV was under purifying selection according to the four genes (RNA-dependent RNA polymerase, glycoprotein, nucleocapsid protein, non-structural protein), and two sites (37, 1033) of glycoproteins were identified as being under strong positive selection. We concluded that SFTSV originated in central China and spread to other places recently and the virus was under purifying selection with high frequency of reassortment.	[Liu, Jian-Wei; Zhao, Li; Luo, Li-Mei; Liu, Miao-Miao; Sun, Yue; Su, Xiang; Yu, Xue-Jie] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Yu, Xue-Jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; University of Texas System; University of Texas Medical Branch Galveston	Yu, XJ (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China.; Yu, XJ (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	xuyu@utmb.edu	Yu, Xuejie/AAP-9246-2021		Shandong Province Science and Technology Development Program [2014GSF121004]; National Nature Science Foundation of China [31570167]; National Natural Science Funds of China [31570167]	Shandong Province Science and Technology Development Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Shandong Province Science and Technology Development Program (2014GSF121004) and a grant from the National Nature Science Foundation of China (31570167).; This study was supported by the National Natural Science Funds of China (31570167), Shandong Province Science and Technology Development Program (2014GSF121004).	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Biek R, 2006, SCIENCE, V311, P538, DOI 10.1126/science.1121360; Bowden TA, 2011, J STRUCT BIOL, V175, P120, DOI 10.1016/j.jsb.2011.03.016; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Diang SJ, 2014, JPN J INFECT DIS, V67, P1, DOI 10.7883/yoken.67.1; Ding NZ, 2013, VIRUS RES, V178, P543, DOI 10.1016/j.virusres.2013.09.017; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Freire CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11353; Fu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19563; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Huang XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003237; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lam TTY, 2013, EPIDEMICS-NETH, V5, P1, DOI 10.1016/j.epidem.2012.09.002; Lei XY, 2015, MICROBES INFECT, V17, P149, DOI 10.1016/j.micinf.2014.12.002; Liu J, 2013, J IRON STEEL RES INT, V20, P20, DOI 10.1016/S1006-706X(13)60136-3; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Lopes AM, 2014, VIROLOGY, V468, P104, DOI 10.1016/j.virol.2014.08.002; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; Matsuno K, 2013, J VIROL, V87, P3719, DOI 10.1128/JVI.02845-12; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Palacios G, 2011, J VIROL, V85, P3811, DOI 10.1128/JVI.02275-10; Park SW, 2014, TICKS TICK-BORNE DIS, V5, P975, DOI 10.1016/j.ttbdis.2014.07.020; Perrone LA, 2007, J VIROL, V81, P884, DOI 10.1128/JVI.01074-06; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Rodriguez LL, 1998, VIROLOGY, V242, P99, DOI 10.1006/viro.1997.8990; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Schrauwen EJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059889; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wen HL, 2014, EMERG INFECT DIS, V20, P1, DOI 10.3201/eid2001.120532; Yoshikawa T, 2015, J INFECT DIS, V212, P889, DOI 10.1093/infdis/jiv144; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI [DOI 10.1371/J0URNAL.P0NE.0111127, DOI 10.2147/NDT.S56020]; Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	47	23	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151677	10.1371/journal.pone.0151677	http://dx.doi.org/10.1371/journal.pone.0151677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999664	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700055
J	Primrose, RJ; Zaveri, T; Bakke, AJ; Ziegler, GR; Moskowitz, HR; Hayes, JE				Primrose, Rachel J.; Zaveri, Toral; Bakke, Alyssa J.; Ziegler, Gregory R.; Moskowitz, Howard R.; Hayes, John E.			Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint Analysis	PLOS ONE			English	Article							HIV VACCINE ACCEPTABILITY; SEXUAL PLEASURE; CLINICAL-TRIAL; AFRICAN WOMEN; YOUNG-WOMEN; BLACK-WOMEN; MICROBICIDE; PREFERENCES; GEL; FEASIBILITY	Vaginal microbicides potentially empower women to protect themselves from HIV and other sexually transmitted infections (STIs), especially when culture, religion, or social status may prevent them from negotiating condom use. The open literature contains minimal information on factors that drive user acceptability of women's health products or vaginal drug delivery systems. By understanding what women find to be most important with regard to sensory properties and product functionality, developers can iteratively formulate a more desirable product. Conjoint analysis is a technique widely used in market research to determine what combination of elements influence a consumer's willingness to try or use a product. We applied conjoint analysis here to better understand what sexually-active woman want in a microbicide, toward our goal of formulating a product that is highly acceptable to women. Both sensory and non-sensory attributes were tested, including shape, color, wait time, partner awareness, messiness/leakage, duration of protection, and functionality. Heterosexually active women between 18 and 35 years of age in the United States (n = 302) completed an anonymous online conjoint survey using IdeaMap software. Attributes (product elements) were systematically presented in various combinations; women rated these combinations of a 9-point willingness-to-try scale. By coupling systematic combinations and regression modeling, we can estimate the unique appeal of each element. In this population, a multifunctional product (i.e., broad spectrum STI protection, coupled with conception) is far more desirable than a microbicide targeted solely for HIV protection; we also found partner awareness and leakage are potentially strong barriers to use.	[Primrose, Rachel J.; Zaveri, Toral; Bakke, Alyssa J.; Hayes, John E.] Penn State Univ, Sensory Evaluat Ctr, University Pk, PA 16802 USA; [Primrose, Rachel J.; Zaveri, Toral; Bakke, Alyssa J.; Ziegler, Gregory R.; Hayes, John E.] Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA; [Moskowitz, Howard R.] Mind Genom Associates Inc, White Plains, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hayes, JE (corresponding author), Penn State Univ, Sensory Evaluat Ctr, University Pk, PA 16802 USA.; Hayes, JE (corresponding author), Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA.	jeh40@psu.edu	Hayes, John E/A-5893-2008	Hayes, John E/0000-0001-9065-6326; Ziegler, Gregory/0000-0002-3881-649X	National Institute of Allergy and Infectious Diseases [R33AI094514]; Mind Genomics Associates, Inc.; Mind Genomics Associates; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI094514] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mind Genomics Associates, Inc.; Mind Genomics Associates; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R33AI094514 from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) to JEH and GRZ, and Mind Genomics Associates, Inc. Mind Genomics Associates donated use of the IdeaMap software platform, and provided support in the form of salaries for author HRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil A, 2011, DRUG DELIV TRANSL RE, V1, P209, DOI 10.1007/s13346-011-0022-6; [Anonymous], 2014, NAT SURV SEX HLTH BE; [Anonymous], 2014, FACT SHEET MICR; [Anonymous], 2014, PENNS 2013 STAT HLTH; [Anonymous], 2012, GLOB REP UNAIDS REP; Beusterien KM, 2005, VALUE HEALTH, V8, P453, DOI 10.1111/j.1524-4733.2005.00036.x; Centers for Disease Control and Prevention, 2014, HIV AM WOM; Cole AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015111; Colquhoun TA, 2012, J BERRY RES, V2, P45, DOI 10.3233/JBR-2011-027; Devlin B, 2013, ANTIVIR RES, V100, pS3, DOI 10.1016/j.antiviral.2013.09.025; Fetherston SM, 2013, EUR J PHARM SCI, V48, P406, DOI 10.1016/j.ejps.2012.12.002; Foley M, 2009, APPETITE, V52, P554, DOI 10.1016/j.appet.2009.01.006; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Green PE, 2001, INTERFACES, V31, pS56, DOI 10.1287/inte.31.3s.56.9676; GREEN PE, 1990, J MARKETING      OCT, P3; Hammett TM, 2000, SEX TRANSM DIS, V27, P119, DOI 10.1097/00007435-200002000-00011; Hoffman S, 2010, ARCH SEX BEHAV, V39, P748, DOI 10.1007/s10508-009-9509-3; Holt BY, 2006, J WOMENS HEALTH, V15, P281, DOI 10.1089/jwh.2006.15.281; Jansen S, 2009, J HOUS BUILT ENVIRON, V24, P271, DOI 10.1007/s10901-009-9149-x; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Lee SJ, 2012, INT J STD AIDS, V23, P235, DOI 10.1258/ijsa.2011.011189; Levin LA, 2012, HORTSCIENCE, V47, P1658, DOI 10.21273/HORTSCI.47.11.1658; Li BD, 2013, ANTIVIR RES, V97, P280, DOI 10.1016/j.antiviral.2012.12.024; Li BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054975; Mahan ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105614; Mahan ED, 2011, CONTRACEPTION, V84, P184, DOI 10.1016/j.contraception.2010.11.012; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; MJI-DesignLab, 2014, IDEAMAP R WHIT PLAIN; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; Moskowitz HR, 2012, PHYSIOL BEHAV, V107, P606, DOI 10.1016/j.physbeh.2012.04.009; Moskowitz HR, 2005, CRIT REV FOOD SCI, V45, P165, DOI 10.1080/10408690590956350; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Prevention CoDCa, 2014, INC PREV COST SEX TR; Rees H, 2015, C RETR OPP INF CROI; Reiff M, 2008, J WOMENS HEALTH, V17, P1345, DOI 10.1089/jwh.2008.0886; Robertson Angela M, 2013, Glob Public Health, V8, P619, DOI 10.1080/17441692.2012.762412; Rosen M, 2015, CONTRACEPTION; Saulo AA, 2011, FOOD QUAL PREFER, V22, P422, DOI 10.1016/j.foodqual.2011.02.005; Tanner AE, 2008, J ADOLESCENT HEALTH, V43, P349, DOI 10.1016/j.jadohealth.2008.02.017; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Terris-Prestholt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083193; van den Berg JJ, 2014, AIDS BEHAV, V18, P862, DOI 10.1007/s10461-013-0652-4; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Weaver J, 2013, CAN J PUBLIC HEALTH, V104, pE413, DOI 10.17269/cjph.104.3915; WHO, 2012, GLOB INC PREV SEL CU; Zaveri T, 2012, SOC SENS PROF 3 TECH; Zaveri Toral, 2014, Pharmaceutics, V6, P512, DOI 10.3390/pharmaceutics6030512; Zaveri Toral, 2014, Pharmaceutics, V6, P366, DOI 10.3390/pharmaceutics6030366	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150896	10.1371/journal.pone.0150896	http://dx.doi.org/10.1371/journal.pone.0150896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999009	Green Submitted, gold, Green Published			2022-12-27	WOS:000372694700018
J	El Kishawi, RR; Soo, KL; Abed, YA; Muda, WAMW				El Kishawi, Rima Rafiq; Soo, Kah Leng; Abed, Yehia Awad; Muda, Wan Abdul Manan Wan			Prevalence and Associated Factors for Dual Form of Malnutrition in Mother-Child Pairs at the Same Household in the Gaza Strip-Palestine	PLOS ONE			English	Article							NUTRITION TRANSITION; UNDERWEIGHT; OVERWEIGHT; BURDEN	Background In many developing countries nutritional, and epidemiological transitions are emerging into continuing undernutrition and escalating overnutrition, giving rise to the double burden of the malnutrition phenomenon. Objectives This study aims to determine the prevalence of the dual form of malnutrition (overweight mother/underweight child) in the same household and its associated factors in the Gaza Strip. Methods A total of 357 mother-child pairs from the same households were surveyed from three different geographical locations in the Gaza Strip, namely, El Remal urban area, Jabalia refugee camp, and Al Qarara rural area. The height and weight of mothers aged 18-50 years were measured, and their body mass index (BMI) was computed. The mothers were categorized according to the criterion of the World Health Organization (WHO) for BMI as overweight if they have a BMI >= 25 kg/m(2). Anthropometric indices were measured for children aged two to five years to classify the underweight children Z-score <-1. Results The results showed the prevalence of the dual form of malnutrition in the Gaza Strip was 15.7%, and its associated factors were child's birth order (ORadj, 1.50, 95% CL, 1.22, 1.82; p = < 0.001), father's educational (low or medium) levels (ORadj, 3.19, 95% CL, 1.07, 9.5; p = 0. 036), or (ORadj, 3.4, 95% CL, 1.12, 10.37; p = 0. 031), high scores of mothers' nutrition knowledge (ORadj, 1.23, 95% CL, 1.01, 1.52; p = 0. 048), and low monthly income (ORadj, 0.28, 95% CL, 0.09, 0.88; p = 0. 030). Conclusions The results from this study showed the dual form of malnutrition in the same household was prevalent in the Gaza Strip. This is a public health issue that must be understood and addressed and policy makers must implement an appropriate nutrition action plan to control dual form of malnutrition based on the underlying specific risk factors in the study population. In addition, interventions are needed to help individuals to translate their nutrition knowledge into healthy dietary behaviors.	[El Kishawi, Rima Rafiq; Soo, Kah Leng; Muda, Wan Abdul Manan Wan] Univ Sains Malaysia, Sch Hlth Sci, Program Nutr, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia; [Abed, Yehia Awad] Al Quds Univ, Sch Publ Hlth, Gaza City, Gaza Strip, Israel	Universiti Sains Malaysia	El Kishawi, RR (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Program Nutr, Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	rimaa2_us@yahoo.com	Muda, Wan A Manan A Wan/H-5475-2016	Muda, Wan A Manan A Wan/0000-0003-4241-3869				Al-Majdalawi J., 2008, THESIS AL QUDS U; Angeles-Agdeppa I, 2003, ASIA PAC J CLIN NUTR, V12, P438; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; Doak C, 2002, PUBLIC HEALTH NUTR, V5, P215, DOI 10.1079/PHN2001296; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Doak CM, 2000, J NUTR, V130, P2965, DOI 10.1093/jn/130.12.2965; Garrett James L., 2005, Food and Nutrition Bulletin, V26, P209; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; Husseini A, 2009, LANCET, V373, P1041, DOI 10.1016/S0140-6736(09)60109-4; Ihab AN, 2013, INT J PREVENTIVE MED, V4, P690; Kapoor SK, 2002, J EPIDEMIOL COMMUN H, V56, P804, DOI 10.1136/jech.56.11.804; Khor GL, 2003, ASIA PAC J CLIN NUTR, V12, P427; Massad S, 2012, LANCET, V380, pS5; Mikki N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-485; Mostafa Kamal S M, 2011, Malays J Nutr, V17, P105; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Radi SM, 2013, E MEDITERR HEALTH J, V19, P234, DOI 10.26719/2013.19.3.234; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Roemling C, 2012, DUAL BURDEN HOUSEHOL; Saibul N, 2009, ASIA PAC J CLIN NUTR, V18, P412; Singh GCP, 2009, ASIA-PAC J PUBLIC HE, V21, P144, DOI 10.1177/1010539509332063; Vega-Franco L, 1999, SALUD PUBLICA MEXICO, V41, P328; W.H.O, 1983, MEAS CHANG NUTR STAT; WHO, 2000, OB PREV MAN GLOB EP; World Food Program, 2013, STAT PAL SOC FOOD SE; World Health Organization, 2007, P CONCL CONS M WASH	31	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151494	10.1371/journal.pone.0151494	http://dx.doi.org/10.1371/journal.pone.0151494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990551	Green Submitted, gold, Green Published			2022-12-27	WOS:000372582800067
J	Maruyama, Y; Ito, T; Kodama, H; Matsuura, A				Maruyama, Yo; Ito, Toshiyuki; Kodama, Hiroaki; Matsuura, Akira			Availability of Amino Acids Extends Chronological Lifespan by Suppressing Hyper-Acidification of the Environment in Saccharomyces cerevisiae	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PLASMA-MEMBRANE; OXIDATIVE STRESS; YEAST AMMONIUM; CELL-DEATH; RESTRICTION; TRANSPORT; GROWTH; DETERMINANT; SUPEROXIDE	The chronological lifespan of Saccharomyces cerevisiae represents the duration of cell survival in the postdiauxic and stationary phases. Using a prototrophic strain derived from the standard auxotrophic laboratory strain BY4742, we showed that supplementation of nonessential amino acids to a synthetic defined (SD) medium increases maximal cell growth and extends the chronological lifespan. The positive effects of amino acids can be reproduced by modulating the medium pH, indicating that amino acids contribute to chronological longevity in a cell-extrinsic manner by alleviating medium acidification. In addition, we showed that the amino acid-mediated effects on extension of chronological longevity are independent of those achieved through a reduction in the TORC1 pathway, which is mediated in a cell-intrinsic manner. Since previous studies showed that extracellular acidification causes mitochondrial dysfunction and leads to cell death, our results provide a path to premature chronological aging caused by differences in available nitrogen sources. Moreover, acidification of culture medium is generally associated with culture duration and cell density; thus, further studies are required on cell physiology of auxotrophic yeast strains during the stationary phase because an insufficient supply of essential amino acids may cause alterations in environmental conditions.	[Maruyama, Yo; Ito, Toshiyuki; Kodama, Hiroaki; Matsuura, Akira] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Inage Ku, Chiba 2638522, Japan; [Matsuura, Akira] Chiba Univ, Mol Chiral Res Ctr, Inage Ku, Chiba 2638522, Japan; [Ito, Toshiyuki] Keiyo Plant Engn Co Ltd, 2-8-8 Ichikawaminami, Ichikawa, Chiba 2720032, Japan	Chiba University; Chiba University	Matsuura, A (corresponding author), Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Inage Ku, Chiba 2638522, Japan.; Matsuura, A (corresponding author), Chiba Univ, Mol Chiral Res Ctr, Inage Ku, Chiba 2638522, Japan.	amatsuur@faculty.chiba-u.jp	Matsuura, Akira/J-3864-2017; Matsuura, Akira/AAO-1572-2021	Matsuura, Akira/0000-0002-2300-7227; Matsuura, Akira/0000-0002-2300-7227	Keiyo Plant Engineering Co., Ltd	Keiyo Plant Engineering Co., Ltd	Keiyo Plant Engineering Co., Ltd provided support in the form of salaries for one of the authors [TI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the Author Contributions section.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Aris JP, 2013, EXP GERONTOL, V48, P1107, DOI 10.1016/j.exger.2013.01.006; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; BRANDRISS MC, 1979, J BACTERIOL, V140, P498, DOI 10.1128/JB.140.2.498-503.1979; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Carmelo V, 1996, ARCH MICROBIOL, V166, P315, DOI 10.1007/s002030050389; Carmona-Gutierrez D, 2014, YEAST, V31, P289, DOI 10.1002/yea.3020; Choi JS, 2013, BIOCHEM BIOPH RES CO, V439, P126, DOI 10.1016/j.bbrc.2013.08.014; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Giannattasio S, 2005, GENE, V354, P93, DOI 10.1016/j.gene.2005.03.030; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Holyoak CD, 1996, APPL ENVIRON MICROB, V62, P3158, DOI 10.1128/AEM.62.9.3158-3164.1996; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; Jara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086533; Jiang JC, 2000, FASEB J, V14, P2135; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Jones M., 1964, J I BREWING, V70, P307, DOI [10.1002/j.2050-0416.1964.tb01996.x, DOI 10.1002/J.2050-0416.1964.TB01996.X]; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, COLD SPRING HARBOR M, P283; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Santos J, 2015, ONCOTARGET, V6, P6511, DOI 10.18632/oncotarget.2989; Santos J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/161986; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soga T, 2001, ELECTROPHORESIS, V22, P3418, DOI 10.1002/1522-2683(200109)22:16<3418::AID-ELPS3418>3.0.CO;2-8; Sokolov S, 2006, BBA-BIOENERGETICS, V1757, P1366, DOI 10.1016/j.bbabio.2006.07.005; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tahara EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056388; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Wacker T, 2014, P NATL ACAD SCI USA, V111, P9995, DOI 10.1073/pnas.1406409111; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215	52	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151894	10.1371/journal.pone.0151894	http://dx.doi.org/10.1371/journal.pone.0151894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991662	gold, Green Submitted, Green Published			2022-12-27	WOS:000372582800116
J	Matsumoto, N; Ikeda, H; Shigefuku, R; Hattori, N; Watanabe, T; Matsunaga, K; Hiraishi, T; Tamura, T; Noguchi, Y; Fukuda, Y; Ishii, T; Okuse, C; Sato, A; Suzuki, M; Itoh, F				Matsumoto, Nobuyuki; Ikeda, Hiroki; Shigefuku, Ryuta; Hattori, Nobuhiro; Watanabe, Tsunamasa; Matsunaga, Kotaro; Hiraishi, Tetsuya; Tamura, Tomohiro; Noguchi, Yohei; Fukuda, Yasunobu; Ishii, Toshiya; Okuse, Chiaki; Sato, Akira; Suzuki, Michihiro; Itoh, Fumio			Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b	PLOS ONE			English	Article							FERRITIN; AMINOTRANSFERASE; HCV	Background Decreased hemoglobin (Hb) level has been supposed to be a relatively rare side effect of a combination therapy against hepatitis C virus that consists of the NS5A inhibitor daclatasvir (DCV) and the NS3/4A protease inhibitor asunaprevir (ASV). Methods The study was conducted in 75 patients with genotype 1b chronic hepatitis C virus infection who had started combination therapy with DCV and ASV at St. Marianna University School of Medicine Hospital between September 2014 and December 2014. Results Among the patients examined, decreased Hb level by >= 1.5 g/dL from the values at treatment initiation was observed in 11 individuals. This was accompanied by decreased mean corpuscular volume, and iron and ferritin levels. Conclusions These findings suggest that the mechanism of the phenomenon is caused by iron deficiency. The underlying mechanism and clinical impacts will need to be further examined.	[Matsumoto, Nobuyuki; Ikeda, Hiroki; Shigefuku, Ryuta; Hattori, Nobuhiro; Watanabe, Tsunamasa; Matsunaga, Kotaro; Hiraishi, Tetsuya; Tamura, Tomohiro; Noguchi, Yohei; Fukuda, Yasunobu; Ishii, Toshiya; Okuse, Chiaki; Sato, Akira; Suzuki, Michihiro; Itoh, Fumio] St Marianna Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan	Saint Marianna University	Matsumoto, N (corresponding author), St Marianna Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	nobu1020@marianna-u.ac.jp	Matsumoto, Nobuyuki/AAK-6459-2020		Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED	Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This research was partially supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED.	Busti F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00083; FINCH CA, 1986, WESTERN J MED, V145, P657; Iwasa M, 2002, HEPATO-GASTROENTEROL, V49, P529; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; LIPSCHITZ DA, 1974, NEW ENGL J MED, V290, P1213, DOI 10.1056/NEJM197405302902201; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; POIGER H, 1979, N-S ARCH PHARMACOL, V306, P89, DOI 10.1007/BF00515599; Polin V, 2013, DIGEST LIVER DIS, V45, P803, DOI 10.1016/j.dld.2013.02.019; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; TAKIKAWA T, 1994, J GASTROENTEROL, V29, P593, DOI 10.1007/BF02365441; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151238	10.1371/journal.pone.0151238	http://dx.doi.org/10.1371/journal.pone.0151238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990758	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800049
J	Melo, R; Richer, L; Johnson, DL; Gomes-Solecki, M				Melo, Rita; Richer, Luciana; Johnson, Daniel L.; Gomes-Solecki, Maria			Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection	PLOS ONE			English	Article							OUTER-SURFACE-PROTEIN; LYME-DISEASE SPIROCHETE; RESERVOIR TARGETED VACCINE; IXODES-PERSULCATUS; ANTIBODY-RESPONSE; IMMUNE-RESPONSE; MICE; TRANSMISSION; CHALLENGE; IDENTIFICATION	Oral vaccination strategies are of interest to prevent transmission of Lyme disease as they can be used to deliver vaccines to humans, pets, and to natural wildlife reservoir hosts of Borrelia burgdorferi. We developed a number of oral vaccines based in E. coli expressing recombinant OspC type K, OspB, BBK32 from B. burgdorferi, and Salp25, Salp15 from Ixodes scapularis. Of the five immunogenic candidates only OspC induced significant levels of antigen-specific IgG and IgA when administered to mice via the oral route. Antibodies to OspC did not prevent dissemination of B. burgdorferi as determined by the presence of spirochetes in ear, heart and bladder tissues four weeks after challenge. Next generation sequencing of genomic DNA from ticks identified multiple phyletic types of B. burgdorferi OspC (A, D, E, F, I, J, K, M, Q, T, X) in nymphs that engorged on vaccinated mice. PCR amplification of OspC types A and K from flat and engorged nymphal ticks, and from heart and bladder tissues collected after challenge confirmed sequencing analysis. Quantification of spirochete growth in a borreliacidal assay shows that both types of spirochetes (A and K) survived in the presence of OspC-K specific serum whereas the spirochetes were killed by OspA specific serum. We show that oral vaccination of C3H-HeN mice with OspC-K induced significant levels of antigen-specific IgG. However, these serologic antibodies did not protect mice from infection with B. burgdorferi expressing homologous or heterologous types of OspC after tick challenge.	[Melo, Rita; Gomes-Solecki, Maria] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Richer, Luciana; Gomes-Solecki, Maria] Immuno Technol Inc, Memphis, TN USA; [Johnson, Daniel L.] Univ Tennessee, Ctr Hlth Sci, Mol Resource Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Gomes-Solecki, M (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.; Gomes-Solecki, M (corresponding author), Immuno Technol Inc, Memphis, TN USA.	mgomesso@uthsc.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [R44 AI096551]; Immuno Technologies, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI096551] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Immuno Technologies, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the National Institutes of Health, National Institute of Allergy and Infectious Diseases for funding support (R44 AI096551) to MGS via Immuno Technologies, Inc. Immuno Technologies, Inc. provided support in the form of salaries for authors [LR, MGS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Ancelet LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045888; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Barrett PN, 2013, EXPERT REV VACCINES, V12, P973, DOI 10.1586/14760584.2013.824704; Bhattacharya D, 2011, VACCINE, V29, P7818, DOI 10.1016/j.vaccine.2011.07.100; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2010, EMERG INFECT DIS, V16, P911, DOI 10.3201/eid1606.090329; Brown EL, 2005, VACCINE, V23, P3687, DOI 10.1016/j.vaccine.2005.02.006; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Caine JA, 2015, INFECT IMMUN, V83, P3184, DOI 10.1128/IAI.00349-15; del Rio B, 2008, CLIN VACCINE IMMUNOL, V15, P1429, DOI 10.1128/CVI.00169-08; del Rio B, 2010, VACCINE, V28, P6714, DOI 10.1016/j.vaccine.2010.07.084; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; FIKRIG E, 1992, INFECT IMMUN, V60, P773, DOI 10.1128/IAI.60.3.773-777.1992; Gilmore RD, 2003, J MED MICROBIOL, V52, P551, DOI 10.1099/jmm.0.05068-0; Gilmore RD, 1996, INFECT IMMUN, V64, P2234, DOI 10.1128/IAI.64.6.2234-2239.1996; Gomes-Solecki MJC, 2006, VACCINE, V24, P4440, DOI 10.1016/j.vaccine.2005.08.089; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; Hallstrom T, 2013, MBIO, V4, DOI 10.1128/mBio.00481-13; Hojgaard A, 2009, J MED ENTOMOL, V46, P1458, DOI 10.1603/033.046.0631; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Kumar M, 2011, VACCINE, V29, P9012, DOI 10.1016/j.vaccine.2011.09.035; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13; Lovrich SD, 2005, CLIN DIAGN LAB IMMUN, V12, P746, DOI 10.1128/CDLI.12.6.746-751.2005; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Probert WS, 1997, J INFECT DIS, V175, P400, DOI 10.1093/infdis/175.2.400; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Richer LM, 2014, J INFECT DIS, V209, P1972, DOI 10.1093/infdis/jiu005; Richer LM, 2011, CLIN VACCINE IMMUNOL, V18, P1809, DOI 10.1128/CVI.05226-11; Scheckelhoff MR, 2006, VACCINE, V24, P1949, DOI 10.1016/j.vaccine.2005.10.044; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Shtannikov A. V., 2009, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P40; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Strother KO, 2007, INFECT IMMUN, V75, P2786, DOI 10.1128/IAI.01307-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x	44	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151850	10.1371/journal.pone.0151850	http://dx.doi.org/10.1371/journal.pone.0151850			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990760	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800109
J	Yap, TWC; Gan, HM; Lee, YP; Leow, AHR; Azmi, AN; Francois, F; Perez-Perez, GI; Loke, MF; Goh, KL; Vadivelu, J				Yap, Theresa Wan-Chen; Gan, Han-Ming; Lee, Yin-Peng; Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Francois, Fritz; Perez-Perez, Guillermo I.; Loke, Mun-Fai; Goh, Khean-Lee; Vadivelu, Jamuna			Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GASTRIC EPITHELIAL-CELLS; PLASMA GHRELIN; DIVISION TM7; SP NOV.; COLONIZATION; BACTERIA; OBESITY; ENERGY; HEALTH	Background Accumulating evidence shows that Helicobacter pylori protects against some metabolic and immunological diseases in which the development of these diseases coincide with temporal or permanent dysbiosis. The aim of this study was to assess the effect of H. pylori eradication on the human gut microbiome. Methods As part of the currently on-going ESSAY (Eradication Study in Stable Adults/Youths) study, we collected stool samples from 17 H. pylori-positive young adult (18-30 years-old) volunteers. The same cohort was followed up 6, 12 and 18 months-post H. pylori eradication. The impact of H. pylori on the human gut microbiome pre- and post-eradication was investigated using high throughput 16S rRNA gene (V3-V4 region) sequencing using the Illumina Miseq followed by data analysis using Qiime pipeline. Results We compared the composition and diversity of bacterial communities in the fecal microbiome of the H. pylori-positive volunteers, before and after H. pylori eradication therapy. The 16S rRNA gene was sequenced at an average of 150,000-170,000 reads/sample. The microbial diversity were similar pre- and post-H. pylori eradication with no significant differences in richness and evenness of bacterial species. Despite that the general profile of the gut microbiome was similar pre- and post-eradication, some changes in the bacterial communities at the phylum and genus levels were notable, particularly the decrease in relative abundance of Bacterioidetes and corresponding increase in Firmicutes after H. pylori eradication. The significant increase of short-chain fatty acids (SCFA)-producing bacteria genera could also be associated with increased risk of metabolic disorders. Conclusions Our preliminary stool metagenomics study shows that eradication of H. pylori caused perturbation of the gut microbiome and may indirectly affect the health of human. Clinicians should be aware of the effect of broad spectrum antibiotics used in H. pylori eradication regimen and be cautious in the clinical management of H. pylori infection, particularly in immunocompromised patients.	[Yap, Theresa Wan-Chen; Loke, Mun-Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Gan, Han-Ming; Lee, Yin-Peng] Monash Univ Malaysia, Sch Sci, Bandar Sunway 47500, Selangor, Malaysia; [Gan, Han-Ming; Lee, Yin-Peng] Monash Univ Malaysia, Genom Facil, Bandar Sunway 47500, Selangor, Malaysia; [Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia; [Azmi, Ahmad Najib] Univ Sains Islam Malaysia, Fac Med & Hlth Sci, Kuala Lumpur 55100, Malaysia; [Francois, Fritz] NYU, Inst Canc, New York, NY 10016 USA; [Francois, Fritz; Perez-Perez, Guillermo I.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Perez-Perez, Guillermo I.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Universiti Malaya; Monash University; Monash University Sunway; Monash University; Monash University Sunway; Universiti Malaya; Universiti Sains Islam Malaysia; New York University; New York University; New York University	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	jamuna@ummc.edu.my	Leow, Alex HR/B-1626-2017; Perez, Guillermo Perez/AAJ-3761-2020; VADIVELU, JAMUNARANI S/B-8696-2010; Gan, Han Ming/AAF-9519-2019; Goh, Khean-Lee/B-6404-2009; Loke, Mun Fai/B-1060-2011	Leow, Alex HR/0000-0003-1752-0435; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Gan, Han Ming/0000-0001-7987-738X; Goh, Khean-Lee/0000-0002-9965-1561; Loke, Mun Fai/0000-0002-3554-5313; Francois, Fritz/0000-0003-4491-2637; Perez Perez, Guillermo/0000-0002-0131-5798	University of Malaya-Ministry of Education (UM-MOE) [UM.C/HIR/MOE/13/4, H-50001-00-A000029]; Diane Belfer Program for Human Microbial Ecology; Knapp Family Fund	University of Malaya-Ministry of Education (UM-MOE); Diane Belfer Program for Human Microbial Ecology; Knapp Family Fund	This study was supported by the University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) Grant UM.C/HIR/MOE/13/4 (HIR Account No: H-50001-00-A000029), by the Diane Belfer Program for Human Microbial Ecology, the C and D fund (anonymous donors), and the Knapp Family Fund.	Amberbir A, 2011, CLIN EXP ALLERGY, V41, P1422, DOI 10.1111/j.1365-2222.2011.03831.x; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Anini Y, 1999, PFLUG ARCH EUR J PHY, V438, P299, DOI 10.1007/s004240050913; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chassard C, 2008, FEMS MICROBIOL ECOL, V66, P496, DOI 10.1111/j.1574-6941.2008.00595.x; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Clyne M, 2007, FEMS MICROBIOL LETT, V268, P135, DOI 10.1111/j.1574-6968.2007.00648.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dinis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021280; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ELLIOTT TSJ, 1990, ALIMENT PHARM THERAP, V4, P227; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Erejuwa OO, 2014, INT J MOL SCI, V15, P4158, DOI 10.3390/ijms15034158; Finegold SM, 2004, ANAEROBE, V10, P41, DOI 10.1016/j.anaerobe.2003.10.002; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Hua J, 1996, MICROBIOS, V87, P103; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lender N, 2014, ALIMENT PHARM THER, V40, P24, DOI 10.1111/apt.12790; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Malaty HM, 2010, ADV M C M, P1, DOI 10.1079/9781845935948.0001; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Menard A, 2016, SYST APPL MICROBIOL; NILIUS M, 1993, ZBL BAKT-INT J MED M, V280, P259; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Osawa H, 2008, WORLD J GASTROENTERO, V14, P6327, DOI 10.3748/wjg.14.6327; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; PETERS DH, 1992, DRUGS, V44, P117, DOI 10.2165/00003495-199244010-00009; Petersen AM, 2003, FEMS IMMUNOL MED MIC, V36, P117, DOI 10.1016/S0928-8244(03)00020-8; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rainey F.A., 2009, BERGEYS MANUAL SYSTE, V3, P921, DOI [10.1007/978-0-387-68489-5_3, DOI 10.1007/978-0-387-68489-5_3]; RAINEY FA, 2009, BERGEYS MANUAL SYSTE, V3, P1016; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schauer D.B., 2001, HELICOBACTER PYLORI; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sonnenberg A, 2013, AM J GASTROENTEROL, V108, P208, DOI 10.1038/ajg.2012.407; Sun J, 2014, GENES DIS, V1, P132, DOI 10.1016/j.gendis.2014.08.001; Szylit O, 1993, World Rev Nutr Diet, V74, P88; Tan GMY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11046; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VanEldere J, 1996, APPL ENVIRON MICROB, V62, P656, DOI 10.1128/AEM.62.2.656-661.1996; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Weingart V, 2004, J CLIN MICROBIOL, V42, P1319, DOI 10.1128/JCM.42.3.1319-1321.2004; Yap TWC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135771; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	96	79	94	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151893	10.1371/journal.pone.0151893	http://dx.doi.org/10.1371/journal.pone.0151893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991500	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800115
J	Chang, CJ; Lee, CC; Chan, YT; Trudeau, DL; Wu, MH; Tsai, CH; Yu, SM; Ho, THD; Wang, AHJ; Hsiao, CD; Arnold, FH; Chao, YC				Chang, Chia-Jung; Lee, Cheng-Chung; Chan, Yueh-Te; Trudeau, Devin L.; Wu, Mei-Huey; Tsai, Chih-Hsuan; Yu, Su-May; Ho, Tuan-Hua David; Wang, Andrew H. -J.; Hsiao, Chwan-Deng; Arnold, Frances H.; Chao, Yu-Chan			Exploring the Mechanism Responsible for Cellulase Thermostability by Structure-Guided Recombination	PLOS ONE			English	Article							ISOLATED BACILLUS-SUBTILIS; ELEVATED-TEMPERATURES; SEQUENCE ELEMENTS; PLANT BIOMASS; HYDROLYSIS; ENZYMES; ACID; EXPRESSION; STABILITY; PROTEINS	Cellulases from Bacillus and Geobacillus bacteria are potentially useful in the biofuel and animal feed industries. One of the unique characteristics of these enzymes is that they are usually quite thermostable. We previously identified a cellulase, GsCelA, from thermophilic Geobacillus sp. 70PC53, which is much more thermostable than its Bacillus homolog, BsCel5A. Thus, these two cellulases provide a pair of structures ideal for investigating the mechanism regarding how these cellulases can retain activity at high temperature. In the present study, we applied the SCHEMA non-contiguous recombination algorithm as a novel tool, which assigns protein sequences into blocks for domain swapping in a way that lessens structural disruption, to generate a set of chimeric proteins derived from the recombination of GsCelA and BsCel5A. Analyzing the activity and thermostability of this designed library set, which requires only a limited number of chimeras by SCHEMA calculations, revealed that one of the blocks may contribute to the higher thermostability of GsCelA. When tested against swollen Avicel, the highly thermostable chimeric cellulase C10 containing this block showed significantly higher activity (22%-43%) and higher thermostability compared to the parental enzymes. With further structural determinations and mutagenesis analyses, a 310 helix was identified as being responsible for the improved thermostability of this block. Furthermore, in the presence of ionic calcium and crown ether (CR), the chimeric C10 was found to retain 40% residual activity even after heat treatment at 90 degrees C. Combining crystal structure determinations and structure-guided SCHEMA recombination, we have determined the mechanism responsible for the high thermostability of GsCelA, and generated a novel recombinant enzyme with significantly higher activity.	[Chang, Chia-Jung; Tsai, Chih-Hsuan; Yu, Su-May; Hsiao, Chwan-Deng; Chao, Yu-Chan] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lee, Cheng-Chung; Chan, Yueh-Te; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Cheng-Chung; Chan, Yueh-Te; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Trudeau, Devin L.; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Wu, Mei-Huey] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Wu, Mei-Huey; Ho, Tuan-Hua David] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Yu, Su-May; Ho, Tuan-Hua David; Chao, Yu-Chan] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Chia-Jung] Reber Genet Co Ltd, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; California Institute of Technology; National Cheng Kung University; Academia Sinica - Taiwan; National Chung Hsing University	Chao, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.; Chao, YC (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan.	mbycchao@imb.sinica.edu.tw	Chao, Yu-Chan/ABF-6571-2021; Hsiao, Chwan-Deng/AAZ-8869-2021; Yu, Su-May/ABB-6950-2021	Chao, Yu-Chan/0000-0002-9528-8806; Hsiao, Chwan-Deng/0000-0002-7012-1532; Yu, Su-May/0000-0001-8744-9246; Arnold, Frances H./0000-0002-4027-364X	Ministry of Science and Technology [MOST105-2321-B-001-024, MOST104-2811-B-001-112]; Academia Sinica, Taiwan, ROC [5202402020-4006]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica, Taiwan, ROC(Academia Sinica - Taiwan)	This work was supported by grants MOST105-2321-B-001-024 and MOST104-2811-B-001-112 from Ministry of Science and Technology, and 5202402020-4006 from Academia Sinica, Taiwan, ROC.	Abdel-Banat BMA, 2010, APPL MICROBIOL BIOT, V85, P861, DOI 10.1007/s00253-009-2248-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Heinzelman P, 2013, METHOD ENZYMOL, V523, P351, DOI 10.1016/B978-0-12-394292-0.00016-3; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Karypis G, 2000, VLSI DES, V11, P285, DOI 10.1155/2000/19436; Karypis G, 1999, IEEE T VLSI SYST, V7, P69, DOI 10.1109/92.748202; Komor RS, 2012, PROTEIN ENG DES SEL, V25, P827, DOI 10.1093/protein/gzs058; Lee CC, 2014, ANGEW CHEM INT EDIT, V53, P13054, DOI 10.1002/anie.201405664; Li W, 2008, MOL BIOTECHNOL, V40, P195, DOI 10.1007/s12033-008-9079-y; Meng F, 2014, LETT APPL MICROBIOL, V59, P306, DOI 10.1111/lam.12276; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng IS, 2009, EXTREMOPHILES, V13, P425, DOI 10.1007/s00792-009-0228-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rastogi G, 2010, BIORESOURCE TECHNOL, V101, P8798, DOI 10.1016/j.biortech.2010.06.001; Romero PA, 2012, ACS SYNTH BIOL, V1, P221, DOI 10.1021/sb300014t; Santos CR, 2012, BIOCHEM J, V441, P95, DOI 10.1042/BJ20110869; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; Smith MA, 2013, ACS SYNTH BIOL, V2, P690, DOI 10.1021/sb400010m; Smith MA, 2013, PROTEIN SCI, V22, P231, DOI 10.1002/pro.2202; Smith MA, 2012, FEBS J, V279, P4453, DOI 10.1111/febs.12032; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Taylor MP, 2009, TRENDS BIOTECHNOL, V27, P398, DOI 10.1016/j.tibtech.2009.03.006; Trudeau DL, 2014, BIOTECHNOL BIOENG, V111, P2390, DOI 10.1002/bit.25308; Trudeau DL, 2013, CURR OPIN CHEM BIOL, V17, P902, DOI 10.1016/j.cbpa.2013.10.007; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Viikari L, 2007, ADV BIOCHEM ENG BIOT, V108, P121, DOI 10.1007/10_2007_065; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wu I, 2013, BIOTECHNOL BIOENG, V110, P1874, DOI 10.1002/bit.24864; Yang DL, 2010, MOL BIOL REP, V37, P1923, DOI 10.1007/s11033-009-9635-y; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zambare VP, 2011, EXTREMOPHILES, V15, P611, DOI 10.1007/s00792-011-0391-2; Zhang XZ, 2011, METAB ENG, V13, P364, DOI 10.1016/j.ymben.2011.04.003; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c	34	35	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0147485	10.1371/journal.pone.0147485	http://dx.doi.org/10.1371/journal.pone.0147485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986867	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000372580300010
J	Eipper, S; Steiner, R; Lesner, A; Sienczyk, M; Palesch, D; Halatsch, ME; Zaczynska, E; Heim, C; Hartmann, MD; Zimecki, M; Wirtz, CR; Burster, T				Eipper, Steffen; Steiner, Robin; Lesner, Adam; Sienczyk, Marcin; Palesch, David; Halatsch, Marc-Eric; Zaczynska, Ewa; Heim, Christopher; Hartmann, Marcus D.; Zimecki, Michal; Wirtz, Christian Rainer; Burster, Timo			Lactoferrin Is an Allosteric Enhancer of the Proteolytic Activity of Cathepsin G	PLOS ONE			English	Article							NEUTROPHIL ELASTASE; SERINE PROTEASES; ACTIVATION; PROTEIN; INHIBITION; INCLUDES; GRANULES	Protease-mediated degradation of proteins is critical in a plethora of physiological processes. Neutrophils secrete serine proteases including cathepsin G (CatG), neutrophile elastase (NE), and proteinase 3 (PR3) together with lactoferrin (LF) as a first cellular immune response against pathogens. Here, we demonstrate that LF increases the catalytic activity of CatG at physiological concentration, with its highest enhancing capacity under acidic (pH 5.0) conditions, and broadens the substrate selectivity of CatG. On a functional level, the enzymatic activity of CatG was increased in the presence of LF in granulocyte-derived supernatant. Furthermore, LF enhanced CatG-induced activation of platelets as determined by cell surface expression of CD62P. Consequently, LF-mediated enhancement of CatG activity might promote innate immunity during acute inflammation.	[Eipper, Steffen; Steiner, Robin; Halatsch, Marc-Eric; Wirtz, Christian Rainer; Burster, Timo] Univ Ulm, Med Ctr, Dept Neurosurg, D-89069 Ulm, Germany; [Lesner, Adam] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [Sienczyk, Marcin] Wroclaw Univ Technol, Fac Chem, PL-50370 Wroclaw, Poland; [Palesch, David] Univ Ulm, Med Ctr, Inst Mol Virol, D-89069 Ulm, Germany; [Zaczynska, Ewa; Zimecki, Michal] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland; [Heim, Christopher; Hartmann, Marcus D.] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	Ulm University; Fahrenheit Universities; University of Gdansk; Wroclaw University of Science & Technology; Ulm University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Max Planck Society	Burster, T (corresponding author), Univ Ulm, Med Ctr, Dept Neurosurg, D-89069 Ulm, Germany.	timo.burster@uni-ulm.de	Halatsch, Marc-Eric/B-7807-2008; Hartmann, Marcus/L-8759-2019; Lesner, Adam/M-2732-2019	Hartmann, Marcus/0000-0001-6937-5677; Lesner, Adam/0000-0001-8335-3431; Zimecki, Michal/0000-0002-6206-8006; Wirtz, Christian Rainer/0000-0001-8358-1813; Zaczynska, Ewa/0000-0003-0174-3677; Burster, Timo/0000-0002-9596-6558; Nilson, Robin/0000-0002-2528-9547	DAAD [91506408]; Deutsche Diabetes Stiftung "Das zuckerkranke Kind" (DDS) [226/06/13]; Humboldt grant [DPK-422-1658/2013]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Diabetes Stiftung "Das zuckerkranke Kind" (DDS); Humboldt grant	This work was supported by DAAD 91506408, Deutsche Diabetes Stiftung "Das zuckerkranke Kind" (DDS) 226/06/13, and Humboldt DPK-422-1658/2013 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcella A, 2015, J NEUROSURG, P1; Arciniega-Martinez IM, 2015, MODULATORY EFFECTS O; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; BROZNA JP, 1977, J CLIN INVEST, V60, P1280, DOI 10.1172/JCI108887; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Burster T, 2004, J IMMUNOL, V172, P5495, DOI 10.4049/jimmunol.172.9.5495; El Ouriaghli F, 2003, BLOOD, V101, P1752, DOI 10.1182/blood-2002-06-1734; ERMOLIEFF J, 1994, J BIOL CHEM, V269, P29502; GALLIN JI, 1984, CLIN RES, V32, P320; Ganz T, 2002, J CLIN INVEST, V109, P693, DOI 10.1172/JCI200215218; Grzywa R, 2014, CHEMBIOCHEM, V15, P2605, DOI 10.1002/cbic.201402360; Guillen C, 1998, ANN RHEUM DIS, V57, P309, DOI 10.1136/ard.57.5.309; He SH, 2003, BIOCHEM PHARMACOL, V65, P1007, DOI 10.1016/S0006-2952(02)01651-9; HECK LW, 1990, AM J PATHOL, V136, P1267; Hendrixson DR, 2003, MOL MICROBIOL, V47, P607, DOI 10.1046/j.1365-2958.2003.03327.x; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kruzel Marian L, 2007, Postepy Hig Med Dosw (Online), V61, P261; Kruzel ML, 2013, J BIOTECHNOL, V168, P666, DOI 10.1016/j.jbiotec.2013.09.011; Kruzel ML, 2013, J BIOTECHNOLOGY; Ledoux D, 2003, FEBS LETT, V537, P23, DOI 10.1016/S0014-5793(03)00064-4; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Menkin V, 1956, BIOCH MECH INFLAMMAT, P66; Miyata J, 2007, RHEUMATOL INT, V27, P375, DOI 10.1007/s00296-006-0210-8; ODEBERG H, 1975, J CLIN INVEST, V56, P1118, DOI 10.1172/JCI108186; Palesch D, 2011, ACTA BIOCHIM POL, V58, P39; Reich M, 2009, MOL IMMUNOL, V46, P2994, DOI 10.1016/j.molimm.2009.06.017; Rogan MP, 2004, J INFECT DIS, V190, P1245, DOI 10.1086/423821; SCUDERI P, 1991, CELL IMMUNOL, V135, P299, DOI 10.1016/0008-8749(91)90275-G; Sedor J, 2007, PEDIATR RES, V61, P26, DOI 10.1203/01.pdr.0000250043.90468.c2; SELAK MA, 1988, BIOCHEM J, V251, P293, DOI 10.1042/bj2510293; Shafer WM, 1996, INFECT IMMUN, V64, P4842, DOI 10.1128/IAI.64.11.4842-4845.1996; Siqueiros-Cendon T, 2014, ACTA PHARMACOL SIN, V35, P557, DOI 10.1038/aps.2013.200; STOCKLEY RA, 1983, CLIN SCI, V64, P119, DOI 10.1042/cs0640119; van Velzen JF, 2012, THROMB RES, V130, P92, DOI 10.1016/j.thromres.2012.02.041; Wang J, 2014, BBA-MOL BASIS DIS, V1842, P2174, DOI 10.1016/j.bbadis.2014.07.026; Wilson TJ, 2009, MOL CANCER RES, V7, P1224, DOI 10.1158/1541-7786.MCR-09-0028; Zhou Q, 1997, BIOCHEM J, V324, P361, DOI 10.1042/bj3240361; Zimecki M, 2012, POSTEP HIG MED DOSW, V66, P16, DOI 10.5604/17322693.975145; Zou F, 2012, ANAL BIOCHEM, V421, P667, DOI 10.1016/j.ab.2011.11.016; Zou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022815	43	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151509	10.1371/journal.pone.0151509	http://dx.doi.org/10.1371/journal.pone.0151509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986619	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300080
J	Li, R; Chen, LZ; Zhao, SP; Huang, XS				Li, Rong; Chen, Lu-zhu; Zhao, Shui-ping; Huang, Xian-sheng			Inflammation Activation Contributes to Adipokine Imbalance in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; ATHEROSCLEROSIS; ADIPONECTIN	Inflammation can be activated as a defensive response by the attack of acute coronary syndrome (ACS) for ischemic tissue injury. The aim of the present study was to investigate the impact of ACS-activated inflammation on adipokine imbalance and the effects of statins on the crosstalk between inflammation and adipokine imbalance during ACS. In this study, 586 subjects were categorized into: (1) control group; (2) SA (stable angina) group; and (3) ACS group. Circulating levels of hs-CRP, adiponectin and resistin were measured by ELISA. Furthermore, forty C57BL/6 mice were randomized into: sham, AMI, low-statin (atorvastatin, 2 mg/kg/day) and high-statin (atorvastatin, 20 mg/kg/day) group. After 3 weeks, AMI models were established by surgical coronary artery ligation. Circulating levels and adipose expressions of adiponectin and resistin were assessed in animals. Besides, we investigate the effects of atorvastatin on ox-LDL-induced adipokine imbalance in vitro. As a result, we found that ACS patients had higher hs-CRP and resistin levels and lower adiponectin levels. Our correlation analysis demonstrated hs-CRP concentrations were positively correlated with resistin but negatively with adiponectin levels in humans. Our animal findings indicated higher circulating hs-CRP and resistin levels and lower adiponectin levels in AMI mice. Atorvastatin pre-treatment dose-dependently decreased hs-CRP and resistin levels but increased adiponectin levels in mice. The consistent findings were observed about the adipose expressions of resistin and adiponectin in mice. In study in vitro, ox-LDL increased cellular resistin expressions and otherwise for adiponectin expressions, which dose-dependently reversed by the addition of atorvastatin. Therefore, our study indicates that the ACS attack activates inflammation leading to adipokine imbalance that can be ameliorated by anti-inflammation of atorvastatin.	[Li, Rong] Cent S Univ, Xiangya Hosp 2, Dept Stomatol, Changsha, Hunan, Peoples R China; [Chen, Lu-zhu; Zhao, Shui-ping; Huang, Xian-sheng] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Huang, XS (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China.	initialhxs@163.com			National Natural Science Foundation of China [81000121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 81000121.	Abdelmeguid AE, 1996, CIRCULATION, V94, P1528, DOI 10.1161/01.CIR.94.7.1528; Alam SR, 2015, HEART, V101, P1639, DOI 10.1136/heartjnl-2015-307745; Brunetti ND, 2014, ATHEROSCLEROSIS, V236, P456, DOI 10.1016/j.atherosclerosis.2014.07.037; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Ellis SG, 2009, J AM COLL CARDIOL, V54, P566, DOI 10.1016/j.jacc.2009.04.070; Kim BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137366; Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF; Kiyan Y, 2014, J MOL CELL CARDIOL, V66, P72, DOI 10.1016/j.yjmcc.2013.11.005; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Levitsky S, 2006, CIRCULATION, V114, pI339, DOI 10.1161/CIRCULATIONAHA.105.001685; MAGER A, 1991, CHEST, V99, P386, DOI 10.1378/chest.99.2.386; Margaritis M, 2013, CIRCULATION, V127, P2209, DOI 10.1161/CIRCULATIONAHA.112.001133; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Patti G, 2011, CIRCULATION, V123, P1622, DOI 10.1161/CIRCULATIONAHA.110.002451; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Wu ZH, 2009, PHARMACOLOGY, V84, P282, DOI 10.1159/000242999; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535	22	6	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151916	10.1371/journal.pone.0151916	http://dx.doi.org/10.1371/journal.pone.0151916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986475	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300151
J	Zhao, W; Huang, XD; Zhang, LX; Yang, XJ; Wang, LH; Chen, YS; Wang, JH; Wu, GL				Zhao, Wei; Huang, XuDong; Zhang, LiXia; Yang, XinJun; Wang, Lihui; Chen, YunShuang; Wang, JingHua; Wu, GuangLi			Penehyclidine Hydrochloride Pretreatment Ameliorates Rhabdomyolysis-Induced AKI by Activating the Nrf2/HO-1 Pathway and Alleviating Endoplasmic Reticulum Stress in Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; UNFOLDED PROTEIN RESPONSE; HEME OXYGENASE-1; OXIDATIVE STRESS; CELL-DEATH; INDUCED APOPTOSIS; GENE-EXPRESSION; RENAL-FAILURE; KIDNEY INJURY; ER-STRESS	Acute kidney injury (AKI) is one of the most severe complications of rhabdomyolysis (RM). The underlying mechanisms and potential preventions need to be investigated. Penehyclidine hydrochloride (PHC) was reported to ameliorate renal ischemia-reperfusion injury, but the effect of PHC on RM-reduced AKI is unknown. In this study, we established a rat model of RM-induced AKI using an intramuscular glycerol injection in the hind limbs. Rats were pretreated with PHC before the glycerol injection, and the heme oxygenase-1 (HO-1) inhibitor ZnPP was introduced to evaluate the effect of HO-1 on RM-induced AKI. PHC pretreatment ameliorated the pathological renal injury and renal dysfunction, and decreased the renal apoptosis rate in RM-induced AKI. PHC significantly up-regulated HO-1 expression, increased HO-1 enzymatic activity and decreased the accumulation of myoglobin in renal tissues. This effect was partly inhibited by ZnPP. PHC pretreatment also effectively up-regulated nuclear factor erythroid 2-related factor 2 (Nrf2) and down-regulated glucose regulated protein 78 (GRP78) and caspase-12 at both the gene and protein levels. These results suggest that the protective effects of PHC pretreatment on RM-induced AKI occur at least in part through activating the Nrf2/HO-1 pathway and alleviating endoplasmic reticulum stress (ERS) in rat renal tissues.	[Zhao, Wei] Chinese Peoples Liberat Army Gen Hosp, Dept Nephrol, Beijing 100853, Peoples R China; [Zhao, Wei; Huang, XuDong; Zhang, LiXia; Yang, XinJun; Wang, Lihui; Chen, YunShuang; Wang, JingHua; Wu, GuangLi] Bethune Int Peace Hosp, Dept Nephrol, Shijiazhuang, Hebei Province, Peoples R China	Chinese People's Liberation Army General Hospital	Wu, GL (corresponding author), Bethune Int Peace Hosp, Dept Nephrol, Shijiazhuang, Hebei Province, Peoples R China.	wugl@medmail.com.cn			Application Basic Research Project of Hebei Province [13967702D]; Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences [BWS11J058, CWS12J061]; Youth Cultivation Project of Chinese PLA for Medical Sciences [13QNP013]	Application Basic Research Project of Hebei Province; Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences; Youth Cultivation Project of Chinese PLA for Medical Sciences	This study was supported by the grants from the Application Basic Research Project of Hebei Province (13967702D), the Fund of Chinese PLA 12th Five-Year Plan for Medical Sciences (BWS11J058, CWS12J061) and the Youth Cultivation Project of Chinese PLA for Medical Sciences (13QNP013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2009, AM J PHYSIOL-RENAL, V297, pF1137, DOI 10.1152/ajprenal.90449.2008; Agarwal Anupam, 2013, Trans Am Clin Climatol Assoc, V124, P111; BETTER OS, 1990, NEPHRON, V55, P97, DOI 10.1159/000185934; Chatzizisis YS, 2008, EUR J INTERN MED, V19, P568, DOI 10.1016/j.ejim.2007.06.037; Cui J, 2013, CHINESE MED J-PEKING, V126, P4764, DOI 10.3760/cma.j.issn.0366-6999.20130230; Gaut JR, 1993, CURR OPIN CELL BIOL, V5, P589, DOI 10.1016/0955-0674(93)90127-C; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Holt S, 2000, EXP NEPHROL, V8, P72; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; Jin QH, 2004, CELL MOL LIFE SCI, V61, P1816, DOI 10.1007/s00018-004-4143-7; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Knochel James P., 1993, Current Opinion in Rheumatology, V5, P725; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; Lee YS, 2006, APOPTOSIS, V11, P1091, DOI 10.1007/s10495-006-7110-y; Liu XM, 2005, J BIOL CHEM, V280, P872, DOI 10.1074/jbc.M410413200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2013, KIDNEY INT, V84, P3, DOI 10.1038/ki.2013.88; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tang WX, 2013, ARTIF ORGANS, V37, P390, DOI 10.1111/j.1525-1594.2012.01574.x; Vanholder R, 2000, J AM SOC NEPHROL, V11, P1553, DOI 10.1681/ASN.V1181553; Wang J, 2013, ANAESTHESIA, V68, P136, DOI 10.1111/anae.12092; Wang YA, 2005, LIFE SCI, V78, P210, DOI 10.1016/j.lfs.2005.04.071; Wang YP, 2014, J SURG RES, V186, P390, DOI 10.1016/j.jss.2013.07.041; Wang Z, 2014, KIDNEY INT, V86, P338, DOI 10.1038/ki.2014.65; Wu GL, 2012, INT J SPORTS MED, V33, P1, DOI 10.1055/s-0031-1284397; Wu XJ, 2012, INJURY, V43, P232, DOI 10.1016/j.injury.2011.10.009; Yang CW, 2003, FASEB J, V17, P1754, DOI 10.1096/fj.02-1191fje; Yin XL, 2011, AM J CHINESE MED, V39, P853, DOI 10.1142/S0192415X11009251; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; ZAGER RA, 1991, J AM SOC NEPHROL, V2, P848; Zhang Xue-mei, 2015, Sichuan Da Xue Xue Bao Yi Xue Ban, V46, P22; Zhao W, 2013, CHIN J INTEGR TRADIT, V14, P17, DOI [10.3969/j.issn.1009-587X.2013.01.006, DOI 10.3969/J.ISSN.1009-587X.2013.01.006]; [赵维 Zhao Wei], 2013, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V33, P366; Zhou JH, 2012, THER APHER DIAL, V16, P272, DOI 10.1111/j.1744-9987.2011.01057.x	45	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151158	10.1371/journal.pone.0151158	http://dx.doi.org/10.1371/journal.pone.0151158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987113	gold, Green Published			2022-12-27	WOS:000372580300049
J	Benito, A; Jeffares, D; Palomero, F; Calderon, F; Bai, FY; Bahler, J; Benito, S				Benito, Angel; Jeffares, Daniel; Palomero, Felipe; Calderon, Fernando; Bai, Feng-Yan; Bahler, Jurg; Benito, Santiago			Selected Schizosaccharomyces pombe Strains Have Characteristics That Are Beneficial for Winemaking	PLOS ONE			English	Article							NON-SACCHAROMYCES YEASTS; REMOVING GLUCONIC ACID; MALOLACTIC FERMENTATION; LACHANCEA-THERMOTOLERANS; TORULASPORA-DELBRUECKII; CO-FERMENTATION; BIOGENIC-AMINES; ALCOHOL CONTENT; TABLE WINES; RED	At present, wine is generally produced using Saccharomyces yeast followed by Oenococus bacteria to complete malolactic fermentation. This method has some unsolved problems, such as the management of highly acidic musts and the production of potentially toxic products including biogenic amines and ethyl carbamate. Here we explore the potential of the fission yeast Schizosaccharomyces pombe to solve these problems. We characterise an extensive worldwide collection of S. pombe strains according to classic biochemical parameters of oenological interest. We identify three genetically different S. pombe strains that appear suitable for winemaking. These strains compare favourably to standard Saccharomyces cerevisiae winemaking strains, in that they perform effective malic acid deacidification and significantly reduce levels of biogenic amines and ethyl carbamate precursors without the need for any secondary bacterial malolactic fermentation. These findings indicate that the use of certain S. pombe strains could be advantageous for winemaking in regions where malic acid is problematic, and these strains also show superior performance with respect to food safety.	[Benito, Angel; Palomero, Felipe; Calderon, Fernando; Benito, Santiago] Univ Politecn Madrid, Dept Chem & Food Technol, Madrid, Spain; [Jeffares, Daniel; Bahler, Jurg] UCL, Res Dept Genet Evolut & Environm, London, England; [Bai, Feng-Yan] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Universidad Politecnica de Madrid; University of London; University College London; Chinese Academy of Sciences; Institute of Microbiology, CAS	Benito, S (corresponding author), Univ Politecn Madrid, Dept Chem & Food Technol, Madrid, Spain.	santiago.benito@upm.es	Fernandez, Fernando Calderon/AAS-1635-2020; Benito, Santiago/ABH-2117-2020; Bahler, Jurg/B-4572-2009; Bai, Feng-Yan/E-7860-2019; Jeffares, Daniel/N-2632-2018	Bahler, Jurg/0000-0003-4036-1532; Jeffares, Daniel/0000-0001-7320-0706; BENITO SAEZ, SANTIAGO/0000-0002-1674-8246	Wellcome Trust [095598/Z/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Jurg Bahler and Daniel Jeffares were supported by a Wellcome Trust Senior Investigator Award to JB, Grant Number: 095598/Z/11/Z, URL: http://www.wellcome.ac.uk/. The rest of the authors have no support or funding to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide-Hidalgo JM, 2007, FOOD CHEM, V103, P572, DOI 10.1016/j.foodchem.2006.09.002; Bai FY, STATE KEY LAB MYCOLO; Belda I, 2015, APPL MICROBIOL BIOT, V99, P1911, DOI 10.1007/s00253-014-6197-2; Bely M, 2008, INT J FOOD MICROBIOL, V122, P312, DOI 10.1016/j.ijfoodmicro.2007.12.023; Benito A, 2015, FOOD TECHNO IN PRESS, DOI 10.17113/ftb.54.02.16.4220; Benito A, 2015, MOLECULES, V20, P9510, DOI 10.3390/molecules20069510; Benito S, 2014, FOOD MICROBIOL, V42, P218, DOI 10.1016/j.fm.2014.03.014; Benito S., 2013, African Journal of Microbiology Research, V7, P3026; Benito S, 2013, EUR FOOD RES TECHNOL, V236, P29, DOI 10.1007/s00217-012-1836-2; Benito S., 2014, ENCY FOOD MICROBIOLO, P365; Benito S., 2015, J FOOD PROCESS TECHN, V6, P9; Benito S, 2015, EUR FOOD RES TECHNOL, V241, P707, DOI 10.1007/s00217-015-2497-8; Benito S, 2014, FOOD TECHNOL BIOTECH, V52, P376; Benito S, 2012, INT J FOOD SCI TECH, V47, P2101, DOI 10.1111/j.1365-2621.2012.03076.x; Bonciani T, 2016, EUR FOOD RES TECHNOL, V242, P899, DOI 10.1007/s00217-015-2596-6; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Clemente-Jimenez JM, 2004, FOOD MICROBIOL, V21, P149, DOI 10.1016/S0740-0020(03)00063-7; Contreras A, 2015, APPL MICROBIOL BIOT, V99, P1885, DOI 10.1007/s00253-014-6193-6; Contreras A, 2014, APPL ENVIRON MICROB, V80, P1670, DOI 10.1128/AEM.03780-13; Cui Xia, 2014, Journal of Food Safety and Quality, V5, P2617; Deak T., 2008, HDB FOOD SPOILAGE YE, P294; Ding S, 2015, YEAST, V32, P317, DOI 10.1002/yea.3053; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; GALLANDER JF, 1977, AM J ENOL VITICULT, V28, P65; Gobbi M, 2014, EUR FOOD RES TECHNOL, V239, P41, DOI 10.1007/s00217-014-2187-y; Gobbi M, 2013, FOOD MICROBIOL, V33, P271, DOI 10.1016/j.fm.2012.10.004; Husnik JI, 2007, AM J ENOL VITICULT, V58, P42; Husnik JI, 2006, METAB ENG, V8, P315, DOI 10.1016/j.ymben.2006.02.003; Hyma KE, 2011, FEMS YEAST RES, V11, P540, DOI 10.1111/j.1567-1364.2011.00746.x; Jansen SC, 2003, ANN ALLERG ASTHMA IM, V91, P233, DOI 10.1016/S1081-1206(10)63523-5; Jeffares DC, 2015, NAT GENET, V47, P235, DOI 10.1038/ng.3215; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Jolly NP, 2014, FEMS YEAST RES, V14, P215, DOI 10.1111/1567-1364.12111; Kanny G, 2001, J ALLERGY CLIN IMMUN, V107, P375, DOI 10.1067/mai.2001.112122; Kutyna DR, 2010, TRENDS FOOD SCI TECH, V21, P293, DOI 10.1016/j.tifs.2010.03.004; Lehtonen P, 1996, AM J ENOL VITICULT, V47, P127; Liu YL, 2009, AGR SCI CHINA, V8, P821, DOI 10.1016/S1671-2927(08)60283-7; Lubbers MW, 1996, CAN J MICROBIOL, V42, P132, DOI 10.1139/m96-021; MAYNARD LS, 1962, NATURE, V196, P575, DOI 10.1038/196575a0; Medina K, 2013, FOOD CHEM, V141, P2513, DOI 10.1016/j.foodchem.2013.04.056; Mendes I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066523; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Morales P, 2015, APPL MICROBIOL BIOT, V99, P3993, DOI 10.1007/s00253-014-6321-3; Moreno-Arribas MV, 2008, FOOD MICROBIOL, V25, P875, DOI 10.1016/j.fm.2008.05.004; Palomero F, 2009, FOOD CHEM, V112, P432, DOI 10.1016/j.foodchem.2008.05.098; Parapouli M, 2010, J IND MICROBIOL BIOT, V37, P85, DOI 10.1007/s10295-009-0651-7; Peinado RA, 2005, J AGR FOOD CHEM, V53, P1017, DOI 10.1021/jf048764b; Peinado RA, 2004, J AGR FOOD CHEM, V52, P4529, DOI 10.1021/jf049853r; Peinado RA, 2004, J AGR FOOD CHEM, V52, P493, DOI 10.1021/jf035030a; Peinado RA, 2007, FOOD CHEM, V104, P457, DOI 10.1016/j.foodchem.2006.11.070; Pitt J. I, 1999, FUNGI FOOD SPOILAGE, P459; Pretorius IS, 2002, TRENDS BIOTECHNOL, V20, P426, DOI 10.1016/S0167-7799(02)02049-8; Redzepovic S, 2003, INT J FOOD MICROBIOL, V83, P49, DOI 10.1016/S0168-1605(02)00320-3; RODRIGUEZ SB, 1990, FEMS MICROBIOL LETT, V72, P17, DOI 10.1016/0378-1097(90)90337-P; ROMANO P, 1993, J APPL BACTERIOL, V75, P541, DOI 10.1111/j.1365-2672.1993.tb01592.x; ROMANO P, 1992, J APPL BACTERIOL, V73, P126, DOI 10.1111/j.1365-2672.1992.tb01698.x; Silva S, 2003, AM J ENOL VITICULT, V54, P50; Smit AY, 2013, FOOD BIOPROCESS TECH, V6, P198, DOI 10.1007/s11947-011-0702-8; SNOW PG, 1979, AM J ENOL VITICULT, V30, P45; Su J, 2014, APPL MICROBIOL BIOT, V98, P2395, DOI 10.1007/s00253-014-5508-y; Sumby KM, 2014, APPL MICROBIOL BIOT, V98, P8111, DOI 10.1007/s00253-014-5976-0; Thornton RJ, 1996, FOOD MICROBIOL, V13, P475, DOI 10.1006/fmic.1996.0054; Unterholzner O., 1988, Mitteilungen Klosterneuburg, Rebe und Wein, Obstbau und Fruechteverwertung, V38, P66; Vaughan-Martini, 1998, YEASTS, P107, DOI DOI 10.1016/B978-044481312-1/50017-4; Vaughnan-Martini A., 1999, YEAST TAXONOMIC STUD, P107; YOKOTSUKA K, 1993, AM J ENOL VITICULT, V44, P371; Zheng YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133889; ZIRONI R, 1993, BIOTECHNOL LETT, V15, P235, DOI 10.1007/BF00128311	68	62	65	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151102	10.1371/journal.pone.0151102	http://dx.doi.org/10.1371/journal.pone.0151102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007548	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200042
J	Watanabe, T; Tsujino, I; Konno, S; Ito, YM; Takashina, C; Sato, T; Isada, A; Ohira, H; Ohtsuka, Y; Fukutomi, Y; Nakamura, H; Kawagishi, Y; Okada, C; Hizawa, N; Taniguchi, M; Akasawa, A; Nishimura, M				Watanabe, Taku; Tsujino, Ichizo; Konno, Satoshi; Ito, Yoichi M.; Takashina, Chisa; Sato, Takahiro; Isada, Akira; Ohira, Hiroshi; Ohtsuka, Yoshinori; Fukutomi, Yuma; Nakamura, Hiroyuki; Kawagishi, Yukio; Okada, Chiharu; Hizawa, Nobuyuki; Taniguchi, Masami; Akasawa, Akira; Nishimura, Masaharu			Association between Smoking Status and Obesity in a Nationwide Survey of Japanese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; GENERAL-POPULATION SAMPLE; WEIGHT-GAIN; CIGARETTE-SMOKING; UNITED-STATES; CESSATION; OVERWEIGHT; WOMEN; FAT	Objective A positive association between the number of cigarettes smoked per day and obesity has been reported, whereas how other smoking-related indices, such as pack-years and duration of smoking, are related with obesity has been less investigated. We analyzed the age-adjusted cross-sectional association between smoking and obesity in a general Japanese population. Methods We used data from a nationwide epidemiological study of Japanese adults (N = 23,106). We compared the prevalence of obesity (defined as body mass index >= 25kg/m(2)) among groups classified by smoking behavior, pack-years, number of cigarettes per day, duration of smoking, and duration and time of smoking cessation. Results In men, current smokers had a lower odds ratio (OR) for obesity of 0.80 (95% confidence interval (CI): 0.72-0.88) compared to non-smokers, whereas past smokers had a higher OR of 1.23 (95% CI: 1.09-1.37) compared to current smokers. In women, there were no differences in obesity between the three groups classified by smoking behavior. However, in both sexes, the prevalence of obesity tended to increase with pack-years and the number of cigarettes per day, but not with duration of smoking in current and past smokers. Further, in male smokers, the risks for obesity were markedly higher in short-term heavy smokers compared with long-term light smokers, even with the same number of pack-years. Regarding the impact of smoking cessation, female past smokers who quit smoking at an age > 55-years had an elevated OR of 1.60 (95% CI: 1.05-2.38) for obesity. Conclusions In a general Japanese population, obesity is progressively associated with pack-years and number of cigarettes per day, but not with the duration of smoking. When investigating the association between obesity and cigarette smoking, the daily smoking burden and the duration of smoking require to be independently considered.	[Watanabe, Taku; Tsujino, Ichizo; Konno, Satoshi; Takashina, Chisa; Sato, Takahiro; Isada, Akira; Ohira, Hiroshi; Ohtsuka, Yoshinori; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan; [Fukutomi, Yuma; Taniguchi, Masami] Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan; [Kawagishi, Yukio] Kurobe City Hosp, Dept Internal Med, Toyama, Japan; [Okada, Chiharu] Headquarter Natl Hosp Org, Dept Med, Tokyo, Japan; [Okada, Chiharu] Natl Hosp Org Tokyo Med Ctr, Dept Allergy, Tokyo, Japan; [Hizawa, Nobuyuki] Univ Tsukuba, Fac Med, Dept Pulm Med, Tsukuba, Ibaraki, Japan; [Akasawa, Akira] Tokyo Metropolitan Childrens Med Ctr, Dept Allergy, Tokyo, Japan	Hokkaido University; Hokkaido University; Kanazawa University; University of Tsukuba; Tokyo Metropolitan Children's Medical Center	Konno, S (corresponding author), Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan.	satkonno@med.hokudai.ac.jp	Nishimura, Masaharu/A-4062-2012; Fukutomi, Yuma/AFQ-4306-2022	Nishimura, Masaharu/0000-0002-6456-4361; Ito, Yoichi M./0000-0001-5073-0827; Watanabe, Taku/0000-0002-3195-2413	Ministry of Health, Labor, and Welfare, Japan [H16-meneki-ippan-010]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health and Labor Science Research Grants from the Ministry of Health, Labor, and Welfare, Japan. The grant number is "H16-meneki-ippan-010". The URL is http:// www.mhlw.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; [Anonymous], 2006, HLTH CONS INV EXP TO; [Anonymous], 2000, WHO TECHN REP SER; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; Caan B, 1996, J AM DIET ASSOC, V96, P1150, DOI 10.1016/S0002-8223(96)00296-9; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Clair C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-23; de Marco R, 1999, EUR RESPIR J, V14, P1044, DOI 10.1183/09031936.99.14510449; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Froom P, 1998, J FAM PRACTICE, V46, P460; Fuente-Martin E, 2013, ADIPOCYTE, V2, P128, DOI 10.4161/adip.24075; Fukutomi Y, 2010, INT ARCH ALLERGY IMM, V153, P280, DOI 10.1159/000314369; Hermann AP, 2000, J BONE MINER RES, V15, P780, DOI 10.1359/jbmr.2000.15.4.780; Japan Society for the Study of Obesity, 2011, J JPN SOC STUDY OBES, V17, P1; John U, 2005, INT J OBESITY, V29, P1289, DOI 10.1038/sj.ijo.0803028; Kawada T, 2004, ARCH MED RES, V35, P181, DOI 10.1016/j.arcmed.2003.09.012; Kim JH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045815, DOI 10.1371/J0URNAL.P0NE.0045815]; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; Mackay DF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-348; MCKINLAY SM, 1985, ANN INTERN MED, V103, P350, DOI 10.7326/0003-4819-103-3-350; Ministry of Health Labour and Welfare Japan, 2007, OUTL RES NAT HLTH NU; National Center for Chronic Disease Prevention, 2010, TOB SMOK CAUS DIS BI; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Park YW, 2001, OBES RES, V9, P381, DOI 10.1038/oby.2001.49; PERKINS KA, 1993, J CONSULT CLIN PSYCH, V61, P768, DOI 10.1037/0022-006X.61.5.768; Stokes ME, 2000, CATEGORICAL DATA ANA; SWAN GE, 1995, AM J PUBLIC HEALTH, V85, P73, DOI 10.2105/AJPH.85.1.73; Troost JP, 2012, J EPIDEMIOL GLOB HEA, V2, P135, DOI 10.1016/j.jegh.2012.06.003; Vartiainen E, 2002, J EPIDEMIOL COMMUN H, V56, P167, DOI 10.1136/jech.56.3.167; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; Xu F, 2007, ASIA PAC J CLIN NUTR, V16, P240; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0148926	10.1371/journal.pone.0148926	http://dx.doi.org/10.1371/journal.pone.0148926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007232	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200016
J	Audemard-Verger, A; Silva, NM; Verstuyft, C; Costedoat-Chalumeau, N; Hummel, A; Le Guern, V; Sacre, K; Meyer, O; Daugas, E; Goujard, C; Sultan, A; Lobbedez, T; Galicier, L; Pourrat, J; Le Hello, C; Godin, M; Morello, R; Lambert, M; Hachulla, E; Vanhille, P; Queffeulou, G; Potier, J; Dion, JJ; Bataille, P; Chauveau, D; Moulis, G; Farge-Bancel, D; Duhaut, P; Saint-Marcoux, B; Deroux, A; Manuzak, J; Frances, C; Aumaitre, O; Bezanahary, H; Becquemont, L; Bienvenu, B				Audemard-Verger, Alexandra; Silva, Nicolas Martin; Verstuyft, Celine; Costedoat-Chalumeau, Nathalie; Hummel, Aurelie; Le Guern, Veronique; Sacre, Karim; Meyer, Olivier; Daugas, Eric; Goujard, Cecile; Sultan, Audrey; Lobbedez, Thierry; Galicier, Lionel; Pourrat, Jacques; Le Hello, Claire; Godin, Michel; Morello, Remy; Lambert, Marc; Hachulla, Eric; Vanhille, Philippe; Queffeulou, Guillaume; Potier, Jacky; Dion, Jean-Jacques; Bataille, Pierre; Chauveau, Dominique; Moulis, Guillaume; Farge-Bancel, Dominique; Duhaut, Pierre; Saint-Marcoux, Bernadette; Deroux, Alban; Manuzak, Jennifer; Frances, Camille; Aumaitre, Olivier; Bezanahary, Holy; Becquemont, Laurent; Bienvenu, Boris			Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide	PLOS ONE			English	Article							PULSE CYCLOPHOSPHAMIDE; GENETIC-POLYMORPHISM; ERYTHEMATOSUS; PREVALENCE; EXPRESSION; PHARMACOKINETICS; PREDICTOR; MORBIDITY; TOXICITY; THERAPY	Objective To investigate association between genetic polymorphisms of GST, CYP and renal outcome or occurrence of adverse drug reactions (ADRs) in lupus nephritis (LN) treated with cyclophosphamide (CYC). CYC, as a pro-drug, requires bioactivation through multiple hepatic cytochrome P450s and glutathione S transferases (GST). Methods We carried out a multicentric retrospective study including 70 patients with proliferative LN treated with CYC. Patients were genotyped for polymorphisms of the CYP2B6, CYP2C19, GSTP1, GSTM1 and GSTT1 genes. Complete remission (CR) was defined as proteinuria <= 0.33g/day and serum creatinine <= 124 mu mol/l. Partial remission (PR) was defined as proteinuria <= 1.5g/day with a 50% decrease of the baseline proteinuria value and serum creatinine no greater than 25% above baseline. Results Most patients were women (84%) and 77% were Caucasian. The mean age at LN diagnosis was 41 +/- 10 years. The frequency of patients carrying the GST null genotype GSTT1-, GSTM1-, and the Ile -> 105Val GSTP1 genotype were respectively 38%, 60% and 44%. In multivariate analysis, the Ile -> 105Val GSTP1 genotype was an independent factor of poor renal outcome (achievement of CR or PR) (OR = 5.01 95% CI [1.02-24.51]) and the sole factor that influenced occurrence of ADRs was the GSTM1 null genotype (OR = 3.34 95% CI [1.064-10.58]). No association between polymorphisms of cytochrome P450s gene and efficacy or ADRs was observed. Conclusion This study suggests that GST polymorphisms highly impact renal outcome and occurrence of ADRs related to CYC in LN patients.	[Audemard-Verger, Alexandra; Silva, Nicolas Martin; Sultan, Audrey; Bienvenu, Boris] CHU Caen, Dept Internal Med, F-14000 Caen, France; [Verstuyft, Celine; Becquemont, Laurent] Hop Kremlin Bicetre, Dept Pharmacol, Le Kremlin Bicetre, France; [Costedoat-Chalumeau, Nathalie; Le Guern, Veronique] Univ Paris 05, Hop Cochin, AP HP, Dept Internal Med, Paris, France; [Hummel, Aurelie] Hop Necker Enfants Malad, Dept Nephrol, Paris, France; [Sacre, Karim] Hop Bichat Claude Bernard, Dept Internal Med, F-75877 Paris, France; [Meyer, Olivier] Hop Bichat Claude Bernard, Dept Rheumatol, F-75877 Paris, France; [Daugas, Eric] Hop Bichat Claude Bernard, Dept Nephrol, F-75877 Paris, France; [Goujard, Cecile] Hop Kremlin Bicetre, Dept Internal Med, Le Kremlin Bicetre, France; [Lobbedez, Thierry] CHU Caen, Dept Nephrol, F-14000 Caen, France; [Galicier, Lionel] Hop St Louis, Dept Clin Immunopathol, Paris, France; [Pourrat, Jacques; Chauveau, Dominique] CHU Toulouse, Dept Nephrol & Clin Immunol, Toulouse, France; [Le Hello, Claire] CHU Caen, Dept Vasc Med, F-14000 Caen, France; [Godin, Michel] CHU Rouen, Dept Nephrol, Rouen, France; [Morello, Remy] CHU Caen, Biostat Unity, F-14000 Caen, France; [Lambert, Marc; Hachulla, Eric] CHU Lille, Dept Internal Med, F-59037 Lille, France; [Vanhille, Philippe] CH Valenciennes, Dept Nephrol, Valenciennes, France; [Queffeulou, Guillaume; Potier, Jacky] CH Cherbourg, Dept Nephrol, Cherbourg, France; [Dion, Jean-Jacques] CH Charleville Meziere, Dept Nephrol, Charleville Meziere, France; [Bataille, Pierre] CH Boulogne Sur Mer, Dept Nephrol, Boulogne Sur Mer, France; [Moulis, Guillaume] CHU Toulouse, Dept Internal Med, Toulouse, France; [Moulis, Guillaume] Univ Toulouse, INSERM, UMR 1027, Toulouse, France; [Moulis, Guillaume] CIC 1436, Toulouse, France; [Farge-Bancel, Dominique] Hop St Louis, Dept Internal Med, Paris, France; [Duhaut, Pierre] CHU Amiens, Dept Internal Med, Amiens, France; [Saint-Marcoux, Bernadette] Hop Aulnay Sous Bois, Dept Rheumatol, Aulnay Sous Bois, France; [Deroux, Alban] CHU Grenoble, Dept Internal Med, F-38043 Grenoble, France; [Manuzak, Jennifer] Inst Cochin, Dept Immunol, Paris, France; [Frances, Camille] Hop Tenon, Dept Dermatol, F-75970 Paris, France; [Aumaitre, Olivier] CHU Clermont Ferrand, Dept Internal Med, Clermont Ferrand, France; [Bezanahary, Holy] CHU Limoges, Dept Internal Med, Limoges, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU de Caen NORMANDIE; Universite de Caen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Rouen; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Lille - ISITE; CHU Lille; CH de Valenciennes; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; CHU Limoges	Audemard-Verger, A (corresponding author), CHU Caen, Dept Internal Med, F-14000 Caen, France.	alexandra.audemard@gmail.com	lambert, marc/V-7380-2017; verstuyft, celine/AAU-3343-2021; DEROUX, Alban/AGN-3318-2022; HACHULLA, ERIC/R-8488-2018; Silva, Nicolas Martins da/HDO-6805-2022; MORELLO, Rémy/L-7724-2015; LOBBEDEZ, Thierry/L-7730-2015	lambert, marc/0000-0002-3485-8238; verstuyft, celine/0000-0002-8534-224X; DEROUX, Alban/0000-0002-9098-7368; HACHULLA, ERIC/0000-0001-7432-847X; Silva, Nicolas Martins da/0000-0001-8288-3174; MORELLO, Rémy/0000-0002-1282-2306; Sacre, Karim/0000-0002-6544-234X; DAUGAS, Eric/0000-0001-7256-7979; Manuzak, Jennifer/0000-0002-0079-2306; , nathalie/0000-0002-1555-9021				Arnaud L, 2014, AUTOIMMUN REV, V13, P1082, DOI 10.1016/j.autrev.2014.08.034; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; CAMPBELL JAH, 1991, CANCER, V67, P1608, DOI 10.1002/1097-0142(19910315)67:6<1608::AID-CNCR2820670623>3.0.CO;2-S; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chou M, 2010, ANTIMICROB AGENTS CH, V54, P4432, DOI 10.1128/AAC.00512-10; de Jonge ME, 2005, CLIN PHARMACOKINET, V44, P1135, DOI 10.2165/00003088-200544110-00003; DIRVEN HAAM, 1994, CANCER RES, V54, P6215; Ekhart C, 2008, PHARMACOGENET GENOM, V18, P515, DOI 10.1097/FPC.0b013e3282fc9766; Hadshiew I, 1997, DERMATOLOGY, V195, P362, DOI 10.1159/000245989; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; McLeod HL, 2010, J CLIN ONCOL, V28, P3227, DOI 10.1200/JCO.2009.21.7943; Moroni G, 2013, LUPUS, V22, P810, DOI 10.1177/0961203313492576; Sim SC, 2006, CLIN PHARMACOL THER, P79103; Simon T, 2000, CLIN PHARMACOL THER, V67, P432, DOI 10.1067/mcp.2000.104944; Singh G, 2007, J RHEUMATOL, V34, P731; STEINBERG AD, 1991, ARTHRITIS RHEUM-US, V34, P945, DOI 10.1002/art.1780340803; Takada K, 2004, ARTHRITIS RHEUM-US, V50, P2202, DOI 10.1002/art.20338; Vester U, 2005, PEDIATR NEPHROL, V20, P478, DOI 10.1007/s00467-004-1759-7; Wang F, 1997, LUPUS, V6, P248, DOI 10.1177/096120339700600306; Winoto J, 2011, CLIN NEPHROL, V75, P451, DOI 10.5414/CN106886; Xie HG, 1999, PHARMACOGENETICS, V9, P539, DOI 10.1097/01213011-199910000-00001; Zanger UM, 2007, PHARMACOGENOMICS, V8, P743, DOI 10.2217/14622416.8.7.743; Zhong SL, 2006, BRIT J CLIN PHARMACO, V62, P457, DOI 10.1111/j.1365-2125.2006.02690.x	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151696	10.1371/journal.pone.0151696	http://dx.doi.org/10.1371/journal.pone.0151696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002825	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400037
J	Lonic, D; Pai, BCJ; Yamaguchi, K; Chortrakarnkij, P; Lin, HH; Lo, LJ				Lonic, Daniel; Pai, Betty Chien-Jung; Yamaguchi, Kazuaki; Chortrakarnkij, Peerasak; Lin, Hsiu-Hsia; Lo, Lun-Jou			Computer-Assisted Orthognathic Surgery for Patients with Cleft Lip/Palate: From Traditional Planning to Three-Dimensional Surgical Simulation	PLOS ONE			English	Article							OF-LIFE MEASURE; FACIAL ASYMMETRY; INTRAOPERATIVE NAVIGATION; CRANIOFACIAL MORPHOLOGY; DENTOFACIAL DEFORMITY; SPLINT; ACCURACY; CEPHALOMETRICS; RELIABILITY; PROTOCOL	Background Although conventional two-dimensional (2D) methods for orthognathic surgery planning are still popular, the use of three-dimensional (3D) simulation is steadily increasing. In facial asymmetry cases such as in cleft lip/palate patients, the additional information can dramatically improve planning accuracy and outcome. The purpose of this study is to investigate which parameters are changed most frequently in transferring a traditional 2D plan to 3D simulation, and what planning parameters can be better adjusted by this method. Patients and Methods This prospective study enrolled 30 consecutive patients with cleft lip and/or cleft palate (mean age 18.6 +/- 2.9 years, range 15 to 32 years). All patients received two-jaw single-splint orthognathic surgery. 2D orthodontic surgery plans were transferred into a 3D setting. Severe bony collisions in the ramus area after 2D plan transfer were noted. The position of the maxillo-mandibular complex was evaluated and eventually adjusted. Position changes of roll, midline, pitch, yaw, genioplasty and their frequency within the patient group were recorded as an alternation of the initial 2D plan. Patients were divided in groups of no change from the original 2D plan and changes in one, two, three and four of the aforementioned parameters as well as subgroups of unilateral, bilateral cleft lip/palate and isolated cleft palate cases. Postoperative OQLQ scores were obtained for 20 patients who finished orthodontic treatment. Results 83.3% of 2D plans were modified, mostly concerning yaw (63.3%) and midline (36.7%) adjustments. Yaw adjustments had the highest mean values in total and in all subgroups. Severe bony collisions as a result of 2D planning were seen in 46.7% of patients. Possible asymmetry was regularly foreseen and corrected in the 3D simulation. Conclusion Based on our findings, 3D simulation renders important information for accurate planning in complex cleft lip/palate cases involving facial asymmetry that is regularly missed in conventional 2D planning.	[Lonic, Daniel; Yamaguchi, Kazuaki; Lo, Lun-Jou] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Lonic, Daniel; Pai, Betty Chien-Jung; Yamaguchi, Kazuaki; Lo, Lun-Jou] Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan; [Pai, Betty Chien-Jung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Craniofacial Orthodont, Taoyuan, Taiwan; [Chortrakarnkij, Peerasak] Mahidol Univ, Siriraj Hosp, Div Plast Surg, Bangkok 10700, Thailand; [Lin, Hsiu-Hsia] Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Mahidol University; Chang Gung Memorial Hospital	Lo, LJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan.; Lo, LJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan.	lunjoulo@cgmh.org.tw		Lin, Hsiu-Hsia/0000-0002-4252-4182	Chang Gung Memorial Hospital [CMRPG381601-3, CMRPG3B0291-3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by Chang Gung Memorial Hospital, Grants CMRPG381601-3 and CMRPG3B0291-3, cgmh.org.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Abuhijleh E, 2014, J ORAL SCI, V56, P165, DOI 10.2334/josnusd.56.165; ALTOBELLI DE, 1993, PLAST RECONSTR SURG, V92, P576, DOI 10.1097/00006534-199309001-00003; Bergeron L, 2008, PLAST RECONSTR SURG, V122, P1535, DOI 10.1097/PRS.0b013e31818820d8; Caloss Ron, 2007, Oral Maxillofac Surg Clin North Am, V19, P287, DOI 10.1016/j.coms.2007.04.006; Chang HW, 2015, J CRANIO MAXILL SURG, V43, P1119, DOI 10.1016/j.jcms.2015.06.009; Chien PC, 2009, DENTOMAXILLOFAC RAD, V38, P262, DOI 10.1259/dmfr/81889955; Cunningham SJ, 2002, COMMUNITY DENT ORAL, V30, P81, DOI 10.1034/j.1600-0528.2002.300201.x; Cunningham ST, 2000, COMMUNITY DENT ORAL, V28, P195, DOI 10.1034/j.1600-0528.2000.280305.x; Silva Maurício Barbosa Guerra da, 2013, Dental Press J. Orthod., V18, P63; Dai JW, 2014, J CRANIOFAC SURG, V25, pE140, DOI 10.1097/SCS.0000000000000414; De Riu G, 2014, BRIT J ORAL MAX SURG, V52, P251, DOI 10.1016/j.bjoms.2013.12.010; FARKAS LG, 1981, ANGLE ORTHOD, V51, P70; Gateno J, 2007, J ORAL MAXIL SURG, V65, P728, DOI 10.1016/j.joms.2006.04.001; Gateno J, 2011, J ORAL MAXIL SURG, V69, P606, DOI 10.1016/j.joms.2010.09.010; Guyuron B, 2008, PLAST RECONSTR SURG, V121, P1015, DOI [10.1097/01.prs.0000305931.98111.c3, 10.1097/01.prs.0000305955.67554.40, 10.1097/01.prs.0000299464.02430.78]; Haas OL, 2015, INT J ORAL MAX SURG, V44, P329, DOI 10.1016/j.ijom.2014.10.025; Halazonetis DJ, 2005, AM J ORTHOD DENTOFAC, V127, P627, DOI 10.1016/j.ajodo.2005.01.004; Hammoudeh JA, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000184; Hernandez-Alfaro F, 2013, INT J ORAL MAX SURG, V42, P1547, DOI 10.1016/j.ijom.2013.03.025; Hsu SSP, 2013, J ORAL MAXIL SURG, V71, P128, DOI 10.1016/j.joms.2012.03.027; Huang C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1016/J.J0MS.2013.08.004; Huang CS, 2013, ORTHOD CRANIOFAC RES, V16, P97, DOI 10.1111/ocr.12010; Hurst C. A., 2007, PLAST RECONSTR SURG, V120, p92e; Kusnoto B, 2007, CLIN PLAST SURG, V34, P417, DOI 10.1016/j.cps.2007.04.005; Kwon TG, 2006, INT J ORAL MAX SURG, V35, P43, DOI 10.1016/j.ijom.2005.04.006; Lee S, 2008, J ORAL MAXIL SURG, V66, P1194, DOI 10.1016/j.joms.2008.01.006; Li B, 2013, BRIT J ORAL MAX SURG, V51, pE239, DOI 10.1016/j.bjoms.2013.03.007; Lin HH, 2015, INT J COMPUT ASS RAD, V10, P2021, DOI 10.1007/s11548-015-1223-0; Lin HH, 2015, J FORMOS MED ASSOC, V114, P300, DOI 10.1016/j.jfma.2015.01.017; Lin HH, 2015, ANN PLAS SURG, V74, pS118, DOI 10.1097/SAP.0000000000000455; Lin HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117604; Lin HH, 2013, J ORAL MAXIL SURG, V71, P1933, DOI 10.1016/j.joms.2013.06.199; Lonic D, 2016, J FORMOS MED ASSOC, V115, P387, DOI 10.1016/j.jfma.2015.09.002; Maglione M, 2012, INT J DENT, V2012, DOI 10.1155/2012/285693; Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2008.11.023; Mori Y, 2011, ORAL MAXILLOFAC SURG, V15, P131, DOI 10.1007/s10006-010-0247-4; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Rinchuse DJ, 2006, AM J ORTHOD DENTOFAC, V129, P299, DOI 10.1016/j.ajodo.2005.03.019; Shehab MF, 2013, OR SURG OR MED OR PA, V115, pE16, DOI 10.1016/j.oooo.2011.09.035; Song WW, 2013, J ORAL MAXIL SURG, V71, P752, DOI 10.1016/j.joms.2012.07.043; Sun Y, 2013, J CRANIOFAC SURG, V24, P1871, DOI 10.1097/SCS.0b013e31829a80d9; Xia JJ, 2007, J ORAL MAXIL SURG, V65, P248, DOI 10.1016/j.joms.2006.10.005; Xia JJ, 2011, J ORAL MAXIL SURG, V69, P2014, DOI 10.1016/j.joms.2011.02.018; Zinser MJ, 2013, J ORAL MAXILLOFAC SU, V71, P2151, DOI DOI 10.1016/J.J0MS.2013.07.007; Zizelmann C, 2012, J ORAL MAXIL SURG, V70, P1944, DOI 10.1016/j.joms.2011.08.025	46	45	48	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152014	10.1371/journal.pone.0152014	http://dx.doi.org/10.1371/journal.pone.0152014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002726	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400064
J	Uriarte, JJ; Meirelles, T; del Blanco, DG; Nonaka, PN; Campillo, N; Sarri, E; Navajas, D; Egea, G; Farre, R				Uriarte, Juan J.; Meirelles, Thayna; del Blanco, Darya Gorbenko; Nonaka, Paula N.; Campillo, Noelia; Sarri, Elisabet; Navajas, Daniel; Egea, Gustavo; Farre, Ramon			Early Impairment of Lung Mechanics in a Murine Model of Marfan Syndrome	PLOS ONE			English	Article							IN-VITRO; MICROMECHANICAL PROPERTIES; EXTRACELLULAR-MATRIX; PULMONARY-FUNCTION; TGF-BETA; FIBRILLIN; MICE; PATHOGENESIS; EMPHYSEMA; PRESSURE	Early morbidity and mortality in patients with Marfan syndrome (MFS) -a connective tissue disease caused by mutations in fibrillin-1 gene- are mainly caused by aorta aneurysm and rupture. However, the increase in the life expectancy of MFS patients recently achieved by reparatory surgery promotes clinical manifestations in other organs. Although some studies have reported respiratory alterations in MFS, our knowledge of how this connective tissue disease modifies lung mechanics is scarce. Hence, we assessed whether the stiffness of the whole lung and of its extracellular matrix (ECM) is affected in a well-characterized MFS mouse model (FBN1(C1039G/+)). The stiffness of the whole lung and of its ECM were measured by conventional mechanical ventilation and atomic force microscopy, respectively. We studied 5-week and 9-month old mice, whose ages are representative of early and late stages of the disease. At both ages, the lungs of MFS mice were significantly more compliant than in wild type (WT) mice. By contrast, no significant differences were found in local lung ECM stiffness. Moreover, histopathological lung evaluation showed a clear emphysematous-like pattern in MFS mice since alveolar space enlargement was significantly increased compared with WT mice. These data suggest that the mechanism explaining the increased lung compliance in MFS is not a direct consequence of reduced ECM stiffness, but an emphysema-like alteration in the 3D structural organization of the lung. Since lung alterations in MFS are almost fully manifested at an early age, it is suggested that respiratory monitoring could provide early biomarkers for diagnosis and/or follow-up of patients with the Marfan syndrome.	[Uriarte, Juan J.; Nonaka, Paula N.; Campillo, Noelia; Navajas, Daniel; Farre, Ramon] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Uriarte, Juan J.; Campillo, Noelia; Navajas, Daniel; Farre, Ramon] CIBER Enfermedades Resp, Madrid, Spain; [Meirelles, Thayna; del Blanco, Darya Gorbenko; Sarri, Elisabet; Egea, Gustavo] Univ Barcelona, Dept Biol Cel Lular Immunol & Neurociencies, Barcelona 7, Spain; [Nonaka, Paula N.] Nove Julho Univ, Masters & Doctoral Degree Programs Rehabil Sci, Sao Paulo, Brazil; [Campillo, Noelia; Navajas, Daniel] Inst Bioengn Catalunya, Barcelona, Spain; [Egea, Gustavo] Univ Barcelona, Inst Nanociencies & Nanotecnol, Barcelona 7, Spain; [Egea, Gustavo; Farre, Ramon] Inst Invest Biomed August Pi Sunyer, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Universidade Nove de Julho; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Farre, R (corresponding author), Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain.; Farre, R (corresponding author), CIBER Enfermedades Resp, Madrid, Spain.; Farre, R (corresponding author), Inst Invest Biomed August Pi Sunyer, Barcelona, Spain.	rfarre@ub.edu	Sarri, Elisabet/AHA-6911-2022; Farre, Ramon/L-2664-2017; Navajas, Daniel/E-4233-2010; Gorbenko del Blanco, Darya/N-6069-2018; Egea, Gustavo/I-2394-2014	Sarri, Elisabet/0000-0002-2435-399X; Farre, Ramon/0000-0002-9084-7824; Campillo, Noelia/0000-0001-9712-3784; Navajas, Daniel/0000-0001-7150-9363; Gorbenko del Blanco, Darya/0000-0002-9674-2388; Egea, Gustavo/0000-0001-5242-150X	National Counsel of Technological and Scientific Development-Science without Borders scholarship program (Brazilian federal government); Fundacio Marato-TV3 [122310]; Fundacion Ramon Areces; Spanish Ministry of Economy and Competitiveness [FIS14-22576, FIS-PI11/00089, BFU2012-33932]	National Counsel of Technological and Scientific Development-Science without Borders scholarship program (Brazilian federal government); Fundacio Marato-TV3; Fundacion Ramon Areces; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Thayna Meirelles and Paula N. Nonaka were supported by fellowships from National Counsel of Technological and Scientific Development-Science without Borders scholarship program (Brazilian federal government). This work was supported by grants of Fundacio Marato-TV3 (122310), Fundacion Ramon Areces, and the Spanish Ministry of Economy and Competitiveness (FIS14-22576, FIS-PI11/00089 and BFU2012-33932).	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Andreu I, 2014, ACTA BIOMATER, V10, P3235, DOI 10.1016/j.actbio.2014.03.034; BATES JHT, 1985, J APPL PHYSIOL, V58, P1840, DOI 10.1152/jappl.1985.58.6.1840; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Canadas V, 2010, NAT REV CARDIOL, V7, P256, DOI 10.1038/nrcardio.2010.30; Cannizzaro V, 2009, RESP PHYSIOL NEUROBI, V165, P61, DOI 10.1016/j.resp.2008.10.006; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Chiumello D, 2014, INTENS CARE MED, V40, P1670, DOI 10.1007/s00134-014-3415-4; Cistulli PA, 2001, CHEST, V120, P1455, DOI 10.1378/chest.120.5.1455; Corsico AG, 2014, PANMINERVA MED, V56, P177; Davis MR, 2012, MOL GENET METAB, V107, P635, DOI 10.1016/j.ymgme.2012.07.023; Deb PP, 2014, J TISSUE ENG REGEN M; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dinwiddie Robert, 2005, Paediatr Respir Rev, V6, P181, DOI 10.1016/j.prrv.2005.06.007; Dyhdalo K, 2011, AM J CLIN PATHOL, V136, P857, DOI 10.1309/AJCP79SNDHGKQFIN; Faffe DS, 2009, PHYSIOL REV, V89, P759, DOI 10.1152/physrev.00019.2007; Ferruzzi J, 2011, CARDIOVASC RES, V92, P287, DOI 10.1093/cvr/cvr195; Giske L, 2003, J REHABIL MED, V35, P221, DOI 10.1080/16501970306095; Gould RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044639; Groves AM, 2013, AM J PHYSIOL-LUNG C, V305, pL555, DOI 10.1152/ajplung.00027.2013; Huang KW, 2007, J APPL PHYSIOL, V102, P1632, DOI 10.1152/japplphysiol.00833.2006; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; Jensen T, 2012, TISSUE ENG PART C-ME, V18, P632, DOI [10.1089/ten.tec.2011.0584, 10.1089/ten.TEC.2011.0584]; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; da Palma RK, 2015, RESP PHYSIOL NEUROBI, V207, P58, DOI 10.1016/j.resp.2014.12.013; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548; Lima BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014136; Limjunyawong N, 2015, AM J PHYSIOL-LUNG C, V309, pL662, DOI 10.1152/ajplung.00214.2015; Liu F, 2011, JOVE-J VIS EXP, DOI 10.3791/2911; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044; Machado MN, 2014, RESP PHYSIOL NEUROBI, V200, P90, DOI 10.1016/j.resp.2014.06.005; Mariko B, 2011, J PATHOL, V224, P33, DOI 10.1002/path.2840; MECHAM RP, 1991, ANN NY ACAD SCI, V624, P137, DOI 10.1111/j.1749-6632.1991.tb17013.x; Melo E, 2014, J MECH BEHAV BIOMED, V37, P186, DOI 10.1016/j.jmbbm.2014.05.019; Melo E, 2014, TISSUE ENG PART C-ME, V20, P412, DOI [10.1089/ten.tec.2013.0325, 10.1089/ten.TEC.2013.0325]; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng DK, 1999, J PAEDIATR CHILD H, V35, P321, DOI 10.1046/j.1440-1754.1999.00355.x; Nonaka PN, 2014, J BIOMED MATER RES A, V102, P413, DOI 10.1002/jbm.a.34708; Perea-Gil I, 2015, AM J TRANSL RES, V7, P558; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pyeritz RE, 2009, HEART, V95, P173, DOI 10.1136/hrt.2008.160515; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Robbesom AA, 2008, MODERN PATHOL, V21, P297, DOI 10.1038/modpathol.3801004; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SALDIVA PHN, 1992, J APPL PHYSIOL, V72, P302, DOI 10.1152/jappl.1992.72.1.302; Sato S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00146; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Silversides CK, 2010, CAN J CARDIOL, V26, pE80, DOI 10.1016/S0828-282X(10)70355-X; STREETEN EA, 1987, CHEST, V91, P408, DOI 10.1378/chest.91.3.408; SUKI B, 1994, J APPL PHYSIOL, V76, P2749, DOI 10.1152/jappl.1994.76.6.2749; Suki B, 2011, COMPREHENSIVE PHYSL; Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015; Szabari MV, 2012, AM J PHYSIOL-LUNG C, V303, pL567, DOI 10.1152/ajplung.00217.2012; Turner JA, THORAX, V31, P771; Von Kodolitsch Y, 2015, APPL CLIN GENET, V8, P137, DOI 10.2147/TACG.S60472; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780	60	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152124	10.1371/journal.pone.0152124	http://dx.doi.org/10.1371/journal.pone.0152124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003297	gold, Green Published			2022-12-27	WOS:000372697400082
J	Jiang, YH; Jhang, JF; Kuo, HC				Jiang, Yuan-Hong; Jhang, Jia-Fong; Kuo, Hann-Chorng			Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis	PLOS ONE			English	Article							HYPERSENSITIVE BLADDER; PATHOGENESIS; EPITHELIUM; EXPRESSION; SYMPTOMS; BIOPSY; WOMEN	Objectives To revisit the diagnostic roles of cystoscopic hydrodistention and the potassium sensitivity test (PST) for the diagnosis of interstitial cystitis (IC). Methods We prospectively enrolled 214 patients clinically diagnosed with IC, 125 non-IC patients who underwent video urodynamic studies and PST, and another 144 non-IC patients who underwent cystoscopic hydrodistention before transurethral surgery. The sensitivity, specificity, and positive and negative predictive values were calculated for the PST and glomerulations after cystoscopic hydrodistention. Results After cystoscopic hydrodistention, glomerulations developed in 211/214 (98.6%) IC patients and 61/144 (42.4%) of the non-IC patients including patients with stones (45/67, 67%), hematuria (2/5, 40%), and stress urinary incontinence (SUI) (6/17, 35%). When positive glomerulation was defined as grade 2 or more, the sensitivity was 61.7%. The PST was positive in 183/214 (85.5%) IC patients and 7/17 (41%) with hypersensitive bladder, 7/32 (22%) with detrusor overactivity, 5/27 (18%) with SUI, 2/21 (10%) with lower urinary tract symptoms, and 2/25 (8%) with bladder outlet obstruction. The PST had a sensitivity of 85.5% and a specificity of 81.6% for diagnosis of IC. IC patients with a positive PST had a significantly smaller urgency sensation capacity, smaller voided volume, and greater bladder pain score. Conclusions Both the PST and glomerulations after hydrodistention are sensitive indicators of IC, but the specificity of glomerulations in the diagnosis of IC is lower than that of the PST. A positive PST is associated with a more hypersensitive bladder and bladder pain, but not the grade of glomerulations in IC patients. Neither test provided 100% diagnostic accuracy for IC, we might select patients into different subgroups based on different PST and hydrodistention results, not for making a diagnosis of IC but for guidance of different treatments.	[Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; Tzu Chi Univ, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Birder LA, 2014, NEUROUROL URODYNAM, V33, P597, DOI 10.1002/nau.22604; Chancellor MB, 2004, UROLOGY, V63, P85, DOI 10.1016/j.urology.2003.10.034; Chung SD, 2011, NEUROUROL URODYNAM, V30, P1300, DOI 10.1002/nau.21057; Engles CD, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.010; Hanno P, 2010, NEUROUROL URODYNAM, V29, P191, DOI 10.1002/nau.20847; Hanno PM, 1999, J UROLOGY, V161, P553, DOI 10.1016/S0022-5347(01)61948-7; Hanno PM, 2001, UROLOGY, V57, P2, DOI 10.1016/S0090-4295(01)01112-8; Hassan AA, 2007, INT J UROL, V14, P738, DOI 10.1111/j.1442-2042.2007.01821.x; Homma Y, 2014, INT J UROL, V21, P43, DOI 10.1111/iju.12314; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; HUNNER GL, 1914, T S SURG GYNECOL, V27, P247; Jiang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110754; Kuo YC, 2012, INT J CLIN PRACT, V66, P146, DOI 10.1111/j.1742-1241.2011.02767.x; Lee JD, 2011, UROLOGY, V78, DOI [10.1016/j.urology.2011.04.055, 10.1016/j.urology.2011.05.050]; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Nigro DA, 1997, UROLOGY, V49, P86, DOI 10.1016/S0090-4295(99)80337-9; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; Parsons CL, 2011, BJU INT, V107, P370, DOI 10.1111/j.1464-410X.2010.09843.x; Parsons CL, 2009, J UROLOGY, V182, P432; Parsons CL, 1998, J UROLOGY, V159, P1862, DOI 10.1016/S0022-5347(01)63178-1; PARSONS CL, 1987, J UROLOGY, V138, P513, DOI 10.1016/S0022-5347(17)43243-5; Saban R, 2008, AM J PHYSIOL-RENAL, V295, pF1613, DOI 10.1152/ajprenal.90344.2008; Shie JH, 2013, BJU INT, V111, P638, DOI 10.1111/j.1464-410X.2012.11466.x; Shie JH, 2012, UROLOGY, V79, P750, DOI 10.1016/j.urology.2011.10.045; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Tamaki M, 2004, J UROLOGY, V172, P945, DOI 10.1097/01.ju.0000135009.55905.cb; Tomaszewski JE, 2001, UROLOGY, V57, P67, DOI 10.1016/S0090-4295(01)01166-9; Waxman JA, 1998, J UROLOGY, V160, P1663, DOI 10.1016/S0022-5347(01)62376-0; Yamada T, 2007, WORLD J UROL, V25, P407, DOI 10.1007/s00345-007-0174-7	29	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151692	10.1371/journal.pone.0151692	http://dx.doi.org/10.1371/journal.pone.0151692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999787	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700057
J	Loewen, RT; Brown, EN; Roy, P; Schuman, JS; Sigal, IA; Loewen, NA				Loewen, Ralitsa T.; Brown, Eric N.; Roy, Pritha; Schuman, Joel S.; Sigal, Ian A.; Loewen, Nils A.			Regionally Discrete Aqueous Humor Outflow Quantification Using Fluorescein Canalograms	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; UVEOSCLERAL OUTFLOW; PORCINE EYES; FACILITY; EXPRESSION; PATHWAY; FLUOROPHOTOMETRY; ANGIOGRAPHY; INJECTION; GLAUCOMA	Purpose To visualize and quantify conventional outflow directly in its anatomic location. Methods We obtained fluorescein canalograms in six porcine whole eyes and six porcine anterior segment cultures. Eyes were perfused with a constant pressure of 15 mmHg using media containing 0.017 mg/ml fluorescein. Flow patterns were visualized using a stereo dissecting microscope equipped for fluorescent imaging. Images were captured every 30 seconds for 20 minutes for time lapse analysis. Anterior chamber cultures were imaged again on day three of culture. Canalograms were first analyzed for filling time per quadrant. We then wrote a program to automatically compute focal flow fits for each macropixel and to detect convergent perilimbal flow patterns with macropixels grouped into 3 equal-radial width rings around the cornea. A generalized additive model was used to determine fluorescence changes of individual macropixels. Results The resulting imaging algorithm deployed 1024 macropixels that were fit to determine maximum intensity and time to fill. These individual fits highlighted the focal flow function. In whole eyes, significantly faster flow was seen in the inferonasal (IN) and superonasal (SN) quadrants compared to the superotemporal (ST) and inferotemporal (IT) ones (p<0.05). In anterior chamber cultures, reduced flow on day 1 increased in all quadrants on day 3 except in IT (p<0.05). Perilimbal ring analysis uncovered convergent perilimbal flow. Conclusions An algorithm was developed that analyzes regional and circumferential outflow patterns. This algorithm found flow patterns that changed over time and differ in whole eyes and anterior segment cultures.	[Loewen, Ralitsa T.; Roy, Pritha; Schuman, Joel S.; Sigal, Ian A.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Brown, Eric N.] Vanderbilt Univ, Sch Med, Dept Ophthalmol, Nashville, TN 37212 USA; [Loewen, Ralitsa T.; Roy, Pritha; Schuman, Joel S.; Sigal, Ian A.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.; Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA USA.	loewenna@upmc.edu	Brown, Eric/A-1018-2010; Schuman, Joel/K-7304-2012	Brown, Eric/0000-0002-2641-1890; Schuman, Joel/0000-0002-8885-3766	National Eye Institute [5R01EY013178-16, 2T32EY017271-06A1, EY023966, KO8EY022737]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [T32EY017271, K08EY022737, P30EY008098, R01EY023966, R01EY013178] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by 5R01EY013178-16 (National Eye Institute; nei.nih.gov) to JSS; Research to Prevent Blindness, Departmental (www.rpbusa.org), to JSS; 2T32EY017271-06A1 (National Eye Institute, nei.nih.gov; IVS Training Program); EY023966 (National Eye Institute, nei.nih.gov) to IAS; and KO8EY022737 (National Eye Institute, nei.nih.gov) to NAL.	Abu-Hassan DW, 2015, STEM CELLS, V33, P751, DOI 10.1002/stem.1885; ASHTON N, 1951, BRIT J OPHTHALMOL, V35, P291, DOI 10.1136/bjo.35.5.291; Barraza RA, 2010, MOL THER, V18, P491, DOI 10.1038/mt.2009.278; BENEDIKT O, 1976, A GRAEF ARCH KLIN EX, V199, P45, DOI 10.1007/BF00660815; Bentzen CF, 1895, GRAEFES ARCH OPHTHAL, V41, P208; BRUBAKER RF, 1985, GRAEF ARCH CLIN EXP, V222, P190, DOI 10.1007/BF02133672; Chung WY, 2015, J KOREAN MED SCI, V30, P716, DOI 10.3346/jkms.2015.30.6.716; Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056; FEGHALI JG, 1986, INVEST OPHTH VIS SCI, V27, P1776; Fellman RL, 2014, J GLAUCOMA, V23, P347, DOI 10.1097/IJG.0b013e31827a06d8; Francis AW, 2012, INVEST OPHTH VIS SCI, V53, P5198, DOI 10.1167/iovs.11-9229; Gabelt BT, 2006, EXP EYE RES, V82, P935, DOI 10.1016/j.exer.2005.12.002; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Grundeken Maik J, 2015, EuroIntervention, V11 Suppl V, pV44, DOI 10.4244/EIJV11SVA10; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Hastie T, 1986, STAT SCI JSTOR; HAYASHI M, 1989, EXP EYE RES, V48, P621, DOI 10.1016/0014-4835(89)90004-3; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; JOHNSON DH, 1987, INVEST OPHTH VIS SCI, V28, P945; Kagemann L, 2010, INVEST OPHTH VIS SCI, V51, P4054, DOI 10.1167/iovs.09-4559; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Khare PD, 2008, MOL THER, V16, P97, DOI 10.1038/sj.mt.6300318; Loewen N, 2002, INVEST OPHTH VIS SCI, V43, P3686; Loewen N, 2001, HUM GENE THER, V12, P2109, DOI 10.1089/10430340152677449; MCMENAMIN PG, 1991, J ANAT, V178, P65; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; MORRISON JC, 1995, INVEST OPHTH VIS SCI, V36, P751; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Sandrian MG, 2012, BRIT J OPHTHALMOL, V96, P1522, DOI 10.1136/bjophthalmol-2012-301904; Schuman JS, 1999, INVEST OPHTH VIS SCI, V40, P1676; Schwalbe G., 1870, ARCH MIKROSK ANAT, V6, P261, DOI DOI 10.1007/BF02955984; Suarez T, 2006, MOL VIS, V12, P1467; Toris CB, 1995, EXP EYE RES, V61, P649, DOI 10.1016/S0014-4835(05)80015-6; TRIPATHI RC, 1971, EXP EYE RES, V12, P311, DOI 10.1016/0014-4835(71)90155-2; Wagner JA, 2004, INVEST OPHTH VIS SCI, V45, P3203, DOI 10.1167/iovs.03-1176; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090690; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yu SY, 2006, EXP EYE RES, V83, P758, DOI 10.1016/j.exer.2006.03.014; Zeppa Lucio, 2014, JAMA Ophthalmol, V132, P1281, DOI 10.1001/jamaophthalmol.2014.567	39	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151754	10.1371/journal.pone.0151754	http://dx.doi.org/10.1371/journal.pone.0151754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998833	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000372694700061
J	Zaccaria, E; Cao, R; Wells, JM; van Baarlen, P				Zaccaria, Edoardo; Cao, Rui; Wells, Jerry M.; van Baarlen, Peter			A Zebrafish Larval Model to Assess Virulence of Porcine Streptococcus suis Strains	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; MURAMIDASE-RELEASED PROTEIN; INNATE IMMUNE-RESPONSE; FUNCTIONAL-ANALYSIS; INFECTIOUS-DISEASE; SEROTYPE-2; PATHOGEN; HOST; PIGS; IDENTIFICATION	Streptococcus suis is an encapsulated Gram-positive bacterium, and the leading cause of sepsis and meningitis in young pigs resulting in considerable economic losses in the porcine industry. It is also considered an emerging zoonotic agent. In the environment, both avirulent and virulent strains occur in pigs, and virulent strains appear to cause disease in both humans and pigs. There is a need for a convenient, reliable and standardized animal model to assess S.suis virulence. A zebrafish (Danio rerio) larvae infection model has several advantages, including transparency of larvae, low cost, ease of use and exemption from ethical legislation up to 6 days post fertilization, but has not been previously established as a model for S. suis. Microinjection of different porcine strains of S. suis in zebrafish larvae resulted in highly reproducible dose- and strain-dependent larval death, strongly correlating with presence of the S. suis capsule and to the original virulence of the strain in pigs. Additionally we compared the virulence of the two-component system mutant of ciaRH, which is attenuated for virulence in both mice and pigs in vivo. Infection of larvae with the Delta ciaRH strain resulted in significantly higher survival rate compared to infection with the S10 wild-type strain. Our data demonstrate that zebrafish larvae are a rapid and reliable model to assess the virulence of clinical porcine S. suis isolates.	[Zaccaria, Edoardo; Cao, Rui; Wells, Jerry M.; van Baarlen, Peter] Wageningen Univ, Dept Anim Sci, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	van Baarlen, P (corresponding author), Wageningen Univ, Dept Anim Sci, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands.	peter.vanbaarlen@wur.nl	Zaccaria, Edoardo/AAP-9740-2020	van Baarlen, Peter/0000-0003-3530-5472				Allgaier A, 2001, J CLIN MICROBIOL, V39, P445, DOI 10.1128/JCM.39.2.445-453.2001; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Benard EL, 2012, JOVE-J VIS EXP, DOI 10.3791/3781; Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779; Cui C, 2011, METHOD CELL BIOL, V105, P273, DOI 10.1016/B978-0-12-381320-6.00012-6; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Ferrando ML, 2015, J INFECT DIS, V212, P95, DOI 10.1093/infdis/jiu813; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kim BJ, 2015, MICROB PATHOGENESIS, V79, P57, DOI 10.1016/j.micpath.2015.01.007; Lakkitjaroen N, 2011, J MED MICROBIOL, V60, P1669, DOI 10.1099/jmm.0.034686-0; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; Levraud JP, 2009, INFECT IMMUN, V77, P3651, DOI 10.1128/IAI.00408-09; Li JQ, 2011, VET MICROBIOL, V148, P99, DOI 10.1016/j.vetmic.2010.08.005; Li YJ, 2012, J GENET GENOMICS, V39, P521, DOI 10.1016/j.jgg.2012.07.006; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Madsen LW, 2002, J VET MED B, V49, P211, DOI 10.1046/j.1439-0450.2002.00491.x; Marini E, 2015, VET MICROBIOL, V178, P99, DOI 10.1016/j.vetmic.2015.04.013; Marois C, 2004, J CLIN MICROBIOL, V42, P3169, DOI 10.1128/JCM.42.7.3169-3175.2004; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Miller JD, 2004, ACTA TROP, V91, P53, DOI 10.1016/j.actatropica.2003.10.020; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 1997, J CLIN MICROBIOL, V35, P1049, DOI 10.1128/JCM.35.5.1049-1053.1997; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Tang F, 2013, GENOMICS, V101, P336, DOI 10.1016/j.ygeno.2013.04.005; Tang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054227; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Vecht U, 1996, VET MICROBIOL, V51, P125, DOI 10.1016/0378-1135(96)00028-4; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Watkins EJ, 2001, LANCET, V357, P38, DOI 10.1016/S0140-6736(00)03570-4; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2001, VET REC, V148, P473, DOI 10.1136/vr.148.15.473; Wu ZF, 2014, GENE, V535, P156, DOI 10.1016/j.gene.2013.11.044; Wu ZF, 2010, MICROB PATHOGENESIS, V48, P178, DOI 10.1016/j.micpath.2010.02.007; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang H, 2010, CURR MICROBIOL, V61, P494, DOI 10.1007/s00284-010-9643-0	60	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151623	10.1371/journal.pone.0151623	http://dx.doi.org/10.1371/journal.pone.0151623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999052	gold, Green Published			2022-12-27	WOS:000372694700049
J	Becker, MA; Ibrahim, YH; Oh, AS; Fagan, DH; Byron, SA; Sarver, AL; Lee, AV; Shaw, LM; Fan, C; Perou, CM; Yee, D				Becker, Marc A.; Ibrahim, Yasir H.; Oh, Annabell S.; Fagan, Dedra H.; Byron, Sara A.; Sarver, Aaron L.; Lee, Adrian V.; Shaw, Leslie M.; Fan, Cheng; Perou, Charles M.; Yee, Douglas			Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; PHASE-II; IRS-1; GANITUMAB; CELLS; ACTIVATION; ANTIBODY; SARCOMA; FAMILY; TUMORS	Therapies targeting the type I insulin-like growth factor receptor (IGF-1R) have not been developed with predictive biomarkers to identify tumors with receptor activation. We have previously shown that the insulin receptor substrate (IRS) adaptor proteins are necessary for linking IGF1R to downstream signaling pathways and the malignant phenotype in breast cancer cells. The purpose of this study was to identify gene expression profiles downstream of IGF1R and its two adaptor proteins. IRS-null breast cancer cells (T47D-YA) were engineered to express IRS-1 or IRS-2 alone and their ability to mediate IGF ligand-induced proliferation, motility, and gene expression determined. Global gene expression signatures reflecting IRS adaptor specific and primary vs. secondary ligand response were derived (Early IRS-1, Late IRS-1, Early IRS-2 and Late IRS-2) and functional pathway analysis examined. IRS isoforms mediated distinct gene expression profiles, functional pathways, and breast cancer subtype association. For example, IRS-1/2-induced TGFb2 expression and blockade of TGFb2 abrogated IGF-induced cell migration. In addition, the prognostic value of IRS proteins was significant in the luminal B breast tumor subtype. Univariate and multivariate analyses confirmed that IRS adaptor signatures correlated with poor outcome as measured by recurrence-free and overall survival. Thus, IRS adaptor protein expression is required for IGF ligand responses in breast cancer cells. IRS-specific gene signatures represent accurate surrogates of IGF activity and could predict response to anti-IGF therapy in breast cancer.	[Becker, Marc A.; Ibrahim, Yasir H.; Oh, Annabell S.; Fagan, Dedra H.; Byron, Sara A.; Sarver, Aaron L.; Yee, Douglas] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Lee, Adrian V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Shaw, Leslie M.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Fan, Cheng; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Fan, Cheng; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; [Becker, Marc A.] Mayo Clin, Ctr Canc, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Yee, D (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA.	yeexx006@umn.edu	Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247; Byron, Sara/0000-0003-0093-0374; Lee, Adrian/0000-0001-9917-514X; Yee, Douglas/0000-0002-3387-4009	Breast Cancer Research Foundation-American Association for Cancer Research Grant for Translational Breast Cancer Research [07-60-26]; Department of Defense Predoctoral Traineeship Award [BC073039]; National Cancer Institute Cancer Center Support Grant [P30 077598]; BCRF-AACR Grant for Translational Breast Cancer Research [07-60-26]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA148761, P50CA058223] Funding Source: NIH RePORTER	Breast Cancer Research Foundation-American Association for Cancer Research Grant for Translational Breast Cancer Research; Department of Defense Predoctoral Traineeship Award(United States Department of Defense); National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCRF-AACR Grant for Translational Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Breast Cancer Research Foundation-American Association for Cancer Research Grant for Translational Breast Cancer Research 07-60-26 (DY), Department of Defense Predoctoral Traineeship Award BC073039 (MAB), and the National Cancer Institute Cancer Center Support Grant P30 077598.; This work was supported by a BCRF-AACR Grant for Translational Breast Cancer Research 07-60-26 (DY), Department of Defense Predoctoral Traineeship Award BC073039 (MAB), and the National Cancer Institute Cancer Center Support Grant P30 077598. We extend our appreciation to Eva Feldman for the use of the IRS overexpressing SH-EP human neuroblastoma cells.	Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jackson JG, 1998, J BIOL CHEM, V273, P9994, DOI 10.1074/jbc.273.16.9994; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; McCaffery I, 2013, CLIN CANCER RES, V19, P4282, DOI 10.1158/1078-0432.CCR-12-1840; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Robertson JFR, 2013, LANCET ONCOL, V14, P228, DOI 10.1016/S1470-2045(13)70026-3; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Schwartz GK, 2013, LANCET ONCOL, V14, P371, DOI 10.1016/S1470-2045(13)70049-4; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Tap WD, 2012, J CLIN ONCOL, V30, P1849, DOI 10.1200/JCO.2011.37.2359; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; Yang YZ, 2014, CANCER RES, V74, P2295, DOI 10.1158/0008-5472.CAN-13-1803; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258	26	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150564	10.1371/journal.pone.0150564	http://dx.doi.org/10.1371/journal.pone.0150564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991655	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000372582800036
J	Janssen, JAMJL; Hofland, LJ; Strasburger, CJ; van den Dungen, ESR; Thevis, M				Janssen, Joseph A. M. J. L.; Hofland, Leo J.; Strasburger, Christian J.; van den Dungen, Elisabeth S. R.; Thevis, Mario			Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations	PLOS ONE			English	Article							MECHANO-GROWTH-FACTOR; SKELETAL-MUSCLE; INSULIN; PEPTIDE; BIOACTIVITY; PROTEINS; PRODUCT; ANALOGS; BINDING	Aims To compare full-length mechano growth factor (full-length MGF) with human recombinant insulin-like growth factor-I (IGF-I) and human recombinant insulin (HI) in their ability to activate the human IGF-I receptor (IGF-IR), the human insulin receptor (IR-A) and the human insulin receptor-B (IR-B), respectively. In addition, we tested the stimulatory activity of human MGF and its stabilized analog Goldspink-MGF on the IGF-IR. Methods The effects of full-length MGF, IGF-I, human mechano growth factor (MGF), Goldspink-MGF and HI were compared using kinase specific receptor activation (KIRA) bioassays specific for IGF-I, IR-A or IR-B, respectively. These assays quantify activity by measuring auto-phosphorylation of the receptor upon ligand binding. Results IGF-IR: At high equimolar concentrations maximal IGF-IR stimulating effects generated by full-length MGF were similar to that of IGF-I (89-fold vs. 77-fold, respectively). However, EC50 values of IGF-I and full-length MGF for the IGF-I receptor were 0.86 nmol/L (95% CI 0.69-1.07) and 7.83 nmol/L (95% CI: 4.87-12.58), respectively. No IGF-IR activation was observed by human MGF and Goldspink-MGF, respectively. IR-A/IR-B: At high equimolar concentrations similar maximal IR-A stimulating effects were observed for full-length MGF and HI, but maximal IR-B stimulation achieved by full -length MGF was stronger than that by HI (292-fold vs. 98-fold). EC50 values of HI and full-length MGF for the IR-A were 1.13 nmol/L (95% CI 0.69-1.84) and 73.11 nmol/L (42.87-124.69), respectively; for IR-B these values were 1.28 nmol/L (95% CI 0.64-2.57) and 35.10 nmol/L (95% 17.52-70.33), respectively. Conclusions Full-length MGF directly stimulates the IGF-IR. Despite a higher EC50 concentration, at high equimolar concentrations full-length MGF showed a similar maximal potency to activate the IGF-IR as compared to IGF-I. Further research is needed to understand the actions of full-length MGF in vivo and to define the physiological relevance of our in vitro findings.	[Janssen, Joseph A. M. J. L.; Hofland, Leo J.; van den Dungen, Elisabeth S. R.] Erasmus MC, Dept Internal Med, Div Endocrinol, Rotterdam, Netherlands; [Strasburger, Christian J.] Charite, Dept Med Endocrinol Diabet & Nutr Med, D-13353 Berlin, Germany; [Thevis, Mario] German Sport Univ Cologne, Inst Biochem, Ctr Prevent Doping Res, Cologne, Germany	Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Sport University Cologne; University of Cologne	Janssen, JAMJL (corresponding author), Erasmus MC, Dept Internal Med, Div Endocrinol, Rotterdam, Netherlands.	j.a.m.j.l.janssen@erasmusmc.nl	Janssen, Joseph A.M.J.L./AAU-5133-2021	Janssen, Joseph A.M.J.L./0000-0002-9363-6408	Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany)	Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany)	The Center for Preventive Doping Research is supported by the Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany)	BASTIAN SEP, 1993, J ENDOCRINOL, V138, P327, DOI 10.1677/joe.0.1380327; Brisson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045588; Brugts MP, 2008, J CLIN ENDOCR METAB, V93, P2539, DOI 10.1210/jc.2007-2454; Chen JW, 2003, AM J PHYSIOL-ENDOC M, V284, pE1149, DOI 10.1152/ajpendo.00410.2002; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Durzynska J, 2013, HORM METAB RES, V45, P415, DOI 10.1055/s-0032-1331699; Durzynska J, 2013, ENDOCRINOLOGY, V154, P1215, DOI 10.1210/en.2012-1992; Fornaro M, 2014, AM J PHYSIOL-ENDOC M, V306, pE150, DOI 10.1152/ajpendo.00408.2013; FRANCIS GL, 1992, J MOL ENDOCRINOL, V8, P213, DOI 10.1677/jme.0.0080213; Goldspink G, 2006, INT J BIOCHEM CELL B, V38, P480, DOI 10.1016/j.biocel.2005.10.013; Goldspink G, 2002, STRENGTH POWER SPORT, P231; Goodman HM, 2009, BASIC MEDICAL ENDOCRINOLOGY, 4TH EDITION, P91; Hede MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051152; JENKINS N, 1994, ENZYME MICROB TECH, V16, P354, DOI 10.1016/0141-0229(94)90149-X; Martins KJB, 2013, GROWTH HORM IGF RES, V23, P128, DOI 10.1016/j.ghir.2013.03.002; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; Philippou A, 2014, MOL MED, V20, P202, DOI 10.2119/molmed.2014.00011; Sadick MD, 1999, J PHARMACEUT BIOMED, V19, P883, DOI 10.1016/S0731-7085(98)00144-7; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Thevis M, 2014, GROWTH HORM IGF RES, V24, P276, DOI 10.1016/j.ghir.2014.10.004; Tomas FM, 1997, J ENDOCRINOL, V155, P377, DOI 10.1677/joe.0.1550377; Varewijck AJ, 2013, DIABETES, V62, P2539, DOI 10.2337/db12-1773; Varewijck AJ, 2013, MOL CELL ENDOCRINOL, V365, P17, DOI 10.1016/j.mce.2012.08.021; Varewijck AJ, 2012, ENDOCR-RELAT CANCER, V19, pF63, DOI 10.1530/ERC-12-0026; Voorhamme D, 2006, MOL BIOTECHNOL, V34, P201, DOI 10.1385/MB:34:2:201; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150453	10.1371/journal.pone.0150453	http://dx.doi.org/10.1371/journal.pone.0150453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991004	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800031
J	Mandal, S; Mahapa, A; Biswas, A; Jana, B; Polley, S; Sau, K; Sau, S				Mandal, Sukhendu; Mahapa, Avisek; Biswas, Anindya; Jana, Biswanath; Polley, Soumitra; Sau, Keya; Sau, Subrata			A Surfactant-Induced Functional Modulation of a Global Virulence Regulator from Staphylococcus aureus	PLOS ONE			English	Article							METHICILLIN-RESISTANT; TRITON X-100; CRYSTAL-STRUCTURE; GENE-REGULATION; IN-VITRO; SARA; PROTEIN; DETERMINANTS; OXACILLIN; BINDING	Triton X-100 (TX-100), a useful non-ionic surfactant, reduced the methicillin resistance in Staphylococcus aureus significantly. Many S. aureus proteins were expressed in the presence of TX-100. SarA, one of the TX-100-induced proteins, acts as a global virulence regulator in S. aureus. To understand the effects of TX-100 on the structure, and function of SarA, a recombinant S. aureus SarA (rSarA) and its derivative (C9W) have been investigated in the presence of varying concentrations of this surfactant using various probes. Our data have revealed that both rSarA and C9W bind to the cognate DNA with nearly similar affinity in the absence of TX-100. Interestingly, their DNA binding activities have been significantly increased in the presence of pre-micellar concentration of TX-100. The increase of TX-100 concentrations to micellar or post-micellar concentration did not greatly enhance their activities further. TX-100 molecules have altered the secondary and tertiary structures of both proteins to some extents. Size of the rSarA-TX-100 complex appears to be intermediate to those of rSarA and TX-100. Additional analyses show a relatively moderate interaction between C9W and TX-100. Binding of TX-100 to C9W has, however, occurred by a cooperative pathway particularly at micellar and higher concentrations of this surfactant. Taken together, TX-100-induced structural alteration of rSarA and C9W might be responsible for their increased DNA binding activity. As TX-100 has stabilized the somewhat weaker SarA-DNA complex effectively, it could be used to study its structure in the future.	[Mandal, Sukhendu; Biswas, Anindya; Jana, Biswanath; Polley, Soumitra; Sau, Subrata] Bose Inst, Dept Biochem, Kolkata, W Bengal, India; [Mahapa, Avisek; Sau, Keya] Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India	Department of Science & Technology (India); Bose Institute; Haldia Institute of Technology	Sau, S (corresponding author), Bose Inst, Dept Biochem, Kolkata, W Bengal, India.; Sau, K (corresponding author), Haldia Inst Technol, Dept Biotechnol, Haldia, W Bengal, India.	keya_sau@yahoo.co.in; subratasau@yahoo.co.in	Mandal, Sukhendu/AAX-6423-2021; jana, biswanath/AAC-7540-2022	Mandal, Sukhendu/0000-0002-7752-0982; Polley, Soumitra/0000-0002-6337-7935; Biswas, Anindya/0000-0003-1645-2856; Jana, Biswanath/0000-0002-6464-7570	Council of Scientific and Industrial Research (India) [37 (1529)/12/EMR-II]; Board of Research in Nuclear Sciences / Department of Atomic Energy (India) [2013/37B/25/BRNS]	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Board of Research in Nuclear Sciences / Department of Atomic Energy (India)(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	SM, AM and SP received Senior Research Fellowships from the Council of Scientific and Industrial Research (India). AB and BJ received Senior Research Fellowships from the Board of Research in Nuclear Sciences / Department of Atomic Energy (India). SS and KS received financial assistance for the work from the Board of Research in Nuclear Sciences / Department of Atomic Energy (India) (2013/37B/25/BRNS) and from the Council of Scientific and Industrial Research (India) [37 (1529)/12/EMR-II], respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya R, 2013, FUTURE MICROBIOL, V8, P1339, DOI 10.2217/fmb.13.92; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Ballal A, 2010, J BACTERIOL, V192, P336, DOI 10.1128/JB.01202-09; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; Bandhu A, 2010, BIOCHEMISTRY-US, V49, P4235, DOI 10.1021/bi9020956; Biswas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095012; Biswas H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103579; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Ruiz CC, 2007, BIOMACROMOLECULES, V8, P2497, DOI 10.1021/bm0704121; Ruiz CC, 2011, J COLLOID INTERF SCI, V361, P178, DOI 10.1016/j.jcis.2011.05.019; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Cordwell SJ, 2002, MICROBIOL-SGM, V148, P2765, DOI 10.1099/00221287-148-9-2765; Creighton T.E., 1997, PROTEIN STRUCTURE PR; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; De S, 2005, J COLLOID INTERF SCI, V285, P562, DOI 10.1016/j.jcis.2004.12.022; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; DIMROTH P, 1990, J BIOL CHEM, V265, P7221; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Fujimoto DF, 2009, MOL MICROBIOL, V74, P1445, DOI 10.1111/j.1365-2958.2009.06942.x; Fujimoto DF, 1998, J BACTERIOL, V180, P3724, DOI 10.1128/JB.180.14.3724-3726.1998; Ganguly T, 2009, FEBS J, V276, P1975, DOI 10.1111/j.1742-4658.2009.06924.x; Gooi HC, 2013, J MICROBIOL BIOTECHN, V23, P1554, DOI 10.4014/jmb.1306.06073; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Grover N, 2014, ENZYME MICROB TECH, V63, P1, DOI 10.1016/j.enzmictec.2014.04.018; HOLTJE JV, 1975, J BACTERIOL, V124, P1023, DOI 10.1128/JB.124.2.1023-1027.1975; Jana B, 2012, BIOCHEMISTRY-US, V51, P1223, DOI 10.1021/bi2015037; Juntachai W, 2011, MICROBIOL-SGM, V157, P3492, DOI 10.1099/mic.0.054528-0; Karbarz MJ, 2009, J BIOL CHEM, V284, P414, DOI 10.1074/jbc.M808390200; KOMATSUZAWA H, 1995, FEMS MICROBIOL LETT, V134, P209, DOI 10.1016/0378-1097(95)00406-X; KOMATSUZAWA H, 1994, J ANTIMICROB CHEMOTH, V34, P885, DOI 10.1093/jac/34.6.885; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li RG, 2003, J BACTERIOL, V185, P4219, DOI 10.1128/JB.185.14.4219-4225.2003; Linke D, 2009, METHOD ENZYMOL, V463, P603, DOI 10.1016/S0076-6879(09)63034-2; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu YF, 2006, P NATL ACAD SCI USA, V103, P2392, DOI 10.1073/pnas.0510439103; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; Mahapa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122168; Manna AC, 2007, MICROBIOL-SGM, V153, P1538, DOI 10.1099/mic.0.2006/004309-0; Morrison JM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00026; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; RAYCHAUDHURI D, 1985, J BACTERIOL, V164, P1337, DOI 10.1128/JB.164.3.1337-1349.1985; Rechtin TM, 1999, MOL MICROBIOL, V33, P307, DOI 10.1046/j.1365-2958.1999.01474.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Singh SK, 2006, J PHYS CHEM B, V110, P9728, DOI 10.1021/jp0608426; Sun F, 2012, P NATL ACAD SCI USA, V109, P15461, DOI 10.1073/pnas.1205952109; Suzuki J, 1997, FEMS MICROBIOL LETT, V153, P327, DOI 10.1016/S0378-1097(97)00269-3; Tatkiewicz W, 2015, METHODS MOL BIOL, V1258, P387, DOI 10.1007/978-1-4939-2205-5_22; Weng LY, 2012, GENE, V496, P79, DOI 10.1016/j.gene.2012.01.044; Zalucki YM, 2012, MBIO, V3, DOI 10.1128/mBio.00446-12; Zhu YW, 2014, ACTA CRYSTALLOGR D, V70, P2467, DOI 10.1107/S1399004714015326; Ziebandt AK, 2001, PROTEOMICS, V1, P480, DOI 10.1002/1615-9861(200104)1:4<480::AID-PROT480>3.0.CO;2-O	58	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151426	10.1371/journal.pone.0151426	http://dx.doi.org/10.1371/journal.pone.0151426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989900	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800062
J	Meyer, J; Gonelle-Gispert, C; Morel, P; Buhler, L				Meyer, Jeremy; Gonelle-Gispert, Carmen; Morel, Philippe; Buehler, Leo			Methods for Isolation and Purification of Murine Liver Sinusoidal Endothelial Cells: A Systematic Review	PLOS ONE			English	Review							RECEPTOR-MEDIATED ENDOCYTOSIS; LOW-DENSITY LIPOPROTEINS; FAT-STORING CELLS; RAT-LIVER; GROWTH-FACTOR; HYALURONAN RECEPTOR; PARENCHYMAL-CELLS; MOUSE-LIVER; HIGH-YIELD; IN-VITRO	To study the biological functions of liver sinusoidal endothelial cells (LSEC) and to identify their interplay with blood or liver cells, techniques allowing for the isolation and purification of LSEC have been developed over the last decades. The objective of the present review is to summarize and to compare the efficiency of existing methods for isolating murine LSEC. Toward this end, the MEDLINE database was searched for all original articles describing LSEC isolation from rat and mouse livers. Out of the 489 publications identified, 23 reported the main steps and outcomes of the procedure and were included in our review. Here, we report and analyse the technical details of the essential steps of the techniques used for LSEC isolation. The correlations between the prevalence of some steps and the efficiency of LSEC isolation were also identified. We found that centrifugal elutriation, selective adherence and, more recently, magnetic-activated cell sorting were used for LSEC purification. Centrifugal elutriation procured high yields of pure LSEC (for rats 30-141.9 million cells for 85-98% purities; for mice 9-9.25 million cells for >95% purities), but the use of this method remained limited due to its high technical requirements. Selective adherence showed inconsistent results in terms of cell yields and purities in rats (5-100 million cells for 73.7-95% purities). In contrast, magnetic-activated cell sorting allowed for the isolation of highly pure LSEC, but overall lower cell yields were reported (for rats 10.7 million cells with 97.6% purity; for mice 0.5-9 million cells with 90-98% purities). Notably, the controversies regarding the accuracy of several phenotypic markers for LSEC should be considered and their use for both magnetic sorting and characterization remain doubtful. It appears that more effort is needed to refine and standardize the procedure for LSEC isolation, with a focus on the identification of specific antigens. Such a procedure is required to identify the molecular mechanisms regulating the function of LSEC and to improve our understanding of their role in complex cellular processes in the liver.	[Meyer, Jeremy; Morel, Philippe; Buehler, Leo] Univ Hosp Geneva, Div Digest & Transplantat Surg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland; [Meyer, Jeremy; Gonelle-Gispert, Carmen; Morel, Philippe; Buehler, Leo] Univ Geneva, Unit Surg Res, Rue Michel Servet 1, CH-1206 Geneva, Switzerland	University of Geneva; University of Geneva	Meyer, J (corresponding author), Univ Hosp Geneva, Div Digest & Transplantat Surg, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.; Meyer, J (corresponding author), Univ Geneva, Unit Surg Res, Rue Michel Servet 1, CH-1206 Geneva, Switzerland.	jeremy.meyer@hcuge.ch	Meyer, Jeremy/AAP-3367-2020	Buhler, Leo/0000-0002-9461-8498; Meyer, Jeremy/0000-0003-3381-9146	Swiss National Science Foundation (Switzerland); Private Foundation of the University Hospitals of Geneva (Switzerland); Ernst and Lucy Schmidheiny Foundation (Switzerland)	Swiss National Science Foundation (Switzerland)(Swiss National Science Foundation (SNSF)); Private Foundation of the University Hospitals of Geneva (Switzerland); Ernst and Lucy Schmidheiny Foundation (Switzerland)	Funded by Swiss National Science Foundation (Switzerland), LB, Private Foundation of the University Hospitals of Geneva (Switzerland), LB, and Ernst and Lucy Schmidheiny Foundation (Switzerland), JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartneck M, 2015, MAT SCI ENG C-MATER, V51, P64, DOI 10.1016/j.msec.2015.02.045; Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BLOMHOFF R, 1984, EXP CELL RES, V150, P186, DOI 10.1016/0014-4827(84)90713-4; BRAET F, 1995, J GASTROEN HEPATOL, V10, pS3, DOI 10.1111/j.1440-1746.1995.tb01792.x; BRAET F, 1994, LAB INVEST, V70, P944; Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929; Casu A, 2002, BBA-MOL CELL BIOL L, V1583, P266, DOI 10.1016/S1388-1981(02)00251-2; Chang CF, 2010, CELL BIOL INT, V34, P1189, DOI 10.1042/CBI20090352; Chang ML, 2004, P NATL ACAD SCI USA, V101, P18093, DOI 10.1073/pnas.0408439102; Cheluvappa Rajkumar, 2014, Curr Protoc Cell Biol, V65, DOI 10.1002/0471143030.cb0209s65; Chen P, 2006, ARCH MED RES, V37, P576, DOI 10.1016/j.arcmed.2005.12.004; Chen XG, 2010, GENOME, V53, P608, DOI [10.1139/G10-040, 10.1139/g10-040]; Chou CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122060; Cottalasso D, 2003, FREE RADICAL BIO MED, V34, P337, DOI 10.1016/S0891-5849(02)01291-1; DELEEUW AM, 1982, CELL TISSUE RES, V223, P201, DOI 10.1007/BF00221510; DELEEUW AM, 1984, HEPATOLOGY, V4, P392; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; DeLeve LD, 2006, AM J PHYSIOL-GASTR L, V291, pG1187, DOI 10.1152/ajpgi.00229.2006; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; DELEVE LD, 1994, J PHARMACOL EXP THER, V268, P1261; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4; EYHORN S, 1988, J HEPATOL, V6, P23, DOI 10.1016/S0168-8278(88)80459-8; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P207, DOI 10.1016/0003-2697(87)90673-7; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; George J, 2000, AM J PATHOL, V156, P115, DOI 10.1016/S0002-9440(10)64711-6; Geraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618; GRANT AG, 1977, BRIT J EXP PATHOL, V58, P301; HAN K, 1995, DIGEST DIS SCI, V40, P1213, DOI 10.1007/BF02065526; He Y, 2008, AM J PHYSIOL-GASTR L, V295, pG305, DOI 10.1152/ajpgi.90229.2008; HELDIN P, 1991, EXP CELL RES, V193, P364, DOI 10.1016/0014-4827(91)90108-7; HOWARD RB, 1967, J CELL BIOL, V35, P675, DOI 10.1083/jcb.35.3.675; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Katz SC, 2004, J IMMUNOL, V173, P230, DOI 10.4049/jimmunol.173.1.230; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; KNOOK DL, 1981, INFECT IMMUN, V33, P620, DOI 10.1128/IAI.33.2.620-622.1981; KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4; Krause P, 2000, J HEPATOL, V32, P718, DOI 10.1016/S0168-8278(00)80239-1; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Mandili G, 2015, J HEPATOL, V62, P573, DOI 10.1016/j.jhep.2014.10.007; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; Meyer J, 2015, J HEPATOL, V63, P1538, DOI 10.1016/j.jhep.2015.08.029; Meyer J, 2015, J HEPATOL, V63, P1263, DOI 10.1016/j.jhep.2015.07.002; Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103; Miyao M, 2015, LAB INVEST, V95, P1130, DOI 10.1038/labinvest.2015.95; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MOMMAASKIENHUIS AM, 1985, EUR J CELL BIOL, V38, P42; Mookhtiar K A, 1992, Matrix Suppl, V1, P116; Moriga T, 2000, TRANSPLANTATION, V69, P141, DOI 10.1097/00007890-200001150-00024; Morin O, 1988, Revis Biol Celular, V15, P1; MUNTHEKAAS AC, 1974, FEBS LETT, V43, P252, DOI 10.1016/0014-5793(74)80654-X; MUNTHEKAAS AC, 1975, J EXP MED, V141, P1, DOI 10.1084/jem.141.1.1; NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221; Ohi N, 2006, AM J PATHOL, V168, P1097, DOI 10.2353/ajpath.2006.050462; OHMURA T, 1993, J HISTOCHEM CYTOCHEM, V41, P1253, DOI 10.1177/41.8.8331290; Onoe T, 2005, J IMMUNOL, V175, P139, DOI 10.4049/jimmunol.175.1.139; Onoe T, 2005, TRANSPL INT, V18, P206, DOI 10.1111/j.1432-2277.2004.00025.x; Paez-Cortez J, 2008, ENDOTHELIUM-J ENDOTH, V15, P165, DOI 10.1080/10623320802174464; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; PITAS RE, 1985, J CELL BIOL, V100, P103, DOI 10.1083/jcb.100.1.103; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Pollok JM, 1998, EUR J PEDIATR SURG, V8, P195, DOI 10.1055/s-2008-1071153; Rausa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122696; Sakata K, 2014, BIOCHEM BIOPH RES CO, V443, P950, DOI 10.1016/j.bbrc.2013.12.074; Salado C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-59; Salnikova O, 2013, INT J CANCER, V133, P2372, DOI 10.1002/ijc.28268; Schrage A, 2008, HEPATOLOGY, V48, P1262, DOI 10.1002/hep.22443; Schroyen B, 2012, EUR J GASTROEN HEPAT, V24, P1370, DOI 10.1097/MEG.0b013e328357ce1c; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4; Shah V, 2001, AM J PHYSIOL-GASTR L, V280, pG1209, DOI 10.1152/ajpgi.2001.280.6.G1209; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; SMIT MJ, 1987, J BIOL CHEM, V262, P13020; Sun BW, 2007, J BURN CARE RES, V28, P173, DOI 10.1097/BCR.0b013E31802CA491; Thiele GM, 1999, HEPATOLOGY, V29, P1511, DOI 10.1002/hep.510290517; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Topp SA, 2004, LIVER TRANSPLANT, V10, P1041, DOI 10.1002/lt.20216; Upadhya GA, 2002, TRANSPLANTATION, V73, P1764, DOI 10.1097/00007890-200206150-00012; VILLAFUERTE BC, 1994, ENDOCRINOLOGY, V134, P2044, DOI 10.1210/en.134.5.2044; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200; Weigel JA, 2002, BIOCHEM BIOPH RES CO, V294, P918, DOI 10.1016/S0006-291X(02)00558-2; Xie GH, 2013, GUT, V62, P299, DOI 10.1136/gutjnl-2011-301494; Xie GH, 2010, AM J PHYSIOL-GASTR L, V299, pG1204, DOI 10.1152/ajpgi.00302.2010; YANNARIELLOBROWN J, 1992, J CELL BIOCHEM, V48, P73, DOI 10.1002/jcb.240480111; ZAHLTEN RN, 1978, GASTROENTEROLOGY, V75, P80	95	20	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151945	10.1371/journal.pone.0151945	http://dx.doi.org/10.1371/journal.pone.0151945			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992171	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800121
J	Bulat, T; Smidak, R; Sialana, FJ; Jung, G; Rattei, T; Bilban, M; Sattmann, H; Lubec, G; Aradska, J				Bulat, Tanja; Smidak, Roman; Sialana, Fernando J.; Jung, Gangsoo; Rattei, Thomas; Bilban, Martin; Sattmann, Helmut; Lubec, Gert; Aradska, Jana			Transcriptomic and Proteomic Analysis of Arion vulgaris-Proteins for Probably Successful Survival Strategies?	PLOS ONE			English	Article							MASS-SPECTROMETRIC ANALYSIS; ACID-BINDING LECTIN; C1Q-DOMAIN-CONTAINING PROTEIN; MOQUIN-TANDON; LAND SLUG; ANNOTATION; CLONING; GENES; SNAIL; IDENTIFICATION	The Spanish slug, Arion vulgaris, is considered one of the hundred most invasive species in Central Europe. The immense and very successful adaptation and spreading of A. vulgaris suggest that it developed highly effective mechanisms to deal with infections and natural predators. Current transcriptomic and proteomic studies on gastropods have been restricted mainly to marine and freshwater gastropods. No transcriptomic or proteomic study on A. vulgaris has been carried out so far, and in the current study, the first transcriptomic database from adult specimen of A. vulgaris is reported. To facilitate and enable proteomics in this non-model organism, a mRNA-derived protein database was constructed for protein identification. A gel-based proteomic approach was used to obtain the first generation of a comprehensive slug mantle proteome. A total of 2128 proteins were unambiguously identified; 48 proteins represent novel proteins with no significant homology in NCBI non-redundant database. Combined transcriptomic and proteomic analysis revealed an extensive repertoire of novel proteins with a role in innate immunity including many associated pattern recognition, effector proteins and cytokine-like proteins. The number and diversity in gene families encoding lectins point to a complex defense system, probably as a result of adaptation to a pathogen-rich environment. These results are providing a fundamental and important resource for subsequent studies on molluscs as well as for putative antimicrobial compounds for drug discovery and biomedical applications.	[Bulat, Tanja; Smidak, Roman; Sialana, Fernando J.; Jung, Gangsoo; Aradska, Jana] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Rattei, Thomas] Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Computat Syst Biol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Dept Lab Med & Core Facil Genom, Vienna, Austria; [Sattmann, Helmut] Museum Nat Hist Vienna, Zool Dept 3, Vienna, Austria; [Lubec, Gert] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria	Medical University of Vienna; University of Vienna; Medical University of Vienna; University of Vienna	Aradska, J (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.; Lubec, G (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria.	gert.lubec@univie.ac.at; jana.aradska@gmail.com	Rattei, Thomas/F-1366-2011; Sialana, Fernando J./J-1303-2018	Rattei, Thomas/0000-0002-0592-7791; Sialana, Fernando J./0000-0001-9083-1657; Bilban, Martin/0000-0001-7043-7142; Lubec, Jana/0000-0003-0657-7647; Bennett, Keiryn L./0000-0001-9356-7708; Bulat, Tanja/0000-0001-7427-5611; Lubec, Gert/0000-0002-6333-9461				Ahmed KEAM, 2010, AMINO ACIDS, V38, P1043, DOI 10.1007/s00726-009-0312-1; Allam B, 2014, FISH SHELLFISH IMMUN, V41, P2, DOI 10.1016/j.fsi.2014.05.022; Amin Shorash, 2014, BMC Research Notes, V7, P488, DOI 10.1186/1756-0500-7-488; Bae N, 2012, ELECTROPHORESIS, V33, P1787, DOI 10.1002/elps.201100569; Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chen WQ, 2014, AMINO ACIDS, V46, P995, DOI 10.1007/s00726-013-1657-z; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Gerlach D, 2004, FEMS IMMUNOL MED MIC, V40, P215, DOI 10.1016/S0928-8244(03)00367-5; Gestal C, 2010, DEV COMP IMMUNOL, V34, P926, DOI 10.1016/j.dci.2010.02.012; Gismervik K, 2015, J APPL MICROBIOL, V118, P809, DOI 10.1111/jam.12750; Gismervik K, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0065-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatteland Bjorn A., 2013, Fauna Norvegica, V32, P13, DOI 10.5324/fn.v31i0.1473; He XC, 2011, FISH SHELLFISH IMMUN, V31, P1247, DOI 10.1016/j.fsi.2011.08.021; Huang Y, 2014, DEV COMP IMMUNOL, V46, P255, DOI 10.1016/j.dci.2014.04.015; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kang SU, 2011, PROTEOMICS, V11, P2171, DOI 10.1002/pmic.201000374; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kozlowski Jan, 2007, Journal of Plant Protection Research, V47, P219; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Patel Z, 2014, PARASITOL RES, V113, P4363, DOI 10.1007/s00436-014-4111-6; Pfenninger M, 2014, EVOL APPL, V7, P702, DOI 10.1111/eva.12177; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Schroeder FC, 1999, P NATL ACAD SCI USA, V96, P13620, DOI 10.1073/pnas.96.24.13620; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Stalder GL, 2014, SCI TOTAL ENVIRON, V479, P11, DOI 10.1016/j.scitotenv.2014.01.103; Sun J, 2012, MOL ECOL RESOUR, V12, P1133, DOI 10.1111/1755-0998.12014; Sun J, 2012, J PROTEOME RES, V11, P4240, DOI 10.1021/pr3003613; Tahtouh M, 2009, MOL IMMUNOL, V46, P523, DOI 10.1016/j.molimm.2008.07.026; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Xu T, 2012, FISH SHELLFISH IMMUN, V32, P1106, DOI 10.1016/j.fsi.2012.03.012; Yu YH, 2008, J IMMUNOL, V181, P7024, DOI 10.4049/jimmunol.181.10.7024; Yuasa HJ, 1998, COMP BIOCHEM PHYS B, V119, P479, DOI 10.1016/S0305-0491(98)00008-X; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang H, 2008, FISH SHELLFISH IMMUN, V25, P281, DOI 10.1016/j.fsi.2008.06.003; Zhang Q, 2014, DEV COMP IMMUNOL, V46, P356, DOI 10.1016/j.dci.2014.05.009	45	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150614	10.1371/journal.pone.0150614	http://dx.doi.org/10.1371/journal.pone.0150614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986963	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300023
J	Gonzalez, E; Diez, JJ; Bajo, MA; del Peso, G; Grande, C; Rodriguez, O; Diaz-Almiron, M; Iglesias, P; Selgas, R				Gonzalez, Elena; Diez, Juan J.; Auxiliadora Bajo, M.; del Peso, Gloria; Grande, Cristina; Rodriguez, Olaia; Diaz-Almiron, Mariana; Iglesias, Pedro; Selgas, Rafael			Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INSULIN-RESISTANCE; RENAL-FUNCTION; GLUCOSE; DYSFUNCTION	Background Human fibroblast growth factor 21 (FGF-21) is an endocrine liver hormone that stimulates adipocyte glucose uptake independently of insulin, suppresses hepatic glucose production and is involved in the regulation of body fat. Peritoneal dialysis (PD) patients suffer potential interference with FGF-21 status with as yet unknown repercussions. Objectives The aim of this study was to define the natural history of FGF-21 in PD patients, to analyze its relationship with glucose homeostasis parameters and to study the influence of residual renal function and peritoneal functional parameters on FGF-21 levels and their variation over time. Methods We studied 48 patients with uremia undergoing PD. Plasma samples were routinely obtained from each patient at baseline and at 1, 2 and 3 years after starting PD therapy. Results Plasma FGF-21 levels substantially increased over the first year and were maintained at high levels during the remainder of the study period (253 pg/ml (59; 685) at baseline; 582 pg/ml (60.5-949) at first year and 647 pg/ml (120.5-1116.6) at third year) (p<0.01). We found a positive correlation between time on dialysis and FGF-21 levels (p<0.001), and also, those patients with residual renal function (RRF) had significantly lower levels of FGF-21 than those without RRF (rho-0.484, p<0.05). Lastly, there was also a significant association between FGF-21 levels and peritoneal protein losses (PPL), independent of the time on dialysis (rho 0.410, p<0.05). Conclusion Our study shows that FGF-21 plasma levels in incident PD patients significantly increase during the first 3 years. This increment is dependent on or is associated with RRF and PPL (higher levels in patients with lower RRF and higher PPL). FGF-21 might be an important endocrine agent in PD patients and could act as hormonal signaling to maintain glucose homeostasis and prevent potential insulin resistance. These preliminary results suggest that FGF-21 might play a protective role as against the development of insulin resistance over time in patients undergoing a continuous glucose load.	[Gonzalez, Elena; Auxiliadora Bajo, M.; del Peso, Gloria; Selgas, Rafael] La Paz Univ Hosp, REDinREN, FRIAT IRSIN, Dept Nephrol,IdiPAZ, Madrid, Spain; [Diez, Juan J.; Grande, Cristina; Iglesias, Pedro] Univ Hosp Ramon Y Cajal, Dept Endocrinol, Madrid, Spain; [Rodriguez, Olaia] La Paz Univ Hosp, REDinREN, FRIAT IRSIN, Dept Biochem,IdiPAZ, Madrid, Spain; [Diaz-Almiron, Mariana] La Paz Univ Hosp, REDinREN, FRIAT IRSIN, Biostat Sect,IdiPAZ, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Hospital Universitario La Paz	Iglesias, P (corresponding author), Univ Hosp Ramon Y Cajal, Dept Endocrinol, Madrid, Spain.	piglo65@gmail.com	Iglesias, Pedro/AAC-1016-2020; González, Elena/A-2635-2017; Diez, Juan J./W-1803-2017; Bajo, Maria A/ABF-6991-2020; Iglesias, P/AAU-1011-2020	Iglesias, Pedro/0000-0003-0126-1985; González, Elena/0000-0003-2003-4737; Diez, Juan J./0000-0002-2017-0694; Bajo, Maria A/0000-0001-7364-557X; Iglesias, P/0000-0003-0126-1985	Rio Hortega Grant Program from the ISCIII; Extramural Grant Program from Baxter; Health Research Fund [FIS-12/00241]; REDinREN program from the ISCIII-FEDER Funds, IRSIN-FRIAT	Rio Hortega Grant Program from the ISCIII; Extramural Grant Program from Baxter; Health Research Fund(Instituto de Salud Carlos III); REDinREN program from the ISCIII-FEDER Funds, IRSIN-FRIAT	This study was partially funded with the Rio Hortega Grant Program from the ISCIII, the Extramural Grant Program from Baxter, Health Research Fund FIS-12/00241 and the REDinREN program from the ISCIII-FEDER Funds, IRSIN-FRIAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crasto C, 2012, J AM GERIATR SOC, V60, P792, DOI 10.1111/j.1532-5415.2011.03879.x; Cuevas-Ramos D, 2012, CURR OPIN PEDIATR, V24, P523, DOI 10.1097/MOP.0b013e3283557d22; Han SH, 2012, PERITON DIALYSIS INT, V32, P149, DOI 10.3747/pdi.2010.00111; Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018; Hindricks J, 2014, CLIN ENDOCRINOL, V80, P918, DOI 10.1111/cen.12380; Holmes CJ, 2000, PERITON DIALYSIS INT, V20, pS37; Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kralisch S, 2011, CURR OPIN CLIN NUTR, V14, P354, DOI 10.1097/MCO.0b013e328346a326; Krediet RT, 2013, CLIN KIDNEY J, V6, P568, DOI 10.1093/ckj/sft122; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ohta Hiroya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P302; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; Sanchez-Villanueva R, 2013, NEFROLOGIA, V33, P85, DOI 10.3265/Nefrologia.pre2012.Nov.11430; SELGAS R, 1994, AM J KIDNEY DIS, V23, P64, DOI 10.1016/S0272-6386(12)80814-6; Selgas R, PERIT DIAL INT, V25, P68; Semba RD, 2012, J CLIN ENDOCR METAB, V97, P1375, DOI 10.1210/jc.2011-2823; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Ulu SM, 2014, INT UROL NEPHROL, V46, P2409, DOI 10.1007/s11255-014-0753-7; Wu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030337	21	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151698	10.1371/journal.pone.0151698	http://dx.doi.org/10.1371/journal.pone.0151698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986485	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300115
J	Jaiteh, M; Taly, A; Henin, J				Jaiteh, Mariama; Taly, Antoine; Henin, Jerome			Evolution of Pentameric Ligand-Gated Ion Channels: Pro-Loop Receptors	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTOR; GLYCINE RECEPTOR; CROSS-LINKING; GENOME; BINDING; DYNAMICS; GABA(A); SUBUNIT	Pentameric ligand-gated ion channels (pLGICs) are ubiquitous neurotransmitter receptors in Bilateria, with a small number of known prokaryotic homologues. Here we describe a new inventory and phylogenetic analysis of pLGIC genes across all kingdoms of life. Our main finding is a set of pLGIC genes in unicellular eukaryotes, some of which are metazoan-like Cys-loop receptors, and others devoid of Cys-loop cysteines, like their prokaryotic relatives. A number of such "Cys-less" receptors also appears in invertebrate metazoans. Together, those findings draw a new distribution of pLGICs in eukaryotes. A broader distribution of prokaryotic channels also emerges, including a major new archaeal taxon, Thaumarchaeota. More generally, pLGICs now appear nearly ubiquitous in major taxonomic groups except multicellular plants and fungi. However, pLGICs are sparsely present in unicellular taxa, suggesting a high rate of gene loss and a non-essential character, contrasting with their essential role as synaptic receptors of the bilaterian nervous system. Multiple alignments of these highly divergent sequences reveal a small number of conserved residues clustered at the interface between the extracellular and transmembrane domains. Only the "Cys-loop" proline is absolutely conserved, suggesting the more fitting name "Pro loop" for that motif, and "Pro-loop receptors" for the superfamily. The infered molecular phylogeny shows a Cys-loop and a Cys-less clade in eukaryotes, both containing metazoans and unicellular members. This suggests new hypotheses on the evolutionary history of the superfamily, such as a possible origin of the Cys-loop cysteines in an ancient unicellular eukaryote. Deeper phylogenetic relationships remain uncertain, particularly around the split between bacteria, archaea, and eukaryotes.	[Henin, Jerome] CNRS, Lab Biochim Theor, Inst Biol Physicochim, Paris, France; Univ Paris Diderot, Paris, France; [Jaiteh, Mariama] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Uppsala, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Swedish University of Agricultural Sciences	Henin, J (corresponding author), CNRS, Lab Biochim Theor, Inst Biol Physicochim, Paris, France.	henin@ibpc.fr	Hénin, Jérôme/AAX-5604-2020; Taly, Antoine/B-3339-2008; Hénin, Jérôme/A-7080-2008	Taly, Antoine/0000-0001-5109-0091; Hénin, Jérôme/0000-0003-2540-4098; Jaiteh, Mariama/0000-0002-9229-5314	Agence Nationale de la Recherche grant PentaGate; French Agence Nationale de la Recherche (Project PentaGate)	Agence Nationale de la Recherche grant PentaGate(French National Research Agency (ANR)); French Agence Nationale de la Recherche (Project PentaGate)(French National Research Agency (ANR))	Agence Nationale de la Recherche grant PentaGate (http://www.agence-nationale-recherche.fr/?Projet=ANR-13-BSV8-0020) benefitted all three authors by funding missions for AT and JH and a stipend for MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Drs. Alessandra Carbone (Universite Pierre et Marie Curie), Celine Brochier-Armanet (Universite Claude Bernard), Grace Brannigan (Rutgers University), and Pierre-Jean Corringer and Francis Biville (Institut Pasteur) for fruitful discussions. This work was supported by a grant from the French Agence Nationale de la Recherche (Project PentaGate).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Avila-Poveda OH, 2014, TISSUE CELL, V46, P379, DOI 10.1016/j.tice.2014.07.001; Bailly X, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00498; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Baussand J, 2008, EVOL BIOINFORM, V4, P255; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cadugan DJ, 2007, BIOPHYS J, V93, P859, DOI 10.1529/biophysj.107.105171; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; COCKCROFT VB, 1990, MOL NEUROBIOL, V4, P129, DOI 10.1007/BF02780338; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Dent JA, 2010, ADV EXP MED BIOL, V683, P11; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Dufour V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003586; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fairclough SR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r15; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henin J, 2014, BIOPHYS J, V106, P1938, DOI 10.1016/j.bpj.2014.03.024; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; IMOTO K, 1986, NATURE, V324, P670, DOI 10.1038/324670a0; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kehoe J, 2009, J MOL EVOL, V69, P125, DOI 10.1007/s00239-009-9256-z; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liebeskind BJ, 2015, P NATL ACAD SCI USA, V112, pE846, DOI 10.1073/pnas.1501195112; Lobo IA, 2004, J NEUROCHEM, V90, P962, DOI 10.1111/j.1471-4159.2004.02561.x; Lynagh T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08558; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mnatsakanyan N, 2015, BIOCHEMISTRY-US, V54, P2670, DOI 10.1021/acs.biochem.5b00203; Mnatsakanyan N, 2013, J NEUROCHEM, V125, P843, DOI 10.1111/jnc.12260; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Purohit P, 2015, J PHYSIOL-LONDON, V593, P2851, DOI 10.1113/JP270223; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rendon G, 2011, CHANNELS, V5, P325, DOI 10.4161/chan.5.4.16822; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Scott S, 2015, J BIOL CHEM, V290, P5621, DOI 10.1074/jbc.M114.616573; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Tan G, 2015, SYST BIOL, V64, P778, DOI 10.1093/sysbio/syv033; Tasneem A, 2005, GENOME BIOL, V6; Tillman T, 2013, BIOCHEM J, V449, P61, DOI 10.1042/BJ20121072; Vernot B, 2007, Comput Syst Bioinformatics Conf, V6, P441, DOI 10.1142/9781860948732_0044; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yates DM, 2004, EXP PARASITOL, V108, P182, DOI 10.1016/j.exppara.2004.08.003; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	82	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151934	10.1371/journal.pone.0151934	http://dx.doi.org/10.1371/journal.pone.0151934			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986966	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300155
J	Jones, LD; Jackson, JW; Maggirwar, SB				Jones, Letitia D.; Jackson, Joseph W.; Maggirwar, Sanjay B.			Modeling HIV-1 Induced Neuroinflammation in Mice: Role of Platelets in Mediating Blood-Brain Barrier Dysfunction	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; POTENT ANTIRETROVIRAL THERAPY; BOWEL-DISEASE PATIENTS; SOLUBLE CD40 LIGAND; ENDOTHELIAL-CELLS; NEUROCOGNITIVE DISORDERS; SODIUM FLUORESCEIN; THROMBOCYTOPENIC PURPURA; CLAUDIN-5 EXPRESSION	The number of HIV-1 positive individuals developing some form of HIV-associated neurocognitive disorder (HAND) is increasing. In these individuals, the integrity of the blood-brain barrier (BBB) is compromised due to an increase in exposure to pro-inflammatory mediators, viral proteins, and virus released from infected cells. It has been shown that soluble CD40L (sCD40L) is released upon platelet activation and is an important mediator of the pathogenesis of HAND but the underlying mechanisms are unclear, emphasizing the need of an effective animal model. Here, we have utilized a novel animal model in which wild-type (WT) mice were infected with EcoHIV; a derivative of HIV-1 that contains a substitution of envelope protein gp120 with that of gp80 derived from murine leukemia virus-1 (MuLV-1). As early as two-weeks post-infection, EcoHIV led to increased permeability of the BBB associated with decreased expression of tight junction protein claudin-5, in CD40L and platelet activation-dependent manner. Treatment with an antiplatelet drug, eptifibatide, in EcoHIV-infected mice normalized BBB function, sCD40L release and platelet activity, thus implicating platelet activation and platelet-derived CD40L in virally induced BBB dysfunction. Our results also validate and underscore the importance of EcoHIV infection mouse model as a tool to explore therapeutic targets for HAND.	[Jones, Letitia D.; Jackson, Joseph W.; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester	Maggirwar, SB (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Sanjay_Maggirwar@urmc.rochester.edu		Jackson, Joseph/0000-0002-3826-2749; Jones, Letitia/0000-0002-1889-5629	National Institutes of Health, USA [4F31NS086256-03, R01 NS054578, R01 HL128155, R01 NS066801, T32 AI049815]; University of Rochester Center for AIDS (CFAR) research grant [P30 AI078498]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815, P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS086256, R01NS066801, R01NS054578] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS (CFAR) research grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health, USA (4F31NS086256-03 to LDJ; R01 NS054578, R01 HL128155 and R01 NS066801 to SBM; T32 AI049815 to JWJ). It was also supported in part by the University of Rochester Center for AIDS (CFAR) research grant (P30 AI078498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afessa B, 1998, CHEST, V113, P1225, DOI 10.1378/chest.113.5.1225; Ahmad R, 2006, AIDS, V20, P1907, DOI 10.1097/01.aids.0000244217.46445.45; Alcantara S, 2009, JAIDS-J ACQ IMM DEF, V51, P374, DOI 10.1097/QAI.0b013e3181a9cbcf; Amasheh S, 2009, ANN NY ACAD SCI, V1165, P211, DOI 10.1111/j.1749-6632.2009.04439.x; Andras IE, 2011, METHODS MOL BIOL, V762, P355, DOI 10.1007/978-1-61779-185-7_26; Andras IE, 2005, J CEREBR BLOOD F MET, V25, P1159, DOI 10.1038/sj.jcbfm.9600115; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; BETTAIEB A, 1992, BLOOD, V80, P162; BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Chandler AB, 2010, THROMB RES, V125, P44, DOI 10.1016/j.thromres.2009.04.017; Chen CQ, 2015, CURR DRUG TARGETS, V16, P219, DOI 10.2174/1389450116666150113122229; Chen JF, 2012, HEMATOLOGY, V17, P283, DOI 10.1179/1607845412Y.0000000014; Cioni C, 2002, NEUROSCI LETT, V330, P299, DOI 10.1016/S0304-3940(02)00814-5; Corrales-Medina VF, 2010, JAIDS-J ACQ IMM DEF, V54, P217, DOI 10.1097/QAI.0b013e3181c8f4c9; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Danese S, 2003, GUT, V52, P1435, DOI 10.1136/gut.52.10.1435; Danese S, 2003, GASTROENTEROLOGY, V124, P1249, DOI 10.1016/S0016-5085(03)00289-0; Dang Q, 2012, J VIROL, V86, P13795, DOI 10.1128/JVI.02174-12; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; Davidson DC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-144; Davidson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051793; Denton PW, 2011, AIDS REV, V13, P135; DIEHL LJ, 1995, J VIROL, V69, P2328, DOI 10.1128/JVI.69.4.2328-2332.1995; Dominguez V, 1998, J ACQ IMMUN DEF SYND, V17, P385, DOI 10.1097/00042560-199804150-00001; Dow SW, 1999, J VIROL, V73, P6852, DOI 10.1128/JVI.73.8.6852-6861.1999; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Elzey BD, 2005, CELL IMMUNOL, V238, P1, DOI 10.1016/j.cellimm.2005.12.005; Elzey BD, 2005, J LEUKOCYTE BIOL, V78, P80, DOI 10.1189/jlb.1104669; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Flaujac C, 2010, CELL MOL LIFE SCI, V67, P545, DOI 10.1007/s00018-009-0209-x; Fletcher NF, 2011, VET J, V188, P260, DOI 10.1016/j.tvjl.2010.03.022; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Gibellini D, 2007, J CELL PHYSIOL, V210, P315, DOI 10.1002/jcp.20815; Gorantla S, 2010, AM J PATHOL, V177, P2938, DOI 10.2353/ajpath.2010.100536; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Hadas E, 2013, DIS MODEL MECH, V6, P1292, DOI 10.1242/dmm.012617; He XL, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0247-2; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; HOFFMAN HJ, 1961, NEUROLOGY, V11, P1081, DOI 10.1212/WNL.11.12.1081; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178; Idzko M, 2015, J ALLERGY CLIN IMMUN, V135, P1416, DOI 10.1016/j.jaci.2015.04.028; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jantzie LL, 2006, NEUROCHEM INT, V49, P717, DOI 10.1016/j.neuint.2006.06.010; Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003459; Ju SM, 2009, EXP MOL MED, V41, P86, DOI 10.3858/emm.2009.41.2.011; Kanmogne GD, 2002, J NEUROPATH EXP NEUR, V61, P992, DOI 10.1093/jnen/61.11.992; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Kelschenbach JL, 2012, J NEUROIMMUNE PHARM, V7, P380, DOI 10.1007/s11481-011-9316-1; Kiebala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130061; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; KORNGOLD R, 1978, J EXP MED, V148, P1687; Langer HF, 2013, THROMB HAEMOSTASIS, V110, P888, DOI 10.1160/TH13-02-0096; Letendre Scott, 2011, Top Antivir Med, V19, P137; Li H, 2014, AM J RESP CRIT CARE, V190, P85, DOI 10.1164/rccm.201106-1151OC; Luabeya MK, 2000, NEUROPATH APPL NEURO, V26, P454, DOI 10.1046/j.1365-2990.2000.00275.x; Maclean AG, 2005, J MED PRIMATOL, V34, P237, DOI 10.1111/j.1600-0684.2005.00121.x; MALMGREN LT, 1980, J COMP NEUROL, V191, P103, DOI 10.1002/cne.901910106; Marks KM, 2009, JAIDS-J ACQ IMM DEF, V52, P595, DOI 10.1097/QAI.0b013e3181b79aff; Matter K, 2003, J CELL BIOL, V161, P459, DOI 10.1083/jcb.200304039; Mercier E, 2013, BMJ-BRIT MED J, P346; Milush JM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00236; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; Mourao MPG, 2007, PLATELETS, V18, P605, DOI 10.1080/09537100701426604; Muller KAL, 2015, THROMB HAEMOSTASIS, V114, P498, DOI 10.1160/TH14-11-0947; Muscarella LA, 2014, J NEUROPATH EXP NEUR, V73, P50, DOI [10.1097/NEN.0000000000000026, 10.1097/NEN.0000000000000024]; Nair Madhavan, 2015, J Alcohol Drug Depend, V3, P182; Pate KAM, 2013, J INFECT DIS, V208, P874, DOI 10.1093/infdis/jit278; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Ramirez SH, 2010, J NEUROSCI, V30, P9454, DOI 10.1523/JNEUROSCI.5796-09.2010; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Rausch DM, 1999, J LEUKOCYTE BIOL, V65, P466, DOI 10.1002/jlb.65.4.466; Ryan G, 2003, J VIROL, V77, P7477, DOI 10.1128/JVI.77.13.7477-7485.2003; Saini M, 2007, VACCINE, V25, P8660, DOI 10.1016/j.vaccine.2007.10.019; Satchell CS, 2010, AIDS, V24, P649, DOI 10.1097/QAD.0b013e328336098c; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schwartzkopff F, 2009, INNATE IMMUN-LONDON, V15, P368, DOI 10.1177/1753425909106171; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sindberg GM, 2015, J NEUROIMMUNE PHARM, V10, P74, DOI 10.1007/s11481-014-9574-9; Singh MV, 2012, J VIROL METHODS, V181, P170, DOI 10.1016/j.jviromet.2012.02.005; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Strazza M, 2011, BRAIN RES, V1399, P96, DOI 10.1016/j.brainres.2011.05.015; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Tcheng JE, 2001, AM J CARDIOL, V88, P1097, DOI 10.1016/S0002-9149(01)02041-0; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; UNAIDS, 2012, GLOBAL REPORT UNAIDS; van Gils JM, 2009, J LEUKOCYTE BIOL, V85, P195, DOI 10.1189/jlb.0708400; Vigorito M, 2015, BRAIN BEHAV IMMUN, V48, P336, DOI 10.1016/j.bbi.2015.02.020; Le VB, 2015, AM J RESP CRIT CARE, V191, P804, DOI 10.1164/rccm.201406-1031OC; Wang HW, 2008, J VIROL, V82, P7591, DOI 10.1128/JVI.00768-08; Wang J, 2011, J THROMB HAEMOST, V9, P562, DOI 10.1111/j.1538-7836.2010.04168.x; Wassmer SC, 2006, INFECT IMMUN, V74, P645, DOI 10.1128/IAI.74.1.645-653.2006; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Wiley CA, 1999, AIDS, V13, P2055, DOI 10.1097/00002030-199910220-00007; Williams DW, 2014, CURR HIV RES, V12, P85, DOI 10.2174/1570162X12666140526114526; Williams DW, 2012, J LEUKOCYTE BIOL, V91, P401, DOI 10.1189/jlb.0811394; Williams R, 2008, J NEUROVIROL, V14, P292, DOI 10.1080/13550280802074539; Wiwanitkit V, 2008, BLOOD COAGUL FIBRIN, V19, P739, DOI 10.1097/MBC.0b013e32830b14cb; World Health Organization, 2014, GLOB SUMM HIV AIDS E; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003	116	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151702	10.1371/journal.pone.0151702	http://dx.doi.org/10.1371/journal.pone.0151702			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986758	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300117
J	Ma, WL; Lin, M; Ding, H; Lin, GR; Zhang, ZZ				Ma, Weilie; Lin, Margarita; Ding, Hang; Lin, Guorong; Zhang, Zhizhen			beta-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; A-I; LIPID EFFLUX; TANGIER-DISEASE; BINDING; ABCA1; RECEPTOR; CELLS; PROTEINS	Objective HDL and its apolipoproteins protect against atherosclerotic disease partly by removing excess cholesterol from macrophage foam cells. But the underlying mechanisms of cholesterol clearance are still not well defined. We investigated roles of vesicle trafficking of coatomer beta-COP in delivering cholesterol to the cell surface during apoA-1 and apoE-mediated lipid efflux from fibroblasts and THP-1 macrophages. Methods shRNA knockout, confocal and electron microscopy and biochemical analysis were used to investigate the roles of beta-COP in apolipoprotein-mediated cholesterol efflux in fibroblasts and THP-1 macrophages. Results We showed that beta-COP knockdown by lentiviral shRNA resulted in reduced apoA-1-mediated cholesterol efflux, while increased cholesterol accumulation and formation of larger vesicles were observed in THP-1 macrophages by laser scanning confocal microscopy. Immunogold electron microscopy showed that beta-COP appeared on the membrane protrusion complexes and colocalized with apoA-1 or apoE during cholesterol efflux. This was associated with releasing heterogeneous sizes of small particles into the culture media of THP-1 macrophage. Western blotting also showed that apoA-1 promotes beta-COP translocation to the cell membrane and secretion into culture media, in which a total of 17 proteins were identified by proteomics. Moreover, beta-COP exclusively associated with human plasma HDL fractions. Conclusion ApoA-1 and apoE promoted transport vesicles consisting of beta-COP and other candidate proteins to exocytose cholesterol, forming the protrusion complexes on cell surface, which were then released from the cell membrane as small particles to media.	[Ma, Weilie; Lin, Margarita; Ding, Hang; Lin, Guorong; Zhang, Zhizhen] Guangdong Med Univ, Dept Biochem & Mol Biol, Key Lab Med Mol Diagnost Guangdong Prov, Dongguan 523808, Guangdong, Peoples R China	Guangdong Medical University	Lin, GR; Zhang, ZZ (corresponding author), Guangdong Med Univ, Dept Biochem & Mol Biol, Key Lab Med Mol Diagnost Guangdong Prov, Dongguan 523808, Guangdong, Peoples R China.	glin@omegacoffee.com; zzzhang@gdmc.edu.cn	ZHANG, ZHIZHEN/GYA-3230-2022		National Natural Science Foundation of China [81170267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grant (81170267) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielicki JK, 1999, J LIPID RES, V40, P85; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chao WT, 2005, BIOCHEM BIOPH RES CO, V332, P743, DOI 10.1016/j.bbrc.2005.05.019; Duong PT, 2006, J LIPID RES, V47, P832, DOI 10.1194/jlr.M500531-JLR200; Engel T, 2004, FEBS LETT, V566, P241, DOI 10.1016/j.febslet.2004.04.048; Enrich C, 2011, BBA-MOL CELL RES, V1813, P935, DOI 10.1016/j.bbamcr.2010.09.015; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HARDING C, 1984, EUR J CELL BIOL, V35, P256; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; HERSCOVITZ H, 1992, J LIPID RES, V33, P791; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; Ito J, 2014, J LIPIDS, V2014, DOI 10.1155/2014/530720; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lin GR, 2000, ATHEROSCLEROSIS, V149, P359, DOI 10.1016/S0021-9150(99)00503-1; Lin GR, 2002, BIOCHEM BIOPH RES CO, V291, P727, DOI 10.1006/bbrc.2002.6505; Lin SS, 2013, ARTERIOSCL THROM VAS, V33, pE31, DOI 10.1161/ATVBAHA.112.300720; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Ma WL, 2015, ATHEROSCLEROSIS, V239, P566, DOI 10.1016/j.atherosclerosis.2015.02.034; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mendez AJ, 1996, J LIPID RES, V37, P2510; MENDEZ AJ, 1995, J BIOL CHEM, V270, P5891, DOI 10.1074/jbc.270.11.5891; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; ORAM JF, 1983, J CLIN INVEST, V72, P1611, DOI 10.1172/JCI111120; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PFEFFER SR, 1983, J CELL BIOL, V97, P40, DOI 10.1083/jcb.97.1.40; Quazi F, 2013, J BIOL CHEM, V288, P34414, DOI 10.1074/jbc.M113.508812; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reboul E, 2013, BIOCHIMIE, V95, P957, DOI 10.1016/j.biochi.2012.11.009; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Takashima K, 2011, CELL STRUCT FUNCT, V36, P223, DOI 10.1247/csf.11035; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Weinert S, 2013, CARDIOVASC RES, V97, P544, DOI 10.1093/cvr/cvs367; WU YQ, 1988, ENDOCRINOLOGY, V123, P1879, DOI 10.1210/endo-123-4-1879; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zech T, 2012, CELL ADHES MIGR, V6, P476, DOI 10.4161/cam.21373; Zhang HT, 2013, J BIOL CHEM, V288, P20966, DOI 10.1074/jbc.M113.484535	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151767	10.1371/journal.pone.0151767	http://dx.doi.org/10.1371/journal.pone.0151767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986486	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300127
J	Ciblis, AS; Butler, ML; Quinn, C; Clare, L; Bokde, ALW; Mullins, PG; McNulty, JP				Ciblis, Aurelia S.; Butler, Marie-Louise; Quinn, Catherine; Clare, Linda; Bokde, Arun L. W.; Mullins, Paul G.; McNulty, Jonathan P.			Current Practice in the Referral of Individuals with Suspected Dementia for Neuroimaging by General Practitioners in Ireland and Wales	PLOS ONE			English	Article							PRIMARY-CARE; DIAGNOSIS	Objectives While early diagnosis of dementia is important, the question arises whether general practitioners (GPs) should engage in direct referrals. The current study investigated current referral practices for neuroimaging in dementia, access to imaging modalities and investigated related GP training in Ireland and North Wales. Methods A questionnaire was distributed to GPs in the programme regions which included approximately two thirds of all GPs in the Republic of Ireland and all general practitioners in North Wales. A total of 2,093 questionnaires were issued. Results 48.6% of Irish respondents and 24.3% of Welsh respondents directly referred patients with suspected dementia for neuroimaging. Irish GPs reported greater direct access to neuroimaging than their Welsh counterparts. A very small percentage of Irish and Welsh GPs (4.7% and 10% respectively) had received training in neuroimaging and the majority who referred patients for neuroimaging were not aware of any dementia-specific protocols for referrals (93.1% and 95% respectively). Conclusions The benefits of direct GP access to neuroimaging investigations for dementia have yet to be established. Our findings suggest that current GP speciality training in Ireland and Wales is deficient in dementia-specific and neuroimaging training with the concern being that inadequate training will lead to inadequate referrals. Further training would complement guidelines and provide a greater understanding of the role and appropriateness of neuroimaging techniques in the diagnosis of dementia.	[Ciblis, Aurelia S.; Butler, Marie-Louise; McNulty, Jonathan P.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Quinn, Catherine; Mullins, Paul G.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Clare, Linda] Univ Exeter, Sch Psychol, Exeter, Devon, England; [Bokde, Arun L. W.] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland	University College Dublin; Bangor University; University of Exeter; Trinity College Dublin	McNulty, JP (corresponding author), Univ Coll Dublin, Sch Med, Dublin 2, Ireland.	jonathan.mcnulty@ucd.ie	Quinn, Catherine/H-6498-2019	Quinn, Catherine/0000-0001-9553-853X; Clare, Linda/0000-0003-3989-5318; McNulty, Jonathan/0000-0002-1365-8747; Bokde, Arun/0000-0003-0114-4914; Ryan, Marie-Louise/0000-0002-7424-0045	European Regional Development Fund INTERREG 4 A Ireland Wales Programme [087]; Bangor University; University College Dublin; Trinity College Dublin	European Regional Development Fund INTERREG 4 A Ireland Wales Programme; Bangor University; University College Dublin; Trinity College Dublin	This work was part-funded under the European Regional Development Fund INTERREG 4 A Ireland Wales Programme (Project number: 087; www.irelandwales.ie) with matching funding from Bangor University, University College Dublin and Trinity College Dublin. The funding bodies had no role in the study design, data collection, analysis, decision to publish or manuscript preparation.	Ahmad S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515386; Alzheimer's Society, 2013, PROGR IMPR DIAGN DEM; Alzheimer's Society, 2012, ONL 37 PER CENT GPS; American College of Radiology, 2015, ACR APPR CRIT; Audit Commission, 2002, FORG ME NOT 2002 DEV; Bermingham S L, 2014, Ont Health Technol Assess Ser, V14, P1; Brooker D, 2014, INT J GERIATR PSYCH, V29, P682, DOI 10.1002/gps.4066; Cahill S, 2008, INT J GERIATR PSYCH, V23, P663, DOI 10.1002/gps.1956; Cahill S, 2006, INT J GERIATR PSYCH, V21, P319, DOI 10.1002/gps.1464; Cahill S., 2012, CREATING EXCELLENCE; Cahill S, 2014, INT PSYCHOGERIATR, V26, P605, DOI 10.1017/S104161021300238X; Cahill S, 2010, INT J GERIATR PSYCH, V25, P912, DOI 10.1002/gps.2597; Ciblis AS, 2016, IRISH J MED SCI, V185, P597, DOI 10.1007/s11845-015-1315-4; Department of Health, 2014, IR NAT DEM STRAT; Department of Health, 2014, PRIV HLTH INS; Downs MG, 1996, INT J GERIATR PSYCH, V11, P937, DOI 10.1002/(SICI)1099-1166(199611)11:11<937::AID-GPS540>3.0.CO;2-0; Foley T, 2014, DEMENTIA DIAGNOSIS M; Health Information and Quality Authority, 2011, REP REC PAT REF GEN; Iliffe S, 2000, AGING MENT HEALTH, V4, P286, DOI 10.1080/713649957; Knapp M, 2007, DEMENTIA INT COMP SU; Menon R, 2011, FAM PRACT, V28, P272, DOI 10.1093/fampra/cmq100; National Health Service England, 2014, ENH SERV SPEC DEM ID; National Health Service Wales, 2013, SNAPSH HLTH N WAL AG; O'Connell H, 2012, NATL DEMENTIA STRATE; O'Riordan M, 2013, ACCESS DIAGNOSTICS K; Office of the Minister for Children and Youth Affairs, 2010, STAT NAT CHILDR 2010; Prince M, 2011, WORLD ALZHEIMER REPO; Rosen B, 2009, HLTH SYST TRANSIT, V11, P1; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Social Care Institute for Excellence National Institute for Health and clinical Excellence, 2006, NAT CLIN PRACT GUID; The Royal College of Radiologists, 2012, IREFER MAK BEST US C; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Waldemar G, 2007, INT J GERIATR PSYCH, V22, P47, DOI 10.1002/gps.1652; Yi Jiming, 2014, UK PRIV HLTH MARK	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151793	10.1371/journal.pone.0151793	http://dx.doi.org/10.1371/journal.pone.0151793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007435	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200065
J	Wang, W; Hong, JS; Rab, A; Sorscher, EJ; Kirk, KL				Wang, Wei; Hong, Jeong S.; Rab, Andras; Sorscher, Eric J.; Kirk, Kevin L.			Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAINS; CONDUCTANCE REGULATOR CHANNELS; CYSTIC-FIBROSIS PATIENTS; CFTR CHLORIDE CHANNEL; ATP BINDING; PHOSPHORYLATION; PROTEIN; VX-770; DIMERIZATION; POTENTIATOR	W1282X is a common nonsense mutation among cystic fibrosis patients that results in the production of a truncated Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channel. Here we show that the channel activity of the W1282X-CFTR polypeptide is exceptionally low in excised membrane patches at normally saturating doses of ATP and PKA (single channel open probability (P-O) < 0.01). However, W1282X-CFTR channels were stimulated by two CFTR modulators, the FDA-approved VX-770 and the dietary compound curcumin. Each of these compounds is an allosteric modulator of CFTR gating that promotes channel activity in the absence of the native ligand, ATP. Although W1282X-CFTR channels were stimulated by VX-770 in the absence of ATP their activities remained dependent on PKA phosphorylation. Thus, activated W1282X-CFTR channels should remain under physiologic control by cyclic nucleotide signaling pathways in vivo. VX-770 and curcumin exerted additive effects on W1282X-CFTR channel gating (opening/ closing) in excised patches such that the P-O of the truncated channel approached unity (> 0.9) when treated with both modulators. VX-770 and curcumin also additively stimulated W1282XCFTR mediated currents in polarized FRT epithelial monolayers. In this setting, however, the stimulated W1282X-CFTR currents were smaller than those mediated by wild type CFTR (3-5%) due presumably to lower expression levels or cell surface targeting of the truncated protein. Combining allosteric modulators of different mechanistic classes is worth considering as a treatment option for W1282X CF patients perhaps when coupled with maneuvers to increase expression of the truncated protein.	[Wang, Wei; Hong, Jeong S.; Rab, Andras; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Wang, Wei; Hong, Jeong S.; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Sorscher, Eric J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Wang, W; Kirk, KL (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA.; Wang, W; Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	weiwang@uab.edu; klkirk@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021	Rab, András/0000-0003-2154-0017; Sorscher, Eric J./0000-0001-9341-3354	National Institutes of Health [RO1DK056796, P30DK072482]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796, P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants RO1DK056796 (awarded to KK) and P30DK072482 (ES as Program Director).	Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Rowe SM, 2011, J MOL MED, V89, P1149, DOI 10.1007/s00109-011-0787-6; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; Sohma Y, 2013, CURR PHARM DESIGN, V19, P3521, DOI 10.2174/13816128113199990320; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272	22	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152232	10.1371/journal.pone.0152232	http://dx.doi.org/10.1371/journal.pone.0152232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007499	gold, Green Submitted, Green Published			2022-12-27	WOS:000372701200114
J	dos Santos, HG; Nunez-Castilla, J; Siltberg-Liberles, J				dos Santos, Helena G.; Nunez-Castilla, Janelle; Siltberg-Liberles, Jessica			Functional Diversification after Gene Duplication: Paralog Specific Regions of Structural Disorder and Phosphorylation in p53, p63, and p73	PLOS ONE			English	Article							INDUCED FIT; PROTEINS; PREDICTION; SEQUENCE; EVOLUTION; FAMILY; DATABASE; GENOME; MDM2; GENERATION	Conformational and functional flexibility promote protein evolvability. High evolvability allows related proteins to functionally diverge and perhaps to neostructuralize. p53 is a multifunctional protein frequently referred to as the Guardian of the Genome-a hub for e.g. incoming and outgoing signals in apoptosis and DNA repair. p53 has been found to be structurally disordered, an extreme form of conformational flexibility. Here, p53, and its paralogs p63 and p73, were studied for further insights into the evolutionary dynamics of structural disorder, secondary structure, and phosphorylation. This study is focused on the post gene duplication phase for the p53 family in vertebrates, but also visits the origin of the protein family and the early domain loss and gain events. Functional divergence, measured by rapid evolutionary dynamics of protein domains, structural properties, and phosphorylation propensity, is inferred across vertebrate p53 proteins, in p63 and p73 from fish, and between the three paralogs. In particular, structurally disordered regions are redistributed among paralogs, but within clades redistribution of structural disorder also appears to be an ongoing process. Despite its deemed importance as the Guardian of the Genome, p53 is indeed a protein with high evolvability as seen not only in rearranged structural disorder, but also in fluctuating domain sequence signatures among lineages.	[dos Santos, Helena G.; Nunez-Castilla, Janelle; Siltberg-Liberles, Jessica] Florida Int Univ, Dept Biol Sci, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University	Siltberg-Liberles, J (corresponding author), Florida Int Univ, Dept Biol Sci, Biomol Sci Inst, Miami, FL 33199 USA.	jliberle@fiu.edu		Nunez-Castilla, Janelle/0000-0002-3608-4512				Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assis R, 2014, MOL BIOL EVOL, V31, P419, DOI 10.1093/molbev/mst217; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Berna L, 2014, GENOME BIOL EVOL, V6, P1724, DOI 10.1093/gbe/evu122; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Brandt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047889; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cai QL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r29; Chao CCK, 2015, CLIN CHIM ACTA, V438, P139, DOI 10.1016/j.cca.2014.08.015; Chen YH, 2013, NUCLEIC ACIDS RES, V41, P8368, DOI 10.1093/nar/gkt584; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; Cohen O, 2010, BIOINFORMATICS, V26, P2914, DOI 10.1093/bioinformatics/btq549; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Costanzo A, 2014, FEBS LETT, V588, P2590, DOI 10.1016/j.febslet.2014.06.047; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Domenico T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S3; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Joerger AC, 2014, STRUCTURE, V22, P1301, DOI 10.1016/j.str.2014.07.010; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lane DP, 2011, CELL CYCLE, V10, P4272, DOI 10.4161/cc.10.24.18567; Lane DP, 2010, CELL CYCLE; Lee JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1933; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nedelcu AM, 2007, DEV GENES EVOL, V217, P801, DOI 10.1007/s00427-007-0185-9; Nguyen TA, 2014, HUM MUTAT, V35, P738, DOI 10.1002/humu.22506; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; R Core Team, 2021, R LANGUAGE ENV STAT; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Siltberg-Liberles J, 2011, GENES-BASEL, V2, P748, DOI 10.3390/genes2040748; Siltberg-Liberles J, 2011, MOL BIOL EVOL, V28, P59, DOI 10.1093/molbev/msq291; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11383, DOI 10.1093/nar/16.23.11383; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wu H, 2015, ONCOTARGET, V6, P21479, DOI 10.18632/oncotarget.4086; Xue B, 2013, BBA-PROTEINS PROTEOM, V1834, P725, DOI 10.1016/j.bbapap.2013.01.012; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078318, 10.1371/journal.pone.0059627]; Zdzalik M, 2010, CELL CYCLE, V9, P4584, DOI 10.4161/cc.9.22.13871	74	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151961	10.1371/journal.pone.0151961	http://dx.doi.org/10.1371/journal.pone.0151961			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003913	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400060
J	Emokpae, AA; Mabogunje, CA; Imam, ZO; Olusanya, BO				Emokpae, Abieyuwa A.; Mabogunje, Cecilia A.; Imam, Zainab O.; Olusanya, Bolajoko O.			Heliotherapy for Neonatal Hyperbilirubinemia in Southwest, Nigeria: A Baseline Pre-Intervention Study	PLOS ONE			English	Article							FILTERED-SUNLIGHT; EXCHANGE TRANSFUSIONS; INTENSIVE-CARE; JAUNDICE; PHOTOTHERAPY; MANAGEMENT; NEWBORNS; KERNICTERUS; MORBIDITY; INFANTS	Background A novel filtered-sunlight phototherapy (FSPT) device has been demonstrated to be safe and efficacious for treating infants with neonatal jaundice in resource-constrained tropical settings. We set out to provide baseline data for evaluating the clinical impact of this device in a referral pediatric hospital. Methods We reviewed the medical records of infants admitted for neonatal hyperbilirubinemia in an inner-city Children's Hospital in Lagos, between January 2012 and December 2014 to determine the pattern, treatment and outcomes during the pre-intervention period. Factors associated with adverse outcomes were identified through multivariable logistic regression. Results Of the 5,229 neonatal admissions over the period, a total of 1,153 (22.1%) were admitted for neonatal hyperbilirubinemia. Complete records for 1,118 infants were available for analysis. The incidence of acute bilirubin encephalopathy (ABE) and exchange transfusion (ET) were 17.0% (95% CI: 14.9%-19.3%) and 31.5% (95% CI: 28.8%-34.3%) respectively. A total of 61 (5.5%, 95% CI: 4.3%-6.9%) of the jaundiced infants died. Weight on admission, peak total serum bilirubin (TSB), sepsis and exposure to hemolytic products were predictive of ABE, while age on admission, peak TSB, ABO incompatibility and ABE were predictive of ET. Rhesus incompatibility, asphyxia, exposure to hemolytic substances and ABE were associated with elevated mortality risk, while ET was a protective factor. Lack of routine irradiance monitoring and steady energy supply were frequent challenges for conventional blue-light phototherapy. Conclusions Severe hyperbilirubinemia is associated with high rates of ABE and ET in this setting, and remains a significant contributor to neonatal admissions and mortality. To be impactful, FSPT, complemented with improved diagnostic facilities, should effectively curtail jaundice-related adverse outcomes in this and comparable settings.	[Emokpae, Abieyuwa A.; Mabogunje, Cecilia A.; Imam, Zainab O.] Massey St Childrens Hosp, Lagos, Nigeria; [Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, 286A Corp Dr, Lagos, Nigeria		Olusanya, BO (corresponding author), Ctr Hlth Start Initiat, 286A Corp Dr, Lagos, Nigeria.	bolajoko.olusanya@uclmail.net	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583				Abu-Ekteish F, 2000, ANN TROP PAEDIATR, V20, P57, DOI 10.1080/02724930092084; American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297, DOI DOI 10.1542/PEDS.114.1.297; Basnet S, 2011, PEDIATRICS, V128, pE986, DOI 10.1542/peds.2010-3657; Bhutani VK, 2013, PEDIATR RES, V74, P86, DOI 10.1038/pr.2013.208; Bhutani VK, 2011, SEMIN PERINATOL, V35, P192, DOI 10.1053/j.semperi.2011.02.015; Burke BL, 2009, PEDIATRICS, V123, P524, DOI 10.1542/peds.2007-2915; Calado CS, 2009, PEDIATR EMERG CARE, V25, P244, DOI 10.1097/PEC.0b013e31819e361d; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, P362; Chitty HE, 2013, J PAEDIATR CHILD H, V49, P825, DOI 10.1111/jpc.12290; Cline BK, 2013, J TROP PEDIATRICS, V59, P321, DOI 10.1093/tropej/fmt027; Disu EA, 2015, NIGER J CLIN PRACT, V18, P102, DOI 10.4103/1119-3077.146989; Gamaleldin R, 2011, PEDIATRICS, V128, pE925, DOI 10.1542/peds.2011-0206; Habib HS, 2013, JCPSP-J COLL PHYSICI, V23, P715, DOI 10.2013/JCPSP.715719; Hameed NN, 2011, NEONATOLOGY, V100, P57, DOI 10.1159/000321990; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hess Dean R, 2004, Respir Care, V49, P1171; Iskander I., 2012, Eastern Mediterranean Health Journal, V18, P882; Kaplan M, 2008, PEDIATR RES, V63, P109, DOI 10.1203/PDR.0b013e31815b8e7e; Mabogunje CA, 2016, WORLD J CLI IN PRESS; Maisels MJ, 2015, CAN MED ASSOC J, V187, P335, DOI 10.1503/cmaj.122117; Narang A, 2005, INDIAN PEDIATR, V42, P989; National Institute for Health and Clinical Excellence, 2010, NEON JAUND CLIN GUID; Ogunlesi T A, 2007, Niger J Med, V16, P354; Olusanya BO, 2016, NIGER J CLIN PRACT, V19, P1, DOI 10.4103/1119-3077.173703; Olusanya BO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0358-z; Olusanya BO, 2014, ACTA PAEDIATR, V103, P1102, DOI 10.1111/apa.12735; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Olusanya BO, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-180; Opondo C, 2009, TROP MED INT HEALTH, V14, P1165, DOI 10.1111/j.1365-3156.2009.02358.x; Owa JA, 2009, WORLD J PEDIATR, V5, P51, DOI 10.1007/s12519-009-0009-2; Pejaver Ranjan Kumar, 2000, Indian Journal of Pediatrics, V67, P883, DOI 10.1007/BF02723951; Rasul CH, 2010, MALAYS J MED SCI, V17, P40; Salas AA, 2008, ACTA PAEDIATR, V97, P754, DOI 10.1111/j.1651-2227.2008.00743.x; Slusher TM, 2015, NEW ENGL J MED, V373, P1115, DOI 10.1056/NEJMoa1501074; Slusher TM, 2014, PEDIATRICS, V133, pE1568, DOI 10.1542/peds.2013-3500; SLUSHER TM, 1995, J PEDIATR-US, V126, P102, DOI 10.1016/S0022-3476(95)70510-4; Steiner LA, 2007, PEDIATRICS, V120, P27, DOI 10.1542/peds.2006-2910; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; World Health Organization, 2013, POCK BOOK HOSP CAR C; Zhang L, 2015, MED SCI MONITOR, V21, P1668	41	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151375	10.1371/journal.pone.0151375	http://dx.doi.org/10.1371/journal.pone.0151375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003893	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400031
J	Kugelman, JR; Rossi, CA; Wiley, MR; Ladner, JT; Nagle, ER; Pfeffer, BP; Garcia, K; Prieto, K; Wada, J; Kuhn, JH; Palacios, G				Kugelman, Jeffrey R.; Rossi, Cynthia A.; Wiley, Michael R.; Ladner, Jason T.; Nagle, Elyse R.; Pfeffer, Bradley P.; Garcia, Karla; Prieto, Karla; Wada, Jiro; Kuhn, Jens H.; Palacios, Gustavo			Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus/H.sapiens-tc/COD/1995/Kikwit-9510621 Challenge Stock "R4368" and Its Replacement "R4415"	PLOS ONE			English	Article							SMALL GLYCOPROTEIN SGP; VARIANTS; RNA; NOMENCLATURE; GUINEA	The creation of licensed medical countermeasures against Select Agents such as Ebola virus (EBOV) is critically dependent on the use of standardized reagents, assays, and animal models. We performed full genome reconstruction, population genomics, contaminant analysis, and characterization of the glycoprotein gene editing site of historical United States Army Medical Research Institute of Infectious Diseases (USAMRIID) nonhuman-primate challenge stock Ebola virus Kikwit "R4368" and its 2014 replacement "R4415." We also provide characterization of the master stock used to create "R4415." The obtained data are essential to understanding the quality of the seed stock reagents used in pivotal animal studies that have been used to inform medical countermeasure development. Furthermore, these data might add to the understanding of the influence of EBOV variant populations on pathogenesis and disease outcome and inform attempts to avoid the evolution of EBOV escape mutants in response to current therapeutics. Finally, as the primary challenge stocks have changed over time, these data will provide a baseline for understanding and correlating past and future animal study results.	[Kugelman, Jeffrey R.; Rossi, Cynthia A.; Wiley, Michael R.; Ladner, Jason T.; Nagle, Elyse R.; Pfeffer, Bradley P.; Garcia, Karla; Prieto, Karla; Palacios, Gustavo] USAMRIID, Frederick, MD USA; [Wada, Jiro; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, NIH, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Palacios, G (corresponding author), USAMRIID, Frederick, MD USA.	gustavo.f.palacios.ctr@mail.mil	Kuhn, Jens H./B-7615-2011; Palacios, Gustavo/I-7773-2015; Ladner, Jason/G-3486-2011	Kuhn, Jens H./0000-0002-7800-6045; Palacios, Gustavo/0000-0001-5062-1938; Ladner, Jason/0000-0001-7751-4366; Wiley, Michael/0000-0001-6688-007X	Battelle Memorial Institute; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]	Battelle Memorial Institute; US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The content of this publication does not necessarily reflect the views or policies of the US Department of Defense, the US Department of Health and Human Services, the US Department of the Army, or the institutions and companies affiliated with the authors. This work was funded in part through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272200700016I (J.H.K.). A subcontractor to Battelle Memorial Institute who performed this work is: J.H.K, an employee of Tunnell Government Services, Inc. Tunnell Government Services provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All work under contract HHSN272200700016I is performed under the agreement/understanding that it will belong to the client and will be affiliated directly to the NIH/NIAID Integrated Research Facility at Fort Detrick. The specific roles of these authors are articulated in the 'author contributions' section.	Alfson KJ, 2015, J INFECT DIS, V212, pS295, DOI 10.1093/infdis/jiv216; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Barrientos LG, 2004, BIOCHEM BIOPH RES CO, V323, P696, DOI 10.1016/j.bbrc.2004.08.148; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Kilgore N, 2012, VIRUSES-BASEL, V4, P2312, DOI 10.3390/v4102312; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Kuhn JH, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01178-14; Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760; Kuhn JH, 2014, VIRUSES-BASEL, V6, P3663, DOI 10.3390/v6093663; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2011, BIOSECUR BIOTERROR, V9, P361, DOI 10.1089/bsp.2011.0051; Kuhn JH, 2011, VIRUS TAXONOMY, P665; KUHN JH, 2008, ARCH VIROLOGY S, V20; Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14; Mehedi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003677; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Natl Res Council, 2011, ANIMAL MODELS FOR ASSESSING COUNTERMEASURES TO BIOTERRORISM AGENTS, P1; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shurtleff AC, 2012, VIRUSES-BASEL, V4, P3511, DOI 10.3390/v4123511; Trefry JC, 2015, VIRUSES-BASEL, V7, P6739, DOI 10.3390/v7122969; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkova VA, 1998, VIROLOGY, V250, P408, DOI 10.1006/viro.1998.9389; Volchkova VA, 1999, VIROLOGY, V265, P164, DOI 10.1006/viro.1999.0034; Volchkova VA, 2015, J INFECT DIS, V212, pS226, DOI 10.1093/infdis/jiv309; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; W.H. Organization, 2016, WHO EB SIT REP; Wahl-Jensen V, 2014, VIRAL HEMORRHAGIC FEVERS, P99	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150919	10.1371/journal.pone.0150919	http://dx.doi.org/10.1371/journal.pone.0150919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002733	Green Published, gold			2022-12-27	WOS:000372697400022
J	Li, XS; Luo, YQ; Yang, HY; Yang, QS; Settele, J; Schweiger, O				Li, Xiushan; Luo, Youqing; Yang, Haiyu; Yang, Qingsen; Settele, Josef; Schweiger, Oliver			On the Ecology and Conservation of Sericinus montelus (Lepidoptera: Papilionidae) - Its Threats in Xiaolongshan Forests Area (China)	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT; RESPONSES; IMPACTS	Contents and Methods Here we present a detailed analysis of the life history, mobility and habitat requirements of the butterfly Sericinus montelus on the basis of extensive field observations, experimental breeding, capture-mark-recapture (CMR) and transect surveys. Life History We found that S. montelus has three generations per year and overwinters as pupae on shrub branches in Xiaolongshan. The adults of first generation have a peak of emergence in late April. The second generation emerges at the end of June and the third in early to middle August. Within the study region, larvae of S. montelus are monophagous on Aristolochia contorta. Adults fly slowly and lay eggs in clusters. Key Factors Life tables show that natural enemies and human activities such as mowing, weeding and trampling during the egg and larval stages are key factors causing high mortality, killing up to 43% of eggs and 72% of larvae thereby limiting population growth and recovery. Population Ecology The populations of S. montelus in Xiaolongshan have a rather patchy distribution. According to CMR data, adults fly a maximum distance of 700m within a lifespan of 6 days. The host plant A. contorta, grows along the low banks of fields, irrigation ditches and paths, and can be highly affected by agricultural activities, like mowing, weeding and herding, which impact larval survival. Population Maintenance For S. montelus should mainly focus on reducing agricultural threats to the host plant A. contorta and on increasing habitat connectivity.	[Li, Xiushan; Luo, Youqing] Beijing Forestry Univ, Key Lab Forest Silviculture & Conservat, Minist Educ, Beijing 100083, Peoples R China; [Li, Xiushan] Chinese Res Inst Environm Sci, Biodivers Res Ctr, Beijing 100012, Peoples R China; [Yang, Haiyu] Xiaolongshan Forestry Expt Agcy, Res Inst Forestry Sci, Key Lab Oak Secondary Forest Ecosyst Gansu Prov, Tianshui, Peoples R China; [Yang, Qingsen] Xiaolongshan Forestry Expt Agcy, Stn Forests Dis & Pests Control & Quarantine, Tianshui 741020, Peoples R China; [Settele, Josef; Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany; [Settele, Josef] German Ctr Integrat Biodivers Res iDiv, IDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany	Beijing Forestry University; Chinese Research Academy of Environmental Sciences; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Luo, YQ (corresponding author), Beijing Forestry Univ, Key Lab Forest Silviculture & Conservat, Minist Educ, Beijing 100083, Peoples R China.	yqluo@bjfu.edu.cn	Schweiger, Oliver/B-4909-2008; Settele, Josef/A-6371-2009; Li, Xiushan/AAA-3856-2021	Schweiger, Oliver/0000-0001-8779-2335; Settele, Josef/0000-0002-8624-4983; 				An DG, 2002, HIGH PLANTS FLORA XI; [Anonymous], 2009, BUTTERFLIES EUROPE, DOI DOI 10.1111/j.1365-3113.2006.00333.x; BELLOWS TS, 1992, ANNU REV ENTOMOL, V37, P587, DOI 10.1146/annurev.en.37.010192.003103; Chou I, 2000, MONOGRAPHIA RHOPALOC; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Ehrlich P.R., 1984, Symposia of the Royal Entomological Society of London, P25; Fischer Klaus, 1998, Nota Lepidopterologica, V21, P14; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Hanspach J, 2014, ECOGRAPHY, V37, P301, DOI 10.1111/j.1600-0587.2013.00195.x; Koh LP, 2007, J APPL ECOL, V44, P703, DOI 10.1111/j.1365-2664.2007.01324.x; Leidner AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009534; Li XS, 2011, J INSECT CONSERV, V15, P617, DOI 10.1007/s10841-010-9361-8; Li XS, 2010, J INSECT CONSERV, V14, P257, DOI 10.1007/s10841-009-9254-x; Li Xiu-Shan, 2006, Acta Ecologica Sinica, V26, P3184, DOI 10.1016/S1872-2032(06)60049-8; Luo Z.W., 2005, SERICINUS MONTELUS J, V23, P437; Luo ZB, 2011, MORPHOLOGY BIOL CHAR; Luo ZB, 2010, INSECT RES MIDDLE CH, V6, P71; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Maes D, 2005, BIOL CONSERV, V123, P177, DOI 10.1016/j.biocon.2004.11.005; Marschalek DA, 2010, J INSECT CONSERV, V14, P721, DOI 10.1007/s10841-010-9302-6; Nilsson SG, 2008, INSECT CONSERV DIVER, V1, P197, DOI 10.1111/j.1752-4598.2008.00027.x; Nowicki P, 2008, ISR J ECOL EVOL, V54, P69, DOI 10.1560/IJEE.54.1.69; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Poyry J, 2009, GLOBAL CHANGE BIOL, V15, P732, DOI 10.1111/j.1365-2486.2008.01789.x; Pollard E., 1986, MONITORING ABUNDANCE; Schtickzelle N, 2007, BIOL CONSERV, V136, P651, DOI 10.1016/j.biocon.2007.01.012; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Schweiger O, 2006, LANDSCAPE ECOL, V21, P989, DOI 10.1007/s10980-005-6057-7; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Wang XP, 2007, APPL ENTOMOL ZOOL, V42, P419, DOI 10.1303/aez.2007.419; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; WATANABE M, 1979, Japanese Journal of Ecology, V29, P85; WATANABE M, 1981, RES POPUL ECOL, V23, P74, DOI 10.1007/BF02514094; Wilson Robert J., 2009, P81; Wu CS, 2001, FAUNA SINICA INSECTA, V25, P241; Xu RM., 1987, INSECT POPULATION EC; Yang Darong, 1998, Acta Entomologica Sinica, V41, P48; Yang Qiu-Sheng, 2007, Chinese Bulletin of Entomology, V44, P223; Ye SX, 2002, CHINESE HIGHER PLANT; Zhang XX., 2002, INSECT ECOLOGY FOREC	43	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150833	10.1371/journal.pone.0150833	http://dx.doi.org/10.1371/journal.pone.0150833			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002639	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400021
J	Perilli, MLL; Lima, F; Rodrigues, FHG; Cavalcanti, SMC				Perilli, Miriam L. L.; Lima, Fernando; Rodrigues, Flavio H. G.; Cavalcanti, Sandra M. C.			Can Scat Analysis Describe the Feeding Habits of Big Cats? A Case Study with Jaguars (Panthera onca) in Southern Pantanal, Brazil	PLOS ONE			English	Article							PUMA PUMA-CONCOLOR; FOOD-HABITS; PREDATION; ECOLOGY; PREY; CARNIVORES; LANDSCAPE; PATTERNS; CLUSTERS; FOREST	Large cats feeding habits have been studied through two main methods: scat analysis and the carcasses of prey killed by monitored animals. From November 2001 to April 2004, we studied jaguar predation patterns using GPS telemetry location clusters on a cattle ranch in southern Pantanal. During this period, we recorded 431 carcasses of animals preyed upon by monitored jaguars. Concurrently, we collected 125 jaguar scats opportunistically. We compared the frequencies of prey found through each method. We also compared the prey communities using Bray-Curtis similarity coefficient. These comparisons allowed us to evaluate the use of scat analysis as a means to describe jaguar feeding habits. Both approaches identified prey communities with high similarity (Bray-Curtis coefficient >70). According to either method, jaguars consume three main prey: cattle (Bos taurus), caiman (Caiman yacare) and peccaries (Tayassu pecari and Pecari tajacu). The two methods did not differ in the frequency of the three main prey over dry and wet seasons or years sampled. Our results show that scat analysis is effective and capable of describing jaguar feeding habits.	[Perilli, Miriam L. L.] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil; [Perilli, Miriam L. L.] Univ Fed Mato Grosso do Sul UFMS, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Perilli, Miriam L. L.; Rodrigues, Flavio H. G.; Cavalcanti, Sandra M. C.] Inst Conservacao Carnivoros Neotropicais Procarni, Sao Paulo, Brazil; [Lima, Fernando] IPE, Sao Paulo, Brazil; [Lima, Fernando] Univ Estadual Paulista UNESP, Inst Biociencias, Programa Posgrad Ecol & Biodiversidade, Sao Paulo, Brazil; [Rodrigues, Flavio H. G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Perilli, MLL (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil.; Perilli, MLL (corresponding author), Univ Fed Mato Grosso do Sul UFMS, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil.; Perilli, MLL (corresponding author), Inst Conservacao Carnivoros Neotropicais Procarni, Sao Paulo, Brazil.	miriamperilli@gmail.com	Rodrigues, Flávio/E-4924-2012; Lima, Fernando/E-8023-2016	Rodrigues, Flávio/0000-0002-4797-0085; Lima, Fernando/0000-0002-8644-9647	Fundacao Grupo Boticario de Protecao a Natureza (Boticario Group Foundation); Wildlife Conservation Society (WCS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Grupo Boticario de Protecao a Natureza (Boticario Group Foundation); Wildlife Conservation Society (WCS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Scat analysis funding was provided by Fundacao Grupo Boticario de Protecao a Natureza (Boticario Group Foundation). Funding for jaguar monitoring was provided by the Wildlife Conservation Society (WCS). Sociedade Civil Mamiraua (SCM) and Fundacao Brasileira para o Desenvolvimento Sustentavel (FBDS - Brazilian Foundation for Sustainable Development) provided administrative and logistical support at the research station. MLLP received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2003, TECHNOMETRICS; [Anonymous], 2008, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2008.RLTS.T15953A5327466.EN; Aranda M, 1996, STUD NEOTROP FAUNA E, V31, P65, DOI 10.1076/snfe.31.2.65.13334; Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; de Azevedo FCC, 2008, BIOTROPICA, V40, P494, DOI 10.1111/j.1744-7429.2008.00404.x; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Cavalcanti SMC, 2010, J MAMMAL, V91, P722, DOI 10.1644/09-MAMM-A-171.1; Ceballos G., 2005, BIODIVERSITAS, V62, P1; Chinchilla FA, 1997, REV BIOL TROP, V45, P1223; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Crawshaw, 1995, COMP ECOLOGY OCELOT; Crawshaw PG, 2002, JAGUAR NUEVO MILENIO, P223; Dalponte J, 2002, JAGUAR NUEVO MILENIO; de Azevedo FCC, 2007, J WILDLIFE MANAGE, V71, P2379, DOI 10.2193/2006-520; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Facure KG, 1996, MAMMALIA, V60, P499; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Garla RC, 2001, BIOTROPICA, V33, P691, DOI 10.1111/j.1744-7429.2001.tb00226.x; Gomez-Ortiz Y, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-014-0102-7; Harris MB, 2005, CONSERV BIOL, V19, P714, DOI 10.1111/j.1523-1739.2005.00708.x; Hernandez-SaintMartin AD, 2015, NAT AREA J, V35, P308, DOI 10.3375/043.035.0213; Hoogesteijn R, 2010, WILD FELID MONIT, V3, P1; Desbiez ALJ, 2010, BIOTROPICA, V42, P372, DOI 10.1111/j.1744-7429.2009.00601.x; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Leite Y, 2002, JAGUAR NUEVO MILENIO; Loveridge Andrew J., 2010, P161; Martins Q, 2011, J ZOOL, V283, P81, DOI 10.1111/j.1469-7998.2010.00757.x; Morato Ronaldo G., 2002, P91; Novack AJ, 2005, J ZOOL, V267, P167, DOI 10.1017/S0952836905007338; Nunez R, 2000, J ZOOL, V252, P373, DOI 10.1111/j.1469-7998.2000.tb00632.x; Pitman RT, 2012, J ZOOL, V288, P222, DOI 10.1111/j.1469-7998.2012.00945.x; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Quadros J, 2006, REV BRAS ZOOL, V23, P279, DOI 10.1590/S0101-81752006000100023; QUIGLEY HB, 1992, BIOL CONSERV, V61, P149, DOI 10.1016/0006-3207(92)91111-5; Quigley HB, 1987, ECOLOGY CONSERVATION; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Rosas-Rosas OC, 2008, RANGELAND ECOL MANAG, V61, P554, DOI 10.2111/08-038.1; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; SCHALLER GB, 1978, Z SAUGETIERKD, V43, P296; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Sollmann R, 2013, EUR J WILDLIFE RES, V59, P445, DOI 10.1007/s10344-013-0708-9; Taber AB, 1997, BIOTROPICA, V29, P204, DOI 10.1111/j.1744-7429.1997.tb00025.x; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; Wallach AD, 2015, OIKOS, V124, P1453, DOI 10.1111/oik.01977; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x; Zar J. H., 1996, BIOSTATISTICAL ANAL	60	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151814	10.1371/journal.pone.0151814	http://dx.doi.org/10.1371/journal.pone.0151814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002524	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400048
J	Steinwender, B; Thrimawithana, AH; Crowhurst, R; Newcomb, RD				Steinwender, Bernd; Thrimawithana, Amali H.; Crowhurst, Ross; Newcomb, Richard D.			Odorant Receptors of the New Zealand Endemic Leafroller Moth Species Planotortrix octo and P. excessana	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENTS; BROWN APPLE MOTH; CTENOPSEUSTIS-OBLIQUANA LEPIDOPTERA; FUNCTIONAL-CHARACTERIZATION; BROWNHEADED LEAFROLLER; EPIPHYAS-POSTVITTANA; EVOLUTION; RESPONSES; ALIGNMENT; QUANTIFICATION	Moths use their sense of smell to find food sources, mating partners and oviposition sites. For this they possess a family of odorant receptors (ORs). Some ORs are used by both sexes whereas others have sex-specific roles. For example, male moths possess ORs specifically tuned to sex pheromones produced by conspecific females. Here we identify sets of ORs from the antennae of New Zealand endemic leafroller moths Planotortrix octo (48 ORs) and P. excessana (47 ORs) using an RNA-Seq approach. Two orthologous ORs show male-biased expression in the adult antennae of both species (OR7 and OR30) and one other OR in each species was female-biased in its expression (PoctOR25, PexcOR14) by qPCR. PAML analysis conducted on male-biased ORs indicated positive selection acting on the male-biased OR7. The fact that OR7 is likely under positive selection, that it is male-biased in its expression and that its orthologue in C. obliquana, CoblOR7, responds to sex pheromone components also utilised by Planotortrix species, suggests that this receptor may also be important in sex pheromone reception in Planotortrix species.	[Steinwender, Bernd; Thrimawithana, Amali H.; Crowhurst, Ross; Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Steinwender, Bernd; Newcomb, Richard D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Steinwender, Bernd; Newcomb, Richard D.] Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; Massey University	Newcomb, RD (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand.; Newcomb, RD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.; Newcomb, RD (corresponding author), Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand.	Richard.Newcomb@plantandfood.co.nz	Thrimawithana, Amali H/O-4702-2017; Crowhurst, Ross N/N-8892-2017; Newcomb, Richard/C-2067-2009	Thrimawithana, Amali H/0000-0001-6325-2334; Crowhurst, Ross N/0000-0003-0608-2134; Newcomb, Richard/0000-0002-7307-9755	Allan Wilson Centre for Molecular Ecology and Evolution	Allan Wilson Centre for Molecular Ecology and Evolution	We would like to thank Anne Barrington for supplying moths. Funding was provided by the Allan Wilson Centre for Molecular Ecology and Evolution.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Albre J, 2013, J HERED, V104, P627, DOI 10.1093/jhered/est043; Albre J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002489; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Aronesty E., 2011, EA UTILS COMMAND LIN; Bengtsson JM, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00033; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bradbury Jack W., 1998, pi; Carraher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038391; CLARE GK, 1988, NEW ZEAL J ZOOL, V15, P435, DOI 10.1080/03014223.1988.10422971; Corcoran, 2014, THESIS U AUCKLAND NZ; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; CROSBY T K, 1976, New Zealand Journal of Zoology, V3, P69; Davie LC, 2010, ANIM BEHAV, V79, P391, DOI 10.1016/j.anbehav.2009.11.015; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P1063, DOI 10.1016/j.jinsphys.2007.05.013; DUGDALE JS, 1990, NEW ZEAL J ZOOL, V17, P437, DOI 10.1080/03014223.1990.10422943; FOSTER SP, 1986, NATURWISSENSCHAFTEN, V73, P156, DOI 10.1007/BF00367406; FOSTER SP, 1990, J CHEM ECOL, V16, P2461, DOI 10.1007/BF01017469; FOSTER SP, 1987, J CHEM ECOL, V13, P623, DOI 10.1007/BF01880104; FOSTER SP, 1988, BIOCHEM SYST ECOL, V16, P227, DOI 10.1016/0305-1978(88)90102-0; FOSTER SP, 1989, J CHEM ECOL, V15, P457, DOI 10.1007/BF01014692; GALBREATH RA, 1985, Z NATURFORSCH C, V40, P266; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HANSSON BS, 1989, ENTOMOL EXP APPL, V53, P137, DOI 10.1007/BF00187995; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hillier NK, 2011, J CHEM ECOL, V37, P1127, DOI 10.1007/s10886-011-0017-2; Hillier NK, 2004, CHEM SENSES, V29, P499, DOI 10.1093/chemse/bjh052; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Johns SJ, 2005, TRANSMEMBRANE PROTEI; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KOH YH, 1995, ANN ENTOMOL SOC AM, V88, P519, DOI 10.1093/aesa/88.4.519; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Langhoff P, 2009, MOL ECOL RESOUR, V9, P691, DOI 10.1111/j.1755-0998.2009.02537.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linn Charles E. Jr., 1995, P263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Newcomb RD, 2015, PHEROMONE COMMUNICTA; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phelan P.L., 1992, P265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; ROELOFS WL, 1982, ANNU REV ECOL SYST, V13, P395, DOI 10.1146/annurev.es.13.110182.002143; RUMBO ER, 1983, PHYSIOL ENTOMOL, V8, P195, DOI 10.1111/j.1365-3032.1983.tb00349.x; RUMBO ER, 1981, PHYSIOL ENTOMOL, V6, P87; Sakai R, 2009, INSECT BIOCHEM MOLEC, V39, P62, DOI 10.1016/j.ibmb.2008.10.001; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; STADELBACHER EA, 1983, EXPERIENTIA, V39, P1174, DOI 10.1007/BF01943168; Steinwender B, 2015, J MOL EVOL, V80, P42, DOI 10.1007/s00239-014-9650-z; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tunstall NE, 2007, J MOL EVOL, V64, P628, DOI 10.1007/s00239-006-0151-6; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; WEARING C. H., 1991, TORTRICID PESTS THEI, P453; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; YOUNG H, 1985, Z NATURFORSCH C, V40, P262	81	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152147	10.1371/journal.pone.0152147	http://dx.doi.org/10.1371/journal.pone.0152147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003722	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400086
J	Tan, TL; Ahmad, NS; Nasuruddin, DN; Ithnin, A; Arifin, KT; Zaini, IZ; Ngah, WZW				Tan, Toh Leong; Ahmad, Nurul Saadah; Nasuruddin, Dian Nasriana; Ithnin, Azlin; Arifin, Khaizurin Tajul; Zaini, Ida Zarina; Ngah, Wan Zurinah Wan			CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department	PLOS ONE			English	Article							FC-GAMMA-RI; CRITICALLY-ILL PATIENTS; C-REACTIVE PROTEIN; ORGAN FAILURE; EARLY-DIAGNOSIS; SEPTIC SHOCK; INFLAMMATORY RESPONSES; SERUM PHOSPHOLIPASE-A2; FEBRILE PATIENTS; A(2)	Introduction Early diagnosis of sepsis and bacterial infection is imperative as treatment relies on early antibiotic administration. There is a need to develop new biomarkers to detect patients with sepsis and bacterial infection as early as possible, thereby enabling prompt antibiotic treatment and improving the survival rate. Methods Fifty-one adult patients with suspected bacterial sepsis on admission to the Emergency Department (ED) of a teaching hospital were included into the study. All relevant cultures and serology tests were performed. Serum levels for Group II Secretory Phospholipase A2 (sPLA2-IIA) and CD64 were subsequently analyzed. Results and Discussion Sepsis was confirmed in 42 patients from a total of 51 recruited subjects. Twenty-one patients had culture-confirmed bacterial infections. Both biomarkers were shown to be good in distinguishing sepsis from non-sepsis groups. CD64 and sPLA2-IIA also demonstrated a strong correlation with early sepsis diagnosis in adults. The area under the curve (AUC) of both Receiver Operating Characteristic curves showed that sPLA2-IIA was better than CD64 (AUC = 0.93, 95% confidence interval (CI) = 0.83-0.97 and AUC = 0.88, 95% CI = 0.82-0.99, respectively). The optimum cutoff value was 2.13 mu g/l for sPLA2-IIA (sensitivity = 91%, specificity = 78%) and 45 antigen bound cell (abc) for CD64 (sensitivity = 81%, specificity = 89%). In diagnosing bacterial infections, sPLA2-IIA showed superiority over CD64 (AUC = 0.97, 95% CI = 0.85-0.96, and AUC = 0.95, 95% CI = 0.93-1.00, respectively). The optimum cutoff value for bacterial infection was 5.63 mu g/l for sPLA2-IIA (sensitivity = 94%, specificity = 94%) and 46abc for CD64 (sensitivity = 94%, specificity = 83%). Conclusions sPLA2-IIA showed superior performance in sepsis and bacterial infection diagnosis compared to CD64. sPLA2-IIA appears to be an excellent biomarker for sepsis screening and for diagnosing bacterial infections, whereas CD64 could be used for screening bacterial infections. Both biomarkers either alone or in combination with other markers may assist in decision making for early antimicrobial administration. We recommend incorporating sPLA2-IIA and CD64 into the diagnostic algorithm of sepsis in ED.	[Tan, Toh Leong; Ahmad, Nurul Saadah; Zaini, Ida Zarina] Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Kuala Lumpur 56000, Malaysia; [Nasuruddin, Dian Nasriana; Ithnin, Azlin] Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Kuala Lumpur 56000, Malaysia; [Arifin, Khaizurin Tajul; Ngah, Wan Zurinah Wan] Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Kuala Lumpur 56000, Malaysia; [Tan, Toh Leong; Ahmad, Nurul Saadah; Nasuruddin, Dian Nasriana; Ithnin, Azlin; Arifin, Khaizurin Tajul; Zaini, Ida Zarina; Ngah, Wan Zurinah Wan] Univ Kebangsaan Malaysia, Med Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Tan, TL (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Emergency Med, Kuala Lumpur 56000, Malaysia.; Tan, TL (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.	sebastianttl@yahoo.co.uk	TAN, TOH LEONG/N-1653-2015; Nasuruddin, Dian Nasriana/AAY-2914-2020; ., Nurul Saadah Ahmad/AAS-1361-2021; Zaini, Ida Zarina/AAQ-3508-2020	TAN, TOH LEONG/0000-0002-6771-0141; ., Nurul Saadah Ahmad/0000-0002-1032-4004; Zaini, Ida Zarina/0000-0003-0127-8453	Universiti Kebangsaan Malaysia [GGPM-2013-103, ETP-2013-050]	Universiti Kebangsaan Malaysia	This study was supported by the 'Geran Galakan Penyelidik Muda' (GGPM-2013-103) and Economic Transformation Programme Research Fund Scheme (ETP-2013-050) from Universiti Kebangsaan Malaysia.	Abraham E, 2003, CRIT CARE MED, V31, P718, DOI 10.1097/01.CCM.0000053648.42884.89; Aikawa Naoki, 2005, Journal of Infection and Chemotherapy, V11, P152, DOI 10.1007/s10156-005-0388-9; Bauer P, 2015, CRIT CARE S1, V19, pP55; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cardelli P, 2008, INT J IMMUNOPATH PH, V21, P43, DOI 10.1177/039463200802100106; Chioato L, 2012, BIOCHIMIE, V94, P132, DOI 10.1016/j.biochi.2011.09.027; Cid J, 2010, J INFECTION, V60, P313, DOI 10.1016/j.jinf.2010.02.013; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; Curcic S, 2015, BBA-MOL CELL BIOL L, V1851, P184, DOI 10.1016/j.bbalip.2014.11.010; DEHAAS M, 1995, J LAB CLIN MED, V126, P330; Dimoula A, 2014, CLIN INFECT DIS, V58, P820, DOI 10.1093/cid/cit936; FAILI A, 1993, BIOCHEM PHARMACOL, V45, P1815, DOI 10.1016/0006-2952(93)90438-3; Gambero A, 2002, BIOCHEM PHARMACOL, V63, P65, DOI 10.1016/S0006-2952(01)00841-3; GERICKE GH, 1995, J LEUKOCYTE BIOL, V57, P455, DOI 10.1002/jlb.57.3.455; Gerstmeier J, 2016, FASEB J OFFICIAL PUB; Gerstmeier J, 2014, BBA-GEN SUBJECTS, V1840, P2961, DOI 10.1016/j.bbagen.2014.05.016; GIJON MA, 1995, BIOCHEM J, V306, P167, DOI 10.1042/bj3060167; Guidet B, 1996, INFECTION, V24, P103, DOI 10.1007/BF01713312; Hietaranta A, 1999, PANCREAS, V18, P385, DOI 10.1097/00006676-199905000-00009; Hollie NI, 2014, ATHEROSCLEROSIS, V234, P377, DOI 10.1016/j.atherosclerosis.2014.03.027; Hong CW, 2010, J IMMUNOL, V184, P4401, DOI 10.4049/jimmunol.0902814; Huang Q, 2015, INT J MOL MED, V35, P587, DOI 10.3892/ijmm.2014.2047; Jin J, 2013, J LIPID RES, V54, P754, DOI 10.1194/jlr.M033746; Katagiri H, 2004, HEPATOLOGY, V39, P139, DOI 10.1002/hep.20000; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Li S, 2013, INT J INFECT DIS, V17, pE12, DOI 10.1016/j.ijid.2012.07.017; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Movert E, 2013, J INFECT DIS, V208, P2025, DOI 10.1093/infdis/jit359; Movert E, 2011, J IMMUNOL, V187, P6437, DOI 10.4049/jimmunol.1100499; Nahecr RA, 2016, J BIOL CHEM, V291, P3076, DOI 10.1074/jbc.M115.677799; Nakae H, 1996, RES COMMUN MOL PATH, V92, P131; Nakamura A, 2009, SHOCK, V31, P586, DOI 10.1097/SHK.0b013e31819716fa; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; NEVALAINEN TJ, 1993, CLIN CHEM, V39, P2453; Ng PC, 2006, CURR OPIN PEDIATR, V18, P125, DOI 10.1097/01.mop.0000193293.87022.4c; Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002; Nyman KM, 1996, J SURG RES, V60, P7, DOI 10.1006/jsre.1996.0003; Osma-Garcia IC, 2015, EUROPEAN J IMMUNOLOG; Pappa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1036-1; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; RINTALA E, 1995, SCAND J INFECT DIS, V27, P39; RINTALA EM, 1993, EUR J HAEMATOL, V50, P11; Rintala EM, 2001, SCAND J CLIN LAB INV, V61, P523; RINTALA EM, 1993, CLIN INFECT DIS, V17, P864, DOI 10.1093/clinids/17.5.864; Schiff DE, 1997, BLOOD, V90, P3187, DOI 10.1182/blood.V90.8.3187; Siljehav V, 2015, J PEDIATR-US, V167, P1207, DOI 10.1016/j.jpeds.2015.08.053; Steudel W, 1997, J APPL PHYSIOL, V83, P18, DOI 10.1152/jappl.1997.83.1.18; Sumi-Akamaru H, 2015, NEUROPATHOLOGY, V35, P289, DOI 10.1111/neup.12202; Szewczuk LM, 2009, CURRENT PROTOCOLS TO; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; VADAS P, 1992, LIFE SCI, V50, P807, DOI 10.1016/0024-3205(92)90186-S; Wang SN, 2015, BIOCHEM BIOPH RES CO, V465, P305, DOI 10.1016/j.bbrc.2015.08.032; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; Yan JJ, 2004, NAT MED, V10, P161, DOI 10.1038/nm989; Yang YI, 2016, J AGR FOOD CHEM, V64, P570, DOI 10.1021/acs.jafc.5b04482; Yedgar S, 2006, BBA-MOL CELL BIOL L, V1761, P1373, DOI 10.1016/j.bbalip.2006.08.003; Yui DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143518; Zameer F, 2015, PHARM BIOL, P1; Zschaler J, 2015, FREE RADICAL BIO MED, V85, P148, DOI 10.1016/j.freeradbiomed.2015.04.015	62	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152065	10.1371/journal.pone.0152065	http://dx.doi.org/10.1371/journal.pone.0152065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003588	Green Submitted, gold, Green Published			2022-12-27	WOS:000372697400071
J	Tarjan, LM; Tinker, MT				Tarjan, L. Max; Tinker, M. Tim			Permissible Home Range Estimation (PHRE) in Restricted Habitats: A New Algorithm and an Evaluation for Sea Otters	PLOS ONE			English	Article							ENHYDRA-LUTRIS; SPACE USE; SAMPLE-SIZE; SELECTION; BEHAVIOR; MOVEMENT; FOX	Parametric and nonparametric kernel methods dominate studies of animal home ranges and space use. Most existing methods are unable to incorporate information about the underlying physical environment, leading to poor performance in excluding areas that are not used. Using radio-telemetry data from sea otters, we developed and evaluated a new algorithm for estimating home ranges (hereafter Permissible Home Range Estimation, or "PHRE") that reflects habitat suitability. We began by transforming sighting locations into relevant landscape features (for sea otters, coastal position and distance from shore). Then, we generated a bivariate kernel probability density function in landscape space and back-transformed this to geographic space in order to define a permissible home range. Compared to two commonly used home range estimation methods, kernel densities and local convex hulls, PHRE better excluded unused areas and required a smaller sample size. Our PHRE method is applicable to species whose ranges are restricted by complex physical boundaries or environmental gradients and will improve understanding of habitat-use requirements and, ultimately, aid in conservation efforts.	[Tarjan, L. Max; Tinker, M. Tim] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Tinker, M. Tim] US Geol Survey, Western Ecol Res Ctr, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey	Tarjan, LM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	ltarjan@ucsc.edu	Tinker, Martin T/D-3249-2018	Tinker, Martin T/0000-0002-3314-839X	United States Geological Survey; American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals; Sigma Xi Grants-in-Aid of Research [G20111015158929]; Friends of Long Marine Laboratory Student Research Award; National Geographic Society Young Explorers Grant [9120-12]; Dr. Earl H. and Ethyl M. Myers Oceanographic and Marine Biology Trust; NSF EEID grant "Roles of marine host cycle and particle aggregation in transmission of zoonotic pathogens in coastal ecosystems" [OCE1065990]; GK-12 Santa Cruz-Watsonville Inquiry-Based Learning in Environmental Sciences [NSF DGE-0947923]; Division Of Graduate Education [0947923] Funding Source: National Science Foundation	United States Geological Survey(United States Geological Survey); American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals; Sigma Xi Grants-in-Aid of Research; Friends of Long Marine Laboratory Student Research Award; National Geographic Society Young Explorers Grant(National Geographic Society); Dr. Earl H. and Ethyl M. Myers Oceanographic and Marine Biology Trust; NSF EEID grant "Roles of marine host cycle and particle aggregation in transmission of zoonotic pathogens in coastal ecosystems"; GK-12 Santa Cruz-Watsonville Inquiry-Based Learning in Environmental Sciences; Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This study would not have been possible without the field and financial support of the United States Geological Survey. Thank you to the following funding sources for supporting field research: the American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award (LMT, http://associations.sou.edu/aaaspd/Students/StudentResearchGrants.html), the Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals (LMT), the Sigma Xi Grants-in-Aid of Research (LMT, G20111015158929, https://www.sigmaxi.org/programs/grants-in-aid), the Friends of Long Marine Laboratory Student Research Award (LMT), the National Geographic Society Young Explorers Grant (LMT, 9120-12, http://www.nationalgeographic.com/explorers/grants-programs/young-explorers/), and the Dr. Earl H. and Ethyl M. Myers Oceanographic and Marine Biology Trust (LMT). The authors thank the National Science Foundation for contributing funds for data analysis via the NSF EEID grant "Roles of marine host cycle and particle aggregation in transmission of zoonotic pathogens in coastal ecosystems" (MTT, OCE1065990, https://www.nsf.gov/funding). Manuscript preparation was partially supported by GK-12 Santa Cruz-Watsonville Inquiry-Based Learning in Environmental Sciences (LMT, NSF DGE-0947923, http://scwibles.ucsc.edu/, https://www.nsf.gov/div/index.jsp?div=DGE).	Ames RA, 1986, SIMULATED TRANSLOCAT; ANDERSON DJ, 1982, ECOLOGY, V63, P103, DOI 10.2307/1937036; Barding EE, 2008, AM MIDL NAT, V159, P394, DOI 10.1674/0003-0031(2008)159[394:RUHEIN]2.0.CO;2; Barry RP, 2011, ECOL MODEL, V222, P1666, DOI 10.1016/j.ecolmodel.2011.02.016; BEKOFF M, 1984, BEHAV RES METH INS C, V16, P32, DOI 10.3758/BF03201046; Bivand R., 2015, **DATA OBJECT**; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Bodkin JL, 2004, MAR MAMMAL SCI, V20, P305, DOI 10.1111/j.1748-7692.2004.tb01159.x; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; BRODY AJ, 1989, WILDLIFE SOC B, V17, P5; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C., 2011, HOME RANGE ESTIMATIO, DOI DOI 10.1111/J.1365-2656.2006.01186.X; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; California Department of Fish and Game Bathymetry Project & State of California Teale Data Center GIS Solutions Group, 2002, BD200M V2I; California Department of Forestry and Fire Protection, 2007, CNTY24K09 1 DISS M S; Campos FA, 2009, AM J PHYS ANTHROPOL, V138, P101, DOI 10.1002/ajpa.20908; CAVALLINI P, 1994, ACTA THERIOL, V39, P279, DOI 10.4098/AT.arch.94-31; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Duong T, 2014, KS KERNEL SMOOTHING; EBERHARDT LE, 1982, J WILDLIFE MANAGE, V46, P183, DOI 10.2307/3808421; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hedmark E, 2007, WILDLIFE BIOL, V13, P13, DOI 10.2981/0909-6396(2007)13[13:PAMSIW]2.0.CO;2; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hijmans RJ, 2011, PACKAGE DISMO SPECIE; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; Knight CM, 2009, WILDLIFE RES, V36, P213, DOI 10.1071/WR08032; Larson SD, 2013, CAN J FISH AQUAT SCI, V70, P1498, DOI 10.1139/cjfas-2013-0025; Lucas A, 2014, AMAP ANOTHER MULTIDI; MacDonald DW, 2004, BIOLOGIA, V59, P235; Major RE, 2001, WILDLIFE RES, V28, P565, DOI 10.1071/WR01040; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Miller M. A., 2002, International Journal for Parasitology, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Mitchell MS, 2012, J MAMMAL, V93, P917, DOI 10.1644/11-MAMM-S-157.1; Monson DH, 2001, J ZOO WILDLIFE MED, V32, P181, DOI 10.1638/1042-7260(2001)032[0181:CAONSO]2.0.CO;2; Moorcroft PR, 2012, J MAMMAL, V93, P903, DOI 10.1644/11-MAMM-S-254.1; Moorcroft PR, 1999, ECOLOGY, V80, P1656, DOI 10.2307/176554; Pattison CA, 1997, SEA OTTER ENHYDRA LU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ralls K, 1996, CAN J ZOOL, V74, P1841, DOI 10.1139/z96-207; REDPATH SM, 1995, J ANIM ECOL, V64, P652, DOI 10.2307/5807; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; SAIN SR, 1994, J AM STAT ASSOC, V89, P807, DOI 10.2307/2290906; Seton E.T., 1909, LIFE HIST NO ANIMALS, V1; Silverman B.W., 1986, DENSITY ESTIMATION S; Skern-Mauritzen M, 2011, MAR ECOL PROG SER, V426, P289, DOI 10.3354/meps09027; Slaght JC, 2013, J APPL ECOL, V50, P1350, DOI 10.1111/1365-2664.12143; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Thometz NM, 2014, J EXP BIOL, V217, P2053, DOI 10.1242/jeb.099739; Tinker MT, 2008, ECOL APPL, V18, P1781, DOI 10.1890/07-0735.1; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Tinker MT, 2006, ECOL APPL, V16, P2293, DOI 10.1890/1051-0761(2006)016[2293:IDDARC]2.0.CO;2; Tinker MT, SEA OTTER P IN PRESS; Vanpe C, 2009, J ANIM ECOL, V78, P42, DOI 10.1111/j.1365-2656.2008.01467.x; Vokoun JC, 2003, N AM J FISH MANAGE, V23, P1020, DOI 10.1577/M02-141; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; Wand MP., 1994, KERNEL SMOOTHING; White G.C., 1990, ANAL WILDLIFE RADIO; WILLIAMS TD, 1983, J AM VET MED ASSOC, V183, P1290; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	68	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150547	10.1371/journal.pone.0150547	http://dx.doi.org/10.1371/journal.pone.0150547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003710	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400016
J	Willner, M; Viermetz, M; Marschner, M; Scherer, K; Braun, C; Fingerle, A; Noel, P; Rummeny, E; Pfeiffer, F; Herzen, J				Willner, Marian; Viermetz, Manuel; Marschner, Mathias; Scherer, Kai; Braun, Christian; Fingerle, Alexander; Noel, Peter; Rummeny, Ernst; Pfeiffer, Franz; Herzen, Julia			Quantitative Three-Dimensional Imaging of Lipid, Protein, and Water Contents via X-Ray Phase-Contrast Tomography	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BREAST-TISSUE CHARACTERIZATION; NEOADJUVANT CHEMOTHERAPY; GRATING INTERFEROMETER; COMPUTED-TOMOGRAPHY; HIGH-RESOLUTION; MEAT; SPECTROSCOPY; CANCER; MICROSTRUCTURE	X-ray phase-contrast computed tomography is an emerging imaging technology with powerful capabilities for three-dimensional (3D) visualization of weakly absorbing objects such as biological soft tissues. This technique is an extension of existing X-ray applications because conventional attenuation-contrast images are simultaneously acquired. The complementary information provided by both the contrast modalities suggests that enhanced material characterization is possible when performing combined data analysis. In this study, we describe how protein, lipid, and water concentrations in each 3D voxel can be quantified by vector decomposition. Experimental results of dairy products, porcine fat and rind, and different human soft tissue types are presented. The results demonstrate the potential of phase-contrast imaging as a new analysis tool. The 3D representations of protein, lipid, and water contents open up new opportunities in the fields of biology, medicine, and food science.	[Willner, Marian; Viermetz, Manuel; Marschner, Mathias; Scherer, Kai; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Dept Phys, Garching, Germany; [Willner, Marian; Viermetz, Manuel; Marschner, Mathias; Scherer, Kai; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Braun, Christian] Univ Munich, Inst Forens Med, Munich, Germany; [Willner, Marian; Fingerle, Alexander; Noel, Peter; Rummeny, Ernst] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Willner, M (corresponding author), Tech Univ Munich, Dept Phys, Garching, Germany.; Willner, M (corresponding author), Tech Univ Munich, Inst Med Engn, Garching, Germany.; Willner, M (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany.	marian.willner@tum.de		Viermetz, Manuel/0000-0002-7332-1900; Noel, Peter/0000-0002-9671-6171	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). M.W. further acknowledges the Graduate School of Information Science in Health (GSISH). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT).	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Bech M, 2010, Z MED PHYS, V20, P7, DOI 10.1016/j.zemedi.2009.11.003; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Cerussi A, 2007, P NATL ACAD SCI USA, V104, P4014, DOI 10.1073/pnas.0611058104; COLMENERO FJ, 1995, LEBENSM WISS TECHNOL, V28, P481, DOI DOI 10.1006/FSTL.1995.0081; Ding HJ, 2014, RADIOLOGY, V272, P731, DOI 10.1148/radiol.14132732; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Einarsdottir H, 2014, INNOV FOOD SCI EMERG, V24, P88, DOI 10.1016/j.ifset.2013.11.003; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Frisullo P, 2009, J FOOD ENG, V94, P283, DOI 10.1016/j.jfoodeng.2009.03.020; Guinee TP, 2013, J DAIRY SCI, V96, P6830, DOI 10.3168/jds.2013-6685; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Holme MN, 2014, NAT PROTOC, V9, P1401, DOI 10.1038/nprot.2014.091; Janhoj T, 2006, J TEXTURE STUD, V37, P276, DOI 10.1111/j.1745-4603.2006.00052.x; Kalender WA, 2012, EUR RADIOL, V22, P1, DOI 10.1007/s00330-011-2169-4; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Ligabue G, 2013, QUANT IMAGING MED SU, V3, P192, DOI 10.3978/j.issn.2223-4292.2013.08.01; Machann J, 2003, J MAGN RESON IMAGING, V17, P350, DOI 10.1002/jmri.10255; O'Sullivan A, 1999, INT J DAIRY TECHNOL, V52, P139, DOI 10.1111/j.1471-0307.1999.tb02856.x; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Prieto N, 2009, MEAT SCI, V83, P175, DOI 10.1016/j.meatsci.2009.04.016; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Togersen G, 1999, MEAT SCI, V51, P97, DOI 10.1016/S0309-1740(98)00106-5; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Willner M, 2013, OPT EXPRESS, V21, P4155, DOI 10.1364/OE.21.004155; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; Wu MG, 2009, J FOOD SCI, V74, pE207, DOI 10.1111/j.1750-3841.2009.01140.x; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Youssef MK, 2010, J FOOD SCI, V75, pS108, DOI 10.1111/j.1750-3841.2009.01475.x; Zanette I, 2011, PHYS STATUS SOLIDI A, V208, P2526, DOI 10.1002/pssa.201184276; Zanette I, 2013, RSC ADV, V3, P19816, DOI 10.1039/c3ra41372a; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	40	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151889	10.1371/journal.pone.0151889	http://dx.doi.org/10.1371/journal.pone.0151889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003308	Green Published, gold			2022-12-27	WOS:000372697400054
J	Gao, XN; Huang, QL; Zhao, ZB; Han, QM; Ke, XW; Qin, HQ; Huang, LL				Gao, Xiaoning; Huang, Qiling; Zhao, Zhibo; Han, Qingmei; Ke, Xiwang; Qin, Huqiang; Huang, Lili			Studies on the Infection, Colonization, and Movement of Pseudomonas syringae pv. actinidiae in Kiwifruit Tissues Using a GFPuv-Labeled Strain	PLOS ONE			English	Article							BACTERIAL CANKER; REAL-TIME; EPIDEMICS; PCR	Kiwifruit bacterial canker, an economically important disease caused by Pseudomonas syringae pv. actinidiae (Psa), has caused severe losses in all major areas of kiwifruit cultivation. Using a GFPuv-labeled strain of Psa, we monitored the invasion, colonization, and movement of the pathogen in kiwifruit twigs, leaves and veins. The pathogen can invade twigs through both wounds and natural openings; the highest number of Psa is obtained in cut tissues. We determined that, following spray inoculation, Psa-GFPuv could infect leaves and cause lesions in the presence and absence of wounds. Light and transmission electron microscopic observations showed that bacterial cells colonize both phloem and xylem vessels. Bacterial infection resulted in marked alterations of host tissues including the disintegration of organelles and degeneration of protoplasts and cell walls. Furthermore, low temperature was conducive to colonization and movement of Psa-GFPuv in kiwifruit tissues. Indeed, the pathogen migrated faster at 4 degrees C than at 16 degrees C or 25 degrees C in twigs. However, the optimum temperature for colonization and movement of Psa in leaf veins was 16 degrees C. Our results, revealing a better understanding of the Psa infection process, might contribute to develop more efficacious disease management strategies.	[Gao, Xiaoning; Huang, Qiling; Zhao, Zhibo; Han, Qingmei; Ke, Xiwang; Qin, Huqiang; Huang, Lili] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Gao, Xiaoning; Huang, Qiling; Zhao, Zhibo; Han, Qingmei; Ke, Xiwang; Qin, Huqiang; Huang, Lili] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Huang, LL (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	huanglili@nwsuaf.edu.cn	Zhao, Zhibo/AAA-3701-2020	Zhao, Zhibo/0000-0001-5043-1384	Fundamental Research Funds for the Central Universities of China [QN2013007]; Natural Science Basic Research Plan in Shaanxi Province of China [2014JQ2-3011]; Education Ministry of China [B07049]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Basic Research Plan in Shaanxi Province of China; Education Ministry of China(Ministry of Education, China)	This study was supported by the Fundamental Research Funds for the Central Universities of China (No. QN2013007), Natural Science Basic Research Plan in Shaanxi Province of China (No. 2014JQ2-3011), and the 111 project from the Education Ministry of China (No. B07049).	Balestra GM, 2009, AUSTRALAS PLANT DIS, V4, P34, DOI 10.1071/DN09014; Biondi E, 2013, ANN APPL BIOL, V162, P60, DOI 10.1111/aab.12001; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cameron A, 2014, PLANT PATHOL, V63, P1, DOI 10.1111/ppa.12066; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; Donati I, 2014, J BERRY RES, V4, P53, DOI 10.3233/JBR-140073; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Ferrante P, 2015, EUR J PLANT PATHOL, V142, P677, DOI 10.1007/s10658-015-0643-6; Ferrante P, 2015, PLANT PATHOL, V64, P51, DOI 10.1111/ppa.12236; Ferrante P, 2012, J PLANT PATHOL, V94, P455; Froud K. J., 2015, New Zealand Plant Protection, V68, P313; Gallelli A, 2014, PLANT PATHOL, V63, P264, DOI 10.1111/ppa.12082; Gallelli A, 2011, J PLANT PATHOL, V93, P425; [黄其玲 Huang Qiling], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P282; Kang ZS, 2000, MYCOL RES, V104, P1083, DOI 10.1017/S0953756200002495; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Koh YoungJin, 1996, Korean Journal of Plant Pathology, V12, P324; [刘丽珍 Liu Lizhen], 2007, [灾害学, Journal of Catastrophology], V22, P91; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; Mazzaglia A, 2011, CAN J PLANT PATHOL, V33, P8, DOI 10.1080/07060661.2010.538556; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Qin HuQiang, 2013, Acta Phytophylacica Sinica, V40, P225; Rees-George J, 2010, PLANT PATHOL, V59, P453, DOI 10.1111/j.1365-3059.2010.02259.x; Renzi M, 2012, PHYTOPATHOLOGY, V102, P827, DOI 10.1094/PHYTO-02-12-0019-R; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427; Serizawa S, 1993, ANN PHYTOPATHOL SOC, V60, P237; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P694, DOI 10.3186/jjphytopath.59.694; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P469, DOI 10.3186/jjphytopath.59.469; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P452, DOI 10.3186/jjphytopath.59.452; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P460, DOI 10.3186/jjphytopath.59.460; Spinelli F, 2011, ACTA HORTIC, P461, DOI 10.17660/ActaHortic.2011.913.61; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE; Vanneste JL, 2012, NEW ZEAL J CROP HORT, V40, P265, DOI 10.1080/01140671.2012.736084; Vanneste J. L., 2010, New Zealand Plant Protection, V63, P7; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang ZS., 1992, J SW AGR U SCI CHINA, V6, P500; Young JM, 2012, J PLANT PATHOLOGY S, V1, pS15; Zhao ZB, 2013, J PLANT PATHOL, V95, P155; Zhao ZB, 2015, CROP PROT, V75, P55, DOI 10.1016/j.cropro.2015.05.008	43	31	35	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151169	10.1371/journal.pone.0151169	http://dx.doi.org/10.1371/journal.pone.0151169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999596	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700024
J	Giesbrecht, CJ; O'Rourke, N; Leonova, O; Strehlau, V; Paquet, K; Vila-Rodriguez, F; Panenka, WJ; MacEwan, GW; Smith, GN; Thornton, AE; Honer, WG				Giesbrecht, Chantelle J.; O'Rourke, Norm; Leonova, Olga; Strehlau, Verena; Paquet, Karine; Vila-Rodriguez, Fidel; Panenka, William J.; MacEwan, G. William; Smith, Geoffrey N.; Thornton, Allen E.; Honer, William G.			The Positive and Negative Syndrome Scale (PANSS): A Three-Factor Model of Psychopathology in Marginally Housed Persons with Substance Dependence and Psychiatric Illness	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; MENTAL-DISORDERS; 5-FACTOR MODEL; SCHIZOPHRENIA; HOMELESS; PREVALENCE; SYMPTOMS; VALIDITY; ADULTS; TIME	Rates of psychopathology are elevated in marginalized and unstably housed persons, underscoring the need for applicable clinical measures for these populations. The Positive and Negative Syndrome Scale (PANSS) is a clinical instrument principally developed for use in schizophrenia to identify the presence and severity of psychopathology symptoms. The current study investigates whether a reliable and valid PANSS factor structure emerges in a marginally housed, heterogeneous sample recruited from the Downtown Eastside of Vancouver where substance use disorders and psychiatric illness are pervasive. Participants (n = 270) underwent structured clinical assessments including the PANSS and then were randomly assigned to either exploratory (EFA) or confirmatory factor analytic (CFA) subsamples. EFA pointed to a novel three factor PANSS. This solution was supported by CFA. All retained items (28 out of 30) load significantly upon hypothesized factors and model goodness of fit analyses are in the acceptable to good range. Each of the three firstorder factor constructs, labeled Psychosis/Disorganized, Negative Symptoms/Hostility, and Insight/Awareness, contributed significantly to measurement of a higher-order psychopathology construct. Further, the latent structure of this 3-factor solution appears temporally consistent over one-year. This PANSS factor structure appears valid and reliable for use in persons with multimorbidity, including substance use disorders. The structure is somewhat distinct from existing solutions likely due to the unique characteristics of this marginally housed sample.	[Giesbrecht, Chantelle J.; Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [O'Rourke, Norm] Ben Gurion Univ Negev, Dept Publ Hlth, IL-84105 Beer Sheva, Israel; [O'Rourke, Norm] Ben Gurion Univ Negev, Ctr Multidisciplinary Res Aging, IL-84105 Beer Sheva, Israel; [Leonova, Olga; Strehlau, Verena; Paquet, Karine; Vila-Rodriguez, Fidel; Panenka, William J.; MacEwan, G. William; Smith, Geoffrey N.; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Paquet, Karine] Inst Univ Sante Mentale Quebec, Montreal, PQ, Canada	Simon Fraser University; Ben Gurion University; Ben Gurion University; University of British Columbia	Thornton, AE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	aethornt@sfu.ca	O'Rourke, Norm/AAP-5428-2020; Vila, Fidel/L-3463-2019	O'Rourke, Norm/0000-0001-5100-427X; Vila, Fidel/0000-0002-8273-8820; Panenka, William/0000-0001-7143-6512; Thornton, Allen/0000-0002-9942-0122	Canadian Institute of Health Research [CBG-101827]; BC Mental Health and Addictions Services; William and Ada Isabelle Steel Fund	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); BC Mental Health and Addictions Services; William and Ada Isabelle Steel Fund	This research was funded by a grant from the Canadian Institute of Health Research (CBG-101827 to WGH, GNS, AET); BC Mental Health and Addictions Services (to WGH); and the William and Ada Isabelle Steel Fund (to AET, WGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benoit C, 2003, SOC SCI MED, V56, P821, DOI 10.1016/S0277-9536(02)00081-3; Bryson G, 1999, SCHIZOPHR RES, V38, P27, DOI 10.1016/S0920-9964(99)00004-3; Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Chou PHB, 2012, AGING MENT HEALTH, V16, P145, DOI 10.1080/13607863.2011.602962; Citrome L, 2011, SCHIZOPHR RES, V131, P75, DOI 10.1016/j.schres.2011.05.018; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Council on Welfare, 2010, NAT COUNC WELF REP; Daneluzzo E, 2002, SCHIZOPHR RES, V56, P129, DOI 10.1016/S0920-9964(01)00277-8; DeVellis R., 2011, SCALE DEV THEORY APP, VXXVI; Eisenberg DP, 2009, PSYCHOPATHOLOGY, V42, P242, DOI 10.1159/000218522; Emsley R, 2003, SCHIZOPHR RES, V61, P47, DOI 10.1016/S0920-9964(02)00302-X; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Folsom D, 2002, ACTA PSYCHIAT SCAND, V105, P404, DOI 10.1034/j.1600-0447.2002.02209.x; Gicas KM, 2014, J CLIN EXP NEUROPSYC, V36, P1009, DOI 10.1080/13803395.2014.963519; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gomez R, 2014, J PSYCHOPATHOL BEHAV, V36, P308, DOI 10.1007/s10862-013-9391-0; Hall CS, 2004, J GEN INTERN MED, V19, P357, DOI 10.1111/j.1525-1497.2004.30613.x; Jones AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079754; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Koegel P, 1999, MED CARE, V37, P306, DOI 10.1097/00005650-199903000-00010; Loranger A. W, 1999, INT PERSONALITY DISO; Meade AW, 2005, INT J TEST, V5, P279, DOI 10.1207/s15327574ijt0503_6; ORourke Norm, 2013, STEP BY STEP APPROAC; Rapado-Castro M, 2010, J CLIN PSYCHIAT, V71, P327, DOI 10.4088/JCP.08m04845yel; Reichenberg A, 2005, J ABNORM PSYCHOL, V114, P363, DOI 10.1037/0021-843X.114.3.363; Robertson MJ, 2004, AM J PUBLIC HEALTH, V94, P1207, DOI 10.2105/AJPH.94.7.1207; Roe RA, 2014, EUR J WORK ORGAN PSY, V23, P754, DOI 10.1080/1359432X.2013.804177; Stefanovics EA, 2014, COMPR PSYCHIAT, V55, P887, DOI 10.1016/j.comppsych.2014.01.014; Tsai J, 2011, J COMMUNITY PSYCHOL, V39, P76, DOI 10.1002/jcop.20418; Van den Oord EJCG, 2006, SCHIZOPHR RES, V82, P213, DOI 10.1016/j.schres.2005.09.002; van der Gaag M, 2006, SCHIZOPHR RES, V85, P273, DOI 10.1016/j.schres.2006.04.001; Vazquez C, 1997, ACTA PSYCHIAT SCAND, V95, P523, DOI 10.1111/j.1600-0447.1997.tb10141.x; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Wallwork RS, 2012, SCHIZOPHR RES, V137, P246, DOI 10.1016/j.schres.2012.01.031; White L, 1997, PSYCHOPATHOLOGY, V30, P263, DOI 10.1159/000285058	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151648	10.1371/journal.pone.0151648	http://dx.doi.org/10.1371/journal.pone.0151648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999280	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700050
J	Leone, DA; Kozakowski, N; Kornauth, C; Waidacher, T; Neudert, B; Loeffler, AG; Haitel, A; Rees, AJ; Kain, R				Leone, Dario A.; Kozakowski, Nicolas; Kornauth, Christoph; Waidacher, Theresa; Neudert, Barbara; Loeffler, Agnes G.; Haitel, Andrea; Rees, Andrew J.; Kain, Renate			The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury	PLOS ONE			English	Article							DENDRITIC CELL SUBSETS; GENE-EXPRESSION; IMMUNE-SYSTEM; MACROPHAGES; KIDNEY; MONOCYTES; TISSUE; RESIDENT; ORIGINS; POPULATION	Mammalian tissues contain networks of mononuclear phagocytes (MPh) that sense injury and orchestrate the response to it. In mice, this is affected by distinct populations of dendritic cells (DC), monocytes and macrophages and recent studies suggest the same is true for human skin and intestine but little is known about the kidney. Here we describe the analysis of MPh populations in five human kidneys and show they are highly heterogeneous and contain discrete populations of DC, monocytes and macrophages. These include: plasmacytoid DC (CD303(+)) and both types of conventional DC-cDC1 (CD141(+) cells) and CD2 (CD1c(+) cells); classical, non-classical and intermediate monocytes; and macrophages including a novel population of CD141(+) macrophages clearly distinguishable from cDC1 cells. The relative size of the MPh populations differed between kidneys: the pDC population was bi-modally distributed being less than 2% of DC in two kidneys without severe injury and over 35% in the remaining three with low grade injury in the absence of morphological evidence of inflammation. There were profound differences in the other MPh populations in kidneys with high and low numbers of pDC. Thus, cDC1 cells were abundant (55 and 52.3%) when pDC were sparse and sparse (12.8-12.5%) when pDC were abundant, whereas the proportions of cDC2 cells and classical monocytes increased slightly in pDC high kidneys. We conclude that MPh are highly heterogeneous in human kidneys and that pDC infiltration indicative of low-grade injury does not occur in isolation but is part of a coordinated response affecting all renal DC, monocyte and macrophage populations.	[Leone, Dario A.; Kozakowski, Nicolas; Kornauth, Christoph; Waidacher, Theresa; Neudert, Barbara; Haitel, Andrea; Rees, Andrew J.; Kain, Renate] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Loeffler, Agnes G.] Univ Wisconsin, Surg Pathol, Madison, WI USA	Medical University of Vienna; University of Wisconsin System; University of Wisconsin Madison	Leone, DA (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	dario.leone@meduniwien.ac.at; renate.kain@meduniwien.ac.at	Kozakowski, Nicolas/I-1005-2019; Kain, Renate/ACR-4709-2022; Kornauth, Christoph/AAA-3935-2022	Kozakowski, Nicolas/0000-0001-9180-620X; Kain, Renate/0000-0002-2428-543X; Kornauth, Christoph/0000-0003-0443-3498; Leone, Dario Armando/0000-0002-4103-670X	European Union [261382, 238756]; Vienna Science and Technology Fund (WWTF) [LS09-75]	European Union(European Commission); Vienna Science and Technology Fund (WWTF)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreements no 261382 (INTRICATE) and no 238756 (TranSVIR) and was supported by the Vienna Science and Technology Fund (WWTF) project Nr LS09-75.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Batal I, 2015, J AM SOC NEPHROLOGY; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Duffield JS, 2011, J AM SOC NEPHROL, V22, P199, DOI 10.1681/ASN.2010121301; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; HART DNJ, 1981, TRANSPLANTATION, V31, P318, DOI 10.1097/00007890-198105010-00003; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339; Howe R, 2009, CLIN IMMUNOL, V131, P317, DOI 10.1016/j.clim.2008.12.003; Iqbal AJ, 2014, BLOOD, V124, pE33, DOI 10.1182/blood-2014-04-568691; John R, 2007, J AM SOC NEPHROL, V18, P2628, DOI 10.1681/ASN.2007030273; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; McCarthy NE, 2007, CLIN EXP ALLERGY, V37, P72, DOI 10.1111/j.1365-2222.2006.02631.x; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Ozaki KS, 2012, KIDNEY INT, V81, P1015, DOI 10.1038/ki.2011.458; Pindjakova J, 2013, J AM SOC NEPHROL, V24, P519, DOI 10.1681/ASN.2013020164; Rogers NM, 2014, NAT REV NEPHROL, V10, P625, DOI 10.1038/nrneph.2014.170; Segerer S, 2008, KIDNEY INT, V74, P37, DOI 10.1038/ki.2008.99; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Soos TJ, 2006, CX3CR1 INTERSTITIAL; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Teteris SA, 2011, KIDNEY INT, V80, P140, DOI 10.1038/ki.2011.129; Teteris SA, 2012, NEPHROLOGY, V17, P364, DOI 10.1111/j.1440-1797.2012.01581.x; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Ziegler-Heitbrock L, 2013, FRONTIERS IMMUNOLOGY, P4; Zuidwijk K, 2012, KIDNEY INT, V81, P64, DOI 10.1038/ki.2011.289	48	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151674	10.1371/journal.pone.0151674	http://dx.doi.org/10.1371/journal.pone.0151674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999595	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700054
J	Lin, YW; Hussain, M; Avery, PB; Qasim, M; Fang, DL; Wang, LD				Lin, Yongwen; Hussain, Mubasher; Avery, Pasco Bruce; Qasim, Muhammad; Fang, Dalin; Wang, Liande			Volatiles from Plants Induced by Multiple Aphid Attacks Promote Conidial Performance of Lecanicillium lecanii	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; SPORE GERMINATION; FIELD-EVALUATION; PATHOGENICITY; APPRESSORIA; RESPONSES; ECOLOGY; DEFENSE; ARTHROPODS; BEHAVIOR	Herbivore-induced plant volatiles (HIPVs) are clues that help predatory insects search for food. The hypothesis that entomopathogenic fungi, which protect plants, benefit from the release of HIPVs was tested. The plant Arabidopsis thaliana was used as the source of HIPVs. The insect herbivore Lipaphis erysimi (Kaltenbach) was used as the inducer, and the fungal pathogen of the aphid Lecanicillium lecanii was exposed to HIPVs to test our hypothesis. When exposed to aphid-induced A. thaliana volatiles, the mortality of aphids pre-treated with a conidial suspension of L. lecanii, the conidial germination and the appressorial formation were significantly increased compared with the control. The decan-3-ol and 4-methylpentyl isothiocyanate that were detected in the headspace seemed to have positive and negative affection, respectively. Moreover, HIPVs generated from groups of eight aphids per plant promoted significantly increased conidial germination and appressorial formation compared with HIPVs from groups of one, two and four aphids per plant. Our results demonstrated that the pathogenicity of the entomopathogenic fungus L. lecanii was enhanced when exposed to HIPVs and that the HIPVs were affected by the number of insect herbivores that induced them.	[Lin, Yongwen; Hussain, Mubasher; Qasim, Muhammad; Fang, Dalin; Wang, Liande] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China; [Lin, Yongwen; Hussain, Mubasher; Qasim, Muhammad; Fang, Dalin; Wang, Liande] Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Lin, Yongwen; Hussain, Mubasher] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Peoples R China; [Avery, Pasco Bruce] Univ Florida, Indian River Res & Educ Ctr, Inst Food & Agr Sci, Ft Pierce, FL USA	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; State University System of Florida; University of Florida	Wang, LD (corresponding author), Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China.; Wang, LD (corresponding author), Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	wang_liande@126.com	Hussain, Mubasher/N-8785-2017; Qasim, Muhammad/T-9636-2019; Qasim, Muhammad/R-2570-2019	Hussain, Mubasher/0000-0003-0833-7399; Qasim, Muhammad/0000-0002-8063-9140; Wang, Liande/0000-0001-8395-7243	National Nature Science Foundation of China (NSFC) [31371998]; Research Fund for the Doctoral Program of Higher Education of China [20123515110003]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funding provided by National Nature Science Foundation of China (NSFC) with grant number 31371998(http://www.nsfc.gov.cn/), LDW received the funding and Research Fund for the Doctoral Program of Higher Education of China with grant number 20123515110003(http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm), LDW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Askary H, 1999, J INVERTEBR PATHOL, V74, P1, DOI 10.1006/jipa.1999.4857; Baldwin IT, 2002, CURR OPIN PLANT BIOL, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Braasch J, 2012, J CHEM ECOL, V38, P1264, DOI 10.1007/s10886-012-0202-y; Bramley GN, 2001, J CHEM ECOL, V27, P1029, DOI 10.1023/A:1010399322861; Brown GC, 1995, ENVIRON ENTOMOL, V24, P1637, DOI 10.1093/ee/24.6.1637; BUTT TM, 1995, MYCOL RES, V99, P945, DOI 10.1016/S0953-7562(09)80754-5; Gonzalez LC, 2012, J FOOD AGRIC ENVIRON, V10, P1142; Chakraborty U, 1995, FOLIA MICROBIOL, V40, P159, DOI 10.1007/BF02815415; Chung SH, 2013, P NATL ACAD SCI USA, V110, P15728, DOI 10.1073/pnas.1308867110; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Truong DH, 2014, ARTHROPOD-PLANT INTE, V8, P317, DOI 10.1007/s11829-014-9311-6; Ekesi S, 2000, BIOCONTROL, V45, P79, DOI 10.1023/A:1009927302916; Elliot SL, 2000, ECOL LETT, V3, P228; Erb M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7273; Farquharson KL, 2008, PLANT CELL, V20, P244, DOI 10.1105/tpc.108.200210; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Ganassi S, 2010, BIOCONTROL, V55, P299, DOI 10.1007/s10526-009-9250-9; Gourgues M, 2004, MOL MICROBIOL, V51, P619, DOI 10.1046/j.1365-2958.2003.03866.x; HALL RA, 1976, J INVERTEBR PATHOL, V27, P41, DOI 10.1016/0022-2011(76)90026-4; HASSAN AEM, 1989, J INVERTEBR PATHOL, V54, P277, DOI 10.1016/0022-2011(89)90040-2; Hatzipapas P, 2002, MYCOL RES, V106, P1349, DOI 10.1017/S0953756202006792; Hountondji FCC, 2010, TRENDS IN ACAROLOGY, P249, DOI 10.1007/978-90-481-9837-5_40; Hountondji FCC, 2005, J CHEM ECOL, V31, P1003, DOI 10.1007/s10886-005-4244-2; Ishiwari H, 2007, J CHEM ECOL, V33, P1670, DOI 10.1007/s10886-007-9344-8; James DG, 2005, J CHEM ECOL, V31, P481, DOI 10.1007/s10886-005-2020-y; Jones VP, 2011, BIOL CONTROL, V56, P98, DOI 10.1016/j.biocontrol.2010.10.001; Kaplan I, 2012, BIOL CONTROL, V60, P77, DOI 10.1016/j.biocontrol.2011.10.017; Khan ZR, 2008, BIOL CONTROL, V45, P210, DOI 10.1016/j.biocontrol.2007.11.009; Lins JC, 2014, BIOCONTROL, V59, P707, DOI 10.1007/s10526-014-9602-y; Orre GUS, 2010, BIOL CONTROL, V53, P62, DOI 10.1016/j.biocontrol.2009.10.010; Perez-Hedo M, 2015, BIOL CONTROL, V86, P46, DOI 10.1016/j.biocontrol.2015.04.006; Pierik R, 2014, PLANT CELL ENVIRON, V37, P1845, DOI 10.1111/pce.12330; Pineda A, 2013, PLANT CELL ENVIRON, V36, P393, DOI 10.1111/j.1365-3040.2012.02581.x; Quintana-Rodriguez E, 2015, J ECOL, V103, P250, DOI 10.1111/1365-2745.12340; Rodriguez-Saona CR, 2010, PLANT SIGNAL BEHAV, V5, P58, DOI 10.4161/psb.5.1.10160; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Salamanca J, 2015, BIOL CONTROL, V80, P103, DOI 10.1016/j.biocontrol.2014.10.003; Savchenko T, 2013, PLANT J, V73, P653, DOI 10.1111/tpj.12064; Schwartzberg EG, 2014, FUNCT ECOL, V28, P386, DOI 10.1111/1365-2435.12182; Spence C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-130; Tajul MI, 2012, EUR J PLANT PATHOL, V132, P91, DOI 10.1007/s10658-011-9851-x; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Tamiru A, 2015, CAN J ZOOL, V93, P281, DOI 10.1139/cjz-2014-0266; Tan XL, 2014, ENTOMOL EXP APPL, V151, P259, DOI 10.1111/eea.12190; Uefune M, 2013, BIOCONTROL, V58, P187, DOI 10.1007/s10526-012-9483-x; van Veen FJF, 2015, CURR OPIN INSECT SCI, V8, P29, DOI 10.1016/j.cois.2015.02.009; Venkatesan R, 2015, J INDIAN I SCI, V95, P25; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200; Wang L, 2005, J APPL ENTOMOL, V129, P32, DOI 10.1111/j.1439-0418.2005.00929.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Yoneya K, 2014, PLANT BIOTECHNOL-NAR, V31, P409, DOI 10.5511/plantbiotechnology.14.0827a	55	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151844	10.1371/journal.pone.0151844	http://dx.doi.org/10.1371/journal.pone.0151844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999795	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700072
J	Marcus, SA; Sidiropoulos, SW; Steinberg, H; Talaat, AM				Marcus, Sarah A.; Sidiropoulos, Sarah W.; Steinberg, Howard; Talaat, Adel M.			CsoR Is Essential for Maintaining Copper Homeostasis in Mycobacterium tuberculosis	PLOS ONE			English	Article							CONTAINING PHAGOSOMES; HYPOXIC RESPONSE; NITRIC-OXIDE; RESISTANCE; EXPRESSION; TRANSPORT; VIRULENCE; SYSTEM; GALAXY; OXYGEN	Mycobacterium tuberculosis, a pathogen infecting one third of the world population, faces numerous challenges within the host, including high levels of copper. We have previously shown that M. tuberculosis CsoR is a copper inducible transcriptional regulator. Here we examined the hypothesis that csoR is necessary for maintaining copper homeostasis and surviving under various stress conditions. With an unmarked csoR knockout strain, we were able to characterize the role of csoR in M. tuberculosis as it faced copper and host stress. Growth under high levels of copper demonstrated that M. tuberculosis survives copper stress significantly better in the absence of csoR. Yet under minimal levels of copper, differential expression analysis revealed that the loss of csoR results in a cell wide hypoxia-type stress response with the induction of the DosR regulon. Despite the stress placed on M. tuberculosis by the loss of csoR, survival of the knockout strain was increased compared to wild type during the early chronic stages of mouse infection, suggesting that csoR could play an active role in modulating M. tuberculosis fitness within the host. Overall, analysis of CsoR provided an increased understanding of the M. tuberculosis copper response with implications for other intracellular pathogens harboring CsoR.	[Marcus, Sarah A.; Sidiropoulos, Sarah W.; Steinberg, Howard; Talaat, Adel M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Sidiropoulos, Sarah W.] Oakland Community Coll, Auburn Hills, MI USA	University of Wisconsin System; University of Wisconsin Madison	Talaat, AM (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	atalaat@wisc.edu		Marcus, Sarah/0000-0002-3795-0806	National Institutes of Health [R21AI090308]; University of Wisconsin-Madison Graduate School [MSN174746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work in this report was supported by National Institutes of Health grant R21AI090308 and the University of Wisconsin-Madison Graduate School (MSN174746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abomoelak B, 2009, J BACTERIOL, V191, P5941, DOI 10.1128/JB.00778-09; Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dicks AP, 1996, CHEM BIOL, V3, P655, DOI 10.1016/S1074-5521(96)90133-7; DOMEK MJ, 1984, APPL ENVIRON MICROB, V48, P289, DOI 10.1128/AEM.48.2.289-293.1984; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hsu CY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00236; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Neyrolles O, 2015, IMMUNOL REV, V264, P249, DOI 10.1111/imr.12265; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland JL, 2013, J BACTERIOL, V195, P3724, DOI 10.1128/JB.00546-13; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schaible UE, 1998, J IMMUNOL, V160, P1290; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Speer A, 2013, J BACTERIOL, V195, P5133, DOI 10.1128/JB.00763-13; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	50	21	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151816	10.1371/journal.pone.0151816	http://dx.doi.org/10.1371/journal.pone.0151816			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999439	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700067
J	Salahudeen, MS; Chyou, TY; Nishtala, PS				Salahudeen, Mohammed Saji; Chyou, Te-yuan; Nishtala, Prasad S.			Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature	PLOS ONE			English	Review							PRESCRIBED MEDICATIONS; DRUG BURDEN; ASSOCIATION; DELIRIUM; PERFORMANCE; IMPACT; RISK; INDIVIDUALS; DYSFUNCTION; POPULATION	Introduction Studies have reported associations between serum anticholinergic activity (SAA) and decline in cognitive performance, delirium, and functional impairment. The aim of this meta-analysis was to explore and quantify associations between SAA and adverse cognitive and functional outcomes in older people. Materials and Methods A literature search in Ovid MEDLINE, EMBASE, PsycINFO and IPA from 1946-2014 was completed. The primary outcomes of interest were cognitive and functional adverse outcomes associated with SAA in older people aged 55 years and above. The Cochrane Risk-Bias assessment tool was used to assess bias in randomised controlled trials (RCTs). The Newcastle-Ottawa Scale was used to assess the quality of non-RCTs. Meta-analyses were conducted for RCTs and cohort studies separately. Heterogeneity was assessed using I-2 tests. Results The primary electronic literature search identified a total of 1559 records in the 4 different databases. On the basis of full-text analysis, 33 studies that met the inclusion criteria. The review included 4 RCTs, 5 prospective cohort studies, 3 longitudinal cohort studies, 17 cross-sectional studies, and 4 case-control studies. Twenty-four of the retrieved studies examined an association between SAA and cognitive outcomes, 2 studies examined an association with SAA and functional outcomes and 8 studies examined associations between SAA and both cognitive, and functional outcomes. The meta-analysis on 4 RCTs showed no association with higher SAA and cognitive performance (I-2 = 89.38%, H-2 = 25.53 and p-value = < 0.05) however, the pooled data from 4 observational studies showed elevated SAA was associated with reduced cognitive performance (I-2 = 0.00%, H-2 = 3.37 and p-value = 0.34). Conclusion This systematic review summarises the limitations of the SAA on predicting cognitive and functional outcomes in older people. SAA measured by receptor bioassay is flawed and its use in older people with multimorbidity and polypharmacy is questionable.	[Salahudeen, Mohammed Saji; Chyou, Te-yuan; Nishtala, Prasad S.] Univ Otago, Sch Pharm, POB 56, Dunedin 9054, New Zealand	University of Otago	Nishtala, PS (corresponding author), Univ Otago, Sch Pharm, POB 56, Dunedin 9054, New Zealand.	prasad.nishtala@otago.ac.nz	Chyou, Te-yuan David/N-9085-2018; Salahudeen, Mohammed/X-7096-2019; Nishtala, Prasad/B-6988-2012	Chyou, Te-yuan David/0000-0001-6986-5342; Salahudeen, Mohammed/0000-0001-9131-7465; Nishtala, Prasad/0000-0002-4155-8540				Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Bostock Clare V, 2010, Expert Rev Clin Pharmacol, V3, P441, DOI 10.1586/ecp.10.34; Bottiggi KA, 2006, AM J GERIAT PSYCHIAT, V14, P980, DOI 10.1097/01.JGP.0000224619.87681.71; Brecht S, 2007, METHOD FIND EXP CLIN, V29, P223, DOI 10.1358/mf.2007.29.3.1075357; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Carnahan RM, 2006, J CLIN PHARMACOL, V46, P1481, DOI 10.1177/0091270006292126; Carnahan Ryan M, 2002, Psychopharmacol Bull, V36, P24; Chew ML, 2008, J AM GERIATR SOC, V56, P1333, DOI 10.1111/j.1532-5415.2008.01737.x; Chew ML, 2005, AM J GERIAT PSYCHIAT, V13, P535, DOI 10.1176/appi.ajgp.13.6.535; Cox EA, 2009, J AM GERIATR SOC, V57, P1707, DOI 10.1111/j.1532-5415.2009.02411.x; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pM12, DOI 10.1093/gerona/54.1.M12; Flacker JM, 1998, AM J GERIAT PSYCHIAT, V6, P31; Gerretsen P, 2011, EXPERT OPIN DRUG SAF, V10, P751, DOI 10.1517/14740338.2011.579899; GOLINGER RC, 1987, AM J PSYCHIAT, V144, P1218; Higgins JPT., 2011, COCHRANE HDB SYSTEMA, P187, DOI DOI 10.1249/01.MSS.0000043545.02712.A7; Hori K, 2011, NEUROPSYCHOBIOLOGY, V63, P147, DOI 10.1159/000321591; Kashyap M, 2015, AM J GERIAT PSYCHIAT, V23, P326, DOI 10.1016/j.jagp.2014.09.009; Kersten H, 2014, BASIC CLIN PHARMACOL, V114, P151, DOI 10.1111/bcpt.12140; Kersten H, 2013, J GERONTOL A-BIOL, V68, P271, DOI 10.1093/gerona/gls176; Kersten H, 2013, BRIT J CLIN PHARMACO, V75, P842, DOI 10.1111/j.1365-2125.2012.04411.x; Konishi K, 2010, PSYCHOGERIATRICS, V10, P34, DOI 10.1111/j.1479-8301.2010.00310.x; Lackner TE, 2008, J AM GERIATR SOC, V56, P862, DOI 10.1111/j.1532-5415.2008.01680.x; Lampela P, 2015, DRUG AGING, V32, P963, DOI 10.1007/s40266-015-0321-6; Lampela P, 2013, DRUG AGING, V30, P321, DOI 10.1007/s40266-013-0063-2; Landi F, 2007, CLIN PHARMACOL THER, V81, P235, DOI 10.1038/sj.clpt.6100035; Lechevallier-Michel N, 2005, BRIT J CLIN PHARMACO, V59, P143, DOI 10.1111/j.1365-2125.2004.02232.x; MACH JR, 1995, J AM GERIATR SOC, V43, P491, DOI 10.1111/j.1532-5415.1995.tb06094.x; Mangoni AA, 2013, AM J GERIAT PSYCHIAT, V21, P785, DOI 10.1016/j.jagp.2013.01.012; MILLER PS, 1988, AM J PSYCHIAT, V145, P342; Moher D, 2009, PREFERRED REPORTING, V10, p[46, 49]; MONDIMORE FM, 1983, AM J PSYCHIAT, V140, P930; Mulsant BH, 2003, ARCH GEN PSYCHIAT, V60, P198, DOI 10.1001/archpsyc.60.2.198; Mussi C, 1999, J GERIATR PSYCH NEUR, V12, P82, DOI 10.1177/089198879901200208; Nebes RD, 2005, NEUROLOGY, V65, P1487, DOI 10.1212/01.wnl.0000183152.16690.26; Nebes RD, 1997, PSYCHOPHARMACOL BULL, V33, P715; Nebes RD, 2007, J GERONTOL A-BIOL, V62, P83, DOI 10.1093/gerona/62.1.83; Nebes RD, 2011, AM J GERIAT PSYCHIAT, V19, P169, DOI 10.1097/JGP.0b013e3181e4490d; Nishtala PS, 2009, J CLIN PHARMACOL, V49, P1176, DOI 10.1177/0091270009345690; Plaschke K, 2007, ANAESTHESIA, V62, P1217, DOI 10.1111/j.1365-2044.2007.05255.x; Plaschke K, 2007, NEUROSCI LETT, V417, P16, DOI 10.1016/j.neulet.2007.02.015; Plaschke K, 2013, J THORAC CARDIOV SUR, V145, P805, DOI 10.1016/j.jtcvs.2012.07.043; Plaschke K, 2010, J NEUROPSYCH CLIN N, V22, P433, DOI 10.1176/appi.neuropsych.22.4.433; REMILLARD AJ, 1994, PHARMACOTHERAPY, V14, P482; RICHARDSON JS, 1994, INT CLIN PSYCHOPHARM, V9, P35, DOI 10.1097/00004850-199400910-00006; Roe CM, 2002, J AM GERIATR SOC, V50, P836, DOI 10.1046/j.1532-5415.2002.50208.x; Rossi A, 2014, ANESTH ANALG, V119, P947, DOI 10.1213/ANE.0000000000000390; ROVNER BW, 1988, AM J PSYCHIAT, V145, P107; Salahudeen MS, 2015, J AM GERIATR SOC, V63, P85, DOI 10.1111/jgs.13206; Salahudeen MS, 2014, DRUG AGING, V31, P185, DOI 10.1007/s40266-014-0158-4; Salahudeen MS, 2015, DEMENT GERIATR COGN, V5, P530, DOI [10.1159/000441718, DOI 10.1159/000441718]; THIENHAUS OJ, 1990, EUR ARCH PSY CLIN N, V240, P28, DOI 10.1007/BF02190089; Thomas C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-86; TOLLEFSON GD, 1991, J NEUROPSYCH CLIN N, V3, P314; TUNE L, 1980, ARCH GEN PSYCHIAT, V37, P293; TUNE L, 1993, J NEUROPSYCH CLIN N, V5, P208; TUNE L, 1992, AM J PSYCHIAT, V149, P1393; TUNE LE, 1982, AM J PSYCHIAT, V139, P1460; Tune LE, 2001, J CLIN PSYCHIAT, V62, P11; TUNE LE, 1981, LANCET, V2, P651; van Munster BC, 2012, J PSYCHIATR RES, V46, P1339, DOI 10.1016/j.jpsychires.2012.06.015; Vinogradov S, 2009, AM J PSYCHIAT, V166, P1055, DOI 10.1176/appi.ajp.2009.09010017; Watne LO, 2014, J AM GERIATR SOC, V62, P94, DOI 10.1111/jgs.12612; Wells BS GA, NEWCASTLE OTTAWA SCA	63	30	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151084	10.1371/journal.pone.0151084	http://dx.doi.org/10.1371/journal.pone.0151084			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999286	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700020
J	Fajardo, AM; MacKenzie, DA; Olguin, SL; Scariano, JK; Rabinowitz, I; Thompson, TA				Fajardo, Alexandra M.; MacKenzie, Debra A.; Olguin, Sarah L.; Scariano, John K.; Rabinowitz, Ian; Thompson, Todd A.			Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells	PLOS ONE			English	Article							PREVENTION TRIAL SELECT; VITAMIN-E; BRONCHOALVEOLAR LAVAGE; TOCOPHEROL QUINONES; BETA-CAROTENE; LINE LNCAP; RISK; GROWTH; EXPRESSION; CASTRATION	Tocopherylquinone (TQ), the oxidation product of alpha-tocopherol (AT), is a bioactive molecule with distinct properties from AT. In this study, AT and TQ are investigated for their comparative effects on growth and androgenic activity in prostate cancer cells. TQ potently inhibited the growth of androgen-responsive prostate cancer cell lines (e.g., LAPC4 and LNCaP cells), whereas the growth of androgen-independent prostate cancer cells (e.g., DU145 cells) was not affected by TQ. Due to the growth inhibitory effects induced by TQ on androgen-responsive cells, the anti-androgenic properties of TQ were examined. TQ inhibited the androgen-induced activation of an androgen-responsive reporter and inhibited the release of prostate specific antigen from LNCaP cells. TQ pretreatment was also found to inhibit AR activation as measured using the Multifunctional Androgen Receptor Screening assay. Furthermore, TQ decreased androgen-responsive gene expression, including TM4SF1, KLK2, and PSA over 5-fold, whereas AT did not affect the expression of androgen- responsive genes. Of importance, the antiandrogenic effects of TQ on prostate cancer cells were found to result from androgen receptor protein down-regulation produced by TQ that was not observed with AT treatment. Moreover, none of the androgenic endpoints assessed were affected by AT. The down-regulation of androgen receptor protein by TQ was abrogated by co-treatment with antioxidants. Overall, the biological actions of TQ were found to be distinct from AT, where TQ was found to be a potent inhibitor of cell growth and androgenic activity in androgen-responsive prostate cancer cells.	[Fajardo, Alexandra M.; MacKenzie, Debra A.; Olguin, Sarah L.; Thompson, Todd A.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Scariano, John K.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Rabinowitz, Ian] Univ New Mexico, Sch Med, Dept Internal Med, Div Hematol Oncol, Albuquerque, NM 87131 USA; [Rabinowitz, Ian; Thompson, Todd A.] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico	Thompson, TA (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.; Thompson, TA (corresponding author), Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA.	tthompson@salud.unm.edu			National Institutes of Health Grant [1 R03 CA133941]; University of New Mexico Cancer Center Focus-Interactive Group Award; NATIONAL CANCER INSTITUTE [R03CA133941] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Cancer Center Focus-Interactive Group Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by National Institutes of Health Grant, grant number: 1 R03 CA133941 (TAT) and the University of New Mexico Cancer Center Focus-Interactive Group Award (TAT and IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Cheng TYD, 2011, J NUTR, V141, P1731, DOI 10.3945/jn.111.141713; Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689; Cornwell DG, 2007, VITAM HORM, V76, P99, DOI 10.1016/S0083-6729(07)76005-3; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Dennis MK, 2008, CYTOM PART A, V73A, P390, DOI 10.1002/cyto.a.20552; Dolfi SC, 2013, J AGR FOOD CHEM, V61, P8533, DOI 10.1021/jf401076g; DOWD P, 1995, P NATL ACAD SCI USA, V92, P8171, DOI 10.1073/pnas.92.18.8171; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gomez L, 2015, STEROIDS, V95, P80, DOI 10.1016/j.steroids.2014.12.021; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Heer R, 2007, J CELL PHYSIOL, V212, P572, DOI 10.1002/jcp.21154; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Kirsh VA, 2006, JNCI-J NATL CANCER I, V98, P245, DOI 10.1093/jnci/djj050; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; LANGELER EG, 1993, PROSTATE, V23, P213, DOI 10.1002/pros.2990230304; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Ni J, 2003, BIOCHEM BIOPH RES CO, V300, P357, DOI 10.1016/S0006-291X(02)02851-6; Peters U, 2008, CANCER CAUSE CONTROL, V19, P75, DOI 10.1007/s10552-007-9072-y; Prins G S, 2000, Mayo Clin Proc, V75 Suppl, pS32; Rodriguez C, 2004, CANCER EPIDEM BIOMAR, V13, P378; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; TANGNEY CC, 1989, J AM COLL NUTR, V8, P203; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Thompson IM, 2009, J UROLOGY, V182, P499, DOI 10.1016/j.juro.2009.04.015; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thompson TA, 2003, MOL CANCER THER, V2, P797; THOMPSON TA, 1993, IN VITRO CELL DEV-AN, V29, P165, DOI 10.1007/BF02630949; WILDING G, 1995, CANCER SURV, V23, P43; WURZEL H, 1995, J BIOCHEM TOXICOL, V10, P11; Xu JC, 2001, CANCER RES, V61, P1563; Yang Q, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-8; YOUNG CYF, 1991, CANCER RES, V51, P3748; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	41	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151525	10.1371/journal.pone.0151525	http://dx.doi.org/10.1371/journal.pone.0151525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986969	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300083
J	Hu, XJ; Zhang, H; Lu, HF; Qian, GR; Lv, LX; Zhang, CX; Guo, J; Jiang, HY; Zheng, BW; Yang, FL; Gu, SL; Chen, YT; Bao, QL; Yu, L; Jiang, XW; Hu, Q; Shi, HY; Gao, HN; Li, LJ				Hu, Xinjun; Zhang, Hua; Lu, Haifeng; Qian, Guirong; Lv, Longxian; Zhang, Chunxia; Guo, Jing; Jiang, Haiyin; Zheng, Beiwen; Yang, Fengling; Gu, Silan; Chen, Yuanting; Bao, Qiongling; Yu, Liang; Jiang, Xiawei; Hu, Qian; Shi, Haiyan; Gao, Hainv; Li, Lanjuan			The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus	PLOS ONE			English	Article							GEL-ELECTROPHORESIS ANALYSIS; 16S RIBOSOMAL-RNA; CLOSTRIDIUM-BUTYRICUM; IMMUNE-RESPONSES; GUT MICROBIOTA; DOUBLE-BLIND; BACTERIA; COMMUNITIES; DIVERSITY; MUTUALISM	Background A novel avian-origin influenza A (H7N9) virus emerged and spread among humans in Eastern China in 2013. Prophylactic treatment with antibiotics and probiotics for secondary infection is as important as antiviral treatment. This study aims to assess the ability of probiotic treatment to restore internal homeostasis under antibiotic pressure and to reduce/ameliorate the risk of secondary infections resulting from infection with the H7N9 virus. Methods This is a retrospective study in archival samples. Between April 1 and May 10, 2013, 113 stool, sputum, and blood specimens were collected and analyzed by denaturing gradient gel electrophoresis (DGGE) to determine the composition of the patient microbiomes. Microbial diversity was calculated using Gel-Pro analyzer and Past software. Cluster analysis of DGGE pattern profiles was employed to create a phylogenetic tree for each patient, and multidimensional scaling (MDS) and principal component analysis (PCA) were performed to visualize relationships between individual lanes. Results Five patients had secondary infections, including Klebsiella pneumonia, Acinetobacter baumanii and Candida albicans infection. The DGGE profiles of fecal samples obtained at different time points from the same individual were clearly different, particularly for patients with secondary infections. Shannon's diversity index and evenness index were lower in all infected groups compared to the control group. After B. subtilis and E. faecium or C. butyricum administration, the fecal bacterial profiles of patients who had not been treated with antibiotics displayed a trend of increasing diversity and evenness. C. butyricum failed to reduce/ameliorate secondary infection in H7N9-infected patients, but administration of B. subtilis and E. faecium appeared to reduce/ameliorate secondary infection in one patient. Conclusion H7N9 infection might decrease intestinal microbial diversity and species richness in humans. C. butyricum failed to reduce/ameliorate secondary infection in H7N9-infected patients. B. subtilis and E. faecium may also play a role in reducing/ameliorating secondary infection in these patients.	[Hu, Xinjun; Zhang, Hua; Lu, Haifeng; Qian, Guirong; Lv, Longxian; Guo, Jing; Jiang, Haiyin; Zheng, Beiwen; Yang, Fengling; Gu, Silan; Chen, Yuanting; Bao, Qiongling; Yu, Liang; Jiang, Xiawei; Hu, Qian; Shi, Haiyan; Gao, Hainv; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Xinjun] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Infect Dis, Luoyang 471003, Peoples R China; [Hu, Xinjun] Henan Univ Sci & Technol, Coll Clin Med, Luoyang 471003, Peoples R China; [Zhang, Chunxia] Zhejiang Univ, Affiliated Hosp 1, Dept Geriatr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Henan University of Science & Technology; Henan University of Science & Technology; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Diag & Treatment Infect Dis,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			National Basic Research Program of China (973 program) [2013CB531401]; Key Program of the National Natural Science Foundation of China [81330011]; Scientific Research Fund of the Department of Education of Zhejiang Province [Y200805384]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of the Department of Education of Zhejiang Province	This study was supported by the National Basic Research Program of China (973 program) (No. 2013CB531401), the Key Program of the National Natural Science Foundation of China (No. 81330011), and the Scientific Research Fund of the Department of Education of Zhejiang Province (Y200805384).; This study was supported by the National Basic Research Program of China (973 program) (No. 2013CB531401), the Key Program of the National Natural Science Foundation of China (No. 81330011), and the Scientific Research Fund of the Department of Education of Zhejiang Province (Y200805384). The authors do not have any commercial or other associations that might pose a conflict of interest.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; de Vrese M, 2006, VACCINE, V24, P6670, DOI 10.1016/j.vaccine.2006.05.048; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fooladi AAI, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7521; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Hatakka K, 2001, BMJ-BRIT MED J, V322, P1327, DOI 10.1136/bmj.322.7298.1327; Hedlund M, 2010, J INFECT DIS, V201, P1007, DOI 10.1086/651170; Hogenauer C, 1998, CLIN INFECT DIS, V27, P702, DOI 10.1086/514958; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Imase K, 2008, MICROBIOL IMMUNOL, V52, P156, DOI 10.1111/j.1348-0421.2008.00026.x; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Karlsson C, 2010, ATHEROSCLEROSIS, V208, P228, DOI 10.1016/j.atherosclerosis.2009.06.019; Lofmark S, 2006, J ANTIMICROB CHEMOTH, V58, P1160, DOI 10.1093/jac/dkl420; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Macfarlane S, 2014, ENVIRON MICROBIOL, V16, P919, DOI 10.1111/1462-2920.12399; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Morrow LE, 2010, AM J RESP CRIT CARE, V182, P1058, DOI 10.1164/rccm.200912-1853OC; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sato R, 1997, MICROBIOL IMMUNOL, V41, P665, DOI 10.1111/j.1348-0421.1997.tb01909.x; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Wilks J, 2013, IMMUNOL REV, V255, P222, DOI 10.1111/imr.12097; Yu L, 2013, CLIN INFECT DIS, V57, P1449, DOI 10.1093/cid/cit541; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	43	11	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151976	10.1371/journal.pone.0151976	http://dx.doi.org/10.1371/journal.pone.0151976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987119	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300157
J	Meyer, HE; Stoer, NC; Samuelsen, SO; Blomhoff, R; Robsahm, TE; Brustad, M; Giovannucci, EL; Bjorge, T				Meyer, Haakon E.; Stoer, Nathalie C.; Samuelsen, Sven O.; Blomhoff, Rune; Robsahm, Trude E.; Brustad, Magritt; Giovannucci, Edward L.; Bjorge, Tone			Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men	PLOS ONE			English	Article							NESTED CASE-CONTROL; PROSTATE-CANCER RISK; VITAMIN-D CONCENTRATIONS; J-SHAPED ASSOCIATION; CARDIOVASCULAR-DISEASE; GENETIC-VARIATION; METAANALYSIS; CONSORTIUM	Objective A number of observational studies have shown an inverse association between circulating 25-hydroxyvitamin D and total mortality, but a reverse J-shaped association has also been reported. In a large nested case-control study, serum-25-hydroxyvitamin D (s-25(OH)D) was positively associated with incident prostate cancer. Based on the same study population, the primary aim of the present study was to investigate the association between s-25 (OH)D and total mortality. Methods Men participating in population based health screenings during 1981-1991 and enrolled in a nested case-control study were followed throughout 2007 with respect to all-cause and cause-specific mortality. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated using Cox proportional hazards regression. Results In men with prostate cancer (n = 2282), there was a significant inverse association between s-25(OH)D and total mortality after controlling for potential confounders (HR = 1.25 (95% CI 1.05-1.50), s-25(OH)D <50 nmol/l versus s-25(OH)D >= 50 nmol/l). The corresponding figure among controls (n = 2147) was HR = 1.15 (95% CI 0.88-1.50) and in the total study population HR = 1.19 (95% CI 1.03-1.38). For cause-specific deaths, we found no significant associations. Conclusions In this study population, s-25(OH)D was inversely associated with total mortality during more than two decades of follow-up, despite, as previous reported, high s-25(OH)D was associated with increased risk of prostate cancer.	[Meyer, Haakon E.] Univ Oslo, Fac Med, Dept Community Med, Oslo, Norway; [Meyer, Haakon E.; Stoer, Nathalie C.; Samuelsen, Sven O.] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Meyer, Haakon E.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stoer, Nathalie C.; Samuelsen, Sven O.] Univ Oslo, Dept Math, Fac Math & Nat Sci, Oslo, Norway; [Stoer, Nathalie C.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Blomhoff, Rune] Oslo Univ Hosp, Div Canc Surg & Transplantat, N-0450 Oslo, Norway; [Robsahm, Trude E.] Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway; [Brustad, Magritt] Artic Univ Norway, Dept Community Med, UIT, Tromso, Norway; [Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bjorge, Tone] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo; Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; Harvard University; Harvard T.H. Chan School of Public Health; University of Bergen	Meyer, HE (corresponding author), Univ Oslo, Fac Med, Dept Community Med, Oslo, Norway.; Meyer, HE (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.; Meyer, HE (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	h.e.meyer@medisin.uio.no	Meyer, Haakon E./AAH-9333-2019	Bjorge, Tone/0000-0002-9096-5257; Meyer, Haakon E/0000-0002-3262-8260; Stoer, Nathalie C./0000-0001-8994-9332	Norwegian Cancer Society; Throne Holst Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Throne Holst Foundation	The serum analysis of vitamins was supported by a grant from the Norwegian Cancer Society and the Throne Holst Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Albanes D, 2011, CANCER EPIDEM BIOMAR, V20, P1850, DOI 10.1158/1055-9965.EPI-11-0403; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007469.pub2; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Durup D, 2015, J CLIN ENDOCR METAB, V100, P2339, DOI 10.1210/jc.2014-4551; Keum N, 2014, BRIT J CANCER, V111, P976, DOI 10.1038/bjc.2014.294; Khaw KT, 2014, AM J CLIN NUTR, V100, P1361, DOI 10.3945/ajcn.114.086413; Meyer HE, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h321; Meyer HE, 2013, AM J CLIN NUTR, V97, P147, DOI 10.3945/ajcn.112.039222; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Samuelsen SO, 1997, BIOMETRIKA, V84, P379, DOI 10.1093/biomet/84.2.379; Schenk JM, 2014, CANCER EPIDEM BIOMAR, V23, P1484, DOI 10.1158/1055-9965.EPI-13-1340; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Schottker B, 2013, AGEING RES REV, V12, P708, DOI 10.1016/j.arr.2012.02.004; Sempos CT, 2013, J CLIN ENDOCR METAB, V98, P3001, DOI 10.1210/jc.2013-1333; Shui IM, 2015, CANCER-AM CANCER SOC, V121, P1949, DOI 10.1002/cncr.29320; Shui IM, 2012, JNCI-J NATL CANCER I, V104, P690, DOI 10.1093/jnci/djs189; Stoer NC, 2014, EPIDEMIOLOGY, V25, P315, DOI 10.1097/EDE.0000000000000057; Tretli S, 2009, BRIT J CANCER, V100, P450, DOI 10.1038/sj.bjc.6604865; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375	25	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151441	10.1371/journal.pone.0151441	http://dx.doi.org/10.1371/journal.pone.0151441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986958	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300071
J	Liu, T; Li, P; Chen, Y; Zhang, J				Liu, Ting; Li, Ping; Chen, Yan; Zhang, Jie			Community Size Effects on Epidemic Spreading in Multiplex Social Networks	PLOS ONE			English	Article								The dynamical process of epidemic spreading has drawn much attention of the complex network community. In the network paradigm, diseases spread from one person to another through the social ties amongst the population. There are a variety of factors that govern the processes of disease spreading on the networks. A common but not negligible factor is people's reaction to the outbreak of epidemics. Such reaction can be related information dissemination or self-protection. In this work, we explore the interactions between disease spreading and population response in terms of information diffusion and individuals' alertness. We model the system by mapping multiplex networks into two-layer networks and incorporating individuals' risk awareness, on the assumption that their response to the disease spreading depends on the size of the community they belong to. By comparing the final incidence of diseases in multiplex networks, we find that there is considerable mitigation of diseases spreading for full phase of spreading speed when individuals' protection responses are introduced. Interestingly, the degree of community overlap between the two layers is found to be critical factor that affects the final incidence. We also analyze the consequences of the epidemic incidence in communities with different sizes and the impacts of community overlap between two layers. Specifically, as the diseases information makes individuals alert and take measures to prevent the diseases, the effective protection is more striking in small community. These phenomena can be explained by the multiplexity of the networked system and the competition between two spreading processes.	[Liu, Ting; Li, Ping; Chen, Yan] Southwest Petr Univ, Sch Comp Sci, Ctr Intelligent & Networked Syst, Chengdu 610500, Peoples R China; [Zhang, Jie] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	Southwest Petroleum University; Fudan University	Li, P (corresponding author), Southwest Petr Univ, Sch Comp Sci, Ctr Intelligent & Networked Syst, Chengdu 610500, Peoples R China.	dping.li@gmail.com	Li, Ping/K-7445-2016; Li, Ping/I-6143-2013	Li, Ping/0000-0002-8391-6510	National Natural Science Foundation of China [61104224, 61104143, 61573107]; Foundations of SiChuan Educational Committee [13ZB0198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundations of SiChuan Educational Committee	This work is partly supported by National Natural Science Foundation of China 61104224, 61104143, and 61573107 and Foundations of SiChuan Educational Committee (13ZB0198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ACAD MARKET SCI REV; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonaccorsi S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012810; Bu YL, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042801; Budak C., 2011, PROC 20 INT C WORLD, P665, DOI 10.1145/1963405.1963499; Buono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092200; Chung K, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052811; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Dajun Qian, 2012, GLOBECOM 2012 - 2012 IEEE Global Communications Conference, P2072, DOI 10.1109/GLOCOM.2012.6503421; Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Goldenberg J, 2001, MARKET LETT, V12, P211, DOI 10.1023/A:1011122126881; Granell C, 2014, ARXIV14054480; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Guo QT, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012822; Katz D, 1978, SOCIAL PSYCHOL ORG; Kennedy J, 1999, P 1999 C EV COMP 199, P3; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Min Byungjoon, 2013, ARXIV13072967; OLIVER PE, 1988, AM SOCIOL REV, V53, P1, DOI 10.2307/2095728; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Salehi M, 2014, ARXIV E PRINTS; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tunc I, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022801; Wang HJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022801; Wei XT, 2012, ACM SIGCOMM COMP COM, V42, P5, DOI 10.1145/2378956.2378958; Zhang HF, 2011, PHYSICA D, V240, P943, DOI 10.1016/j.physd.2011.02.001; Zhao DW, 2014, PHYS LETT A, V378, P770, DOI 10.1016/j.physleta.2014.01.014	34	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152021	10.1371/journal.pone.0152021	http://dx.doi.org/10.1371/journal.pone.0152021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007112	gold, Green Submitted, Green Published			2022-12-27	WOS:000372701200087
J	Bailey, K; Yazdi, T; Masharani, U; Tyrrell, B; Butch, A; Schaufele, F				Bailey, Kathy; Yazdi, Tahmineh; Masharani, Umesh; Tyrrell, Blake; Butch, Anthony; Schaufele, Fred			Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs	PLOS ONE			English	Article							BACKDOOR PATHWAY; FLUORESCENT PROTEIN; MODULATORS; SPORTS; TESTOSTERONE; CONSEQUENCES; DEFICIENCY; ACTIVATION; MICROSCOPY; AGENTS	Testosterone (T) and related androgens are performance enhancing drugs (PEDs) abused by some athletes to gain competitive advantage. To monitor unauthorized androgen abuse, doping control programs use mass spectrometry (MS) to detect androgens, synthetic anabolic-androgenic steroids (AASs) and their metabolites in an athlete's urine. AASs of unknown composition will not be detected by these procedures. Since AASs achieve their anabolic effects by activating the Androgen Receptor (AR), cell-based bioassays that measure the effect of a urine sample on AR activity are under investigation as complementary, pan-androgen detection methods. We evaluated an AR BioAssay as a monitor for androgen activity in urine pre-treated with glucuronidase, which releases T from the inactive T-glucuronide that predominates in urine. AR BioAssay activity levels were expressed as 'T-equivalent' concentrations by comparison to a T dose response curve. The T-equivalent concentrations of androgens in the urine of hypogonadal participants supplemented with T (in whom all androgenic activity should arise from T) were quantitatively identical to the T measurements conducted by MS at the UCLA Olympic Analytical Laboratory (0.96 +/- 0.22). All 17 AASs studied were active in the AR BioAssay; other steroids were inactive. 12 metabolites of 10 commonly abused AASs, which are used for MS monitoring of AAS doping because of their prolonged presence in urine, had reduced or no AR BioAssay activity. Thus, the AR BioAssay can accurately and inexpensively monitor T, but its ability to monitor urinary AASs will be limited to a period immediately following doping in which the active AASs remain intact.	[Bailey, Kathy; Yazdi, Tahmineh; Schaufele, Fred] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Masharani, Umesh; Tyrrell, Blake] Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA; [Butch, Anthony] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Schaufele, Fred] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Schaufele, F (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA.; Schaufele, F (corresponding author), Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA.	fred.schaufele@ucsf.edu			Partnership for Clean Competition; National Institutes of Health [P30 DK63720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Partnership for Clean Competition; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a research grant to FS from the Partnership for Clean Competition (http://www.cleancompetition.org/). Maintenance of microscopy equipment was partially offset with Center grant (P30 DK63720, PI: Michael German) support from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Basaria S, 2010, J CLIN ENDOCR METAB, V95, P1533, DOI 10.1210/jc.2009-1579; Bhasin S, 2009, CURR OPIN CLIN NUTR, V12, P232, DOI 10.1097/MCO.0b013e32832a3d79; Biason-Lauber A, 2013, MOL CELL ENDOCRINOL, V371, P124, DOI 10.1016/j.mce.2013.01.017; Bowers LD, 2014, CLIN CHEM, V60, P1279, DOI 10.1373/clinchem.2014.226175; Bowers LD, 2009, ANNU REV ANAL CHEM, V2, P485, DOI 10.1146/annurev-anchem-060908-155159; Bowers LD, 2009, STEROIDS, V74, P285, DOI 10.1016/j.steroids.2009.01.007; Bowers LD, 2002, THER DRUG MONIT, V24, P178, DOI 10.1097/00007691-200202000-00028; Cadwallader AB, 2011, J ANAL TOXICOL, V35, P594, DOI 10.1093/anatox/35.9.594; Catlin DH, 2008, J INTERN MED, V264, P99, DOI 10.1111/j.1365-2796.2008.01993.x; Dalton JT, 2013, CURR OPIN SUPPORT PA, V7, P345, DOI 10.1097/SPC.0000000000000015; DEHENNIN L, 1994, J ENDOCRINOL, V142, P353, DOI 10.1677/joe.0.1420353; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Gao WQ, 2007, DRUG DISCOV TODAY, V12, P241, DOI 10.1016/j.drudis.2007.01.003; Geyer H, 2014, BRIT J SPORT MED, V48, P820, DOI 10.1136/bjsports-2014-093526; Gregory CW, 2001, CANCER RES, V61, P2892; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hartig SM, 2011, METHODS MOL BIOL, V776, P313, DOI 10.1007/978-1-61779-243-4_18; Hebborn P., 2013, SCREENING METHODS PH, V2, P75; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; Houtman CJ, 2009, ANAL CHIM ACTA, V637, P247, DOI 10.1016/j.aca.2008.09.037; Johnston L, 2014, MONITORING FUTURE NA, V2; Johnston L. D., 2014, MONITORING FUTURE NA, V1; Jones JO, 2009, ACS CHEM BIOL, V4, P199, DOI 10.1021/cb900024z; Kamrath C, 2012, J CLIN ENDOCR METAB, V97, pE367, DOI 10.1210/jc.2011-1997; Kanayama G, 2010, HORM BEHAV, V58, P111, DOI 10.1016/j.yhbeh.2009.09.006; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kofoed EM, 2010, J BIOL CHEM, V285, P2428, DOI 10.1074/jbc.M109.045203; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Krylova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063286; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Martinez ED, 2006, METHOD ENZYMOL, V414, P37, DOI 10.1016/S0076-6879(06)14003-3; Momaya A, 2015, SPORTS MED, V45, P517, DOI 10.1007/s40279-015-0308-9; Parr MK, 2010, J STEROID BIOCHEM, V121, P528, DOI 10.1016/j.jsbmb.2009.12.008; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Rane A, 2012, BRIT J CLIN PHARMACO, V74, P3, DOI 10.1111/j.1365-2125.2012.04294.x; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Saugy M, 2014, BRIT J SPORT MED, V48, P827, DOI 10.1136/bjsports-2014-093512; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schaufele F, 2014, METHODS, V66, P188, DOI 10.1016/j.ymeth.2013.07.040; Schulze JJ, 2008, J CLIN ENDOCR METAB, V93, P2500, DOI 10.1210/jc.2008-0218; Sjoqvist F, 2008, LANCET, V371, P1872, DOI 10.1016/S0140-6736(08)60801-6; Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009; Sottas PE, 2010, ENDOCRIN METAB CLIN, V39, P59, DOI 10.1016/j.ecl.2009.11.003; Swanson C, 2007, J CLIN ENDOCR METAB, V92, P4878, DOI 10.1210/jc.2007-0359; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; Taplin ME, 1999, CANCER RES, V59, P2511; Thevis M, 2015, DRUG TEST ANAL, V7, P1, DOI 10.1002/dta.1769; Wolf S, 2011, ARCH TOXICOL, V85, P285, DOI 10.1007/s00204-010-0590-0; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779; Zierau O, 2008, STEROIDS, V73, P1143, DOI 10.1016/j.steroids.2008.04.015	52	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151860	10.1371/journal.pone.0151860	http://dx.doi.org/10.1371/journal.pone.0151860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998755	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700075
J	Banihashemian, SM; Periasamy, V; Tong, GB; Rahman, SA				Banihashemian, Seyedeh Maryam; Periasamy, Vengadesh; Tong, Goh Boon; Rahman, Saadah Abdul			Spectroscopic (UV/VIS, Raman) and Electrophoresis Study of Cytosine-Guanine Oligonucleotide DNA Influenced by Magnetic Field	PLOS ONE			English	Article							CURRENT-VOLTAGE CHARACTERISTICS; GOLD STRUCTURE; BAND-GAP; HYBRIDIZATION; MOLECULES; STRAND; MODEL	Studying the effect of a magnetic field on oligonucleotide DNA can provide a novel DNA manipulation technique for potential application in bioengineering and medicine. In this work, the optical and electrochemical response of a 100 bases oligonucleotides DNA, cytosine-guanine (CG(100)), is investigated via exposure to different magnetic fields (250, 500, 750, and 1000 mT). As a result of the optical response of CG(100) to the magnetic field, the ultra-violet-visible spectrum indicated a slight variation in the band gap of CG(100) of about 0.3 eV. Raman spectroscopy showed a significant deviation in hydrogen and phosphate bonds' vibration after exposure to the magnetic field. Oligonucleotide DNA mobility was investigated in the external electric field using the gel electrophoresis technique, which revealed a small decrease in the migration of CG(100) after exposure to the magnetic field.	[Banihashemian, Seyedeh Maryam; Periasamy, Vengadesh; Tong, Goh Boon; Rahman, Saadah Abdul] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Banihashemian, SM (corresponding author), Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 50603, Malaysia.	banihashemian_physics@yahoo.com	PERIASAMY, VENGADESH/B-9993-2010; RAHMAN, SAADAH BINTI ABDUL/A-8561-2010; GOH, BOON TONG/B-8545-2010	PERIASAMY, VENGADESH/0000-0002-0435-4944; RAHMAN, SAADAH BINTI ABDUL/0000-0002-5738-5920; GOH, BOON TONG/0000-0003-3933-7594	IPPP-BKP [BK003-2015]; UM/MOHE [F000006-21001]; HIR grants [J-21002-73823, UM.C/HIR/MOHE/SC/06]; FRGS grant [FP004/2013A]; BKP grant [BK003-2015]	IPPP-BKP; UM/MOHE; HIR grants; FRGS grant; BKP grant	This research was supported by IPPP-BKP grant BK003-2015, UM/MOHE High Impact Research Grant allocation of F000006-21001, HIR grants (J-21002-73823 and UM.C/HIR/MOHE/SC/06) and FRGS grant (FP004/2013A). S. M. Banihashemian conducted the experiments and took the measurements with advice and consultation from all authors and BK003-2015 is her BKP grant. Set up preparation, picture and redraw of schematic also prepared by Seyedeh Maryam. Saadah Abdul Rahman, Vengadesh Periasamand and Goh Boon Tong helped to prepare the designed set up and all authors contributed to writing, editing and reviewing the paper that UM/MOHE High Impact Research Grant allocation of F000006-21001, HIR grants (J-21002-73823 and UM.C/HIR/MOHE/SC/06) and FRGS grant (FP004/2013A) are their grant respectively.	Ahmad M, 2005, SENSOR ACTUAT A-PHYS, V119, P84, DOI 10.1016/j.sna.2004.09.007; Banihashemian SM, 2013, MOLECULES, V18, P11797, DOI 10.3390/molecules181011797; Bende A, 2011, SOLID STATE COMMUN, V151, P301, DOI 10.1016/j.ssc.2010.12.001; Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420; Epstein JR, 2002, ANAL CHIM ACTA, V469, P3, DOI 10.1016/S0003-2670(02)00030-2; Gabelica V, 2007, J AM CHEM SOC, V129, P4706, DOI 10.1021/ja068440z; Gullu O, 2008, APPL SURF SCI, V254, P5175, DOI 10.1016/j.apsusc.2008.02.019; Hu DS, 2008, CHINESE PHYS LETT, V25, P1822, DOI 10.1088/0256-307X/25/5/081; Iguchi K, 2001, J PHYS SOC JPN, V70, P593, DOI 10.1143/JPSJ.70.593; Khatir NM, 2015, MAT SCI SEMICON PROC, V36, P134, DOI 10.1016/j.mssp.2015.02.085; Khatir NM, 2014, APPL MECH MATER, V554, P155, DOI 10.4028/www.scientific.net/AMM.554.155; Khatir NM, 2014, SENSORS-BASEL, V14, P19229, DOI 10.3390/s141019229; Khatir NM, 2012, ADV MATER RES-SWITZ, V535-537, P1350, DOI 10.4028/www.scientific.net/AMR.535-537.1350; Khatir NM, 2012, SENSORS-BASEL, V12, P3578, DOI 10.3390/s120303578; Khatir NM, 2011, SENSORS-BASEL, V11, P6719, DOI 10.3390/s110706719; Kilina S, 2007, J PHYS CHEM C, V111, P14541, DOI 10.1021/jp070805u; Kumar S, 2005, INDIAN J PURE AP PHY, V43, P609; Martins SAM, 2010, ANAL LETT, V43, P2694, DOI 10.1080/00032711003731431; Muehsam D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061752; Muehsam DJ, 2009, BIOELECTROMAGNETICS, V30, P462, DOI 10.1002/bem.20494; Peter C, 2001, FRESEN J ANAL CHEM, V371, P120, DOI 10.1007/s002160101006; Rogers KR, 2001, ANAL CHIM ACTA, V444, P51, DOI 10.1016/S0003-2670(01)01150-3; Singh TB, 2009, ADV POLYM SCI, P73; Slavicek P, 2009, J AM CHEM SOC, V131, P6460, DOI 10.1021/ja8091246; Song J, 2005, SYNTHETIC MET, V155, P607, DOI 10.1016/j.synthmet.2005.08.011; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Tauc J., 1974, AMORPHOUS LIQUID SEM; Vlassakis J, 2010, PROC SPIE, V7762, DOI 10.1117/12.868284; Wang H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.016401; Xiu-feng JY-xLJ-tG, 2006, CHINESE J CLIN REHAB, V10, P3; Yang X, 2004, P NATL ACAD SCI USA, V101, P17588, DOI 10.1073/pnas.0405157101; Yousef TA, 2010, J MOL STRUCT, V1035, P307	32	0	0	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0149488	10.1371/journal.pone.0149488	http://dx.doi.org/10.1371/journal.pone.0149488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999445	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700008
J	Chen, G; Wei, BJ; Wang, J; Feng, B; Li, ZL; Zhang, ZP; He, QY				Chen, Guang; Wei, Benjun; Wang, Jie; Feng, Bo; Li, Zhaoling; Zhang, Zhenpeng; He, Qingyong			Shensongyangxin Capsules for Paroxysmal Atrial Fibrillation: A Systematic Review of Randomized Clinical Trials	PLOS ONE			English	Review							RISK-FACTORS; PREVALENCE; STROKE; MANAGEMENT; JAPAN; COSTS	Objective To evaluate the evidence for the effectiveness and safety of Shensongyangxin Capsules (SSYX) for treating paroxysmal atrial fibrillation (PAF). Methods We searched for randomized clinical trials for SSYX in PAF up to June 2015. The Cochrane risk of bias tool was used to assess the methodological quality. RevMan 5.3 was used to synthesize the results. Results We included 22 trials involving 2,347 PAF patients. The quality of the included studies was generally poor. The results of the meta-analysis showed that SSYX plus routine treatment was more effective at improving P-wave dispersion (Pwd) and the frequency of PAF attacks compared with routine treatment alone. The results from the included trials that compared SSYX plus routine treatment and arrhythmic drugs plus routine treatment were inconsistent. Trials reported on Pwd, quality of life, frequency of PAF attacks or maintenance rate of sinus rhythm and found that SSYX combined with anti-arrhythmic drugs plus routine treatment was more effective than anti-arrhythmic drugs plus routine treatment. Four of the trials reported adverse events, indicating that SSYX was potentially safer than anti-arrhythmic drugs. Conclusions There appears to be some benefit from the use of SSYX. However, due to poor methodological quality, we could not draw confirmative conclusions regarding the beneficial effect of using SSYX.	[Chen, Guang; Wei, Benjun; Wang, Jie; Feng, Bo; Li, Zhaoling; Zhang, Zhenpeng; He, Qingyong] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Cardiol, Beixiange 5, Beijing 100053, Peoples R China; [Chen, Guang] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wei, Benjun] Hubei Univ Chinese Med, Wuhan 430065, Hubei, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Beijing University of Chinese Medicine; Hubei University of Chinese Medicine	Chen, G (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Dept Cardiol, Beixiange 5, Beijing 100053, Peoples R China.; Chen, G (corresponding author), Beijing Univ Chinese Med, Beijing 100029, Peoples R China.	wdclgz0000@163.com		Chen, Guang/0000-0001-6644-9618				Camm AJ, 2012, EUR HEART J, V33; Cao D, 2013, J CLIN RATIONAL DRUG, V6, P49; Coyne KS, 2006, VALUE HEALTH, V9, P348, DOI 10.1111/j.1524-4733.2006.00124.x; Ge K F, 2009, T 2009 QIANJ INT C C, V2, P81; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Han H Y, 2007, J VIROL, V6, P389; Han Y H, 2010, CHINESE J MISDIAGNOS, V10, P6827; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hu DY, 2008, J AM COLL CARDIOL, V52, P865, DOI 10.1016/j.jacc.2008.05.042; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; [金壹伍 Jin Yiwu], 2012, [中国循环杂志, Chinese Circulation Journal], V27, P353; Li F C, 2009, BASIC CLIN STUDY COL, V5, P512; Li L, 2009, BASIC CLIN STUDY COL, V5, P494; Li Y X, 2011, BASIC CLIN STUDY COL, V7, P288; Liu, 2012, CHINA J CHINESE MED, V27, P750; Liu HZ, 2011, YUNNAN J TCM, V32, P60; Liu Y X, 2013, HEILONGJIANG MED, V26, P408; Lu J Z, 2012, CARDIOVASCULAR CEREB, V12, P134; Men R., 2012, CHINA PHARM, V21, P69; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Ohsawa M, 2005, J EPIDEMIOL, V15, P194, DOI 10.2188/jea.15.194; Quan T, 2008, MODERN MED HLTH, V24, P24; Ringborg A, 2008, EUROPACE, V10, P403, DOI 10.1093/europace/eun048; Shao J K, 2013, CHINA PHARM GUIDE, V11, P141; Sheng H P, 2010, GANSU J TRADITIONAL, V23, P24; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Tang Yan-Long, 2012, Acta Entomologica Sinica, V55, P55; Wang Ai-hu, 2011, Zhonghua Yi Xue Za Zhi, V91, P1677; Wang J., 2012, INTERNAL MED, V2, P1, DOI [10.4172/2165-8048.1000113, DOI 10.4172/2165-8048.1000113]; Wang J, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/268542; Wen-Hang QI, 2005, INT J CARDIOL, V105, P283, DOI 10.1016/j.ijcard.2004.12.042; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Wolf PA, 1996, AM HEART J, V131, P790, DOI 10.1016/S0002-8703(96)90288-4; Wu P T, 2007, J VIROL, V6, P270; Yu Z W, 2010, ZHEJIANG J TRADITION, V1, P73; Zhang C M, 2012, BASIC CLIN STUDY COL, V8, P265; Zhou F Y, 2008, BASIC CLIN STUDY COL, V4, P300	38	9	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151880	10.1371/journal.pone.0151880	http://dx.doi.org/10.1371/journal.pone.0151880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999010	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700078
J	Dileepan, M; Sarver, AE; Rao, SP; Panettieri, RA; Subramanian, S; Kannan, MS				Dileepan, Mythili; Sarver, Anne E.; Rao, Savita P.; Panettieri, Reynold A., Jr.; Subramanian, Subbaya; Kannan, Mathur S.			MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-INDUCED SECRETION; TNF-ALPHA; SEVERE ASTHMA; MESSENGER-RNA; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY PHENOTYPE; TRANSCRIPTION FACTORS; CD38-DEFICIENT MICE	Airway smooth muscle (ASM) cells play a critical role in the pathophysiology of asthma due to their hypercontractility and their ability to proliferate and secrete inflammatory mediators. microRNAs (miRNAs) are gene regulators that control many signaling pathways and thus serve as potential therapeutic alternatives for many diseases. We have previously shown that miR-708 and miR-140-3p regulate the MAPK and PI3K signaling pathways in human ASM (HASM) cells following TNF-alpha exposure. In this study, we investigated the regulatory effect of these miRNAs on other asthma-related genes. Microarray analysis using the Illumina platform was performed with total RNA extracted from miR-708 (or control miR)-transfected HASM cells. Inhibition of candidate inflammation-associated gene expression was further validated by qPCR and ELISA. The most significant biologic functions for the differentially expressed gene set included decreased inflammatory response, cytokine expression and signaling. qPCR revealed inhibition of expression of CCL11, CXCL10, CCL2 and CXCL8, while the release of CCL11 was inhibited in miR-708-transfected cells. Transfection of cells with miR-140-3p resulted in inhibition of expression of CCL11, CXCL12, CXCL10, CCL5 and CXCL8 and of TNF-alpha-induced CXCL12 release. In addition, expression of RARRES2, CD44 and ADAM33, genes known to contribute to the pathophysiology of asthma, were found to be inhibited in miR-708-transfected cells. These results demonstrate that miR-708 and miR-140-3p exert distinct effects on inflammation-associated gene expression and biological function of ASM cells. Targeting these miRNA networks may provide a novel therapeutic mechanism to down-regulate airway inflammation and ASM proliferation in asthma.	[Dileepan, Mythili; Rao, Savita P.; Kannan, Mathur S.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Sarver, Anne E.; Subramanian, Subbaya] Univ Minnesota, Surg, Minneapolis, MN USA; [Panettieri, Reynold A., Jr.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Kannan, MS (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	kanna001@umn.edu	panettieri, reynold/AAG-9485-2019	Subramanian, Subbaya/0000-0002-2544-480X	National Institutes of Health [P01-HL114471, P30-ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	RAP received funding from the National Institutes of Health (Grant Numbers: P01-HL114471 and P30-ES013508 to RAP).	Al Heialy S, 2013, AM J RESP CELL MOL, V49, P563, DOI 10.1165/rcmb.2012-0356OC; Alkhouri H, 2014, J Allergy (Cairo), V2014, P875105, DOI 10.1155/2014/875105; Alrashdan YA, 2012, AM J PHYSIOL-LUNG C, V302, pL1118, DOI 10.1152/ajplung.00232.2011; Amiri KI, 2003, PROG NUCLEIC ACID RE, V74, P1, DOI 10.1016/S0079-6603(03)01009-2; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Ammit AJ, 2000, AM J RESP CELL MOL, V23, P794, DOI 10.1165/ajrcmb.23.6.4184; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Amrani Y, 1999, J IMMUNOL, V163, P2128; Androlewicz MJ, 1999, IMMUNOL RES, V20, P79, DOI 10.1007/BF02786464; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berkman N, 1996, AM J RESP CRIT CARE, V154, P1804, DOI 10.1164/ajrccm.154.6.8970374; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; Burgess JK, 2008, J CELL PHYSIOL, V216, P673, DOI 10.1002/jcp.21450; Chiba S, 2014, EUROPEAN RESP J S58, V44; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Damera G, 2011, BRIT J PHARMACOL, V163, P68, DOI 10.1111/j.1476-5381.2010.01165.x; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Deshpande DA, 2005, AM J RESP CELL MOL, V32, P149, DOI 10.1165/rcmb.2004-0243OC; Dileepan M, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0107-0; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Eynott PR, 2003, BRIT J PHARMACOL, V140, P1373, DOI 10.1038/sj.bjp.0705569; Gao YD, 2014, J ASTHMA, V51, P997, DOI 10.3109/02770903.2014.939283; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Ghaffar O, 1999, AM J RESP CRIT CARE, V159, P1933, DOI 10.1164/ajrccm.159.6.9805039; Girodet PO, 2010, ALLERGY, V65, P1004, DOI 10.1111/j.1398-9995.2009.02308.x; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Grunstein MM, 2000, AM J PHYSIOL-LUNG C, V278, pL1154, DOI 10.1152/ajplung.2000.278.6.L1154; Guedes AGP, 2006, AM J PHYSIOL-LUNG C, V291, pL1286, DOI 10.1152/ajplung.00187.2006; Guedes AGP, 2015, CAN J PHYSIOL PHARM, V93, P145, DOI 10.1139/cjpp-2014-0410; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Holgate Stephen T, 2006, Proc Am Thorac Soc, V3, P440, DOI 10.1513/pats.200603-026AW; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Hu RX, 2014, FASEB J, V28, P2347, DOI 10.1096/fj.13-247247; Ishikawa T, 2013, EUROPEAN RESP J S57, V42; John AE, 2009, J IMMUNOL, V183, P4682, DOI 10.4049/jimmunol.0803832; John M, 1998, AM J RESP CELL MOL, V18, P84, DOI 10.1165/ajrcmb.18.1.2813; John M, 1997, J IMMUNOL, V158, P1841; Jude JA, 2012, AM J PHYSIOL-LUNG C, V303, pL460, DOI 10.1152/ajplung.00041.2012; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Khan MA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-11; Knox AJ, 2001, FASEB J, V15, P2480, DOI 10.1096/fj.01-0256com; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Lazaar AL, 2001, J IMMUNOL, V166, P155, DOI 10.4049/jimmunol.166.1.155; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; Lazzeri N, 2001, EUR J PHARMACOL, V433, P231, DOI 10.1016/S0014-2999(01)01520-5; Lee IS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/872142; Lin TY, 2014, CLIN EXP ALLERGY, V44, P1347, DOI 10.1111/cea.12421; Manetsch M, 2012, AM J PHYSIOL-LUNG C, V302, pL838, DOI 10.1152/ajplung.00317.2011; Mariani F, 2015, INFLAMM RES, V64, P85, DOI 10.1007/s00011-014-0792-7; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; McKay S, 2000, AM J RESP CELL MOL, V23, P103, DOI 10.1165/ajrcmb.23.1.3765; NOVERAL JP, 1994, AM J PHYSIOL-LUNG C, V267, pL761, DOI 10.1152/ajplung.1994.267.6.L761; Ozier Annaig, 2011, J Allergy (Cairo), V2011, P742710, DOI 10.1155/2011/742710; PANETTIERI RA, 1995, J IMMUNOL, V154, P2358; Paulissen G, 2006, MOL MED, V12, P171, DOI 10.2119/2006-00028.Paulissen; Perez-Zoghbi JF, 2007, AM J PHYSIOL-LUNG C, V293, pL1000, DOI 10.1152/ajplung.00184.2007; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Rajah R, 1999, AM J RESP CELL MOL, V20, P199, DOI 10.1165/ajrcmb.20.2.3148; Redhu NS, 2011, AM J PHYSIOL-LUNG C, V300, pL479, DOI 10.1152/ajplung.00301.2009; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Saunders MA, 1997, BRIT J PHARMACOL, V120, P545, DOI 10.1038/sj.bjp.0700998; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Sutcliffe A, 2006, THORAX, V61, P657, DOI 10.1136/thx.2005.056770; Tan XH, 2012, AM J PHYSIOL-LUNG C, V302, P1700, DOI 10.1152/ajplung.00167.2011; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tliba O, 2009, ANNU REV PHYSIOL, V71, P509, DOI 10.1146/annurev.physiol.010908.163227; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Wuyts WA, 2003, RESP MED, V97, P811, DOI 10.1016/S0954-6111(03)00036-2; Xu J, 1999, Respirology, V4, P413, DOI 10.1046/j.1440-1843.1999.00214.x; Zhang KQ, 2007, AM J PHYSIOL-LUNG C, V293, pL375, DOI 10.1152/ajplung.00045.2007	89	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150842	10.1371/journal.pone.0150842	http://dx.doi.org/10.1371/journal.pone.0150842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998837	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700016
J	Keys, PW; Wang-Erlandsson, L; Gordon, LJ				Keys, Patrick W.; Wang-Erlandsson, Lan; Gordon, Line J.			Revealing Invisible Water: Moisture Recycling as an Ecosystem Service	PLOS ONE			English	Article							HYDROLOGICAL CYCLE; CONTRASTING ROLES; PRECIPITATION; IRRIGATION; RAINFALL; IMPACT; FOREST; TRANSPIRATION; DEFORESTATION; VULNERABILITY	An ecosystem service is a benefit derived by humanity that can be traced back to an ecological process. Although ecosystem services related to surface water have been thoroughly described, the relationship between atmospheric water and ecosystem services has been mostly neglected, and perhaps misunderstood. Recent advances in land-atmosphere modeling have revealed the importance of terrestrial ecosystems for moisture recycling. In this paper, we analyze the extent to which vegetation sustains the supply of atmospheric moisture and precipitation for downwind beneficiaries, globally. We simulate land-surface evaporation with a global hydrology model and track changes to moisture recycling using an atmospheric moisture budget model, and we define vegetation-regulated moisture recycling as the difference in moisture recycling between current vegetation and a hypothetical desert world. Our results show that nearly a fifth of annual average precipitation falling on land is from vegetation-regulated moisture recycling, but the global variability is large, with many places receiving nearly half their precipitation from this ecosystem service. The largest potential impacts for changes to this ecosystem service are land-use changes across temperate regions in North America and Russia. Likewise, in semi-arid regions reliant on rainfed agricultural production, land-use change that even modestly reduces evaporation and subsequent precipitation, could significantly affect human well-being. We also present a regional case study in the Mato Grosso region of Brazil, where we identify the specific moisture recycling ecosystem services associated with the vegetation in Mato Grosso. We find that Mato Grosso vegetation regulates some internal precipitation, with a diffuse region of benefit downwind, primarily to the south and east, including the La Plata River basin and the megacities of Sao Paulo and Rio de Janeiro. We synthesize our global and regional results into a generalized framework for describing moisture recycling as an ecosystem service. We conclude that future work ought to disentangle whether and how this vegetationregulated moisture recycling interacts with other ecosystem services, so that trade-offs can be assessed in a comprehensive and sustainable manner.	[Keys, Patrick W.; Wang-Erlandsson, Lan; Gordon, Line J.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Keys, Patrick W.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Wang-Erlandsson, Lan] Delft Univ Technol, Fac Civil Engn & Geosci, Dept Water Management, Delft, Netherlands	Stockholm University; Colorado State University; Delft University of Technology	Keys, PW (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.; Keys, PW (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.	patrick.keys@su.se	Wang-Erlandsson, Lan/V-5999-2019; Keys, Patrick/AAK-1359-2021	Wang-Erlandsson, Lan/0000-0002-7739-5069; Keys, Patrick/0000-0002-7250-1563; Gordon, Line/0000-0002-3520-4340	Swedish Research Council Formas [1364115]; BioCycle Group at Colorado State University	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); BioCycle Group at Colorado State University	The research for this work was supported by The Swedish Research Council Formas, under grant number 1364115. Auxiliary support was provided by Scott Denning and the BioCycle Group at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SOCIAL ECOLOGICAL RE; Ayres MP, 2014, ADV GLOB CHANGE RES, V57, P55, DOI 10.1007/978-94-007-7515-2_4; Bagley JE, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014009; Berger M, 2014, ENVIRON SCI TECHNOL, V48, P4521, DOI 10.1021/es404994t; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Daily G.C., 1997, NATURES SERVICES SOC, P1; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dirmeyer PA, 1999, J GEOPHYS RES-ATMOS, V104, P19383, DOI 10.1029/1999JD900222; Dominguez F, 2006, J CLIMATE, V19, P1513, DOI 10.1175/JCLI3691.1; Ebbesson J., 2014, SCAND STUD, V59, P259; Ellison D, 2012, GLOBAL CHANGE BIOL, V18, P806, DOI 10.1111/j.1365-2486.2011.02589.x; Falkenmark M., 2007, WATER FOOD WATER LIF, P234; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gimeno L, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000389; Goessling HF, 2011, HYDROL EARTH SYST SC, V15, P3217, DOI 10.5194/hess-15-3217-2011; Gordon LJ, 2010, AGR WATER MANAGE, V97, P512, DOI 10.1016/j.agwat.2009.03.017; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Green PA, 2015, GLOBAL ENVIRON CHANG, V34, P108, DOI 10.1016/j.gloenvcha.2015.06.007; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Guimberteau M, 2012, CLIM DYNAM, V39, P1329, DOI 10.1007/s00382-011-1252-5; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Jacobi P, 2004, ENVIRON URBAN, V16, P199, DOI 10.1177/095624780401600211; Keys PW, 2014, HYDROL EARTH SYST SC, V18, P3937, DOI 10.5194/hess-18-3937-2014; Keys PW, 2012, BIOGEOSCIENCES, V9, P733, DOI 10.5194/bg-9-733-2012; Kiage LM, 2013, PROG PHYS GEOG, V37, P664, DOI 10.1177/0309133313492543; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; LETTAU H, 1979, MON WEATHER REV, V107, P227, DOI 10.1175/1520-0493(1979)107<0227:AHCATR>2.0.CO;2; Lo MH, 2013, GEOPHYS RES LETT, V40, P301, DOI 10.1002/grl.50108; Maes J, 2015, LANDSCAPE ECOL, V30, P517, DOI 10.1007/s10980-014-0083-2; Makarieva AM, 2014, J HYDROMETEOROL, V15, P411, DOI 10.1175/JHM-D-12-0190.1; McDonald RI, 2014, GLOBAL ENVIRON CHANG, V27, P96, DOI 10.1016/j.gloenvcha.2014.04.022; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Nabinger C, 2000, CAMPOS SO BRAZIL GRA, P355; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Peden D., 2007, WATER FOOD WATER LIF; Pitman AJ, 2012, EARTH SYST DYNAM, V3, P213, DOI 10.5194/esd-3-213-2012; Potschin MB, 2011, PROG PHYS GEOG, V35, P575, DOI 10.1177/0309133311423172; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Rost S, 2008, ADV GEOSCIENCES, V18, P43, DOI [DOI 10.5194/ADGEO-18-43-2008, DOI 10.5194/ADGE0-18-43-2008]; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schar C, 1999, J CLIMATE, V12, P722, DOI 10.1175/1520-0442(1999)012<0722:TSPFAP>2.0.CO;2; Shvidenko AZ, 2013, CONTEMP PROBL ECOL+, V6, P683, DOI 10.1134/S199542551307010X; Spera SA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064010; Spracklen DV, 2015, GEOPHYS RES LETT, V42, P9546, DOI 10.1002/2015GL066063; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Tuinenburg OA, 2014, J HYDROMETEOROL, V15, P1028, DOI 10.1175/JHM-D-13-078.1; Tuinenburg OA, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016221; van der Ent RJ, 2014, EARTH SYST DYNAM, V5, P471, DOI 10.5194/esd-5-471-2014; van der Ent RJ, 2011, ATMOS CHEM PHYS, V11, P1853, DOI 10.5194/acp-11-1853-2011; van der Ent RJ, 2013, WATER RESOUR RES, V49, P3993, DOI 10.1002/wrcr.20296; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang-Erlandsson L, 2014, EARTH SYST DYNAM, V5, P441, DOI 10.5194/esd-5-441-2014; Wei JF, 2013, J HYDROMETEOROL, V14, P275, DOI 10.1175/JHM-D-12-079.1; Zambelli Mônica, 2011, Sba Controle & Automação, V22, P598, DOI 10.1590/S0103-17592011000600005; Zemp DC, 2014, ATMOS CHEM PHYS, V14, P13337, DOI 10.5194/acp-14-13337-2014	57	73	73	8	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151993	10.1371/journal.pone.0151993	http://dx.doi.org/10.1371/journal.pone.0151993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998832	Green Published, gold			2022-12-27	WOS:000372694700091
J	Bogart, E; Myers, CR				Bogart, Eli; Myers, Christopher R.			Multiscale Metabolic Modeling of C4 Plants: Connecting Nonlinear Genome-Scale Models to Leaf-Scale Metabolism in Developing Maize Leaves	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; C-4 PHOTOSYNTHESIS; BUNDLE-SHEATH; DEVELOPMENTAL DYNAMICS; MESSENGER-RNA; PATHWAY; EVOLUTION; DATABASE; DECARBOXYLATION; PROTEOMICS	C4 plants, such as maize, concentrate carbon dioxide in a specialized compartment surrounding the veins of their leaves to improve the efficiency of carbon dioxide assimilation. Nonlinear relationships between carbon dioxide and oxygen levels and reaction rates are key to their physiology but cannot be handled with standard techniques of constraint-based metabolic modeling. We demonstrate that incorporating these relationships as constraints on reaction rates and solving the resulting nonlinear optimization problem yields realistic predictions of the response of C4 systems to environmental and biochemical perturbations. Using a new genome-scale reconstruction of maize metabolism, we build an 18000-reaction, nonlinearly constrained model describing mesophyll and bundle sheath cells in 15 segments of the developing maize leaf, interacting via metabolite exchange, and use RNA-seq and enzyme activity measurements to predict spatial variation in metabolic state by a novel method that optimizes correlation between fluxes and expression data. Though such correlations are known to be weak in general, we suggest that developmental gradients may be particularly suited to the inference of metabolic fluxes from expression data, and we demonstrate that our method predicts fluxes that achieve high correlation with the data, successfully capture the experimentally observed base-to-tip transition between carbon-importing tissue and carbon-exporting tissue, and include a nonzero growth rate, in contrast to prior results from similar methods in other systems.	[Bogart, Eli; Myers, Christopher R.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Bogart, Eli; Myers, Christopher R.] Cornell Univ, Inst Biotechnol, Ithaca, NY USA; [Bogart, Eli] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital	Myers, CR (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.; Myers, CR (corresponding author), Cornell Univ, Inst Biotechnol, Ithaca, NY USA.	c.myers@cornell.edu	Myers, Christopher R/I-8516-2017		National Science Foundation [IOS-1127017]; Bill and Melinda Gates Foundation	National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the National Science Foundation (www.nsf.gov) grant IOS-1127017 to CRM and a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org) to the International Rice Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker BE, 2015, COMPUT BIOL CHEM, V59, P98, DOI 10.1016/j.compbiolchem.2015.08.002; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bellasio C, 2014, PLANT CELL ENVIRON, V37, P1046, DOI 10.1111/pce.12194; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Boyd S., 2004, CONVEX OPTIMIZATION; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Brown R.H., 1999, C4 PLANT BIOL, P473, DOI DOI 10.1016/B978-012614440-6/50015-X; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Cheung CYM, 2014, PLANT PHYSIOL, V165, P917, DOI 10.1104/pp.113.234468; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Chowdhury A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003487; Christin PA, 2009, GENOME BIOL EVOL, V1, P221, DOI 10.1093/gbe/evp020; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Cotten C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-32; Covshoff S, 2012, CURR OPIN BIOTECH, V23, P209, DOI 10.1016/j.copbio.2011.12.011; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Feng XY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002376; Fernandez-Pozo N, 2014, NUCLEIC ACIDS RES, V39, pD1149; Furbank RT, 2011, J EXP BOT, V62, P3103, DOI 10.1093/jxb/err080; GLPK, 2011, GNU LIN PROGR KIT VE; Grafahrend-Belau E, 2013, PLANT PHYSIOL, V163, P637, DOI 10.1104/pp.113.224006; Griffiths H, 2013, PLANT CELL ENVIRON, V36, P249, DOI 10.1111/j.1365-3040.2012.02585.x; Gutenkunst RN, 2007, SLOPPYCELL; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Heckmann D, 2013, CELL, V153, P1579, DOI 10.1016/j.cell.2013.04.058; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Hoppe A, 2012, METABOLITES, V2, P614, DOI 10.3390/metabo2030614; HSL, 2013, COLL FORTR COD LARG; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jamshidi N, 2010, BIOPHYS J, V98, P175, DOI 10.1016/j.bpj.2009.09.064; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275, DOI 10.1016/B978-012614440-6/50004-5]; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Kromdijk J, 2010, PLANT CELL ENVIRON, V33, P1935, DOI 10.1111/j.1365-3040.2010.02196.x; Latendresse M, 2012, BIOINFORMATICS, V28, P388, DOI 10.1093/bioinformatics/btr681; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Myers CR, 2007, COMPUT SCI ENG, V9, P34, DOI 10.1109/MCSE.2007.60; Naithani S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00644; Nelson T, 2011, J EXP BOT, V62, P3039, DOI 10.1093/jxb/err072; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Plant Metabolic Network (PMN), 2014, ENZ FUNCT ANN METH; Plant Metabolic Network (PMN), 2014, PMN DAT CONT STAT; Plant Metabolic Network (PMN), 2013, CORNCYC 4 0; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Salimi F, 2010, BIOTECHNOL J, V5, P726, DOI 10.1002/biot.201000159; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schwender J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00668; Simons M, 2014, PLANT PHYSIOL, V166, P1659, DOI 10.1104/pp.114.245787; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Stanford NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079195; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Studer AJ, 2014, PLANT PHYSIOL, V165, P608, DOI 10.1104/pp.114.237602; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Tan Y, 2011, METAB ENG, V13, P60, DOI 10.1016/j.ymben.2010.11.001; Tausta SL, 2014, J EXP BOT, V65, P3543, DOI 10.1093/jxb/eru152; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Urbanczyk-Wochniak E, 2007, BIOINFORMATICS, V23, P1418, DOI 10.1093/bioinformatics/btm040; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; von Caemmerer S., 2000, BIOCH MODELS LEAF PH; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wang L, 2014, NAT BIOTECHNOL, V32, P1158, DOI 10.1038/nbt.3019; Wang Y, 2014, J EXP BOT, V65, P3567, DOI 10.1093/jxb/eru058; Wang Y, 2014, PLANT PHYSIOL, V164, P2231, DOI 10.1104/pp.113.230284; Way DA, 2014, J EXP BOT, V65, P3683, DOI 10.1093/jxb/eru205; Wingler A, 1999, PLANT PHYSIOL, V120, P539, DOI 10.1104/pp.120.2.539; Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763; Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363; Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307	87	26	26	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151722	10.1371/journal.pone.0151722	http://dx.doi.org/10.1371/journal.pone.0151722			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990967	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800091
J	Leventhal, JS; Ni, J; Osmond, M; Lee, K; Gusella, GL; Salem, F; Ross, MJ				Leventhal, Jeremy S.; Ni, Jie; Osmond, Morgan; Lee, Kyung; Gusella, G. Luca; Salem, Fadi; Ross, Michael J.			Autophagy Limits Endotoxemic Acute Kidney Injury and Alters Renal Tubular Epithelial Cell Cytokine Expression	PLOS ONE			English	Article							SEPSIS; MICE; PROTECTS; DISEASE; INACTIVATION; APOPTOSIS; PREVENTS; FAILURE; PLAYS; GENE	Sepsis related acute kidney injury (AKI) is a common in-hospital complication with a dismal prognosis. Our incomplete understanding of disease pathogenesis has prevented the identification of hypothesis-driven preventive or therapeutic interventions. Increasing evidence in ischemia-reperfusion and nephrotoxic mouse models of AKI support the theory that autophagy protects renal tubular epithelial cells (RTEC) from injury. However, the role of RTEC autophagy in septic AKI remains unclear. We observed that lipopolysaccharide (LPS), a mediator of gram-negative bacterial sepsis, induces RTEC autophagy in vivo and in vitro through TLR4-initiated signaling. We modeled septic AKI through intraperitoneal LPS injection in mice in which autophagy-related protein 7 was specifically knocked out in the renal proximal tubules (ATG7KO). Compared to control littermates, ATG7KO mice developed more severe renal dysfunction (24hr BUN 100.1mg/dl +/- 14.8 vs 54.6mg/dl +/- 11.3) and parenchymal injury. After injection with LPS, analysis of kidney lysates identified higher IL-6 expression and increased STAT3 activation in kidney lysates from ATG7KO mice compared to controls. In vitro experiments confirmed an altered response to LPS in RTEC with genetic or pharmacological impairment of autophagy. In conclusion, RTEC autophagy protects against endotoxin induced injury and regulates downstream effects of RTEC TLR4 signaling.	[Leventhal, Jeremy S.; Ni, Jie; Osmond, Morgan; Lee, Kyung; Gusella, G. Luca; Ross, Michael J.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Leventhal, Jeremy S.; Ross, Michael J.] James J Peters Bronx VA Med Ctr, Div Renal, Bronx, NY USA; [Salem, Fadi] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Leventhal, JS (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA.; Leventhal, JS (corresponding author), James J Peters Bronx VA Med Ctr, Div Renal, Bronx, NY USA.	jeremy.leventhal@mssm.edu	Salem, Fadi/AAP-9399-2020; Lee, Kyung/AAD-5009-2021	Salem, Fadi/0000-0002-2603-2778; Lee, Kyung/0000-0002-9756-1765	NIH/NIDDK grant [R01 DK101338, DK108346, K08 DK090217]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108346, R01DK101338, K08DK090217] Funding Source: NIH RePORTER	NIH/NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the NIH/NIDDK grant R01 DK101338 and DK108346 (MR) and an NIH/NIDDK K08 DK090217 grant (JSL).; This research was supported by the NIH/NIDDK grant R01 DK101338 and DK108346 (M.R.) and an NIH/NIDDK K08 DK090217 (J.S.L). Microscopy was performed at the Microscopy CORE at the Icahn School of Medicine at Mount Sinai.	CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Chen P, 2011, J AM SOC NEPHROL, V22, P496, DOI 10.1681/ASN.2010040379; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; El-Achkar TM, 2008, EUR J CLIN INVEST, V38, P39, DOI 10.1111/j.1365-2362.2008.02007.x; Escobar DA, 2015, J SURG RES, V194, P262, DOI 10.1016/j.jss.2014.10.009; Evans RG, 2008, AM J PHYSIOL-RENAL, V295, pF1259, DOI 10.1152/ajprenal.90230.2008; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Hartleben B, 2010, J CLIN INVEST; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Hsiao HW, 2012, SHOCK, V37, P289, DOI 10.1097/SHK.0b013e318240b52a; Jiang M, 2010, AM J PATHOL; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee K, 2015, J AM SOC NEPHROL, V26, P888, DOI 10.1681/ASN.2013111179; Leventhal JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020688; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097985; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nechemia-Arbely Y, 2008, J AM SOC NEPHROL, V19, P1106, DOI 10.1681/ASN.2007070744; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoemaker MH, 2002, J HEPATOL, V36, P742, DOI 10.1016/S0168-8278(02)00063-6; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007	32	27	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150001	10.1371/journal.pone.0150001	http://dx.doi.org/10.1371/journal.pone.0150001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990086	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800023
J	Lim, M; Roosink, M; Kim, JS; Kim, HW; Lee, EB; Son, KM; Kim, HA; Chung, CK				Lim, Manyoel; Roosink, Meyke; Kim, June Sic; Kim, Hye Won; Lee, Eun Bong; Son, Kyeong Min; Kim, Hyun Ah; Chung, Chun Kee			Augmented Pain Processing in Primary and Secondary Somatosensory Cortex in Fibromyalgia: A Magnetoencephalography Study Using Intra-Epidermal Electrical Stimulation	PLOS ONE			English	Article							EVOKED MAGNETIC-FIELDS; 2ND PAIN; TEMPORAL SUMMATION; CORTICAL RESPONSES; CLINICAL PAIN; FUNCTIONAL CONNECTIVITY; CERVICAL RADICULOPATHY; LASER STIMULATION; FIBER STIMULATION; MODULATION	The aim of this study was to investigate augmented pain processing in the cortical somatosensory system in patients with fibromyalgia (FM). Cortical evoked responses were recorded in FM (n = 19) and healthy subjects (n = 21) using magnetoencephalography after noxious intra-epidermal electrical stimulation (IES) of the hand dorsum (pain rating 6 on a numeric rating scale, perceptually-equivalent). In addition, healthy subjects were stimulated using the amplitude corresponding to the average stimulus intensity rated 6 in patients with FM (intensity-equivalent). Quantitative sensory testing was performed on the hand dorsum or thenar muscle (neutral site) and over the trapezius muscle (tender point), using IES (thresholds, ratings, temporal summation of pain, stimulus-response curve) and mechanical stimuli (threshold, ratings). Increased amplitude of cortical responses was found in patients with FM as compared to healthy subjects. These included the contralateral primary (S1) and bilateral secondary somatosensory cortices (S2) in response to intensity-equivalent stimuli and the contralateral S1 and S2 in response to perceptually-equivalent stimuli. The amplitude of the contralateral S2 response in patients with FM was positively correlated with average pain intensity over the last week. Quantitative sensory testing results showed that patients with FM were more sensitive to painful IES as well as to mechanical stimulation, regardless of whether the stimulation site was the hand or the trapezius muscle. Interestingly, the slope of the stimulus-response relationship as well as temporal summation of pain in response to IES was not different between groups. Together, these results suggest that the observed pain augmentation in response to IES in patients with FM could be due to sensitization or disinhibition of the cortical somatosensory system. Since the S2 has been shown to play a role in higher-order functions, further studies are needed to clarify the role of augmented S2 response in clinical characteristics of FM.	[Lim, Manyoel; Roosink, Meyke; Chung, Chun Kee] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Roosink, Meyke] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Kim, Hye Won; Lee, Eun Bong] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul 151, South Korea; [Kim, Hye Won] Eulji Univ, Sch Med, Eulji Gen Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Son, Kyeong Min; Kim, Hyun Ah] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Kim, Hyun Ah] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Anyang, South Korea; [Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea	Seoul National University (SNU); Radboud University Nijmegen; Seoul National University (SNU); Seoul National University (SNU); Eulji University; Hallym University; Hallym University; Seoul National University (SNU); Seoul National University Hospital	Chung, CK (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea.	chungc@snu.ac.kr	Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A2A1A11049662]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2014R1A2A1A11049662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2; Blumenstiel K, 2011, CLIN J PAIN, V27, P682, DOI 10.1097/AJP.0b013e3182177654; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgmer M, 2009, NEUROIMAGE, V44, P502, DOI 10.1016/j.neuroimage.2008.09.008; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caetano G, 2010, CEREB CORTEX, V20, P1898, DOI 10.1093/cercor/bhp260; Choi W, 2015, CLIN NEUROPHYSIOL, V126, P1310, DOI 10.1016/j.clinph.2014.10.012; Cook DB, 2004, J RHEUMATOL, V31, P364; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Fallon N, 2013, CLIN NEUROPHYSIOL, V124, P154, DOI 10.1016/j.clinph.2012.06.014; Forss N, 2005, NEUROIMAGE, V24, P132, DOI 10.1016/j.neuroimage.2004.09.032; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Inui K, 2006, CEREB CORTEX, V16, P355, DOI 10.1093/cercor.bhi114; Inui K, 2003, EUR J NEUROSCI, V18, P2859, DOI 10.1111/j.1460-9568.2003.02995.x; Inui K, 2003, NEUROSCIENCE, V120, P235, DOI 10.1016/S0306-4522(03)00261-6; Inui K, 2002, PAIN, V96, P247, DOI 10.1016/S0304-3959(01)00453-5; Inui K, 2012, J NEUROL NEUROSUR PS, V83, P551, DOI 10.1136/jnnp-2011-301484; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Kim DJ, 2014, ARTHRITIS RHEUMATOL, V66, P3190, DOI 10.1002/art.38771; Kirveskari E, 2015, EUR J PAIN, V19, P1168, DOI 10.1002/ejp.642; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kosek E, 1996, PAIN, V68, P375, DOI 10.1016/S0304-3959(96)03188-0; Lannersten L, 2010, PAIN, V151, P77, DOI 10.1016/j.pain.2010.06.021; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; LAUTENBACHER S, 1994, PAIN, V59, P45, DOI 10.1016/0304-3959(94)90046-9; Lim M, 2015, PAIN, V156, P666, DOI 10.1097/j.pain.0000000000000096; Lim M, 2012, NEUROIMAGE, V61, P660, DOI 10.1016/j.neuroimage.2012.04.003; Lim M, 2011, CLIN NEUROPHYSIOL, V122, P2246, DOI 10.1016/j.clinph.2011.03.001; Lorenz J, 1996, EVOKED POTENTIAL, V100, P165, DOI 10.1016/0013-4694(95)00259-6; Maestu C, 2013, CLIN NEUROPHYSIOL, V124, P752, DOI 10.1016/j.clinph.2012.09.015; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mima T, 1998, J NEUROPHYSIOL, V80, P2215, DOI 10.1152/jn.1998.80.4.2215; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Motogi J, 2014, NEUROSCI LETT, V570, P69, DOI 10.1016/j.neulet.2014.04.001; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Mouraux A, 2014, NEUROSCI LETT, V561, P69, DOI 10.1016/j.neulet.2013.12.017; Nakata H, 2004, PAIN, V107, P91, DOI 10.1016/j.pain.2003.10.001; Nakata H, 2008, NEUROIMAGE, V42, P858, DOI 10.1016/j.neuroimage.2008.05.017; Nakata H, 2009, NEUROREPORT, V20, P1149, DOI 10.1097/WNR.0b013e32832f81d6; Nielsen LA, 2007, BEST PRACT RES CL RH, V21, P465, DOI 10.1016/j.berh.2007.03.007; Ogino Y, 2005, ANESTHESIOLOGY, V103, P821, DOI 10.1097/00000542-200510000-00021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omori S, 2013, CLIN NEUROPHYSIOL, V124, P1422, DOI 10.1016/j.clinph.2013.01.006; Persson AL, 2004, J REHABIL MED, V36, P17, DOI 10.1080/16501970310015218; Petzke F, 2003, PAIN, V105, P403, DOI 10.1016/S0304-3959(03)00204-5; Pfau DB, 2012, CURR PAIN HEADACHE R, P1; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Ploner M, 1999, J NEUROPHYSIOL, V81, P3100, DOI 10.1152/jn.1999.81.6.3100; Pollok B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015804; Potvin S, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/938595; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rhudy JL, 2013, PAIN, V154, P1045, DOI 10.1016/j.pain.2013.03.025; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005; Schweinhardt P, 2008, NEUROSCIENTIST, V14, P415, DOI 10.1177/1073858407312521; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; Serra J, 2014, ANN NEUROL, V75, P196, DOI 10.1002/ana.24065; Staud R, 2003, PAIN, V101, P167, DOI 10.1016/S0304-3959(02)00325-1; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089086; Staud R, 2012, J PAIN, V13, P725, DOI 10.1016/j.jpain.2012.04.006; Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6; Staud R, 2009, RHEUM DIS CLIN N AM, V35, P263, DOI 10.1016/j.rdc.2009.05.006; Tampin B, 2013, EUR J PAIN, V17, P621, DOI 10.1002/j.1532-2149.2012.00227.x; Tampin B, 2012, PAIN, V153, P2403, DOI 10.1016/j.pain.2012.08.007; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Torquati K, 2003, NEUROIMAGE, V20, P1704, DOI 10.1016/S1053-8119(03)00439-7; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Vartiainen NV, 2008, CLIN NEUROPHYSIOL, V119, P2380, DOI 10.1016/j.clinph.2008.06.008; Vierck CJ, 2006, PAIN, V124, P242, DOI 10.1016/j.pain.2006.06.001; Wolfe F, 2012, CLIN EXP RHEUMATOL, V30, pS88	86	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151776	10.1371/journal.pone.0151776	http://dx.doi.org/10.1371/journal.pone.0151776			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992095	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800100
J	Ma, QF; Wu, M; Pei, WF; Wang, XY; Zhai, HH; Wang, WK; Li, XL; Zhang, JF; Yu, JW; Yu, SX				Ma, Qifeng; Wu, Man; Pei, Wenfeng; Wang, Xiaoyan; Zhai, Honghong; Wang, Wenkui; Li, Xingli; Zhang, Jinfa; Yu, Jiwen; Yu, Shuxun			RNA-Seq-Mediated Transcriptome Analysis of a Fiberless Mutant Cotton and Its Possible Origin Based on SNP Markers	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; DISEASE RESISTANCE; IDENTIFICATION; DIVERSITY; EVOLUTION; SEQUENCE; GENES; YIELD; LIGHT	As the longest known single-celled trichomes, cotton (Gossypium L.) fibers constitute a classic model system to investigate cell initiation and elongation. In this study, we used a high-throughput transcriptome sequencing technology to identify fiber-initiation-related single nucleotide polymorphism (SNP) markers and differentially expressed genes (DEGs) between the wild-type (WT) Upland cotton (G. hirsutum) Xuzhou 142 and its natural fuzzless-lintless mutant Xuzhou 142 fl. Approximately 700 million high-quality cDNA reads representing over 58 Gb of sequences were obtained, resulting in the identification of 28,610 SNPs-of which 17,479 were novel-from 13,960 expressed genes. Of these SNPs, 50% of SNPs in fl were identical to those of G. barbadense, which suggests the likely origin of the fl mutant from an interspecific hybridization between Xuzhou 142 and an unknown G. barbadense genotype. Of all detected SNPs, 15,555, 12,750, and 305 were classified as non-synonymous, synonymous, and pre-terminated ones, respectively. Moreover, 1,352 insertion/deletion polymorphisms (InDels) were also detected. A total of 865 DEGs were identified between the WT and fl in ovules at -3 and 0 days post-anthesis, with 302 candidate SNPs selected from these DEGs for validation by a high-resolution melting analysis and Sanger sequencing in seven cotton genotypes. The number of genotypic pairwise polymorphisms varied from 43 to 302, indicating that the identified SNPs are reliable. These SNPs should serve as good resources for breeding and genetic studies in cotton.	[Ma, Qifeng; Wu, Man; Pei, Wenfeng; Zhai, Honghong; Wang, Wenkui; Li, Xingli; Yu, Jiwen; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Wang, Xiaoyan] Anyang Inst Technol, Coll Biol & Food Technol, Anyang, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Anyang Institute of Technology; New Mexico State University	Yu, JW; Yu, SX (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.; Zhang, JF (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	jinzhang@nmsu.edu; yujw666@hotmail.com; yu@cricaas.com.cn			National Natural Science Foundation of China [31301367, 31301368]; National High Technology Research and Development Program of China [2013AA102601-01-14]; New Mexico Agricultural Experiment Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); New Mexico Agricultural Experiment Station	This program was financially supported in part by the National Natural Science Foundation of China (grant No. 31301367 and grant No. 31301368), the National High Technology Research and Development Program of China (grant No. 2013AA102601-01-14), and the New Mexico Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An C, 2008, THEOR APPL GENET, V116, P1015, DOI 10.1007/s00122-008-0732-4; [Anonymous], 2012, GENOME BIOL; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; ENDRIZZI JE, 1980, J HERED, V71, P45, DOI 10.1093/oxfordjournals.jhered.a109309; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hulse-Kemp AM, 2015, G3-GENES GENOM GENET, V4, P1; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu YZ, 2009, CROP SCI, V49, P1695, DOI 10.2135/cropsci2008.12.0693; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Ma QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-466; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Malik W, 2014, SCI WORLD J, V2014; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Nagalakshmi U, CURR PROTO MOL BIOL, V4, P1; Pang MX, 2012, MOL BREEDING, V30, P1143, DOI 10.1007/s11032-012-9702-2; Park JE, 2007, PLANT CELL PHYSIOL, V48, P1236, DOI 10.1093/pcp/pcm086; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rong JK, 2005, THEOR APPL GENET, V111, P1137, DOI 10.1007/s00122-005-0041-0; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Said JI, 2015, MOL GENET GENOMICS, P1; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Schunter C, 2014, MOL ECOL RESOUR, V14, P157, DOI 10.1111/1755-0998.12155; Shan CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6519; Singla B, 2006, J EXP BOT, V57, P4059, DOI 10.1093/jxb/erl182; STEWART JM, 1975, AM J BOT, V62, P723, DOI 10.2307/2442061; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Van Deynze A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-125; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097313; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Yao Y, 2014, PLOS ONE, V10; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Yu J, 2014, NUCLEIC ACIDS RES, V42, pD1229, DOI 10.1093/nar/gkt1064; Zhang JinFa, 2000, Journal of Cotton Science, V4, P193; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 1991, JIANGSU J AGR SCI, V7, P13	48	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151994	10.1371/journal.pone.0151994	http://dx.doi.org/10.1371/journal.pone.0151994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990639	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800128
J	Srivastava, K; Narang, R; Bhatia, J; Saluja, D				Srivastava, Kamna; Narang, Rajiv; Bhatia, Jagriti; Saluja, Daman			Expression of Heat Shock Protein 70 Gene and Its Correlation with Inflammatory Markers in Essential Hypertension	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-PRESSURE VARIABILITY; HEAT-SHOCK PROTEINS; ESTABLISHED HYPERTENSION; MOLECULAR CHAPERONES; ADHESION MOLECULES; IN-VITRO; STRESS; CELLS; RISK	Objectives Hypertension is characterized by systemic high blood pressure and is the most common and important risk factor for the development of cardiovascular diseases. Studies have shown that the circulating levels of certain inflammatorymarkers such as tumor necrosis factor-alpha (TNF-alpha), interlukin-6 (IL-6), c-reactive protein (CRP), and tumor suppressor protein-53 (p53) are upregulated and are independently associated with essential hypertension. However, mechanism of increase in the levels of HSP70 protein is not clear. No such studies are reported in the blood circulation of patients with essential hypertension. In the present study, we investigated the expression of circulating HSP70 at mRNA and protein levels and its relationship with other inflammatory markers in patients with essential hypertension. Materials and Methods We recruited 132 patients with essential hypertension and 132 normal controls from similar socio-economic-geographical background. The expression of HSP70 at mRNA levels was determined by Real Time PCR and at protein levels by indirect Elisa and Western Blot techniques. Results We found a significantly higher expression of HSP70 gene expression (approximately 6.45 fold, P < 0.0001) in hypertensive patients as compared to healthy controls. A significant difference (P < 0.0001) in the protein expression of HSP70 was also observed in plasma of patients as compared to that of controls. Conclusion Higher expression of HSP70 is positively correlated with inflammatory markers in patients with essential hypertension and this correlation could play an important role in essential hypertension.	[Srivastava, Kamna; Saluja, Daman] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Narang, Rajiv] All India Inst Med Sci, Dept Cardiol, New Delhi 110029, India; [Bhatia, Jagriti] All India Inst Med Sci, Dept Pharmacol, New Delhi 110029, India	University of Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Srivastava, K (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	kamna605@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Srivastava, Kamna/0000-0003-4318-9483	Department of Science and Technology, India [SR/WOS-A/LS-29/2012(G)]	Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by the financial grant [SR/WOS-A/LS-29/2012(G)] from the Department of Science and Technology, India to Dr. Kamna Srivastava. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2006, AM J CARDIOL, V98, P649, DOI 10.1016/j.amjcard.2006.03.045; Anand MP, 2010, INDIAN HEART J, V62, P378; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bassan M, 1998, NEUROSCI LETT, V250, P37, DOI 10.1016/S0304-3940(98)00428-5; Bautista LE, 2005, J HUM HYPERTENS, V19, P149, DOI 10.1038/sj.jhh.1001785; Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; BLAKE MJ, 1990, MOL BRAIN RES, V8, P89, DOI 10.1016/0169-328X(90)90014-5; Bolla MK, 1998, DIS MARKERS, V13, P227, DOI 10.1155/1998/235151; BOMFIM GF, 2011, ENDOCRINOL METABOL S, V2, P117; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; CHILD DF, 1995, DIABETIC MED, V12, P595, DOI 10.1111/j.1464-5491.1995.tb00548.x; Favatier F, 1997, CELL STRESS CHAPERON, V2, P141, DOI 10.1379/1466-1268(1997)002<0141:VIHGEA>2.3.CO;2; GOWER DJ, 1989, J NEUROSURG, V70, P605, DOI 10.3171/jns.1989.70.4.0605; Helmbrecht K, 2000, CELL PROLIFERAT, V33, P341, DOI 10.1046/j.1365-2184.2000.00189.x; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Jastrzebski Marek, 2006, Kardiol Pol, V64, P802; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Jimenez MC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002073; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kim KI, 2008, CIRC J, V72, P293, DOI 10.1253/circj.72.293; Krause M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/249205; KUNES J, 1992, ACTA PHYSIOL SCAND, V146, P307, DOI 10.1111/j.1748-1716.1992.tb09424.x; Li JX, 2009, CELL STRESS CHAPERON, V14, P355, DOI 10.1007/s12192-008-0089-2; Madec S, 2010, J HYPERTENS, V28, P1459, DOI 10.1097/HJH.0b013e3283388871; Miller MA, 2004, J HYPERTENS, V22, P705, DOI 10.1097/00004872-200404000-00012; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Mohan S, 2013, INDIAN J MED RES, V137, P627; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Pauletto P, 2006, NEPHROL DIAL TRANSPL, V21, P850, DOI 10.1093/ndt/gfl019; Pockley AG, 2009, CELL STRESS CHAPERON, V14, P545, DOI 10.1007/s12192-009-0113-1; Pockley AG, 2002, J HYPERTENS, V20, P1815, DOI 10.1097/00004872-200209000-00027; Pockley AG, 2003, HYPERTENSION, V42, P235, DOI 10.1161/01.HYP.0000086522.13672.23; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Savoia C, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001815; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; Srivastava K, 2006, J HUM HYPERTENS, V20, P537, DOI 10.1038/sj.jhh.1002034; Stefanadi E, 2010, CURR VASC PHARMACOL, V8, P509, DOI 10.2174/157016110791330870; Stumpf C, 2005, J HYPERTENS, V23, P995, DOI 10.1097/01.hjh.0000166840.63312.12; Tanaka F, 2010, AM J HYPERTENS, V23, P1108, DOI 10.1038/ajh.2010.134; Tran LT, 2009, MOL CELL BIOCHEM, V330, P219, DOI 10.1007/s11010-009-0136-z; Tsounis D, 2014, MED CHEM, V10, P672, DOI 10.2174/1573406410666140318111328; Vargas-Alarcon G, 2002, ANN RHEUM DIS, V61, P48, DOI 10.1136/ard.61.1.48; VASS K, 1988, ACTA NEUROPATHOL, V77, P128; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang CH, 2003, CIRCULATION, V107, P1783, DOI 10.1161/01.CIR.0000061916.95736.E5; WELCH WJ, 1993, PHILOS T ROY SOC B, V339, P327, DOI 10.1098/rstb.1993.0031; Woods A, 2000, EUR HEART J, V21, P1574, DOI 10.1053/euhj.1999.2207; XU QB, 1995, CIRCULATION, V92, P1223, DOI 10.1161/01.CIR.92.5.1223	51	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151060	10.1371/journal.pone.0151060	http://dx.doi.org/10.1371/journal.pone.0151060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989902	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800042
J	Zhu, H; Behr, B; Reddy, VV; Hughes, M; Pan, YQ; Baker, J				Zhu, Hui; Behr, Barry; Reddy, Vikrant V.; Hughes, Mark; Pan, Yuqiong; Baker, Julie			Human Embryonic Stem Cell Lines with Lesions in FOXP3 and NF1	PLOS ONE			English	Article							ENTEROPATHY; GENE; POLYENDOCRINOPATHY; OLIGODENDROCYTES; DIFFERENTIATION; GENERATION; DERIVATION; MYELINATE; PROTEIN; IPEX	Human embryonic stem cells (hESCs) are derived from the inner cell mass (ICM) of blastocyst staged embryos. Spare blastocyst staged embryos were obtained by in vitro fertilization (IVF) and donated for research purposes. hESCs carrying specific mutations can be used as a powerful cell system in modeling human genetic disorders. We obtained preimplantation genetic diagnosed (PGD) blastocyst staged embryos with genetic mutations that cause human disorders and derived hESCs from these embryos. We applied laser assisted micromanipulation to isolate the inner cell mass from the blastocysts and plated the ICM onto the mouse embryonic fibroblast cells. Two hESC lines with lesions in FOXP3 and NF1 were established. Both lines maintain a typical undifferentiated hESCs phenotype and present a normal karyotype. The two lines express a panel of pluripotency markers and have the potential to differentiate to the three germ layers in vitro and in vivo. The hESC lines with lesions in FOXP3 and NF1 are available for the scientific community and may serve as an important resource for research into these disease states.	[Zhu, Hui; Baker, Julie] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Behr, Barry; Reddy, Vikrant V.] Lucile Packard Childrens Hosp, Stanford Fertil & Reprod Hlth, Stanford IVF Lab, Palo Alto, CA 94304 USA; [Behr, Barry] Stanford Univ, Sch Med, Dept Obstet Gynecol, Stanford, CA 94305 USA; [Hughes, Mark] Genesis Genet Inst, Plymouth, MI 48170 USA; [Pan, Yuqiong] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University	Baker, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jbaker@stanford.edu			California Institute of Regenerative Medicine [RL1-00630-1]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This work was supported by the California Institute of Regenerative Medicine: Grant number RL1-00630-1, https://www.cirm.ca.gov/node/6722/review. JB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the California Institute of Regenerative Medicine: Grant number RL1-00630-1.	Ben-Yosef D, 2008, MOL CELL ENDOCRINOL, V282, P153, DOI 10.1016/j.mce.2007.11.010; Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chronopoulou E, 2015, HUM REPROD UPDATE, V21, P39, DOI 10.1093/humupd/dmu040; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Ferner Rosalie E, 2010, Pract Neurol, V10, P82, DOI 10.1136/jnnp.2010.206532; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Musunuru K, 2013, DIS MODEL MECH, V6, P896, DOI 10.1242/dmm.012054; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turetsky T, 2008, HUM REPROD, V23, P46, DOI 10.1093/humrep/dem351; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	27	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151836	10.1371/journal.pone.0151836	http://dx.doi.org/10.1371/journal.pone.0151836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990425	Green Published, gold			2022-12-27	WOS:000372582800106
J	Bonaterra, GA; Then, H; Oezel, L; Schwarzbach, H; Ocker, M; Thieme, K; Di Fazio, P; Kinscherf, R				Bonaterra, Gabriel Alejandro; Then, Hanna; Oezel, Lisa; Schwarzbach, Hans; Ocker, Matthias; Thieme, Kati; Di Fazio, Pietro; Kinscherf, Ralf			Morphological Alterations in Gastrocnemius and Soleus Muscles in Male and Female Mice in a Fibromyalgia Model	PLOS ONE			English	Article							EXPERIMENTAL MOUSE MODEL; STRESS; HYPERALGESIA; INFLAMMATION; ANALGESIA; BREAKDOWN; ATROPHY; PAIN	Background Fibromyalgia (FM) is a chronic musculoskeletal pain disorder, characterized by chronic widespread pain and bodily tenderness and is often accompanied by affective disturbances, however often with unknown etiology. According to recent reports, physical and psychological stress trigger FM. To develop new treatments for FM, experimental animal models for FM are needed to be development and characterized. Using a mouse model for FM including intermittent cold stress (ICS), we hypothesized that ICS leads to morphological alterations in skeletal muscles in mice. Methods Male and female ICS mice were kept under alternating temperature (4 degrees C/room temperature [22 degrees C]); mice constantly kept at room temperature served as control. After scarification, gastrocnemius and soleus muscles were removed and snap-frozen in liquid nitrogen-cooled isopentane or fixed for electron microscopy. Results In gastrocnemius/soleus muscles of male ICS mice, we found a 21.6% and 33.2% decrease of fiber cross sectional area (FCSA), which in soleus muscle concerns the loss of type IIa and IIx FCSA. This phenomenon was not seen in muscles of female ICS mice. However, this loss in male ICS mice was associated with an increase in gastrocnemius of the density of MIF+ (8.6%)-, MuRF(+) (14.7%)-, Fbxo32(+) (17.8%)-cells, a 12.1% loss of capillary contacts/muscle fiber as well as a 30.7% increase of damaged mitochondria in comparison with male control mice. Moreover, significant positive correlations exist among densities (n/mm(2)) of MIF+, MuRF(+), Fbxo32(+)-cells in gastrocnemius/soleus muscles of male ICS mice; these cell densities inversely correlate with FCSA especially in gastrocnemius muscle of male ICS mice. Conclusion The ICS-induced decrease of FCSA mainly concerns gastrocnemius muscle of male mice due to an increase of inflammatory and atrogenic cells. In soleus muscle of male ICS and soleus/gastrocnemius muscles of female ICS mice morphological alterations seem to occur not at all or delayed. The sex-specificity of findings, which is not easily reconciled with the epidemiology of FM (female predominance), implicate that gastrocnemius muscle of male ICS mice should preferentially be used for future investigations with FM. Moreover, we suggest to investigate morphological and/or molecular alterations at different time-points (up to two weeks) after ICS.	[Bonaterra, Gabriel Alejandro; Then, Hanna; Schwarzbach, Hans; Kinscherf, Ralf] Univ Marburg, Dept Med Cell Biol, Anat & Cell Biol, Marburg, Hessen, Germany; [Oezel, Lisa; Ocker, Matthias; Di Fazio, Pietro] Univ Marburg, Inst Surg Res, Marburg, Hessen, Germany; [Thieme, Kati] Univ Marburg, Inst Med Psychol, Marburg, Hessen, Germany; [Ocker, Matthias] Bayer Pharma AG, Expt Med Oncol, Berlin, Germany; [Di Fazio, Pietro] Univ Marburg, Dept Visceral Thorac & Vasc Surg, Marburg, Hessen, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Bayer AG; Bayer Healthcare Pharmaceuticals; Philipps University Marburg	Bonaterra, GA (corresponding author), Univ Marburg, Dept Med Cell Biol, Anat & Cell Biol, Marburg, Hessen, Germany.	gabriel.bonaterra@staff.uni-marburg.de	Di Fazio, Pietro/ABC-1524-2020; Di Fazio, Pietro/AAU-4575-2020; Kinscherf, Ralf/AAV-7164-2021	Di Fazio, Pietro/0000-0003-0091-8498; Ocker, Matthias/0000-0001-8263-6288				Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Attaix Didier, 2003, P219, DOI 10.1079/9780851996790.0219; Bazzichi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-36; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Brown AS, 2008, J NEUROIMMUNOL, V205, P25, DOI 10.1016/j.jneuroim.2008.08.005; Cordero MD, 2014, ANTIOXID REDOX SIGN, V20, P1169, DOI 10.1089/ars.2013.5198; Cordero MD, 2013, ANTIOXID REDOX SIGN, V18, P800, DOI 10.1089/ars.2012.4892; Cordero Mario D, 2011, PLoS One, V6, pe26915, DOI 10.1371/journal.pone.0026915; Friedmann-Bette B, 2010, EUR J APPL PHYSIOL, V108, P821, DOI 10.1007/s00421-009-1292-2; Gerdle B, 2013, EUR J PAIN, V17, P1205, DOI 10.1002/j.1532-2149.2013.00284.x; KALYANRAMAN UP, 1984, J RHEUMATOL, V11, P808; Khasar SG, 2003, J PAIN, V4, P278, DOI 10.1016/S1526-5900(03)00631-X; KITA T, 1979, JPN J PHARMACOL, V29, P479, DOI 10.1254/jjp.29.479; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Le Goff P, 2006, JOINT BONE SPINE, V73, P239, DOI 10.1016/j.jbspin.2005.03.022; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; LUND N, 1986, SCAND J RHEUMATOL, V15, P165, DOI 10.3109/03009748609102084; Manfredi LH, 2013, J APPL PHYSIOL, V115, P1496, DOI 10.1152/japplphysiol.00474.2013; Montserrat-de La Paz S, 2015, MOD RHEUMATOL, V25, P116, DOI 10.3109/14397595.2014.924194; Nasu T, 2010, EUR J PAIN, V14, P236, DOI 10.1016/j.ejpain.2009.05.009; Nishiyori M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-69; Nishiyori M, 2010, NEUROSCI LETT, V472, P184, DOI 10.1016/j.neulet.2010.01.080; Nishiyori M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-52; OHARA H, 1991, JPN J PHARMACOL, V57, P243, DOI 10.1254/jjp.57.243; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Pongratz D, 2001, FORTSCHR NEUROL PSYC, V69, P189, DOI 10.1055/s-2001-12677; Schmelzer C, 2008, BIOFACTORS, V32, P179, DOI 10.1002/biof.5520320121; Sprott H, 2004, ANN RHEUM DIS, V63, P245, DOI 10.1136/ard.2002.004762; Srikuea R, 2013, ARTHRITIS RHEUM-US, V65, P519, DOI 10.1002/art.37763; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Wallace DJ, 2001, RHEUMATOLOGY, V40, P743, DOI 10.1093/rheumatology/40.7.743; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; YUNUS MB, 1986, AM J MED, V81, P38, DOI 10.1016/0002-9343(86)90872-7	35	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151116	10.1371/journal.pone.0151116	http://dx.doi.org/10.1371/journal.pone.0151116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986947	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300047
J	Heckman, MG; Robinson, JL; Tzou, KS; Parker, AS; Wu, KJ; Hilton, TW; Howat, WJ; Miller, JL; Kreinest, PA; Pisansky, TM; Schild, SE; Peterson, JL; Vallow, LA; Carroll, JS; Buskirk, SJ				Heckman, Michael G.; Robinson, Jessica L.; Tzou, Katherine S.; Parker, Alexander S.; Wu, Kevin J.; Hilton, Tracy W.; Howat, William J.; Miller, Jodi L.; Kreinest, Pamela A.; Pisansky, Thomas M.; Schild, Steven E.; Peterson, Jennifer L.; Vallow, Laura A.; Carroll, Jason S.; Buskirk, Steven J.			An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; ANDROGEN RECEPTOR; RADIOTHERAPY; TRANSCRIPTION; PROGRESSION; METASTASIS; VALIDATION; CHROMATIN; ANTIGEN; DEATH	Background Standardly collected clinical and pathological patient information has demonstrated only moderate ability to predict risk of biochemical recurrence (BCR) of prostate cancer in men undergoing salvage radiation therapy (SRT) for a rising PSA after radical prostatectomy (RP). Although elevated FOXA1 staining has been associated with poor patient outcomes following RP, it has not been studied in the specific setting of SRT after RP. The aim of this study was to evaluate the association between FOXA1 staining level and BCR after SRT for recurrent prostate cancer. Methods A total of 141 men who underwent SRT at our institution were included. FOXA1 staining levels in primary tumor samples were detected using immunohistochemistry. FOXA1 staining percentage and intensity were measured and multiplied together to obtain a FOXA1 H-score (range 0-12) which was our primary staining measure. P-values <= 0.0056 were considered as statistically significant after applying a Bonferroni correction for multiple comparisons. Results There was not a significant association between FOXA1 H-score and risk of BCR when considering H-score as an ordinal variable or as a categorical variable (all P >= 0.090). Similarly, no significant associations with BCR were observed for FOXA1 staining percentage or staining intensity (all P >= 0.14). Conclusions FOXA1 staining level does not appear to have a major impact on risk of BCR after SRT.	[Heckman, Michael G.; Parker, Alexander S.; Hilton, Tracy W.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Robinson, Jessica L.; Howat, William J.; Miller, Jodi L.; Carroll, Jason S.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Tzou, Katherine S.; Peterson, Jennifer L.; Vallow, Laura A.; Buskirk, Steven J.] Mayo Clin, Dept Radiat Oncol, Jacksonville, FL 32224 USA; [Wu, Kevin J.] Mayo Clin, Dept Pathol, Jacksonville, FL 32224 USA; [Kreinest, Pamela A.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Pisansky, Thomas M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Schild, Steven E.] Mayo Clin, Dept Radiat Oncol, Scottsdale, AZ USA	Mayo Clinic; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Heckman, MG (corresponding author), Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA.	heckman.michael@mayo.edu		Carroll, Jason/0000-0003-3643-0080	Cancer Research UK; Cancer Research UK [22310, 20411] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	JSC has funding from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Imamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042456; Jackson W, 2013, CANCER-AM CANCER SOC, V119, P3287, DOI 10.1002/cncr.28215; Jain RK, 2011, HISTOPATHOLOGY, V58, P766, DOI 10.1111/j.1365-2559.2011.03796.x; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Johnson S, 2014, PRACT RADIAT ONCOL, V4, P422, DOI 10.1016/j.prro.2014.02.003; Katz MS, 2003, J CLIN ONCOL, V21, P483, DOI 10.1200/JCO.2003.12.043; Lee R, BJU INT IN PRESS; Leventis AK, 2001, J CLIN ONCOL, V19, P1030, DOI 10.1200/JCO.2001.19.4.1030; Moreira DM, 2009, BJU INT, V104, P1452, DOI 10.1111/j.1464-410X.2009.08623.x; Patel AR, 2011, NAT REV UROL, V8, P385, DOI 10.1038/nrurol.2011.80; Robinson JLL, 2014, ONCOGENE, V33, P5666, DOI 10.1038/onc.2013.508; Robinson Jessica L L, 2012, Front Endocrinol (Lausanne), V3, P68, DOI 10.3389/fendo.2012.00068; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Sunkel B, NUCL ACIDS IN PRESS; Swanson GP, 2011, INT J RADIAT ONCOL, V80, P62, DOI 10.1016/j.ijrobp.2010.01.043; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006	23	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151785	10.1371/journal.pone.0151785	http://dx.doi.org/10.1371/journal.pone.0151785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986977	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300131
J	Park, JB				Park, Jae B.			Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor	PLOS ONE			English	Article							PROSTATE-CANCER; CRYSTAL-STRUCTURE; CONSUMPTION; RISK; ACETYLATION; MECHANISM; BETA; TAU	Recent studies suggest that Sirt inhibition may have beneficial effects on several human diseases such as neurodegenerative diseases and cancer. Coffee is one of most popular beverages with several positive health effects. Therefore, in this paper, potential Sirt inhibitors were screened using coffee extract. First, HPLC was utilized to fractionate coffee extract, then screened using a Sirt1/2 inhibition assay. The screening led to the isolation of a potent Sirt1/2 inhibitor, whose structure was determined as javamide-II (N-caffeoyltryptophan) by NMR. For confirmation, the amide was chemically synthesized and its capacity of inhibiting Sirt1/2 was also compared with the isolated amide. Javamide-II inhibited Sirt2 (IC50; 8.7 mu M) better than Sirt1(IC50; 34 mu M). Since javamide-II is a stronger inhibitor for Sirt2 than Sirt1. The kinetic study was performed against Sirt2. The amide exhibited noncompetitive Sirt2 inhibition against the NAD(+) (K-i = 9.8 mu M) and showed competitive inhibition against the peptide substrate (K-i = 5.3 mu M). Also, a docking simulation showed stronger binding pose of javamide-II to Sirt2 than AGK2. In cellular levels, javamide-II was able to increase the acetylation of total lysine, cortactin and histone H3 in neuronal NG108-15 cells. In the same cells, the amide also increased the acetylation of lysine (K382) in p53, but not (K305). This study suggests that Javamide-II found in coffee may be a potent Sirt1/2 inhibitor, probably with potential use in some conditions of human diseases.	[Park, Jae B.] ARS, Diet Genom & Immunol Lab, BHNRC, USDA, Bldg 307C,Rm 131, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Park, JB (corresponding author), ARS, Diet Genom & Immunol Lab, BHNRC, USDA, Bldg 307C,Rm 131, Beltsville, MD 20705 USA.	jae.park@ars.usda.gov			ARS/USDA grant [8040-51000-057-00]	ARS/USDA grant	This study was supported by an ARS/USDA grant (project number 8040-51000-057-00). The funder had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Alonso-Salces RM, 2009, J AGR FOOD CHEM, V57, P4224, DOI 10.1021/jf8037117; Arendash GW, 2010, J ALZHEIMERS DIS, V20, pS117, DOI 10.3233/JAD-2010-091249; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002; CHARRIER A, 1985, COFFEE BOT BIOCH PRO; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Dai H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8645; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Davenport AM, 2014, J MOL BIOL, V426, P526, DOI 10.1016/j.jmb.2013.10.009; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Goate A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P341; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hou HL, 2012, J CLIN PATHOL, V65, P1088, DOI 10.1136/jclinpath-2012-200940; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Liu H, 2015, NUTR CANCER, V67, P392, DOI 10.1080/01635581.2015.1004727; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Moniot S, 2013, J STRUCT BIOL, V182, P136, DOI 10.1016/j.jsb.2013.02.012; Musiek Erik S, 2013, Mo Med, V110, P395; O'Keefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Park JB, 2012, NAT PROD RES, V26, P1465, DOI 10.1080/14786419.2011.562207; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Reitz C, 2012, BIOCHEM PHARMACOL, V88, P640; Rumpf T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7263; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Tatum PR, 2014, BIOORG MED CHEM LETT, V24, P1871, DOI 10.1016/j.bmcl.2014.03.026; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tverdal A, 2015, BRIT J CANCER, V112, P576, DOI 10.1038/bjc.2014.645; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Yamagata K, 2014, STRUCTURE, V22, P345, DOI 10.1016/j.str.2013.12.001; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y	45	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150392	10.1371/journal.pone.0150392	http://dx.doi.org/10.1371/journal.pone.0150392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986569	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300020
J	Ratzinger, F; Tsirkinidou, I; Haslacher, H; Perkmann, T; Schmetterer, KG; Mitteregger, D; Makristathis, A; Burgmann, H				Ratzinger, Franz; Tsirkinidou, Irene; Haslacher, Helmuth; Perkmann, Thomas; Schmetterer, Klaus G.; Mitteregger, Dieter; Makristathis, Athanasios; Burgmann, Heinz			Evaluation of the Septifast M-Grade Test on Standard Care Wards-A Cohort Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; BLOOD-STREAM PATHOGENS; MOLECULAR-DETECTION; RAPID DETECTION; ANTIMICROBIAL TREATMENT; LIGHTCYCLER SEPTIFAST; SERUM PROCALCITONIN; SUSPECTED SEPSIS; PROGNOSTIC VALUE	Background The immediate need for appropriate antimicrobial therapy in septic patients requires the detection of the causative pathogen in a timely and reliable manner. In this study, the realtime PCR Septifast M-Grade test was evaluated in adult patients meeting the systemic inflammatory response syndrome (SIRS) criteria that were treated at standard care wards. Methods Patients with clinical suspected infection, drawn blood cultures (BC), the Septifast M-Grade test (SF) and sepsis biomarkers were prospectively screened for fulfillment of SIRS criteria and evaluated using the criteria of the European Centre of Disease Control (ECDC) for infection point prevalence studies. Results In total, 220 patients with SIRS were prospectively enrolled, including 56 patients with detection of bacteria in the blood (incidence: 25.5%). BC analysis resulted in 75.0% sensitivity (95% confidence interval, CI: 61.6%-85.6%) with 97.6% specificity (CI: 93.9%-99.3%) for detecting bacteria in the blood. In comparison to BC, SF presented with 80.4% sensitivity (CI: 67.6%-89.8%) and with 97.6% specificity (CI: 93.9%-99.3%). BC and SF analysis yielded comparable ROC-AUCs (0.86, 0.89), which did not differ significantly (p = 0.558). A trend of a shorter time-to-positivity of BC analysis was not seen in bacteremic patients with a positive SF test than those with a negative test result. Sepsis biomarkers, including PCT, IL-6 or CRP, did not help to explain discordant test results for BC and SF. Conclusion Since negative results do not exclude bacteremia, the Septifast M-Grade test is not suited to replacing BC, but it is a valuable tool with which to complement BC for faster detection of pathogens.	[Ratzinger, Franz; Haslacher, Helmuth; Perkmann, Thomas; Schmetterer, Klaus G.] Med Univ Vienna, Div Med & Chem Lab Diagnost, Dept Lab Med, Vienna, Austria; [Tsirkinidou, Irene; Burgmann, Heinz] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Mitteregger, Dieter; Makristathis, Athanasios] Med Univ Vienna, Div Clin Microbiol, Dept Lab Med, Vienna, Austria; [Mitteregger, Dieter] Grp Practice Labors, Div Microbiol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Burgmann, H (corresponding author), Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013; Perkmann, Thomas/F-3074-2012	Haslacher, Helmuth/0000-0003-4605-2503; Ratzinger, Franz/0000-0002-1910-1018; Burgmann, Heinz/0000-0002-2114-0999; Perkmann, Thomas/0000-0002-7976-0285				Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; [Anonymous], 2012, POINT PREV SURV HEAL; Ataoglu HE, 2010, J INT MED RES, V38, P52, DOI 10.1177/147323001003800106; Avolio M, 2014, SHOCK, V42, P86, DOI 10.1097/SHK.0000000000000191; Avolio M, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181d49299; Bacconi A, 2014, J CLIN MICROBIOL, V52, P3164, DOI 10.1128/JCM.00801-14; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; Charles PE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-38; Chuang YC, 2012, CRIT CARE MED, V40, P2273, DOI 10.1097/CCM.0b013e3182515190; Conti G, 2005, J NEPHROL, V18, P282; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Grif K, 2012, WIEN KLIN WOCHENSCHR, V124, P266, DOI 10.1007/s00508-012-0159-4; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hanon FX, 2002, SCAND J INFECT DIS, V34, P520, DOI 10.1080/00365540110080827; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Idelevich E, 2015, MED MICROBIOL IMMUN, V204, P585, DOI 10.1007/s00430-014-0385-7; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7; Leli C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/701480; Leli C, 2014, SCAND J INFECT DIS, V46, P745, DOI 10.3109/00365548.2014.936493; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lodes U, 2009, ZBL CHIR, V134, P249, DOI 10.1055/s-0028-1098776; Machens A, 2014, J CLIN ENDOCR METAB, V99, P2986, DOI 10.1210/jc.2014-1278; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Mauro MV, 2012, DIAGN MICR INFEC DIS, V73, P308, DOI 10.1016/j.diagmicrobio.2012.04.006; Mencacci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053279; Molter GP, 2003, ANAESTHESIST, V52, P210, DOI 10.1007/s00101-003-0460-8; Pasqualini L, 2012, J CLIN MICROBIOL, V50, P1285, DOI 10.1128/JCM.06793-11; Patout M, 2014, CLIN BIOCHEM, V47, P263, DOI 10.1016/j.clinbiochem.2014.09.002; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Ratzinger F, 2015, INFECTION; Ratzinger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082946; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Sulyok I, 2012, BRIT J ANAESTH, V109, P754, DOI 10.1093/bja/aes248; Tafelski S, 2015, J INT MED RES, V43, P364, DOI 10.1177/0300060514561135; Tschaikowsky K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023615; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Willems E, 2012, DIAGN MICR INFEC DIS, V73, P1, DOI 10.1016/j.diagmicrobio.2012.01.009; Yanagihara K, 2010, CRIT CARE, V14, DOI 10.1186/cc9234; Yu CW, 2013, AM J EMERG MED, V31, P935, DOI 10.1016/j.ajem.2013.03.008	49	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151108	10.1371/journal.pone.0151108	http://dx.doi.org/10.1371/journal.pone.0151108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986826	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300046
J	Kasanova, Z; Hernaus, D; Vaessen, T; Van Amelsvoort, T; Winz, O; Heinzel, A; Pruessner, J; Mottaghy, FM; Collip, D; Myin-Germeys, I				Kasanova, Zuzana; Hernaus, Dennis; Vaessen, Thomas; Van Amelsvoort, Therese; Winz, Oliver; Heinzel, Alexander; Pruessner, Jens; Mottaghy, Felix M.; Collip, Dina; Myin-Germeys, Inez			Early-Life Stress Affects Stress-Related Prefrontal Dopamine Activity in Healthy Adults, but Not in Individuals with Psychotic Disorder	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; POSITRON-EMISSION-TOMOGRAPHY; ABUSE QUESTIONNAIRE CECA.Q; CHILDHOOD TRAUMA; RELEASE; SCHIZOPHRENIA; CORTEX; RISK; STRIATUM; EXPERIENCE	Early life stress may have a lasting impact on the developmental programming of the dopamine (DA) system implicated in psychosis. Early adversity could promote resilience by calibrating the prefrontal stress-regulatory dopaminergic neurotransmission to improve the individual's fit with the predicted stressful environment. Aberrant reactivity to such match between proximal and distal environments may, however, enhance psychosis disease risk. We explored the combined effects of childhood adversity and adult stress by exposing 12 unmedicated individuals with a diagnosis of non-affective psychotic disorder (NAPD) and 12 healthy controls (HC) to psychosocial stress during an [F-18]fallypride positron emission tomography. Childhood trauma divided into early (ages 0-11 years) and late (12-18 years) was assessed retrospectively using a questionnaire. A significant group x childhood trauma interaction on the spatial extent of stress-related [18F] fallypride displacement was observed in the mPFC for early (b=-8.45, t(1,23) = -3.35, p=.004) and late childhood trauma (b=7.86, t(1,23) = -2.48, p=.023). In healthy individuals, the spatial extent of mPFC DA activity under acute psychosocial stress was positively associated with the severity of early (b=7.23, t(11) = 3.06, p=.016) as well as late childhood trauma (b=-7.86, t(1,23) = -2.48, p=.023). Additionally, a trend-level main effect of early childhood trauma on subjective stress response emerged within this group (b=-.7, t(11) = -2, p=.07), where higher early trauma correlated with lower subjective stress response to the task. In the NAPD group, childhood trauma was not associated with the spatial extent of the tracer displacement in mPFC (b=-1.22, t(11) = -0.67), nor was there a main effect of trauma on the subjective perception of stress within this group (b=.004, t(11) = .01, p=.99). These findings reveal a potential mechanism of neuroadaptation of prefrontal DA transmission to early life stress and suggest its role in resilience and vulnerability to psychosis.	[Kasanova, Zuzana; Vaessen, Thomas; Van Amelsvoort, Therese; Myin-Germeys, Inez] KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium; [Hernaus, Dennis; Collip, Dina] Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands; [Van Amelsvoort, Therese] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Winz, Oliver; Heinzel, Alexander; Mottaghy, Felix M.] Univ Hosp RWTH Aachen Univ, Dept Nucl Med, Aachen, Germany; [Pruessner, Jens] McGill Univ, Dept Psychiat, Douglas Mental Hlth Inst, Montreal, PQ, Canada; [Mottaghy, Felix M.] Maastricht Univ Hosp, Dept Nucl Med, Maastricht, Netherlands	KU Leuven; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; RWTH Aachen University; RWTH Aachen University Hospital; McGill University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kasanova, Z (corresponding author), KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium.	zuzana.kasanova@kuleuven.be	Myin Germeys, Inez/HIR-3364-2022; Myin-Germeys, Inez/L-5106-2014; Heinzel, Alexander/G-7725-2017; Mottaghy, Felix/AAU-2673-2020	Myin Germeys, Inez/0000-0002-3731-4930; Heinzel, Alexander/0000-0002-2430-4557; Mottaghy, Felix/0000-0002-7212-6521; Vaessen, Thomas/0000-0002-9300-3117; Kasanova, Zuzana/0000-0002-8795-5373; Hernaus, Dennis/0000-0002-8370-5756; Pruessner, Jens/0000-0002-8582-2980	ERC [309767 - INTERACT]; Maastricht University; Network of European Neuroscience Schools	ERC(European Research Council (ERC)European Commission); Maastricht University; Network of European Neuroscience Schools	This study was supported by an ERC consolidator grant to Inez Myin-Germeys (ERC-2012-StG, project 309767 - INTERACT). Dina Collip and Zuzana Kasanova were supported by a Maastricht University post-doc and pre-doc Kootstra fellowship, respectively. Dennis Hernaus was funded by the Network of European Neuroscience Schools. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Badgaiyan RD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00125; Bet PM, 2009, AM J MED GENET B, V150B, P660, DOI 10.1002/ajmg.b.30886; Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Butts KA, 2011, P NATL ACAD SCI USA, V108, P18459, DOI 10.1073/pnas.1111746108; Cansino S, 2009, INT J PSYCHOPHYSIOL, V71, P64, DOI 10.1016/j.ijpsycho.2008.07.005; Ceccarini J, 2012, J NUCL MED, V53, P1565, DOI 10.2967/jnumed.111.099416; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008; Eacott MJ, 1999, MEMORY, V7, P279, DOI 10.1080/096582199387922; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Green MJ, 2014, J PSYCHIATR RES, V49, P43, DOI 10.1016/j.jpsychires.2013.10.018; Grunder G, 2003, J NUCL MED, V44, P109; Hermans EJ, 2014, TRENDS NEUROSCI, V37, P304, DOI 10.1016/j.tins.2014.03.006; Hernaus D., 2015, TRANSLATIONAL PSYCHI; Hernaus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065662; Holtzman CW, 2013, NEUROSCIENCE, V249, P172, DOI 10.1016/j.neuroscience.2012.12.017; Horga G, 2014, JAMA PSYCHIAT, V71, P489, DOI 10.1001/jamapsychiatry.2014.191; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x; KEEFE KA, 1990, BRAIN RES, V527, P350, DOI 10.1016/0006-8993(90)91158-D; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Latagliata EC, 2014, PSYCHOPHARMACOLOGY, V231, P4099, DOI 10.1007/s00213-014-3549-7; Lataster J, 2014, SCHIZOPHRENIA BULL, V40, P66, DOI 10.1093/schbul/sbs187; Lataster J, 2011, NEUROIMAGE, V58, P1081, DOI 10.1016/j.neuroimage.2011.07.030; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; McLaughlin KA, 2013, J AM ACAD CHILD PSY, V52, P815, DOI 10.1016/j.jaac.2013.05.011; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Nagano-Saito A, 2013, SYNAPSE, V67, P821, DOI 10.1002/syn.21700; Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Ramsay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079741; Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602; Roy CA, 2004, J NERV MENT DIS, V192, P343, DOI 10.1097/01.nmd.0000126701.23121.fa; Scornaiencki R, 2009, INT J NEUROPSYCHOPH, V12, P1195, DOI 10.1017/S1461145709000121; Smith N, 2002, SOC PSYCH PSYCH EPID, V37, P572, DOI 10.1007/s00127-002-0589-9; Soliman A, 2008, NEUROPSYCHOPHARMACOL, V33, P2033, DOI 10.1038/sj.npp.1301597; SUDHA S, 1995, PHYSIOL BEHAV, V57, P1061, DOI 10.1016/0031-9384(94)00369-G; van Os J, 2006, ACTA PSYCHIAT SCAND, V113, P91, DOI 10.1111/j.1600-0447.2005.00659.x; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Ventura R, 2013, CEREB CORTEX, V23, P1606, DOI 10.1093/cercor/bhs145; Walker EF, 1997, PSYCHOL REV, V104, P667, DOI 10.1037/0033-295X.104.4.667; Walker EF, 2013, DEV PSYCHOPATHOL, V25, P1585, DOI 10.1017/S0954579413000783; Watt MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1627, DOI 10.1007/s00213-013-3353-9	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150746	10.1371/journal.pone.0150746	http://dx.doi.org/10.1371/journal.pone.0150746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007554	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200030
J	Murakami, G				Murakami, Gen			Distinct Effects of Estrogen on Mouse Maternal Behavior: The Contribution of Estrogen Synthesis in the Brain	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; GENE-EXPRESSION; CORTICOMEDIAL AMYGDALA; GOLDEN-HAMSTER; RECEPTOR; FEMALE; RAT; CONNECTIONS; VASOPRESSIN; EXPERIENCE	Estrogen surge following progesterone withdrawal at parturition plays an important role in initiating maternal behavior in various rodent species. Systemic estrogen treatment shortens the latency to onset of maternal behavior in nulliparous female rats that have not experienced parturition. In contrast, nulliparous laboratory mice show rapid onset of maternal behavior without estrogen treatment, and the role of estrogen still remains unclear. Here the effect of systemic estrogen treatment (for 2 h, 1 day, 3 days, and 7 days) after progesterone withdrawal was examined on maternal behavior of C57BL/6 mice. This estrogen regimen led to different effects on nursing, pup retrieval, and nest building behaviors. Latency to nursing was shortened by estrogen treatment within 2 h. Moreover, pup retrieval and nest building were decreased. mRNA expression was also investigated for estrogen receptor a (ER alpha) and for genes involved in regulating maternal behavior, specifically, the oxytocin receptor (OTR) and vasopressin receptor in the medial amygdala (MeA) and medial preoptic area (MPOA). Estrogen treatment led to decreased ER alpha mRNA in both regions. Although OTR mRNA was increased in the MeA, OTR and vasopressin receptor mRNA were reduced in the MPOA, showing region-dependent transcription regulation. To determine the mechanisms for the actions of estrogen treatment, the contribution of estrogen synthesis in the brain was examined. Blockade of estrogen synthesis in the brain by systemic letrozole treatment in ovariectomized mice interfered with pup retrieval and nest building but not nursing behavior, indicating different contributions of estrogen synthesis to maternal behavior. Furthermore, letrozole treatment led to an increase in ER alpha mRNA in the MeA but not in the MPOA, suggesting that involvement of estrogen synthesis is brain region dependent. Altogether, these results suggest that region-dependent estrogen synthesis leads to differential transcriptional activation due to exogenous estrogen treatment, and thereby results in different effects on maternal behavior.	[Murakami, Gen] Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave,Box 275, New York, NY 10065 USA; [Murakami, Gen] Hamamatsu Univ Sch Med, Dept Psychol & Behav Neurosci, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Murakami, Gen] Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan	Rockefeller University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Murakami, G (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave,Box 275, New York, NY 10065 USA.; Murakami, G (corresponding author), Hamamatsu Univ Sch Med, Dept Psychol & Behav Neurosci, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.; Murakami, G (corresponding author), Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	murakami@hama-med.ac.jp			Hamamatsu University School of Medicine project research	Hamamatsu University School of Medicine project research	Funding provided by Hamamatsu University School of Medicine project research.	Bender RA, 2010, CEREB CORTEX, V20, P2985, DOI 10.1093/cercor/bhq047; Bosch OJ, 2008, P NATL ACAD SCI USA, V105, P17139, DOI 10.1073/pnas.0807412105; BRIDGES RS, 1978, HORM BEHAV, V10, P30, DOI 10.1016/0018-506X(78)90022-3; BRIDGES RS, 1984, ENDOCRINOLOGY, V114, P930, DOI 10.1210/endo-114-3-930; Bridges RS, 1996, ADV STUD BEHAV, V25, P215; BROWN TJ, 1994, MOL CELL NEUROSCI, V5, P283, DOI 10.1006/mcne.1994.1033; DOERR HK, 1981, BEHAV NEURAL BIOL, V32, P35, DOI 10.1016/S0163-1047(81)90242-9; DONCARLOS LL, 1995, NEUROREPORT, V6, P2054, DOI 10.1097/00001756-199510010-00024; FLEMING AS, 1981, PHYSIOL BEHAV, V27, P863, DOI 10.1016/0031-9384(81)90054-8; GANDELMAN R, 1973, PHYSIOL BEHAV, V10, P153, DOI 10.1016/0031-9384(73)90101-7; Gonzalez-Mariscal G, 1998, DEV PSYCHOBIOL, V32, P101, DOI 10.1002/(SICI)1098-2302(199803)32:2<101::AID-DEV3>3.0.CO;2-T; HAUSER H, 1985, HORM BEHAV, V19, P454, DOI 10.1016/0018-506X(85)90041-8; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; JACOBSON CD, 1980, BRAIN RES, V194, P471, DOI 10.1016/0006-8993(80)91226-3; KEVETTER GA, 1981, J COMP NEUROL, V197, P81, DOI 10.1002/cne.901970107; KEVETTER GA, 1981, J COMP NEUROL, V197, P99, DOI 10.1002/cne.901970108; KOCH M, 1989, PHYSIOL BEHAV, V45, P771, DOI 10.1016/0031-9384(89)90293-X; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; LAUBER AH, 1991, ENDOCRINOLOGY, V129, P3180, DOI 10.1210/endo-129-6-3180; LEGOASCOGNE C, 1991, J REPROD FERTIL, V93, P609, DOI 10.1530/jrf.0.0930609; LISK RD, 1971, ANIM BEHAV, V19, P606, DOI 10.1016/S0003-3472(71)80118-5; LISK RD, 1969, ANIM BEHAV, V17, P730, DOI 10.1016/S0003-3472(69)80020-5; Litvin Y, 2011, PHYSIOL BEHAV, V103, P393, DOI 10.1016/j.physbeh.2011.03.007; MANN MA, 1983, PHYSIOL BEHAV, V30, P697, DOI 10.1016/0031-9384(83)90165-8; MICELI MO, 1983, BEHAV BRAIN RES, V9, P337, DOI 10.1016/0166-4328(83)90137-7; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Murakami G, 2006, DRUG METAB REV, V38, P353, DOI 10.1080/03602530600724068; Noirot E, 1972, ADV STUDY BEHAV; NUMAN M, 1980, PHYSIOL BEHAV, V25, P653, DOI 10.1016/0031-9384(80)90367-4; Numan M, 1994, PHYSL REPROD, V2; Numan M., 2003, HORM BR BEHAV; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; ORPEN BG, 1987, PHYSIOL BEHAV, V40, P47, DOI 10.1016/0031-9384(87)90184-3; Patel H, 2002, ACTA PHYSIOL SCAND, V176, P177, DOI 10.1046/j.1365-201X.2002.01033.x; PERKINS LM, 1988, ENDOCRINOLOGY, V123, P2675, DOI 10.1210/endo-123-6-2675; Ribeiro AC, 2012, P NATL ACAD SCI USA, V109, P16324, DOI 10.1073/pnas.1214094109; Ribeiro AC, 2009, EUR J NEUROSCI, V29, P795, DOI 10.1111/j.1460-9568.2009.06620.x; Rosenblatt JS, 1995, BEHAV DEV; ROSENBLATT JS, 1985, HDB BEHAV NEUROBIOLO, V7; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; Solomon N. G., 1997, COOPERATIVE BREEDING; Spiteri T, 2012, BEHAV BRAIN RES, V230, P11, DOI 10.1016/j.bbr.2012.01.048; Stolzenberg DS, 2011, J NEUROENDOCRINOL, V23, P345, DOI 10.1111/j.1365-2826.2011.02112.x; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Ubuka T, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00323; Vierk R, 2012, J NEUROSCI, V32, P8116, DOI 10.1523/JNEUROSCI.5319-11.2012	47	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150728	10.1371/journal.pone.0150728	http://dx.doi.org/10.1371/journal.pone.0150728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007402	Green Submitted, gold, Green Published			2022-12-27	WOS:000372701200029
J	Navarro-Millan, I; Herrinton, LJ; Chen, L; Harrold, L; Liu, LY; Curtis, JR				Navarro-Millan, Iris; Herrinton, Lisa J.; Chen, Lang; Harrold, Leslie; Liu, Liyan; Curtis, Jeffrey R.			Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability	PLOS ONE			English	Article							CLINICAL-DISEASE ACTIVITY; RHEUMATOID-ARTHRITIS; ANTIRHEUMATIC DRUGS; ROUTINE ASSESSMENT; PROPOSED SEVERITY; BIOLOGIC THERAPY; DECISION-MAKING; HEALTH SURVEY; PREFERENCES; CATEGORIES	Objective To describe patient preferences in selecting specific biologics and compare clinical response using patient reported outcomes (PROs) among patients with rheumatoid arthritis (RA) started on different anti-tumor necrosis factor (TNF) therapies. Methods Participants were enrollees in Kaiser Permanente Northern California. Patients with RA who had at least two provider visits and started a new anti-TNF therapy from 10/2010-8/2011, were eligible for participation in this longitudinal study. Using a telephone survey, patient preferences in biologic selection and RAPID3, MDHAQ, and SF-12 scores were collected at baseline and at 6 months. Patient scores rating injection/infusion-site burning and stinging (ISBS) were collected at 6 months. Results In all, 267 patients with RA responded to the baseline survey, of whom 57% preferred an injectable biologic, 22% preferred an infused biologic, and 21% had no preference. Motivation for injectable biologics was convenience (92%) and for infusion therapy was dislike or lack of self-efficacy for self-injection (16%). After 6 months of treatment with anti-TNF, 70% of the 177 patients who answered the ISBS question reported ISBS with the last dose; on a scale of 1 (none) to 10 (worst), 41% of these reported a score of 2-5; and 29% reported a score of 6-10. Adalimumab users experienced 3.2 times (95% confidence interval 1.2-8.6) the level of ISBS that etanercept users experienced. There were no significant differences in RAPID3, MDHAQ, or SF-12 scores between etanercept or adalimumab initiators. Conclusion Convenience and fear of self-injection were important considerations to patients selecting a biologic drug. Although more convenient, adalimumab associated with more ISBS than did etanercept, and this rate was higher than reported in clinical trials. At 6 months, PROs did not differ between etanercept and adalimumab users.	[Navarro-Millan, Iris; Chen, Lang; Curtis, Jeffrey R.] Univ Alabama Birmingham, Birmingham, AL USA; [Herrinton, Lisa J.; Liu, Liyan] Kaiser Permanente No Calif, San Francisco, CA USA; [Harrold, Leslie] Univ Massachusetts, Worcester, MA 01605 USA	University of Alabama System; University of Alabama Birmingham; Kaiser Permanente; University of Massachusetts System; University of Massachusetts Worcester	Curtis, JR (corresponding author), Univ Alabama Birmingham, Birmingham, AL USA.	jcurtis@uab.edu		Navarro-Millan, Iris/0000-0002-9540-6614	National Institute for Allergy and Infectious Diseases [1RC1AI086107]; Agency for Healthcare Research and Quality (AHRQ) [R01HS018517, HS021589]; National Institutes of Health [R01 AR062376-S1, AR053351, 18910, AR053856]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS021589, R01HS018517, K12HS023009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR053351, R01AR062376, K23AR053856] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the National Institute for Allergy and Infectious Diseases (1RC1AI086107) and received support from the Agency for Healthcare Research and Quality (AHRQ) (R01HS018517). Dr Navarro-Millan received support from the National Institutes of Health (R01 AR062376-S1). Dr. Herrinton receives support from the Agency for Healthcare Research and Quality (AHRQ) (HS021589). Dr. Curtis receives support from the National Institutes of Health (AR053351). Dr. Harrold receives support form the National Institutes of Health (18910 and AR053856). URLs for the funders are: http://www.ahrq.gov/; http://www.niams.nih.gov/.	Abbvie, 2014, HUM PRESCR INF ABBV; Amgen, ENBR PRESCR INF 2013; [Anonymous], 2002, AD PRESCR INF ABB; [Anonymous], 1998, ET PRESCR INF AMG PF; Barton JL, 2009, PATIENT PREFER ADHER, V3, P335; Chen DY, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-203893; Chilton F, 2008, MUSCULOSKELET CARE, V6, P1, DOI 10.1002/msc.110; Clement ND, 2013, BONE JOINT J, V95B, P360, DOI 10.1302/0301-620X.95B3.29563; Curtis JR, 2011, CURR MED RES OPIN, V27, P71, DOI 10.1185/03007995.2010.534959; Curtis JR, 2010, ARTHRIT CARE RES, V62, P101, DOI 10.1002/acr.20020; Erdogan BD, 2016, J RHEUMATOL, V43, P194, DOI 10.3899/jrheum.141150; Fajri DW, 2009, CLIN RHEUMATOL, V28, P599, DOI 10.1007/s10067-009-1104-4; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Greenberg JD, 2012, ANN RHEUM DIS, V71, P1134, DOI 10.1136/annrheumdis-2011-150573; Health UDo, 2001, INTERPRETING THE SF; Jamnitski A, 2012, ANN RHEUM DIS, V71, P88, DOI 10.1136/annrheumdis-2011-200184; Jamnitski A, 2011, ANN RHEUM DIS, V70, P284, DOI 10.1136/ard.2010.135111; Jobanputra P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001395; Kivitz A, 2006, CLIN THER, V28, P1619, DOI 10.1016/j.clinthera.2006.10.006; Krieckaert CL, 2012, ARTHRITIS RHEUM-US, V64, P3850, DOI 10.1002/art.34680; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Pease C, 2011, SEMIN ARTHRITIS RHEU, V41, P81, DOI 10.1016/j.semarthrit.2010.09.004; Pincus T, 1999, ARTHRITIS RHEUM-US, V42, P2220, DOI 10.1002/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5; Pincus T, 2008, J RHEUMATOL, V35, P2136, DOI 10.3899/jrheum.080182; Pincus T, 2011, J RHEUMATOL, V38, P2565, DOI 10.3899/jrheum.110262; Scarpato S, 2010, RHEUMATOLOGY, V49, P289, DOI 10.1093/rheumatology/kep354; Schmitt JS, 2004, J CLIN EPIDEMIOL, V57, P1008, DOI 10.1016/j.jclinepi.2004.02.007; Sokka T, 2005, RHEUM DIS CLIN N AM, V31, P729, DOI 10.1016/j.rdc.2005.07.007; Sokka T, 2008, MOD RHEUMATOL, V18, P228, DOI 10.1007/s10165-008-0056-x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yazici Y, 2008, BULL HOSP JT DIS, V66, P77; Zhang Jie, 2013, Arthritis Care Res (Hoboken), V65, P1743; Zhang J, 2011, ARTHRIT CARE RES, V63, P1672, DOI 10.1002/acr.20643	33	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0149781	10.1371/journal.pone.0149781	http://dx.doi.org/10.1371/journal.pone.0149781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007811	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200020
J	Julovi, SM; Xue, AQ; Thanh, LETN; Gill, AJ; Bulanadi, JC; Patel, M; Waddington, LJ; Rye, KA; Moghaddam, MJ; Smith, RC				Julovi, Sohel M.; Xue, Aiqun; Thanh, Thao N. L. E.; Gill, Anthony J.; Bulanadi, Jerikho C.; Patel, Mili; Waddington, Lynne J.; Rye, Kerry-Anne; Moghaddam, Minoo J.; Smith, Ross C.			Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; B TYPE-I; SCAVENGER RECEPTOR; SELECTIVE UPTAKE; PROSTATE-CANCER; CHOLESTEROL; PROTEIN; HDL; PROLIFERATION; INHIBITION	Background Apolipoprotein A-II (ApoA-II) is down regulated in the sera of pancreatic ductal adenocarcinoma (PDAC) patients, which may be due to increase utilization of high density lipoprotein (HDL) lipid by pancreatic cancer tissue. This study examined the influence of exogenous ApoA-II on lipid uptake and cell growth in pancreatic cancer (PC) both in vitro and in vivo. Methods Cryo transmission electron microscopy (TEM) examined ApoA-II's influence on morphology of SMOFLipid emulsion. The influence of ApoA-II on proliferation of cancer cell lines was determined by incubating them with lipid+/-ApoA-II and anti-SR-B1 antibody. Lipid was labeled with the fluorophore, DiD, to trace lipid uptake by cancer cells in vitro by confocal microscopy and in vivo in PDAC patient derived xenograft tumours (PDXT) by fluorescence imaging. Scavenger receptor class B type-1(SR-B1) expression in PDAC cell lines and in PDAC PDXT was measured by western blotting and immunohistochemistry, respectively. Results ApoA-II spontaneously converted lipid emulsion into very small unilamellar rHDL like vesicles (rHDL/A-II) and enhanced lipid uptake in PANC-1, CFPAC-1 and primary tumour cells as shown by confocal microscopy. SR-B1 expression was 13.2, 10.6, 3.1 and 2.3 fold higher in PANC-1, MIAPaCa-2, CFPAC-1 and BxPC3 cell lines than the normal pancreatic cell line (HPDE6) and 3.7 fold greater in PDAC tissue than in normal pancreas. ApoA-II plus lipid significantly increased the uptake of labeled lipid and promoted cell growth in PANC-1, MIAPaCa-2, CFPAC-1 and BxPC3 cells which was inhibited by anti SR-B1 antibody. Further, ApoA-II increased the uptake of lipid in xenografts by 3.4 fold. Conclusion Our data suggest that ApoA-II enhance targeting potential of lipid in pancreatic cancer which may have imaging and drug delivery potentialities.	[Julovi, Sohel M.; Xue, Aiqun; Thanh, Thao N. L. E.; Bulanadi, Jerikho C.; Smith, Ross C.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Canc Surg Grp, St Leonards, NSW 2065, Australia; [Smith, Ross C.] Royal N Shore Hosp, Dept Gastrointestinal Surg, St Leonards, NSW 2065, Australia; [Gill, Anthony J.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia; [Bulanadi, Jerikho C.; Moghaddam, Minoo J.] CSIRO, CSIRO Mfg, N Ryde, NSW 2113, Australia; [Waddington, Lynne J.] CSIRO, CSIRO Mfg, Parkville, Vic, Australia; [Patel, Mili; Rye, Kerry-Anne] Univ New S Wales, Fac Med, Ctr Vasc Res, Sydney, NSW 2052, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New South Wales Sydney	Smith, RC (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Canc Surg Grp, St Leonards, NSW 2065, Australia.; Smith, RC (corresponding author), Royal N Shore Hosp, Dept Gastrointestinal Surg, St Leonards, NSW 2065, Australia.	ross.smith@sydney.edu.au	Julovi, Sohel/AAQ-4539-2020; Gill, Anthony/D-4215-2015; Gill, Anthony J./M-5015-2019	Gill, Anthony/0000-0002-9447-1967; Julovi, Sohel/0000-0003-0834-2366	CanSur foundation; Ramsay Research Teaching Fund	CanSur foundation; Ramsay Research Teaching Fund	Part of this study was presented and awarded as best poster at New Horizons 2014 and the Scientific Research Meeting, 17th-19th November, 2014. This study has not been published elsewhere or is not under consideration for a publication. The study was supported by the CanSur foundation and partly by the Ramsay Research Teaching Fund but did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Commercial affiliation of the authors at CSIRO did not play any role in the study and did not have any competing interests relating to employment, consultancy, patents, products in development and marketed products.	Ahmad S, 2006, INT J TOXICOL, V25, P17, DOI 10.1080/10915810500488361; Biswas S, 2012, CANCER METAST REV, V31, P689, DOI 10.1007/s10555-012-9384-6; CALDERON P, 1979, BIOCHIM BIOPHYS ACTA, V574, P379, DOI 10.1016/0005-2760(79)90234-0; Cao WM, 2004, CANCER RES, V64, P1515, DOI 10.1158/0008-5472.CAN-03-0675; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Connelly MA, 2003, TRENDS ENDOCRIN MET, V14, P467, DOI 10.1016/j.tem.2003.10.002; Czernin J, 2002, ANNU REV MED, V53, P89, DOI 10.1146/annurev.med.53.082901.104028; Daerr WH, 1990, BIOCHIM BIOPHYS ACTA, P1043; de Beer MC, 2001, J BIOL CHEM, V276, P15832, DOI 10.1074/jbc.M100228200; EISENBERG S, 1973, J LIPID RES, V14, P446; Fan YB, 2014, BIOMATERIALS, V35, P7870, DOI 10.1016/j.biomaterials.2014.05.054; Felix K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082755; Gabizon A, 1997, ADV DRUG DELIVER REV, V24, P337, DOI 10.1016/S0169-409X(96)00476-0; GABIZON AA, 1994, HEMATOL ONCOL CLIN N, V8, P431; Gao X, 2012, BIOCHEMISTRY-US, V51, P4633, DOI 10.1021/bi300555d; GOSPODAROWICZ D, 1982, CANCER RES, V42, P3704; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; HO YK, 1978, BLOOD, V52, P1099; Honda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046908; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Huang H, 2015, WIRES NANOMED NANOBI, V7, P298, DOI 10.1002/wnan.1308; Imachi H, 1999, ENDOCR J, V46, P27, DOI 10.1507/endocrj.46.27; Julovi SM, 2013, MOL MED; Julovi SM, 2011, AM J PATHOL, V179, P2233, DOI 10.1016/j.ajpath.2011.07.024; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim JY, 2009, J SEP SCI, V32, P4161, DOI 10.1002/jssc.200900442; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; OSBORNE CK, 1987, BREAST CANCER RES TR, V9, P111, DOI 10.1007/BF01807363; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pussinen PJ, 2000, BIOCHEM J, V349, P559, DOI 10.1042/0264-6021:3490559; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; RYE KA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P316, DOI 10.1016/0005-2760(93)90235-2; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Surugau N, 2009, J SEP SCI, V32, P1889, DOI 10.1002/jssc.200900071; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Twiddy AL, 2012, PROSTATE, V72, P955, DOI 10.1002/pros.21499; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; VITOLS S, 1990, P NATL ACAD SCI USA, V87, P2598, DOI 10.1073/pnas.87.7.2598; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; Weng W, 1999, J LIPID RES, V40, P1064; Wong MH, 2014, CLIN CANCER RES, V20, P4047, DOI 10.1158/1078-0432.CCR-13-3377; Xue A, 2010, BRIT J CANCER, V103, P391, DOI 10.1038/sj.bjc.6605764; Xue AQ, 2015, PANCREATOLOGY, V15, P397, DOI 10.1016/j.pan.2015.04.008	51	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151475	10.1371/journal.pone.0151475	http://dx.doi.org/10.1371/journal.pone.0151475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002321	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400033
J	Meunier, CNJ; Dallerac, G; Le Roux, N; Sacchi, S; Levasseur, G; Amar, M; Pollegioni, L; Mothet, JP; Fossier, P				Meunier, Claire N. J.; Dallerac, Glenn; Le Roux, Nicolas; Sacchi, Silvia; Levasseur, Gregoire; Amar, Muriel; Pollegioni, Loredano; Mothet, Jean-Pierre; Fossier, Philippe			D-Serine and Glycine Differentially Control Neurotransmission during Visual Cortex Critical Period	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; OCULAR DOMINANCE PLASTICITY; EXCITATION-INHIBITION BALANCE; AMINO-ACID OXIDASE; NMDA RECEPTOR; IN-VIVO; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CORTICAL NETWORKS; SITE	N-methyl-D-aspartate receptors (NMDARs) play a central role in synaptic plasticity. Their activation requires the binding of both glutamate and D-serine or glycine as co-agonist. The prevalence of either co-agonist on NMDA-receptor function differs between brain regions and remains undetermined in the visual cortex (VC) at the critical period of postnatal development. Here, we therefore investigated the regulatory role that D-serine and/or glycine may exert on NMDARs function and on synaptic plasticity in the rat VC layer 5 pyramidal neurons of young rats. Using selective enzymatic depletion of D-serine or glycine, we demonstrate that D-serine and not glycine is the endogenous co-agonist of synaptic NMDARs required for the induction and expression of Long Term Potentiation (LTP) at both excitatory and inhibitory synapses. Glycine on the other hand is not involved in synaptic efficacy per se but regulates excitatory and inhibitory neurotransmission by activating strychnine-sensitive glycine receptors, then producing a shunting inhibition that controls neuronal gain and results in a depression of synaptic inputs at the somatic level after dendritic integration. In conclusion, we describe for the first time that in the VC both D-serine and glycine differentially regulate somatic depolarization through the activation of distinct synaptic and extrasynaptic receptors.	[Meunier, Claire N. J.; Le Roux, Nicolas; Amar, Muriel; Fossier, Philippe] Univ Paris 11, Inst Neurosci Paris Saclay NeuroPSI, UMR CNRS 9197, Bat 446, F-91405 Orsay, France; [Dallerac, Glenn; Levasseur, Gregoire; Mothet, Jean-Pierre] Aix Marseille Univ, CNRS CRN2M UMR7286, 51 Bd Pierre Dramard, F-13344 Marseille, France; [Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, Varese, Italy; [Sacchi, Silvia; Pollegioni, Loredano] Politecn Milan, ICRM CNR, Ctr Interuniv Biotecnol Prote, Prot Factory, I-20133 Milan, Italy; [Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Via Mancinelli 7, Milan, Italy; [Meunier, Claire N. J.; Dallerac, Glenn] Coll France, CNRS UMR 7241, CIRB, INSERM U1050, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Polytechnic University of Milan; University of Insubria; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Fossier, P (corresponding author), Univ Paris 11, Inst Neurosci Paris Saclay NeuroPSI, UMR CNRS 9197, Bat 446, F-91405 Orsay, France.; Mothet, JP (corresponding author), Aix Marseille Univ, CNRS CRN2M UMR7286, 51 Bd Pierre Dramard, F-13344 Marseille, France.	jean-pierre.mothet@univ-amu.fr; philippe.fossier@u-psud.fr	Mothet, Jean-Pierre/ABE-3066-2020	POLLEGIONI, LOREDANO/0000-0003-1733-7243; MOTHET, Jean-Pierre/0000-0003-4991-0614	Centre National pour la Recherche Scientifique (CNRS); SANOFI-AVENTIS; Agence Nationale de la Recherche (ANR); CNRS; SANOFI-AVENTIS RD Exploratory Unit; Agence Nationale pour la Recherche [ANR-09-MNPS-022-01]; Universite Aix-Marseille; Fondation pour la Recherche Medicale	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); SANOFI-AVENTIS(Sanofi-Aventis); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); SANOFI-AVENTIS RD Exploratory Unit; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Universite Aix-Marseille; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This research was supported by grants from the Centre National pour la Recherche Scientifique (CNRS), SANOFI-AVENTIS and Agence Nationale de la Recherche (ANR). CNJM received a studentship from CNRS and SANOFI-AVENTIS RD Exploratory Unit. JPM and GD were supported by Agence Nationale pour la Recherche (Grant number ANR-09-MNPS-022-01), CNRS, Universite Aix-Marseille and Fondation pour la Recherche Medicale (to J-P.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anver H, 2011, NEUROPSYCHOPHARMACOL, V36, P519, DOI 10.1038/npp.2010.183; Aroeira RI, 2011, J NEUROCHEM, V118, P339, DOI 10.1111/j.1471-4159.2011.07197.x; Atkinson BN, 2001, MOL PHARMACOL, V60, P1414, DOI 10.1124/mol.60.6.1414; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; BECKER CM, 1993, BRAIN RES, V606, P220, DOI 10.1016/0006-8993(93)90988-Y; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Cao ZP, 2007, EXP BRAIN RES, V177, P64, DOI 10.1007/s00221-006-0647-8; Chen RQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1948, DOI 10.1038/npp.2011.86; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Curcio L, 2013, BRAIN, V136, P1216, DOI 10.1093/brain/awt036; Czepita D, 1996, J NEUROPHYSIOL, V75, P311, DOI 10.1152/jn.1996.75.1.311; Danglot L, 2004, MOL CELL NEUROSCI, V27, P394, DOI 10.1016/j.mcn.2004.05.007; Fantinato S., 2001, ENZYME MICROB TECHNO, V29, P407; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Hagiwara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062438; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HASHIMOTO A, 1995, NEUROSCIENCE, V66, P635, DOI 10.1016/0306-4522(94)00597-X; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Ito K, 2001, NEUROSCI LETT, V303, P95, DOI 10.1016/S0304-3940(01)01709-8; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Keck T, 2008, J NEUROSCI, V28, P7359, DOI 10.1523/JNEUROSCI.5618-07.2008; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Krahe TE, 2010, J NEUROPHYSIOL, V103, P2700, DOI 10.1152/jn.00442.2009; Krasteniakov NV, 2005, EUR J NEUROSCI, V21, P2782, DOI 10.1111/j.1460-9568.2005.04099.x; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Le Roux N, 2007, EUR J NEUROSCI, V26, P289, DOI 10.1111/j.1460-9568.2007.05671.x; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Levitt JB, 1997, PLOS ONE, P73; Li Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2779; Li YH, 2008, BRAIN RES, V1190, P49, DOI 10.1016/j.brainres.2007.11.006; Li YH, 2007, J NEUROPHYSIOL, V97, P817, DOI 10.1152/jn.00980.2006; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Pratte MS, 2013, J NEUROPHYSIOL, V110, P1346, DOI 10.1152/jn.00127.2013; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Salling MC, 2014, J NEUROPHYSIOL, V112, P1169, DOI 10.1152/jn.00714.2013; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Song WF, 2006, J NEUROPHYSIOL, V95, P2366, DOI 10.1152/jn.00386.2005; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Stevens ER, 2010, NEUROREPORT, V21, P239, DOI 10.1097/WNR.0b013e32833313b7; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; Tuckwell HC, 1996, J THEOR BIOL, V181, P25, DOI 10.1006/jtbi.1996.0111; Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yan XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041419; Yang KY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00203; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	69	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151233	10.1371/journal.pone.0151233	http://dx.doi.org/10.1371/journal.pone.0151233			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003418	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400027
J	Morimoto, S; Remijn, GB; Nakajima, Y				Morimoto, Satoshi; Remijn, Gerard B.; Nakajima, Yoshitaka			Computational-Model-Based Analysis of Context Effects on Harmonic Expectancy	PLOS ONE			English	Article							TONAL CENTERS; MUSIC; CHORDS; ORGANIZATION; FACILITATION; PERCEPTION; HIERARCHY; JUDGMENTS	Expectancy for an upcoming musical chord, harmonic expectancy, is supposedly based on automatic activation of tonal knowledge. Since previous studies implicitly relied on interpretations based on Western music theory, the underlying computational processes involved in harmonic expectancy and how it relates to tonality need further clarification. In particular, short chord sequences which cannot lead to unique keys are difficult to interpret in music theory. In this study, we examined effects of preceding chords on harmonic expectancy from a computational perspective, using stochastic modeling. We conducted a behavioral experiment, in which participants listened to short chord sequences and evaluated the subjective relatedness of the last chord to the preceding ones. Based on these judgments, we built stochastic models of the computational process underlying harmonic expectancy. Following this, we compared the explanatory power of the models. Our results imply that, even when listening to short chord sequences, internally constructed and updated tonal assumptions determine the expectancy of the upcoming chord.	[Morimoto, Satoshi] Kyushu Univ, Grad Sch Design, Dept Design, Fukuoka 812, Japan; [Remijn, Gerard B.; Nakajima, Yoshitaka] Kyushu Univ, Res Ctr Appl Perceptual Sci, Fukuoka 812, Japan; [Remijn, Gerard B.; Nakajima, Yoshitaka] Kyushu Univ, Fac Design, Dept Human Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Morimoto, S (corresponding author), Kyushu Univ, Grad Sch Design, Dept Design, Fukuoka 812, Japan.	satoshi.morimo@gmail.com	Remijn, Gerard/CAF-9960-2022	Remijn, Gerard/0000-0002-8681-9951	Japan Society for the Promotion of Science (JSPS) [KAKENHI 26540145]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Challenging Exploratory Research (KAKENHI 26540145) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, MUSIC PERCEPT, V5, P1; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Bigand E, 1997, PERCEPT PSYCHOPHYS, V59, P1098, DOI 10.3758/BF03205524; Bigand E, 1999, J EXP PSYCHOL HUMAN, V25, P184, DOI 10.1037/0096-1523.25.1.184; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; BUTLER D, 1989, MUSIC PERCEPT, V6, P219; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Huron D.B., 2006, SWEET ANTICIPATION M; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jurafsky Daniel, 2000, SPEECH LANGUAGE PROC, V1st; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1990, MUSIC PERCEPT, V7, P309; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; KRUMHANSL CL, 1979, J EXP PSYCHOL HUMAN, V5, P579, DOI 10.1037/0096-1523.5.4.579; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lee Michael D, 2006, Cogn Sci, V30, P1, DOI 10.1207/s15516709cog0000_69; Meyer L., 1956, EMOTION MEANING MUSI; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Mulder MJ, 2014, NEUROSCIENCE, V277, P872, DOI 10.1016/j.neuroscience.2014.07.031; Pearce MT, 2012, TOP COGN SCI, V4, P625, DOI 10.1111/j.1756-8765.2012.01214.x; Piston W., 1948, HARMONY, V5th ed.; Raphael C, 2004, COMPUT MUSIC J, V28, P45, DOI 10.1162/0148926041790676; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Sawai K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00524; SCHMUCKLER MA, 1989, MUSIC PERCEPT, V7, P109; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Temperley D., 2007, MUSIC PROBABILITY; THOMPSON WF, 1989, MUSIC PERCEPT, V7, P151; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tillmann B, 2003, J EXP PSYCHOL HUMAN, V29, P470, DOI 10.1037/0096-1523.29.2.470; Tillmann B, 2001, J EXP PSYCHOL HUMAN, V27, P1185, DOI 10.1037//0096-1523.27.5.1185; Tillmann B, 2013, PSYCHOMUSICOL MUSIC, V23, P1, DOI [10.1037/a0030454, DOI 10.1037/A0030454]; Tillmann B, 2008, J EXP PSYCHOL HUMAN, V34, P1031, DOI 10.1037/0096-1523.34.4.1031; Tillmann B, 2006, PSYCHOL RES-PSYCH FO, V70, P345, DOI 10.1007/s00426-005-0222-0; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	43	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151374	10.1371/journal.pone.0151374	http://dx.doi.org/10.1371/journal.pone.0151374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003807	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400030
J	Natsume-Kitatani, Y; Mamitsuka, H				Natsume-Kitatani, Yayoi; Mamitsuka, Hiroshi			Classification of Promoters Based on the Combination of Core Promoter Elements Exhibits Different Histone Modification Patterns	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMATIN-STATE; TATA BOX; EXPRESSION; DROSOPHILA; DPE; IDENTIFICATION; INITIATION; ALIGNMENT; MAP	Four different histones (H2A, H2B, H3, and H4; two subunits each) constitute a histone octamer, around which DNA wraps to form histone-DNA complexes called nucleosomes. Amino acid residues in each histone are occasionally modified, resulting in several biological effects, including differential regulation of transcription. Core promoters that encompass the transcription start site have well-conserved DNA motifs, including the initiator (Inr), TATA box, and DPE, which are collectively called the core promoter elements (CPEs). In this study, we systematically studied the associations between the CPEs and histone modifications by integrating the Drosophila Core Promoter Database and time-series ChIP-seq data for histone modifications (H3K4me3, H3K27ac, and H3K27me3) during development in Drosophila melanogaster via the modENCODE project. We classified 96 core promoters into four groups based on the presence or absence of the TATA box or DPE, calculated the histone modification ratio at the core promoter region, and transcribed region for each core promoter. We found that the histone modifications in TATA-less groups were static during development and that the core promoters could be clearly divided into three types: i) core promoters with continuous active marks (H3K4me3 and H3K27ac), ii) core promoters with a continuous inactive mark (H3K27me3) and occasional active marks, and iii) core promoters with occasional histone modifications. Linear regression analysis and non-linear regression by random forest showed that the TATA-containing groups included core promoters without histone modifications, for which the measured RNA expression values were not predictable accurately from the histone modification status. DPE-containing groups had a higher relative frequency of H3K27me3 in both the core promoter region and transcribed region. In summary, our analysis showed that there was a systematic link between the existence of the CPEs and the dynamics, frequency and influence on transcriptional activity of histone modifications.	[Natsume-Kitatani, Yayoi] Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, Saitama, Japan; [Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan; [Natsume-Kitatani, Yayoi] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan	Japan Science & Technology Agency (JST); Kyoto University	Natsume-Kitatani, Y (corresponding author), Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, Saitama, Japan.; Natsume-Kitatani, Y (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan.	natsume@nibiohn.go.jp	Mamitsuka, Hiroshi/R-1110-2016	Mamitsuka, Hiroshi/0000-0002-6607-5617	JST (Japan Science and Technology Agency) PRESTO program; MEXT KAKENHI [24300054]	JST (Japan Science and Technology Agency) PRESTO program; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JST (Japan Science and Technology Agency) PRESTO program. HM is supported by MEXT KAKENHI #24300054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato A., 2008, NATURE ED, V1, P26; [Anonymous], 1957, COLD SPRING HARB SYM; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Crawley MJ, 2005, STAT INTRO USING R; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Karolchik Donna, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s17; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindeman R., 1980, INTRO BIVARIATE MULT; Liu L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1281; Liu L, 2015, NUCLEIC ACIDS RES, V43, P3873, DOI 10.1093/nar/gkv255; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151917	10.1371/journal.pone.0151917	http://dx.doi.org/10.1371/journal.pone.0151917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003446	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400056
J	Szczecinska, M; Sramko, G; Wolosz, K; Sawicki, J				Szczecinska, Monika; Sramko, Gabor; Wolosz, Katarzyna; Sawicki, Jakub			Genetic Diversity and Population Structure of the Rare and Endangered Plant Species Pulsatilla patens (L.) Mill in East Central Europe	PLOS ONE			English	Article							ALLELE FREQUENCY; COMPUTER-PROGRAM; HABITAT QUALITY; SIZE; CONSERVATION; FITNESS; SOFTWARE; DECLINES; MARKERS; FLOW	Pulsatilla patens s.s. is a one of the most endangered plant species in Europe. The present range of this species in Europe is highly fragmented and the size of the populations has been dramatically reduced in the past 50 years. The rapid disappearance of P. patens localities in Europe has prompted the European Commission to initiate active protection of this critically endangered species. The aim of this study was to estimate the degree and distribution of genetic diversity within European populations of this endangered species. We screened 29 populations of P. patens using a set of six microsatellite primers. The results of our study indicate that the analyzed populations are characterized by low levels of genetic diversity (H-o = 0.005) and very high levels of inbreeding (F-IS = 0.90). These results suggest that genetic erosion could be partially responsible for the lower fitness in smaller populations of this species. Private allelic richness was very low, being as low as 0.00 for most populations. Average genetic diversity over loci and mean number of alleles in P. patens populations were significantly correlated with population size, suggesting severe genetic drift. The results of AMOVA point to higher levels of variation within populations than between populations. The results of Structure and PCoA analyses suggest that the genetic structure of the studied P. patens populations fall into three clusters corresponding to geographical regions. The most isolated populations (mostly from Romania) formed a separate group with a homogeneous gene pool located at the southern, steppic part of the distribution range. Baltic, mostly Polish, populations fall into two genetic groups which were not fully compatible with their geographic distribution. Our results indicate the serious genetic depauperation of P. patens in the western part of its range, even hinting at an ongoing extinction vortex. Therefore, special conservation attention is required to maintain the populations of this highly endangered species of European Community interest.	[Szczecinska, Monika; Wolosz, Katarzyna; Sawicki, Jakub] Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland; [Sramko, Gabor] Univ Debrecen, Dept Bot, Debrecen, Hungary; [Sramko, Gabor] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Sawicki, Jakub] Univ Ostrava, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic	University of Warmia & Mazury; University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Ostrava	Szczecinska, M (corresponding author), Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland.	monika.szczecinska@uwm.edu.pl	Sawicki, Jakub/H-4432-2012; Bilska, Katarzyna/K-2376-2019; Szczecinska, Monika/J-2400-2012; Sramko, Gabor/A-1165-2009	Sawicki, Jakub/0000-0002-4759-8113; Bilska, Katarzyna/0000-0003-2817-2317; Sramko, Gabor/0000-0001-8588-6362; Szczecinska, Monika/0000-0002-5377-4304	Polish National Science Centre [NN 304 364438]; Hungarian Research Fund (OTKA PD) [109686, K108992]	Polish National Science Centre; Hungarian Research Fund (OTKA PD)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Polish National Science Centre, NN 304 364438, and Hungarian Research Fund (OTKA PD 109686 and K108992).	BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BILLINGTON HL, 1991, CONSERV BIOL, V5, P115, DOI 10.1111/j.1523-1739.1991.tb00394.x; Biro E, 2015, APPL ECOL ENV RES, V13, P181; BOCK JH, 1975, AM MIDL NAT, V94, P476, DOI 10.2307/2424441; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Bothwell H, 2013, CONSERV GENET, V14, P467, DOI 10.1007/s10592-012-0411-5; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Bunnell FL, 2004, CAN J FOREST RES, V34, P2240, DOI [10.1139/x04-102, 10.1139/X04-102]; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chmura D., 2003, CHRO MY PRZYR OJCZ, V59, P14; Cornuet JM, 1996, GENETICS, V144, P2001; Couvet D, 2002, CONSERV BIOL, V16, P369, DOI 10.1046/j.1523-1739.2002.99518.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Vere N, 2009, OECOLOGIA, V159, P59, DOI 10.1007/s00442-008-1203-y; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dostalek T, 2010, CONSERV GENET, V11, P773, DOI 10.1007/s10592-009-9879-z; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ERNST M, 1970, POPULATIONS SPECIES; *EUNIS, 2007, SPEC FACTSH PULS PAT; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Diniz JAF, 2009, J BIOGEOGR, V36, P2222, DOI 10.1111/j.1365-2699.2009.02163.x; Fischer M, 1998, J ECOL, V86, P195, DOI 10.1046/j.1365-2745.1998.00246.x; Frankel OH, 1995, CONSERVATION PLANT B, P91; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Fraser DF, 2000, P C BIOL MAN SPEC HA, P49; Freeland J. R., 2011, MOL ECOLOGY; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gaston KJ, 2003, THE STRUCTURE AND DY; Ge S, 1998, INT J PLANT SCI, V159, P351, DOI 10.1086/297556; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hensen I, 2005, FLORA, V200, P3, DOI 10.1016/j.flora.2004.05.001; HILL WG, 1986, GENET RES, V48, P41, DOI 10.1017/S0016672300024642; HOFFMANN A, 1997, EXTREME ENVIRONMENTA; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Hollingsworth PM, 2005, MOL ECOL, V14, P497, DOI 10.1111/j.1365-294X.2005.02431.x; Holub Josef, 2000, Preslia (Prague), V72, P187; Hulten E., 1986, ATLAS N EUROPEAN VAS, V3, P969; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; Ilves A, 2013, CONSERV GENET, V14, P661, DOI 10.1007/s10592-013-0459-x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kalamees R, 2005, CAN J BOT, V83, P688, DOI [10.1139/B05-038, 10.1139/b05-038]; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalliovirta M., 2003, MONITORING THREATENE, P37; Kalliovirta M, 2006, BIODIVERS CONSERV, V15, P3095, DOI 10.1007/s10531-005-5403-z; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; LESKU B, 2014, NATURA 2000 FAJOK ES, P43; Lindell T, 1998, NORD J BOT, V18, P549, DOI 10.1111/j.1756-1051.1998.tb01535.x; Lonn M, 2002, OIKOS, V99, P489, DOI 10.1034/j.1600-0706.2002.11907.x; Lowe A., 2004, ECOLOGICAL GENETICS; Meusel H, 1965, TEXT U KARTEN TEXT U KARTEN, V1; Millar C, 1991, NATURA 2000 HALOZAT, P149; MILLAR CI, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P149; Molnar VA, 2015, APPL ECOL ENV RES, V13, P1097, DOI 10.15666/aeer/1304_10971108; MOURA AE, 2014, MOL BIOL EVOL, V32, DOI DOI 10.1093/MOLBER/MSU058; Neel MC, 2003, CONSERV GENET, V4, P337, DOI 10.1023/A:1024017029933; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Pandey M, 2012, AM J BOT, V99, P690, DOI 10.3732/ajb.1100116; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson A, 2008, PLANT ECOL, V198, P101, DOI 10.1007/s11258-007-9388-4; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pilt Indrek, 2002, Proceedings of the Estonian Academy of Sciences Biology Ecology, V51, P242; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritchard JK, 2000, GENETICS, V155, P945; Prsa D., 2005, CHRANENE RASTLINY CE; Prusa D, 2005, CONSERVATION BIOL; Pullin AS, 2002, SCHRIFTEN DES VEREIN; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rasmussen IR, 1992, THE 2000 RED LIST OF, V89, P278; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roder D, 2006, FLORA, V201, P499, DOI 10.1016/j.flora.2005.11.001; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYBKA V, 2005, PLANTS OF THE NATURA; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smidova A, 2011, FLORA, V206, P151, DOI 10.1016/j.flora.2010.03.003; SOULE ME, 1986, BIOL CONSERV, V35, P19, DOI 10.1016/0006-3207(86)90025-X; Sramko G, 2014, ANN BOT-LONDON, V114, P1609, DOI 10.1093/aob/mcu179; StatSoft I, 2011, STATISTICA DAT AN SO; Szczecinska M, 2013, CONSERV GENET RESOUR, V5, P421, DOI 10.1007/s12686-012-9818-z; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tutin T.G., 1993, FLORA EUROPAEA, V2nd, P264; Uotila Pertti, 1996, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V31, P205; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; Vergeer P, 2003, J ECOL, V91, P18, DOI 10.1046/j.1365-2745.2003.00736.x; Vinceti B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059987; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; W?jtowicz W., 2000, BIUL OGR BOT, V9, P45; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Wojtowicz W., 2004, PORADNIK OCHRONY SIE; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; WRIGHT S, 1951, ANN EUGENIC, V15, P323; YUZEPCHUK SV, 1937, FLORA USSR, P285; Yuzepchuk SV, 1937, DIE KULTURPFANZE BEI, P285; Zimmermann W, 1962, KRAJOWY PLAN OCHRONY, V3, P93; Zimmermann W, 1963, OECOLOGIA, V103, P99	121	62	69	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151730	10.1371/journal.pone.0151730	http://dx.doi.org/10.1371/journal.pone.0151730			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003296	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000372697400040
J	Xue, Y; Yang, ZY; Wang, XY; Lin, ZP; Li, DX; Su, SF				Xue, Yang; Yang, Zhongyang; Wang, Xiaoyan; Lin, Zhipan; Li, Dunxi; Su, Shaofeng			Tree Biomass Allocation and Its Model Additivity for Casuarina equisetifolia in a Tropical Forest of Hainan Island, China	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; ABOVEGROUND BIOMASS; ALLOMETRIC MODELS; EXPANSION FACTORS; LOBLOLLY-PINE; WOOD DENSITY; EQUATIONS; STAND; DIAMETER; PREDICTIONS	Casuarina equisetifolia is commonly planted and used in the construction of coastal shelter-belt protection in Hainan Island. Thus, it is critical to accurately estimate the tree biomass of Casuarina equisetifolia L. for forest managers to evaluate the biomass stock in Hainan. The data for this work consisted of 72 trees, which were divided into three age groups: young forest, middle-aged forest, and mature forest. The proportion of biomass from the trunk significantly increased with age (P<0.05). However, the biomass of the branch and leaf decreased, and the biomass of the root did not change. To test whether the crown radius (CR) can improve biomass estimates of C. equisetifolia, we introduced CR into the biomass models. Here, six models were used to estimate the biomass of each component, including the trunk, the branch, the leaf, and the root. In each group, we selected one model among these six models for each component. The results showed that including the CR greatly improved the model performance and reduced the error, especially for the young and mature forests. In addition, to ensure biomass additivity, the selected equation for each component was fitted as a system of equations using seemingly unrelated regression (SUR). The SUR method not only gave efficient and accurate estimates but also achieved the logical additivity. The results in this study provide a robust estimation of tree biomass components and total biomass over three groups of C. equisetifolia.	[Xue, Yang; Yang, Zhongyang; Wang, Xiaoyan; Lin, Zhipan; Li, Dunxi; Su, Shaofeng] Forestry Res Inst Hainan Prov, Haikou 57L100, Hainan, Peoples R China		Yang, ZY (corresponding author), Forestry Res Inst Hainan Prov, Haikou 57L100, Hainan, Peoples R China.	yangzy_hk@163.com			State Forestry Bureau research and public service industry [201304320]; Beijing Natural Science Foundation [8152033]; National Natural Science Foundation of China [31400538]	State Forestry Bureau research and public service industry; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the State Forestry Bureau research and public service industry (No. 201304320), Beijing Natural Science Foundation (No. 8152033), and the National Natural Science Foundation of China (No. 31400538).	Albaugh TJ, 2004, FOREST ECOL MANAG, V192, P3, DOI 10.1016/j.foreco.2004.01.002; Antonio N, 2007, CAN J FOREST RES, V37, P895, DOI 10.1139/X06-276; BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Bi HQ, 2004, TREES-STRUCT FUNCT, V18, P467, DOI 10.1007/s00468-004-0333-z; Bijak S, 2013, SILVA FENN, V47, DOI 10.14214/sf.963; BORDERS BE, 1989, FOREST SCI, V35, P548; Burkes EC, 2003, FOREST SCI, V49, P224; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; CANNELL MGR, 1984, FOREST ECOL MANAG, V8, P299, DOI 10.1016/0378-1127(84)90062-8; Case BS, 2008, CAN J FOREST RES, V38, P878, DOI 10.1139/X07-212; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clutter JL, 1983, TIMBER MANAGEMENT QU; F.S. Popoola, 2012, Journal of forest and environmental science, V28, P63; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Goodman RC, 2014, ECOL APPL, V24, P680, DOI 10.1890/13-0070.1; Gower ST, 1996, ECOLOGY, V77, P1750, DOI 10.2307/2265780; Hasenauer H, 1996, FOREST ECOL MANAG, V84, P49, DOI 10.1016/0378-1127(96)03768-1; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; Jalkanen A, 2005, ANN FOREST SCI, V62, P845, DOI 10.1051/forest:2005075; Jenkins JC, 2003, FOREST SCI, V49, P12; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; KOZAK A, 1970, FOREST CHRON, V46, P402, DOI 10.5558/tfc46402-5; Laar A. van, 1982, South African Forestry Journal, P8; LEECH JW, 1984, AUST FOREST RES, V14, P333; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; Levy PE, 2004, FORESTRY, V77, P421, DOI 10.1093/forestry/77.5.421; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Lie G, 2015, TREES-STRUCT FUNCT, P1; Liu XZ, 2014, FOREST ECOL MANAG, V322, P19, DOI 10.1016/j.foreco.2014.03.020; MacFarlane DW, 2015, FOREST ECOL MANAG, V354, P43, DOI 10.1016/j.foreco.2015.06.038; Makela A, 2006, ECOLOGY, V87, P2967, DOI 10.1890/0012-9658(2006)87[2967:CRIASI]2.0.CO;2; Mbow C, 2014, J FOREST RES-JPN, V19, P340, DOI 10.1007/s10310-013-0414-1; Medhurst JL, 1999, TREES-STRUCT FUNCT, V14, P91, DOI 10.1007/s004680050213; Mendonza LA, 1983, CASUARINA ECOLOGY MA, P53; Mugasha WA, 2013, FOREST ECOL MANAG, V310, P87, DOI 10.1016/j.foreco.2013.08.003; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P990, DOI 10.1016/j.foreco.2008.06.001; Overman Johannes Petrus Maria, 1994, Journal of Tropical Ecology, V10, P207; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; Parresol BR, 1999, FOREST SCI, V45, P573; Parresol BR, 2001, CAN J FOREST RES, V31, P865, DOI 10.1139/cjfr-31-5-865; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Petersson H, 2012, FOREST ECOL MANAG, V270, P78, DOI 10.1016/j.foreco.2012.01.004; Russell M., 2008, FOREST ECOL MANAG; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Saint-Andre L, 2005, FOREST ECOL MANAG, V205, P199, DOI 10.1016/j.foreco.2004.10.006; Sanquetta CR, 2015, ANN FOREST SCI, V72, P1099, DOI 10.1007/s13595-015-0497-2; Schroeder P, 1997, FOREST SCI, V43, P424; Segura M, 2005, BIOTROPICA, V37, P2, DOI 10.1111/j.1744-7429.2005.02027.x; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; SNOWDON P, 1991, CAN J FOREST RES, V21, P720, DOI 10.1139/x91-101; Soethe N, 2007, ECOL MODEL, V207, P363, DOI 10.1016/j.ecolmodel.2007.05.007; Tobin B, 2006, FORESTRY, V79, P453, DOI 10.1093/forestry/cpl030; VANLEAR DH, 1995, CAN J FOREST RES, V25, P361, DOI 10.1139/x95-040; Vanninen P, 1996, TREES-STRUCT FUNCT, V10, P231, DOI 10.1007/BF02185674; Wagner RG, 1999, ANN FOREST SCI, V56, P193, DOI 10.1051/forest:19990301; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang JS, 2013, DENDROBIOLOGY, V70, P13, DOI 10.12657/denbio.070.002; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; WARING RH, 1985, ECOLOGY, V66, P889, DOI 10.2307/1940551; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WIANT HV, 1979, FOREST SCI, V25, P167; [吴春燕 Wu Chunyan], 2014, [东北林业大学学报, Journal of North-East Forestry University], V42, P67; Yang Jenq-Chun, 1995, Bulletin of Taiwan Forestry Research Institute New Series, V10, P195; [杨众养 Yang Zongyang], 2015, [东北林业大学学报, Journal of North-East Forestry University], V43, P36; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]; Ye G., 2011, COASTAL ECOSYSTEM CA; Zhang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079868; Zhang XQ, 2010, FOREST SCI, V56, P552; Zhang XL, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/249485; Zhong Chong-lu, 2005, Forest Research, V18, P345; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5	76	18	19	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151858	10.1371/journal.pone.0151858	http://dx.doi.org/10.1371/journal.pone.0151858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002822	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400051
J	Yamagata, K; Makino, H; Iseki, K; Ito, S; Kimura, K; Kusano, E; Shibata, T; Tomita, K; Narita, I; Nishino, T; Fujigaki, Y; Mitarai, T; Watanabe, T; Wada, T; Nakamura, T; Matsuo, S				Yamagata, Kunihiro; Makino, Hirofumi; Iseki, Kunitoshi; Ito, Sadayoshi; Kimura, Kenjiro; Kusano, Eiji; Shibata, Takanori; Tomita, Kimio; Narita, Ichiei; Nishino, Tomoya; Fujigaki, Yoshihide; Mitarai, Tetsuya; Watanabe, Tsuyoshi; Wada, Takashi; Nakamura, Teiji; Matsuo, Seiichi		Study Grp Frontier Renal Outcome	Effect of Behavior Modification on Outcome in Early-to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial	PLOS ONE			English	Article							PREDIALYSIS PSYCHOEDUCATIONAL INTERVENTION; GLOMERULAR-FILTRATION-RATE; FOLLOW-UP; MULTIFACTORIAL INTERVENTION; CARDIOVASCULAR OUTCOMES; RENAL-INSUFFICIENCY; GENERAL-POPULATION; RISK; DIALYSIS; CARE	Objectives Owing to recent changes in our understanding of the underlying cause of chronic kidney disease (CKD), the importance of lifestyle modification for preventing the progression of kidney dysfunction and complications has become obvious. In addition, effective cooperation between general physicians (GPs) and nephrologists is essential to ensure a better care system for CKD treatment. In this cluster-randomized study, we studied the effect of behavior modification on the outcome of early-to moderate-stage CKD. Design Stratified open cluster-randomized trial. Setting A total of 489 GPs belonging to 49 local medical associations (clusters) in Japan. Participants A total of 2,379 patients (1,195 in group A (standard intervention) and 1,184 in group B (advanced intervention)) aged between 40 and 74 years, who had CKD and were under consultation with GPs. Intervention All patients were managed in accordance with the current CKD guidelines. The group B clusters received three additional interventions: patients received both educational intervention for lifestyle modification and a CKD status letter, attempting to prevent their withdrawal from treatment, and the group B GPs received data sheets to facilitate reducing the gap between target and practice. Main outcome measure The primary outcome measures were 1) the non-adherence rate of accepting continuous medical follow-up of the patients, 2) the collaboration rate between GPs and nephrologists, and 3) the progression of CKD. Results The rate of discontinuous clinical visits was significantly lower in group B (16.2% in group A vs. 11.5% in group B, p = 0.01). Significantly higher referral and co-treatment rates were observed in group B (p<0.01). The average eGFR deterioration rate tended to be lower in group B (group A: 2.6 +/- 5.8 ml/min/1.73 m(2)/year, group B: 2.4 +/- 5.1 ml/min/1.73 m(2)/year, p = 0.07). A significant difference in eGFR deterioration rate was observed in subjects with Stage 3 CKD (group A: 2.4 +/- 5.9 ml/min/1.73 m(2)/year, group B: 1.9 +/- 4.4 ml/min/1.73 m(2)/year, p = 0.03). Conclusion Our care system achieved behavior modification of CKD patients, namely, significantly lower discontinuous clinical visits, and behavior modification of both GPs and nephrologists, namely significantly higher referral and co-treatment rates, resulting in the retardation of CKD progression, especially in patients with proteinuric Stage 3 CKD.	[Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan; [Makino, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008530, Japan; [Iseki, Kunitoshi] Univ Hosp Ryukyus, Dialysis Unit, Okinawa, Japan; [Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Hypertens & Nephrol, Yokohama, Kanagawa, Japan; [Kusano, Eiji] Jichi Med Univ, Dept Med, Div Nephrol, Shimotsuke, Tochigi, Japan; [Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Tomita, Kimio] Kumamoto Univ, Dept Nephrol, Kumamoto, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Nishino, Tomoya] Nagasaki Univ, Sch Med, Dept Internal Med 2, Div Nephrol, Nagasaki 852, Japan; [Fujigaki, Yoshihide] Hamamatsu Univ Sch Med, Internal Med 1, Shizuoka, Japan; [Mitarai, Tetsuya] Saitama Med Sch, Saitama Med Ctr, Div Nephrol & Hypertens, Saitama, Japan; [Watanabe, Tsuyoshi] Fukushima Med Univ, Sch Med, Dept Internal Med 3, Fukushima, Japan; [Wada, Takashi] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Div Nephrol,Dept Lab Med, Ishikawa, Japan; [Nakamura, Teiji] Japan Dietitian Assoc, Tokyo, Japan; [Matsuo, Seiichi] Nagoya Univ, Dept Nephrol, Nagoya, Aichi 4648601, Japan	University of Tsukuba; Okayama University; University of the Ryukyus; Tohoku University; Saint Marianna University; Jichi Medical University; Showa University; Kumamoto University; Niigata University; Nagasaki University; Hamamatsu University School of Medicine; Saitama Medical University; Fukushima Medical University; Kanazawa University; Nagoya University	Yamagata, K (corresponding author), Univ Tsukuba, Fac Med, Dept Nephrol, Tsukuba, Ibaraki, Japan.	k-yamaga@md.tsukuba.ac.jp	Narita, Ichiei/G-5204-2017; Ito, Sadayoshi/A-3933-2015	Narita, Ichiei/0000-0001-7692-3096; Ito, Sadayoshi/0000-0002-5092-3626	Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and development, AMED; Institute of Statistical Mathematics Cooperative Use Registration Program [2013-ISM CRP-0006]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Institute of Statistical Mathematics Cooperative Use Registration Program	This study was supported by a grant for a strategic outcome study project from the Ministry of Health, Labour and Welfare of Japan and a Grant-in-Aid for Research on Advanced Chronic Kidney Disease, Practical Research Project for Renal Diseases from Japan Agency for Medical Research and development, AMED. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The statistical analysis in this study was carried out using the Institute of Statistical Mathematics Cooperative Use Registration Program (2013-ISM CRP-0006).; This study was supported by a grant for a strategic outcome study project from the Ministry of Health, Labour and Welfare of Japan, and supported in part by a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Diseases from Japan Agency for Medical Research and development, AMED.	Akizawa T, 2009, AM J KIDNEY DIS, V54, P459, DOI 10.1053/j.ajkd.2009.05.011; Brugts JJ, 2005, ARCH INTERN MED, V165, P2659, DOI 10.1001/archinte.165.22.2659; Chen YR, 2013, NEPHROL DIAL TRANSPL, V28, P671, DOI 10.1093/ndt/gfs469; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Denker M, 2015, CLIN J AM SOC NEPHRO; Devins GM, 2005, AM J KIDNEY DIS, V46, P1088, DOI 10.1053/j.ajkd.2005.08.017; Devins GM, 2003, AM J KIDNEY DIS, V42, P693, DOI 10.1016/S0272-6386(03)00835-7; Evans CD, 2012, AM J HYPERTENS, V25, P195, DOI 10.1038/ajh.2011.198; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Imai E, 2011, DIABETOLOGIA, V54, P2978, DOI 10.1007/s00125-011-2325-z; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jungers P, 2002, NEPHROL DIAL TRANSPL, V17, P371, DOI 10.1093/ndt/17.3.371; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; Munger Mark A, 2007, MedGenMed, V9, P58; Nakayama M, 2010, CLIN EXP NEPHROL, V14, P333, DOI 10.1007/s10157-010-0295-y; Okubo R, 2014, CLIN EXP NEPHROL, V18, P697, DOI 10.1007/s10157-013-0901-x; Peeters MJ, 2014, J AM SOC NEPHROL, V25, P390, DOI 10.1681/ASN.2012121222; Pladevall M, 2010, CIRCULATION, V122, P1183, DOI 10.1161/CIRCULATIONAHA.109.892778; RCore Team, 2020, R LANG ENV STAT COMP; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Usami T, 2000, JAMA-J AM MED ASSOC, V284, P2622, DOI 10.1001/jama.284.20.2622; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yamagata K, 2012, THER APHER DIAL, V16, P54, DOI 10.1111/j.1744-9987.2011.01005.x; Yamagata K, 2010, CLIN EXP NEPHROL, V14, P144, DOI 10.1007/s10157-009-0249-4; Yokoyama Y, 2009, NEPHRON CLIN PRACT, V113, pC191, DOI 10.1159/000232601	32	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151422	10.1371/journal.pone.0151422	http://dx.doi.org/10.1371/journal.pone.0151422			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999730	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700041
J	Lozada, M; Adamo, PD; Buteler, M; Kuperman, MN				Lozada, Mariana; Adamo, Paola D'; Buteler, Micaela; Kuperman, Marcelo N.			Social Learning in Vespula Germanica Wasps: Do They Use Collective Foraging Strategies?	PLOS ONE			English	Article							STINGLESS BEES HYMENOPTERA; CUE-MEDIATED RECRUITMENT; VISUAL CUES; INFORMATION-TRANSFER; DECISION-MAKING; FOOD SOURCE; VESPIDAE; APIDAE; NEST; COMMUNICATION	Vespula germanica is a social wasp that has become established outside its native range in many regions of the world, becoming a major pest in the invaded areas. In the present work we analyze social communication processes used by V. germanica when exploiting undepleted food sources. For this purpose, we investigated the arrival pattern of wasps at a protein bait and evaluated whether a forager recruited conspecifics in three different situations: foragers were able to return to the nest (full communication), foragers were removed on arrival (communication impeded), or only one forager was allowed to return to the nest (local enhancement restricted). Results demonstrated the existence of recruitment in V. germanica, given that very different patterns of wasp arrivals and a higher frequency of wasp visits to the resource were observed when communication flow between experienced and naive foragers was allowed. Our findings showed that recruitment takes place at a distance from the food source, in addition to local enhancement. When both local enhancement and distant recruitment were occurring simultaneously, the pattern of wasp arrival was exponential. When recruitment occurred only distant from the feeder, the arrival pattern was linear, but the number of wasps arriving was twice as many as when neither communication nor local enhancement was allowed. Moreover, when return to the nest was impeded, wasp arrival at the bait was regular and constant, indicating that naive wasps forage individually and are not spatially aggregated. In conclusion, this is the first study to demonstrate recruitment in V. germanica at a distance from the food source by modelling wasps' arrival to a protein-based resource. In addition, the existence of correlations when communication was allowed and reflected in tandem arrivals indicates that we were not in the presence of random processes.	[Lozada, Mariana; Adamo, Paola D'; Buteler, Micaela] Univ Nacl Comahue, CONICET, INIBIOMA, Quintral 1250, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Kuperman, Marcelo N.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Kuperman, Marcelo N.] Ctr Atom Bariloche CNEA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Kuperman, Marcelo N.] Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Kuperman, MN (corresponding author), Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina.; Kuperman, MN (corresponding author), Ctr Atom Bariloche CNEA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.; Kuperman, MN (corresponding author), Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	kuperman@cab.cnea.gov.ar	Kuperman, Marcelo N/N-3783-2019	Kuperman, Marcelo N/0000-0003-0935-7949; D'Adamo, Paola/0000-0003-3037-5914	CONICET, Argentina	CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by CONICET, Argentina.	Aguilar I, 2005, APIDOLOGIE, V36, P313, DOI 10.1051/apido:2005005; Akre R. D., 1986, EC IMPACT CONTROL SO; Akre RD, 1982, SOCIAL INSECTS; [Anonymous], 1971, INSECT SOC; Archer Michael E., 1998, Entomologist's Monthly Magazine, V134, P279; Bartlett MS, 1981, INTRO STOCHASTIC PRO; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; COLLETT TS, 1993, P ROY SOC B-BIOL SCI, V252, P129, DOI 10.1098/rspb.1993.0056; D'Adamo P, 2000, INSECT SOC, V47, P289, DOI 10.1007/PL00001717; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; D'Adamo P, 2005, ANN ENTOMOL SOC AM, V98, P236, DOI 10.1603/0013-8746(2005)098[0236:CAFAIT]2.0.CO;2; D'Adamo P, 2007, INSECT SCI, V14, P383, DOI 10.1111/j.1744-7917.2007.00165.x; D'Adamo P, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.10301; D'Adamo P, 2009, ANN ENTOMOL SOC AM, V102, P1109, DOI 10.1603/008.102.0620; EDWARDS R, 1976, Entomologica Germanica, V3, P269; Hrncir M, 2007, BEHAV ECOL SOCIOBIOL, V61, P975, DOI 10.1007/s00265-006-0326-6; Jandt JM, 2005, ETHOLOGY, V111, P641, DOI 10.1111/j.1439-0310.2005.01088.x; JEANNE RL, 1995, J KANSAS ENTOMOL SOC, V68, P279; Jeanne RL, 2009, CONTEMP TOP ENTOMOL, P53; LEHRER M, 1994, J COMP PHYSIOL A, V175, P171, DOI 10.1007/BF00215113; Lozada M, 2009, ENVIRON ENTOMOL, V38, P803, DOI 10.1603/022.038.0333; Lozada M, 2006, J INSECT BEHAV, V19, P591, DOI 10.1007/s10905-006-9045-0; Lozada M, 2014, J PHYSIOL-PARIS, V108, P187, DOI 10.1016/j.jphysparis.2014.05.006; Lozada M, 2011, J INSECT BEHAV, V24, P159, DOI 10.1007/s10905-010-9244-6; MASCHWITZ U, 1974, NATURWISSENSCHAFTEN, V61, P506, DOI 10.1007/BF00622975; Mc Cabe SI, 2010, J COMP PHYSIOL A, V196, P481, DOI 10.1007/s00359-010-0536-2; Mc Cabe SI, 2009, J COMP PHYSIOL A, V195, P113, DOI 10.1007/s00359-008-0391-6; Moreyra S, 2006, AUST J ZOOL, V54, P393, DOI 10.1071/ZO06029; Moreyra S, 2012, ANN ENTOMOL SOC AM, V105, P128, DOI 10.1603/AN11097; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; Nieh JC, 2009, ORG INSECTS SOC GENO; Overmyer SL, 1998, BEHAV ECOL SOCIOBIOL, V42, P17, DOI 10.1007/s002650050407; PARRISH MD, 1983, ECOL ENTOMOL, V8, P185, DOI 10.1111/j.1365-2311.1983.tb00497.x; Pasteels J.M., 1987, INDIVIDUAL COLLECTIV; Richter MR, 1999, INSECT SOC, V46, P131, DOI 10.1007/s000400050123; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Santoro D, 2015, INSECT SOC, V62, P207, DOI 10.1007/s00040-015-0395-5; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Schueller Teresa I., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/585014; Schueller TI, 2010, NATURWISSENSCHAFTEN, V97, P1017, DOI 10.1007/s00114-010-0712-9; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Taylor Benjamin J., 2011, Psyche (Cambridge), V2011, P1, DOI 10.1155/2011/378576; Taylor BJ, 2010, NATURWISSENSCHAFTEN, V97, P1041, DOI 10.1007/s00114-010-0724-5; Thorpe, 1963, LEARNING INSTINCT AN; Wilson-Rankin EE, 2015, BEHAV ECOL SOCIOBIOL, V69, P491, DOI 10.1007/s00265-014-1861-1; Wilson-Rankin EE, 2014, BEHAV ECOL SOCIOBIOL, V68, P1151, DOI 10.1007/s00265-014-1726-7; Zeil J, 1996, J EXP BIOL, V199, P245	51	10	10	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0152080	10.1371/journal.pone.0152080	http://dx.doi.org/10.1371/journal.pone.0152080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990864	Green Published, gold			2022-12-27	WOS:000372582800130
J	Yu, HL; Gao, Q; Shao, ZQ; Ying, AN; Sun, YY; Liu, JW; Mao, W; Zhang, B				Yu, Hailing; Gao, Qiang; Shao, Zeqiang; Ying, Anning; Sun, Yuyang; Liu, Jingwei; Mao, Wei; Zhang, Bin			Decreasing Nitrogen Fertilizer Input Had Little Effect on Microbial Communities in Three Types of Soils	PLOS ONE			English	Article							BIOMASS; ACIDIFICATION; BARLEY; CARBON	In this study, we examined the influence of different nitrogen (N) application rates (0, 168, 240, 270 and 312 kg N ha(-1)) on soil properties, maize (Zea mays L.) yields and microbial communities of three types of soils (clay, alluvial and sandy soils). Phospholipid fatty acid analysis was used to characterize soil microbial communities. Results indicated that N fertilization significantly decreased microbial biomass in both clay and sandy soils regardless of application rate. These decreases were more likely a result of soil pH decreases induced by N fertilization, especially in the sandy soils. This is supported by structural equation modeling and redundancy analysis results. Nitrogen fertilization also led to significant changes in soil microbial community composition. However, the change differences were gradually dismissed with increase in N application rate. We also observed that N fertilization increased maize yields to the same level regardless of application rate. This suggests that farmers could apply N fertilizers at a lower rate (i.e. 168 kg N ha(-1)), which could achieve high maize yield on one hand while maintain soil microbial functions on the other hand.	[Yu, Hailing; Gao, Qiang; Shao, Zeqiang; Ying, Anning; Sun, Yuyang; Liu, Jingwei; Mao, Wei] Jilin Agr Univ, Coll Resources & Environm, Changchun 130122, Jilin, Peoples R China; [Zhang, Bin] Shenyang Agr Univ, Coll Land & Environm, Shenyang 110161, Liaoning, Peoples R China	Jilin Agricultural University; Shenyang Agricultural University	Gao, Q (corresponding author), Jilin Agr Univ, Coll Resources & Environm, Changchun 130122, Jilin, Peoples R China.; Zhang, B (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang 110161, Liaoning, Peoples R China.	gyt199962@163.com; bzhang@syau.edu.cn	shao, zeqiang/AAE-2180-2022	shao, zeqiang/0000-0003-3268-4876	Special Fund for Agro-scientific Research in the Public Interest [201103003]; National Natural Science Foundation of China [41401332]; Modern agricultural maize industry technology system [CARS-02]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern agricultural maize industry technology system	This work was financially supported by the Special Fund for Agro-scientific Research in the Public Interest (201103003, http://www.moa.gov.cn/), the National Natural Science Foundation of China (41401332, http://www.nsfc.gov.cn/), and the Modern agricultural maize industry technology system (CARS-02, http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Barak P, 1997, PLANT SOIL, V197, P61, DOI 10.1023/A:1004297607070; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Burow KR, 2010, ENVIRON SCI TECHNOL, V44, P4988, DOI 10.1021/es100546y; Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; IUSS Working Group WRB, 2014, WOLRD SOIL RES REP, V106; Kirchmann H, 2013, ACTA AGR SCAND B-S P, V63, P25, DOI 10.1080/09064710.2012.711352; Lu RK, 2000, METHODS SOIL AGROCHI; Lupwayi NZ, 2012, SOIL TILL RES, V118, P139, DOI 10.1016/j.still.2011.11.006; Lupwayi NZ, 2011, AGRON J, V103, P1064, DOI 10.2134/agronj2010.0334; Muller T, 2006, CURR MICROBIOL, V52, P400, DOI 10.1007/s00284-005-0370-x; Omar SA, 1999, FOLIA MICROBIOL, V44, P205, DOI 10.1007/BF02816244; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Roberts BA, 2011, SOIL SCI, V176, P487, DOI 10.1097/SS.0b013e31822769d3; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Rutherford PM, 2006, SOIL SAMPLING METHOD; Savci S., 2012, International Journal of Environmental Science and Development, V3, P77; SCHWAB AP, 1990, SOIL SCI, V149, P35, DOI 10.1097/00010694-199001000-00004; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith J.L., 1996, SSSA SPEC PUBL, V49, P169, DOI DOI 10.2136/SSSASPECPUB49.C10; Sommers D.W., 1996, METHODS SOIL ANAL; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Yevdokimov I, 2008, BIOL FERT SOILS, V44, P1103, DOI 10.1007/s00374-008-0315-1; Zhang B, 2016, J AGR SCI-CAMBRIDGE, V154, P1051, DOI 10.1017/S0021859615001008; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	35	15	18	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151622	10.1371/journal.pone.0151622	http://dx.doi.org/10.1371/journal.pone.0151622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992097	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800080
J	Auge, AC; Auld, HL; Sherratt, TN; Godin, JGJ				Auge, Anne-Christine; Auld, Heather L.; Sherratt, Thomas N.; Godin, Jean-Guy J.			Do Males Form Social Associations Based on Sexual Attractiveness in a Fission-Fusion Fish Society?	PLOS ONE			English	Article							MALE TRINIDADIAN GUPPIES; ALTERNATIVE MATING TACTICS; SPERM COMPETITION RISK; FEMALE MATE PREFERENCE; POECILIA-RETICULATA; MALE PHENOTYPE; INTERACTING PHENOTYPES; SHOALING PREFERENCES; MULTIPLE PATERNITY; PREDATION RISK	Recent theory predicts that males should choose social environments that maximize their relative attractiveness to females by preferentially associating with less attractive rivals, so as to enhance their mating success. Using the Trinidadian guppy (Poecilia reticulata), a highly social species, we tested for non-random social associations among males in mixedsex groups based on two phenotypic traits (body length and coloration) that predict relative sexual attractiveness to females and sexual (sperm) competitiveness. Based on a well-replicated laboratory dichotomous-choice test of social group preference, we could not reject the null hypothesis that focal males chose randomly between a mixed-sex group that comprised a female and a rival male that was less sexually attractive than themselves and another mixed-sex group containing a sexually more attractive male. The same conclusion was reached when females were absent from the two groups. As might be expected from these laboratory findings, free-ranging males in the field were not assorted by either body length or colour in mixed-sex shoals. The apparent lack of an evolved and expressed preference in wild male guppies from our study population to form social associations with other males based on their relative sexual attractiveness and competitiveness might be due to the fission-fusion dynamics of guppy shoals in nature. Such social dynamics likely places constraints on the formation of stable phenotype-based social associations among males. This possibility is supported by a simulation model which assumes group departure rules based on relative body size and coloration in males.	[Auge, Anne-Christine; Auld, Heather L.; Sherratt, Thomas N.; Godin, Jean-Guy J.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Auge, Anne-Christine] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	Carleton University; University of Ottawa	Godin, JGJ (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	jgodin@carleton.ca	Auld, Heather/V-6772-2019	Auld, Heather/0000-0002-8239-1572; Auge, Anne-Christine/0000-0002-1111-2003	Natural Sciences and Engineering Research Council of Canada; Research Grant (RGPIN) [8074-2010]; German Academic Exchange Service (DAAD)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research Grant (RGPIN); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (www.nserc.ca); Research Grant (RGPIN 8074-2010) awarded to JGJG and a German Academic Exchange Service (DAAD) (www.daad.de/en/) Scholarship Awarded to ACA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; [Anonymous], 2013, MATLAB STAT TOOLB RE; Auld HL, 2015, BEHAV ECOL SOCIOBIOL, V69, P1191, DOI 10.1007/s00265-015-1933-x; Bailey NW, 2012, TRENDS ECOL EVOL, V27, P561, DOI 10.1016/j.tree.2012.05.011; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; BISAZZA A, 1989, ETHOLOGY, V83, P335, DOI 10.1111/j.1439-0310.1989.tb00541.x; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Callander S, 2013, BEHAV ECOL, V24, P730, DOI 10.1093/beheco/ars208; Couzin ID, 2009, CURR BIOL, V19, pR633, DOI 10.1016/j.cub.2009.05.034; Croft DP, 2012, OECOLOGIA, V170, P955, DOI 10.1007/s00442-012-2379-8; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1495, DOI 10.1007/s00265-009-0802-x; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; DUGATKIN LA, 1994, BEHAV ECOL SOCIOBIOL, V35, P141, DOI 10.1007/BF00171504; DUGATKIN LA, 1995, ETHOLOGY, V99, P265; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; FARR JA, 1976, EVOLUTION, V30, P707, DOI 10.1111/j.1558-5646.1976.tb00951.x; Formica VA, 2011, EVOLUTION, V65, P2771, DOI 10.1111/j.1558-5646.2011.01340.x; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Godin JGJ, 2013, ECOL EVOL, V3, P2020, DOI 10.1002/ece3.607; GODIN JGJ, 1995, OECOLOGIA, V103, P224, DOI 10.1007/BF00329084; Godin JGJ, 2003, CAN J ZOOL, V81, P1899, DOI [10.1139/z03-186, 10.1139/Z03-186]; Godin JGJ, 1996, ANIM BEHAV, V51, P117, DOI 10.1006/anbe.1996.0010; Griffiths SW, 1997, ANIM BEHAV, V53, P945, DOI 10.1006/anbe.1996.0315; Griffiths SW, 1997, P ROY SOC B-BIOL SCI, V264, P547, DOI 10.1098/rspb.1997.0078; Guevara-Fiore P, 2010, ANIM BEHAV, V79, P1191, DOI 10.1016/j.anbehav.2010.02.027; Guevara-Fiore P, 2009, ANIM BEHAV, V77, P425, DOI 10.1016/j.anbehav.2008.10.018; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Jeswiet SB, 2011, ETHOLOGY, V117, P422, DOI 10.1111/j.1439-0310.2011.01891.x; Jeswiet SB, 2011, ANIM BEHAV, V81, P639, DOI 10.1016/j.anbehav.2010.12.013; Jirotkul M, 1999, ANIM BEHAV, V58, P287, DOI 10.1006/anbe.1999.1149; Jirotkul M, 1999, ANIM BEHAV, V58, P1169, DOI 10.1006/anbe.1999.1248; Jirotkul M, 2000, J FISH BIOL, V56, P1427, DOI 10.1111/j.1095-8649.2000.tb02154.x; Jordan LA, 2012, EVOLUTION, V66, P280, DOI 10.1111/j.1558-5646.2011.01421.x; Kelley JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024280; Kelly CD, 1999, P ROY SOC B-BIOL SCI, V266, P2403, DOI 10.1098/rspb.1999.0938; Krause J, 2002, LIVING GROUPS; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Locatello L, 2006, J EVOLUTION BIOL, V19, P1595, DOI 10.1111/j.1420-9101.2006.01117.x; Magellan K, 2005, BEHAV ECOL SOCIOBIOL, V58, P366, DOI 10.1007/s00265-005-0950-6; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; Miller LK, 2005, EVOLUTION, V59, P2414; Neff BD, 2008, MOL ECOL, V17, P2975, DOI 10.1111/j.1365-294X.2008.03816.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Oh KP, 2010, AM NAT, V176, pE80, DOI 10.1086/655216; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Pilastro A, 1999, P ROY SOC B-BIOL SCI, V266, P1887, DOI 10.1098/rspb.1999.0862; Pitcher TE, 2007, J FISH BIOL, V70, P165, DOI 10.1111/j.1095-8649.2006.01292.x; Pitcher TE, 2001, CAN J ZOOL, V79, P1891, DOI 10.1139/cjz-79-10-1891; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Pitcher Tony J., 1993, Fish and Fisheries Series, V7, P363; R Core Team, 2021, R LANGUAGE ENV STAT; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; RODD FH, 1995, ANIM BEHAV, V49, P1139, DOI 10.1006/anbe.1995.0149; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; Song ZB, 2011, ETHOLOGY, V117, P1009, DOI 10.1111/j.1439-0310.2011.01952.x; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168	71	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151243	10.1371/journal.pone.0151243	http://dx.doi.org/10.1371/journal.pone.0151243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986565	Green Published, gold			2022-12-27	WOS:000372580300056
J	Carpenter, SM; Yates, JF; Preston, SD; Chen, L				Carpenter, Stephanie M.; Yates, J. Frank; Preston, Stephanie D.; Chen, Lydia			Regulating Emotions during Difficult Multiattribute Decision Making: The Role of Pre-Decisional Coherence Shifting	PLOS ONE			English	Article							ANAGRAM SOLUTION TIMES; DOWN-REGULATION; INFORMATION; DIFFERENTIATION; CONSOLIDATION; DISTORTION; PATTERNS; STRESS	Almost all real-life decisions entail attribute conflict; every serious choice alternative is better than its competitors on some attribute dimensions but worse on others. In pre-decisional "coherence shifting," the decision maker gradually softens that conflict psychologically to the point where one alternative is seen as dominant over its competitors, or nearly so. Specifically, weaknesses of the eventually chosen alternative come to be perceived as less severe and less important while its strengths seem more desirable and significant. The research described here demonstrates that difficult multiattribute decision problems are aversive and that pre-decisional coherence shifting aids individuals in regulating that emotional discomfort. Across three studies, attribute conflict was confirmed to be aversive (Study 1), and skin conductance responses and ratings of decision difficulty both decreased in participants who coherence shifted (Study 2). Coherence shifting was also diminished among decision makers who were depleted of regulatory resources, known to be required for common emotion regulation mechanisms. Further, coherence shifting was shown to be relatively common among people who reported strong suppression tendencies in everyday emotion regulation (Study 3). Overall, the data suggest that, at least in part, coherence shifting serves as a tool that helps decision makers manage the pre-decisional discomfort generated by attribute conflict. Theoretical and practical implications are discussed.	[Carpenter, Stephanie M.; Yates, J. Frank; Preston, Stephanie D.; Chen, Lydia] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Carpenter, Stephanie M.; Yates, J. Frank] Univ Michigan, Dept Mkt, Ross Sch Business, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Carpenter, SM; Yates, JF (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI USA.; Carpenter, SM; Yates, JF (corresponding author), Univ Michigan, Dept Mkt, Ross Sch Business, Ann Arbor, MI 48109 USA.	smcarpen@umich.edu; jfyates@umich.edu	Preston, Stephanie/U-6518-2019		University of Michigan Rackham research grant; University of Michigan Thurnau Professorship Award	University of Michigan Rackham research grant; University of Michigan Thurnau Professorship Award	This research was partly supported by a University of Michigan Rackham research grant that was awarded to the first author, and a University of Michigan Thurnau Professorship Award granted to the second author. There was no additional external funding received for these studies.	[Anonymous], 2001, J CONSUM RES; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Chaplin JE, 2012, B FRANKLINS AUTOBIOG, P259; Cooper J, 2007, COGNITIVE DISSONANCE; CROYLE RT, 1983, J PERS SOC PSYCHOL, V45, P782, DOI 10.1037/0022-3514.45.4.782; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Festinger L., 1962, THEORY COGNITIVE DIS; Fishburn PC, 1967, MANAGEMENT SCI, V13, P435, DOI DOI 10.1287/MNSC.13.7.435; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Gigerenzer G, 1999, SIMPLE HEURISTICS MA, P77; Glockner A, 2010, J BEHAV DECIS MAKING, V23, P439, DOI 10.1002/bdm.668; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1997, J PERS SOC PSYCHOL, V72, P435, DOI 10.1037/0022-3514.72.2.435; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hammond J., 1999, SMART CHOICES; Hobson NM, 2014, EMOTION, V14, P1014, DOI 10.1037/a0038028; HOGARTH RM, 1992, COGNITIVE PSYCHOL, V24, P1, DOI 10.1016/0010-0285(92)90002-J; Kiesler CA, 1976, PSYCHOL B, V83; Lerner JS, 1999, PSYCHOL BULL, V125, P255, DOI 10.1037/0033-2909.125.2.255; Mann L, 1997, J BEHAV DECIS MAKING, V10, P1, DOI 10.1002/(SICI)1099-0771(199703)10:1<1::AID-BDM242>3.0.CO;2-X; MAYZNER MS, 1962, J EXP PSYCHOL, V63, P510, DOI 10.1037/h0043721; MAYZNER MS, 1966, J EXP PSYCHOL, V71, P66, DOI 10.1037/h0022665; Meloy MG, 2000, J CONSUM RES, V27, P345, DOI 10.1086/317589; MOGG K, 1990, J PERS SOC PSYCHOL, V59, P1230, DOI 10.1037/0022-3514.59.6.1230; MONTGOMERY H, 1976, SCAND J PSYCHOL, V17, P283, DOI 10.1111/j.1467-9450.1976.tb00241.x; Montgomery H., 1983, ANAL AIDING DECISION, V14, P343, DOI DOI 10.1016/S0166-4115(08)62243-8; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Russo JE, 2008, J EXP PSYCHOL GEN, V137, P456, DOI 10.1037/a0012786; Russo JE, 1998, J MARKETING RES, V35, P438, DOI 10.2307/3152163; Russo JE, 1996, ORGAN BEHAV HUM DEC, V66, P102, DOI 10.1006/obhd.1996.0041; Russo JE, 2000, MANAGE SCI, V46, P13, DOI 10.1287/mnsc.46.1.13.15127; Saunders B, 2015, PSYCHOL INQ, V26, P108, DOI 10.1080/1047840X.2015.962396; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schwartz B, 2002, J PERS SOC PSYCHOL, V83, P1178, DOI 10.1037//0022-3514.83.5.1178; Sheppes G, 2011, PSYCHOL SCI, V22, P1391, DOI 10.1177/0956797611418350; Simon D, 2004, PSYCHOL SCI, V15, P331, DOI 10.1111/j.0956-7976.2004.00678.x; Simon D, 2008, J BEHAV DECIS MAKING, V21, P1, DOI 10.1002/bdm.575; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SVENSON O, 1992, ACTA PSYCHOL, V80, P143, DOI 10.1016/0001-6918(92)90044-E; SVENSON O, 1994, ACTA PSYCHOL, V87, P181, DOI 10.1016/0001-6918(94)90050-7; Svenson O, 2010, SCAND J PSYCHOL, V51, P93, DOI 10.1111/j.1467-9450.2009.00739.x	43	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150873	10.1371/journal.pone.0150873	http://dx.doi.org/10.1371/journal.pone.0150873			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986752	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300033
J	Kidd, S; Lieber, T				Kidd, Simon; Lieber, Toby			Mechanism of Notch Pathway Activation and Its Role in the Regulation of Olfactory Plasticity in Drosophila melanogaster	PLOS ONE			English	Article							LONG-TERM-MEMORY; TARGETED GENE-EXPRESSION; ANTENNAL LOBE; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; ADULT DROSOPHILA; HIPPOCAMPAL NETWORKS; TRANSGENIC RNAI; NEURAL ACTIVITY; MOSAIC ANALYSIS	The neural plasticity of sensory systems is being increasingly recognized as playing a role in learning and memory. We have previously shown that Notch, part of an evolutionarily conserved intercellular signaling pathway, is required in adult Drosophila melanogaster olfactory receptor neurons (ORNs) for the structural and functional plasticity of olfactory glomeruli that is induced by chronic odor exposure. In this paper we address how long-term exposure to odor activates Notch and how Notch in conjunction with chronic odor mediates olfactory plasticity. We show that upon chronic odor exposure a non-canonical Notch pathway mediates an increase in the volume of glomeruli by a mechanism that is autonomous to ORNs. In addition to activating a pathway that is autonomous to ORNs, chronic odor exposure also activates the Notch ligand Delta in second order projection neurons (PNs), but this does not appear to require acetylcholine receptor activation in PNs. Delta on PNs then feeds back to activate canonical Notch signaling in ORNs, which restricts the extent of the odor induced increase in glomerular volume. Surprisingly, even though the pathway that mediates the increase in glomerular volume is autonomous to ORNs, nonproductive transsynaptic Delta/Notch interactions that do not activate the canonical pathway can block the increase in volume. In conjunction with chronic odor, the canonical Notch pathway also enhances cholinergic activation of PNs. We present evidence suggesting that this is due to increased acetylcholine release from ORNs. In regulating physiological plasticity, Notch functions solely by the canonical pathway, suggesting that there is no direct connection between morphological and physiological plasticity.	[Kidd, Simon; Lieber, Toby] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, 701 W 168th St, New York, NY USA	Columbia University	Lieber, T (corresponding author), Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, 701 W 168th St, New York, NY USA.	toby.lieber@gmail.com			National Institutes of Health/National Institute of General Medical Sciences [RO1GM095797, RO1GM109183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095797, R01GM109183] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences grants RO1GM095797 and RO1GM109183 to Gary Struhl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2014, ELIFE, V3, DOI 10.7554/eLife.02109; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Arenas A, 2012, EUR J NEUROSCI, V35, P682, DOI 10.1111/j.1460-9568.2012.07999.x; Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Arenas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008046; Brai E, 2014, EUR J NEUROSCI, V40, P3436, DOI 10.1111/ejn.12719; Busto GU, 2010, PHYSIOLOGY, V25, P338, DOI 10.1152/physiol.00026.2010; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chakraborty TS, 2009, J NEUROGENET, V23, P210, DOI 10.1080/01677060802491559; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Conboy L, 2007, NEUROBIOL LEARN MEM, V88, P342, DOI 10.1016/j.nlm.2007.04.006; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahlhaus M, 2008, J NEUROSCI, V28, P10794, DOI 10.1523/JNEUROSCI.1348-08.2008; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Dias BG, 2014, NEURON, V83, P906, DOI 10.1016/j.neuron.2014.07.019; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Guven-Ozkan T, 2014, LEARN MEMORY, V21, P519, DOI 10.1101/lm.034363.114; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Kass MD, 2013, SCIENCE, V342, P1389, DOI 10.1126/science.1244916; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kidd S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005244; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuzina I, 2011, DEVELOPMENT, V138, P1839, DOI 10.1242/dev.062471; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Lee KS, 2013, GENE DEV, V27, P2642, DOI 10.1101/gad.225169.113; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li Q, 2015, CURR BIOL, V25, pR120, DOI 10.1016/j.cub.2014.11.044; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lieber T, 2011, NEURON, V69, P468, DOI 10.1016/j.neuron.2010.12.015; Liu SX, 2015, HIPPOCAMPUS, V25, P670, DOI 10.1002/hipo.22402; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Matsuno M, 2009, P NATL ACAD SCI USA, V106, P310, DOI 10.1073/pnas.0807665106; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Mejia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064685; Morrison FG, 2015, P NATL ACAD SCI USA; Morsut L, 2016, CELL, P1; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pavlopoulos E, 2008, P NATL ACAD SCI USA, V105, P14674, DOI 10.1073/pnas.0801605105; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Sargin D, 2013, NEUROBIOL LEARN MEM, V103, P39, DOI 10.1016/j.nlm.2013.03.001; Song JK, 2011, DEV DYNAM, V240, P324, DOI 10.1002/dvdy.22525; Spors H, 2012, J NEUROSCI, V32, P14102, DOI 10.1523/JNEUROSCI.3328-12.2012; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tan ZJ, 2010, P NATL ACAD SCI USA, V107, P9873, DOI 10.1073/pnas.1003480107; Twick I, 2014, PROG BRAIN RES, V208, P3, DOI 10.1016/B978-0-444-63350-7.00001-2; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Xie XH, 2012, DEV BIOL, V363, P399, DOI 10.1016/j.ydbio.2012.01.004; Yew JY, 2009, J PROTEOME RES, V8, P1271, DOI 10.1021/pr800601x; Yoon KJ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-40; Zhang JB, 2013, J NEUROSCI, V33, P12825, DOI 10.1523/JNEUROSCI.0783-13.2013; Zhang Jun-Jie, 2015, Chin J Integr Med	81	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151279	10.1371/journal.pone.0151279	http://dx.doi.org/10.1371/journal.pone.0151279			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986723	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300057
J	Salunkhe, VA; Elvstam, O; Eliasson, L; Wendt, A				Salunkhe, Vishal A.; Elvstam, Olof; Eliasson, Lena; Wendt, Anna			Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CA2+ CHANNELS; RAB3 EFFECTOR; STATINS; RIM; ATORVASTATIN; METAANALYSIS; SIMVASTATIN; INVOLVEMENT; PRAVASTATIN	Rosuvastatin is a member of the statin family. Like the other statins it is prescribed to lower cholesterol levels and thereby reduce the risk of cardiovascular events. Rosuvastatin lowers the cholesterol levels by inhibiting the key enzyme 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase) in the cholesterol producing mevalonate pathway. It has been recognized that apart from their beneficial lipid lowering effects, statins also exhibit diabetogenic properties. The molecular mechanisms behind these remain unresolved. To investigate the effects of rosuvastatin on insulin secretion, we treated INS-1 832/13 cells with varying doses (20 nM to 20 mu M) of rosuvastatin for 48 h. At concentrations of 2 mu M and above basal insulin secretion was significantly increased. Using diazoxide we could determine that rosuvastatin did not increase basal insulin secretion by corrupting the K-ATP channels. Glucose-induced insulin secretion on the other hand seemed to be affected differently at different rosuvastatin concentrations. Rosuvastatin treatment (20 mu M) for 24-48 h inhibited voltage-gated Ca2+ channels, which lead to reduced depolarization-induced exocytosis of insulin-containing granules. At lower concentrations of rosuvastatin (<= 2 mu M) the stimulus-secretion coupling pathway was intact downstream of the K-ATP channels as assessed by the patch clamp technique. However, a reduction in glucose-induced insulin secretion could be observed with rosuvastatin concentrations as low as 200 nM. The inhibitory effects of rosuvastatin on glucose-induced insulin secretion could be reversed with mevalonate, but not squalene, indicating that rosuvastatin affects insulin secretion through its effects on the mevalonate pathway, but not through the reduction of cholesterol biosynthesis. Taken together, these data suggest that rosuvastatin has the potential to increase basal insulin secretion and reduce glucose-induced insulin secretion. The latter is possibly an unavoidable side effect of rosuvastatin treatment as it occurs through the same mechanisms as the lipid-lowering effects of the drug.	[Salunkhe, Vishal A.; Elvstam, Olof; Eliasson, Lena; Wendt, Anna] Lund Univ, Clin Res Ctr, Unit Islet Cell Exocytosis, Diabet Ctr,Dept Clin Sci Malmo,SUS Malmo, Malmo, Sweden	Lund University	Salunkhe, VA (corresponding author), Lund Univ, Clin Res Ctr, Unit Islet Cell Exocytosis, Diabet Ctr,Dept Clin Sci Malmo,SUS Malmo, Malmo, Sweden.	vishal.salunkhe@med.lu.se	Eliasson, Lena/E-9294-2012; Elvstam, Olof/AAH-6991-2020	Eliasson, Lena/0000-0002-6467-5029; Elvstam, Olof/0000-0003-3799-9869; Wendt, Anna/0000-0001-8807-5979	Swedish Research Council [K2012-55X-13147]; Diabetes Foundation; Albert Pahlssons Foundation; Ake Wiberg Foundation; medical faculty at Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Diabetes Foundation; Albert Pahlssons Foundation; Ake Wiberg Foundation; medical faculty at Lund University	The study was funded by the Swedish Research Council (Project grant K2012-55X-13147 to LE; Linneus grant to LUDC; SFO-EXODIAB), The Diabetes Foundation (LE), the Albert Pahlssons Foundation (AW, LE), and the Ake Wiberg Foundation (LE). OE was supported by the medical faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Banach M, 2015, PHARMACOL RES, V99, P329, DOI 10.1016/j.phrs.2015.07.008; Bugliani M, 2013, ACTA DIABETOL, V50, P983, DOI 10.1007/s00592-013-0465-y; Cederberg H, 2015, DIABETOLOGIA, V58, P1962, DOI 10.1007/s00125-015-3674-9; Cederberg H, 2015, DIABETOLOGIA, V58, P1109, DOI 10.1007/s00125-015-3528-5; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Corkey BE, 2012, DIABETES CARE, V35, P2432, DOI 10.2337/dc12-0825; DeGorter MK, 2013, CIRC-CARDIOVASC GENE, V6, P400, DOI 10.1161/CIRCGENETICS.113.000099; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Ishikawa M, 2006, J ATHEROSCLER THROMB, V13, P329, DOI 10.5551/jat.13.329; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kitamura S, 2008, DRUG METAB DISPOS, V36, P2014, DOI 10.1124/dmd.108.021410; Koh KK, 2011, ATHEROSCLEROSIS, V215, P1, DOI 10.1016/j.atherosclerosis.2010.10.036; LI GD, 1993, BIOCHEM J, V289, P379, DOI 10.1042/bj2890379; Li XN, 2010, CLIN THER, V32, P575, DOI 10.1016/j.clinthera.2010.03.015; MacDonald PE, 2011, AM J PHYSIOL-ENDOC M, V301, pE1065, DOI 10.1152/ajpendo.00426.2011; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Salunkhe VA, 2015, ACTA PHYSIOL, V213, P882, DOI 10.1111/apha.12460; Sampson UK, 2011, CURR OPIN CARDIOL, V26, P342, DOI 10.1097/HCO.0b013e3283470359; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schwabedissen HEMZ, 2014, DIABETES, V63, P775, DOI 10.2337/db13-1005; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; White CM, 2002, J CLIN PHARMACOL, V42, P963; Yada T, 1999, BRIT J PHARMACOL, V126, P1205, DOI 10.1038/sj.bjp.0702397; Yaluri N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142902; Zuniga-Hertz JP, 2015, J ENDOCRINOL, V224, P75, DOI 10.1530/JOE-14-0348	34	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151592	10.1371/journal.pone.0151592	http://dx.doi.org/10.1371/journal.pone.0151592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986474	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300091
J	Tapio, I; Shingfield, KJ; McKain, N; Bonin, A; Fischer, D; Bayat, AR; Vilkki, J; Taberlet, P; Snelling, TJ; Wallace, RJ				Tapio, Ilma; Shingfield, Kevin J.; McKain, Nest; Bonin, Aurelie; Fischer, Daniel; Bayat, Ali R.; Vilkki, Johanna; Taberlet, Pierre; Snelling, Timothy J.; Wallace, R. John			Oral Samples as Non-Invasive Proxies for Assessing the Composition of the Rumen Microbial Community	PLOS ONE			English	Article							RESIDUAL FEED-INTAKE; METHANOGENIC ARCHAEA; METHANE EMISSIONS; ANAEROBIC FUNGI; DIVERSITY; BACTERIAL; DIGESTA; DISCOVERY; BREAKDOWN; MARKERS	Microbial community analysis was carried out on ruminal digesta obtained directly via rumen fistula and buccal fluid, regurgitated digesta (bolus) and faeces of dairy cattle to assess if non-invasive samples could be used as proxies for ruminal digesta. Samples were collected from five cows receiving grass silage based diets containing no additional lipid or four different lipid supplements in a 5 x 5 Latin square design. Extracted DNA was analysed by qPCR and by sequencing 16S and 18S rRNA genes or the fungal ITS1 amplicons. Faeces contained few protozoa, and bacterial, fungal and archaeal communities were substantially different to ruminal digesta. Buccal and bolus samples gave much more similar profiles to ruminal digesta, although fewer archaea were detected in buccal and bolus samples. Bolus samples overall were most similar to ruminal samples. The differences between both buccal and bolus samples and ruminal digesta were consistent across all treatments. It can be concluded that either proxy sample type could be used as a predictor of the rumen microbial community, thereby enabling more convenient large-scale animal sampling for phenotyping and possible use in future animal breeding programs aimed at selecting cattle with a lower environmental footprint.	[Tapio, Ilma; Shingfield, Kevin J.; Fischer, Daniel; Bayat, Ali R.; Vilkki, Johanna] Nat Resources Inst Finland, Green Technol, Jokioinen, Finland; [McKain, Nest; Snelling, Timothy J.; Wallace, R. John] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Bonin, Aurelie; Taberlet, Pierre] CNRS, Lab Ecol Alpine, Grenoble, France; [Shingfield, Kevin J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3FG, Dyfed, Wales	Natural Resources Institute Finland (Luke); University of Aberdeen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Wallace, RJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	john.wallace@abdn.ac.uk	Fischer, Daniel/C-8791-2017; Bayat, Ali-Reza/O-5769-2016	Fischer, Daniel/0000-0002-7513-683X; Bayat, Ali-Reza/0000-0002-4894-0662; /0000-0002-8952-8826; Tapio, Ilma/0000-0002-0752-9551; Bonin, Aurelie/0000-0001-7800-8609	European Commission [289319]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission 289319.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Duffield T, 2004, J DAIRY SCI, V87, P59, DOI 10.3168/jds.S0022-0302(04)73142-2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farthing MJG, 2006, NAT CLIN PRACT GASTR, V3, P436, DOI 10.1038/ncpgasthep0557; Franzolin R, 2012, MICROB ECOL, V64, P131, DOI 10.1007/s00248-012-0007-0; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fuller Z, 2007, BRIT J NUTR, V98, P364, DOI 10.1017/S0007114507709091; Gill FL, 2010, ORG GEOCHEM, V41, P467, DOI 10.1016/j.orggeochem.2010.02.001; Gruninger RJ, 2014, FEMS MICROBIOL ECOL, V90, P1, DOI 10.1111/1574-6941.12383; Hegarty RS, 2007, J ANIM SCI, V85, P1479, DOI 10.2527/jas.2006-236; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hook SE, 2009, APPL ENVIRON MICROB, V75, P374, DOI 10.1128/AEM.01672-08; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; KENNEDY PM, 1985, AUST J AGR RES, V36, P819, DOI 10.1071/AR9850819; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Khejornsart P, 2010, J ANIM VET ADV, V9, P3062; Kittelmann S, 2015, APPL ENVIRON MICROB, V81, P7470, DOI 10.1128/AEM.02385-15; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Koetschan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091928; Lodge-Ivey SL, 2009, J ANIM SCI, V87, P2333, DOI 10.2527/jas.2008-1472; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; McAllister TA, 2015, J ANIM SCI, V93, P1431, DOI 10.2527/jas.2014-8329; McCartney CA, 2013, ANIMAL, V7, P409, DOI 10.1017/S1751731113000694; McCartney CA, 2013, J DAIRY SCI, V96, P1211, DOI 10.3168/jds.2012-6042; MCLEOD MN, 1988, J ANIM SCI, V66, P992; Michelland RJ, 2009, J APPL MICROBIOL, V107, P1642, DOI 10.1111/j.1365-2672.2009.04346.x; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Odongo NE, 2007, J DAIRY SCI, V90, P1851, DOI 10.3168/jds.2006-541; Pfeffer E, 2005, NITROGEN AND PHOSPHORUS NUTRITION OF CATTLE: REDUCING THE ENVIRONMENTAL IMPACT OF CATTLE OPERATIONS, P1, DOI 10.1079/9780851990132.0001; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Robinson D L, 2014, J Anim Sci, V92, P4349, DOI 10.2527/jas.2014-8042; Rochfort S, 2008, PHYTOCHEMISTRY, V69, P299, DOI 10.1016/j.phytochem.2007.08.017; Roehe R, BMC GENOMIC IN PRESS; Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09; Seedorf H, 2014, PEERJ, V2, DOI 10.7717/peerj.494; Shen JS, 2012, J DAIRY SCI, V95, P5978, DOI 10.3168/jds.2012-5499; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tap J, 2009, MICROB ECOL, V57, P580; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Wallace RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05892; Williams A.G., 1997, RUMEN MICROBIAL ECOS, P73, DOI DOI 10.1007/978-94-009-1453-7_3; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08	58	47	49	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151220	10.1371/journal.pone.0151220	http://dx.doi.org/10.1371/journal.pone.0151220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986467	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300055
J	Alves, LGA; Scariot, DB; Guimaraes, RR; Nakamura, CV; Mendes, RS; Ribeiro, HV				Alves, Luiz G. A.; Scariot, Debora B.; Guimaraes, Renato R.; Nakamura, Celso V.; Mendes, Renio S.; Ribeiro, Haroldo V.			Transient Superdiffusion and Long-Range Correlations in the Motility Patterns of Trypanosomatid Flagellate Protozoa	PLOS ONE			English	Article							ANOMALOUS DIFFUSION; ANTIGENIC VARIATION; PROBABILITY-DISTRIBUTIONS; TRANSMISSION; INFECTION	We report on a diffusive analysis of the motion of flagellate protozoa species. These parasites are the etiological agents of neglected tropical diseases: leishmaniasis caused by Leishmania amazonensis and Leishmania braziliensis, African sleeping sickness caused by Trypanosoma brucei, and Chagas disease caused by Trypanosoma cruzi. By tracking the positions of these parasites and evaluating the variance related to the radial positions, we find that their motions are characterized by a short-time transient superdiffusive behavior. Also, the probability distributions of the radial positions are self-similar and can be approximated by a stretched Gaussian distribution. We further investigate the probability distributions of the radial velocities of individual trajectories. Among several candidates, we find that the generalized gamma distribution shows a good agreement with these distributions. The velocity time series have long-range correlations, displaying a strong persistent behavior (Hurst exponents close to one). The prevalence of "universal" patterns across all analyzed species indicates that similar mechanisms may be ruling the motion of these parasites, despite their differences in morphological traits. In addition, further analysis of these patterns could become a useful tool for investigating the activity of new candidate drugs against these and others neglected tropical diseases.	[Alves, Luiz G. A.; Guimaraes, Renato R.; Mendes, Renio S.; Ribeiro, Haroldo V.] Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, PR, Brazil; [Alves, Luiz G. A.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Alves, Luiz G. A.; Guimaraes, Renato R.; Mendes, Renio S.] CNPq, Natl Inst Sci & Technol Complex Syst, BR-22290180 Rio De Janeiro, RJ, Brazil; [Scariot, Debora B.; Nakamura, Celso V.] Univ Estadual Maringa, Dept Ciencias Basicas Saude, BR-87020900 Maringa, PR, Brazil	Universidade Estadual de Maringa; Northwestern University; Universidade Estadual de Maringa	Alves, LGA (corresponding author), Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, PR, Brazil.; Alves, LGA (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.; Alves, LGA (corresponding author), CNPq, Natl Inst Sci & Technol Complex Syst, BR-22290180 Rio De Janeiro, RJ, Brazil.	lgaalves@dfi.uem.br	Nakamura, Celso Vataru/AAA-5620-2019; Ribeiro, Haroldo Valentin/C-8614-2012; Alves, Luiz G A/H-3389-2013; Mendes, Renio/F-9261-2017	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Alves, Luiz G A/0000-0001-6204-5552; Botura Scariot, Debora/0000-0002-8681-0172	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria (FA); CNPq [440650/2014-3]; CAPES [99999.006842/2015-01]; RSM [263/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria (FA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); RSM	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao Araucaria (FA). HVR is thankful for the financial support of CNPq (grant 440650/2014-3), LGAA is thankful for the financial support of CAPES (grant 99999.006842/2015-01) and RSM gives thanks to FA (grant 263/2014) for partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadehrad D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003967; Amselem G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037213; [Anonymous], 2015, PARASITES LEISHMANIA; Ballesteros-Rodea G, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/520380; Baron S, 1996, MED MICROBIOLOGY, P1; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Carta JA, 2009, RENEW SUST ENERG REV, V13, P933, DOI 10.1016/j.rser.2008.05.005; de Noya BA, 2015, TRYPANOSOMA CRUZI FO; de Paula, 2006, PHYS CHEM THERMODYNA; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Donelson JE, 2003, ACTA TROP, V85, P391, DOI 10.1016/S0001-706X(02)00237-1; Farrar J, 2014, MANSONS TROPICAL INF, pxi, DOI [10.1016/b978-0-7020-5101-2.00094-7, DOI 10.1016/B978-0-7020-5101-2.00094-7]; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Heddergott N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003023; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kiss P, 2008, ENERG CONVERS MANAGE, V49, P2142, DOI 10.1016/j.enconman.2008.02.003; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; Makarava N, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042703; Manderson L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000332; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; Morgan EC, 2011, ENERG CONVERS MANAGE, V52, P15, DOI 10.1016/j.enconman.2010.06.015; Nigeria, 2015, NEGLECTED TROPICAL D; Nussbaum K, 2010, CURR MED CHEM, V17, P1594, DOI 10.2174/092986710790979953; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Plastino AR, 1995, PHYSICA A, V222, P347, DOI 10.1016/0378-4371(95)00211-1; Reverey JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11690; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Rogers M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000555; Rogers ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00223; Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439; Rozenberg Gillian, 2011, MICROSCOPIC HAEMATOL; Silverberg JL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228701; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Theves M, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/28007; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Thurner S, 2003, PHYSICA A, V320, P475, DOI 10.1016/S0378-4371(02)01598-4; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; VANDERAUWERA L, 1980, J APPL METEOROL, V19, P819, DOI 10.1175/1520-0450(1980)019<0819:TUOTWT>2.0.CO;2; Wauthier F., 2015, MOTION TRACKING IMAG; ZARLEY JH, 1991, J CLIN INVEST, V88, P1511, DOI 10.1172/JCI115461	53	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152092	10.1371/journal.pone.0152092	http://dx.doi.org/10.1371/journal.pone.0152092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007779	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200092
J	Boubour, J; Jenson, K; Richter, H; Yarbrough, J; Oden, ZM; Schuler, DA				Boubour, Jean; Jenson, Katherine; Richter, Hannah; Yarbrough, Josiah; Oden, Z. Maria; Schuler, Douglas A.			A Shipping Container-Based Sterile Processing Unit for Low Resources Settings	PLOS ONE			English	Article							INFECTION; SYSTEM	Deficiencies in the sterile processing of medical instruments contribute to poor outcomes for patients, such as surgical site infections, longer hospital stays, and deaths. In low resources settings, such as some rural and semi-rural areas and secondary and tertiary cities of developing countries, deficiencies in sterile processing are accentuated due to the lack of access to sterilization equipment, improperly maintained and malfunctioning equipment, lack of power to operate equipment, poor protocols, and inadequate quality control over inventory. Inspired by our sterile processing fieldwork at a district hospital in Sierra Leone in 2013, we built an autonomous, shipping-container-based sterile processing unit to address these deficiencies. The sterile processing unit, dubbed "the sterile box," is a full suite capable of handling instruments from the moment they leave the operating room to the point they are sterile and ready to be reused for the next surgery. The sterile processing unit is self-sufficient in power and water and features an intake for contaminated instruments, decontamination, sterilization via non-electric steam sterilizers, and secure inventory storage. To validate efficacy, we ran tests of decontamination and sterilization performance. Results of 61 trials validate convincingly that our sterile processing unit achieves satisfactory outcomes for decontamination and sterilization and as such holds promise to support healthcare facilities in low resources settings.	[Boubour, Jean] Assoc Soleil Vapeur, Evreux, France; [Jenson, Katherine; Schuler, Douglas A.] Rice Univ, Jones Grad Sch Business, Houston, TX USA; [Richter, Hannah] Rice Univ, Dept Mech Engn, Brown Sch Engn, Houston, TX 77005 USA; [Yarbrough, Josiah] Rice Univ, Dept Chem Engn, Brown Sch Engn, Houston, TX 77251 USA; [Oden, Z. Maria] Rice Univ, Dept Bioengn, Brown Sch Engn, Houston, TX USA; [Oden, Z. Maria; Schuler, Douglas A.] Rice Univ, Rice Inst Global Hlth 360, Houston, TX USA	Rice University; Rice University; Rice University; Rice University; Rice University	Schuler, DA (corresponding author), Rice Univ, Jones Grad Sch Business, Houston, TX USA.; Schuler, DA (corresponding author), Rice Univ, Rice Inst Global Hlth 360, Houston, TX USA.	schuler@rice.edu		Yarbrough, Josiah/0000-0002-4521-0656	Shell Center for Sustainability, Rice University; Brown School of Engineering, Rice University; Jones Graduate School of Business, Rice University; Rice Engineering Alumni, Rice University	Shell Center for Sustainability, Rice University; Brown School of Engineering, Rice University; Jones Graduate School of Business, Rice University; Rice Engineering Alumni, Rice University	This work was supported by the Shell Center for Sustainability, Rice University, to DS, JB; Brown School of Engineering, Rice University, to DS ZMO, JY, HR; Jones Graduate School of Business, Rice University, DS KJ; and Rice Engineering Alumni, Rice University, DS ZMO. These funders listed above had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the authors received in-kind donations of equipment and testing materials from the following organizations: Getinge USA (biological testing materials), WAFCO (non-electric steam sterilizers), KeySurgical (brushes), Certol (enzymatic and other cleaners), NovoSurgical (medical instruments), Protek Specialty Company, Bellaire, Texas (water pump). By email exchange, Rodney Gray at Getinge USA answered technical questions about the testing equipment and testing materials. However, he played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other in-kind donors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Jean Boubour is the founder of Association Soleil-Vapeur. Association Soleil-Vapeur did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adair-Rohani H, 2013, GLOB HEALTH-SCI PRAC, V1, P249, DOI 10.9745/GHSP-D-13-00037; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; [Anonymous], 2015, AFR HLTH OBS; [Anonymous], 2015, HLTH CARE ASS FACT S; [Anonymous], 2011, GETINGE ASSURE SAFES; [Anonymous], 2003, SURG CARE DISTRICT H; Aveling EL, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0096-x; Dancer SJ, 2012, J HOSP INFECT, V81, P231, DOI 10.1016/j.jhin.2012.04.023; Dentaid, 2015, THE DENT TRAG; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Jovanovic BD, 1997, AM STAT, V51, P137, DOI 10.2307/2685405; Kaseman T, 2012, AM J TROP MED HYG, V87, P602, DOI 10.4269/ajtmh.2012.12-0061; Lind N, 2007, CENTRAL SERVICE TECH; Petersen P, 2004, DEV DENTISTRY, V1, P9; Rogers E.M., 1995, DIFFUSION INNOVATION; Rutala W.A., 2019, GUIDELINE DISINFECTI; Saito Y, 2014, AM J INFECT CONTROL, V42, P43, DOI 10.1016/j.ajic.2013.06.022; Samuel RA, 2013, SOUTH AFR J ANAESTH, V19, P146, DOI 10.1080/22201173.2013.10872914; Shomali M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130043; Sigler K, 2003, FOLIA MICROBIOL, V48, P95, DOI 10.1007/BF02931283; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	21	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0149624	10.1371/journal.pone.0149624	http://dx.doi.org/10.1371/journal.pone.0149624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007568	Green Submitted, gold, Green Published			2022-12-27	WOS:000372701200018
J	Dubey, AA; Singh, MI; Jain, V				Dubey, Abhishek Anil; Singh, Manika Indrajit; Jain, Vikas			Rapid and Robust PCR-Based All-Recombinant Cloning Methodology	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEINS; VECTORS; PURIFICATION	We report here a PCR-based cloning methodology that requires no post-PCR modifications such as restriction digestion and phosphorylation of the amplified DNA. The advantage of the present method is that it yields only recombinant clones thus eliminating the need for screening. Two DNA amplification reactions by PCR are performed wherein the first reaction amplifies the gene of interest from a source template, and the second reaction fuses it with the designed expression vector fragments. These vector fragments carry the essential elements that are required for the fusion product selection. The entire process can be completed in less than 8 hours. Furthermore, ligation of the amplified DNA by a DNA ligase is not required before transformation, although the procedure yields more number of colonies upon transformation if ligation is carried out. As a proof-of-concept, we show the cloning and expression of GFP, adh, and rho genes. Using GFP production as an example, we further demonstrate that the E. coli T7 express strain can directly be used in our methodology for the protein expression immediately after PCR. The expressed protein is without or with 6xHistidine tag at either terminus, depending upon the chosen vector fragments. We believe that our method will find tremendous use in molecular and structural biology.	[Dubey, Abhishek Anil; Singh, Manika Indrajit; Jain, Vikas] IISER, Dept Biol Sci, Microbiol & Mol Biol Lab, Bhopal, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Jain, V (corresponding author), IISER, Dept Biol Sci, Microbiol & Mol Biol Lab, Bhopal, India.	vikas@iiserb.ac.in	JAIN, VIKAS/B-3142-2008	JAIN, VIKAS/0000-0003-0238-8144; Singh, Manika Indrajit/0000-0001-9784-7969; Dubey, Abhishek/0000-0003-2285-7526	Council of Scientific and Industrial Research (CSIR), Govt. of India; Innovative Young Biotechnologist Award from Department of Biotechnology, Govt. of India [BT/07/IYBA/2013-20]	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Innovative Young Biotechnologist Award from Department of Biotechnology, Govt. of India	AAD and MIS thank the Council of Scientific and Industrial Research (CSIR), Govt. of India for the Junior and Senior research fellowships, respectively. The work is supported by an Innovative Young Biotechnologist Award number BT/07/IYBA/2013-20 from Department of Biotechnology, Govt. of India to VJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chaudhary VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111538; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; HAUN RS, 1992, BIOTECHNIQUES, V13, P515; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; KALUZ S, 1992, NUCLEIC ACIDS RES, V20, P4369, DOI 10.1093/nar/20.16.4369; Kneusel RE, 1998, METH MOLEC MED, V13, P293, DOI 10.1385/0-89603-485-2:293; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; MEAD DA, 1991, BIO-TECHNOL, V9, P657, DOI 10.1038/nbt0791-657; Parr RD, 2003, PLASMID, V49, P179, DOI 10.1016/S0147-619X(02)00148-8; Sambrook J., 2001, MOL CLONING LAB MANU; SHUMAN S, 1994, J BIOL CHEM, V269, P32678; Singh M.K., 2013, J TEXT, V2013, P6, DOI DOI 10.1371/J0URNAL.P0NE.0063922; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; WEINER MP, 1994, PCR METH APPL, V4, pS131	17	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152106	10.1371/journal.pone.0152106	http://dx.doi.org/10.1371/journal.pone.0152106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007922	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200093
J	Hearn, AJ; Ross, J; Bernard, H; Abu Bakar, S; Hunter, LTB; Macdonald, DW				Hearn, Andrew J.; Ross, Joanna; Bernard, Henry; Abu Bakar, Soffian; Hunter, Luke T. B.; Macdonald, David W.			The First Estimates of Marbled Cat Pardofelis marmorata Population Density from Bornean Primary and Selectively Logged Forest	PLOS ONE			English	Article							LEOPARD NEOFELIS-DIARDI; NON-PANTHERA CATS; NATIONAL-PARK; PROTECTED AREA; HABITAT USE; SABAH; CARNIVORES; RESERVES; SUMATRA	The marbled cat Pardofelis marmorata is a poorly known wild cat that has a broad distribution across much of the Indomalayan ecorealm. This felid is thought to exist at low population densities throughout its range, yet no estimates of its abundance exist, hampering assessment of its conservation status. To investigate the distribution and abundance of marbled cats we conducted intensive, felid-focused camera trap surveys of eight forest areas and two oil palm plantations in Sabah, Malaysian Borneo. Study sites were broadly representative of the range of habitat types and the gradient of anthropogenic disturbance and fragmentation present in contemporary Sabah. We recorded marbled cats from all forest study areas apart from a small, relatively isolated forest patch, although photographic detection frequency varied greatly between areas. No marbled cats were recorded within the plantations, but a single individual was recorded walking along the forest/plantation boundary. We collected sufficient numbers of marbled cat photographic captures at three study areas to permit density estimation based on spatially explicit capture-recapture analyses. Estimates of population density from the primary, lowland Danum Valley Conservation Area and primary upland, Tawau Hills Park, were 19.57 (SD: 8.36) and 7.10 (SD: 1.90) individuals per 100 km(2), respectively, and the selectively logged, lowland Tabin Wildlife Reserve yielded an estimated density of 10.45 (SD: 3.38) individuals per 100 km(2). The low detection frequencies recorded in our other survey sites and from published studies elsewhere in its range, and the absence of previous density estimates for this felid suggest that our density estimates may be from the higher end of their abundance spectrum. We provide recommendations for future marbled cat survey approaches.	[Hearn, Andrew J.; Ross, Joanna; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, S Parks Rd, Oxford, England; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia; [Abu Bakar, Soffian] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Hunter, Luke T. B.] Panthera, New York, NY USA	University of Oxford; Universiti Malaysia Sabah	Hearn, AJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, S Parks Rd, Oxford, England.	Andrew.hearn@zoo.ox.ac.uk	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544	Darwin Initiative; Recaniti-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera AJH; Point Defiance Zoo and Aquarium; Wild About Cats	Darwin Initiative; Recaniti-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera AJH; Point Defiance Zoo and Aquarium; Wild About Cats	This research was primarily funded by the Darwin Initiative (https://www.gov.uk/government/groups/the-darwin-initiative) [DWM], Recaniti-Kaplan Foundation to DWM, Robertson Foundation (http://www.robertsonfoundation.org/) [DWM] and Sime Darby Foundation (http://www.yayasansimedarby.com/). The authors received additional funding from Clouded Leopard project (http://www.cloudedleopard.org/) [AJH and JR]; Felidae Conservation Fund (http://felidaefund.org/) [AJH and JR]; Houston Zoo (http://www.houstonzoo.org/) [AJH]; HG Wills International Trust for Nature Conservation [AJH, JR]; Panthera AJH (https://www.panthera.org/); Point Defiance Zoo and Aquarium (http://www.pdza.org/) [AJH] and Wild About Cats [AJH and JR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard H, 2013, RAFFLES B ZOOL, V61, P861; Borries C, 2014, RAFFLES B ZOOL, V62, P561; Brodie J, 2012, ORYX, V46, P427, DOI 10.1017/S0030605312000087; Brodie Jedediah, 2011, Small Carnivore Conservation, V44, P1; Chutipong W, 2014, RAFFLES B ZOOL, V62, P521; Costa PM, 1996, AMBIO, V25, P279; Coudrat Camille N.Z., 2014, Cat News, P45; Duckworth J.W., 2014, Cat News, P62; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Goldberg JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140757; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Grassman Lon I. Jr, 2002, Cat News, V36, P19; Gray Thomas N.E., 2014, Cat News, P19; Guggisberg CAW, 1975, WILD CATS WORLD; Gumal Melvin, 2014, Cat News, P10; Hunter Luke, 2015, P1; Lyngdoh S, 2011, CURR SCI INDIA, V101, P1284; McCarthy JL, 2015, GLOB ECOL CONSERV, V3, P210, DOI 10.1016/j.gecco.2014.11.009; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mohamed A, 2009, CAT NEWS, V51, P12; Mohamed A, 2013, J MAMMAL, V94, P82, DOI 10.1644/11-MAMM-A-394.1; Nowell K., 1996, WILD CATS STATUS SUR; Pusparini Wulan, 2014, Cat News, P4; R Development Team, 2014, R LANG ENV STAT COMP; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Ross J., 2015, IUCN RED LIST THREAT; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2011, J WILDLIFE MANAGE, V75, P604, DOI 10.1002/jwmg.79; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Simcharoen Saksit, 2014, Cat News, P31; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Sunquist ME, 2002, WILD CATS WORLD; Suzuki Al, 2015, Cat News, V62, P14; Tempa T, 2013, ORYX, V47, P207, DOI 10.1017/S0030605312001317; Tonkin B.A., 1979, CAT BEHAV PREDATORY; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Willcox Daniel H.A., 2014, Cat News, P53; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694; Zaw Than, 2014, Cat News, P24	41	21	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151046	10.1371/journal.pone.0151046	http://dx.doi.org/10.1371/journal.pone.0151046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007219	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200040
J	Tyden, J; Herwald, H; Sjoberg, F; Johansson, J				Tyden, Jonas; Herwald, Heiko; Sjoberg, Folke; Johansson, Joakim			Increased Plasma Levels of Heparin-Binding Protein on Admission to Intensive Care Are Associated with Respiratory and Circulatory Failure	PLOS ONE			English	Article							ORGAN FAILURE; HBP/CAP37; LINK	Purpose Heparin-binding protein (HBP) is released by granulocytes and has been shown to increase vascular permeability in experimental investigations. Increased vascular permeability in the lungs can lead to fluid accumulation in alveoli and respiratory failure. A generalized increase in vascular permeability leads to loss of circulating blood volume and circulatory failure. We hypothesized that plasma concentrations of HBP on admission to the intensive care unit (ICU) would be associated with decreased oxygenation or circulatory failure. Methods This is a prospective, observational study in a mixed 8-bed ICU. We investigated concentrations of HBP in plasma at admission to the ICU from 278 patients. Simplified acute physiology score (SAPS) 3 was recorded on admission. Sequential organ failure assessment (SOFA) scores were recorded daily for three days. Results Median SAPS 3 was 58.8 (48-70) and 30-day mortality 64/278 (23%). There was an association between high plasma concentrations of HBP on admission with decreased oxygenation (p<0.001) as well as with circulatory failure (p<0.001), after 48-72 hours in the ICU. There was an association between concentrations of HBP on admission and 30-day mortality (p = 0.002). ROC curves showed areas under the curve of 0,62 for decreased oxygenation, 0,65 for circulatory failure and 0,64 for mortality. Conclusions A high concentration of HBP in plasma on admission to the ICU is associated with respiratory and circulatory failure later during the ICU care period. It is also associated with increased 30-day mortality. Despite being an interesting biomarker for the composite ICU population it's predictive value at the individual patient level is low.	[Tyden, Jonas; Johansson, Joakim] Ostersund Hosp, Dept Anaesthesiol & Intens Care, Ostersund, Sweden; [Tyden, Jonas; Johansson, Joakim] Umea Univ, Dept Surg & Perioperat Sci Anaesthesiol & Intens, Umea, Sweden; [Herwald, Heiko] Lund Univ, Dept Cell & Mol Biol, Lund, Sweden; [Sjoberg, Folke] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Sjoberg, Folke] Linkoping Cty Council, Dept Hand Plast Surg & Intens Care, Burn Ctr, Linkoping, Sweden	Umea University; Lund University; Linkoping University	Tyden, J (corresponding author), Ostersund Hosp, Dept Anaesthesiol & Intens Care, Ostersund, Sweden.; Tyden, J (corresponding author), Umea Univ, Dept Surg & Perioperat Sci Anaesthesiol & Intens, Umea, Sweden.	jonas.tyden@regionjh.se	Herwald, Heiko/AAN-3708-2021	Herwald, Heiko/0000-0002-8111-2842; Johansson, Joakim/0000-0001-6866-0177				Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540; Berkestedt I, 2010, J INNATE IMMUN, V2, P478, DOI 10.1159/000317036; Chew MS, 2012, INFLAMM RES, V61, P375, DOI 10.1007/s00011-011-0422-6; Dankiewicz J, 2013, RESUSCITATION, V84, P935, DOI 10.1016/j.resuscitation.2013.01.006; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Johansson J, 2013, ACTA ANAESTH SCAND, V57, P580, DOI 10.1111/aas.12070; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lin QH, 2013, CRIT CARE, V17, DOI 10.1186/cc12834; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Persson BP, 2014, ACTA ANAESTH SCAND, V58, P549, DOI 10.1111/aas.12301; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Russell JA, 2000, CRIT CARE MED, V28, P3405, DOI 10.1097/00003246-200010000-00005; Sakr Y, 2012, CRIT CARE, V16, DOI 10.1186/cc11868; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785	15	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152035	10.1371/journal.pone.0152035	http://dx.doi.org/10.1371/journal.pone.0152035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007333	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200089
J	Borgeraas, H; Hertel, JK; Svingen, GFT; Pedersen, ER; Seifert, R; Nygard, O; Hjelmesaeth, J				Borgeraas, Heidi; Hertel, Jens Kristoffer; Svingen, Gard Frodahl Tveitevag; Pedersen, Eva Ringdal; Seifert, Reinhard; Nygard, Ottar; Hjelmesaeth, Joran			Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INDUCIBLE NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATION; OXIDATIVE STRESS; FOLLOW-UP; HEART; DEATH; WOMEN	Background Asymmetric dimethylarginine (ADMA) is associated with increased risk of atherosclerotic cardiovascular disease and mortality through inhibition of nitrogen oxide (NO) synthesis. As positive correlations between serum concentrations of NO and body mass index (BMI) have been observed, we aimed to explore whether the potential associations between plasma ADMA levels and the risk of acute myocardial infarction (AMI) and mortality were modified by BMI. Methods Multivariable Cox proportional hazard models were used to estimate the hazard ratios (HR) for AMI, cardiovascular death and all-cause mortality according to baseline plasma ADMA levels in 4122 patients with suspected stable angina pectoris. Analyses were subsequently repeated in patients with BMI below (low BMI) or above (high BMI) median. Results A total of 2982 patients (72%) were men. Median (range) age, plasma ADMA level and BMI were 62 (21-88) years, 0.54 (0.10-1.25) mu mol/L and 26.3 (18.5-54.3) kg/m(2), respectively. During a mean (standard deviation) follow-up time of 4.7 (1.4) years, 337 (8%) patients suffered from an AMI, 300 (7%) died, whereof 165 (55%) due to cardiovascular disease. Each 0.1 mu mol/L increment in plasma ADMA level was associated with an increased risk of AMI (HR (95% CI) 1.21 (1.08, 1.35) and cardiovascular death 1.30 (1.13, 1.49) in participants with low BMI only. Interactions were significant for AMI (p = 0.04) and CV death (p = 0.03). BMI did not modify the association between plasma ADMA levels and all-cause mortality. Conclusion Plasma ADMA levels were associated with risk of AMI and cardiovascular death among patients with low BMI only.	[Borgeraas, Heidi; Hertel, Jens Kristoffer; Hjelmesaeth, Joran] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway; [Borgeraas, Heidi; Hjelmesaeth, Joran] Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Svingen, Gard Frodahl Tveitevag; Pedersen, Eva Ringdal; Nygard, Ottar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Svingen, Gard Frodahl Tveitevag; Pedersen, Eva Ringdal; Seifert, Reinhard; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Nygard, Ottar] Haukeland Hosp, KG Jebsen Ctr Diabet Res, N-5021 Bergen, Norway	University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Borgeraas, H (corresponding author), Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway.; Borgeraas, H (corresponding author), Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.	heibor@siv.no			Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease at Haukeland University Hospital, Bergen; Meltzer Foundation, Bergen, Norway	Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease at Haukeland University Hospital, Bergen; Meltzer Foundation, Bergen, Norway	The study was funded by the Norwegian Ministry of Health and Care Services, the Western Norway Regional Health Authority, the Department of Heart Disease at Haukeland University Hospital, Bergen, and the Meltzer Foundation, Bergen, Norway.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Bleie O, 2004, AM J CLIN NUTR, V80, P641; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Borgeraas H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-68; Borgeraas H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/201742; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Choi JW, 2001, CLIN CHEM, V47, P1106; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Codoner-Franch P, 2011, ATHEROSCLEROSIS, V215, P475, DOI 10.1016/j.atherosclerosis.2010.12.035; Duckelmann C, 2007, ARTERIOSCL THROM VAS, V27, P2037, DOI 10.1161/ATVBAHA.107.147595; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fujii H, 2008, AM J HYPERTENS, V21, P650, DOI 10.1038/ajh.2008.29; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Heitzer T, 2005, ARTERIOSCL THROM VAS, V25, P1174, DOI 10.1161/01.ATV.0000166516.52477.81; Ing DJ, 1999, CIRC RES, V84, P21; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Krzyzanowska K, 2007, DIABETES CARE, V30, P1834, DOI 10.2337/dc07-0019; Lajer M, 2008, DIABETES CARE, V31, P747, DOI 10.2337/dc07-1762; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Leong T, 2008, ARTERIOSCL THROM VAS, V28, P961, DOI 10.1161/ATVBAHA.107.156596; Loland KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064774; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Mittermayer F, 2006, ARTERIOSCL THROM VAS, V26, P2536, DOI 10.1161/01.ATV.0000242801.38419.48; Muhl H, 1996, EUR J PHARMACOL, V317, P137, DOI 10.1016/S0014-2999(96)00701-7; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; Olszanecka-Glinianowicz M, 2004, METABOLISM, V53, P1268, DOI 10.1016/j.metabol.2004.07.001; Paik JK, 2015, AGE, V37, DOI 10.1007/s11357-015-9770-4; Pedersen ER, 2010, ATHEROSCLEROSIS, V212, P644, DOI 10.1016/j.atherosclerosis.2010.06.027; PINSKY DJ, 1995, J CLIN INVEST, V95, P677, DOI 10.1172/JCI117713; Qiu CB, 1998, HYPERTENSION, V31, P21, DOI 10.1161/01.HYP.31.1.21; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Svingen GF, 2013, ARTERIOSCLER THROMB; Therneau T.M., 2000, MODELING SURVIVAL DA; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	51	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152029	10.1371/journal.pone.0152029	http://dx.doi.org/10.1371/journal.pone.0152029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003294	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400068
J	Hsu, CE; Lin, TK; Lee, MH; Lee, ST; Chang, CN; Lin, CL; Hsu, YH; Huang, YC; Hsieh, TC; Chang, CJ				Hsu, Chung-En; Lin, Tzu-Kang; Lee, Ming-Hsueh; Lee, Shih-Tseng; Chang, Chen-Nen; Lin, Chih-Lung; Hsu, Yung-Hsin; Huang, Yin-Cheng; Hsieh, Tsung-Che; Chang, Chee-Jen			The Impact of Surgical Experience on Major Intraoperative Aneurysm Rupture and Their Consequences on Outcome: A Multivariate Analysis of 538 Microsurgical Clipping Cases	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; IN-HOSPITAL MORTALITY; SUBARACHNOID HEMORRHAGE; SURGEON VOLUME; UNITED-STATES; RATES; COMPLICATIONS; SPECIALTY; MORBIDITY	The incidence and associated mortality of major intraoperative rupture (MIOR) in intracranial aneurysm surgery is diverse. One possible reason is that many studies failed to consider and properly adjust the factor of surgical experience in the context. We conducted this study to clarify the role of surgical experience on MIOR and associated outcome. 538 consecutive intracranial aneurysm surgeries performed on 501 patients were enrolled in this study. Various potential predictors of MIOR were evaluated with stratified analysis and multivariate logistic regression. The impact of surgical experience and MIOR on outcome was further studied in a logistic regression model with adjustment of each other. The outcome was evaluated using the Glasgow Outcome Scale one year after the surgery. Surgical experience and preoperative Glasgow Coma Scale (GCS) were identified as independent predictors of MIOR. Experienced neurovascular surgeons encountered fewer cases of MIOR compared to novice neurosurgeons (MIOR, 18/225, 8.0% vs. 50/313, 16.0%, P = 0.009). Inexperience and MIOR were both associated with a worse outcome. Compared to experienced neurovascular surgeons, inexperienced neurosurgeons had a 1.90-fold risk of poor outcome. On the other hand, MIOR resulted in a 3.21-fold risk of unfavorable outcome compared to those without it. Those MIOR cases managed by experienced neurovascular surgeons had a better prognosis compared with those managed by inexperienced neurosurgeons (poor outcome, 4/18, 22% vs. 30/50, 60%, P = 0.013).	[Hsu, Chung-En; Lin, Tzu-Kang; Lee, Shih-Tseng; Chang, Chen-Nen; Hsu, Yung-Hsin; Huang, Yin-Cheng] Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan; [Hsu, Chung-En; Lin, Tzu-Kang; Lee, Shih-Tseng; Chang, Chen-Nen; Hsu, Yung-Hsin; Huang, Yin-Cheng] Chang Gung Univ, Taoyuan, Taiwan; [Lee, Ming-Hsueh] Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan; [Lee, Ming-Hsueh] Chang Gung Inst Technol, Chiayi, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Hsieh, Tsung-Che] St Pauls Hosp, Div Neurosurg, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung University	Lin, TK (corresponding author), Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan.; Lin, TK (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.	tklin100@cgmh.org.tw			Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital [CLRPG3D0041]	Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital	The authors received no specific funding for this work. Nevertheless, Mr. Yu Jr Lin who assisted in the statistics of this work was supported by grants from Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital (CLRPG3D0041).	Barker FG, 2003, NEUROSURGERY, V52, P995, DOI 10.1227/01.NEU.0000057743.56678.5F; BATJER H, 1986, NEUROSURGERY, V18, P701, DOI 10.1227/00006123-198606000-00004; Berman MF, 2003, STROKE, V34, P2200, DOI 10.1161/01.STR.0000086528.32334.06; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Boogaarts HD, 2014, J NEUROSURG, V120, P605, DOI 10.3171/2013.9.JNS13640; Carter D, 2003, BRIT MED J, V326, P832, DOI 10.1136/bmj.326.7394.832; Chyatte D, 2001, J NEUROSURG, V94, P417, DOI 10.3171/jns.2001.94.3.0417; Cowan JA, 2003, J NEUROSURG, V99, P947, DOI 10.3171/jns.2003.99.6.0947; Cowan JA, 2002, J AM COLL SURGEONS, V195, P814, DOI 10.1016/S1072-7515(02)01345-5; Cowan JA, 2003, NEUROSURGERY, V52, P48, DOI 10.1097/00006123-200301000-00005; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; Davies JM, 2014, NEUROSURGERY, V74, pS7, DOI 10.1227/NEU.0000000000000193; Elijovich L, 2008, STROKE, V39, P1501, DOI 10.1161/STROKEAHA.107.504670; Fridriksson S, 2002, J NEUROSURG, V96, P515, DOI 10.3171/jns.2002.96.3.0515; Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238; Hattori N, 2007, NEUROL MED-CHIR, V47, P95, DOI 10.2176/nmc.47.95; Hattori NKY, 2007, NEUROL MED CHIR TOKY, V47, P1; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359.EE; Lawton MT, 2005, NEUROSURGERY, V57, P9, DOI 10.1227/01.NEU.0000163082.20941.EF; Leipzig TJ, 2005, NEUROSURGERY, V56, P455, DOI 10.1227/01.NEU.0000154697.75300.C2; Lin Tzu-Kang, 2013, Acta Neurol Taiwan, V22, P106; Sandalcioglu IE, 2004, CLIN NEUROL NEUROSUR, V106, P88, DOI 10.1016/j.clineuro.2003.10.011; SCHRAMM J, 1993, SURG NEUROL, V40, P26, DOI 10.1016/0090-3019(93)90165-W; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; Taylor CL, 1997, J NEUROSURG, V86, P583, DOI 10.3171/jns.1997.86.4.0583; van Lindert EJ, 2001, SURG NEUROL, V56, P151, DOI 10.1016/S0090-3019(01)00547-X; von Meyenfeldt EM, 2012, J THORAC ONCOL, V7, P1170, DOI 10.1097/JTO.0b013e318257cc45; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12181; Wouters MWJM, 2012, CANCER-AM CANCER SOC, V118, P1754, DOI 10.1002/cncr.26383; Yasunaga H, 2008, NEUROL MED-CHIR, V48, P531, DOI 10.2176/nmc.48.531	30	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151805	10.1371/journal.pone.0151805	http://dx.doi.org/10.1371/journal.pone.0151805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003926	Green Submitted, gold, Green Published			2022-12-27	WOS:000372697400046
J	de Rooij, MMT; Borlee, F; Smit, LAM; de Bruin, A; Janse, I; Heederik, DJJ; Wouters, IM				de Rooij, Myrna M. T.; Borlee, Floor; Smit, Lidwien A. M.; de Bruin, Arnout; Janse, Ingmar; Heederik, Dick J. J.; Wouters, Inge M.			Detection of Coxiella burnetii in Ambient Air after a Large Q Fever Outbreak	PLOS ONE			English	Article							DAIRY GOAT; SPATIAL VARIATION; NATURAL-HISTORY; PREGNANT GOATS; SHEEP; NETHERLANDS; EPIDEMIC; INFECTION; SAMPLES; FARMS	One of the largest Q fever outbreaks ever occurred in the Netherlands from 2007-2010, with 25 fatalities among 4,026 notified cases. Airborne dispersion of Coxiella burnetii was suspected but not studied extensively at the time. We investigated temporal and spatial variation of Coxiella burnetii in ambient air at residential locations in the most affected area in the Netherlands (the South-East), in the year immediately following the outbreak. One-week average ambient particulate matter < 10 mu m samples were collected at eight locations from March till September 2011. Presence of Coxiella burnetii DNA was determined by quantitative polymerase chain reaction. Associations with various spatial and temporal characteristics were analyzed by mixed logistic regression. Coxiella burnetii DNA was detected in 56 out of 202 samples (28%). Airborne Coxiella burnetii presence showed a clear seasonal pattern coinciding with goat kidding. The spatial variation was significantly associated with number of goats on the nearest goat farm weighted by the distance to the farm (OR per IQR: 1.89, CI: 1.31-2.76). We conclude that in the year after a large Q fever outbreak, temporal variation of airborne Coxiella burnetii is suggestive to be associated with goat kidding, and spatial variation with distance to and size of goat farms. Aerosol measurements show to have potential for source identification and attribution of an airborne pathogen, which may also be applicable in early stages of an outbreak.	[de Rooij, Myrna M. T.; Borlee, Floor; Smit, Lidwien A. M.; Heederik, Dick J. J.; Wouters, Inge M.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [de Bruin, Arnout; Janse, Ingmar] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment	de Rooij, MMT (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	M.M.T.deRooij@uu.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; de Rooij, Myrna Maria Theresia/0000-0002-6560-4839; Heederik, Dick/0000-0002-4550-1437; Wouters, Inge M./0000-0001-7834-9390	ZonMW [Zorg Onderzoek Nederland/ Mediche Wetenschappen] [205520010]	ZonMW [Zorg Onderzoek Nederland/ Mediche Wetenschappen]	The study was financially supported through a research grant of ZonMW [Zorg Onderzoek Nederland/ Mediche Wetenschappen, grant number 205520010, website (http://www.zonmw.nl/en/)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astobiza I, 2011, RES VET SCI, V91, pE58, DOI 10.1016/j.rvsc.2010.11.014; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Brooke RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-488; Commandeur M, 2014, INT J ENVIRON HEAL R, V24, P137, DOI 10.1080/09603123.2013.800963; de Bruin A, 2013, J APPL MICROBIOL, V114, P1395, DOI 10.1111/jam.12163; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Duarte ASR, 2015, INT J FOOD MICROBIOL, V195, P48, DOI 10.1016/j.ijfoodmicro.2014.11.024; Dungan RS, 2010, J ANIM SCI, V88, P3693, DOI 10.2527/jas.2010-3094; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Evstigneeva A. S., 2005, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P57; Gilsdorf A, 2008, EPIDEMIOL INFECT, V136, P1084, DOI 10.1017/S0950268807009533; Gyuranecz M, 2014, EUROSURVEILLANCE, V19, P9, DOI 10.2807/1560-7917.ES2014.19.30.20863; Hatchette T, 2003, VECTOR-BORNE ZOONOT, V3, P11, DOI 10.1089/153036603765627415; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hermans T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096607; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; Hogerwerf L, 2011, EMERG INFECT DIS, V17, P379, DOI 10.3201/eid1703.101157; Jones RM, 2011, J VET DIAGN INVEST, V23, P108, DOI 10.1177/104063871102300118; Jonges M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125401; Klompniaker JO, 2015, SCI TOTAL ENVIRON, V508, P266, DOI 10.1016/j.scitotenv.2014.11.088; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; National Institute for Public Health and the Environment (RIVM), 2015, Q KOORTS Q FEV; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Reedijk M, 2013, EPIDEMIOL INFECT, V141, P2623, DOI 10.1017/S0950268813000460; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Schneeberger PM, 2014, MED MALADIES INFECT, V44, P339, DOI 10.1016/j.medmal.2014.02.006; Schulz J, 2005, DEUT TIERARZTL WOCH, V112, P470; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; van den Brom R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121355; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; van Leuken JPG, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0003-y	38	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151281	10.1371/journal.pone.0151281	http://dx.doi.org/10.1371/journal.pone.0151281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991094	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800052
J	Hajna, S; Ross, NA; Joseph, L; Harper, S; Dasgupta, K				Hajna, Samantha; Ross, Nancy A.; Joseph, Lawrence; Harper, Sam; Dasgupta, Kaberi			Neighbourhood Walkability and Daily Steps in Adults with Type 2 Diabetes	PLOS ONE			English	Article							ASSESSING PHYSICAL-ACTIVITY; LAND-USE MIX; ENVIRONMENTAL ATTRIBUTES; CARDIOVASCULAR-DISEASE; WALKING BEHAVIOR; OLDER-ADULTS; SAMPLE-SIZE; ASSOCIATIONS; DEPRESSION; PREVALENCE	Introduction There is evidence that greater neighbourhood walkability (i.e., neighbourhoods with more amenities and well-connected streets) is associated with higher levels of total walking in Europe and in Asia, but it remains unclear if this association holds in the Canadian context and in chronic disease populations. We examined the relationships of different walkability measures to biosensor-assessed total walking (i.e., steps/day) in adults with type 2 diabetes living in Montreal (QC, Canada). Materials and Methods Participants (60.5 +/- 10.4 years; 48.1% women) were recruited through McGill University-affiliated clinics (June 2006 to May 2008). Steps/day were assessed once per season for one year with pedometers. Neighbourhood walkability was evaluated through participant reports, in-field audits, Geographic Information Systems (GIS)-derived measures, and the Walk Score1. Relationships between walkability and daily steps were estimated using Bayesian longitudinal hierarchical linear regression models (n = 131). Results Participants who reported living in the most compared to the least walkable neighbourhoods completed 1345 more steps/day (95% Credible Interval: 718, 1976; Quartiles 4 versus 1). Those living in the most compared to the least walkable neighbourhoods (based on GIS-derived walkability) completed 606 more steps per day (95% CrI: 8, 1203). No statistically significant associations with steps were observed for audit-assessed walkability or the Walk Score1. Conclusions Adults with type 2 diabetes who perceived their neighbourhoods as more walkable accumulated more daily steps. This suggests that knowledge of local neighborhood features that enhance walking is a meaningful predictor of higher levels of walking and an important component of neighbourhood walkability.	[Hajna, Samantha; Ross, Nancy A.; Joseph, Lawrence; Harper, Sam; Dasgupta, Kaberi] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ, Canada; [Ross, Nancy A.] McGill Univ, Dept Geog, 805 Sherbrooke St W, Montreal, PQ, Canada; [Joseph, Lawrence; Dasgupta, Kaberi] McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, 687 Pine Ave W, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Dasgupta, K (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ, Canada.; Dasgupta, K (corresponding author), McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, 687 Pine Ave W, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca	Harper, Sam/A-3406-2008	Harper, Sam/0000-0002-2767-1053; Hajna, Samantha/0000-0002-0431-2787	Canadian Institutes of Health Research (CIHR) [MOP-79275]; CIHR [94431]; Heart and Stroke Foundation of Canada [G-12-000251]; Canadian Institutes of Health Research (CIHR) Doctoral Research Award; Fonds de Recherche Sante Quebec; Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society); Canada Research Chair program; Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR) Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante Quebec; Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society); Canada Research Chair program(Canada Research Chairs); Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2)	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (KD: MOP-79275), a Catalyst Grant (NAR and KD: 94431) from CIHR, and a grant from the Heart and Stroke Foundation of Canada (KD: G-12-000251). SHajna was supported by a Canadian Institutes of Health Research (CIHR) Doctoral Research Award. KD is supported through a Senior Clinician Scientist Award from the Fonds de Recherche Sante Quebec. NAR was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society). NAR is also supported by the Canada Research Chair program (http://www.chairs-chaires.gc.ca<http://www.chairs-chaires.gc.ca/>). SHarper was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2).; The authors thank Patrick Belisle and Deborah Chan for their assistance with programming and data management, Max Halparin, Alexandre Poisson, and Elizabeth McNamee for conducting the neighbourhood audits, and Max Halparin for conducting the GIS mapping. This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (KD: MOP-79275), a Catalyst Grant (NAR and KD: 94431) from CIHR, and a grant from the Heart and Stroke Foundation of Canada (KD: G-12-000251). SHajna was supported by a Canadian Institutes of Health Research (CIHR) Doctoral Research Award. KD is supported through a Senior Clinician Scientist Award from the Fonds de Recherche Sante Quebec. NAR was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society) and the Canada Research Chair program (http://www.chairs-chaires.gc.ca). SHarper was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2).	Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Aoyagi Y, 2009, SPORTS MED, V39, P423, DOI 10.2165/00007256-200939060-00001; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Carr LJ, 2011, BRIT J SPORT MED, V45, P1144, DOI 10.1136/bjsm.2009.069609; Carr LJ, 2010, AM J PREV MED, V39, P460, DOI 10.1016/j.amepre.2010.07.007; Casey D, 2010, DIABETIC MED, V27, P79, DOI 10.1111/j.1464-5491.2009.02873.x; Cerin E, 2014, MED SCI SPORT EXER, V46, P2253, DOI 10.1249/MSS.0000000000000367; Christian HE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-55; Christine PJ, 2015, JAMA INTERN MED, V175, P1311, DOI 10.1001/jamainternmed.2015.2691; Clifton KJ, 2007, LANDSCAPE URBAN PLAN, V80, P95, DOI 10.1016/j.landurbplan.2006.06.008; Dasgupta K, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-1; Dasgupta K, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-7; Dasgupta K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-81; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; Deshpande AD, 2005, DIABETES CARE, V28, P1012, DOI 10.2337/diacare.28.5.1012; Ding D, 2014, J AGING PHYS ACTIV, V22, P421, DOI [10.1123/japa.2012-0332, 10.1123/JAPA.2012-0332]; DMTI Spatial Inc, 2008, STREET SEGM FIL; DMTI Spatial Inc, 2008, QUEB LAND US FIL; Eriksson U, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-123; FORD ES, 1995, DIABETES CARE, V18, P27, DOI 10.2337/diacare.18.1.27; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Frumkin H., 2004, URBAN SPRAWL PUBLIC; Gebel K, 2011, HEALTH PLACE, V17, P519, DOI 10.1016/j.healthplace.2010.12.008; Gilmour Heather, 2007, Health Rep, V18, P45; Guo Y, 2015, AM J ORTHOD DENTOFAC, V147, P146, DOI 10.1016/j.ajodo.2014.10.009; Guo Y, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-100; Hajna S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008964; Hajna S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2082-x; Hajna S, 2013, AM J PREV MED, V44, pE55, DOI 10.1016/j.amepre.2013.01.033; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Hoffmann K, 2002, AM J EPIDEMIOL, V156, P862, DOI 10.1093/aje/kwf121; Huebschmann AG, 2011, DIABETES CARE, V34, P1717, DOI 10.2337/dc10-1801; Inoue S, 2011, AM J PREV MED, V40, P566, DOI 10.1016/j.amepre.2010.12.023; Kamada M, 2009, PREV MED, V49, P490, DOI 10.1016/j.ypmed.2009.09.014; Koohsari MJ, 2015, J URBAN HEALTH, V92, P242, DOI 10.1007/s11524-014-9928-x; Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016; Korkiakangas EE, 2009, HEALTH PROMOT INT, V24, P416, DOI 10.1093/heapro/dap031; Leslie E, 2007, HEALTH PLACE, V13, P111, DOI 10.1016/j.healthplace.2005.11.001; Mier Nelda, 2007, Prev Chronic Dis, V4, pA24; Okun A, 1996, PSYCHOL REP, V79, P1059, DOI 10.2466/pr0.1996.79.3.1059; Oliver M, 2010, J PHYS ACT HEALTH, V7, P102, DOI 10.1123/jpah.7.1.102; Public Health Agency of Canada, WHAT CAN HAPP I HAV; Rhodes RE, 2012, PREV MED, V54, P309, DOI 10.1016/j.ypmed.2012.02.014; Rodriguez DA, 2005, MED SCI SPORT EXER, V37, pS572, DOI 10.1249/01.mss.0000185297.72328.ce; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Schneider KL, 2015, MED SCI SPORT EXER, V47, P631, DOI 10.1249/MSS.0000000000000441; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Schondorf T, 2010, DIABETES VASC DIS RE, V7, P145, DOI 10.1177/1479164109358241; Statistics Canada, 2006, 2006 CAN CENS FIL; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Taylor LM, 2008, ANN BEHAV MED, V35, P170, DOI 10.1007/s12160-008-9021-3; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Troped PJ, 2010, AM J PREV MED, V38, P429, DOI 10.1016/j.amepre.2009.12.032; Tudor-Locke C, 2004, ANN BEHAV MED, V28, P158, DOI 10.1207/s15324796abm2803_3; Tudor-Locke C, 2004, SPORTS MED, V34, P281, DOI 10.2165/00007256-200434050-00001; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Tudor-Locke Catrine, 2005, Int J Behav Nutr Phys Act, V2, P5, DOI 10.1186/1479-5868-2-5; Tudor-Locke CE, 2002, DIABETES RES CLIN PR, V55, P191, DOI 10.1016/S0168-8227(01)00317-5; Van Dyck D, 2009, HEALTH PLACE, V15, P496, DOI 10.1016/j.healthplace.2008.08.010; Van Vrancken C, 2004, SOUTH MED J, V97, P141, DOI 10.1097/01.SMJ.0000091027.41012.05; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9	68	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151544	10.1371/journal.pone.0151544	http://dx.doi.org/10.1371/journal.pone.0151544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991308	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800073
J	Hegazy, R; Salama, A; Mansour, D; Hassan, A				Hegazy, Rehab; Salama, Abeer; Mansour, Dina; Hassan, Azza			Renoprotective Effect of Lactoferrin against Chromium-Induced Acute Kidney Injury in Rats: Involvement of IL-18 and IGF-1 Inhibition	PLOS ONE			English	Article							GROWTH-FACTOR-I; INDUCED OXIDATIVE STRESS; NF-KAPPA-B; BOVINE LACTOFERRIN; INDUCED NEPHROTOXICITY; FACTOR SYSTEM; RENAL DAMAGE; TNF-ALPHA; CELLS; INTERLEUKIN-18	Hexavalent chromium (CrVI) is a heavy metal widely used in more than 50 industries. Nephrotoxicity is a major adverse effect of chromium poisoning. The present study investigated the potential renoprotective effect of lactoferrin (Lf) against potassium dichromate (PDC)-induced acute kidney injury (AKI) in rats. Beside, because previous studies suggest that interlukin-18 (IL-18) and insulin-like growth factor-1 (IGF-1) play important roles in promoting kidney damage, the present work aimed to evaluate the involvement of these two cytokines in PDC model of AKI and in the potential renoprotective effect of lactoferrin. Adult male albino Wistar rats were pretreated with Lf (200mg/kg/day, p.o.) or (300mg/kg/day, p.o.); the doses that are usually used in the experiment studies, for 14 days followed by a single dose of PDC (15mg/kg, s.c.). PDC caused significant increase in serum urea, creatinine, and total protein levels. This was accompanied with decreased renal glutathione content, and increased renal malondialdehyde, IL-18, IL-4, nuclear factor kappa B (NF kappa B), IGF-1, and the phosphorylated form of forkhead box protein O1 (FoxO1) levels. Moreover, normal expression IFN-gamma mRNA and enhanced expression of TNF-alpha mRNA was demonstrated in renal tissues. Histopathological investigations provoked deleterious changes in the renal tissues. Tubular epithelial hyperplasia and apoptosis were demonstrated immunohistochemically by positive proliferating cell nuclear antigen (PCNA), Bax, and Caspase-3 expression, respectively. Pretreatment of rats with Lf in both doses significantly corrected all previously mentioned PDC-induced changes with no significant difference between both doses. In conclusion, the findings of the present study demonstrated the involvement of oxidative stress, inflammatory reactions, tubular hyperplasia and apoptosis in PDC-induced AKI. It suggested a role of IL-18 through stimulation of IL-4-induced inflammatory pathway, and IGF-1 through triggering FoxO1-induced cell proliferation. Moreover, the study revealed that Lf protected the kidney against Cr-induced AKI in rats and significantly showed antioxidant, anti-inflammatory, and anti-proliferative properties with down-regulation of IL-18 and IGF-1.	[Hegazy, Rehab; Salama, Abeer; Mansour, Dina] Natl Res Ctr, Div Med, Dept Pharmacol, Giza, Egypt; [Hassan, Azza] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Div Med, Dept Pharmacol, Giza, Egypt.	rehab_hegazy@hotmail.com		Hegazy, Rehab/0000-0002-2586-2104; Salama, Abeer/0000-0001-9870-5583; Mansour, Dina/0000-0002-5656-2462				Abrink M, 2000, KIDNEY INT, V57, P2004, DOI 10.1046/j.1523-1755.2000.00050.x; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Alfaro-Lira S, 2012, INT J ENV RES PUB HE, V9, P1630, DOI 10.3390/ijerph9051630; [Anonymous], 2003, EXP GROUP VIT MIN EV; Arreola-Mendoza L, 2006, TOXICOLOGY, V218, P237, DOI 10.1016/j.tox.2005.11.010; Aruldhas MM, 2005, HUM REPROD, V20, P2801, DOI 10.1093/humrep/dei148; Aukema HM, 2001, KIDNEY INT, V59, P52, DOI 10.1046/j.1523-1755.2001.00465.x; Bartoskova A, 2009, REPROD DOMEST ANIM, V44, P193, DOI 10.1111/j.1439-0531.2009.01409.x; Beaver LM, 2009, TOXICOL APPL PHARM, V235, P47, DOI 10.1016/j.taap.2008.11.018; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; BERRY JP, 1978, J HISTOCHEM CYTOCHEM, V26, P651, DOI 10.1177/26.8.690404; Carvalho CAM, 2014, VIROLOGY, V452, P297, DOI 10.1016/j.virol.2014.01.022; COCCHETTO DM, 1983, J PHARM SCI-US, V72, P465, DOI 10.1002/jps.2600720503; Cumberbatch M, 2003, CLIN EXP IMMUNOL, V132, P352, DOI 10.1046/j.1365-2249.2003.02146.x; Drury R.A.B., 1967, CARLETONS HISTOLOGIC, P432; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elass E, 2002, INFECT IMMUN, V70, P1860, DOI 10.1128/IAI.70.4.1860-1866.2002; Eldridge SR, 1996, FUND APPL TOXICOL, V32, P159, DOI 10.1006/faat.1996.0119; Fang B, 2014, BBA-MOL CELL BIOL L, V1841, P535, DOI 10.1016/j.bbalip.2013.12.008; Fatima S, 2007, CLIN CHIM ACTA, V386, P94, DOI 10.1016/j.cca.2007.08.006; Faubel S, 2007, J PHARMACOL EXP THER, V322, P8, DOI 10.1124/jpet.107.119792; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Flores A, 1999, TOXICOL APPL PHARM, V161, P75, DOI 10.1006/taap.1999.8779; GAHR M, 1991, J LEUKOCYTE BIOL, V49, P427, DOI 10.1002/jlb.49.5.427; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Halade GV, 2010, J IMMUNOL, V184, P5280, DOI 10.4049/jimmunol.0903282; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Hessin Alyaa, 2015, Open Access Maced J Med Sci, V3, P195, DOI 10.3889/oamjms.2015.038; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirschberg R, 1998, AM J KIDNEY DIS, V31, P901, DOI 10.1053/ajkd.1998.v31.pm9631833; Ibrahim MA, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1068-z; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kanwar JR, 2015, MOLECULES, V20, P9703, DOI 10.3390/molecules20069703; Keane M, 2015, J OCCUP ENV HYG, V0; Kimoto Y, 2013, J VET MED SCI, V75, P159, DOI 10.1292/jvms.12-0154; Kuhara T, 2000, NUTR CANCER, V38, P192, DOI 10.1207/S15327914NC382_8; Latorre D, 2010, TOXINS, V2, P54, DOI 10.3390/toxins2010054; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Liu YH, 2002, CURR OPIN NEPHROL HY, V11, P23, DOI 10.1097/00041552-200201000-00004; Liu ZQ, 2015, CELL PHYSIOL BIOCHEM, V37, P225, DOI 10.1159/000430347; Lopez-Franco O, 2002, AM J PATHOL, V161, P1497, DOI 10.1016/S0002-9440(10)64425-2; MACHNICKI M, 1993, INT J EXP PATHOL, V74, P433; Maneva A, 2003, Z NATURFORSCH C, V58, P256; Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089; Mignini F, 2009, ENVIRON TOXICOL, V24, P594, DOI 10.1002/tox.20464; MILLER SB, 1992, P NATL ACAD SCI USA, V89, P11876, DOI 10.1073/pnas.89.24.11876; MILLER SB, 1994, AM J PHYSIOL, V266, pF949, DOI 10.1152/ajprenal.1994.266.6.F949; Mohan KVPC, 2006, BBA-GEN SUBJECTS, V1760, P1536, DOI 10.1016/j.bbagen.2006.06.009; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Morel JCM, 2001, LAB INVEST, V81, P1371, DOI 10.1038/labinvest.3780351; NAKAMURA T, 1993, J AM SOC NEPHROL, V3, P1378; Norrby K, 2001, INT J CANCER, V91, P236, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1024&gt;3.3.CO;2-K; Nudler SI, 2009, TOXICOL LETT, V185, P187, DOI 10.1016/j.toxlet.2009.01.003; Ogasawara Y, 2014, INT J MOL SCI, V15, P1003, DOI 10.3390/ijms15011003; Oh YM, 2012, KIDNEY RES CLIN PRAC, V31, P26, DOI 10.1016/j.krcp.2011.12.005; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; Parker E, 2007, KIDNEY INT, V72, P157, DOI 10.1038/sj.ki.5002229; Pesch B, 2015, INT J HYG ENVIR HEAL, V218, P500, DOI 10.1016/j.ijheh.2015.04.004; Roelfsema V, 2001, J AM SOC NEPHROL, V12, P1297, DOI 10.1681/ASN.V1261297; Salama A. A. A., 2014, Journal of Chemical and Pharmaceutical Research, V6, P168; Shi HP, 2014, ONCOL LETT, V7, P820, DOI 10.3892/ol.2013.1776; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sorimachi K, 1997, BIOCHEM MOL BIOL INT, V43, P79; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Swain SL, 2001, J EXP MED, V194, pF11, DOI 10.1084/jem.194.3.F11; Tsubota A, 2008, J HEPATOL, V48, P486, DOI 10.1016/j.jhep.2007.11.013; Varadhachary A, 2004, INT J CANCER, V111, P398, DOI 10.1002/ijc.20271; Velusamy SK, 2014, ANTIMICROB AGENTS CH, V58, P397, DOI 10.1128/AAC.00020-13; Vesce F, 2014, GYNECOL OBSTET INVES; Wu HL, 2008, J AM SOC NEPHROL, V19, P2331, DOI 10.1681/ASN.2008020170; Xiao Y, 2004, CLIN CANCER RES, V10, P8683, DOI 10.1158/1078-0432.CCR-04-0988; Xue HM, 2015, CELL PHYSIOL BIOCHEM, V36, P2456, DOI 10.1159/000430206; Yam-Canul P, 2008, FOOD CHEM TOXICOL, V46, P1089, DOI 10.1016/j.fct.2007.11.003; Yamada Y, 2008, J VET MED SCI, V70, P443, DOI 10.1292/jvms.70.443; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhou XW, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/786528; Zimecki M, 2001, ARCH IMMUNOL THER EX, V49, P325; Zimecki Michal, 2007, Postepy Hig Med Dosw (Online), V61, P283	82	40	42	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151486	10.1371/journal.pone.0151486	http://dx.doi.org/10.1371/journal.pone.0151486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990190	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800064
J	Alfonzo, E; Ellstrom, AA; Nemes, S; Strander, B				Alfonzo, Emilia; Ellstrom, Agneta Andersson; Nemes, Szilard; Strander, Bjorn			Effect of Fee on Cervical Cancer Screening Attendance-ScreenFee, a Swedish Population-Based Randomised Trial	PLOS ONE			English	Article							PAP-SMEAR; WOMEN; PARTICIPATION; BREAST; KNOWLEDGE; ATTITUDES; PROGRAM	Background Attendance in the cervical cancer screening programme is one of the most important factors to lower the risk of contracting the disease. Attendance rates are often low in areas with low socioeconomic status. Charging a fee for screening might possibly decrease attendance in this population. Screening programme coverage is low in low socio-economic status areas in Gothenburg, Sweden, but has increased slightly after multiple interventions in recent years. For many years, women in the region have paid a fee for screening. We studied the effect of abolishing this fee in a trial emanating from the regular cervical cancer screening programme. Method Individually randomised controlled trial. All 3 124 women in three low-resource areas in Gothenburg, due for screening during the study period, were randomised to receive an offer of a free test or the standard invitation stating the regular fee of 100 SEK (approximate to 11 (sic)). The study was conducted during the first six months of 2013. Attendance was defined as a registered Pap smear within 90 days from the date the invitation was sent out. Results Attendance did not differ significantly between women who were charged and those offered free screening (RR 0.93; CI 0.85-1.02). No differences were found within the districts or as an effect of age, attendance after the most recent previous invitation or previous experience of smear taking. Conclusion Abolishment of a modest screening fee in socially disadvantaged urban districts with low coverage, after previous multiple systematic interventions, does not increase attendance in the short term. Other interventions might be more important for increasing attendance in low socio-economic status areas.	[Alfonzo, Emilia; Ellstrom, Agneta Andersson; Nemes, Szilard; Strander, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Alfonzo, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	emilia.alfonzo@vgregion.se	Strander, Björn/AAB-2609-2021	Strander, Björn/0000-0001-8369-7955; Nemes, Szilard/0000-0002-4145-1786	Research and Development in Narhalsan Primary Care, Region Vastra Gotaland, Sweden; Regional Cancer Centre Western Health Care Region, Sweden	Research and Development in Narhalsan Primary Care, Region Vastra Gotaland, Sweden; Regional Cancer Centre Western Health Care Region, Sweden	The study was funded by grants from Research and Development in Narhalsan Primary Care, Region Vastra Gotaland and from the Regional Cancer Centre Western Health Care Region, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; [Anonymous], 2014, GOTEBORGS STAD STADS; Azerkan F, 2008, INT J CANCER, V123, P2664, DOI 10.1002/ijc.23843; Bonfill X., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002943, DOI 10.1002/14651858.CD002943]; Broberg G, 2014, INT J CANCER, V134, P2223, DOI 10.1002/ijc.28545; Broberg G, 2013, INT J CANCER, V133, P164, DOI 10.1002/ijc.27985; Eaker S, 2004, CANCER EPIDEM BIOMAR, V13, P346; Eaker S, 2001, PREV MED, V32, P482, DOI 10.1006/pmed.2001.0844; Everett T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002834.pub2; Fylan F, 1998, BRIT J GEN PRACT, V48, P1509; Idestrom M, 2002, ACTA OBSTET GYN SCAN, V81, P962, DOI 10.1034/j.1600-0412.2002.811011.x; Immonen-Raiha P, 2001, LANCET, V358, P1425, DOI 10.1016/S0140-6736(01)06520-5; Kuroki H, 2012, J OBSTET GYNAECOL RE, V38, P35, DOI 10.1111/j.1447-0756.2011.01672.x; Nationellt kvalitetsregister for cervixcancerprevention, 2015, PREV CERV CANC SWED; NORDCAN, 2015, MORT CERV CANC SWED; Patnick J, 2000, EUR J CANCER, V36, P2205, DOI 10.1016/S0959-8049(00)00310-5; Price Rebecca Anhang, 2010, Journal of the National Cancer Institute Monographs, P38, DOI 10.1093/jncimonographs/lgq008; R-Core-Team, 2015, LANG ENV STAT COMP; Raghubir P, 2004, J CONSUM PSYCHOL, V14, P181, DOI 10.1207/s15327663jcp1401&2_20; Regionalt Cancer Centrum Vast, 2015, LANG ENV STAT COMP; Segnan N, 1998, TUMORI J, V84, P348, DOI 10.1177/030089169808400307; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Stoner TJ, 1998, HEALTH SERV RES, V33, P11; Tornberg Sven, 2014, Lakartidningen, V111, P278; Vastra Gotalandsregionen, 2012, SLUTRAPPORT TA MED V; Virtanen A, 2011, CANCER EPIDEM BIOMAR, V20, P1960, DOI 10.1158/1055-9965.EPI-11-0307; Wikstrom I, 2011, BRIT J CANCER, V105, P337, DOI 10.1038/bjc.2011.236; World Health Organization, 2008, WORLD CANC REPORT 20	28	8	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150888	10.1371/journal.pone.0150888	http://dx.doi.org/10.1371/journal.pone.0150888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986848	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300034
J	Deng, K; Zhu, H; Chen, M; Wu, JC; Hu, RW; Tang, CW				Deng, Kai; Zhu, Hong; Chen, Mo; Wu, Junchao; Hu, Renwei; Tang, Chengwei			Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; MESSENGER-RNA DETECTION; QUANTITATIVE CARCINOEMBRYONIC ANTIGEN; LAVAGE FLUID; RT-PCR; CLINICAL-SIGNIFICANCE; CURATIVE RESECTION; TUMOR-CELLS; RECURRENCE; WASHES	Background Accurately distinguishing serosal invasion in patients with gastric cancer (GC) prior to surgery can be difficult. Molecular analysis of peritoneal fluid (MAPF) for free cancer cells with higher sensitivity than other methods; however, its prognostic value for GC remains controversial, precluding its application in clinical practice. Methods PubMed, EMBASE and other databases were systematically searched. Thirty-one studies were eligible for the meta-analysis. Hazard ratios (HRs) and 95% confidence intervals (CIs) were pooled for overall survival (OS), disease-free survival (DFS) and peritoneal recurrence-free survival (PRF). Results The current meta-analysis focused on patients with GC and negative cytological diagnoses. The results showed that positive MAPF status (MAPF(+)) led to poorer prognoses for OS (HR 2.59, 95% CI 1.99-3.37), DFS (HR 4.92, 95% CI 3.28-7.37) and PRF (HR 2.81, 95% CI 2.12-3.72) compared with negative MAPF status (MAPF(-)). Moreover, among the patients with GC who received curative treatment, the MAPF(+) patients had poorer prognoses for OS (HR 3.27, 95% CI 2.49-4.29), DFS (HR 3.90, 95% CI 2.74-5.57) and PRF (HR 5.45, 95% CI 3.70-8.03). A meta-analysis of multivariate-adjusted HRs demonstrated that MAPF(+) status was an independent prognostic factor for patients with GC who underwent curative treatment (OS: HR 2.19, 95% CI 1.47-3.28; PRF: HR 3.44, 95% CI 2.01-5.87). Using the identical target genes (CEA, CEA/CK20) as molecular markers, the patients with GC who were MAPF(+) had significantly worse prognoses for OS (CEA: HR 3.03, 95% CI 2.29-4.01; CEA/CK20: HR 4.24, 95% CI 2.42-7.40), DFS (CEA: HR 3.99, 95% CI 2.24-7.12; CEA/CK20: HR 4.31, 95% CI 1.49-2.48) and PRF ( CEA: HR 4.45, 95% CI 2.72-7.31; CEA/CK20: HR 6.46, 95% CI 3.62-11.55) than the patients who were MAPF(-) Conclusion/Significance The above results demonstrate that MAPF could be a prognostic indicator for patients with GC who have a negative cytological diagnosis and/or are receiving curative treatment. MAPF could provide clinicians with additional prognostic information that could aid in developing individualized treatment plans prior to surgery. The widely used target genes CEA, CEA/CK20 were confirmed to be valuable MAPF markers for predicting the prognosis of GC.	[Deng, Kai; Wu, Junchao; Hu, Renwei; Tang, Chengwei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R China; [Zhu, Hong] Sichuan Univ, West China Hosp, Dept Abdominal Canc, Chengdu 610041, Peoples R China; [Chen, Mo] Chengdu Second Peoples Hosp, Dept Crit Care Med, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Tang, CW (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610041, Peoples R China.	ChengweiTang@126.com			Science Foundation of Sichuan Health Planning Commission [150168]	Science Foundation of Sichuan Health Planning Commission	Kai Deng was supported by the Science Foundation of Sichuan Health Planning Commission (No. 150168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the statisticians Tao Liyuan and Li Guoxin (School of Public Health, Peking University) in the Department of Epidemiology and Statistics for their critical support with statistical analysis. This research was supported by the Science Foundation of Sichuan Health Planning Commission (No. 150168).	Abe S, 2015, GASTRIC CANCER, V18, P188, DOI 10.1007/s10120-014-0341-7; Chang-Qing F, 2011, APMIS, V119, P173, DOI 10.1111/j.1600-0463.2010.02707.x; Coccolini F, 2014, EJSO-EUR J SURG ONC, V40, P12, DOI 10.1016/j.ejso.2013.10.019; Del Monte SR, 2012, J SURG ONCOL, V106, P17, DOI 10.1002/jso.23052; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fujii H, 2015, DIGEST ENDOSC, V27, P159, DOI 10.1111/den.12261; Fujii S, 2002, J EXP CLIN CANC RES, V21, P547; Fujiwara Y, 2014, SURGERY, V155, P417, DOI 10.1016/j.surg.2013.10.004; Fukumoto Youji, 2006, Gastric Cancer, V9, P271, DOI 10.1007/s10120-006-0390-7; Han J, 2014, DIGEST DIS SCI, V59, P1160, DOI 10.1007/s10620-013-3007-0; Hara M, 2007, CLIN EXP METASTAS, V24, P179, DOI 10.1007/s10585-007-9067-9; Hayes N, 1999, BRIT J CANCER, V79, P520, DOI 10.1038/sj.bjc.6690081; Hiraki M, 2011, ANN SURG ONCOL, V18, P3013, DOI 10.1245/s10434-011-1636-0; Hiraki M, 2010, WORLD J GASTROENTERO, V16, P330, DOI 10.3748/wjg.v16.i3.330; Horikawa M, 2011, ONCOL REP, V25, P1413, DOI 10.3892/or.2011.1191; Ishii T, 2004, ANN SURG ONCOL, V11, P778, DOI 10.1245/ASO.2004.12.043; Ito S, 2005, BRIT J CANCER, V93, P986, DOI 10.1038/sj.bjc.6602802; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon CH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000083; Jeon CH, 2010, J CLIN GASTROENTEROL, V44, P682, DOI 10.1097/MCG.0b013e3181d6bb0b; Katsuragi K, 2007, BRIT J CANCER, V97, P550, DOI 10.1038/sj.bjc.6603909; Kodera Y, 1998, INT J CANCER, V79, P429, DOI 10.1002/(SICI)1097-0215(19980821)79:4<429::AID-IJC20>3.0.CO;2-Z; Kodera Y, 2006, J AM COLL SURGEONS, V202, P231, DOI 10.1016/j.jamcollsurg.2005.09.008; Kodera Y, 2004, JPN J CLIN ONCOL, V34, P525, DOI 10.1093/jjco/hyh097; Kodera Y, 2002, ANN SURG, V235, P499, DOI 10.1097/00000658-200204000-00007; Kodera Yasuhiro, 2005, Gastric Cancer, V8, P142, DOI 10.1007/s10120-005-0318-7; Kodera Yasuhiro, 2002, Gastric Cancer, V5, P69, DOI 10.1007/s101200200012; KOGA S, 1984, J CANCER RES CLIN, V108, P236, DOI 10.1007/BF00402474; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee SR, 2013, HEPATO-GASTROENTEROL, V60, P1237, DOI 10.5754/hge121058; Li Z, 2014, TUMOR BIOL, V35, P3463, DOI 10.1007/s13277-013-1458-8; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miyagawa K, 2008, ANTICANCER RES, V28, P1169; Mori K, 2004, BIOCHEM BIOPH RES CO, V313, P931, DOI 10.1016/j.bbrc.2003.12.025; Mori K, 2007, ANN SURG ONCOL, V14, P1694, DOI 10.1245/s10434-006-9321-4; Nakabayashi K, 2015, CLIN CHIM ACTA, V439, P137, DOI 10.1016/j.cca.2014.10.014; NAKAJIMA T, 1978, Acta Cytologica, V22, P225; Nakanishi H, 1999, CANCER CHEMOTH PHARM, V43, pS32, DOI 10.1007/s002800051095; Okada K, 2012, J SURG ONCOL, V105, P780, DOI 10.1002/jso.22108; Oyama K, 2004, BRIT J SURG, V91, P435, DOI 10.1002/bjs.4455; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pecqueux M, 2015, ONCOTARGET, V6, P35564, DOI 10.18632/oncotarget.5595; Satoh Y, 2012, JPN J CLIN ONCOL, V42, P148, DOI 10.1093/jjco/hyr179; Song J, 2010, ANN SURG ONCOL, V17, P1777, DOI 10.1245/s10434-010-0932-4; Sugita Y, 2003, INT J ONCOL, V23, P1419; Takata A, 2014, WORLD J SURG, V38, P1107, DOI 10.1007/s00268-013-2385-y; Takebayashi K, 2014, ANN SURG ONCOL, V21, P1991, DOI 10.1245/s10434-014-3525-9; Tamura N, 2007, ONCOL REP, V17, P667; Tamura S, 2014, J SURG ONCOL, V109, P75, DOI 10.1002/jso.23472; Tokuda K, 2003, INT J MOL MED, V11, P79; Tong JH, 2011, SURGERY, V149, P356, DOI 10.1016/j.surg.2010.07.006; Wang JY, 2005, CANCER LETT, V223, P129, DOI 10.1016/j.canlet.2004.09.031; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wong J, 2012, J GASTROINTEST SURG, V16, P889, DOI 10.1007/s11605-012-1845-2; Xiao Y, 2014, IRISH J MED SCI, V183, P557, DOI 10.1007/s11845-013-1051-6; Yabusaki N, 2015, MOL CLIN ONCOL, V3, P435, DOI 10.3892/mco.2014.462; Yoneda A, 2014, J SURG RES, V187, pE1, DOI 10.1016/j.jss.2013.01.001; Yonemura Y, 2001, ANZ J SURG, V71, P521, DOI 10.1046/j.1440-1622.2001.02187.x; Yonemura Y, 2001, CLIN CANCER RES, V7, P1647; Yu JL, 2014, ARCH PATHOL LAB MED, V138, P1466, DOI 10.5858/arpa.2013-0285-OA	62	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151608	10.1371/journal.pone.0151608	http://dx.doi.org/10.1371/journal.pone.0151608			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986965	Green Published, gold			2022-12-27	WOS:000372580300095
J	Gong, YN; Chen, GW; Yang, SL; Lee, CJ; Shih, SR; Tsao, KC				Gong, Yu-Nong; Chen, Guang-Wu; Yang, Shu-Li; Lee, Ching-Ju; Shih, Shin-Ru; Tsao, Kuo-Chien			A Next-Generation Sequencing Data Analysis Pipeline for Detecting Unknown Pathogens from Mixed Clinical Samples and Revealing Their Genetic Diversity	PLOS ONE			English	Article							HUMAN PARECHOVIRUS; VIRUS DETECTION; IDENTIFICATION; ENTEROVIRUS; RECOMBINATION; PREVALENCE; DISCOVERY; ALIGNMENT; GENOMES; CULTURE	Forty-two cytopathic effect (CPE)-positive isolates were collected from 2008 to 2012. All isolates could not be identified for known viral pathogens by routine diagnostic assays. They were pooled into 8 groups of 5-6 isolates to reduce the sequencing cost. Next-generation sequencing (NGS) was conducted for each group of mixed samples, and the proposed data analysis pipeline was used to identify viral pathogens in these mixed samples. Polymerase chain reaction (PCR) or enzyme-linked immunosorbent assay (ELISA) was individually conducted for each of these 42 isolates depending on the predicted viral types in each group. Two isolates remained unknown after these tests. Moreover, iteration mapping was implemented for each of these 2 isolates, and predicted human parechovirus (HPeV) in both. In summary, our NGS pipeline detected the following viruses among the 42 isolates: 29 human rhinoviruses (HRVs), 10 HPeVs, 1 human adenovirus (HAdV), 1 echovirus and 1 rotavirus. We then focused on the 10 identified Taiwanese HPeVs because of their reported clinical significance over HRVs. Their genomes were assembled and their genetic diversity was explored. One novel 6-bp deletion was found in one HPeV-1 virus. In terms of nucleotide heterogeneity, 64 genetic variants were detected from these HPeVs using the mapped NGS reads. Most importantly, a recombination event was found between our HPeV-3 and a known HPeV-4 strain in the database. Similar event was detected in the other HPeV-3 strains in the same clade of the phylogenetic tree. These findings demonstrated that the proposed NGS data analysis pipeline identified unknown viruses from the mixed clinical samples, revealed their genetic identity and variants, and characterized their genetic features in terms of viral evolution.	[Gong, Yu-Nong; Chen, Guang-Wu; Yang, Shu-Li; Lee, Ching-Ju; Shih, Shin-Ru; Tsao, Kuo-Chien] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Gong, Yu-Nong; Chen, Guang-Wu] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chen, Guang-Wu; Shih, Shin-Ru; Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Yang, Shu-Li; Shih, Shin-Ru; Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Tsao, KC (corresponding author), Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Tsao, KC (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.	kctsao@cgmh.org.tw	Shih, Shin-Ru/M-9711-2016; Chen, Guang-Wu/M-6768-2016	Shih, Shin-Ru/0000-0003-4874-401X; Gong, Yu-Nong/0000-0002-6799-1561	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPG3C0731, CMRPG3C0733, CLRPG3B0042, CLRPG3B0043]; Ministry of Science and Technology, Taiwan [MOST-103-2221-E-182022]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	KCT received five grants from Chang Gung Memorial Hospital, Taoyuan, Taiwan (from No. CMRPG3C0731 to CMRPG3C0733, CLRPG3B0042 and CLRPG3B0043; http://www.cgmh.org.tw). GWC received one grant from the Ministry of Science and Technology, Taiwan (No. MOST-103-2221-E-182022; http://www.most.gov.tw/). A total of 6 grants partially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017722; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aw TG, 2014, J VIROL METHODS, V210, P15, DOI 10.1016/j.jviromet.2014.09.017; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Benschop KSM, 2010, J GEN VIROL, V91, P145, DOI 10.1099/vir.0.014670-0; Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647; Chen GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045946; de Crom SCM, 2013, J CLIN VIROL, V58, P449, DOI 10.1016/j.jcv.2013.07.017; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Ho T, 2014, VIROLOGY, V471, P54, DOI 10.1016/j.virol.2014.09.019; Huang YP, 2016, J MICROBIOL IMMUNOL, V49, P321, DOI 10.1016/j.jmii.2014.06.013; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuo RL, 2014, J VIROL METHODS, V208, P41, DOI 10.1016/j.jviromet.2014.07.020; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Tan LV, 2013, MBIO, V4, DOI 10.1128/mBio.00231-13; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu XY, 2013, J CLIN MICROBIOL, V51, P1089, DOI 10.1128/JCM.03297-12; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Mok CK, 2015, J MICROBIOL IMMUNOL, V48, P465, DOI 10.1016/j.jmii.2013.09.010; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Shah G, 2014, CAN J INFECT DIS MED, V25, P186, DOI 10.1155/2014/602501; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; Suwantarat N, 2015, CURR OPIN INFECT DIS, V28, P349, DOI 10.1097/QCO.0000000000000183; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; Vezzi F, 2011, EMBNET J, V17, P46, DOI DOI 10.14806/EJ.17.1.208; Wang QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064465; Westerhuis BM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-146; Wong S, 2008, J MED VIROL, V80, P856, DOI 10.1002/jmv.21136; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151495	10.1371/journal.pone.0151495	http://dx.doi.org/10.1371/journal.pone.0151495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986479	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300079
J	Wang, Y; Miao, F; Yan, LL				Wang, Ying; Miao, Fang; Yan, Liuling			Branching Shoots and Spikes from Lateral Meristems in Bread Wheat	PLOS ONE			English	Article							SUPERNUMERARY SPIKELETS; CHROMOSOMAL LOCATION; GENE; INHERITANCE; EVOLUTION; GENOME; BARLEY	Wheat grain yield consists of three components: spikes per plant, grains per spike (i.e. head or ear), and grain weight; and the grains per spike can be dissected into two subcomponents: spikelets per spike and grains per spikelet. An increase in any of these components will directly contribute to grain yield. Wheat morphology biology tells that a wheat plant has no lateral meristem that forms any branching shoot or spike. In this study, we report two novel shoot and spike traits that were produced from lateral meristems in bread wheat. One is supernumerary shoot that was developed from an axillary bud at the axil of leaves on the elongated internodes of the main stem. The other is supernumerary spike that was generated from a spikelet meristem on a spike. In addition, supernumerary spikelets were generated on the same rachis node of the spike in the plant that had supernumerary shoot and spikes. All of these supernumerary shoots/spikes/spikelets found in the super wheat plants produced normal fertility and seeds, displaying huge yield potential in bread wheat.	[Wang, Ying; Miao, Fang; Yan, Liuling] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Miao, Fang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Oklahoma State University System; Oklahoma State University - Stillwater; Northwest A&F University - China	Yan, LL (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	liuling.yan@okstate.edu						AHRENS J. F., 1963, CROP SCI, V3, P463, DOI 10.2135/cropsci1963.0011183X000300060001x; Alieva A. Dzh., 2009, Russian Agricultural Sciences, V35, P144, DOI 10.3103/S1068367409030033; Alieva AJ, 2013, RUSS J GENET+, V49, P1119, DOI 10.1134/S1022795413110021; Aliyeva AJ, 2011, GENET RESOUR CROP EV, V58, P621, DOI 10.1007/s10722-011-9702-9; Beveridge CA, 2010, CURR OPIN PLANT BIOL, V13, P34, DOI 10.1016/j.pbi.2009.10.003; Chalupska D, 2008, P NATL ACAD SCI USA, V105, P9691, DOI 10.1073/pnas.0803981105; Dobrovolskaya O, 2009, THEOR APPL GENET, V119, P867, DOI 10.1007/s00122-009-1095-1; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DVORAK J, 1993, GENOME, V36, P21, DOI 10.1139/g93-004; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gao ZY, 2009, PLANT MOL BIOL, V71, P265, DOI 10.1007/s11103-009-9522-x; GARDNER JS, 1985, AM J BOT, V72, P548, DOI 10.2307/2443587; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; KIRBY EJM, 1974, J AGR SCI, V82, P437, DOI 10.1017/S0021859600051339; KLINDWORTH DL, 1990, GENOME, V33, P509, DOI 10.1139/g90-075; KLINDWORTH DL, 1990, GENOME, V33, P515, DOI 10.1139/g90-076; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lin QB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1716; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; McMaster GS, 2005, J AGR SCI-CAMBRIDGE, V143, P137, DOI 10.1017/S0021859605005083; MILLET E, 1986, THEOR APPL GENET, V72, P105, DOI 10.1007/BF00261463; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; PATIL J. A., 1958, CURRENT SCI, V27, P404; Peng ZS, 1998, EUPHYTICA, V103, P109, DOI 10.1023/A:1018323310621; PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; RAWSON HM, 1970, AUST J BIOL SCI, V23, P1, DOI 10.1071/BI9700001; Sears E. R., 1954, ANEUPLOIDS COMMON WH, P3; Sharman BC, 1944, NATURE, V153, P497, DOI 10.1038/153497a0; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; WILLIAMS RF, 1966, AUST J BIOL SCI, V19, P949, DOI 10.1071/BI9660949; Yang W.Y., 2011, TRITICEAE GENOM GENE, V2, P1; Yang WY, 2005, GENET RESOUR CROP EV, V52, P847, DOI 10.1007/s10722-003-6089-2; Zhang RuiQi, 2013, Acta Agronomica Sinica, V39, P29, DOI 10.3724/SP.J.1006.2013.00029; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108; Zuo J, 2013, NATL SCI REV, P1	42	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151656	10.1371/journal.pone.0151656	http://dx.doi.org/10.1371/journal.pone.0151656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986738	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300105
J	Chen, R; Lu, DR; Xie, ZL; Feng, J; Jia, ZF; Ho, JM; Coote, ML; Wu, YL; Monteiro, MJ; Chung, SH				Chen, Rong; Lu, Derong; Xie, Zili; Feng, Jing; Jia, Zhongfan; Ho, Junming; Coote, Michelle L.; Wu, Yingliang; Monteiro, Michael J.; Chung, Shin-Ho			Peptidomimetic Star Polymers for Targeting Biological Ion Channels	PLOS ONE			English	Article							K+ CHANNEL; AUTOIMMUNE-DISEASES; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; KV1.3; DENDRIMERS; PEPTIDES; TOXINS; BINDING	Four end-functionalized star polymers that could attenuate the flow of ionic currents across biological ion channels were first de novo designed computationally, then synthesized and tested experimentally on mammalian K+ channels. The 4-arm ethylene glycol conjugate star polymers with lysine or a tripeptide attached to the end of each arm were specifically designed to mimic the action of scorpion toxins on K+ channels. Molecular dynamics simulations showed that the lysine side chain of the polymers physically occludes the pore of Kv1.3, a target for immuno-suppression therapy. Two of the compounds tested were potent inhibitors of Kv1.3. The dissociation constants of these two compounds were computed to be 0.1 mu M and 0.7 mu M, respectively, within 3-fold to the values derived from subsequent experiments. These results demonstrate the power of computational methods in molecular design and the potential of star polymers as a new infinitely modifiable platform for ion channel drug discovery.	[Chen, Rong; Chung, Shin-Ho] Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 2601, Australia; [Lu, Derong; Jia, Zhongfan; Monteiro, Michael J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Xie, Zili; Feng, Jing; Wu, Yingliang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ho, Junming; Coote, Michelle L.] Australian Natl Univ, ARC Ctr Excellence Electromat Sci, Res Sch Chem, GPO Box 4, Canberra, ACT 2601, Australia	Australian National University; University of Queensland; Wuhan University; Australian National University	Chen, R (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 2601, Australia.; Monteiro, MJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.	rong.chen@anu.edu.au; m.monteiro@uq.edu.au	Ho, Junming/A-1070-2012; Feng, Jing/C-1729-2018; Coote, Michelle L/B-2267-2010; lu, derong/HCH-1625-2022; Jia, Zhongfan/AAD-2308-2020; Ho, Junming/J-9366-2019; Monteiro, Michael/C-5658-2009	Ho, Junming/0000-0001-9381-924X; Feng, Jing/0000-0001-6726-7912; Coote, Michelle L/0000-0003-0828-7053; Jia, Zhongfan/0000-0001-9690-7288; Ho, Junming/0000-0001-9381-924X; Monteiro, Michael/0000-0001-5624-7115	Australian Research Council; National Health and Medical Research Council of Australia; Medical Advances Without Animals Trust (MAWA)	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Advances Without Animals Trust (MAWA)	This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council of Australia, and The Medical Advances Without Animals Trust (MAWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047253; Chen R, 2011, BIOPHYS J, V101, P2652, DOI 10.1016/j.bpj.2011.10.029; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; England S, 2009, BRIT J PHARMACOL, V158, P1413, DOI 10.1111/j.1476-5381.2009.00437.x; Gordon D, 2013, PHYSIOL REV, V93, P767, DOI 10.1152/physrev.00035.2012; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grossfield A., WHAM WEIGHTED HISTOG; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Liu TY, 2013, BIOMACROMOLECULES, V14, P2798, DOI 10.1021/bm400626w; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu DR, 2015, MACROMOLECULES, V48, P1688, DOI 10.1021/acs.macromol.5b00195; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; McGivern Joseph G, 2007, Neuropsychiatr Dis Treat, V3, P69, DOI 10.2147/nedt.2007.3.1.69; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Shieh CC, 2000, PHARMACOL REV, V52, P557; Skwarczynski M, 2010, ANGEW CHEM INT EDIT, V49, P5742, DOI 10.1002/anie.201002221; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zaydman MA, 2012, CHEM REV, V112, P6319, DOI 10.1021/cr300360k	33	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152169	10.1371/journal.pone.0152169	http://dx.doi.org/10.1371/journal.pone.0152169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007701	Green Published, gold			2022-12-27	WOS:000372701200103
J	Kang, S; Hong, SY				Kang, Sinkyu; Hong, Suk Young			Assessing Seasonal and Inter-Annual Variations of Lake Surface Areas in Mongolia during 2000-2011 Using Minimum Composite MODIS NDVI	PLOS ONE			English	Article							WATER INDEX NDWI; LANDSAT TM; CLASSIFICATION; IMAGES; THRESHOLD; DISASTER	A minimum composite method was applied to produce a 15-day interval normalized difference vegetation index (NDVI) dataset from Moderate Resolution Imaging Spectroradiometer (MODIS) daily 250 m reflectance in the red and near-infrared bands. This dataset was applied to determine lake surface areas in Mongolia. A total of 73 lakes greater than 6.25 km(2)in area were selected, and 28 of these lakes were used to evaluate detection errors. The minimum composite NDVI showed a better detection performance on lake water pixels than did the official MODIS 16-day 250 m NDVI based on a maximum composite method. The overall lake area detection performance based on the 15-day minimum composite NDVI showed -2.5% error relative to the Landsat-derived lake area for the 28 evaluated lakes. The errors increased with increases in the perimeter-to-area ratio but decreased with lake size over 10 km(2). The lake area decreased by -9.3% at an annual rate of -53.7 km(2) yr(-1) during 2000 to 2011 for the 73 lakes. However, considerable spatial variations, such as slight-to-moderate lake area reductions in semi-arid regions and rapid lake area reductions in arid regions, were also detected. This study demonstrated applicability of MODIS 250 m reflectance data for biweekly monitoring of lake area change and diagnosed considerable lake area reduction and its spatial variability in arid and semi-arid regions of Mongolia. Future studies are required for explaining reasons of lake area changes and their spatial variability.	[Kang, Sinkyu] Kangwon Natl Univ, Dept Environm Sci, Chunchon 200701, South Korea; [Hong, Suk Young] Natl Acad Agr Sci, Agr Environm Dept, Wonju 565851, South Korea	Kangwon National University; Rural Development Administration (RDA)	Kang, S (corresponding author), Kangwon Natl Univ, Dept Environm Sci, Chunchon 200701, South Korea.	kangsk@kangwon.ac.kr			Agenda Program of the Rural Development Agency [PJ00997802]; Korea Forest Service [S211212L06301]; Korea Ministry of Environment [2015001370002]	Agenda Program of the Rural Development Agency; Korea Forest Service(Korea Forest Service); Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This work was supported by grants from the Agenda Program of the Rural Development Agency (PJ00997802), the Korea Forest Service (S211212L06301), and the Korea Ministry of Environment (2015001370002).	Batima P, 2005, AIACC WORKING PAPER, V12, P5; Cai YL, 2005, INT GEOSCI REMOTE SE, P4539; Castaneda C, 2005, J ARID ENVIRON, V63, P497, DOI 10.1016/j.jaridenv.2005.03.021; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Cretaux JF, 2011, ADV SPACE RES, V47, P1497, DOI 10.1016/j.asr.2011.01.004; Cretaux JF, 2006, CR GEOSCI, V338, P1098, DOI 10.1016/j.crte.2006.08.002; Davaa G, 2008, MONGOLIA ENV HDB, P42; Du Y, 2002, REMOTE SENS ENVIRON, V82, P123, DOI 10.1016/S0034-4257(02)00029-9; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jang K, 2013, J GEOPHYS RES-ATMOS, V118, P12927, DOI 10.1002/2013JD020639; Kang SY, 2015, J ARID LAND, V7, P146, DOI 10.1007/s40333-014-0081-x; KAWATA Y, 1990, IEEE T GEOSCI REMOTE, V28, P755, DOI 10.1109/TGRS.1990.573015; Komatsu G, 2001, GEOMORPHOLOGY, V39, P83, DOI 10.1016/S0169-555X(00)00095-7; Koponen S, 2002, REMOTE SENS ENVIRON, V79, P51, DOI 10.1016/S0034-4257(01)00238-3; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lee EH, 2011, ATMOS ENVIRON, V45, P4611, DOI 10.1016/j.atmosenv.2011.05.065; Lillesand TM, 2004, REMOTE SENSING IMAGE, P574; Liu YB, 2012, INT J REMOTE SENS, V33, P5862, DOI 10.1080/01431161.2012.675452; Ma JZ, 2006, HYDROGEOL J, V14, P1231, DOI 10.1007/s10040-006-0045-0; Ma M, 2007, INT J REMOTE SENS, V28, P5523, DOI 10.1080/01431160601009698; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Michishita R, 2012, INT J REMOTE SENS, V33, P3373, DOI 10.1080/01431161.2011.611185; Nakayama Y, 2007, ADV SPACE RES, V39, P52, DOI 10.1016/j.asr.2006.02.045; Neupert R F., 1996, POPUL ENVIRON, V20, P413; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ryu Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2011GB004053; Scepan J, 1999, PHOTOGRAMM ENG REM S, V65, P1075; Sharkhuu N, 2003, PERMAFROST, VOLS 1 AND 2, P1029; Song C, 2001, REMOTE SENS ENVIRON, V75, P230, DOI 10.1016/S0034-4257(00)00169-3; Sternberg T, 2010, NOMAD PEOPLES, V14, P72, DOI 10.3167/np.2010.140105; Subramaniam S, 2011, IEEE J-STARS, V4, P205, DOI 10.1109/JSTARS.2010.2085032; Tachiiri K, 2008, J ARID ENVIRON, V72, P2251, DOI 10.1016/j.jaridenv.2008.06.015; Tao SL, 2015, P NATL ACAD SCI USA, V112, P2281, DOI 10.1073/pnas.1411748112; Tsogtbaatar J, 2009, UNESCO CHAIR WORKSH, P25; Tsutomu K, 2007, ANN GLACIOL-SER, V46, P185, DOI 10.3189/172756407782871675; UNEP RRC.AP, 2002, STAT ENV MONG 2002; Vermote E, 2008, MODIS LAND SURFACE R; Wang Y, 2008, INT J REMOTE SENS, V29, P293, DOI 10.1080/01431160701253311; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yang H, 2012, KOREAN J REMOTE SENS, V28, P267, DOI 10.7780/kjrs.2012.28.3.267; Zhao L, 2010, PERMAFROST PERIGLAC, V21, P198, DOI 10.1002/ppp.688	41	9	10	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151395	10.1371/journal.pone.0151395	http://dx.doi.org/10.1371/journal.pone.0151395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007233	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200052
J	Laws, TR; Kuchuloria, T; Chitadze, N; Little, SF; Webster, WM; Debes, AK; Saginadze, S; Tsertsvadze, N; Chubinidze, M; Rivard, RG; Tsanava, S; Dyson, EH; Simpson, AJH; Hepburn, MJ; Trapaidze, N				Laws, Thomas R.; Kuchuloria, Tinatin; Chitadze, Nazibriola; Little, Stephen F.; Webster, Wendy M.; Debes, Amanda K.; Saginadze, Salome; Tsertsvadze, Nikoloz; Chubinidze, Mariam; Rivard, Robert G.; Tsanava, Shota; Dyson, Edward H.; Simpson, Andrew J. H.; Hepburn, Matthew J.; Trapaidze, Nino			A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PROTECTIVE ANTIGEN; INFECTION; MACROPHAGE; EXPOSURE; SPORES; TOXINS	Several different human vaccines are available to protect against anthrax. We compared the human adaptive immune responses generated by three different anthrax vaccines or by previous exposure to cutaneous anthrax. Adaptive immunity was measured by ELISPOT to count cells that produce interferon (IFN)-gamma in response to restimulation ex vivo with the anthrax toxin components PA, LF and EF and by measuring circulating IgG specific to these antigens. Neutralising activity of antisera against anthrax toxin was also assayed. We found that the different exposures to anthrax antigens promoted varying immune responses. Cutaneous anthrax promoted strong IFN-gamma responses to all three antigens and antibody responses to PA and LF. The American AVA and Russian LAAV vaccines induced antibody responses to PA only. The British AVP vaccine produced IFN-gamma responses to EF and antibody responses to all three antigens. Anti-PA (in AVA and LAAV vaccinees) or anti-LF (in AVP vaccinees) antibody titres correlated with toxin neutralisation activities. Our study is the first to compare all three vaccines in humans and show the diversity of responses against anthrax antigens.	[Laws, Thomas R.; Dyson, Edward H.; Simpson, Andrew J. H.] DSTL Porton Down, Def Sci & Technol Lab, Salisbury, Wilts, England; [Kuchuloria, Tinatin; Tsanava, Shota] Tbilisi State Univ, Dept Publ Hlth, GE-380086 Tbilisi, Georgia; [Kuchuloria, Tinatin; Trapaidze, Nino] Technol Management Co, Clin Res Unit, Tbilisi, Georgia; [Chitadze, Nazibriola; Saginadze, Salome; Tsertsvadze, Nikoloz; Chubinidze, Mariam; Tsanava, Shota; Trapaidze, Nino] Natl Ctr Dis Control & Publ Hlth NCDC, Tbilisi, Georgia; [Little, Stephen F.; Webster, Wendy M.; Debes, Amanda K.; Rivard, Robert G.; Hepburn, Matthew J.] USAMRIID, Ft Detrick, MD USA; [Debes, Amanda K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Simpson, Andrew J. H.] Publ Hlth England, Salisbury, Wilts, England; [Hepburn, Matthew J.] DARPA, Arlington, VA USA	Defence Science & Technology Laboratory; Ivane Javakhishvili Tbilisi State University; National Center for Disease Control & Public Health - Georgia; United States Army Medical Research Institute of Infectious Diseases; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Public Health England; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA)	Laws, TR (corresponding author), DSTL Porton Down, Def Sci & Technol Lab, Salisbury, Wilts, England.	trlaws@dstl.gov.uk	Laws, Thomas/L-2935-2018	Laws, Thomas/0000-0002-0142-9162	UK Ministry of Defence; US Department of Defense Cooperative Threat Reduction Program	UK Ministry of Defence; US Department of Defense Cooperative Threat Reduction Program	Funding for this project was provided by the UK Ministry of Defence and US Department of Defense Cooperative Threat Reduction Program, implemented by the US Defense Threat Reduction Agency. The views of the authors do not purport to reflect the positions of the US Department of Defense. During this study, author T. Kuchuloria worked as a sub-contractor for the commercial entity Technology Management Company (TMC), on behalf of the US Defense Threat Reduction Agency via USAMRIID. TMC administered a salary for T. Kuchuloria but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Ascough S, 2014, J INFECTION, V68, P200, DOI 10.1016/j.jinf.2013.10.007; Ascough S, 2012, TOXINS, V4, P878, DOI 10.3390/toxins4100878; Baillie L, 2003, FEMS IMMUNOL MED MIC, V36, P83, DOI 10.1016/S0928-8244(03)00085-3; Beedham RJ, 2001, VACCINE, V19, P4409, DOI 10.1016/S0264-410X(01)00197-9; Berger T, 2014, EUROSURVEILLANCE B E, V19; Bliss CI, 1967, STAT BIOL STAT METHO, V1, P152; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; Brenneman KE, 2011, FEMS IMMUNOL MED MIC, V62, P164, DOI 10.1111/j.1574-695X.2011.00800.x; Brojatsch Jurgen, 2014, Front Biosci (Elite Ed), V6, P139; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cote CK, 2005, MICROB PATHOGENESIS, V38, P209, DOI 10.1016/j.micpath.2005.02.001; Doganay M, 2009, VECTOR-BORNE ZOONOT, V9, P131, DOI 10.1089/vbz.2008.0032; Feodorova VA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.82; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20; Graham-Smith GS, 1930, J HYG-CAMBRIDGE, V30, P213, DOI 10.1017/S0022172400010391; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hepburn MJ, 2007, VACCINE, V25, P6089, DOI 10.1016/j.vaccine.2007.05.018; Ingram RJ, 2013, CLIN EXP IMMUNOL, V173, P84, DOI 10.1111/cei.12090; Ingram RJ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0011-4; Ingram RJ, 2010, J IMMUNOL, V184, P3814, DOI 10.4049/jimmunol.0901581; Miller J, 1998, LETT APPL MICROBIOL, V26, P56, DOI 10.1046/j.1472-765X.1998.00274.x; Owen JL, 2015, TRENDS MOL MED, V21, P154, DOI 10.1016/j.molmed.2014.12.003; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Semenova VA, 2004, CLIN DIAGN LAB IMMUN, V11, P919, DOI 10.1128/CDLI.11.5.919-923.2004; Shlyakhov E, 1997, VACCINE, V15, P631, DOI 10.1016/S0264-410X(96)00286-1; Shlyakhov E, 1996, EUR J CLIN MICROBIOL, V15, P242, DOI 10.1007/BF01591362; SHLYAKHOV EN, 1994, VACCINE, V12, P727, DOI 10.1016/0264-410X(94)90223-2; Splino M, 2005, ANN SAUDI MED, V25, P143, DOI 10.5144/0256-4947.2005.143; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; Turner WC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1785; Williamson ED, 2002, VACCINE, V20, P2933, DOI 10.1016/S0264-410X(02)00232-3	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0148713	10.1371/journal.pone.0148713	http://dx.doi.org/10.1371/journal.pone.0148713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007118	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200015
J	Tam, PYI; Hernandez-Alvarado, N; Schleiss, MR; Hassan-Hanga, F; Onuchukwu, C; Umoru, D; Obaro, SK				Tam, Pui-Ying Iroh; Hernandez-Alvarado, Nelmary; Schleiss, Mark R.; Hassan-Hanga, Fatimah; Onuchukwu, Chuma; Umoru, Dominic; Obaro, Stephen K.			Molecular Detection of Streptococcus pneumoniae on Dried Blood Spots from Febrile Nigerian Children Compared to Culture	PLOS ONE			English	Article							REAL-TIME PCR; INVASIVE PNEUMOCOCCAL DISEASE; COMMUNITY-ACQUIRED BACTEREMIA; POLYMERASE-CHAIN-REACTION; NEISSERIA-MENINGITIDIS; HAEMOPHILUS-INFLUENZAE; PLASMODIUM-FALCIPARUM; DIAGNOSIS; DNA; IDENTIFICATION	Background Nigeria has one of the highest burdens of pneumococcal disease in the world, but accurate surveillance is lacking. Molecular detection of infectious pathogens in dried blood spots (DBS) is an ideal method for surveillance of infections in resource-limited settings because of its low cost, minimal blood volumes involved, and ease of storage at ambient temperature. Our study aim was to evaluate a Streptococcus pneumoniae real-time polymerase chain reaction (rt-PCR) assay on DBS from febrile Nigerian children on Whatman 903 and FTA filter papers, compared to the gold standard of culture. Methods Between September 2011 to May 2015, blood was collected from children 5 years of age or under who presented to six hospital study sites throughout northern and central Nigeria with febrile illness, and inoculated into blood culture bottles or spotted onto Whatman 903 or FTA filter paper. Culture and rt-PCR were performed on all samples. Results A total of 537 DBS specimens from 535 children were included in the study, of which 15 were culture-positive for S. pneumoniae. The rt-PCR assay detected S. pneumoniae in 12 DBS specimens (2.2%). One positive rt-PCR result was identified in a culture-negative specimen from a high-risk subject, and two positive rt-PCR results were negative on repeat testing. Six culture-confirmed cases of S. pneumoniae bacteremia were missed. Compared to culture, the overall sensitivities of Whatman 903 and FTA DBS for detection of S. pneumoniae were 57.1% (95% CI 18.4-90.1%) and 62.5%(95% CI 24.5-91.5%), respectively. Nonspecific amplification was noted in an additional 22 DBS (4.1%). Among these, six were positive for a non-S. pneumoniae pathogen on culture. Conclusions Rt-PCR was able to detect S. pneumoniae from clinical DBS specimens, including from a culture-negative specimen. Our findings show promise of this approach as a surveillance diagnostic, but also raise important cautionary questions. Several DBS specimens were detected as S. pneumoniae by rt-PCR despite growth of a non-S. pneumoniae pathogen on culture. A precise definition of what constitutes a positive result is required to avoid falsely over-identifying specimens.	[Tam, Pui-Ying Iroh; Schleiss, Mark R.] Univ Minnesota, Mason Childrens Hosp, Div Pediat Infect Dis & Immunol, Minneapolis, MN USA; [Tam, Pui-Ying Iroh; Hernandez-Alvarado, Nelmary; Schleiss, Mark R.] Ctr Infect Dis Microbiol & Translat Res, Minneapolis, MN USA; [Hassan-Hanga, Fatimah] Aminu Kano Teaching Hosp, Dept Paediat, Kano, Nigeria; [Onuchukwu, Chuma] Fed Med Ctr, Dept Paediat, Keffi, Nasarawa, Nigeria; [Umoru, Dominic] Nyanya Gen Hosp, Dept Paediat, Abuja, Nigeria; [Obaro, Stephen K.] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE USA	University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Medical Center	Tam, PYI (corresponding author), Univ Minnesota, Mason Childrens Hosp, Div Pediat Infect Dis & Immunol, Minneapolis, MN USA.; Tam, PYI (corresponding author), Ctr Infect Dis Microbiol & Translat Res, Minneapolis, MN USA.	irohtam@umn.edu	Schleiss, Mark/ABI-8450-2020	Schleiss, Mark/0000-0002-2108-9433; Iroh Tam, Pui-Ying/0000-0002-3682-8892	Thrasher Research Fund [12162]; University of Minnesota Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD079918] Funding Source: NIH RePORTER	Thrasher Research Fund; University of Minnesota Foundation(University of Minnesota System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Thrasher Research Fund (grant 12162 to PI), and the University of Minnesota Foundation. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Adetifa IMO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030548; Avni T, 2010, J CLIN MICROBIOL, V48, P489, DOI 10.1128/JCM.01636-09; Bereczky S, 2005, AM J TROP MED HYG, V72, P249, DOI 10.4269/ajtmh.2005.72.249; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Centers for Disease Control and Prevention, 2016, REAL TIM PCR TARG ST; Centres for Disease Control and Prevention, 2014, ACT BACT COR SURV RE; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; ElBadry MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-426; Elliott I, 2013, CLIN MICROBIOL INFEC, V19, pE466, DOI 10.1111/1469-0691.12260; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Flinders Technology Associates, GE Health Care. US Patent, Patent No. 5985327; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Lundgren IS, 2015, J TROP PEDIATRICS, V61, P81, DOI 10.1093/tropej/fmu069; Minnesota Department of Health, 2013, TAQMAN PCR ASS DET N; Nhantumbo AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138249; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-137; Rothman R, 2010, ACAD EMERG MED, V17, P741, DOI 10.1111/j.1553-2712.2010.00790.x; Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675; SANTOSHAM M, 1977, J PEDIATR-US, V91, P719, DOI 10.1016/S0022-3476(77)81022-6; Selva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076970; Selva L, 2011, EMERG INFECT DIS, V17, P1125, DOI [10.3201/eid1706.100997, 10.3201/eid/1706.100997]; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sigurdson AJ, 2006, CANCER EPIDEM BIOMAR, V15, P385, DOI 10.1158/1055-9965.EPI-05-0662; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Sutton S., 2011, J VALID TECHNOL, Vvol. 17, P42; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Tempia S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1198-z; Tzanakaki G, 2005, CLIN MICROBIOL INFEC, V11, P386, DOI 10.1111/j.1469-0691.2005.01109.x; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Wroblewski D, 2013, MOL CELL PROBE, V27, P86, DOI 10.1016/j.mcp.2012.11.003; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152253	10.1371/journal.pone.0152253	http://dx.doi.org/10.1371/journal.pone.0152253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007889	Green Published, gold			2022-12-27	WOS:000372701200117
J	Victor, VM; Rovira-Llopis, S; Banuls, C; Diaz-Morales, N; de Maranon, AM; Rios-Navarro, C; Alvarez, A; Gomez, M; Rocha, M; Hernandez-Mijares, A				Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Diaz-Morales, Noelia; Martinez de Maranon, Arantxa; Rios-Navarro, Cesar; Alvarez, Angeles; Gomez, Marcelino; Rocha, Milagros; Hernandez-Mijares, Antonio			Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; LEUKOCYTE/ENDOTHELIAL CELL-INTERACTIONS; GRADE CHRONIC INFLAMMATION; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; GLYCEMIC CONTROL; WOMEN; NEUTROPHILS; EXPRESSION	Cardiovascular diseases and oxidative stress are related to polycystic ovary syndrome (PCOS) and insulin resistance (IR). We have evaluated the relationship between myeloperoxidase (MPO) and leukocyte activation in PCOS patients according to homeostatic model assessment of IR (HOMA-IR), and have explored a possible correlation between these factors and endocrine and inflammatory parameters. This was a prospective controlled study conducted in an academic medical center. The study population consisted of 101 PCOS subjects and 105 control subjects. We divided PCOS subjects into PCOS non-IR (HOMA-IR<2.5) and PCOS IR (HOMA-IR>2.5). Metabolic and anthropometric parameters, total and mitochondrial reactive oxygen species (ROS) production, MPO levels, interactions between human umbilical vein endothelial cells and leukocytes, adhesion molecules (E-selectin, ICAM-1 and VCAM-1) and proinflammatory cytokines (IL-6 and TNF-alpha) were evaluated. Oxidative stress was observed in PCOS patients, in whom there was an increase in total and mitochondrial ROS production and MPO levels. Enhanced rolling flux and adhesion, and a decrease in polymorphonuclear cell rolling velocity were also detected in PCOS subjects. Increases in IL-6 and TNF-alpha and adhesion molecules (E-selectin, ICAM-1 and VCAM-1) were also observed, particularly in the PCOS IR group, providing evidence that inflammation and oxidative stress are related in PCOS patients. HOMA-IR was positively correlated with hsCRP (p<0.001, r = 0.304), ROS production (p<0.01, r = 0.593), leukocyte rolling flux (p<0.05, r = 0.446), E-selectin (p<0.01, r = 0.436) and IL-6 (p<0.001, r = 0.443). The results show an increase in the rate of ROS and MPO levels in PCOS patients in general, and particularly in those with IR. Inflammation in PCOS induces leukocyte-endothelium interactions and a simultaneous increase in IL-6, TNF-alpha, E-selectin, ICAM-1 and VCAM-1. These conditions are aggravated by the presence of IR.	[Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Diaz-Morales, Noelia; Martinez de Maranon, Arantxa; Gomez, Marcelino; Rocha, Milagros; Hernandez-Mijares, Antonio] Univ Hosp Doctor Peset, Serv Endocrinol, Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Valencia, Spain; [Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Rocha, Milagros; Hernandez-Mijares, Antonio] Univ Valencia, Inst Hlth Res INCLIVA, Valencia, Spain; [Victor, Victor M.; Rios-Navarro, Cesar; Alvarez, Angeles; Rocha, Milagros] Univ Valencia, CIBERehd Dept Pharmacol & Physiol, Valencia, Spain; [Victor, Victor M.] Univ Valencia, Dept Physiol, Valencia, Spain; [Alvarez, Angeles] Univ Valencia, Gen Fdn, Valencia, Spain; [Hernandez-Mijares, Antonio] Univ Valencia, Dept Med, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia; University of Valencia; University of Valencia; University of Valencia	Victor, VM; Rocha, M; Hernandez-Mijares, A (corresponding author), Univ Hosp Doctor Peset, Serv Endocrinol, Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Valencia, Spain.; Victor, VM; Rocha, M; Hernandez-Mijares, A (corresponding author), Univ Valencia, Inst Hlth Res INCLIVA, Valencia, Spain.; Victor, VM; Rocha, M (corresponding author), Univ Valencia, CIBERehd Dept Pharmacol & Physiol, Valencia, Spain.; Victor, VM (corresponding author), Univ Valencia, Dept Physiol, Valencia, Spain.; Hernandez-Mijares, A (corresponding author), Univ Valencia, Dept Med, Valencia, Spain.	Victor.Victor@uv.es; milagros.rocha@uv.es; hernandez_antmij@gva.es	Alvarez, Angeles/ABF-4589-2020; victor, victor/Q-4843-2019; Diaz-Morales, Noelia/ABH-3698-2020; Rovira-Llopis, Susana/AAX-8666-2021; de Marañón Peris, Aranzazu Martínez/H-4399-2017; BaÃuls, Celia/H-7359-2017; VICTOR, VICTOR M/I-3270-2015; Cerviño, Alejandro/L-5853-2014; Diaz-Morales, Noelia/H-1978-2015; Ríos-Navarro, Cesar/AAB-3875-2019; Rocha, Milagros/ABE-4931-2020; Rocha, Milagros/I-4987-2015	Rovira-Llopis, Susana/0000-0002-8476-5128; de Marañón Peris, Aranzazu Martínez/0000-0002-4153-0396; BaÃuls, Celia/0000-0001-8077-7642; Cerviño, Alejandro/0000-0001-8014-3279; Diaz-Morales, Noelia/0000-0003-1657-2700; Ríos-Navarro, Cesar/0000-0002-6405-6279; Rocha, Milagros/0000-0003-2923-6546; Rocha, Milagros/0000-0003-2923-6546; VICTOR, VICTOR/0000-0002-3027-3945; Alvarez, Angeles/0000-0002-2301-9746	European Regional Development Fund (ERDF "A way to build Europe"); Ministry of Health of the Valencian Regional Government; Carlos III Health Institute [CES10/030, CP10/0360, FI11/00637, CD14/00043, FI14/00125]; Conselleria de Educacion, Cultura y Deporte [CPI-13-194]; Ministerio de Ciencia e Innovacion [RYC2005-002295];  [PI12/1984];  [PI13/1025];  [PI13/0073];  [PI15/1424];  [CIBERehd CB06/04/0071];  [PROMETEOII2014/035];  [SAF2010/16030];  [UGP-14-93];  [UGP-14-95]	European Regional Development Fund (ERDF "A way to build Europe"); Ministry of Health of the Valencian Regional Government; Carlos III Health Institute(Instituto de Salud Carlos III); Conselleria de Educacion, Cultura y Deporte; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ; ; ; ; ; ; ; ; 	This study was financed by grants PI12/1984, PI13/1025, PI13/0073, PI15/1424, CIBERehd CB06/04/0071, PROMETEOII2014/035, SAF2010/16030, UGP-14-93, UGP-14-95 and by the European Regional Development Fund (ERDF "A way to build Europe"). VMV and MR are recipients of contracts from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030 and CP10/0360, respectively). SR-L is the recipient of a predoctoral fellowship from Carlos III Health Institute (FI11/00637). CB is the recipient of a postdoctoral contract from Carlos III Health Institute (CD14/00043). ND-M is the recipient of a predoctoral contract from Carlos III Health Institute (FI14/00125). CR-N was supported by Conselleria de Educacion, Cultura y Deporte (CPI-13-194). AA was supported by Ministerio de Ciencia e Innovacion (Ramon y Cajal program RYC2005-002295 and I3 program).	Anatoliotakis N, 2013, CURR TOP MED CHEM, V13, P115, DOI 10.2174/1568026611313020004; Armeni E, 2013, J HYPERTENS, V31, P1998, DOI 10.1097/HJH.0b013e3283630362; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Baldus S, 2004, FREE RADICAL BIO MED, V37, P902, DOI 10.1016/j.freeradbiomed.2004.06.003; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Blair SA, 2013, J REPROD MED, V58, P107; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Diamanti-Kandarakis E, 1999, J CLIN ENDOCR METAB, V84, P4006, DOI 10.1210/jc.84.11.4006; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gonzalez F, 2006, J ENDOCRINOL, V188, P521, DOI 10.1677/joe.1.06579; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Gorudko IV, 2016, ARCH BIOCHEM BIOPHYS, V591, P87, DOI 10.1016/j.abb.2015.12.007; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Hernandez Mijares A, 2003, MED CLIN BARC, V121, P204; Hernandez-Mijares A, 2013, DIABETES CARE, V36, P1695, DOI 10.2337/dc12-1224; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513; Kurdoglu Z, 2012, GYNECOL ENDOCRINOL, V28, P115, DOI 10.3109/09513590.2011.583959; Li Q, 2013, CIRC RES, V113, P418, DOI 10.1161/CIRCRESAHA.113.301074; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mahalingaiah S, 2015, EXPERT OPIN THER TAR, V19, P1561, DOI 10.1517/14728222.2015.1101067; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Nasiek M, 2004, GYNECOL ENDOCRINOL, V19, P208, DOI 10.1080/09513590400014313; Nussbaum C, 2013, ANTIOXID REDOX SIGN, V18, P692, DOI 10.1089/ars.2012.4783; Orio F, 2005, J CLIN ENDOCR METAB, V90, P2, DOI 10.1210/jc.2004-0628; Palomba S, 2014, J CLIN ENDOCR METAB, V99, P2942, DOI 10.1210/jc.2014-1214; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Prieto D, 2014, CURR VASC PHARMACOL, V12, P412, DOI 10.2174/1570161112666140423221008; Ribeiro AL, 2012, GYNECOL ENDOCRINOL, V28, P3, DOI 10.3109/09513590.2011.579656; Rovira-Llopis S, 2014, ANTIOXID REDOX SIGN, V21, P1759, DOI 10.1089/ars.2014.6030; Rovira-Llopis S, 2013, ANTIOXID REDOX SIGN, V19, P1452, DOI 10.1089/ars.2013.5307; Studen KB, 2013, FRONT HORM RES, V40, P64, DOI 10.1159/000341838; Unubol M, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0115-3; Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651; Victor VM, 2009, J CLIN ENDOCR METAB, V94, P3505, DOI 10.1210/jc.2009-0466; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Zhang CX, 2004, DIABETES, V53, P2950, DOI 10.2337/diabetes.53.11.2950; Zhao Y, 2015, J CLIN ENDOCR METAB, V100, P201, DOI 10.1210/jc.2014-2419	44	71	76	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151960	10.1371/journal.pone.0151960	http://dx.doi.org/10.1371/journal.pone.0151960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007571	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200078
J	Zheng, LY; Zhao, XL; Zhang, P; Chen, CD; Liu, SJ; Huang, RQ; Zhong, MQ; Wei, CJ; Zhang, YL				Zheng, Liyuan; Zhao, Xianliang; Zhang, Pei; Chen, Chuandao; Liu, Shangjie; Huang, Runqing; Zhong, Mingqi; Wei, Chiju; Zhang, Yueling			Hemocyanin from Shrimp Litopenaeus vannamei Has Antiproliferative Effect against HeLa Cell In Vitro	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; IMMUNE-ENHANCING PROTEINS; CANCER; IDENTIFICATION; APOPTOSIS; PHENOLOXIDASE; BREAST; DEATH; BINDS; MODEL	Hemocyanin (HMC) has been shown to participate in multiple roles of immune defence. In this study, we investigated the antiproliferative effect and underpinning mechanism of HMC from Litopenaeus vannamei in vitro. Sulforhodamine B (SRB) assay indicated that HMC could dramatically inhibit the growth of HeLa cells, but not 293T cells under the same conditions. Moreover, typical morphological features of apoptosis in HeLa cells including the formation of apoptotic body-like vesicles, chromatin condensation and margination were observed by using 4, 6-diamidino-2-phenylindole dihydrochloride (DAPI) staining and fluorescence analysis. An apoptotic DNA ladder from 180 to 300 bp was also detected. Furthermore, 10 variation proteins associated with apoptosis pathway, viz. G3PDH isoforms 1/2 (G3PDH1/2), aldosereductase, ectodemal dysplasia receptor associated death receptor domain isoform CRA_a (EDARADD), heat shock 60kD protein 1 variant 1 (HSP60), heat shock 70kDa protein 5 precursor (HSP70), heat shock protein 90kDa beta member 1 precursor (HSP90), 14-3-3 protein zeta/delta, Ran and ubiquitin activating enzyme E1(UBE1), were identified from HMC-treated HeLa cells by the proteomic and quantitative real-time RT-PCR strategies. Importantly, the reactive oxygen species (ROS), mitochondrial membrane potential (Delta psi m) and caspase-9/3 activities were changed significantly in HMC-treated HeLa cells. Together, the data suggests that L. vannamei HMC mediates antiproliferative properties through the apoptosis mechanism involving the mitochondria triggered pathway.	[Zheng, Liyuan; Zhao, Xianliang; Zhang, Pei; Chen, Chuandao; Liu, Shangjie; Huang, Runqing; Zhong, Mingqi; Zhang, Yueling] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China; [Zheng, Liyuan; Zhao, Xianliang; Zhang, Pei; Chen, Chuandao; Liu, Shangjie; Huang, Runqing; Zhong, Mingqi; Zhang, Yueling] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Peoples R China; [Wei, Chiju] Shantou Univ, Res Inst Biomed & Adv Mat, Shantou 515063, Peoples R China	Shantou University; Shantou University; Shantou University	Zhang, YL (corresponding author), Shantou Univ, Dept Biol, Shantou 515063, Peoples R China.; Zhang, YL (corresponding author), Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Peoples R China.	zhangyl@stu.edu.cn		Xianliang, Zhao/0000-0002-1485-0407	National Natural Science Foundation of China [31372558, 31072237]; New Century Excellent Talents Program of Ministry of Education of China [NCET-11-0922]; Natural Science Foundation of Guangdong Province [S2013010015190, 10251503101000002]; Key Innovation Project of Science and Technology of Guangdong Province College [2012CXZD0025, cxzd1123]; National Key Growth Project of Guangdong Province College [2014GKXM043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Program of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key Innovation Project of Science and Technology of Guangdong Province College; National Key Growth Project of Guangdong Province College	This work was sponsored by National Natural Science Foundation of China (Nos. 31372558 & 31072237), New Century Excellent Talents Program of Ministry of Education of China (No. NCET-11-0922), Natural Science Foundation of Guangdong Province (Nos. S2013010015190 & 10251503101000002), The Key Innovation Project of Science and Technology of Guangdong Province College (Nos. 2012CXZD0025 & cxzd1123) and The National Key Growth Project of Guangdong Province College (No. 2014GKXM043).	Adachi K, 2005, PIGM CELL RES, V18, P214, DOI 10.1111/j.1600-0749.2005.00232.x; Antonova O, 2014, Z NATURFORSCH C, V69, P325, DOI 10.5560/ZNC.2013-0148; Arancibia A, 2014, EUR J IMMUNOL, V42, P688; Arancibia S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087240, 10.1371/journal.pone.0101786]; Arroyo JC, 2004, J CLIN IMMUNOL, V24, P86, DOI 10.1023/B:JOCI.0000018067.71622.fb; Bogdan C, 2007, NAT IMMUNOL, V8, P1029, DOI 10.1038/ni1007-1029; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cao JS, 2014, MOL IMMUNOL, V57, P263, DOI 10.1016/j.molimm.2013.10.003; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Coates CJ, 2013, APOPTOSIS, V18, P1319, DOI 10.1007/s10495-013-0891-x; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; Dias N, 2005, BIOCHEM PHARMACOL, V70, P1, DOI 10.1016/j.bcp.2005.03.021; Gesheva V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0034-3; Gesheva V, 2011, FISH SHELLFISH IMMUN, V30, P135, DOI 10.1016/j.fsi.2010.09.018; Giomi F, 2007, GENE, V398, P192, DOI 10.1016/j.gene.2007.02.039; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Guncheva M, 2015, RSC ADV, V5, P63345, DOI 10.1039/c5ra12214g; Guo DY, 2011, PARASITOL INT, V60, P242, DOI 10.1016/j.parint.2011.03.005; Jaenicke E, 1999, J BIOL CHEM, V274, P34267, DOI 10.1074/jbc.274.48.34267; Jaenicke E, 2009, DEV COMP IMMUNOL, V33, P1055, DOI 10.1016/j.dci.2009.05.005; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lin MC, 2010, PEPTIDES, V31, P1019, DOI 10.1016/j.peptides.2010.02.023; Liossis SNC, 1997, J IMMUNOL, V158, P5668; Liu C, 2001, INT J CANCER, V129, P1519; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; McFadden DW, 2003, AM J SURG, V186, P552, DOI 10.1016/j.amjsurg.2003.08.002; Murakawa M, 2001, CELL DEATH DIFFER, V8, P298, DOI 10.1038/sj.cdd.4400811; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; Neckers L, 2007, CHEM BIOL, V14, P1204, DOI 10.1016/j.chembiol.2007.11.002; OLSSON CA, 1974, J UROLOGY, V111, P173, DOI 10.1016/S0022-5347(17)59919-X; Paul R., 1998, ZOOLOGY, V100, P319; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao J, 2011, FISH SHELLFISH IMMUN, V31, P736, DOI 10.1016/j.fsi.2011.07.005; Riggs DR, 2005, AM J SURG, V189, P680, DOI 10.1016/j.amjsurg.2004.10.005; Riggs DR, 2002, J SURG RES, V108, P279, DOI 10.1006/jsre.2002.6548; Sagias FG, 2010, CELL TRANSPLANT, V19, P1487, DOI 10.3727/096368910X514620; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Wilde A, 2009, NAT CELL BIOL, V11, P11, DOI 10.1038/ncb0109-11; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Youn UJ, 2013, PHYTOTHER RES, V27, P1419, DOI 10.1002/ptr.4893; Zanjani NT, 2016, ANTIMICROB AGENTS CH, V60, P1003, DOI 10.1128/AAC.01738-15; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhang YL, 2006, J PROTEOME RES, V5, P815, DOI 10.1021/pr0503984; Zhang YL, 2004, J EXP MAR BIOL ECOL, V301, P39, DOI 10.1016/j.jembe.2003.09.011; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017; Zhen-Jun Shao, 2012, Biochem Pharmacol, V84, P507, DOI 10.1016/j.bcp.2012.05.013	51	35	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151801	10.1371/journal.pone.0151801	http://dx.doi.org/10.1371/journal.pone.0151801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007573	gold, Green Submitted, Green Published			2022-12-27	WOS:000372701200066
J	Zhou, YY; Hu, ZG; Zeng, FJ; Han, J				Zhou, Yuan Yuan; Hu, Zhi Gang; Zeng, Fan Jun; Han, Jiao			Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials	PLOS ONE			English	Article							GEMCITABINE PLUS CARBOPLATIN; PHASE-III TRIAL; GROWTH-FACTOR; DOUBLE-BLIND; CELECOXIB; EXPRESSION; COMBINATION; EFFICACY; PLACEBO; CHEMOTHERAPY	Background Evidence on the benefits of combining cyclooxygenase-2 inhibitor (COX-2) in treating non-small cell lung cancer (NSCLC) is still controversial. We investigated the efficacy and safety profile of cyclooxygenase-2 inhibitors in treating NSCLC. Methods The first meta-analysis of eligible studies was performed to assess the effect of COX-2 inhibitors for patients with NSCLC on the overall response rate (ORR), overall survival (OS), progression-free survival (PFS), one-year survival, and toxicities. The fixed-effects model was used to calculate the pooled RR and HR and between-study heterogeneity was assessed. Subgroup analyses were conducted according to the type of COX-2 inhibitors, treatment pattern, and treatment line. Results Nine randomized clinical trials, comprising 1679 patents with NSCLC, were included in the final meta-analysis. The pooled ORR of patients who have NSCLC with COX-2 inhibitors was significantly higher than that without COX-2 inhibitors. In subgroup analysis, significantly increased ORR results were found on celecoxib (RR = 1.29, 95% CI: 1.09, 1.51), rofecoxib (RR = 1.61, 95% CI: 1.14, 2.28), chemotherapy (RR = 1.40, 95% CI: 1.20, 1.63), and first-line treatment (RR = 1.39, 95% CI: 1.19, 1.63). However, COX-2 inhibitors had no effect on the one-year survival, OS, and PFS. Increased RR of leucopenia (RR = 1.21, 95% CI: 1.01, 1.45) and thrombocytopenia (RR = 1.36, 95% CI: 1.06, 1.76) suggested that COX-2 inhibitors increased hematologic toxicities (grade >= 3) of chemotherapy Conclusions COX-2 inhibitors increased ORR of advanced NSCLC and had no impact on survival indices, but it may increase the risk of hematologic toxicities associated with chemotherapy.	[Zhou, Yuan Yuan; Hu, Zhi Gang; Zeng, Fan Jun; Han, Jiao] Three Gorges Univ, Coll Clin Med Sci 1, Dept Resp Med, Yichang 443003, Peoples R China	China Three Gorges University	Zeng, FJ (corresponding author), Three Gorges Univ, Coll Clin Med Sci 1, Dept Resp Med, Yichang 443003, Peoples R China.	zfj68@qq.com	Hu, Zhigang/GRF-2430-2022	Hu, Zhigang/0000-0003-3421-0674	 [WJ2015MB260]		This study was supported by WJ2015MB260.	Achiwa H, 1999, CLIN CANCER RES, V5, P1001; Altorki NK, 2003, J CLIN ONCOL, V21, P2645, DOI 10.1200/JCO.2003.07.127; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Chen J, 2014, CLIN THER, V36, P1253, DOI 10.1016/j.clinthera.2014.06.015; Ruysscher D, 2007, RADIOTHER ONCOL, V84, P23, DOI 10.1016/j.radonc.2007.05.008; Edelman MJ, 2008, J CLIN ONCOL, V26, P848, DOI 10.1200/JCO.2007.13.8081; Edelman MJ, 2015, J CLIN ONCOL, V33, P189, DOI 10.1200/JCO.2014.55.5789; Gitlitz BJ, 2014, J THORAC ONCOL, V9, P577, DOI 10.1097/JTO.0000000000000082; Gridelli C, 2007, LANCET ONCOL, V8, P500, DOI 10.1016/S1470-2045(07)70146-8; Groen HJM, 2011, J CLIN ONCOL, V29, P4320, DOI 10.1200/JCO.2011.35.5214; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Helbekkmo N, 2007, BRIT J CANCER, V97, P283, DOI 10.1038/sj.bjc.6603869; Hida T, 1998, CANCER RES, V58, P3761; Hida T, 2002, CLIN CANCER RES, V8, P2443; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Jendrossek V, 2013, CANCER LETT, V332, P313, DOI 10.1016/j.canlet.2011.01.012; Jiang H, 2013, CLIN CHIM ACTA, V419, P26, DOI 10.1016/j.cca.2013.01.012; Koch A, 2011, EUR J CANCER, V47, P1546, DOI 10.1016/j.ejca.2011.03.035; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lilenbaum R, 2006, J CLIN ONCOL, V24, P4825, DOI 10.1200/JCO.2006.07.4773; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Masferrer JL, 2000, CANCER RES, V60, P1306; Mutter R, 2009, CLIN CANCER RES, V15, P2158, DOI 10.1158/1078-0432.CCR-08-0629; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Qi WX, 2015, CURR MED RES OPIN, V31, P25, DOI 10.1185/03007995.2014.978448; Qian HL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-683; Reckamp KL, 2015, CANCER-AM CANCER SOC, V121, P3298, DOI 10.1002/cncr.29480; Sandler AB, 2004, SEMIN ONCOL, V31, P45, DOI 10.1053/j.seminoncol.2004.03.045; Sederholm C, 2005, J CLIN ONCOL, V23, P8380, DOI 10.1200/JCO.2005.01.2781; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Sorenson S, 2013, EUR J CANCER, V49, P115, DOI 10.1016/j.ejca.2012.07.032; von Plessen C, 2006, BRIT J CANCER, V95, P966, DOI 10.1038/sj.bjc.6603383	33	29	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151939	10.1371/journal.pone.0151939	http://dx.doi.org/10.1371/journal.pone.0151939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007231	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200076
J	Carvalho, PF; Braithwaite, DW; de Leeuw, JR; Motz, BA; Goldstone, RL				Carvalho, Paulo F.; Braithwaite, David W.; de Leeuw, Joshua R.; Motz, Benjamin A.; Goldstone, Robert L.			An In Vivo Study of Self-Regulated Study Sequencing in Introductory Psychology Courses	PLOS ONE			English	Article							CONTEXTUAL INTERFERENCE; METACOGNITIVE CONTROL; TRANSFER PERFORMANCE; ORDER; VARIABILITY; JUDGMENTS; BENEFIT	Study sequence can have a profound influence on learning. In this study we investigated how students decide to sequence their study in a naturalistic context and whether their choices result in improved learning. In the study reported here, 2061 undergraduate students enrolled in an Introductory Psychology course completed an online homework tutorial on measures of central tendency, a topic relevant to an exam that counted towards their grades. One group of students was enabled to choose their own study sequence during the tutorial (Self-Regulated group), while the other group of students studied the same materials in sequences chosen by other students (Yoked group). Students who chose their sequence of study showed a clear tendency to block their study by concept, and this tendency was positively associated with subsequent exam performance. In the Yoked group, study sequence had no effect on exam performance. These results suggest that despite findings that blocked study is maladaptive when assigned by an experimenter, it may actually be adaptive when chosen by the learner in a naturalistic context.	[Carvalho, Paulo F.; de Leeuw, Joshua R.; Motz, Benjamin A.; Goldstone, Robert L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Braithwaite, David W.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Indiana University System; Indiana University Bloomington; Carnegie Mellon University	Carvalho, PF (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.	pcarvalh@indiana.edu	Carvalho, Paulo/I-4781-2017	Carvalho, Paulo/0000-0002-0449-3733; Braithwaite, David/0000-0001-8111-607X; Motz, Benjamin/0000-0002-0379-2184; de Leeuw, Joshua/0000-0003-4815-2364	National Science Foundation REESE grant [0910218]; Department of Education IES grant [R305A1100060]; Graduate Training Fellowship from the Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/78083/2011]; European Social Found; National Science Foundation Graduate Research Fellowship [DGE-1342962]	National Science Foundation REESE grant; Department of Education IES grant; Graduate Training Fellowship from the Portuguese Foundation for Science and Technology (FCT); European Social Found(European Social Fund (ESF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This research was supported in part by National Science Foundation REESE grant 0910218 and Department of Education IES grant R305A1100060 to RLG, Graduate Training Fellowship SFRH/BD/78083/2011 from the Portuguese Foundation for Science and Technology (FCT), co-sponsored by the European Social Found to PFC, and a National Science Foundation Graduate Research Fellowship under Grant No. DGE-1342962 to JRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin AS, 2006, J MEM LANG, V55, P126, DOI 10.1016/j.jml.2006.02.003; Birnbaum MS, 2013, MEM COGNITION, V41, P392, DOI 10.3758/s13421-012-0272-7; Bjork R., 1994, METACOGNITION KNOWIN, P185; Bjork RA, 2013, ANNU REV PSYCHOL, V64, P417, DOI 10.1146/annurev-psych-113011-143823; Braithwaite DW, 2015, COGNITION INSTRUCT, V33, P226, DOI 10.1080/07370008.2015.1067215; Braithwaite DW, 2012, P 34 ANN C COGN SCI, P138; Bronfenbrenner U., 1976, EDUC RESEARCHER, V5, P5, DOI [10.3102/0013189X005009005, DOI 10.3102/0013189X005009005, 10.2307/1174755]; Brunel L, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00358; Carpenter SK, 2013, MEM COGNITION, V41, P671, DOI 10.3758/s13421-012-0291-4; Carvalho PF, 2015, PSYCHON B REV, V22, P281, DOI 10.3758/s13423-014-0676-4; Carvalho PF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00936; Carvalho PF, 2014, MEM COGNITION, V42, P481, DOI 10.3758/s13421-013-0371-0; Day SB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01876; de Croock MBM, 1998, COMPUT HUM BEHAV, V14, P249, DOI 10.1016/S0747-5632(98)00005-3; Dunlosky J, 1998, EDUC PSYCHO, P249; ELIO R, 1984, MEM COGNITION, V12, P20, DOI 10.3758/BF03196994; GENTNER D, 1994, PSYCHOL SCI, V5, P152, DOI 10.1111/j.1467-9280.1994.tb00652.x; Goldstone RL, 1996, MEM COGNITION, V24, P608, DOI 10.3758/BF03201087; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Gureckis TM, 2012, PERSPECT PSYCHOL SCI, V7, P464, DOI 10.1177/1745691612454304; HALL KG, 1994, PERCEPT MOTOR SKILL, V78, P835, DOI 10.2466/pms.1994.78.3.835; Horn S, 2015, CHEM EDUC RES PRACT, V16, P918, DOI 10.1039/c5rp00133a; Josephs RA, 1996, J EXP PSYCHOL LEARN, V22, P510; Kang SHK, 2012, APPL COGNITIVE PSYCH, V26, P97, DOI 10.1002/acp.1801; Kaplan R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001267; Kimball DR, 2003, MEM COGNITION, V31, P918, DOI 10.3758/BF03196445; Koedinger KR, 2013, SCIENCE, V342, P935, DOI 10.1126/science.1238056; Koedinger KR, 2009, HDB METACOGNITION ED, P647, DOI [10.1002/lsm.20954, DOI 10.1002/LSM.20954]; Kornell N, 2008, PSYCHOL SCI, V19, P585, DOI 10.1111/j.1467-9280.2008.02127.x; KURTZ KH, 1956, J EXP PSYCHOL, V51, P239, DOI 10.1037/h0040295; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; Li N, 2013, INT J ARTIF INTELL E, V23, P71, DOI 10.1007/s40593-013-0005-5; MEDIN DL, 1994, PSYCHON B REV, V1, P250, DOI 10.3758/BF03200776; Metcalfe J, 2009, CURR DIR PSYCHOL SCI, V18, P159, DOI 10.1111/j.1467-8721.2009.01628.x; Newman D, 2010, CAN SCI LAB RES ANY, V43, P260; Ostrow K, 2015, LECT NOTES ARTIF INT, V9112, P852, DOI 10.1007/978-3-319-19773-9_131; Perry LK, 2010, PSYCHOL SCI, V21, P1894, DOI 10.1177/0956797610389189; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; Pyc MA, 2010, MEM COGNITION, V38, P431, DOI 10.3758/MC.38.4.431; Rau MA, 2013, LEARN INSTR, V23, P98, DOI 10.1016/j.learninstruc.2012.07.003; Rawson KA, 2015, EDUC PSYCHOL REV, V27, P483, DOI 10.1007/s10648-014-9273-3; Rohrer D, 2007, INSTR SCI, V35, P481, DOI 10.1007/s11251-007-9015-8; Rohrer D, 2015, J EDUC PSYCHOL, V107, P900, DOI 10.1037/edu0000001; Rohrer D, 2014, PSYCHON B REV, V21, P1323, DOI 10.3758/s13423-014-0588-3; Son LK, 2012, EDUC PSYCHOL REV, V24, P379, DOI 10.1007/s10648-012-9206-y; Son LK, 2010, J EXP PSYCHOL LEARN, V36, P255, DOI 10.1037/a0017892; Son LK, 2004, J EXP PSYCHOL LEARN, V30, P601, DOI 10.1037/0278-7393.30.3.601; Tauber SK, 2013, PSYCHON B REV, V20; Taylor K, 2010, APPL COGNITIVE PSYCH, V24, P837, DOI 10.1002/acp.1598; Tullis JG, 2011, J MEM LANG, V64, P109, DOI 10.1016/j.jml.2010.11.002; van Merrienboer JJG, 2005, EDUC PSYCHOL REV, V17, P147, DOI 10.1007/s10648-005-3951-0; vanMerrienboer JJG, 1997, PERCEPT MOTOR SKILL, V84, P784, DOI 10.2466/pms.1997.84.3.784; Voss JL, 2011, NAT NEUROSCI, V14, P115, DOI 10.1038/nn.2693; Wahlheim CN, 2011, MEM COGNITION, V39, P750, DOI 10.3758/s13421-010-0063-y; Zulkiply N, 2013, MEM COGNITION, V41, P16, DOI 10.3758/s13421-012-0238-9	55	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152115	10.1371/journal.pone.0152115	http://dx.doi.org/10.1371/journal.pone.0152115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003164	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400081
J	Cong, LL; Muir, ER; Chen, C; Qian, YS; Liu, JW; Biju, KC; Clark, RA; Li, SL; Duong, TQ				Cong, Linlin; Muir, Eric R.; Chen, Cang; Qian, Yusheng; Liu, Jingwei; Biju, K. C.; Clark, Robert A.; Li, Senlin; Duong, Timothy Q.			Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; IRON-DEPOSITION; ANIMAL-MODELS; COGNITIVE IMPAIRMENT; SUBSTANTIA-NIGRA; BRAIN-TISSUE; DIFFUSION; MICE; DOPAMINE; ATROPHY	The MitoPark mouse, a relatively new genetic model of Parkinson's disease (PD), has a dopaminergic neuron-specific knock-out that inactivates the mitochondrial transcription factor A (Tfam), a protein essential for mitochondrial DNA expression and maintenance. This study used multimodal MRI to characterize the neuroanatomical correlates of PD-related deficits in MitoPark mice, along with functional behavioral tests. Compared with age-matched wild-type animals, MitoPark mice at 30 weeks showed: i) reduced whole-brain volume and increased ventricular volume, indicative of brain atrophy, ii) reduced transverse relaxation time (T-2*) of the substantia nigra and striatum, suggestive of abnormal iron accumulation, iii) reduced apparent diffusion coefficient in the substantia nigra, suggestive of neuronal loss, iv) reduced fractional anisotropy in the corpus callosum and substantia nigra, indicative of white-matter damages, v) cerebral blood flow was not significantly affected, and vi) reduced motor activity in open-field tests, reduced memory in novel object recognition tests, as well as decreased mobility in tail suspension tests, an indication of depression. In sum, MitoPark mice recapitulate changes in many MRI parameters reported in PD patients. Multimodal MRI may prove useful for evaluating neuroanatomical correlates of PD pathophysiology in MitoPark mice, and for longitudinally monitoring disease progression and therapeutic interventions for PD.	[Cong, Linlin; Muir, Eric R.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Cong, Linlin] Univ Texas San Antonio, Grad Sch Biomed Sci, San Antonio, TX USA; [Muir, Eric R.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Chen, Cang; Qian, Yusheng; Liu, Jingwei; Biju, K. C.; Clark, Robert A.; Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Clark, Robert A.; Li, Senlin; Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Muir, ER; Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.; Muir, ER; Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA.; Duong, TQ (corresponding author), South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA.	muire@uthscsa.edu; duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021; Liu, Jingwei/AAZ-9739-2021; Clark, Robert/Q-6764-2019	Duong, Tim/0000-0001-6403-2827; Liu, Jingwei/0000-0003-1381-7039; Clark, Robert/0000-0002-4892-3619; Qian, Yusheng/0000-0003-3341-0762; Chandu, Biju/0000-0002-8409-6374	United States (U.S.) Department of Veterans Biomedical Laboratory Research and Development Service [I01BX000737]; William and Ella Owens Medical Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER	United States (U.S.) Department of Veterans Biomedical Laboratory Research and Development Service; William and Ella Owens Medical Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	work was supported by Merit Review Award #I01BX000737 from the United States (U.S.) Department of Veterans Biomedical Laboratory Research and Development Service and by a grant from the William and Ella Owens Medical Research Foundation awarded to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EL, 2005, NMR BIOMED, V18, P499, DOI 10.1002/nbm.979; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Burton EJ, 2005, MOVEMENT DISORD, V20, P1571, DOI 10.1002/mds.20652; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Fernandez-Seara MA, 2012, NEUROIMAGE, V59, P2743, DOI 10.1016/j.neuroimage.2011.10.033; Firbank M, 2003, NEUROIMAGE, V20, P1309, DOI 10.1016/S1053-8119(03)00364-1; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Halliday GM, 2009, PARKINSONISM RELAT D, V15, pS152, DOI 10.1016/S1353-8020(09)70804-1; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; JAGUST WJ, 1992, BRAIN, V115, P521, DOI 10.1093/brain/115.2.521; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Krabbe K, 2005, J NEUROL SCI, V239, P45, DOI 10.1016/j.jns.2005.07.013; Lau JC, 2008, NEUROIMAGE, V42, P19, DOI 10.1016/j.neuroimage.2008.04.252; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Mueggler T, 2004, EUR J NEUROSCI, V20, P811, DOI 10.1111/j.1460-9568.2004.03534.x; Muir ER, 2008, MAGN RESON MED, V60, P744, DOI 10.1002/mrm.21721; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nicoletti G, 2006, BRAIN, V129, P2679, DOI 10.1093/brain/awl166; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pyatigorskaya N, 2014, THER ADV NEUROL DISO, V7, P12, DOI 10.1177/1756285613511507; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Shen Q, 2015, BRAIN RES, V1599, P126, DOI 10.1016/j.brainres.2014.12.049; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Symonds LL, 1999, J NEUROIMAGING, V9, P201, DOI 10.1111/jon199994201; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Wang Y, 2012, AM J NEURORADIOL, V33, P266, DOI 10.3174/ajnr.A2765; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032	56	14	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151884	10.1371/journal.pone.0151884	http://dx.doi.org/10.1371/journal.pone.0151884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003179	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400053
J	Hammamieh, R; Muhie, S; Borschel, R; Gautam, A; Miller, SA; Chakraborty, N; Jett, M				Hammamieh, Rasha; Muhie, Seid; Borschel, Richard; Gautam, Aarti; Miller, Stacy-Ann; Chakraborty, Nabarun; Jett, Marti			Temporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic Analysis	PLOS ONE			English	Article							YERSINIA-PESTIS CO92; TOLL-LIKE RECEPTORS; MOUSE MODEL; KAPPA-B; BIOLOGICAL AGENTS; IMMUNE-RESPONSE; INNATE IMMUNITY; BUBONIC PLAGUE; INFECTION; EXPRESSION	Early identification of impending illness during widespread exposure to a pathogenic agent offers a potential means to initiate treatment during a timeframe when it would be most likely to be effective and has the potential to identify novel therapeutic strategies. The latter could be critical, especially as antibiotic resistance is becoming widespread. In order to examine pre-symptomatic illness, African green monkeys were challenged intranasally with aerosolized Yersinia pestis strain CO92 and blood samples were collected in short intervals from 45 m till 42 h post-exposure. Presenting one of the first genomic investigations of a NHP model challenged by pneumonic plague, whole genome analysis was annotated in silico and validated by qPCR assay. Transcriptomic profiles of blood showed early perturbation with the number of differentially expressed genes increasing until 24 h. By then, Y. pestis had paralyzed the host defense, as suggested by the functional analyses. Early activation of the apoptotic networks possibly facilitated the pathogen to overwhelm the defense mechanisms, despite the activation of the pro-inflammatory mechanism, toll-like receptors and microtubules at the port-of-entry. The overexpressed transcripts encoding an early pro-inflammatory response particularly manifested in active lymphocytes and ubiquitin networks were a potential deviation from the rodent models, which needs further verification. In summary, the present study recognized a pattern of Y. pestis pathogenesis potentially more applicable to the human system. Independent validation using the complementary omics approach with comprehensive evaluation of the organs, such as lungs which showed early bacterial infection, is essential.	[Hammamieh, Rasha; Muhie, Seid; Gautam, Aarti; Miller, Stacy-Ann; Chakraborty, Nabarun; Jett, Marti] US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Muhie, Seid] NCI, Adv Biomed Ctr, Fredrick Natl Lab Canc Res, Frederick, MD 21702 USA; [Borschel, Richard] Walter Reed Army Med Ctr, Silver Spring, MD 20910 USA; [Gautam, Aarti; Miller, Stacy-Ann; Chakraborty, Nabarun] Geneva Fdn, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army	Hammamieh, R (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	Rasha.Hammamieh1.civ@mail.mil		Hammamieh, Rasha/0000-0001-8643-6232	Defense Threat Reduction Agency [TMTI0029_09_WR_T]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Defense Threat Reduction Agency, Funding #: TMTI0029_09_WR_T received by: MJ and RH.	Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; Agar SL, 2009, MICROBES INFECT, V11, P205, DOI 10.1016/j.micinf.2008.11.009; Amedei A, 2011, J INFECT DEV COUNTR, V5, P628, DOI 10.3855/jidc.1999; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Broussard LA, 2001, MOL DIAGN, V6, P323, DOI 10.1054/modi.2001.29155; Bubeck SS, 2007, INFECT IMMUN, V75, P697, DOI 10.1128/IAI.00403-06; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Comer JE, 2010, INFECT IMMUN, V78, P5086, DOI 10.1128/IAI.00256-10; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Demeure CE, 2012, J INFECT DIS, V205, P134, DOI 10.1093/infdis/jir696; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Durrenberger PF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-1; Ferrazzi Fulvia, 2005, Appl Bioinformatics, V4, P263, DOI 10.2165/00822942-200504040-00006; Filipovich AH, 2008, IMMUNOL ALLERGY CLIN, V28, P293, DOI 10.1016/j.iac.2008.01.010; Galindo CL, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/914762; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Gonzalez RJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004587; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Hammamieh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090425; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kwit N, 2015, MMWR-MORBID MORTAL W, V64, P918, DOI 10.15585/mmwr.mm6433a6; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Layton RC, 2011, J MED PRIMATOL, V40, P6, DOI 10.1111/j.1600-0684.2010.00443.x; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Levkau B, 2001, CIRC RES, V88, P282, DOI 10.1161/01.RES.88.3.282; Liu HH, 2009, J BASIC MICROB, V49, P92, DOI 10.1002/jobm.200800027; Magni P, 2008, BIOINFORMATICS, V24, P430, DOI 10.1093/bioinformatics/btm605; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Peters KN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003324; Rollins Sarah E, 2003, Am J Clin Pathol, V119 Suppl, pS78; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sha J, 2013, MICROB PATHOGENESIS, V55, P39, DOI 10.1016/j.micpath.2012.09.011; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; Smiley ST, 2007, ADV EXP MED BIOL, V603, P376; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tourdjman M, 2012, CLIN INFECT DIS, V55, pE58, DOI 10.1093/cid/cis578; Trulzsch K, 2005, J IMMUNOL, V174, P4244, DOI 10.4049/jimmunol.174.7.4244; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Webel DM, 1997, J ANIM SCI, V75, P1514; Whitby M, 2002, MED J AUSTRALIA, V176, P605, DOI 10.5694/j.1326-5377.2002.tb04594.x; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yang RF, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00157; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006	59	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151788	10.1371/journal.pone.0151788	http://dx.doi.org/10.1371/journal.pone.0151788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003632	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400043
J	Hymowitz, MB; Chang, D; Feinberg, EB; Roy, S				Hymowitz, Maggie B.; Chang, Donny; Feinberg, Edward B.; Roy, Sayon			Increased Intraocular Pressure and Hyperglycemic Level in Diabetic Patients	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; AQUEOUS-HUMOR DYNAMICS; BEAVER DAM EYE; EXTRACELLULAR-MATRIX; MELLITUS; RISK; EXPRESSION; GLUCOSE	Purpose To determine whether hyperglycemic levels as determined from high hemoglobin A1c (HbA1c) levels influence intraocular pressure (IOP) in patients with non-proliferative diabetic retinopathy (NPDR). Methods A retrospective chart review was performed on subjects with a diagnosis of NPDR and a corresponding HbA1c level measured within 90 days before or after an IOP measurement over a two-year period. Exclusion criteria included a diagnosis of glaucoma or treatment with IOP lowering medications or oral or topical steroids. Results Using 14.5mmHg as a baseline mean value for IOP, 42 subjects had an IOP < 14.5mmHg and mean HbA1c of 8.1 +/- 1.1, while 72 subjects had an IOP >= 14.5mmHg and a mean HbA1c of 9.0 +/- 2.1. Although there was an overlap in the confidence intervals, a significant difference (P = 0.01) in the mean HbA1c level was observed in regression analysis between the two groups. Importantly, diabetic subjects with elevated HbA1c levels rarely (< 1%) exhibited reduced IOP levels. Conclusions Diabetic subjects with elevated HbA1c levels exhibited significantly higher IOPs compared to those with lower HbA1c levels. Findings from this study indicate an association between hyperglycemia and elevated IOP and that poor glycemic control may contribute to increased IOP levels in long-term diabetic patients.	[Hymowitz, Maggie B.; Chang, Donny; Feinberg, Edward B.; Roy, Sayon] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Roy, Sayon] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Roy, S (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.; Roy, S (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	sayon@bu.edu			Massachusetts Lions Eye Research Fund, Incorporated	Massachusetts Lions Eye Research Fund, Incorporated	This study was supported by a departmental grant from the Massachusetts Lions Eye Research Fund, Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacharach J, 2003, J OCUL PHARMACOL TH, V19, P93, DOI 10.1089/108076803321637618; Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; DAVIES PD, 1984, EXP EYE RES, V39, P605, DOI 10.1016/0014-4835(84)90060-5; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Ignat Florica, 2002, Oftalmologia, V55, P43; KAHN HA, 1980, AM J EPIDEMIOL, V111, P769, DOI 10.1093/oxfordjournals.aje.a112955; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Li A-F, 2003, INVESTIGATIVE OPHTHA, V44; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Oshitari T, 2007, AM J OPHTHALMOL, V143, P363, DOI 10.1016/j.ajo.2006.09.033; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Perez-Rico C, 2015, ACTA OPHTHALMOL, V93, pe193, DOI 10.1111/aos.12530; Qureshi Imran Ahmad, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P150; Rombold F, 2005, OPHTHALMOLOGE, V102, P158, DOI 10.1007/s00347-004-1078-1; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Soto I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107291; Tane N, 2007, EXP EYE RES, V84, P832, DOI 10.1016/j.exer.2007.01.002; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151833	10.1371/journal.pone.0151833	http://dx.doi.org/10.1371/journal.pone.0151833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002725	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400050
J	Kroigard, AB; Thomassen, M; Laenkholm, AV; Kruse, TA; Larsen, MJ				Kroigard, Anne Bruun; Thomassen, Mads; Laenkholm, Anne-Vibeke; Kruse, Torben A.; Larsen, Martin Jakob			Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data	PLOS ONE			English	Article							POINT MUTATIONS; CANCER; IDENTIFICATION; DISCOVERY; FRAMEWORK; SAMPLES; PAIRS	Next generation sequencing is extensively applied to catalogue somatic mutations in cancer, in research settings and increasingly in clinical settings for molecular diagnostics, guiding therapy decisions. Somatic variant callers perform paired comparisons of sequencing data from cancer tissue and matched normal tissue in order to detect somatic mutations. The advent of many new somatic variant callers creates a need for comparison and validation of the tools, as no de facto standard for detection of somatic mutations exists and only limited comparisons have been reported. We have performed a comprehensive evaluation using exome sequencing and targeted deep sequencing data of paired tumor-normal samples from five breast cancer patients to evaluate the performance of nine publicly available somatic variant callers: EBCall, Mutect, Seurat, Shimmer, Indelocator, Somatic Sniper, Strelka, VarScan 2 and Virmid for the detection of single nucleotide mutations and small deletions and insertions. We report a large variation in the number of calls from the nine somatic variant callers on the same sequencing data and highly variable agreement. Sequencing depth had markedly diverse impact on individual callers, as for some callers, increased sequencing depth highly improved sensitivity. For SNV calling, we report EBCall, Mutect, Virmid and Strelka to be the most reliable somatic variant callers for both exome sequencing and targeted deep sequencing. For indel calling, EBCall is superior due to high sensitivity and robustness to changes in sequencing depths.	[Kroigard, Anne Bruun; Thomassen, Mads; Kruse, Torben A.; Larsen, Martin Jakob] Odense Univ Hosp, Dept Clin Genet, Sdr Blvd 29, DK-5000 Odense, Denmark; [Kroigard, Anne Bruun; Thomassen, Mads; Kruse, Torben A.; Larsen, Martin Jakob] Univ Southern Denmark, Inst Clin Res, Human Genet, Winslovpk 19, DK-5000 Odense, Denmark; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Dept Pathol, Ingemannsvej 18, DK-4200 Slagelse, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Kroigard, AB (corresponding author), Odense Univ Hosp, Dept Clin Genet, Sdr Blvd 29, DK-5000 Odense, Denmark.; Kroigard, AB (corresponding author), Univ Southern Denmark, Inst Clin Res, Human Genet, Winslovpk 19, DK-5000 Odense, Denmark.	anne.kroeigaard@rsyd.dk	Larsen, Martin Jakob/L-5794-2019	Larsen, Martin Jakob/0000-0003-4107-8771; Kroigard, Anne Bruun/0000-0002-1839-8817; Laenkholm, Anne-Vibeke/0000-0003-2166-8686	Odense University Hospital Free Research Fund; Harboefonden; Aase og Ejnar Danielsen Fond; Fabrikant Einar Willumsens Mindelegat; Grosserer M. Brogaard og Hustrus Mindefond; Kong Christian Den Tiendes Fond; Dagmar Marshalls Fond; Axel Muusfeldts Fond; Kraeftfonden; Raimond og Dagmar Ringgard-Bohns Fond; Grete og Sigurd Pedersens Fond; Syddansk Universitets Forskningsfond; Poul og Ellen Hertz' Fond; Fonden til Laegevidenskabens Fremme; Grosserer A.V. Lykfeldt og Hustrus Legat; Familien Hede Nielsens Fond; Lykfeldts Legat; Dansk Kraeftforskningsfond; Ulla og Mogens Folmer Andersens Fond; Ingenior K. A. Rohde og Hustrus Legat; Krista og Viggo Petersens Fond; Danish Strategic Research Counsil; DBCG-TIBCAT	Odense University Hospital Free Research Fund; Harboefonden; Aase og Ejnar Danielsen Fond; Fabrikant Einar Willumsens Mindelegat; Grosserer M. Brogaard og Hustrus Mindefond; Kong Christian Den Tiendes Fond; Dagmar Marshalls Fond; Axel Muusfeldts Fond; Kraeftfonden; Raimond og Dagmar Ringgard-Bohns Fond; Grete og Sigurd Pedersens Fond; Syddansk Universitets Forskningsfond; Poul og Ellen Hertz' Fond; Fonden til Laegevidenskabens Fremme; Grosserer A.V. Lykfeldt og Hustrus Legat; Familien Hede Nielsens Fond; Lykfeldts Legat; Dansk Kraeftforskningsfond; Ulla og Mogens Folmer Andersens Fond; Ingenior K. A. Rohde og Hustrus Legat; Krista og Viggo Petersens Fond; Danish Strategic Research Counsil; DBCG-TIBCAT	This work was supported by Odense University Hospital Free Research Fund, Harboefonden, Aase og Ejnar Danielsen Fond, Fabrikant Einar Willumsens Mindelegat, Grosserer M. Brogaard og Hustrus Mindefond, Kong Christian Den Tiendes Fond, Dagmar Marshalls Fond, Axel Muusfeldts Fond, Kraeftfonden, Raimond og Dagmar Ringgard-Bohns Fond, Grete og Sigurd Pedersens Fond, Syddansk Universitets Forskningsfond, Poul og Ellen Hertz' Fond, Fonden til Laegevidenskabens Fremme, Grosserer A.V. Lykfeldt og Hustrus Legat, Familien Hede Nielsens Fond, Lykfeldts Legat, Dansk Kraeftforskningsfond, Ulla og Mogens Folmer Andersens Fond, Ingenior K. A. Rohde og Hustrus Legat, Krista og Viggo Petersens Fond, Danish Strategic Research Counsil, DBCG-TIBCAT.	Christoforides A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-302; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Griffith M, 2015, CELL SYST, V1, P210, DOI 10.1016/j.cels.2015.08.015; Hansen NF, 2013, BIOINFORMATICS, V29, P1498, DOI 10.1093/bioinformatics/btt183; Kim S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r90; Kim SY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-154; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kroigard AB, 2015, ONCOTARGET, V6, P5634, DOI 10.18632/oncotarget.3111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Pabinger S, 2013, BRIEFBIOINFORM, DOI [10.1093/bib/bbs086, DOI 10.1093/BIB/BBS086]; Rashid M, 2013, BIOINFORMATICS, V29, P2208, DOI 10.1093/bioinformatics/btt371; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Stead LF, 2013, HUM MUTAT, V34, P1432, DOI 10.1002/humu.22365; Wang Q, 2012, INT WORKSH GEN SIGN; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Xu HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-244	21	97	97	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151664	10.1371/journal.pone.0151664	http://dx.doi.org/10.1371/journal.pone.0151664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002637	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400035
J	Pan, D; Vargas-Morales, O; Zern, B; Anselmo, AC; Gupta, V; Zakrewsky, M; Mitragotri, S; Muzykantov, V				Pan, Daniel; Vargas-Morales, Omayra; Zern, Blaine; Anselmo, Aaron C.; Gupta, Vivek; Zakrewsky, Michael; Mitragotri, Samir; Muzykantov, Vladimir			The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells	PLOS ONE			English	Article							BIOTINYLATED ERYTHROCYTES; PLASMINOGEN-ACTIVATOR; DRUG-DELIVERY; INDUCED LYSIS; COMPLEMENT; MEMBRANE; ADSORPTION; BINDING; THROMBOPROPHYLAXIS; BIODISTRIBUTION	Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound drugs and carriers. Coupling to RBC prolongs circulation of nanoparticles (NP, 200 nm spheres, a conventional model of polymeric drug delivery carrier) enabling their transfer to the pulmonary vasculature without provoking overt RBC elimination. However, little is known about more subtle and potentially harmful effects of drugs and drug carriers on RBCs. Here we devised high-throughput in vitro assays to determine the sensitivity of loaded RBCs to osmotic stress and other damaging insults that they may encounter in vivo (e.g. mechanical, oxidative and complement insults). Sensitivity of these tests is inversely proportional to RBC concentration in suspension and our results suggest that mouse RBCs are more sensitive to damaging factors than human RBCs. Loading RBCs by NP at 1: 50 ratio did not affect RBCs, while 10-50 fold higher NP load accentuated RBC damage by mechanical, osmotic and oxidative stress. This extensive loading of RBC by NP also leads to RBCs agglutination in buffer; however, addition of albumin diminished this effect. These results provide a template for analyses of the effects of diverse cargoes loaded on carrier RBCs and indicate that: i) RBCs can tolerate carriage of NP at doses providing loading of millions of nanoparticles per microliter of blood; ii) tests using protein-free buffers and mouse RBCs may overestimate adversity that may be encountered in humans.	[Pan, Daniel; Vargas-Morales, Omayra; Zern, Blaine; Muzykantov, Vladimir] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pan, Daniel; Vargas-Morales, Omayra; Zern, Blaine; Muzykantov, Vladimir] Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA; [Anselmo, Aaron C.; Gupta, Vivek; Zakrewsky, Michael; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Anselmo, Aaron C.; Gupta, Vivek; Zakrewsky, Michael; Mitragotri, Samir] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Muzykantov, V (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Muzykantov, V (corresponding author), Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu		Gupta, Vivek/0000-0002-3618-8178; Anselmo, Aaron/0000-0003-3290-7857	National Heart, Lung, and Blood Institute (NHLBI) [R01 HL121134-02, T32 HL07915, T32 HL07748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121134, T32HL007748, T32HL007915] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI): R01 HL121134-02, Muzykantov, Vladimir R, Drug delivery by carrier erythrocytes; T32 HL07915, Shaddy, Robert E and Levy, Robert J (co-PI), Training in Molecular Therapeutics for Pediatric Cardiology; and T32 HL07748, Fisher, AB (PI) Training in Lung Cell and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo AC, 2015, BIOMATERIALS, V68, P1, DOI 10.1016/j.biomaterials.2015.07.043; Anselmo AC, 2014, J CONTROL RELEASE, V190, P531, DOI 10.1016/j.jconrel.2014.03.050; Anselmo AC, 2013, ACS NANO, V7, P11129, DOI 10.1021/nn404853z; Atukorale PU, 2015, NANOSCALE, V7, P11420, DOI 10.1039/c5nr01355k; Barodka VM, 2014, BLOOD CELL MOL DIS, V52, P230, DOI 10.1016/j.bcmd.2013.10.004; BARTOSZ G, 1991, GERONTOLOGY, V37, P33, DOI 10.1159/000213251; BECKER PS, 1986, J BIOL CHEM, V261, P4620; Brazile D, 1996, J PHARM SCI, V84, P493; Chambers E, 2007, EXP BIOL MED, V232, P958; Chen LQ, 2015, CHEM RES TOXICOL, V28, P501, DOI 10.1021/tx500479m; CLEMENS MR, 1987, CHEM PHYS LIPIDS, V45, P251, DOI 10.1016/0009-3084(87)90068-5; Cremel M, 2013, INT J PHARMACEUT, V443, P39, DOI 10.1016/j.ijpharm.2012.12.044; Danielyan K, 2008, CIRCULATION, V118, P1442, DOI 10.1161/CIRCULATIONAHA.107.750257; Down LA, 2011, ANN BIOMED ENG, V39, P1632, DOI 10.1007/s10439-011-0262-0; Evans BC, 2013, JOVE-J VIS EXP, DOI 10.3791/50166; Gersh KC, 2011, BLOOD, V117, P4964, DOI 10.1182/blood-2010-10-310409; Godfrin Y, 2012, EXPERT OPIN BIOL TH, V12, P127, DOI 10.1517/14712598.2012.631909; GONZALES R, 1984, CANCER RES, V44, P4137; Grey JL, 2012, BIOCHEMISTRY-US, V51, P6838, DOI 10.1021/bi300693k; Gundersen SI, 2007, BIOTECHNOL BIOENG, V96, P1199, DOI 10.1002/bit.21204; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HEBBEL RP, 1990, BLOOD, V76, P1015; Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110; Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009; Kuypers FA, 1998, J HEART VALVE DIS, V7, P387; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li CM, 2014, ACS APPL MATER INTER, V6, P13956, DOI 10.1021/am503332z; Lin JS, 2015, BBA-GEN SUBJECTS, V1850, P419, DOI 10.1016/j.bbagen.2014.11.016; Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021; Mandal D, 2003, J BIOL CHEM, V278, P52551, DOI 10.1074/jbc.M306914200; Mukthavaram R, 2014, J CONTROL RELEASE, V183, P146, DOI 10.1016/j.jconrel.2014.03.038; Murad KT, 1999, BLOOD, V93, P2121, DOI 10.1182/blood.V93.6.2121.406a30_2121_2127; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; MUZYKANTOV V R, 1985, Journal of Applied Biochemistry, V7, P223; Muzykantov VR, 2010, EXPERT OPIN DRUG DEL, V7, P403, DOI 10.1517/17425241003610633; MUZYKANTOV VR, 1987, AM J PATHOL, V128, P276; MUZYKANTOV VR, 1992, BIOCHIM BIOPHYS ACTA, V1107, P119, DOI 10.1016/0005-2736(92)90336-K; Muzykantov VR, 1996, BIOTECHNOL APPL BIOC, V24, P41; MUZYKANTOV VR, 1993, J IMMUNOL METHODS, V158, P183, DOI 10.1016/0022-1759(93)90212-P; MUZYKANTOV VR, 1991, BIOCHEM J, V273, P393, DOI 10.1042/bj2730393; Muzykantov VR, 1996, ANAL BIOCHEM, V241, P109, DOI 10.1006/abio.1996.0384; MUZYKANTOV VR, 1993, FEBS LETT, V318, P108, DOI 10.1016/0014-5793(93)80002-C; MUZYKANTOV VR, 1992, INT J ARTIF ORGANS, V15, P622, DOI 10.1177/039139889201501010; MUZYKANTOV VR, 1991, FEBS LETT, V280, P112, DOI 10.1016/0014-5793(91)80216-P; Nagababu E, 2013, FREE RADICAL RES, V47, P164, DOI 10.3109/10715762.2012.756138; Nagababu E, 2008, FREE RADICAL RES, V42, P824, DOI 10.1080/10715760802459879; Nagababu E, 2010, LIFE SCI, V86, P133, DOI 10.1016/j.lfs.2009.11.015; Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g; Rossi Luiga, 2005, Expert Opin Drug Deliv, V2, P311, DOI 10.1517/17425247.2.2.311; SALLAM AM, 1984, BIORHEOLOGY, V21, P783; Scott MD, 1997, P NATL ACAD SCI USA, V94, P7566, DOI 10.1073/pnas.94.14.7566; Serafini S, 2004, TRANSFUS MED HEMOTH, V31, P92, DOI 10.1159/000078042; Villa CH, 2015, THER DELIV, V6, P795, DOI [10.4155/TDE.15.34, 10.4155/tde.15.34]; WAGNER GM, 1987, BLOOD, V69, P1777; WAUGH RE, 1992, BLOOD, V79, P1351; Yen JH, 2014, J ARTIF ORGANS, V17, P178, DOI 10.1007/s10047-014-0755-3; Zaitsev S, 2006, BLOOD, V108, P1895, DOI 10.1182/blood-2005-11-012336; Zaitsev S, 2012, BLOOD, V119, P4779, DOI 10.1182/blood-2011-12-398149; Zaitsev S, 2010, BLOOD, V115, P5241, DOI 10.1182/blood-2010-01-261610; Zaitzev S, 2010, J PHARMACOL EXP THER, V332, P1022, DOI 10.1124/jpet.109.159194; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	61	82	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152074	10.1371/journal.pone.0152074	http://dx.doi.org/10.1371/journal.pone.0152074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003833	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400073
J	Corbel, A; Baud, D; Chaouch, A; Beney, J; Csajka, C; Panchaud, A				Corbel, Aline; Baud, David; Chaouch, Aziz; Beney, Johnny; Csajka, Chantal; Panchaud, Alice			Utility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical Setting	PLOS ONE			English	Article							RECONCILIATION; DISCHARGE; ADMISSION; RECORDS; RECALL; DESIGN	Background In an obstetrical setting, inaccurate medication histories at hospital admission may result in failure to identify potentially harmful treatments for patients and/or their fetus(es). Methods This prospective study was conducted to assess average concordance rates between (1) a medication list obtained with a one-page structured medication history algorithm developed for the obstetrical setting and (2) the medication list reported in medical records and obtained by open-ended questions based on standard procedures. Both lists were converted into concordance rate using a best possible medication history approach as the reference (information obtained by patients, prescribers and community pharmacists' interviews). Results The algorithm-based method obtained a higher average concordance rate than the standard method, with respectively 90.2% [CI95% 85.8-94.3] versus 24.6% [CI95% 15.3-34.4] concordance rates (p<0.01). Conclusion Our algorithm-based method strongly enhanced the accuracy of the medication history in our obstetric population, without using substantial resources. Its implementation is an effective first step to the medication reconciliation process, which has been recognized as a very important component of patients' drug safety.	[Corbel, Aline; Csajka, Chantal; Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Corbel, Aline; Csajka, Chantal; Panchaud, Alice] Univ Lausanne, Geneva, Switzerland; [Baud, David] Univ Lausanne Hosp, Dept Gynecol & Obstet, Lausanne, Switzerland; [Chaouch, Aziz] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Beney, Johnny] Valais Hosp, Cent Inst, Div Pharm, Sion, Switzerland; [Csajka, Chantal; Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland	University of Geneva; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Panchaud, A (corresponding author), Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.	alice.panchaud@chuv.ch	Panchaud, Alice/S-6535-2019	Panchaud, Alice/0000-0001-6086-2401; Csajka, Chantal/0000-0002-0660-082X; Baud, David/0000-0001-9914-6496				Gama H, 2009, PHARMACOEPIDEM DR S, V18, P175, DOI 10.1002/pds.1703; Glintborg B, 2008, BRIT J CLIN PHARMACO, V65, P265, DOI 10.1111/j.1365-2125.2007.03017.x; Greenwald JL, 2010, J HOSP MED, V5, P477, DOI 10.1002/jhm.849; Halapy Henry, 2012, Can J Hosp Pharm, V65, P360; Kimmel SE, 2003, PHARMACOEPIDEM DR S, V12, P1, DOI 10.1002/pds.764; Lau HS, 2000, BRIT J CLIN PHARMACO, V49, P597, DOI 10.1046/j.1365-2125.2000.00204.x; Leguelinel-Blache G, 2014, EUR J INTERN MED, V25, P808, DOI 10.1016/j.ejim.2014.09.012; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Oppermann M, 2013, BRIT J CLIN PHARMACO, V75, P822, DOI 10.1111/j.1365-2125.2012.04388.x; Parlato S, 2010, DEV OUTIL ANAMNESE M; Perennes M, 2012, PRESSE MED, V41, pe77; Poon EG, 2006, J AM MED INFORM ASSN, V13, P581, DOI 10.1197/jamia.M2142; Schnipper JL, 2011, J AM MED INFORM ASSN, V18, P309, DOI 10.1136/amiajnl-2010-000040; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Tamblyn R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-150; Turchin A, 2008, J AM MED INFORM ASSN, V15, P449, DOI 10.1197/jamia.M2561; World Health Organisation, 2012, STAND OP PROT MED RE; World Health Organization, 2013, HIGH 5S PROJ INT REP; World Health Organization, 2007, ASS MED ACC TRANS CA	20	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151205	10.1371/journal.pone.0151205	http://dx.doi.org/10.1371/journal.pone.0151205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999743	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700026
J	Harron, K; Mok, Q; Hughes, D; Muller-Pebody, B; Parslow, R; Ramnarayan, P; Gilbert, R				Harron, Katie; Mok, Quen; Hughes, Dyfrig; Muller-Pebody, Berit; Parslow, Roger; Ramnarayan, Padmanabhan; Gilbert, Ruth			Generalisability and Cost-Impact of Antibiotic-Impregnated Central Venous Catheters for Reducing Risk of Bloodstream Infection in Paediatric Intensive Care Units in England	PLOS ONE			English	Article							UNCERTAINTY	Background We determined the generalisability and cost-impact of adopting antibiotic-impregnated CVCs in all paediatric intensive care units (PICUs) in England, based on results from a large randomised controlled trial (the CATCH trial; ISRCTN34884569). Methods BSI rates using standard CVCs were estimated through linkage of national PICU audit data (PICANet) with laboratory surveillance data. We estimated the number of BSI averted if PICUs switched from standard to antibiotic-impregnated CVCs by applying the CATCH trial rate-ratio (0.40; 95% CI 0.17,0.97) to the BSI rate using standard CVCs. The value of healthcare resources made available by averting one BSI as estimated from the trial economic analysis was 10,975; pound 95% CI -2,801 pound, 24,751 pound. Results The BSI rate using standard CVCs was 4.58 (95% CI 4.42,4.74) per 1000 CVC-days in 2012. Applying the rate-ratio gave 232 BSI averted using antibiotic CVCs. The additional cost of purchasing antibiotic-impregnated compared with standard CVCs was 36 pound for each child, corresponding to additional costs of 317,916 pound for an estimated 8831 CVCs required in PICUs in 2012. Based on 2012 BSI rates, management of BSI in PICUs cost 2.5 pound million annually (95% uncertainty interval: -160,986 pound, 5,603,005) pound. The additional cost of antibiotic CVCs would be less than the value of resources associated with managing BSI in PICUs with standard BSI rates >1.2 per 1000 CVC-days. Conclusions The cost of introducing antibiotic-impregnated CVCs is less than the cost associated with managing BSIs occurring with standard CVCs. The long-term benefits of preventing BSI could mean that antibiotic CVCs are cost-effective even in PICUs with extremely low BSI rates.	[Harron, Katie; Gilbert, Ruth] UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Mok, Quen] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London WC1N 3JH, England; [Hughes, Dyfrig] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor LL57 2PZ, Gwynedd, Wales; [Muller-Pebody, Berit] Publ Hlth England, 61 Colindale Ave, London NW9 5EQ, England; [Parslow, Roger] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Ramnarayan, Padmanabhan] Great Ormond St Hosp Sick Children, Childrens Acute Transport Serv, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Bangor University; Public Health England; University of Leeds; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Harron, K (corresponding author), UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	k.harron@ucl.ac.uk	Mok, Quen/AAA-2648-2019; Parslow, Roger/AAV-1477-2020; Ramnarayan, Padmanabhan/AAI-6783-2020; Hughes, Dyfrig/H-5252-2012	Mok, Quen/0000-0003-4807-9275; Ramnarayan, Padmanabhan/0000-0003-0784-8154; Hughes, Dyfrig/0000-0001-8247-7459; Harron, Katie/0000-0002-3418-2856; Muller-Pebody, Berit/0000-0002-8874-480X; Parslow, Roger/0000-0002-3945-5294; Gilbert, Ruth/0000-0001-9347-2709	National Institute of Health Resarch [08/13/47]; Medical Research Council [MR/K006584/1] Funding Source: researchfish	National Institute of Health Resarch; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Institute of Health Resarch Health Technology Assessment programme (project number 08/13/47). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elella R, 2010, PEDIATR CARDIOL, V31, P483, DOI 10.1007/s00246-009-9624-x; Briggs A, 2005, VALUE HEALTH, V8, P1, DOI 10.1111/j.1524-4733.2005.08101.x; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Department of Health, 2007, SAV LIV RED INF DEL; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Gilbert R, 2016, LANCET IN PRESS; Gilbert RE, 2008, CURR OPIN INFECT DIS, V21, P235, DOI 10.1097/QCO.0b013e3282ffd6e0; Harron K, 2015, CRIT CARE M IN PRESS; Harron K, 2014, EVALUATING DATA LINK; Harron K, 2014, INTENS CARE MED, V40, P1916, DOI 10.1007/s00134-014-3516-0; Harron K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085278; Harron K, 2013, INTENS CARE MED, V39, P1080, DOI 10.1007/s00134-013-2841-z; Harron K, 2011, INTENS CARE MED, V37, P1641, DOI 10.1007/s00134-011-2343-9; Hockenhull JC, 2008, HEALTH TECHNOL ASSES, V12, P1; Lakshmi KS, 2007, J TROP PEDIATRICS, V53, P87, DOI 10.1093/tropej/fml073; Nowak JE, 2010, PEDIATR CRIT CARE ME, V11, P579, DOI 10.1097/PCC.0b013e3181d90569; O'Hagan A, 2005, PHARMACOECONOMICS, V23, P529, DOI 10.2165/00019053-200523060-00001; Universities of Leeds and Leicester, 2013, PAED INT CAR AUD NET; Wilson J, 2011, CLIN MICROBIOL INFEC, V17, P451, DOI 10.1111/j.1469-0691.2010.03262.x; Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481	20	16	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151348	10.1371/journal.pone.0151348	http://dx.doi.org/10.1371/journal.pone.0151348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999045	Green Published, Green Accepted, gold			2022-12-27	WOS:000372694700034
J	Martin-Prevel, Y; Allemand, P; Nikiema, L; Ayassou, KA; Ouedraogo, HG; Moursi, M; De Moura, FF				Martin-Prevel, Yves; Allemand, Pauline; Nikiema, Laetitia; Ayassou, Kossiwavi A.; Ouedraogo, Henri Gautier; Moursi, Mourad; De Moura, Fabiana F.			Biological Status and Dietary Intakes of Iron, Zinc and Vitamin A among Women and Preschool Children in Rural Burkina Faso	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; YOUNG-CHILDREN; PREGNANT-WOMEN; PLASMA RETINOL; DEFICIENCY; INFLAMMATION; SUPPLEMENTATION; INFECTION; FERRITIN; IMPACT	Background Food-based approaches such as biofortification are meant to sustainably address micronutrient deficiencies in poor settings. Knowing more about micronutrient intakes and deficiencies is a prerequisite to designing and evaluating interventions. Objective The objectives of the study were to assess biological status and dietary intakes of iron, zinc and vitamin A among women and children aged 36-59 months in rural Burkina Faso and to study relationships between intake and status to better inform future food-based interventions. Design A cross-sectional survey was carried out in two rural provinces of Burkina Faso on a random cluster sample of 480 mother-child pairs. Dietary data was obtained by 24-hour recalls repeated on a random sub-selection of 37.5% of subjects to allow calculation of nutrient's probability of adequacy (PA). Biomarkers were measured on a sub-sample of 180 mother-child pairs. Blood samples were analyzed for hemoglobin, serum ferritin, soluble transferrin receptors (sTfR), C-reactive protein, alpha-1-glycoprotein, serum zinc concentration (SZnC) and retinol. For each micronutrient the relationship between biomarker and dietary intake was investigated by multiple linear regression models accounting for inflammatory biomarkers. Results Mean PA for iron, zinc and vitamin A was 0.49, 0.87 and 0.21 among women and 0.61, 0.95 and 0.33 among children, respectively. Prevalence of anemia, corrected low serum ferritin and high sTfR was 37.6%, 4.0% and 77.5% among women and 72.1%, 1.5% and 87.6% among children, respectively. Prevalence of low SZnC and corrected low serum retinol was 39.4% and 12.0% among women and 63.7% and 24.8% among children, respectively. There was a tendency for a positive relationship between vitamin A intakes and serum retinol among women (beta = 0.0003, P = 0.06). Otherwise, no link was found between micronutrients biomarkers and intakes. Conclusion Our study depicted different images of micronutrient deficiencies when based on dietary intakes or biomarkers results, thus highlighting the need for more suitable biomarkers and more precise measures of absorbable micronutrient intakes at the individual level. It thus points to challenges in the design and evaluation of future biofortification or other food-based interventions in rural areas of Burkina Faso.	[Martin-Prevel, Yves; Allemand, Pauline; Ayassou, Kossiwavi A.] Inst Rech Dev, Res Unit Nutripass 204, Montpellier, France; [Nikiema, Laetitia; Ouedraogo, Henri Gautier] Inst Natl Rech Sci Sante, Ouagadougou, Burkina Faso; [Moursi, Mourad; De Moura, Fabiana F.] Int Food Policy Res Inst, HarvestPlus, Washington, DC 20036 USA	Institut de Recherche pour le Developpement (IRD); CGIAR; International Food Policy Research Institute (IFPRI)	Martin-Prevel, Y (corresponding author), Inst Rech Dev, Res Unit Nutripass 204, Montpellier, France.	yves.martin-prevel@ird.fr	Martin-Prevel, Yves/E-7637-2011	Martin-Prevel, Yves/0000-0002-4689-7867; Moursi, Mourad/0000-0002-5071-8534; De Moura, Fabiana F./0000-0001-8176-5352	Institut de Recherche pour le Developpement; Grand Challenges in Global Health; Bill and Melinda Gates Foundation	Institut de Recherche pour le Developpement; Grand Challenges in Global Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work is part of the Grand Challenges in Global Health (#9), an initiative of the Bill and Melinda Gates Foundation through a grant to the International Food Policy Research Institute; with additional funds from the Institut de Recherche pour le Developpement.	Ahmed F, 2003, ASIA PAC J CLIN NUTR, V12, P460; [Anonymous], 2011, VIT MIN NUTR INF SYS; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arsenault JE, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.53; Artacho R, 1997, SCI TOTAL ENVIRON, V205, P159, DOI 10.1016/S0048-9697(97)00196-4; Asakura K, 2009, PUBLIC HEALTH NUTR, V12, P1373, DOI 10.1017/S1368980008004072; Asare GA, 2010, BIOL TRACE ELEM RES, V137, P139, DOI 10.1007/s12011-009-8571-y; Becquey E, 2010, J NUTR, V140, p2079S, DOI 10.3945/jn.110.123356; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bui VQ, 2013, FOOD NUTR BULL, V34, P143, DOI 10.1177/156482651303400203; Casgrain A, 2012, AM J CLIN NUTR, V96, P768, DOI 10.3945/ajcn.112.040626; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Ribeiro KDD, 2010, J HUM NUTR DIET, V23, P154, DOI 10.1111/j.1365-277X.2009.01026.x; de Pee S, 1998, AM J CLIN NUTR, V68, P1068, DOI 10.1093/ajcn/68.5.1068; Deegan Heather, 2005, J Adolesc Health, V37, P75, DOI 10.1016/j.jadohealth.2004.07.008; Engle-Stone R, 2014, J NUTR, V144, P382, DOI 10.3945/jn.113.188383; Engle-Stone R, 2012, J NUTR, V142, P555, DOI 10.3945/jn.111.148783; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Food and Agriculture Organization/World Health Organization/United Nations University, 2001, HUM EN REQ; Gegios A, 2010, PLANT FOOD HUM NUTR, V65, P64, DOI 10.1007/s11130-010-0157-5; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2012, ADV NUTR, V3, P772, DOI 10.3945/an.112.002287; Grant FKE, 2012, J NUTR, V142, P105, DOI 10.3945/jn.111.146316; Hotz C, 2007, FOOD NUTR BULL, V28, pS430, DOI 10.1177/15648265070283S304; Hotz C, 2007, FOOD NUTR BULL, V28, pS271, DOI 10.1177/15648265070282S206; Hotz C, 2012, PUBLIC HEALTH NUTR, V15, P1688, DOI 10.1017/S1368980012000924; Huybregts LF, 2009, MATERN CHILD NUTR, V5, P211, DOI 10.1111/j.1740-8709.2008.00180.x; Icard-Verniere C, 2013, J AGR FOOD CHEM, V61, P10377, DOI 10.1021/jf402612k; Institut Nationalde la Statistique et de la Demographie (INSD) et ICF International, 2012, ENQ DEM SANT IND MUL; Institute Of Medicine, 2001, DIET REF INT VIT A V; Institute Of Medicine, 2000, DIET REF INT APPL DI; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Lowe NM, 2012, BRIT J NUTR, V108, P1962, DOI 10.1017/S0007114512004382; Martin-Prevel Y, 2013, ANN NUTR METAB, V63, P215; Moran VH, 2012, NUTRIENTS, V4, P841, DOI 10.3390/nu4080841; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Nana CP, 2006, PUBLIC HEALTH NUTR, V9, P808, DOI 10.1079/PHN2005911; Nana Constance P., 2005, Food and Nutrition Bulletin, V26, P356; Nikiema L, IRON ZINC P IN PRESS; Ouedraogo C, 2014, MICR FOR GLOB C JUN; Pollard J, 2003, EUR J CLIN NUTR, V57, P988, DOI 10.1038/sj.ejcn.1601634; Righetti AA, 2013, AM J CLIN NUTR, V97, P1364, DOI 10.3945/ajcn.112.050302; Rohner F., 2013, PUBLIC HEALTH NUTR, V15, P1; Rohner F, 2014, PUBLIC HEALTH NUTR, V17, P2016, DOI 10.1017/S136898001300222X; ROIDT L, 1988, AM J EPIDEMIOL, V128, P645, DOI 10.1093/oxfordjournals.aje.a115012; Samuelson G, 1996, ACTA PAEDIATR, V85, P1033, DOI 10.1111/j.1651-2227.1996.tb14212.x; Spodaryk K, 1999, ARCH PHYSIOL BIOCHEM, V107, P361, DOI 10.1076/1381-3455(199912)107:05;1-5;FT361; Swindale A., 2006, FHI 360FANTA; Thane CW, 2004, EUR J CLIN NUTR, V58, P363, DOI 10.1038/sj.ejcn.1601792; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wessells KR, 2012, J PEDIATR-US, V160, P129, DOI 10.1016/j.jpeds.2011.06.051; WHO, 2007, ASS IR STAT POP INCL; WHO, 2011, SERUM RETINOL CONCEN; WHO, 2001, IRON DEFICIENCY ANAE; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zagre No l-Marie, 2002, Sante, V12, P38; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729	63	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0146810	10.1371/journal.pone.0146810	http://dx.doi.org/10.1371/journal.pone.0146810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991908	gold, Green Submitted, Green Published			2022-12-27	WOS:000372582800018
J	Sandberg, JC; Bjorck, IME; Nilsson, AC				Sandberg, Jonna C.; Bjorck, Inger M. E.; Nilsson, Anne C.			Rye-Based Evening Meals Favorably Affected Glucose Regulation and Appetite Variables at the Following Breakfast; A Randomized Controlled Study in Healthy Subjects	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CHAIN FATTY-ACIDS; SUBSEQUENT STANDARDIZED BREAKFAST; FOOD-INTAKE; ENERGY-INTAKE; INSULIN SENSITIVITY; DIABETES-MELLITUS; INCREASES SATIETY; RESISTANT STARCH; DIETARY FIBER	Background Whole grain has shown potential to prevent obesity, cardiovascular disease and type 2 diabetes. Possible mechanism could be related to colonic fermentation of specific indigestible carbohydrates, i.e. dietary fiber (DF). The aim of this study was to investigate effects on cardiometabolic risk factors and appetite regulation the next day when ingesting rye kernel bread rich in DF as an evening meal. Method Whole grain rye kernel test bread (RKB) or a white wheat flour based bread (reference product, WWB) was provided as late evening meals to healthy young adults in a randomized cross-over design. The test products RKB and WWB were provided in two priming settings: as a single evening meal or as three consecutive evening meals prior to the experimental days. Test variables were measured in the morning, 10.5-13.5 hours after ingestion of RKB or WWB. The postprandial phase was analyzed for measures of glucose metabolism, inflammatory markers, appetite regulating hormones and short chain fatty acids (SCFA) in blood, hydrogen excretion in breath and subjective appetite ratings. Results With the exception of serum CRP, no significant differences in test variables were observed depending on length of priming (P>0.05). The RKB evening meal increased plasma concentrations of PYY (0-120 min, P<0.001), GLP-1 (0-90 min, P<0.05) and fasting SCFA (acetate and butyrate, P<0.05, propionate, P = 0.05), compared to WWB. Moreover, RKB decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P<0.05) and fasting FFA concentrations (P<0.05). Additionally, RKB improved subjective appetite ratings during the whole experimental period (P<0.05), and increased breath hydrogen excretion (P<0.001), indicating increased colonic fermentation activity. Conclusion The results indicate that RKB evening meal has an anti-diabetic potential and that the increased release of satiety hormones and improvements of appetite sensation could be beneficial in preventing obesity. These effects could possibly be mediated through colonic fermentation.	[Sandberg, Jonna C.; Bjorck, Inger M. E.; Nilsson, Anne C.] Lund Univ, Food Hlth Sci Ctr, SE-22100 Lund, Sweden	Lund University	Sandberg, JC (corresponding author), Lund Univ, Food Hlth Sci Ctr, SE-22100 Lund, Sweden.	jonna.sandberg@food-health-science.lu.se		Nilsson, Anne/0000-0002-9780-7876	Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University [2013/46]	Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University	This study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University (grant number 2013/46). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg AKE, 1998, J NUTR, V128, P651; Andersson AAM, 2014, J CEREAL SCI, V59, P294, DOI 10.1016/j.jcs.2014.01.003; ASP NG, 1983, J AGR FOOD CHEM, V31, P476, DOI 10.1021/jf00117a003; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; BJORCK IME, 1992, J SCI FOOD AGR, V58, P541, DOI 10.1002/jsfa.2740580414; Brighenti F., 1998, FUNCTIONAL PROPERTIE, P150; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Frolich W, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.18503; Fssrch K, 2015, DIABETES; Guo Y, 2006, OBESITY, V14, P1562, DOI 10.1038/oby.2006.180; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; Hansen HB, 2004, J AGR FOOD CHEM, V52, P2282, DOI 10.1021/jf0307191; Ibrugger S, 2014, APPETITE, V80, P248, DOI 10.1016/j.appet.2014.05.026; Isaksson H., 2008, FOOD NUTR RES, V52; Isaksson H, 2012, PHYSIOL BEHAV, V105, P877, DOI 10.1016/j.physbeh.2011.10.023; Isaksson H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-31; Isaksson H, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-39; Johansson EV, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-46; Kaji L, 2014, DIGESTION, V89, P31, DOI 10.1159/000356211; Karaki SI, 2008, J MOL HISTOL, V39, P135, DOI 10.1007/s10735-007-9145-y; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lee YS, 2014, METABOLISM, V63, P9, DOI 10.1016/j.metabol.2013.09.010; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Nielsen TS, 2014, BRIT J NUTR, V112, P1837, DOI 10.1017/S000711451400302X; Nilsson A, 2006, EUR J CLIN NUTR, V60, P1092, DOI 10.1038/sj.ejcn.1602423; Nilsson AC, 2015, BR J NUTR, P1; Nilsson AC, 2008, J NUTR, V138, P732, DOI 10.1093/jn/138.4.732; Nilsson AC, 2008, AM J CLIN NUTR, V87, P645, DOI 10.1093/ajcn/87.3.645; Nilsson AC, 2010, J NUTR, V140, P1932, DOI 10.3945/jn.110.123604; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Priebe MG, 2010, AM J CLIN NUTR, V91, P90, DOI 10.3945/ajcn.2009.28521; Rosen LAH, 2011, J AGR FOOD CHEM, V59, P12149, DOI 10.1021/jf2019837; Rosen LAH, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-42; Rosen LA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-7; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Tasyurek HM, 2014, DIABETES-METAB RES, V30, P354, DOI 10.1002/dmrr.2501; Tazoe H, 2009, BIOMED RES-TOKYO, V30, P149, DOI 10.2220/biomedres.30.149; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tsuchiya T, 2010, CLIN ENDOCRINOL, V73, P484, DOI 10.1111/j.1365-2265.2010.03835.x; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Williams PG, 2008, NUTR REV, V66, P171, DOI 10.1111/j.1753-4887.2008.00022.x; WOLEVER TMS, 1991, AM J CLIN NUTR, V53, P681, DOI 10.1093/ajcn/53.3.681; WOLEVER TMS, 1989, AM J GASTROENTEROL, V84, P1027; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; World Health Organization, 2015, GLOB STAT REP NONC D; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	56	36	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151985	10.1371/journal.pone.0151985	http://dx.doi.org/10.1371/journal.pone.0151985			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990559	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800127
J	Tsai, CF; Anderson, N; Thomas, B; Sudlow, CLM				Tsai, Chung-Fen; Anderson, Niall; Thomas, Brenda; Sudlow, Cathie L. M.			Comparing Risk Factor Profiles between Intracerebral Hemorrhage and Ischemic Stroke in Chinese and White Populations: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SUBTYPES; PREDICTORS; MORTALITY; SEVERITY; REGISTRY; RATES	Background Chinese populations have a higher proportion of intracerebral hemorrhage (ICH) in total strokes. However, the reasons are not fully understood. Methods To assess the differences in frequency of major risk factors between ICH and ischemic stroke (IS) in Chinese versus white populations of European descent, we systematically sought studies conducted since 1990 that compared frequency of risk factors between ICH and IS in Chinese or white populations. For each risk factor, in Chinese and Whites separately, we calculated study-specific and random effects pooled prevalence and odds ratios (ORs) for ICH versus IS. Results Six studies among 36190 Chinese, and seven among 52100 white stroke patients studied hypertension, diabetes, atrial fibrillation (AF), ischemic heart disease (IHD), hypercholesterolemia, smoking and alcohol. Pooled prevalence of AF was significantly lower in Chinese. Pooled ORs for ICH versus IS were mostly similar in Chinese and Whites. However, in Chinese-but not Whites-mean age was lower (62 versus 69 years), while hypertension and alcohol were significantly more frequent in ICH than IS (ORs 1.38, 95% CI 1.18-1.62, and 1.46, 1.12-1.91). Hypercholesterolemia and smoking were significantly less frequent in ICH in Whites, but not Chinese, while IHD, AF and diabetes were less frequent in ICH in both. Conclusions Different risk factor distributions in ICH and IS raise interesting possibilities about variation in mechanisms underlying the different distributions of pathological types of stroke between Chinese and Whites. Further analyses in large, prospective studies, including adjustment for potential confounders, are needed to consolidate and extend these findings.	[Tsai, Chung-Fen] Fu Jen Catholic Univ, Sch Med, Cardinal Tien Hosp, Dept Neurol, Taipei, Taiwan; [Tsai, Chung-Fen; Thomas, Brenda; Sudlow, Cathie L. M.] Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland; [Anderson, Niall] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Sudlow, Cathie L. M.] Univ Edinburgh, Inst Genet & Mol Med CLMS, Edinburgh, Midlothian, Scotland	Fu Jen Catholic University; University of Edinburgh; University of Edinburgh; University of Edinburgh	Sudlow, CLM (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Div Clin Neurosci, Edinburgh, Midlothian, Scotland.; Sudlow, CLM (corresponding author), Univ Edinburgh, Inst Genet & Mol Med CLMS, Edinburgh, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk		Sudlow, Cathie/0000-0002-7725-7520	Cardinal Tien hospital (Graduate Students Study Program, GSSP); Ministry of Education, Taiwan (Study Abroad scholarship); Scottish Funding Council; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Cardinal Tien hospital (Graduate Students Study Program, GSSP); Ministry of Education, Taiwan (Study Abroad scholarship); Scottish Funding Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	C.-F. Tsai has received scholarships from Cardinal Tien hospital (Graduate Students Study Program, GSSP, from 2010 to 2012; http://www.cth.org.tw/) and Ministry of Education, Taiwan (Study Abroad scholarship 2010; http://english.moe.gov.tw/). C. Sudlow has received funding from Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; [Anonymous], 2009, INTRO METAANALYSIS, DOI DOI 10.1002/9780470743386.CH19; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Asia Pacific Cohort Studies Collaboration, 2003, INT J EPIDEMIOL, V32, P565; Bhalla A, 2013, STROKE, V44, P2174, DOI 10.1161/STROKEAHA.113.001263; Chen YW, 2010, INT J STROKE, V5, P403, DOI 10.1111/j.1747-4949.2010.00466.x; Chiu JF, 2010, EUR J CARDIOV PREV R, V17, P668, DOI 10.1097/HJR.0b013e328339eb74; Fang J, 2004, ETHNIC DIS, V14, P378; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Feigin VL, 2011, STROKE, V42, P3655, DOI 10.1161/STROKEAHA.110.596858; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Hao ZL, 2011, CHINESE J NEUROLOGY, V44, P825; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu L C, 1997, Zhonghua Yi Xue Za Zhi (Taipei), V59, P225; Hsu WC, 1995, ACTA NEUROL SIN, V4, P171; Jeng JS, 1998, J NEUROL SCI, V156, P220, DOI 10.1016/S0022-510X(98)00046-X; Jorgensen HS, 1997, NEUROLOGY, V48, P891; Kelly PJ, 2012, STROKE, V43, P2042, DOI 10.1161/STROKEAHA.111.645721; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Liu XF, 2006, CEREBROVASC DIS, V22, P130, DOI 10.1159/000093241; Marti-Vilalta JL, 1999, EUR NEUROL, V41, P135, DOI 10.1159/000008036; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Qizilbash N, 1995, LANCET, V346, P1647; Rodgers A, 1998, LANCET, V352, P1801; Rodgers A, 2005, CIRCULATION, V112, P3384, DOI 10.1161/CIRCULATIONHA.105.537472; Shen Q, 2011, AUSTRALAS J AGEING, V30, P143, DOI 10.1111/j.1741-6612.2010.00477.x; Silvestrelli G, 2006, CLIN EXP HYPERTENS, V28, P279, DOI 10.1080/10641960600549231; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; The INTERSTROKE investigators, 2010, LANCET, V376, P112, DOI [10.1016/S0140-6736(10)60834-3, DOI 10.1016/S0140-6736(10)60834-3]; The Taiwan Stroke Registry Investigators, 2010, CIRCULATION, V122, P1116, DOI [10.1161/CIRCULATIONAHA.110.936526, DOI 10.1161/CIRCULATIONAHA.110.936526]; Tsai CF, 2015, INT J STROKE, V10, P485, DOI 10.1111/ijs.12508; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vemmos KN, 2000, CEREBROVASC DIS, V10, P133, DOI 10.1159/000016042; WHISNANT JP, 1990, STROKE, V21, P707, DOI 10.1161/01.STR.21.5.707; Yeung SLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068054	39	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151743	10.1371/journal.pone.0151743	http://dx.doi.org/10.1371/journal.pone.0151743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991497	Green Published, gold			2022-12-27	WOS:000372582800095
J	Wang, Y; Zhang, HY; Yue, SY; Zhang, K; Wang, H; Dong, R; Yang, XM; Liu, Y; Ma, YH				Wang, Ying; Zhang, Haiyan; Yue, Shuying; Zhang, Kun; Wang, Hui; Dong, Rui; Yang, Xiaomeng; Liu, Yi; Ma, Yanhui			Evaluation of High Resolution Melting for MTHFR C677T Genotyping in Congenital Heart Disease	PLOS ONE			English	Article							POLYMORPHISM; RISK; ASSOCIATION; GENE; HOMOCYSTEINE; VARIANTS; CHILDREN; DEFECTS; DNA	Background High resolution melting (HRM) is a simple, flexible and low-cost mutation screening technique. The methylenetetrahydrofolate reductase (MTHFR) gene encoding a critical enzyme, potentially affects susceptibility to some congenital defects like congenital heart disease (CHD). We evaluate the performance of HRM for genotyping of the MTHFR gene C677T locus in CHD cases and healthy controls of Chinese Han population. Methods A total of 315 blood samples from 147 CHD patients (male72, female 75) and 168 healthy controls (male 92, female 76) were enrolled in the study. HRM was utilized to genotype MTHFR C677T locus of all the samples. The results were compared to that of PCR-RFLP and Sanger sequencing. The association of the MTHFR C677T genotypes and the risk of CHD was analyzed using odds ratio with their 95% confidence interval (CIs) from unconditional logistic regression. Results All the samples were successfully genotyped by HRM within 1 hour and 30 minutes while at least 6 hours were needed for PCR-RFLP and sequencing. The genotypes of MTHFR C677T CC, CT, and TT were 9.52%, 49.66%, and 40.82% in CHD group but 29.17%, 50% and 20.83% in control group, which were identical using both methods of HRM and PCR-RFLP, demonstrating the sensitivity and specificity of HRM were all 100%. Conclusion MTHFR C677T is a potential risk factor for CHD in our local residents of Shandong province in China. HRM is a fast, sensitive, specific and reliable method for clinical application of genotyping.	[Wang, Ying; Zhang, Haiyan; Dong, Rui; Yang, Xiaomeng; Liu, Yi; Ma, Yanhui] Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250022, Peoples R China; [Yue, Shuying] Shandong Med Coll, Dept Med, Jinan 250002, Peoples R China; [Zhang, Kun; Wang, Hui] Shandong Univ, Qilu Childrens Hosp, Cardiovasc Dept, Jinan 250022, Peoples R China	Shandong University; Shandong University	Liu, Y; Ma, YH (corresponding author), Shandong Univ, Qilu Childrens Hosp, Pediat Res Inst, Jinan 250022, Peoples R China.	y.liu99@yahoo.com; myhcdc@163.com			Development Project of Science and Technology in Shandong Province [2013GSF11829]; Health development of science and technology projects in Shandong Province [2013WS0002]	Development Project of Science and Technology in Shandong Province; Health development of science and technology projects in Shandong Province	This work was funded by Development Project of Science and Technology in Shandong Province (2013GSF11829) and Health development of science and technology projects in Shandong Province (2013WS0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderrabano-Saucedo NA, 2013, PEDIATR CARDIOL, V34, P46, DOI 10.1007/s00246-012-0380-y; Bruzzone CM, 2015, METHODS MOL BIOL, V1310, P5, DOI 10.1007/978-1-4939-2690-9_2; Chen KH, 2013, GENET MOL RES, V12, P6212, DOI 10.4238/2013.December.4.8; Christensen KE, 2013, CARDIOL YOUNG, V23, P89, DOI 10.1017/S1047951112000431; [董睿 Dong Rui], 2014, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V40, P424; Garcia-Fragoso Lourdes, 2010, Int J Genet Mol Biol, V2, P43; Goldmuntz E, 2008, CIRC-CARDIOVASC GENE, V1, P126, DOI 10.1161/CIRCGENETICS.108.796342; Hobbs CA, 2006, AM J OBSTET GYNECOL, V194, P218, DOI 10.1016/j.ajog.2005.06.016; Junker R, 2001, CARDIOVASC RES, V51, P251, DOI 10.1016/S0008-6363(01)00286-3; Li Z, 2015, HERZ, V40, P160, DOI 10.1007/s00059-014-4144-8; MAEDA M, 1989, TISSUE ANTIGENS, V34, P290, DOI 10.1111/j.1399-0039.1989.tb01745.x; Marinho Claudia, 2009, Rev Port Cardiol, V28, P809; Norambuena PA, 2009, CLIN BIOCHEM, V42, P1308, DOI 10.1016/j.clinbiochem.2009.04.015; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayin Kocakap BD, 2014, CARDIOL YOUNG, V30, P1; Shi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128646; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Wang WJ, 2013, META GENE, V1, P109, DOI 10.1016/j.mgene.2013.09.009; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Xuan C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07311; Yin M, 2012, ANN HUM GENET, V76, P9, DOI 10.1111/j.1469-1809.2011.00687.x; Zidan HE, 2013, GENE, V529, P119, DOI 10.1016/j.gene.2013.07.053	23	5	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151140	10.1371/journal.pone.0151140	http://dx.doi.org/10.1371/journal.pone.0151140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990189	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800044
J	Wu, YJ; Zhang, HY; Guo, TM				Wu, Yan Jing; Zhang, Haoyun; Guo, Taomei			Does Speaking Two Dialects in Daily Life Affect Executive Functions? An Event-Related Potential Study	PLOS ONE			English	Article							COGNITIVE CONTROL; BILINGUAL ADVANTAGE; ANTERIOR CINGULATE; INTERFERENCE; INHIBITION; CHILDREN; CHINESE; TASKS; TRANSLATION; MECHANISMS	Whether using two languages enhances executive functions is a matter of debate. Here, we take a novel perspective to examine the bilingual advantage hypothesis by comparing bidialect with mono-dialect speakers' performance on a non-linguistic task that requires executive control. Two groups of native Chinese speakers, one speaking only the standard Chinese Mandarin and the other also speaking the Southern-Min dialect, which differs from the standard Chinese Mandarin primarily in phonology, performed a classic Flanker task. Behavioural results showed no difference between the two groups, but event-related potentials recorded simultaneously revealed a number of differences, including an earlier P2 effect in the bi-dialect as compared to the mono-dialect group, suggesting that the two groups engage different underlying neural processes. Despite differences in the early ERP component, no between-group differences in the magnitude of the Flanker effects, which is an index of conflict resolution, were observed in the N2 component. Therefore, these findings suggest that speaking two dialects of one language does not enhance executive functions. Implications of the current findings for the bilingual advantage hypothesis are discussed.	[Wu, Yan Jing] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Zhang, Haoyun; Guo, Taomei] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Haoyun; Guo, Taomei] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Guo, Taomei] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Zhang, Haoyun] Penn State Univ, Dept Psychol, State Coll, PA USA	University of Sheffield; Beijing Normal University; Beijing Normal University; Beijing Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Guo, TM (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.; Guo, TM (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China.; Guo, TM (corresponding author), Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China.	guotm@bnu.edu.cn		Wu, Yan Jing/0000-0002-4162-3322	Open Grant of State Key Laboratory of Cognitive Neural Science and Learning; National Key Basic Research Program of China [2014CB846102]; National Natural Science Foundation of China [31170970]; British Academy Small Research Grant [SG132429]	Open Grant of State Key Laboratory of Cognitive Neural Science and Learning; National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); British Academy Small Research Grant	This study was supported by the Open Grant of State Key Laboratory of Cognitive Neural Science and Learning for Yan Jing Wu and Taomei Guo, the National Key Basic Research Program of China (2014CB846102), the National Natural Science Foundation of China (31170970), and the British Academy Small Research Grant (SG132429).; This study was supported by the Open Grant of State Key Laboratory of Cognitive Neural Science and Learning for Yan Jing Wu and Taomei Guo, the National Key Basic Research Program of China (2014CB846102), the National Natural Science Foundation of China (31170970), and the British Academy Small Research Grant (SG132429). Haoyun Zhang is now a PhD candidate of the Department of Psychology, Pennsylvania State University. The authors would like to thank Chunyan Kang for data collection.	Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; [Anonymous], 2000, M C TONE SANDHI PATT; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E, 2005, NEUROIMAGE, V24, P40, DOI 10.1016/j.neuroimage.2004.09.044; Bialystok E, 2012, TRENDS COGN SCI, V16, P240, DOI 10.1016/j.tics.2012.03.001; Bialystok E, 2011, J EXP CHILD PSYCHOL, V110, P461, DOI 10.1016/j.jecp.2011.05.005; Bialystok E, 2010, DEV PSYCHOL, V46, P93, DOI 10.1037/a0015466; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Bialystok E, 2009, BRAIN LANG, V109, P93, DOI 10.1016/j.bandl.2008.09.001; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; de Bruin A, 2015, PSYCHOL SCI, V26, P99, DOI 10.1177/0956797614557866; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Garbin G, 2011, BRAIN LANG, V119, P129, DOI 10.1016/j.bandl.2011.03.011; Gold BT, 2013, J NEUROSCI, V33, P387, DOI 10.1523/JNEUROSCI.3837-12.2013; Goldman MC, 2014, DEVELOPMENTAL SCI, V17, P956, DOI 10.1111/desc.12175; Gomez CM, 1998, INT J NEUROSCI, V95, P17; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Guo TM, 2011, NEUROIMAGE, V56, P2300, DOI 10.1016/j.neuroimage.2011.03.049; Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hou J.-Y., 2002, INTRO MODERN CHINESE; Li A, 2003, 6 NAT MOD PHON AC C; Li XP, 2012, LINGUA, V122, P335, DOI 10.1016/j.lingua.2011.12.002; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; Misra M, 2012, J MEM LANG, V67, P224, DOI 10.1016/j.jml.2012.05.001; Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x; Morton JB, 2009, DEVELOPMENTAL SCI, V12, P502, DOI 10.1111/j.1467-7687.2009.00867.x; Neuhaus AH, 2010, INT J PSYCHOPHYSIOL, V76, P72, DOI 10.1016/j.ijpsycho.2010.02.005; Paap KR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00962; Paap KR, 2014, AIMS NEUROSCI, V1, P245, DOI 10.3934/Neuroscience.2014.3.245; Paap KR, 2014, J COGN PSYCHOL, V26, P242, DOI 10.1080/20445911.2014.891597; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Prior A, 2010, BILING-LANG COGN, V13, P253, DOI 10.1017/S1366728909990526; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Shedden JM, 2001, COGNITIVE BRAIN RES, V11, P59, DOI 10.1016/S0926-6410(00)00064-1; Sullivan MD, 2014, BRAIN LANG, V139, P84, DOI 10.1016/j.bandl.2014.10.004; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Sybesma R, 2008, LINGUIST REV, V25, P453, DOI 10.1515/TLIR.2008.013; Thierry G, 2007, P NATL ACAD SCI USA, V104, P12530, DOI 10.1073/pnas.0609927104; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Zhang TL, 2011, PSYCHOL SCI, V22, P1237, DOI 10.1177/0956797611421492	49	9	10	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150492	10.1371/journal.pone.0150492	http://dx.doi.org/10.1371/journal.pone.0150492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991456	gold, Green Published			2022-12-27	WOS:000372582800034
J	Liu, SY; Yue, LT; Gu, WR; Li, XY; Zhang, LP; Sun, SJ				Liu, Shuyuan; Yue, Longtao; Gu, Wenrui; Li, Xiuyun; Zhang, Liuping; Sun, Shujuan			Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; IN-VITRO INTERACTION; CLINICAL BREAKPOINTS; ANTIFUNGAL ACTIVITY; DRUG-RESISTANCE; HYPHAL GROWTH; CALCINEURIN; COMBINATION; AMIODARONE; VIRULENCE	Candidiasis has increased significantly recently that threatens patients with low immunity. However, the number of antifungal drugs on the market is limited in comparison to the number of available antibacterial drugs. This fact, coupled with the increased frequency of fungal resistance, makes it necessary to develop new therapeutic strategies. Combination drug therapy is one of the most widely used and effective strategy to alleviate this problem. In this paper, we were aimed to evaluate the combined antifungal effects of four CCBs (calcium channel blockers), amlodipine (AML), nifedipine (NIF), benidipine (BEN) and flunarizine (FNZ) with fluconazole against C. albicans by checkerboard and time-killing method. In addition, we determined gene (CCH1, MID1, CNA1, CNB1, YVC1, CDR1, CDR2 and MDR1) expression by quantitative PCR and investigated the efflux pump activity of resistant candida albicans by rhodamine 6G assay to reveal the potential mechanisms. Finally, we concluded that there was a synergy when fluconazole combined with the four tested CCBs against resistant strains, with fractional inhibitory concentration index (FICI) <0.5, but no interaction against sensitive strains (FICI = 0.56 similar to 2). The mechanism studies revealed that fluconazole plus amlodipine caused down-regulating of CNA1, CNB1 (encoding calcineurin) and YVC1 (encoding calcium channel protein in vacuole membrane).	[Liu, Shuyuan; Gu, Wenrui; Li, Xiuyun] Shandong Univ, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China; [Liu, Shuyuan] Ordos Cent Hosp, Dept Pharm, Ordos 017000, Inner Mongolia, Peoples R China; [Yue, Longtao] Shandong Univ, Qianfoshan Hosp, Translat Med Res Ctr, Jinan 250014, Shandong, Peoples R China; [Zhang, Liuping] Taishan Med Univ, Sch Pharmaceut Sci, Tai An 271000, Shandong, Peoples R China; [Sun, Shujuan] Shandong Univ, Qianfoshan Hosp, Dept Pharm, Jinan 250014, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, SJ (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Pharm, Jinan 250014, Shandong, Peoples R China.	sunshujuan888@163.com			Department of Science and Technology of Shandong Province [2013GSF11848]; Shandong Provincial Natural Science Foundation China [ZR2011HL049]	Department of Science and Technology of Shandong Province; Shandong Provincial Natural Science Foundation China(Natural Science Foundation of Shandong Province)	This work was supported by the Department of Science and Technology of Shandong Province (2013GSF11848) and Shandong Provincial Natural Science Foundation China (ZR2011HL049).	Afeltra J, 2004, ANTIMICROB AGENTS CH, V48, P1335, DOI 10.1128/AAC.48.4.1335-1343.2004; Azevedo MM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00669; Bagar T, 2012, FUNGAL GENET BIOL, V49, P779, DOI 10.1016/j.fgb.2012.07.007; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Bulatova NR, 2008, MED PRIN PRACT, V17, P117, DOI 10.1159/000112964; Chen TC, 2012, KAOHSIUNG J MED SCI, V28, P306, DOI 10.1016/j.kjms.2011.11.011; Chen YL, 2014, EUKARYOT CELL, V13, P844, DOI 10.1128/EC.00302-13; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; da Silva CR, 2013, ANTIMICROB AGENTS CH, V57, P1691, DOI 10.1128/AAC.00966-12; Eddouzi J, 2013, ANTIMICROB AGENTS CH, V57, P3182, DOI 10.1128/AAC.00555-13; Gao Y, 2013, FEMS YEAST RES, V13, P453, DOI 10.1111/1567-1364.12048; Golabek K, 2015, ACTA BIOCHIM POL, V62, P247, DOI 10.18388/abp.2014_940; Guo FM, 2013, J ANTIMICROB CHEMOTH, V68, P1660, DOI 10.1093/jac/dkt083; Guo Q, 2008, J MED MICROBIOL, V57, P457, DOI 10.1099/jmm.0.47651-0; Jensen RH, 2015, J ANTIMICROB CHEMOTH, V70, P2551, DOI 10.1093/jac/dkv140; Krajewska-Kulak Elzbieta, 1993, Materia Medica Polona, V25, P143; Liu FF, 2015, FUNGAL GENET BIOL, V81, P182, DOI 10.1016/j.fgb.2014.12.005; Liu SY, 2015, EUKARYOT CELL, V14, P324, DOI 10.1128/EC.00271-14; Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009; Lockhart SR, 2011, J CLIN MICROBIOL, V49, P4322, DOI 10.1128/JCM.05479-11; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Orasch C, 2014, CLIN MICROBIOL INFEC, V20, P698, DOI 10.1111/1469-0691.12440; Patenaude C, 2013, J BIOL CHEM, V288, P26256, DOI 10.1074/jbc.M113.494815; Pfaller MA, 2015, DIAGN MICR INFEC DIS, V82, P303, DOI 10.1016/j.diagmicrobio.2015.04.008; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2004, CLIN MICROBIOL REV, V17, P268, DOI 10.1128/CMR.17.2.268-280.2004; Pierce CG, 2013, EXPERT OPIN DRUG DIS, V8, P1117, DOI 10.1517/17460441.2013.807245; Rodrigues AAG, 2000, CURR MICROBIOL, V40, P145, DOI 10.1007/s002849910030; Sharma M, 2015, J CLIN DIAGN RES, V9, pDC20, DOI 10.7860/JCDR/2015/10094.5494; Shi WN, 2010, FEMS YEAST RES, V10, P885, DOI 10.1111/j.1567-1364.2010.00664.x; Sun LM, 2015, J APPL MICROBIOL, V118, P826, DOI 10.1111/jam.12737; Sun S, 2008, ANTIMICROB AGENTS CH, V52, P409, DOI 10.1128/AAC.01070-07; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; Yu QL, 2014, FREE RADICAL BIO MED, V77, P152, DOI 10.1016/j.freeradbiomed.2014.09.011; Yu QL, 2014, FEMS YEAST RES, V14, P633, DOI 10.1111/1567-1364.12150; Yu QL, 2014, INT J MED MICROBIOL, V304, P339, DOI 10.1016/j.ijmm.2013.11.022; Yu QL, 2014, MYCOPATHOLOGIA, V177, P167, DOI 10.1007/s11046-014-9735-7; Yu QL, 2013, INT J ANTIMICROB AG, V41, P179, DOI 10.1016/j.ijantimicag.2012.10.009; Yu SJ, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov016; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044192	41	48	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150859	10.1371/journal.pone.0150859	http://dx.doi.org/10.1371/journal.pone.0150859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986478	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300031
J	Shan, J; Oshima, T; Wu, LP; Fukui, H; Watari, J; Miwa, H				Shan, Jing; Oshima, Tadayuki; Wu, Liping; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto			Interferon gamma-Induced Nuclear Interleukin-33 Potentiates the Release of Esophageal Epithelial Derived Cytokines	PLOS ONE			English	Article							TIGHT JUNCTION PROTEINS; BARRIER FUNCTION; GASTROESOPHAGEAL-REFLUX; IFN-GAMMA; INCREASED EXPRESSION; IL-33 EXPRESSION; KAPPA-B; CELLS; MUCOSA; INFLAMMATION	Background Esophageal epithelial cells are an initiating cell type in esophageal inflammation, playing an essential role in the pathogenesis of gastroesophageal reflux disease (GERD). A new tissue-derived cytokine, interleukin-33 (IL-33), has been shown to be upregulated in esophageal epithelial cell nuclei in GERD, taking part in mucosal inflammation. Here, inflammatory cytokines secreted by esophageal epithelial cells, and their regulation by IL-33, were investigated. Methods In an in vitro stratified squamous epithelial model, IL-33 expression was examined using quantitative RT-PCR, western blot, ELISA, and immunofluorescence. Epithelial cell secreted inflammatory cytokines were examined using multiplex flow immunoassay. IL-33 was knocked down with small interfering RNA (siRNA) in normal human esophageal epithelial cells (HEECs). Pharmacological inhibitors and signal transducers and activators of transcription 1 (STAT1) siRNA were used to explore the signaling pathways. Results Interferon (IFN)gamma treatment upregulated nuclear IL-33 in HEECs. Furthermore, HEECs can produce various inflammatory cytokines, such as IL-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), regulated on activation normal T-cell expressed and presumably secreted (RANTES), and granulocyte-macrophage colony-stimulating factor (GM-CSF) in response to IFN gamma. Nuclear, but not exogenous IL-33, amplified IFN induction of these cytokines. P38 mitogen-activated protein kinase (MAPK) and janus protein tyrosine kinases (JAK)/STAT1 were the common signaling pathways of IFN gamma-mediated induction of IL-33 and other cytokines. Conclusions Esophageal epithelial cells can actively participate in GERD pathogenesis through the production of various cytokines, and epithelial-derived IL-33 might play a central role in the production of these cytokines.	[Shan, Jing; Oshima, Tadayuki; Wu, Liping; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan; [Shan, Jing; Wu, Liping] Third Peoples Hosp Chengdu, Dept Gastroenterol, Chengdu, Peoples R China	Hyogo College of Medicine	Oshima, T (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo 6638501, Japan.	t-oshima@hyo-med.ac.jp			Japan Society for the Promotion of Science (JSPS) [25460939]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) (25460939 to TO); Grant-in-Aid for Researchers, Hyogo College of Medicine, 2014.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Buzzelli JN, 2015, CELL MOL GASTROENTER, V1, P203, DOI 10.1016/j.jcmgh.2014.12.003; Chen X, 2012, AM J PHYSIOL-GASTR L, V303, pG199, DOI 10.1152/ajpgi.00454.2011; Chen X, 2011, AM J PHYSIOL-GASTR L, V301, pG203, DOI 10.1152/ajpgi.00096.2011; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Hamaguchi M, 2003, DIGESTION, V68, P189, DOI 10.1159/000075698; Huo XF, 2014, GUT, V63, P1042, DOI 10.1136/gutjnl-2013-305533; Isomoto H, 2003, AM J GASTROENTEROL, V98, P551, DOI 10.1016/S0002-9270(02)06025-2; Isomoto H, 2007, SCAND J GASTROENTERO, V42, P410, DOI 10.1080/00365520600931469; Judd LM, 2016, AM J PHYSIOL-GASTR L, V310, pG13, DOI 10.1152/ajpgi.00290.2015; Lin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060963; Liu L, 2004, J INTERF CYTOK RES, V24, P334, DOI 10.1089/107999004323142196; Lopetuso LR, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-18; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Nomura K, 2012, LARYNGOSCOPE, V122, P1185, DOI 10.1002/lary.23261; Oshima T, 2012, LAB INVEST, V92, P22, DOI 10.1038/labinvest.2011.139; Oshima T, 2011, AM J PHYSIOL-CELL PH, V300, pC1422, DOI 10.1152/ajpcell.00376.2010; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Polumuri SK, 2012, J IMMUNOL, V189, P50, DOI 10.4049/jimmunol.1003554; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rieder F, 2007, GASTROENTEROLOGY, V132, P154, DOI 10.1053/j.gastro.2006.10.009; Rieder F, 2010, AM J PHYSIOL-GASTR L, V298, pG571, DOI 10.1152/ajpgi.00454.2009; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076; Shan J, 2015, J GASTROENTEROL, V50, P414, DOI 10.1007/s00535-014-0988-1; Shan J, 2013, J GASTROEN HEPATOL, V28, P823, DOI 10.1111/jgh.12139; Shan J, 2012, AM J PHYSIOL-GASTR L, V303, pG1105, DOI 10.1152/ajpgi.00220.2012; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055; Yin H, 2013, INT IMMUNOPHARMACOL, V17, P432, DOI 10.1016/j.intimp.2013.07.008	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151701	10.1371/journal.pone.0151701	http://dx.doi.org/10.1371/journal.pone.0151701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986625	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300116
J	Yang, SS; Deng, HC; Zhang, QZ; Xie, J; Zeng, H; Jin, XL; Ling, ZX; Shan, QY; Liu, MM; Ma, YF; Tang, J; Wei, QP				Yang, Shasha; Deng, Huacong; Zhang, Qunzhou; Xie, Jing; Zeng, Hui; Jin, Xiaolong; Ling, Zixi; Shan, Qiaoyun; Liu, Momo; Ma, Yuefei; Tang, Juan; Wei, Qianping			Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling	PLOS ONE			English	Article							BINDING PROTEIN 10; CELL PROLIFERATION; APOPTOSIS; MICE; DISRUPTION; ADAPTER; CANCER; INJURY; LIPIDS; GAMMA	Growth factor receptor-bound protein 10 (Grb10) is an adaptor protein that can negatively regulate the insulin-like growth factor 1 receptor (IGF-1R). The IGF1-1R pathway is critical for cell growth and apoptosis and has been implicated in kidney diseases; however, it is still unknown whether Grb10 expression is up-regulated and plays a role in diabetic nephropathy. Catalpol, a major active ingredient of a traditional Chinese medicine, Rehmannia, has been reported to possess anti-inflammatory and anti-aging activities and then used to treat diabetes. Herein, we aimed to assess the therapeutic effect of catalpol on a mouse model diabetic nephropathy and the potential role of Grb10 in the pathogenesis of this diabetes-associated complication. Our results showed that catalpol treatment improved diabetes-associated impaired renal functions and ameliorated pathological changes in kidneys of diabetic mice. We also found that Grb10 expression was significantly elevated in kidneys of diabetic mice as compared with that in non-diabetic mice, while treatment with catalpol significantly abrogated the elevated Grb10 expression in diabetic kidneys. On the contrary, IGF-1 mRNA levels and IGF-1R phosphorylation were significantly higher in kidneys of catalpol-treated diabetic mice than those in non-treated diabetic mice. Our results suggest that elevated Grb10 expression may play an important role in the pathogenesis of diabetic nephropathy through suppressing IGF-1/IGF-1R signaling pathway, which might be a potential molecular target of catalpol for the treatment of this diabetic complication.	[Yang, Shasha; Xie, Jing; Zeng, Hui; Jin, Xiaolong; Ling, Zixi; Shan, Qiaoyun; Liu, Momo; Ma, Yuefei; Tang, Juan; Wei, Qianping] Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China; [Deng, Huacong] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Chongqing, Peoples R China; [Zhang, Qunzhou] Univ Penn, Sch Dent Med, Dept Oral Surg & Pharmacol, Philadelphia, PA 19104 USA	Chongqing Medical University; Chongqing Medical University; University of Pennsylvania	Wei, QP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Geriatr, Chongqing, Peoples R China.	wqp68894940@163.com			National Key Clinical Specialties Construction Program of China [[2013]544]; Chongqing Postgraduate Research Innovation Project [CYS14120]	National Key Clinical Specialties Construction Program of China; Chongqing Postgraduate Research Innovation Project	This work was supported by National Key Clinical Specialties Construction Program of China (No. [2013]544), The Chongqing Postgraduate Research Innovation Project (CYS14120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Uzri A, 2013, PEDIATR NEPHROL, V28, P2323, DOI 10.1007/s00467-013-2570-0; Alarcon-Aguilar FJ, 2000, J ETHNOPHARMACOL, V72, P21, DOI 10.1016/S0378-8741(00)00202-6; [Anonymous], 2012, SYST URD USRDS 2012; Bi J, 2013, TOXICOL IN VITRO, V27, P543, DOI 10.1016/j.tiv.2012.09.023; Chen CJ, 2013, J RADIAT RES, V54, P76, DOI 10.1093/jrr/rrs080; Chen WN, 2013, BRIT J PHARMACOL, V169, P1140, DOI 10.1111/bph.12200; Deng YP, 2003, J BIOL CHEM, V278, P39311, DOI 10.1074/jbc.M304599200; Dong LQ, 1997, J BIOL CHEM, V272, P29104, DOI 10.1074/jbc.272.46.29104; Dong Z, 2013, PHYTOMEDICINE, V20, P1023, DOI 10.1016/j.phymed.2013.04.007; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Faraj M, 2004, BIOCHEM CELL BIOL, V82, P170, DOI 10.1139/o03-078; Fu K, 2014, INT IMMUNOPHARMACOL, V23, P400, DOI 10.1016/j.intimp.2014.07.011; Gao N, 2014, INT J MOL SCI, V15, P19394, DOI 10.3390/ijms151119394; Giovannone B, 2003, J BIOL CHEM, V278, P31564, DOI 10.1074/jbc.M211572200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Holt LJ, 2012, FASEB J, V26, P3658, DOI 10.1096/fj.11-199349; Hu ZQ, 2010, MOL BIOL REP, V37, P3547, DOI 10.1007/s11033-010-0002-9; Ising C, 2015, EMBO MOL MED, V7, P275, DOI 10.15252/emmm.201404916; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Lawal AO, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0040-y; Lawrence JM, 2004, ATHEROSCLEROSIS, V174, P141, DOI 10.1016/j.atherosclerosis.2004.01.016; Lee MJ, 2010, J ETHNOPHARMACOL, V132, P497, DOI 10.1016/j.jep.2010.07.057; Li L, 2013, CLIN EXP PHARMACOL P, V40, P841, DOI 10.1111/1440-1681.12160; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; Ma L, 2013, J NEUROENDOCRINOL, V25, P626, DOI 10.1111/jne.12040; Mokbel N, 2014, J CELL PHYSIOL, V229, P1753, DOI 10.1002/jcp.24628; Mroue R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005235; O-Sullivan I, 2008, CANCER RES, V68, P2463, DOI 10.1158/0008-5472.CAN-07-5685; Prokopenko I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004235; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Varga ZV, 2015, BBA-MOL BASIS DIS, V1852, P232, DOI 10.1016/j.bbadis.2014.06.030; White KE, 2000, J AM SOC NEPHROL, V11, P1667, DOI 10.1681/ASN.V1191667; Xie JL, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-91; Yang S, 2005, AM J PHYSIOL-RENAL, V289, pF1144, DOI 10.1152/ajprenal.00094.2005; Yin DK, 2014, J ETHNOPHARMACOL, V151, P667, DOI 10.1016/j.jep.2013.11.025; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang JJ, 2012, DIABETES, V61, P3189, DOI 10.2337/db12-0249; Zhou HC, 2014, CHINESE MED J-PEKING, V127, P916, DOI 10.3760/cma.j.issn.0366-6999.20132137; Zhu JL, 2015, INT J CLIN EXP MED, V8, P2038	40	11	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151857	10.1371/journal.pone.0151857	http://dx.doi.org/10.1371/journal.pone.0151857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986757	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300141
J	Salazar, MFM; Waldner, C; Stookey, J; Bollinger, TK				Salazar, Maria Fernanda Mejia; Waldner, Cheryl; Stookey, Joseph; Bollinger, Trent K.			Infectious Disease and Grouping Patterns in Mule Deer	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; ELK CERVUS-ELAPHUS; GROUP-SIZE; ODOCOILEUS-HEMIONUS; SOCIAL-ORGANIZATION; PRION TRANSMISSION; BEHAVIOR; DYNAMICS; HABITAT	Infectious disease dynamics are determined, to a great extent, by the social structure of the host. We evaluated sociality, or the tendency to form groups, in Rocky Mountain mule deer (Odocoileus hemionus hemionus) from a chronic wasting disease (CWD) endemic area in Saskatchewan, Canada, to better understand factors that may affect disease transmission. Using group size data collected on 365 radio-collared mule deer (2008-2013), we built a generalized linear mixed model (GLMM) to evaluate whether factors such as CWD status, season, habitat and time of day, predicted group occurrence. Then, we built another GLMM to determine factors associated with group size. Finally, we used 3 measures of group size (typical, mean and median group sizes) to quantify levels of sociality. We found that mule deer showing clinical signs of CWD were less likely to be reported in groups than clinically healthy deer after accounting for time of day, habitat, and month of observation. Mule deer groups were much more likely to occur in February and March than in July. Mixed-sex groups in early gestation were larger than any other group type in any season. Groups were largest and most likely to occur at dawn and dusk, and in open habitats, such as cropland. We discuss the implication of these results with respect to sociobiology and CWD transmission dynamics.	[Salazar, Maria Fernanda Mejia; Bollinger, Trent K.] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada; [Waldner, Cheryl; Stookey, Joseph] Univ Saskatchewan, Dept Large Anim Clin Sci, Saskatoon, SK, Canada; [Bollinger, Trent K.] Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Bollinger, TK (corresponding author), Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada.; Bollinger, TK (corresponding author), Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada.	trent.bollinger@usask.ca		Waldner, Cheryl/0000-0002-7152-4261	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded primarily by PrioNet Canada a Network of Centres of Excellence of Canada (www.nce-rce.gc.ca). Additional funding and support was provided by Saskatchewan Ministry of Environment (http://environment.gov.sk.ca/) and the Canadian Wildlife Health Cooperative (http://www.ccwhc.ca/). MFMS received a scholarship funding from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020; Alcock J, 2009, ANIMAL BEHAV EVOLUTI; Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Arakawa H, 2010, HORM BEHAV, V57, P330, DOI 10.1016/j.yhbeh.2010.01.002; Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858; Behringer DC, 2006, NATURE, V441, P421, DOI 10.1038/441421a; Bender LC, 1996, AM MIDL NAT, V135, P261, DOI 10.2307/2426708; Bishop R.C., 2004, HUM DIMENS WILDL, V9, P181, DOI [10.1080/10871200490479963, DOI 10.1080/10871200490479963]; Body G, 2015, ACTA ETHOL, V18, P101, DOI 10.1007/s10211-014-0190-8; Bouwman KM, 2010, BIOL LETTERS, V6, P462, DOI 10.1098/rsbl.2010.0020; Bowyer RT, 2001, ALCES-N AM MOOSE CON, V37, P371; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Butler MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126374; Canadian Wildlife Health Cooperative, 2013, CHRON WAST DIS TEST; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603; Cross PC, 2005, DIS INVASION CONTROL; DEVOS A, 1967, AM MIDL NAT, V77, P390, DOI 10.2307/2423349; Dohoo I., 2009, VET EPIDEMIOLOGICAL, P579; Efron B., 1994, INTRO BOOTSTRAP; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; Godfrey Stephanie S., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P235, DOI 10.1016/j.ijppaw.2013.09.001; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Hjeljord O, 2001, ALCES-N AM MOOSE CON, V37, P353; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Karns GR, 2009, J WILDLIFE DIS, V45, P196, DOI 10.7589/0090-3558-45.1.196; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503; KUCERA TE, 1978, J MAMMAL, V59, P463, DOI 10.2307/1380224; Kurvers RHJM, 2014, TRENDS ECOL EVOL, V29, P326, DOI 10.1016/j.tree.2014.04.002; LAGORY KE, 1986, BEHAVIOUR, V98, P168, DOI 10.1163/156853986X00955; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lingle S, 2001, ETHOLOGY, V107, P295, DOI 10.1046/j.1439-0310.2001.00664.x; Lingle S, 2003, CAN J ZOOL, V81, P1119, DOI 10.1139/Z03-097; Lingle S, 2000, CAN J ZOOL, V78, P85, DOI 10.1139/cjz-78-1-85; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665; Monteith KL, 2007, J WILDLIFE MANAGE, V71, P1712, DOI 10.2193/2005-763; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0115; Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0111; Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003; Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Potapov A, 2012, P ROY SOC B-BIOL SCI, V279, P3139, DOI 10.1098/rspb.2012.0520; Putman R., 1988, NATURAL HIST DEER; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, P687; Reiczigel J, 2005, J PARASITOL, V91, P245, DOI 10.1645/GE-281R1; Reiczigel J, 2016, EUROPEAN J ECOLOGY; Reiczigel J, 2013, QUANTITATIVE PARASIT; Reiczigel J, 2008, ANIM BEHAV, V75, P715, DOI 10.1016/j.anbehav.2007.05.020; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; SAS, 2006, GLIMMIX PROC SAS STA; Semeniuk MB, 2015, MAMMALIA, V79, P131, DOI 10.1515/mammalia-2014-0054; Silbernagel E, 2010, THESIS U SASKATTCHEW; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; SKELTON NK, 2010, THESIS U SASKATCHEWA; Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546; Sullivan L., 2008, ESSENTIAL BIOSTATIST, P175; Time and Date AS, 2014, SWIFT CAN SUNR SUNS; VanderWaal KL, 2013, BEHAV ECOL SOCIOBIOL, V67, P1951, DOI 10.1007/s00265-013-1602-x; Vasilyeva O, 2015, MATH BIOSCI ENG, V12, P209, DOI 10.3934/mbe.2015.12.209; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; [No title captured]	86	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150830	10.1371/journal.pone.0150830	http://dx.doi.org/10.1371/journal.pone.0150830			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007808	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200032
J	Goncalves, AZ; Oliveira, RS; Oliveira, PS; Romero, GQ				Goncalves, Ana Z.; Oliveira, Rafael S.; Oliveira, Paulo S.; Romero, Gustavo Q.			Species-Specific Effects of Ant Inhabitants on Bromeliad Nutrition	PLOS ONE			English	Article							NEOTROPICAL ANT; NITROGEN FLUXES; URSUS-ARCTOS; PLANT; MUTUALISM; FORMICIDAE; PREDATORS; ECOLOGY; MARINE; FOREST	Predator activities may lead to the accumulation of nutrients in specific areas of terrestrial habitats where they dispose of prey carcasses. In their feeding sites, predators may increase nutrient availability in the soil and favor plant nutrition and growth. However, the translocation of nutrients from one habitat to another may depend on predator identity and diet, as well as on the amount of prey intake. Here we used isotopic (N-15) and physiological methods in greenhouse experiments to evaluate the effects of the identity of predatory ants (i.e., the consumption of prey and nest sites) on the nutrition and growth of the bromeliad Quesnelia arvensis. We showed that predatory ants with protein-based nutrition (i.e., Odontomachus hastatus, Gnamptogenys moelleri) improved the performance of their host bromeliads (i.e., increased foliar N, production of soluble proteins and growth). On the other hand, the contribution of Camponotus crassus for the nutritional status of bromeliads did not differ from bromeliads without ants, possibly because this ant does not have arthropod prey as a preferred food source. Our results show, for the first time, that predatory ants can translocate nutrients from one habitat to another within forests, accumulating nutrients in their feeding sites that become available to bromeliads. Additionally, we highlight that ant contribution to plant nutrition may depend on predator identity and its dietary requirements. Nest debris may be especially important for epiphytic and terrestrial bromeliads in nutrient-poor environments.	[Goncalves, Ana Z.] Univ Estadual Campinas UNICAMP, Inst Biol, Posgrad Ecol, CP 6109, BR-13083970 Campinas, SP, Brazil; [Oliveira, Rafael S.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, CP 6109, BR-13083970 Campinas, SP, Brazil; [Oliveira, Paulo S.; Romero, Gustavo Q.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Anim, CP 6109, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Goncalves, AZ (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Posgrad Ecol, CP 6109, BR-13083970 Campinas, SP, Brazil.	zangirolame@gmail.com	Oliveira, Rafael S/B-3422-2013; Gonçalves, Ana Z/AAR-8968-2020; Romero, Gustavo Q/H-8974-2012; Romero, Gustavo Q/N-1896-2019; Gonçalves, Ana Z./E-6735-2016; Oliveira, Paulo S./E-1910-2013	Oliveira, Rafael S/0000-0002-6392-2526; Gonçalves, Ana Z/0000-0002-9036-8831; Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759; Gonçalves, Ana Z./0000-0002-9036-8831; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo scholarship [2011/10137-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [2010/17204-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo scholarship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo scholarship to A.Z. Goncalves (2011/10137-8), and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico research grants to P.S. Oliveira, G.Q. Romero and R.S. Oliveira (2010/17204-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2003, OIKOS, V102, P221, DOI 10.1034/j.1600-0706.2003.12478.x; Anderson B, 2002, OECOLOGIA, V132, P369, DOI 10.1007/s00442-002-0998-1; Barneix AJ, 1996, J PLANT PHYSIOL, V149, P358; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; BENZING DH, 2000, BROMELIACEAE PROFILE; Bluthgen N, 2000, INSECT SOC, V47, P313, DOI 10.1007/PL00001722; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo RX, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4801; Camargo RX, 2002, THESIS U ESTADUAL CA; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cogni R, 2004, INSECT SOC, V51, P123, DOI 10.1007/s00040-003-0711-3; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DEJEAN A, 1995, BIOTROPICA, V27, P57, DOI 10.2307/2388903; Ellis AG, 1996, OECOLOGIA, V106, P478, DOI 10.1007/BF00329705; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; Endres L, 2003, PLANT PHYSIOL BIOCH, V41, P181, DOI 10.1016/S0981-9428(02)00025-6; Fischer RC, 2003, J ECOL, V91, P126, DOI 10.1046/j.1365-2745.2003.00747.x; Gibernau M, 2007, BIOL J LINN SOC, V91, P341, DOI 10.1111/j.1095-8312.2007.00799.x; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Goncalves AZ, 2014, BIOTROPICA, V46, P170, DOI 10.1111/btp.12086; Goncalves AZ, 2011, ANN BOT-LONDON, V107, P1047, DOI 10.1093/aob/mcr047; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Holtgrieve GW, 2009, ECOL RES, V24, P1125, DOI 10.1007/s11284-009-0591-8; HUXLEY C, 1980, BIOL REV, V55, P321, DOI 10.1111/j.1469-185X.1980.tb00696.x; Inselsbacher E, 2007, NEW PHYTOL, V175, P311, DOI 10.1111/j.1469-8137.2007.02098.x; Kempf WW, 1972, STUD ENTOMOL, V15, P1; Kolb GS, 2015, ECOSYSTEMS, V18, P643, DOI 10.1007/s10021-015-9853-1; Lattke John E., 1995, Journal of Hymenoptera Research, V4, P137; Leroy C, 2013, ANN BOT-LONDON, V112, P919, DOI 10.1093/aob/mct147; Leroy C, 2012, ANN BOT-LONDON, V109, P145, DOI 10.1093/aob/mcr253; Martins Susian Christian, 2015, Geoderma Regional, V5, P106, DOI 10.1016/j.geodrs.2015.04.005; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Oliveira PS, 2011, INSECT SOC, V58, P207, DOI 10.1007/s00040-010-0138-6; Oliveira PS, 2004, NATURWISSENSCHAFTEN, V91, P557, DOI 10.1007/s00114-004-0585-x; Pereira CG, 2012, P NATL ACAD SCI USA, V109, P1154, DOI 10.1073/pnas.1114199109; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; RICOGRAY V, 1989, AM J BOT, V76, P603, DOI 10.2307/2444355; Rodrigues PAP, 2014, BEHAV PROCESS, V109, P48, DOI 10.1016/j.beproc.2014.06.007; Romero GQ, 2006, ECOLOGY, V87, P803, DOI 10.1890/0012-9658(2006)87[803:BSIHPN]2.0.CO;2; Romero GQ, 2010, J ANIM ECOL, V79, P1122, DOI 10.1111/j.1365-2656.2010.01716.x; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Rudolf VHW, 2014, P ROYAL SOC B, V281, P1; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0	49	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152113	10.1371/journal.pone.0152113	http://dx.doi.org/10.1371/journal.pone.0152113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002980	Green Submitted, gold, Green Published			2022-12-27	WOS:000372697400080
J	Li, X; Li, XY; Zhu, ZL; Huang, PW; Zhuang, ZX; Liu, JJ; Gao, W; Liu, YP; Huang, HY				Li, Xuan; Li, Xiyi; Zhu, Zhiliang; Huang, Peiwu; Zhuang, Zhixiong; Liu, Jianjun; Gao, Wei; Liu, Yinpin; Huang, Haiyan			Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation	PLOS ONE			English	Article							DNA-DAMAGE; CARCINOGENESIS; POLYMERASE-1; INHIBITION; METABOLISM; PROTECTS; REPAIR; GENE	Benzo(a) pyrene (BaP) is a ubiquitously distributed environmental pollutant and known carcinogen, which can induce malignant transformation in rodent and human cells. Poly(ADPribose) glycohydrolase (PARG), the primary enzyme that catalyzes the degradation of poly (ADP-ribose) (PAR), has been known to play an important role in regulating DNA damage repair and maintaining genomic stability. Although PARG has been shown to be a downstream effector of BaP, the role of PARG in BaP induced carcinogenesis remains unclear. In this study, we used the PARG-deficient human bronchial epithelial cell line (shPARG) as a model to examine how PARG contributed to the carcinogenesis induced by chronic BaP exposure under various concentrations (0, 10, 20 and 40 mu M). Our results showed that PARG silencing dramatically reduced DNA damages, chromosome abnormalities, and micronuclei formations in the PARG-deficient human bronchial epithelial cells compared to the control cells (16HBE cells). Meanwhile, the wound healing assay showed that PARG silencing significantly inhibited BaP-induced cell migration. Furthermore, silencing of PARG significantly reduced the volume and weight of tumors in Balb/c nude mice injected with BaP induced transformed human bronchial epithelial cells. This was the first study that reported evidences to support an oncogenic role of PARG in BaP induced carcinogenesis, which provided a new perspective for our understanding in BaP exposure induced cancer.	[Li, Xuan; Huang, Peiwu; Zhuang, Zhixiong; Liu, Jianjun; Gao, Wei; Liu, Yinpin; Huang, Haiyan] Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen, Guangdong, Peoples R China; [Li, Xiyi] Guangxi Med Univ, Sch Publ Hlth, Guangxi, Peoples R China; [Zhu, Zhiliang] Baoan Ctr Dis Control & Prevent, Dept Occupat Dis Prevent, Guangzhou, Guangdong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Guangxi Medical University	Huang, HY (corresponding author), Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen, Guangdong, Peoples R China.	hhy424@126.com			NSFC [81001261, 81370080, 81273127]; Future Industry Special Project of Shenzhen [ZDSYS20140509101335476]; Shenzhen Science and Technology Development Fund Project [JCYJ20130329103949642]	NSFC(National Natural Science Foundation of China (NSFC)); Future Industry Special Project of Shenzhen; Shenzhen Science and Technology Development Fund Project	This study was supported by NSFC (Project No: 81001261, 81370080 and 81273127) in the study design and data collection. The Future Industry Special Project of Shenzhen (No. ZDSYS20140509101335476) was funded for analysis. The Shenzhen Science and Technology Development Fund Project (Project No: JCYJ20130329103949642) was funded for publish.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andreassi Maria Grazia, 2004, Cardiovasc Ultrasound, V2, P25, DOI 10.1186/1476-7120-2-25; Asaithamby A, 2011, MUTAT RES-FUND MOL M, V711, P87, DOI 10.1016/j.mrfmmm.2010.11.002; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; BROCHU G, 1994, BBA-GENE STRUCT EXPR, V1219, P342, DOI 10.1016/0167-4781(94)90058-2; Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Fauzee NJS, 2012, PATHOL ONCOL RES, V18, P191, DOI 10.1007/s12253-011-9428-1; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Feng XX, 2013, INT J ONCOL, V42, P749, DOI 10.3892/ijo.2012.1740; Feng XX, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-48; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fujihara H, 2009, CURR CANCER DRUG TAR, V9, P953, DOI 10.2174/156800909790192419; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Gurung RL, 2010, GENOME INTEGR, V1, P1; Han ZY, 2014, TOXICOL LETT, V225, P275, DOI 10.1016/j.toxlet.2013.12.008; HEIDELBERGER C, 1983, MUTAT RES, V114, P283, DOI 10.1016/0165-1110(83)90036-2; Huang HY, 2012, EXP CELL RES, V318, P682, DOI 10.1016/j.yexcr.2012.01.007; Huang HY, 2015, AM J CANCER RES, V5, P155; Huang HY, 2014, BIOCHEM BIOPH RES CO, V452, P708, DOI 10.1016/j.bbrc.2014.08.146; Ji WD, 2008, CARCINOGENESIS, V29, P1267, DOI 10.1093/carcin/bgn012; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Li M, 2015, ONCOGENE, V34, P3349, DOI 10.1038/onc.2014.295; Li QZ, 2012, CELL PHYSIOL BIOCHEM, V29, P361, DOI 10.1159/000338491; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Min W, 2010, CARCINOGENESIS, V31, P2058, DOI 10.1093/carcin/bgq205; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; Nkrumah-Elie YM, 2012, FOOD CHEM TOXICOL, V50, P2524, DOI 10.1016/j.fct.2012.04.010; Shirai H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.133; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Vodicka P, 2015, CARCINOGENESIS; Zhang C, 2015, BMB REP, V48, P354, DOI 10.5483/BMBRep.2015.48.6.012	37	4	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151172	10.1371/journal.pone.0151172	http://dx.doi.org/10.1371/journal.pone.0151172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003318	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400026
J	Paiva, VH; Fagundes, AI; Romao, V; Gouveia, C; Ramos, JA				Paiva, Vitor H.; Fagundes, Ana I.; Romao, Vera; Gouveia, Catia; Ramos, Jaime A.			Population-Scale Foraging Segregation in an Apex Predator of the North Atlantic	PLOS ONE			English	Article							PELAGIC SEABIRD; AZORES ARCHIPELAGO; ROUND DISTRIBUTION; STABLE-ISOTOPES; MAXIMUM-ENTROPY; MANX SHEARWATER; STORM-PETREL; MOVEMENTS; TRACKING; ECOLOGY	In this work we investigated the between-colony spatial, behavioural and trophic segregation of two sub-populations of the elusive Macaronesian shearwaters Puffinus baroli breeding only similar to 340 km apart in Cima Islet (Porto Santo Island) and Selvagem Grande Island. Global location sensing (gls) loggers were used in combination with the trophic ecology of tracked individuals, inferred from the isotopic signatures of wing feathers. Results suggest that these two Macaronesian shearwater sub-populations do segregate during the non-breeding period in some 'sub-population-specific' regions, by responding to different oceanographic characteristics (habitat modelling). Within these disparate areas, both sub-populations behave differently (at-sea activity) and prey on disparate trophic niches (stable isotope analysis). One hypothesis would be that each sub-population have evolved and adapted to feed on particular and 'sub-population-specific' resources, and the segregation observed at the three different levels (spatial, behavioural and trophic) might be in fact a result of such adaptation, from the emergence of 'cultural foraging patterns'. Finally, when comparing to the results of former studies reporting on the spatial, behavioural and trophic choices of Macaronesian shearwater populations breeding on Azores and Canary Islands, we realized the high ecological plasticity of this species inhabiting and foraging over the North-East Atlantic Ocean.	[Paiva, Vitor H.; Romao, Vera; Ramos, Jaime A.] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, P-3004517 Coimbra, Portugal; [Fagundes, Ana I.; Gouveia, Catia] SPEA, Travessa das Torres 2A 1, P-9060314 Funchal, Madeira, Portugal	Universidade de Coimbra	Paiva, VH (corresponding author), Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, P-3004517 Coimbra, Portugal.	vitorpaiva@ci.uc.pt	Ramos, Jaime/B-6616-2018; Paiva, Vitor Hugo/GRX-9179-2022; Paiva, Vitor H./J-1092-2019	Ramos, Jaime/0000-0002-9533-987X; Paiva, Vitor H./0000-0001-6368-9579	EU [NAT/PT/000041]; British Ornithologists' Union; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/63825/2009, SFRH/BPD/85024/2012]	EU(European Commission); British Ornithologists' Union; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support for the fieldwork on Cima Islet was provided by the EU project LIFE09 NAT/PT/000041. Fieldwork on Selvagem Grande was partially funded by a small grant from the British Ornithologists' Union (2011). VHP received postdoctoral grants given by 'Fundacao para a Ciencia e Tecnologia' (SFRH/BPD/63825/2009 and SFRH/BPD/85024/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afan I, 2014, MAR BIOL, V161, P657, DOI 10.1007/s00227-013-2368-4; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bates D., 2013, LME4 LINEAR MIXED EF; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Camphuysen CJ, 2005, AFR J MAR SCI, V27, P427, DOI 10.2989/18142320509504101; Catry P, 2013, ECOLOGY, V94, P1230, DOI 10.1890/12-2177.1; Catry P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026079; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kubetzki U, 2009, MAR ECOL PROG SER, V391, P257, DOI 10.3354/meps08254; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Lorenzo JA, 2003, ATLAS AVES NIDIFICAN; Louzao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035728; Roscales JL, 2011, MAR ECOL PROG SER, V434, P1, DOI 10.3354/meps09211; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Monteiro LR, 1996, BIOL CONSERV, V78, P319, DOI 10.1016/S0006-3207(96)00037-7; Monteiro LR, 1999, WATERBIRDS, V22, P358, DOI 10.2307/1522111; Monteiro LR, 1996, COLON WATERBIRD, V19, P82, DOI 10.2307/1521810; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Muller MS, 2014, CURR ZOOL, V60, P631, DOI 10.1093/czoolo/60.5.631; Navarro J, 2013, DEEP SEA RES 2, P1, DOI 10.1016/j.dsr2.2013.01.031; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Neves VC, 2012, MAR ECOL PROG SER, V452, P269, DOI 10.3354/meps09670; Oliveira P, 1995, POPULATION SIZE BREE; Paiva VH, 2013, MAR ECOL PROG SER, V477, P15, DOI 10.3354/meps10180; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Paiva VH, 2010, ZOOLOGY, V113, P47, DOI 10.1016/j.zool.2009.05.003; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Peron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072713; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008; R Core Team, 2013, R LANG ENV STAT COMP; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; Ramos JA, 1997, CONDOR, V99, P634, DOI 10.2307/1370475; Ramos JA, 2015, DEEP-SEA RES PT I, V104, P60, DOI 10.1016/j.dsr.2015.07.001; Ramos R, 2013, DIVERS DISTRIB, V19, P1284, DOI 10.1111/ddi.12088; Ramos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040822; Reiertsen TK, 2014, MAR ECOL PROG SER, V509, P289, DOI 10.3354/meps10825; Rodriguez A, 2012, IBIS, V154, P167, DOI 10.1111/j.1474-919X.2011.01175.x; Santos RS, 1995, AQUAT CONSERV, V5, P311, DOI 10.1002/aqc.3270050406; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Sousa FM, 2008, REMOTE SENS ENVIRON, V112, P2817, DOI 10.1016/j.rse.2008.01.014; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Werner AC, 2014, AUK, V131, P265, DOI 10.1642/AUK-13-172.1; Zino F., 2011, BIRDING WORLD, V24, P216	67	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151340	10.1371/journal.pone.0151340	http://dx.doi.org/10.1371/journal.pone.0151340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003687	gold, Green Submitted, Green Published			2022-12-27	WOS:000372697400029
J	Wohrle, J; Gonska, B; Rodewald, C; Seeger, J; Scharnbeck, D; Rottbauer, W				Woehrle, Jochen; Gonska, Birgid; Rodewald, Christoph; Seeger, Julia; Scharnbeck, Dominik; Rottbauer, Wolfgang			Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis-Impact of Valve Size in a Single Center Experience	PLOS ONE			English	Article							TRANSCATHETER HEART-VALVE; PARAVALVULAR REGURGITATION; REPLACEMENT; PREDICTORS; OUTCOMES	Aims The third generation Edwards Sapien 3 (Edwards Lifesciences Inc., Irvine, California) system was optimized to reduce residual aortic regurgitation and vascular complications. Methods and Results 235 patients with severe symptomatic aortic stenosis were prospectively enrolled. Trans-catheter aortic valve implantations (TAVI) were performed without general anesthesia by transfemoral approach. Patients were followed for 30 days. Patients received 23mm (N = 77), 26mm (N = 91) or 29mm (N = 67) valve based on pre-procedural 256 multislice computer tomography. Mean oversizing did not differ between the 3 valves. There was no residual moderate or severe aortic regurgitation. Rate of mild aortic regurgitation and regurgitation index did not differ between groups. There was no switch to general anesthesia or conversion to surgery. Rate of major vascular complication was 3.0% with no difference between valve and delivery sheath sizes. Within 30 days rates of all cause mortality (2.6%) and stroke (2.1%) were low. Conclusions In patients with severe aortic stenosis transfemoral TAVI with the Edwards Sapien 3 valve without general anesthesia was associated with a high rate of device success, no moderate or severe residual aortic regurgitation, low rates of major vascular complication, mortality and stroke within 30 days with no difference between the 3 valve sizes.	[Woehrle, Jochen; Gonska, Birgid; Rodewald, Christoph; Seeger, Julia; Scharnbeck, Dominik; Rottbauer, Wolfgang] Univ Ulm, Dept Internal Med 2, Robert Koch Str 8, D-89069 Ulm, Germany	Ulm University	Wohrle, J (corresponding author), Univ Ulm, Dept Internal Med 2, Robert Koch Str 8, D-89069 Ulm, Germany.	jochen.woehrle@uniklinik-ulm.de						Abdel-Wahab M, 2014, JAMA-J AM MED ASSOC, V311, P1503, DOI 10.1001/jama.2014.3316; Achenbach S, 2012, J CARDIOVASC COMPUT, V6, P366, DOI 10.1016/j.jcct.2012.11.002; Athappan G, 2013, J AM COLL CARDIOL, V61, P1585, DOI 10.1016/j.jacc.2013.01.047; Binder RK, 2013, JACC-CARDIOVASC INTE, V6, P293, DOI 10.1016/j.jcin.2012.09.019; Binder RK, 2012, EUROINTERVENTION, V8, pQ83, DOI 10.4244/EIJV8SQA15; Collas VM, 2015, INT J CARDIOL, V194, P13, DOI 10.1016/j.ijcard.2015.05.015; Fateh-Moghadam S, 2016, THROMB HAEMOSTASIS, V115, P109, DOI 10.1160/TH15-03-0267; Genereux P, 2014, J AM COLL CARDIOL, V63, P1100, DOI 10.1016/j.jacc.2013.10.058; Jilaihawi H, 2015, EUROINTERVENTION, V11, P456, DOI 10.4244/EIJY14M12_08; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Schymik G, 2015, JACC-CARDIOVASC INTE, V8, P657, DOI 10.1016/j.jcin.2014.10.026; Schymik G, 2015, J INTERV CARDIOL, V28, P82, DOI 10.1111/joic.12165; Seeger J, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.08.025; SELLERS RD, 1964, AM J CARDIOL, V14, P437, DOI 10.1016/0002-9149(64)90027-X; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Tarantini G, 2015, EUROINTERVENTION, V11, P343, DOI 10.4244/EIJY14M11_06; Webb J, 2014, J AM COLL CARDIOL, V64, P2235, DOI 10.1016/j.jacc.2014.09.026; Wohrle J, 2016, CATHETER CARDIO INTE, V87, P993, DOI 10.1002/ccd.26062; Wohrle J, 2015, INT J CARDIOL, V195, P171, DOI 10.1016/j.ijcard.2015.05.139; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	22	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151247	10.1371/journal.pone.0151247	http://dx.doi.org/10.1371/journal.pone.0151247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003573	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400028
J	Wu, FX; He, Y; Di, HT; Sun, YM; Pan, RR; Yu, WF; Liu, RY				Wu, Fei-xiang; He, Yan; Di, Hui-ting; Sun, Yu-ming; Pan, Rui-rui; Yu, Wei-feng; Liu, Renyu			An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome	PLOS ONE			English	Article							SPINAL SUBARACHNOID SPACE; INJECTION-DRUG USERS; ADENOVIRAL VECTORS; NEUROPATHIC PAIN; BETA-ENDORPHIN; ENZYMATIC DEGRADATION; ADDICTION TREATMENT; CLINICAL-TRIAL; SAFETY PROFILE; THERAPY	An optimal therapeutics to manage opioid withdrawal syndrome is desired for opioid addiction treatment. Down-regulation of endogenous endomorphin-2 (EM2) level in the central nervous system after continuous morphine exposure was observed, which suggested that increase of EM2 could be an alternative novel method for opioid dependence. As a short peptide, the short half-life of EM2 limits its clinical usage through conventional administration. In the present study, we engineered an EM2 gene using a signal peptide of mouse growth factor for an out-secretory expression of EM2 and an adenovirus as a vector, which ultimately sustained the release of EM-2. After administration of the adenovirus in central nervous system, a sustained increase of EM2 level in the cerebral spinal fluid (CSF) was observed along with a reduction of morphine withdrawal syndrome. These findings suggest that the engineered EM2 gene delivered to the central nervous system could be a novel therapeutics for withdrawal syndrome in opioid dependent subjects.	[Wu, Fei-xiang; Di, Hui-ting; Sun, Yu-ming; Pan, Rui-rui; Yu, Wei-feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesiol & Intens Care, Shanghai 200438, Peoples R China; [Wu, Fei-xiang; Liu, Renyu] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [He, Yan] Dongfang Hosp, Dept Anesthesiol, Fujian 354200, Peoples R China	Naval Medical University; University of Pennsylvania; Pennsylvania Medicine	Yu, WF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesiol & Intens Care, Shanghai 200438, Peoples R China.; Liu, RY (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	ywf808@sohu.com; liur@uphs.upenn.edu	Yu, Wei/GZL-3831-2022		National Natural Science Foundation of China [30901403]; National Institutes of Health (NIH) [K08-GM-093115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM093115] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Natural Science Foundation of China (no. 30901403, PI, WFY); National Institutes of Health (NIH, K08-GM-093115) (PI: RYL).	BIAN D, 1995, NEUROREPORT, V6, P1981, DOI 10.1097/00001756-199510010-00007; Brunetti-Pierri N, 2008, GENE THER, V15, P553, DOI 10.1038/gt.2008.14; Cao HB, 2004, VIRAL IMMUNOL, V17, P327, DOI 10.1089/0882824041857111; Capasso A, 2002, PROG NEURO-PSYCHOPH, V26, P313, DOI 10.1016/S0278-5846(01)00274-3; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; FARRELL M, 1994, BMJ-BRIT MED J, V309, P997, DOI 10.1136/bmj.309.6960.997; Finegold AA, 1999, HUM GENE THER, V10, P1251, DOI 10.1089/10430349950018238; Fukunaga Y, 1998, JPN J PHARMACOL, V78, P455, DOI 10.1254/jjp.78.455; Gao Y, 2006, CELL MOL NEUROBIOL, V26, P357, DOI 10.1007/s10571-006-9050-z; Gartry CC, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-2; Gupta DS, 2007, J PHARMACOL EXP THER, V321, P635, DOI 10.1124/jpet.106.118505; Hau VS, 2002, J PHARM SCI-US, V91, P2140, DOI 10.1002/jps.10202; He Y, 2011, BRAIN RES, V1422, P13, DOI 10.1016/j.brainres.2011.07.063; Honda T, 2007, BIOORGAN MED CHEM, V15, P3883, DOI 10.1016/j.bmc.2007.03.009; Ishii K, 2000, EXP NEUROL, V166, P90, DOI 10.1006/exnr.2000.7491; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Karila L, 2008, AM J PSYCHIAT, V165, P400, DOI 10.1176/appi.ajp.2007.07071103; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Liu HM, 2007, BIOORGAN MED CHEM, V15, P1694, DOI 10.1016/j.bmc.2006.12.007; MALDONADO R, 1992, NEUROPHARMACOLOGY, V31, P1231, DOI 10.1016/0028-3908(92)90051-P; Manzoni P, 2006, DEVIANT BEHAV, V27, P351, DOI 10.1080/01639620600605705; March JC, 2006, EUR ADDICT RES, V12, P33, DOI 10.1159/000088581; Mata Marina, 2004, Curr Neurol Neurosci Rep, V4, P1, DOI 10.1007/s11910-004-0001-0; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Mayer P, 2006, PHARMACOGENET GENOM, V16, P1, DOI 10.1097/01.fpc.0000182781.87932.0d; Miller CL, 2006, SUBST USE MISUSE, V41, P199, DOI 10.1080/10826080500391795; Milligan ED, 1999, J NEUROSCI METH, V90, P81, DOI 10.1016/S0165-0270(99)00075-8; Muhammad AKMG, 2012, HUM GENE THER METHOD, V23, P271, DOI 10.1089/hgtb.2012.060; Okada Y, 2012, INT J MED CHEM, V2012, DOI 10.1155/2012/715123; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Peter A, 1999, J CHROMATOGR A, V846, P39, DOI 10.1016/S0021-9673(99)00146-6; Pohl M, 2001, EUR J PHARMACOL, V429, P39, DOI 10.1016/S0014-2999(01)01304-8; Przewlocka B, 1999, EUR J PHARMACOL, V367, P189, DOI 10.1016/S0014-2999(98)00956-X; Puntel M, 2013, TOXICOL APPL PHARM, V268, P318, DOI 10.1016/j.taap.2013.02.001; Robles E, 2002, J SUBST ABUSE TREAT, V23, P409, DOI 10.1016/S0740-5472(02)00274-X; St George JA, 2003, GENE THER, V10, P1135, DOI 10.1038/sj.gt.3302071; Stevens RC, 2003, JAIDS-J ACQ IMM DEF, V33, P650, DOI 10.1097/00126334-200308150-00016; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sugimoto-Watanabe A, 1999, JPN J PHARMACOL, V81, P264, DOI 10.1254/jjp.81.264; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; Tseng LF, 2000, J PHARMACOL EXP THER, V292, P576; Vigezzi P, 2006, J SUBST ABUSE TREAT, V31, P3, DOI 10.1016/j.jsat.2006.03.007; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; Wilson S P, 2000, Curr Rev Pain, V4, P445; Wood E, 2005, SUBST USE MISUSE, V40, P1153, DOI 10.1081/JA-200042287; Wu FX, 2012, INT J CLIN EXP PATHO, V5, P914; Wu FX, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406435; Xiao H, 2009, BRAIN RES, V1271, P74, DOI 10.1016/j.brainres.2009.02.084; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149877	10.1371/journal.pone.0149877	http://dx.doi.org/10.1371/journal.pone.0149877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003293	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400012
J	Ban, CX; Zhong, L; Wang, T; Zhu, MJ; Wang, JH; Zhang, ZL; Wang, Z; Su, N; Liu, YY; Shi, YC; Xiao, SF; Li, X				Ban, Chun-xia; Zhong, Li; Wang, Tao; Zhu, Min-jie; Wang, Jing-hua; Zhang, Zhen-lian; Wang, Zhe; Su, Ning; Liu, Yuan-yuan; Shi, Yan-chen; Xiao, Shi-fu; Li, Xia			Enhanced Diabetes Susceptibility in Community Dwelling Han Elders Carrying the Apolipoprotein E 3/3 Genotype	PLOS ONE			English	Article							E GENE POLYMORPHISM; CARDIOVASCULAR RISK; LIPID PROFILE; ASSOCIATION; DISEASE; ALLELE; APOE; POPULATION; PREVALENCE; MELLITUS	Despite Apolipoprotein E (ApoE) being one of the main apolipoproteins in the blood, the association between its genotype and the high cholesterol or blood glucose levels commonly seen in clinical practice is inconclusive. Such research is also lacking in the Han population. The aim of this study was to investigate the association between APOE genotype, diabetes, and plasma glucose and lipid levels. We included 243 community-dwelling elderly residents in this study. Participant APOE genotypes were assessed and were simultaneously tested for weight, height, blood glucose, triglycerides, cholesterol, and high- and low-density lipoprotein. In addition, gender, age, years of education, cognitive function, and medical history was recorded. Subjects were divided into 3 groups based on APOE genotype: APOE epsilon 2 group (epsilon 2/epsilon 2 and epsilon 2/3), APOE epsilon 3 group (epsilon 3/epsilon 3), and APOE epsilon 4 group (epsilon 2/epsilon 4, epsilon 3/epsilon 4 and epsilon 4/epsilon 4). Comparisons between groups were conducted for the incidence of diabetes, high blood pressure, and dementia, as well as for differences in body-mass index, fasting plasma glucose, and blood lipids. The APOE epsilon 3/epsilon 3 genotype exhibited the highest frequency (70.4%) among the subjects. Participants in the APOE epsilon 3 group demonstrated significantly higher levels of fasting plasma glucose than those in the APOE epsilon 2 and APOE epsilon 4 groups (P<0.05). The APOE epsilon 3 group had slightly higher abnormal fasting plasma glucose values than did the APOE epsilon 2 group (P = 0.065). Furthermore, the APOE3 genotype was significantly correlated with both fasting plasma glucose level and glucose abnormality (P<0.05) and trended toward statistically significant correlation with diabetes (P = 0.082). The correlation between APOE2 and low low-density lipoprotein levels also approached statistical significance (P = 0.052). Thus, elderly community dwelling residents of Han ethnicity carrying the APOE epsilon 3/epsilon 3 genotype might have higher plasma glucose levels and a higher occurrence of diabetes.	[Ban, Chun-xia; Wang, Tao; Zhu, Min-jie; Wang, Jing-hua; Su, Ning; Liu, Yuan-yuan; Shi, Yan-chen; Xiao, Shi-fu; Li, Xia] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychogeriatr, Shanghai 200030, Peoples R China; [Zhong, Li; Zhang, Zhen-lian; Wang, Zhe] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Shanghai Jiao Tong University; Xiamen University	Xiao, SF; Li, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychogeriatr, Shanghai 200030, Peoples R China.	xiaoshifu@msn.com; ja_1023@aliyun.com		Zhong, Li/0000-0003-3815-6484	National Key Project for IND [2012ZX09303-303]; National Natural Science Foundation of China [81101007]; Shanghai Science & Technology Committee [15411961400]	National Key Project for IND; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Committee(Shanghai Science & Technology Committee)	This work was financially supported mostly by the grants from National Key Project for IND (No. 2012ZX09303-303, SFX, http://www.most.gov.cn/), partially supported from National Natural Science Foundation of China (No. 81101007, XL, http://www.nsfc.gov.cn/) and the Shanghai Science & Technology Committee (No. 15411961400, XL, http://www.stcsm.gov.cn/).	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; de Freitas RGA, 2015, ARQ BRAS CARDIOL, V104, P468, DOI 10.5935/abc.20150036; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; Bojar I, 2015, ANN AGR ENV MED, V22, P313, DOI 10.5604/12321966.1152086; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Chen XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143157; Colagiuri S, 2005, DIABETOLOGIA, V48, P1459, DOI 10.1007/s00125-005-1843-y; Duman BS, 2004, DIABETES NUTR METAB, V17, P267; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Hu G, 2013, EUR J PREV CARDIOL, V20, P89, DOI 10.1177/1741826711428242; Igbavboa U, 2005, J NEUROL SCI, V229, P225, DOI 10.1016/j.jns.2004.11.037; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Lin SK, 2004, ANN CLIN LAB SCI, V34, P443; Linhartova PB, 2015, ARCH ORAL BIOL, V60, P456, DOI 10.1016/j.archoralbio.2014.10.003; Mazzotti DR, 2014, GENE, V535, P370, DOI 10.1016/j.gene.2013.11.040; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; RALL SC, 1992, J INTERN MED, V231, P653, DOI 10.1111/j.1365-2796.1992.tb01254.x; Sapkota B, 2015, J DIABETES COMPLICAT, V29, P1191, DOI 10.1016/j.jdiacomp.2015.07.025; Scuteri A, 2005, AM J PHYSIOL-ENDOC M, V289, pE322, DOI 10.1152/ajpendo.00408.2004; Serrano-Pozo A, 2015, ANN NEUROL, V77, P917, DOI 10.1002/ana.24369; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SIEST G, 1995, CLIN CHEM, V41, P1068; Tao QQ, 2014, CLIN INTERV AGING, V9, P1063, DOI 10.2147/CIA.S62554; Wang H, 2011, DIABETES CARE, V34, P1952, DOI 10.2337/dc11-0329; Windler E, 2005, ATHEROSCLEROSIS SUPP, V6, P11, DOI 10.1016/j.atherosclerosissup.2005.06.003; Xiao Shifu, 2013, Shanghai Arch Psychiatry, V25, P91, DOI 10.3969/j.issn.1002-0829.2013.02.005; Yousuf FA, 2015, PAK J PHARM SCI, V28, P1439; Zhan XH, 2015, EXP THER MED, V9, P469, DOI 10.3892/etm.2014.2097; Zheng YX, 2009, CLIN CARDIOL, V32, P491, DOI 10.1002/clc.20605; Zhu H, 2015, MINERVA CARDIOANGIOL	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151336	10.1371/journal.pone.0151336	http://dx.doi.org/10.1371/journal.pone.0151336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998902	Green Published, gold			2022-12-27	WOS:000372694700032
J	Farooqi, A; Adamsson, M; Serenius, F; Hagglof, B				Farooqi, A.; Adamsson, M.; Serenius, F.; Hagglof, B.			Executive Functioning and Learning Skills of Adolescent Children Born at Fewer than 26 Weeks of Gestation	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXTREMELY PRETERM CHILDREN; ACTIVE PERINATAL MANAGEMENT; SCHOOL-AGE OUTCOMES; FTF 5; MATHEMATICS DIFFICULTIES; ACADEMIC ATTAINMENT; PROCESSING SPEED; 15 QUESTIONNAIRE; WORKING-MEMORY	Aims To assess the cognitive and behavioral aspects of executive functioning (EF) and learning skills in extremely preterm (EPT) children compared with term control children aged 10 to 15 years. Methods A total of 132 of 134 (98% of all eligible survivors) EPT children born at the 2 Swedish regional tertiary care centers from 1992 to 1998 (mean age = 12 years, mean birth weight = 718 g, and mean gestational age = 24.4 weeks) and 103 matched term controls were assessed. General intelligence was assessed using the Wechsler Intelligence Scale for Children (WISC-III-R), and cognitive aspects of EF were analyzed using EF-sensitive sub-scales of the WISC-III-R and Tower test of the Delis-Kaplan Executive Function Scale (D-KEFS). Behaviors related to EF and learning skills were assessed using the Five to Fifteen questionnaire, which is a validated parent and teacher instrument. Academic performance in school was assessed by teachers' responses on Achenbach's Teachers Report Form. Analyses performed included multivariate analyses of covariance (ANCOVA and MANCOVA) and logistic regression analyses. Results The EPT children displayed significant deficits in cognitive aspects of EF compared with the controls, exhibiting decreases on the order of 0.9 SD to 1.2 SD for tasks of verbal conceptual reasoning, verbal and non-verbal working memory, processing speed and planning ability (P < 0.001 for all). After excluding the children with major neurosensory impairment (NSI) or a Full Scale intelligence quotient (FSIQ) of < 70, significant differences were observed on all tests. Compared with controls, parents and teachers of EPT children reported significantly more EF-related behavioral problems. MANCOVA of teacher-reported learning skills in children with FSIQ > 70 and without major NSI revealed no interactions, but significant main effects were observed for the behavioral composite executive function score, group status (EPT vs control) and FSIQ, for which all effect sizes were medium to large. The corresponding findings of MANCOVA of the parent-reported learning skills were very similar. According to the teachers' ratings, the EPT children were less well adjusted to the school environment. Conclusion EPT children born in the 1990s who received active perinatal care are at an increased risk of executive dysfunction, even after excluding children with significant neurodevelopmental disabilities. Even mild to moderate executive dysfunctions has a significant impact on learning skills. These findings suggest the need for timely interventions that address specific cognitive vulnerabilities and executive dysfunctions.	[Farooqi, A.; Adamsson, M.] Umea Univ, Inst Clin Sci, Pediat, Umea, Sweden; [Serenius, F.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Hagglof, B.] Umea Univ, Inst Clin Sci Child & Adolescent Psychiat, Umea, Sweden	Umea University; Uppsala University; Umea University	Farooqi, A (corresponding author), Umea Univ, Inst Clin Sci, Pediat, Umea, Sweden.	aijaz.farooqi@umu.se			ALF - Vasterbotten; Umea univesrity [ALF-VLL 67971]; Vastebotten county council, Sweden [ALF-VLL 67971]; Jerringfonden	ALF - Vasterbotten; Umea univesrity; Vastebotten county council, Sweden; Jerringfonden	The work was was funded by the ALF - Vasterbotten, jointly funded by Umea univesrity and Vastebotten county council, Sweden, grant no. ALF-VLL 67971 (agreement concerning reasearch and education of doctors), and Jerringfonden. The funders had no role in study design, data collection and analysis, or decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2012, DEV MED CHILD NEUROL, V54, P247, DOI 10.1111/j.1469-8749.2011.04150.x; Aarnoudse-Moens CSH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055994; Achenbach T.M., 1991, MANUAL YOUTH SELF RE; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anderson PJ, 2008, SEMIN PERINATOL, V32, P51, DOI 10.1053/j.semperi.2007.12.009; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; [Anonymous], 2004, EUR CHILD ADOLESC S3, V13, pIII/50; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Berntsson L, 2000, THESIS NORDIC SCH PU; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bohm B, 2002, DEV MED CHILD NEUROL, V44, P508; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crijnen AAM, 1999, AM J PSYCHIAT, V156, P569; Delis C. D., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Farooqi A, 2013, ACTA PAEDIATR, V102, P625, DOI 10.1111/apa.12219; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Guarini A, 2006, WORLD J PEDIATR, V2, P102; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Holsti A, 1990, CHRONIC CONDIT UNPUB; Holsti A, NEURODEVELOPME UNPUB; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Hutchinson EA, 2013, PEDIATRICS, V131, pE1053, DOI 10.1542/peds.2012-2311; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2011, DEV NEUROPSYCHOL, V36, P74, DOI 10.1080/87565641.2011.540541; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Kadesjo B, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-3002-2; Kohen DE, 1997, J DEV BEHAV PEDIATR, V18, P295, DOI 10.1097/00004703-199710000-00003; Korkman M, 2004, EUR CHILD ADOLES PSY, V13, P31, DOI 10.1007/s00787-004-3005-z; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Litt JS, 2012, ACTA PAEDIATR, V101, P1240, DOI 10.1111/j.1651-2227.2012.02790.x; Locascio G, 2010, J LEARN DISABIL-US, V43, P441, DOI 10.1177/0022219409355476; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moore Tamanna, 2012, BMJ, V345, pe7961, DOI 10.1136/bmj.e7961; Mulder H, 2011, BRIT J EDUC PSYCHOL, V81, P147, DOI 10.1348/000709910X505527; Mulder H, 2010, ARCH DIS CHILD-FETAL, V95, pF267, DOI 10.1136/adc.2009.167965; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Rubinsten O, 2009, TRENDS COGN SCI, V13, P92, DOI 10.1016/j.tics.2008.11.002; Serenius F, 2004, ACTA PAEDIATR, V93, P1090, DOI [10.1111/j.1651-2227.2004.tb02722.x, 10.1080/08035250410027760]; Serenius F, 2004, ACTA PAEDIATR, V93, P1081, DOI [10.1080/08035250410027751, 10.1111/j.1651-2227.2004.tb02721.x]; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Simms V, 2013, ARCH DIS CHILD-FETAL, V98, pF457, DOI 10.1136/archdischild-2013-303777; Simms V, 2013, PEDIATR RES, V73, P236, DOI 10.1038/pr.2012.157; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 2002, CHILD NEUROPSYCHOL, V8, P163, DOI 10.1076/chin.8.3.163.13500; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; Thuy ML, 2011, PEDIATRICS, V127, pE639, DOI 10.1542/peds.2010-1421; Trillingsgaard A, 2004, EUR CHILD ADOLES PSY, V13, P39, DOI 10.1007/s00787-004-3006-y; Wechsler D., 1999, WECHSLER INTELLIGENC, V1	63	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151819	10.1371/journal.pone.0151819	http://dx.doi.org/10.1371/journal.pone.0151819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999522	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700068
J	Jokela, M; Huovinen, S; Raheem, O; Lindfors, M; Palmio, J; Penttila, S; Udd, B				Jokela, Manu; Huovinen, Sanna; Raheem, Olayinka; Lindfors, Mikaela; Palmio, Johanna; Penttila, Sini; Udd, Bjarne			Distinct Muscle Biopsy Findings in Genetically Defined Adult-Onset Motor Neuron Disorders	PLOS ONE			English	Article								The objective of this study was to characterize and compare muscle histopathological findings in 3 different genetic motor neuron disorders. We retrospectively re-assessed muscle biopsy findings in 23 patients with autosomal dominant lower motor neuron disease caused by p.G66V mutation in CHCHD10 (SMAJ), 10 X-linked spinal and bulbar muscular atrophy (SBMA) and 11 autosomal dominant c9orf72-mutated amyotrophic lateral sclerosis (c9ALS) patients. Distinct large fiber type grouping consisting of non-atrophic type IIA muscle fibers were 100% specific for the late-onset spinal muscular atrophies (SMAJ and SBMA) and were never observed in c9ALS. Common, but less specific findings included small groups of highly atrophic rounded type IIA fibers in SMAJ/SBMA, whereas in c9ALS, small group atrophies consisting of small-caliber angular fibers involving both fiber types were more characteristic. We also show that in the 2 slowly progressive motor neuron disorders (SMAJ and SBMA) the initial neurogenic features are often confused with considerable secondary "myopathic" changes at later disease stages, such as rimmed vacuoles, myofibrillar aggregates and numerous fibers reactive for fetal myosin heavy chain (dMyHC) antibodies. Based on our findings, muscle biopsy may be valuable in the diagnostic work-up of suspected motor neuron disorders in order to avoid a false ALS diagnosis in patients without clear findings of upper motor neuron lesions.	[Jokela, Manu] Turku Univ Hosp, Div Clin Neurosci, FIN-20520 Turku, Finland; [Jokela, Manu] Univ Turku, Turku, Finland; [Jokela, Manu; Raheem, Olayinka; Lindfors, Mikaela; Palmio, Johanna; Penttila, Sini; Udd, Bjarne] Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Ctr, Tampere, Finland; [Jokela, Manu; Raheem, Olayinka; Lindfors, Mikaela; Palmio, Johanna; Penttila, Sini; Udd, Bjarne] Univ Tampere, FIN-33101 Tampere, Finland; [Huovinen, Sanna] Tampere Univ Hosp, Dept Pathol, Fimlab Labs, Tampere, Finland; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa, Finland; [Udd, Bjarne] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, Helsinki, Finland	University of Turku; University of Turku; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Vaasa Central Hospital; University of Helsinki	Jokela, M (corresponding author), Turku Univ Hosp, Div Clin Neurosci, FIN-20520 Turku, Finland.; Jokela, M (corresponding author), Univ Turku, Turku, Finland.; Jokela, M (corresponding author), Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Ctr, Tampere, Finland.	mejoke@utu.fi		Huovinen, Sanna/0000-0001-7659-7921	Folkhalsan Genetic Institute; Tampere University Hospital	Folkhalsan Genetic Institute; Tampere University Hospital	The study was funded by research grants from Folkhalsan Genetic Institute and Tampere University Hospital Research Funds (BU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloh RH, 2007, MUSCLE NERVE, V36, P107, DOI 10.1002/mus.20755; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Malena A, 2013, ACTA NEUROPATHOL, V126, P109, DOI 10.1007/s00401-013-1122-9; Mascorro J, 2007, METHOD MOL BIOL, P19; Palmio J, 2015, J NEUROL NE IN PRESS; Penttila S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319; Penttila S, 2014, NEUROMUSCULAR DISORD, V24, P259, DOI 10.1016/j.nmd.2013.11.010; Raheem O, 2010, ACTA NEUROPATHOL, V119, P495, DOI 10.1007/s00401-010-0643-8; Vogel H, 2013, MUSCLE DISEASE: PATHOLOGY AND GENETICS, 2ND EDITION, P68	11	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151376	10.1371/journal.pone.0151376	http://dx.doi.org/10.1371/journal.pone.0151376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999347	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700036
J	Tuand, K; Stijnen, P; Volders, K; Declercq, J; Nuytens, K; Meulemans, S; Creemers, J				Tuand, Krizia; Stijnen, Pieter; Volders, Karolien; Declercq, Jeroen; Nuytens, Kim; Meulemans, Sandra; Creemers, John			Nuclear Localization of the Autism Candidate Gene Neurobeachin and Functional Interaction with the NOTCH1 Intracellular Domain Indicate a Role in Regulating Transcription	PLOS ONE			English	Article							KINASE ANCHOR PROTEIN; COPY NUMBER VARIANTS; AGGREGATED PROTEINS; BEACH-DOMAIN; MUTATIONS; HOMOLOG; EXPRESSION; RUGOSE; INVOLVEMENT; TRAFFICKING	Background Neurobeachin (NBEA) is an autism spectrum disorders (ASD) candidate gene. NBEA deficiency affects regulated secretion, receptor trafficking, synaptic architecture and protein kinase A (PKA)-mediated phosphorylation. NBEA is a large multidomain scaffolding protein. From N-to C-terminus, NBEA has a concanavalin A-like lectin domain flanked by armadillo repeats (ACA), an A-kinase anchoring protein domain that can bind to PKA, a domain of unknown function (DUF1088) and a BEACH domain, preceded by a pleckstrin homology-like domain and followed by WD40 repeats (PBW). Although most of these domains mediate protein-protein interactions, no interaction screen has yet been performed. Methods Yeast two-hybrid screens with the ACA and PBW domain modules of NBEA gave a list of interaction partners, which were analyzed for Gene Ontology (GO) enrichment. Neuro-2a cells were used for confocal microscopy and nuclear extraction analysis. NOTCH-mediated transcription was studied with luciferase reporter assays and qRT-PCR, combined with NBEA knockdown or overexpression. Results Both domain modules showed a GO enrichment for the nucleus. PBW almost exclusively interacted with transcription regulators, while ACA interacted with a number of PKA substrates. NBEA was partially localized in the nucleus of Neuro-2a cells, albeit much less than in the cytoplasm. A nuclear localization signal was found in the DUF1088 domain, which was shown to contribute to the nuclear localization of an EGFP-DPBW fusion protein. Yeast two-hybrid identified the Notch1 intracellular domain as a physical interactor of the PBW domain and a role for NBEA as a negative regulator in Notch-mediated transcription was demonstrated. Conclusion Defining novel interaction partners of conserved NBEA domain modules identified a role for NBEA as transcriptional regulator in the nucleus. The physical interaction of NBEA with NOTCH1 is most relevant for ASD pathogenesis because NOTCH signaling is essential for neural development.	[Tuand, Krizia; Stijnen, Pieter; Volders, Karolien; Declercq, Jeroen; Nuytens, Kim; Meulemans, Sandra; Creemers, John] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Tuand, Krizia; Volders, Karolien; Nuytens, Kim] Katholieke Univ Leuven, Leuven Autism Res Consortium LAuRes, Leuven, Belgium	KU Leuven; KU Leuven	Creemers, J (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium.	john.creemers@med.kuleuven.be	Tuand, Krizia/AAF-7888-2019; Tuand, Krizia/E-1657-2015	Tuand, Krizia/0000-0003-2670-5415; Tuand, Krizia/0000-0003-2670-5415; stijnen, pieter/0000-0002-3047-6902	Research Fund - Flanders (FWO) [1187213N]; Steunfonds Marguerite-Marie Delacroix	Research Fund - Flanders (FWO)(FWO); Steunfonds Marguerite-Marie Delacroix	The work of Krizia Tuand is supported by the Research Fund - Flanders (FWO; 1187213N; www.fwo.be) and the "Steunfonds Marguerite-Marie Delacroix" (www.fondsmmdelacroix.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Barrett S, 1999, AM J MED GENET, V88, P609; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Burgess A, 2009, BIOINFORMATICS, V25, P1219, DOI 10.1093/bioinformatics/btp151; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Correia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112399; Cullinane AR, 2013, TRAFFIC, V14, P749, DOI 10.1111/tra.12069; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; del Pino I, 2011, BIOCHEM BIOPH RES CO, V412, P435, DOI 10.1016/j.bbrc.2011.07.110; Farzana F, 2016, MOL NEUROBIOL, V53, P2112, DOI 10.1007/s12035-015-9164-8; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fromont-Racine M, 1997, NAT GENET, V15, P57; Gadad Bharathi S, 2013, Autism Res Treat, V2013, P731935, DOI 10.1155/2013/731935; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Garcia-Cazorla A, 2014, HUM MUTAT, V35, P470, DOI 10.1002/humu.22513; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lauks J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039420; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Miller AC, 2015, CURR BIOL, V25, P16, DOI 10.1016/j.cub.2014.10.071; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Nair R, 2013, J CELL BIOL, V200, P61, DOI 10.1083/jcb.201207113; Nakahara J, 2009, J CLIN INVEST, V119, P169, DOI 10.1172/JCI35440; Niesmann K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1565; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Nuytens K, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-43; Nuytens K, 2013, NEUROBIOL DIS, V51, P144, DOI 10.1016/j.nbd.2012.11.004; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; Orosco LA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5692; Reddy KS, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-3; Reiser M, 2014, AUSTIN J CLIN IMMUNO, V1, P1; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber SL, 2002, GENESIS, V33, P141, DOI 10.1002/gene.10102; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Shamloula HK, 2002, GENETICS, V161, P693; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith M, 2002, CYTOGENET GENOME RES, V98, P233, DOI 10.1159/000071040; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Volders K, 2012, J NEUROSCI, V32, P15193, DOI 10.1523/JNEUROSCI.6424-11.2012; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang XL, 2000, J NEUROSCI, V20, P8551; Wech I, 2005, CELL DEATH DIFFER, V12, P145, DOI 10.1038/sj.cdd.4401538; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Yamamoto A, 2011, AUTOPHAGY, V7, P346, DOI 10.4161/auto.7.3.14234; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zeidan-Chulia F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.227	75	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151954	10.1371/journal.pone.0151954	http://dx.doi.org/10.1371/journal.pone.0151954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999814	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700088
J	Chandramouleeswaran, PM; Shen, DW; Lee, AJ; Benitez, A; Dods, K; Gambanga, F; Wilkins, BJ; Merves, J; Noah, Y; Toltzis, S; Yearley, JH; Spergel, JM; Nakagawa, H; Malefyt, RD; Muir, AB; Wang, ML				Chandramouleeswaran, Prasanna M.; Shen, Dawen; Lee, Anna J.; Benitez, Alain; Dods, Kara; Gambanga, Fiona; Wilkins, Benjamin J.; Merves, Jamie; Noah, Yuliana; Toltzis, Sarit; Yearley, Jennifer H.; Spergel, Jonathan M.; Nakagawa, Hiroshi; Malefyt, Rene deWaal; Muir, Amanda B.; Wang, Mei-Lun			Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE)	PLOS ONE			English	Article							ORAL VISCOUS BUDESONIDE; SQUAMOUS DIFFERENTIATION; ELEMENTAL DIET; MOUSE MODELS; EXPRESSION; INFLAMMATION; ASTHMA; TOLERANCE; CHILDREN; FLUTICASONE	Eosinophilic esophagitis (EoE) is a chronic Th2 and food antigen-mediated disease characterized by esophageal eosinophilic infiltration. Thymic stromal lymphopoetin (TSLP), an epithelial derived cytokine which bridges innate and Th2-type adaptive immune responses in other allergic conditions, is overexpressed in esophageal biopsies of EoE subjects. However, the triggers of TSLP expression in the esophageal epithelium are unknown. The objective of the current study was to characterize TSLP expression in human esophageal epithelium in EoE in vivo and to determine the role of food antigens upon epithelial TSLP expression in vitro. Using immunohistochemistry (IHC), we localized TSLP in esophageal biopsies of active EoE (>= 15 eos/hpf), inactive EoE (<15 eos/hpf) and non-EoE control subjects, and found that TSLP expression was restricted to the differentiated suprabasal layer of the epithelium in actively inflamed EoE biopsies. Consistent with these results in vivo, inducible TSLP protein secretion was higher in CaCl2 differentiated telomerase-immortalized esophageal epithelial cells (EPC2-hTERT) compared to undifferentiated cells of the basal phenotype, following stimulation with the TLR3 ligand poly(I:C). To determine whether food antigens could directly induce epithelial TSLP secretion, differentiated and undifferentiated primary esophageal epithelial cells from EoE and non-EoE subjects were challenged with food antigens clinically relevant to EoE: Chicken egg ovalbumin (OVA), wheat, and milk proteins beta-lactoglobulin (blg) and beta-casein. Food antigens failed to induce TSLP secretion by undifferentiated cells; in contrast, only OVA induced TSLP secretion in differentiated epithelial cells from both EoE and control cell lines, an effect abolished by budesonide and NF-kappa b inhibition. Together, our study shows that specific food antigens can trigger innate immune mediated esophageal TSLP secretion, suggesting that esophageal epithelial cells at the barrier surface may play a significant role in the pathogenesis of EoE by regulating TSLP expression.	[Chandramouleeswaran, Prasanna M.; Shen, Dawen; Lee, Anna J.; Benitez, Alain; Dods, Kara; Gambanga, Fiona; Merves, Jamie; Noah, Yuliana; Toltzis, Sarit; Muir, Amanda B.; Wang, Mei-Lun] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Merves, Jamie; Yearley, Jennifer H.; Muir, Amanda B.; Wang, Mei-Lun] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wilkins, Benjamin J.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yearley, Jennifer H.; Malefyt, Rene deWaal] Merck Res Labs, Dept Immunol, Palo Alto, CA 94304 USA; [Spergel, Jonathan M.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Nakagawa, Hiroshi] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Merck & Company; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Muir, AB; Wang, ML (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.; Muir, AB; Wang, ML (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	muira@email.chop.edu; wangm@email.chop.edu		de Waal Malefyt, Rene/0000-0002-2663-383X; Spergel, Jonathan/0000-0002-4658-5353	NIH [R01 DK087789, R01 DK087789-02S1, 1K08DK106444-01]; Abbott Nutrition United States [1013]; AGA Donald and June Castell Award; Molecular Pathology and Imaging Core of the National Institute of Diabetes and Digestive and Kidney Diseases Center Grant [DK-50306]; Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS [U54 AI117804]; NCATS; NIAID; NIDDK;  [K08 DK099379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, K08DK099379, K08DK106444, R01DK087789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Nutrition United States; AGA Donald and June Castell Award; Molecular Pathology and Imaging Core of the National Institute of Diabetes and Digestive and Kidney Diseases Center Grant; Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 DK087789 (to MLW and JMS) and R01 DK087789-02S1 (to MLW); Abbott Nutrition United States (Project 1013, to MLW); ABM is supported by NIH 1K08DK106444-01 and the AGA Donald and June Castell Award; BJW is supported by K08 DK099379. The work is also supported by the Molecular Pathology and Imaging Core of the National Institute of Diabetes and Digestive and Kidney Diseases Center Grant DK-50306. In addition this study is supported in part by the U54 AI117804, which is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS, and is funded through collaboration between NCATS, NIAID and NIDDK, which have collectively resulted in the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2007, AM J GASTROENTEROL, V102, P2271, DOI 10.1111/j.1572-0241.2007.01379.x; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Arora AS, 2004, CLIN GASTROENTEROL H, V2, P523, DOI 10.1016/S1542-3565(04)00236-8; Biancheri P, 2015, GUT BMJ PUBLISHING G, DOI [10. 1136/g ugn1-2014-308876, DOI 10.1136/G]; Birmingham JM, 2013, J ASTHMA, V50, P122, DOI 10.3109/02770903.2012.753455; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Blazquez AB, 2010, GASTROENTEROLOGY, V139, P1301, DOI 10.1053/j.gastro.2010.06.055; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cornelissen LH, 2007, SKIN RES TECHNOL, V13, P369, DOI 10.1111/j.1600-0846.2007.00239.x; Dohil R, 2010, GASTROENTEROLOGY, V139, P418, DOI 10.1053/j.gastro.2010.05.001; Ek A, 1999, ALLERGY, V54, P691, DOI 10.1034/j.1398-9995.1999.00087.x; Foerg C, 2007, PHARM RES-DORDR, V24, P628, DOI 10.1007/s11095-006-9212-1; Fornasa G, 2015, J ALLERGY CLIN IMMUN, V136, P413, DOI 10.1016/j.jaci.2015.04.011; Gulati N, 2013, J INVEST DERMATOL, V133, P2640, DOI 10.1038/jid.2013.190; Harada H, 2003, MOL CANCER RES, V1, P729; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; JETTEN AM, 1989, EXP CELL RES, V182, P622, DOI 10.1016/0014-4827(89)90264-4; Jyonouchi S, 2014, CLIN EXP ALLERGY, V44, P58, DOI 10.1111/cea.12201; Kagalwalla AF, 2006, CLIN GASTROENTEROL H, V4, P1097, DOI 10.1016/j.cgh.2006.05.026; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; KASTURI L, 1993, EXP CELL RES, V205, P84, DOI 10.1006/excr.1993.1061; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li DQ, 2011, J ALLERGY CLIN IMMUN, V128, P1318, DOI 10.1016/j.jaci.2011.06.041; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lim DM, 2009, AM J PHYSIOL-GASTR L, V297, pG1172, DOI 10.1152/ajpgi.00065.2009; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Markowitz JE, 2003, AM J GASTROENTEROL, V98, P777, DOI 10.1111/j.1572-0241.2003.07390.x; Masterson JC, 2014, GUT, V63, P43, DOI 10.1136/gutjnl-2012-303631; Matsuda A, 2010, INVEST OPHTH VIS SCI, V51, P151, DOI 10.1167/iovs.09-4183; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Muir AB, 2013, EXP CELL RES, V319, P850, DOI 10.1016/j.yexcr.2012.12.002; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Peterson KA, 2013, AM J GASTROENTEROL, V108, P759, DOI 10.1038/ajg.2012.468; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Smolinski KN, 2002, GENOMICS, V79, P875, DOI 10.1006/geno.2002.6775; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Tang MLK, 2013, PEDIAT ALLERG IMM-UK, V24, P512, DOI 10.1111/pai.12100; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Teitelbaum JE, 2002, GASTROENTEROLOGY, V122, P1216, DOI 10.1053/gast.2002.32998; Tunis MC, 2012, J ALLERGY CLIN IMMUN, V130, P705, DOI 10.1016/j.jaci.2012.04.011; Vu AT, 2011, J INVEST DERMATOL, V131, P2205, DOI 10.1038/jid.2011.185; Wang XQ, 2013, J INFLAMM RES, V6, P109, DOI 10.2147/JIR.S43736; Wangi JK, 2008, CELL MOL IMMUNOL, V5, P99, DOI 10.1038/cmi.2008.12; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang F, 2011, CLIN EXP IMMUNOL, V164, P256, DOI 10.1111/j.1365-2249.2011.04328.x; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	63	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150968	10.1371/journal.pone.0150968	http://dx.doi.org/10.1371/journal.pone.0150968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992000	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800039
J	Chen, WP; Li, QK; Fan, YT; Li, DC; Jiang, L; Qiu, PN; Tang, LL				Chen, Weiping; Li, Qiken; Fan, Yongtian; Li, Dechuan; Jiang, Lai; Qiu, Pengnian; Tang, Lilong			Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique	PLOS ONE			English	Article							RECTOSIGMOID CARCINOMA; COLORECTAL-CANCER; SURGERY; COLECTOMY; SURVIVAL; BENEFIT; SAFETY; TRIAL; COLON; TIME	Background Laparoscopic sphincter-preserving low anterior resection for rectal cancer is a surgery demanding great skill. Immense efforts have been devoted to identifying factors that can predict operative difficulty, but the results are inconsistent. Objective Our study was conducted to screen patients' factors to build models for predicting the operative difficulty using well controlled data. Method We retrospectively reviewed records of 199 consecutive patients who had rectal cancers 5-8 cm from the anal verge. All underwent laparoscopic sphincter-preserving low anterior resections with total mesorectal excision (TME) and double stapling technique (DST). Data of 155 patients from one surgeon were utilized to build models to predict standardized end-points (operative time, blood loss) and postoperative morbidity. Data of 44 patients from other surgeons were used to test the predictability of the built models. Results Our results showed prior abdominal surgery, preoperative chemoradiotherapy, tumor distance to anal verge, interspinous distance, and BMI were predictors for the standardized operative times. Gender and tumor maximum diameter were related to the standardized blood loss. Temporary diversion and tumor diameter were predictors for postoperative morbidity. The model constructed for the operative time demonstrated excellent predictability for patients from different surgeons. Conclusions With a well-controlled patient population, we have built a predictable model to estimate operative difficulty. The standardized operative time will make it possible to significantly increase sample size and build more reliable models to predict operative difficulty for clinical use.	[Chen, Weiping; Li, Qiken; Fan, Yongtian; Li, Dechuan; Jiang, Lai; Qiu, Pengnian] Zhejiang Canc Hosp, Dept Colorectal Surg, Hangzhou 310022, Zhejiang, Peoples R China; [Tang, Lilong] Zhejiang Canc Hosp, Dept Radiol, Hangzhou 310022, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Chen, WP (corresponding author), Zhejiang Canc Hosp, Dept Colorectal Surg, Hangzhou 310022, Zhejiang, Peoples R China.	cwp819@yahoo.com	Chen, Wei/GZK-7348-2022		Zhejiang Medical Technology and Education [2011RCA010]	Zhejiang Medical Technology and Education	This work is supported by Zhejiang Medical Technology and Education (2011RCA010).; We greatly appreciate critical data interpretation and manuscript review by Dr. Shihua Wang of Departments of Cancer Biology, Wake Forest University School of Medicine. We are also grateful to Ms. Kristin Best for her proof reading of this manuscript. This work is supported by Zhejiang Medical Technology and Education (2011RCA010).	Akagi T, 2012, SURG LAPARO ENDO PER, V22, P52, DOI 10.1097/SLE.0b013e31824019fc; Akiyoshi T, 2009, SURGERY, V146, P483, DOI 10.1016/j.surg.2009.03.030; Akiyoshi T, 2009, J GASTROINTEST SURG, V13, P521, DOI 10.1007/s11605-008-0744-z; American Cancer Society, 2015, CANC FACTS FIG 2015; American Cancer Society, 2011, GLOB CANC FACTS FIG; Baik SH, 2008, ANN SURG ONCOL, V15, P721, DOI 10.1245/s10434-007-9706-z; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Denost Q, 2013, COLORECTAL DIS, V15, P463, DOI 10.1111/codi.12026; Denost Q, 2012, SURG ENDOSC, V26, P1878, DOI 10.1007/s00464-011-2119-x; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Franko Jan, 2006, JSLS, V10, P169; Gu J, 2006, DIS COLON RECTUM, V49, P1517, DOI 10.1007/s10350-006-0665-4; Hamabe A, 2014, J GASTROINTEST SURG, V18, P977, DOI 10.1007/s11605-014-2463-y; Havel PJ, 1996, NAT MED, V2, P949, DOI 10.1038/nm0996-949b; Ishihara S, 2014, TECH COLOPROCTOL, V18, P247, DOI 10.1007/s10151-013-1048-1; Ishihara S, 2011, HEPATO-GASTROENTEROL, V58, P756; Jin KT, 2014, INT J CLIN EXP MED, V7, P4635; Killeen T, 2010, SURG ENDOSC, V24, P2974, DOI 10.1007/s00464-010-1075-1; KOTANI K, 1994, INT J OBESITY, V18, P207; Kuroyanagi H, 2008, SURG ENDOSC, V22, P557, DOI 10.1007/s00464-007-9626-9; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Laurent C, 2009, ANN SURG, V250, P54, DOI 10.1097/SLA.0b013e3181ad6511; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Liu SZ, 2015, CHINESE J CANCER RES, V27, P22, DOI 10.3978/j.issn.1000-9604.2015.02.01; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nussbaum DP, 2015, J GASTROINTEST SURG, V19, P124, DOI 10.1007/s11605-014-2614-1; Ogiso S, 2011, SURG ENDOSC, V25, P1907, DOI 10.1007/s00464-010-1485-0; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Petrelli NJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju376; Poylin V, 2014, ANN SURG ONCOL, V21, P3587, DOI 10.1245/s10434-014-3703-9; Seki Y, 2007, SURG ENDOSC, V21, P929, DOI 10.1007/s00464-006-9084-9; Targarona EM, 2008, ANN SURG, V247, P642, DOI 10.1097/SLA.0b013e3181612c6a; Wang C, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-44; Yeh CY, 2005, ANN SURG, V241, P9, DOI 10.1097/01.sla.0000150067.99651.6a; Yeo H, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju362	35	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151773	10.1371/journal.pone.0151773	http://dx.doi.org/10.1371/journal.pone.0151773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992004	Green Submitted, gold, Green Published			2022-12-27	WOS:000372582800099
J	Cova, I; Clerici, F; Rossi, A; Cucumo, V; Ghiretti, R; Maggiore, L; Pomati, S; Galimberti, D; Scarpini, E; Mariani, C; Caracciolo, B				Cova, Ilaria; Clerici, Francesca; Rossi, Annalia; Cucumo, Valentina; Ghiretti, Roberta; Maggiore, Laura; Pomati, Simone; Galimberti, Daniela; Scarpini, Elio; Mariani, Claudio; Caracciolo, Barbara			Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease	PLOS ONE			English	Article							BODY-MASS INDEX; RATING-SCALE; DEMENTIA; DIAGNOSIS; CONSENSUS; ILLNESS; LEPTIN	Background Weight loss is common in people with Alzheimer's disease (AD) and it could be a marker of impending AD in Mild Cognitive Impairment (MCI) and improve prognostic accuracy, if accelerated progression to AD would be shown. Aims To assess weight loss as a predictor of dementia and AD in MCI. Methods One hundred twenty-five subjects with MCI (age 73.8 +/- 7.1 years) were followed for an average of 4 years. Two weight measurements were carried out at a minimum time interval of one year. Dementia was defined according to DSM-IV criteria and AD according to NINCDS-ADRDA criteria. Weight loss was defined as a >= 4% decrease in baseline weight. Results Fifty-three (42.4%) MCI progressed to dementia, which was of the AD-type in half of the cases. Weight loss was associated with a 3.4-fold increased risk of dementia (95% CI = 1.5-6.9) and a 3.2-fold increased risk of AD (95% CI = 1.4-8.3). In terms of years lived without disease, weight loss was associated to a 2.3 and 2.5 years earlier onset of dementia and AD. Conclusions Accelerated progression towards dementia and AD is expected when weight loss is observed in MCI patients. Weight should be closely monitored in elderly with mild cognitive impairment.	[Cova, Ilaria; Clerici, Francesca; Rossi, Annalia; Cucumo, Valentina; Ghiretti, Roberta; Maggiore, Laura; Pomati, Simone; Mariani, Claudio] Univ Milan, Luigi Sacco Hosp, Biomed & Clin Sci Dept, Ctr Res & Treatment Cognit Dysfunct, Milan, Italy; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Fdn Ca Granda, IRCCS Osped Policlin, Neurol Unit,Dept Pathophysiol & Transplantat, Milan, Italy; [Caracciolo, Barbara] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Hlth Care Sci & Soc, Stockholm, Sweden; [Caracciolo, Barbara] Karolinska Inst, Stockholm Gerontol Res Ctr, Stockholm, Sweden	University of Milan; Luigi Sacco Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Karolinska Institutet; Karolinska Institutet	Cova, I (corresponding author), Univ Milan, Luigi Sacco Hosp, Biomed & Clin Sci Dept, Ctr Res & Treatment Cognit Dysfunct, Milan, Italy.	ilaria.cova@unimi.it	Galimberti, Daniela/N-7209-2019; Pomati, Simone/AAP-5414-2021; Cova, Ilaria/K-9454-2016; Scarpini, Elio/K-6547-2016	Galimberti, Daniela/0000-0002-9284-5953; Cova, Ilaria/0000-0001-7831-6791; Pomati, Simone/0000-0001-8930-6361; Scarpini, Elio/0000-0002-6395-2119				American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Besser LM, 2014, ALZ DIS ASSOC DIS, V28, P36, DOI 10.1097/WAD.0000000000000005; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Caracciolo B, 2011, J NEUROL NEUROSUR PS, V82, P788, DOI 10.1136/jnnp.2010.225003; Clerici F, 2012, DEMENT GERIATR COGN, V34, P235, DOI 10.1159/000343776; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillette-Guyonnet S, 2000, AM J CLIN NUTR, V71, p637S; GREEN MW, 1995, PSYCHOL MED, V25, P1003, DOI 10.1017/S0033291700037491; Guerin O, 2005, AM J CLIN NUTR, V82, P435, DOI 10.1093/ajcn/82.2.435; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MARIANI C, 1991, CLIN NEUROPATHOL, V10, P171; Mauri M, 2012, FUNCT NEUROL, V27, P49; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Patra SK, 2012, CLIN CHIM ACTA, V413, P1025, DOI 10.1016/j.cca.2011.12.008; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Quintanilla RA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.007; Rebeck GW, 2010, J BIOL CHEM, V285, P7440, DOI 10.1074/jbc.M109.083915; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; Sobow T, 2014, EUR J CLIN NUTR, V68, P1216, DOI 10.1038/ejcn.2014.167; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Volicer L, 2013, J AM MED DIR ASSOC, V14, P417, DOI 10.1016/j.jamda.2012.12.004; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Waite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005; Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40; White H, 1996, J AM GERIATR SOC, V44, P265, DOI 10.1111/j.1532-5415.1996.tb00912.x; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wysokinski A, 2015, AGE, V37, DOI 10.1007/s11357-015-9821-x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	50	47	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151710	10.1371/journal.pone.0151710	http://dx.doi.org/10.1371/journal.pone.0151710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990757	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800089
J	Forcato, C; Bavassi, L; De Pino, G; Fernandez, RS; Villarreal, MF; Pedreira, ME				Forcato, Cecilia; Bavassi, Luz; De Pino, Gabriela; Sebastian Fernandez, Rodrigo; Fabiana Villarreal, Mirta; Eugenia Pedreira, Maria			Differential Left Hippocampal Activation during Retrieval with Different Types of Reminders: An fMRI Study of the Reconsolidation Process	PLOS ONE			English	Article							MEMORY RECONSOLIDATION; DECLARATIVE MEMORY; PROTEIN-SYNTHESIS; EXTINCTION; HUMANS; INVOLVEMENT; MISMATCH; AMYGDALA; TIME	Consolidated memories return to a labile state after the presentation of cues (reminders) associated with acquisition, followed by a period of stabilization (reconsolidation). However not all cues are equally effective in initiating the process, unpredictable cues triggered it, predictable cues do not. We hypothesize that the different effects observed by the different reminder types on memory labilization-reconsolidation depend on a differential neural involvement during reminder presentation. To test it, we developed a declarative task and compared the efficacy of three reminder types in triggering the process in humans (Experiment 1). Finally, we compared the brain activation patterns between the different conditions using functional magnetic resonance imaging (fMRI) (Experiment 2). We confirmed that the unpredictable reminder is the most effective in initiating the labilization-reconsolidation process. Furthermore, only under this condition there was differential left hippocampal activation during its presentation. We suggest that the left hippocampus is detecting the incongruence between actual and past events and allows the memory to be updated.	[Forcato, Cecilia; Bavassi, Luz; Sebastian Fernandez, Rodrigo; Eugenia Pedreira, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular,CONICET, Lab Neurobiol Mem,Inst Fisiol Biol Mol & Neurocie, Buenos Aires, DF, Argentina; [De Pino, Gabriela; Fabiana Villarreal, Mirta] Consejo Nacl Invest Cient & Tecn, Fdn Lucha Enfermedades Neurol Infancia, RA-1033 Buenos Aires, DF, Argentina; [De Pino, Gabriela] Univ Nacl San Martin, Escuela Ciencia & Tecnol, Ctr Univ Imagenes Med, Buenos Aires, DF, Argentina; [Fabiana Villarreal, Mirta] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pedreira, ME (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular,CONICET, Lab Neurobiol Mem,Inst Fisiol Biol Mol & Neurocie, Buenos Aires, DF, Argentina.	mpedreira@fbmc.fcen.uba.ar	Fernández, Rodrigo S/AAP-3748-2021; Fernandez, Rodrigo/GRF-1350-2022	Fernández, Rodrigo S/0000-0002-0213-9108; Bavassi, Luz/0000-0001-7839-3973; FORCATO, CECILIA/0000-0002-5954-4008	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2010-0391, PICT2013-0412]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) PICT2010-0391 and PICT2013-0412 (MEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Forcato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061688; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Kleiner M, 2007, PERCEPTION, V36, P14; Kumaran D, 2007, J NEUROSCI, V27, P8517, DOI 10.1523/JNEUROSCI.1677-07.2007; Kumaran D, 2006, PLOS BIOL, V4, P2372, DOI 10.1371/journal.pbio.0040424; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rodriguez MLC, 2013, NEUROPHARMACOLOGY, V64, P432, DOI 10.1016/j.neuropharm.2012.06.059; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schiller D, 2013, P NATL ACAD SCI USA, V110, P20040, DOI 10.1073/pnas.1320322110; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; St Jacques PL, 2013, P NATL ACAD SCI USA, V110, P19671, DOI 10.1073/pnas.1319630110; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001	34	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151381	10.1371/journal.pone.0151381	http://dx.doi.org/10.1371/journal.pone.0151381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991776	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800057
J	Nebenzahl, YM; Blau, K; Kushnir, T; Shagan, M; Portnoi, M; Cohen, A; Azriel, S; Malka, I; Adawi, A; Kafka, D; Dotan, S; Guterman, G; Troib, S; Fishilevich, T; Gershoni, JM; Braiman, A; Mitchell, AM; Mitchell, TJ; Porat, N; Goliand, I; Caspi, VC; Swiatlo, E; Tal, M; Ellis, R; Elia, N; Dagan, R				Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Dotan, Shahar; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Gershoni, Jonathan M.; Braiman, Alex; Mitchell, Andrea M.; Mitchell, Timothy J.; Porat, Nurith; Goliand, Inna; Caspi, Vered Chalifa; Swiatlo, Edwin; Tal, Michael; Ellis, Ronald; Elia, Natalie; Dagan, Ron			Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; EPITHELIAL-CELLS; SURFACE PROTEIN; PNEUMOCOCCAL INFECTIONS; BACTERIAL-INFECTION; ANTIBODY-RESPONSES; PUTATIVE ADHESIN; BINDING PROTEIN; FUSION PROTEIN; PHT PROTEINS	In Streptococcus pneumonia, phosphoenolpyruvate protein phosphotransferase (PtsA) is an intracellular protein of the monosaccharide phosphotransferase systems. Biochemical and immunostaining methods were applied to show that PtsA also localizes to the bacterial cell-wall. Thus, it was suspected that PtsA has functions other than its main cytoplasmic enzymatic role. Indeed, recombinant PtsA and anti-rPtsA antiserum were shown to inhibit adhesion of S. pneumoniae to cultured human lung adenocarcinoma A549 cells. Screening of a combinatorial peptide library expressed in a filamentous phage with rPtsA identified epitopes that were capable of inhibiting S. pneumoniae adhesion to A549 cells. The insert peptides in the phages were sequenced, and homologous sequences were found in human BMPER, multimerin1, protocadherin19, integrin beta 4, epsin1 and collagen type VII alpha 1 proteins, all of which can be found in A549 cells except the latter. Six peptides, synthesized according to the homologous sequences in the human proteins, specifically bound rPtsA in the micromolar range and significantly inhibited pneumococcal adhesion in vitro to lung- and tracheal-derived cell lines. In addition, the tested peptides inhibited lung colonization after intranasal inoculation of mice with S. pneumoniae. Immunization with rPtsA protected the mice against a sublethal intranasal and a lethal intravenous pneumococcal challenge. In addition, mouse anti rPtsA antiserum reduced bacterial virulence in the intravenous inoculation mouse model. These findings showed that the surface-localized PtsA functions as an adhesin, PtsA binding peptides derived from its putative target molecules can be considered for future development of therapeutics, and rPtsA should be regarded as a candidate for vaccine development.	[Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Porat, Nurith] Soroka Univ, Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel; [Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Braiman, Alex; Porat, Nurith] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Nebenzahl, Yaffa Mizrachi; Blau, Karin; Kushnir, Tatyana; Shagan, Marilou; Portnoi, Maxim; Cohen, Aviad; Azriel, Shalhevet; Malka, Itai; Adawi, Asad; Kafka, Daniel; Guterman, Gali; Troib, Shany; Fishilevich, Tali; Porat, Nurith; Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Dotan, Shahar; Tal, Michael; Ellis, Ronald] NasVax Ltd, Ness Ziona, Israel; [Gershoni, Jonathan M.; Mitchell, Timothy J.] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Mitchell, Andrea M.] Univ Birmingham, Inst Microbiol & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Goliand, Inna; Caspi, Vered Chalifa; Elia, Natalie] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Goliand, Inna; Elia, Natalie] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Swiatlo, Edwin] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Tel Aviv University; University of Birmingham; Ben Gurion University; Ben Gurion University; University of Mississippi; University of Mississippi Medical Center	Nebenzahl, YM (corresponding author), Soroka Univ, Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel.; Nebenzahl, YM (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.; Nebenzahl, YM (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	ymizr@bgu.ac.il	Braiman, Alex/F-2179-2012; Braiman, Alex/ABC-3482-2021	Braiman, Alex/0000-0003-2802-1148; Braiman, Alex/0000-0003-2802-1148; Mitchell, Timothy/0000-0002-8309-5556; Mitchell, Andrea/0000-0002-2530-4460; Chalifa-Caspi, Vered/0000-0001-6030-5816; Guterman-Ram, Gali/0000-0002-8583-3401	Israel Ministry of Health [4776, 5540, 3000003867]; BG Negev Technologies, Ben-Gurion University of the Negev [80904101]; Center of Emerging Diseases [2506]; Israel Academy of Science [613/04]; Israel Ministry of Commerce and Industry; Medical Research Council; Wellcome Trust; NasVax Ltd.; Israeli minister of Health; center of immerging disease; BG Negev; Israel Academy of Science; Israel ministry of commerce; NasVax	Israel Ministry of Health; BG Negev Technologies, Ben-Gurion University of the Negev; Center of Emerging Diseases; Israel Academy of Science; Israel Ministry of Commerce and Industry; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NasVax Ltd.; Israeli minister of Health; center of immerging disease; BG Negev; Israel Academy of Science; Israel ministry of commerce; NasVax	Work in the Y.M.N. laboratory is supported by grants from The Israel Ministry of Health (grants 4776, 5540 and 3000003867) to Y.M.N., from BG Negev Technologies, Ben-Gurion University of the Negev (grant 80904101) to Y.M.N., from The Center of Emerging Diseases (grant 2506) to Y.M.N., from The Israel Academy of Science (grant 613/04) to Y.M.N., and from The Israel Ministry of Commerce and Industry to NasVax Ltd. Work in TJM laboratory is supported by the Medical Research Council and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NasVax Ltd. provided support in the form of salaries for authors SD, MTand RE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Role of the funders: Israeli minister of Health, The center of immerging disease, BG Negev and The Israel Academy of Science, The Israel ministry of commerce provided support in the form of salaries for authors [MS, SA, IM, AA, GG, ST, TF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funders BG Negev and NasVax provided support in the form of salaries for authors [MP, DK, SD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; Ausubel FM, 1988, MOL REPROD DEV; AVERY OT, 1995, MOL MED, V1, P344, DOI 10.1007/BF03401572; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; BALIS JU, 1984, EXP LUNG RES, V6, P197, DOI 10.3109/01902148409109248; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Benisty R, 2010, BBA-MOL CELL BIOL L, V1801, P1098, DOI 10.1016/j.bbalip.2010.06.004; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Binsker U, 2015, J BIOL CHEM, V290, P14542, DOI 10.1074/jbc.M114.623876; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Brock SC, 2002, INFECT IMMUN, V70, P5091, DOI 10.1128/IAI.70.9.5091-5095.2002; Brown AO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004383; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Cherian Thomas, 2007, Vaccine, V25, P6557, DOI 10.1016/j.vaccine.2007.06.044; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Cron LE, 2011, INFECT IMMUN, V79, P3697, DOI 10.1128/IAI.01383-10; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dagan R, 2010, VACCINE, V28, P5513, DOI 10.1016/j.vaccine.2010.06.026; Dagan R, 2009, VACCINE, V27, pC22, DOI 10.1016/j.vaccine.2009.06.004; Daniely D, 2006, CLIN EXP IMMUNOL, V144, P254, DOI 10.1111/j.1365-2249.2006.03047.x; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Elm C, 2004, INDIAN J MED RES, V119, P61; Freund Natalia Tarnovitski, 2009, Curr Protoc Immunol, VChapter 9, DOI 10.1002/0471142735.im0908s86; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Gravelle S, 2010, INNATE IMMUN-LONDON, V16, P14, DOI 10.1177/1753425909106170; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hagerman A, 2013, EUR J CLIN MICROBIOL, V32, P43, DOI 10.1007/s10096-012-1712-9; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammitt LL, 2011, VACCINE, V29, P2287, DOI 10.1016/j.vaccine.2011.01.029; Harfouche C, 2012, INFECT IMMUN, V80, P451, DOI 10.1128/IAI.05780-11; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kallio A, 2014, INFECT IMMUN, V82, P1683, DOI 10.1128/IAI.00699-13; Kayhty H, 1996, EMERG INFECT DIS, V2, P289, DOI 10.3201/eid0204.9604; Khan MN, 2012, VACCINE, V30, P2900, DOI 10.1016/j.vaccine.2012.02.023; Laine C, 2004, INFECT IMMUN, V72, P3331, DOI 10.1128/IAI.72.6.3331-3335.2004; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lifshitz S, 2002, CLIN EXP IMMUNOL, V127, P344, DOI 10.1046/j.1365-2249.2002.01745.x; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; MCDANIEL LS, 1991, INFECT IMMUN, V59, P222, DOI 10.1128/IAI.59.1.222-228.1991; Menoud A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038823; Mitchell Tim J, 2014, Subcell Biochem, V80, P145, DOI 10.1007/978-94-017-8881-6_8; Mlacha SZK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-383; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Muchnik L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061128; Nau R, 2013, EXPERT REV ANTI-INFE, V11, P1079, DOI 10.1586/14787210.2013.839381; Nebenzahl YM, 2007, J INFECT DIS, V196, P945, DOI 10.1086/521028; Nebenzahl YM, 2004, FEMS MICROBIOL LETT, V233, P147, DOI 10.1016/j.femsle.2004.02.003; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Oldak M, 2006, INT J MOL MED, V17, P195; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; PATON JC, 1983, INFECT IMMUN, V40, P548, DOI 10.1128/IAI.40.2.548-552.1983; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Pope C, 2015, VACCINE, V33, P1711, DOI 10.1016/j.vaccine.2015.02.012; Portnoi M, 2006, VACCINE, V24, P1868, DOI 10.1016/j.vaccine.2005.10.053; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Price KE, 2012, J BACTERIOL, V194, P3651, DOI 10.1128/JB.00114-12; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; SAIER MH, 1992, J BACTERIOL, V174, P1433, DOI 10.1128/jb.174.5.1433-1438.1992; SELA BA, 1975, J BIOL CHEM, V250, P7535; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; SIEGEL JL, 1981, INFECT IMMUN, V31, P808, DOI 10.1128/IAI.31.2.808-815.1981; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Song JY, 2013, INFECT CHEMOTHER, V45, P351, DOI 10.3947/ic.2013.45.4.351; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; WATSON DA, 1990, INFECT IMMUN, V58, P3135, DOI 10.1128/IAI.58.9.3135-3138.1990; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101	88	12	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150320	10.1371/journal.pone.0150320	http://dx.doi.org/10.1371/journal.pone.0150320			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990554	Green Published, gold			2022-12-27	WOS:000372582800027
J	Xu, XM; Chao, J; Cheng, XL; Wang, R; Sun, BJ; Wang, HM; Luo, SB; Xu, XW; Wu, TQ; Li, Y				Xu, Xiaomei; Chao, Juan; Cheng, Xueli; Wang, Rui; Sun, Baojuan; Wang, Hengming; Luo, Shaobo; Xu, Xiaowan; Wu, Tingquan; Li, Ying			Mapping of a Novel Race Specific Resistance Gene to Phytophthora Root Rot of Pepper (Capsicum annuum) Using Bulked Segregant Analysis Combined with Specific Length Amplified Fragment Sequencing Strategy	PLOS ONE			English	Article							QTL ANALYSIS; MAP; CONSTRUCTION	Phytophthora root rot caused by Phytophthora capsici (P. capsici) is a serious limitation to pepper production in Southern China, with high temperature and humidity. Mapping PRR resistance genes can provide linked DNA markers for breeding PRR resistant varieties by molecular marker-assisted selection (MAS). Two BC1 populations and an F-2 population derived from a cross between P. capsici-resistant accession, Criollo de Morelos 334 (CM334) and P. capsici-susceptible accession, New Mexico Capsicum Accession 10399 (NMCA10399) were used to investigate the genetic characteristics of PRR resistance. PRR resistance to isolate Byl4 (race 3) was controlled by a single dominant gene, PhR10, that was mapped to an interval of 16.39Mb at the end of the long arm of chromosome 10. Integration of bulked segregant analysis (BSA) and Specific Length Amplified Fragment sequencing (SLAF-seq) provided an efficient genetic mapping strategy. Ten polymorphic Simple Sequence Repeat (SSR) markers were found within this region and used to screen the genotypes of 636 BC1 plants, delimiting PhR10 to a 2.57 Mb interval between markers P52-11-21 (1.5 cM away) and P52-11-41 (1.1 cM). A total of 163 genes were annotated within this region and 31 were predicted to be associated with disease resistance. PhR10 is a novel race specific gene for PRR, and this paper describes linked SSR markers suitable for marker-assisted selection of PRR resistant varieties, also laying a foundation for cloning the resistance gene.	[Xu, Xiaomei; Chao, Juan; Cheng, Xueli; Wang, Rui; Sun, Baojuan; Wang, Hengming; Luo, Shaobo; Xu, Xiaowan; Wu, Tingquan; Li, Ying] Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China; [Xu, Xiaomei; Chao, Juan; Cheng, Xueli; Wang, Rui; Sun, Baojuan; Luo, Shaobo; Wu, Tingquan] Guangdong Key Lab New Technol Res Vegetables, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Li, Y (corresponding author), Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China.	390020225@qq.com			Guangdong Natural Science Foundation [2014A030310321]; Guangdong Academy of Agricultural Sciences Dean Fund [201304]; Guangzhou Science and Technology Program key projects [2014Y2-00112]; Guangdong Science and Technology Project [2015B0202009, 2014A020208045]; Common key technology research of Guangdong Lingnan characteristic vegetable Crossbreeding [2012A020100006]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Academy of Agricultural Sciences Dean Fund; Guangzhou Science and Technology Program key projects; Guangdong Science and Technology Project; Common key technology research of Guangdong Lingnan characteristic vegetable Crossbreeding	Support was provided by: Guangdong Natural Science Foundation (2014A030310321) XMX; Guangdong Academy of Agricultural Sciences Dean Fund (201304) XMX; Guangzhou Science and Technology Program key projects (2014Y2-00112) YL; Guangdong Science and Technology Project (2015B0202009) YL; Common key technology research of Guangdong Lingnan characteristic vegetable Crossbreeding (2012A020100006) SBL; and Guangdong Science and Technology Project (2014A020208045) XWX.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Bonnet J, 2007, THEOR APPL GENET, V115, P253, DOI 10.1007/s00122-007-0561-x; BOSLAND PW, 1991, PLANT DIS, V75, P1048, DOI 10.1094/PD-75-1048; Chague V, 1997, THEOR APPL GENET, V95, P671, DOI 10.1007/s001220050611; Ribeiro CSD, 2012, J AM SOC HORTIC SCI, V137, P421; Glosier BR, 2008, EUPHYTICA, V162, P23, DOI 10.1007/s10681-007-9532-1; Hai THT, 2013, EUR J PLANT PATHOL, V135, P289, DOI 10.1007/s10658-012-0085-3; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Hill JT, 2013, GENOME RES, V23, P687, DOI 10.1101/gr.146936.112; Huang Q, 2014, THEOR APPL GENET, V127, P843, DOI 10.1007/s00122-014-2261-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HJ, 2008, THEOR APPL GENET, V118, P15, DOI 10.1007/s00122-008-0873-5; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kiraly L, 2007, J PHYTOPATHOL, V155, P385, DOI 10.1111/j.1439-0434.2007.01264.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lefebvre V, 1996, THEOR APPL GENET, V93, P503, DOI 10.1007/BF00417941; Leonian LH, 1922, PHYTOPATHOLOGY, V12, P401; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li Qiang, 2005, Yichuan, V27, P808; Li ZhiJun, 2007, Journal of South China Agricultural University, V28, P50; Liu WY, 2014, THEOR APPL GENET, V127, P2503, DOI 10.1007/s00122-014-2394-8; Liu WY., 2006, COMP GENETICS RESIST; Mallard S, 2013, MOL BREEDING, V32, P349, DOI 10.1007/s11032-013-9875-3; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Minamiyama Y, 2007, BREEDING SCI, V57, P129, DOI 10.1270/jsbbs.57.129; Monroy-Barbosa A, 2008, J AM SOC HORTIC SCI, V133, P825, DOI 10.21273/JASHS.133.6.825; Ogundiwin EA, 2005, GENOME, V48, P698, DOI 10.1139/G05-028; ORTEGA RG, 1991, PLANT BREEDING, V107, P50, DOI 10.1111/j.1439-0523.1991.tb00527.x; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Quirin EA, 2005, THEOR APPL GENET, V110, P605, DOI 10.1007/s00122-004-1874-7; Reeves G, 2013, PHYTOPATHOLOGY, V103, P472, DOI 10.1094/PHYTO-09-12-0242-R; Sugita T, 2006, BREEDING SCI, V56, P137, DOI 10.1270/jsbbs.56.137; Sun XW, 2013, PLOS ONE, V3; Sy O, 2005, J AM SOC HORTIC SCI, V130, P75, DOI 10.21273/JASHS.130.1.75; Thabuis A, 2003, THEOR APPL GENET, V106, P1473, DOI 10.1007/s00122-003-1206-3; Truong HTH, 2012, PLANT PATHOL, V61, P48, DOI 10.1111/j.1365-3059.2011.02483.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Walker SJ, 1999, J AM SOC HORTIC SCI, V124, P14, DOI 10.21273/JASHS.124.1.14; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xu FF, 2015, PLOS ONE, V3; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yi B, 2006, THEOR APPL GENET, V113, P643, DOI 10.1007/s00122-006-0328-9; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	46	37	42	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151401	10.1371/journal.pone.0151401	http://dx.doi.org/10.1371/journal.pone.0151401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992080	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800060
J	Liu, YL; Wang, SC; Hwu, HG; Fann, CSJ; Yang, UC; Yang, WC; Hsu, PC; Chang, CC; Wen, CC; Tsai-Wu, JJ; Hwang, TJ; Hsieh, MH; Liu, CC; Chien, YL; Fang, CP; Faraone, SV; Tsuang, MT; Chen, WJ; Liu, CM				Liu, Yu-Li; Wang, Sheng-Chang; Hwu, Hai-Gwo; Fann, Cathy Shen-Jang; Yang, Ueng-Cheng; Yang, Wei-Chih; Hsu, Pei-Chun; Chang, Chien-Ching; Wen, Chun-Chiang; Tsai-Wu, Jyy-Jih; Hwang, Tzung-Jeng; Hsieh, Ming H.; Liu, Chen-Chung; Chien, Yi-Ling; Fang, Chiu-Ping; Faraone, Stephen V.; Tsuang, Ming T.; Chen, Wei J.; Liu, Chih-Min			Haplotypes of the D-Amino Acid Oxidase Gene Are Significantly Associated with Schizophrenia and Its Neurocognitive Deficits	PLOS ONE			English	Article							CARD SORTING TEST; SUSTAINED ATTENTION DEFICITS; GENOMIC DNA-SEQUENCES; NONPSYCHOTIC RELATIVES; MISMATCH NEGATIVITY; NMDA RECEPTOR; GLYCINE SITE; TAIWAN; DAAO; LINKAGE	D-amino acid oxidase (DAO) has been reported to be associated with schizophrenia. This study aimed to search for genetic variants associated with this gene. The genomic regions of all exons, highly conserved regions of introns, and promoters of this gene were sequenced. Potentially meaningful single-nucleotide polymorphisms (SNPs) obtained from direct sequencing were selected for genotyping in 600 controls and 912 patients with schizophrenia and in a replicated sample consisting of 388 patients with schizophrenia. Genetic associations were examined using single-locus and haplotype association analyses. In single-locus analyses, the frequency of the C allele of a novel SNP rs55944529 located at intron 8 was found to be significantly higher in the original large patient sample (p = 0.016). This allele was associated with a higher level of DAO mRNA expression in the Epstein-Barr virus-transformed lymphocytes. The haplotype distribution of a haplotype block composed of rs11114083-rs2070586-rs2070587-rs55944529 across intron 1 and intron 8 was significantly different between the patients and controls and the haplotype frequencies of AAGC were significantly higher in patients, in both the original (corrected p < 0.0001) and replicated samples (corrected p = 0.0003). The CGTC haplotype was specifically associated with the subgroup with deficits in sustained attention and executive function and the AAGC haplotype was associated with the subgroup without such deficits. The DAO gene was a susceptibility gene for schizophrenia and the genomic region between intron 1 and intron 8 may harbor functional genetic variants, which may influence the mRNA expression of DAO and neurocognitive functions in schizophrenia.	[Liu, Yu-Li; Wang, Sheng-Chang; Fang, Chiu-Ping] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli 35053, Taiwan; [Liu, Yu-Li; Hwu, Hai-Gwo; Wen, Chun-Chiang; Hwang, Tzung-Jeng; Hsieh, Ming H.; Liu, Chen-Chung; Chien, Yi-Ling; Liu, Chih-Min] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10051, Taiwan; [Liu, Yu-Li; Hwu, Hai-Gwo; Wen, Chun-Chiang; Hwang, Tzung-Jeng; Hsieh, Ming H.; Liu, Chen-Chung; Chien, Yi-Ling; Liu, Chih-Min] Natl Taiwan Univ, Coll Med, Taipei 10051, Taiwan; [Hwu, Hai-Gwo; Hwang, Tzung-Jeng; Liu, Chen-Chung; Liu, Chih-Min] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10051, Taiwan; [Fann, Cathy Shen-Jang; Yang, Wei-Chih; Chang, Chien-Ching] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Yang, Ueng-Cheng] Natl Yang Ming Univ, Inst Bioinformat, Taipei 112, Taiwan; [Hsu, Pei-Chun] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10051, Taiwan; [Tsai-Wu, Jyy-Jih] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10051, Taiwan; [Faraone, Stephen V.] SUNY Upstate Med Univ, Med Genet Res Ctr, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat & Neurosci & Physiol, Syracuse, NY 13210 USA; [Tsuang, Ming T.] Harvard Univ, Harvard Inst Psychiat Epidemiol & Genet, Boston, MA 02115 USA; [Tsuang, Ming T.] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Tsuang, Ming T.] Harvard Univ, Dept Psychiat, Boston, MA 02115 USA; [Tsuang, Ming T.] Univ Calif San Diego, Inst Behav Genom, San Diego, CA 92093 USA; [Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10051, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard University; University of California System; University of California San Diego; National Taiwan University	Liu, CM (corresponding author), Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10051, Taiwan.; Liu, CM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10051, Taiwan.	cmliu1968@ntu.edu.tw	Faraone, Stephen/AAE-7334-2019; Hwang, TJ/K-4768-2019; Faraone, Stephen V/O-7239-2018; Fann, Cathy SJ/F-9410-2010; Hsieh, Ming H./B-2970-2010	Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982; Fann, Cathy SJ/0000-0001-9025-2276; Hsieh, Ming H./0000-0002-3585-7843; LIU, CHEN-CHUNG/0000-0002-9290-110X; LIU, CHIH-MIN/0000-0001-7016-8990; Chen, Wei Jen/0000-0001-5899-5870; Hwang, Tzung-Jeng/0000-0001-7894-9484; CHIEN, YI-LING/0000-0002-3477-3015	National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan [NSC91-2314-B-002-216, NSC91-3112-B-002-011, NSC 92-3112-B-002-019, NSC93-3112-B-002-012, NSC94-3112-B-002-020, NSC95-3112-B002-011, NSC 97-3112-B-002-046-, NSC 97-2321-B-002-041, NSC 98-2321-B-002-008-, NSC 97-2314-B-400-001-MY3, NSC 101-2325-B-400-018]; National Health Research Institute, Taiwan [NHRI-EX-91, NHRI-EX-92, NHRI-EX-93-9113PP, MD095PP14, MD097PP02, MD096PP12, MD097PP14, MD096SP01, MD097SP01, PH098, 99-46]; National Institutes of Health, U.S.A. [IR01 MH 59624-01]; National Taiwan University [97HM00271similar to7]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059624] Funding Source: NIH RePORTER	National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health, U.S.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Taiwan University(National Taiwan University); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Research Program for Genomic Medicine (NRPGM), National Science Council, Taiwan [grant number NSC91-2314-B-002-216, NSC91-3112-B-002-011, NSC 92-3112-B-002-019, NSC93-3112-B-002-012, NSC94-3112-B-002-020, NSC95-3112-B002-011, NSC 97-3112-B-002-046-, NSC 97-2321-B-002-041, NSC 98-2321-B-002-008- to HGW, NSC 97-2314-B-400-001-MY3, NSC 101-2325-B-400-018 to HGW and LCM], the National Health Research Institute, Taiwan [grant number NHRI-EX-91,92,93-9113PP, MD095PP14, MD096PP12, MD097PP02, MD096PP12, MD097PP14, MD096SP01, MD097SP01 to HGW, and PH098, 99-46 to SCW], the National Institutes of Health, U.S.A. [grant number IR01 MH 59624-01 to MTT], and National Taiwan University [grant number 97HM00271 similar to 7 to HGW and LCM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnet PWJ, 2008, MOL PSYCHIATR, V13, P658, DOI 10.1038/mp.2008.47; Chang SS, 2009, SCHIZOPHRENIA BULL, V35, P213, DOI 10.1093/schbul/sbm153; Chen CH, 1999, AM J PSYCHIAT, V156, P1273; Chen WJ, 2000, AM J MED GENET, V97, P52, DOI 10.1002/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6; Chen WJ, 2004, BIOL PSYCHIAT, V55, P995, DOI 10.1016/j.biopsych.2004.01.010; Chen WJ, DIAGNOSTIC INTERVIEW; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CORNBLATT BA, 1994, SCHIZOPHRENIA BULL, V20, P31, DOI 10.1093/schbul/20.1.31; Corvin A, 2007, AM J MED GENET B, V144B, P949, DOI 10.1002/ajmg.b.30452; Coyle JT, 2012, SCHIZOPHRENIA BULL, V38, P920, DOI 10.1093/schbul/sbs076; Faraone SV, 2006, AM J PSYCHIAT, V163, P1760, DOI 10.1176/appi.ajp.163.10.1760; Faraone SV, 1999, J ABNORM PSYCHOL, V108, P176, DOI 10.1037/0021-843X.108.1.176; Faraone SV, 2000, BIOL PSYCHIAT, V48, P120, DOI 10.1016/S0006-3223(99)00263-2; FARAONE SV, 1995, AM J PSYCHIAT, V152, P1286; Fu CL, 2004, THESIS NATL YANG MIN; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GOLDBERG TE, 1987, ARCH GEN PSYCHIAT, V44, P1008; Goldberg TE, 2006, NEUROPSYCHOPHARMACOL, V31, P2022, DOI 10.1038/sj.npp.1301049; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hwu H. G., 1999, PSYCHIAT DIAGNOSTIC; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Hwu HG, 2002, SCHIZOPHR RES, V56, P105, DOI 10.1016/S0920-9964(01)00251-1; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Kapoor R, 2006, BRAIN RES, V1106, P205, DOI 10.1016/j.brainres.2006.05.082; Koren D, 1998, NEUROPSYCHOLOGY, V12, P289, DOI 10.1037/0894-4105.12.2.289; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Liu XM, 2004, NEUROSCI LETT, V369, P228, DOI 10.1016/j.neulet.2004.07.078; Liu YL, 2006, SCHIZOPHR RES, V87, P15, DOI 10.1016/j.schres.2006.06.020; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Nuechterlein KH, 1991, VIGILANCE SCHIZOPHRE, P397; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Papagni SA, 2011, NEUROIMAGE, V56, P2283, DOI 10.1016/j.neuroimage.2011.03.037; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Rodi CP, 2002, BIOTECHNIQUES, P62; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Roussos P, 2011, NEUROPSYCHOPHARMACOL, V36, P1677, DOI 10.1038/npp.2011.49; Rozen S, 2000, Methods Mol Biol, V132, P365; *SAS I INC, 2002, SAS GEN US GUID; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Tien Allen Y., 1996, Kaohsiung Journal of Medical Sciences, V12, P479; Tost J, 2005, CLIN BIOCHEM, V38, P335, DOI 10.1016/j.clinbiochem.2004.12.005; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Wolf LE, 2002, SCHIZOPHR RES, V57, P173, DOI 10.1016/S0920-9964(01)00301-2; Wong EHM, 2014, SCHIZOPHRENIA BULL, V40, P777, DOI 10.1093/schbul/sbt104; Wood LS, 2007, BIOL PSYCHIAT, V61, P1195, DOI 10.1016/j.biopsych.2006.07.005; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Yang HC, 2006, J BIOMED SCI, V13, P489, DOI 10.1007/s11373-006-9077-7	59	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150435	10.1371/journal.pone.0150435	http://dx.doi.org/10.1371/journal.pone.0150435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986737	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300021
J	Xie, XS; Chen, W; Fu, Q; Zhang, PH; An, TC; Cui, AM; An, DR				Xie, Xiansheng; Chen, Wei; Fu, Qiang; Zhang, Penghui; An, Tianci; Cui, Aimin; An, Derong			Molecular Variability and Distribution of Sugarcane Mosaic Virus in Shanxi, China	PLOS ONE			English	Article							RECOMBINATION	Background Sugarcane mosaic virus (SCMV) is responsible for large-scale economic losses in the global production of sugarcane, maize, sorghum, and some other graminaceous species. To understand the evolutionary mechanism of SCMV populations, this virus was studied in Shanxi, China. A total of 86 maize leaf samples (41 samples in 2012 and 45 samples in 2013) were collected from 4 regions of Shanxi. Results Double-antibody sandwich (DAS)-ELISA and RT-PCR showed 59 samples (30 samples in 2012 and 29 samples in 2013) to be positive for SCMV, from which 10 new isolates of SCMV were isolated and sequenced. The complete genomes of these isolates are 9610 nt long, including the 50 and 30 non-coding regions, and encode a 3063-amino acid polyprotein. Phylogenetic analyses revealed that 24 SCMV isolates could be divided on the basis of the whole genome into 2 divergent evolutionary groups, which were associated with the host species. Among the populations, 15 potential recombination events were identified. The selection pressure on the genes of these SCMV isolates was also calculated. The results confirmed that all the genes were under negative selection. Conclusions Negative selection and recombination appear to be important evolutionary factors shaping the genetic structure of these SCMV isolates. SCMV is distributed widely in China and exists as numerous strains with distinct genetic diversity. Our findings will provide a foundation for evaluating the epidemiological characteristics of SCMV in China and will be useful in designing long-term, sustainable management strategies for SCMV.	[Xie, Xiansheng; Fu, Qiang; Zhang, Penghui; An, Tianci; An, Derong] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Xie, Xiansheng; Cui, Aimin] Shanxi Acad Agr Sci, Wheat Res Inst, Linfen, Shanxi, Peoples R China; [Chen, Wei] Shanxi Normal Univ, Coll Life Sci, Linfen, Shanxi, Peoples R China	Northwest A&F University - China; Shanxi Agricultural University; Shanxi Normal University	An, DR (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	anderong323@163.com			111 Project from the Education Ministry of China [B07049]; National Natural Science Foundation of China [31471816]	111 Project from the Education Ministry of China(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the 111 Project from the Education Ministry of China (No. B07049) and the National Natural Science Foundation of China (No. 31471816). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ISRN STROKE, DOI [DOI 10.1007/S00531-013-0931-3, DOI 10.1155/2013/858945]; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; Gell G, 2015, VIRUS GENES, V50, P79, DOI 10.1007/s11262-014-1142-0; Gemechu AL, 2006, ARCH VIROL, V151, P167, DOI 10.1007/s00705-005-0643-5; Goncalves MC, 2011, PESQUI AGROPECU BRAS, V46, P362, DOI 10.1590/S0100-204X2011000400004; Ilbagi H, 2006, PHYTOPROTECTION, V87, P115, DOI 10.7202/015853ar; Keizerweerd AT, 2015, J VIROL METHODS, V212, P23, DOI 10.1016/j.jviromet.2014.10.013; Li YC, 2010, J NANOMATER, V2010, DOI 10.1155/2010/261748; Liu XH, 2009, AFR J BIOTECHNOL, V8, P3747; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Padhi A, 2011, VIRUS GENES, V42, P282, DOI 10.1007/s11262-010-0564-6; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Wang Xingguo, 2015, Journal of Chinese Institute of Food Science and Technology, V15, P1; Wu LJ, 2013, J PROTEOMICS, V89, P124, DOI 10.1016/j.jprot.2013.06.005; Wu LJ, 2012, CROP PROT, V42, P74, DOI 10.1016/j.cropro.2012.07.005; Wu LJ, 2013, PLOS ONE, V7; Xu DL, 2008, ARCH VIROL, V153, P1031, DOI 10.1007/s00705-008-0072-3; Yang Z. Y., 2005, J SHANXI AGR U, V25, P223; Zhang CL, 2011, VIRUS RES, V158, P188, DOI 10.1016/j.virusres.2011.03.031; Zhang XM, 2008, VIROLOGY, V374, P351, DOI 10.1016/j.virol.2007.12.045; Zheng XY, 2015, CHIN AGR SCI B, V31, P68; Zhu M, 2014, NEW PHYTOL, V203, P1291, DOI 10.1111/nph.12890	29	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151549	10.1371/journal.pone.0151549	http://dx.doi.org/10.1371/journal.pone.0151549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987060	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300084
J	Bo, L; Jiang, S; Xie, YQ; Kan, HD; Song, WM; Zhao, JZ				Bo, Liang; Jiang, Shuo; Xie, Yuquan; Kan, Haidong; Song, Weimin; Zhao, Jinzhuo			Effect of Vitamin E and Omega-3 Fatty Acids on Protecting Ambient PM2.5-Induced Inflammatory Response and Oxidative Stress in Vascular Endothelial Cells	PLOS ONE			English	Article							PARTICULATE MATTER EXPOSURE; AIR-POLLUTION; CIRCULATING BIOMARKERS; SYSTEMIC INFLAMMATION; FINE; SUPPLEMENTATION; DYSFUNCTION; INCREASES; DISEASES; INJURY	Although the mechanisms linking cardiopulmonary diseases to ambient fine particles (PM2.5) are still unclear, inflammation and oxidative stress play important roles in PM2.5-induced injury. It is well known that inflammation and oxidative stress could be restricted by vitamin E (Ve) or omega-3 fatty acids (O-3 FA) consumption. This study investigated the effects of Ve and O-3 FA on PM2.5-induced inflammation and oxidative stress in vascular endothelial cells. The underlying mechanisms linking PM2.5 to vascular endothelial injury were also explored. Human umbilical vein endothelial cells (HUVECs) were treated with 50 mu g/mL PM2.5 in the presence or absence of different concentrations of Ve and O-3 FA. The inflammatory cytokines and oxidative stress markers were determined. The results showed that Ve induced a significant decrease in PM2.5-induced inflammation and oxidative stress. Malondialdehyde (MDA) in supernatant and reactive oxygen species (ROS) in cytoplasm decreased by Ve, while the superoxide dismutase (SOD) activity elevated. The inflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) also reduced by Ve. Moreover, O-3 FA played the same role on decreasing the inflammation and oxidative stress. IL-6 and TNF-a expressions were significantly lower in combined Ve with O-3 FA than treatment with Ve or O-3 FA alone. The Ve and O-3 FA intervention might abolish the PM2.5-induced oxidative stress and inflammation in vascular endothelial cells. There might be an additive effect of these two nutrients in mediating the PM2.5-induced injury in vascular endothelial cells. The results suggested that inflammation and oxidative stress might be parts of the mechanisms linking PM2.5 to vascular endothelial injury.	[Bo, Liang; Jiang, Shuo; Kan, Haidong; Song, Weimin; Zhao, Jinzhuo] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Bo, Liang; Jiang, Shuo; Kan, Haidong; Song, Weimin; Zhao, Jinzhuo] Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200032, Peoples R China; [Xie, Yuquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Zhao, JZ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China.; Zhao, JZ (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200032, Peoples R China.	jinzhuozhao@fudan.edu.cn	Song, Weimin/AAJ-5415-2020; Kan, Haidong/AGU-0328-2022	Song, Weimin/0000-0003-1376-2293; 	nutrition research fund of Chinese Nutrition Society [2014-012]; National Natural Science Foundation of China [91543119]	nutrition research fund of Chinese Nutrition Society; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the nutrition research fund of Chinese Nutrition Society (No. 2014-012), and the National Natural Science Foundation of China (No. 91543119).	Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Behbod B, 2013, OCCUP ENVIRON MED, V70, P761, DOI 10.1136/oemed-2013-101498; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; Bulger EM, 2003, SHOCK, V19, P99, DOI 10.1097/00024382-200302000-00001; Cachon BF, 2014, ENVIRON POLLUT, V185, P340, DOI 10.1016/j.envpol.2013.10.026; Chandran PA, 2014, IMMUNOPHARMACOL IMMU, P1; Davel AP, 2012, TOXICOLOGY, V295, P39, DOI 10.1016/j.tox.2012.02.004; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GOLDFARB AH, 1993, MED SCI SPORT EXER, V25, P232; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Kurhanewicz N, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0054-4; Liu CQ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0053-5; MCCORD JM, 1978, ANN INTERN MED, V89, P122, DOI 10.7326/0003-4819-89-1-122; Nigam A, 2014, J AM COLL CARDIOL, V64, P1441, DOI 10.1016/j.jacc.2014.07.956; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ozkaya D, 2011, CELL BIOCHEM FUNCT, V29, P287, DOI 10.1002/cbf.1749; ROMIEU I, 2008, PMID, V179, DOI DOI 10.1183/09031936.00128106; Samet JM, 2001, AM J RESP CRIT CARE, V164, P819, DOI 10.1164/ajrccm.164.5.2008003; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stafoggia M, 2014, ENVIRON HEALTH PERSP, V122, P919, DOI 10.1289/ehp.1307301; van Eeden SF, 2002, J TOXICOL ENV HEAL A, V65, P1597, DOI 10.1080/00984100290071685; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zhao JZ, 2012, TOXICOL LETT, V208, P225, DOI 10.1016/j.toxlet.2011.11.012; Zhao JZ, 2011, HUM EXP TOXICOL, V30, P1828, DOI 10.1177/0960327111401050	32	55	63	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152216	10.1371/journal.pone.0152216	http://dx.doi.org/10.1371/journal.pone.0152216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007186	Green Published, gold			2022-12-27	WOS:000372701200112
J	Sharp, JD; Singh, AK; Park, ST; Lyubetskaya, A; Peterson, MW; Gomes, ALC; Potluri, LP; Raman, S; Galagan, JE; Husson, RN				Sharp, Jared D.; Singh, Atul K.; Park, Sang Tae; Lyubetskaya, Anna; Peterson, Matthew W.; Gomes, Antonio L. C.; Potluri, Lakshmi-Prasad; Raman, Sahadevan; Galagan, James E.; Husson, Robert N.			Comprehensive Definition of the SigH Regulon of Mycobacterium tuberculosis Reveals Transcriptional Control of Diverse Stress Responses	PLOS ONE			English	Article							CHIP-SEQ; IMMUNOPATHOLOGY; SEQUENCE; NETWORK	Expression of SigH, one of 12 Mycobacterium tuberculosis alternative sigma factors, is induced by heat, oxidative and nitric oxide stresses. SigH activation has been shown to increase expression of several genes, including genes involved in maintaining redox equilibrium and in protein degradation. However, few of these are known to be directly regulated by SigH. The goal of this project is to comprehensively define the Mycobacterium tuberculosis genes and operons that are directly controlled by SigH in order to gain insight into the role of SigH in regulating M. tuberculosis physiology. We used ChIP-Seq to identify in vivo SigH binding sites throughout the M. tuberculosis genome, followed by quantification of SigH-dependent expression of genes linked to these sites and identification of SigH-regulated promoters. We identified 69 SigH binding sites, which are located both in intergenic regions and within annotated coding sequences in the annotated M. tuberculosis genome. 41 binding sites were linked to genes that showed greater expression following heat stress in a SigH-dependent manner. We identified several genes not previously known to be regulated by SigH, including genes involved in DNA repair, cysteine biosynthesis, translation, and genes of unknown function. Experimental and computational analysis of SigH-regulated promoter sequences within these binding sites identified strong consensus -35 and -10 promoter sequences, but with tolerance for non-consensus bases at specific positions. This comprehensive identification and validation of SigH-regulated genes demonstrates an extended SigH regulon that controls an unexpectedly broad range of stress response functions.	[Sharp, Jared D.; Singh, Atul K.; Potluri, Lakshmi-Prasad; Husson, Robert N.] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sharp, Jared D.; Singh, Atul K.; Potluri, Lakshmi-Prasad; Husson, Robert N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Park, Sang Tae; Raman, Sahadevan; Galagan, James E.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA; [Lyubetskaya, Anna; Gomes, Antonio L. C.; Galagan, James E.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Galagan, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Peterson, Matthew W.; Galagan, James E.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Sharp, Jared D.] Affinivax, Cambridge, MA 02139 USA; [Park, Sang Tae] Macrogen Clin Lab, Rockville, MD 20850 USA; [Lyubetskaya, Anna] Beth Israel Deaconess Med Ctr, Bioinformat Program, Boston, MA 02115 USA; [Gomes, Antonio L. C.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Raman, Sahadevan] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Columbia University; Harvard University; Brigham & Women's Hospital	Husson, RN (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.; Husson, RN (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.; Galagan, JE (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA.; Galagan, JE (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.; Galagan, JE (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Galagan, JE (corresponding author), Boston Univ, Dept Microbiol, Boston, MA 02215 USA.	jgalag@bu.edu; robert.husson@childrens.harvard.edu	Potluri, Lakshmi-Prasad/D-3318-2013; Husson, Robert/Y-7288-2019	Potluri, Lakshmi-Prasad/0000-0001-5260-6678; Galagan, James/0000-0003-0542-3291; Lyubetskaya, Anna/0000-0003-2485-3924; Raman, Sahadevan/0000-0001-5309-8169; Gomes, Antonio LC/0000-0003-3790-3724	National Institute of Allergy and Infectious Diseases [R01AI37901]; Boston Children's Hospital internal funding; National Institute of General Medical Sciences [R01GM114812]; National Institutes of Health [T32HD055148]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800059C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114812] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boston Children's Hospital internal funding; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Allergy and Infectious Diseases R01AI37901 to RNH; Boston Children's Hospital internal funding (no grant number) to RNH; and National Institute of General Medical Sciences R01GM114812 to JEG. JDS was supported in part by National Institutes of Health training grant T32HD055148. This project was funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract no. HHSN272200800059C to JEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z., 2001, HIGH THROUGHPUT QUAN; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Fitzgerald DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004649; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Ghosh P, 2013, INFECT IMMUN, V81, P2242, DOI 10.1128/IAI.01273-12; Gomes ALC, 2014, GENOME RES, V24, P1686, DOI 10.1101/gr.161711.113; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kahramanoglou C, 2014, NUCLEIC ACIDS RES, V42, P8320, DOI 10.1093/nar/gku548; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0007-2013; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Song T, 2008, J BACTERIOL, V190, P2227, DOI 10.1128/JB.01642-07; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07	38	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152145	10.1371/journal.pone.0152145	http://dx.doi.org/10.1371/journal.pone.0152145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003599	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400085
J	Ju, CR; Chen, M; Zhang, JH; Lin, ZY; Chen, RC				Ju, Chun-rong; Chen, Miao; Zhang, Jian-heng; Lin, Zhi-ya; Chen, Rong-chang			Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; BRAIN NATRIURETIC PEPTIDE; SKELETAL-MUSCLE ATROPHY; ECHOCARDIOGRAPHIC-ASSESSMENT; HEART-FAILURE; EXPRESSION; GROWTH; HYPERTENSION; MYOCARDIUM; GUIDELINES	Objective To analyze plasma myostatin levels and investigate their relationship with right ventricular (RV) function in patients with cor pulmonale secondary to chronic obstructive pulmonary disease (COPD). Methods The study recruited 81 patients with advanced COPD and 40 age-matched controls. The patients were divided into two groups: those with cor pulmonale and those without. Echocardiography was used to evaluate RV function and morphology, and the value of tricuspid annular plane systolic excursion (TAPSE) less than 16 mm was considered RV dysfunction. Plasma myostatin levels were analyzed by enzyme-linked immunosorbent assay, and B-type natriuretic peptide (BNP) levels were analyzed as a comparison of myostatin. Results The data detected cor pulmonale in 39/81 patients, with the mean value of TAPSE of 14.3 mm. Plasma myostatin levels (ng/mL) were significantly higher in patients with cor pulmonale (16.68 +/- 2.95) than in those without (13.56 +/- 3.09), and much higher than in controls (8.79 +/- 2.79), with each p<0.01. Significant differences were also found in plasma BNP levels among the three groups (p<0.05). Multivariate regression analysis suggested that myostatin levels were significantly correlated with the values of TAPSE and RV myocardium performance index among the COPD patients, and that BNP levels were significantly correlated only with systolic pulmonary arterial pressure, with each p<0.05. Conclusions Plasma myostatin levels are increased in COPD patients who have cor pulmonale. Stronger correlations of plasma myostatin levels with echocardiographic indexes of the right heart suggest that myostatin might be superior to BNP in the early diagnosis of cor pulmonale in COPD.	[Ju, Chun-rong; Chen, Miao; Zhang, Jian-heng; Lin, Zhi-ya; Chen, Rong-chang] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrc_1234@163.com			Chinese Natural Science Foundation [81100034]; Guangdong Provincial Natural Science Foundation [2015A030313457]; American Thoracic Society	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); American Thoracic Society	This work was funded by Chinese Natural Science Foundation Program (Grant 81100034) and Guangdong Provincial Natural Science Foundation Program (2015A030313457).; We thank the MECOR faculty, especially Prof Sonia Buist and Dr Jeffrey Curtis for their generous help during project preparation. The manuscript was developed at MECOR CHINA sponsored by the American Thoracic Society. This study was supported by both the Chinese Natural Science Foundation Program (Grant 81100034) and Guangdong Provincial Natural Science Foundation Program (2015A030313457). The authors thank Xiao-lu Bao, who is the director of Guangzhou Old Age Association, for coordinating and contributing to the recruitment of healthy controls in this study.	Bin Yap L, 2004, CHEST, V126, P1330, DOI 10.1378/chest.126.4.1330; Bish LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010230; Budev MM, 2003, SEMIN RESP CRIT CARE, V24, P233; Casserly B, 2009, DRUG DES DEV THER, V3, P269; Chua S, 2009, EUR J ECHOCARDIOGR, V10, P619, DOI 10.1093/ejechocard/jep013; Damy T, 2012, J CARD FAIL, V18, P216, DOI 10.1016/j.cardfail.2011.12.003; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Freixa X, 2013, EUR RESPIR J, V41, P784, DOI 10.1183/09031936.00222511; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Granton John, 2008, Anesthesiol Clin, V26, P337, DOI 10.1016/j.anclin.2008.01.010; Grignola JC, 2006, INT J CARDIOL, V113, P25, DOI 10.1016/j.ijcard.2005.10.012; Gruson D, 2012, PEPTIDES, V33, P351, DOI 10.1016/j.peptides.2011.12.017; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hilde JM, 2013, J AM COLL CARDIOL, V62, P1103, DOI 10.1016/j.jacc.2013.04.091; Ho SY, 2006, HEART, V92, pI2, DOI 10.1136/hrt.2005.077875; Hoiseth AD, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-97; Jespersen J, 2006, SCAND J MED SCI SPOR, V16, P74, DOI 10.1111/j.1600-0838.2005.00498.x; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Kolb TM, 2012, CARDIOL CLIN, V30, P243, DOI 10.1016/j.ccl.2012.03.005; Lee-Chiong TL, 2003, SEMIN RESP CRIT CARE, V24, P263; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; Leuchte HH, 2005, CHEST, V128, P2368, DOI 10.1378/chest.128.4.2368; Mckoy G, 2007, CARDIOVASC RES, V74, P304, DOI 10.1016/j.cardiores.2007.02.023; McNally EM, 2004, NEW ENGL J MED, V350, P2642, DOI 10.1056/NEJMp048124; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Radom-Aizik S, 2013, PEDIATR RES, V74, P111, DOI 10.1038/pr.2013.80; Rafacho BPM, 2011, CELL PHYSIOL BIOCHEM, V27, P305, DOI 10.1159/000327957; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sabit R, 2010, RESP MED, V104, P1171, DOI 10.1016/j.rmed.2010.01.020; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shujaat Adil, 2007, Int J Chron Obstruct Pulmon Dis, V2, P273; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Tulevski II, 2001, HEART, V86, P27, DOI 10.1136/heart.86.1.27; Ventetuolo Corey E, 2012, Pulm Circ, V2, P379, DOI 10.4103/2045-8932.101657; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang RW, 2008, J ENDOCRINOL, V197, P85, DOI 10.1677/JOE-07-0596; Weitzenblum E, 2003, HEART, V89, P225, DOI 10.1136/heart.89.2.225; Wintgens KF, 2012, CLIN CHIM ACTA, V413, P1288, DOI 10.1016/j.cca.2012.04.023; Zachwieja J J, 1999, J Gravit Physiol, V6, P11; Zangiabadi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/739674	45	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150838	10.1371/journal.pone.0150838	http://dx.doi.org/10.1371/journal.pone.0150838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998756	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700015
J	Mayer-Scholl, A; Murugaiyan, J; Neumann, J; Bahn, P; Reckinger, S; Nockler, K				Mayer-Scholl, Anne; Murugaiyan, Jayaseelan; Neumann, Jennifer; Bahn, Peter; Reckinger, Sabine; Noeckler, Karsten			Rapid Identification of the Foodborne Pathogen Trichinella spp. by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry	PLOS ONE			English	Article							MIXED INFECTION; TRICHINOSIS; SPIRALIS; ANIMALS; PCR	Human trichinellosis occurs through consumption of raw or inadequately processed meat or meat products containing larvae of the parasitic nematodes of the genus Trichinella. Currently, nine species and three genotypes are recognized, of which T. spiralis, T. britovi and T. pseudospiralis have the highest public health relevance. To date, the differentiation of the larvae to the species and genotype level is based primarily on molecular methods, which can be relatively time consuming and labor intensive. Due to its rapidness and ease of use a matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) reference spectra database using Trichinella strains of all known species and genotypes was created. A formicacid/acetonitrile protein extraction was carried out after pooling 10 larvae of each Trichinella species and genotype. Each sample was spotted 9 times using a-cyano 4-hydoxy cinnamic acid matrix and a MicroFlex LT mass spectrometer was used to acquire 3 spectra (m/z 2000 to 20000 Da) from each spot resulting in 27 spectra/species or genotype. Following the spectra quality assessment, Biotyper software was used to create a main spectra library (MSP) representing nine species and three genotypes of Trichinella. The evaluation of the spectra generated by MALDI-TOF MS revealed a classification which was comparable to the results obtained by molecular methods. Also, each Trichinella species utilized in this study was distinct and distinguishable with a high confidence level. Further, different conservation methods such as freezing and conservation in alcohol and the host species origin of the isolated larvae did not have a significant influence on the generated spectra. Therefore, the described MALDI-TOF MS can successfully be implemented for both genus and species level identification and represents a major step forward in the use of this technique in foodborne parasitology.	[Mayer-Scholl, Anne; Neumann, Jennifer; Bahn, Peter; Reckinger, Sabine; Noeckler, Karsten] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Murugaiyan, Jayaseelan] Free Univ Berlin, Ctr Infect Med, Inst Anim Hyg & Environm Hlth, Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin	Mayer-Scholl, A (corresponding author), Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	anne.mayer-scholl@bfr.bund.de	Murugaiyan, Jayaseelan/D-4619-2009	Murugaiyan, Jayaseelan/0000-0002-1924-2988				FAO WHO, 2014, REP JOINT FAO WHO EX; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Hoppenheit A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002305; IQACA, ESS QUAL ASS STAND T; Krivokapich SJ, 2012, INT J PARASITOL, V42, P903, DOI 10.1016/j.ijpara.2012.07.009; La Grange LJ, 2014, ONDERSTEPOORT J VET, V81; Liciardi M, 2009, VET PARASITOL, V161, P345, DOI 10.1016/j.vetpar.2009.01.013; Mayer-Scholl A, 2014, VET PARASITOL, V203, P247, DOI 10.1016/j.vetpar.2014.01.015; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Murugaiyan J, 2012, CLIN MICROBIOL INFEC, V18, P461, DOI 10.1111/j.1469-0691.2011.03593.x; Nockler K, 2006, VET PARASITOL, V137, P364, DOI 10.1016/j.vetpar.2006.01.031; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Pozio Edoardo, 2003, Methods Mol Biol, V216, P299; Pozio E, 2009, INFECT GENET EVOL, V9, P606, DOI 10.1016/j.meegid.2009.03.003; Richter C, 2012, J MED MICROBIOL, V61, P1409, DOI 10.1099/jmm.0.042606-0; Trichinellosis, 2012, TRICHINELLOSIS; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Zarlenga DS, 2006, P NATL ACAD SCI USA, V103, P7354, DOI 10.1073/pnas.0602466103; Zarlenga DS, 1999, INT J PARASITOL, V29, P1859, DOI 10.1016/S0020-7519(99)00107-1	21	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152062	10.1371/journal.pone.0152062	http://dx.doi.org/10.1371/journal.pone.0152062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999436	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700097
J	Ahmed, S; Zhan, CS; Yang, YY; Wang, XK; Yang, TW; Zhao, ZY; Zhang, QY; Li, XH; Hu, XB				Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo			The Transcript Profile of a Traditional Chinese Medicine, Atractylodes lancea, Revealing Its Sesquiterpenoid Biosynthesis of the Major Active Components	PLOS ONE			English	Article							SSR MARKER DEVELOPMENT; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; GENE-EXPRESSION; SYNTHASE GENES; ESSENTIAL OILS; RNA-SEQ; RHIZOMES; L.; EVOLUTION	Atractylodes lancea (Thunb.) DC., named "Cangzhu" in China, which belongs to the Asteraceae family. In some countries of Southeast Asia (China, Thailand, Korea, Japan etc.) its rhizome, commonly called rhizoma atractylodis, is used to treat many diseases as it contains a variety of sesquiterpenoids and other components of medicinal importance. Despite its medicinal value, the information of the sesquiterpenoid biosynthesis is largely unknown. In this study, we investigated the transcriptome analysis of different tissues of non-model plant A. lancea by using short read sequencing technology (Illumina). We found 62,352 high quality unigenes with an average sequence length of 913 bp in the transcripts of A. Lancea. Among these, 43,049 (69.04%), 30,264 (48.53%), 26,233 (42.07%), 17,881 (28.67%) and 29,057(46.60%) unigenes showed significant similarity (E-value<1e(-5)) to known proteins in Nr, KEGG, SWISS- PROT, GO, and COG databases, respectively. Of the total 62,352 unigenes, 43,049 (Nr Database) open reading frames were predicted. On the basis of different bioinformatics tools we identify all the enzymes that take part in the terpenoid biosynthesis as well as five different known sesquiterpenoids via cytosolic mevalonic acid (MVA) pathway and plastidal methylerythritol phosphate (MEP) pathways. In our study, 6, 864 Simple Sequence Repeats (SSRs) were also found as great potential markers in A. lancea. This transcriptomic resource of A. lancea provides a great contribution in advancement of research for this specific medicinal plant and more specifically for the gene mining of different classes of terpenoids and other chemical compounds that have medicinal as well as economic importance.	[Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Dept Med Plant, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China; [Ahmed, Shakeel; Zhan, Chuansong; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Ctr Plant Funct Components, Wuhan 430070, Peoples R China; [Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Natl Reg Joint Engn Res Ctr Hubei Med Plant Breed, Wuhan 430070, Peoples R China; [Ahmed, Shakeel; Zhan, Chuansong; Yang, Yanyan; Wang, Xuekui; Yang, Tewu; Zhao, Zeying; Zhang, Qiyun; Li, Xiaohua; Hu, Xuebo] Huazhong Agr Univ, Engn Res Ctr Med Plants, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Hu, XB (corresponding author), Huazhong Agr Univ, Dept Med Plant, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China.; Hu, XB (corresponding author), Huazhong Agr Univ, Ctr Plant Funct Components, Wuhan 430070, Peoples R China.; Hu, XB (corresponding author), Huazhong Agr Univ, Natl Reg Joint Engn Res Ctr Hubei Med Plant Breed, Wuhan 430070, Peoples R China.; Hu, XB (corresponding author), Huazhong Agr Univ, Engn Res Ctr Med Plants, Wuhan 430070, Peoples R China.	xuebohu@mail.hzau.edu.cn	Awan, Shakeel Ahmed/AAG-2097-2019	Awan, Shakeel Ahmed/0000-0003-0086-2279	Fundamental Research Funds for the Central Universities Program [2014PY057]; Natural Science Foundation of Hubei Province, China [2015CFA091]	Fundamental Research Funds for the Central Universities Program; Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This research was supported by the Fundamental Research Funds for the Central Universities Program No. 2014PY057 (XH) and Natural Science Foundation of Hubei Province, China, No. 2015CFA091 (XH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MH, 2002, PHYTOCHEMISTRY, V60, P255, DOI 10.1016/S0031-9422(02)00103-6; Bushman BS, 2011, THEOR APPL GENET, V123, P119, DOI 10.1007/s00122-011-1571-2; Cane D.E., 1999, COMPR NAT PROD CHEM, V2, P155, DOI [10.1016/B978-0-08-091283-7.00039-4, DOI 10.1016/B978-0-08-091283-7.00039-4]; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Chen HP, 2015, CHEM BIODIVERS, V12, P593, DOI 10.1002/cbdv.201400161; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chung J, 2009, J KOREAN SOC INT AGR; CORNWELL PA, 1994, J PHARM PHARMACOL, V46, P261, DOI 10.1111/j.2042-7158.1994.tb03791.x; Crock J, 1997, P NATL ACAD SCI USA, V94, P12833, DOI 10.1073/pnas.94.24.12833; de Kraker JW, 1998, PLANT PHYSIOL, V117, P1381, DOI 10.1104/pp.117.4.1381; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Di Sotto A, 2008, MUTAT RES-GEN TOX EN, V653, P130, DOI 10.1016/j.mrgentox.2008.04.004; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Dong SB, 2014, GENE, V544, P220, DOI 10.1016/j.gene.2014.04.031; Duan JA, 2008, ARCH PHARM RES, V31, P965, DOI 10.1007/s12272-001-1252-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Herb ECoNCMMBC, 1999, HERB ECONCMMBC; Inagaki N, 2001, PLANTA MED, V67, P428, DOI 10.1055/s-2001-15822; Irmisch S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-84; Iseli C, 1999, ESTSCAN PROGRAM DETE; Jia Chunxiao, 2004, Zhong Yao Cai, V27, P571; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kitajima J, 2003, CHEM PHARM BULL, V51, P673, DOI 10.1248/cpb.51.673; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P169, DOI 10.1111/pbi.12022; Legault J, 2007, J PHARM PHARMACOL, V59, P1643, DOI 10.1211/jpp.59.12.0005; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Liu MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1477-5; Liu Yanju, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2276; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074441; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masuda Y, 2015, J NAT MED-TOKYO, V69, P332, DOI 10.1007/s11418-015-0897-5; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Na-Bangchang Kesara, 2014, Trop Med Health, V42, P3, DOI 10.2149/tmh.2014-S01; Nakai Y, 2003, J ETHNOPHARMACOL, V84, P51, DOI 10.1016/S0378-8741(02)00260-X; Neeraja CN, 2007, THEOR APPL GENET, V115, P767, DOI 10.1007/s00122-007-0607-0; Parshikov IA, 2014, PROCESS BIOCHEM, V49, P2086, DOI 10.1016/j.procbio.2014.09.005; Picaud S, 2005, PHYTOCHEMISTRY, V66, P961, DOI 10.1016/j.phytochem.2005.03.027; Picaud S, 2006, ARCH BIOCHEM BIOPHYS, V452, P17, DOI 10.1016/j.abb.2006.06.007; Prosser I, 2002, PHYTOCHEMISTRY, V60, P691, DOI 10.1016/S0031-9422(02)00165-6; Prosser I, 2004, ARCH BIOCHEM BIOPHYS, V432, P136, DOI 10.1016/j.abb.2004.06.030; Reineccius G. A., 2007, FLAVOURS FRAGRANCES; Resch M, 1998, J NAT PROD, V61, P347, DOI 10.1021/np970430b; Resch M, 2001, PLANTA MED, V67, P437, DOI 10.1055/s-2001-15817; Sangwan RS, 2013, GENE, V525, P58, DOI 10.1016/j.gene.2013.04.057; Senior ML, 1998, CROP SCI, V38, P1088, DOI 10.2135/cropsci1998.0011183X003800040034x; Sharon-Asa L, 2003, PLANT J, V36, P664, DOI 10.1046/j.1365-313X.2003.01910.x; Simonsen H.T., 2013, NATURAL PRODUCTS, P3069, DOI [10.1007/978-3-642-22144-6_134, DOI 10.1007/978-3-642-22144-6_134]; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Hoeven RS, 2000, PLANT CELL, V12, P2283, DOI 10.1105/tpc.12.11.2283; Verma VK, 2007, SCI HORTIC-AMSTERDAM, V113, P231, DOI 10.1016/j.scienta.2007.03.019; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HX, 2008, PHYTOCHEMISTRY, V69, P2088, DOI 10.1016/j.phytochem.2008.04.008; Wang KT, 2010, J PHARM PHARMACOL, V62, P381, DOI 10.1211/jpp.62.03.0014; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y, 2002, GENOME, V45, P319, DOI 10.1139/G01-153; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Xia JH, 2012, PHYTOCHEMISTRY, V74, P178, DOI 10.1016/j.phytochem.2011.11.011; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yang Y, 2014, GENE, V534, P155, DOI 10.1016/j.gene.2013.10.073; Yin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073767; Yu F, 2008, FEBS LETT, V582, P565, DOI 10.1016/j.febslet.2008.01.020; Yu Y, 2015, J ETHNOPHARMACOL, V160, P211, DOI 10.1016/j.jep.2014.10.066; Zhao CL, 2010, NAT PROD COMMUN, V5, P1147; Zhao WG, 2009, J INTEGR PLANT BIOL, V51, P1126, DOI 10.1111/j.1744-7909.2009.00883.x; Zhuang XF, 2012, PLANT J, V69, P70, DOI 10.1111/j.1365-313X.2011.04771.x; Zwenger S., 2008, Biotechnology and Molecular Biology Reviews, V3, P001	79	20	23	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151975	10.1371/journal.pone.0151975	http://dx.doi.org/10.1371/journal.pone.0151975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990438	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800126
J	Nam, SK; Yun, S; Koh, J; Kwak, Y; Seo, AN; Park, KU; Kim, DW; Kang, SB; Kim, WH; Lee, HS				Nam, Soo Kyung; Yun, Sumi; Koh, Jiwon; Kwak, Yoonjin; Seo, An Na; Park, Kyoung Un; Kim, Duck-Woo; Kang, Sung-Bum; Kim, Woo Ho; Lee, Hye Seung			BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis	PLOS ONE			English	Article							ANTI-EGFR THERAPY; MONOCLONAL-ANTIBODIES; ACQUIRED-RESISTANCE; KOREAN PATIENTS; PI3K PATHWAY; CARCINOMA; HETEROGENEITY; NRAS; IMPACT	Background Anti-EGFR antibody-based treatment is an important therapeutic strategy for advanced colorectal cancer (CRC); despite this, several mutations-including KRAS, BRAF, and PIK3CA mutations, and HER2 amplification-are associated with the mechanisms underlying the development of resistance to anti-EGFR therapy. The aim of our study was to investigate the frequencies and clinical implications of these genetic alterations in advanced CRC. Methods KRAS, BRAF, and PIK3CA mutations were determined by Cobas real-time polymerase chain reaction (PCR) in 191 advanced CRC patients with distant metastasis. Microsatellite instability (MSI) status was determined by a fragmentation assay and HER2 amplification was assessed by silver in situ hybridization. In addition, KRAS mutations were investigated by the Sanger sequencing method in 97 of 191 CRC cases. Results Mutations in KRAS, BRAF, and PIK3CA were found in 104 (54.5%), 6 (3.1%), and 25 (13.1%) cases of advanced CRC, respectively. MSI-high status and HER2 amplification were observed in 3 (1.6%) and 16 (8.4%) cases, respectively. PIK3CA mutations were more frequently found in KRAS mutant type (18.3%) than KRAS wild type (6.9%) (P = 0.020). In contrast, HER2 amplifications and BRAF mutations were associated with KRAS wild type with borderline significance (P = 0.052 and 0.094, respectively). In combined analyses with KRAS, BRAF and HER2 status, BRAF mutations or HER2 amplifications were associated with the worst prognosis in the wild type KRAS group (P = 0.004). When comparing the efficacy of detection methods, the results of real time PCR analysis revealed 56 of 97 (57.7%) CRC cases with KRAS mutations, whereas Sanger sequencing revealed 49 cases (50.5%). Conclusions KRAS mutations were found in 54.5% of advanced CRC patients. Our results support that subgrouping using PIK3CA and BRAF mutation or HER2 amplification status, in addition to KRAS mutation status, is helpful for managing advanced CRC patients.	[Nam, Soo Kyung; Yun, Sumi; Kwak, Yoonjin; Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Yun, Sumi; Koh, Jiwon; Kwak, Yoonjin; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Seo, An Na] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Pathol, Daegu, South Korea; [Park, Kyoung Un] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Lab Med, Songnam, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011; Park, Kyoung Un/J-5473-2012	Lee, Hye Seung/0000-0002-1667-7986; Park, Kyoung Un/0000-0002-2402-7633	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1813]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1813, https://www.khidi.or.kr/eps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Er TK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591867; Heppner BI, 2014, BRIT J CANCER, V111, P1977, DOI 10.1038/bjc.2014.483; Imamura Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-135; Kawazoe A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1276-z; Kim B, 2014, WORLD J GASTROENTERO, V20, P4370, DOI 10.3748/wjg.v20.i15.4370; Kim Jung Ho, 2014, Korean J Pathol, V48, P276, DOI 10.4132/KoreanJPathol.2014.48.4.276; Kim MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-347; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Leto SM, 2014, J MOL MED, V92, P709, DOI 10.1007/s00109-014-1161-2; Ma BB, 2015, ASIA-PAC J CLIN ONCO, V11, P160, DOI 10.1111/ajco.12342; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Martin V, 2013, BRIT J CANCER, V108, P668, DOI 10.1038/bjc.2013.4; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Neumann J, 2013, VIRCHOWS ARCH, V463, P509, DOI 10.1007/s00428-013-1450-0; Normanno N, 2015, ANN ONCOL, V26, P1710, DOI 10.1093/annonc/mdv176; Oh JR, 2012, FAM CANCER, V11, P459, DOI 10.1007/s10689-012-9536-4; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Sahin IH, 2013, J CANCER, V4, P320, DOI 10.7150/jca.3619; Seo AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098528; Shaib W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/j.issn.2078-6891.2013.029; Temraz S, 2015, INT J MOL SCI, V16, P22976, DOI 10.3390/ijms160922976; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163, DOI 10.2174/187152012799014968; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010	34	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151865	10.1371/journal.pone.0151865	http://dx.doi.org/10.1371/journal.pone.0151865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991109	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800112
J	Oji, S; Nicolussi, EM; Kaufmann, N; Zeka, B; Schanda, K; Fujihara, K; Illes, Z; Dahle, C; Reindl, M; Lassmann, H; Bradl, M				Oji, Satoru; Nicolussi, Eva-Maria; Kaufmann, Nathalie; Zeka, Bleranda; Schanda, Kathrin; Fujihara, Kazuo; Illes, Zsolt; Dahle, Charlotte; Reindl, Markus; Lassmann, Hans; Bradl, Monika			Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENTIRE C1QR(2)S(2) COMPLEX; NECROSIS-FACTOR FAMILY; CELL-ACTIVATING FACTOR; BLOOD-BRAIN-BARRIER; C VIRUS-INFECTION; MULTIPLE-SCLEROSIS; IFN-BETA; CEREBROSPINAL-FLUID; STIMULATED GENES	Neuromyelitis optica (NMO) is an acute inflammatory disease of the central nervous system (CNS) which predominantly affects spinal cord and optic nerves. Most patients harbor pathogenic autoantibodies, the so-called NMO-IgGs, which are directed against the water channel aquaporin 4 (AQP4) on astrocytes. When these antibodies gain access to the CNS, they mediate astrocyte destruction by complement-dependent and by antibody-dependent cellular cytotoxicity. In contrast to multiple sclerosis (MS) patients who benefit from therapies involving type I interferons (I-IFN), NMO patients typically do not profit from such treatments. How is I-IFN involved in NMO pathogenesis? To address this question, we made gene expression profiles of spinal cords from Lewis rat models of experimental neuromyelitis optica (ENMO) and experimental autoimmune encephalomyelitis (EAE). We found an upregulation of I-IFN signature genes in EAE spinal cords, and a further upregulation of these genes in ENMO. To learn whether the local I-IFN signature is harmful or beneficial, we induced ENMO by transfer of CNS antigen-specific T cells and NMO-IgG, and treated the animals with I-IFN at the very onset of clinical symptoms, when the blood-brain barrier was open. With this treatment regimen, we could amplify possible effects of the I-IFN induced genes on the transmigration of infiltrating cells through the blood brain barrier, and on lesion formation and expansion, but could avoid effects of I-IFN on the differentiation of pathogenic T and B cells in the lymph nodes. We observed that I-IFN treated ENMO rats had spinal cord lesions with fewer T cells, macrophages/activated microglia and activated neutrophils, and less astrocyte damage than their vehicle treated counterparts, suggesting beneficial effects of I-IFN.	[Oji, Satoru; Nicolussi, Eva-Maria; Kaufmann, Nathalie; Zeka, Bleranda; Lassmann, Hans; Bradl, Monika] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Vienna, Austria; [Schanda, Kathrin; Reindl, Markus] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria; [Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan; [Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Illes, Zsolt] Univ Southern Denmark, Dept Neurol, Odense, Denmark; [Dahle, Charlotte] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Dahle, Charlotte] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Medical University of Vienna; Medical University of Innsbruck; Tohoku University; Tohoku University; University of Southern Denmark; Linkoping University; Linkoping University	Bradl, M (corresponding author), Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Vienna, Austria.	monika.bradl@meduniwien.ac.at	Oji, Satoru/AAX-4144-2021; Lassmann, Hans/Z-2269-2019; Reindl, Markus/ABE-5880-2020	Lassmann, Hans/0000-0001-8617-5052; Reindl, Markus/0000-0003-2817-1402; Kaufmann, Nathalie/0000-0002-4823-6923; Illes, Zsolt/0000-0001-9655-0450	Austrian Science Fund [P25240-B24]; Austrian Ministry of Science, Research and Economy (BIGWIG-MS); Ministry of Education, Culture, Sports, Science and Technology of Japan; Alumni Association of Saitama Medical University; Austrian Science Fund (FWF) [P 25240] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science, Research and Economy (BIGWIG-MS); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Alumni Association of Saitama Medical University; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (grant number P25240-B24 to MB), by the Austrian Ministry of Science, Research and Economy (BIGWIG-MS to HL and MR), by Grants-in-aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan to KF, and by a travel grant from the Alumni Association of Saitama Medical University to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2014, WORLD J DIABETES, V5, P586, DOI 10.4239/wjd.v5.i5.586; Asgari N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/713519; Austin BA, 2005, J IMMUNOL, V175, P1100, DOI 10.4049/jimmunol.175.2.1100; Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; BARNUM SR, 1992, BIOCHEM J, V287, P595, DOI 10.1042/bj2870595; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bergman CM, 2012, J IMMUNOL, V188, P6001, DOI 10.4049/jimmunol.1101898; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Borysiewicz E, 2009, J NEUROSCI RES, V87, P1565, DOI 10.1002/jnr.21968; Boutros T, 1997, J NEUROCHEM, V69, P939; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Brand-Schieber E, 2004, BRAIN RES, V1007, P178, DOI 10.1016/j.brainres.2003.12.051; Brendecke SM, 2012, J LEUKOCYTE BIOL, V92, P479, DOI 10.1189/jlb.0112043; Brodsky LI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000584; Bulwin GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001576; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Carter RH, 2005, ARTHRITIS RHEUM-US, V52, P3943, DOI 10.1002/art.21489; Chabot S, 1997, J CLIN INVEST, V100, P604, DOI 10.1172/JCI119571; Chen CH, 1998, IMMUNOLOGY, V95, P648; Chen CH, 1998, CLIN IMMUNOL IMMUNOP, V87, P68, DOI 10.1006/clin.1997.4515; Chen F, 2013, J CEREBR BLOOD F MET, V33, P1041, DOI 10.1038/jcbfm.2013.45; Chihara N, 2011, P NATL ACAD SCI USA, V108, P3701, DOI 10.1073/pnas.1017385108; COLLINS JM, 1985, CANC DRUG DEL, V2, P247, DOI 10.1089/cdd.1985.2.247; Das A, 2014, J VIROL, V88, P3103, DOI 10.1128/JVI.03202-13; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Feng X, 2011, J NEUROL SCI; Giannattasio G, 2011, J IMMUNOL, V187, P1486, DOI 10.4049/jimmunol.1003669; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Gveric D, 1999, NEUROPATH APPL NEURO, V25, P215; Harmel J, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0247-3; Hasham A, 2013, J AUTOIMMUN, V44, P61, DOI 10.1016/j.jaut.2013.04.002; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Howe CL, 2014, GLIA, V62, P692, DOI 10.1002/glia.22635; Howie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073610; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hultcrantz M, 2007, VIROLOGY, V367, P92, DOI 10.1016/j.virol.2007.05.010; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Inglis HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048555; Ittah M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1912; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jacob A, 2012, MULT SCLER J, V18, P1801, DOI 10.1177/1352458512443994; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalinke U, 2012, IMMUNOL CELL BIOL, V90, P505, DOI 10.1038/icb.2012.8; Khan TH, 2014, J IMMUNOL, V193, P3644, DOI 10.4049/jimmunol.1400620; Khorooshi R, 2015, ACTA NEUROPATHOL, V130, P107, DOI 10.1007/s00401-015-1418-z; Khorooshi R, 2013, EXP NEUROL, V247, P744, DOI 10.1016/j.expneurol.2013.02.005; Kim SG, 2003, BIOCHEM PHARMACOL, V65, P923, DOI 10.1016/S0006-2952(02)01614-3; Kocur M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0192-4; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krumbholz M, 2008, BRAIN, V131, P1455, DOI 10.1093/brain/awn077; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Major MB, 2004, J BIOL CHEM, V279, P5278, DOI 10.1074/jbc.M311517200; Mangioni D, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-56; Matus-Nicodemos R, 2011, J IMMUNOL, V186, P2164, DOI 10.4049/jimmunol.1003236; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; McGlasson S, 2015, NAT REV NEUROL, V11, P515, DOI 10.1038/nrneurol.2015.143; Mendoza P, 2014, CURR MOL MED, V14, P235, DOI 10.2174/1566524014666140128111347; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Ni W, 1997, BRAIN RES, V769, P97, DOI 10.1016/S0006-8993(97)00676-8; Nicolussi EM, 2009, NEUROBIOL DIS, V35, P24, DOI 10.1016/j.nbd.2009.03.010; Okenwa C, 2013, J IMMUNOL, V191, P2589, DOI 10.4049/jimmunol.1300466; Oliveira TL, 2014, ACTA REUMATOL PORT, V39, P327; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Ortuno-Sahagun D, 2010, HIPPOCAMPUS; Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Papadopoulos MC, 2014, NAT REV NEUROL, V10, P493, DOI 10.1038/nrneurol.2014.141; Papeix C, 2007, MULT SCLER, V13, P256, DOI 10.1177/1352458506070732; Park OK, 2010, J NEUROL SCI, V294, P7, DOI 10.1016/j.jns.2010.04.013; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; PIDDLESDEN S, 1991, CLIN EXP IMMUNOL, V83, P245; Pohl M, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-85; Pohl M, 2011, ACTA NEUROPATHOL, V122, P21, DOI 10.1007/s00401-011-0824-0; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; Ratelade J, 2013, ACTA NEUROPATHOL, V126, P699, DOI 10.1007/s00401-013-1172-z; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Satoh J, 2008, NEUROPATHOLOGY, V28, P561, DOI 10.1111/j.1440-1789.2008.00915.x; Savarin C, 2013, ASN NEURO, V5, DOI 10.1042/AN20130033; Schick N, 2004, J BIOL CHEM, V279, P38787, DOI 10.1074/jbc.M312581200; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sene D, 2007, RHEUMATOLOGY, V46, P65, DOI 10.1093/rheumatology/kel177; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Shimizu Y, 2008, J NEUROL, V255, P305, DOI 10.1007/s00415-007-0730-5; Strokin M, 2007, J NEUROCHEM, V102, P1771, DOI 10.1111/j.1471-4159.2007.04663.x; Strokin M, 2011, AM J PHYSIOL-CELL PH, V300, pC542, DOI 10.1152/ajpcell.00428.2010; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Takata Y, 2007, ARTHRITIS RHEUM-US, V56, P30, DOI 10.1002/art.22262; Takeyama K, 2003, J BIOL CHEM, V278, P21930, DOI 10.1074/jbc.M301157200; Tanaka M, 2009, EUR NEUROL, V62, P167, DOI 10.1159/000227277; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Toubi E, 2006, J AUTOIMMUN, V27, P134, DOI 10.1016/j.jaut.2006.07.005; Usmani N, 2014, J NEUROL, V261, P240, DOI 10.1007/s00415-013-7202-x; Uzawa A, 2010, EUR J NEUROL, V17, P672, DOI 10.1111/j.1468-1331.2009.02897.x; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Vaknin-Dembinsky A, 2010, MULT SCLER, V16, P1453, DOI 10.1177/1352458510380416; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Wang HH, 2012, J CLIN IMMUNOL, V32, P1007, DOI 10.1007/s10875-012-9709-9; Wang J, 2008, MOL PSYCHIATR, V13, P293, DOI 10.1038/sj.mp.4002013; Wang KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098192; Witwer KW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008129; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Wu LJ, 2009, STROKE, V40, P2973, DOI 10.1161/STROKEAHA.109.551747; Xu X, 2013, MOL CELLS, V36, P322, DOI 10.1007/s10059-013-0114-x; Xu Y, 2011, NEUROL SCI; Yamasaki Masayoshi, 2012, Rinsho Shinkeigaku, V52, P19; Yokoyama T, 2010, J PERIODONTAL RES, V45, P780, DOI 10.1111/j.1600-0765.2010.01300.x; Zeka B, 2015, ACTA NEUROPATHOL, V130, P783, DOI 10.1007/s00401-015-1501-5; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	145	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151244	10.1371/journal.pone.0151244	http://dx.doi.org/10.1371/journal.pone.0151244			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990978	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800051
J	Thayer, KM; Beyer, GA				Thayer, Kelly M.; Beyer, George A.			Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; TUMOR-SUPPRESSOR P53; IN-VIVO; P53-HDM2 INTERACTION; PEPTIDE INHIBITORS; ONCOPROTEIN MDM2; PROTEIN; CANCER; CELLS; DISCOVERY	The ubiquitin ligase MDM2, a principle regulator of the tumor suppressor p53, plays an integral role in regulating cellular levels of p53 and thus a prominent role in current cancer research. Computational analysis used MUMBO to rotamerize the MDM2-p53 crystal structure 1YCR to obtain an exhaustive search of point mutations, resulting in the calculation of the Delta Delta G comprehensive energy landscape for the p53-bound regulator. The results herein have revealed a set of residues R65-E69 on MDM2 proximal to the p53 hydrophobic binding pocket that exhibited an energetic profile deviating significantly from similar residues elsewhere in the protein. In light of the continued search for novel competitive inhibitors for MDM2, we discuss possible implications of our findings on the drug discovery field.	[Thayer, Kelly M.] Dept Chem, 124 Raymond Ave, Poughkeepsie, NY 12604 USA; [Beyer, George A.] Vassar Coll, Biochem Program, 124 Raymond Ave, Poughkeepsie, NY 12604 USA; [Thayer, Kelly M.] Wesleyan Univ, Hall Atwater Labs, Middletown, CT 06459 USA	Vassar College; Wesleyan University	Thayer, KM (corresponding author), Dept Chem, 124 Raymond Ave, Poughkeepsie, NY 12604 USA.; Thayer, KM (corresponding author), Wesleyan Univ, Hall Atwater Labs, Middletown, CT 06459 USA.	kthayer@wesleyan.edu						Allen JG, 2009, J MED CHEM, V52, P7044, DOI 10.1021/jm900681h; Almerico AM, 2012, BIOCHEM BIOPH RES CO, V424, P341, DOI 10.1016/j.bbrc.2012.06.138; Anil B, 2013, ACTA CRYSTALLOGR D, V69, P1358, DOI 10.1107/S0907444913004459; Aragam NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062427; Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Beck B, 2006, QSAR COMB SCI, V25, P527, DOI 10.1002/qsar.200540300; Bizzarri AR, 2011, PHYS CHEM CHEM PHYS, V13, P2738, DOI 10.1039/c0cp01474e; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUESORAMOS CE, 1993, BLOOD, V82, P2617; Chao CCK, 2015, CLIN CHIM ACTA, V438, P139, DOI 10.1016/j.cca.2014.08.015; Chee SMQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104914; Chen HB, 2011, DRUG DISCOV TODAY, V16, P354, DOI 10.1016/j.drudis.2010.02.009; Chen JZ, 2011, J MOL GRAPH MODEL, V30, P46, DOI 10.1016/j.jmgm.2011.06.003; Chene P, 2002, FEBS LETT, V529, P293, DOI 10.1016/S0014-5793(02)03362-8; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cinatl J, 2014, BIOCHEM SOC T, V42, P752, DOI 10.1042/BST20140035; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; DeLano WL, PYMOLMOLECULAR GRAPH; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Ding Q, 2013, DISCOVERY RG7388 POT, P4; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Furet P, 2012, BIOORG MED CHEM LETT, V22, P3498, DOI 10.1016/j.bmcl.2012.03.083; Garcia PB, 2014, SEMIN CELL DEV BIOL, V27, P74, DOI 10.1016/j.semcdb.2013.12.014; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Graves B, 2012, P NATL ACAD SCI USA, V109, P11788, DOI 10.1073/pnas.1203789109; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu GD, 2010, J COMPUT AID MOL DES, V24, P687, DOI 10.1007/s10822-010-9366-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javid J, 2015, TUMOR BIOL, V36, P5425, DOI 10.1007/s13277-015-3208-6; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Khoury K, 2012, CURR PHARM DESIGN, V18, P4668, DOI 10.2174/138161212802651580; Koblish HK, 2006, MOL CANCER THER, V5, P160, DOI 10.1158/1535-7163.MCT-05-0199; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; MacCallum DE, 1996, ONCOGENE, V13, P2575; MARCHETTI A, 1995, J PATHOL, V175, P31, DOI 10.1002/path.1711750106; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Michaelis M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.35; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Millard M, 2011, SMALL MOL INHIBITORS; Moller MB, 2002, HISTOPATHOLOGY, V41, P322, DOI 10.1046/j.1365-2559.2002.01506.x; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nag S, 2014, CURR MED CHEM, V21, P553, DOI 10.2174/09298673113206660325; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; PURDIE CA, 1994, ONCOGENE, V9, P603; REIFENBERGER G, 1993, CANCER RES, V53, P2736; Rew Y, 2014, J MED CHEM, V57, P6332, DOI 10.1021/jm500627s; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; Stiebritz MT, 2010, J MOL BIOL, V403, P371, DOI 10.1016/j.jmb.2010.07.055; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Unni S, 2012, NIH PUBLIC ACCESS, V32, P1488, DOI [10.1002/jcc.21720.Web, DOI 10.1002/JCC.21720.WEB]; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062564; Zhang ZM, 2014, ACS MED CHEM LETT, V5, P124, DOI 10.1021/ml400359z; Zhao YJ, 2013, J AM CHEM SOC, V135, P7223, DOI 10.1021/ja3125417; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275	71	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0147806	10.1371/journal.pone.0147806	http://dx.doi.org/10.1371/journal.pone.0147806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992014	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800019
J	Yuan, WF; Li, L; Hu, YJ; Li, WF; Guo, ZH; Huang, WJ				Yuan Weifeng; Li Li; Hu Yujie; Li Weifeng; Guo Zhenhui; Huang Wenjie			Inhibition of Acute Lung Injury by TNFR-Fc through Regulation of an Inflammation-Oxidative Stress Pathway	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; RESPIRATORY-DISTRESS-SYNDROME; RHEUMATOID-ARTHRITIS; SEPTIC SHOCK; ALPHA; ETANERCEPT; CACHECTIN; ENDOTOXIN; MICE	Background Acute lung injury (ALI), characterized by disruption of the lung alveolar-capillary membrane barrier and resultant pulmonary edema, and associated with a proteinaceous alveolar exudate, is a leading cause of morbidity and mortality. Currently, inflammation-oxidative stress interaction between TNF-alpha and NF-kappa B was identified as a key pathway of ALI. We hypothesized that a TNFR-Fc fusion protein would have beneficial effects in experimental ALI, and sought to test this idea in mice by blocking TNF-alpha. Methods and Results Intratracheal instillation of lipopolysaccharide (LPS) into the lungs of ALI mice led to histiocyte apoptosis, and detection of serum and bronchoalveolar lavage fluid (BALF) cytokines, feedback between NF-kappa B and TNF-alpha, lung albumin leakage, lung damage, I kappa B kinase (IKK) and NF-kappa B activation, I-kappa B degradation, and oxidative injury. LPS administration raised pulmonary inflammation as reflected by increased inflammatory cytokines, alveoli protein concentration, and ALI scores. IKK is phosphorylated following LPS challenge, leading to I-kappa B degradation and NF-kappa B p65 phosphorylation. Furthermore, NF-kappa B is translocated into the nucleus and up-regulates TNF-alpha gene transcription. Infusion of TNFR-Fc 24h before LPS challenge significantly abrogated the increase of inflammatory cytokines, especially serum TNF-alpha concentration, as well as pulmonary alveoli protein levels, and diminished IKK and NF-kappa B activation and I-kappa B degradation. The nuclear translocation of NF-kappa B was inhibited, following by down-regulation of TNF-alpha gene transcription. In addition, LPS intratracheal instillation induced marked oxidative damage, such as a decrease in total anti-oxidation products and an increase in malondialdehyde (MDA), as well as up-regulation of oxidation enzymes. Histologic analysis and apoptosis scores revealed that the extent of tissue lesions was significantly reduced, but not abrogated, by TNF-alpha blockade. Conclusion Treatment with LPS alone increased inflammation and oxidative stress in ALI mice, whil administration of TNFR-Fc 24h before LPS challenge broke the feedback between NF-kappa B and TNF-alpha, resulting in decreased pulmonary inflammation/oxidative damage and tissue destruction. These results suggest a potential role for TNF-alpha therapy to treat clinical ALI.	[Yuan Weifeng; Li Li; Li Weifeng; Huang Wenjie] PLA, Guangzhou Mil Command, Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Hu Yujie] PLA, Hosp 458, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Guo Zhenhui] PLA, Guangzhou Mil Command, Gen Hosp, MICU,Key Lab Geriatr Infect & Organ Funct Support, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital	Huang, WJ (corresponding author), PLA, Guangzhou Mil Command, Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	huangyelu1029@vip.163.com			National Nature Science Foundation of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Nature Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Nature Science Foundation of China. We also thank our colleagues in our laboratory for their scientific contributions and thought-provoking discussions.	Ahmad SF, 2015, IMMUNOBIOLOGY, V220, P889, DOI 10.1016/j.imbio.2015.01.008; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; Kataoka H, 2015, EUR J PHARMACOL, V746, P174, DOI 10.1016/j.ejphar.2014.11.013; KATSIKIS PD, 1994, J EXP MED, V179, P1517, DOI 10.1084/jem.179.5.1517; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Kotyla P, 2015, ISR MED ASSOC J, V17, P14; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Liu YF, 2014, EXP THER MED, V8, P1585, DOI 10.3892/etm.2014.1974; Lyseng-Williams KA, 2004, PHARMACOECONOMICS, V22, P107, DOI 10.2165/00019053-200422020-00004; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13; MILLAR AB, 1989, LANCET, V2, P712, DOI 10.1016/S0140-6736(89)90772-1; ROTEN R, 1991, AM REV RESPIR DIS, V143, P590, DOI 10.1164/ajrccm/143.3.590; SCHIRMER WJ, 1989, ARCH SURG-CHICAGO, V124, P445; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Tang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102967; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Valente AJ, 2008, FREE RADICAL BIO MED, V44, P430, DOI 10.1016/j.freeradbiomed.2007.10.035; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VINCENT JL, 1992, CHEST, V101, P810, DOI 10.1378/chest.101.3.810; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yuan Wei-feng, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P435	26	20	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151672	10.1371/journal.pone.0151672	http://dx.doi.org/10.1371/journal.pone.0151672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990441	Green Published, gold			2022-12-27	WOS:000372582800086
J	Zhang, DJ; Lees, RS; Xi, ZY; Bourtzis, K; Gilles, JRL				Zhang, Dongjing; Lees, Rosemary Susan; Xi, Zhiyong; Bourtzis, Kostas; Gilles, Jeremie R. L.			Combining the Sterile Insect Technique with the Incompatible Insect Technique: III-Robust Mating Competitiveness of Irradiated Triple Wolbachia-Infected Aedes albopictus Males under Semi-Field Conditions	PLOS ONE			English	Article							DENGUE VECTOR MOSQUITO; CYTOPLASMIC INCOMPATIBILITY; GENETIC MANIPULATION; DIELDRIN TREATMENT; GAMMA-RADIATION; FITNESS; ERADICATION; PERFORMANCE; RELEASE; DIPTERA	Combination of the sterile insect technique with the incompatible insect technique is considered to be a safe approach to control Aedes albopictus populations in the absence of an accurate and scalable sex separation system or genetic sexing strain. Our previous study has shown that the triple Wolbachia-infected Ae. albopictus strain (wAlbA, wAlbB and wPip) was suitable for mass rearing and females could be completely sterilized as pupae with a radiation dose of at least 28 Gy. However, whether this radiation dose can influence the mating competitiveness of the triple infected males was still unknown. In this study we aimed to evaluate the effects of irradiation on the male mating competitiveness of the triple infected strain under laboratory and semi-field conditions. The results herein indicate that irradiation with a lower, female-sterilizing dose has no negative impact on the longevity of triple infected males while a reduced lifespan was observed in the wild type males (wAlbA and wAlbB) irradiated with a higher male-sterilizing dose, in small cages. At different sterile: fertile release ratios in small cages, triple-infected males induced 39.8, 81.6 and 87.8% sterility in a wild type female population at 1:1, 5:1 and 10:1 release ratios, respectively, relative to a fertile control population. Similarly, irradiated triple infected males induced 31.3, 70.5 and 89.3% sterility at 1:1, 5:1 and 10:1 release ratios, respectively, again relative to the fertile control. Under semi-field conditions at a 5:1 release ratio, relative to wild type males, the mean male mating competitiveness index of 28 Gy irradiated triple-infected males was significantly higher than 35 Gy irradiated wild type males, while triple infected males showed no difference in mean mating competitiveness to either irradiated triple-infected or irradiated wild type males. An unexpected difference was also observed in the relative male mating competitiveness of the triple infected strain after irradiation at 28 Gy dose in small vs large cages, with a higher male mating competitiveness index calculated from results of experiments in the large cages. Based on these results, we consider that the male mating performance of the triple infected strain after irradiation at 28 Gy, a dose required for complete female sterility and the avoidance of population replacement, is approximately equal to that of the wild type males under semi-field conditions. Though field evaluation is required, this suggests that the triple infected strain is suitable for irradiation and release as part of a combined SIT-IIT approach to Ae. albopictus control.	[Zhang, Dongjing; Xi, Zhiyong] Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Dongjing; Lees, Rosemary Susan; Bourtzis, Kostas; Gilles, Jeremie R. L.] Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Vienna, Austria; [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Sun Yat Sen University; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Michigan State University	Gilles, JRL (corresponding author), Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Vienna, Austria.	J.Gilles@iaea.org	Xi, Zhiyong/AAD-7936-2022; Lees, Rosemary Susan/H-3425-2019	Xi, Zhiyong/0000-0001-7786-012X; Lees, Rosemary Susan/0000-0002-4232-9125	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI080597]; Chinese Ministry of Education [311030]; Guangdong Innovative Research Team Program [2011S009]; Scientific and Technological Leading Talents of Guangzhou Development District [2013L-P116]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080597] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chinese Ministry of Education(Ministry of Education, China); Guangdong Innovative Research Team Program; Scientific and Technological Leading Talents of Guangzhou Development District; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in Prof. Zhiyong Xi's laboratory was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI080597, the Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.; The authors would like to thank David Damiens, Hanano Yamada, Maiga Hamidou and Minlin Zheng for collecting the GUA females in the large cages in the greenhouse at IPCL. Research in Prof. Zhiyong Xi's laboratory was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI080597, the Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	ABDELMALEK AA, 1966, J ECON ENTOMOL, V59, P672, DOI 10.1093/jee/59.3.672; Andreasen MH, 2005, MED VET ENTOMOL, V19, P238, DOI 10.1111/j.1365-2915.2005.00565.x; Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271; Chapman T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000273; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Damiens D, 2013, J MED ENTOMOL, V50, P314, DOI 10.1603/ME12058; Dyck VA, 2005, STERILE INSECT QUALI, P269; Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Helinski MEH, 2008, REPROD BIOL INDUCED, V11, P166; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Jin X, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.3; Joshi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-336; KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020; Maiga H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-460; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021; Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294; SHARMA VP, 1978, J ECON ENTOMOL, V71, P449, DOI 10.1093/jee/71.3.449; Sow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037124; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Yamada H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-318; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126	51	107	112	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151864	10.1371/journal.pone.0151864	http://dx.doi.org/10.1371/journal.pone.0151864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990981	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800111
J	Liu, XL; Li, XJ; Liu, HB; Xu, CH; Lin, XQ; Li, CJ; Deng, ZH				Liu, Xinlong; Li, Xujuan; Liu, Hongbo; Xu, Chaohua; Lin, Xiuqin; Li, Chunjia; Deng, Zuhu			Phylogenetic Analysis of Different Ploidy Saccharum spontaneum Based on rDNA-ITS Sequences	PLOS ONE			English	Article							SUGARCANE; POLYMORPHISM; SOFTWARE; POACEAE; GENES; WHEAT; DNA	Saccharum spontaneum L. is a crucial wild parent of modern sugarcane cultivars whose ploidy clones have been utilized successfully in improving the stress resistance and yield related traits of sugarcane cultivars. To establish knowledge regarding the genetic variances and evolutional relationships of ploidy clones of Saccharum spontaneum collected in China, the rDNA-ITS sequences of 62 ploidy clones including octaploid clones (2n = 64), nonaploid clones (2n = 72), decaploid clones (2n = 80), and dodecaploid clones (2n = 96), were obtained and analyzed. The rDNA-ITS sequences of four species from Saccharumand Sorghumbicolor selected as controls. The results showed that decaploid clones (2n = 80) possess the most abundant variances with 58 variable sites and 20 parsim-informative sites in ITS sequences, which were then followed by octaploid clones with 43 variable sites and 17 parsim-informative sites. In haplotype diversity, all four population exhibited high diversity, especially nonaploid and decaploid populations. By comparing the genetic distances among four ploidy populations, the dodecaploid population exhibited the closest relationship with the nonaploid population, and then the relationship strength decreased successively for the decaploid population and then for the octaploid population. Population differentiation analysis showed that the phenomena of population differentiation were not found among different ploidy populations, and low coefficient of gene differentiation(Gst) and high gene flow(Nm) occur among these populations possessing close genetic relationship. These results mentioned above will contribute to the understanding of the evolution of different ploidy populations of Saccharumspontaneum and provide vital knowledge for their utilization in sugarcane breeding and innovation.	[Liu, Xinlong; Deng, Zuhu] Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Peoples R China; [Liu, Xinlong; Li, Xujuan; Liu, Hongbo; Xu, Chaohua; Lin, Xiuqin; Li, Chunjia] Yunnan Acad Agr Sci, Sugarcane Res Inst, Yunnan Key Lab Sugarcane Genet Improvement, Kaiyuan, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Yunnan Academy of Agricultural Sciences	Deng, ZH (corresponding author), Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Peoples R China.	dengzuhu@163.com		Li, Chunjia/0000-0001-5181-4328	Yunnan Natural Science Foundation [2011FB120]; National Natural Science Foundation of China [31360359]; Earmarked Fund for the Modern Agriculture Technology of China [CARS-20-1-5]; Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province [2014HB038]	Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for the Modern Agriculture Technology of China; Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province	This work was supported by the Yunnan Natural Science Foundation (2011FB120) funder name: Xinlong Liu, conceived and designed the experiments, the National Natural Science Foundation of China (31360359) funder name: Xinlong Liu, conceived and designed the experiments; the Earmarked Fund for the Modern Agriculture Technology of China (CARS-20-1-5), funder name: Zuhu Deng, conceived and designed the experiments; Candidates of the Young and Middle Aged Academic Leaders of Yunnan Province (2014HB038), funder name: Xinlong Liu, conceived and designed the experiments.	Bacci M, 2001, GENET MOL BIOL, V24, P169, DOI 10.1590/S1415-47572001000100023; Cai Qing, 2002, Southwest China Journal of Agricultural Sciences, V15, P16; CHEN H, 2001, ACTA AGRONOMICA SINI, V27, P645; Chen Hui, 2003, Acta Agronomica Sinica, V29, P379; Cuadrado A, 2004, J EXP BOT, V55, P847, DOI 10.1093/jxb/erh093; D'Hont A, 2005, CYTOGENET GENOME RES, V109, P27, DOI 10.1159/000082378; DASILVA J, 1995, MOL BREEDING, V1, P165, DOI 10.1007/BF01249701; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Giles RJ, 2006, THEOR APPL GENET, V112, P1563, DOI 10.1007/s00122-006-0259-5; Guo BZ, 1987, THE FLORA OF CHINA; Guzman C, 2012, ANN BOT-LONDON, V110, P1161, DOI 10.1093/aob/mcs201; Ha S, 1999, PLANT MOL BIOL, V39, P1165, DOI 10.1023/A:1006133804170; Henry R, 2010, GENETICS GENOMICS BR; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; HSIAO C, 1995, GENOME, V38, P211, DOI 10.1139/g95-026; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu SM, 2011, SUGARCANE CANESUGAR, V4, P5; LIU X L, 2013, J HUNAN AGR U NAT SC, V38, P574; Liu XinLong, 2010, Acta Agronomica Sinica, V36, P1853, DOI 10.3724/SP.J.1006.2010.01853; Mary S, 2006, GENET RESOUR CROP EV, V53, P1221, DOI 10.1007/s10722-005-2433-z; MUKHERJEE SUNIL KUMAR, 1957, BOT GAZ, V119, P55, DOI 10.1086/335962; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Nei M., 1987, MOL EVOLUTIONARY GEN; Pan YB, 2004, GENET RESOUR CROP EV, V51, P895, DOI 10.1007/s10722-005-1933-1; PANJE R. R., 1960, CYTOLOGIA, V25, P152, DOI 10.1508/cytologia.25.152; Qian Jin, 2009, Acta Agronomica Sinica, V35, P1021; Qiu JW, 2007, THEOR APPL GENET, V115, P159, DOI 10.1007/s00122-007-0551-z; Simko I, 2006, GENETICS, V173, P2237, DOI 10.1534/genetics.106.060905; Speranskaya AS, 2012, BIOCHIMIE, V94, P1687, DOI 10.1016/j.biochi.2012.03.010; SREENIVASAN TV, 1975, P INDIAN ACAD SCI B, V81, P131; Tai PYP, 1997, SUGAR CANE, V1, P15; Takahashi S, 2005, THEOR APPL GENET, V110, P1523, DOI 10.1007/s00122-005-1990-z; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang SQ, 1996, SUGARCANE CANESUGAR, V5, P9; Yang QH, 1996, CHINA SUGARCANE, V1, P10; Zhang GeMin, 2006, Southwest China Journal of Agricultural Sciences, V19, P1127; Zhang Yun-Wu, 2002, Acta Botanica Yunnanica, V24, P29	39	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151524	10.1371/journal.pone.0151524	http://dx.doi.org/10.1371/journal.pone.0151524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986847	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300082
J	Crespo, A; Rodrigues, M; Telletxea, I; Ibanez, R; Diez, F; Tobar, JF; Arizaga, J				Crespo, Arine; Rodrigues, Marcos; Telletxea, Ibon; Ibanez, Ruben; Diez, Felipe; Tobar, Joseba F.; Arizaga, Juan			No Habitat Selection during Spring Migration at a Meso-Scale Range across Mosaic Landscapes: A Case Study with the Woodcock (Scolopax rusticola)	PLOS ONE			English	Article							EURASIAN WOODCOCK; REED WARBLERS; STOPOVER; BEHAVIOR; MIGRANT; ECOLOGY; SUCCESS; SITES; NORTH; LOADS	Success of migration in birds in part depends on habitat selection. Overall, it is still poorly known whether there is habitat selection amongst landbird migrants moving across landscapes. Europe is chiefly covered by agro-forestry mosaic landscapes, so migratory species associated to either agricultural landscapes or woodland habitats should theoretically find suitable stopover sites along migration. During migration from wintering to breeding quarters, woodcocks (Scolopax rusticola) tagged with PTT satellite-tracking transmitters were used to test for the hypothesis that migrants associated to agro-forest habitats have no habitat selection during migration, at a meso-scale level. Using a GIS platform we extracted at a meso-scale range habitat cover at stopover localities. Results obtained from comparisons of soil covers between points randomly selected and true stopover localities sites revealed, as expected, the species may not select for particular habitats at a meso-scale range, because the habitat (or habitats) required by the species can be found virtually everywhere on their migration route. However, those birds stopping over in places richer in cropland or mosaic habitats including both cropland and forest and with proportionally less closed forest stayed for longer than in areas with lower surfaces of cropland and mosaic and more closed forest. This suggests that areas rich in cropland or mosaic habitat were optimal.	[Crespo, Arine; Arizaga, Juan] Aranzadi Sci Soc, Dept Ornithol, Zorroagagaina 11, E-20014 Donostia S Sebastian, Spain; [Rodrigues, Marcos] Univ Zaragoza, Dept Geog & Land Management, IUCA, GEOFOREST Grp, Pedro Cerbuna 12, E-50009 Zaragoza, Spain; [Telletxea, Ibon; Ibanez, Ruben; Diez, Felipe; Tobar, Joseba F.] Club Cazadores Becada, Avda Schulz 8,4 Dcha, E-33208 Gijon, Asturias, Spain		Arizaga, J (corresponding author), Aranzadi Sci Soc, Dept Ornithol, Zorroagagaina 11, E-20014 Donostia S Sebastian, Spain.	jarizaga@aranzadi.eus	Rodrigues, Marcos/L-7931-2014	Rodrigues, Marcos/0000-0002-0477-0796; Arizaga, Juan/0000-0003-1911-4078	Government of Gipuzkoa; Government of Cataluna; Government of Baleares; Government of Bizkaia; Government of Navarra; FEDENCA; IREC (CSIC-University of Castilla-La Mancha); Microwave Telemetry Inc.; Urdaibai Bird Center-Sociedad de Ciencias Aranzadi; Club de Cazadores de Becada (CCB); CAM	Government of Gipuzkoa; Government of Cataluna; Government of Baleares; Government of Bizkaia; Government of Navarra; FEDENCA; IREC (CSIC-University of Castilla-La Mancha); Microwave Telemetry Inc.; Urdaibai Bird Center-Sociedad de Ciencias Aranzadi; Club de Cazadores de Becada (CCB); CAM	This work was funded by: Regional Councils or Governments of Gipuzkoa, Cataluna, Baleares, Bizkaia and Navarra; FEDENCA, IREC (CSIC-University of Castilla-La Mancha), Microwave Telemetry Inc., Urdaibai Bird Center-Sociedad de Ciencias Aranzadi, Club de Cazadores de Becada (CCB), CAM. Funders had no role in the design of this work, data collection, data analysis, decision to publish, or preparation of this manuscript.	Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Andueza M, 2014, ARDEOLA, V61, P269, DOI 10.13157/arla.61.2.2014.269; Arizaga J, 2015, EUR J WILDLIFE RES, V61, P407, DOI 10.1007/s10344-015-0908-6; Arizaga J, 2015, J ORNITHOL, V156, P515, DOI 10.1007/s10336-014-1152-7; Baldock, 1990, AGR HABITAT LOSS EUR; Barton K., MUMIN MULTIMODEL INF; Berthold P, 2001, AUK, V2nd; Biebach H., 1990, P352; Bolshakov C, 2003, IBIS, V145, P106, DOI 10.1046/j.1474-919X.2003.00128.x; Brana F, 2013, ACTA ORNITHOL, V48, P27, DOI 10.3161/000164513X669973; Brana F, 2010, ANN ZOOL FENN, V47, P206, DOI 10.5735/086.047.0305; Burnham K. P., 1998, MODEL SELECTION INFE; Cerasale DJ, 2010, AUK, V127, P636, DOI 10.1525/auk.2010.09124; Chernetsov N., 2012, PASSERINE MIGRATION; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Dierschke V, 2003, J ORNITHOL, V144, P33, DOI 10.1007/BF02465515; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duriez O, 2005, IBIS, V147, P519, DOI 10.1111/j.1474-919x.2005.00423.x; Duriez O, 2005, BIOL CONSERV, V122, P479, DOI 10.1016/j.biocon.2004.08.011; ELLEGREN H, 1992, Ringing and Migration, V13, P1; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fuller R.J., 2012, BIRDS HABITAT RELATI; GUDMUNDSSON GA, 1991, IBIS, V133, P140, DOI 10.1111/j.1474-919X.1991.tb04825.x; Guzman JL, 2013, THESIS U CASTILLA MA; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Herrera JM, 2014, J BIOGEOGR, V41, P700, DOI 10.1111/jbi.12236; Hoodless Andrew, 1995, British Birds, V88, P578; Hoodless AN, 2007, IBIS, V149, P234, DOI 10.1111/j.1474-919X.2007.00725.x; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Lindstrom A, 2010, J AVIAN BIOL, V41, P154, DOI 10.1111/j.1600-048X.2009.04810.x; Machado AL, 2008, WILDLIFE BIOL, V14, P129, DOI 10.2981/0909-6396(2008)14[129:DAHPOE]2.0.CO;2; Martell MS, 2001, CONDOR, V103, P715, DOI 10.1650/0010-5422(2001)103[0715:FMRTAW]2.0.CO;2; Martin TE, 1995, ECOLOGY MANAGEMENT N; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Onrubia A, 2003, ATLAS AVES REPROD ES, P258; Overdijk O, 2012, AQUAT CONSERV, V22, P695, DOI 10.1002/aqc.2275; Piersma Theunis, 2005, P262; Prop J, 1998, NORSK POLARINST SKRI, P175; R Core Team, 2014, R LANG ENV STAT COMP; Revelle W., 2014, PSYCH PROCEDURES PER; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Tsiakiris R, 2009, ENVIRON MANAGE, V44, P874, DOI 10.1007/s00267-009-9359-8	49	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149790	10.1371/journal.pone.0149790	http://dx.doi.org/10.1371/journal.pone.0149790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002975	Green Published, gold			2022-12-27	WOS:000372697400010
J	Cuenca, M; Pfister, SP; Buschor, S; Bayramova, F; Hernandez, SB; Cava, F; Kuru, E; Van Nieuwenhze, MS; Brun, YV; Coelho, FM; Hapfelmeier, S				Cuenca, Miguelangel; Pfister, Simona P.; Buschor, Stefanie; Bayramova, Firuza; Hernandez, Sara B.; Cava, Felipe; Kuru, Erkin; Van Nieuwenhze, Michael S.; Brun, Yves V.; Coelho, Fernanda M.; Hapfelmeier, Siegfried			D-Alanine-Controlled Transient Intestinal Mono-Colonization with Non-Laboratory-Adapted Commensal E. coli Strain HS	PLOS ONE			English	Article							D-AMINO ACIDS; ESCHERICHIA-COLI; IN-SITU; MICROBIOTA; PEPTIDOGLYCAN; RESISTANCE; RESPONSES; DYNAMICS; DISEASE; MICE	Soon after birth the mammalian gut microbiota forms a permanent and collectively highly resilient consortium. There is currently no robust method for re-deriving an already microbially colonized individual again-germ-free. We previously developed the in vivo growth-incompetent E. coli K-12 strain HA107 that is auxotrophic for the peptidoglycan components D-alanine (D-Ala) and meso-diaminopimelic acid (Dap) and can be used to transiently associate germ-free animals with live bacteria, without permanent loss of germ-free status. Here we describe the translation of this experimental model from the laboratory-adapted E. coli K-12 prototype to the better gut-adapted commensal strain E. coli HS. In this genetic background it was necessary to complete the D-Ala auxotrophy phenotype by additional knockout of the hypothetical third alanine racemase metC. Cells of the resulting fully auxotrophic strain assembled a peptidoglycan cell wall of normal composition, as long as provided with D-Ala and Dap in the medium, but could not proliferate a single time after D-Ala/Dap removal. Yet, unsupplemented bacteria remained active and were able to complete their cell cycle with fully sustained motility until immediately before autolytic death. Also in vivo, the transiently colonizing bacteria retained their ability to stimulate a live-bacteria-specific intestinal Immunoglobulin (Ig) A response. Full D-Ala auxotrophy enabled rapid recovery to again-germ-free status. E. coli HS has emerged from human studies and genomic analyses as a paradigm of benign intestinal commensal E. coli strains. Its reversibly colonizing derivative may provide a versatile research tool for mucosal bacterial conditioning or compound delivery without permanent colonization.	[Cuenca, Miguelangel; Pfister, Simona P.; Buschor, Stefanie; Bayramova, Firuza; Coelho, Fernanda M.; Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Cuenca, Miguelangel; Pfister, Simona P.; Buschor, Stefanie] Univ Bern, Grad Sch GCB, Bern, Switzerland; [Hernandez, Sara B.; Cava, Felipe] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea, Sweden; [Kuru, Erkin; Van Nieuwenhze, Michael S.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Kuru, Erkin; Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN USA	University of Bern; University of Bern; Umea University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hapfelmeier, S (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	siegfried.hapfelmeier@ifik.unibe.ch	VanNieuwenhze, Michael/B-5120-2018; Hapfelmeier, Siegfried/B-6005-2011; Hernandez, Sara B./M-2986-2019; Hernandez, Sara/L-2220-2017; Cava, Felipe/L-2082-2017	VanNieuwenhze, Michael/0000-0001-6093-5949; Hapfelmeier, Siegfried/0000-0002-6913-7932; Hernandez, Sara B./0000-0002-8349-360X; Hernandez, Sara/0000-0002-8349-360X; Cava, Felipe/0000-0001-5995-718X; Brun, Yves/0000-0002-9289-1909; Cuenca, Miguelangel/0000-0003-3435-9102	Swiss National Science Foundation [310030_138452]; ERC Starting Grant from the European Research Council under the European Union's Seventh Framework Programme [281904]; Molecular Infection Medicine Sweden; Knut and Alice Wallenberg Foundation [KAW 2012-0184]; Kempe foundation [JCK-1422]; Swedish Research Council [K201457X-22450-01-5]; Boehringer Ingelheim Foundation; Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113172] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC Starting Grant from the European Research Council under the European Union's Seventh Framework Programme; Molecular Infection Medicine Sweden; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SH was supported by the Swiss National Science Foundation (http://www.snf.ch; Grant 310030_138452) and an ERC Starting Grant from the European Research Council (http://erc.europa.eu) under the European Union's Seventh Framework Programme (FP/2007-2013), ERC Grant Agreement 281904. The FC laboratory received funding support by Molecular Infection Medicine Sweden (http://www.mims.umu.se), Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/kaw/en; grant KAW 2012-0184), Kempe foundation (http://www.kempe.com; grant JCK-1422) and the Swedish Research Council (http://www.vr.se; grant K201457X-22450-01-5). SB was supported by a Boehringer Ingelheim Foundation (https://www.bifonds.de) PhD scholarship. SBH was supported by an Alfonso Martin Escudero Foundation (http://www.fundame.org) postdoctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2000, MICROBIOL-SGM, V146, P1727, DOI 10.1099/00221287-146-7-1727; Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Curtiss R, 1980, US Patent, Patent No. [US4190495 A, 4190495]; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; DUCLUZEAU R, 1986, ANN INST PASTEUR MIC, V137A, P79, DOI 10.1016/S0769-2609(86)80007-2; Espaillat A, 2014, ACTA CRYSTALLOGR D, V70, P79, DOI 10.1107/S1399004713024838; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Giraudoux P., 2015, R PACKAGE VERSION 1; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Kuru E, 2015, NAT PROTOC, V10, P33, DOI 10.1038/nprot.2014.197; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; LEVINE MM, 1978, LANCET, V1, P1119; Macpherson AJ, 2015, MUCOSAL IMMUNOL, V8, P476, DOI 10.1038/mi.2014.113; Macpherson A. J., 2009, ENCY MICROBIOLOGY, P237; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Nam SH, 2011, J BACTERIOL, V193, P1014, DOI [10.1128/JB.01394-10, 10.1128/JB.01027-10]; R Development Core Team, 2014, R LANG ENV STAT COMP; Radkov AD, 2013, J BACTERIOL, V195, P5016, DOI 10.1128/JB.00761-13; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; WELLS CL, 1978, NATURE, V274, P397, DOI 10.1038/274397a0; Wickham H, 2015, R PACKAGE VERSION 0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016	35	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151872	10.1371/journal.pone.0151872	http://dx.doi.org/10.1371/journal.pone.0151872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002976	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400052
J	Hyona, J; Ekholm, M				Hyona, Jukka; Ekholm, Miia			Background Speech Effects on Sentence Processing during Reading: An Eye Movement Study	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; IRRELEVANT SPEECH; DISRUPTION; INTELLIGIBILITY; MANIPULATIONS; COMPREHENSION; INTERFERENCE; DISTRACTION	Effects of background speech on reading were examined by playing aloud different types of background speech, while participants read long, syntactically complex and less complex sentences embedded in text. Readers' eye movement patterns were used to study online sentence comprehension. Effects of background speech were primarily seen in rereading time. In Experiment 1, foreign-language background speech did not disrupt sentence processing. Experiment 2 demonstrated robust disruption in reading as a result of semantically and syntactically anomalous scrambled background speech preserving normal sentence-like intonation. Scrambled speech that was constructed from the text to-be read did not disrupt reading more than scrambled speech constructed from a different, semantically unrelated text. Experiment 3 showed that scrambled speech exacerbated the syntactic complexity effect more than coherent background speech, which also interfered with reading. Experiment 4 demonstrated that both semantically and syntactically anomalous speech produced no more disruption in reading than semantically anomalous but syntactically correct background speech. The pattern of results is best explained by a semantic account that stresses the importance of similarity in semantic processing, but not similarity in semantic content, between the reading task and background speech.	[Hyona, Jukka] Univ Turku, Dept Psychol, Turku, Finland; [Ekholm, Miia] Stockholm South Gen Hosp Sodersjukhuset, Stockholm, Sweden	University of Turku	Hyona, J (corresponding author), Univ Turku, Dept Psychol, Turku, Finland.	hyona@utu.fi	Hyönä, Jukka/K-5280-2019	Hyönä, Jukka/0000-0002-5950-3361				Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A. D, 1986, WORKING MEMORY; Banbury S, 1998, BRIT J PSYCHOL, V89, P499, DOI 10.1111/j.2044-8295.1998.tb02699.x; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P1542, DOI 10.1037/a0028459; Boyle R, 1996, Q J EXP PSYCHOL-A, V49, P398, DOI 10.1080/027249896392702; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Cauchard F, 2012, APPL COGNITIVE PSYCH, V26, P381, DOI 10.1002/acp.1837; Cowan N, ATTENTION MEMORY INT; Emberson LL, 2010, PSYCHOL SCI, V21, P1383, DOI 10.1177/0956797610382126; Gathercole S. E., 1993, WORKING MEMORY LANGU; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Gordon PC, 2001, J EXP PSYCHOL LEARN, V27, P1411, DOI 10.1037/0278-7393.27.6.1411; Haapakangas A, 2014, APPL ACOUST, V86, P1, DOI 10.1016/j.apacoust.2014.04.018; Hakulinen A., 1980, SUOMEN TEKSTILAUSEID; Halin N, 2014, J EXP PSYCHOL-APPL, V20, P69, DOI 10.1037/xap0000002; HEMFORTH B, 1993, PROCEEDINGS OF THE FIFTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P539; HOLMES VM, 1981, J VERB LEARN VERB BE, V20, P417, DOI 10.1016/S0022-5371(81)90533-8; Hughes RW, 2007, J EXP PSYCHOL LEARN, V33, P1050, DOI 10.1037/0278-7393.33.6.1050; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Hyona J, 1997, Q J EXP PSYCHOL-A, V50, P841; Hyona J, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P313, DOI 10.1016/B978-044451020-4/50018-9; Hyona J, 2002, J EDUC PSYCHOL, V94, P44, DOI 10.1037//0022-0663.94.1.44; Inhoff AW, 2004, PSYCHON B REV, V11, P320, DOI 10.3758/BF03196577; Johnston M, 2002, AUST J PSYCHOL, V54, P54; JONES D, 1992, Q J EXP PSYCHOL-A, V44, P645, DOI 10.1080/14640749208401304; JONES DM, 1990, APPL COGNITIVE PSYCH, V4, P89, DOI 10.1002/acp.2350040203; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Kliegl R., 1999, CONSTRAINTS LANGUAGE, P137, DOI [10.1007/0-306-46902-2_6, DOI 10.1007/0-306-46902-2_]; LECOMPTE DC, 1995, PSYCHON B REV, V2, P391, DOI 10.3758/BF03210978; Liversedge S. P., 1998, EYE GUIDANCE READING, P55, DOI DOI 10.1016/B978-008043361-5/50004-3; MACWHINNEY B, 1988, COGNITION, V29, P95, DOI 10.1016/0010-0277(88)90034-0; Marsh JE, 2008, J MEM LANG, V58, P682, DOI 10.1016/j.jml.2007.05.002; Marsh JE, 2014, MEM COGNITION, V42, P1285, DOI 10.3758/s13421-014-0438-6; Marsh JE, 2009, COGNITION, V110, P23, DOI 10.1016/j.cognition.2008.08.003; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; MARTIN RC, 1988, J MEM LANG, V27, P382, DOI 10.1016/0749-596X(88)90063-0; MARTIN RC, 1994, J MEM LANG, V33, P83, DOI 10.1006/jmla.1994.1005; MURRAY WS, 1988, Q J EXP PSYCHOL-A, V40, P693, DOI 10.1080/14640748808402294; Oswald CJP, 2000, MEMORY, V8, P345, DOI 10.1080/09658210050117762; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Robison MK, 2015, APPL COGNITIVE PSYCH, V29, P680, DOI 10.1002/acp.3150; Sorqvist P, 2015, CURR DIR PSYCHOL SCI; Sorqvist P, 2010, MEMORY, V18, P310, DOI 10.1080/09658211003601530; Sorqvist P, 2010, J ENVIRON PSYCHOL, V30, P112, DOI 10.1016/j.jenvp.2009.11.004; Sorqvist P, 2010, APPL COGNITIVE PSYCH, V24, P67, DOI 10.1002/acp.1543; van Gompel RPG, 2001, J MEM LANG, V45, P225, DOI 10.1006/jmla.2001.2773; Venetjoki N, 2006, ERGONOMICS, V49, P1068, DOI 10.1080/00140130600679142	48	15	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152133	10.1371/journal.pone.0152133	http://dx.doi.org/10.1371/journal.pone.0152133			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003410	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400083
J	Liao, Y; Gilmour, S; Shibuya, K				Liao, Yi; Gilmour, Stuart; Shibuya, Kenji			Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey	PLOS ONE			English	Article							BLOOD-PRESSURE; CHRONIC DISEASE; UNITED-STATES; COUNTRIES	Background China has rapidly expanded health insurance coverage over the past decade but its impact on hypertension control is not well known. We analyzed factors associated with hypertension and the impact of health insurance on the management of hypertension in China from 1991 to 2009. Methods and Findings We used individual-level data from the China Health and Nutrition Survey (CHNS) for blood pressure, BMI, and other socio-economic variables. We employed multi-level logistic regression models to estimate the factors associated with prevalence and management of hypertension. We also estimated the effects of health insurance on management of hypertension using propensity score matching. We found that prevalence of hypertension increased from 23.8% (95% CI: 22.5-25.1%) in 1991 to 31.5% (28.5-34.7%) in 2009. The proportion of hypertensive patients aware of their condition increased from 31.7%(28.7-34.9%) to 51.1% (45.1-57.0%). The proportion of diagnosed hypertensive patients in treatment increased by 35.5% in the 19 years, while the proportion of those in treatment with controlled blood pressure remained low. Among diagnosed hypertensives, health insurance increased the probability of receiving treatment by 28.7% (95% CI: 10.6-46.7%) compared to propensity-matched individuals not covered by health insurance. Conclusions Hypertension continues to be a major health threat in China and effective control has not improved over time despite large improvements in awareness and treatment access. This suggests problems in treatment quality, medication adherence and patient understanding of the condition. Improvements in hypertension management, quality of medical care for those at high risk, and better health insurance packages are needed.	[Liao, Yi; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	University of Tokyo	Liao, Y (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	liaoyi.pku@gmail.com		Shibuya, Kenji/0000-0003-2528-7530	Japan Ministry of Health and Welfare [H25-chikyukibo-ippan-007, H27-chikyukibo-shitei-004]; Ministry of Education, Culture, Sports, Science and Technology [22390130]; National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R01-HD38700]; Fogarty International Center, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030880] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Japan Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by grants from the Japan Ministry of Health and Welfare (H25-chikyukibo-ippan-007 and H27-chikyukibo-shitei-004) and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-aid for scientific research A, grant number 22390130). The funders had no influence over the content of the research or the decision to publish.; This study was supported in part by grants from the Japan Ministry of Health and Welfare (H25-chikyukibo-ippan-007 and H27-chikyukibo-shitei-004) and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-aid for scientific research A, grant number 22390130). The funders had no influence over the content of the research or the decision to publish. We are grateful to the National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention, Carolina Population Center, the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, and R01-HD38700) and the Fogarty International Center, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2006 and both parties plus the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009 and future surveys.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Barber SL, 2010, HLTH INSURANCE SYSTE, P1; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Biao Y, 2011, INT C HUM HLTH BIOM, V2011, P852; Black HR, 2001, HYPERTENSION, V37, P12, DOI 10.1161/01.HYP.37.1.12; Bramlage P, 2010, J CLIN HYPERTENS, V12, P666, DOI 10.1111/j.1751-7176.2010.00322.x; Duru OK, 2007, AM J HYPERTENS, V20, P348, DOI 10.1016/j.amjhyper.2006.11.007; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Hagihara A, 2001, HEALTH POLICY, V58, P231, DOI 10.1016/S0168-8510(01)00171-3; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978; Ikeda N, 2014, B WORLD HEALTH ORGAN, V92, P10, DOI 10.2471/BLT.13.121954; Institute for Health Metrics and Evaluation, GBD ARR DIAGR 2013; Izzo JL, 2000, HYPERTENSION, V35, P1021, DOI 10.1161/01.HYP.35.5.1021; Lei XY, 2012, CHINA ECON REV, V23, P105, DOI 10.1016/j.chieco.2011.08.004; Li Jian-xin, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P301; Li L, 2008, CHINESE HLTH EC, V27, P26; Liu LS, 2010, ZHONGHUA XIN XUE GUA, V201139, P579; Ma JS, 2005, CHINESE J PREVENTIVE, V39, P311; Ma JT, 2012, CHINA STAT YB 2012; Parry J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e248; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Song YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068599; STAMLER R, 1993, J HUM HYPERTENS, V7, P429; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; World Bank, OFF EXCH RAT; Xiao HM, 2005, CHINESE J CLIN REHAB, V31, P30; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066	29	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152091	10.1371/journal.pone.0152091	http://dx.doi.org/10.1371/journal.pone.0152091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002634	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400077
J	Gao, Y; Liu, PY; Wu, YY; Jia, KB; Gao, GD				Gao, Yuan; Liu, Pengyu; Wu, Yueying; Jia, Kebin; Gao, Guandong			Fast Coding Unit Encoding Mechanism for Low Complexity Video Coding	PLOS ONE			English	Article							ALGORITHM; DECISION	high efficiency video coding (HEVC), coding tree contributes to excellent compression performance. However, coding tree brings extremely high computational complexity. Innovative works for improving coding tree to further reduce encoding time are stated in this paper. A novel low complexity coding tree mechanism is proposed for HEVC fast coding unit (CU) encoding. Firstly, this paper makes an in-depth study of the relationship among CU distribution, quantization parameter (QP) and content change (CC). Secondly, a CU coding tree probability model is proposed for modeling and predicting CU distribution. Eventually, a CU coding tree probability update is proposed, aiming to address probabilistic model distortion problems caused by CC. Experimental results show that the proposed low complexity CU coding tree mechanism significantly reduces encoding time by 27% for lossy coding and 42% for visually lossless coding and lossless coding. The proposed low complexity CU coding tree mechanism devotes to improving coding performance under various application conditions.	[Gao, Yuan; Liu, Pengyu; Wu, Yueying; Jia, Kebin; Gao, Guandong] Beijing Univ Technol, Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China; [Gao, Yuan; Liu, Pengyu; Wu, Yueying; Jia, Kebin; Gao, Guandong] Beijing Lab Adv Informat Networks, Beijing, Peoples R China; [Gao, Yuan; Liu, Pengyu; Wu, Yueying; Jia, Kebin; Gao, Guandong] Beijing Univ Technol, Coll Elect Informat & Control Engn, Beijing, Peoples R China	Beijing University of Technology; Beijing University of Technology	Jia, KB (corresponding author), Beijing Univ Technol, Beijing Adv Innovat Ctr Future Internet Technol, Beijing, Peoples R China.; Jia, KB (corresponding author), Beijing Lab Adv Informat Networks, Beijing, Peoples R China.; Jia, KB (corresponding author), Beijing Univ Technol, Coll Elect Informat & Control Engn, Beijing, Peoples R China.	kebinj@bjut.edu.cn			Beijing Municipal Education Commission [KZ201310005004]; Beijing Postdoctoral Research Foundation [2015ZZ-23]; China Postdoctoral Research Foundation [2015M580029]; Computational Intelligence and Intelligent System of Beijing Key Laboratory Research Foundation [002000546615004]	Beijing Municipal Education Commission(Beijing Municipal Commission of Education); Beijing Postdoctoral Research Foundation(China Postdoctoral Science Foundation); China Postdoctoral Research Foundation(China Postdoctoral Science Foundation); Computational Intelligence and Intelligent System of Beijing Key Laboratory Research Foundation	This paper is supported by the Project for the Key Project of Beijing Municipal Education Commission under Grant No. KZ201310005004, Beijing Postdoctoral Research Foundation under Grant No. 2015ZZ-23, China Postdoctoral Research Foundation under Grant No. 2015M580029, and Computational Intelligence and Intelligent System of Beijing Key Laboratory Research Foundation under Grant No. 002000546615004.	Ahn YJ, 2015, J REAL-TIME IMAGE PR, P1; Bjontegaard G., 2001, VCEG M AUST US; Bossen F, 2013, 12 JCTVC M GEN; Cen YF, 2015, INFORM PROCESS LETT, V115, P719, DOI 10.1016/j.ipl.2015.04.001; Chi G, 2014, MULT EXP WORKSH ICME; Cho S, 2013, IEEE T CIRC SYST VID, V23, P1555, DOI 10.1109/TCSVT.2013.2249017; Guo LL, 2015, J ELECTRON IMAGING, V24, DOI 10.1117/1.JEI.24.2.023036; Hanhart P., 2012, SPIE OPTICAL ENG APP; Hong RC, 2015, IEEE T MULTIMEDIA, V17, P1980, DOI 10.1109/TMM.2015.2476657; Hong Richang, 2010, P 18 ACM INT C MULTI, P421, DOI [10.1145/1873951.1874013, DOI 10.1145/1873951.1874013]; Huade S, 2014, AUD LANG IM PROC ICA; Lee J, 2015, IEEE T CIRC SYST VID, V25, P411, DOI 10.1109/TCSVT.2014.2339612; Ohm JR, 2012, IEEE T CIRC SYST VID, V22, P1669, DOI 10.1109/TCSVT.2012.2221192; Park C.-S., 2014, LECT NOTES ELECT ENG, V279, P293; Shen LQ, 2013, IEEE T CONSUM ELECTR, V59, P207, DOI 10.1109/TCE.2013.6490261; Song Y, 2015, J VISUAL COMMUNICATI; Sullivan G., 2012, CIRCUITS SYSTEMS VID, V12, P1649, DOI DOI 10.1109/TCSVT.2012.2221191; Sullivan GJ, 2010, SPIE OPTICAL ENG APP; Wang ZY, 2014, J VIS COMMUN IMAGE R, V25, P1918, DOI 10.1016/j.jvcir.2014.08.008; Xiong J, 2014, IEEE T MULTIMEDIA, V16, P2141, DOI 10.1109/TMM.2014.2356795; Zhang MM, 2015, IEICE T INF SYST, VE98D, P467, DOI 10.1587/transinf.2014EDL8081	21	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151689	10.1371/journal.pone.0151689	http://dx.doi.org/10.1371/journal.pone.0151689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999741	Green Published, gold			2022-12-27	WOS:000372694700056
J	Guess, N; Perreault, L; Kerege, A; Strauss, A; Bergman, BC				Guess, Nicola; Perreault, Leigh; Kerege, Anna; Strauss, Allison; Bergman, Bryan C.			Dietary Fatty Acids Differentially Associate with Fasting Versus 2-Hour Glucose Homeostasis: Implications for The Management of Subtypes of Prediabetes	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; INSULIN SENSITIVITY; ADIPOSE-TISSUE; LIVER FAT; RISK; TOLERANCE; METABOLISM; OBESE; MEN; RESISTANCE	Over-nutrition has fuelled the global epidemic of type 2 diabetes, but the role of individual macronutrients to the diabetogenic process is not well delineated. We aimed to examine the impact of dietary fatty acid intake on fasting and 2-hour plasma glucose concentrations, as well as tissue-specific insulin action governing each. Normoglycemic controls (n = 15), athletes (n = 14), and obese (n = 23), as well as people with prediabetes (n = 10) and type 2 diabetes (n = 11), were queried about their habitual diet using a Food Frequency Questionnaire. All subjects were screened by an oral glucose tolerance test (OGTT) and studied using the hyperinsulinemic/euglycemic clamp with infusion of 6,6(2)H(2)-glucose. Multiple regression was performed to examine relationships between dietary fat intake and 1) fasting plasma glucose, 2) % suppression of endogenous glucose production, 3) 2-hour post-OGTT plasma glucose, and 4) skeletal muscle insulin sensitivity (glucose rate of disappearance (Rd) and non-oxidative glucose disposal (NOGD)). The % kcal from saturated fat (SFA) was positively associated with fasting (beta = 0.303, P = 0.018) and 2-hour plasma glucose (beta = 0.415, P<0.001), and negatively related to % suppression of hepatic glucose production (beta = -0.245, P = 0.049), clamp Rd (beta = -0.256, P = 0.001) and NOGD (beta = -0.257, P = 0.001). The % kcal from trans fat was also negatively related to clamp Rd (beta = -0.209, P = 0.008) and NOGD (beta = -0.210, P = 0.008). In contrast, the % kcal from polyunsaturated fat (PUFA) was negatively associated with 2-hour glucose levels (beta = -0.383, P = 0.001), and positively related to Rd (beta = 0.253, P = 0.007) and NOGD (beta = 0.246, P = 0.008). Dietary advice to prevent diabetes should consider the underlying pathophysiology of the prediabetic state.	[Guess, Nicola] Univ London Imperial Coll Sci Technol & Med, Dept Med, Du Cane Rd, London, England; [Guess, Nicola] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Perreault, Leigh; Kerege, Anna; Strauss, Allison; Bergman, Bryan C.] Univ Colorado, Div Endocrinol Metab & Diabet, Anschutz Med Ctr, Aurora, CO USA	Imperial College London; University of London; King's College London; University of Colorado System; University of Colorado Anschutz Medical Campus	Guess, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Du Cane Rd, London, England.; Guess, N (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England.	n.guess10@imperial.ac.uk	Bergman, Bryan/T-8055-2019	Guess, Nicola/0000-0001-6829-0671; Bergman, Bryan/0000-0002-9561-1052	National Institutes of Health [R01 DK089170]; American Diabetes Association [1-14-CE-05]; Winston Churchill Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089170, P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Winston Churchill Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	BB was funded by the National Institutes of Health (R01 DK089170, http://grants.nih.gov/grants/funding/r01.htm) and the American Diabetes Association (1-14-CE-05, http://professional.diabetes.org/HomeResearchGrantsAndFunding.aspx?hsid=2). NG was funded by a Winston Churchill Trust Travel Fellowship (http://www.wcmt.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; [Anonymous], 2015, SCI REP 2015 DIET GU; Bergman BC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1103, DOI 10.1152/ajpendo.00613.2006; Bjermo H, 2012, AM J CLIN NUTR, V95, P1003, DOI 10.3945/ajcn.111.030114; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Bozzetto L, 2012, DIABETES CARE, V35, P1429, DOI 10.2337/dc12-0033; Clore JN, 2004, AM J PHYSIOL-ENDOC M, V287, pE358, DOI 10.1152/ajpendo.00360.2003; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Faerch K, 2013, LANCET DIABETES ENDO, V1, P43, DOI 10.1016/S2213-8587(13)70008-1; FESKENS EJM, 1990, INT J EPIDEMIOL, V19, P953, DOI 10.1093/ije/19.4.953; FINEGOOD DT, 1987, DIABETES, V36, P914, DOI 10.2337/diabetes.36.8.914; FOLCH J, 1951, J BIOL CHEM, V191, P807; Franz MJ, 2002, DIABETES CARE, V25, P148, DOI 10.2337/diacare.25.1.148; Goldberg PA, 2004, DIABETES CARE, V27, P461, DOI 10.2337/diacare.27.2.461; Harding AH, 2004, AM J EPIDEMIOL, V159, P73, DOI 10.1093/aje/kwh004; Heikkila HM, 2012, EUR J CLIN NUTR, V66, P819, DOI 10.1038/ejcn.2012.23; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Jimenez-Gomez Y, 2014, MOL NUTR FOOD RES, V58, P2177, DOI 10.1002/mnfr.201300901; Kuhnt K, 2011, EUR J LIPID SCI TECH, V113, P1281, DOI 10.1002/ejlt.201100037; Mozaffarian D, 2013, AM J CLIN NUTR, V97, P854, DOI 10.3945/ajcn.112.045468; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Sarkkinen E, 1996, EUR J CLIN NUTR, V50, P592; Schwingshackl L, 2011, ANN NUTR METAB, V58, P290, DOI 10.1159/000331214; Segovia-Siapco G, 2008, NUTR CANCER, V60, P603, DOI 10.1080/01635580802065294; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Thanopoulou AC, 2003, DIABETES CARE, V26, P302, DOI 10.2337/diacare.26.2.302; THERET N, 1993, METABOLISM, V42, P562, DOI 10.1016/0026-0495(93)90213-8; Thomson CA, 2003, AM J EPIDEMIOL, V157, P754, DOI 10.1093/aje/kwg025; Tierney AC, 2011, INT J OBESITY, V35, P800, DOI 10.1038/ijo.2010.209; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; Tooze JA, 2012, EUR J CLIN NUTR, V66, P569, DOI 10.1038/ejcn.2011.198; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; Wang Y, 2000, DIABETES CARE, V23, P460, DOI 10.2337/diacare.23.4.460; Wanjihia V W, 2009, East Afr Med J, V86, P259; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4; Xiao C, 2006, DIABETOLOGIA, V49, P1371, DOI 10.1007/s00125-006-0211-x	42	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150148	10.1371/journal.pone.0150148	http://dx.doi.org/10.1371/journal.pone.0150148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999667	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700011
J	Mitchell, EJ; McCallum, S; Dewar, D; Maxwell, DJ				Mitchell, Emma J.; McCallum, Sarah; Dewar, Deborah; Maxwell, David J.			Corticospinal and Reticulospinal Contacts on Cervical Commissural and Long Descending Propriospinal Neurons in the Adult Rat Spinal Cord; Evidence for Powerful Reticulospinal Connections	PLOS ONE			English	Article							CHOLERA-TOXIN; VENTROLATERAL FUNICULUS; HORSERADISH-PEROXIDASE; QUADRUPEDAL LOCOMOTION; VESTIBULOSPINAL TRACT; RETICULAR-FORMATION; NEONATAL RAT; SUBUNIT-B; PHA-L; CAT	Descending systems have a crucial role in the selection of motor output patterns by influencing the activity of interneuronal networks in the spinal cord. Commissural interneurons that project to the contralateral grey matter are key components of such networks as they coordinate left-right motor activity of fore and hind-limbs. The aim of this study was to determine if corticospinal (CST) and reticulospinal (RST) neurons make significant numbers of axonal contacts with cervical commissural interneurons. Two classes of commissural neurons were analysed: 1) local commissural interneurons (LCINs) in segments C4-5;2) long descending propriospinal neurons (LDPNs) projecting from C4 to the rostral lumbar cord. Commissural interneurons were labelled with Fluorogold and CST and RST axons were labelled by injecting the b subunit of cholera toxin in the forelimb area of the primary somatosensory cortex or the medial longitudinal fasciculus respectively. The results show that LCINs and LDPNs receive few contacts from CST terminals but large numbers of contacts are formed by RST terminals. Use of vesicular glutamate and vesicular GABA transporters revealed that both types of cell received about 80% excitatory and 20% inhibitory RST contacts. Therefore the CST appears to have a minimal influence on LCINs and LDPNs but the RST has a powerful influence. This suggests that left-right activity in the rat spinal cord is not influenced directly via CST systems but is strongly controlled by the RST pathway. Many RST neurons have monosynaptic input from corticobulbar pathways therefore this pathway may provide an indirect route from the cortex to commissural systems. The corticoreticulospinal- commissural system may also contribute to functional recovery following damage to the CST as it has the capacity to deliver information from the cortex to the spinal cord in the absence of direct CST input.	[Mitchell, Emma J.; McCallum, Sarah; Dewar, Deborah; Maxwell, David J.] Univ Glasgow, Coll Med Vet Med & Life Sci, Inst Neurosci & Psychol, Spinal Cord Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Maxwell, DJ (corresponding author), Univ Glasgow, Coll Med Vet Med & Life Sci, Inst Neurosci & Psychol, Spinal Cord Grp, Glasgow G12 8QQ, Lanark, Scotland.	David.Maxwell@Glasgow.ac.uk			Medical Research Council; Neurosciences Foundation, Glasgow	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neurosciences Foundation, Glasgow	EM funded by PhD Studentship from Medical Research Council (http://www.mrc.ac.uk/). Additional support from Neurosciences Foundation, Glasgow (http://neurosciencesfoundation.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTERMARK B, 1987, BRAIN RES, V404, P382, DOI 10.1016/0006-8993(87)91400-4; ALSTERMARK B, 1991, EXP BRAIN RES, V84, P561; ALSTERMARK B, 1991, EXP BRAIN RES, V84, P569; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1985, EXP BRAIN RES, V59, P353; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; ALSTERMARK B, 1990, EXP BRAIN RES, V80, P96, DOI 10.1007/BF00228851; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Bachmann LC, 2014, J NEUROSCI, V34, P3378, DOI 10.1523/JNEUROSCI.4384-13.2014; Ballion B, 2001, EUR J NEUROSCI, V14, P1727, DOI 10.1046/j.0953-816x.2001.01794.x; Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129; Bannatyne BA, 2003, EUR J NEUROSCI, V18, P2273, DOI 10.1046/j.1460-9568.2003.02973.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BOLTON PS, 1991, NEUROREPORT, V2, P743, DOI 10.1097/00001756-199112000-00003; Brockett EG, 2013, NEUROSCIENCE, V240, P83, DOI 10.1016/j.neuroscience.2013.02.039; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; CASALE EJ, 1988, J COMP NEUROL, V278, P275, DOI 10.1002/cne.902780210; CAVADA C, 1984, BRAIN RES, V308, P123, DOI 10.1016/0006-8993(84)90923-5; CHEN S, 1995, BRAIN RES, V674, P107, DOI 10.1016/0006-8993(95)00020-Q; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; ERICSON H, 1988, J NEUROSCI METH, V24, P225, DOI 10.1016/0165-0270(88)90167-7; HUISMAN AM, 1981, BRAIN RES, V209, P271, DOI 10.1016/0006-8993(81)90153-0; Huma Z, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00040; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jankowska E, 2003, J NEUROSCI, V23, P1867; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LIANG F, 1991, J COMP NEUROL, V311, P356, DOI 10.1002/cne.903110306; Matsuyama K, 1997, J COMP NEUROL, V377, P234; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Matsuyama K, 2004, J COMP NEUROL, V474, P546, DOI 10.1002/cne.20131; Matsuyama K, 1999, J COMP NEUROL, V410, P413; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ni YC, 2014, J NEUROSCI, V34, P9404, DOI 10.1523/JNEUROSCI.1771-14.2014; NYBERGHANSEN R, 1964, J COMP NEUROL, V122, P369, DOI 10.1002/cne.901220307; Olave MJ, 2003, J NEUROSCI, V23, P6837; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PETRAS J. M., 1967, BRAIN RES, V6, P275, DOI 10.1016/0006-8993(67)90196-5; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Reed WR, 2008, NEUROSCIENCE, V151, P505, DOI 10.1016/j.neuroscience.2007.10.025; Reed WR, 2009, BRAIN RES, V1302, P76, DOI 10.1016/j.brainres.2009.09.049; SHINODA Y, 1992, J COMP NEUROL, V316, P151, DOI 10.1002/cne.903160203; Sivertsen MS, 2016, J COMP NEUROL, V524, P1270, DOI 10.1002/cne.23904; Sivertsen MS, 2014, J NEUROPHYSIOL, V112, P1628, DOI 10.1152/jn.00820.2013; Soteropoulos DS, 2013, J NEUROSCI, V33, P9614, DOI 10.1523/JNEUROSCI.0269-13.2013; Soteropoulos DS, 2012, J PHYSIOL-LONDON, V590, P4011, DOI 10.1113/jphysiol.2011.225169; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; SUGIUCHI Y, 1992, NEUROSCI LETT, V145, P221, DOI 10.1016/0304-3940(92)90027-5; Todd AJ, 1997, J NEUROSCI METH, V73, P149, DOI 10.1016/S0165-0270(97)02222-X; VALTSCHANOFF JG, 1993, EXP BRAIN RES, V93, P95; WILSON VJ, 1978, PHYSIOL REV, V58, P80, DOI 10.1152/physrev.1978.58.1.80; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115; ZEMLAN FP, 1978, EXP NEUROL, V62, P298, DOI 10.1016/0014-4886(78)90059-6	57	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152094	10.1371/journal.pone.0152094	http://dx.doi.org/10.1371/journal.pone.0152094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999665	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000372694700100
J	Faizy, TD; Thaler, C; Kumar, D; Sedlacik, J; Broocks, G; Grosser, M; Stellmann, JP; Heesen, C; Fiehler, J; Siemonsen, S				Faizy, Tobias Djamsched; Thaler, Christian; Kumar, Dushyant; Sedlacik, Jan; Broocks, Gabriel; Grosser, Malte; Stellmann, Jan-Patrick; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging	PLOS ONE			English	Article							APPEARING BRAIN-TISSUE; MAGNETIZATION-TRANSFER; DIFFUSION TENSOR; WHITE-MATTER; INSIGHTS; EVOLUTION; INJURY; IMAGES; MRI	Purpose To assess neuroprotection and remyelination in Multiple Sclerosis (MS), we applied a more robust myelin water imaging (MWI) processing technique, including spatial priors into image reconstruction, which allows for lower SNR, less averages and shorter acquisition times. We sought to evaluate this technique in MS-patients and healthy controls (HC). Materials and Methods Seventeen MS-patients and 14 age-matched HCs received a 3T Magnetic Resonance Imaging (MRI) examination including MWI (8 slices, 12 minutes acquisition time), T2w and T1mprage pre and post gadolinium (GD) administration. Black holes (BH), contrast enhancing lesions (CEL) and T2 lesions were marked and registered to MWI. Additionally, regions of interest (ROI) were defined in the frontal, parietal and occipital normal appearing white matter (NAWM)/white matter (WM), the corticospinal tract (CST), the splenium (SCC) and genu (GCC) of the corpus callosum in patients and HCs. Mean values of myelin water fraction (MWF) were determined for each ROI. Results Significant differences (p < 0.05) of the MWF were found in all three different MS-lesion types (BH, CEL, T2 lesions), compared to the WM of HCs. The mean MWF values among the different lesion types were significantly differing from each other. Comparing MS-patients vs. HCs, we found a significant (p < 0.05) difference of the MWF in all measured ROIs except of GCC and SCC. The mean reduction of MWF in the NAWM of MS-patients compared to HCs was 37%. No age, sex, disability score and disease duration dependency was found for the NAWM MWF. Conclusion MWF measures were in line with previous studies and lesions were clearly visible in MWI. MWI allows for quantitative assessment of NAWM and lesions in MS, which could be used as an additional sensitive imaging endpoint for larger MS studies. Measurements of the MWF also differ between patients and healthy controls.	[Faizy, Tobias Djamsched; Thaler, Christian; Kumar, Dushyant; Sedlacik, Jan; Broocks, Gabriel; Grosser, Malte; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Kumar, Dushyant; Stellmann, Jan-Patrick; Heesen, Christoph; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Faizy, TD (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	T.Faizy@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833; Gellissen, Susanne/0000-0002-7444-7265	German Federal Ministry of Education and Research [0315610-0315620 NEU2]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (Proposal/Contract 0315610-0315620 NEU2).	Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; Filippi M, 2000, NEUROLOGY, V55, P940, DOI 10.1212/WNL.55.7.940; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hein T, 2000, NERVENARZT, V71, P288, DOI 10.1007/s001150050559; HIEHLE JF, 1995, AM J NEURORADIOL, V16, P69; Kappos L, 2015, NEUROLOGY, V84, P1582, DOI 10.1212/WNL.0000000000001462; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Kumar D, 2012, MAGN RESON MED, V68, P1536, DOI 10.1002/mrm.24170; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2007, J MAGN RESON IMAGING, V26, P1117, DOI 10.1002/jmri.21132; Laule C, 2011, MULT SCLER J, V17, P144, DOI 10.1177/1352458510384008; LOEVNER LA, 1995, RADIOLOGY, V196, P511, DOI 10.1148/radiology.196.2.7617869; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Oh J, 2004, J NEUROL NEUROSUR PS, V75, P1281, DOI 10.1136/jnnp.2004.039032; Oh J, 2007, J NEUROIMAGING, V17, P156, DOI 10.1111/j.1552-6569.2007.00098.x; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pichler A, 2013, MULT SCLER J, V19, P167, DOI 10.1177/1352458512448107; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; REVESZ T, 1994, BRAIN, V117, P759, DOI 10.1093/brain/117.4.759; Siemonsen S, 2015, CLIN NEURORADIOL; Tortorella C, 2000, NEUROLOGY, V54, P186, DOI 10.1212/WNL.54.1.186; TRAUGOTT U, 1983, J NEUROIMMUNOL, V4, P201, DOI 10.1016/0165-5728(83)90036-X; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Vavasour IM, 1998, MAGNET RESON MED, V40, P763, DOI 10.1002/mrm.1910400518; Vavasour IM, 2007, J NEUROL, V254, P1653, DOI 10.1007/s00415-007-0604-x; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Vrenken H, 2007, MULT SCLER, V13, P708, DOI 10.1177/1352458506075521; Vrenken H, 2006, RADIOLOGY, V240, P811, DOI 10.1148/radiol.2403050569; Ziemssen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138243	41	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151496	10.1371/journal.pone.0151496	http://dx.doi.org/10.1371/journal.pone.0151496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990645	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800068
J	Hong, JY; Han, K; Shin, DH; Chun, EM				Hong, Jae-Young; Han, Kyungdo; Shin, Dong-Hyup; Chun, Eun Mi			Quality of Life Analysis and Smoking Correlation in Symptomatic Spine Osteoarthritis: A Nationwide Health Survey Analysis of an Elderly Population with EQ-5D	PLOS ONE			English	Article							HIP OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; GENERAL-POPULATION; PREVALENCE; ASSOCIATION; OVERWEIGHT; ARTHRITIS; HISTORY; IMPACT; COHORT	Objectives To analyze quality of life in people with symptomatic spine osteoarthritis (OA) using the results of a cross-sectional, nationwide survey. Materials and Methods This study used data from the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-5; 2010-2012). After excluding ineligible subjects, the total number of subjects in the study was 8,963, including 4,091 males and 4,872 females. All participants reported disabilities related to spine OA. Plain radiographs of the spine were taken for all participants. Results Age, sex, smoking, drinking, education, and income level were significantly related to spine OA morbidity (P<0.05). OA morbidity was significantly higher in female ex-smokers (OR; 2.94, P<0.05). Quality of life (EQ-5D: L1 similar to 5) was significantly compromised in the group with spine OA compared to the group without spine OA (P<0.05). Overall, LQ 1, 2, 3, 4, and 5 domain scores were significantly higher in the group with spine OA (P<0.05). In the group with spine OA, quality of life was reduced on more than three questions for 34.3% of the group (EQ-5D: grade >= 2); on two questions, for 18.5% of the group; and on one question, for 11.1% of the group. Mental stress, melancholy, and suicidal thinking were also more common in the group with spine OA (P<0.05). The group with radiographic spine OA but without symptoms did not have compromised EQ-5D scores, whereas the group with radiographic OA and symptoms showed a significantly reduced quality of life. Conclusions Quality of life was significantly reduced in the group with symptomatic spine OA in a large cross-sectional analysis. Physicians should consider quality of life in the treatment of patients with spine OA	[Hong, Jae-Young; Shin, Dong-Hyup] Korea Univ, Ansan Hosp, Dept Orthoped, Ansan, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Chun, Eun Mi] Ewha Womans Univ, Div Pulm & Crit Care Med, Dept Internal Med, Mokdong Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Ewha Womans University	Chun, EM (corresponding author), Ewha Womans Univ, Div Pulm & Crit Care Med, Dept Internal Med, Mokdong Hosp, Seoul, South Korea.	cem@ewha.ac.kr						Akmal M, 2004, SPINE, V29, P568, DOI 10.1097/01.BRS.0000101422.36419.D8; Amin S, 2007, ANN RHEUM DIS, V66, P18, DOI 10.1136/ard.2006.056697; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Andrianakos AA, 2006, J RHEUMATOL, V33, P2507; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Chung JH, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.94; Ding CH, 2007, ARTHRITIS RHEUM-US, V56, P1521, DOI 10.1002/art.22591; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; Eisele M, 2015, BRIT J GEN PRACT, V65, pE716, DOI 10.3399/bjgp15X687337; Ernest S, 2001, P 26 ANN SAS US GROU, P222; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Geryk LL, 2015, CLIN EXP RHEUMATOL, V33, P366; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Gullihorn L, 2005, J ORTHOP TRAUMA, V19, P17, DOI 10.1097/00005131-200501000-00004; Hill CL, 1999, J RHEUMATOL, V26, P2029; Hui M, 2011, ANN RHEUM DIS, V70, P1231, DOI 10.1136/ard.2010.142323; Hung MC, 2015, J OCCUP REHABIL, V25, P387, DOI 10.1007/s10926-014-9547-0; Hunter DJ, 2009, MED CLIN N AM, V93, P127, DOI [10.1016/j.rdc.2008.05.008, 10.1016/j.mcna.2008.07.009]; Hwang IC, 2015, ASIA-PAC J PUBLIC HE, V27, P4; Jordan JM, 2007, J RHEUMATOL, V34, P172; Jorgensen KT, 2011, OSTEOARTHR CARTILAGE, V19, P1176, DOI 10.1016/j.joca.2011.07.009; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kent S, 2015, MED DECIS MAKING, V35, P902, DOI 10.1177/0272989X15584921; Kim C, 2014, ARTHRITIS RHEUMATOL, V66, P3013, DOI 10.1002/art.38795; Kim KH, 2013, SUPPORT CARE CANCER, V21, P3471, DOI 10.1007/s00520-013-1939-8; Kim Y, 2014, EPIDEMIOL HLTH, V30; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Leicht H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070018; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Nelson AE, 2013, ARTHRITIS RHEUM-US, V65, P373, DOI 10.1002/art.37775; Nho SJ, 2013, J AM ACAD ORTHOP SUR, V21, pS1, DOI 10.5435/JAAOS-21-07-S1; Oda H, 2004, J ORTHOP SCI, V9, P135, DOI 10.1007/s00776-003-0759-y; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Ramsey SD, 2015, J CLIN ONCOLOGY, V33; Sandmark H, 1999, ANN RHEUM DIS, V58, P151, DOI 10.1136/ard.58.3.151; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Yu ST, 2015, QUAL LIFE RES, V24, P2541, DOI 10.1007/s11136-015-0978-7	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151315	10.1371/journal.pone.0151315	http://dx.doi.org/10.1371/journal.pone.0151315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991429	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800054
J	Nielsen, KK; Damm, P; Kapur, A; Balaji, V; Balaji, MS; Seshiah, V; Bygbjerg, IC				Nielsen, Karoline Kragelund; Damm, Peter; Kapur, Anil; Balaji, Vijayam; Balaji, Madhuri S.; Seshiah, Veerasamy; Bygbjerg, Ib C.			Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; MIDDLE-INCOME COUNTRIES; SOCIOECONOMIC-STATUS; SOUTH-INDIA; EARLY-LIFE; PREVALENCE; WOMEN; POPULATION; AMERICAN	Introduction Hyperglycaemia in pregnancy (HIP), i.e. gestational diabetes mellitus (GDM) and diabetes in pregnancy (DIP), increases the risk of various short-and long-term adverse outcomes. However, much remains to be understood about the role of different risk factors in development of HIP. Objective The aims of this observational study were to examine the role of potential risk factors for HIP, and to investigate whether any single or accumulated risk factor(s) could be used to predict HIP among women attending GDM screening at three centres in urban, semi-urban and rural Tamil Nadu, India. Methodology Pregnant women underwent a 75 g oral glucose tolerance test. Data on potential risk factors was collected and analysed using logistical regression analysis. Receiver operating characteristic (ROC) curves, sensitivity, specificity and predictive values were calculated for significant risk factors and a risk factor scoring variable was constructed. Results HIP was prevalent in 18.9% of the study population (16.3% GDM; 2.6% DIP). Increasing age and BMI as well as having a mother only or both parents with diabetes were significant independent risk factors for HIP. Among women attending the rural health centre a doubling of income corresponded to an 80% increased risk of HIP (OR 1.80, 95% CI 1.10-2.93; p = 0.019), whereas it was not significantly associated with HIP among women attending the other health centres. The performance of the individual risk factors and the constructed scoring variable differed substantially between the three health centres, but none of them were good enough to discriminate between those with and without HIP. Conclusions The findings highlight the importance of socio-economic circumstances and intergenerational risk transmission in the occurrence of HIP as well as the need for universal screening.	[Nielsen, Karoline Kragelund; Bygbjerg, Ib C.] Univ Copenhagen, Global Hlth Sect, Dept Publ Hlth, Copenhagen, Denmark; [Nielsen, Karoline Kragelund; Kapur, Anil] World Diabet Fdn, Gentofte, Denmark; [Damm, Peter] Univ Copenhagen, Rigshosp, Ctr Pregnant Women Diabet, Dept Obstet,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Damm, Peter] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Balaji, Vijayam; Balaji, Madhuri S.; Seshiah, Veerasamy] Dr Seshiah Diabet Res Inst, Chennai, Tamil Nadu, India; [Balaji, Vijayam; Balaji, Madhuri S.; Seshiah, Veerasamy] Dr Balaji Diabet Care Ctr, Chennai, Tamil Nadu, India	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Nielsen, KK (corresponding author), Univ Copenhagen, Global Hlth Sect, Dept Publ Hlth, Copenhagen, Denmark.; Nielsen, KK (corresponding author), World Diabet Fdn, Gentofte, Denmark.	kani@sund.ku.dk	Sánchez-Margalet, Victor/AAB-9986-2021; Nielsen, Karoline Kragelund/AAX-3883-2020	Sánchez-Margalet, Victor/0000-0001-8638-8680; Nielsen, Karoline Kragelund/0000-0002-4058-0615; Bygbjerg, Ib/0000-0001-9100-2754	World Diabetes Foundation [WDF-I-12-606, WDF11-612]	World Diabetes Foundation	This work was supported by the World Diabetes Foundation, grant no. WDF-I-12-606; (worlddiabetesfoundation.org); recipient: KKN and the World Diabetes Foundation, grant no. WDF11-612; (worlddiabetesfoundation.org); recipient: VB. The funder provided support in the form of salaries for authors [KKN through grant; AK as honorarium, in capacity as chairman], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwal KN, 2006, IAP TXB PEDIAT; Arora G, 2015, EUR J ENDOCRINOL; Balaji V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0378-y; Balaji V, 2012, DIABETES TECHNOL THE, V14, P131, DOI 10.1089/dia.2011.0060; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bhat M, 2010, INT J DIABETES DEV C, V30, P91, DOI 10.4103/0973-3930.62599; Black MH, 2010, DIABETES CARE, V33, P2524, DOI 10.2337/dc10-1445; Cullinan J, 2012, Ir Med J, V105, P21; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; DORNHORST A, 1992, DIABETIC MED, V9, P820, DOI 10.1111/j.1464-5491.1992.tb01900.x; Hanson MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1025; Hawkes C., 2007, GLOBALIZATION FOOD N; Huy C, 2012, GEBURTSH FRAUENHEILK, V72, P311, DOI 10.1055/s-0031-1298390; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kale Shailaja D, 2005, J Assoc Physicians India, V53, P857; Kalra Priyanka, 2013, Indian J Endocrinol Metab, V17, P677, DOI 10.4103/2230-8210.113760; Kanguru L, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23987; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2013, AM J PUBLIC HEALTH, V103, pE65, DOI 10.2105/AJPH.2013.301469; Kragelund Nielsen K, 2015, FACTORS INFLUE UNPUB; Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; PETTITT DJ, 1991, DIABETES, V40, P126, DOI 10.2337/diab.40.2.S126; Public Health Foundation of India, 2015, CERT COURS GEST DIAB; Rajput Meena, 2014, Indian J Endocrinol Metab, V18, P350, DOI 10.4103/2230-8210.131176; Rajput R, 2013, INDIAN J MED RES, V137, P728; Ramachandran A, 2004, DIABETOLOGIA, V47, P860, DOI 10.1007/s00125-004-1387-6; Rathmann W, 2005, EUR J PUBLIC HEALTH, V15, P627, DOI 10.1093/eurpub/cki037; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Savitz DA, 2008, BJOG-INT J OBSTET GY, V115, P969, DOI 10.1111/j.1471-0528.2008.01763.x; Seshiah V, 2007, DIABETES RES CLIN PR, V77, P482, DOI 10.1016/j.diabres.2007.01.001; Seshiah V, 2006, J Assoc Physicians India, V54, P622; Seshiah V, 2008, J Assoc Physicians India, V56, P329; Seshiah V, 2015, INDIAN J ENDOCRINOL, V19, P529, DOI [10.4103/2230-8210.159064, DOI 10.4103/2230-8210.159064]; Sharma Kavita, 2013, J Assoc Physicians India, V61, P558; Skar Mette, 2013, Indian J Endocrinol Metab, V17, P1084, DOI 10.4103/2230-8210.122632; Somani Bl, 2012, Med J Armed Forces India, V68, P6, DOI 10.1016/S0377-1237(11)60124-X; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Subburaj T.V.K., 2007, SCREENING GLUCOSE IN; Tripathi R, 2012, J OBSTET GYNAECOL RE, V38, P351, DOI 10.1111/j.1447-0756.2011.01706.x; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; Wahi Preeti, 2011, J Assoc Physicians India, V59, P227; WHO, 2013, DIAGN CRIT CLASS HYP; World Health Organization, 2011, SER FERR CONC ASS IR; Zargar AH, 2004, DIABETES RES CLIN PR, V66, P139, DOI 10.1016/j.diabres.2004.02.023	46	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151311	10.1371/journal.pone.0151311	http://dx.doi.org/10.1371/journal.pone.0151311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991305	gold, Green Published			2022-12-27	WOS:000372582800053
J	Song, GJ; Ji, ZZ				Song, GuangJia; Ji, ZhenZhou			Novel Duplicate Address Detection with Hash Function	PLOS ONE			English	Article								Duplicate address detection (DAD) is an important component of the address resolution protocol (ARP) and the neighbor discovery protocol (NDP). DAD determines whether an IP address is in conflict with other nodes. In traditional DAD, the target address to be detected is broadcast through the network, which provides convenience for malicious nodes to attack. A malicious node can send a spoofing reply to prevent the address configuration of a normal node, and thus, a denial-of-service attack is launched. This study proposes a hash method to hide the target address in DAD, which prevents an attack node from launching destination attacks. If the address of a normal node is identical to the detection address, then its hash value should be the same as the "Hash_64" field in the neighboring solicitation message. Consequently, DAD can be successfully completed. This process is called DAD-h. Simulation results indicate that address configuration using DAD-h has a considerably higher success rate when under attack compared with traditional DAD. Comparative analysis shows that DAD-h does not require third-party devices and considerable computing resources; it also provides a lightweight security resolution.	[Song, GuangJia; Ji, ZhenZhou] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China	Harbin Institute of Technology	Song, GJ (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China.	35059899@QQ.com			National Natural Science Foundation of China [61173024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no. 61173024), http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsa'deh A., 2012, 2012 International Conference on Information Networking (ICOIN 2012), P257, DOI 10.1109/ICOIN.2012.6164388; AlSa'deh A, 2011, IEEE INT CONF NETWOR, P299, DOI 10.1109/ICON.2011.6168492; Arkko J., 2005, 3971 IETF RFC; Aura Tuomas, 2005, CRYPTOGRAPHICALLY GE; Bagnulo M., 2006, CRYPTOGRAPHICALLY GE; Bagnulo M, 2013, IEEE COMMUN MAG, V51, P66, DOI 10.1109/MCOM.2013.6495763; Beck F., 2007, P INT MULT COMP GLOB, P57; Cheshire S., 2008, IPV4 ADDRESS CONFLIC; D. C. Plummer, ETHERNET ADDRESS RES; Garcia-Martinez A, 2012, IEEE COMMUN LETT, V16, P1900, DOI 10.1109/LCOMM.2012.100812.121517; Heuse M, THC IPV6 ATTACK TOOL; Kevin R, 2011, TCP IP ILLUSTRATED, V1; Kim PS, 2013, ENG LET, V21, P68; LI ZM, 2008, P INT S IEEE COMP SC, P277, DOI DOI 10.1109/ISCSCT.2008.62; Narten T., 2001, 3041 RFC, DOI DOI 10.17487/RFC3041; Narten T., 2007, PRIVACY EXTENSIONS S; Narten T., NEIGHBOR DISCOVERY I; Netze Heise, 2008, SOURCE ADDRESS VALID; Nikander Pekka, 2004, IPV6 NEIGHBOR DISCOV; Rafiee H., 2012, 2012 International Conference on Information Networking (ICOIN 2012), P269, DOI 10.1109/ICOIN.2012.6164390; Rehman SU, 2015, INT J SECUR APPL, V9, P77, DOI 10.14257/ijsia.2015.9.11.08; Seo Karen, 2005, SECURITY ARCHITECTUR; Shigei Noritaka, 2012, IAENG International Journal of Computer Science, V39, P321; Stinson D. R., 2005, CRYPTOGRAPHY THEORY; Thomson S., 2007, RFC, V4862, P1; Tseng CC, 2006, IEEE INTERNET COMPUT, V10, P50, DOI 10.1109/MIC.2006.131; Yu-xuan Hong, 2011, Proceedings of the 2011 Fifth International Conference on Innovative Mobile and Internet Services in Ubiquitous Computing (IMIS), P353, DOI 10.1109/IMIS.2011.121	27	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151612	10.1371/journal.pone.0151612	http://dx.doi.org/10.1371/journal.pone.0151612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991901	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800078
J	Thibert, J; Farine, JP; Cortot, J; Ferveur, JF				Thibert, Julien; Farine, Jean-Pierre; Cortot, Jerome; Ferveur, Jean-Francois			Drosophila Food-Associated Pheromones: Effect of Experience, Genotype and Antibiotics on Larval Behavior	PLOS ONE			English	Article							SEX-PHEROMONES; MELANOGASTER; AGGRESSION; COURTSHIP; COMMUNICATION; RECOGNITION; ATTRACTION; EVOLUTION; MUTATION; INSECTS	Animals ubiquitously use chemical signals to communicate many aspects of their social life. These chemical signals often consist of environmental cues mixed with species-specific signals-pheromones-emitted by conspecifics. During their life, insects can use pheromones to aggregate, disperse, choose a mate, or find the most suitable food source on which to lay eggs. Before pupariation, larvae of several Drosophila species migrate to food sources depending on their composition and the presence of pheromones. Some pheromones derive from microbiota gut activity and these food-associated cues can enhance larval attraction or repulsion. To explore the mechanisms underlying the preference (attraction/repulsion) to these cues and clarify their effect, we manipulated factors potentially involved in larval response. In particular, we found that the (i) early exposure to conspecifics, (ii) genotype, and (iii) antibiotic treatment changed D. melanogaster larval behavior. Generally, larvae-tested either individually or in groups-strongly avoided food processed by other larvae. Compared to previous reports on larval attractive pheromones, our data suggest that such attractive effects are largely masked by food-associated compounds eliciting larval aversion. The antagonistic effect of attractive vs. aversive compounds could modulate larval choice of a pupariation site and impact the dispersion of individuals in nature.	[Thibert, Julien; Farine, Jean-Pierre; Cortot, Jerome; Ferveur, Jean-Francois] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, CNRS, UMR6265,UMR1324,INRA, 6 Bd Gabriel, F-21000 Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Ferveur, JF (corresponding author), Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, CNRS, UMR6265,UMR1324,INRA, 6 Bd Gabriel, F-21000 Dijon, France.	jean-francois.ferveur@u-bourgogne.fr			Centre National de la Recherche Scientifique (Insb); Burgundy Regional Council (PARI); UNiversite de Bourgogne; Agence nationale de la Recherche (GUSTAILE); CONICYT [MEC80140013]	Centre National de la Recherche Scientifique (Insb)(Centre National de la Recherche Scientifique (CNRS)); Burgundy Regional Council (PARI)(Region Bourgogne-Franche-Comte); UNiversite de Bourgogne; Agence nationale de la Recherche (GUSTAILE)(French National Research Agency (ANR)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funded by Centre National de la Recherche Scientifique (Insb) http://www.cnrs.fr/insb/ (JPF, JFF and JC), Burgundy Regional Council (PARI 2012) http://www.region-bourgogne.fr/ (JFF), UNiversite de Bourgogne http://www.u-bourgogne.fr/ (JT), Agence nationale de la Recherche (GUSTAILE2012) http://www.agence-nationale-recherche.fr/ (JFF), and CONICYT (MEC80140013) http://www.conicyt.cl/ (JFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee WC, 1932, J EXP ZOOL, V61, P185, DOI 10.1002/jez.1400610202; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Beltrami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039393; Beltrami M, 2010, EVOL ECOL, V24, P347, DOI 10.1007/s10682-009-9310-8; Bubak AN, 2014, CURR ZOOL, V60, P778, DOI 10.1093/czoolo/60.6.778; COBB M, 1992, P ROY SOC B-BIOL SCI, V248, P103, DOI 10.1098/rspb.1992.0048; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Del Pino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102159; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Durisko Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1398; Farine JP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0043; Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Flaven-Pouchon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092352; Flowers RW, 2003, ANN ENTOMOL SOC AM, V96, P336, DOI 10.1603/0013-8746(2003)096[0336:LCAGFD]2.0.CO;2; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gomez-Diaz C, 2013, EMBO REP, V14, P874, DOI 10.1038/embor.2013.140; Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428; Hassanali A, 2005, ANNU REV ENTOMOL, V50, P223, DOI 10.1146/annurev.ento.50.071803.130345; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Marcillac F, 2005, GENETICS, V171, P1617, DOI 10.1534/genetics.104.033159; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Mast JD, 2014, ELIFE, V3, DOI 10.7554/eLife.04205; Newell PD, 2014, APPL ENVIRON MICROB, V80, P788, DOI 10.1128/AEM.02742-13; North G, 2007, COLD SPRING HARB MON, V49, pIX; Pires HHR, 2002, ACTA TROP, V81, P47, DOI 10.1016/S0001-706X(01)00185-1; Poivet E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2050; Secondi J, 2014, EVOL BIOL, V41, P71, DOI 10.1007/s11692-013-9248-1; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Venu I, 2014, J EXP BIOL, V217, P1346, DOI 10.1242/jeb.099648; Witzgall P, 2012, J CHEM ECOL, V38, P949, DOI 10.1007/s10886-012-0158-y; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	37	12	12	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151451	10.1371/journal.pone.0151451	http://dx.doi.org/10.1371/journal.pone.0151451			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987117	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300073
J	Widderich, N; Kobus, S; Hoppner, A; Riclea, R; Seubert, A; Dickschat, JS; Heider, J; Smits, SHJ; Bremer, E				Widderich, Nils; Kobus, Stefanie; Hoeppner, Astrid; Riclea, Ramona; Seubert, Andreas; Dickschat, Jeroen S.; Heider, Johann; Smits, Sander H. J.; Bremer, Erhard			Biochemistry and Crystal Structure of Ectoine Synthase: A Metal-Containing Member of the Cupin Superfamily	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; ESCHERICHIA-COLI; MARINE BACTERIUM; OSMOTIC-STRESS; AMINO-ACID; HYDROXYECTOINE; BIOSYNTHESIS; OSMOLYTES; RESPONSES; BINDING	Ectoine is a compatible solute and chemical chaperone widely used by members of the Bacteria and a few Archaea to fend-off the detrimental effects of high external osmolarity on cellular physiology and growth. Ectoine synthase (EctC) catalyzes the last step in ectoine production and mediates the ring closure of the substrate N-gamma-acetyl-L-2,4-diaminobutyric acid through a water elimination reaction. However, the crystal structure of ectoine synthase is not known and a clear understanding of how its fold contributes to enzyme activity is thus lacking. Using the ectoine synthase from the cold-adapted marine bacterium Sphingopyxis alaskensis (Sa), we report here both a detailed biochemical characterization of the EctC enzyme and the high-resolution crystal structure of its apo-form. Structural analysis classified the (Sa) EctC protein as a member of the cupin superfamily. EctC forms a dimer with a head-to-tail arrangement, both in solution and in the crystal structure. The interface of the dimer assembly is shaped through backbone-contacts and weak hydrophobic interactions mediated by two beta-sheets within each monomer. We show for the first time that ectoine synthase harbors a catalytically important metal co-factor; metal depletion and reconstitution experiments suggest that EctC is probably an iron-dependent enzyme. We found that EctC not only effectively converts its natural substrate N-gamma-acetyl-L-2,4-diaminobutyric acid into ectoine through a cyclocondensation reaction, but that it can also use the isomer N-alpha-acetyl-L-2,4-diaminobutyric acid as its substrate, albeit with substantially reduced catalytic efficiency. Structure-guided site-directed mutagenesis experiments targeting amino acid residues that are evolutionarily highly conserved among the extended EctC protein family, including those forming the presumptive iron-binding site, were conducted to functionally analyze the properties of the resulting EctC variants. An assessment of enzyme activity and iron content of these mutants give important clues for understanding the architecture of the active site positioned within the core of the EctC cupin barrel.	[Widderich, Nils; Heider, Johann; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany; [Kobus, Stefanie; Hoeppner, Astrid] Univ Dusseldorf, Xray Facil & Crystal Farm, Dusseldorf, Germany; [Riclea, Ramona; Dickschat, Jeroen S.] Univ Bonn, Kekule Inst Organ Chem & Biochem, Bonn, Germany; [Riclea, Ramona; Dickschat, Jeroen S.] TU Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Seubert, Andreas] Univ Marburg, Dept Chem, Analyt Chem, D-35043 Marburg, Germany; [Heider, Johann; Bremer, Erhard] Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany; [Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany	Philipps University Marburg; University of Bonn; Braunschweig University of Technology; Philipps University Marburg; Philipps University Marburg; Heinrich Heine University Dusseldorf	Bremer, E (corresponding author), Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany.; Bremer, E (corresponding author), Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany.; Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	sander.smits@hhu.de; bremer@staff.uni-marburg.de	Heider, Johann/ABA-7877-2021; Heider, Johann/Y-2291-2018; Heider, Johann/A-1833-2012	Heider, Johann/0000-0001-8328-9716; Heider, Johann/0000-0001-8328-9716	Deutsche Forschungsgemeinschaft (DFG) [SFB 987, SFB TR41]; LOEWE program of the state of Hessen (via the Center for Synthetic Microbiology, Marburg); Strategischer Forschungs-Fond (SFF) (Heinrich-Heine-University Dusseldorf); Strategischer Forschungs-Fond (SFF) (Institute of Biochemistry); International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LOEWE program of the state of Hessen (via the Center for Synthetic Microbiology, Marburg); Strategischer Forschungs-Fond (SFF) (Heinrich-Heine-University Dusseldorf); Strategischer Forschungs-Fond (SFF) (Institute of Biochemistry); International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG) through the SFB 987 (Philipps-University Marburg; to J.H. and E.B.), by the LOEWE program of the state of Hessen (via the Center for Synthetic Microbiology, Marburg; to J.H. and E.B.), by the Strategischer Forschungs-Fond (SFF) (Heinrich-Heine-University Dusseldorf and its Institute of Biochemistry; to S.H.J.S.) and the DFG-funded Transregio SFB TR41 (Braunschweig/Oldenburg; to J.S.D.). N.W. is the recipient of a Ph.D. fellowship from the International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg) and gratefully acknowledges its generous support.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; Claesson M, 2012, J MOL BIOL, V417, P279, DOI 10.1016/j.jmb.2012.02.001; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gopal B, 2005, BIOCHEMISTRY-US, V44, P193, DOI 10.1021/bi0484421; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Hajnal I, 2013, FEBS J, V280, P5815, DOI 10.1111/febs.12501; Harishchandra RK, 2010, BIOPHYS CHEM, V150, P37, DOI 10.1016/j.bpc.2010.02.007; Hoppner A, 2014, J BIOL CHEM, V289, P29570, DOI 10.1074/jbc.M114.576769; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; INBAR L, 1988, J BIOL CHEM, V263, P16014; Jaroszewski L, 2004, PROTEINS, V56, P611, DOI 10.1002/prot.20130; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knapp S, 1999, EXTREMOPHILES, V3, P191, DOI 10.1007/s007920050116; Kobus S, 2015, ACTA CRYSTALLOGR F, V71, P1027, DOI 10.1107/S2053230X15011115; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; KUNTE HJ, 1993, J MICROBIOL METH, V17, P129; Kunte HJ, 2014, CURR BIOTECHNOL, V3, P10, DOI [10.2174/22115501113026660037, DOI 10.2174/22115501113026660037]; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; Link H, 2015, NAT METHODS, V12, P1091, DOI [10.1038/NMETH.3584, 10.1038/nmeth.3584]; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Moritz KD, 2015, EXTREMOPHILES, V19, P87, DOI 10.1007/s00792-014-0687-0; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Ono H, 1998, J FERMENT BIOENG, V85, P362, DOI 10.1016/S0922-338X(98)80078-0; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Silvennoinen L, 2009, FEBS LETT, V583, P2917, DOI 10.1016/j.febslet.2009.07.061; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Tanne C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00150; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Uberto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074477; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Widderich N, 2016, ENVIRON MICROBIOL, V18, P1227, DOI 10.1111/1462-2920.13156; Widderich N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093809; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Witt EMHJ, 2011, APPL MICROBIOL BIOT, V91, P113, DOI 10.1007/s00253-011-3211-9; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Yancey Paul H., 2004, Science Progress, V87, P1, DOI 10.3184/003685004783238599; Yoshida H, 2014, FEBS J, V281, P3150, DOI 10.1111/febs.12850	69	19	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151285	10.1371/journal.pone.0151285	http://dx.doi.org/10.1371/journal.pone.0151285			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986827	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300058
J	Segura, DF; Nussenbaum, AL; Viscarret, MM; Devescovi, F; Bachmann, GE; Corley, JC; Ovruski, SM; Cladera, JL				Segura, Diego F.; Nussenbaum, Ana L.; Viscarret, Mariana M.; Devescovi, Francisco; Bachmann, Guillermo E.; Corley, Juan C.; Ovruski, Sergio M.; Cladera, Jorge L.			Innate Host Habitat Preference in the Parasitoid Diachasmimorpha longicaudata: Functional Significance and Modifications through Learning	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; MEDITERRANEAN FRUIT-FLY; EGG LOAD DYNAMICS; CERATITIS-CAPITATA; HYMENOPTERA-BRACONIDAE; INFOCHEMICAL USE; PLANT SELECTION; TEPHRITIDAE; HERBIVORE; SIZE	Parasitoids searching for polyphagous herbivores can find their hosts in a variety of habitats. Under this scenario, chemical cues from the host habitat (not related to the host) represent poor indicators of host location. Hence, it is unlikely that naive females show a strong response to host habitat cues, which would become important only if the parasitoids learn to associate such cues to the host presence. This concept does not consider that habitats can vary in profitability or host nutritional quality, which according to the optimal foraging theory and the preference-performance hypothesis (respectively) could shape the way in which parasitoids make use of chemical cues from the host habitat. We assessed innate preference in the fruit fly parasitoid Diachasmimorpha longicaudata among chemical cues from four host habitats (apple, fig, orange and peach) using a Y-tube olfactometer. Contrary to what was predicted, we found a hierarchic pattern of preference. The parasitism rate realized on these fruit species and the weight of the host correlates positively, to some extent, with the preference pattern, whereas preference did not correlate with survival and fecundity of the progeny. As expected for a parasitoid foraging for generalist hosts, habitat preference changed markedly depending on their previous experience and the abundance of hosts. These findings suggest that the pattern of preference for host habitats is attributable to differences in encounter rate and host quality. Host habitat preference seems to be, however, quite plastic and easily modified according to the information obtained during foraging.	[Segura, Diego F.; Nussenbaum, Ana L.; Devescovi, Francisco; Bachmann, Guillermo E.; Cladera, Jorge L.] INTA, CICVyA, IGEAF, Lab Genet Insectos Importancia Econ, Hurlingham, Argentina; [Segura, Diego F.; Nussenbaum, Ana L.; Devescovi, Francisco; Bachmann, Guillermo E.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Viscarret, Mariana M.] INTA, CICVyA, IMyZA, Insectario Invest Lucha Biol, Hurlingham, Argentina; [Corley, Juan C.] INTA EEA Bariloche, Grp Ecol Poblac Insectos, San Carlos De Bariloche, Rio Negro, Argentina; [Ovruski, Sergio M.] CCT Tucuman CONICET, PROIMI Biotecnol, Div Control Biol Plagas, San Miguel De Tucuman, Tucuman, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Segura, DF (corresponding author), INTA, CICVyA, IGEAF, Lab Genet Insectos Importancia Econ, Hurlingham, Argentina.; Segura, DF (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	segura.diego@inta.gob.ar	Nussenbaum, Ana Laura/AAT-7037-2020	Nussenbaum, Ana Laura/0000-0003-1795-1980; Segura, Diego Fernando/0000-0003-2927-9028; Ovruski, Sergio M./0000-0002-0137-4499	Fondo para la Investigacion Cientifica y Tecnologica [PICT 2010-1324]; CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS, PIP	Fondo para la Investigacion Cientifica y Tecnologica; CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS, PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by the following: Fondo para la Investigacion Cientifica y Tecnologica, PICT 2010-1324 (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt); and CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS, PIP 2011-2013 (www.conicet.gov.ar).	[Anonymous], 1992, FRUIT FLIES EC SIGNI; Belda C, 2010, BIOL CONTROL, V54, P29, DOI 10.1016/j.biocontrol.2010.02.005; Benelli G, 2012, BIOCONTROL, V57, P767, DOI 10.1007/s10526-012-9456-0; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Birke A, 2011, J ECON ENTOMOL, V104, P1204, DOI 10.1603/EC11042; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bukovinszky T, 2012, J INSECT PHYSIOL, V58, P367, DOI 10.1016/j.jinsphys.2011.12.017; Carrasco M, 2005, ENVIRON ENTOMOL, V34, P576, DOI 10.1603/0046-225X-34.3.576; CHARNOV EL, 1988, AM NAT, V132, P707, DOI 10.1086/284883; Chinajariyawong A, 2000, RAFFLES B ZOOL, V48, P71; Cicero L, 2012, PHYSIOL ENTOMOL, V37, P177, DOI 10.1111/j.1365-3032.2012.00833.x; Cicero L, 2011, J INSECT PHYSIOL, V57, P1471, DOI 10.1016/j.jinsphys.2011.07.014; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Cortesero AM, 1997, J CHEM ECOL, V23, P1589, DOI 10.1023/B:JOEC.0000006424.41365.0d; CROFT P, 1995, ENTOMOL EXP APPL, V74, P121, DOI 10.1007/BF02383003; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DENNO RF, 1990, ECOLOGY, V71, P124, DOI 10.2307/1940253; Devescovi F, 2015, AGR FOREST ENTOMOL, V17, P325, DOI 10.1111/afe.12111; Dicke M, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P483; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Eben A, 2000, ENVIRON ENTOMOL, V29, P87, DOI 10.1603/0046-225X-29.1.87; Ero MM, 2012, AGR FOREST ENTOMOL, V14, P101, DOI 10.1111/j.1461-9563.2011.00545.x; Ero MM, 2011, AUST J ENTOMOL, V50, P234, DOI 10.1111/j.1440-6055.2011.00821.x; Fathi SAA, 2012, BIOCONTROL, V57, P49, DOI 10.1007/s10526-011-9373-7; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hackermann J, 2007, J ANIM ECOL, V76, P376, DOI 10.1111/j.1365-2656.2006.01206.x; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; Harvey JA, 2004, ECOL ENTOMOL, V29, P35, DOI 10.1111/j.0307-6946.2004.00568.x; Harvey JA, 2015, ECOL ENTOMOL, V40, P114, DOI 10.1111/een.12165; Harvey JA, 2011, J CHEM ECOL, V37, P1081, DOI 10.1007/s10886-011-0024-3; Hoffmeister TS, 1999, ETHOLOGY, V105, P223, DOI 10.1046/j.1439-0310.1999.00361.x; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Jandricic SE, 2014, BIOL CONTROL, V76, P28, DOI 10.1016/j.biocontrol.2014.04.007; Kerguelen V, 1998, J INSECT BEHAV, V11, P221, DOI 10.1023/A:1021095907381; LEVINS R, 1969, Ecology (Washington D C), V50, P910, DOI 10.2307/1933709; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; LEYVA JL, 1991, ENVIRON ENTOMOL, V20, P1469, DOI 10.1093/ee/20.5.1469; Li XW, 2014, APPL ENTOMOL ZOOL, V49, P67, DOI 10.1007/s13355-013-0225-z; Luhring KA, 2004, BIOL CONTROL, V30, P382, DOI 10.1016/j.biocontrol.2004.01.008; Mavrikakis PG, 2000, ENVIRON ENTOMOL, V29, P1180, DOI 10.1603/0046-225X-29.6.1180; Mayhew PJ, 1998, P ROY SOC B-BIOL SCI, V265, P383, DOI 10.1098/rspb.1998.0306; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; MESSING RH, 1992, ENVIRON ENTOMOL, V21, P1189, DOI 10.1093/ee/21.5.1189; Ngumbi E, 2009, J CHEM ECOL, V35, P1009, DOI 10.1007/s10886-009-9700-y; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Ode PJ, 2004, OIKOS, V104, P388, DOI 10.1111/j.0030-1299.2004.12323.x; Ovrusiu SM, 2007, BIOCONTROL SCI TECHN, V17, P1079, DOI 10.1080/09583150701661620; Ovruski S, 2012, BIOCONTROL SCI TECHN, V22, P187, DOI 10.1080/09583157.2011.648167; Ovruski Sergio M., 2003, Rev. Soc. Entomol. Argent., V62, P49; Patt JM, 1999, ENTOMOL EXP APPL, V90, P1, DOI 10.1023/A:1003554332259; Rivero A, 2000, ECOL ENTOMOL, V25, P467, DOI 10.1046/j.1365-2311.2000.00276.x; Rutledge CE, 1999, BIOL CONTROL, V16, P144, DOI 10.1006/bcon.1999.0745; Rwomushana I, 2008, ANN ENTOMOL SOC AM, V101, P331, DOI 10.1603/0013-8746(2008)101[331:HPAHPP]2.0.CO;2; Sarfraz RM, 2012, BIOL CONTROL, V62, P38, DOI 10.1016/j.biocontrol.2012.03.004; Sato M, 2000, J INSECT BEHAV, V13, P263, DOI 10.1023/A:1007796400186; Segura DF, 2006, ANN ENTOMOL SOC AM, V99, P70, DOI 10.1603/0013-8746(2006)099[0070:RAOCCA]2.0.CO;2; Segura DF, 2007, ANIM BEHAV, V74, P131, DOI 10.1016/j.anbehav.2006.12.005; Segura Diego F, 2004, Ecol. austral, V14, P3; Segura DF, 2012, ENTOMOL EXP APPL, V143, P164, DOI 10.1111/j.1570-7458.2012.01246.x; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Silva JWP, 2007, BIOL CONTROL, V41, P304, DOI 10.1016/j.biocontrol.2007.03.005; SIVINSKI J, 1991, ENTOMOPHAGA, V36, P447, DOI 10.1007/BF02377951; StatSoft Inc., 2000, STAT WIND PROGR MAN; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; Stephens D.W., 1986, pi; Stireman JO, 2002, J INSECT BEHAV, V15, P689, DOI 10.1023/A:1020752024329; Stoepler TM, 2011, ECOL ENTOMOL, V36, P724, DOI 10.1111/j.1365-2311.2011.01322.x; Suarez L., 2014, Natural Science, V6, P664, DOI 10.4236/ns.2014.69066; Takemoto H, 2012, ANIM BEHAV, V83, P1491, DOI 10.1016/j.anbehav.2012.03.023; Tentelier C, 2005, ECOL ENTOMOL, V30, P739, DOI 10.1111/j.0307-6946.2005.00735.x; Tentelier C, 2007, J ANIM ECOL, V76, P1, DOI 10.1111/j.1365-2656.2006.01171.x; TERAN H R, 1977, Revista Agronomica del Noroeste Argentino, V14, P17; THOMPSON JN, 1988, ECOLOGY, V69, P893, DOI 10.2307/1941238; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings Ted C. J., 1993, P51; Uefune M, 2010, BIOL CONTROL, V54, P19, DOI 10.1016/j.biocontrol.2010.02.008; vansAlphen JJM, 1986, INSECT PARASITOIDS, P23; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Viscarret MM, 2006, BIOL CONTROL, V36, P147, DOI 10.1016/j.biocontrol.2005.08.009; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; WHARTON RA, 1983, ANN ENTOMOL SOC AM, V76, P721, DOI 10.1093/aesa/76.4.721; Wyckhuys KAG, 2007, ENTOMOL EXP APPL, V123, P149, DOI 10.1111/j.1570-7458.2007.00532.x	92	25	25	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152222	10.1371/journal.pone.0152222	http://dx.doi.org/10.1371/journal.pone.0152222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007298	Green Published, gold			2022-12-27	WOS:000372701200113
J	Chew, BH; Vos, R; Mohd-Sidik, S; Rutten, GEHM				Chew, Boon-How; Vos, Rimke; Mohd-Sidik, Sherina; Rutten, Guy E. H. M.			Diabetes-Related Distress, Depression and Distress-Depression among Adults with Type 2 Diabetes Mellitus in Malaysia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; PSYCHOLOGICAL DISTRESS; ANXIETY DISORDERS; SYMPTOMS; PEOPLE; ASSOCIATION; ADHERENCE; PATIENT	Type 2 diabetes mellitus (T2DM) brings about an increasing psychosocial problem in adult patients. Prevalence data on and associated factors of diabetes related distress (DRD) and depression have been lacking in Asia. This study aimed to examine the prevalence of DRD and depression, and their associated factors in Asian adult T2DM patients. This study was conducted in three public health clinics measuring DRD (Diabetes Distress Scale, DDS), and depression (Patient Health Questionnaire, PHQ). Patients who were at least 30 years of age, had T2DM for more than one year, with regular follow-up and recent laboratory results (<3 months) were consecutively recruited. Associations between DRD, depression and the combination DRD-depression with demographic and clinical characteristics were analysed using generalized linear models. From 752 invited people, 700 participated (mean age 56.9 years, 52.8% female, 52.9% Malay, 79.1% married). Prevalence of DRD and depression were 49.2% and 41.7%, respectively. Distress and depression were correlated, spearman's r = 0.50. Patients with higher DRD were younger (OR 0.995, 95% CI 0.996 to 0.991), Chinese (OR 1.2, 95% CI 1.04 to 1.29), attending Dengkil health clinic (OR 1.1, 95% CI 1.00 to 1.22) and had higher scores on the PHQ (OR 1.1, 95% CI 1.04 to 1.06). Depression was less likely in the unmarried compared to divorced/separately living and those attending Dengkil health clinic, but more likely in patients with microvascular complications (OR 1.4, 95% CI 1.06 to 1.73) and higher DDS (OR 1.03, 95% CI 1.02 to 1.03). For the combination of DRD and depression, unemployment (OR 4.7, 95% CI 1.02 to 21.20) had positive association, whereas those under medical care at the Salak health clinics (OR 0.28, 95% CI 0.12 to 0.63), and those with a blood pressure > 130/80 mmHg (OR 0.53, 95% CI 0.32 to 0.89) were less likely to experience both DRD and depression. DRD and depression were common and correlated in Asian adults with T2DM at primary care level. Socio-demographic more than clinical characteristics were related to DRD and depression.	[Chew, Boon-How] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia; [Chew, Boon-How; Vos, Rimke; Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Dept Gen Practice, Julius Ctr Hlth Sci & Primary Care, Huispost Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands; [Mohd-Sidik, Sherina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Psychiat, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Utrecht University; Utrecht University Medical Center; Universiti Putra Malaysia	Chew, BH (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.; Chew, BH (corresponding author), Univ Med Ctr Utrecht, Dept Gen Practice, Julius Ctr Hlth Sci & Primary Care, Huispost Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	chewboonhow@gmail.com	Vos, Rimke C/Y-6460-2018; Chew, Boon How/GPS-9821-2022; Chew, Boon-How/B-2385-2010	Vos, Rimke C/0000-0003-1074-6255; Chew, Boon-How/0000-0002-8627-6248; Mohd Sidik, Sherina/0000-0001-6754-6145	Research University Grants Scheme 2 [RUGS/04-02-2105RU]; Sepang District health Office; Petaling District health Office	Research University Grants Scheme 2; Sepang District health Office; Petaling District health Office	BHC received funding for this study from the Research University Grants Scheme 2 (grant number: RUGS/04-02-2105RU), http://www.rmc.upm.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We record our acknowledgment also to Dr. Al-Qazaz HK et al., Morisky et al., World Health Organization, Polonsky et al., Sherina Mohd-Sidik and Xiaonan Yu for the use of the different versions of the MMAS-8, WHOQOL-BREF, DDS-17 and PHQ-9 questionnaires. We also like to acknowledge the Sepang and Petaling District health Offices and officers for their support in this study. We thank the Director General of Health for his permission to publish this report. We thank Dr. Firdaus Mukhtar, Dr. Nor-Kasmawati Jamaludin and Dr. Fuziah Paimin for their input during the study planning and assistance in data collection. Lastly, we would like to thank all the clinic staffs for facilitating the data collection.	Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105; Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8; August KJ, 2013, J FAM PSYCHOL, V27, P712, DOI 10.1037/a0034181; Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384; Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239; Chew B H, 2015, Malays Fam Physician, V10, P22; Chew B H, 2013, Med J Malaysia, V68, P397; Chew BH, 2015, INT J DIABETES DEV C, P1; Chew BH, 2015, PATIENT PREFER ADHER, V9, P639, DOI 10.2147/PPA.S81612; Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4; Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x; Dimitraki G, 2014, INT J BEHAV MED, V21, P230, DOI 10.1007/s12529-013-9296-z; Donkin L, 2006, PSYCHOL HEALTH, V21, P421, DOI 10.1080/14768320500329292; Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0; Feisul M. I., 2013, NATL DIABETES REGIST; Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x; Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428; Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572; Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238; Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001; Franks MM, 2012, FAM SYST HEALTH, V30, P154, DOI 10.1037/a0028614; Gallo JJ, 2005, AM J GERIAT PSYCHIAT, V13, P748, DOI 10.1176/appi.ajgp.13.9.748; Gariepy G, 2013, J PSYCHOSOM RES, V75, P147, DOI 10.1016/j.jpsychores.2013.05.009; Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636; Gentili P, 2001, DIABETES NUTR METAB, V14, P140; Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x; Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134; Hosoya T, 2012, INTERNAL MED, V51, P263, DOI 10.2169/internalmedicine.51.5768; Iida M, 2013, J SOC PERS RELAT, V30, P293, DOI 10.1177/0265407512455308; Ismail K, 2000, AM J EPIDEMIOL, V152, P651, DOI 10.1093/aje/152.7.651; Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x; Kasteleyn MJ, 2015, DIABET MED; Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69; Kneckt MC, 2001, J CLIN PERIODONTOL, V28, P175, DOI 10.1034/j.1600-051x.2001.028002175.x; Koch T, 1999, J CLIN NURS, V8, P712, DOI 10.1046/j.1365-2702.1999.00320.x; Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee S, 2006, DIABETES RES CLIN PR, V74, P282, DOI 10.1016/j.diabres.2006.03.026; Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1; Lloyd C., 2005, Diabetes Spectrum, V18, P121, DOI 10.2337/diaspect.18.2.121; Low LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147127; Mimi O, 2011, Malays Fam Physician, V6, P19; Misra R, 2008, J DIABETES COMPLICAT, V22, P217, DOI 10.1016/j.jdiacomp.2006.09.002; Mohamed R, 2012, INT J COLLAB RES INT, V4, P1589; Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Rane K, 2011, DIABETES RES CLIN PR, V93, P371, DOI 10.1016/j.diabres.2011.05.009; Rasmussen NH, 2013, PRIM CARE DIABETES, V7, P213, DOI 10.1016/j.pcd.2013.04.006; REPORT OF A WHO CONSULTATION, 1999, 992 WHO; Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899; Rutten GEHM, 2014, LANCET DIABETES ENDO, V2, P191, DOI 10.1016/S2213-8587(13)70122-0; Sherina M S, 2012, Med J Malaysia, V67, P309; Skinner TC, 2010, DIABETIC MED, V27, P965, DOI 10.1111/j.1464-5491.2010.03028.x; Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472; Stuckey HL, 2014, DIABETES CARE, V37, P2466, DOI 10.2337/dc13-2536; Talley NJ, 2001, AM J GASTROENTEROL, V96, P1033; Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612; Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x; Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038; West Christina, 2002, Br J Community Nurs, V7, P606; Yu XN, 2012, COMPR PSYCHIAT, V53, P95, DOI 10.1016/j.comppsych.2010.11.002; Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1289, DOI 10.2147/NDT.S49798	66	56	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152095	10.1371/journal.pone.0152095	http://dx.doi.org/10.1371/journal.pone.0152095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002728	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400078
J	Iimura, K; Watanabe, N; Masunaga, K; Miyazaki, S; Hotta, H; Kim, H; Hisajima, T; Takahashi, H; Kasuya, Y				Iimura, Kaori; Watanabe, Nobuhiro; Masunaga, Koichi; Miyazaki, Shogo; Hotta, Harumi; Kim, Hunkyung; Hisajima, Tatsuya; Takahashi, Hidenori; Kasuya, Yutaka			Effects of a Gentle, Self-Administered Stimulation of Perineal Skin for Nocturia in Elderly Women: A Randomized, Placebo-Controlled, Double-Blind Crossover Trial	PLOS ONE			English	Article							OVERACTIVE BLADDER SYNDROME; QUALITY-OF-LIFE; MICTURITION CONTRACTIONS; CUTANEOUS STIMULATION; SOLIFENACIN SUCCINATE; URINARY-INCONTINENCE; INHIBITION; REFLEX; SYMPTOMS; HEAT	Background Somatic afferent nerve stimuli are used for treating an overactive bladder (OAB), a major cause of nocturia in the elderly. Clinical evidence for this treatment is insufficient because of the lack of appropriate control stimuli. Recent studies on anesthetized animals show that gentle stimuli applied to perineal skin with a roller could inhibit micturition contractions depending on the roller's surface material. We examined the efficacy of gentle skin stimuli for treating nocturia. Methods The study was a cross-over, placebo-controlled, double-blind randomized clinical study using two rollers with different effects on micturition contractions. Participants were elderly women (79-89 years) with nocturia. Active (soft elastomer roller) or placebo (hard polystyrene roller) stimuli were applied to perineal skin by participants for 1 min at bedtime. A 3-day baseline assessment period was followed by 3-day stimulation and 4-day resting periods, after which the participants were subjected to other stimuli for another 3 days. The primary outcome was change in the frequency of nighttime urination, for which charts were maintained during each 3-day period. Results Twenty-four participants were randomized, of which 22 completed all study protocols. One participant discontinued treatment because of an adverse event (abdominal discomfort). In participants with OAB (n = 9), change from baseline in the mean frequency of urination per night during the active stimuli period (mean +/- standard deviation, -0.74 +/- 0.7 times) was significantly greater than that during placebo stimuli periods (-0.15 +/- 0.8 times [p < 0.05]). In contrast, this difference was not observed in participants without OAB (n = 13). Conclusions These results suggest that gentle perineal stimulation with an elastomer roller is effective for treating OAB-associated nocturia in elderly women. Here the limitation was a study period too short to assess changes in the quality of sleep and life.	[Iimura, Kaori; Miyazaki, Shogo; Hisajima, Tatsuya; Takahashi, Hidenori] Teikyo Heisei Univ, Grad Sch Hlth Sci, Tokyo, Japan; [Iimura, Kaori; Watanabe, Nobuhiro; Miyazaki, Shogo; Hotta, Harumi] Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Tokyo, Japan; [Masunaga, Koichi; Kasuya, Yutaka] Tokyo Metropolitan Geriatr Hosp, Dept Urol, Tokyo 173, Japan; [Miyazaki, Shogo; Hisajima, Tatsuya; Takahashi, Hidenori] Teikyo Heisei Univ, Fac Hlth Care, Dept Acupuncture & Moxibust, Tokyo, Japan; [Kim, Hunkyung] Tokyo Metropolitan Inst Gerontol, Dept Promot Prevent Musculoskeletal Aging, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology	Hotta, H (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Tokyo, Japan.	hhotta@tmig.or.jp		Miyazaki, Shogo/0000-0001-7270-0725; Hotta, Harumi/0000-0002-4590-7162	Translational research fund in Tokyo Metropolitan Institute of Gerontology	Translational research fund in Tokyo Metropolitan Institute of Gerontology	This study was supported by Translational research fund in Tokyo Metropolitan Institute of Gerontology (http://www.tmig.or.jp/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham L, 2004, UROLOGY, V63, P481, DOI 10.1016/j.urology.2003.10.019; Abrams P, 2006, J UROLOGY, V175, P1063, DOI 10.1016/S0022-5347(05)00348-4; Bing MH, 2007, J UROLOGY, V178, P552, DOI 10.1016/j.juro.2007.03.141; Bosch JLHR, 2010, J UROLOGY, V184, P440, DOI 10.1016/j.juro.2010.04.011; But I, 2005, J UROLOGY, V173, P1644, DOI 10.1097/01.ju.0000157336.87781.32; Cardozo L, 2004, J UROLOGY, V172, P1919, DOI 10.1097/01.ju.0000140729.07840.16; Cevik C, 2013, ACUPUNCTURE ELECTRO, V38, P199, DOI 10.3727/036012913X13831832269298; Chapple CR, 2007, EUR UROL, V52, P1195, DOI 10.1016/j.eururo.2007.05.027; Chapple CR, 2005, EUR UROL, V48, P464, DOI 10.1016/j.eururo.2005.05.015; Chen FY, 2007, INT UROGYNECOL J, V18, P431, DOI 10.1007/s00192-006-0167-x; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1111/j.1464-410X.2003.04527.x; Guo ZF, 2014, CLIN INTERV AGING, V9, P851, DOI 10.2147/CIA.S61084; Herbison P, 2003, BMJ-BRIT MED J, V326, P841, DOI 10.1136/bmj.326.7394.841; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Hotta H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135185; Hotta H, 2013, J PHYSIOL SCI, V63, pS63; Hotta H, 2012, AUTON NEUROSCI-BASIC, V167, P12, DOI 10.1016/j.autneu.2011.11.002; Hotta H, 2010, EUR J PAIN, V14, P806, DOI 10.1016/j.ejpain.2010.02.009; Iimura K, 2013, 62 ANN C JAP SOC AC, P142; Iimura K, 2014, AUTON NERV SYST, V51, P168; Kim H, 2011, GERIATR GERONTOL INT, V11, P452, DOI 10.1111/j.1447-0594.2011.00705.x; Kim H, 2011, ARCH GERONTOL GERIAT, V52, P99, DOI 10.1016/j.archger.2010.02.008; Kim Sun-Ouck, 2011, Int Neurourol J, V15, P82, DOI 10.5213/inj.2011.15.2.82; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Paik SH, 2013, EXP THER MED, V6, P773, DOI 10.3892/etm.2013.1210; Peters KM, 2010, J UROLOGY, V183, P1438, DOI 10.1016/j.juro.2009.12.036; Portney LG, 2000, FDN CLIN RES APPL PR, V2; SATO A, 1980, J AUTONOM NERV SYST, V1, P229, DOI 10.1016/0165-1838(80)90019-3; SATO A, 1992, NEUROSCI RES, V15, P189, DOI 10.1016/0168-0102(92)90004-V; Sato A, 1997, REV PHYSIOL BIOCH P, V130, P1, DOI 10.1007/BFb0046598; SATO A, 1975, BRAIN RES, V94, P465, DOI 10.1016/0006-8993(75)90229-2; SATO A, 1977, NEUROSCIENCE, V2, P111, DOI 10.1016/0306-4522(77)90072-0; Tikkinen KAO, 2010, EUR UROL, V57, P488, DOI 10.1016/j.eururo.2009.03.080; Tomita K, 2009, J JPN SOC ACUPUNCT M, V59, P116; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Watanabe N, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0001-x; Watanabe N, 2012, J PHYSIOL SCI, V62, P343, DOI 10.1007/s12576-012-0210-2; Weiss JP, 2013, J UROLOGY, V189, P1396, DOI 10.1016/j.juro.2012.11.067; Woock JP, 2008, AM J PHYSIOL-REG I, V294, pR1880, DOI 10.1152/ajpregu.00029.2008; Yamaguchi O, 2009, INT J UROL, V16, P126, DOI 10.1111/j.1442-2042.2008.02177.x	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151726	10.1371/journal.pone.0151726	http://dx.doi.org/10.1371/journal.pone.0151726			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003163	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400039
J	Li, M; Ye, T; Wang, XX; Li, X; Qiang, O; Yu, T; Tang, CW; Liu, R				Li, Mao; Ye, Ting; Wang, Xiao-Xia; Li, Xian; Qiang, Ou; Yu, Tao; Tang, Cheng-Wei; Liu, Rui			Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; HIGH-FAT DIET; APOLIPOPROTEIN B100; SOMATOSTATIN ANALOGS; INSULIN-RESISTANCE; SREBP ACTIVITY; LIVER-DISEASE; DOUBLE-BLIND; WEIGHT-LOSS; APO-B	Background Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked to obesity. Somatostatin (SST) and its analogs have been used to treat pediatric hypothalamic obesity. However, the application of such drugs for the treatment of NAFLD has not been evaluated. Objective This study aimed to investigate the expression levels of important regulators of hepatic lipid metabolism and the possible effect of the SST analog octreotide on these regulators. Methods SD rats were assigned to a control group and a high-fat diet group. Obese rats from the high-fat diet group were further divided into the obese and octreotide-treated groups. The body weight, plasma SST, fasting plasma glucose (FPG), insulin, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and free fatty acid (FFA) levels were measured. Hepatic steatosis was evaluated based on the liver TG content, HE staining and oil red O staining. The SREBP-1c, ACC1, FAS, MTP, apoB and ADRP expression levels in the liver were also determined by RT-PCR, qRT-PCR, western blot or ELISA. Results The obese rats induced by high-fat diet expressed more SREBP-1c, FAS and ADRP but less MTP protein in the liver than those of control rats, whereas octreotide intervention reversed these changes and increased the level of apoB protein. Compared to the control group, obese rats showed increased liver ACC1, SREBP-1c and apoB mRNA levels, whereas octreotide-treated rats showed decreased mRNA levels of apoB and SREBP-1c. This was accompanied by increased body weight, liver TG contents, FPG, TG, TC, LDL-C, FFA, insulin and derived homeostatic model assessment (HOMA) values. Octreotide intervention significantly decreased these parameters. Compared to the control group, the obese group showed a decreasing trend on plasma SST levels, which were significantly increased by the octreotide intervention. Conclusion Octreotide can ameliorate hepatic steatosis in obese rats, possibly by decreasing hepatic lipogenesis and increasing TG export from hepatocytes.	[Li, Mao; Ye, Ting; Wang, Xiao-Xia; Li, Xian; Qiang, Ou; Yu, Tao; Liu, Rui] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Peptides Related Human Dis, Chengdu 610064, Peoples R China; [Li, Mao; Ye, Ting; Wang, Xiao-Xia; Yu, Tao; Tang, Cheng-Wei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China; [Li, Mao] Chongqing Inst Accid & Emergency Med, Chongqing Emergency Med Ctr, Dept Internal Med, Chongqing, Peoples R China	Sichuan University; Sichuan University	Liu, R (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Peptides Related Human Dis, Chengdu 610064, Peoples R China.	lrui60@163.com			National Natural Science Foundation of China [30870919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Natural Science Foundation of China. The grant number was No. 30870919 and Rui Liu received the funding. Rui Liu had an important role in study design, decision to publish, and preparation of the manuscript.	Ahmed MH, 2007, DRUG DISCOV TODAY, V12, P740, DOI 10.1016/j.drudis.2007.07.009; Bakillah A, 2003, FRONT BIOSCI-LANDMRK, V8, pD294; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Daemen S, 2013, GENES NUTR, V8, P289, DOI 10.1007/s12263-013-0342-x; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Figarola JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083801; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gambino R, 2007, HEPATOLOGY, V45, P1097, DOI 10.1002/hep.21631; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Guturu P, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/212865; Higuchi N, 2011, EXP THER MED, V2, P1077, DOI 10.3892/etm.2011.328; Huang W, 2013, NUTRITION, V29, P1259, DOI 10.1016/j.nut.2013.01.013; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kohjima M, 2007, INT J MOL MED, V20, P351; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Leung GK, 2000, J BIOL CHEM, V275, P7515, DOI 10.1074/jbc.275.11.7515; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li XH, 1997, J LIPID RES, V38, P1277; Li XW, 2014, J STEROID BIOCHEM, V143, P174, DOI 10.1016/j.jsbmb.2014.02.009; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu R, 2013, EUR J NUTR, V52, P1067, DOI 10.1007/s00394-012-0413-6; Lui R, 2003, CHIN J PUBLIC HLTH, V5, P563; Lustig RH, 2006, INT J OBESITY, V30, P331, DOI 10.1038/sj.ijo.0803074; Lustig RH, 2003, J CLIN ENDOCR METAB, V88, P2586, DOI 10.1210/jc.2002-030003; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Quesada H, 2009, INT J OBESITY, V33, P1007, DOI 10.1038/ijo.2009.136; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]; Shiomi M, 2001, EUR J PHARMACOL, V431, P127, DOI 10.1016/S0014-2999(01)01419-4; Silva AP, 2005, EUR J ENDOCRINOL, V152, P887, DOI 10.1530/eje.1.01914; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; [王重建 Wang Chongjian], 2005, [华中科技大学学报. 医学版, Journal of Huazhong University of Science and Technology], V34, P65; Wang ZX, 2002, J MATH MED, V15, P125; Yu Tao, 2014, Wei Sheng Yan Jiu, V43, P186; Yue JTY, 2012, CIRC RES, V110, P1345, DOI [10.1161/CIRCRESAHA.112.268276, 10.1161/circresaha.112.268276]; Zambre Y, 1999, BIOCHEM PHARMACOL, V57, P1159, DOI 10.1016/S0006-2952(99)00010-6; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117008	49	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152085	10.1371/journal.pone.0152085	http://dx.doi.org/10.1371/journal.pone.0152085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002331	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400075
J	Richter, JN; Hochner, B; Kuba, MJ				Richter, Jonas N.; Hochner, Binyamin; Kuba, Michael J.			Pull or Push? Octopuses Solve a Puzzle Problem	PLOS ONE			English	Article							TACTILE DISCRIMINATION; INDIVIDUAL VARIATION; VULGARIS LAMARCK; ARM MOVEMENTS; CEPHALOPODS; COGNITION; INNOVATION; MEMORY; EVOLUTION; SYSTEM	Octopuses have large brains and exhibit complex behaviors, but relatively little is known about their cognitive abilities. Here we present data from a five-level learning and problem-solving experiment. Seven octopuses (Octopus vulgaris) were first trained to open an L shaped container to retrieve food (level 0). After learning the initial task all animals followed the same experimental protocol, first they had to retrieve this L shaped container, presented at the same orientation, through a tight fitting hole in a clear Perspex partition (level 1). This required the octopuses to perform both pull and release or push actions. After reaching criterion the animals advanced to the next stage of the test, which would be a different consistent orientation of the object (level 2) at the start of the trial, an opaque barrier (level 3) or a random orientation of the object (level 4). All octopuses were successful in reaching criterion in all levels of the task. At the onset of each new level the performance of the animals dropped, shown as an increase in working times. However, they adapted quickly so that overall working times were not significantly different between levels. Our findings indicate that octopuses show behavioral flexibility by quickly adapting to a change in a task. This can be compared to tests in other species where subjects had to conduct actions comprised of a set of motor actions that cannot be understood by a simple learning rule alone.	[Richter, Jonas N.; Hochner, Binyamin; Kuba, Michael J.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, Givat Ram, Israel; [Richter, Jonas N.] Max Planck Florida Inst, Jupiter, FL USA	Hebrew University of Jerusalem; Max Planck Society	Kuba, MJ (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, Givat Ram, Israel.	michi.kuba@lobster.ls.huji.ac.il	Kuba, Michael J/AAE-7934-2022; Kuba, Michael/ABH-8394-2020	Kuba, Michael J/0000-0003-2688-736X; 	European Commission [231608, 287728]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under the 7th Framework Programme in the theme of the Future and Emerging Technologies (FET, OCTOPUS IP, FP7-ICT 2007.8.5, FET) [231608]-www.octopus.eu<http://www.octopus.eu>; and STIFFness controllable Flexible and Learn-able manipulator for surgical Operations [STIFF-FLOP] FP7-ICT-2011-7 Project Number 287728 (http://www.stiff-flop.eu/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1986, MAR BEHAV PHYSIOL, V12, P81, DOI 10.1080/10236248609378636; Alves C, 2008, COGN PROCESS, V9, P239, DOI 10.1007/s10339-007-0192-9; Anderson Roland C., 2010, Ferrantia, V59, P8; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Boal JG, 2011, VIE MILIEU, V61, P203; Boal JG, 1996, BIOL REV, V71, P157, DOI 10.1111/j.1469-185X.1996.tb00746.x; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; BOYCOTT BB, 1955, PROC R SOC SER B-BIO, V143, P449, DOI 10.1098/rspb.1955.0024; Boyle PR, 1986, NEURAL CONTROL CEPHA; Budelmann BU, 1995, CEPHALOPOD NEUROBIOL; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; DEWS PB, 1959, J EXP ANAL BEHAV, V2, P57, DOI 10.1901/jeab.1959.2-57; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; FELLOWS BJ, 1967, PSYCHOL BULL, V67, P87, DOI 10.1037/h0024098; FIORITO G, 1990, BEHAV NEURAL BIOL, V53, P217, DOI 10.1016/0163-1047(90)90441-8; Fiorito G, 2014, INVERTEBR NEUROSCI, V14, P13, DOI 10.1007/s10158-013-0165-x; Fiorito Graziano, 1998, Animal Cognition, V1, P107, DOI 10.1007/s100710050015; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Giurfa M, 2013, TRENDS NEUROSCI, V36, P285, DOI 10.1016/j.tins.2012.12.011; Greenberg Russell, 2003, P175; Griffin AS, 2015, ANIM BEHAV, V100, P84, DOI 10.1016/j.anbehav.2014.11.012; Griffin AS, 2014, ANIM BEHAV, V92, P221, DOI 10.1016/j.anbehav.2014.04.009; Griffin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084907; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Gutfreund Y, 2006, BIOL BULL-US, V211, P212, DOI 10.2307/4134544; Gutnick T, 2011, CURR BIOL, V21, P460, DOI 10.1016/j.cub.2011.01.052; Hanlon RT, 1996, CEPHALOPOD BEHAV; Hochner B, 2006, BIOL BULL-US, V210, P308, DOI 10.2307/4134567; Hochner Binyamin, 2010, Front Biosci (Schol Ed), V2, P764; HOLLARD VD, 1982, SCIENCE, V218, P804, DOI 10.1126/science.7134976; Hvorecny LM, 2007, ANIM COGN, V10, P449, DOI 10.1007/s10071-007-0085-4; Kuba M.J., 2006, INT J COMP PSYCHOL, V19, P426; Kuba MJ, 2006, J COMP PSYCHOL, V120, P184, DOI 10.1037/0735-7036.120.3.184; Kuba MJ, 2010, ANIM COGN, V13, P507, DOI 10.1007/s10071-009-0301-5; Kummer H., 1985, T ROYAL SOC LONDON B, V308, P203, DOI DOI 10.1098/RSTB.1985.0020; Lefebvre L, 2011, BIOL LETTERS, V7, P631, DOI 10.1098/rsbl.2010.0556; Manrique HM, 2013, ANIM BEHAV, V85, P195, DOI 10.1016/j.anbehav.2012.10.026; MATHER JA, 1991, J COMP PHYSIOL A, V168, P491, DOI 10.1007/BF00199609; Mather JA, 2008, AM MALACOL BULL, V24, P51, DOI 10.4003/0740-2783-24.1.51; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; MUNTZ WRA, 1970, Q J EXP PSYCHOL, V22, P82, DOI 10.1080/00335557043000005; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; PACKARD A, 1972, BIOL REV, V47, P241, DOI 10.1111/j.1469-185X.1972.tb00975.x; Perry CJ, 2013, WILEY INTERDISCIPLIN; Pronk R, 2010, J EXP BIOL, V213, P1035, DOI 10.1242/jeb.040675; Reader S.M., 2003, ANIMAL INNOVATION; Reader SM, 2007, BEHAV BRAIN SCI, V30, P420, DOI 10.1017/S0140525X07002518; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Richter JN, 2015, J EXP BIOL, V218, P1069, DOI 10.1242/jeb.115915; ROBERTSON JD, 1994, P ROY SOC B-BIOL SCI, V256, P269, DOI 10.1098/rspb.1994.0080; Sanders G.D., 1975, INVERTEBRATE LEARNIN; SCHILLER PH, 1949, J COMP PHYSIOL PSYCH, V42, P220, DOI 10.1037/h0056879; Seed AM, 2013, CURR BIOL, V23, pR67, DOI 10.1016/j.cub.2012.11.043; Shomrat T, 2008, CURR BIOL, V18, P337, DOI 10.1016/j.cub.2008.01.056; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Sumbre G, 2005, NATURE, V433, P595, DOI 10.1038/433595a; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; VILLANUEVA R, 1995, NATURE, V377, P107, DOI 10.1038/377107a0; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wells M.J., 1978, OCTOPUS PHYSL BEHAV, V1st; WELLS MJ, 1961, J EXP BIOL, V38, P811; WELLS MJ, 1964, J EXP BIOL, V41, P621; WELLS MJ, 1957, J EXP BIOL, V34, P131; WELLS MJ, 1964, J EXP BIOL, V41, P433; YOUNG JZ, 1991, BIOL BULL, V180, P200, DOI 10.2307/1542389; Young JZ, 1963, P ZOOLOGICAL SOC LON; Young JZ, 1983, P ROY SOC LOND B BIO, V219, P135	70	25	25	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152048	10.1371/journal.pone.0152048	http://dx.doi.org/10.1371/journal.pone.0152048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003439	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400070
J	Asadi-Eydivand, M; Solati-Hashjin, M; Shafiei, SS; Mohammadi, S; Hafezi, M; Abu Osman, NA				Asadi-Eydivand, Mitra; Solati-Hashjin, Mehran; Shafiei, Seyedeh Sara; Mohammadi, Sepideh; Hafezi, Masoud; Abu Osman, Noor Azuan			Structure, Properties, and In Vitro Behavior of Heat-Treated Calcium Sulfate Scaffolds Fabricated by 3D Printing	PLOS ONE			English	Article							3-DIMENSIONAL SCAFFOLDS; ENGINEERING SCAFFOLDS; MECHANICAL-PROPERTIES; BONE SCAFFOLDS; FILL DEFECTS; TISSUE; DESIGN; PHOSPHATE; BIOMATERIALS; DELIVERY	The ability of inkjet-based 3D printing (3DP) to fabricate biocompatible ceramics has made it one of the most favorable techniques to generate bone tissue engineering (BTE) scaffolds. Calcium sulfates exhibit various beneficial characteristics, and they can be used as a promising biomaterial in BTE. However, low mechanical performance caused by the brittle character of ceramic materials is the main weakness of 3DP calcium sulfate scaffolds. Moreover, the presence of certain organic matters in the starting powder and binder solution causes products to have high toxicity levels. A post-processing treatment is usually employed to improve the physical, chemical, and biological behaviors of the printed scaffolds. In this study, the effects of heat treatment on the structural, mechanical, and physical characteristics of 3DP calcium sulfate prototypes were investigated. Different microscopy and spectroscopy methods were employed to characterize the printed prototypes. The in vitro cytotoxicity of the specimens was also evaluated before and after heat treatment. Results showed that the as-printed scaffolds and specimens heat treated at 300 degrees C exhibited severe toxicity in vitro but had almost adequate strength. By contrast, the specimens heat treated in the 500 degrees C-1000 degrees C temperature range, although non-toxic, had insufficient mechanical strength, which was mainly attributed to the exit of the organic binder before 500 degrees C and the absence of sufficient densification below 1000 degrees C. The sintering process was accelerated at temperatures higher than 1000 degrees C, resulting in higher compressive strength and less cytotoxicity. An anhydrous form of calcium sulfate was the only crystalline phase existing in the samples heated at 500 degrees C-1150 degrees C. The formation of calcium oxide caused by partial decomposition of calcium sulfate was observed in the specimens heat treated at temperatures higher than 1200 degrees C. Although considerable improvements in cell viability of heat-treated scaffolds were observed in this study, the mechanical properties were not significantly improved, requiring further investigations. However, the findings of this study give a better insight into the complex nature of the problem in the fabrication of synthetic bone grafts and scaffolds via post-fabrication treatment of 3DP calcium sulfate prototypes.	[Asadi-Eydivand, Mitra; Hafezi, Masoud; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Solati-Hashjin, Mehran; Mohammadi, Sepideh] Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran; [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran; [Shafiei, Seyedeh Sara] Natl Inst Genet Engn & Biotechnol, Stem Cell & Regenerat Med Grp, Tehran 14965161, Iran	Universiti Malaya; Amirkabir University of Technology; Amirkabir University of Technology	Abu Osman, NA (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.; Solati-Hashjin, M (corresponding author), Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran.; Solati-Hashjin, M (corresponding author), Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran.	solati@aut.ac.ir; azuan@um.edu.my	Solati-Hashjin, Mehran/X-8822-2019; Asadi-Eydivand, Mitra/H-4092-2019; ABU OSMAN, NOOR AZUAN/B-9265-2010; Shafiei, Seyedeh Sara/R-7755-2017; Hafezi, Masoud/K-3589-2013	Solati-Hashjin, Mehran/0000-0002-1187-1237; Asadi-Eydivand, Mitra/0000-0002-7809-7880; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Shafiei, Seyedeh Sara/0000-0002-4517-5969; Hafezi, Masoud/0000-0002-7199-3180	University of Malaya [UM.C/HIR/MOHE/ENG/14 D000014-16001]	University of Malaya(Universiti Malaya)	This study was supported by High Impact Research Grant UM.C/HIR/MOHE/ENG/14 D000014-16001 from the University of Malaya.	Aghajani F, 2004, DENT MATER J, V23, P373, DOI 10.4012/dmj.23.373; Amini AR, 2012, CRITICAL REV BIOMEDI, V40; Asadi-Eydivand M, 2016, ROBOT CIM-INT MANUF, V37, P57, DOI 10.1016/j.rcim.2015.06.005; Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083; Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833; Bergmann C, 2010, J EUR CERAM SOC, V30, P2563, DOI 10.1016/j.jeurceramsoc.2010.04.037; Blom A, 2007, CURR ORTHOPAED, V21, P280, DOI 10.1016/j.cuor.2007.06.005; Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008; Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Brand RA, 2012, CLIN ORTHOP RELAT R, V470, P3628, DOI 10.1007/s11999-012-2571-5; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039; Chen A. A., 2007, BIOMEMS BIOMEDICAL N, P23; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7; Farzadi A, 2014, EFFECT LAYER THICKNE, DOI [10.1371/journal.pone.0108252, DOI 10.1371/JOURNAL.PONE.0108252]; Farzadi A, 2015, CERAM INT, V41, P8320, DOI 10.1016/j.ceramint.2015.03.004; Fereshteh Z, 2015, MAT SCI ENG C-MATER, V54, P50, DOI 10.1016/j.msec.2015.05.011; Frascati J., 2007, THESIS U CENTRAL FLO; Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042; Galeta T, 2013, MATER TEHNOL, V47, P781; Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019; Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640; Guo BL, 2015, REGEN BIOMATER, V2, P47, DOI 10.1093/rb/rbu016; Hollinger J.O., 2011, INTRO BIOMATERALS; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Impens D., 2015, THESIS U WINDSOR; Insights P., BONE REGENERATION CA; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2; Kassim B, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12098; Khalyfa A, 2007, J MATER SCI-MATER M, V18, P909, DOI 10.1007/s10856-006-0073-2; Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033; Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020; Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI 10.1205/cherd06196; Mazzoli A, 2015, RAPID PROTOTYPING J, V21, P386, DOI 10.1108/RPJ-04-2013-0040; Munch E, 2008, JOM-US, V60, P54, DOI 10.1007/s11837-008-0072-5; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184; Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007; Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021; PELTIER LF, 1957, ANN SURG, V146, P61, DOI 10.1097/00000658-195707000-00007; Pina S, 2015, ADV MATER, V27, P1143, DOI 10.1002/adma.201403354; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Rajzer I, 2014, MAT SCI ENG C-MATER, V44, P183, DOI 10.1016/j.msec.2014.08.017; Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045; Rauschmann M, 2010, EUR SPINE J, V19, P887, DOI 10.1007/s00586-010-1279-z; Razak S.I.A., 2012, INT J BASIC APPL SCI, V12, P31, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/JBBTE.10.95; Sadeghpour S, 2014, CERAM INT, V40, P16107, DOI 10.1016/j.ceramint.2014.07.039; Sadiasa A, 2014, J BIOMAT SCI-POLYM E, V25, P150, DOI 10.1080/09205063.2013.846633; Shen Y, 2014, ACS APPL MATER INTER, V6, P12177, DOI 10.1021/am501448t; Sottosanti J, 1992, Compendium, V13, P226; Suwanprateeb J, 2010, J MATER SCI-MATER M, V21, P419, DOI 10.1007/s10856-009-3883-1; Swift W.M., 1976, DECOMPOSITION CALCIU; Technology NIoSa, 2011, 2 PYRR INFR SPECTR; Technology NIoSa, 2011, WAT INFR SPECTR; Thomas M. V., 2005, J LONG TERM EFFECTS, V15; Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269; Utela B., 2008, J MANUF PROCESS, V10, P96, DOI [DOI 10.1016/J.JMAPRO.2009.03.002, 10.1016/j.jmapro.2009.03.002]; Vorndran E, 2011, ADV APPL CERAM, V110, P476, DOI 10.1179/1743676111Y.0000000030; Vorndran E, 2015, MRS BULL, V40, P127, DOI 10.1557/mrs.2015.326; Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009; Zhou Z, 2012, ISRN BIOMATERIALS, P2013; Zhou ZX, 2014, MAT SCI ENG C-MATER, V38, P1, DOI 10.1016/j.msec.2014.01.027	68	45	45	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151216	10.1371/journal.pone.0151216	http://dx.doi.org/10.1371/journal.pone.0151216			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999789	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700027
J	Clark, AL; Maruyama, S; Sano, S; Accorsi, A; Girgenrath, M; Walsh, K; Naya, FJ				Clark, Amanda L.; Maruyama, Sonomi; Sano, Soichi; Accorsi, Anthony; Girgenrath, Mahasweta; Walsh, Kenneth; Naya, Francisco J.			miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HUMAN HEART; MICRORNAS; EXPRESSION; GENE; ACTIVATION; CLUSTER; MEF2; DYSFUNCTION; DEFICIENCY	Noncoding RNAs have emerged as important modulators in cardiac development and pathological remodeling. Recently, we demonstrated that regulation of the Gtl2-Dio3 noncoding RNA locus is dependent on the MEF2 transcription factor in cardiac muscle, and that two of its encoded miRNAs, miR-410 and miR-495, induce robust cardiomyocyte proliferation. Given the possibility of manipulating the expression of these miRNAs to repair the damaged heart by stimulating cardiomyocyte proliferation, it is important to determine whether the Gtl2-Dio3 noncoding RNAs are regulated in cardiac disease and whether they function downstream of pathological cardiac stress signaling. Therefore, we examined expression of the above miRNAs processed from the Gtl2-Dio3 locus in various cardiomyopathies. These noncoding RNAs were upregulated in all cardiac disease models examined including myocardial infarction (MI) and chronic angiotensin II (Ang II) stimulation, and in the cardiomyopathies associated with muscular dystrophies. Consistent with these observations, we show that the Gtl2-Dio3 proximal promoter is activated by stress stimuli in cardiomyocytes and requires MEF2 for its induction. Furthermore, inhibiting miR-410 or miR-495 in stressed cardiomyocytes attenuated the hypertrophic response. Thus, the Gtl2-Dio3 noncoding RNA locus is a novel marker of cardiac disease and modulating the activity of its encoded miRNAs may mitigate pathological cardiac remodeling in these diseases.	[Clark, Amanda L.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA; [Maruyama, Sonomi; Sano, Soichi; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Accorsi, Anthony; Girgenrath, Mahasweta] Boston Univ, Coll Hlth & Rehabil Sci, Dept Hlth Sci, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL073304, HL120160, HL131006]; Cure CMD, Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association [218938]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131006, R01HL073304, R01HL120160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure CMD, Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health HL073304 to FJN, HL120160 and HL131006 to KW, and Cure CMD, Struggle Against Muscular Dystrophy (SAM) and Muscular Dystrophy Association (218938) to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Institutes of Health HL073304 to FJN, HL120160 and HL131006 to KW, and Cure CMD, Struggle Against Muscular Dystrophy (SAM) and Muscular Dystrophy Association (218938) to MG. We thank members of the Naya laboratory for critical reading of the manuscript.	Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Carboni N, 2011, MUSCLE NERVE, V44, P826, DOI 10.1002/mus.22228; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Clark AL, 2015, J BIOL CHEM, V290, P23162, DOI 10.1074/jbc.M115.672659; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Das PP, 2015, CELL REP, V12, P1456, DOI 10.1016/j.celrep.2015.07.053; Duan DS, 2006, HUM MOL GENET, V15, pR253, DOI 10.1093/hmg/ddl180; Finsterer J, 2014, NAT REV CARDIOL, V11, P168, DOI 10.1038/nrcardio.2013.213; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hashemi S, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.19; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Janssen R, 2013, ENDOCRINOLOGY, V154, P1973, DOI 10.1210/en.2012-2017; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kim S, 2000, PHARMACOL REV, V52, P11; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kumar A, 2011, HUM MOL GENET, V20, P2333, DOI 10.1093/hmg/ddr126; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; McNally EM, 2007, ANNU REV MED, V58, P75, DOI 10.1146/annurev.med.58.011706.144703; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Neppl RL, 2014, GENES DIS, V1, P18, DOI 10.1016/j.gendis.2014.06.003; Prat-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054785; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Spyrou N, 1998, AM HEART J, V136, P474, DOI 10.1016/S0002-8703(98)70222-4; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yang KC, 2012, J MOL CELL CARDIOL, V53, P101, DOI 10.1016/j.yjmcc.2012.04.012; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	38	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151515	10.1371/journal.pone.0151515	http://dx.doi.org/10.1371/journal.pone.0151515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999812	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700043
J	Kennedy, MW; Crowell, CR; Villano, M; Schmiedeler, JP				Kennedy, Michael W.; Crowell, Charles R.; Villano, Michael; Schmiedeler, James P.			Effects of Filtering the Center of Pressure Feedback Provided in Visually Guided Mediolateral Weight Shifting	PLOS ONE			English	Article							POSTURAL CONTROL; STIFFNESS CONTROL; GRAVITY MOTIONS; STROKE PATIENTS; BALANCE; BIOFEEDBACK; IMPROVES; THERAPY; BEARING; STANCE	Thirty healthy adults completed a mediolateral weight-shifting balance task in which they were instructed to shift their weight to visually displayed target regions. A model-based filter and three different moving average filters employing 10, 34, and 58 samples were applied to the center of pressure visual feedback that guided the activity. The effects of filter selection on both the displayed feedback and the shift performance were examined in terms of shift time and non-minimum phase behavior. Shift time relates to feedback delay and shift speed, whereas non-minimum phase behavior relates to the force applied in shift initiation. Results indicated that increasing the number of samples in moving average filters (indicative of stronger filtering) significantly increases shift speed and shift initiation force. These effects indicate that careful selection and documentation of data filtering is warranted in future work and suggest opportunities for strategic filtering of visual feedback in clinical weight-shifting balance activities in order to improve outcomes based on such feedback.	[Kennedy, Michael W.; Schmiedeler, James P.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Crowell, Charles R.; Villano, Michael] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Kennedy, MW (corresponding author), Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.	michaelwkennedy@gmail.com	Villano, Michael Anthony/AAH-4760-2021; /B-9681-2012	/0000-0002-1692-4414	National Institutes of Health [UL1 RR 02576]; National Science Foundation [IIS-1117706]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (http://www.nih.gov/): #UL1 RR 02576 to JPS, and the National Science Foundation (http://www.nsf.gov/): #IIS-1117706 to JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudrahem S, 2009, EXP BRAIN RES, V195, P145, DOI 10.1007/s00221-009-1761-1; Caron O, 1997, J BIOMECH, V30, P1169, DOI 10.1016/S0021-9290(97)00094-8; Cheng PT, 2004, CLIN REHABIL, V18, P747, DOI 10.1191/0269215504cr778oa; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Dault MC, 2003, HUM MOVEMENT SCI, V22, P221, DOI 10.1016/S0167-9457(03)00034-4; de Haart M, 2005, ARCH PHYS MED REHAB, V86, P755, DOI 10.1016/j.apmr.2004.10.010; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; de Vries EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098494; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Goldie PA, 1996, CLIN BIOMECH, V11, P333, DOI 10.1016/0268-0033(96)00014-9; Hatzitaki V, 2007, EXP BRAIN RES, V182, P525, DOI 10.1007/s00221-007-1007-z; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Kennedy M, 2011, 13 INT C E HLTH NETW, DOI [10.1109/HEALTH.2011.6026735, DOI 10.1109/HEALTH.2011.6026735]; Kennedy MW, 2014, GAIT POSTURE, V40, P134, DOI 10.1016/j.gaitpost.2014.03.011; Kennedy MW, 2013, EXP BRAIN RES, V230, P117, DOI 10.1007/s00221-013-3634-x; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; Patton JL, 2000, EXP BRAIN RES, V135, P117, DOI 10.1007/s002210000500; Rougier P, 2000, J MOTOR BEHAV, V32, P405, DOI 10.1080/00222890009601390; Rougier P, 2005, EXP BRAIN RES, V165, P193, DOI 10.1007/s00221-005-2288-8; Rougier P, 2003, CLIN BIOMECH, V18, P341, DOI 10.1016/S0268-0033(03)00003-2; Rougier PR, 2012, TOP STROKE REHABIL, V19, P1, DOI 10.1310/tsr1901-1; Stanton R, 2011, J PHYSIOTHER, V57, P145, DOI 10.1016/S1836-9553(11)70035-2; Van Peppen RPS, 2006, J REHABIL MED, V38, P3, DOI 10.1080/16501970500344902; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 2001, J NEUROPHYSIOL, V85, P2630, DOI 10.1152/jn.2001.85.6.2630; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yeh TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091554; Zijlstra A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-58	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151393	10.1371/journal.pone.0151393	http://dx.doi.org/10.1371/journal.pone.0151393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991996	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800059
J	Mora-Navarro, C; Mendez-Vega, J; Caraballo-Leon, J; Lee, MR; Palecek, S; Torres-Lugo, M; Ortiz-Bermudez, P				Mora-Navarro, Camilo; Mendez-Vega, Janet; Caraballo-Leon, Jean; Lee, Myung-ryul; Palecek, Sean; Torres-Lugo, Madeline; Ortiz-Bermudez, Patricia			Hydrophobicity of Antifungal beta-Peptides Is Associated with Their Cytotoxic Effect on In Vitro Human Colon Caco-2 and Liver HepG2 Cells	PLOS ONE			English	Article							CANDIDA-ALBICANS; LIQUID-CHROMATOGRAPHY; AMPHOTERICIN-B; RELEVANCE; BIOFILMS; LIBRARY; MODEL; ASSAY	The widespread distribution of fungal infections, with their high morbidity and mortality rate, is a global public health problem. The increase in the population of immunocompromised patients combined with the selectivity of currents treatments and the emergence of drug-resistant fungal strains are among the most imperative reasons to develop novel antifungal formulations. Antimicrobial beta-peptides are peptidomimetics of natural antimicrobial peptides (AMPs), which have been proposed as developmental platforms to enhance the AMPs selectivity and biostability. Their tunability allows the design of sequences with remarkable activity against a wide spectrum of microorganisms such as the human pathogenic Candida spp., both in planktonic and biofilm morphology. However, the beta-peptide's effect on surrounding host cells remains greatly understudied. Assessments have mainly relied on the extent of hemolysis that a candidate peptide is able to cause. This work investigated the in vitro cytotoxicity of various beta-peptides in the Caco-2 and HepG2 mammalian cell lines. Results indicated that the cytotoxic effect of the beta-peptides was influenced by cell type and was also correlated to structural features of the peptide such as hydrophobicity. We found that the selectivity of the most hydrophobic beta-peptide was 2-3 times higher than that of the least hydrophobic one, for both cell types according to the selectivity index parameter (IC50/MIC). The IC50 of Caco-2 and HepG2 increased with hydrophobicity, which indicates the importance of testing putative therapeutics on different cell types. We report evidence of peptide-cell membrane interactions in Caco-2 and HepG2 using a widely studied beta-peptide against C. albicans.	[Mora-Navarro, Camilo; Mendez-Vega, Janet; Caraballo-Leon, Jean; Torres-Lugo, Madeline; Ortiz-Bermudez, Patricia] Univ Puerto Rico, Dept Chem Engn, Mayaguez Campus, Mayaguez, PR USA; [Lee, Myung-ryul; Palecek, Sean] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA	University of Puerto Rico; University of Puerto Rico Mayaguez; University of Wisconsin System; University of Wisconsin Madison	Ortiz-Bermudez, P (corresponding author), Univ Puerto Rico, Dept Chem Engn, Mayaguez Campus, Mayaguez, PR USA.	patricia.ortiz3@upr.edu	Caraballo-León, Jean/P-6424-2019	Caraballo-León, Jean/0000-0002-7067-2131; Lee, Myung-Ryul/0000-0002-9111-2969; Mora-Navarro, Camilo/0000-0001-6863-8068	National Science Foundation Division of Material Research through the Partnership for Research and Education in Materials Program [DMR-0934115]; NIH [1R01 AI092225]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092225] Funding Source: NIH RePORTER	National Science Foundation Division of Material Research through the Partnership for Research and Education in Materials Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Science Foundation Division of Material Research, Grant DMR-0934115, through the Partnership for Research and Education in Materials Program to POB and MTL. This work was also supported by NIH grant 1R01 AI092225 to SPP. The funders participated in the design and conception of the experiments, data analysis, decision to publish and manuscript development.	Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087542; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bruggemann RJM, 2009, CLIN INFECT DIS, V48, P1441, DOI 10.1086/598327; Cabrele C, 2014, J MED CHEM, V57, P9718, DOI 10.1021/jm5010896; CONRADI RA, 1991, PHARMACEUT RES, V8, P1453, DOI 10.1023/A:1015825912542; Domenech M, 2013, ACS NANO, V7, P5091, DOI 10.1021/nn4007048; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Gupta N, 1996, RADIAT RES, V145, P636, DOI 10.2307/3579284; Inselmann G, 2002, Eur J Intern Med, V13, P288, DOI 10.1016/S0953-6205(02)00065-1; Karlsson AJ, 2006, J AM CHEM SOC, V128, P12630, DOI 10.1021/ja064630y; Karlsson AJ, 2009, ACS CHEM BIOL, V4, P567, DOI 10.1021/cb900093r; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lakshminarayanan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087730; Lee MR, 2014, ACS CHEM BIOL, V9, P1613, DOI 10.1021/cb500203e; Lestner JM, 2010, ANTIMICROB AGENTS CH, V54, P3432, DOI 10.1128/AAC.01586-09; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188, DOI 10.2174/138620710790596736; MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632; Menez C, 2006, ANTIMICROB AGENTS CH, V50, P3793, DOI 10.1128/AAC.00837-06; Mora-Navarro C, 2015, J PEPT SCI, V21, P853, DOI 10.1002/psc.2827; Murray JK, 2006, J COMB CHEM, V8, P58, DOI 10.1021/cc0501099; Murray JK, 2005, ORG LETT, V7, P1517, DOI 10.1021/ol0501727; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Pauletti GM, 1997, PHARMACEUT RES, V14, P164, DOI 10.1023/A:1012040425146; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Raguse TL, 2002, J AM CHEM SOC, V124, P12774, DOI 10.1021/ja0270423; Raman N, 2014, J CONTROL RELEASE, V191, P54, DOI 10.1016/j.jconrel.2014.05.026; Sahu SC, 2014, J APPL TOXICOL, V34, P1226, DOI 10.1002/jat.3065; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhao M, 2000, FEBS LETT, V485, P104, DOI 10.1016/S0014-5793(00)02195-5; Zhou JH, 2013, TOXIN REV, V32, P60, DOI 10.3109/15569543.2013.852108	38	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0149271	10.1371/journal.pone.0149271	http://dx.doi.org/10.1371/journal.pone.0149271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992117	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800020
J	Accordini, S; Calciano, L; Bombieri, C; Malerba, G; Belpinati, F; Lo Presti, AR; Baldan, A; Ferrari, M; Perbellini, L; de Marco, R				Accordini, Simone; Calciano, Lucia; Bombieri, Cristina; Malerba, Giovanni; Belpinati, Francesca; Lo Presti, Anna Rita; Baldan, Alessandro; Ferrari, Marcello; Perbellini, Luigi; de Marco, Roberto			An Interleukin 13 Polymorphism Is Associated with Symptom Severity in Adult Subjects with Ever Asthma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IL-13 GENE POLYMORPHISMS; TOBACCO-SMOKE; PROMOTER POLYMORPHISM; INCREASED EXPRESSION; PATHWAY GENES; LUNG-FUNCTION; IL13; HYPERRESPONSIVENESS; VARIANTS	Different genes are associated with categorical classifications of asthma severity. However, continuous outcomes should be used to catch the heterogeneity of asthma phenotypes and to increase the power in association studies. Accordingly, the aim of this study was to evaluate the association between single nucleotide polymorphisms (SNPs) in candidate gene regions and continuous measures of asthma severity, in adult patients from the general population. In the Gene Environment Interactions in Respiratory Diseases (GEIRD) study (www.geird.org), 326 subjects (aged 20q-64) with ever asthma were identified from the general population in Verona (Italy) between 2007 and 2010. A panel of 236 SNPs tagging 51 candidate gene regions (including one or more genes) was analysed. A symptom and treatment score (STS) and preq-bronchodilator FEV1% predicted were used as continuous measures of asthma severity. The association of each SNP with STS and FEV1% predicted was tested by fitting quasiq-gamma and linear regression models, respectively, with gender, body mass index and smoking habits as potential confounders. The Simes multipleq-test procedure was used for controlling the false discovery rate (FDR). SNP rs848 in the IL13 gene region (IL5/RAD50/IL13/IL4) was associated with STS (TG/GG vs TT genotype: uncorrected pq-value = 0.00006, FDRq-corrected pq-value = 0.04), whereas rs20541 in the same gene region, in linkage disequilibrium with rs848 (r(2) = 0.94) in our sample, did not reach the statistical significance after adjusting for multiple testing (TC/CC vs TT: uncorrected pq-value = 0.0003, FDRq-corrected pq-value = 0.09). Polymorphisms in other gene regions showed a nonq-significant moderate association with STS (IL12B, TNS1) or lung function (SERPINE2, GATA3, IL5, NPNT, FAM13A) only. After adjusting for multiple testing and potential confounders, SNP rs848 in the IL13 gene region is significantly associated with a continuous measure of symptom severity in adult subjects with ever asthma.	[Accordini, Simone; Calciano, Lucia; de Marco, Roberto] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Bombieri, Cristina; Malerba, Giovanni; Belpinati, Francesca; Lo Presti, Anna Rita; Baldan, Alessandro] Univ Verona, Dept Neurol Biomed & Movement Sci, Sect Biol & Genet, I-37100 Verona, Italy; [Ferrari, Marcello] Univ Verona, Dept Med, Resp Med Unit, I-37100 Verona, Italy; [Perbellini, Luigi] Univ Verona, Dept Diagnost & Publ Hlth, Unit Occupat Med, I-37100 Verona, Italy	University of Verona; University of Verona; University of Verona; University of Verona	Accordini, S (corresponding author), Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy.	simone.accordini@univr.it	Malerba, Giovanni/T-3278-2019	Calciano, Lucia/0000-0001-9801-5080; Baldan, Alessandro/0000-0002-5129-3419	Cariverona Foundation (Bando); Italian Ministry of Health [RF-2009-1471235]; Chiesi Farmaceutici; Italian Medicines Agency (AIFA)	Cariverona Foundation (Bando)(Fondazione Cariverona); Italian Ministry of Health(Ministry of Health, Italy); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Italian Medicines Agency (AIFA)	The GEIRD project was funded by the Cariverona Foundation (Bando 2006), the Italian Ministry of Health (RF-2009-1471235), Chiesi Farmaceutici and the Italian Medicines Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Beghe B, 2010, ALLERGY, V65, P474, DOI 10.1111/j.1398-9995.2009.02167.x; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Chen CH, 2012, PEDIAT ALLERG IMM-UK, V23, P456, DOI 10.1111/j.1399-3038.2012.01278.x; Chiang CH, 2007, RESPIROLOGY, V12, P42, DOI 10.1111/j.1440-1843.2006.00960.x; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Cui L, 2012, CLIN BIOCHEM, V45, P285, DOI 10.1016/j.clinbiochem.2011.12.012; Cunningham J, 2011, ANN ALLERG ASTHMA IM, V106, P381, DOI 10.1016/j.anai.2011.01.030; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Dijkstra A, 2011, EUR RESPIR J, V38, P1036, DOI 10.1183/09031936.00182410; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; *GLOB IN ASTHM, 1995, NIH PUBL; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Harada M, 2009, AM J RESP CRIT CARE, V180, P1048, DOI 10.1164/rccm.200905-0652OC; Hawkins GA, 2012, J ALLERGY CLIN IMMUN, V130, P510, DOI 10.1016/j.jaci.2012.03.018; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Himes BE, 2011, CHEST, V140, P667, DOI 10.1378/chest.10-2973; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Lee SY, 2002, CHEST, V122, P171, DOI 10.1378/chest.122.1.171; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; McCullagh P, 1989, GEN LINEAR MODELS; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Noonan M, 2013, J ALLERGY CLIN IMMUN, V132, P567, DOI 10.1016/j.jaci.2013.03.051; Palikhe NS, 2010, ALLERGY ASTHMA IMMUN, V2, P134, DOI 10.4168/aair.2010.2.2.134; Pascual RM, 2009, AM J RESP CRIT CARE, V179; Postma Dirkje S, 2004, Chest, V126, p96S, DOI 10.1378/chest.126.2_suppl_1.96S; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Pulleyn LJ, 2001, HUM GENET, V109, P623, DOI 10.1007/s00439-001-0617-y; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Rose G., 1992, STRATEGY PREVENTIVE; Sadeghnejad A, 2007, AM J RESP CRIT CARE, V176, P748, DOI 10.1164/rccm.200704-543OC; Sadeghnejad A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-2; Song GG, 2013, HUM IMMUNOL, V74, P256, DOI 10.1016/j.humimm.2012.11.003; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Tripathi P, 2011, J GENET, V90, P265, DOI 10.1007/s12041-011-0073-y; Tsai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051970; Utsumi Y, 2013, RESPIR INVESTIG, V51, P147, DOI 10.1016/j.resinv.2013.02.003; Vonk JM, 2010, PHARMACOGENET GENOM, V20, P179, DOI 10.1097/FPC.0b013e328336c7fd; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Zhang Q, 2011, J INVEST ALLERG CLIN, V21, P370	53	15	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151292	10.1371/journal.pone.0151292	http://dx.doi.org/10.1371/journal.pone.0151292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986948	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300059
J	Chen, L; Mongan, M; Meng, QH; Wang, Q; Kao, W; Xia, Y				Chen, Liang; Mongan, Maureen; Meng, Qinghang; Wang, Qin; Kao, Winston; Xia, Ying			Corneal Wound Healing Requires IKB kinase beta Signaling in Keratocytes	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; CELL; ACTIVATION; EXPRESSION; MYOFIBROBLAST; INHIBITOR; PROLIFERATION; DEFICIENCY; APOPTOSIS	kinase beta (IKK beta) is a key signaling kinase for inflammatory responses, but it also plays diverse cell type-specific roles that are not yet fully understood. Here we investigated the role of IKK beta in the cornea using Ikk beta(Delta CS) mice in which the Ikk beta gene was specifically deleted in the corneal stromal keratocytes. The Ikk beta(Delta CS) corneas had normal morphology, transparency and thickness; however, they did not heal well from mild alkali burn injury. In contrast to the Ikk beta(F/F) corneas that restored transparency in 2 weeks after injury, over 50% of the Ikk beta(Delta CS) corneas failed to fully recover. They instead developed recurrent haze with increased stromal thickness, severe inflammation and apoptosis. This pathogenesis correlated with sustained myofibroblast transformation with increased alpha smooth muscle actin (alpha-SMA) expression, higher levels of senescence beta-Gal activity and scar tissue formation at the late stage of wound healing. In addition, the Ikk beta(Delta CS) corneas displayed elevated expression of hemo-oxygenase-1 (HO-1), a marker of oxidative stress, and activation of stress signaling pathways with increased JNK, c-Jun and SMAD2/3 phosphorylation. These data suggest that IKK beta in keratocytes is required to repress oxidative stress and attenuate fibrogenesis and senescence in corneal wound healing.	[Chen, Liang; Mongan, Maureen; Meng, Qinghang; Wang, Qin; Xia, Ying] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Chen, Liang; Mongan, Maureen; Meng, Qinghang; Wang, Qin; Xia, Ying] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Kao, Winston] Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Chen, Liang] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Meng, Qinghang] Cincinnati Childrens Hosp, Dept Mol Cardiovasc Biol, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; Cincinnati Children's Hospital Medical Center	Xia, Y (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.; Xia, Y (corresponding author), Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA.	ying.xia@uc.edu	Chen, Liang/G-2990-2013	Chen, Liang/0000-0002-6748-9416	National Eye Institute [EY15227]; NATIONAL EYE INSTITUTE [R01EY015227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Eye Institute, Grant EY15227. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Bockhart V, 2009, J NEUROSCI, V29, P12919, DOI 10.1523/JNEUROSCI.1496-09.2009; Chae S, 2006, J IMMUNOL, V177, P1214, DOI 10.4049/jimmunol.177.2.1214; Chen F, 2003, CANCER RES, V63, P7689; Chen LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016132; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fleckenstein K, 2007, INT J RADIAT ONCOL, V68, P196, DOI 10.1016/j.ijrobp.2006.12.056; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Kubota M, 2011, INVEST OPHTH VIS SCI, V52, P427, DOI 10.1167/iovs.10-6167; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu CY, 2000, GENE, V250, P85, DOI 10.1016/S0378-1119(00)00165-7; Liu HS, 2012, J CELL MOL MED, V16, P1114, DOI 10.1111/j.1582-4934.2011.01418.x; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Miyazaki KI, 2008, INVEST OPHTH VIS SCI, V49, P1367, DOI 10.1167/iovs.07-1007; Myrna KE, 2009, VET OPHTHALMOL, V12, P25, DOI 10.1111/j.1463-5224.2009.00742.x; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Peng Z, 2010, MOL PHARM; Peng ZM, 2007, J BIOL CHEM, V282, P21487, DOI 10.1074/jbc.M702510200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfister RR, 1998, INVEST OPHTH VIS SCI, V39, P1744; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Roy S, 2011, BIOL TRACE ELEM RES, V139, P55, DOI 10.1007/s12011-010-8635-z; Saika S, 2006, AM J PATHOL, V168, P1848, DOI 10.2353/ajpath.2006.050980; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sarchahi AA, 2008, OPHTHALMIC RES, V40, P41, DOI 10.1159/000111158; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	42	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151869	10.1371/journal.pone.0151869	http://dx.doi.org/10.1371/journal.pone.0151869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987064	Green Published, gold			2022-12-27	WOS:000372580300144
J	Przybylowski, M; Ghosh, P; Gibou, F				Przybylowski, Magda; Ghosh, Pratim; Gibou, Frederic			An Efficient Object Tracking Method on Quad-/Oc-Trees	PLOS ONE			English	Article							LEVEL SET METHOD; SEGMENTATION; REGISTRATION; ALGORITHMS	We introduce a fast error-free tracking method applicable to sequences of two and three dimensional images. The core idea is to use Quadtree (resp. Octree) data structures for representing the spatial discretization of an image in two (resp. three) spatial dimensions. This representation enables one to merge into large computational cells the regions that can be faithfully described with such a coarse representation, thus significantly reducing the total number of degrees of freedom that are processed, without compromising accuracy. This encoding is particularly effective in the case of algorithms based on moving fronts, since the adaptive refinement provides a natural means to focus the processing resources on information near the moving front. In this paper, we use an existing contour based tracker and reformulate it to the case of Quad-/Oc-tree data structures. Relevant mathematical assumptions and derivations are presented for this purpose. We then demonstrate that, on standard biomedical image sequences, a speed up of 5X is easily achieved in 2D and about 10X in 3D.	[Gibou, Frederic] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Przybylowski, Magda; Gibou, Frederic] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA; [Ghosh, Pratim] Univ Calif Santa Barbara, Dept Elect & Comp Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Przybylowski, M (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	magda.przyby@gmail.com	Gibou, Frederic/AAU-4944-2020		National Science Foundation [CHE 1027817]; NSF [CHE 1027817]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This research was supported by the National Science Foundation under agreement CHE 1027817.; This research was supported by NSF CHE 1027817.	An JH, 2005, LECT NOTES COMPUT SC, V3749, P286; Aujol JF, 2006, INT J COMPUT VISION, V67, P111, DOI 10.1007/s11263-006-4331-z; Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35; Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226; Black MJ, 1996, COMPUT VIS IMAGE UND, V63, P75, DOI 10.1006/cviu.1996.0006; Bresson X, 2007, J MATH IMAGING VIS, V28, P151, DOI 10.1007/s10851-007-0002-0; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Cremers D, 2005, INT J COMPUT VISION, V62, P249, DOI 10.1007/s11263-005-4882-4; Cremers D., 2003, IEEE 2 INT WORKSH VA, P169; Ghosh P, 2013, IEEE T PATTERN ANAL, V35, P425, DOI 10.1109/TPAMI.2012.103; Ghosh P, 2010, PROC CVPR IEEE, P1363, DOI 10.1109/CVPR.2010.5539809; Ghosh P, 2009, IEEE I CONF COMP VIS, P709, DOI 10.1109/ICCV.2009.5459170; Ishikawa H, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P509, DOI 10.1109/ICCV.2001.937559; Liu X.-D, 1996, J COMPUT PHYS, V126, P202; Mei X., 2009, P INT C COMP VIS; Min C, 2007, J COMPUT PHYS, V225, P300, DOI 10.1016/j.jcp.2006.11.034; Mitchell SC, 2001, IEEE T MED IMAGING, V20, P415, DOI 10.1109/42.925294; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Papenberg N, 2006, INT J COMPUT VISION, V67, P141, DOI 10.1007/s11263-005-3960-y; Russo G, 2000, J COMPUT PHYS, V163, P51, DOI 10.1006/jcph.2000.6553; Samet H., 1990, APPL SPATIAL DATA ST; Samet H., 1989, DESIGN ANAL SPATIAL; Schoenemann T, 2008, P IEEE C COMP VIS PA, P1; Schoenemann T, 2009, IEEE T PAMI, P1153; SHU CW, 1989, J COMPUT PHYS, V83, P32, DOI 10.1016/0021-9991(89)90222-2; Strain J, 1999, J COMPUT PHYS, V151, P616, DOI 10.1006/jcph.1999.6205; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Taron M, 2009, IEEE T PATTERN ANAL, V31, P99, DOI 10.1109/TPAMI.2008.36; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Unal G, 2005, PROC CVPR IEEE, P168; Wedel A, 2009, LECT NOTES COMPUT SC, V5604, P23, DOI 10.1007/978-3-642-03061-1_2; Zhu Y.P., 2008, SMALL ANGLE XRAY SCA, V406, P57	33	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150889	10.1371/journal.pone.0150889	http://dx.doi.org/10.1371/journal.pone.0150889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986970	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300035
J	Tsujiuchi, T; Yamaguchi, M; Masuda, K; Tsuchida, M; Inomata, T; Kumano, H; Kikuchi, Y; Augusterfer, EF; Mollica, RF				Tsujiuchi, Takuya; Yamaguchi, Maya; Masuda, Kazutaka; Tsuchida, Marisa; Inomata, Tadashi; Kumano, Hiroaki; Kikuchi, Yasushi; Augusterfer, Eugene F.; Mollica, Richard F.			High Prevalence of Post-Traumatic Stress Symptoms in Relation to Social Factors in Affected Population One Year after the Fukushima Nuclear Disaster	PLOS ONE			English	Article							EAST JAPAN EARTHQUAKE; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; RESCUE WORKERS; EVENT SCALE; SURVIVORS; DISORDER; SUPPORT; DEPRESSION; VICTIMS	Objective This study investigated post-traumatic stress symptoms in relation to the population affected by the Fukushima Nuclear Disaster, one year after the disaster. Additionally, we investigated social factors, such as forced displacement, which we hypothesize contributed to the high prevalence of post-traumatic stress. Finally, we report of written narratives that were collected from the impacted population. Design and Settings Using the Impact of Event Scale-Revised (IES-R), questionnaires were sent to 2,011 households of those displaced from Fukushima prefecture living temporarily in Saitama prefecture. Of the 490 replies; 350 met the criteria for inclusion in the study. Multiple logistic regression analysis was performed to examine several characteristics and variables of social factors as predictors of probable post-traumatic stress disorder, PTSD. Results The mean score of IES-R was 36.15 +/- 21.55, with 59.4% having scores of 30 or higher, thus indicating a probable PTSD. No significant differences in percentages of high-risk subjects were found among sex, age, evacuation area, housing damages, tsunami affected, family split-up, and acquaintance support. By the result of multiple logistic regression analysis, the significant predictors of probable PTSD were chronic physical diseases (OR = 1.97), chronic mental diseases (OR = 6.25), worries about livelihood (OR = 2.27), lost jobs (OR = 1.71), lost social ties (OR = 2.27), and concerns about compensation (OR = 3.74). Conclusion Although there are limitations in assuming a diagnosis of PTSD based on self-report IES-R, our findings indicate that there was a high-risk of PTSD strongly related to the nuclear disaster and its consequent evacuation and displacement. Therefore, recovery efforts must focus not only on medical and psychological treatment alone, but also on social and economic issues related to the displacement, as well.	[Tsujiuchi, Takuya; Yamaguchi, Maya; Kumano, Hiroaki] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan; [Tsujiuchi, Takuya; Masuda, Kazutaka; Tsuchida, Marisa; Inomata, Tadashi; Kumano, Hiroaki; Kikuchi, Yasushi; Mollica, Richard F.] Waseda Inst Med Anthropol Disaster Reconstruct, Shinjuku Ku, Tokyo, Japan; [Tsujiuchi, Takuya; Augusterfer, Eugene F.; Mollica, Richard F.] Harvard Univ, Sch Med, Harvard Program Refugee Trauma, Cambridge, MA 02138 USA; [Masuda, Kazutaka] Int Univ Kagoshima, Dept Social Welf, Kagoshima, Kagoshima, Japan; [Tsuchida, Marisa] Idente Fdn Studies & Res, Rome, Italy; [Inomata, Tadashi] Saitama Sogo Law Firm, Shinsai Shien Network Saitama, Saitama, Saitama, Japan; [Kikuchi, Yasushi] Waseda Univ, Grad Sch Asia Pacific Studies, Shinjuku Ku, Tokyo, Japan	Waseda University; Harvard University; International University Kagoshima; Waseda University	Tsujiuchi, T (corresponding author), Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan.; Tsujiuchi, T (corresponding author), Waseda Inst Med Anthropol Disaster Reconstruct, Shinjuku Ku, Tokyo, Japan.; Tsujiuchi, T (corresponding author), Harvard Univ, Sch Med, Harvard Program Refugee Trauma, Cambridge, MA 02138 USA.	tsujiuchi@waseda.jp	Kumano, Hiroaki/AAN-1730-2020	Kumano, Hiroaki/0000-0001-6245-5535	"Disaster Relief Volunteer & Nonprofit Organization Support Fund" by Central Community Chest of Japan; Japan Society for the Promotion of Science KAKENHI [25460915]; "Ministry of Education, Culture, Sports, Science and Technology Japan" KIBANKEISEI	"Disaster Relief Volunteer & Nonprofit Organization Support Fund" by Central Community Chest of Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "Ministry of Education, Culture, Sports, Science and Technology Japan" KIBANKEISEI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the grant of "Disaster Relief Volunteer & Nonprofit Organization Support Fund" 2012 by Central Community Chest of Japan, and "Japan Society for the Promotion of Science KAKENHI" Grant Number 25460915, partially supported by "Ministry of Education, Culture, Sports, Science and Technology Japan" KIBANKEISEI 2012. Saitama Sogo Law Firm provided support in the form of salaries for author [TI], but did not have any additional role in the study design data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'authors contributions' section.	Arnberg FK, 2011, J TRAUMA STRESS, V24, P183, DOI 10.1002/jts.20629; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bromet EJ, 2014, HEALTH PHYS, V106, P206, DOI 10.1097/HP.0000000000000012; Cetin M, 2005, J TRAUMA STRESS, V18, P485, DOI 10.1002/jts.20056; Contis George, 2015, J Clin Med Res, V7, P332, DOI 10.14740/jocmr2018w; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; D'Andrea Wendy, 2011, J Am Psychiatr Nurses Assoc, V17, P378, DOI 10.1177/1078390311425187; Daly ES, 2008, J TRAUMA STRESS, V21, P227, DOI 10.1002/jts.20311; Dougall AL, 2000, ENCY STRESS, V3, P595; Fushimi M, 2012, PREHOSP DISASTER MED, V27, P416, DOI 10.1017/S1049023X12001070; Gerrity Ellen T., 1994, P220, DOI 10.1017/CBO9780511570162.012; Hori Arinobu, 2014, Seishin Shinkeigaku Zasshi, V116, P212; Hull AM, 2002, BRIT J PSYCHIAT, V181, P433, DOI 10.1192/bjp.181.5.433; Japan Reconstruction Agency, 2013, TOK CURR STAT PATH R; Johannesson KB, 2011, J NERV MENT DIS, V199, P162, DOI 10.1097/NMD.0b013e31820c73d1; Kato H., 2000, MED J KOBE U, V60, P27; Kato Yutaka, 2012, Keio Journal of Medicine, V61, P15, DOI 10.2302/kjm.61.15; Kikuchi Y, 2004, DEV ANTHR EC, P43; Koyama S, 2014, TOHOKU J EXP MED, V234, P241, DOI 10.1620/tjem.234.241; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V68, P524, DOI 10.1111/pcn.12159; Kurokawa K, 2012, OFFICIAL REPORT FUKU, P38; Maegele M, 2006, CRIT CARE, V10, DOI 10.1186/cc4868; Matsuoka Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-249; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; Mollica RF, 2004, LANCET, V364, P2058, DOI 10.1016/S0140-6736(04)17519-3; Moriyama K, 2013, BRAIN DEV-JPN, V35, P201, DOI 10.1016/j.braindev.2012.11.003; Nagata S, 2015, JPN J NURS SCI, V12, P162, DOI 10.1111/jjns.12051; Naoi K, 2009, JPN B SOCIAL PSYCHIA, V18, P52; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Nishi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035248; Nomura Ayumi, 2010, Acta Medica Nagasakiensia, V55, P41; Roberts B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-38; Shigemura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087516; Shigemura J, 2012, JAMA-J AM MED ASSOC, V308, P667, DOI 10.1001/jama.2012.9699; Shigemura J, 2012, AM J PSYCHIAT, V169, P784, DOI 10.1176/appi.ajp.2012.12030387; Takada S, 2013, BRAIN DEV-JPN, V35, P214, DOI 10.1016/j.braindev.2012.09.013; Wang L, 2011, J ANXIETY DISORD, V25, P369, DOI 10.1016/j.janxdis.2010.10.011; Weisaeth L, 1996, BAILLIERES CLIN PSYC, V2, P217; Weisaeth L, 2000, ENCY STRESS, V1, P435; Weisaeth Lars, 1994, P72, DOI 10.1017/CBO9780511570162.006; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102497; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022371	43	29	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151807	10.1371/journal.pone.0151807	http://dx.doi.org/10.1371/journal.pone.0151807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002324	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400047
J	Veguilla, V; Lopez-Gatell, H; Lopez-Martinez, I; Aparicio-Antonio, R; Barrera-Badillo, G; Rojo-Medina, J; Gross, FL; Jefferson, SN; Katz, JM; Hernandez-Avila, M; Alpuche-Aranda, CM				Veguilla, Vic; Lopez-Gatell, Hugo; Lopez-Martinez, Irma; Aparicio-Antonio, Rodrigo; Barrera-Badillo, Gisela; Rojo-Medina, Julieta; Gross, Felicia Liaini; Jefferson, Stacie N.; Katz, Jacqueline M.; Hernandez-Avila, Mauricio; Alpuche-Aranda, Celia M.			A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1) pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic	PLOS ONE			English	Article							SEROLOGIC ASSAYS; H1N1 VIRUS; SEROPREVALENCE	Background The 2009 H1N1 influenza pandemic initially affected Mexico from April 2009 to July 2010. By August 2010, a fourth of the population had received the monovalent vaccine against the pandemic virus (A(H1N1) pdm09). To assess the proportion of the Mexican population who remained potentially susceptible to infection throughout the summer of 2010, we estimated the population seroprevalence to A(H1N1) pdm09 in a serosurvey of blood donors. Methods We evaluated baseline cross-reactivity to the pandemic strain and set the threshold for seropositivity using pre-pandemic (2005-2008) stored serum samples and sera from confirmed A(H1N1) pdm09 infected individuals. Between June and September 2010, a convenience sample serosurvey of adult blood donors, children, and adolescents was conducted in six states of Mexico. Sera were tested by the microneutralization (MN) and hemagglutination inhibition (HI) assays, and regarded seropositive if antibody titers were equal or exceeded 1: 40 for MN and 1: 20 for HI. Age-standardized seroprevalence were calculated using the 2010 National Census population. Results Sera from 1,484 individuals were analyzed; 1,363 (92%) were blood donors, and 121 (8%) children or adolescents aged <= 19 years. Mean age (standard deviation) was 31.4 (11.5) years, and 276 (19%) were women. A total of 516 (35%) participants declared history of influenza vaccination after April 2009. The age-standardized seroprevalence to A(H1N1) pdm09 was 48% by the MN and 41% by the HI assays, respectively. The youngest quintile, aged 1 to 22 years, had the highest the seroprevalence; 61% (95% confidence interval [CI]: 56, 66%) for MN, and 56% (95% CI: 51, 62%) for HI. Conclusions Despite high transmission of A(H1N1) pdm09 observed immediately after its emergence and extensive vaccination, over a half of the Mexican population remained potentially susceptible to A(H1N1) pdm09 infection. Subsequent influenza seasons with high transmission of A(H1N1) pdm09, as 2011-2012 and 2013-2014, are compatible with these findings.	[Veguilla, Vic; Gross, Felicia Liaini; Jefferson, Stacie N.; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Lopez-Gatell, Hugo] Secretaria Salud Mexico, Direcc Gen Adjunta Epidemiol, Mexico City, DF, Mexico; [Lopez-Martinez, Irma; Aparicio-Antonio, Rodrigo; Barrera-Badillo, Gisela] Inst Diagnost & Referencia Epidemiol, Dept Virol, Lab Virus Resp, Mexico City, DF, Mexico; [Rojo-Medina, Julieta] Secretaria Salud Mexico, Ctr Nacl Transfus Sanguinea, Mexico City, DF, Mexico; [Hernandez-Avila, Mauricio] Secretaria Salud Mexico, Subsecretaria Prevenc & Promoc Salud, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia M.] Inst Diagnost & Referencia Epidemiol, Direcc Gen Adjunta, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia M.] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Hernandez-Avila, Mauricio] Inst Nacl Salud Publ, Direcc Gen, Cuernavaca, Morelos, Mexico	Centers for Disease Control & Prevention - USA; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Alpuche-Aranda, CM (corresponding author), Inst Diagnost & Referencia Epidemiol, Direcc Gen Adjunta, Mexico City, DF, Mexico.; Alpuche-Aranda, CM (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	celia.alpuche@insp.mx						Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Davila J., 2014, PLOS CURR-TREE LIFE, V6, DOI [10.1371/currents.outbreaks.a855a92f19db1d90ca955f5e908d6631, DOI 10.1371/CURRENTS.OUTBREAKS.A855A92F19DB1D90CA955F5E908D6631, DOI 10.1371/CURRENTS.0UTBREAKS.A855A92F19DB1D90CA955F5E908D6631]; Direccion General de Epidemiologia Secretaria de Salud, 2009, PERF EP PAND INFL A, P1; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Elizondo-Montemayor L, 2011, INT J INFECT DIS, V15, pE781, DOI 10.1016/j.ijid.2011.07.002; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI DOI 10.1111/IRV.12074; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150428	10.1371/journal.pone.0150428	http://dx.doi.org/10.1371/journal.pone.0150428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003409	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400013
J	Chrisman, SD; Waite, CB; Scoville, AG; Carnell, L				Chrisman, Steven D.; Waite, Christopher B.; Scoville, Alison G.; Carnell, Lucinda			C. elegans Demonstrates Distinct Behaviors within a Fixed and Uniform Electric Field	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY NEURONS; ODOR DISCRIMINATION; CIRCUIT; ELECTRORECEPTION; TEMPERATURE; THERMOTAXIS; CHEMOTAXIS; ASYMMETRY; GENETICS	C. elegans will orient and travel in a straight uninterrupted path directly towards the negative pole of a DC electric field. We have sought to understand the strategy worms use to navigate to the negative pole in a uniform electric field that is fixed in both direction and magnitude. We examined this behavior by quantifying three aspects of electrotaxis behavior in response to different applied field strengths: the mean approach trajectory angles of the animals' tracks, turning behavior (pirouettes) and average population speeds. We determined that C. elegans align directly to the negative pole of an electric field at sub-preferred field strength and alter approach trajectories at higher field strengths to maintain taxis within a preferred range we have calculated to be similar to 5V/cm. We sought to identify the sensory neurons responsible for the animals' tracking to a preferred field strength. eat-4 mutant animals defective in glutamatergic signaling of the amphid sensory neurons are severely electrotaxis defective and ceh-36 mutant animals, which are defective in the terminal differentiation of two types of sensory neurons, AWC and ASE, are partially defective in electrotaxis. To further elucidate the role of the AWC neurons, we examined the role of each of the pair of AWC neurons (AWC(OFF) and AWC(ON)), which are functionally asymmetric and express different genes. nsy-5/inx-19 mutant animals, which express both neurons as AWC(OFF), are severely impaired in electrotaxis behavior while nsy-1 mutants, which express both neurons as AWC(ON), are able to differentiate field strengths required for navigation to a specific field strength within an electric field. We also tested a strain with targeted genetic ablation of AWC neurons and found that these animals showed only slight disruption of directionality and turning behavior. These results suggest a role for AWC neurons in which complete loss of function is less disruptive than loss of functional asymmetry in electrotaxis behavior within a uniform fixed field.	[Chrisman, Steven D.; Waite, Christopher B.; Scoville, Alison G.; Carnell, Lucinda] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA; [Chrisman, Steven D.] Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, Ellensburg, WA USA; [Waite, Christopher B.] Virginia Commonwealth Univ, Med Ctr, Dept Physiol & Biophys, Richmond, VA USA	Central Washington University; Central Washington University; Virginia Commonwealth University	Carnell, L (corresponding author), Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA.	carnelll@cwu.edu			Central Washington University College of the Science, Provost's Office; Science Honors Research Program; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Central Washington University College of the Science, Provost's Office; Science Honors Research Program; NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by Central Washington University College of the Science, Provost's Office (LC), and the Science Honors Research Program (SDC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We especially would like to thank Dr. Michael Jackson of the CWU Physics Department for many valuable discussions and Dr. Andrew Davies for comments on the manuscript. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We also thank Dr. Joshua Kaplan (Massachusetts General Hospital/Harvard University, Boston, MA) and Dr. Joy Alcedo (Wayne State University, Detroit, MI) for strains.	[Anonymous], 2013, LSMEANS LEAST SQUARE; AVERY L, 1993, GENETICS, V133, P897; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Bodznick D, 1999, J EXP BIOL, V202, P1357; BRENNER S, 1974, GENETICS, V77, P71; BULLOCK TH, 1983, BRAIN RES REV, V6, P25, DOI 10.1016/0165-0173(83)90003-6; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Choi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005359; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; Clarke D, 2013, SCIENCE, V340, P66, DOI 10.1126/science.1230883; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; Croll NA, CAN J ZOOL, P894; Czech-Damal NU, 2013, J COMP PHYSIOL A, V199, P555, DOI 10.1007/s00359-012-0780-8; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gillis JA, 2012, DEVELOPMENT, V139, P3142, DOI 10.1242/dev.084046; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Huang SLB, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-24; Kempster RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052551; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; Luo LJ, 2006, J EXP BIOL, V209, P4652, DOI 10.1242/jeb.02590; Newland PL, 2008, J EXP BIOL, V211, P3682, DOI 10.1242/jeb.019901; O'Halloran DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000761; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Peters RC, 2007, BIOL REV, V82, P361, DOI 10.1111/j.1469-185X.2007.00015.x; Pettigrew JD, 1999, J EXP BIOL, V202, P1447; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pinheiro J., 2019, NLME LINEAR NONLINEA; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Serrano-Saiz E, 2013, CELL, V155, P659, DOI 10.1016/j.cell.2013.09.052; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; SUKUL NC, 1978, J NEMATOL, V10, P314; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Werner KM, 2014, J BIOL CHEM, V289, P26566, DOI 10.1074/jbc.M114.573832; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581	57	12	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151320	10.1371/journal.pone.0151320	http://dx.doi.org/10.1371/journal.pone.0151320			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998749	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700030
J	Leite, GC; Oliveira, MS; Perdigao-Neto, LV; Rocha, CKD; Guimaraes, T; Rizek, C; Levin, AS; Costa, SF				Leite, Gleice Cristina; Oliveira, Maura Salaroli; Perdigao-Neto, Lauro Vieira; Dias Rocha, Cristiana Kamia; Guimaraes, Thais; Rizek, Camila; Levin, Anna Sara; Costa, Silvia Figueiredo			Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; IN-VITRO ACTIVITY; TIME-KILL; CARBAPENEM; COLISTIN; DISSEMINATION; FOSFOMYCIN; SYNERGY; STRAINS; VANCOMYCIN	The study investigated the effect of antibiotic combinations against 20 clinical isolates of A. baumannii (seven colistin-resistant and 13 colistin-susceptible) with different resistance mechanisms. Clinical data, treatment, and patient mortality were evaluated. The following methods were used: MIC, PCRs, and outer membrane protein (OMP) analysis. Synergy was investigated using the checkerboard and time-kill methods. Clonality was evaluated by PFGE. Based on clonality, the whole genome sequence of six A. baumannii isolates was analyzed. All isolates were resistant to meropenem, rifampicin, and fosfomycin. OXA-23 and OXA-143 were the most frequent carbapenemases found. Four isolates showed loss of a 43kDa OMP. The colistin-susceptible isolates belonged to different clones and showed the highest synergistic effect with fosfomycin-amikacin. Among colistin-resistant isolates, the highest synergistic effect was observed with the combinations of colistin-rifampicin followed by colistin-vancomycin. All colistin-resistant isolates harbored bla(OXA-23-like) and belonged to CC113. Clinical and demographic data were available for 18 of 20 patients. Fourteen received treatment and eight patients died during treatment. The most frequent site of infection was the blood in 13 of 14 patients. Seven patients received vancomycin plus an active drug against A. baumannii; however, mortality did not differ in this group. The synergistic effect was similar for colistin-susceptible isolates of distinct clonal origin presenting with the same resistance mechanism. Overall mortality and death during treatment was high, and despite the high synergism in vitro with vancomycin, death did not differ comparing the use or not of vancomycin plus an active drug against A. baumannii.	[Leite, Gleice Cristina; Oliveira, Maura Salaroli; Perdigao-Neto, Lauro Vieira; Levin, Anna Sara; Costa, Silvia Figueiredo] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Leite, Gleice Cristina; Perdigao-Neto, Lauro Vieira; Dias Rocha, Cristiana Kamia; Rizek, Camila; Levin, Anna Sara; Costa, Silvia Figueiredo] LIM 54, Sao Paulo, Brazil; [Oliveira, Maura Salaroli; Perdigao-Neto, Lauro Vieira; Levin, Anna Sara; Costa, Silvia Figueiredo] Hosp Clin FMUSP, Sao Paulo, Brazil; [Guimaraes, Thais] Univ Sao Paulo, Dept Infect Control, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Costa, SF (corresponding author), Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.; Costa, SF (corresponding author), LIM 54, Sao Paulo, Brazil.; Costa, SF (corresponding author), Hosp Clin FMUSP, Sao Paulo, Brazil.	costasilviaf@ig.com.br	Costa, Silvia F/K-4768-2012; Figueiredo Costa, silvia/ABC-7704-2021; Levin, Anna S/C-8831-2012; Guimarães, Thais/C-7134-2014; Neto, Lauro V Perdigao/S-2351-2016; Levin, Anna S./AAJ-1712-2021	Costa, Silvia F/0000-0003-1087-752X; Figueiredo Costa, silvia/0000-0003-1087-752X; Levin, Anna S/0000-0003-2427-8368; Guimarães, Thais/0000-0002-7282-5453; Neto, Lauro V Perdigao/0000-0002-7681-8090; Levin, Anna S./0000-0003-2427-8368	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (GCL) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (SFC).	Agodi A, 2014, J HOSP INFECT, V86, P260, DOI 10.1016/j.jhin.2014.02.001; Aydemir H, 2013, EPIDEMIOL INFECT, V141, P1214, DOI 10.1017/S095026881200194X; Bishburg E, 2009, INT J ANTIMICROB AG, V34, P395, DOI 10.1016/j.ijantimicag.2009.06.021; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonapace CR, 2002, DIAGN MICR INFEC DIS, V44, P363, DOI 10.1016/S0732-8893(02)00473-X; Bonapace CR, 2000, DIAGN MICR INFEC DIS, V38, P43, DOI 10.1016/S0732-8893(00)00163-2; Carvalho KR, 2009, INT J ANTIMICROB AG, V34, P25, DOI 10.1016/j.ijantimicag.2008.12.009; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Climaco EC, 2013, INFECT GENET EVOL, V19, P127, DOI 10.1016/j.meegid.2013.06.024; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Coelho-Souza T, 2013, CLIN MICROBIOL INFEC, V19, pE241, DOI 10.1111/1469-0691.12145; Custovic Amer, 2014, Med Arch, V68, P402, DOI 10.5455/medarh.2014.68.402-406; Cavalcanti FLD, 2013, DIAGN MICR INFEC DIS, V77, P250, DOI 10.1016/j.diagmicrobio.2013.07.022; ELIOPOULOS GM, 1996, ANTIBIOTICS LAB MED, P330; European Committee on Antimicrobial Susceptibility Testing, 2013, EUR COMM ANT SUSC TE; Falagas ME, 2009, INT J ANTIMICROB AG, V34, P111, DOI 10.1016/j.ijantimicag.2009.03.009; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Garnacho-Montero J, 2013, CHEMOTHERAPY, V59, P225, DOI 10.1159/000356004; Giamarellos-Bourboulis EJ, 2001, DIAGN MICR INFEC DIS, V40, P117, DOI 10.1016/S0732-8893(01)00258-9; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; Grosso F, 2011, J ANTIMICROB CHEMOTH, V66, P62, DOI 10.1093/jac/dkq406; Gusatti CD, 2012, BRAZ J MICROBIOL, V43, P243, DOI [10.1590/S1517-83822012000100027, 10.1590/S1517-838220120001000027]; Higgins PG, 2009, ANTIMICROB AGENTS CH, V53, P5035, DOI 10.1128/AAC.00856-09; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim CK, 2010, DIAGN MICR INFEC DIS, V68, P432, DOI 10.1016/j.diagmicrobio.2010.07.014; Kim Uh Jin, 2014, Chonnam Med J, V50, P37, DOI 10.4068/cmj.2014.50.2.37; Koh TH, 2007, J ANTIMICROB CHEMOTH, V59, P627, DOI 10.1093/jac/dkl544; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee Y, 2012, J APPL MICROBIOL, V112, P1207, DOI 10.1111/j.1365-2672.2012.05283.x; Lu CL, 2011, ANTIMICROB AGENTS CH, V55, P4295, DOI 10.1128/AAC.00349-11; Lu PL, 2009, J ANTIMICROB CHEMOTH, V63, P641, DOI 10.1093/jac/dkn553; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martins N, 2013, MICROB DRUG RESIST, V19, P216, DOI 10.1089/mdr.2012.0174; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Mostachio AK, 2012, INT J ANTIMICROB AG, V39, P396, DOI 10.1016/j.ijantimicag.2012.01.021; Nigro SJ, 2012, J ANTIMICROB CHEMOTH, V67, P1342, DOI 10.1093/jac/dks037; O'Hara JA, 2013, ANTIMICROB AGENTS CH, V57, P2103, DOI 10.1128/AAC.02501-12; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Pillai S. K., 2005, ANTIMICROBIAL COMBIN; Principe L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-18; Rossi F, 2009, J MED MICROBIOL, V58, P1522, DOI 10.1099/jmm.0.011080-0; Santimaleeworagun W, 2011, SE ASIAN J TROP MED, V42, P890; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shahcheraghi F, 2011, IRAN J MICROBIOL, V3, P68; Stietz MS, 2013, INFECT GENET EVOL, V14, P294, DOI 10.1016/j.meegid.2012.12.020; Sirijatuphat R, 2014, ANTIMICROB AGENTS CH, V58, P5598, DOI 10.1128/AAC.02435-13; Ramirez MS, 2013, CURR MICROBIOL, V67, P9, DOI 10.1007/s00284-013-0326-5; Tognim MCB, 2004, INT J INFECT DIS, V8, P284, DOI 10.1016/j.ijid.2003.11.009; Vidaillac C, 2012, ANTIMICROB AGENTS CH, V56, P4856, DOI 10.1128/AAC.05996-11; Wei WJ, 2016, J CHEMOTHERAPY, V28, P159, DOI 10.1179/1973947815Y.0000000030; Werneck JS, 2011, J ANTIMICROB CHEMOTH, V66, P452, DOI 10.1093/jac/dkq462; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhang YJ, 2013, EXP THER MED, V5, P1737, DOI 10.3892/etm.2013.1039	56	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151270	10.1371/journal.pone.0151270	http://dx.doi.org/10.1371/journal.pone.0151270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998609	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700029
J	Kim, JH; Kang, MS; Eltohamy, M; Kim, TH; Kim, HW				Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won			Dynamic Mechanical and Nanofibrous Topological Combinatory Cues Designed for Periodontal Ligament Engineering	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; CELLS IN-VITRO; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; OSTEOBLAST DIFFERENTIATION; MINERALIZED NODULES; GENE-EXPRESSION; CYCLIC STRETCH; STRESS; REGENERATION	Complete reconstruction of damaged periodontal pockets, particularly regeneration of periodontal ligament (PDL) has been a significant challenge in dentistry. Tissue engineering approach utilizing PDL stem cells and scaffolding matrices offers great opportunity to this, and applying physical and mechanical cues mimicking native tissue conditions are of special importance. Here we approach to regenerate periodontal tissues by engineering PDL cells supported on a nanofibrous scaffold under a mechanical-stressed condition. PDL stem cells isolated from rats were seeded on an electrospun polycaprolactone/ gelatin directionally-oriented nanofiber membrane and dynamic mechanical stress was applied to the cell/nanofiber construct, providing nanotopological and mechanical combined cues. Cells recognized the nanofiber orientation, aligning in parallel, and the mechanical stress increased the cell alignment. Importantly, the cells cultured on the oriented nanofiber combined with the mechanical stress produced significantly stimulated PDL specific markers, including periostin and tenascin with simultaneous down-regulation of osteogenesis, demonstrating the roles of topological and mechanical cues in altering phenotypic change in PDL cells. Tissue compatibility of the tissue-engineered constructs was confirmed in rat subcutaneous sites. Furthermore, in vivo regeneration of PDL and alveolar bone tissues was examined under the rat premaxillary periodontal defect models. The cell/nanofiber constructs engineered under mechanical stress showed sound integration into tissue defects and the regenerated bone volume and area were significantly improved. This study provides an effective tissue engineering approach for periodontal regeneration-culturing PDL stem cells with combinatory cues of oriented nanotopology and dynamic mechanical stretch.	[Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea; [Kim, Joong-Hyun; Kang, Min Sil; Eltohamy, Mohamed; Kim, Tae-Hyun; Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea; [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea	Dankook University; Dankook University; Dankook University; Dankook University	Kim, HW (corresponding author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.; Kim, HW (corresponding author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.; Kim, HW (corresponding author), Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea.; Kim, HW (corresponding author), Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan, South Korea.	kimhw@dku.edu	Eltohamy, Mohamed/J-8507-2015	Eltohamy, Mohamed/0000-0003-2344-3501	National Research Foundation, South Korea [2009-0093829, NRF-2013R1A1A2013414, 2015032163]	National Research Foundation, South Korea(National Research Foundation of Korea)	This study was supported by grants from the Priority Research Centers Program (2009-0093829), Basic Research Program (NRF-2013R1A1A2013414), and Global Research Laboratory Program (GRL; 2015032163), National Research Foundation, South Korea.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bartold PM, 2006, PERIODONTOL 2000, V41, P123, DOI 10.1111/j.1600-0757.2006.00156.x; BENES AJ, 1985, J CELL SCI, V75, P35; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1002/cbf.1097; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CHO MI, 1992, CALCIFIED TISSUE INT, V50, P459, DOI 10.1007/BF00296778; Cillo JE, 2000, ORAL SURG ORAL MED O, V90, P147, DOI 10.1067/moe.2000.107531; Doi T, 2003, ARCH ORAL BIOL, V48, P573, DOI 10.1016/S0003-9969(03)00103-1; Doroski DM, 2010, TISSUE ENG PT A, V16, P3457, DOI 10.1089/ten.tea.2010.0233; Edwards Paul C, 2006, Head Face Med, V2, P16, DOI 10.1186/1746-160X-2-16; English A, 2015, ACTA BIOMATER, V27, P3, DOI 10.1016/j.actbio.2015.08.035; Fujii S, 2010, CELL TISSUE RES, V342, P233, DOI 10.1007/s00441-010-1037-x; Gauvin R, 2011, ACTA BIOMATER, V7, P3294, DOI 10.1016/j.actbio.2011.05.034; Han J, 2014, AUST DENT J, V59, P117, DOI 10.1111/adj.12100; Hasegawa D, 2015, J CELL PHYSIOL, V230, P2647, DOI 10.1002/jcp.24950; Jin Y, 2015, ANGLE ORTHOD, V85, P87, DOI 10.2319/123113-955.1; Kaku M, 2016, J CELL PHYSIOL, V231, P926, DOI 10.1002/jcp.25184; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kim JH, 2014, J DENT RES, V93, P1203, DOI 10.1177/0022034514540682; Kono K, 2013, CELL TISSUE RES, V352, P249, DOI 10.1007/s00441-012-1543-0; Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037; Li L, 2013, DNA CELL BIOL, V32, P488, DOI 10.1089/dna.2013.2070; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Liu MY, 2012, GENE, V491, P187, DOI 10.1016/j.gene.2011.09.031; Ma JY, 2015, ARCH ORAL BIOL, V60, P447, DOI 10.1016/j.archoralbio.2014.11.019; MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; Monnouchi S, 2015, J PERIODONTAL RES, V50, P231, DOI 10.1111/jre.12200; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; Oortgiesen DAW, 2012, TISSUE ENG PART C-ME, V18, P81, DOI [10.1089/ten.tec.2011.0367, 10.1089/ten.TEC.2011.0367]; Ozaki S, 2005, J PERIODONTAL RES, V40, P110, DOI 10.1111/j.1600-0765.2004.00782.x; RAMAKRISHNAN PR, 1995, CALCIFIED TISSUE INT, V57, P52, DOI 10.1007/BF00298997; Ren DP, 2015, J CELL PHYSIOL, V230, P2426, DOI 10.1002/jcp.24972; Saminathan A, 2012, J PERIODONTAL RES, V47, P212, DOI 10.1111/j.1600-0765.2011.01423.x; Saminathan A, 2015, TISSUE ENG PT A, V21, P518, DOI [10.1089/ten.tea.2014.0221, 10.1089/ten.TEA.2014.0221]; Shin SH, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412443530; Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15; Yamashiro K, 2007, INT J BIOCHEM CELL B, V39, P910, DOI 10.1016/j.biocel.2007.01.015; Yang L, 2015, ARCH ORAL BIOL, V60, P416, DOI 10.1016/j.archoralbio.2014.11.012; Yang Y, 2010, BIOMATERIALS, V31, P8574, DOI 10.1016/j.biomaterials.2010.06.026; Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083; Yu N, 2013, J PERIODONTOL, V84, P1504, DOI 10.1902/jop.2012.120513; ZHANG XL, 1993, J HISTOCHEM CYTOCHEM, V41, P245, DOI 10.1177/41.2.7678270; Ziegler N, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-10	46	34	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0149967	10.1371/journal.pone.0149967	http://dx.doi.org/10.1371/journal.pone.0149967			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989897	gold, Green Published			2022-12-27	WOS:000372582800022
J	Wang, CB; Dollard, SC; Amin, MM; Bialek, SR				Wang, Chengbin; Dollard, Sheila C.; Amin, Minal M.; Bialek, Stephanie R.			Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States	PLOS ONE			English	Article							BLOOD-DONORS; INFECTION; AVIDITY; ANTIBODIES; PREGNANCY	Cytomegalovirus (CMV) IgM indicates recent active CMV infection. CMV IgM seroprevalence is a useful marker for prevalence of transmission. Using data from the National Health and Nutrition Examination Survey (NHANES) III 1988-1994, we present estimates of CMV IgM prevalence by race/ethnicity, provide a comparison of IgM seroprevalence among all women and among CMV IgG positive women, and explore factors possibly associated with IgM seroprevalence, including socioeconomic status and exposure to young children. There was no difference in IgM seroprevalence by race/ethnicity among all women (3.1%, 2.2%, and 1.6% for non-Hispanic white, non-Hispanic black and Mexican American, respectively; P = 0.11). CMV IgM seroprevalence decreased significantly with increasing age in non-Hispanic black women (P<0.001 for trend) and marginally among Mexican American women (P = 0.07), while no apparent trend with age was seen in non-Hispanic white women (P = 0.99). Among 4001 IgG+ women, 118 were IgM+, resulting in 4.9% IgM seroprevalence. In IgG+ women, IgM seroprevalence varied significantly by age (5.3%, 7.3%, and 3.7% for women of 12-19, 20-29, and 30-49 years; P = 0.04) and race/ethnicity (6.1%, 2.7%, and 2.0% for non-Hispanic white, non-Hispanic black, and Mexican American; P<0.001). The factors reported associated with IgG seroprevalence were not associated with IgM seroprevalence. The patterns of CMV IgM seroprevalence by age, race/ethnicity, and IgG serostatus may help understanding the epidemiology of congenital CMV infection as a consequence of vertical transmission and are useful for identifying target populations for intervention to reduce CMV transmission.	[Wang, Chengbin; Dollard, Sheila C.; Amin, Minal M.; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Wang, CB (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.	cwang1@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bowen EF, 1996, AIDS, V10, pS37; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Centers for Disease Control and Prevention, NHANES 3 CYT IGG IGM; Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS), 1988, AN REP GUID 3 NAT HL; Das B, 2014, TRANSFUS APHER SCI, V50, P438, DOI 10.1016/j.transci.2014.02.022; Dollard SC, 2011, CLIN VACCINE IMMUNOL, V18, P1895, DOI 10.1128/CVI.05228-11; Kaneko M, 2013, J PERINATOL, V33, P831, DOI 10.1038/jp.2013.87; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Leruez-Ville M, 2013, CLIN INFECT DIS, V56, P1428, DOI 10.1093/cid/cit059; Mwintshi K, 2007, EXPERT REV ANTI-INFE, V5, P295, DOI 10.1586/14787210.5.2.295; PASS RF, 1987, NEW ENGL J MED, V316, P1366, DOI 10.1056/NEJM198705283162203; Prince HE, 2014, CLIN VACCINE IMMUNOL, V21, P1377, DOI 10.1128/CVI.00487-14; Qi Y, 2015, 5 INT CONG CMV C APR; Seo S, 2009, KOREAN J LAB MED, V29, P557, DOI 10.3343/kjlm.2009.29.6.557; Souza MA, 2010, REV SOC BRAS MED TRO, V43, P359, DOI 10.1590/S0037-86822010000400004; Staras SAS, 2008, SEX TRANSM DIS, V35, P472, DOI 10.1097/OLQ.0b013e3181644b70; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Uysal A, 2012, ARCH GYNECOL OBSTET, V286, P605, DOI 10.1007/s00404-012-2353-z; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wreghitt TG, 2003, CLIN INFECT DIS, V37, P1603, DOI 10.1086/379711	21	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151996	10.1371/journal.pone.0151996	http://dx.doi.org/10.1371/journal.pone.0151996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990759	gold, Green Published			2022-12-27	WOS:000372582800129
J	Zouache, MA; Eames, I; Samsudin, A				Zouache, Moussa A.; Eames, Ian; Samsudin, Amir			Allometry and Scaling of the Intraocular Pressure and Aqueous Humour Flow Rate in Vertebrate Eyes	PLOS ONE			English	Article							OPHTHALMIC DIAGNOSTIC-TESTS; FLAMINGOS PHOENICOPTERUS-RUBER; EPISCLERAL VENOUS-PRESSURE; CENTRAL CORNEAL THICKNESS; SCHIRMER TEAR TEST; REFERENCE VALUES; OCULAR PARAMETERS; ECHOBIOMETRIC FINDINGS; APPLANATION TONOMETER; SPHENISCUS-HUMBOLDTI	In vertebrates, intraocular pressure (IOP) is required to maintain the eye into a shape allowing it to function as an optical instrument. It is sustained by the balance between the production of aqueous humour by the ciliary body and the resistance to its outflow from the eye. Dysregulation of the IOP is often pathological to vision. High IOP may lead to glaucoma, which is in man the second most prevalent cause of blindness. Here, we examine the importance of the IOP and rate of formation of aqueous humour in the development of vertebrate eyes by performing allometric and scaling analyses of the forces acting on the eye during head movement and the energy demands of the cornea, and testing the predictions of the models against a list of measurements in vertebrates collated through a systematic review. We show that the IOP has a weak dependence on body mass, and that in order to maintain the focal length of the eye, it needs to be an order of magnitude greater than the pressure drop across the eye resulting from gravity or head movement. This constitutes an evolutionary constraint that is common to all vertebrates. In animals with cornea-based optics, this constraint also represents a condition to maintain visual acuity. Estimated IOPs were found to increase with the evolution of terrestrial animals. The rate of formation of aqueous humour was found to be adjusted to the metabolic requirements of the cornea, scaling as V-ac(0:67), where V-ac is the volume of the anterior chamber. The present work highlights an interdependence between IOP and aqueous flow rate crucial to ocular function that must be considered to understand the evolution of the dioptric apparatus. It should also be taken into consideration in the prevention and treatment of glaucoma.	[Zouache, Moussa A.] UCL, Inst Ophthalmol, London, England; [Eames, Ian] UCL, Dept Mech Engn, London, England; [Samsudin, Amir] Univ Malaya, Kuala Lumpur, Malaysia	University of London; University College London; University of London; University College London; Universiti Malaya	Zouache, MA (corresponding author), UCL, Inst Ophthalmol, London, England.	moussa.zouache.10@ucl.ac.uk	Eames, Ian/AAC-2864-2020; SAMSUDIN, AMIR/B-8217-2010	SAMSUDIN, AMIR/0000-0002-7707-7001; Zouache, Moussa/0000-0003-3689-7748				Aihara M, 2003, CURR EYE RES, V27, P355, DOI 10.1076/ceyr.27.6.355.18194; Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Andrade SF, 2011, J VET SCI, V12, P171, DOI 10.4142/jvs.2011.12.2.171; [Anonymous], 2008, EYES AQUEOUS HUMOR; [Anonymous], 2008, SHIELDS TXB GLAUCOMA; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; Bapodra P, 2014, J ZOO WILDLIFE MED, V45, P859, DOI 10.1638/2014-0063.1; Barsotti G, 2013, VET OPHTHALMOL, V16, P365, DOI 10.1111/vop.12008; BARTELS SP, 1988, INVEST OPHTH VIS SCI, V29, P1498; BAYON A, 2006, VET OPHTHALMOL, V9, P426; Beckwith-Cohen B, 2015, VET OPHTHALMOL, V18, P98, DOI 10.1111/vop.12126; BILL ANDERS, 1965, INVEST OPHTHALMOL, V4, P911; BILL ANDERS, 1965, INVEST OPHTHALMOL, V4, P920; Blackwood SE, 2010, VET OPHTHALMOL, V13, P72, DOI 10.1111/j.1463-5224.2010.00816.x; Bliss CD, 2015, VET OPHTHALMOL, V18, P86, DOI 10.1111/vop.12123; Broadwater JJ, 2007, VET OPHTHALMOL, V10, P269, DOI 10.1111/j.1463-5224.2007.00548.x; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; BROWN JD, 1989, OPHTHALMOLOGY, V96, P1468; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brubaker RF, 2004, EXP EYE RES, V78, P633, DOI 10.1016/j.exer.2003.07.002; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton RF, 2006, J ZOOL, V269, P225, DOI 10.1111/j.1469-7998.2006.00111.x; Burton RF, 2008, VISION RES, V48, P2345, DOI 10.1016/j.visres.2008.08.001; Castejon H, 2010, INVEST OPHTH VIS SCI, V51, P1599, DOI 10.1167/iovs.09-4215; Chidlow G, 2001, CURR EYE RES, V23, P144, DOI 10.1076/ceyr.23.2.144.5480; Chittick B, 2001, VET REC, V149, P587, DOI 10.1136/vr.149.19.587; Chu TC, 2002, J OCUL PHARMACOL TH, V18, P293, DOI 10.1089/10807680260218461; Church ML, 2013, VET OPHTHALMOL, V16, P65, DOI 10.1111/j.1463-5224.2012.01008.x; Clough JD, 2003, INVEST OPHTH VIS SCI, V44, pU127; Cole DF, 1974, THE EYE, V5; Colitz C.M.H., 2009, OPHTHALMOLOGY, V12, P405; Colitz CMH, 2014, VET OPHTHALMOL, V17, P294, DOI 10.1111/vop.12100; Collin HB, 2000, PHILOS T ROY SOC B, V355, P1171, DOI 10.1098/rstb.2000.0661; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Cox PG, 2010, J ANAT, V216, P37, DOI 10.1111/j.1469-7580.2009.01172.x; Crowston JG, 2004, INVEST OPHTH VIS SCI, V45, P2240, DOI 10.1167/iovs.03-0990; Cullen CL, 2003, VET OPHTHALMOL, V6, P279, DOI 10.1111/j.1463-5224.2003.00307.x; DAWSON WW, 1993, BRIT J OPHTHALMOL, V77, P302, DOI 10.1136/bjo.77.5.302; DAWSON WW, 1992, MAR MAMMAL SCI, V8, P135, DOI 10.1111/j.1748-7692.1992.tb00372.x; Delgado C, 2014, VET OPHTHALMOL, V17, P261, DOI 10.1111/vop.12114; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Duke-Elder S, 1958, SYSTEMS OPHTHALMOLOG, VIV; Duke-Elder S, 1958, SYSTEMS OPHTHALMOLOG, V1; FELDMAN HA, 1983, RESP PHYSIOL, V52, P149, DOI 10.1016/0034-5687(83)90002-6; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernald RD, 2000, CURR OPIN NEUROBIOL, V10, P444, DOI 10.1016/S0959-4388(00)00114-8; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; Friend J, 1979, Int Ophthalmol Clin, V19, P73; Gabelt BT, 2003, INVEST OPHTH VIS SCI, V44, P2118, DOI 10.1167/iovs.02-0569; Gancz AY, 2005, J AVIAN MED SURG, V19, P30, DOI 10.1647/2004-017; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Ghaffari MS, 2012, J ZOO WILDLIFE MED, V43, P229, DOI 10.1638/2010-0103.1; Ghaffari MS, 2012, VET OPHTHALMOL, V15, P206, DOI 10.1111/j.1463-5224.2011.00967.x; GOLDMANN H, 1951, Doc Ophthalmol, V5-6, P278, DOI 10.1007/BF00143664; Gomes FE, 2015, VET OPHTHALMOL, P1; Gonzalez-Alonso-Alegre EM, 2015, VET OPHTHALMOL, V18, P94, DOI 10.1111/vop.12206; Gum Glenwood G., 1998, Veterinary Ophthalmology, V1, P159, DOI 10.1046/j.1463-5224.1998.00017.x; Hahn A, 2014, J ZOO WILDLIFE MED, V45, P686, DOI 10.1638/2013-0208R.1; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Harris MC, 2008, VET OPHTHALMOL, V11, P186, DOI 10.1111/j.1463-5224.2008.00618.x; HAYASHI M, 1987, INVEST OPHTH VIS SCI, V28, P1639; HEINERMANN PH, 1984, EXP BIOL, V43, P127; HEUSNER AA, 1982, RESP PHYSIOL, V48, P1, DOI 10.1016/0034-5687(82)90046-9; Hipel KW, 1994, DEV WATER SCI, V45; HIRST LW, 1992, J WILDLIFE DIS, V28, P419, DOI 10.7589/0090-3558-28.3.419; HOFFERT JR, 1966, COMP BIOCHEM PHYSIOL, V17, P107; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hughes A, 1977, HDB SENSORY PHYSL, VVII/5; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Jeong MB, 2007, VET OPHTHALMOL, V10, P376, DOI 10.1111/j.1463-5224.2007.00573.x; Jonasova K, 2008, SEMIN CELL DEV BIOL, V19, P71, DOI 10.1016/j.semcdb.2007.10.005; Kendall MG, 1976, RANK CORRELATION MET; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Kuhn SE, 2013, J AVIAN MED SURG, V27, P90, DOI 10.1647/2012-032; Labelle AL, 2012, VET OPHTHALMOL, V15, P5, DOI 10.1111/j.1463-5224.2011.00899.x; Labelle AL, 2010, J ZOO WILDLIFE MED, V41, P461, DOI 10.1638/2009-0179.1; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Land MF, 2002, ANIMAL EYES; LANGHAM ME, 1987, EXP EYE RES, V45, P665, DOI 10.1016/S0014-4835(87)80115-X; Liang D, 2005, J ZOO WILDLIFE MED, V36, P430, DOI 10.1638/03-121.1; Lima L, 2010, VET OPHTHALMOL, V13, P14, DOI 10.1111/j.1463-5224.2010.00785.x; LINDER BJ, 1988, INVEST OPHTH VIS SCI, V29, P1492; Link BA, 2004, INVEST OPHTH VIS SCI, V45, P4415, DOI 10.1167/iovs.04-0557; Lynch GL, 2007, VET OPHTHALMOL, V10, P211, DOI 10.1111/j.1463-5224.2007.00538.x; Mann I.C., 1928, DEV HUMAN EYE; MARTIN GR, 1984, PROC R SOC SER B-BIO, V223, P197, DOI 10.1098/rspb.1984.0090; Martins BC, 2007, J ZOO WILDLIFE MED, V38, P526, DOI 10.1638/MS05-084.1; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; Matas M, 2010, VET OPHTHALMOL, V13, P116, DOI 10.1111/j.1463-5224.2010.00803.x; Meekins JM, 2015, J AVIAN MED SURG, V29, P95, DOI 10.1647/2014-021; Melena J, 1999, J OCUL PHARMACOL TH, V15, P19, DOI 10.1089/jop.1999.15.19; Mercado JA, 2010, J AVIAN MED SURG, V24, P138, DOI 10.1647/2009-002.1; Mermoud A, 1996, GRAEF ARCH CLIN EXP, V234, pS198, DOI 10.1007/BF02343072; MERMOUD A, 1994, INVEST OPHTH VIS SCI, V35, P2455; Molter CM, 2014, J ZOO WILDLIFE MED, V45, P664, DOI 10.1638/2013-0123R1.1; Montiani-Ferreira F, 2008, VET OPHTHALMOL, V11, P386, DOI 10.1111/j.1463-5224.2008.00663.x; Montiani-Ferreira F, 2008, VET OPHTHALMOL, V11, P197, DOI 10.1111/j.1463-5224.2008.00620.x; Montiani-Ferreira F, 2006, VET OPHTHALMOL, V9, P209, DOI 10.1111/j.1463-5224.2006.00475.x; Montiani-Ferreira F, 2010, VET OPHTHALMOL, V13, P91, DOI 10.1111/j.1463-5224.2009.00733.x; Ofri R, 1998, J ZOO WILDLIFE MED, V29, P307; Ofri R, 2000, J GLAUCOMA, V9, P187; Ofri R, 2002, VET REC, V151, P265, DOI 10.1136/vr.151.9.265; Ofri R, 2001, J WILDLIFE DIS, V37, P387, DOI 10.7589/0090-3558-37.2.387; Ofri Ron, 1998, Veterinary Ophthalmology, V1, P21; Ogidigben MJ, 2001, CURR EYE RES, V22, P358, DOI 10.1076/ceyr.22.5.358.5492; Okka Mehmet, 2004, Trans Am Ophthalmol Soc, V102, P251; OKSALA O, 1988, EXP EYE RES, V47, P787, DOI 10.1016/0014-4835(88)90045-0; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P23, DOI 10.1111/j.1463-5224.2004.00316.x; Oria AP, 2015, VET OPHTHALMOL, V18, P125, DOI 10.1111/vop.12221; Oria AP, 2015, VET OPHTHALMOL, V18, P30, DOI 10.1111/vop.12115; PEIFFER RL, 1980, LAB ANIM, V14, P331, DOI 10.1258/002367780781071094; PICKETTSELTNER RL, 1988, VISION RES, V28, P323, DOI 10.1016/0042-6989(88)90160-5; Polyak S. L., 1941, RETINA-J RET VIT DIS; Rajaei SM, 2015, J ZOO WILDLIFE MED, V46, P421, DOI 10.1638/2014-0234R.1; Reuter A, 2011, J AVIAN MED SURG, V25, P165, DOI 10.1647/2009-056.1; Ribeiro AP, 2014, VET OPHTHALMOL, V17, P397, DOI 10.1111/vop.12121; Ringvold A, 1998, ACTA OPHTHALMOL SCAN, V76, P149, DOI 10.1034/j.1600-0420.1998.760205.x; Rosenberg LF, 1996, INVEST OPHTH VIS SCI, V37, P2029; Ruiz T, 2015, VET OPHTHALMOL, V18, P40, DOI 10.1111/vop.12146; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Schmidt-Nielsen K, 1985, SCALING WHY IS ANIMA, P7; Selleri P, 2012, AM J VET RES, V73, P1807, DOI 10.2460/ajvr.73.11.1807; Selmi AL, 2003, VET OPHTHALMOL, V6, P305, DOI 10.1111/j.1463-5224.2003.00311.x; Selmi AL, 2002, J ZOO WILDLIFE MED, V33, P58, DOI 10.1638/1042-7260(2002)033[0058:IPDICN]2.0.CO;2; SIVAK J, 1987, PROC R SOC SER B-BIO, V229, P467, DOI 10.1098/rspb.1987.0005; SMYTHE RH, 1956, VET OPHTHALMOLOGY; STILES J, 1994, AM J VET RES, V55, P477; Stokkan KA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2451; SUBURO AM, 1990, AM J ANAT, V189, P245, DOI 10.1002/aja.1001890307; Swinger RL, 2009, J ZOO WILDLIFE MED, V40, P430, DOI 10.1638/2007-0126.1; Takle GL, 2010, J ZOO WILDLIFE MED, V41, P224, DOI 10.1638/2009-0105R1.1; Team RC, 2015, R LANG ENV STAT COMP; Toris CB, 2006, EXP EYE RES, V83, P865, DOI 10.1016/j.exer.2006.04.005; Toris CB, 2000, J OCUL PHARMACOL TH, V16, P19, DOI 10.1089/jop.2000.16.19; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WALKER SD, 1982, INVEST OPHTH VIS SCI, V22, P744; Wang YL, 1999, EXP EYE RES, V68, P439, DOI 10.1006/exer.1998.0623; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Whikehart DR, 2003, CLIN OCULAR PHARM, P285; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; WHITTAKER CJG, 1995, AM J VET RES, V56, P1380; Willis AM, 2000, AM J VET RES, V61, P1542, DOI 10.2460/ajvr.2000.61.1542; Wojick KB, 2013, J ZOO WILDLIFE MED, V44, P116, DOI 10.1638/1042-7260-44.1.116; World Health Organisation, 2012, GLOB DAT VIS IMP; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; ZAGROD ME, 1981, CURR EYE RES, V1, P49, DOI 10.3109/02713688109019972; Zhan GL, 2002, CURR EYE RES, V25, P99, DOI 10.1076/ceyr.25.2.99.10161	152	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151490	10.1371/journal.pone.0151490	http://dx.doi.org/10.1371/journal.pone.0151490			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990431	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800066
J	Pohle, S; Baty, F; Brutsche, M				Pohle, Susanne; Baty, Florent; Brutsche, Martin			In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012	PLOS ONE			English	Article							UNITED-STATES; CANCER-RISK; FOLLOW-UP; MORTALITY; POPULATION	Sarcoidosis is a multisystem disease with an unpredictable and sometimes fatal course while the underlying pathomechanism is still unclear. Reasons of the increasing hospitalization rate and mortality in the United States remain in dispute but incriminated are a number of distinct comorbidities and risk factors as well as the application of more aggressive therapeutic agents. Studies reflecting the recent development in central Europe are lacking. Our aim was to investigate the recent mortality and hospitalization rates as well as the underlying comorbidities of hospitalized sarcoidosis patients in Switzerland. In this longitudinal, nested case-control study, a nation-wide database provided by the Swiss Federal Office for Statistics enclosing every hospital entry covering the years 2002-2012 (n = 15,627,573) was analyzed. There were 8,385 cases with a diagnosis of sarcoidosis representing 0.054% (8,385 / 15,627,573) of all hospitalizations in Switzerland. These cases were compared with age- and sex-matched controls without the diagnosis of sarcoidosis. Hospitalization and mortality rates in Switzerland remained stable over the observed time period. Comorbidity analysis revealed that sarcoidosis patients had significantly higher medication-related comorbidities compared to matched controls, probably due to systemic corticosteroids and immunosuppressive therapy. Sarcoidosis patients were also more frequently re-hospitalized (median annual hospitalization rate 0.28 [IQR 0.15-0.65] vs. 0.19 [IQR 0.13-0.36] per year; p < 0.001), had a longer hospital stay (6 [IQR 2-13] vs. 4 [IQR 1-8] days; p < 0.001), had more comorbidities (4 [IQR 2-7] vs. 2 [IQR 1-5]; p < 0.001), and had a significantly higher in-hospital mortality (2.6% [95% CI 2.3%-2.9%] vs. 1.8% [95% CI 1.5%-2.1%] (p < 0.001). A worse outcome was observed among sarcoidosis patients having co-occurrence of associated respiratory diseases. Moreover, age was an important risk factor for re-hospitalization.	[Pohle, Susanne; Baty, Florent; Brutsche, Martin] Cantonal Hosp St Gallen, Dept Pulm Med, St Gallen, Switzerland	Kantonsspital St. Gallen	Baty, F (corresponding author), Cantonal Hosp St Gallen, Dept Pulm Med, St Gallen, Switzerland.	florent.baty@kssg.ch		Brutsche, Martin/0000-0002-1612-3609	Lungenliga St. Gallen; Kantonsspital St. Gallen	Lungenliga St. Gallen; Kantonsspital St. Gallen	The study was supported by an unconditional research grant by the Lungenliga St. Gallen and an institutional grant by the Kantonsspital St. Gallen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by an unconditional research grant by the Lungenliga St. Gallen and an institutional grant by the Kantonsspital St. Gallen.	[Anonymous], 2010, BIPLOTS PRACTICE; [Anonymous], 2014, R LANG ENV STAT COMP; Baty F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063285; Bonifazi M, 2015, CHEST, V147, P778, DOI 10.1378/chest.14-1475; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deubelbeiss U, 2010, EUR RESPIR J, V35, P1088, DOI 10.1183/09031936.00197808; Duncan ME, 2012, INT J TUBERC LUNG D, V16, P38, DOI 10.5588/ijtld.11.0077; Foreman MG, 2006, SARCOIDOSIS VASC DIF, V23, P124; Gerke AK, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-19; Gideon NM, 1996, AM J MED, V100, P423, DOI 10.1016/S0002-9343(97)89518-6; Ji J, 2009, ANN ONCOL, V20, P1121, DOI 10.1093/annonc/mdn767; Le Jeune I, 2007, RESP MED, V101, P2534, DOI 10.1016/j.rmed.2007.07.012; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Nardi A, 2011, EUR RESPIR J, V38, P1368, DOI 10.1183/09031936.00187410; Oksanen, 2010, MULTIVARIATE ANAL EC; Romer FK, 1998, EUR RESPIR J, V12, P906, DOI 10.1183/09031936.98.12040906; Swigris JJ, 2011, CHEST, V140, P1261, DOI 10.1378/chest.11-0324; Swigris JJ, 2011, AM J RESP CRIT CARE, V183, P1524, DOI 10.1164/rccm.201010-1679OC; Tukey MH, 2013, SARCOIDOSIS VASC DIF, V30, P128; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7	20	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151940	10.1371/journal.pone.0151940	http://dx.doi.org/10.1371/journal.pone.0151940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987059	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300156
J	Pallares, J				Pallares, Jordi			A Criterion for the Complete Deposition of Magnetic Beads on the Walls of Microchannels	PLOS ONE			English	Article							TURBULENT-FLOW; CHANNEL; MICROSPHERES; PARTICLES; TRANSPORT; FORCE	This paper analyzes numerical simulations of the trajectories of magnetic beads in a microchannel, with a nearby permanent cubical magnet, under different flow and magnetic conditions. Analytically derived local fluid velocities and local magnetic forces have been used to track the particles. A centered position and a lateral position of the magnet above the microchannel are considered. The computed fractions of deposited particles on the walls are compared successfully with a new theoretically derived criterion that imposes a relation between the sizes of the magnet and the microchannel and the particle Stokes and Alfven numbers to obtain the complete deposition of the flowing particles on the wall. In the cases in which all the particles, initially distributed uniformly across the section of the microchannel, are deposited on the walls, the simulations predict the accumulation of the major part of particles on the wall closest to the magnet and near the first half of the streamwise length of the magnet.	[Pallares, Jordi] Univ Rovira & Virgili, Dept Mech Engn, E-43007 Tarragona, Spain	Universitat Rovira i Virgili	Pallares, J (corresponding author), Univ Rovira & Virgili, Dept Mech Engn, E-43007 Tarragona, Spain.	jordi.pallares@urv.cat	Pallares, Jordi/E-4036-2012	Pallares, Jordi/0000-0003-0305-2714	Spanish Ministerio de Economia y Competitividad [CTQ2013-46799-C2-1-P]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This study has been supported by the Spanish Ministerio de Economia y Competitividad under project CTQ2013-46799-C2-1-P.	Ando B, 2009, IEEE T INSTRUM MEAS, V58, P3232, DOI 10.1109/TIM.2009.2017167; Berthier J, 2010, ARTECH HSE INTEGR MI, P1; Das C, 2013, SENSOR ACTUAT A-PHYS, V201, P43, DOI 10.1016/j.sna.2013.06.023; Erb RM, 2009, NANOSCALE MAGNETIC MATERIALS AND APPLICATIONS, P563, DOI 10.1007/978-0-387-85600-1_19; Felinto MCFC, 2005, NUCL INSTRUM METH B, V236, P495, DOI 10.1016/j.nimb.2005.04.056; Furlani E. P., 2001, PERMANENT MAGNET ELE; Furlani EP, 2012, MICROFLUID NANOFLUID, V13, P589, DOI 10.1007/s10404-012-0975-x; GERBER R, 1983, IEEE T MAGN, V19, P2115, DOI 10.1109/TMAG.1983.1062795; Gijs MAM, 2010, CHEM REV, V110, P1518, DOI 10.1021/cr9001929; Hatch A, 2001, J MICROELECTROMECH S, V10, P215, DOI 10.1109/84.925748; Jang JS, 2000, SENSOR ACTUAT A-PHYS, V80, P84, DOI 10.1016/S0924-4247(99)00302-7; Lee D, 2001, J FLUID MECH, V439, P367, DOI 10.1017/S0022112001004621; Longest PW, 2004, COMPUT FLUIDS, V33, P577, DOI 10.1016/j.compfluid.2003.06.002; Michaelides EE, 2006, PARTICLES BUBBLES DR; Oh DW, 2007, J MICROMECH MICROENG, V17, P2077, DOI 10.1088/0960-1317/17/10/020; Pallares J, 2012, J AEROSOL SCI, V43, P45, DOI 10.1016/j.jaerosci.2011.09.002; Pallares J, 2014, EUR J MECH B-FLUID, V46, P144, DOI 10.1016/j.euromechflu.2014.03.001; Pamme N, 2006, LAB CHIP, V6, P24, DOI 10.1039/b513005k; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Papavassiliou DV, 1997, INT J HEAT MASS TRAN, V40, P1303, DOI 10.1016/S0017-9310(96)00202-5; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Shah R. K., 1978, LAMINAR FLOW FORCED, P196; Shevkoplyas SS, 2007, LAB CHIP, V7, P1294, DOI 10.1039/b705045c; Verbruggen B, 2015, MICROFLUID NANOFLUID, V18, P91, DOI 10.1007/s10404-014-1409-8; WACHOLDER E, 1972, CHEM ENG SCI, V27, P1817, DOI 10.1016/0009-2509(72)85043-7; Wolfram Research, MATHEMATICA; Yamaura M, 2004, J MAGN MAGN MATER, V279, P210, DOI 10.1016/j.jmmm.2004.01.094; Yang RJ, 2016, SENSOR ACTUAT B-CHEM, V224, P1, DOI 10.1016/j.snb.2015.10.053; Zhang QY, 2007, J MAGN MAGN MATER, V311, P140, DOI 10.1016/j.jmmm.2006.11.181; Zhu GP, 2012, LAB CHIP, V12, P4772, DOI 10.1039/c2lc40818j	30	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151053	10.1371/journal.pone.0151053	http://dx.doi.org/10.1371/journal.pone.0151053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007336	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200041
J	Luo, JY; Zhang, S; Wang, L; Lv, LM; Wang, CY; Li, CH; Zhu, XZ; Zhou, ZG; Cui, JJ				Luo, Jun-Yu; Zhang, Shuai; Wang, Li; Lv, Li-Min; Wang, Chun-Yi; Li, Chun-Hua; Zhu, Xiang-Zhen; Zhou, Zhi-Guo; Cui, Jin-Jie			The Distribution and Host Shifts of Cotton-Melon Aphids in Northern China	PLOS ONE			English	Article							POPULATION GENETIC SOFTWARE; GOSSYPII GLOVER; SEXUAL REPRODUCTION; GENOTYPIC DATA; DIVERSITY; DIFFERENTIATION; RESISTANCE; PROGRAM	Aphis gossypii Glover (Hemiptera: Aphididae) is a serious pest of cotton in northern China. A microsatellite analysis was used to characterize the genetic structure of A. gossypii populations from different geographic, host plant, and seasonal populations in 2014. Among 906 individuals, 507 multilocus genotypes were identified, with genotypic richness values of 0.07-1.00 for the populations. We observed moderate levels of genetic differentiation among geographic populations (F-ST = 0.103; 95% confidence interval: 0.065-0.145) and host plant populations (F-ST = 0.237; 95% confidence interval: 0.187-0.296). A Mantel test of isolation by distance revealed no significant correlations between Slatkin's linearized F-ST and the natural logarithm of geographic distance. A Bayesian analysis of population genetic structures identified three clusters. An analysis of molecular variance revealed significant differences among the three clusters (F = 0.26596, P < 0.0001), among seasons (F = 0.04244, P = 0.00381), and among host populations (F = 0.12975, P = 0.0029). Thus, the A. gossypii populations in northern China exhibit considerable genotypic diversity. Additionally, our findings indicated that the 31 analyzed populations could be classified as one of three host biotypes (i.e., cotton, cucumber, and pomegranate biotypes). There were also clear seasonal effects on population genetic structure diversity among aphids collected from Anyang.	[Luo, Jun-Yu; Zhou, Zhi-Guo] Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol, Nanjing 210095, Jiangsu, Peoples R China; [Luo, Jun-Yu; Zhang, Shuai; Wang, Li; Lv, Li-Min; Wang, Chun-Yi; Li, Chun-Hua; Zhu, Xiang-Zhen; Cui, Jin-Jie] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhou, ZG (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol, Nanjing 210095, Jiangsu, Peoples R China.; Cui, JJ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	giscott@njau.edu.cn; cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522	Transgenic Major Projects program of the Ministry of Science and Technology, China [2016ZX08011-002]; National Natural Science Foundation of China [31572015]	Transgenic Major Projects program of the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Transgenic Major Projects program of the Ministry of Science and Technology, China (2016ZX08011-002) and the National Natural Science Foundation of China (31572015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Blackman R.L., 2000, J ECON ENTOMOL, V2; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; Chen YZ, 2013, PEST MANAG SCI, V69, P938, DOI 10.1002/ps.3455; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebert TA, 1997, SOUTHWEST ENTOMOL, V22, P116; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrari Roberto, 1994, IF (Informatore Fitopatologico), V44, P59; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemaud T, 2003, HEREDITY, V91, P143, DOI 10.1038/sj.hdy.6800292; GULDEMOND JA, 1994, ENVIRON ENTOMOL, V23, P1235, DOI 10.1093/ee/23.5.1235; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Komazaki S, 2011, ENTOMOL EXP APPL, V140, P171, DOI 10.1111/j.1570-7458.2011.01145.x; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083180; Liu XiangDong, 2002, Agricultural Sciences in China, V1, P1211; Lombaert E, 2009, ENTOMOL EXP APPL, V133, P46, DOI 10.1111/j.1570-7458.2009.00904.x; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Razmjou J, 2010, ENTOMOL EXP APPL, V134, P191, DOI 10.1111/j.1570-7458.2009.00951.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubiano-Rodriguez JA, 2014, B ENTOMOL RES, V104, P182, DOI 10.1017/S000748531300062X; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Thomas S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-47; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanlerberghe-Masutti F, 1998, MOL ECOL, V7, P905, DOI 10.1046/j.1365-294x.1998.00421.x; Vanlerberghe-Masutti F, 1999, MOL ECOL, V8, P693, DOI 10.1046/j.1365-294x.1999.00876.x; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146345; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu ZS, 2004, ANN ENTOMOL SOC AM, V97, P209, DOI 10.1603/0013-8746(2004)097[0209:TSAICA]2.0.CO;2; Xia J., 1997, THESIS WAGENINGEN U	38	7	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152103	10.1371/journal.pone.0152103	http://dx.doi.org/10.1371/journal.pone.0152103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002824	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400079
J	Ali, HO; Stavik, B; Myklebust, CF; Andersen, E; Dahm, AEA; Iversen, N; Sandset, PM; Skretting, G				Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Dahm, Anders E. A.; Iversen, Nina; Sandset, Per Morten; Skretting, Grethe			Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5 '-Flanking Region	PLOS ONE			English	Article							LIPOPROTEIN-ASSOCIATED COAGULATION; BREAST-CANCER CELLS; RECEPTOR BINDING; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; HALF-SITE; ALPHA; DNA; IDENTIFICATION; PROMOTER	Oestrogens influence the pathology and development of hormone-sensitive breast cancers. Tissue factor pathway inhibitor (TFPI) has been shown to be associated with breast cancer pathogenesis. Recently, we found TFPI mRNA levels to be significantly reduced by oestrogens in a breast cancer cell line (MCF7), a process mediated through the oestrogen receptor alpha (ERa). The aim of the present study was to investigate the mechanism(s) by which oestrogens may regulate TFPI at the transcriptional level. The TFPI 5'-flanking region contains three oestrogen response element (ERE) half-sites at positions -845, -769 and -50. Constructs containing the wild type or mutated ERE half-sites of the TFPI 5'-flanking region were generated in a luciferase reporter gene vector and transiently co-transfected with an ERa expression vector into HEK293 cells and subsequently treated with oestrogens. We found that luciferase activity was significantly downregulated after oestrogen stimulation in cells transfected with the wild type construct, an effect that was abolished by mutating either ERE half-sites. Electrophoretic mobility shift assay suggested direct and specific interaction of ERa with the ERE half-sites in the TFPI 5'-flanking region. Chromatin immunoprecipitation showed that ERa was recruited to the region -899 to -578 of the TFPI 5'-flanking region in vivo, where the ERE half-sites -845 and -769 are located. Our results indicate that ERa can interact with all three ERE half-sites in the TFPI 5'-flanking region and thus participate in the repression of oestrogen mediated TFPI transcription in breast cancer cells.	[Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Sandset, Per Morten; Skretting, Grethe] Oslo Univ Hosp, Dept Haematol, Oslo, Norway; [Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Dahm, Anders E. A.; Sandset, Per Morten; Skretting, Grethe] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Ali, Huda Omar; Andersen, Elisabeth; Dahm, Anders E. A.; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Oslo, Norway; [Dahm, Anders E. A.] Akershus Univ Hosp, Dept Haematol, Nordbyhagen, Norway; [Iversen, Nina] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Skretting, G (corresponding author), Oslo Univ Hosp, Dept Haematol, Oslo, Norway.; Skretting, G (corresponding author), Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway.	grethe.skretting@medisin.uio.no	Dahm, Anders Erik Astrup/N-4260-2019; Stavik, Benedicte/U-3406-2017; Sandset, Per Morten/J-8141-2019	Stavik, Benedicte/0000-0003-3341-9847; Sandset, Per Morten/0000-0001-5556-8099; Dahm, Anders Erik Astrup/0000-0003-4477-3526; Andersen, Elisabeth/0000-0003-2902-2003				Ali HO, 2014, THROMB RES, V134, P138, DOI 10.1016/j.thromres.2014.04.004; Anderson I, 2000, BIOCHEMISTRY-US, V39, P3842, DOI 10.1021/bi9924516; Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Eilertsen AL, 2007, THROMB RES, V120, P371, DOI 10.1016/j.thromres.2006.10.013; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FURLOW JD, 1993, J BIOL CHEM, V268, P12519; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GOSDEN JR, 1986, CYTOGENET CELL GENET, V43, P218, DOI 10.1159/000132325; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hart K, 2008, MUTAT RES-GEN TOX EN, V656, P14, DOI 10.1016/j.mrgentox.2008.06.013; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Joshi SR, 2011, MOL ENDOCRINOL, V25, P980, DOI 10.1210/me.2010-0302; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Liu W, 2007, THROMB HAEMOSTASIS, V97, P839, DOI 10.1160/TH06-09-0536; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; Mason CE, 2010, NUCLEIC ACIDS RES, V38, P2355, DOI 10.1093/nar/gkp1188; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MURDOCH FE, 1990, BIOCHEMISTRY-US, V29, P8377, DOI 10.1021/bi00488a026; Nekoo AA, 2008, THROMB RES, V121, P813, DOI 10.1016/j.thromres.2007.08.012; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Petit L, 1999, THROMB RES, V95, P255, DOI 10.1016/S0049-3848(99)00040-7; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Skretting G, 2010, BIOCHEM BIOPH RES CO, V397, P106, DOI 10.1016/j.bbrc.2010.05.078; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-5; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; VANDERLOGT CPE, 1991, BIOCHEMISTRY-US, V30, P1571, DOI 10.1021/bi00220a018; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152114	10.1371/journal.pone.0152114	http://dx.doi.org/10.1371/journal.pone.0152114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999742	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700101
J	Bai, L; Li, QW; Li, LM; Lin, Y; Zhao, SH; Wang, WR; Wang, R; Li, YQ; Yuan, JB; Wang, CJ; Wang, ZF; Fan, JL; Liu, EQ				Bai, Liang; Li, Qianwei; Li, Lingmei; Lin, Yan; Zhao, Sihai; Wang, Weirong; Wang, Rong; Li, Yongqin; Yuan, Jiangbei; Wang, Chengjian; Wang, Zhongfu; Fan, Jianglin; Liu, Enqi			Plasma High-Mannose and Complex/Hybrid N-Glycans Are Associated with Hypercholesterolemia in Humans and Rabbits	PLOS ONE			English	Article							MASS-SPECTROMETRY; GLYCOSYLATION; GLYCOMICS; CANCER; INFLAMMATION; EXPRESSION; BINDING	N-glycans play important roles in various pathophysiological processes and can be used as clinical diagnosis markers. However, plasma N-glycans change and their pathophysiological significance in the setting of hypercholesterolemia, a major risk factor for atherosclerosis, is unknown. Here, we collected plasma from both hypercholesterolemic patients and cholesterol-fed hypercholesterolemic rabbits, and determined the changes in the whole-plasma N-glycan profile by electrospray ionization mass spectrometry. We found that both the hypercholesterolemic patients and rabbits showed a dramatic change in their plasma glycan profile. Compared with healthy subjects, the hypercholesterolemic patients exhibited higher plasma levels of a cluster of high-mannose and complex/hybrid N-glycans (mainly including undecorated or sialylated glycans), whereas only a few fucosylated or fucosylated and sialylated N-glycans were increased. Additionally, cholesterol-fed hypercholesterolemic rabbits also displayed increased plasma levels of high-mannose in addition to high complex/hybrid N-glycan levels. The whole-plasma glycan profiles revealed that the plasma N-glycan levels were correlated with the plasma cholesterol levels, implying that N-glycans may be a target for treatment of hypercholesterolemia.	[Bai, Liang; Li, Qianwei; Lin, Yan; Zhao, Sihai; Wang, Weirong; Wang, Rong; Liu, Enqi] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian 710061, Shaanxi, Peoples R China; [Bai, Liang; Li, Qianwei; Lin, Yan; Zhao, Sihai; Wang, Weirong; Wang, Rong; Liu, Enqi] Xi An Jiao Tong Univ, Hlth Sci Ctr, Lab Anim Ctr, Xian 710061, Shaanxi, Peoples R China; [Li, Lingmei; Yuan, Jiangbei; Wang, Chengjian; Wang, Zhongfu] NW Univ Xian, Coll Life Sci, Educ Minist, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China; [Li, Yongqin] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China; [Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi 4093898, Japan	Xi'an Jiaotong University; Xi'an Jiaotong University; Northwest University Xi'an; Xi'an Jiaotong University; University of Yamanashi	Liu, EQ (corresponding author), Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian 710061, Shaanxi, Peoples R China.; Liu, EQ (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Lab Anim Ctr, Xian 710061, Shaanxi, Peoples R China.; Wang, ZF (corresponding author), NW Univ Xian, Coll Life Sci, Educ Minist, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China.	wangzhf@nwu.edu.cn; liuenqi@mail.xjtu.edu.cn	liu, enqi/S-7771-2019; Yuan, Jiangbei/HHZ-8184-2022	Zhao, Sihai/0000-0002-5845-6639; Fan, Jianglin/0000-0002-1737-6130; Liu, Enqi/0000-0002-2092-3158; Wang, Rong/0000-0002-9947-4307	National Natural Science Foundation of China [81070250, 81200207]; Public Service Platform Grant from Shaanxi Province [2014FWPT-07]; Grants-in-Aid for Scientific Research [25670190] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Platform Grant from Shaanxi Province; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by the National Natural Science Foundation of China (81070250, 81200207) and a Public Service Platform Grant from Shaanxi Province (2014FWPT-07).	Alaupovic P, 1991, ADV EXP MED BIOL, V285, P299; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P601, DOI 10.1016/j.cbpa.2009.08.015; [Anonymous], [No title captured]; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Banuls C, 2012, CLIN CHIM ACTA, V413, P251, DOI 10.1016/j.cca.2011.09.047; Barone R, 2009, MASS SPECTROM REV, V28, P517, DOI 10.1002/mas.20201; Chacko BK, 2011, J BIOL CHEM, V286, P38738, DOI 10.1074/jbc.M111.247981; Chen CC, 2010, REJUV RES, V13, P439, DOI 10.1089/rej.2009.0992; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Fan J, 2014, PHARM THER; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Furukawa Kiyoshi, 1992, Current Opinion in Biotechnology, V3, P554, DOI 10.1016/0958-1669(92)90085-W; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Garner B, 2001, GLYCOBIOLOGY, V11, P791, DOI 10.1093/glycob/11.10.791; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hatakeyama S, 2013, SCI WORLD J, DOI 10.1155/2013/268407; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Igl W, 2011, MOL BIOSYST, V7, P1852, DOI 10.1039/c0mb00095g; Jensen MK, 2014, NAT REV ENDOCRINOL, V10, P659, DOI 10.1038/nrendo.2014.155; Jiang K, 2014, J AGR FOOD CHEM, V62, P7245, DOI 10.1021/jf501352j; Kaprio T, 2015, MOL CELL PROTEOMICS, V14, P277, DOI 10.1074/mcp.M114.041632; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kelly Shawn C, 2014, S D Med, V67, P320; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Matthijsen RA, 2009, CIRCULATION, V119, P2188, DOI 10.1161/CIRCULATIONAHA.108.830661; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pabst M, 2011, PROTEOMICS, V11, P631, DOI 10.1002/pmic.201000517; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Qian YF, 2012, GLYCOCONJUGATE J, V29, P399, DOI 10.1007/s10719-012-9408-z; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Ruhaak LR, 2011, J PROTEOME RES, V10, P1667, DOI 10.1021/pr1009959; Ryden I, 2002, CLIN CHIM ACTA, V317, P221, DOI 10.1016/S0009-8981(01)00803-8; Sano M, 2012, GLYCOBIOLOGY, V22, P714, DOI 10.1093/glycob/cws010; Scott DW, 2012, ARTERIOSCL THROM VAS, V32, pE51, DOI 10.1161/ATVBAHA.112.253203; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Wang CJ, 2014, J PROTEOME RES, V13, P372, DOI 10.1021/pr4010647; Wang CJ, 2013, ANALYST, V138, P5344, DOI 10.1039/c3an00931a; Wang YL, 2014, HISTOL HISTOPATHOL, V29, P1593, DOI 10.14670/HH-29.1593	40	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0146982	10.1371/journal.pone.0146982	http://dx.doi.org/10.1371/journal.pone.0146982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999365	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700007
J	Baiocchini, A; Montaldo, C; Conigliaro, A; Grimaldi, A; Correani, V; Mura, F; Ciccosanti, F; Rotiroti, N; Brenna, A; Montalbano, M; D'Offizi, G; Capobianchi, MR; Alessandro, R; Piacentini, M; Schinina, ME; Maras, B; Del Nonno, F; Tripodi, M; Mancone, C				Baiocchini, Andrea; Montaldo, Claudia; Conigliaro, Alice; Grimaldi, Alessio; Correani, Virginia; Mura, Francesco; Ciccosanti, Fabiola; Rotiroti, Nicolina; Brenna, Alessia; Montalbano, Marzia; D'Offizi, Gianpiero; Capobianchi, Maria Rosaria; Alessandro, Riccardo; Piacentini, Mauro; Schinina, Maria Eugenia; Maras, Bruno; Del Nonno, Franca; Tripodi, Marco; Mancone, Carmine			Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution	PLOS ONE			English	Article							VI COLLAGEN; EXPRESSION; TISSUE; PROTEIN; MICE	Chronic liver damage leads to pathological accumulation of ECM proteins (liver fibrosis). Comprehensive characterization of the human ECM molecular composition is essential for gaining insights into the mechanisms of liver disease. To date, studies of ECM remodeling in human liver diseases have been hampered by the unavailability of purified ECM. Here, we developed a decellularization method to purify ECM scaffolds from human liver tissues. Histological and electron microscopy analyses demonstrated that the ECM scaffolds, devoid of plasma and cellular components, preserved the three-dimensional ECM structure and zonal distribution of ECM components. This method has been then applied on 57 liver biopsies of HCV-infected patients at different stages of liver fibrosis according to METAVIR classification. Label-free nLC-MS/MS proteomics and computation biology were performed to analyze the ECM molecular composition in liver fibrosis progression, thus unveiling protein expression signatures specific for the HCV-related liver fibrotic stages. In particular, the ECM molecular composition of liver fibrosis was found to involve dynamic changes in matrix stiffness, flexibility and density related to the dysregulation of predominant collagen, elastic fibers and minor components with both structural and signaling properties. This study contributes to the understanding of the molecular bases underlying ECM remodeling in liver fibrosis and suggests new molecular targets for fibrolytic strategies.	[Baiocchini, Andrea; Montaldo, Claudia; Grimaldi, Alessio; Ciccosanti, Fabiola; Rotiroti, Nicolina; Brenna, Alessia; Montalbano, Marzia; D'Offizi, Gianpiero; Capobianchi, Maria Rosaria; Piacentini, Mauro; Del Nonno, Franca; Tripodi, Marco; Mancone, Carmine] IRCCS, Natl Inst Infect Dis L Spallanzani, Via Portuense 292, I-00149 Rome, Italy; [Conigliaro, Alice; Tripodi, Marco; Mancone, Carmine] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Via Regina Elena 324, I-00161 Rome, Italy; [Conigliaro, Alice; Tripodi, Marco; Mancone, Carmine] Fdn Cenci Bolognetti, Ist Pasteur, Via Regina Elena 324, I-00161 Rome, Italy; [Correani, Virginia; Schinina, Maria Eugenia; Maras, Bruno] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ple Aldo Moro 5, I-00185 Rome, Italy; [Mura, Francesco] Univ Roma La Sapienza, Dipartimento Chim, Ple Aldo Moro 5, I-00185 Rome, Italy; [Alessandro, Riccardo] Univ Palermo, Dipartimento Biopatol & Biotecnol Med, Via Divisi 83, I-90133 Palermo, Italy; [Alessandro, Riccardo] Natl Res Council Italy, IBIM, Palermo, Italy; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	IRCCS Lazzaro Spallanzani; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Rome Tor Vergata	Tripodi, M; Mancone, C (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Via Portuense 292, I-00149 Rome, Italy.; Tripodi, M; Mancone, C (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Via Regina Elena 324, I-00161 Rome, Italy.; Tripodi, M; Mancone, C (corresponding author), Fdn Cenci Bolognetti, Ist Pasteur, Via Regina Elena 324, I-00161 Rome, Italy.	tripodi@bce.uniroma1.it; carmine.mancone@uniroma1.it	Mura, Francesco/AAD-5114-2020; Ciccosanti, Fabiola/B-5284-2017; Tripodi, Marco/ABO-1160-2022; Piacentini, Mauro/I-2411-2016; Conigliaro, Alice/L-5590-2019; Montaldo, Claudia/B-5055-2017; Tripodi, Marco/F-1143-2011; Conigliaro, Alice/J-8717-2016	Mura, Francesco/0000-0001-8490-9438; Ciccosanti, Fabiola/0000-0003-0481-6878; Tripodi, Marco/0000-0001-6135-971X; Piacentini, Mauro/0000-0003-2919-1296; Conigliaro, Alice/0000-0002-3037-835X; Montaldo, Claudia/0000-0001-6487-7176; Tripodi, Marco/0000-0001-6135-971X; Conigliaro, Alice/0000-0002-3037-835X; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Mancone, Carmine/0000-0002-9569-5030	MIUR Ministero dell'Universita e Ricerca Scientifica (FIRB) [RBFR12NSCF]; Ministero della Salute (Ricerca Corrente), Associazione Italiana per la Ricerca sul Cancro (AIRC); CNIS (Research Center for the Nanotechnology Applied to the Engineering of Sapienza University of Rome)	MIUR Ministero dell'Universita e Ricerca Scientifica (FIRB); Ministero della Salute (Ricerca Corrente), Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CNIS (Research Center for the Nanotechnology Applied to the Engineering of Sapienza University of Rome)	This work was supported by grants from MIUR Ministero dell'Universita e Ricerca Scientifica (FIRB 2012, codice progetto RBFR12NSCF), and Ministero della Salute (Ricerca Corrente), Associazione Italiana per la Ricerca sul Cancro (AIRC).; We are deeply grateful to Ms. Andrea Baker (INMI Rome, Italy) for the editing. We would like to thank Prof. Marco Rossi and CNIS (Research Center for the Nanotechnology Applied to the Engineering of Sapienza University of Rome) for their support.	Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bracht T, 2015, J PROTEOME RES, V14, P2278, DOI 10.1021/acs.jproteome.5b00053; Chen W, 2014, HUM PATHOL, V45, P160, DOI 10.1016/j.humpath.2013.08.015; Corchero J, 2004, INT J EXP PATHOL, V85, P295, DOI 10.1111/j.0959-9673.2004.00397.x; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Defamie V, 2015, ONCOGENE, V34, P4098, DOI 10.1038/onc.2014.339; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; GRIFFITHS MR, 1992, HISTOPATHOLOGY, V21, P335, DOI 10.1111/j.1365-2559.1992.tb00404.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kielty CM, 2002, J CELL SCI, V115, P2817; Kinnman N, 2000, SCAND J GASTROENTERO, V35, P1294, DOI 10.1080/003655200453656; Lorena D, 2004, LAB INVEST, V84, P203, DOI 10.1038/labinvest.3700023; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Montaldo C, 2014, PROTEOMICS, V14, P1107, DOI 10.1002/pmic.201300422; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Pellicoro A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S26; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193	27	125	128	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151736	10.1371/journal.pone.0151736	http://dx.doi.org/10.1371/journal.pone.0151736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998606	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700059
J	van Lummel, RC; Walgaard, S; Hobert, MA; Maetzler, W; van Dieen, JH; Galindo-Garre, F; Terwee, CB				van Lummel, Rob C.; Walgaard, Stefan; Hobert, Markus A.; Maetzler, Walter; van Dieen, Jaap H.; Galindo-Garre, Francisca; Terwee, Caroline B.			Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease	PLOS ONE			English	Article							FUNCTIONAL REACH; STAND; PERFORMANCE; VALIDITY; BALANCE; PEOPLE	Background The "Timed Up and Go" (TUG) is a widely used measure of physical functioning in older people and in neurological populations, including Parkinson's Disease. When using an inertial sensor measurement system (instrumented TUG [iTUG]), the individual components of the iTUG and the trunk kinematics can be measured separately, which may provide relevant additional information. Objective The aim of this study was to determine intra-rater, inter-rater and test-retest reliability of the iTUG in patients with Parkinson's Disease. Methods Twenty eight PD patients, aged 50 years or older, were included. For the iTUG the DynaPort Hybrid (McRoberts, The Hague, The Netherlands) was worn at the lower back. The device measured acceleration and angular velocity in three directions at a rate of 100 samples/s. Patients performed the iTUG five times on two consecutive days. Repeated measurements by the same rater on the same day were used to calculate intra-rater reliability. Repeated measurements by different raters on the same day were used to calculate intra-rater and inter-rater reliability. Repeated measurements by the same rater on different days were used to calculate test-retest reliability. Results Nineteen ICC values (15%) were >= 0.9 which is considered as excellent reliability. Sixty four ICC values (49%) were >= 0.70 and <0.90 which is considered as good reliability. Thirty one ICC values (24%) were >= 0.50 and < 0.70, indicating moderate reliability. Sixteen ICC values (12%) were >= 0.30 and < 0.50 indicating poor reliability. Two ICT values (2%) were < 0.30 indicating very poor reliability. Conclusions In conclusion, in patients with Parkinson's disease the intra-rater, inter-rater, and test-retest reliability of the individual components of the instrumented TUG (iTUG) was excellent to good for total duration and for turning durations, and good to low for the sub durations and for the kinematics of the SiSt and StSi. The results of this fully automated analysis of instrumented TUG movements demonstrate that several reliable TUG parameters can be identified that provide a basis for a more precise, quantitative use of the TUG test, in clinical practice.	[van Lummel, Rob C.; Walgaard, Stefan] McRoberts BV, The Hague, Netherlands; [van Lummel, Rob C.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Hobert, Markus A.; Maetzler, Walter] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Hobert, Markus A.; Maetzler, Walter] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Hobert, Markus A.; Maetzler, Walter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Galindo-Garre, Francisca; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Galindo-Garre, Francisca; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Lummel, RC (corresponding author), McRoberts BV, The Hague, Netherlands.; van Lummel, RC (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.vanlummel@mcroberts.nl	van Dieen, Jaap/B-3937-2013; Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020	van Dieen, Jaap/0000-0002-7719-5585; Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Terwee, Caroline/0000-0003-4570-2826				Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Botolfsen P, 2008, PHYSIOTHER RES INT, V13, P94, DOI 10.1002/pri.394; Brusse KJ, 2005, PHYS THER, V85, P134, DOI 10.1093/ptj/85.2.134; Buchman AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086262; de Vet HCW, 2011, MEASUREMENT MED PRAC; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Herman T, 2014, EXP BRAIN RES, V232, P713, DOI 10.1007/s00221-013-3778-8; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Martinez-Martin P, 1997, CLIN NEUROPHARMACOL, P13; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Mirelman A, 2014, J AM GERIATR SOC, V62, P673, DOI 10.1111/jgs.12734; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; O'Suilleabhain P, 2001, J NEUROL NEUROSUR PS, V71, P607, DOI 10.1136/jnnp.71.5.607; Podsiadlo D, J AM GERIATR, P142; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rispens SM, 2014, GAIT POSTURE, V40, P187, DOI 10.1016/j.gaitpost.2014.03.182; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schoppen T, 1999, ARCH PHYS MED REHAB, V80, P825, DOI 10.1016/S0003-9993(99)90234-4; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; van Lummel RC, 2012, PHYSIOL MEAS, V33, P1855, DOI 10.1088/0967-3334/33/11/1855; Weiss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068885; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Williamson R, 2001, MED BIOL ENG COMPUT, V39, P294, DOI 10.1007/BF02345283; Yeung TSM, 2008, J ORTHOP SPORT PHYS, V38, P410, DOI [10.2519/jospt.2008.2657, 10.519/jospt.2008.2657]; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	28	42	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151881	10.1371/journal.pone.0151881	http://dx.doi.org/10.1371/journal.pone.0151881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999051	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700079
J	Andersen, LE; Doyle, AS; del Granado, S; Ledezma, JC; Medinaceli, A; Valdivia, M; Weinhold, D				Andersen, Lykke E.; Doyle, Anna Sophia; del Granado, Susana; Ledezma, Juan Carlos; Medinaceli, Agnes; Valdivia, Montserrat; Weinhold, Diana			Net Carbon Emissions from Deforestation in Bolivia during 1990-2000 and 2000-2010: Results from a Carbon Bookkeeping Model	PLOS ONE			English	Article							LAND-USE CHANGE; ORGANIC-CARBON; SOIL; SEQUESTRATION; EROSION; CO2	Accurate estimates of global carbon emissions are critical for understanding global warming. This paper estimates net carbon emissions from land use change in Bolivia during the periods 1990-2000 and 2000-2010 using a model that takes into account deforestation, forest degradation, forest regrowth, gradual carbon decomposition and accumulation, as well as heterogeneity in both above ground and below ground carbon contents at the 10 by 10 km grid level. The approach permits detailed maps of net emissions by region and type of land cover. We estimate that net CO2 emissions from land use change in Bolivia increased from about 65 million tons per year during 1990-2000 to about 93 million tons per year during 2000-2010, while CO2 emissions per capita and per unit of GDP have remained fairly stable over the sample period. If we allow for estimated biomass increases in mature forests, net CO2 emissions drop to close to zero. Finally, we find these results are robust to alternative methods of calculating emissions.	[Andersen, Lykke E.; Doyle, Anna Sophia; del Granado, Susana; Medinaceli, Agnes; Valdivia, Montserrat] Inst Adv Dev Studies INESAD, CEEMA, La Paz, Bolivia; [Andersen, Lykke E.] Univ Privada Boliviana, La Paz, Bolivia; [Ledezma, Juan Carlos] Conservat Int Bolivia, La Paz, Bolivia; [Weinhold, Diana] Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England	University of London; London School Economics & Political Science	Andersen, LE (corresponding author), Inst Adv Dev Studies INESAD, CEEMA, La Paz, Bolivia.; Andersen, LE (corresponding author), Univ Privada Boliviana, La Paz, Bolivia.	landersen@inesad.edu.bo		Weinhold, Diana/0000-0002-0002-9378	Danida [104.Bolivia.813-203.LPB]; International Development Research Centre through Think Tank Initiative grant [107871-001]	Danida; International Development Research Centre through Think Tank Initiative grant	Some of the authors are benefiting from core funds given to INESAD by Danida (grant no. 104.Bolivia.813-203.LPB) and the International Development Research Centre through Think Tank Initiative grant no. 107871-001. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; ANDERSEN L.E., 2002, DYNAMICS DEFORESTATI; Araujo C, 2009, ECOL ECON, V68, P2461, DOI 10.1016/j.ecolecon.2008.12.015; Asosiacion de productores de oleaginosas y trigo, 2010, AS PROD OL TRIG MEM; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Berhe A, 2005, SOIL DEGRADATION SOI; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Food and Agriculture Organization of the United Nations, 2010, 163 UN FAO; Food and Agriculture Organization of the United Nations International Institute for Applied Systems Analysis International Soil Reference and Information Centre Institute of Soil Science-Chinese Academy of Sciences Joint Research Centre of the European Commission, 2013, HARM WORLD DAT VERS; Gardi C., 2015, SOIL ATLAS LATIN AM; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton RA, 2010, TELLUS B, V62, P337, DOI 10.1111/j.1600-0889.2010.00473.x; Houghton R. A., 2001, ORNLCDIAC131 US DEP, DOI [10.3334/CDIAC/lue.ndp050,2001, DOI 10.3334/CDIAC/LUE.NDP050]; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; HOUGHTON RA, 1983, ECOL MONOGR, V53, P235, DOI 10.2307/1942531; Ibarnegaray V., 2014, COMMUNITY BASED FIRE; Ibisch Pierre, 2003, BIODIVERSIDAD RIQUEZ; IPCC, 2006, IPCC GUID NAT GREENH, P83; Killeen TJ, 2008, ECOL SOC, V13; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Loarie SR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037526; Ministerio de Medio Ambiente y Agua Sala de Observacion Bolivia de la Organizacion del Tratado de Cooperacion Amazonica, 2015, MEM TECN MAP BOSQ 20; Oskarsson H, 2004, CATENA, V56, P225, DOI 10.1016/j.catena.2003.10.013; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Rada OP, 2009, 2 COMUNICACION NACL; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Reis E, 2000, CARBON EMISSIONS DEF, V02; Schlesinger W.H., 1986, CHANGES SOIL CARBON, P194, DOI DOI 10.1007/978-1-4757-1915-4_11; Schlesinger W.H., 1995, BIOTIC FEEDBACKS GLO, V1st, P159; Servicio Nacional de Areas Protegidas, 2013, DEF REG BOSQ BOL SUS; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Song XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126754; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; UNEP, 2013, EM GAP REP 2013 UNEP; Wang X., 2014, PLOS ONE, V9, DOI [DOI 10.1371/journal.pone.0096299, 10.1371/journal.pone.0096299]; Weinhold D, 2015, GLOBAL ENVIRON CHANG, V35, P391, DOI 10.1016/j.gloenvcha.2015.09.013	43	6	9	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151241	10.1371/journal.pone.0151241	http://dx.doi.org/10.1371/journal.pone.0151241			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990865	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000372582800050
J	Bostrom, JE; Dimitrova, M; Canton, C; Hastad, O; Qvarnstrom, A; Odeen, A				Bostrom, Jannika E.; Dimitrova, Marina; Canton, Cindy; Hastad, Olle; Qvarnstrom, Anna; Odeen, Anders			Ultra-Rapid Vision in Birds	PLOS ONE			English	Article							FLICKER FUSION FREQUENCY; GALLUS-GALLUS-DOMESTICUS; CLUTCH-SIZE; INFORMATION; THRESHOLDS; INCUBATION; ACUITY; COSTS	Flying animals need to accurately detect, identify and track fast-moving objects and these behavioral requirements are likely to strongly select for abilities to resolve visual detail in time. However, evidence of highly elevated temporal acuity relative to non-flying animals has so far been confined to insects while it has been missing in birds. With behavioral experiments on three wild passerine species, blue tits, collared and pied flycatchers, we demonstrate temporal acuities of vision far exceeding predictions based on the sizes and metabolic rates of these birds. This implies a history of strong natural selection on temporal resolution. These birds can resolve alternating light-dark cycles at up to 145 Hz (average: 129, 127 and 137, respectively), which is ca. 50 Hz over the highest frequency shown in any other vertebrate. We argue that rapid vision should confer a selective advantage in many bird species that are ecologically similar to the three species examined in our study. Thus, rapid vision may be a more typical avian trait than the famously sharp vision found in birds of prey.	[Bostrom, Jannika E.; Dimitrova, Marina; Canton, Cindy; Qvarnstrom, Anna; Odeen, Anders] Uppsala Univ, Dept Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden; [Dimitrova, Marina] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Hastad, Olle; Odeen, Anders] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Box 7011, S-75007 Uppsala, Sweden	Uppsala University; Stockholm University; Swedish University of Agricultural Sciences	Odeen, A (corresponding author), Uppsala Univ, Dept Anim Ecol, Norbyvagen 18D, S-75236 Uppsala, Sweden.; Odeen, A (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Box 7011, S-75007 Uppsala, Sweden.	anders.odeen@ebc.uu.se	Håstad, Olle E/H-6235-2017	Håstad, Olle E/0000-0001-9280-3051	Carl Trygger's Foundation [CTS 09: 425, CTS10: 432]; Swedish Research Council Formas [22-2007-729]; Swedish Research Council [621-2012-3722]	Carl Trygger's Foundation; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support was provided by Carl Trygger's Foundation (grant numbers CTS 09: 425 and CTS10: 432, to AO; URL: http://www.carltryggersstiftelse.se), The Swedish Research Council Formas (grant number 22-2007-729, to AO; URL: http://www.formas.se) and The Swedish Research Council (grant number 621-2012-3722, to AQ; URL: http://www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTRUM H., 1952, BIOL ZENTRALBL, V71, P129; Bouma PJ, 1941, PHILIPS TECHNISCHE R, V6, P299; DODT E, 1953, ACTA PHYSIOL SCAND, V30, P80; Evans JE, 2006, ANIM BEHAV, V72, P393, DOI 10.1016/j.anbehav.2005.10.031; GINSBURG N, 1971, J EXP ANAL BEHAV, V15, P189, DOI 10.1901/jeab.1971.15-189; Greenwood VJ, 2004, APPL ANIM BEHAV SCI, V86, P145, DOI 10.1016/j.applanim.2003.11.008; Healy K, 2013, ANIM BEHAV, V86, P685, DOI 10.1016/j.anbehav.2013.06.018; HENDRICKS J, 1966, J EXP ANAL BEHAV, V9, P501, DOI 10.1901/jeab.1966.9-501; Inger R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098631; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Lind O, 2012, J COMP PHYSIOL A, V198, P69, DOI 10.1007/s00359-011-0689-7; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; Martin GR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0040; Meyer D.B., 1977, VISUAL SYSTEM VERTEB, V5, P550; MORENO J, 1989, ORNIS SCAND, V20, P123, DOI 10.2307/3676879; MORENO J, 1991, IBIS, V133, P186, DOI 10.1111/j.1474-919X.1991.tb04830.x; NUBOER JFW, 1992, BRIT POULTRY SCI, V33, P123, DOI 10.1080/00071669208417449; Purves D., 2001, NEUROSCIENCE; Qvarnstrom A, 2009, ECOLOGY, V90, P1948, DOI 10.1890/08-0494.1; REYMOND L, 1985, VISION RES, V25, P1477, DOI 10.1016/0042-6989(85)90226-3; SHUMAKE SA, 1968, PSYCHOL REC, V18, P537, DOI 10.1007/BF03393804; SRINIVASAN MV, 1984, J COMP PHYSIOL, V155, P297, DOI 10.1007/BF00610583; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4	26	33	33	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151099	10.1371/journal.pone.0151099	http://dx.doi.org/10.1371/journal.pone.0151099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990087	Green Submitted, gold, Green Published			2022-12-27	WOS:000372582800043
J	Li, WJ; Wang, CC; Shi, ZJ; Wei, Y; Zhou, HL; Deng, K				Li, Wenjie; Wang, Changcheng; Shi, Zejin; Wei, Yi; Zhou, Huailai; Deng, Kun			The Description of Shale Reservoir Pore Structure Based on Method of Moments Estimation	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; GAS-RESERVOIR; SIZE DISTRIBUTION; SICHUAN BASIN; SURFACE-AREA; BARNETT; ADSORPTION; USANS/SANS; MICROSCOPY; MUDROCKS	Shale has been considered as good gas reservoir due to its abundant interior nanoscale pores. Thus, the study of the pore structure of shale is of great significance for the evaluation and development of shale oil and gas. To date, the most widely used approaches for studying the shale pore structure include image analysis, radiation and fluid invasion methods. The detailed pore structures can be studied intuitively by image analysis and radiation methods, but the results obtained are quite sensitive to sample preparation, equipment performance and experimental operation. In contrast, the fluid invasion method can be used to obtain information on pore size distribution and pore structure, but the relative simple parameters derived cannot be used to evaluate the pore structure of shale comprehensively and quantitatively. To characterize the nanoscale pore structure of shale reservoir more effectively and expand the current research techniques, we proposed a new method based on gas adsorption experimental data and the method of moments to describe the pore structure parameters of shale reservoir. Combined with the geological mixture empirical distribution and the method of moments estimation principle, the new method calculates the characteristic parameters of shale, including the mean pore size ((x) over tilde), standard deviation (sigma), skewness (S-k) and variation coefficient (c). These values are found by reconstructing the grouping intervals of observation values and optimizing algorithms for eigenvalues. This approach assures a more effective description of the characteristics of nanoscale pore structures. Finally, the new method has been applied to analyze the Yanchang shale in the Ordos Basin (China) and Longmaxi shale from the Sichuan Basin (China). The results obtained well reveal the pore characteristics of shale, indicating the feasibility of this new method in the study of the pore structure of shale reservoir.	[Li, Wenjie; Wang, Changcheng; Shi, Zejin; Deng, Kun] Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China; [Wang, Changcheng; Shi, Zejin; Zhou, Huailai; Deng, Kun] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Wei, Yi] Daqing Oil Field Co, Res Inst Explorat & Dev, Daqing, Peoples R China; [Zhou, Huailai] Chengdu Univ Technol, Coll Geophys, Chengdu, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; Chengdu University of Technology	Wang, CC (corresponding author), Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China.; Wang, CC (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	wcc-126@163.com		Li, Wenjie/0000-0001-6463-4131	National Natural Science Foundation of China [41272129, 41204091]; Daqing Oil Field Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Daqing Oil Field Company	This study supports from the National Natural Science Foundation of China (Grant Numbers 41272129 and 41204091) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Daqing Oil Field Company provided support in the form of a salary for author YW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al Hinai A, 2014, J UNCONV OIL GAS RES, V8, P1, DOI 10.1016/j.juogr.2014.06.002; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Chalmers GR, 2012, AAPG BULL, V96, P1099, DOI 10.1306/10171111052; Chalmers GRL, 2007, INT J COAL GEOL, V70, P223, DOI 10.1016/j.coal.2006.05.001; [陈尚斌 Chen Shangbin], 2012, [煤炭学报, Journal of China Coal Society], V37, P438; China National Petroleum Corporation, 1996, 61541995 SYT CHIN NA; Clarkson CR, 2013, FUEL, V103, P606, DOI 10.1016/j.fuel.2012.06.119; [耳闯 Er Chuang], 2013, [石油与天然气地质, Oil & Gas Geology], V34, P708; EVANS R, 1984, PHYS REV LETT, V52, P557, DOI 10.1103/PhysRevLett.52.557; General Administration of Quality Aupervision Inspection and Quarantine of the People's Republic of China Standardization Administration of the People's Republic of China, 2008, 20082165022008 GBT G; Gregg SJ, 1982, ADSORPTION SURFACE A; Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1; HORVATH G, 1983, J CHEM ENG JPN, V16, P470, DOI 10.1252/jcej.16.470; Javadpour F, 2012, J CAN PETROL TECHNOL, V51, P236, DOI 10.2118/161015-PA; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; Kuila U, 2013, GEOPHYS PROSPECT, V61, P341, DOI 10.1111/1365-2478.12028; Li GN, 2001, PETROL GEOL, V22, P324; Liu SG, 2011, ACTA PETROL SIN, V27, P2239; Liu WQ, 2014, SCI TECH ENG, V14, P11; Loucks RG, 2012, AAPG BULL, V96, P1071, DOI 10.1306/08171111061; Loucks RG, 2009, J SEDIMENT RES, V79, P848, DOI 10.2110/jsr.2009.092; [罗超 Luo Chao], 2014, [地质科技情报, Geological Science and Techology Information], V33, P93; Luo Z.T., 1986, PORE STRUCTURE RESER; Musa Muhammad Afiq Aizuddin, 2011, Journal of Applied Sciences, V11, P3650, DOI 10.3923/jas.2011.3650.3654; Neimark AV, 2009, CARBON, V47, P1617, DOI 10.1016/j.carbon.2009.01.050; Quantachrome, 2009, QUADRASORB SI QUADR; Ravikovitch PI, 2006, LANGMUIR, V22, P11171, DOI 10.1021/la0616146; Ross DJK, 2009, MAR PETROL GEOL, V26, P916, DOI 10.1016/j.marpetgeo.2008.06.004; Ruppert LF, 2013, ENERG FUEL, V27, P772, DOI 10.1021/ef301859s; Seiichi Kondo, 2005, ADSORPTION SCI; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Slatt RM, 2011, AAPG BULL, V95, P2017, DOI 10.1306/03301110145; Sondergeld CH, 2010, UNC GAS C 23 25 FEB; Tiwari P, 2013, FUEL, V107, P547, DOI 10.1016/j.fuel.2013.01.006; [王长城 Wang Changcheng], 2003, [成都理工大学学报. 自然科学版, Journal of Chengdu University of Technology.Science & Technonogy Edition], V30, P280; [王香增 Wang Xiangzeng], 2014, [石油勘探与开发, Petroleum Exploration and Development], V41, P294; [杨峰 Yang Feng], 2014, [天然气地球科学, Natural Gas Geoscience], V25, P618; Yang F, 2014, FUEL, V115, P378, DOI 10.1016/j.fuel.2013.07.040; [杨峰 Yang Feng], 2013, [石油学报, Acta Petrolei Sinica], V34, P301; [杨侃 Yang Kan], 2013, [煤炭学报, Journal of China Coal Society], V38, P817; Zeng Qiu-nan, 2013, Special Oil & Gas Reservoirs, V20, P23, DOI 10.3969/j.issn.1006-6535.2013.01.006; [曾维特 Zeng Weite], 2014, [煤炭学报, Journal of China Coal Society], V39, P1118; [钟太贤 Zhong Taixian], 2012, [天然气工业, Natural Gas Industry], V32, P1; [朱如凯 Zhu Rukai], 2013, [古地理学报, Journal of Palaeogeography], V15, P615; Zou C, 2013, UNCONVENTIONAL PETROLEUM GEOLOGY, P1; Zou CN, 2011, ACTA PETROL SIN, V27, P1857	46	8	8	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151631	10.1371/journal.pone.0151631	http://dx.doi.org/10.1371/journal.pone.0151631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992168	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800081
J	Lin, XB; Hou, LJ; Liu, M; Li, XF; Yin, GY; Zheng, YL; Deng, FY				Lin, Xianbiao; Hou, Lijun; Liu, Min; Li, Xiaofei; Yin, Guoyu; Zheng, Yanling; Deng, Fengyu			Gross Nitrogen Mineralization in Surface Sediments of the Yangtze Estuary	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MICROBIAL BIOMASS; WATER INTERFACE; INTERTIDAL SEDIMENTS; N MINERALIZATION; SOIL-NITROGEN; RIVER ESTUARY; EAST CHINA; NITRIFICATION RATES; SEASONAL-VARIATION	Nitrogen mineralization is a key biogeochemical process transforming organic nitrogen to inorganic nitrogen in estuarine and coastal sediments. Although sedimentary nitrogen mineralization is an important internal driver for aquatic eutrophication, few studies have investigated sedimentary nitrogen mineralization in these environments. Sediment-slurry incubation experiments combined with N-15 isotope dilution technique were conducted to quantify the potential rates of nitrogen mineralization in surface sediments of the Yangtze Estuary. The gross nitrogen mineralization (GNM) rates ranged from 0.02 to 5.13 mg N kg(-1) d(-1) in surface sediments of the study area. The GNM rates were generally higher in summer than in winter, and the relative high rates were detected mainly at sites near the north branch and frontal edge of this estuary. The spatial and temporal distributions of GNM rates were observed to depend largely on temperature, salinity, sedimentary organic carbon and nitrogen contents, and extracellular enzyme (urease and L-glutaminase) activities. The total mineralized nitrogen in the sediments of the Yangtze Estuary was estimated to be about 6.17 x 10(5) t N yr(-1), and approximately 37% of it was retained in the estuary. Assuming the retained mineralized nitrogen is totally released from the sediments into the water column, which contributed 12-15% of total dissolved inorganic nitrogen (DIN) sources in this study area. This result indicated that the mineralization process is a significant internal nitrogen source for the overlying water of the Yangtze Estuary, and thus may contribute to the estuarine and coastal eutrophication.	[Lin, Xianbiao; Liu, Min; Li, Xiaofei; Yin, Guoyu; Zheng, Yanling] E China Normal Univ, Coll Geog Sci, Shanghai 200241, Peoples R China; [Hou, Lijun; Deng, Fengyu] E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Liu, M (corresponding author), E China Normal Univ, Coll Geog Sci, Shanghai 200241, Peoples R China.; Hou, LJ (corresponding author), E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China.	ljhou@sklec.ecnu.edu.cn; mliu@geo.ecnu.edu.cn	Li, xiaofei/GXF-7187-2022; Yin, Guoyu/H-3393-2016	Yin, Guoyu/0000-0002-8949-3731; xianbiao, lin/0000-0003-4549-158X	National Natural Science Foundation [41322002, 41371451, 41130525, 41271114, 41071135]; Program for New Century Excellent Talents in University (NCET); State Key Laboratory of Estuarine and Coastal Research	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Estuarine and Coastal Research	This work was together funded by the National Natural Science Foundation (Nos. 41322002, 41371451, 41130525, 41271114 and 41071135), the Program for New Century Excellent Talents in University (NCET), and the State Key Laboratory of Estuarine and Coastal Research.; This work was together funded by the National Natural Science Foundation (Nos. 41322002, 41371451, 41130525, 41271114 and 41071135), the Program for New Century Excellent Talents in University (NCET), and the State Key Laboratory of Estuarine and Coastal Research. We also thank Wayne S. Gardner and the anonymous reviewers for their constructive suggestions on a preliminary draft of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bai JH, 2012, CLEAN-SOIL AIR WATER, V40, P1099, DOI 10.1002/clen.201200055; Bedard-Haughn A, 2013, NUTR CYCL AGROECOSYS, V95, P159, DOI 10.1007/s10705-013-9555-z; Benbi DK, 2002, BIOL FERT SOILS, V35, P168, DOI 10.1007/s00374-002-0456-6; Bengtsson G, 2003, SOIL BIOL BIOCHEM, V35, P143, DOI 10.1016/S0038-0717(02)00248-1; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; Cabrita MT, 2000, MAR ECOL PROG SER, V202, P51, DOI 10.3354/meps202051; Cabrita MT, 1997, INORGANIC NITROGEN D; Chai C, 2006, HYDROBIOLOGIA, V563, P313, DOI 10.1007/s10750-006-0021-7; Chen YT, 2012, WETLANDS, V32, P579, DOI 10.1007/s13157-012-0295-7; Cloern James E., 1999, Aquatic Ecology, V33, P3, DOI 10.1023/A:1009952125558; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Dai ZJ, 2011, ENVIRON SCI TECHNOL, V45, P223, DOI 10.1021/es103026a; Deng FY, 2015, J GEOPHYS RES-BIOGEO, V120, P1521, DOI 10.1002/2015JG003007; Denis L, 2001, OCEANOL ACTA, V24, P85, DOI 10.1016/S0399-1784(00)01130-0; Di HJ, 2000, AUST J SOIL RES, V38, P213, DOI 10.1071/SR99005; Dunn RJK, 2012, ESTUAR COAST SHELF S, V113, P272, DOI 10.1016/j.ecss.2012.08.016; FRANKENBERGER WT, 1991, BIOL FERT SOILS, V11, P1, DOI 10.1007/BF00335825; Franzluebbers AJ, 2001, SOIL BIOL BIOCHEM, V33, P1103, DOI 10.1016/S0038-0717(01)00016-5; Gao HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095011; Grenz C, 2010, MAR POLLUT BULL, V61, P399, DOI 10.1016/j.marpolbul.2010.06.014; Hou LJ, 2011, APPL GEOCHEM, V26, P2260, DOI 10.1016/j.apgeochem.2011.08.008; Hou LJ, 2013, J GEOPHYS RES-BIOGEO, V118, P1237, DOI 10.1002/jgrg.20108; Hou LJ, 2012, CONT SHELF RES, V35, P86, DOI 10.1016/j.csr.2012.01.004; Howarth RW, 2008, HARMFUL ALGAE, V8, P14, DOI 10.1016/j.hal.2008.08.015; Huang Q, 2006, REG ENVIRON CHANGE, V6, P125, DOI 10.1007/s10113-005-0001-x; Huygens D, 2013, SSSA BOOK S, V10, P553, DOI 10.2136/sssabookser10.c30; Jin XB, 2012, BIOL FERT SOILS, V48, P363, DOI 10.1007/s00374-011-0631-8; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Keuskamp JA, 2013, SOIL BIOL BIOCHEM, V57, P822, DOI 10.1016/j.soilbio.2012.08.007; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Kirkham D., 1954, SOIL SCI SOC AM P, V18, P33, DOI DOI 10.2136/SSSAJ1954.03615995001800010009X; Kristensen E, 2000, AQUAT MICROB ECOL, V22, P199, DOI 10.3354/ame022199; Li XA, 2010, STUDIES NUTR BUDGETS, P61; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Li XA, 2011, CHIN J OCEANOL LIMN, V29, P762, DOI 10.1007/s00343-011-0505-9; Liu H, 2010, ESTUAR COAST SHELF S, V86, P322, DOI 10.1016/j.ecss.2009.04.020; Liu M, 2006, MAR POLLUT BULL, V52, P1625, DOI 10.1016/j.marpolbul.2006.06.008; Liu SM, 2005, PROG OCEANOGR, V66, P66, DOI 10.1016/j.pocean.2005.03.009; Matheson FE, 2003, BIOL FERT SOILS, V38, P129, DOI 10.1007/s00374-003-0640-3; McCarthy MJ, 2008, ESTUAR COAST, V31, P521, DOI 10.1007/s12237-008-9041-z; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Mishra S, 2005, BIOL FERT SOILS, V42, P45, DOI 10.1007/s00374-005-0863-6; Muruganandam S, 2009, SOIL SCI SOC AM J, V73, P751, DOI 10.2136/sssaj2008.0231; Noe GB, 2013, BIOGEOCHEMISTRY, V114, P225, DOI 10.1007/s10533-012-9805-1; Pratihary AK, 2009, ESTUAR COAST SHELF S, V85, P387, DOI 10.1016/j.ecss.2009.08.012; Regehr A, 2015, PLANT SOIL, V391, P353, DOI 10.1007/s11104-015-2438-0; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roberts KL, 2012, LIMNOL OCEANOGR, V57, P1427, DOI 10.4319/lo.2012.57.5.1427; Schutt M, 2014, SOIL BIOL BIOCHEM, V69, P320, DOI 10.1016/j.soilbio.2013.11.014; de B MIS, 2015, MAR POLLUT BULL, V91, P483, DOI 10.1016/j.marpolbul.2014.10.028; Silva RG, 2005, NUTR CYCL AGROECOSYS, V71, P259, DOI 10.1007/s10705-004-6378-y; Sinsabaugh RL, 2000, SOIL BIOL BIOCHEM, V32, P2095, DOI 10.1016/S0038-0717(00)00102-4; Xu H, 2013, ESTUAR COAST SHELF S, V127, P59, DOI 10.1016/j.ecss.2013.04.020; Xu ZH, 2008, J SOIL SEDIMENT, V8, P99, DOI 10.1065/jss2008.02.276; Yao P, 2014, CONT SHELF RES, V91, P1, DOI 10.1016/j.csr.2014.08.010; Yin GY, 2014, ENVIRON SCI TECHNOL, V48, P9555, DOI 10.1021/es501261s; Zaman M, 2004, BIOL FERT SOILS, V39, P269, DOI 10.1007/s00374-003-0716-0; Zaman M, 1999, SOIL USE MANAGE, V15, P188, DOI 10.1111/j.1475-2743.1999.tb00087.x; Zaman M, 1999, BIOL FERT SOILS, V29, P178, DOI 10.1007/s003740050542; Zhang J, 2007, PROG OCEANOGR, V74, P449, DOI 10.1016/j.pocean.2007.04.019; Zhang JB, 2012, EUR J SOIL SCI, V63, P75, DOI 10.1111/j.1365-2389.2011.01410.x; Zhang L, 2014, J EARTH SCI-CHINA, V25, P197, DOI 10.1007/s12583-014-0413-y; Zhao Y, 2015, ENVIRON SCI POLLUT R, V22, P17975, DOI 10.1007/s11356-015-4873-0; Zheng YL, 2014, APPL ENVIRON MICROB, V80, P408, DOI 10.1128/AEM.03035-13; Zheng YL, 2013, APPL MICROBIOL BIOT, V97, P8351, DOI 10.1007/s00253-012-4512-3; Zhu C, 2011, ESTUAR COAST SHELF S, V93, P182, DOI 10.1016/j.ecss.2010.08.001; Zhu H.F., 1988, PROCESS DYNAMICS GEO, P166; Zhu TB, 2013, BIOL FERT SOILS, V49, P323, DOI 10.1007/s00374-012-0725-y	70	31	34	10	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151930	10.1371/journal.pone.0151930	http://dx.doi.org/10.1371/journal.pone.0151930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991904	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800118
J	Sanchez, LM; Cheng, AT; Warner, CJA; Townsley, L; Peach, KC; Navarro, G; Shikuma, NJ; Bray, WM; Riener, RM; Yildiz, FH; Linington, RG				Sanchez, Laura M.; Cheng, Andrew T.; Warner, Christopher J. A.; Townsley, Loni; Peach, Kelly C.; Navarro, Gabriel; Shikuma, Nicholas J.; Bray, Walter M.; Riener, Romina M.; Yildiz, Fitnat H.; Linington, Roger G.			Biofilm Formation and Detachment in Gram-Negative Pathogens Is Modulated by Select Bile Acids	PLOS ONE			English	Article							CYCLIC DI-GMP; O1 EL-TOR; VIBRIO-CHOLERAE; BACTERIAL BIOFILMS; RESISTANCE; VIRULENCE; ANGUILLARUM; SALTS; TOXR; IDENTIFICATION	Biofilms are a ubiquitous feature of microbial community structure in both natural and host environments; they enhance transmission and infectivity of pathogens and provide protection from human defense mechanisms and antibiotics. However, few natural products are known that impact biofilm formation or persistence for either environmental or pathogenic bacteria. Using the combination of a novel natural products library from the fish microbiome and an image-based screen for biofilm inhibition, we describe the identification of taurine-conjugated bile acids as inhibitors of biofilm formation against both Vibrio cholerae and Pseudomonas aeruginosa. Taurocholic acid (1) was isolated from the fermentation broth of the fish microbiome-derived strain of Rhodococcus erythropolis and identified using standard NMR and MS methods. Screening of the twelve predominant human steroidal bile acid components revealed that a subset of these compounds can inhibit biofilm formation, induce detachment of preformed biofilms under static conditions, and that these compounds display distinct structure-activity relationships against V. cholerae and P. aeruginosa. Our findings highlight the significance of distinct bile acid components in the regulation of biofilm formation and dispersion in two different clinically relevant bacterial pathogens, and suggest that the bile acids, which are endogenous mammalian metabolites used to solubilize dietary fats, may also play a role in maintaining host health against bacterial infection.	[Sanchez, Laura M.; Warner, Christopher J. A.; Peach, Kelly C.; Navarro, Gabriel; Riener, Romina M.; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Cheng, Andrew T.; Townsley, Loni; Shikuma, Nicholas J.; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Bray, Walter M.] Univ Calif Santa Cruz, Chem Screening Ctr, Santa Cruz, CA 95064 USA; [Linington, Roger G.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Simon Fraser University	Linington, RG (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.; Linington, RG (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	rliningt@sfu.ca	Sanchez, Laura/AAT-8338-2020; Linington, Roger/ABD-5582-2021; Townsley, Loni/L-9098-2016	Sanchez, Laura/0000-0001-9223-7977; Linington, Roger/0000-0003-1818-4971; Townsley, Loni/0000-0003-2940-2962; Shikuma, Nicholas/0000-0001-5518-5020	NIH [1R21AI098836-01, 2R25GM05803-12]; NSF Graduate Research Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098836] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 1R21AI098836-01 (RGL and FHY) and NIH grant for Undergraduate Research 2R25GM05803-12 (RMR). LMS and GN were supported by NSF Graduate Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adal KA, 1996, NUTRITION, V12, P208, DOI 10.1016/S0899-9007(96)91126-0; Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; Ambalam P, 2014, APPL BIOCHEM BIOTECH, V172, P1970, DOI 10.1007/s12010-013-0596-1; Amund OD, 2014, BENEF MICROBES, V5, P461, DOI 10.3920/BM2013.0099; Ante VM, 2015, J BACTERIOL, V197, P3499, DOI 10.1128/JB.00419-15; Begley M, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-11; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Cerda-Maira FA, 2013, J BACTERIOL, V195, P307, DOI 10.1128/JB.02008-12; Chen C, 2012, ANTON LEEUW INT J G, V101, P281, DOI 10.1007/s10482-011-9632-8; Chen KM, 2014, MICROB PATHOGENESIS, V77, P89, DOI 10.1016/j.micpath.2014.11.005; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; Crawford RW, 2008, INFECT IMMUN, V76, P5341, DOI 10.1128/IAI.00786-08; Dale JL, 2015, ANTIMICROB AGENTS CH, V59, P4094, DOI 10.1128/AAC.00344-15; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Di Pietro A, 2004, Ann Ig, V16, P615; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Girard V, 2010, J BIOL CHEM, V285, P10616, DOI 10.1074/jbc.M109.069070; Gowda GAN, 2006, LIPIDS, V41, P591, DOI 10.1007/s11745-006-5008-7; Hagey LR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P308, DOI 10.1086/649966; Hay AJ, 2015, INFECT IMMUN, V83, P317, DOI 10.1128/IAI.02617-14; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hofmann AF, 2006, P NATL ACAD SCI USA, V103, P4333, DOI 10.1073/pnas.0600780103; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Hung DT, 2006, MOL MICROBIOL, V59, P193, DOI 10.1111/j.1365-2958.2005.04846.x; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Kim D, 2007, J MICROBIOL BIOTECHN, V17, P403; Kim SH, 2010, INT J SYST EVOL MICR, V60, P2793, DOI 10.1099/ijs.0.016618-0; Kim TK, 2005, ENVIRON MICROBIOL, V7, P509, DOI 10.1111/j.1462-2920.2005.00716.x; Koestler BJ, 2014, GUT MICROBES, V5, P775, DOI 10.4161/19490976.2014.985989; Koestler BJ, 2014, INFECT IMMUN, V82, P3002, DOI 10.1128/IAI.01664-14; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Leung JW, 2002, GASTROINTEST ENDOSC, V56, P72, DOI 10.1067/mge.2002.125366; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Li X, 2015, J APPL MICROBIOL, V119, P25, DOI 10.1111/jam.12813; Li X, 2015, VET MICROBIOL, V175, P44, DOI 10.1016/j.vetmic.2014.10.033; Maneerat S, 2005, APPL MICROBIOL BIOT, V67, P679, DOI 10.1007/s00253-004-1777-1; Melander RJ, 2015, ADV EXP MED BIOL, V831, P69, DOI 10.1007/978-3-319-09782-4_6; Navarro G, 2014, ANTIMICROB AGENTS CH, V58, P1092, DOI 10.1128/AAC.01781-13; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Noga E. J., 2010, Fish disease: diagnosis and treatment; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pagel M, 2007, J BACTERIOL, V189, P8593, DOI 10.1128/JB.01163-07; PARK SC, 1995, BIOSCI BIOTECH BIOCH, V59, P1966, DOI 10.1271/bbb.59.1966; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Peach KC, 2011, MOL BIOSYST, V7, P1176, DOI 10.1039/c0mb00276c; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Pumbwe L, 2007, MICROB PATHOGENESIS, V43, P78, DOI 10.1016/j.micpath.2007.04.002; Rabin N, 2015, FUTURE MED CHEM, V7, P647, DOI 10.4155/fmc.15.7; Reen FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045978; Sanchez LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035398; Slizova M, 2015, CAN J MICROBIOL, V61, P437, DOI 10.1139/cjm-2015-0007; SUNG JY, 1994, DIGEST DIS SCI, V39, P999, DOI 10.1007/BF02087551; Wang SY, 2003, MICROBIOL-SGM, V149, P1061, DOI 10.1099/mic.0.26032-0; Wibbenmeyer JA, 2002, INFECT IMMUN, V70, P121, DOI 10.1128/IAI.70.1.121-126.2002; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Zaidi AH, 2011, APPL ENVIRON MICROB, V77, P2602, DOI 10.1128/AEM.01709-10	68	26	27	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0149603	10.1371/journal.pone.0149603	http://dx.doi.org/10.1371/journal.pone.0149603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992172	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800021
J	Lin, CF; Hsu, SPC; Lin, CJ; Guo, WY; Liao, CH; Chu, WF; Hung, SC; Shih, YS; Lin, YT				Lin, Chun Fu; Hsu, Sanford P. C.; Lin, Chung Jung; Guo, Wan Yuo; Liao, Chih Hsiang; Chu, Wei Fa; Hung, Sheng Che; Shih, Yang Shin; Lin, Yen Tzu			Prolonged Cerebral Circulation Time Is the Best Parameter for Predicting Vasospasm during Initial CT Perfusion in Subarachnoid Hemorrhagic Patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; CEREBROVASCULAR RESERVE; DIGITAL-SUBTRACTION; BLOOD-FLOW; ANGIOGRAPHY; IMPACT	Purpose We sought to imitate angiographic cerebral circulation time (CCT) and create a similar index from baseline CT perfusion (CTP) to better predict vasospasm in patients with subarachnoid hemorrhage (SAH). Methods Forty-one SAH patients with available DSA and CTP were retrospectively included. The vasospasm group was comprised of patients with deterioration in conscious functioning and newly developed luminal narrowing; remaining cases were classified as the control group. The angiography CCT (XA-CCT) was defined as the difference in TTP (time to peak) between the selected arterial ROIs and the superior sagittal sinus (SSS). Four arterial ROIs were selected to generate four corresponding XA-CCTs: the right and left anterior cerebral arteries (XA-CCTRA2 and XA-CCTLA2) and right-and left-middle cerebral arteries (XA-CCTRM2 and XA-CCTLM2). The CCTs from CTP (CT-CCT) were defined as the differences in TTP from the corresponding arterial ROIs and the SSS. Correlations of the different CCTs were calculated and diagnostic accuracy in predicting vasospasm was evaluated. Results Intra-class correlations ranged from 0.96 to 0.98. The correlations of XA-CCTRA2, XA-CCTRM2, XA-CCTLA2, and XA-CCTLM2 with the corresponding CT-CCTs were 0.64, 0.65, 0.53, and 0.68, respectively. All CCTs were significantly prolonged in the vasospasm group (5.8-6.4 s) except for XA-CCTLA2. CT-CCTA2 of 5.62 was the optimal cut-off value for detecting vasospasm with a sensitivity of 84.2% and specificity 82.4% Conclusion CT-CCTs can be used to interpret cerebral flow without deconvolution algorithms, and outperform both MTT and TTP in predicting vasospasm risk. This finding may help facilitate management of patients with SAH.	[Lin, Chun Fu; Hsu, Sanford P. C.; Liao, Chih Hsiang; Shih, Yang Shin] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Taipei, Taiwan; [Lin, Chung Jung; Guo, Wan Yuo; Chu, Wei Fa; Hung, Sheng Che; Lin, Yen Tzu] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Lin, Chun Fu; Hsu, Sanford P. C.; Lin, Chung Jung; Guo, Wan Yuo; Liao, Chih Hsiang; Chu, Wei Fa; Hung, Sheng Che; Shih, Yang Shin; Lin, Yen Tzu] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Guo, WY (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Guo, WY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	wyguo@vghtpe.gov.tw	Hung, Sheng Che/Q-3778-2019	Hung, Sheng Che/0000-0001-6288-3556; Liao, Chih-Hsiang/0000-0003-3459-1913	National Science Council [MOST 104-2314-B-010-037]; Taipei Veterans General Hospital (VGHTPE) grant [T1100200]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital (VGHTPE) grant	This research was co-sponsored by National Science Council of (grant number: MOST 104-2314-B-010-037) and Taipei Veterans General Hospital (VGHTPE) grant T1100200.	Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Aikawa H, 2010, NEUROL MED-CHIR, V50, P269, DOI 10.2176/nmc.50.269; [Anonymous], 1979, PHYSL PATHOPHYSIOLOG; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; CONNOLLY ES, 2012, STROKE J CEREBRAL CI, V43, P1711, DOI [DOI 10.1161/STR.0B013E3182587839, 10.1161/STR.0b013e3182587839]; Dankbaar JW, 2009, NEURORADIOLOGY, V51, P813, DOI 10.1007/s00234-009-0575-y; Figueiredo G, 2012, AM J NEURORADIOL, V33, P1702, DOI 10.3174/ajnr.A3071; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Greenberg ED, 2010, AM J NEURORADIOL, V31, P1853, DOI 10.3174/ajnr.A2246; Greitz T., 1956, RADIOLOGIC STUDY BRA; Heyn C, 2010, AM J NEURORADIOL, V31, P862, DOI 10.3174/ajnr.A1922; Iseda T, 2000, CLIN RADIOL, V55, P679, DOI 10.1053/crad.2000.0507; Jestaedt L, 2008, NEUROSURGERY, V62, P610, DOI 10.1227/01.NEU.0000311351.32904.8B; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Kudo K, 2011, J CEREBR BLOOD F MET, V31, P908, DOI 10.1038/jcbfm.2010.169; Levitt MR, 2014, J NEUROIMAGING, V24, P387, DOI 10.1111/jon.12046; Lin CJ, 2014, AM J NEURORADIOL, V35, P1132, DOI 10.3174/ajnr.A3838; Lin CJ, 2012, AM J NEURORADIOL, V33, P1685, DOI 10.3174/ajnr.A3049; Lin CJ, 2013, J CHIN MED ASSOC, V76, P218, DOI 10.1016/j.jcma.2012.12.009; McGuinness B, 2010, NEUROSURG CLIN N AM, V21, P281, DOI 10.1016/j.nec.2009.10.007; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; Petralia G, 2009, AM J NEURORADIOL, V30, P1107, DOI 10.3174/ajnr.A1540; Rim NJ, 2008, AM J NEURORADIOL, V29, P1658, DOI 10.3174/ajnr.A1229; Rosovsky M, 2006, RADIOLOGY, V240, DOI 10.1148/radiol.2402051816; Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Strother CM, 2010, AM J NEURORADIOL, V31, P919, DOI 10.3174/ajnr.A2020; Struffert T, 2015, AM J NEURORADIOL, V36, P1964, DOI 10.3174/ajnr.A4383; Turowski B, 2005, NEURORADIOLOGY, V47, P134, DOI 10.1007/s00234-004-1281-4; Udoetuk JD, 2007, NEUROSURGERY, V61, P1152, DOI 10.1227/01.neu.0000306092.07647.6d; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Yamamoto S, 2004, AM J NEURORADIOL, V25, P242	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151772	10.1371/journal.pone.0151772	http://dx.doi.org/10.1371/journal.pone.0151772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986626	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300128
J	Lo, HC; Hung, CY; Huang, FH; Su, TC; Lee, CH				Lo, Hui-Chen; Hung, Ching-Yi; Huang, Fu-Huan; Su, Tzu-Cheng; Lee, Chien-Hsing			The Nitric Oxide Synthase Inhibitor N-G-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis	PLOS ONE			English	Article							L-NAME; IMMUNE-RESPONSE; IN-VIVO; SEPSIS; PERMEABILITY; NUTRITION; MODEL	The combined treatment of parenteral arginine and the nitric oxide synthase inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) have been shown to improve liver function and systemic inflammation in subacute peritonitic rats. Here, we investigated the effects of single and combined parenteral arginine and L-NAME treatments on leukocyte and splenocyte immunity. Male Wistar rats were subjected to cecal punctures and were intravenously given total parenteral nutrition solutions with or without arginine and/or L-NAME supplementations for 7 days. Non-surgical and sham-operated rats with no cecal puncture were given a chow diet and parenteral nutrition, respectively. Parenteral feeding elevated the white blood cell numbers and subacute peritonitis augmented the parenteral nutrition-induced alterations in the loss of body weight gain, splenomegaly, and splenocyte decreases. Parenteral arginine significantly increased the B-leukocyte level, decreased the natural killer T (NKT)-leukocyte and splenocyte levels, alleviated the loss in body weight gain and total and cytotoxic T-splenocyte levels, and attenuated the increases in plasma nitrate/nitrite and interferon-gamma production by T-splenocytes. L-NAME infusion significantly decreased NKT-leukocyte level, tumor-necrosis factor (TNF)-alpha production by T-splenocytes and macrophages, and interferon-gamma production by T-leukocytes, monocytes, and T-splenocytes, as well as increased interleukin-6 production by T-leukocytes andmonocytes and nitrate/nitrite production by T-leukocytes. Combined treatment significantly decreased plasma nitrate/nitrite, the NKT-leukocyte level, and TNF-alpha production by T-splenocytes. Parenteral arginine may attenuate immune impairment and L-NAME infusion may augment leukocyte proinflammatory response, eliminate splenocyte proinflammatory and T-helper 1 responses, and diminish arginine-induced immunomodulation in combined treatment in subacute peritonitic rats.	[Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei, Taiwan; [Hung, Ching-Yi; Huang, Fu-Huan; Lee, Chien-Hsing] China Med Univ, Childrens Hosp, Dept Surg, Div Gen Pediat Surg, Taichung, Taiwan; [Su, Tzu-Cheng] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Lee, Chien-Hsing] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan	Fu Jen Catholic University; China Medical University Taiwan; Changhua Christian Hospital; China Medical University Taiwan	Lee, CH (corresponding author), China Med Univ, Childrens Hosp, Dept Surg, Div Gen Pediat Surg, Taichung, Taiwan.; Lee, CH (corresponding author), China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.	hsing27566@gmail.com	Lo, Hui-Chen/AAN-5906-2021	Huang, Fu Huan/0000-0002-2747-2900	Changhua Christian Hospital [102-CCH-IRP-025]	Changhua Christian Hospital	This work was supported by 102-CCH-IRP-025, Changhua Christian Hospital.	Angus DC, 2011, JAMA-J AM MED ASSOC, V305, P1469, DOI 10.1001/jama.2011.438; Avontuur JAM, 1998, CHEST, V113, P1640, DOI 10.1378/chest.113.6.1640; Chang YS, 2006, J KOREAN MED SCI, V21, P965, DOI 10.3346/jkms.2006.21.6.965; Chen YH, 2012, JPEN-PARENTER ENTER, V36, P741, DOI 10.1177/0148607111429793; Cui L, 1999, J NUTR, V129, P792, DOI 10.1093/jn/129.4.792; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Dong J, 2013, PERITON DIALYSIS INT, V33, P28, DOI 10.3747/pdi.2011.00236; Ferrier ML, 2001, KIDNEY INT, V60, P2343, DOI 10.1046/j.1523-1755.2001.00050.x; Fukatsu K, 1997, J SURG RES, V68, P79, DOI 10.1006/jsre.1997.5018; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Hirose T, 2014, CLIN NUTR, V33, P179, DOI 10.1016/j.clnu.2013.11.017; Hsiao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042467; Hsiao CC, 2011, BIOL PHARM BULL, V34, P177, DOI 10.1248/bpb.34.177; Ishikawa K, 2011, CRIT CARE MED, V39, P770, DOI 10.1097/CCM.0b013e318206c1fb; Kalil AC, 2006, CURR OPIN CRIT CARE, V12, P303, DOI 10.1097/01.ccx.0000235206.92697.bf; Krauss H, 2011, CHINESE J PHYSIOL, V54, P7, DOI 10.4077/CJP.2011.AMK011; Lee CH, 2013, J SURG RES, V181, P99, DOI 10.1016/j.jss.2012.05.089; Lo HC, 2010, PEDIATR SURG INT, V26, P625, DOI 10.1007/s00383-010-2582-9; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Luiking YC, 2012, AM J PHYSIOL-ENDOC M, V303, pE1177, DOI 10.1152/ajpendo.00284.2012; Mourad FH, 1996, GUT, V39, P539, DOI 10.1136/gut.39.4.539; Ni J, 2005, PERITON DIALYSIS INT, V25, pS11; Riche F, 2013, CRIT CARE, V17, DOI 10.1186/cc12895; SHOU J, 1994, AM J SURG, V167, P145, DOI 10.1016/0002-9610(94)90065-5; Stahl W, 2010, SHOCK, V34, P321, DOI 10.1097/SHK.0b013e3181d758b5; Stupnisek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123454; TAO RC, 1979, J NUTR, V109, P904, DOI 10.1093/jn/109.5.904; Tisljar M, 2011, COLLEGIUM ANTROPOL, V35, P547; Villalpando S, 2006, AM J CLIN NUTR, V84, P197, DOI 10.1093/ajcn/84.1.197; Wanten GJA, 2015, JPEN-PARENTER ENTER, V39, p33S, DOI 10.1177/0148607115595973; Wijnands KAP, 2015, NUTRIENTS, V7, P1426, DOI 10.3390/nu7031426; Yeh CL, 2002, NUTRITION, V18, P631, DOI 10.1016/S0899-9007(02)00809-2	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151973	10.1371/journal.pone.0151973	http://dx.doi.org/10.1371/journal.pone.0151973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007815	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200080
J	Niimi, M; Hashimoto, K; Kakuda, W; Miyano, S; Momosaki, R; Ishima, T; Abo, M				Niimi, Masachika; Hashimoto, Kenji; Kakuda, Wataru; Miyano, Satoshi; Momosaki, Ryo; Ishima, Tamaki; Abo, Masahiro			Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke	PLOS ONE			English	Article							MOTOR RECOVERY; BDNF; POLYMORPHISM; ASSOCIATION; MECHANISMS; PROBDNF	Background Repetitive transcranial magnetic stimulation (rTMS) can improve upper limb hemiparesis after stroke but the mechanism underlying its efficacy remains elusive. rTMS seems to alter brain-derived neurotrophic factor (BDNF) and such effect is influenced by BDNF gene polymorphism. Objectives To investigate the molecular effects of rTMS on serum levels of BDNF, its precursor proBDNF and matrix metalloproteinase-9 (MMP-9) in poststroke patients with upper limb hemiparesis. Methods Poststroke patients with upper limb hemiparesis were studied. Sixty-two patients underwent rehabilitation plus rTMS combination therapy and 33 patients underwent rehabilitation monotherapy without rTMS for 14 days at our hospital. One Hz rTMS was applied over the motor representation of the first dorsal interosseous muscle on the non-lesional hemisphere. Fugl-Meyer Assessment and Wolf Motor Function (WMFT) were used to evaluate motor function on the affected upper limb before and after intervention. Blood samples were collected for analysis of BDNF polymorphism and measurement of BDNF, proBDNF and MMP-9 levels. Results Two-week combination therapy increased BDNF and MMP-9 serum levels, but not serum proBDNF. Serum BDNF and MMP-9 levels did not correlate with motor function improvement, though baseline serum proBDNF levels correlated negatively and significantly with improvement in WMFT (rho = -0.422, p = 0.002). The outcome of rTMS therapy was not altered by BDNF gene polymorphism. Conclusions The combination therapy of rehabilitation plus low-frequency rTMS seems to improve motor function in the affected limb, by activating BDNF processing. BDNF and its precursor proBDNF could be potentially suitable biomarkers for poststroke motor recovery.	[Niimi, Masachika; Kakuda, Wataru; Momosaki, Ryo; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Hashimoto, Kenji; Ishima, Tamaki] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Miyano, Satoshi] Tokyo Gen Hosp, Dept Rehabil Med, Tokyo, Japan	Jikei University; Chiba University	Abo, M (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan.	abo@jikei.ac.jp	Momosaki, Ryo/H-6486-2018; Hashimoto, Kenji/I-5800-2015	Momosaki, Ryo/0000-0003-3274-3952; Abo, Masahiro/0000-0001-6701-4974; Hashimoto, Kenji/0000-0002-8892-0439				Abo M, 2014, INT J STROKE, V9, P607, DOI 10.1111/ijs.12100; Castren E, 2014, Handb Exp Pharmacol, V220, P461, DOI 10.1007/978-3-642-45106-5_17; Chang WH, 2014, BRAIN STIMUL, V7, P553, DOI 10.1016/j.brs.2014.03.008; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashimoto K, 2015, EUR ARCH PSY CLIN N, V265, P83, DOI 10.1007/s00406-014-0557-x; Hashimoto K, 2014, BRIT J PSYCHIAT, V205, P410, DOI 10.1192/bjp.205.5.410; Hashimoto K, 2014, JAMA NEUROL, V71, P653, DOI 10.1001/jamaneurol.2013.6414; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Itoh K, 2005, AM J MED GENET B, V132B, P70, DOI 10.1002/ajmg.b.30097; Itoh K, 2004, AM J MED GENET B, V124B, P61, DOI 10.1002/ajmg.b.20078; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Levin R, 2015, J PSYCHIATR RES, V61, P188, DOI 10.1016/j.jpsychires.2014.12.007; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Ludemann-Podubecka J, 2015, PROG BRAIN RES, V218, P281, DOI 10.1016/bs.pbr.2014.12.001; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; Mirowska-Guzel D, 2013, NEUROREHABILITATION, V32, P573, DOI 10.3233/NRE-130879; Muller-Dahlhaus F, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00050; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Sodersten K, 2014, J AFFECT DISORDERS, V160, P1, DOI 10.1016/j.jad.2014.01.009; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; VILLARDITA C, 1985, CORTEX, V21, P627, DOI 10.1016/S0010-9452(58)80010-6; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yukimasa T, 2006, PHARMACOPSYCHIATRY, V39, P52, DOI 10.1055/s-2006-931542; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029	33	32	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152241	10.1371/journal.pone.0152241	http://dx.doi.org/10.1371/journal.pone.0152241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007747	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200116
J	Wang, YW; Xing, D; Zhao, M; Wang, J; Yang, Y				Wang, Yawei; Xing, Dan; Zhao, Meng; Wang, Jie; Yang, Yang			The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review	PLOS ONE			English	Review							PHASE-II TRIAL; ENDOTHELIAL GROWTH-FACTOR; BEVACIZUMAB PLUS IRINOTECAN; BILIARY-TRACT CANCER; AGENT BEVACIZUMAB; COMBINATION CHEMOTHERAPY; RANDOMIZED-TRIAL; TUMOR-GROWTH; S-1; TEMOZOLOMIDE	Background Currently, the standard treatment for newly diagnosed glioblastoma multiforme (GBM) is maximal safe surgical resection followed by radiation therapy with concurrent and adjuvant temozolomide. However, disease recurs in almost all patients, and the optimal salvage treatment for recurrent GBM remains unclear. We conducted a systematic review and meta-analysis of published clinical trials to assess the efficacy and toxicities of angiogenesis inhibitors alone as salvage treatment in these patients. Methods Trials published between 1994 and 2015 were identified by an electronic search of public databases (MEDLINE, EMBASE, Cochrane library). Demographic data, treatment regimens, objective response rate (ORR), median progression-free survival (PFS), median overall survival (OS), 6-months PFS rate, 1-year OS and grade 3/4 toxicities were extracted. We also compared the main outcomes of interest between bevacizumab and other angiogenesis inhibitors. All analyses were performed using Comprehensive Meta Analysis software (Version 2.0). Results A total of 842 patients were included for analysis: 343 patients were treated with bevacizumab, 386 with other angiogenesis inhibitors and 81 with thalidomide. The pooled ORR, 6-months PFS, and 1-year OS for recurrent GBM patients receiving angiogenesis inhibitors was 20.1%, 19.5% and 29.3%, respectively. The use of single agent bevacizumab in recurrent GBM significantly improved ORR and 6-months PFS when compared to other angiogenesis inhibitors [relative risk (RR) 2.93, 95% CI 1.38-6.21; p = 0.025; and RR 2.36 95% CI 1.46-3.82; p<0.001, respectively], while no significant difference in 1-year OS was found between the two groups (p = 0.07). when compared to thalidomide, bevacizumab treatment in recurrent GBM significantly improved ORR (RR 6.8, 95% CI: 2.64-17.6, p<0.001), but not for 6-months PFS (p = 0.07) and 1-year OS (p = 0.31). As for grade 3/4 toxicities, the common toxicity was hypertension with pooled incidence of 12.1%, while high-grade thromboembolic events (2.2%), hemorrhage (5.1%) and GI perforation (2.8%) associated with angiogenesis inhibitors were relatively low. Conclusions In comparison with other angiogenesis inhibitors and thalidomide, the use of single agent bevacizumab as salvage treatment for recurrent GBM patients improve ORR and 6-months PFS, but not for 1-year OS.	[Wang, Yawei] Tianjin Hosp, Dept Electromyog, Tianjin, Peoples R China; [Xing, Dan] Peking Univ, Peoples Hosp, Arthrit Clin & Res Ctr, Beijing 100871, Peoples R China; [Zhao, Meng] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Clin Lab,Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Wang, Jie; Yang, Yang] Tianjin Hosp, Dept Orthoped, Tianjin, Peoples R China	Peking University; Tianjin Medical University	Yang, Y (corresponding author), Tianjin Hosp, Dept Orthoped, Tianjin, Peoples R China.	yangyang2016@21cn.com						Batchelor TT, 2014, CLIN CANCER RES, V20, P5612, DOI 10.1158/1078-0432.CCR-14-0834; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Chamberlain MC, 2010, J NEURO-ONCOL, V96, P259, DOI 10.1007/s11060-009-9957-6; de Groot JF, 2011, J CLIN ONCOL, V29, P2689, DOI 10.1200/JCO.2010.34.1636; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Field KM, 2015, CANCER-AM CANCER SOC, V121, P997, DOI 10.1002/cncr.28935; Fine HA, 2000, J CLIN ONCOL, V18, P708, DOI 10.1200/JCO.2000.18.4.708; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fuchs CS, 2003, J CLIN ONCOL, V21, P807, DOI 10.1200/JCO.2003.08.058; Ghiaseddin Ashley, 2015, CNS Oncol, V4, P157, DOI 10.2217/cns.15.8; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Hassler MR, 2014, ANTI-CANCER DRUG, V25, P723, DOI 10.1097/CAD.0000000000000077; Hutterer M, 2014, NEURO-ONCOLOGY, V16, P92, DOI 10.1093/neuonc/not161; Ichinose Y, 2004, CLIN CANCER RES, V10, P7860, DOI 10.1158/1078-0432.CCR-04-1200; Iwamoto FM, 2010, NEURO-ONCOLOGY, V12, P855, DOI 10.1093/neuonc/noq025; Jensen RL, 2006, J NEURO-ONCOL, V78, P233, DOI 10.1007/s11060-005-9103-z; Kawahara M, 2001, BRIT J CANCER, V85, P939, DOI 10.1054/bjoc.2001.2031; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kreisl TN, 2012, NEURO-ONCOLOGY, V14, P1519, DOI 10.1093/neuonc/nos265; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lamszus K, 2003, CLIN CANCER RES, V9, P1399; Malka D, 2014, LANCET ONCOL, V15, P819, DOI 10.1016/S1470-2045(14)70212-8; Marx GM, 2001, J NEURO-ONCOL, V54, P31, DOI 10.1023/A:1012554328801; Moehler M, 2014, EUR J CANCER, V50, P3125, DOI 10.1016/j.ejca.2014.09.013; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muhic A, 2013, J NEURO-ONCOL, V111, P205, DOI 10.1007/s11060-012-1009-y; Nagane M, 2012, JPN J CLIN ONCOL, V42, P887, DOI 10.1093/jjco/hys121; Norden AD, 2015, J NEURO-ONCOL, V121, P297, DOI 10.1007/s11060-014-1631-y; Ozawa Y, 2009, LUNG CANCER, V63, P68, DOI 10.1016/j.lungcan.2008.04.007; Pan E, 2012, J NEURO-ONCOL, V110, P111, DOI 10.1007/s11060-012-0943-z; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Raizer JJ, 2010, CANCER-AM CANCER SOC, V116, P5297, DOI 10.1002/cncr.25462; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taal W, 2014, LANCET ONCOL, V15, P943, DOI 10.1016/S1470-2045(14)70314-6; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Tsang DS, 2015, CLIN ONCOL-UK, V27, P176, DOI 10.1016/j.clon.2014.11.026; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Zhang GB, 2012, J CLIN NEUROSCI, V19, P1636, DOI 10.1016/j.jocn.2011.12.028	41	14	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152170	10.1371/journal.pone.0152170	http://dx.doi.org/10.1371/journal.pone.0152170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007828	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200104
J	Mukhamedshina, YO; Garanina, EE; Masgutova, GA; Galieva, LR; Sanatova, ER; Chelyshev, YA; Rizvanov, AA				Mukhamedshina, Yana O.; Garanina, Ekaterina E.; Masgutova, Galina A.; Galieva, Luisa R.; Sanatova, Elvira R.; Chelyshev, Yurii A.; Rizvanov, Albert A.			Assessment of Glial Scar, Tissue Sparing, Behavioral Recovery and Axonal Regeneration following Acute Transplantation of Genetically Modified Human Umbilical Cord Blood Cells in a Rat Model of Spinal Cord Contusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL RECOVERY; GENE-THERAPY; INJURY; VEGF	Objective and Methods This study investigated the potential for protective effects of human umbilical cord blood mononuclear cells (UCB-MCs) genetically modified with the VEGF and GNDF genes on contusion spinal cord injury (SCI) in rats. An adenoviral vector was constructed for targeted delivery of VEGF and GDNF to UCB-MCs. Using a rat contusion SCI model we examined the efficacy of the construct on tissue sparing, glial scar severity, the extent of axonal regeneration, recovery of motor function, and analyzed the expression of the recombinant genes VEGF and GNDF in vitro and in vivo. Results Transplantation of UCB-MCs transduced with adenoviral vectors expressing VEGF and GDNF at the site of SCI induced tissue sparing, behavioral recovery and axonal regeneration comparing to the other constructs tested. The adenovirus encoding VEGF and GDNF for transduction of UCB-MCs was shown to be an effective and stable vehicle for these cells in vivo following the transplantation into the contused spinal cord. Conclusion Our results show that a gene delivery using UCB-MCs-expressing VEGF and GNDF genes improved both structural and functional parameters after SCI. Further histological and behavioral studies, especially at later time points, in animals with SCI after transplantation of genetically modified UCB-MCs (overexpressing VEGF and GDNF genes) will provide additional insight into therapeutic potential of such cells.	[Mukhamedshina, Yana O.; Garanina, Ekaterina E.; Masgutova, Galina A.; Galieva, Luisa R.; Sanatova, Elvira R.; Rizvanov, Albert A.] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Chelyshev, Yurii A.] Kazan State Med Univ, Dept Histol, Kazan, Russia	Kazan Federal University; Kazan State Medical University	Rizvanov, AA (corresponding author), Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.	rizvanov@gmail.com	Chelyshev, Yuri/P-9412-2015; Rizvanov, Albert/H-4486-2013; Cherenkova, Ekateruna/D-5136-2014; Akhmetzyanova, Elvira/Q-8062-2017	Rizvanov, Albert/0000-0002-9427-5739; Akhmetzyanova, Elvira/0000-0002-5751-6759	Russian Foundation [15-0407527, 14-04-31246]; Russian Federation [MK-4020.2015.7]; Ministry of Education of Russia [RFMEFI59414X0003]; Interdisciplinary Center for Analytical Microscopy; Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia	Russian Foundation(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); Ministry of Education of Russia; Interdisciplinary Center for Analytical Microscopy; Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia	The study was supported by grants 15-0407527 (A.A. Rizvanov) and 14-04-31246 (Y.O. Mukhamedshina) from Russian Foundation for Basic Research. Y.O. Mukhamedshina was supported by a Presidential Grant for government support of young scientists (PhD) from the Russian Federation (MK-4020.2015.7). This work was performed in accordance with Program of Competitive Growth of Kazan Federal University and a subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities. Some of the experiments were conducted using equipment at the Interdisciplinary Center for Collective Use of Kazan Federal University supported by Ministry of Education of Russia (ID RFMEFI59414X0003), Interdisciplinary Center for Analytical Microscopy, and Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia.	Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Barbour HR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-106; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Cheng H, 2002, J NEUROSCI RES, V69, P397, DOI 10.1002/jnr.10303; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Gluckman E, 2000, CURR OPIN HEMATOL, V7, P353, DOI 10.1097/00062752-200011000-00006; Ikeda Y, 2004, HYPERTENS RES, V27, P119, DOI 10.1291/hypres.27.119; Islamov RR, 2004, NEUROREPORT, V15, P2117, DOI 10.1097/00001756-200409150-00024; Islamov RR, 2015, CURR GENE THER, V15, P266, DOI 10.2174/1566523215666150126122317; Jin H, 2009, SPINE, V34, pE952, DOI 10.1097/BRS.0b013e3181c4af80; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kuh SU, 2005, ACTA NEUROCHIR, V147, P985, DOI 10.1007/s00701-005-0538-y; Lebedev SV, 2008, B EXP BIOL MED+, V146, P489, DOI 10.1007/s10517-009-0328-2; Lin Wei-Ting, 2013, PLoS ONE, V8, P1; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011; Mukhamedshina YO, 2016, SPINAL CORD, V54, P347, DOI 10.1038/sc.2015.161; Mukhamedshina YO, 2012, CELLULAR TRANSPLANTA, V7, P125; Park S, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-36; Rodrigues LP, 2012, BRAZ J MED BIOL RES, V45, P49, DOI 10.1590/S0100-879X2011007500162; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y; Yan Hui-bo, 2009, Zhonghua Wai Ke Za Zhi, V47, P1817; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840	28	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151745	10.1371/journal.pone.0151745	http://dx.doi.org/10.1371/journal.pone.0151745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003408	Green Submitted, gold, Green Published			2022-12-27	WOS:000372697400041
J	Storrie, S; Longbottom, D; Barlow, PG; Wheelhouse, N				Storrie, Skye; Longbottom, David; Barlow, Peter G.; Wheelhouse, Nick			MAPK Activation Is Essential for Waddlia chondrophila Induced CXCL8 Expression in Human Epithelial Cells	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; ABORTED BOVINE FETUS; INTERLEUKIN-8; RECEPTOR; RICKETTSIA; SAMPLES; NOD1	Background Waddlia chondrophila (W. chondrophila) is an emerging agent of respiratory and reproductive disease in humans and cattle. The organism is a member of the order Chlamydiales, and shares many similarities at the genome level and in growth studies with other well-characterised zoonotic chlamydial agents, such as Chlamydia abortus (C. abortus). The current study investigated the growth characteristics and innate immune responses of human and ruminant epithelial cells in response to infection with W. chondrophila. Methods Human epithelial cells (HEp2) were infected with W. chondrophila for 24h. CXCL8 release was significantly elevated in each of the cell lines by active-infection with live W. chondrophila, but not by exposure to UV-killed organisms. Inhibition of either p38 or p42/44 MAPK significantly inhibited the stimulation of CXCL8 release in each of the cell lines. To determine the pattern recognition receptor through which CXCL8 release was stimulated, wildtype HEK293 cells which express no TLR2, TLR4, NOD2 and only negligible NOD1 were infected with live organisms. A significant increase in CXCL8 was observed. Conclusions/Significance W. chondrophila actively infects and replicates within both human and ruminant epithelial cells stimulating CXCL8 release. Release of CXCL8 is significantly inhibited by inhibition of either p38 or p42/44 MAPK indicating a role for this pathway in the innate immune response to W. chondrophila infection. W. chondrophila stimulation of CXCL8 secretion in HEK293 cells indicates that TLR2, TLR4, NOD2 and NOD1 receptors are not essential to the innate immune response to infection.	[Storrie, Skye; Longbottom, David; Wheelhouse, Nick] Moredun Res Inst, Pentlands Sci Pk, Edinburgh EH26 0PZ, Midlothian, Scotland; [Barlow, Peter G.; Wheelhouse, Nick] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Sighthill Campus, Edinburgh EH11 4BN, Midlothian, Scotland	Moredun Research Institute; Edinburgh Napier University	Wheelhouse, N (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Sighthill Campus, Edinburgh EH11 4BN, Midlothian, Scotland.	n.wheelhouse@napier.ac.uk	Longbottom, David/GWZ-8448-2022; Barlow, Peter/O-4078-2019	Longbottom, David/0000-0003-0086-8443; Barlow, Peter/0000-0002-6516-9312; Wheelhouse, Nick/0000-0002-2803-0055; Molodiuc, Veaceslav/0000-0002-3014-4203	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Industrial partnership award - Biotechnology and Biological Sciences Research Council (BBSRC); Zoetis [BB/J015083/1]; BBSRC [BB/J015083/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015083/1] Funding Source: researchfish	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Industrial partnership award - Biotechnology and Biological Sciences Research Council (BBSRC); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, http://www.scotland.gov.uk) and through the Industrial partnership award awarded by the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk/) and Zoetis (grant no. BB/J015083/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistleitner K, 2015, ENVIRON MICROBIOL, V17, P1397, DOI 10.1111/1462-2920.12621; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dille S, 2015, INFECT IMMUN, V83, P3268, DOI 10.1128/IAI.00322-15; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Hii CS, 2008, J INFECT DIS, V197, P1537, DOI 10.1086/587905; Jacquier N, 2015, CHEM BIOL, V22, P1217, DOI 10.1016/j.chembiol.2015.08.009; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Krull M, 2004, INFECT IMMUN, V72, P6615, DOI 10.1128/IAI.72.11.6615-6621.2004; Lienard J, 2011, J CLIN MICROBIOL, V49, P2637, DOI 10.1128/JCM.00114-11; Verweij SP, 2015, MICROBES INFECT; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wheelhouse N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102386; Wheelhouse N, 2009, J REPROD IMMUNOL, V80, P49, DOI 10.1016/j.jri.2008.12.003; Zhou H, 2013, SCI CHINA LIFE SCI, V56, P460, DOI 10.1007/s11427-013-4470-8	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152193	10.1371/journal.pone.0152193	http://dx.doi.org/10.1371/journal.pone.0152193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002636	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400091
J	Evans, NJ; Bayliss, AL; Reale, V; Evans, PD				Evans, Nicholas J.; Bayliss, Asha L.; Reale, Vincenzina; Evans, Peter D.			Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18)	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ESTROGEN-RECEPTOR; ADENYLYL-CYCLASE; EXPRESSION; RESPONSES; AGONIST; G-PROTEIN-COUPLED-RECEPTOR-30; 17-BETA-ESTRADIOL; IDENTIFICATION; ALDOSTERONE	Estrogen can modulate neuronal development and signalling by both genomic and non-genomic pathways. Many of its rapid, non-genomic effects on nervous tissue have been suggested to be mediated via the activation of the estrogen sensitive G-protein coupled receptor (GPER1 or GPR30). There has been much controversy over the cellular location, signalling properties and endogenous activators of GPER1. Here we describe the pharmacology and signalling properties of GPER1 in an immortalized embryonic hippocampal cell line, mHippoE-18. This cell line does not suffer fromthe inherent problems associated with the study of this receptor in native tissue or the problems associated with heterologously expression in clonal cell lines. In mHippoE-18 cells, 17 beta-Estradiol can mediate a dose-dependent rapid potentiation of forskolin- stimulated cyclic AMP levels but does not appear to activate the ERK1/2 pathway. The effect of 17 beta-Estradiol can bemimicked by the GPER1 agonist, G1, and also by tamoxifen and ICI 182,780 which activate GPER1 in a variety of other preparations. The response is not mimicked by the application of the classical estrogen receptor agonists, PPT, (an ER alpha agonist) or DPN, (an ER beta agonist), further suggesting that this effect of 17 beta-Estradiol is mediated through the activation of GPER1. However, after exposure of the cells to the GPER1 specific antagonists, G15 and G36, the stimulatory effects of the above agonists are replaced by dose-dependent inhibitions of forskolin-stimulated cyclic AMP levels. This inhibitory effect is mimicked by aldosterone in a dose-dependent way even in the absence of the GPER1 antagonists. The results are discussed in terms of possible "Biased Antagonism" whereby the antagonists change the conformation of the receptor resulting in changes in the agonist induced coupling of the receptor to different secondmessenger pathways.	[Evans, Nicholas J.; Bayliss, Asha L.; Reale, Vincenzina; Evans, Peter D.] Babraham Inst, Signalling Lab, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Evans, PD (corresponding author), Babraham Inst, Signalling Lab, Cambridge CB22 3AT, England.	peter.evans@babraham.ac.uk		Evans, Nicholas/0000-0002-7419-7761	Wellcome Trust Vacation Scholarship; BBSRC through the Babraham Institute; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C194] Funding Source: researchfish; BBSRC [BBS/E/B/0000C194] Funding Source: UKRI	Wellcome Trust Vacation Scholarship(Wellcome Trust); BBSRC through the Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NJE was supported by a Wellcome Trust Vacation Scholarship. ALB, VR and PDE were supported via the BBSRC through the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airriess CN, 1997, BRIT J PHARMACOL, V122, P191, DOI 10.1038/sj.bjp.0701348; Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Ashton AW, 2015, MOL ENDOCRINOL, V29, P1144, DOI 10.1210/ME.2014-1410; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Barton M, 2015, TRENDS ENDOCRIN MET, V26, P396, DOI 10.1016/j.tem.2015.05.005; Bayliss A, 2013, J NEUROCHEM, V125, P37, DOI 10.1111/jnc.12158; Bayliss AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080833; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; Burman C, 2010, INVERTEBR NEUROSCI, V10, P93, DOI 10.1007/s10158-010-0111-0; Burman C, 2009, J NEUROCHEM, V111, P26, DOI 10.1111/j.1471-4159.2009.06295.x; Cheng SB, 2014, MOL CELL ENDOCRINOL, V382, P950, DOI 10.1016/j.mce.2013.11.005; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; EASON MG, 1992, J BIOL CHEM, V267, P15795; Evans PD, 1995, PROG BRAIN RES, V106, P259; Evans PD, 2014, GEN COMP ENDOCR, V195, P157, DOI 10.1016/j.ygcen.2013.10.015; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; FRASER CM, 1989, J BIOL CHEM, V264, P11754; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Gros R, 2013, AM J PHYSIOL-CELL PH, V304, pC532, DOI 10.1152/ajpcell.00203.2012; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kelly MJ, 2015, MOL ENDOCRINOL, V29, P645, DOI 10.1210/me.2014-1397; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Lebesgue D, 2009, J NEUROENDOCRINOL, V21, P743, DOI 10.1111/j.1365-2826.2009.01893.x; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lindsey SH, 2014, STEROIDS, V81, P99, DOI 10.1016/j.steroids.2013.10.017; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; Micevych PE, 2012, NEUROENDOCRINOLOGY, V96, P103, DOI 10.1159/000338400; MUNIRATHINAM G, 1994, PHARMACOL BIOCHEM BE, V48, P813, DOI 10.1016/0091-3057(94)90352-2; Noel SD, 2009, MOL ENDOCRINOL, V23, P349, DOI 10.1210/me.2008-0299; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Peyton C, 2011, BIOL REPROD, V85, P42, DOI 10.1095/biolreprod.110.088765; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ruiz-Palmero I, 2013, MOL CELL ENDOCRINOL, V372, P105, DOI 10.1016/j.mce.2013.03.018; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sellers K, 2015, FRONT NEUROENDOCRIN, V36, P72, DOI 10.1016/j.yfrne.2014.08.001; Srivastava DP, 2013, J NEUROENDOCRINOL, V25, P1219, DOI 10.1111/jne.12071; Srivastava DP, 2013, NEUROSCIENCE, V239, P17, DOI 10.1016/j.neuroscience.2012.12.004; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Toran-Allerand CD, 2004, ENDOCRINOLOGY, V145, P1069, DOI 10.1210/en.2003-1462; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Waters EM, 2015, J NEUROSCI, V35, P2384, DOI 10.1523/JNEUROSCI.1298-14.2015; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680	58	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152138	10.1371/journal.pone.0152138	http://dx.doi.org/10.1371/journal.pone.0152138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998610	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700104
J	Liu, F; Zheng, H; Tong, W; Li, GX; Tian, Q; Liang, C; Li, LW; Zheng, XC; Tong, GZ				Liu, Fei; Zheng, Hao; Tong, Wu; Li, Guo-Xin; Tian, Qing; Liang, Chao; Li, Li-Wei; Zheng, Xu-Chen; Tong, Guang-Zhi			Identification and Analysis of Novel Viral and Host Dysregulated MicroRNAs in Variant Pseudorabies Virus-Infected PK15 Cells	PLOS ONE			English	Article							MESSENGER-RNA TARGETS; GENOMIC CHARACTERIZATION; EXPRESSION; REPLICATION; RECOGNITION; SUPPRESSION; EMERGENCE; LATENCY; MIR-132; CHINA	Pseudorabies (PR) is one of the most devastating diseases in the pig industry. To identify changes in microRNA (miRNA) expression and post-transcriptional regulatory responses to PRV infection in porcine kidney epithelial (PK15) cells, we sequenced a small RNA (sRNA) library prepared from infected PK15 cells and compared it to a library prepared from uninfected cells using Illumina deep sequencing. Here we found 25 novel viral miRNAs by high-throughput sequencing and 20 of these miRNAs were confirmed through stem-loop RT-qPCR. Intriguingly, unlike the usual miRNAs encoded by the alpha-herpesviruses, which are found clustered in the large latency transcript (LLT), these novel viral miRNAs are throughout the PRV genome like beta-herpesviruses. Viral miRNAs are predicted to target multiple genes and form a complex regulatory network. GO analysis on host targets of viral miRNAs were involved in complex cellular processes, including the metabolic pathway, biological regulation, stimulus response, signaling process and immune response. Moreover, 13 host miRNAs were expressed with significant difference after infection with PRV: 8 miRNAs were up-regulated and 5 miRNAs were down-regulated, which may affect viral replication in host cell. Our results provided new insight into the characteristic of miRNAs in response to PRV infection, which is significant for further study of these miRNAs function.	[Liu, Fei; Zheng, Hao; Tong, Wu; Li, Guo-Xin; Tian, Qing; Liang, Chao; Li, Li-Wei; Zheng, Xu-Chen; Tong, Guang-Zhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China; [Zheng, Hao; Tong, Wu; Li, Guo-Xin; Tong, Guang-Zhi] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Tong, GZ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China.; Tong, GZ (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	gztong@shvri.ac.cn			Shanghai Municipal Natural Science Foundation [14ZR1448900]; Shanghai city agriculture science and technology key project [2015,1-7]; National Nonprofit Institute Research Grant of CATAS-ITBB [2014JB02]	Shanghai Municipal Natural Science Foundation; Shanghai city agriculture science and technology key project; National Nonprofit Institute Research Grant of CATAS-ITBB	This work was supported by the Shanghai Municipal Natural Science Foundation (No. 14ZR1448900), the Shanghai city agriculture science and technology key project (2015,1-7), and the National Nonprofit Institute Research Grant of CATAS-ITBB (No. 2014JB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cullen BR, 2011, CURR OPIN VIROL, V1, P211, DOI 10.1016/j.coviro.2011.04.003; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grey F, 2015, J GEN VIROL, V96, P739, DOI 10.1099/vir.0.070862-0; Hook L, 2014, CURR OPIN VIROL, V7, P40, DOI 10.1016/j.coviro.2014.03.015; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Luo YZ, 2014, VET MICROBIOL, V174, P107, DOI 10.1016/j.vetmic.2014.09.003; Mahjoub N, 2015, J VIROL, V89, P428, DOI 10.1128/JVI.02181-14; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Motsch N, 2014, RNA BIOL, V4; Mulik S, 2012, AM J PATHOL, V181, P525, DOI 10.1016/j.ajpath.2012.04.014; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang S, 2011, J VIROL, V85, P4501, DOI 10.1128/JVI.01997-10; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Timoneda O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086965; Tong W, 2015, VET MICROBIOL, V181, P236, DOI 10.1016/j.vetmic.2015.09.021; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wu R, 2013, J VET SCI, V14, P363, DOI 10.4142/jvs.2013.14.3.363; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Yang JS, 2015, TUMOR BIOL, V36, P3035, DOI 10.1007/s13277-014-2938-1; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yu XL, 2014, EMERG INFECT DIS, V20, P102, DOI 10.3201/eid2001.130531; Yuan Q., 1987, CHIN J PREV VET MED, V3, P10; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	45	13	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151546	10.1371/journal.pone.0151546	http://dx.doi.org/10.1371/journal.pone.0151546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998839	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700046
J	Wijckmans, E; Nys, M; Debaveye, S; Brams, M; Pardon, E; Willegems, K; Bertrand, D; Steyaert, J; Efremov, R; Ulens, C				Wijckmans, Eveline; Nys, Mieke; Debaveye, Sarah; Brams, Marijke; Pardon, Els; Willegems, Katrien; Bertrand, Daniel; Steyaert, Jan; Efremov, Rouslan; Ulens, Chris			Functional and Biochemical Characterization of Alvinella pompejana Cys-Loop Receptor Homologues	PLOS ONE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; SIZE-EXCLUSION CHROMATOGRAPHY; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; GLYCINE RECEPTOR; EUKARYOTIC THERMOPHILE; CHLORIDE CHANNEL; SCREENING METHOD	Cys-loop receptors are membrane spanning ligand-gated ion channels involved in fast excitatory and inhibitory neurotransmission. Three-dimensional structures of these ion channels, determined by X-ray crystallography or electron microscopy, have revealed valuable information regarding the molecular mechanisms underlying ligand recognition, channel gating and ion conductance. To extend and validate the current insights, we here present promising candidates for further structural studies. We report the biochemical and functional characterization of Cys-loop receptor homologues identified in the proteome of Alvinella pompejana, an extremophilic, polychaete annelid found in hydrothermal vents at the bottom of the Pacific Ocean. Seven homologues were selected, named Alpo1-7. Five of them, Alpo2-6, were unidentified prior to this study. Two-electrode voltage clamp experiments revealed that wild type Alpo5 and Alpo6, both sharing remarkably high sequence identity with human glycine receptor a subunits, are anion-selective channels that can be activated by glycine, GABA and taurine. Furthermore, upon expression in insect cells fluorescence size-exclusion chromatography experiments indicated that four homologues, Alpo1, Alpo4, Alpo6 and Alpo7, can be extracted out of the membrane by a wide variety of detergents while maintaining their oligomeric state. Finally, large-scale purification efforts of Alpo1, Alpo4 and Alpo6 resulted in milligram amounts of biochemically stable and monodisperse protein. Overall, our results establish the evolutionary conservation of glycine receptors in annelids and pave the way for future structural studies.	[Wijckmans, Eveline; Nys, Mieke; Debaveye, Sarah; Brams, Marijke; Ulens, Chris] Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, Leuven, Belgium; [Pardon, Els; Willegems, Katrien; Steyaert, Jan; Efremov, Rouslan] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Pardon, Els; Willegems, Katrien; Steyaert, Jan; Efremov, Rouslan] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Bertrand, Daniel] HiQscreen, Geneva, Switzerland	KU Leuven; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Nys, M (corresponding author), Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, Leuven, Belgium.	mieke.nys@med.kuleuven.be	Nys, Mieke/AAC-2859-2019; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; Efremov, Rouslan/P-9085-2015	Steyaert, Jan/0000-0002-3825-874X; Efremov, Rouslan/0000-0001-7516-8658; Nys, Mieke/0000-0003-3976-8538; Pardon, Els/0000-0002-2466-0172; Willegems, Katrien/0000-0003-1346-3701	KU Leuven Onderzoekstoelage [OT/13/095]; Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen [G.0939.11, G.0762.13]; Agency for Innovation by Science and Technology in Flanders (IWT) [131118]; Industrieel Onderzoeksfonds (IOF) in Flanders; INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI); Hercules Foundation Flanders; HiQscreen	KU Leuven Onderzoekstoelage(KU Leuven); Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Industrieel Onderzoeksfonds (IOF) in Flanders; INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI); Hercules Foundation Flanders; HiQscreen	Financial support was from KU Leuven Onderzoekstoelage OT/13/095 and Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen, http://www.fwo.be/en/, G.0939.11, G.0762.13 to CU. EW is a recipient of a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT), 131118, http://www.iwt.be/. EP is supported by the Industrieel Onderzoeksfonds (IOF) in Flanders. We thank INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI) and the Hercules Foundation Flanders for their support to the Nanobody discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HiQscreen provided support in the form of salary for author DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abskharon RNN, 2014, J AM CHEM SOC, V136, P937, DOI 10.1021/ja407527p; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BERTRAND D, 1990, P NATL ACAD SCI USA, V87, P1993, DOI 10.1073/pnas.87.5.1993; BIENZ M, 1982, CELL, V29, P811, DOI 10.1016/0092-8674(82)90443-3; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cheng H, 2015, ACTA PHARMACOL SIN, V36, P1013, DOI 10.1038/aps.2015.34; Chevaldonne P, 2000, MAR ECOL PROG SER, V208, P293, DOI 10.3354/meps208293; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Debont T, 1996, NEUROSCI RES, V24, P201, DOI 10.1016/0168-0102(95)00982-5; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Geertsma ER, 2015, NAT STRUCT MOL BIOL, V22, P803, DOI 10.1038/nsmb.3091; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holder T, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-2; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Juneja P, 2014, J BIOL CHEM, V289, P15130, DOI 10.1074/jbc.M113.525576; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Migita K, 2013, J PHARMACOL SCI, V121, P84, DOI 10.1254/jphs.12222SC; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Nishino A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-6; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rees DC, 2001, METHOD ENZYMOL, V334, P423; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tol MB, 2013, J BIOL CHEM, V288, P5756, DOI 10.1074/jbc.M112.422287; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	58	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151183	10.1371/journal.pone.0151183	http://dx.doi.org/10.1371/journal.pone.0151183			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999666	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700025
J	John, S; Seetharaman, S				John, Sona; Seetharaman, Sarada			Exploiting the Adaptation Dynamics to Predict the Distribution of Beneficial Fitness Effects	PLOS ONE			English	Article							CLONAL INTERFERENCE; ADAPTIVE WALKS; DIMINISHING RETURNS; MUTATIONS; SELECTION; SUBSTITUTIONS; RESISTANCE; LANDSCAPE; STEPS; COST	Adaptation of asexual populations is driven by beneficial mutations and therefore the dynamics of this process, besides other factors, depends on the distribution of beneficial fitness effects. It is known that on uncorrelated fitness landscapes, this distribution can only be of three types: truncated, exponential and power law. We performed extensive stochastic simulations to study the adaptation dynamics on rugged fitness landscapes, and identified two quantities that can be used to distinguish the underlying distribution of beneficial fitness effects. The first quantity studied here is the fitness difference between successive mutations that spread in the population, which is found to decrease in the case of truncated distributions, remains nearly a constant for exponentially decaying distributions and increases when the fitness distribution decays as a power law. The second quantity of interest, namely, the rate of change of fitness with time also shows quantitatively different behaviour for different beneficial fitness distributions. The patterns displayed by the two aforementioned quantities are found to hold good for both low and high mutation rates. We discuss how these patterns can be exploited to determine the distribution of beneficial fitness effects in microbial experiments.	[John, Sona; Seetharaman, Sarada] Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Jakkur PO, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	John, S (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Theoret Sci Unit, Jakkur PO, Bangalore 560064, Karnataka, India.	sonajohn@jncasr.ac.in	John, Sona/HGB-1723-2022	John, Sona/0000-0002-2827-0008				Bank C, 2015, MOL BIOL EVOL, V32, P229, DOI 10.1093/molbev/msu301; Bataillon T, 2011, GENETICS, V189, P939, DOI 10.1534/genetics.111.130468; Bull JJ, 2005, NAT GENET, V37, P342, DOI 10.1038/ng0405-342; Campos PRA, 2010, EVOLUTION, V64, P1973, DOI 10.1111/j.1558-5646.2010.00981.x; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Foll M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004185; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gifford DR, 2011, EVOLUTION, V65, P3070, DOI 10.1111/j.1558-5646.2011.01380.x; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Jain K, 2011, GENETICS, V189, P1029, DOI 10.1534/genetics.111.134163; Jain K, 2011, EVOLUTION, V65, P1945, DOI 10.1111/j.1558-5646.2011.01280.x; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; MacLean RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000406; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Orr HA, 2003, GENETICS, V163, P1519; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Park SC, 2010, J STAT PHYS, V138, P381, DOI 10.1007/s10955-009-9915-x; Park SC, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04014; Rokyta DR, 2009, J MOL EVOL, V69, P229, DOI 10.1007/s00239-009-9267-9; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rosenberg NA, 2005, J THEOR BIOL, V237, P17, DOI 10.1016/j.jtbi.2005.03.026; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Schenk MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002783; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Seetharaman S, 2011, THESIS JNCASR BANGAL; Seetharaman S, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032703; Seetharaman S, 2014, EVOLUTION, V68, P965, DOI 10.1111/evo.12327; Somette D, 2000, SPRINGER SERIES SYNE, P178; Sousa A, 2012, MOL BIOL EVOL, V29, P1417, DOI 10.1093/molbev/msr302; Wilke CO, 1999, PHYS REV E, V60, P2154, DOI 10.1103/PhysRevE.60.2154	37	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151795	10.1371/journal.pone.0151795	http://dx.doi.org/10.1371/journal.pone.0151795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990188	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800104
J	Murrell, B; Murrell, D; Murrell, H				Murrell, Ben; Murrell, Daniel; Murrell, Hugh			Discovering General Multidimensional Associations	PLOS ONE			English	Article							DENSITY-FUNCTION; COEFFICIENT	When two variables are related by a known function, the coefficient of determination (denoted R-2) measures the proportion of the total variance in the observations explained by that function. For linear relationships, this is equal to the square of the correlation coefficient, rho When the parametric form of the relationship is unknown, however, it is unclear how to estimate the proportion of explained variance equitably-assigning similar values to equally noisy relationships. Here we demonstrate how to directly estimate a generalised R2 when the form of the relationship is unknown, and we consider the performance of the Maximal Information Coefficient (MIC)-a recently proposed information theoretic measure of dependence. We show that our approach behaves equitably, has more power than MIC to detect association between variables, and converges faster with increasing sample size. Most importantly, our approach generalises to higher dimensions, estimating the strength of multivariate relationships (Y against A, B,...) as well as measuring association while controlling for covariates (Y against X controlling for C). An R package named matie ("Measuring Association and Testing Independence Efficiently")	[Murrell, Ben] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Murrell, Daniel] Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England; [Murrell, Hugh] Univ KwaZulu Natal, Comp Sci, Pietermaritzburg, South Africa	University of California System; University of California San Diego; University of Cambridge; University of Kwazulu Natal	Murrell, B (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	bmurrell@ucsd.edu	Murrell, Ben/AAM-1188-2021	Murrell, Ben/0000-0002-0393-4445	National Institute of Allergy and Infectious Diseases [K99AI120851]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K99AI120851] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BM is supported by K99AI120851 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Joel Wertheim for sharing BEAST log files with us, and Miguel Lacerda and Konrad Scheffler for helpful comments on the manuscript. BM is supported by K99AI120851 from the National Institute of Allergy and Infectious Diseases.	Cox DR., 1989, ANAL BINARY DATA; Hardie W., 2004, SPRINGER SERIES STAT, P39; Heller R, 2012, BIOMETRIKA; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Linfoot EH, 1957, INFORM CONTR, V1, P85, DOI DOI 10.1016/S0019-9958(57)90116-X; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Murrell B, 2014, P NATL ACAD SCI USA, V111, pE2160, DOI 10.1073/pnas.1403623111; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Reshef DN, 2015, EMPIRICAL STUDY LEAD; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Suzuki T, 2009, IEEE INT SYMP INFO, P463, DOI 10.1109/ISIT.2009.5205712; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Vincent P, 2002, ADV NEURAL INFORM PR, V15, P825; Wertheim JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011184	17	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151551	10.1371/journal.pone.0151551	http://dx.doi.org/10.1371/journal.pone.0151551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991498	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800075
J	Lozano-Ojalvo, D; Molina, E; Lopez-Fandino, R				Lozano-Ojalvo, Daniel; Molina, Elena; Lopez-Fandino, Rosina			Regulation of Exacerbated Immune Responses in Human Peripheral Blood Cells by Hydrolysed Egg White Proteins	PLOS ONE			English	Article							BALB/C MOUSE MODEL; IN-VITRO; ALLERGIC SENSITIZATION; ENZYMATIC-HYDROLYSIS; SOYBEAN ISOFLAVONES; IGE-BINDING; MAST-CELLS; PEPTIDES; MICE; IMMUNOTHERAPY	The anti-allergic potential of egg white protein hydrolysates (from ovalbumin, lysozyme and ovomucoid) was evaluated as their ability to hinder cytokine and IgE production by Th2-skewed human peripheral blood mononuclear cells (PBMCs), as well as the release of proinflammatory factors and generation of reactive oxygen species from Th1-stimulated peripheral blood leukocytes (PBLs). The binding to IgE of egg allergic patients was determined and the peptides present in the hydrolysates were identified. The hydrolysates with alcalase down-regulated the production of Th2-biased cytokines and the secretion of IgE to the culture media of Th2-skewed PBMCs, and they significantly neutralized oxidative stress in PBLs. The hydrolysates of ovalbumin and ovomucoid with pepsin helped to re-establish the Th1/Th2 balance in Th2-biased PBMCs, while they also inhibited the release of pro-inflammatory mediators and reduced oxidative stress in PBLs treated with inflammatory stimuli. The hydrolysates with alcalase, in addition to equilibrating Th2 differentiation, exhibited a low IgE-binding. Therefore, they would elicit mild allergic reactions while retaining T cell-stimulating abilities, which might correlate with an anti-allergic benefit.	[Lozano-Ojalvo, Daniel; Molina, Elena; Lopez-Fandino, Rosina] CSIC UAM, Inst Invest Ciencias Alimentac CIAL, Nicolas Cabrera 9, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)	Lopez-Fandino, R (corresponding author), CSIC UAM, Inst Invest Ciencias Alimentac CIAL, Nicolas Cabrera 9, Madrid 28049, Spain.	rosina.lopez@csic.es	López-Fandiño, Rosina/H-4132-2012; Molina, Elena/H-4055-2012; Lozano-Ojalvo, Daniel/AAH-6261-2019; Lozano-Ojalvo, Daniel/AAH-6278-2019	López-Fandiño, Rosina/0000-0002-6979-9258; Molina, Elena/0000-0001-7918-7768; Lozano-Ojalvo, Daniel/0000-0002-3524-2929; Lozano-Ojalvo, Daniel/0000-0002-3524-2929	Ministerio de Economia y Competitividad (MINECO, Spain) [AGL2014-59771-R]; Ministerio de Educacion, Cultura y Deporte (MECD, Spain)	Ministerio de Economia y Competitividad (MINECO, Spain); Ministerio de Educacion, Cultura y Deporte (MECD, Spain)(German Research Foundation (DFG))	Financial support was received from the project AGL2014-59771-R from Ministerio de Economia y Competitividad (MINECO, Spain). DL-O is recipient of a FPU fellowship from Ministerio de Educacion, Cultura y Deporte (MECD, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Benede S, 2014, J AGR FOOD CHEM, V62, P152, DOI 10.1021/jf404226w; Benede S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080810; Berin MC, 2013, CURR BIOL, V23, pR389, DOI 10.1016/j.cub.2013.02.043; Brix S, 2003, J ALLERGY CLIN IMMUN, V112, P1216, DOI 10.1016/j.jaci.2003.08.047; Cecilia M, 2008, J ALLERGY CLIN IMMUN, V121, P1311, DOI 10.1016/j.jaci.2008.04.023; Chicon R, 2006, J DAIRY RES, V73, P121, DOI 10.1017/S0022029905001664; Cosentino M, 2008, J ETHNOPHARMACOL, V116, P501, DOI 10.1016/j.jep.2007.12.014; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; Hacini-Rachinel F, 2014, INT ARCH ALLERGY IMM, V164, P64, DOI 10.1159/000363110; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Holvoet S, 2013, INT ARCH ALLERGY IMM, V161, P142, DOI 10.1159/000343703; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; Jimenez-Saiz R, 2014, MOL NUTR FOOD RES, V58, P614, DOI 10.1002/mnfr.201300442; Jimenez-Saiz R, 2013, FOOD HYDROCOLLOID, V30, P597, DOI 10.1016/j.foodhyd.2012.07.014; Kulis M, 2012, J ALLERGY CLIN IMMUN, V130, P716, DOI 10.1016/j.jaci.2012.05.044; Lopez-Exposito I, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-35; Masilamani M, 2012, IMMUNOL RES, V54, P95, DOI 10.1007/s12026-012-8331-5; Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009; Mine Y, 2004, J AGR FOOD CHEM, V52, P1088, DOI 10.1021/jf0345752; Moldaver D, 2011, ALLERGY, V66, P784, DOI 10.1111/j.1398-9995.2011.02610.x; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Park BK, 2013, J NUTR BIOCHEM, V24, P868, DOI 10.1016/j.jnutbio.2012.05.007; Pascal M, 2013, CLIN EXP ALLERGY, V43, P116, DOI 10.1111/cea.12014; Richard N, 2005, MOL NUTR FOOD RES, V49, P431, DOI 10.1002/mnfr.200400099; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Samaranayaka AGP, 2011, J FUNCT FOODS, V3, P229, DOI 10.1016/j.jff.2011.05.006; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Singh A, 2011, CLIN EXP ALLERGY, V41, P1346, DOI 10.1111/j.1365-2222.2011.03773.x; Untersmayr E, 2007, J ALLERGY CLIN IMMUN, V119, P711, DOI 10.1016/j.jaci.2006.10.039; van den Elsen LWJ, 2013, CLIN EXP ALLERGY, V43, P798, DOI 10.1111/cea.12111; van den Elsen LWJ, 2013, BRIT J NUTR, V109, P1821, DOI 10.1017/S0007114512003959; Yang M, 2010, CLIN EXP ALLERGY, V40, P668, DOI 10.1111/j.1365-2222.2009.03442.x; Yang M, 2009, J AGR FOOD CHEM, V57, P2241, DOI 10.1021/jf803372b; Yano S, 2007, EUR J NUTR, V46, P257, DOI 10.1007/s00394-007-0658-7; You SJ, 2010, FOOD RES INT, V43, P848, DOI 10.1016/j.foodres.2009.12.004; Zaknun D, 2012, INT ARCH ALLERGY IMM, V157, P113, DOI 10.1159/000329137; Zuercher AW, 2010, CLIN EXP ALLERGY, V40, P942, DOI 10.1111/j.1365-2222.2010.03460.x	40	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151813	10.1371/journal.pone.0151813	http://dx.doi.org/10.1371/journal.pone.0151813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007699	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200067
J	Lv, YP; Xue, C; Ge, Y; Ye, F; Liu, X; Liu, Y; Zhang, LL				Lv, Yipeng; Xue, Chen; Ge, Yang; Ye, Feng; Liu, Xu; Liu, Yuan; Zhang, Lulu			Analysis of Factors Influencing Inpatient and Outpatient Satisfaction with the Chinese Military Health Service	PLOS ONE			English	Article							PATIENT SATISFACTION; VISIT CHARACTERISTICS; DENTAL-CARE; PERCEPTIONS; COMMUNICATION; MEMBERS; PERSONNEL; SETTINGS; QUALITY; NURSES	Background Relatively few articles have focused on exploring factors influencing soldiers' overall satisfaction and differences between inpatients' and outpatients' satisfaction, particularly in the Chinese army. Elucidating factors influencing military inpatient and outpatient care separately and analyzing their differences may provide more information for the healthsystem. Methods The Revised China National Health Service Survey questionnaire was used in the survey. The questionnaire included 5 sections and 32 items concerning demographic, inpatient, and outpatient characteristics and perception variables for both inpatients and outpatients. Bivariate and multivariate techniques were used to reveal relationships between satisfaction and the variables assessed. Results Outpatients' and inpatients' overall satisfaction rates were 19.0% and 18.5%, respectively. The strongest determinant of outpatients' satisfaction was satisfaction with doctor's communication regarding therapeutic regimen followed by length of military service, level of trust in medical staff, and disease severity. Determinants of inpatients' satisfactionincludedstaff categories, satisfaction with environment, and satisfaction with medical quality. Conclusion The factors influencing military outpatients' satisfaction differed from those of inpatients. Exploring the causes of satisfaction and dissatisfaction with military health institutions is important in their fulfillment of their responsibility to maintain soldiers' health.	[Lv, Yipeng; Xue, Chen; Ge, Yang; Ye, Feng; Liu, Xu; Liu, Yuan; Zhang, Lulu] Second Mil Med Univ, Dept Mil Hlth Serv, Coll Mil Hlth Serv, Shanghai 200433, Peoples R China	Naval Medical University	Zhang, LL (corresponding author), Second Mil Med Univ, Dept Mil Hlth Serv, Coll Mil Hlth Serv, Shanghai 200433, Peoples R China.	zllrmit@aliyun.com			major project in the '12th Five-Year Plan' of the People's Liberation Army [AWS12J002]; National Nature Science Foundation Project of China [71233008]; joint research project of major diseases of Shanghai health system [2013ZYJB0006]; National Natural Science Foundation of China [71103194, 71303249, 91224005]; National Nature Science Foundation of China (NSFC); General Logistics Department	major project in the '12th Five-Year Plan' of the People's Liberation Army; National Nature Science Foundation Project of China(National Natural Science Foundation of China (NSFC)); joint research project of major diseases of Shanghai health system; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); General Logistics Department	The research was supported by the major project in the '12th Five-Year Plan' of the People's Liberation Army (LZ grant number: AWS12J002), the major program of National Nature Science Foundation Project of China (LZ grant number: 71233008), the joint research project of major diseases of Shanghai health system (LZ grant number 2013ZYJB0006), and the National Natural Science Foundation of China (YL grant number: 71103194, XL grant number: 71303249, LZ grant number: 91224005). These associations had no further role in the study design; collection, analysis, and interpretation of data; writing the paper; or the decision to submit the paper for publication.; This study was supported by the National Nature Science Foundation of China (NSFC) and the General Logistics Department. We are grateful to the participants for their patience in completing our survey and to all participating military officers and soldiers.	Abramowitz S, 1987, QRB Qual Rev Bull, V13, P122; Boudreaux ED, 2000, AM J EMERG MED, V18, P394, DOI 10.1053/ajem.2000.7316; Bredart A, 1998, SUPPORT CARE CANCER, V6, P518, DOI 10.1007/s005200050207; Campanella HC, 2000, MIL MED, V165, P396, DOI 10.1093/milmed/165.5.396; Chaffin Jeffrey G, 2007, J Dent Hyg, V81, P9; Chaffin JG, 2007, MILITARY MED; Chisick MC, 1998, MIL MED, V163, P813, DOI 10.1093/milmed/163.12.813; Chisick MC, 1999, MIL MED, V164, P874, DOI 10.1093/milmed/164.12.874; Fitzpatrick R., 1984, EXPERIENCE ILLNESS, P154; Flynn S, 2005, INT J ORTHOP TRAUMA, V9, P156, DOI 10.1016/j.joon.2005.06.002; Gan-Yadam A, 2013, J EPIDEMIOL, V23, P320, DOI 10.2188/jea.JE20120123; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Lee MA, 2007, INT J NURS STUD, V44, P545, DOI 10.1016/j.ijnurstu.2006.03.006; Leiba A, 2002, MIL MED, V167, P842, DOI 10.1093/milmed/167.10.842; March S, 2006, GESUNDHEITSWESEN, V68, P376, DOI 10.1055/s-2006-926868; McCabe C, 2004, J CLIN NURS, V13, P41, DOI 10.1111/j.1365-2702.2004.00817.x; McLafferty RB, 2006, SURGERY, V140, P616, DOI 10.1016/j.surg.2006.06.021; Newsome P, 1999, BRIT DENT J, V186; Quinn Gwendolyn P, 2004, Hosp Top, V82, P26, DOI 10.3200/HTPS.82.3.26-32; Rahmqvist M, 2001, INT J QUAL HEALTH C, V13, P385, DOI 10.1093/intqhc/13.5.385; RISSER NL, 1975, NURS RES, V24, P45; Schoenfelder T, 2011, OPHTHAL PHYSL OPT, V31, P580, DOI 10.1111/j.1475-1313.2011.00869.x; Schulmeister L, 2005, ONCOL NURS FORUM, V32, P57, DOI 10.1188/05.ONF.57-67; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Soufi G, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-149; Stimson G. V., 1975, GOING SEE DOCTOR CON; Szyca Robert, 2012, Pol Przegl Chir, V84, P136, DOI 10.2478/v10035-012-0022-3; Thi PLN, 2002, SOC SCI MED, V54, P493; THOMPSON B, 1990, OPTOMETRY VISION SCI, V67, P673, DOI 10.1097/00006324-199009000-00003; Wang HY, 2002, INT DENT J, V52, P283, DOI 10.1111/j.1875-595X.2002.tb00632.x; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Yang T, 2013, LANCET, V382, P1703, DOI 10.1016/S0140-6736(13)62401-0; Ziaei Hossain, 2011, BMC Res Notes, V4, P7, DOI 10.1186/1756-0500-4-7; Zimlichman E, 2004, MIL MED, V169, P385, DOI 10.7205/MILMED.169.5.385; Zimlichman E, 2003, MIL MED, V168, P471, DOI 10.1093/milmed/168.6.471	35	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151234	10.1371/journal.pone.0151234	http://dx.doi.org/10.1371/journal.pone.0151234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007805	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200044
J	Zapalski, MK; Berkowski, B; Wrzolek, T				Zapalski, Mikolaj K.; Berkowski, Blazej; Wrzolek, Tomasz			Tabulate Corals after the Frasnian/Famennian Crisis: A Unique Fauna from the Holy Cross Mountains, Poland	PLOS ONE			English	Article							YAVORSKIA TABULATA; GROWTH-PATTERN; TRIMEROCEPHALUS; BRACHIOPODS; ARDENNES; EXAMPLE; KOWALA; REGION; MIDDLE	Famennian tabulate corals were very rare worldwide, and their biodiversity was relatively low. Here we report a unique tabulate fauna from the mid-and late Famennian of the western part of the Holy Cross Mountains (Kowala and Ostrowka), Poland. We describe eight species (four of them new, namely ? Michelinia vinni sp. nov., Thamnoptychia mistiaeni sp. nov., Syringopora kowalensis sp. nov. and Syringopora hilarowiczi sp. nov.); the whole fauna consists of ten species (two others described in previous papers). These corals form two assemblages-the lower, mid-Famennian with Thamnoptychia and the upper, late Famennian with representatives of genera ? Michelinia, Favosites, Syringopora and ? Yavorskia. The Famennian tabulates from Kowala represent the richest Famennian assemblage appearing after the F/F crisis (these faunas appear some 10 Ma after the extinction event). Corals described here most probably inhabited deeper water settings, near the limit between euphotic and disphotic zones or slightly above. At generic level, these faunas show similarities to other Devonian and Carboniferous faunas, which might suggest their ancestry to at least several Carboniferous lineages. Tabulate faunas described here represent new recruits (the basin of the Holy Cross mountains was not a refuge during the F/F crisis) and have no direct evolutionary linkage to Frasnian faunas from Kowala. The colonization of the seafloor took place in two separate steps: first was monospecific assemblage of Thamnoptychia, and later came the diversified Favosites-Syringopora-Michelinia fauna.	[Zapalski, Mikolaj K.] Univ Warsaw, Fac Geol, Warsaw, Poland; [Berkowski, Blazej] Adam Mickiewicz Univ, Inst Geol, Poznan, Poland; [Wrzolek, Tomasz] Univ Silesia, Fac Earth Sci, Sosnowiec, Poland	University of Warsaw; Adam Mickiewicz University; University of Silesia in Katowice	Zapalski, MK (corresponding author), Univ Warsaw, Fac Geol, Warsaw, Poland.	m.zapalski@uw.edu.pl	Zapalski, Mikolaj/D-6359-2017; Berkowski, Blazej/A-1244-2008	Zapalski, Mikolaj/0000-0002-9853-3707; Berkowski, Blazej/0000-0001-7249-0182; Wrzolek, Tomasz/0000-0002-1467-8969	University of Warsaw, Faculty of Geology; Adam Mickiewicz University, Faculty of Geographical and Geological Sciences	University of Warsaw, Faculty of Geology; Adam Mickiewicz University, Faculty of Geographical and Geological Sciences	The research has been funded by the University of Warsaw, Faculty of Geology (funding for MKZ) and Adam Mickiewicz University, Faculty of Geographical and Geological Sciences (funding for BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELKA Z., 2008, GEOLOGY CENTRAL EURO, P383, DOI DOI 10.1144/CEV1P.8; BERKOWSKI B, 1991, Acta Palaeontologica Polonica, V36, P255; Berkowski Blazej, 2002, Palaeontologia Polonica, V61, P3; Berkowski B, 2014, LETHAIA, V47, P176, DOI 10.1111/let.12048; Berkowski Blazej, 2001, Bulletin of the Tohoku University Museum, V1, P285; Copper P, 2002, PALAEOGEOGR PALAEOCL, V181, P27, DOI 10.1016/S0031-0182(01)00472-2; Coronado I, 2015, PALAEONTOLOGY, V58, P111, DOI 10.1111/pala.12127; Czarnocki J., 1989, PRACE PANSTWOWEGO I, V127, P5; De Vleeschouwer D, 2013, EARTH PLANET SC LETT, V365, P25, DOI 10.1016/j.epsl.2013.01.016; Denayer J, 2014, J ASIAN EARTH SCI, V79, P345, DOI 10.1016/j.jseaes.2013.10.012; Dubatolov VN, 1977, T I GIEOLOGII GIEOFI, V336, P3; Dubatolov VN, 1963, POZDENSILURIISKIE DE; Dzik J., 1997, ACTA PALAEONTOLOGICA, V47, P565; Dzik Jerzy, 2006, Palaeontologia Polonica, V63, P1; Feist Raimund, 1994, Courier Forschungsinstitut Senckenberg, V169, P195; Gerth H., 1921, PALAONTOLOGIE TIMOR, V11, P67; Halamski AT, 2009, ACTA PALAEONTOL POL, V54, P289, DOI 10.4202/app.2007.0066; Hill D., 1981, TREATISE INVERTEBRAT, pF430; Hubert BLM, 2007, ACTA GEOL POL, V57, P223; JOHNSON JG, 1985, GEOL SOC AM BULL, V96, P567, DOI 10.1130/0016-7606(1985)96<567:DEFIE>2.0.CO;2; Kin A, 2013, ZOOTAXA, V3626, P345, DOI 10.11646/zootaxa.3626.3.3; Kowala Malec J., 1995, 13 INT C CARB PERM A, P15; Kozur H., 1991, GEOL PALAONT MITT IN, V3, P25; Kuhn A, 1995, GEOL Q, V39, P43; LAFUSTE J, 1988, GEOBIOS-LYON, V21, P515, DOI 10.1016/S0016-6995(88)80048-2; Malec J, 2014, GEOL Q, V58, P217, DOI 10.7306/gq.1142; Marynowski L, 2000, SEDIMENT GEOL, V137, P187, DOI 10.1016/S0037-0738(00)00157-3; Marynowski L, 2007, GEOL MAG, V144, P569, DOI 10.1017/S0016756807003317; Marynowski L, 2012, PALAEOGEOGR PALAEOCL, V346, P66, DOI 10.1016/j.palaeo.2012.05.020; Marynowski L, 2010, GEOL MAG, V147, P527, DOI 10.1017/S0016756809990835; May Andreas, 2006, Bulletin of Geosciences, V81, P163, DOI 10.3140/bull.geosci.2006.03.163; Motus Mari-Ann, 2006, Proceedings of the Estonian Academy of Sciences Geology, V55, P24; NELSON SJ, 1962, J PALEONTOL, V36, P953; Nowinski A., 1992, ACTA PALAENTOL POL, V37, P183; Nowinski A., 1976, PALAEONTOLOGIA POLON, V35, P3; OGG JG, 1987, INITIAL REPORTS DEEP, V93, P1305; Olempska E, 1997, ACTA PALAEONTOL POL, V42, P291; Pisarzowska A, 2006, ACTA PALAEONTOL POL, V51, P609; Poty E, 1999, PALAEOGEOGR PALAEOCL, V154, P11, DOI 10.1016/S0031-0182(99)00084-X; Radwanski A, 2009, ACTA GEOL POL, V59, P459; Rozkowska M., 1969, Acta Palaeontologica Polonica, V14, P5; SHILO N A, 1984, Annales de la Societe Geologique de Belgique, V107, P137; SIMAKOV K V, 1983, Annales de la Societe Geologique de Belgique, V106, P335; Sokolov BS, 1952, CHAST 4 DEVON RUSSKO; STASINSKA A, 1973, Acta Geologica Polonica, V23, P83; STASINSKA ANNA, 1958, ACTA PALEONTOL POLONICA, V3, P161; SZULCZEWSKI M, 1971, Acta Geologica Polonica, V21, P1; SZULCZEWSKI M, 1973, Acta Geologica Polonica, V23, P15; SZULCZEWSKI M, 1978, Acta Geologica Polonica, V28, P283; Szulczewski M, 1996, SEDIMENT GEOL, V106, P21, DOI 10.1016/0037-0738(95)00145-X; Szulczewski M., 1995, 13 INT C CARB PERM G, P18; Szulczewski M., 1995, GEOL Q, V39, P471; Talent JA, 1986, SENCKENBERG LETH, V69, P315; TCHUDINOVA II, 1974, J PALEONTOL, V48, P124; Tchudinova II., 1970, NOVYE VIDY PALIEOZOI, P97; Tchudinova II, 1986, SOSTAV SISTEMA FILOG; Tourneur F., 1985, THESIS U CATHOLIQUE; Weyer D., 1997, CORAL RES B, V5, P247; Weyer D., 1976, HB GEOLOGIE, V7-8, P353; Wood R. A., 1999, REEF EVOLUTION; Zapalski MK, 2007, B SOC GEOL FR, V178, P383, DOI 10.2113/gssgfbull.178.5.383; Zapalski MK, 2008, ACTA GEOL POL, V58, P321; Zapalski MK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2663; Zapalski MK, 2013, LETHAIA, V46, P223, DOI 10.1111/let.12005; Zapalski MK, 2012, SPEC PAP PALAEONTOL, P5; Zapalski MK, 2012, ACTA GEOL POL, V62, P197; Zapalski MK, 2012, PALAEONTOLOGY, V55, P697, DOI 10.1111/j.1475-4983.2012.01141.x; Zapalski MK, 2011, GEODIVERSITAS, V33, P541, DOI 10.5252/g2011n4a1	68	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0149767	10.1371/journal.pone.0149767	http://dx.doi.org/10.1371/journal.pone.0149767			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007689	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200019
J	Kong, BS; Im, SJ; Lee, YJ; Cho, YH; Do, YR; Byun, JW; Ku, CR; Lee, EJ				Kong, Byung Soo; Im, Soo Jung; Lee, Yang Jong; Cho, Yoon Hee; Do, Yu Ri; Byun, Jung Woo; Ku, Cheol Ryong; Lee, Eun Jig			Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; MATRIX METALLOPROTEINASE-2 EXPRESSION; MIGRATION; ATHEROSCLEROSIS; DEHYDROGENASE; INHIBITORS	3-hydroxybenzaldehyde (3-HBA) is a precursor compound for phenolic compounds like Protocatechuic aldehyde (PCA). From recent reports, PCA has shown vasculoprotective potency, but the effects of 3-HBA remain unclear. The aim of this study is to investigate the vasculoprotective effects of 3-HBA in endothelial cells, vascular smooth muscle cells and various animal models. We tested effects of 3-HBA in both vitro and vivo. 3-HBA showed that it prevents PDGF-induced vascular smooth muscle cells (VSMCs) migration and proliferation from MTS, BrdU assays and inhibition of AKT phosphorylation. It arrested S and G0/G1 phase of VSMC cell cycle in PI staining and it also showed inhibited expression levels of Rb1 and CD1. In human umbilical vein endothelial cells (HUVECs), 3-HBA inhibited inflammatory markers and signaling molecules (VCAM-1, ICAM-1, p-NF-kappa B and p-p38). For ex vivo, 3-HBA has shown dramatic effects in suppressing the sprouting from aortic ring of Spargue Dawley (SD) rats. In vivo data supported the vasculoprotective effects of 3-HBA as it inhibited angiogenesis from Matrigel Plug assay in C57BL6mouse, prevented ADP-induced thrombus generation, increased blood circulation after formation of thrombus, and attenuated neointima formation induced by common carotid artery balloon injury of SD rats. 3-HBA, a novel therapeutic agent, has shown vasculoprotective potency in both in vitro and in vivo.	[Kong, Byung Soo; Im, Soo Jung; Lee, Yang Jong; Byun, Jung Woo] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Kong, Byung Soo; Im, Soo Jung; Lee, Yang Jong; Cho, Yoon Hee; Do, Yu Ri; Byun, Jung Woo; Ku, Cheol Ryong; Lee, Eun Jig] Yonsei Univ, Coll Med, Endocrinol, Inst Endocrine Res, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Lee, EJ (corresponding author), Yonsei Univ, Coll Med, Endocrinol, Inst Endocrine Res, Seoul, South Korea.	ejlee423@yuhs.ac		Ku, Cheol Ryong/0000-0001-8693-9630; Lee, Eun Jig/0000-0002-9876-8370; Kong, ByungSoo/0000-0002-7916-7422	Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea [A085136]	Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant (A085136) from the Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea (http://www.nrf.re.kr/nrf).	[Anonymous], 2006, INT J TOXICOL, V25, P11, DOI 10.1080/10915910600716612; Arican D, 2013, ORG LETT, V15, P2582, DOI 10.1021/ol400510j; Barradas S, 2012, ORG LETT, V14, P5952, DOI 10.1021/ol302858r; Cai XL, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-96; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Chen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122577; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Cui Y, 2014, MOL CELL BIOCHEM, V393, P255, DOI 10.1007/s11010-014-2068-5; FORRESTER PI, 1972, BIOCHEMISTRY-US, V11, P1108, DOI 10.1021/bi00756a026; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Furuno K, 2002, BIOL PHARM BULL, V25, P19, DOI 10.1248/bpb.25.19; Gao J, 2008, J BIOMOL SCREEN, V13, P648, DOI 10.1177/1087057108320545; Han HS, 2014, ENDOCRINOL METAB, V29, P435, DOI 10.3803/EnM.2014.29.4.435; Jeong HJ, 2006, BIOORG MED CHEM LETT, V16, P5576, DOI 10.1016/j.bmcl.2006.08.031; Jeong JY, 2013, ENDOCRINOL METAB, V28, P288, DOI 10.3803/EnM.2013.28.4.288; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KLUWE WM, 1983, FOOD CHEM TOXICOL, V21, P245, DOI 10.1016/0278-6915(83)90055-8; Kong BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113242; Lee HJ, 2014, CURR MED CHEM, V21, P3095, DOI 10.2174/0929867321666140601195940; Ma L, 2015, EUR J PHARMACOL, V755, P102, DOI 10.1016/j.ejphar.2015.02.039; Ma YL, 2014, INT J MOL SCI, V15, P16611, DOI 10.3390/ijms150916611; MARSELOS M, 1988, TOXICOL APPL PHARM, V95, P339, DOI 10.1016/0041-008X(88)90170-6; Melian A, 1999, AM J PATHOL, V155, P775, DOI 10.1016/S0002-9440(10)65176-0; Miyabe M, 2014, CARDIOVASC RES, V103, P111, DOI 10.1093/cvr/cvu105; Moon CY, 2012, BIOCHEM BIOPH RES CO, V423, P116, DOI 10.1016/j.bbrc.2012.05.092; Rauch BH, 2000, FEBS LETT, V481, P3, DOI 10.1016/S0014-5793(00)01957-8; Rocha GM, 2001, P NATL ACAD SCI USA, V98, P5317, DOI 10.1073/pnas.091057698; Sabir M, 2014, CELL ONCOL, V37, P203, DOI 10.1007/s13402-014-0173-9; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Singh V, 2015, BRIT J NUTR, V113, P100, DOI 10.1017/S0007114514003195; Song W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111093; Thanigaimalai P, 2010, BIOORG MED CHEM LETT, V20, P2991, DOI 10.1016/j.bmcl.2010.02.067; Wang M, 2013, BIOORG MED CHEM LETT, V23, P524, DOI 10.1016/j.bmcl.2012.11.031; Wang RS, 2002, DRUG METAB DISPOS, V30, P69, DOI 10.1124/dmd.30.1.69; Xu SX, 2015, THROMB RES, V135, P137, DOI 10.1016/j.thromres.2014.10.034; Yi L, 2012, BIOCHIMIE, V94, P2035, DOI 10.1016/j.biochi.2012.05.027; Yoo SJ, 2014, ENDOCRINOL METAB, V29, P356, DOI 10.3803/EnM.2014.29.3.356; Yu X, 2015, CURR VASC PHARM; Zhang WC, 2015, CARDIOVASC RES, V106, P453, DOI 10.1093/cvr/cvv110	40	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149394	10.1371/journal.pone.0149394	http://dx.doi.org/10.1371/journal.pone.0149394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002821	gold, Green Submitted, Green Published			2022-12-27	WOS:000372697400009
J	Duarte, M; Costa, V; Gomes, J; Rodrigues, T; Silva, F; Oliveira, SM; Christensen, AL				Duarte, Miguel; Costa, Vasco; Gomes, Jorge; Rodrigues, Tiago; Silva, Fernando; Oliveira, Sancho Moura; Christensen, Anders Lyhne			Evolution of Collective Behaviors for a Real Swarm of Aquatic Surface Robots	PLOS ONE			English	Article							SELF-ORGANIZING BEHAVIORS; AUTONOMOUS ROBOTS; NEURO-CONTROLLERS; GROUP TRANSPORT; NETWORKS; DESIGN	Swarm robotics is a promising approach for the coordination of large numbers of robots. While previous studies have shown that evolutionary robotics techniques can be applied to obtain robust and efficient self-organized behaviors for robot swarms, most studies have been conducted in simulation, and the few that have been conducted on real robots have been confined to laboratory environments. In this paper, we demonstrate for the first time a swarm robotics system with evolved control successfully operating in a real and uncontrolled environment. We evolve neural network-based controllers in simulation for canonical swarm robotics tasks, namely homing, dispersion, clustering, and monitoring. We then assess the performance of the controllers on a real swarm of up to ten aquatic surface robots. Our results show that the evolved controllers transfer successfully to real robots and achieve a performance similar to the performance obtained in simulation. We validate that the evolved controllers display key properties of swarm intelligence-based control, namely scalability, flexibility, and robustness on the real swarm. We conclude with a proof-of-concept experiment in which the swarm performs a complete environmental monitoring task by combining multiple evolved controllers.	[Duarte, Miguel; Costa, Vasco; Gomes, Jorge; Rodrigues, Tiago; Silva, Fernando; Oliveira, Sancho Moura; Christensen, Anders Lyhne] BioMachines Lab, Lisbon, Portugal; [Duarte, Miguel; Costa, Vasco; Gomes, Jorge; Rodrigues, Tiago; Silva, Fernando; Oliveira, Sancho Moura; Christensen, Anders Lyhne] Inst Telecomunicacoes, Lisbon, Portugal; [Duarte, Miguel; Costa, Vasco; Rodrigues, Tiago; Oliveira, Sancho Moura; Christensen, Anders Lyhne] Inst Univ Lisboa ISCTE IUL, Lisbon, Portugal; [Gomes, Jorge; Silva, Fernando] Univ Lisbon, Fac Ciencias, BioISI, Lisbon, Portugal	Instituto de Telecomunicacoes; Instituto Universitario de Lisboa; BIOISI; Universidade de Lisboa	Duarte, M (corresponding author), BioMachines Lab, Lisbon, Portugal.; Duarte, M (corresponding author), Inst Telecomunicacoes, Lisbon, Portugal.; Duarte, M (corresponding author), Inst Univ Lisboa ISCTE IUL, Lisbon, Portugal.	miguel_duarte@iscte.pt	Oliveira, Sancho M/H-6443-2011; Christensen, Anders Lyhne/E-3384-2010; Gomes, Jorge/U-5840-2017	Oliveira, Sancho M/0000-0003-1391-3194; Christensen, Anders Lyhne/0000-0002-9994-2908; Gomes, Jorge/0000-0002-4684-209X; Costa, Vasco/0000-0003-4840-5157	Fundacao para Ciencia e Tecnologia (FCT) [SFRH/BD/76438/2011, SFRH/BD/89095/2012, SFRH/BD/89573/2012, EXPL/EEI-AUT/0329/2013, UID/EEA/50008/2013]; Fundação para a Ciência e a Tecnologia [EXPL/EEI-AUT/0329/2013] Funding Source: FCT	Fundacao para Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	MD acknowledges support from Fundacao para Ciencia e Tecnologia (FCT), of which he is a doctoral researcher (grant number SFRH/BD/76438/2011). JG acknowledges support from Fundacao para Ciencia e Tecnologia (FCT), of which he is a doctoral researcher (grant number SFRH/BD/89095/2012). FS acknowledges support from Fundacao para Ciencia e Tecnologia (FCT), of which he is a doctoral researcher (grant number SFRH/BD/89573/2012). The work presented in this paper was supported by Fundacao para Ciencia e Tecnologia (FCT) with the projects CORATAM (grant number EXPL/EEI-AUT/0329/2013) and HANCAD (grant number UID/EEA/50008/2013).	Ampatzis C, 2008, ADAPT BEHAV, V16, P5, DOI 10.1177/1059712307087282; Baldassarre G, 2003, ARTIF LIFE, V9, P255, DOI 10.1162/106454603322392460; Baldassarre G, 2007, IEEE T SYST MAN CY B, V37, P224, DOI 10.1109/TSMCB.2006.881299; Basiri M, 2014, IEEE INT CONF ROBOT, P4729, DOI 10.1109/ICRA.2014.6907551; Batalin MA, 2002, DISTRIBUTED AUTONOMOUS ROBOTIC SYSTEMS 5, P373; Bayindir Levent, 2007, Turkish Journal Electrical Engineering and Computer Sciences, Elektrik, V15, P115; Bayindir L., 2015, NEUROCOMPUT IN PRESS; Bongard JC, 2013, COMMUN ACM, V56, P74, DOI [10.1145/2493883, 10.1145/2492007.2493883]; Bongard JC, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION COMPANION (GECCO'12), P1405; Camazine S., 2003, SELF ORG BIOL SYSTEM; Celis S, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P3403; Christensen AL, 2008, AUTON ROBOT, V24, P49, DOI 10.1007/s10514-007-9060-9; Christensen AL, 2006, LECT NOTES COMPUT SC, V4095, P473; Christensen Anders Lyhne, 2006, ARTIFICIAL LIFE X, P248; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; De Cubber G., 2013, SAF SEC RESC ROB SSR, P1, DOI DOI 10.1109/SSRR.2013.6719323; Doncieux S, 2015, FRONTIERS ROBOTICS A, V2, P4, DOI [10.3389/frobt.2015.00004, DOI 10.3389/FR0BT.2015.00004]; Doncieux S, 2014, EVOL INTELL, V7, P71, DOI 10.1007/s12065-014-0110-x; Dorigo M, 2004, AUTON ROBOT, V17, P223, DOI 10.1023/B:AURO.0000033973.24945.f3; Dorigo Marco, 2013, IEEE Robotics & Automation Magazine, V20, P60, DOI 10.1109/MRA.2013.2252996; Duarte M, 2016, P 18 EUR C IN PRESS; Duarte M, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P785, DOI 10.7551/978-0-262-32621-6-ch127; Duarte M, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P657, DOI 10.7551/978-0-262-32621-6-ch105; Duarte M, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P210, DOI 10.7551/978-0-262-32621-6-ch035; Duarte M, 2015, J INTELL ROBOT SYST, V78, P463, DOI 10.1007/s10846-014-0086-x; Floreano D, 1996, IEEE T SYST MAN CY B, V26, P396, DOI 10.1109/3477.499791; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; Francesca G, 2014, LECT NOTES COMPUT SC, V8667, P25, DOI 10.1007/978-3-319-09952-1_3; Gomes J., 2016, EVOLUTIONAR IN PRESS; Gomes J, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P199; Gomes J, 2013, SWARM INTELL-US, V7, P115, DOI 10.1007/s11721-013-0081-z; Gomez F, 1997, ADAPT BEHAV, V5, P317, DOI 10.1177/105971239700500305; Gross R, 2008, ADAPT BEHAV, V16, P285, DOI 10.1177/1059712308090537; Gross R, 2009, INT J BIO-INSPIR COM, V1, P1, DOI 10.1504/IJBIC.2009.022770; Haasdijk E, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P187; Hauert S, 2009, AUTON ROBOT, V26, P21, DOI 10.1007/s10514-008-9104-9; Jakobi N, 1997, ADAPT BEHAV, V6, P325, DOI 10.1177/105971239700600205; Jones C, 2006, SIGN PROC COMMUN SER, P549; Khaldi B., 2015, INT J COMPUT APPL, V126, DOI [10.5120/ijca2015906000, DOI 10.5120/IJCA2015906000]; Koos S, 2013, IEEE T EVOLUT COMPUT, V17, P122, DOI 10.1109/TEVC.2012.2185849; Lee WP, 1999, INFORM SCIENCES, V121, P1, DOI 10.1016/S0020-0255(99)00078-X; Lehman J, 2013, ADAPT BEHAV, V21, P484, DOI 10.1177/1059712313487390; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Lindsey Q, 2012, AUTON ROBOT, V33, P323, DOI 10.1007/s10514-012-9305-0; Lipson H, 2000, NATURE, V406, P974, DOI 10.1038/35023115; Manley J. E., 2008, UNMANNED SURFACE VEH, V2008, P1, DOI DOI 10.1109/OCEANS.2008.5152052; Marques L, 2006, AUTON ROBOT, V20, P277, DOI 10.1007/s10514-006-7567-0; Miglino O, 1995, Artif Life, V2, P417, DOI 10.1162/artl.1995.2.4.417; Mondada F, 2004, AUTON ROBOT, V17, P193, DOI 10.1023/B:AURO.0000033972.50769.1c; Mondada F., 1999, PROC 1 INT KHEPERA W, P7; Mondada F., 2009, P 9 C AUT ROB SYST C, V1, P59; Moore JM, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P239; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Mouret JB, 2008, LECT NOTES ARTIF INT, V5040, P210; Nelson AL, 2009, ROBOT AUTON SYST, V57, P345, DOI 10.1016/j.robot.2008.09.009; Nolfi S, 1998, CONNECT SCI, V10, P167, DOI 10.1080/095400998116396; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Pini G, 2008, CONNECT SCI, V20, P211, DOI 10.1080/09540090802092014; Pinto E, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS IEEE-ROBIO 2014, P443, DOI 10.1109/ROBIO.2014.7090371; Praczyk T, 2014, SOFT COMPUT, V18, P2445, DOI 10.1007/s00500-014-1221-0; Reif JH, 1999, ROBOT AUTON SYST, V27, P171, DOI 10.1016/S0921-8890(99)00004-4; Sahin E, 2005, LECT NOTES COMPUT SC, V3342, P10; Scerri P., 2012, P INT C AUT AG MULT, V3, P1213; Schmickl T., 2011, Proceedings of the 2011 Fifth IEEE Conference on Self-Adaptive and Self-Organizing Systems Workshops (SASOW 2011), P120, DOI 10.1109/SASOW.2011.11; Silva F, 2016, EVOLUTIONAR IN PRESS; Silva F., 2012, ARTIFICIAL LIFE, P251, DOI DOI 10.7551/978-0-262-31050-5-CH034; Silva F, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS & MULTIAGENT SYSTEMS (AAMAS'15), P735; Soysal Onur, 2007, Turkish Journal Electrical Engineering and Computer Sciences, Elektrik, V15, P199; Sperati Valerio, 2008, Swarm Intelligence, V2, P73, DOI 10.1007/s11721-008-0017-1; Sperati V, 2011, SWARM INTELL-US, V5, P97, DOI 10.1007/s11721-011-0055-y; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Stein M.L., 1999, INTERPOLATION SPATIA; Tarapore D, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/1/016014; Trianni V, 2006, ROBOT AUTON SYST, V54, P97, DOI 10.1016/j.robot.2005.09.018; Trianni V, 2003, LECT NOTES ARTIF INT, V2801, P865; Trianni V, 2011, ARTIF LIFE, V17, P183, DOI 10.1162/artl_a_00031; Wagner IA, 1999, IEEE T ROBOTIC AUTOM, V15, P918, DOI 10.1109/70.795795; Yan RJ, 2010, J MAR SCI APPL, V9, P451, DOI 10.1007/s11804-010-1033-2	79	64	65	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151834	10.1371/journal.pone.0151834	http://dx.doi.org/10.1371/journal.pone.0151834			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999614	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700069
J	Lewin, GR; Johnson, AL; Soto, RDM; Perry, K; Book, AJ; Horn, HA; Pinto-Tomas, AA; Currie, CR				Lewin, Gina R.; Johnson, Amanda L.; Moreira Soto, Rolando D.; Perry, Kailene; Book, Adam J.; Horn, Heidi A.; Pinto-Tomas, Adrian A.; Currie, Cameron R.			Cellulose-Enriched Microbial Communities from Leaf-Cutter Ant (Atta colombica) Refuse Dumps Vary in Taxonomic Composition and Degradation Ability	PLOS ONE			English	Article							SP-NOV.; CUTTING ANT; CD-HIT; BACTERIAL; DIVERSITY; DISCOVERY; DECOMPOSITION; BIODIVERSITY; HERBIVORY; DIGESTION	Deconstruction of the cellulose in plant cell walls is critical for carbon flow through ecosystems and for the production of sustainable cellulosic biofuels. Our understanding of cellulose deconstruction is largely limited to the study of microbes in isolation, but in nature, this process is driven by microbes within complex communities. In Neotropical forests, microbes in leaf-cutter ant refuse dumps are important for carbon turnover. These dumps consist of decaying plant material and a diverse bacterial community, as shown here by electron microscopy. To study the portion of the community capable of cellulose degradation, we performed enrichments on cellulose using material from five Atta colombica refuse dumps. The ability of enriched communities to degrade cellulose varied significantly across refuse dumps. 16S rRNA gene amplicon sequencing of enriched samples identified that the community structure correlated with refuse dump and with degradation ability. Overall, samples were dominated by Bacteroidetes, Gammaproteobacteria, and Betaproteobacteria. Half of abundant operational taxonomic units (OTUs) across samples were classified within genera containing known cellulose degraders, including Acidovorax, the most abundant OTU detected across samples, which was positively correlated with cellulolytic ability. A representative Acidovorax strain was isolated, but did not grow on cellulose alone. Phenotypic and compositional analyses of enrichment cultures, such as those presented here, help link community composition with cellulolytic ability and provide insight into the complexity of community-based cellulose degradation.	[Lewin, Gina R.; Johnson, Amanda L.; Perry, Kailene; Book, Adam J.; Currie, Cameron R.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Lewin, Gina R.; Johnson, Amanda L.; Perry, Kailene; Book, Adam J.; Horn, Heidi A.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Moreira Soto, Rolando D.; Pinto-Tomas, Adrian A.] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica; [Moreira Soto, Rolando D.] Univ Costa Rica, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Fac Med, Dept Bioquim, San Jose, Costa Rica; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica	Currie, CR (corresponding author), Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA.; Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	currie@bact.wisc.edu	Lewin, Gina/ADZ-5997-2022	Lewin, Gina/0000-0002-1189-6696	Great Lakes Bioenergy Research Center [Department of Energy, Office of Science, Biological and Environmental Research] [DE-FC02-07ER64494]; National Science Foundation [DGE-1256259, DEB-0747002, MCB-0702025]; National Institutes of Health [National Research Service Award] [T32 GM07215]; UW-Madison's Hilldale Undergraduate/Faculty Research Fellowship; University of Costa Rica; Costa Rican Ministry of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; Division Of Environmental Biology [0747002] Funding Source: National Science Foundation	Great Lakes Bioenergy Research Center [Department of Energy, Office of Science, Biological and Environmental Research](United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health [National Research Service Award](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW-Madison's Hilldale Undergraduate/Faculty Research Fellowship; University of Costa Rica; Costa Rican Ministry of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Great Lakes Bioenergy Research Center [Department of Energy, Office of Science, Biological and Environmental Research DE-FC02-07ER64494, http://science.energy.gov/ber/]; the National Science Foundation [DGE-1256259 to GRL, DEB-0747002, and MCB-0702025, http://www.nsf.gov/]; the National Institutes of Health [National Research Service Award T32 GM07215, http://www.nih.gov/]; the UW-Madison's Hilldale Undergraduate/Faculty Research Fellowship to ALJ and CRC [http://awards.advising.wisc.edu/hilldale-undergraduatefaculty-research-fellowship/]; and support from the University of Costa Rica [http://www.ucr.ac.cr/] and the Costa Rican Ministry of Science and Technology [https://www.micit.go.cr/] to RDMS and AAPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; An DS, 2005, INT J SYST EVOL MICR, V55, P1625, DOI 10.1099/ijs.0.63695-0; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Brumm PJ, 2013, BIOFUELS-UK, V4, P669, DOI 10.4155/BFS.13.44; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Choi JH, 2010, INT J SYST EVOL MICR, V60, P2715, DOI 10.1099/ijs.0.019661-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa AN, 2008, J VEG SCI, V19, P849, DOI 10.3170/2008-8-18461; DeAngelis KM, 2012, MBIO, V3, DOI 10.1128/mBio.00249-11; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eichorst SA, 2013, ENVIRON MICROBIOL, V15, P2573, DOI 10.1111/1462-2920.12159; ELNAKEEB MA, 1963, APPL MICROBIOL, V11, P75, DOI 10.1128/AEM.11.2.75-77.1963; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gladden John M, 2011, Appl Environ Microbiol, V77, P5804, DOI 10.1128/AEM.00032-11; Hattenschwiler S, 2011, CR BIOL, V334, P393, DOI 10.1016/j.crvi.2011.03.001; HAINES BL, 1978, BIOTROPICA, V10, P270, DOI 10.2307/2387679; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Herz H, 2007, BIOTROPICA, V39, P476, DOI 10.1111/j.1744-7429.2007.00283.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hudson TM, 2009, SOIL BIOL BIOCHEM, V41, P1088, DOI 10.1016/j.soilbio.2009.02.014; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Kato S, 2008, MICROB ECOL, V56, P403, DOI 10.1007/s00248-007-9357-4; Khianngam S, 2012, INT J SYST EVOL MICR, V62, P1921, DOI 10.1099/ijs.0.032607-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEMBECK WJ, 1967, APPL MICROBIOL, V15, P300, DOI 10.1128/AEM.15.2.300-303.1967; Li P, 2009, 2008 INTERNATIONAL WORKSHOP ON EDUCATION TECHNOLOGY AND TRAINING AND 2008 INTERNATIONAL WORKSHOP ON GEOSCIENCE AND REMOTE SENSING, VOL 2, PROCEEDINGS,, P344, DOI 10.1109/ETTandGRS.2008.117; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Magurran A.E, 2004, MEASURING BIOL DIVER; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mendes LW, 2015, MICROB ECOL, V70, P255, DOI 10.1007/s00248-014-0559-2; Miller M.A., 2010, P GAT COMP ENV WORKS; Moreira-Soto RD, ULTRASTRUCTURAL MICR; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Poulsen M, 2014, P NATL ACAD SCI USA, V111, P14500, DOI 10.1073/pnas.1319718111; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Reichenbach H, 2006, PROKARYOTES, V7, P549, DOI DOI 10.1007/0-387-30747-8_20; Riederer A, 2011, APPL ENVIRON MICROB, V77, P1243, DOI 10.1128/AEM.02008-10; Rivas R, 2006, INT J SYST EVOL MICR, V56, P2777, DOI 10.1099/ijs.0.64480-0; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Schlesner H., 2006, PROKARYOTES, V7, P881, DOI [10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Scott JJ, 2011, MICROBIAL COMMUNITY; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANCE I, 1980, J GEN MICROBIOL, V117, P235; Voelskow H., 1988, FORUM MIKROBIOL, V6, P273; Wang CM, 2008, LETT APPL MICROBIOL, V47, P46, DOI 10.1111/j.1472-765X.2008.02385.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEIMER PJ, 1990, APPL ENVIRON MICROB, V56, P2421, DOI 10.1128/AEM.56.8.2421-2429.1990; Weon HY, 2009, INT J SYST EVOL MICR, V59, P1685, DOI 10.1099/ijs.0.004838-0; Willems A, 2001, BERGEYS MANUAL DETER, P696; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Zhou YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05288; Zhu LF, 2014, INT J SYST EVOL MICR, V64, P3964, DOI 10.1099/ijs.0.066605-0	73	18	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151840	10.1371/journal.pone.0151840	http://dx.doi.org/10.1371/journal.pone.0151840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999749	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700071
J	Rong, YKS; Golic, MM; Golic, KG				Rong, Yikang S.; Golic, Mary M.; Golic, Kent G.			The pugilist(Dominant) Mutation of Drosophila melanogaster: A Simple-Sequence Repeat Disorder Reveals Localized Transport in the Eye	PLOS ONE			English	Article							XANTHINE DEHYDROGENASE; GENE; EXPRESSION; NEURODEGENERATION; HETEROCHROMATIN; RECOMBINATION; TRANSGENESIS; PHENOTYPE; DELETIONS; WINGLESS	The pugilist-Dominant mutation results from fusion of a portion of the gene encoding the trifunctional Methylene Tetrahydrofolate Dehydrogenase (E.C.1.5.1.5, E.C.3.5.4.9, E.C.6.3.4.3) to approximately one kb of a heterochromatic satellite repeat. Expression of this fusion gene results in an unusual ring pattern of pigmentation around the eye. We carried out experiments to determine the mechanism for this pattern. By using FLP-mediated DNA mobilization to place different pug(D) transgenes at pre-selected sites we found that variation in repeat length makes a strong contribution to variability of the pug phenotype. This variation is manifest primarily as differences in the thickness of the pigmented ring. We show that similar phenotypic variation can also be achieved by changing gene copy number. We found that the pug(D) pattern is not controlled by wingless, which is normally expressed in a similar ring pattern. Finally, we found that physical injury to a pug(D) eye can lead to pigment deposition in parts of the eye that would not have been pigmented in the absence of injury. Our results are consistent with a model in which a metabolite vital for pigment formation is imported from the periphery of the eye, and pug(D) limits the extent of its transport towards the center of the eye, thus revealing the existence of a hitherto unknown mechanism of localized transport in the eye.	[Rong, Yikang S.; Golic, Mary M.; Golic, Kent G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Rong, Yikang S.] Sun Yat Sen Univ, Sch Life Sci, Guangzho, Peoples R China	Utah System of Higher Education; University of Utah; Sun Yat Sen University	Golic, KG (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	golic@biology.utah.edu			National Institutes of Health, National Institute of General Medical Sciences [R01 GM065604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065604] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health, National Institute of General Medical Sciences, R01 GM065604 to KGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire M, 1998, STRUCTURE, V6, P173, DOI 10.1016/S0969-2126(98)00019-7; Ashburner M., 2004, DROSOPHILA LAB HDB; Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Cadigan KM, 1996, DEVELOPMENT, V122, P2801; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; Gendrin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069742; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; HAY BA, 1994, DEVELOPMENT, V120, P2121; Horn C, 2005, P NATL ACAD SCI US; KURKULOS M, 1994, GENETICS, V136, P1001; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; LAURIEAHLBERG CC, 1987, GENETICS, V115, P129; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOHE AR, 1993, GENETICS, V134, P1149; Malmanche N, 2004, GENETICS, V168, P2011, DOI 10.1534/genetics.104.033134; MONTELL I, 1992, BIOCHEM GENET, V30, P61, DOI 10.1007/BF00554428; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; PAQUES F, 1993, GENETICS, V135, P469; Phillips JP, 1980, OMMOCHROMES PTERIDIN; REAUME AG, 1989, GENETICS, V123, P503; REAUME AG, 1991, GENETICS, V129, P1099; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 1998, GENETICS, V150, P1551; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Siegal ML, 1996, GENETICS, V144, P715; Siegal ML, 1998, P NATL ACAD SCI USA, V95, P15513, DOI 10.1073/pnas.95.26.15513; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; TIONG SYK, 1989, BIOCHEM GENET, V27, P333, DOI 10.1007/BF00554168; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745	36	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151377	10.1371/journal.pone.0151377	http://dx.doi.org/10.1371/journal.pone.0151377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999432	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700037
J	Rosenberg, AZ; Armani, MD; Fetsch, PA; Xi, LQ; Pham, TT; Raffeld, M; Chen, Y; O'Flaherty, N; Stussman, R; Blackler, AR; Du, Q; Hanson, JC; Roth, MJ; Filie, AC; Roh, MH; Emmert-Buck, MR; Hipp, JD; Tangrea, MA				Rosenberg, Avi Z.; Armani, Michael D.; Fetsch, Patricia A.; Xi, Liqiang; Tina Thu Pham; Raffeld, Mark; Chen, Yun; O'Flaherty, Neil; Stussman, Rebecca; Blackler, Adele R.; Du, Qiang; Hanson, Jeffrey C.; Roth, Mark J.; Filie, Armando C.; Roh, Michael H.; Emmert-Buck, Michael R.; Hipp, Jason D.; Tangrea, Michael A.			High-Throughput Microdissection for Next-Generation Sequencing	PLOS ONE			English	Article							EXPRESSION MICRODISSECTION; PROMOTER METHYLATION; MUTATION ANALYSIS; CANCER; CELLS; RETRIEVAL; VARIANT; SAMPLES; GENES	Precision medicine promises to enhance patient treatment through the use of emerging molecular technologies, including genomics, transcriptomics, and proteomics. However, current tools in surgical pathology lack the capability to efficiently isolate specific cell populations in complex tissues/tumors, which can confound molecular results. Expression microdissection (xMD) is an immuno-based cell/subcellular isolation tool that procures targets of interest from a cytological or histological specimen. In this study, we demonstrate the accuracy and precision of xMD by rapidly isolating immunostained targets, including cytokeratin AE1/AE3, p53, and estrogen receptor (ER) positive cells and nuclei from tissue sections. Other targets procured included green fluorescent protein (GFP) expressing fibroblasts, in situ hybridization positive Epstein-Barr virus nuclei, and silver stained fungi. In order to assess the effect on molecular data, xMD was utilized to isolate specific targets from a mixed population of cells where the targets constituted only 5% of the sample. Target enrichment from this admixed cell population prior to next-generation sequencing (NGS) produced a minimum 13-fold increase in mutation allele frequency detection. These data suggest a role for xMD in a wide range of molecular pathology studies, as well as in the clinical workflow for samples where tumor cell enrichment is needed, or for those with a relative paucity of target cells.	[Rosenberg, Avi Z.; Hanson, Jeffrey C.; Hipp, Jason D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Armani, Michael D.; Chen, Yun; O'Flaherty, Neil; Stussman, Rebecca; Blackler, Adele R.; Du, Qiang; Emmert-Buck, Michael R.; Tangrea, Michael A.] NCI, Pathogenet Unit, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Fetsch, Patricia A.; Roth, Mark J.; Filie, Armando C.] NCI, Cytopathol Sect, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Xi, Liqiang; Tina Thu Pham; Raffeld, Mark] NCI, Mol Diagnost Unit, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Chen, Yun] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Roh, Michael H.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Emmert-Buck, Michael R.] Avoneaux Med Inst, Oxford, MD USA; [Tangrea, Michael A.] Sinai Hosp, Alvin & Lois Lapidus Canc Inst, 2401 W Belvedere Ave, Baltimore, MD 21215 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of Michigan System; University of Michigan; Sinai Hospital of Baltimore	Emmert-Buck, MR; Tangrea, MA (corresponding author), NCI, Pathogenet Unit, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.; Emmert-Buck, MR (corresponding author), Avoneaux Med Inst, Oxford, MD USA.; Tangrea, MA (corresponding author), Sinai Hosp, Alvin & Lois Lapidus Canc Inst, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.	mikeeb@atlanticbb.net; mtangrea@lifebridgehealth.org	Chen, Yun/AAB-2132-2020	Chen, Yun/0000-0001-6917-7814; Rosenberg, Avi/0000-0003-2356-950X	NIH National Cancer Institute, Center for Cancer Research; Center for Cancer Research at the National Cancer Institute, NIH, Bethesda, MD; NATIONAL CANCER INSTITUTE [ZICBC011079, ZICBC011052] Funding Source: NIH RePORTER	NIH National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research at the National Cancer Institute, NIH, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural program of the NIH National Cancer Institute, Center for Cancer Research.; This work was supported by the intramural program of the Center for Cancer Research at the National Cancer Institute, NIH, Bethesda, MD. We would like to thank Theresa Davies-Hill and Dana Erickson for their help with sample preparation, Kris Ylaya and Stephen Hewitt for their contribution with histology processing, and Rob Robey for donation of cell lines. Michael R. Emmert-Buck and Michael A. Tangrea are inventors on NIH-held patents covering expression microdissection and are eligible to receive royalty-based payments through the NIH Technology Transfer Program. Michael A. Tangrea and Michael R. Emmert-Buck are consultants for xMD Diagnostics, LLC.	Aisner DL, 2012, DIAGN CYTOPATHOL, V40, P511, DOI 10.1002/dc.22820; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Blackler AR, 2013, ANAL CHEM, V85, P7139, DOI 10.1021/ac400691k; Chowdhuri SR, 2012, MODERN PATHOL, V25, P548, DOI 10.1038/modpathol.2011.184; Du Q, 2013, AM J CANCER RES, V3, P402; Grover AC, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-13; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Hanson JC, 2011, NAT PROTOC, V6, P457, DOI 10.1038/nprot.2010.202; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Knoepp SM, 2013, CANCER CYTOPATHOL, V121, P120, DOI 10.1002/cncy.21214; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; PINTOZZI RL, 1978, J CLIN PATHOL, V31, P803, DOI 10.1136/jcp.31.8.803; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Tangrea MA, 2004, DIAGN MOL PATHOL, V13, P207, DOI 10.1097/01.pdm.0000135964.31459.bb; Tangrea MA, 2011, J HISTOCHEM CYTOCHEM, V59, P591, DOI 10.1369/0022155411404704; Town G, 2010, LASER MED SCI, V25, P773, DOI 10.1007/s10103-010-0809-6; Xi LQ, 2012, BLOOD, V119, P3330, DOI 10.1182/blood-2011-09-379339	17	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151775	10.1371/journal.pone.0151775	http://dx.doi.org/10.1371/journal.pone.0151775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999048	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700064
J	Suchan, T; Pitteloud, C; Gerasimova, NS; Kostikova, A; Schmid, S; Arrigo, N; Pajkovic, M; Ronikier, M; Alvarez, N				Suchan, Tomasz; Pitteloud, Camille; Gerasimova, Nadezhda S.; Kostikova, Anna; Schmid, Sarah; Arrigo, Nils; Pajkovic, Mila; Ronikier, Michal; Alvarez, Nadir			Hybridization Capture Using RAD Probes (hyRAD), a New Tool for Performing Genomic Analyses on Collection Specimens	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; POPULATION; ENRICHMENT; DISCOVERY; SOFTWARE; PATTERNS; FORMAT; DAMAGE	In the recent years, many protocols aimed at reproducibly sequencing reduced-genome subsets in non-model organisms have been published. Among them, RAD-sequencing is one of the most widely used. It relies on digesting DNA with specific restriction enzymes and performing size selection on the resulting fragments. Despite its acknowledged utility, this method is of limited use with degraded DNA samples, such as those isolated from museum specimens, as these samples are less likely to harbor fragments long enough to comprise two restriction sites making possible ligation of the adapter sequences (in the case of double-digest RAD) or performing size selection of the resulting fragments (in the case of single-digest RAD). Here, we address these limitations by presenting a novel method called hybridization RAD (hyRAD). In this approach, biotinylated RAD fragments, covering a random fraction of the genome, are used as baits for capturing homologous fragments from genomic shotgun sequencing libraries. This simple and cost-effective approach allows sequencing of orthologous loci even from highly degraded DNA samples, opening new avenues of research in the field of museum genomics. Not relying on the restriction site presence, it improves among-sample loci coverage. In a trial study, hyRAD allowed us to obtain a large set of orthologous loci from fresh and museum samples from a non-model butterfly species, with a high proportion of single nucleotide polymorphisms present in all eight analyzed specimens, including 58-year-old museum samples. The utility of the method was further validated using 49 museum and fresh samples of a Palearctic grasshopper species for which the spatial genetic structure was previously assessed using mtDNA amplicons. The application of the method is eventually discussed in a wider context. As it does not rely on the restriction site presence, it is therefore not sensitive to among-sample loci polymorphisms in the restriction sites that usually causes loci dropout. This should enable the application of hyRAD to analyses at broader evolutionary scales.	[Suchan, Tomasz; Pitteloud, Camille; Schmid, Sarah; Arrigo, Nils; Pajkovic, Mila; Alvarez, Nadir] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Gerasimova, Nadezhda S.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Gerasimova, Nadezhda S.; Kostikova, Anna] InsideDNA Ltd, London, England; [Ronikier, Michal] Polish Acad Sci, Inst Bot, Krakow, Poland	University of Lausanne; Lomonosov Moscow State University; Polish Academy of Sciences	Suchan, T; Alvarez, N (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	tomasz.suchan@unil.ch; nadir.alvarez@unil.ch	Alvarez, Nadir/AAM-2228-2021; Alvarez, Nadir/B-4318-2010; Suchan, Tomasz/B-7765-2016; Gerasimova, Nadezhda S/A-8454-2014	Alvarez, Nadir/0000-0002-0729-166X; Alvarez, Nadir/0000-0002-0729-166X; Suchan, Tomasz/0000-0002-0811-8754; Gerasimova, Nadezhda S/0000-0002-5048-0378; Ronikier, Michal/0000-0001-7652-6787	Swiss National Science Foundation [PP00P3_144870, PZ00P3_148224]; Societe Academique Vaudoise (Switzerland); Switzerland through the Swiss Contribution to the enlarged European Union (Polish-Swiss Research Program) [PSPB-161/2010]; InsideDNA Ltd	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe Academique Vaudoise (Switzerland); Switzerland through the Swiss Contribution to the enlarged European Union (Polish-Swiss Research Program); InsideDNA Ltd	N. Alvarez and N. Arrigo were funded by Swiss National Science Foundation grants (PP00P3_144870, and PZ00P3_148224, respectively). TS was supported by a grant from the Societe Academique Vaudoise (Switzerland). The work was financially supported by a grant from Switzerland through the Swiss Contribution to the enlarged European Union (Polish-Swiss Research Program, project no. PSPB-161/2010). InsideDNA Ltd provided support in the form of salary for NSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, OPENWETWARE CONTR HY; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Aronesty E., 2011, DATABASE GOOGLE CODE; Auton A, 2015, VCFTOOLS DATABASE; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cruaud A, 2014, MOL BIOL EVOL, V31, P1272, DOI 10.1093/molbev/msu063; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Faircloth BC, 2015, MOL ECOL RESOUR, V15, P489, DOI 10.1111/1755-0998.12328; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; FASTX-Toolkit, 2015, FASTX TOOLK DAT; Flouri T, 2015, VSEARCH GITHUB REPOS, DOI DOI 10.5281/ZENODO.15524; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Hipp AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093975; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Jones MR, 2016, MOL ECOL, V25, P185, DOI 10.1111/mec.13304; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kindler E, 2012, MOL PHYLOGENET EVOL, V65, P695, DOI 10.1016/j.ympev.2012.07.025; Krueger F., 2015, TRIM GALORE WRAPPER; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leache AD, 2015, GENOME BIOL EVOL, V7, P706, DOI 10.1093/gbe/evv026; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935; Picard tools, 2015, PIC TOOLS DAT; Puritz JB, 2014, MOL ECOL, V23, P5937, DOI 10.1111/mec.12965; Puritz JB, 2014, PEERJ, V2, DOI 10.7717/peerj.431; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109101; vcflib Garrison E., 2015, VCFLIB DATABASE; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017	62	93	94	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151651	10.1371/journal.pone.0151651	http://dx.doi.org/10.1371/journal.pone.0151651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999359	Green Published, gold			2022-12-27	WOS:000372694700051
J	Brasington, A; Abdelmegeid, A; Dwivedi, V; Kols, A; Kim, YM; Khadka, N; Rawlins, B; Gibson, A				Brasington, Angela; Abdelmegeid, Ali; Dwivedi, Vikas; Kols, Adrienne; Kim, Young-Mi; Khadka, Neena; Rawlins, Barbara; Gibson, Anita			Promoting Healthy Behaviors among Egyptian Mothers: A Quasi-Experimental Study of a Health Communication Package Delivered by Community Organizations	PLOS ONE			English	Article							NEWBORN HEALTH; DEVELOPING-COUNTRIES; NEONATAL-MORTALITY; WOMENS GROUPS; CHILD HEALTH; CARE PRACTICES; HOME-VISITS; INTERVENTION; IMPACT; BIRTH	Decisions made at the household level, for example, to seek antenatal care or breastfeed, can have a direct impact on the health of mothers and newborns. The SMART Community-based Initiatives program in Egypt worked with community development associations to encourage better household decision-making by training community health workers to disseminate information and encourage healthy practices during home visits, group sessions, and community activities with pregnant women, mothers of young children, and their families. A quasi-experimental design was used to evaluate the program, with household surveys conducted before and after the intervention in intervention and comparison areas. Survey questions asked about women's knowledge and behaviors related tomaternal and newborn care and child nutrition and, at the endline, exposure to SMART activities. Exposure to program activities was high in intervention areas of Upper Egypt: 91% of respondents reported receiving home visits and 84% attended group sessions. In Lower Egypt, these figures were 58% and 48%, respectively. Knowledge of danger signs related to pregnancy, delivery, and newborn illness increased significantly more in intervention than comparison areas in both regions (with one exception in Lower Egypt), after controlling for child's age and woman's education; this pattern also occurred for two of five behaviors (antenatal care visits and consumption of iron-folate tablets). Findings suggest that there may have been a significant dose-response relationship between exposure to SMART activities and certain knowledge and behavioral indicators, especially in Upper Egypt. The findings demonstrate the ability of civil society organizations with minimal health programming experience to increase knowledge and promote healthy behaviors among pregnant women and new mothers. The SMART approach offers a promising strategy to fill gaps in health education and counseling and strengthen community support for behavior change.	[Brasington, Angela; Khadka, Neena; Gibson, Anita] Save Children, Maternal & Child Survival Program, Washington, DC USA; [Abdelmegeid, Ali; Rawlins, Barbara] Jhpiego, Maternal & Child Survival Program, Washington, DC USA; [Dwivedi, Vikas] John Snow Inc, Maternal & Child Survival Program, Boston, MA USA; [Kols, Adrienne; Kim, Young-Mi] Jhpiego, Baltimore, MD USA; [Brasington, Angela] Inst Publ Hlth, Global Hlth Fellows Program, Washington, DC USA	Save the Children; Jhpiego; Jhpiego; Public Health Institute	Brasington, A (corresponding author), Inst Publ Hlth, Global Hlth Fellows Program, Washington, DC USA.	abrasing@gmail.com		Kim, Young Mi/0000-0002-8815-4957	United States Agency for International Development (USAID) [GHS-A-00-08-00002-00]; USAID	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); USAID(United States Agency for International Development (USAID))	This work was made possible by the generous support of the American people through the United States Agency for International Development (USAID), under the terms of the Leader with Associates Cooperative Agreement GHS-A-00-08-00002-00 to JHPIEGO. http://www.usaid.gov. USAID provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. John Snow, Inc. (JSI) employed one of the authors [VD]; however, JSI did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.; We gratefully acknowledge members of the more than 100 Egyptian CDAs, including 1,200 women CHWs, who worked tirelessly to support thousands of pregnant women and new mothers with health promotion activities. We also thank Egyptian Ministry of Health and Ministry of Social Affairs staff who were instrumental in supporting program implementation. The authors acknowledge the hard work of Dr. Issam El Adawi and all SMART project staff, and the close collaboration and contributions of Mr. George Sanad and Dr. Shahira Hussein of United States Agency for International Development (USAID)/Egypt, Office of Health and Population, and Dr. Nahed Matta, of USAID/Washington, Global Health Bureau. Thanks to Farouk Salah and Mark Emerson for their help with data analysis and to Eric Sarriot, Jim Ricca, and Jeanne Russell for helpful comments on the draft manuscript. This research was made possible through support provided by USAID. The opinions are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	AbdElAziz SB, 2012, J EGYPT PUBLIC HEAL, V87, P124, DOI 10.1097/01.EPX.0000421567.39976.90; Acharya A, 2015, AM J PUBLIC HEALTH, V105, P144, DOI 10.2105/AJPH.2014.302092; [Anonymous], 2014, SMART END OF PROJ RE; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bahl R, 2010, SEMIN PERINATOL, V34, P477, DOI 10.1053/j.semperi.2010.09.001; Barry D, 2014, J MIDWIFERY WOM HEAL, V59, pS44, DOI 10.1111/jmwh.12171; Bhandari N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1634; Callaghan-Koru JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1052; Chakraborty NM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S2-S6; Costello A, 2012, INDIAN PEDIATR, V49, P73; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Das A, 2014, 6931 WORLD BANK; Davis R, 2009, RAPID HOUSEHOLD SURV; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; El-Gilany Abdel-Hady, 2014, Biomed Res Int, V2014, P258470, DOI 10.1155/2014/258470; El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Eriksson M, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5611; Findley SE, 2013, INT J WOMENS HEALTH, V5, P717, DOI 10.2147/IJWH.S49785; Ghanem H, 2014, 67 BROOK I; Gogia S, 2011, INDIAN PEDIATR, V48, P537, DOI 10.1007/s13312-011-0096-8; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kumar V, 2012, INT J GYNECOL OBSTET, V117, P48, DOI 10.1016/j.ijgo.2011.10.031; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lee ACC, 2009, INT J GYNECOL OBSTET, V107, pS65, DOI 10.1016/j.ijgo.2009.07.012; Lewycka S, 2013, LANCET, V381, P1721, DOI 10.1016/S0140-6736(12)61959-X; Mead EL, 2014, SOC SCI MED, V115, P139, DOI 10.1016/j.socscimed.2014.05.030; Memon ZA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0538-8; Ministry of Health and Population [Egypt] El-Zanaty and Associates ICF International. Egypt Demographic and Health Survey, 2014, EG DEM HLTH SURV 201; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Nair N, 2012, INT J GYNECOL OBSTET, V119, pS22, DOI 10.1016/j.ijgo.2012.03.014; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pati S., 2017, J PREV MED HYG, V58, pE288; Perry H., 2014, DEV STRENGTHENING CO; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Sandberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097253; Schiffman J, 2010, SEMIN PERINATOL, V34, P462, DOI 10.1053/j.semperi.2010.09.008; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; Stephenson R, 2012, PUBLIC HEALTH REP, V127, P96; Story WT, 2013, GLOB PUBLIC HEALTH, V8, P983, DOI 10.1080/17441692.2013.842259; Trevant C, 2014, USAID EGYPT MATERNAL; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; Younes L, 2015, J EPIDEMIOL COMMUN H, V69, P374, DOI 10.1136/jech-2014-204271	47	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151783	10.1371/journal.pone.0151783	http://dx.doi.org/10.1371/journal.pone.0151783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26989898	Green Published, gold			2022-12-27	WOS:000372582800102
J	Duran, BEL; Duncan, DS; Oates, LG; Kucharik, CJ; Jackson, RD				Duran, Brianna E. L.; Duncan, David S.; Oates, Lawrence G.; Kucharik, Christopher J.; Jackson, Randall D.			Nitrogen Fertilization Effects on Productivity and Nitrogen Loss in Three Grass-Based Perennial Bioenergy Cropping Systems	PLOS ONE			English	Article							TRACE-GAS FLUXES; SOUTHERN WISCONSIN; BIOMASS PRODUCTION; SOIL RESPIRATION; PLANT DIVERSITY; SWITCHGRASS; BIODIVERSITY; CLIMATE; USA; AGRICULTURE	Nitrogen (N) fertilization can greatly improve plant productivity but needs to be carefully managed to avoid harmful environmental impacts. Nutrient management guidelines aimed at reducing harmful forms of N loss such as nitrous oxide (N2O) emissions and nitrate (NO3-) leaching have been tailored for many cropping systems. The developing bioenergy industry is likely to make use of novel cropping systems, such as polycultures of perennial species, for which we have limited nutrient management experience. We studied how a switchgrass (Panicum virgatum) monoculture, a 5-species native grass mixture and an 18-species restored prairie responded to annual fertilizer applications of 56 kg N ha(-1) in a field-scale agronomic trial in south-central Wisconsin over a 2-year period. We observed greater fertilizer-induced N2O emissions and sub-rooting zone NO3- concentrations in the switchgrass monoculture than in either polyculture. Fertilization increased aboveground net primary productivity in the polycultures, but not in the switchgrass monoculture. Switchgrass was generally more productive, while the two polycultures did not differ from each other in productivity or N loss. Our results highlight differences between polycultures and a switchgrass monoculture in responding to N fertilization.	[Duran, Brianna E. L.; Duncan, David S.; Oates, Lawrence G.; Kucharik, Christopher J.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Duran, Brianna E. L.; Duncan, David S.; Oates, Lawrence G.; Kucharik, Christopher J.; Jackson, Randall D.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Oates, LG (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.; Oates, LG (corresponding author), Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA.	oates@wisc.edu	Oates, Lawrence G/G-6354-2011; Jackson, Randall/AAE-5573-2022	Kucharik, Christopher/0000-0002-0400-758X; Oates, Lawrence/0000-0003-4829-7600	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]; Water Sustainability and Climate Program of the National Science Foundation [DEB-1038759]; Multi-State Hatch Grant [WISO1420]; UW Department of Agronomy; D.C. Smith Wisconsin Distinguished Graduate Fellowship; Division Of Earth Sciences [1038759] Funding Source: National Science Foundation	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Water Sustainability and Climate Program of the National Science Foundation; Multi-State Hatch Grant; UW Department of Agronomy; D.C. Smith Wisconsin Distinguished Graduate Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded in part by the DOE Great Lakes Bioenergy Research Center (https://www.glbrc.org/)(DOE BER Office of Science DE-FC02-07ER64494; http://science.energy.gov/) and DOE OBP Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830; http://energy.gov/eere/office-energy-efficiency-renewable-energy), the Water Sustainability and Climate Program of the National Science Foundation (DEB-1038759), a Multi-State Hatch Grant (#WISO1420), the UW Department of Agronomy, and the D.C. Smith Wisconsin Distinguished Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Beale CV, 1997, BIOMASS BIOENERG, V12, P419, DOI 10.1016/S0961-9534(97)00016-0; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Davidson E. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P219; de Vries BJM, 2007, ENERG POLICY, V35, P2590, DOI 10.1016/j.enpol.2006.09.002; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Duran BEL, 2013, SOIL SCI SOC AM J, V77, P1601, DOI 10.2136/sssaj2013.01.0023; Elzinga C.L., 1998, 17301 BUR LAND MAN; Epstein HE, 1998, BIOGEOCHEMISTRY, V42, P145, DOI 10.1023/A:1005959001235; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frank DA, 2009, ECOLOGY, V90, P1512, DOI 10.1890/08-0789.1; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Grogan P, 1999, ECOSYSTEMS, V2, P451, DOI 10.1007/s100219900093; Hong CO, 2014, BIOENERG RES, V7, P777, DOI 10.1007/s12155-014-9484-y; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; IPCC, 2006, ENERGY, V2; Jach-Smith LC, 2015, AGR ECOSYST ENVIRON, V204, P62, DOI 10.1016/j.agee.2015.02.006; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jungers JM, 2015, BIOENERG RES, V8, P279, DOI 10.1007/s12155-014-9525-6; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kucharik CJ, 2006, GLOBAL CHANGE BIOL, V12, P122, DOI 10.1111/j.1365-2486.2005.01053.x; Laboski C.A.M., 2012, NUTR APPL GUIDELINES; Lenth R. V., 2013, ISMEANS LEAST SQUARE; Liang C, 2013, SOIL BIOL BIOCHEM, V57, P939, DOI 10.1016/j.soilbio.2012.09.006; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Miesel JR, 2012, BIOMASS BIOENERG, V36, P121, DOI 10.1016/j.biombioe.2011.10.018; Mississippi River/Gulf of Mexico Watershed Nutrient Task Force, 2009, MOV FORW GULF HYP AN; Mitchell R, 2008, BIOFUEL BIOPROD BIOR, V2, P530, DOI 10.1002/bbb.106; Niklaus PA, 2006, PLANT SOIL, V282, P83, DOI 10.1007/s11104-005-5230-8; NOAA, 2012, NAT WEATH SERV MILW; Oates LG, 2015, GCB BIOENERGY; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Palmborg C, 2005, OIKOS, V110, P271, DOI 10.1111/j.0030-1299.2005.13673.x; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Pedersen AR, 2010, EUR J SOIL SCI, V61, P888, DOI 10.1111/j.1365-2389.2010.01291.x; Pedersen A.R., 2012, HMR FLUX ESTIMATION; Perlack, 2011, BILLION TON UPDATE B; Pinheiro J, 2020, R PACKAGE VERSION 31; Rabalais NN, 2001, J ENVIRON QUAL, V30, P320, DOI 10.2134/jeq2001.302320x; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Robertson GP, 1999, LT EC RES NETWK SER, V2, P106; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Sanderson MA, 2008, INT J MOL SCI, V9, P768, DOI 10.3390/ijms9050768; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Vilain G, 2014, NUTR CYCL AGROECOSYS, V98, P169, DOI 10.1007/s10705-014-9604-2; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Wang D, 2010, GCB BIOENERGY, V2, P16, DOI 10.1111/j.1757-1707.2010.01035.x; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Zegada-Lizarazu W, 2010, BIOFUEL BIOPROD BIOR, V4, P674, DOI 10.1002/bbb.242	55	31	32	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151919	10.1371/journal.pone.0151919	http://dx.doi.org/10.1371/journal.pone.0151919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991790	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800117
J	Ganesh, D; Kumarathasan, P; Thomson, EM; St-Germain, C; Blais, E; Crapo, J; Vincent, R				Ganesh, Devi; Kumarathasan, Prem; Thomson, Errol M.; St-Germain, Carly; Blais, Erica; Crapo, James; Vincent, Renaud			Impact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 Rats	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; OXIDATIVE STRESS; REACTIVE OXYGEN; NITRIC-OXIDE; ETB-RECEPTOR; PLASMA ENDOTHELIN-1; CELL-PROLIFERATION; HEART-FAILURE; LUNG; EXPRESSION	Endothelin-1 is a potent vasoconstrictor and mitogenic peptide involved in the regulation of vasomotor tone and maintenance of blood pressure. Oxidative stress activates the endothelin system, and is implicated in pulmonary and cardiovascular diseases including hypertension, congestive heart failure, and atherosclerosis. Superoxide dismutase mimetics designed with the aim of treating diseases that involve reactive oxygen species in their pathophysiology may exert a hypotensive effect, but effects on the endothelin system are unknown. Our objective was to determine the effect of the superoxide dismutase mimetic AEOL 10150 on the basal endothelin system in vivo. Male Fischer-344 rats were injected subcutaneously with 0, 2 or 5 mg/kg body weight of AEOL 10150 in saline. Plasma oxidative stress markers and endothelins (bigET-1, ET-1, ET-2, ET-3) as well as lung and heart endothelin/nitric oxide system gene expressions were measured using HPLC-Coularray, HPLC-Fluorescence and RT-PCR respectively. AEOL 10150 reduced (p<0.05) the circulating levels of isoprostane (-25%) and 3-nitrotyrosine (-50%) measured in plasma 2h and 24h after treatment, confirming delivery of a physiologically-relevant dose and the potent antioxidant activity of the drug. The reduction in markers of oxidative stress coincided with sustained 24h decrease (p<0.05) of plasma levels of ET-1 (-50%) and ET-3 (-10%). Expression of preproET-1 and endothelin converting enzyme-1 mRNA were not altered significantly in the lungs. However preproET-1 (not significant) and ECE-1 mRNA (p<0.05) were increased (10-25%) in the heart. Changes in the lungs included decrease (p<0.05) of mRNA for the ET-1 clearance receptor ETB and the vasoconstriction-signaling ETA receptor (-30%), and an early surge of inducible nitric oxide synthase expression followed by sustained decrease (-40% after 24 hours). The results indicate that interception of the endogenous physiological flux of reactive nitrogen species and reactive oxygen species in rats impacts the endothelin/nitric oxide system, supporting a homeostatic relationship between those systems.	[Ganesh, Devi; Vincent, Renaud] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ganesh, Devi; Kumarathasan, Prem; Thomson, Errol M.; St-Germain, Carly; Blais, Erica; Vincent, Renaud] Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm & Radiat Hlth Sci Directorate, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Crapo, James] Natl Jewish Hlth, Denver, CO USA	University of Ottawa; Health Canada; National Jewish Health	Vincent, R (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Vincent, R (corresponding author), Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm & Radiat Hlth Sci Directorate, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	renaud.vincent@sympatico.ca		Thomson, Errol/0000-0003-1295-5384	Toxic Substance Research Initiative (Health Canada); Genomic Research and Development Initiative (Health Canada); Clean Air Regulatory Agenda (Health Canada)	Toxic Substance Research Initiative (Health Canada); Genomic Research and Development Initiative (Health Canada); Clean Air Regulatory Agenda (Health Canada)	Toxic Substance Research Initiative (Health Canada) RV, Genomic Research and Development Initiative (Health Canada) RV, and Clean Air Regulatory Agenda (Health Canada) RV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistini B, 2006, EXP BIOL MED, V231, P653; Bielecki A, 2012, J ANAL TOXICOL, V36, P595, DOI 10.1093/jat/bks070; Bourgoin F, 2013, CAN J PHYSIOL PHARM, V91, P547, DOI 10.1139/cjpp-2012-0273; Bowler RP, 2003, AM J PHYSIOL-LUNG C, V284, pL680, DOI 10.1152/ajplung.00191.2002; Bowler RP, 2002, FREE RADICAL BIO MED, V33, P1141, DOI 10.1016/S0891-5849(02)01008-0; Channick R., 2001, Journal of Heart and Lung Transplantation, V20, P262, DOI 10.1016/S1053-2498(00)00606-9; Cingolani HE, 2006, HYPERTENSION, V47, P727, DOI 10.1161/01.HYP.0000208302.62399.68; Cowburn PJ, 1998, LANCET, V352, P201, DOI 10.1016/S0140-6736(05)77807-7; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; De Giusti VC, 2008, LIFE SCI, V83, P264, DOI 10.1016/j.lfs.2008.06.008; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Estevez AG, 2006, J NEUROSCI, V26, P8512, DOI 10.1523/JNEUROSCI.0728-06.2006; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; Hemmrich K, 2003, J APPL PHYSIOL, V95, P1937, DOI 10.1152/japplphysiol.00419.2003; Hoffmann E, 1998, AM HEART J, V135, P684, DOI 10.1016/S0002-8703(98)70286-8; Kaehler A, 2002, CLIN SCI, V103, p176S, DOI 10.1042/CS103S176S; Kelland NF, 2010, CAN J PHYSIOL PHARM, V88, P644, DOI 10.1139/Y10-041; Kelland NF, 2010, J VASC RES, V47, P16, DOI 10.1159/000231717; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; KIOWSKI W, 1995, LANCET, V346, P732, DOI 10.1016/S0140-6736(95)91504-4; Knappe D, 2007, J INVEST MED, V55, P306, DOI 10.2310/6650.2007.00013; Kubin AM, 2011, J MOL CELL CARDIOL, V50, P884, DOI 10.1016/j.yjmcc.2011.02.005; Kumarathasan P, 2003, J CHROMATOGR A, V987, P349, DOI 10.1016/S0021-9673(02)01598-4; Kumarathasan P, 2001, ANAL BIOCHEM, V299, P37, DOI 10.1006/abio.2001.5362; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGovern T, 2011, FREE RADICAL BIO MED, V50, P602, DOI 10.1016/j.freeradbiomed.2010.12.001; MCMURRAY JJ, 1992, CIRCULATION, V85, P1374, DOI 10.1161/01.CIR.85.4.1374; Neuhold S, 2010, CLIN CHEM, V56, P121, DOI 10.1373/clinchem.2009.125856; NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1; O'Neill HC, 2011, AM J RESP CELL MOL, V45, P323, DOI 10.1165/rcmb.2010-0214OC; Pfeiffer S, 1998, MOL PHARMACOL, V53, P795, DOI 10.1124/mol.53.4.795; Pollock David M., 2005, Current Vascular Pharmacology, V3, P365, DOI 10.2174/157016105774329408; Quan HH, 2013, NEUROL SCI, V34, P1621, DOI 10.1007/s10072-013-1295-y; Rabbani ZN, 2007, FREE RADICAL RES, V41, P1273, DOI 10.1080/10715760701689550; Rodrigo R, 2011, HYPERTENS RES, V34, P431, DOI 10.1038/hr.2010.264; Rosales MAB, 2010, INVEST OPHTH VIS SCI, V51, P4327, DOI 10.1167/iovs.09-4690; Ross AD, 2002, FREE RADICAL BIO MED, V33, P1657, DOI 10.1016/S0891-5849(02)01140-1; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Ruef J, 2001, CARDIOVASC PATHOL, V10, P311, DOI 10.1016/S1054-8807(01)00095-3; Sakai S, 1996, J AM COLL CARDIOL, V28, P1580, DOI 10.1016/S0735-1097(96)00336-1; SATO K, 1995, AM J PHYSIOL-LUNG C, V269, pL668, DOI 10.1152/ajplung.1995.269.5.L668; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; SCHUMACHER WA, 1990, PROSTAGLANDINS, V40, P71, DOI 10.1016/0090-6980(90)90057-3; Sen S, 2011, PHYTOMEDICINE, V18, P1110, DOI 10.1016/j.phymed.2011.06.013; Skalska AB, 2009, CLIN BIOCHEM, V42, P358, DOI 10.1016/j.clinbiochem.2008.11.002; Smith KR, 2002, FREE RADICAL BIO MED, V33, P1106, DOI 10.1016/S0891-5849(02)01003-1; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; Thomson E, 2005, TOXICOL SCI, V88, P103, DOI 10.1093/toxsci/kfi272; Thomson E, 2005, ANAL BIOCHEM, V337, P347, DOI 10.1016/j.ab.2004.10.047; Thomson E, 2006, EXP BIOL MED, V231, P979; Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005; Upmacis RK, 2011, AM J PHYSIOL-HEART C, V301, pH617, DOI 10.1152/ajpheart.00667.2010; Vincent R, 2001, Res Rep Health Eff Inst, P5; Wedgwood S, 2001, AM J PHYSIOL-LUNG C, V281, pL1058, DOI 10.1152/ajplung.2001.281.5.L1058	56	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151810	10.1371/journal.pone.0151810	http://dx.doi.org/10.1371/journal.pone.0151810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990293	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800105
J	Gauffin, K; Hjern, A; Vinnerljung, B; Bjorkenstam, E				Gauffin, Karl; Hjern, Anders; Vinnerljung, Bo; Bjorkenstam, Emma			Childhood Household Dysfunction, Social Inequality and Alcohol Related Illness in Young Adulthood. A Swedish National Cohort Study	PLOS ONE			English	Article							OF-HOME CARE; SOCIOECONOMIC-STATUS; DRUG-USE; EXPERIENCES; ADVERSE; ABUSE; RISK; DISORDERS; MORTALITY; CHILDREN	The aim of this paper is to estimate the cumulative effect of childhood household dysfunction (CHD) on alcohol related illness and death later in life and to test the interaction between CHD and socioeconomic background. The study utilised Swedish national registers including data of a Swedish national cohort born 1973-82 (n = 872 912), which was followed from age 18 to 29-40 years. Cox regression analyses were used to calculate hazard ratios (HR) for alcohol related illness or death in young adulthood. The CHD measure consisted of seven indicators: parental alcohol/drug misuse, mental health problems, criminality, death, divorce, social assistance, and child welfare interventions. Childhood socioeconomic position (SEP) was indicated by parental occupational status. Outcomes were alcohol related inpatient hospital care, specialised outpatient care or deaths. Using the highest socioeconomic group without CHD experience as a reference, those in the same socioeconomic group with one indicator of CHD had HRs of 2.1 [95% CI: 1.7-2.5], two CHD indicators 5.6 [4.4-7.1], three or more indicators 9.4 [7.1-12.4] for retrieving inpatient care. Socioeconomic disadvantage further increased the risks-those with low socioeconomic background and three CHD indicators or more had a HR of 12.5 [10.9-14.3]. Testing for interaction suggests that the combined HRs deviates from additivity [Synergy index: 1.6, 95% CI: 1.4-1.9]. The results for outpatient care were similar, but not as pronounced. In conclusion, this Swedish national cohort study shows that childhood household dysfunction is strongly and cumulatively associated to alcohol related illness later in life and that it interacts with socioeconomic disadvantage.	[Gauffin, Karl; Hjern, Anders] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Hjern, Anders] Karolinska Inst, Dept Med, Clin Epidemiol, Stockholm, Sweden; [Vinnerljung, Bo] Stockholm Univ, Dept Social Work, S-10691 Stockholm, Sweden; [Bjorkenstam, Emma] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Bjorkenstam, Emma] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA; [Bjorkenstam, Emma] Univ Calif Los Angeles, Calif Ctr Populat Res, Los Angeles, CA USA	Karolinska Institutet; Stockholm University; Karolinska Institutet; Stockholm University; Karolinska Institutet; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gauffin, K (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden.	karlgauffin@chess.su.se		Gauffin, Karl/0000-0001-9349-9936	Swedish Council for Working Life Research [2009-1669, 2013-2729]; Bank of Sweden Tercentenary Foundation [P10 0514]	Swedish Council for Working Life Research; Bank of Sweden Tercentenary Foundation	This work was supported by the Swedish Council for Working Life Research [grant number: 2009-1669], http://forte.se/en/. Dr. Vinnerljung's work was financed by The Bank of Sweden Tercentenary Foundation [grant number P10 0514], http://www.rj.se/. Dr. Bjorkenstam's work was supported by a grant from the Swedish Council for Working Life Research [grant number: 2013-2729], http://forte.se/en/.	Affairs DoS, 2002, HARPS 2002; Anda R, 2006, HLTH SOCIAL IMPACT G; Anda R., 2014, ADVERSE CHILDHOOD EX; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Anda RF, 2002, PSYCHIAT SERV, V53, P1001, DOI 10.1176/appi.ps.53.8.1001; Anda RF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-106; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bjorkenstam E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053551; Bjorklund A., 2009, OXFORD HDB EC INEQUA, P491; CDC, 2003, ACE REPORTER, V1; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Corak M, 2006, RES ECON INEQUAL, V13, P143, DOI 10.1016/S1049-2585(06)13006-9; Diderichsen F, 2001, CHALLENGING INEQUITI; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Dube SR, 2002, ADDICT BEHAV, V27, P713, DOI 10.1016/S0306-4603(01)00204-0; Dube SR, 2001, CHILD ABUSE NEGLECT, V25, P1627, DOI 10.1016/S0145-2134(01)00293-9; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Edwards AC, 2012, PSYCHIAT GENET, V22, P31, DOI 10.1097/YPG.0b013e32834acd07; Elstad JI, 2005, EUR J PUBLIC HEALTH, V15, P51, DOI 10.1093/eurpub/cki114; Erikson R, 2006, SOC SCI MED, V62, P2151, DOI 10.1016/j.socscimed.2005.09.009; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Franzen E, 2008, BRIT J SOC WORK, V38, P1043, DOI 10.1093/bjsw/bcl380; Gauffin K, 2015, INT J EPIDEMIOL, V44, P919, DOI 10.1093/ije/dyv006; Gauffin K, 2013, J EPIDEMIOL COMMUN H, V67, P932, DOI 10.1136/jech-2013-202624; Giordano GN, 2014, ADDICTION, V109, P1119, DOI 10.1111/add.12537; Keyes KM, 2008, ADDICTION, V103, P1120, DOI 10.1111/j.1360-0443.2008.02218.x; LUNDBERG O, 1993, SOC SCI MED, V36, P1047, DOI 10.1016/0277-9536(93)90122-K; Maggi S, 2010, J PAEDIATR CHILD H, V46, P627, DOI 10.1111/j.1440-1754.2010.01817.x; Schmidt LA, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P11; Statistics Sweden, 1983, STOCKH REP STAT COOR; Swedish Government, 2015, SAML JAML HALS; Swedish National Institute of Public Health, 2011, NAT FOLKH HALS LIK V; Vinnerljung B, 2008, INT J SOC WELF, V17, P301, DOI 10.1111/j.1468-2397.2008.00568.x; Weitoft GR, 2000, LANCET, V355, P1215, DOI 10.1016/S0140-6736(00)02087-0; WEST P, 1991, SOC SCI MED, V32, P373, DOI 10.1016/0277-9536(91)90338-D; Wiles NJ, 2007, ADDICTION, V102, P1546, DOI 10.1111/j.1360-0443.2007.01930.x; Wilkinson Richard, 2003, SOCIAL DETERMINANTS	39	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151755	10.1371/journal.pone.0151755	http://dx.doi.org/10.1371/journal.pone.0151755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991657	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800096
J	Tondo, ML; Delprato, ML; Kraiselburd, I; Zenoff, MVF; Farias, ME; Orellano, EG				Laura Tondo, Maria; Laura Delprato, Maria; Kraiselburd, Ivana; Fernandez Zenoff, Maria Veronica; Eugenia Farias, Maria; Orellano, Elena G.			KatG, the Bifunctional Catalase of Xanthomonas citri subsp citri, Responds to Hydrogen Peroxide and Contributes to Epiphytic Survival on Citrus Leaves	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; BIOFILM FORMATION; ESCHERICHIA-COLI; PLANT; RADIATION; OXYGEN; BACTERIA; ENZYMES; PROTEIN	Xanthomonas citri subsp. citri (Xcc) is the bacterium responsible for citrus canker. This bacterium is exposed to reactive oxygen species (ROS) at different points during its life cycle, including those normally produced by aerobic respiration or upon exposition to ultraviolet (UV) radiation. Moreover, ROS are key components of the host immune response. Among enzymatic ROS-detoxifying mechanisms, catalases eliminate H2O2, avoiding the potential damage caused by this specie. Xcc genome includes four catalase genes. In this work, we studied the physiological role of KatG, the only bifunctional catalase of Xcc, through the construction and characterization of a modified strain (XcckatG), carrying an insertional mutation in the katG gene. First, we evaluated the involvement of KatG in the bacterial adaptive response to H2O2. XcckatG cultures exhibited lower catalase activity than those of the wild-type strain, and this activity was not induced upon treatment with sub-lethal doses of H2O2. Moreover, the KatG-deficient mutant exhibited decreased tolerance to H2O2 toxicity compared to wild-type cells and accumulated high intracellular levels of peroxides upon exposure to sub-lethal concentrations of H2O2. To further study the role of KatG in Xcc physiology, we evaluated bacterial survival upon exposure to UV-A or UV-B radiation. In both conditions, XcckatG showed a high mortality in comparison to Xcc wild-type. Finally, we studied the development of bacterial biofilms. While structured biofilms were observed for the Xcc wild-type, the development of these structures was impaired for XcckatG. Based on these results, we demonstrated that KatG is responsible for Xcc adaptive response to H2O2 and a key component of the bacterial response to oxidative stress. Moreover, this enzyme plays an important role during Xcc epiphytic survival, being essential for biofilm formation and UV resistance.	[Laura Tondo, Maria; Laura Delprato, Maria; Kraiselburd, Ivana; Orellano, Elena G.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Fernandez Zenoff, Maria Veronica; Eugenia Farias, Maria] Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Orellano, EG (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, CONICET, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina.	orellano@ibr-conicet.gov.ar	Kraiselburd, Ivana/AAI-8743-2020	Kraiselburd, Ivana/0000-0002-9677-6094; Tondo, Maria Laura/0000-0002-0160-1882; Farias, Maria Eugenia/0000-0002-2771-8915	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1762]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 00873]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2010-1762 to EGO (http://www.agencia.mincyt.gob.ar/), and Consejo Nacional de Investigaciones Cientificas y Tecnicas, PIP 00873 to EGO (http://www.conicet.gov.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; BEERS RF, 1952, J BIOL CHEM, V195, P133; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Charoenlap N, 2011, CURR MICROBIOL, V63, P232, DOI 10.1007/s00284-011-9970-9; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Costa CS, 2010, PHOTOCHEM PHOTOBIOL, V86, P1334, DOI 10.1111/j.1751-1097.2010.00800.x; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeLong JM, 2002, J AGR FOOD CHEM, V50, P248, DOI 10.1021/jf0106695; DEMPLE B, 1991, ANNU REV GENET, V25, P315, DOI 10.1146/annurev.ge.25.120191.001531; Di Capua C, 2011, FEMS MICROBIOL LETT, V317, P181, DOI 10.1111/j.1574-6968.2011.02231.x; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Gnanamanickam SS, 2006, PLANT-ASSOCIATED BACTERIA, P131; Guo M, 2012, J BACTERIOL, V194, P5054, DOI 10.1128/JB.00999-12; Hader DP, 2011, PHOTOCHEM PHOTOBIOL, V87, P263, DOI 10.1111/j.1751-1097.2011.00888.x; HIRANO SS, 1983, ANNU REV PHYTOPATHOL, V21, P243, DOI 10.1146/annurev.py.21.090183.001331; Hoerter JD, 2005, J PHOTOCH PHOTOBIO B, V81, P171, DOI 10.1016/j.jphotobiol.2005.07.005; Italiani VCS, 2010, FEMS MICROBIOL LETT, V303, P48, DOI 10.1111/j.1574-6968.2009.01860.x; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kang Kyong-Suk, 1999, Journal of Plant Biology, V42, P187; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Li JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021804; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Matallana-Surget S, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1020070; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; MITCHELL RL, 1965, SCIENCE, V150, P74, DOI 10.1126/science.150.3692.74; Mongkolsuk S, 1997, FEMS MICROBIOL LETT, V146, P217, DOI 10.1111/j.1574-6968.1997.tb10196.x; Moyano AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004163; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Pattison DI, 2006, EXP SUPPL, V96, P131; Pezzoni M, 2014, J PHOTOCH PHOTOBIO B, V131, P53, DOI 10.1016/j.jphotobiol.2014.01.005; Prapagdee B, 2004, FEMS MICROBIOL LETT, V232, P217, DOI 10.1016/S0378-1097(04)00075-8; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Ryder VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047695; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos AL, 2013, ARCH MICROBIOL, V195, P63, DOI 10.1007/s00203-012-0847-5; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; SCANDALIOS JG, 1968, ANN NY ACAD SCI, V151, P274, DOI 10.1111/j.1749-6632.1968.tb11896.x; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; SWITALA J, 1990, CAN J MICROBIOL, V36, P728, DOI 10.1139/m90-123; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zigman S, 1996, PHOTOCHEM PHOTOBIOL, V63, P818, DOI 10.1111/j.1751-1097.1996.tb09637.x	65	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151657	10.1371/journal.pone.0151657	http://dx.doi.org/10.1371/journal.pone.0151657			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990197	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800084
J	Martin-Clouaire, R; Rellier, JP; Pare, N; Voltz, M; Biarnes, A				Martin-Clouaire, Roger; Rellier, Jean-Pierre; Pare, Nakie; Voltz, Marc; Biarnes, Anne			Modelling Management Practices in Viticulture while Considering Resource Limitations: The Dhivine Model	PLOS ONE			English	Article							DECISION-MAKING PROCESSES; FARM-MANAGEMENT; RUNOFF; ORGANIZATION; SIMULATION; CATCHMENT; VINEYARDS; SYSTEMS; CROP	Many farming-system studies have investigated the design and evaluation of crop-management practices with respect to economic performance and reduction in environmental impacts. In contrast, little research has been devoted to analysing these practices in terms of matching the recurrent context-dependent demand for resources (labour in particular) with those available on the farm. This paper presents Dhivine, a simulation model of operational management of grape production at the vineyard scale. Particular attention focuses on representing a flexible plan, which organises activities temporally, the resources available to the vineyard manager and the process of scheduling and executing the activities. The model relies on a generic production-system ontology used in several agricultural production domains. The types of investigations that the model supports are briefly illustrated. The enhanced realism of the production-management situations simulated makes it possible to examine and understand properties of resource-constrained work-organisation strategies and possibilities for improving them.	[Martin-Clouaire, Roger; Rellier, Jean-Pierre] INRA, UR Math & Informat Appl Toulouse 875, F-31326 Castanet Tolosan, France; [Pare, Nakie] CAPNODIS, Paris, France; [Voltz, Marc] INRA, UMR LISAH, F-34060 Montpellier, France; [Biarnes, Anne] IRD, UMR LISAH, Montpellier, France	INRAE; INRAE; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Martin-Clouaire, R (corresponding author), INRA, UR Math & Informat Appl Toulouse 875, F-31326 Castanet Tolosan, France.	rmc@toulouse.inra.fr		Martin-Clouaire, Roger/0000-0002-1364-7474	French Ministry of Ecology, Sustainable Development, Transport and Housing [10-MBGD-GESSOL-8-CVS-077]; French Ministry of National Education, Advanced Instruction, and Research; Capnodis	French Ministry of Ecology, Sustainable Development, Transport and Housing; French Ministry of National Education, Advanced Instruction, and Research; Capnodis	This work was performed with the financial support of the French Ministry of Ecology, Sustainable Development, Transport and Housing under the third GESSOL programme (Environmental function and management of soil heritage, project 10-MBGD-GESSOL-8-CVS-077, SP3A). The authors are grateful to the French Ministry of National Education, Advanced Instruction, and Research for co-funding this research. NP received funding from Capnodis in the form of a salary. The specific roles of this author are articulated in the 'Author Contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attonaty J-M, 1993, P EURAGENG C OCT 1 2; Aubry C, 1998, AGR SYST, V56, P45, DOI 10.1016/S0308-521X(97)00034-6; Bergez JE, 2001, ECOL MODEL, V137, P43, DOI 10.1016/S0304-3800(00)00431-2; Chahinian N, 2006, J HYDROL, V326, P135, DOI 10.1016/j.jhydrol.2005.10.038; Chandrasekaran B, 1999, IEEE INTELL SYST APP, V14, P20, DOI 10.1109/5254.747902; Chardon X, 2012, ANIMAL, V6, P1711, DOI 10.1017/S1751731112000687; Chavas JP, 2010, AM J AGR ECON, V92, P356, DOI 10.1093/ajae/aaq004; Commissariat General au Developpement Durable, 2015, CHIFFR STAT, V697; deVoil P, 2009, P 18 WORLD IMACS MOD; Goldammer T., 2013, GRAPE GROWERS HDB CO; Hardaker J. B., 2011, AFBM Journal, V8, P1; IUSS Working Group WRB, 2006, WORLD SOIL RES REP; Janssen S, 2007, AGR SYST, V94, P622, DOI 10.1016/j.agsy.2007.03.001; Joannon A, 2005, AGR ECOSYST ENVIRON, V111, P13, DOI 10.1016/j.agee.2005.04.021; Kenny S, 2009, EXTENSION FARMING SY, V5; Lagacherie P, 2004, ORG SPATIALE CONDUIT, P79; Le Gal PY, 2010, ENVIRON MODELL SOFTW, V25, P258, DOI 10.1016/j.envsoft.2008.12.013; Lennartz B, 1997, J ENVIRON QUAL, V26, P1493, DOI 10.2134/jeq1997.00472425002600060007x; Leonard J, 1998, CATENA, V32, P209, DOI 10.1016/S0341-8162(98)00049-6; Louchart X, 2001, J ENVIRON QUAL, V30, P982, DOI 10.2134/jeq2001.303982x; Martin G, 2011, ENVIRON MODELL SOFTW, V26, P371, DOI 10.1016/j.envsoft.2010.10.002; Martin G, 2013, AGRON SUSTAIN DEV, V33, P131, DOI 10.1007/s13593-011-0075-4; Martin Philippe, 1998, Cahiers Agricultures, V7, P111; Martin-Clouaire Roger, 2009, International Journal of Metadata, Semantics and Ontologies, V4, P42, DOI 10.1504/IJMSO.2009.026253; Martin-Clouaire R, 2011, P MODSIM2011 DEC PER; Martin-Clouaire R, 2011, FONDEMENTS ONTOLOGIQ; Merot A, 2008, AGR SYST, V98, P108, DOI 10.1016/j.agsy.2008.05.001; Mottes C, 2014, AGRON SUSTAIN DEV, V34, P229, DOI 10.1007/s13593-013-0176-3; Moussa R, 2002, HYDROL PROCESS, V16, P393, DOI 10.1002/hyp.333; Muehlen M. Z., 2004, Information Technology & Management, V5, P271, DOI 10.1023/B:ITEM.0000031582.55219.2b; PAPY F, 1988, AGR SYST, V27, P295, DOI 10.1016/0308-521X(88)90037-6; Pare N, 2011, THESIS SUPAGRO MONTP; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Rellier J-P, 2011, TRAVAIL AGR SON ORG, P205; Ripoche A, 2011, ENVIRON MODELL SOFTW, V26, P1467, DOI 10.1016/j.envsoft.2011.08.003; Rivera-Ferre MG, 2013, SUSTAINABILITY-BASEL, V5, P3858, DOI 10.3390/su5093858; Rivington M, 2007, ENVIRON MODELL SOFTW, V22, P202, DOI 10.1016/j.envsoft.2005.07.018; Robertson M. J., 2012, AFBM Journal, V9, P13; Rodriguez D, 2014, AGR SYST, V126, P50, DOI 10.1016/j.agsy.2013.04.003; Rolon M, 2012, COMPUT IND, V63, P53, DOI 10.1016/j.compind.2011.10.005; Sierhuis M, 2009, AGENT DIRECTED SIMUL, P475; Van Der Aalst W., 2004, WORKFLOW MANAGEMENT; van Wijk M, 2012, REV FARM HOUSEHOLD M; Yilmaz Levent, 2009, AGENT DIRECTED SIMUL	44	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151952	10.1371/journal.pone.0151952	http://dx.doi.org/10.1371/journal.pone.0151952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990089	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800123
J	Nybakken, GE; Bala, R; Gratzinger, D; Jones, CD; Zehnder, JL; Bangs, CD; Cherry, A; Warnke, RA; Natkunam, Y				Nybakken, Grant E.; Bala, Rajeev; Gratzinger, Dita; Jones, Carol D.; Zehnder, James L.; Bangs, Charles D.; Cherry, Athena; Warnke, Roger A.; Natkunam, Yasodha			Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications	PLOS ONE			English	Article							SITU FOLLICULAR LYMPHOMA; MANTLE CELL LYMPHOMA; IN-SITU; B-CELLS; BCL-2/IGH REARRANGEMENT; HEALTHY-INDIVIDUALS; CLONAL EVOLUTION; GERMINAL-CENTERS; BLOOD; TRANSLOCATION	We sought to address the significance of isolated follicles that exhibit atypical morphologic features that may be mistaken for lymphoma in a background of reactive lymphoid tissue. Seven cases that demonstrated centroblast-predominant isolated follicles and absent BCL2 staining in otherwise-normal lymph nodes were studied. Four of seven cases showed clonal B-cell proliferations amid a polyclonal B cell background; all cases lacked the IGH-BCL2 translocation and BCL2 protein expression. Although three patients had invasive breast carcinoma at other sites, none were associated with systemic lymphoma up to 44 months after diagnosis. The immunoarchitectural features of these highly unusual cases raise the question of whether a predominance of centroblasts and/or absence of BCL2 expression could represent a precursor lesion or atypical reactive phenomenon. Differentiating such cases from follicular lymphoma or another mimic is critical, lest patients with indolent proliferations be exposed to unnecessarily aggressive treatment.	[Nybakken, Grant E.; Bala, Rajeev; Gratzinger, Dita; Jones, Carol D.; Zehnder, James L.; Bangs, Charles D.; Cherry, Athena; Warnke, Roger A.; Natkunam, Yasodha] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Natkunam, Y (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	yaso@stanford.edu	Natkunam, Yasodha/L-5454-2015	Natkunam, Yasodha/0000-0002-9816-1018; Gratzinger, Dita/0000-0002-9182-8123	NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA049605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; Ardeshna KM, 2003, LANCET, V362, P516, DOI 10.1016/S0140-6736(03)14110-4; Attygalle AD, 2004, BLOOD, V104, P3343, DOI 10.1182/blood-2004-01-0385; BELL DA, 1995, JNCI-J NATL CANCER I, V87, P223, DOI 10.1093/jnci/87.3.223; Bonzheim I, 2011, BLOOD, V118, P3442, DOI 10.1182/blood-2011-07-368944; Carbone A, 2012, LEUKEMIA LYMPHOMA, V53, P603, DOI 10.3109/10428194.2011.624229; Carbone A, 2012, HEMATOL ONCOL, V30, P1, DOI 10.1002/hon.993; Carbone A, 2011, AM J HEMATOL, V86, pE66, DOI 10.1002/ajh.22169; Carbone A, 2011, AM J CLIN PATHOL, V136, P481, DOI 10.1309/AJCPDSG2J5IBEYFB; Carbone A, 2011, BLOOD, V117, P3954, DOI 10.1182/blood-2010-10-299628; Cheung MC, 2009, LEUKEMIA, V23, P1176, DOI 10.1038/leu.2009.9; Cong PJ, 2002, BLOOD, V99, P3376, DOI 10.1182/blood.V99.9.3376; Dolken G, 1996, J CLIN ONCOL, V14, P1333; Dolken Gottfried, 2008, J Natl Cancer Inst Monogr, P44, DOI 10.1093/jncimonographs/lgn005; Handa T, 2011, INT J SURG PATHOL, V19, P521, DOI 10.1177/1066896909350174; Jegalian AG, 2011, BLOOD, V118, P2976, DOI 10.1182/blood-2011-05-355255; JI WZ, 1995, CANCER RES, V55, P2876; Jiang XY, 2010, BLOOD, V116, P5217, DOI 10.1182/blood-2010-04-281568; Ladetto M, 2003, J CLIN ONCOL, V21, P1398, DOI 10.1200/JCO.2003.07.070; Leich E, 2011, BLOOD, V118, P5550, DOI 10.1182/blood-2011-06-361972; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; LIMPENS J, 1991, ONCOGENE, V6, P2271; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; Mamessier E, 2014, HAEMATOLOGICA, V99, P481, DOI 10.3324/haematol.2013.094474; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; Montes-Moreno S, 2010, HISTOPATHOLOGY, V56, P658, DOI 10.1111/j.1365-2559.2010.03529.x; Nam-Cha SH, 2008, HISTOPATHOLOGY, V52, P436, DOI 10.1111/j.1365-2559.2008.02965.x; Pillai RK, 2013, HAEMATOLOGICA, V98, P1571, DOI 10.3324/haematol.2013.085506; Roullet MR, 2010, AM J CLIN PATHOL, V133, P584, DOI 10.1309/AJCP5RT4MRSDGKSX; Sapunar F, 2000, LEUKEMIA LYMPHOMA, V37, P163, DOI 10.3109/10428190009057640; Schmidt J, 2014, LEUKEMIA, V28, P1103, DOI 10.1038/leu.2013.307; Schmitt C, 2006, LEUKEMIA RES, V30, P745, DOI 10.1016/j.leukres.2005.10.001; Schuler F, 2009, INT J CANCER, V124, P958, DOI 10.1002/ijc.23958; Sotomayor EA, 2007, EXP MOL PATHOL, V83, P254, DOI 10.1016/j.yexmp.2007.03.001; Summers KE, 2001, J CLIN ONCOL, V19, P420, DOI 10.1200/JCO.2001.19.2.420; Swerdlow SH, 2008, WHO CLASSIFICATION T; Temmins C, 2011, APPL IMMUNOHISTO M M, V19, P266, DOI 10.1097/PAI.0b013e3181f89a4d	37	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151735	10.1371/journal.pone.0151735	http://dx.doi.org/10.1371/journal.pone.0151735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991267	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800093
J	Son, HS; Lee, YS; Im, YJ; Kim, SW; Chi, BH; Han, SW				Son, Hee Seo; Lee, Yong Seung; Im, Young Jae; Kim, Sang Woon; Chi, Byung Hoon; Han, Sang Won			Can Hypertrophy of the Contralateral Testis Predict the Absence of a Viable Testis in Infancy with Cryptorchidism: A Prospective Analysis	PLOS ONE			English	Article							INHIBIN-B LEVELS; TESTICULAR VOLUME; UNDESCENDED TESTES; NONPALPABLE TESTIS; BOYS; ULTRASONOGRAPHY; TESTOSTERONE; GONADOTROPIN; ORCHIDOMETER; MONORCHISM	This prospective study aimed to evaluate whether Contralateral compensatory testicular hypertrophy (CTH) is valid as a predictive tool for a non-viable testis in children aged between 6 and 18 months, and whether CTH is affected by mini-puberty. Seventy-two testes from 60 boys aged between 6 and 18 months were categorized into three groups: 24 testes contralateral to surgically removed non-viable testes (NVTs), 24 testes contralateral to surgically corrected undescended testes (UDTs), and 24 testes from a normal controls. Contralateral testicular length and volume were measured with ultrasonography and compared among the groups. Group 1 (NVT) had a significantly longer length and larger volume than group 2 (UDT). The length and volume of each group among three developmental periods (6-10, 10-14, and 14-18 months) were also analyzed. In the controls, the length was significantly larger at 6-10 months than at 10-14 months in accordance with previously reported changes in testicular size due to the effect of "mini-puberty." The volume of controls showed a similar pattern, though without statistical significance. However, this pattern was not observed in the NVT and UDT groups. A receiver operating curve revealed that a testicular length of 16.1 mm or a volume of 0.59 ml had the highest sensitivity and specificity for predicting NVTs. The CTH was also found to be valid as a predictive tool for a NVT in children of ages 6 to 18 months, as the effect of mini-puberty appeared to be absent in the NVT and UDT groups. However, the cut-off values were less than those of previous reports. The proper cut-off level according to the age and measurement method should be applied in this developmental period.	[Lee, Yong Seung] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, YS (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.	asforthelord@yuhs.ac		Son, Hee Seo/0000-0001-7198-7816; Lee, Yong Seung/0000-0003-3778-9888; Kim, Sang Woon/0000-0002-5790-1948; Han, Sang Won/0000-0003-0941-1300				Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; Braga LH, 2014, J PEDIATR UROL, V10, P693, DOI 10.1016/j.jpurol.2014.05.011; Crofton PM, 2002, CLIN ENDOCRINOL, V56, P215, DOI 10.1046/j.0300-0664.2001.01448.x; GENDREL D, 1980, J PEDIATR-US, V97, P217, DOI 10.1016/S0022-3476(80)80477-X; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Hamza AF, 2001, EUR J PEDIATR SURG, V11, P173, DOI 10.1055/s-2001-15484; Hodhod A, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2015.06.010; HUFF DS, 1992, J UROLOGY, V148, P627, DOI 10.1016/S0022-5347(17)36673-9; Hurwitz RS, 2001, J UROLOGY, V165, P588, DOI 10.1097/00005392-200102000-00077; JOB JC, 1988, HORM RES, V30, P167, DOI 10.1159/000181055; KEIZERSCHRAMA SMPFD, 1988, J CLIN ENDOCR METAB, V66, P159; KOFF SA, 1991, J UROLOGY, V146, P632, DOI 10.1016/S0022-5347(17)37877-1; Kolon TF, 2014, J UROLOGY, V192, P337, DOI 10.1016/j.juro.2014.05.005; Kuijper EAM, 2008, HUM REPROD, V23, P792, DOI 10.1093/humrep/den021; LARON Z, 1980, FERTIL STERIL, V33, P297; Lin CC, 2009, J ANDROL, V30, P685, DOI 10.2164/jandrol.108.006460; Main KM, 2006, J CLIN ENDOCR METAB, V91, P2732, DOI 10.1210/jc.2005-2443; Ritzen EM, 2007, ACTA PAEDIATR, V96, P638, DOI 10.1111/j.1651-2227.2006.00159.x; MULLER J, 1983, INT J ANDROL, V6, P143, DOI 10.1111/j.1365-2605.1983.tb00333.x; Raivio T, 2003, J CLIN ENDOCR METAB, V88, P2597, DOI 10.1210/jc.2002-021676; Sakamoto H, 2007, UROLOGY, V69, P152, DOI 10.1016/j.urology.2006.09.012; Sakamoto H, 2007, UROLOGY, V69, P158, DOI 10.1016/j.urology.2006.09.013; Shibata Y, 2010, UROLOGY, V76, P78, DOI 10.1016/j.urology.2010.02.043; Snodgrass WT, 2007, J UROLOGY, V178, P1718, DOI 10.1016/j.juro.2007.05.089; Suomi AM, 2006, J CLIN ENDOCR METAB, V91, P953, DOI 10.1210/jc.2004-2318; Thorup J, 2015, J UROLOGY, V193, P1632, DOI 10.1016/j.juro.2014.10.110	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151528	10.1371/journal.pone.0151528	http://dx.doi.org/10.1371/journal.pone.0151528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990979	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800071
J	Hao, WR; Schlesinger, LS; Friedman, A				Hao, Wenrui; Schlesinger, Larry S.; Friedman, Avner			Modeling Granulomas in Response to Infection in the Lung	PLOS ONE			English	Article							MATHEMATICAL-MODEL; HOST IMMUNITY; TUBERCULOSIS; MACROPHAGES; INTERLEUKIN-4; INFLAMMATION; ALPHA; IL-13	Alveolar macrophages play a large role in the innate immune response of the lung. However, when these highly immune-regulatory cells are unable to eradicate pathogens, the adaptive immune system, which includes activated macrophages and lymphocytes, particularly T cells, is called upon to control the pathogens. This collection of immune cells surrounds, isolates and quarantines the pathogen, forming a small tissue structure called a granuloma for intracellular pathogens like Mycobacterium tuberculosis (Mtb). In the present work we develop a mathematical model of the dynamics of a granuloma by a system of partial differential equations. The 'strength' of the adaptive immune response to infection in the lung is represented by a parameter a, the flux rate by which T cells and M1 macrophages that immigrated from the lymph nodes enter into the granuloma through its boundary. The parameter a is negatively correlated with the 'switching time', namely, the time it takes for the number of M1 type macrophages to surpass the number of infected, M2 type alveolar macrophages. Simulations of the model show that as a increases the radius of the granuloma and bacterial load in the granuloma both decrease. The model is used to determine the efficacy of potential host-directed therapies in terms of the parameter a, suggesting that, with fixed dosing level, an infected individual with a stronger immune response will receive greater benefits in terms of reducing the bacterial load.	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation under Grant DMS [0931642]; NIH [AI059639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059639, R01AI059639] Funding Source: NIH RePORTER	Mathematical Biosciences Institute; National Science Foundation under Grant DMS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WH and AF have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. LS has been supported under Grant NIH AI059639.	Bajetta E, 1998, CLIN CANCER RES, V4, P75; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bona CA, 2001, CYTOKINES CYTOKINE R; Buttner C, 1997, AM J RESP CELL MOL, V17, P315; Calaras D, 2015, OVERVIEW SARCOIDOSIS; Calaras D, 2012, EURO RESP J; Cardona P-J, 2012, UNDERSTANDING TUBERC; Chroneos ZC, 2012, IMMUNOREGULATORY ROL; Cilfone NA, 2015, J IMMUNOL, V194, P664, DOI 10.4049/jimmunol.1400734; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; Conlon P J, 1989, Biotechnol Ther, V1, P31; Cosio MG, 2002, CHEST, V121, p160S, DOI 10.1378/chest.121.5_suppl.160S; Datta M, 2016, ANN BIOMED ENG, V44, P863, DOI 10.1007/s10439-015-1415-3; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; Deepak P, 2010, INT IMMUNOL, V22, P53, DOI 10.1093/intimm/dxp114; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; Gammack D, 2005, MULTISCALE MODEL SIM, V3, P312, DOI 10.1137/040603127; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hao WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135097; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Hasskamp JH, 2005, AM J HEMATOL, V78, P314, DOI 10.1002/ajh.20296; Janeway CA, 2001, IMMUNOBIOLOGY; Jayaraman P, 2013, J IMMUNOL, V190, P4196, DOI 10.4049/jimmunol.1202688; LI L, 1994, J IMMUNOL, V153, P3967; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin YG, 1998, INFECT IMMUN, V66, P2319, DOI 10.1128/IAI.66.5.2319-2322.1998; Linderman JJ, 2015, INTEGR BIOL-UK, V7, P591, DOI [10.1039/c4ib00295d, 10.1039/C4IB00295D]; Lo W, 2015, PREPRINT; LU ZY, 1995, BLOOD, V86, P3123; Ma JJ, 2014, FASEB J, V28, P3238, DOI 10.1096/fj.13-247056; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marino S, 2015, INFECT IMMUN, V83, P324, DOI 10.1128/IAI.02494-14; Marino S, 2010, J THEOR BIOL, V265, P586, DOI 10.1016/j.jtbi.2010.05.012; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Medicinenet, 2015, DEF GRAN; Miranda MS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139127; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; OKADA M, 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/404929; Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pienaar E, 2015, J THEOR BIOL, V367, P166, DOI 10.1016/j.jtbi.2014.11.021; Pouliot P, 2005, CLIN EXP ALLERGY, V35, P804, DOI 10.1111/j.1365-2222.2005.02246.x; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Reyes N, 2015, COLOMB MEDICA, V46, P26, DOI 10.25100/cm.v46i1.1570; Shaler CR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00030; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Steckelberg JM, 2015, GRANULOMA WHAT DOES; VanHeyningen TK, 1997, J IMMUNOL, V158, P330; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013	68	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0148738	10.1371/journal.pone.0148738	http://dx.doi.org/10.1371/journal.pone.0148738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986986	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300011
J	Ioannoni, R; Brault, A; Labbe, S				Ioannoni, Raphael; Brault, Ariane; Labbe, Simon			Cuf2 Is a Transcriptional Co-Regulator that Interacts with Mei4 for Timely Expression of Middle-Phase Meiotic Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; DNA-BINDING DOMAIN; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MINOR-GROOVE; DIVISION CYCLE; MEIOSIS; COPPER; SPORULATION	The Schizosaccharomyces pombe cuf2(+) gene encodes a nuclear regulator that is required for timely activation and repression of several middle-phase genes during meiotic differentiation. In this study, we sought to gain insight into the mechanism by which Cuf2 regulates meiotic gene expression. Using a chromatin immunoprecipitation approach, we demonstrate that Cuf2 is specifically associated with promoters of both activated and repressed target genes, in a time-dependent manner. In case of the fzr1(+) gene whose transcription is positively affected by Cuf2, promoter occupancy by Cuf2 results in a concomitant increased association of RNA polymerase II along its coding region. In marked contrast, association of RNA polymerase II with chromatin decreases when Cuf2 negatively regulates target gene expression such as wtf13(+). Although Cuf2 operates through a transcriptional mechanism, it is unable to perform its function in the absence of the Mei4 transcription factor, which is a member of the conserved forkhead protein family. Using coimmunoprecipitation experiments, results showed that Cuf2 is a binding partner of Mei4. Bimolecular fluorescence complementation experiments brought further evidence that an association between Cuf2 and Mei4 occurs in the nucleus. Analysis of fzr1(+) promoter regions revealed that two FLEX-like elements, which are bound by the transcription factor Mei4, are required for chromatin occupancy by Cuf2. Together, results reported here revealed that Cuf2 and Mei4 co-regulate the timely expression of middle-phase genes during meiosis.	[Ioannoni, Raphael; Brault, Ariane; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X	 [MOP-114986]		This work was supported by grant number: MOP-114986 http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, GENETICS, V154, P1497; Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; Aoi Y, 2013, EMBO REP, V14, P553, DOI 10.1038/embor.2013.52; Asakawa H, 2001, MOL GENET GENOMICS, V265, P424, DOI 10.1007/s004380000429; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Blanco MA, 2001, J CELL SCI, V114, P2135; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029917; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; HEPWORTH SR, 1995, MOL CELL BIOL, V15, P3934; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Ioannoni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036338; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jensen LT, 1998, J BIOL CHEM, V273, P23805, DOI 10.1074/jbc.273.37.23805; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kimata Y, 2011, MOL BIOL CELL, V22, P1486, DOI 10.1091/mbc.E10-09-0774; Klutstein M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-478; Koch KA, 1996, MOL CELL BIOL, V16, P724; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S., 2013, METALS IN CELLS, P163; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Li YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-125; Lindgren A, 2000, EMBO J, V19, P6489, DOI 10.1093/emboj/19.23.6489; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Nakase Y, 2009, GENETICS, V183, P1195, DOI 10.1534/genetics.109.106906; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Papadopoulou K, 2008, J CELL SCI, V121, P38, DOI 10.1242/jcs.019489; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Staub C, 2001, J ANDROL, V22, P911; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597	58	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151914	10.1371/journal.pone.0151914	http://dx.doi.org/10.1371/journal.pone.0151914			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986212	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300150
J	Lobo, GP; Au, A; Kiser, PD; Hagstrom, SA				Lobo, Glenn P.; Au, Adrian; Kiser, Philip D.; Hagstrom, Stephanie A.			Involvement of Endoplasmic Reticulum Stress in TULP1 Induced Retinal Degeneration	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TUBBY-LIKE PROTEIN-1; RETINITIS-PIGMENTOSA; VALPROIC ACID; CELL-DEATH; ER STRESS; IN-VIVO; MUTATIONS; ACTIVATION; MECHANISMS	Inherited retinal disorders (IRDs) result in severe visual impairments in children and adults. A challenge in the field of retinal degenerations is identifying mechanisms of photoreceptor cell death related to specific genetic mutations. Mutations in the gene TULP1 have been associated with two forms of IRDs, early-onset retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA). TULP1 is a cytoplasmic, membrane-associated protein shown to be involved in transportation of newly synthesized proteins destined for the outer segment compartment of photoreceptor cells; however, how mutant TULP1 causes cell death is not understood. In this study, we provide evidence that common missense mutations in TULP1 express as misfolded protein products that accumulate within the endoplasmic reticulum (ER) causing prolonged ER stress. In an effort to maintain protein homeostasis, photoreceptor cells then activate the unfolded protein response (UPR) complex. Our results indicate that the two major apoptotic arms of the UPR pathway, PERK and IRE1, are activated. Additionally, we show that retinas expressing mutant TULP1 significantly upregulate the expression of CHOP, a UPR signaling protein promoting apoptosis, and undergo photoreceptor cell death. Our study demonstrates that the ER-UPR, a known mechanism of apoptosis secondary to an overwhelming accumulation of misfolded protein, is involved in photoreceptor degeneration caused by missense mutations in TULP1. These observations suggest that modulating the UPR pathways might be a strategy for therapeutic intervention.	[Lobo, Glenn P.; Au, Adrian; Hagstrom, Stephanie A.] Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA; [Kiser, Philip D.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH 44106 USA; [Hagstrom, Stephanie A.] Case Western Reserve Univ, Cleveland Clin, Dept Ophthalmol, Lerner Coll Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation	Hagstrom, SA (corresponding author), Cleveland Clin, Cole Eye Inst, Dept Ophthalm Res, Cleveland, OH 44106 USA.; Hagstrom, SA (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Ophthalmol, Lerner Coll Med, Cleveland, OH 44195 USA.	hagstrs@ccf.org	Au, Adrian/AAE-9654-2019; Lobo, Glenn P./AAI-9736-2020	Au, Adrian/0000-0001-8110-9988; 	National Institute of Health/National Eye Institute [RO1EY016072]; Knights Templar Eye Foundation Career Grants [KTEF2014/06GL, KTEF2015/07GL]; Howard Hughes Medical Institute-Foundation; Veterans Affairs (VA) Career Development Award [IK2BX002683]; NATIONAL EYE INSTITUTE [R01EY016072] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Knights Templar Eye Foundation Career Grants; Howard Hughes Medical Institute-Foundation(Howard Hughes Medical Institute); Veterans Affairs (VA) Career Development Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institute of Health/National Eye Institute (RO1EY016072) to SAH; Knights Templar Eye Foundation Career Grants (KTEF2014/06GL) and (KTEF2015/07GL) to GPL; a Howard Hughes Medical Institute-Foundation to Fight Blindness Medical Research Fellows Award to AA; and a Veterans Affairs (VA) Career Development Award (IK2BX002683) to PDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AH, 2008, MOL VIS, V14, P675; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Athanasiou D, 2012, MOL BIOL CELL, V23, P3522, DOI 10.1091/mbc.E12-02-0168; Beryozkin A, 2014, INVEST OPHTH VIS SCI, V55, P1149, DOI 10.1167/iovs.13-13625; Cai X, 2015, EXP EYE RES, V140, P130, DOI 10.1016/j.exer.2015.08.022; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Chiang WC, 2012, INVEST OPHTH VIS SCI, V53, P7159, DOI 10.1167/iovs.12-10222; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Chinskey ND, 2014, CURR OPIN OPHTHALMOL, V25, P228, DOI 10.1097/ICU.0000000000000043; Choudhury S, 2014, ADV EXP MED BIOL, V801, P455, DOI 10.1007/978-1-4614-3209-8_58; Clemson CM, 2011, BRIT J OPHTHALMOL, V95, P89, DOI 10.1136/bjo.2009.175356; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Datta R, 2009, P NATL ACAD SCI USA, V106, P3437, DOI 10.1073/pnas.0813178106; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Ebke LA, 2016, ADV EXP MED BIOL, V854, P605, DOI 10.1007/978-3-319-17121-0_80; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Gregory-Evans CY, 2013, PROG RETIN EYE RES, V33, P40, DOI 10.1016/j.preteyeres.2012.10.003; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Grossman GH, 2014, ADV EXP MED BIOL, V801, P511, DOI 10.1007/978-1-4614-3209-8_65; Grossman GH, 2013, VISUAL NEUROSCI, V30, P129, DOI 10.1017/S0952523813000138; Grossman GH, 2011, EXP EYE RES, V93, P658, DOI 10.1016/j.exer.2011.08.005; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hagstrom SA, 2001, INVEST OPHTH VIS SCI, V42, P1955; Hagstrom SA, 2012, ADV EXP MED BIOL, V723, P783, DOI 10.1007/978-1-4614-0631-0_100; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Inokuchi Y, 2009, INVEST OPHTH VIS SCI, V50, P334, DOI 10.1167/iovs.08-2123; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jacobson SG, 2014, INVEST OPHTH VIS SCI, V55, P5354, DOI 10.1167/iovs.14-14570; Jayakody SA, 2015, PROG RETIN EYE RES, V46, P31, DOI 10.1016/j.preteyeres.2015.01.003; Jing G, 2012, EXP DIABETES RES, V17, P233; Jing GJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/589589; Kang MJ, 2009, P NATL ACAD SCI USA, V106, P17043, DOI 10.1073/pnas.0905566106; Khan MI, 2011, OPHTHALMOLOGY, V118, P1444, DOI 10.1016/j.ophtha.2010.10.047; Kumar A, 2014, J OCUL PHARMACOL TH, V30, P580, DOI 10.1089/jop.2013.0166; Kunte MM, 2012, INVEST OPHTH VIS SCI, V53, P3792, DOI 10.1167/iovs.11-9235; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lobo GP, 2013, J BIOL CHEM, V288, P9017, DOI 10.1074/jbc.M112.444240; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Lobo GP, 2009, HUM MOL GENET, V18, P2851, DOI 10.1093/hmg/ddp220; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Rebello G, 2004, P NATL ACAD SCI USA, V101, P6617, DOI 10.1073/pnas.0401529101; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tian LF, 2015, GENOMICS, V105, P253, DOI 10.1016/j.ygeno.2015.01.008; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Volgyi K, 2015, CURR ALZHEIMER RES, V12, P655, DOI 10.2174/1567205012666150710095035; Weleber RG, 2004, LEBER CONGENITAL AMA, P1993; Wert KJ, 2014, DEV OPHTHALMOL, V53, P33, DOI 10.1159/000357294; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Xi QS, 2005, INVEST OPHTH VIS SCI, V46, P4754, DOI 10.1167/iovs.05-0693; Xi QS, 2007, INVEST OPHTH VIS SCI, V48, P2837, DOI 10.1167/iovs.06-0059; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015	69	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151806	10.1371/journal.pone.0151806	http://dx.doi.org/10.1371/journal.pone.0151806			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987071	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300132
J	Messaoudi, M; Milenkov, M; Albrich, WC; van der Linden, MPG; Benet, T; Chou, M; Sylla, M; Costa, PB; Richard, N; Klugman, KP; Endtz, HP; Paranhos-Baccala, G; Telles, JN				Messaoudi, Melina; Milenkov, Milen; Albrich, Werner C.; van der Linden, Mark P. G.; Benet, Thomas; Chou, Monidarin; Sylla, Mariam; Costa, Patricia Barreto; Richard, Nathalie; Klugman, Keith P.; Endtz, Hubert P.; Paranhos-Baccala, Glaucia; Telles, Jean-Noel			The Relevance of a Novel Quantitative Assay to Detect up to 40 Major Streptococcus pneumoniae Serotypes Directly in Clinical Nasopharyngeal and Blood Specimens	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; REAL-TIME PCR; CONJUGATE VACCINE; CAPSULAR SEROTYPES; MULTIPLEX PCR; LATEX AGGLUTINATION; CHILDREN; CARRIAGE; ADULTS; IDENTIFICATION	For epidemiological and surveillance purposes, it is relevant to monitor the distribution and dynamics of Streptococcus pneumoniae serotypes. Conventional serotyping methods do not provide rapid or quantitative information on serotype loads. Quantitative serotyping may enable prediction of the invasiveness of a specific serotype compared to other serotypes carried. Here, we describe a novel, rapid multiplex real-time PCR assay for identification and quantification of the 40 most prevalent pneumococcal serotypes and the assay impacts in pneumonia specimens from emerging and developing countries. Eleven multiplex PCR to detect 40 serotypes or serogroups were optimized. Quantification was enabled by reference to standard dilutions of known bacterial load. Performance of the assay was evaluated to specifically type and quantify S. pneumoniae in nasopharyngeal and blood samples from adult and pediatric patients hospitalized with pneumonia (n = 664) from five different countries. Serogroup 6 was widely represented in nasopharyngeal specimens from all five cohorts. The most frequent serotypes in the French, South African, and Brazilian cohorts were 1 and 7A/F, 3 and 19F, and 14, respectively. When both samples were available, the serotype in blood was always present as carriage with other serotypes in the nasopharynx. Moreover, the ability of a serotype to invade the bloodstream may be linked to its nasopharyngeal load. The mean nasopharyngeal concentration of the serotypes that moved to the blood was 3 log-fold higher than the ones only found in the nasopharynx. This novel, rapid, quantitative assay may potentially predict some of the S. pneumoniae serotypes invasiveness and assessment of pneumococcal serotype distribution.	[Messaoudi, Melina; Milenkov, Milen; Endtz, Hubert P.; Paranhos-Baccala, Glaucia; Telles, Jean-Noel] Fdn Merieux, CIRI, Emerging Pathogens Lab, Lyon, France; [Endtz, Hubert P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Albrich, Werner C.] Kantonsspital, Dept Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Albrich, Werner C.; Klugman, Keith P.] Univ Witwatersrand, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa; [van der Linden, Mark P. G.] Univ Hosp RWTH Aachen, Inst Med Microbiol, Natl Reference Ctr Streptococci, Aachen, Germany; [Benet, Thomas] Hosp Civils Lyon, Hop Edouard Herriot, Serv Hygiene Epidemiol & Prevent, Lyon, France; [Chou, Monidarin] Univ Hlth Sci, Fac Pharm, Phnom Penh, Cambodia; [Sylla, Mariam] CHU Gabriel Toure, Bamako, Mali; [Costa, Patricia Barreto] Inst Oswaldo Cruz Fiocruz, Lab Virus Resp Sarampo, Rio De Janeiro, Brazil; [Richard, Nathalie] Groupement Hosp Est, HFME, Serv Reanimat Pediat Med Chirurg, Bron, France; [Klugman, Keith P.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Klugman, Keith P.] Bill & Melinda Gates Fdn, Pneumonia Program, Seattle, WA USA	Ecole Normale Superieure de Lyon (ENS de LYON); Erasmus University Rotterdam; Erasmus MC; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; University of Witwatersrand; RWTH Aachen University; RWTH Aachen University Hospital; CHU Lyon; Fundacao Oswaldo Cruz; CHU Lyon; Emory University; Emory University; Bill & Melinda Gates Foundation	Paranhos-Baccala, G (corresponding author), Fdn Merieux, CIRI, Emerging Pathogens Lab, Lyon, France.	glaucia.baccala@fondation-merieux.org	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313; MESSAOUDI, Melina/0000-0002-7049-7206	Fondation Merieux; Fondation Anber	Fondation Merieux; Fondation Anber	The authors received no specific funding for this work. This research study was funded by the authors' own budget from Fondation Merieux and Fondation Anber.; The authors wish to thank Elodie Paredes and Sandra Dollet for their technical assistance, Drs Florence Komurian-Pradel and Leticia Lobo-Luppi for their scientific support and Dr Jonathan Hoffmann for his help with the Graph Pad software. This work was partly supported by Fondation Anber.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Albrich WC, 2014, J CLIN MICROBIOL, V52, P4224, DOI 10.1128/JCM.01553-14; Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953; AUSTRIAN R, 1976, MT SINAI J MED, V43, P699; Bandettini R, 2012, J Prev Med Hyg, V53, P85; BELL LM, 1985, PEDIATRICS, V76, P901; Benet T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145447; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Blaschke AJ, 2011, PEDIATR INFECT DIS J, V30, P289, DOI 10.1097/INF.0b013e3182002d14; Bogaert D, 2004, FEMS IMMUNOL MED MIC, V41, P259, DOI 10.1016/j.femsim.2004.03.013; Bosch AATM, 2016, VACCINE, V34, P531, DOI 10.1016/j.vaccine.2015.11.060; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Fenoll A, 1997, J CLIN MICROBIOL, V35, P764, DOI 10.1128/JCM.35.3.764-766.1997; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kendall BA, 2016, VACCINE, V34, P474, DOI 10.1016/j.vaccine.2015.12.010; Lipsitch M, 2001, AM J EPIDEMIOL, V154, P85, DOI 10.1093/aje/154.1.85; Magomani V, 2014, J CLIN MICROBIOL, V52, P3271, DOI 10.1128/JCM.01061-14; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Mehr S, 2012, PAEDIATR RESPIR REV, V13, P258, DOI 10.1016/j.prrv.2011.12.001; Menezes APD, 2016, VACCINE, V34, P791, DOI 10.1016/j.vaccine.2015.12.042; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pasinato A, 2014, VACCINE, V32, P1375, DOI 10.1016/j.vaccine.2014.01.023; Peralta G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-79; Pickering JW, 2012, METHODS MOL BIOL, V808, P361, DOI 10.1007/978-1-61779-373-8_24; Picot VS, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0635-8; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Resti M, 2010, CLIN INFECT DIS, V51, P1042, DOI 10.1086/656579; Reynisson E, 2006, J MICROBIOL METH, V66, P206, DOI 10.1016/j.mimet.2005.11.006; Scott JAG, 1996, CLIN INFECT DIS, V22, P973, DOI 10.1093/clinids/22.6.973; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Slotved HC, 2016, VACCINE, V34, P769, DOI 10.1016/j.vaccine.2015.12.056; Slotved HC, 2004, J CLIN MICROBIOL, V42, P2518, DOI 10.1128/JCM.42.6.2518-2522.2004; SNIADACK DH, 1995, PEDIATR INFECT DIS J, V14, P503, DOI 10.1097/00006454-199506000-00007; Spratt BG, 2000, LANCET, V356, P1210, DOI 10.1016/S0140-6736(00)02779-3; SULLIVAN TD, 1982, PEDIATRICS, V69, P699; Telles JN, 2012, PNEUMONIA, V1, P11, DOI 10.15172/pneu.2012.1/228; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Wagenvoort GHJ, 2016, VACCINE, V34, P1077, DOI 10.1016/j.vaccine.2015.12.066; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Zhou F, 2007, J CLIN MICROBIOL, V45, P3411, DOI 10.1128/JCM.01076-07	50	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151428	10.1371/journal.pone.0151428	http://dx.doi.org/10.1371/journal.pone.0151428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986831	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300070
J	Raboisson, D; Trillat, P; Cahuzac, C				Raboisson, Didier; Trillat, Pauline; Cahuzac, Clelia			Failure of Passive Immune Transfer in Calves: A Meta-Analysis on the Consequences and Assessment of the Economic Impact	PLOS ONE			English	Article							SERUM IGG CONCENTRATIONS; DAIRY CALVES; MANAGEMENT-PRACTICES; SUBCLINICAL KETOSIS; BULL CALVES; MORTALITY; COLOSTRUM; HEIFERS; COWS; FRANCE	Low colostrum intake at birth results in the failure of passive transfer (FPT) due to the inadequate ingestion of colostral immunoglobulins (Ig). FPT is associated with an increased risk of mortality and decreased health and longevity. Despite the known management practices associated with low FPT, it remains an important issue in the field. Neither a quantitative analysis of FPT consequences nor an assessment of its total cost are available. To address this point, a meta-analysis on the adjusted associations between FPT and its outcomes was first performed. Then, the total costs of FPT in European systems were calculated using a stochastic method with adjusted values as the input parameters. The adjusted risks (and 95% confidence intervals) for mortality, bovine respiratory disease, diarrhoea and overall morbidity in the case of FPT were 2.12 (1.43-3.13), 1.75 (1.50-2.03), 1.51 (1.05-2.17) and 1.91 (1.63-2.24), respectively. The mean (and 95% prediction interval) total costs per calf with FPT were estimated to be (sic)60 ((sic)10-109) and (sic)80 ((sic)20-139) for dairy and beef, respectively. As a result of the double-step stochastic method, the proposed economic estimation constitutes the first estimate available for FPT. The results are presented in a way that facilitates their use in the field and, with limited effort, combines the cost of each contributor to increase the applicability of the economic assessment to the situations farm-advisors may face. The present economic estimates are also an important tool to evaluate the profitability of measures that aim to improve colostrum intake and FPT prevention.	[Raboisson, Didier; Cahuzac, Clelia] Univ Toulouse, ENVT, INP, IHAP,UMR 1225, F-31076 Toulouse, France; [Raboisson, Didier; Cahuzac, Clelia] INRA, IHAP, UMR1225, F-31076 Toulouse, France; [Trillat, Pauline] Univ Toulouse, ENVT, INP, F-31076 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Raboisson, D (corresponding author), Univ Toulouse, ENVT, INP, IHAP,UMR 1225, F-31076 Toulouse, France.; Raboisson, D (corresponding author), INRA, IHAP, UMR1225, F-31076 Toulouse, France.	d.raboisson@envt.fr	Raboisson, Didier/AAL-4025-2020	Raboisson, Didier/0000-0003-1630-6218				Beam AL, 2009, J DAIRY SCI, V92, P3973, DOI 10.3168/jds.2009-2225; Chigerwe M, 2008, AM J VET RES, V69, P1158, DOI 10.2460/ajvr.69.9.1158; Chigerwe M, 2012, JAVMA-J AM VET MED A, V241, P104, DOI 10.2460/javma.241.1.104; Chigerwe M, 2009, JAVMA-J AM VET MED A, V234, P785, DOI 10.2460/javma.234.6.785; DENISE SK, 1989, J DAIRY SCI, V72, P552, DOI 10.3168/jds.S0022-0302(89)79140-2; Donovan GA, 1998, PREV VET MED, V34, P31, DOI 10.1016/S0167-5877(97)00060-3; Dudek K, 2014, RES VET SCI, V97, P32, DOI 10.1016/j.rvsc.2014.04.005; Faber S. N., 2005, Professional Animal Scientist, V21, P420; Finch R, 2010, LANCET INFECT DIS, V10, P754, DOI 10.1016/S1473-3099(10)70246-2; Godden S, 2008, VET CLIN N AM-FOOD A, V24, P19, DOI 10.1016/j.cvfa.2007.10.005; Gulliksen SM, 2009, J DAIRY SCI, V92, P2782, DOI 10.3168/jds.2008-1807; Hasler Barbara, 2015, Vet Rec Open, V2, pe000035, DOI 10.1136/vetreco-2014-000035; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Institut de l'Elevage [French Livestock Institut], 2013, RES NAT COLL RES ANN, P52; Kovalchik S., 2013, TUTORIAL META ANAL R, V204; National Animal Health Monotoring Sytem (NAHMS), 1993, NAT DAIR HEIF EV PRO; PRITCHETT LC, 1991, J DAIRY SCI, V74, P2336, DOI 10.3168/jds.S0022-0302(91)78406-3; Quigley JD, 1998, J DAIRY SCI, V81, P2779, DOI 10.3168/jds.S0022-0302(98)75836-9; Raboisson D, 2015, PREV VET MED, V122, P417, DOI 10.1016/j.prevetmed.2015.07.010; Raboisson D, 2014, J DAIRY SCI, V97, P7547, DOI 10.3168/jds.2014-8237; Raboisson D, 2013, J DAIRY SCI, V96, P2913, DOI 10.3168/jds.2012-6010; Raboisson D, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0254-z; ROBISON JD, 1988, J DAIRY SCI, V71, P1283, DOI 10.3168/jds.S0022-0302(88)79684-8; Trotz-Williams LA, 2008, J DAIRY SCI, V91, P3840, DOI 10.3168/jds.2007-0898; Tyler JW, 1999, J VET INTERN MED, V13, P335, DOI 10.1892/0891-6640(1999)013&lt;0335:PTMRAW&gt;2.3.CO;2; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wells SJ, 1996, PREV VET MED, V29, P9, DOI 10.1016/S0167-5877(96)01078-1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	75	75	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150452	10.1371/journal.pone.0150452	http://dx.doi.org/10.1371/journal.pone.0150452			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986832	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300022
J	Shin, KJ; Nakakido, R; Horie, S; Managi, S				Shin, Kong Joo; Nakakido, Ryo; Horie, Shinya; Managi, Shunsuke			The Effects of Community Attachment and Information Seeking on Displaced Disaster Victims' Decision Making	PLOS ONE			English	Article							SYSTEMIC MODEL; MASS SOCIETY; PLACE; TIES	This paper uses original survey data of the Great East Japan earthquake disaster victims to examine their decision to apply for the temporary housing as well as the timing of application. We assess the effects of victims' attachment to their locality as well as variation in victims' information seeking behavior. We additionally consider various factors such as income, age, employment and family structure that are generally considered to affect the decision to choose temporary housing as victims' solution for their displacement. Empirical results indicate that, ceteris paribus, as the degree of attachment increases, victims are more likely to apply for the temporary housing but attachment does not affect the timing of application. On the other hand, the victims who actively seek information and are able to collect higher quality information are less likely to apply for the temporary housing and if they do apply then they apply relatively later.	[Shin, Kong Joo; Managi, Shunsuke] Kyushu Univ, Dept Urban & Environm Engn, Sch Engn, Fukuoka 812, Japan; [Nakakido, Ryo] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 980, Japan; [Horie, Shinya] Kobe Univ, Dept Econ, Kobe, Hyogo 657, Japan	Kyushu University; Tohoku University; Kobe University	Shin, KJ (corresponding author), Kyushu Univ, Dept Urban & Environm Engn, Sch Engn, Fukuoka 812, Japan.	kjshin@doc.kyushu-u.ac.jp	Managi, Shunsuke/G-1740-2013	Managi, Shunsuke/0000-0001-7883-1427	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [26000001]; Ministry of Environment [S14]	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This research is supported by the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) under a Specially Promoted Research grant (grant number 26000001, http://www.jsps.go.jp/english/e-grants/) and Ministry of Environment under S14.	Aldrich DP, 2014, AM BEHAV SCI; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; Aldrich DP, 2015, ITS WHO YOU KNOW FAC; Beggs JJ, 1996, RURAL SOCIOL, V61, P407, DOI 10.1111/j.1549-0831.1996.tb00626.x; Botterell A, 1996, EMERGENCY INFORM INF; Boyle MP, 2004, JOURNALISM MASS COMM, V81, P155, DOI 10.1177/107769900408100111; Brehm JM, 2006, AM BEHAV SCI, V50, P142, DOI 10.1177/0002764206290630; Cheng AS, 2003, SOC NATUR RESOUR, V16, P87, DOI 10.1080/08941920309199; GOUDY WJ, 1990, RURAL SOCIOL, V55, P178, DOI 10.1111/j.1549-0831.1990.tb00679.x; Gruntfest E., 1998, INT J MASS EMERGENCI, V16, P55; Hagar C, 2009, TECHNOLOGY INFORM SO; Hidalgo MC, 2001, J ENVIRON PSYCHOL, V21, P273, DOI 10.1006/jevp.2001.0221; Hirayama Y, 2000, HOUSING STUD, V15, P111, DOI 10.1080/02673030082504; Horie S, 2014, WHY DO PEOPLE STAY L; Hummon D. M., 1992, PLACE ATTACHMENT, P253; Johnson C, 2007, DISASTERS, V31, P435, DOI 10.1111/j.1467-7717.2007.01018.x; Kariya N, 2003, J I SOCIAL SAFETY SC, P309; KASARDA JD, 1974, AM SOCIOL REV, V39, P328, DOI 10.2307/2094293; Kimura R, 2004, J SOCIAL SAFETY SCI, V6, P241; Kitayama SE, 1994, EMOTION CULTURE EMPI; Kruger L. E., 1996, UNDERSTANDING PLACE; Low Setha M., 1992, PLACE ATTACHMENT, P165; Mesch GS, 1998, ENVIRON BEHAV, V30, P504, DOI 10.1177/001391659803000405; Omizu T, 2013, CORROBORATIVE EVIDEN; Quarantelli E. L., 1997, DISASTER PREV MANAG, V6, P94, DOI [10.1108/09653569710164053, DOI 10.1108/09653569710164053]; Revival Investigation Committee JAfaIS, 2011, INT VIS TEMP HOUS IW; SAMPSON RJ, 1988, AM SOCIOL REV, V53, P766, DOI 10.2307/2095822; Schneider R., 2002, DISASTER PREV MANAG, V11, P141, DOI DOI 10.1108/09653560210426821; Shklovski I, 2008, P 2008 ACM C COMP SU, P127; SHUMAKER S. A., 1983, ENV PSYCHOL DIRECTIO, V2, P19; Tatsuki S, 2002, P 2 WORKSH COMP STUD, P23; WILLIAMS DR, 1992, LEISURE SCI, V14, P29, DOI 10.1080/01490409209513155; Woldoff RA, 2002, SOC FORCES, V81, P87, DOI 10.1353/sof.2002.0065	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151928	10.1371/journal.pone.0151928	http://dx.doi.org/10.1371/journal.pone.0151928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007117	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200075
J	Aia, P; Kal, M; Lavu, E; John, LN; Johnson, K; Coulter, C; Ershova, J; Tosas, O; Zignol, M; Ahmadova, S; Islam, T				Aia, Paul; Kal, Margaret; Lavu, Evelyn; John, Lucy N.; Johnson, Karen; Coulter, Chris; Ershova, Julia; Tosas, Olga; Zignol, Matteo; Ahmadova, Shalala; Islam, Tauhid			The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey	PLOS ONE			English	Article							WESTERN PROVINCE	Background Reliable estimates of the burden of multidrug-resistant tuberculosis (MDR-TB) are crucial for effective control and prevention of tuberculosis (TB). Papua New Guinea (PNG) is a high TB burden country with limited information on the magnitude of the MDR-TB problem. Methods A cross-sectional study was conducted in four PNG provinces: Madang, Morobe, National Capital District and Western Province. Patient sputum samples were tested for rifampicin resistance by the Xpert MTB/RIF assay and those showing the presence of resistance underwent phenotypic susceptibility testing to first-and second-line anti-TB drugs including streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide, ofloxacin, amikacin, kanamycin and capreomycin. Results Among 1,182 TB patients enrolled in the study, MDR-TB was detected in 20 new (2.7%; 95% confidence intervals [CI] 1.1-4.3%) and 24 previously treated (19.1%; 95% CI: 8.5-29.8%) TB cases. No case of extensively drug-resistant TB (XDR-TB) was detected. Thirty percent (6/20) of new and 33.3%(8/24) of previously treated cases with MDR-TB were detected in a single cluster in Western Province. Conclusion In PNG the proportion of MDR-TB in new cases is slightly lower than the regional average of 4.4% (95% CI: 2.6-6.3%). A large proportion of MDR-TB cases were identified from a single hospital in Western Province, suggesting that the prevalence of MDR-TB across the country is heterogeneous. Future surveys should further explore this finding. The survey also helped strengthening the use of smear microscopy and Xpert MTB/RIF testing as diagnostic tools for TB in the country.	[Aia, Paul; Kal, Margaret; Lavu, Evelyn; John, Lucy N.] Natl Dept Hlth, Port Moresby, Papua N Guinea; [Johnson, Karen] Hlth & HIV Implementat Serv Provider, Abt JTA, Port Moresby, Papua N Guinea; [Coulter, Chris] Pathol Queensland, Queensland Mycobacterium Reference Lab, Herston, Qld, Australia; [Ershova, Julia] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Tosas, Olga] Guys & St Thomas NHS Fdn Trust, London, England; [Zignol, Matteo] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Ahmadova, Shalala] WHO, Western Pacific Reg Off, Stop TB & Leprosy Eliminat, Manila, Philippines; [Islam, Tauhid] WHO, Port Moresby, Papua N Guinea	Centers for Disease Control & Prevention - USA; Guy's & St Thomas' NHS Foundation Trust; World Health Organization; WHO Western Pacific Regional Office; World Health Organization; World Health Organization	Islam, T (corresponding author), WHO, Port Moresby, Papua N Guinea.	islamt@wpro.who.int			Australian Government's aid program through the Australian High Commission PNG; Global Fund to Fight AIDS, Tuberculosis and Malaria	Australian Government's aid program through the Australian High Commission PNG(Australian Government); Global Fund to Fight AIDS, Tuberculosis and Malaria	The study was made possible with funding from the Australian Government's aid program through the Australian High Commission PNG and supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, technical assistance of WHO's Global TB Programme.	[Anonymous], 2014, ANN REP 2013 GOV PAP; Ballif M, INSIGHT GENETI UNPUB; Cross GB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-93; Department of Health Government of Papua New Guinea, 2011, PNG NATL TUBERCULOSI; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gilpin CM, 2008, MED J AUSTRALIA, V188, P148, DOI 10.5694/j.1326-5377.2008.tb01557.x; Islam T, 2014, W PAC SURVEILL RESPO, P5; Ley SD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0307-2; Simpson G, 2011, INT J TUBERC LUNG D, V15, P551, DOI 10.5588/ijtld.10.0347; WHO, 2015, 132015 WHOHTMTB; World Health Organization, 2015, WHOHTMTB201522; World Health Organization, 2011, WHOHTMTB20113; World Health Organization (WHO), 2009, WHOHTMTB2009420	13	34	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149806	10.1371/journal.pone.0149806	http://dx.doi.org/10.1371/journal.pone.0149806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003160	gold, Green Submitted, Green Published			2022-12-27	WOS:000372697400011
J	Harel, A; Ceccarelli, A; Farrell, C; Fabian, M; Howard, J; Riley, C; Miller, A; Lublin, F; Inglese, M				Harel, Asaff; Ceccarelli, Antonia; Farrell, Colleen; Fabian, Michelle; Howard, Jonathan; Riley, Claire; Miller, Aaron; Lublin, Fred; Inglese, Matilde			Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; INTRACORTICAL LESIONS; DIAGNOSTIC-CRITERIA; GUIDELINES; 3T	Previous studies comparing phase sensitive inversion recovery (PSIR) to double inversion recovery (DIR) have demonstrated that use of PSIR improves cross-sectional in vivo detection of cortical lesions (CL) in multiple sclerosis. We studied the utility of PSIR in detection/characterization of accrual of CL over time in a 1-year longitudinal study in primary progressive multiple sclerosis (PPMS) compared to DIR. PSIR and DIR images were acquired with 3T magnetic resonance imaging (MRI) in 25 patients with PPMS and 19 healthy controls at baseline, and after 1 year in 20 patients with PPMS. CL were classified as intracortical, leucocortical or juxtacortical. Lesion counts and volumes were calculated for both time points from both sequences and compared. Correlations with measures of physical and cognitive disability were determined as well as new CL counts and volumes. Compared to DIR, PSIR led to detection of a higher number of CL involving a larger proportion of patients with PPMS both cross-sectionally (p = 0.006, 88%) and longitudinally (p = 0.007, 95%), and led to the reclassification of a third of CL seen on DIR at each time point. Interestingly, PSIR was more sensitive to new CL accumulation over time compared to DIR. PSIR is a promising technique to monitor cortical damage and disease progression in patients with PPMS over a short-term follow-up.	[Harel, Asaff; Ceccarelli, Antonia; Farrell, Colleen; Fabian, Michelle; Miller, Aaron; Lublin, Fred; Inglese, Matilde] Mt Sinai Hosp, Dept Neurol, New York, NY 10029 USA; [Inglese, Matilde] Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA; [Inglese, Matilde] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Farrell, Colleen; Fabian, Michelle; Miller, Aaron; Lublin, Fred; Inglese, Matilde] Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA; [Howard, Jonathan] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA; [Riley, Claire] Columbia Univ, Dept Neurol, Neurol Inst New York, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Columbia University	Inglese, M (corresponding author), Mt Sinai Hosp, Dept Neurol, New York, NY 10029 USA.; Inglese, M (corresponding author), Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA.	matilde.inglese@mssm.edu	Lublin, Fred/L-8405-2017; ceccarelli, antonia/N-9563-2019; Inglese, Matilde/AAH-3189-2020	ceccarelli, antonia/0000-0002-1628-5667; Inglese, Matilde/0000-0002-9610-0297; Howard, Jonathan/0000-0003-2658-3219	Novartis Pharmaceuticals Corporation [CFTY20DUSNC15T]; National MS Society NMSS [RG 5120A3/1]; Noto Foundation	Novartis Pharmaceuticals Corporation(Novartis); National MS Society NMSS(National Multiple Sclerosis Society); Noto Foundation	Funding was provided by Novartis Pharmaceuticals Corporation CFTY20DUSNC15T to MI; National MS Society NMSS RG 5120A3/1 to MI; and Noto Foundation to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Ceccarelli A, 2012, CURR OPIN NEUROL, V25, P402, DOI 10.1097/WCO.0b013e328354f63f; Etemadifar M, 2011, EUR J RADIOL, V80, pE104, DOI 10.1016/j.ejrad.2010.05.018; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Ghassemi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085741; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kuchling J, 2014, MULT SCLER J, V20, P1866, DOI 10.1177/1352458514531084; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Nelson F, 2011, MULT SCLER J, V17, P1122, DOI 10.1177/1352458511405561; Papadopoulou A, 2013, MULT SCLER J, V19, P1290, DOI 10.1177/1352458513475490; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rinaldi F, 2010, NEUROL SCI, V31, P235, DOI 10.1007/s10072-010-0368-4; Rocca MA, 2012, J NEUROL, V259, P611, DOI 10.1007/s00415-011-6195-6; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Ruggieri S, 2015, JAMA NEUROL, V72, P1466, DOI 10.1001/jamaneurol.2015.1897; Seewann A, 2011, MULT SCLER J, V17, P1202, DOI 10.1177/1352458511406575; Sethi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078879; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Stevenson VL, 2000, J NEUROL NEUROSUR PS, V68, P713, DOI 10.1136/jnnp.68.6.713; Wattjes MP, 2007, AM J NEURORADIOL, V28, P54	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152180	10.1371/journal.pone.0152180	http://dx.doi.org/10.1371/journal.pone.0152180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002529	gold, Green Submitted, Green Published			2022-12-27	WOS:000372697400090
J	Montag, C; Hahn, E; Reuter, M; Spinath, FM; Davis, K; Panksepp, J				Montag, Christian; Hahn, Elisabeth; Reuter, Martin; Spinath, Frank M.; Davis, Ken; Panksepp, Jaak			The Role of Nature and Nurture for Individual Differences in Primary Emotional Systems: Evidence from a Twin Study	PLOS ONE			English	Article							PERSONALITY; SEEKING; BRAIN; MODEL	The present study investigated for the first time the relative importance of genetics and environment on individual differences in primary emotionality as measured with the Affe(c)tive Neuroscience Personality Scales (ANPS) by means of a twin-sibling study design. In N = 795 participants (n = 303 monozygotic twins, n = 172 dizygotic twins and n = 267 non-twin full siblings), moderate to strong influences of genetics on individual differences in these emotional systems are observed. Lowest heritability estimates are presented for the SEEKING system (33%) and highest for the PLAY system (69%). Further, multivariate genetic modeling was applied to the data showing that associations among the six ANPS scales were influences by both, a genetic as well as an environmental overlap between them. In sum, the study underlines the usefulness of the ANPS for biologically oriented personality psychology research.	[Montag, Christian] Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany; [Hahn, Elisabeth; Spinath, Frank M.] Univ Saarbrucken, Dept Psychol, Saarbrucken, Germany; [Reuter, Martin] Univ Bonn, Dept Psychol, Bonn, Germany; [Reuter, Martin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Davis, Ken] Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA; [Panksepp, Jaak] Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA	Ulm University; University of Bonn; University of Bonn; University of North Carolina; University of North Carolina Charlotte; Washington State University	Montag, C (corresponding author), Univ Ulm, Inst Psychol & Educ, D-89069 Ulm, Germany.	christian.Montag@uni-ulm.de	Montag, Christian/H-6536-2019	Montag, Christian/0000-0001-8112-0837	Heisenberg grant - German Research Foundation (DFG) [MO 2363/3-1]; German Research Foundation (DFG) [MO 2363/2-1]; German Research Foundation [DFG MO 2363/2-1]; Heisenberg grant - German Research Foundation [DFG MO 2363/3-1]	Heisenberg grant - German Research Foundation (DFG); German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Heisenberg grant - German Research Foundation(German Research Foundation (DFG))	CM is funded by a Heisenberg grant awarded to him by the German Research Foundation (DFG, MO 2363/3-1). Moreover, the present study is funded by the German Research Foundation (DFG, MO 2363/2-1), www.dfg.de.; The present study was funded by a grant awarded to CM by the German Research Foundation (DFG MO 2363/2-1). Moreover, the position of CM is funded by a Heisenberg grant awarded to him by the German Research Foundation (DFG MO 2363/3-1).	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Bartels M, 2009, BEHAV GENET, V39, P605, DOI 10.1007/s10519-009-9294-8; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Bratko D., 2015, PSYCHOL BULL, V141, P1, DOI DOI 10.1037/BU10000017; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Davis KL, 2011, NEUROSCI BIOBEHAV R, V35, P1946, DOI 10.1016/j.neubiorev.2011.04.004; Davis KL., 2003, NEUROPSYCHOANALYSIS, V5, P57, DOI [DOI 10.1080/15294145.2003.10773410, 10.1080/15294145.2003.10773410]; Eaves L, 1999, Twin Res, V2, P62, DOI 10.1375/twin.2.2.62; Felten A, 2011, BRAIN BEHAV, V1, P109, DOI 10.1002/brb3.20; Hahn E, 2013, TWIN RES HUM GENET, V16, P173, DOI 10.1017/thg.2012.106; Hahn E, 2012, BEHAV GENET, V42, P221, DOI 10.1007/s10519-011-9493-y; Harro J., 2004, TXB BIOL PSYCHIAT, P661; Johnson A. M., 2008, SAGE HDB PERSONALITY; Kline R.B., 2010, PRINCIPLES PRACTICE; Loehlin JC, 1996, BEHAV GENET, V26, P65, DOI 10.1007/BF02361160; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Montag C, 2014, NEUROSCI BIOBEHAV R, V43, P228, DOI 10.1016/j.neubiorev.2014.04.006; Montag C, 2013, REV NEUROSCIENCE, V24, P167, DOI 10.1515/revneuro-2012-0085; Montag C, 2011, BIOL PSYCHIAT, V69, P601, DOI 10.1016/j.biopsych.2010.10.026; Neale M. C., 2004, METHODOLOGY GENETIC; OniszczenkoW AngleitnerA, 1993, QUESTIONNAIRE UNPUB; Ozaki K, 2011, BEHAV GENET, V41, P329, DOI 10.1007/s10519-010-9386-5; PANKSEPP J, 1985, BEHAV NEUROSCI, V99, P441, DOI 10.1037/0735-7044.99.3.441; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2006, PROG NEURO-PSYCHOPH, V30, P774, DOI 10.1016/j.pnpbp.2006.01.004; Panksepp J, 2014, CLIN PSYCHOL SCI, V2, P472, DOI 10.1177/2167702614535913; Panksepp J, 2014, PSYCHOPATHOLOGY, V47, P383, DOI 10.1159/000366208; Panksepp J, 2011, PSYCHIATRY, V74, P5, DOI 10.1521/psyc.2011.74.1.5; Plomin R, 2012, BEHAV GENETICS; Plomin R, 2011, INT J EPIDEMIOL, V40, P582, DOI 10.1093/ije/dyq144; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Reuter M, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00038; Reuter M, 2009, BEHAV BRAIN RES, V202, P179, DOI 10.1016/j.bbr.2009.03.032; Rijsdijk F, 2005, ENCY STAT BEHAV SCI, DOI [10.1002/0470013192.bsa115, DOI 10.1002/0470013192.BSA115]; Rijsdijk F, 2005, ENCY STAT BEHAV SCI, DOI [10.1002/0470013192.bsa298, DOI 10.1002/0470013192.BSA298]; Turkheimer E, 2000, CURR DIR PSYCHOL SCI, V9, P160, DOI 10.1111/1467-8721.00084	40	16	16	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151405	10.1371/journal.pone.0151405	http://dx.doi.org/10.1371/journal.pone.0151405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999649	Green Published, gold			2022-12-27	WOS:000372694700040
J	Preusse, M; Theis, FJ; Mueller, NS				Preusse, Martin; Theis, Fabian J.; Mueller, Nikola S.			miTALOS v2: Analyzing Tissue Specific microRNA Function	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTOME-WIDE IDENTIFICATION; RNA-BINDING PROTEIN; HEPATOCELLULAR-CARCINOMA; TARGET; EXPRESSION; LIVER; GENE; PROLIFERATION; PROGRESSION	MicroRNAs are involved in almost all biological processes and have emerged as regulators of signaling pathways. We show that miRNA target genes and pathway genes are not uniformly expressed across human tissues. To capture tissue specific effects, we developed a novel methodology for tissue specific pathway analysis of miRNAs. We incorporated the most recent and highest quality miRNA targeting data (TargetScan and StarBase), RNA-seq based gene expression data (EBI Expression Atlas) and multiple new pathway data sources to increase the biological relevance of the predicted miRNA-pathway associations. We identified new potential roles of miR-199a-3p, miR-199b-3p and the miR-200 family in hepatocellular carcinoma, involving the regulation of metastasis through MAPK and Wnt signaling. Also, an association of miR-571 and Notch signaling in liver fibrosis was proposed. To facilitate data update and future extensions of our tool, we developed a flexible database backend using the graph database neo4j. The new backend as well as the novel methodology were included in the updated miTALOS v2, a tool that provides insights into tissue specific miRNA regulation of biological pathways. miTALOS v2 is available at http://mips.helmholtz-muenchen.de/mitalos.	[Preusse, Martin; Theis, Fabian J.; Mueller, Nikola S.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany; [Preusse, Martin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Diabet & Regenerat Res, Neuherberg, Germany; [Theis, Fabian J.] Tech Univ Munich, Inst Math Sci, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Mueller, NS (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany.	nikola.mueller@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021; Mueller, Nikola/I-6366-2013; Preusse, Martin/B-3716-2013	Theis, Fabian J/0000-0002-2419-1943; Mueller, Nikola/0000-0001-8659-4548; Preusse, Martin/0000-0003-4789-0592	Deutsche Forschungsgemeinschaft [InKoMBio: FKZ TH 900/3-2, PsyCourse: FI 981/9-1]; ERC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (InKoMBio: FKZ TH 900/3-2) to MP, an ERC starting grant award (LatentCauses) to FJT and Deutsche Forschungsgemeinschaft (PsyCourse: FI 981/9-1) to NSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bonet F, 2015, DEV DYNAM, V244, P1259, DOI 10.1002/dvdy.24309; Callegari E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073964; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; de Brevern AG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/904541; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Fan X, 2015, BRIEF BIOINFORM, V16, P780, DOI 10.1093/bib/bbu044; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Jouili S, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P708, DOI 10.1109/SocialCom.2013.106; Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Li JY, 2013, INT CONF MEAS, P1, DOI 10.1109/ICMTMA.2013.11; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Morell CM, 2014, J HEPATOL, V60, P885, DOI 10.1016/j.jhep.2013.11.028; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Rinck A, 2013, RNA BIOL, V10, P1125, DOI 10.4161/rna.24955; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Song JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110074; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sweetwyne MT, 2014, KIDNEY INT SUPPL, V4, P91, DOI 10.1038/kisup.2014.17; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Vicknair C., 2010, P 48 ANN SE REG C AP, P1, DOI 10.1145/1900008.1900067; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wu C, 2014, NUCLEIC ACIDS RES, V42, pW107, DOI 10.1093/nar/gku409; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang J, 2014, FEBS LETT, V588, P3218, DOI 10.1016/j.febslet.2014.07.003; Yuan Y, 2015, P NATL ACAD SCI USA, V112, P3158, DOI 10.1073/pnas.1413896112	55	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151771	10.1371/journal.pone.0151771	http://dx.doi.org/10.1371/journal.pone.0151771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998997	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700063
J	Wakisaka, M; Nagao, T; Yoshinari, M				Wakisaka, Masanori; Nagao, Tetsuhiko; Yoshinari, Mototaka			Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells	PLOS ONE			English	Article							ANGIOTENSIN-II; INTESTINAL NA+/GLUCOSE; ALTERED CONTRACTILITY; TRANSPORT; MECHANISM; EXCHANGE; PROTEIN; PREVENTION; COLLAGEN; CALCIUM	Purpose Mesangial cells play an important role in regulating glomerular filtration by altering their cellular tone. We report the presence of a sodium glucose cotransporter (SGLT) in rat mesangial cells. This study in rat mesangial cells aimed to evaluate the expression and role of SGLT2. Methods The SGLT2 expression in rat mesangial cells was assessed by Western blotting and reverse transcription-polymerase chain reaction (RT-PCR). Changes in the mesangial cell surface area at different glucose concentrations and the effects of extracellular Na+ and Ca2+ and of SGLT and Na+/Ca2+ exchanger (NCX) inhibitors on cellular size were determined. The cellular sizes and the contractile response were examined during a 6-day incubation with high glucose with or without phlorizin, an SGLT inhibitor. Results Western blotting revealed an SGLT2 band, and RT-PCR analysis of SGLT2 revealed the predicted 422-bp band in both rat mesangial and renal proximal tubular epithelial cells. The cell surface area changed according to the extracellular glucose concentration. The glucose-induced contraction was abolished by the absence of either extracellular Na+ or Ca2+ and by SGLT and NCX inhibitors. Under the high glucose condition, the cell size decreased for 2 days and increased afterwards; these cells did not contract in response to angiotensin II, and the SGLT inhibitor restored the abolished contraction. Conclusions These data suggest that SGLT2 is expressed in rat mesangial cells, acts as a normal physiological glucose sensor and regulates cellular contractility in rat mesangial cells.	[Wakisaka, Masanori] Wakisaka Naika Clin Internal Med, Fukuoka, Japan; [Nagao, Tetsuhiko] Midori No Clin, Fukuoka, Japan; [Yoshinari, Mototaka] Yoshinari Int Med Clin, Fukuoka, Japan		Wakisaka, M (corresponding author), Wakisaka Naika Clin Internal Med, Fukuoka, Japan.	wakisakanaika@nag.bbiq.jp		Nagao, Tetsuhiko/0000-0001-7241-418X; Wakisaka, Masanori/0000-0002-1373-4287				ANDERSON WP, 1990, KIDNEY INT, V38, pS109; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bankir L, 2015, AM J PHYSIOL-RENAL, V309, pF2, DOI 10.1152/ajprenal.00614.2014; BARNETT R, 1986, CIRC RES, V59, P529, DOI 10.1161/01.RES.59.5.529; BERS DM, 1988, J MOL CELL CARDIOL, V20, P405, DOI 10.1016/S0022-2828(88)80132-9; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Derylo B, 1998, DIABETOLOGIA, V41, P507, DOI 10.1007/s001250050939; Donnelly SM, 1996, BIOCHEM CELL BIOL, V74, P355, DOI 10.1139/o96-038; Dunlop ME, 2000, KIDNEY INT, V57, P464, DOI 10.1046/j.1523-1755.2000.t01-1-00866.x; GARCIAESCRIBANO C, 1993, KIDNEY INT, V43, P324, DOI 10.1038/ki.1993.50; Gaughan JP, 1999, AM J PHYSIOL, V277, pH14; Gembardt F, 2014, AM J PHYSIOL-RENAL, V307, pF317, DOI 10.1152/ajprenal.00145.2014; Gnudi L., 2015, NEPHROL DIAL TRANSPL; Gnudi L, 2007, J AM SOC NEPHROL, V18, P2226, DOI 10.1681/ASN.2006121362; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; HURST RD, 1995, DIABETES, V44, P759, DOI 10.2337/diabetes.44.7.759; ICHIKAWA I, 1982, KIDNEY INT, pS109; Inoki K, 1999, KIDNEY INT, V55, P1704, DOI 10.1046/j.1523-1755.1999.00438.x; JOHANSSON B, 1987, J CARDIOVASC PHARM, V10, pS75, DOI 10.1097/00005344-198710001-00015; KADOR PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1099, DOI 10.1001/archopht.1988.01060140255036; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; KANAMORI A, 1994, LIFE SCI, V55, pPL365, DOI 10.1016/0024-3205(94)00762-4; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; Lonigro AJ, 1996, DIABETES, V45, pS38, DOI 10.2337/diab.45.1.S38; Mackenzie B, 1996, J BIOL CHEM, V271, P32678, DOI 10.1074/jbc.271.51.32678; Mashburn NA, 1999, AM J PHYSIOL-RENAL, V276, pF574, DOI 10.1152/ajprenal.1999.276.4.F574; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Osei SY, 1999, HYPERTENSION, V33, P559, DOI 10.1161/01.HYP.33.1.559; Ouardani M, 1997, EUR J CELL BIOL, V73, P232; RABITO CA, 1980, J MEMBRANE BIOL, V54, P31, DOI 10.1007/BF01875374; Rhoads DB, 1998, J BIOL CHEM, V273, P9510, DOI 10.1074/jbc.273.16.9510; SIMONSON MS, 1990, J CLIN INVEST, V85, P790, DOI 10.1172/JCI114505; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Touyz RM, 1996, HYPERTENSION, V27, P1097, DOI 10.1161/01.HYP.27.5.1097; Trachtman H, 1997, J AM SOC NEPHROL, V8, P1276; TURNER RJ, 1982, AM J PHYSIOL, V242, pF406, DOI 10.1152/ajprenal.1982.242.4.F406; Ueta M, 2004, KIDNEY INT, V65, P961, DOI 10.1111/j.1523-1755.2004.00474.x; Unlap MT, 2000, AM J PHYSIOL-RENAL, V279, pF177, DOI 10.1152/ajprenal.2000.279.1.F177; Wakisaka M, 1997, BBA-MOL BASIS DIS, V1362, P87, DOI 10.1016/S0925-4439(97)00071-9; Wakisaka M, 2001, CIRC RES, V88, P1183, DOI 10.1161/hh1101.091265; WAKISAKA M, 1995, DIABETOLOGIA, V38, P291; WAKISAKA M, 1994, DIABETES, V43, P95, DOI 10.2337/diabetes.43.1.95; Wakisaka M, 1999, BIOCHIM BIOPHYS ACTA, P1453; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; YOU GF, 1995, J BIOL CHEM, V270, P29365, DOI 10.1074/jbc.270.49.29365	49	21	21	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151585	10.1371/journal.pone.0151585	http://dx.doi.org/10.1371/journal.pone.0151585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999015	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700048
J	Wei, CQ; Ni, WT; Cai, XJ; Zhao, J; Cui, JC				Wei, Chuanqi; Ni, Wentao; Cai, Xuejiu; Zhao, Jin; Cui, Junchang			Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments	PLOS ONE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; ANTIBIOTIC COMBINATIONS; PHARMACOKINETICS; PHARMACODYNAMICS; GLYCYLCYCLINE; MONOTHERAPY	Background The optimal therapy for infections caused by Stenotrophomonas maltophilia (S. maltophilia) has not yet been established. The objective of our study was to evaluate the efficacy of trimethoprim/sulfamethoxazole (SXT), minocycline, tigecycline, moxifloxacin, levofloxacin, ticarcillin-clavulanate, polymyxin E, chloramphenicol, and ceftazidime against clinical isolated S. maltophilia strains by susceptibility testing and carried out time-kill experiments in potential antimicrobials. Methods The agar dilution method was used to test susceptibility of nine candidate antimicrobials, and time-killing experiments were carried out to evaluate the efficacy of SXT, minocycline, tigecycline, moxifloxacin, levofloxacin, and ceftazidime both alone and in combinations at clinically relevant antimicrobial concentrations. Results The susceptibility to SXT, minocycline, tigecycline, moxifloxacin, levofloxacin, ticarcillin-clavulanate, chloramphenicol, polymyxin E, and ceftazidime were 93.8%, 95.0%, 83.8%, 80.0%, 76.3%, 76.3%, 37.5%, 22.5%, and 20.0% against 80 clinical consecutively isolated strains, respectively. Minocycline and tigecycline showed consistent active against 22 SXT-resistant strains. However, resistance rates were high in the remaining antimicrobial agents against SXT-resistant strains. In time-kill experiments, there were no synergisms in most drug combinations in time-kill experiments. SXT plus moxifloxacin displayed synergism when strains with low moxifloxacin MICs. Moxifloxacin plus Minocycline and moxifloxacin plus tigecycline displayed synergism in few strains. No antagonisms were found in these combinations. Overall, compared with single drug, the drug combinations demonstrated lower bacterial concentrations. Some combinations showed bactericidal activity. Conclusions In S. maltophilia infections, susceptibility testing suggests that minocycline and SXT may be considered first-line therapeutic choices while tigecycline, moxifloxacin, levofloxacin, and ticarcillin-clavulanate may serve as second-line choices. Ceftazidime, colistin, and chloramphenicol show poor active against S. maltophilia. However, monotherapy is inadequate in infection management, especially in case of immunocompromised patients. Combination therapy, especially SXT plus moxifloxacin, may benefit than monotherapy in inhibiting or killing S. maltophilia.	[Wei, Chuanqi; Ni, Wentao; Zhao, Jin; Cui, Junchang] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing 100853, Peoples R China; [Cai, Xuejiu] Chinese Peoples Liberat Army, Guangzhou Army Command, Guangzhou Gen Hosp, Dept Resp Dis, Guangzhou 510010, Guangdong, Peoples R China	Chinese People's Liberation Army General Hospital	Cui, JC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing 100853, Peoples R China.	guoguoyoumeng@163.com	Ni, Wentao/HDN-9973-2022	Zhao, Jin/0000-0001-6902-9408	National Natural Science Foundation of China [81371855]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81371855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, M100S25 CLSI; Sanchez MB, 2015, ANTIMICROB AGENTS CH, V59, P4347, DOI 10.1128/AAC.00714-15; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V62, P889, DOI 10.1093/jac/dkn301; Giamarellos-Bourboulis EJ, 2002, ANTIMICROB AGENTS CH, V46, P3997, DOI 10.1128/AAC.46.12.3997-3999.2002; Hand E, 2016, J ANTIMICROB CHEMOTH; JUNG AC, 1994, ARCH INTERN MED, V154, P2402, DOI 10.1001/archinte.154.21.2402; LEROY A, 1984, ANTIMICROB AGENTS CH, V25, P638, DOI 10.1128/AAC.25.5.638; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Meagher AK, 2005, DIAGN MICR INFEC DIS, V52, P165, DOI 10.1016/j.diagmicrobio.2005.05.006; Ni WT, 2015, INT J ANTIMICROB AG, V45, P8, DOI 10.1016/j.ijantimicag.2014.10.002; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; Pillai SK, 2005, ANTIBIOTICS LAB MED, V5, P365; POULOS CD, 1995, ANTIMICROB AGENTS CH, V39, P2220, DOI 10.1128/AAC.39.10.2220; Rodvold KA, 2001, PHARMACOTHERAPY, V21, p233S, DOI 10.1592/phco.21.16.233S.33992; Sader HS, 2014, INT J ANTIMICROB AG, V43, P328, DOI 10.1016/j.ijantimicag.2014.01.007; Sanford Jay P., SANFORD GUIDE ANTIMI, P86; Tangden T, 2014, ANTIMICROB AGENTS CH, V58, P1757, DOI 10.1128/AAC.00741-13; Wang YL, 2014, ANTIMICROB AGENTS CH, V58, P176, DOI 10.1128/AAC.01324-13; Wei CQ, 2015, INFECT DIS-NOR, V47, P846, DOI 10.3109/23744235.2015.1064542; Zelenitsky SA, 2005, DIAGN MICR INFEC DIS, V51, P39, DOI 10.1016/j.diagmicrobio.2004.09.002	23	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152132	10.1371/journal.pone.0152132	http://dx.doi.org/10.1371/journal.pone.0152132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999818	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700103
J	Aziz, MH; Fakhar-e-Alam, M; Fatima, M; Shaheen, F; Iqbal, S; Atif, M; Talha, M; Ali, SM; Afzal, M; Majid, A; Al Harbi, TS; Ismail, M; Wang, ZMM; AlSalhi, MS; Alahmed, ZA				Aziz, Muhammad Hammad; Fakhar-e-Alam, M.; Fatima, Mahvish; Shaheen, Fozia; Iqbal, Seemab; Atif, M.; Talha, Muhammad; Ali, Syed Mansoor; Afzal, Muhammad; Majid, Abdul; Al Harbi, Thamir Shelih; Ismail, Muhammad; Wang, Zhiming M.; AlSalhi, M. S.; Alahmed, Z. A.			Photodynamic Effect of Ni Nanotubes on an HeLa Cell Line	PLOS ONE			English	Article							OXIDATIVE STRESS; NANOPARTICLES	Nickel nanomaterials are promising in the biomedical field, especially in cancer diagnostics and targeted therapy, due to their distinctive chemical and physical properties. In this experiment, the toxicity of nickel nanotubes (Ni NTs) were tested in an in vitro cervical cancer model (HeLa cell line) to optimize the parameters of photodynamic therapy (PDT) for their greatest effectiveness. Ni NTs were synthesized by electrodeposition. Morphological analysis and magnetic behavior were examined using a Scanning electron microscope (SEM), an energy dispersive X-ray analysis (EDAX) and a vibrating sample magnetometer (VSM) analysis. Phototoxic and cytotoxic effects of nanomaterials were studied using the Ni NTs alone as well as in conjugation with aminolevulinic acid (5-ALA); this was performed both in the dark and under laser exposure. Toxic effects on the HeLa cell model were evaluated by a neutral red assay (NRA) and by detection of intracellular reactive oxygen species (ROS) production. Furthermore, 10-200 nM of Ni NTs was prepared in solution form and applied to HeLa cells in 96-well plates. Maximum toxicity of Ni NTs complexed with 5-ALA was observed at 100 J/cm(2) and 200 nM. Up to 65-68% loss in cell viability was observed. Statistical analysis was performed on the experimental results to confirm the worth and clarity of results, with p-values = 0.003 and 0.000, respectively. Current results pave the way for a more rational strategy to overcome the problem of drug bioavailability in nanoparticulate targeted cancer therapy, which plays a dynamic role in clinical practice.	[Aziz, Muhammad Hammad; Majid, Abdul; Al Harbi, Thamir Shelih] Majmaah Univ, Coll Sci Zulfi, Dept Phys, Zulfi, Saudi Arabia; [Aziz, Muhammad Hammad] COMSATS Inst Informat & Technol, Dept Phys, Lahore, Pakistan; [Fakhar-e-Alam, M.; Wang, Zhiming M.] Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu 610054, Peoples R China; [Fakhar-e-Alam, M.; Iqbal, Seemab] GC Univ Faisalabad, Dept Phys, Faisalabad, Pakistan; [Fatima, Mahvish; Afzal, Muhammad] Islamia Univ Bahawalpur, Dept Phys, Bahawalpur, Pakistan; [Shaheen, Fozia] GC Univ Lahore, Dept Phys, Lahore, Pakistan; [Atif, M.; Ali, Syed Mansoor; AlSalhi, M. S.; Alahmed, Z. A.] King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh 11451, Saudi Arabia; [Atif, M.] Natl Inst Laser & Optron, Islamabad, Pakistan; [Talha, Muhammad] King Saud Univ, Sci Res, Riyadh 11421, Saudi Arabia; [Ismail, Muhammad] IBGE, 24 Mauve Area,G-9-1, Islamabad, Pakistan	Majmaah University; COMSATS University Islamabad (CUI); University of Electronic Science & Technology of China; Government College University Faisalabad; Islamia University of Bahawalpur; Government College University Lahore; University of Lahore; King Saud University; King Saud University	Aziz, MH (corresponding author), Majmaah Univ, Coll Sci Zulfi, Dept Phys, Zulfi, Saudi Arabia.; Aziz, MH (corresponding author), COMSATS Inst Informat & Technol, Dept Phys, Lahore, Pakistan.; Atif, M (corresponding author), King Saud Univ, Coll Sci, Dept Phys & Astron, Riyadh 11451, Saudi Arabia.; Atif, M (corresponding author), Natl Inst Laser & Optron, Islamabad, Pakistan.	m.hammad@mu.edu.sa; atifhull@gmail.com	Atif, Muhammad/Z-5682-2019; AlSalhi, Mohamad S/F-2217-2019; Alahmed, Zeyad A/F-1683-2013; alsalhi, mohamad/M-5013-2019; Majid, Abdul/G-5584-2016; Atif, Muhammad/C-4789-2013	Atif, Muhammad/0000-0002-7356-4275; AlSalhi, Mohamad S/0000-0002-4557-8821; Alahmed, Zeyad A/0000-0001-7304-8118; Majid, Abdul/0000-0001-8861-4354; Atif, Muhammad/0000-0002-7356-4275	Deanship of Scientific Research, Majmaah University [37-1-3]	Deanship of Scientific Research, Majmaah University	The authors acknowledge the support from Deanship of Scientific Research, Majmaah University under project No. 37-1-3.	Ahamed M, 2013, CHEMOSPHERE, V93, P2514, DOI 10.1016/j.chemosphere.2013.09.047; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Ali SMU, 2012, INT J MED MED SCI, V2; Atif M, 2011, LASER PHYS, V21, P1235, DOI 10.1134/S1054660X11130020; Atif M, 2010, LASER PHYS LETT, V7, P757, DOI 10.1002/lapl.201010061; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chikazumi S., 1964, PHYSICS MAGNETISM, P130; Fakhar-e-Alam M, 2014, LASER PHYS LETT, V11, DOI 10.1088/1612-2011/11/2/025601; Fakhar-e-Alam M, 2011, LASER PHYS, V21, P1978, DOI 10.1134/S1054660X1119011X; Fakhar-e-Alam M., 2012, REV NANOSCI NANOTECH, V1, P40, DOI [10.1166/rnn.2012.1004, DOI 10.1166/RNN.2012.1004]; Fatima M, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/12/125602; Garland SM, 2012, CANCER EPIDEM BIOMAR, V21, P1414, DOI 10.1158/1055-9965.EPI-12-0164; Hossain MZ, 2011, INT J NANOMED, V6, P1475, DOI 10.2147/IJN.S21697; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Lahiria D, 2010, ACTA BIOMATER; Li X, 2012, J NANOMATER, V2012, P9; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Panchompoo J, 2010, ELECTROANAL, V22, P912, DOI 10.1002/elan.200900547; Patil SS, 2016, ENVIRON TECHNOL INNO, V5, P10, DOI 10.1016/j.eti.2015.11.001; Prina-Mello Adriele, 2006, J Nanobiotechnology, V4, P9, DOI 10.1186/1477-3155-4-9; Tao FF, 2006, ADV MATER, V18, P2161, DOI 10.1002/adma.200600275; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Yu IJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/789312	25	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150295	10.1371/journal.pone.0150295	http://dx.doi.org/10.1371/journal.pone.0150295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990435	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800026
J	He, XJ; Ma, HX; Zhao, XW; Nie, SJ; Li, YH; Zhang, ZM; Shen, YO; Chen, Q; Lu, YL; Lan, H; Zhou, SF; Gao, SB; Pan, GT; Lin, HJ				He, Xiujing; Ma, Haixia; Zhao, Xiongwei; Nie, Shujun; Li, Yuhua; Zhang, Zhiming; Shen, Yaou; Chen, Qi; Lu, Yanli; Lan, Hai; Zhou, Shufeng; Gao, Shibin; Pan, Guangtang; Lin, Haijian			Comparative RNA-Seq Analysis Reveals That Regulatory Network of Maize Root Development Controls the Expression of Genes in Response to N Stress	PLOS ONE			English	Article							ENHANCES NITROGEN ACQUISITION; BINDING TRANSCRIPTION FACTORS; NITRATE TRANSPORT; FACTOR FAMILY; ARABIDOPSIS; PROTEIN; GROWTH; CELL; ALLOCATION; MEMBERS	Nitrogen (N) is an essential nutrient for plants, and it directly affects grain yield and protein content in cereal crops. Plant root systems are not only critical for anchorage in the soil, but also for N acquisition. Therefore, genes controlling root development might also affect N uptake by plants. In this study, the responses of nitrogen on root architecture of mutant rtcs and wild-type of maize were investigated by morphological and physiological analysis. Subsequently, we performed a comparative RNA-Seq analysis to compare gene expression profiles between mutant rtcs roots and wild-type roots under different N conditions. We identified 786 co-modulated differentially expressed genes (DEGs) related to root development. These genes participated in various metabolic processes. A co-expression cluster analysis and a cis-regulatory motifs analysis revealed the importance of the AP2-EREBP transcription factor family in the rtcs-dependent regulatory network. Some genotype-specific DEGs contained at least one LBD motif in their promoter region. Further analyses of the differences in gene transcript levels between rtcs and wild-type under different N conditions revealed 403 co-modulated DEGs with distinct functions. A comparative analysis revealed that the regulatory network controlling root development also controlled gene expression in response to N-deficiency. Several AP2-EREBP family members involved in multiple hormone signaling pathways were among the DEGs. These transcription factors might play important roles in the rtcs-dependent regulatory network related to root development and the N-deficiency response. Genes encoding the nitrate transporters NRT2-1, NAR2.1, NAR2.2, and NAR2.3 showed much higher transcript levels in rtcs than in wildtype under normal-N conditions. This result indicated that the LBD gene family mainly functions as transcriptional repressors, as noted in other studies. In summary, using a comparative RNA-Seq-based approach, we identified DEGs related to root development that also participated in the N-deficiency response in maize. These findings will increase our understanding of the molecular regulatory networks controlling root development and N-stress responses.	[He, Xiujing; Ma, Haixia; Zhao, Xiongwei; Nie, Shujun; Li, Yuhua; Zhang, Zhiming; Shen, Yaou; Chen, Qi; Lu, Yanli; Lan, Hai; Zhou, Shufeng; Gao, Shibin; Pan, Guangtang; Lin, Haijian] Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Wenjiang, Sichuan, Peoples R China	Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Lin, HJ (corresponding author), Sichuan Agr Univ, Maize Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Maize Southwest, Wenjiang, Sichuan, Peoples R China.	hilin0528@gmail.com	Nie, Shujun/GSD-4799-2022; Li, yu/HHZ-5236-2022; Ma, Haixia/ABC-4707-2021	Ma, Haixia/0000-0001-9080-2004	National Natural Science Foundation of China [31201221]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	HJL was supported by Grants from the National Natural Science Foundation of China (No. 31201221). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the anonymous referees and the editor for their comments and suggestions that helped improve the manuscript. The work was supported by grants from the National Natural Science Foundation of China (31201221).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Cheng Q., 2015, 2015 Optical Fiber Communications Conference and Exhibition (OFC). Proceedings; Chun L, 2005, PLANT SOIL, V276, P369, DOI 10.1007/s11104-005-5876-2; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng HM, 2011, PLANT SIGNAL BEHAV, V6, P1286, DOI 10.4161/psb.6.9.16377; Feng ZH, 2012, PLANTA, V236, P1227, DOI 10.1007/s00425-012-1673-3; Gao K, 2015, PLANT CELL ENVIRON, V38, P740, DOI 10.1111/pce.12439; Gelli M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-179; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hetz W, 1996, PLANT J, V10, P845, DOI 10.1046/j.1365-313X.1996.10050845.x; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hochholdinger F, 2004, TRENDS PLANT SCI, V9, P42, DOI 10.1016/j.tplants.2003.11.003; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Jiang Y, 2012, J INTEGR PLANT BIOL, V54, P616, DOI 10.1111/j.1744-7909.2012.01149.x; Kang NY, 2013, PLANT CELL PHYSIOL, V54, P1326, DOI 10.1093/pcp/pct081; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krapp A, 2014, J EXP BOT, V65, P789, DOI 10.1093/jxb/eru001; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HW, 2009, PLANT PHYSIOL, V151, P1377, DOI 10.1104/pp.109.143685; Lee SY, 2015, PLANT CELL REP, V34, P223, DOI 10.1007/s00299-014-1701-9; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Li YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-153; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu JC, 2008, PLANT SOIL, V305, P253, DOI 10.1007/s11104-008-9562-z; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Liu YJ, 2012, J PLANT PHYSIOL, V169, P183, DOI 10.1016/j.jplph.2011.08.018; Lu CM, 2001, J PLANT PHYSIOL, V158, P1423, DOI 10.1078/0176-1617-00501; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Mathelier A, 2013, NUCLEIC ACIDS RES; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Muthreich N, 2013, PLANT PHYSIOL, V163, P419, DOI 10.1104/pp.113.221481; Okamoto M, 2006, PLANT PHYSIOL, V140, P1036, DOI 10.1104/pp.105.074385; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; PAGES L, 1994, PLANT SOIL, V164, P169, DOI 10.1007/BF00010068; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Saengwilai P, 2014, PLANT PHYSIOL, V166, P726, DOI 10.1104/pp.114.241711; Saengwilai P, 2014, PLANT PHYSIOL, V166, P581, DOI 10.1104/pp.113.232603; Saiz-Fernandez I, 2015, J PLANT PHYSIOL, V173, P120, DOI 10.1016/j.jplph.2014.06.018; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Takehisa H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24409; Taramino G, 2007, PLANT J, V50, P649, DOI 10.1111/j.1365-313X.2007.03075.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tian QY, 2008, J PLANT PHYSIOL, V165, P942, DOI 10.1016/j.jplph.2007.02.011; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xin MM, 2013, PLANT CELL, V25, P3212, DOI 10.1105/tpc.113.115592; Xu C, 2015, TRENDS PLANT SCI; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Yan HF, 2011, J PLANT PHYSIOL, V168, P1067, DOI 10.1016/j.jplph.2010.12.018; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x; Zhang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121222; Zhao DL, 2005, EUR J AGRON, V22, P391, DOI 10.1016/j.eja.2004.06.005; Zhao WC, 2015, PLANT CELL PHYSIOL, V56, P455, DOI 10.1093/pcp/pcu172; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078635	69	21	23	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151697	10.1371/journal.pone.0151697	http://dx.doi.org/10.1371/journal.pone.0151697			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990640	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800088
J	Nishizawa, A; Inoue, T; Ohira, S; Takahashi, E; Saruwatari, J; Iwao, K; Tanihara, H				Nishizawa, Asaho; Inoue, Toshihiro; Ohira, Saori; Takahashi, Eri; Saruwatari, Junji; Iwao, Keiichiro; Tanihara, Hidenobu			The Influence of Phacoemulsification on Surgical Outcomes of Trabeculectomy with Mitomycin-C for Uveitic Glaucoma	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR; PROINFLAMMATORY CYTOKINES; PSEUDOPHAKIC EYES; DISTINCT CYTOKINE; PROFILES; FAILURE; COHORT	Purpose To evaluate the influence of phacoemulsification after trabeculectomy on the postoperative intraocular pressure (IOP) in eyes with uveitic glaucoma (UG). Setting Kumamoto University Hospital, Kumamoto, Japan. Design A retrospective cohort study. Methods The medical records of patients with UG who had trabeculectomy with mitomycin-C (MMC) were reviewed. Complete and qualified surgical failures were defined by an IOP of >= 21 mmHg (condition A), >= 18 mmHg (condition B), or >= 15 mmHg (condition C) without and with glaucoma eye drops, respectively. Kaplan-Meier survival analysis, generalized by the Wilcoxon test, and the Cox proportional hazards model analysis were conducted. Post-trabeculectomy phacoemulsification was treated as a time-dependent variable. In 24 (30%) of the included 80 eyes, phacoemulsification was included, and they were divided into two groups: groups I (8 eyes with phacoemulsification within 1 year after trabeculectomy) and group II (16 eyes after 1 year following trabeculectomy). Results Multivariable Cox proportional hazards model analysis showed post-trabeculectomy phacoemulsification was a significant factor in both complete success and qualified success based upon condition C (P = 0.0432 and P = 0.0488, respectively), but not for the other conditions. Kaplan-Meier survival analyses indicated significant differences in success probabilities between groups I and group II for complete success and qualified success based upon condition C (P = 0.020 and P = 0.013, respectively). There was also a significant difference for qualified success based upon condition B (P = 0.034), while there was no significant difference for the other conditions. Conclusion Post-trabeculectomy phacoemulsification, especially within 1 year, can cause poor prognosis of IOP control of UG eyes after trabeculectomy with MMC.	[Nishizawa, Asaho; Inoue, Toshihiro; Ohira, Saori; Takahashi, Eri; Iwao, Keiichiro; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Saruwatari, Junji] Kumamoto Univ, Dept Pharmacol & Therapeut, Fac Life Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp	Saruwatari, Junji/Q-7748-2019	Saruwatari, Junji/0000-0001-6266-1347; Inoue, Toshihiro/0000-0003-3769-7609; Iwao, Keiichiro/0000-0002-4102-9374				Abu El-Asrar AM, 2011, IMMUNOBIOLOGY, V216, P1004, DOI 10.1016/j.imbio.2011.03.007; Awai-Kasaoka N, 2012, J CATARACT REFR SURG, V38, P419, DOI 10.1016/j.jcrs.2011.09.035; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Carreno E, 2011, J OPHTHALMIC INFLAMM, V1, P43, DOI 10.1007/s12348-010-0012-8; COSTA VP, 1993, BRIT J OPHTHALMOL, V77, P693, DOI 10.1136/bjo.77.11.693; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; DERMO F, 1979, AM J OPHTHALMOL, V88, P829, DOI 10.1016/0002-9394(79)90559-2; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Iwao K, 2014, J GLAUCOMA, V23, P88, DOI 10.1097/IJG.0b013e3182685167; Kaburaki T, 2009, EYE, V23, P1509, DOI [10.1038/eye.2009.117, 10.1038/eye.2009.117-cme]; Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Kuiper JJW, 2011, AM J OPHTHALMOL, V152, P177, DOI 10.1016/j.ajo.2011.01.031; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; Shaarawy T., 2009, GUIDELINES DESIGN RE; Shimizu A, 2014, CLIN OPHTHALMOL, V8, P2383, DOI 10.2147/OPTH.S72383; Takase H, 2006, INVEST OPHTH VIS SCI, V47, P1557, DOI 10.1167/iovs.05-0836; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Valentincic NV, 2011, MOL VIS, V17, P2003; van Kooij B, 2006, AM J OPHTHALMOL, V142, P192, DOI 10.1016/j.ajo.2006.02.052; VESTI E, 1993, ACTA OPHTHALMOL, V71, P777	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151947	10.1371/journal.pone.0151947	http://dx.doi.org/10.1371/journal.pone.0151947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989899	Green Submitted, gold, Green Published			2022-12-27	WOS:000372582800122
J	Yildirim, A; Uskudarli, S; Ozgur, A				Yildirim, Ahmet; Uskudarli, Suzan; Ozgur, Arzucan			Identifying Topics in Microblogs Using Wikipedia	PLOS ONE			English	Article								Twitter is an extremely high volume platform for user generated contributions regarding any topic. The wealth of content created at real-time in massive quantities calls for automated approaches to identify the topics of the contributions. Such topics can be utilized in numerous ways, such as public opinion mining, marketing, entertainment, and disaster management. Towards this end, approaches to relate single or partial posts to knowledge base items have been proposed. However, in microblogging systems like Twitter, topics emerge from the culmination of a large number of contributions. Therefore, identifying topics based on collections of posts, where individual posts contribute to some aspect of the greater topic is necessary. Models, such as Latent Dirichlet Allocation (LDA), propose algorithms for relating collections of posts to sets of keywords that represent underlying topics. In these approaches, figuring out what the specific topic(s) the keyword sets represent remains as a separate task. Another issue in topic detection is the scope, which is often limited to specific domain, such as health. This work proposes an approach for identifying domain-independent specific topics related to sets of posts. In this approach, individual posts are processed and then aggregated to identify key tokens, which are then mapped to specific topics. Wikipedia article titles are selected to represent topics, since they are up to date, user-generated, sophisticated articles that span topics of human interest. This paper describes the proposed approach, a prototype implementation, and a case study based on data gathered during the heavily contributed periods corresponding to the four US election debates in 2012. The manually evaluated results (0.96 precision) and other observations from the study are discussed in detail.	[Yildirim, Ahmet; Uskudarli, Suzan; Ozgur, Arzucan] Bogazici Univ, Dept Comp Engn, Istanbul, Turkey	Bogazici University	Yildirim, A (corresponding author), Bogazici Univ, Dept Comp Engn, Istanbul, Turkey.	ahmet.yil@boun.edu.tr	Uskudarli, S/A-8015-2017; Ozgur, Arzucan/I-3147-2012	Uskudarli, S/0000-0002-0106-0182; Ozgur, Arzucan/0000-0001-8376-1056	Turkish State Planning Organization under the TAM Project [2007K120610]; Turkish State Planning Organization (DPT) under the TAM Project [2007K120610]	Turkish State Planning Organization under the TAM Project(Turkiye Cumhuriyeti Kalkinma Bakanligi); Turkish State Planning Organization (DPT) under the TAM Project(Turkiye Cumhuriyeti Kalkinma Bakanligi)	AY is supported by the Turkish State Planning Organization under the TAM Project, number 2007K120610. This work is researched and developed in the SosLab at Bogazici University, Istanbul, Turkey.; This work is supported by the Turkish State Planning Organization (DPT) under the TAM Project, number 2007K120610. This work is researched and developed in the SosLab at Bogazici University, Istanbul, Turkey.	Alvanaki F., 2012, P 15 INT C EXT DAT T, P336, DOI DOI 10.1145/2247596.2247636; [Anonymous], 2011, P 20 ACM INT C INF K; Cataldi Mario, 2010, ACM MIN KDD WORKSH M, P4, DOI DOI 10.1145/1814245.1814249; Chen Y, 2013, SIGIR'13: THE PROCEEDINGS OF THE 36TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH & DEVELOPMENT IN INFORMATION RETRIEVAL, P43; Diao Qiming, 2012, P 50 ANN M ASS COMP, V1, P536; Dornescu I, 2014, NAT LANG ENG, V20, P469, DOI 10.1017/S1351324913000296; Eisenstein J., 2013, P 2013 C N AM CHAPT, V2013, P359, DOI DOI 10.1109/GEOINFORMATICS.2010.5567952; Ferragina P, 2012, IEEE SOFTWARE, V29, P70, DOI 10.1109/MS.2011.122; Ferragina Paolo, 2010, TAGME FLY ANN SHORT, P1625, DOI DOI 10.1145/1871437.1871689; Gattani A, 2013, PROC VLDB ENDOW, V6, P1126, DOI 10.14778/2536222.2536237; Genc Y, 2011, LECT NOTES ARTIF INT, V6780, P484, DOI 10.1007/978-3-642-21852-1_55; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Lansdall-Welfare T., 2012, P 21 INT C WORLD WID, P1221, DOI [10.1145/2187980.2188264, DOI 10.1145/2187980.2188264]; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Marcus A, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P227; Mathioudakis M., 2010, P 2010 ACM SIGMOD IN, P1155, DOI DOI 10.1145/1807167.1807306; Meij E, 2012, P 5 ACM INT C WEB SE, P563, DOI DOI 10.1145/2124295.2124364; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Parker Jon, 2013, 2013 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining (ASONAM), P556; Petrovi S, 2010, HUMAN LANGUAGE TECHN, P181; Phan X., 2008, P 17 INT C WORLD WID, P91, DOI 10.1145/1367497.1367510; Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191; Ramage D., 2010, P 4 INT AAAI C WEBL, P130; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Sharifi Beaux, 2010, Proceedings of the 2010 IEEE Second International Conference on Social Computing (SocialCom 2010). the Second IEEE International Conference on Privacy, Security, Risk and Trust (PASSAT 2010), P49, DOI 10.1109/SocialCom.2010.17; Trilling D, 2015, SOC SCI COMPUT REV, V33, P259, DOI 10.1177/0894439314537886; Vitale Daniele, 2012, Advances in Information Retrieval. Proceedings of the 34th European Conference on IR Research (ECIR 2012), P376, DOI 10.1007/978-3-642-28997-2_32; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34	30	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151885	10.1371/journal.pone.0151885	http://dx.doi.org/10.1371/journal.pone.0151885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991442	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800114
J	Chang, CH; Lee, CY; Feng, SW; Miao, NF; Lin, PH; Lin, CT; Tsai, SH; Huang, YK				Chang, Chia-Huang; Lee, Chang-Yu; Feng, Sheng-Wei; Miao, Nae-Fang; Lin, Pei-Huan; Lin, Che-Tong; Tsai, Shin-Han; Huang, Yung-Kai			Effects of Salivary Oxidative Markers on Edentulous Patients' Satisfaction with Prosthetic Denture Treatments: A Pilot Study	PLOS ONE			English	Article							REMOVABLE PARTIAL DENTURES; ORAL-HEALTH; TOOTH LOSS; NUTRITIONAL-STATUS; SUPEROXIDE-DISMUTASE; OLDER-ADULTS; IMPACT; ASSOCIATION; NUTRIENT; PROFILE	Objectives The purpose of this study was to assess relationships among periodontal conditions, salivary antioxidant levels, and patients' satisfaction with their prostheses. Methods This study was conducted at the Division of Prosthodontics, Department of Dentistry, Taipei Medical University Hospital. The periodontal condition of patients was based on an assessment of the plaque index (PI) and gingival index (GI). The pH value, flow rate, and buffer capacity of the saliva were estimated. The salivary total antioxidant status (TAS) and superoxide dismutase (SOD) level were also determined. Patients' satisfaction with prosthetic treatments was evaluated using the Chinese version of the short-form Oral Health Impact Profile (OHIP-14C). A multivariate regression model was used to determine whether patients' satisfaction with prosthetic treatment was affected by their oral health status. Results In total, 35 edentulous patients were recruited. In the Spearman correlation analysis, salivary pH (r = -0.36, p = 0.03) and the buffer ability (r = -0.48, p<0.01) were associated with OHIP-14C scores. In the multivariate analysis, patients who had a higher GI also had a higher score of physical disabilities (beta = 1.38, p = 0.04). Levels of SOD increased with the scores of psychological discomfort (beta = 0.33 U/g protein, p = 0.04). Conclusions This study suggested that both the GI and SOD levels were associated with patients' satisfaction with prosthetic treatments. To the best of our knowledge, this is the first study to elucidate the relationship between OHIP scores and salivary oxidative markers in edentulous patients.	[Chang, Chia-Huang; Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei 110, Taiwan; [Lee, Chang-Yu; Huang, Yung-Kai] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei 110, Taiwan; [Lee, Chang-Yu] Taipei Med Univ, Taipei Med Univ Hosp, Dept Dent, Div Periodont, Taipei 110, Taiwan; [Feng, Sheng-Wei; Lin, Pei-Huan; Lin, Che-Tong] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan; [Miao, Nae-Fang] Taipei Med Univ, Sch Nursing, Taipei 110, Taiwan; [Lin, Che-Tong] Taipei Med Univ Hosp, Div Prosthodont, Dept Dent, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Huang, YK (corresponding author), Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei 110, Taiwan.	ykhuang@tmu.edu.tw	Huang, Yung-Kai/C-7868-2012	Huang, Yung-Kai/0000-0002-4467-0300	National Science Council, Taiwan [NSC100-2314-B-038-042, NSC 102-2314-B-038-019]; Taipei Medical University Hospital, Taiwan [102TMU-TMUH-02]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University Hospital, Taiwan	This study was supported by a research grant from the National Science Council, Taiwan (NSC100-2314-B-038-042; NSC 102-2314-B-038-019) and Taipei Medical University Hospital, Taiwan (102TMU-TMUH-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin FA, 2005, J CLIN PERIODONTOL, V32, P238, DOI 10.1111/j.1600-051X.2005.00669.x; Allen Patrick Finbarr, 2003, J Can Dent Assoc, V69, P662; Allen PF, 1999, COMMUNITY DENT HLTH, V16, P176; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Arredondo M, 2014, J TRACE ELEM MED BIO, V28, P23, DOI 10.1016/j.jtemb.2013.10.004; Beck JD, 2014, J AM DENT ASSOC, V145, P531, DOI 10.14219/jada.2014.25; CARLSSON GE, 1970, DENT CLIN N AM, V14, P553; De Marchi RJ, 2008, NUTRITION, V24, P546, DOI 10.1016/j.nut.2008.01.054; Department of Household Registration Ministry of the Interior, 2015, HOUS REG STAT DAT AN, V8, P10; Divaris K, 2012, GERODONTOLOGY, V29, pE192, DOI 10.1111/j.1741-2358.2010.00440.x; Doundoulakis JH, 2003, J AM DENT ASSOC, V134, P1455, DOI 10.14219/jada.archive.2003.0073; EICHNER K, 1990, Stomatologie der DDR, V40, P321; Emami E, 2013, INT J DENT, V2013, DOI 10.1155/2013/498305; Gift H C, 1995, Med Care, V33, pNS57, DOI 10.1097/00005650-199511001-00008; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hanioka T, 2007, GERODONTOLOGY, V24, P87, DOI 10.1111/j.1741-2358.2007.00166.x; Hershkovich O, 2007, J GERONTOL A-BIOL, V62, P361, DOI 10.1093/gerona/62.4.361; Hofstede TM, 1999, J PROSTHET DENT, V82, P94, DOI 10.1016/S0022-3913(99)70133-2; Joshipura KJ, 1996, J AM DENT ASSOC, V127, P459, DOI 10.14219/jada.archive.1996.0237; Kim Sang-Chul, 2010, J Periodontal Implant Sci, V40, P164, DOI 10.5051/jpis.2010.40.4.164; Kuo HC, 2011, QUAL LIFE RES, V20, P1707, DOI 10.1007/s11136-011-9901-z; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; Martinez-Gonzalez JM, 2013, ACTA ODONTOL SCAND, V71, P1303, DOI 10.3109/00016357.2012.762989; Muller T, 2007, CLIN ORAL IMPLAN RES, V18, P2, DOI 10.1111/j.1600-0501.2007.01459.x; Nam Hyun-seok, 2012, General Dentistry, V60, P503; Novakovic N, 2014, J PERIODONTAL RES, V49, P129, DOI 10.1111/jre.12088; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; Oh SH, 2014, CLIN ORAL IMPLANTS R; Peltzer K, 2014, INT J ENV RES PUB HE, V11, P11308, DOI 10.3390/ijerph111111308; Petersen PE, 2010, COMMUNITY DENT HLTH, V27, P257, DOI 10.1922/CDH_2711Petersen11; Precheur I, 2015, GERIATR PSYCHOL NEUR, V13, P22, DOI 10.1684/pnv.2015.0515; Quirynen M, 2011, J CLIN PERIODONTOL, V38, P581, DOI 10.1111/j.1600-051X.2011.01728.x; Ryu M, 2010, J ORAL REHABIL, V37, P194, DOI 10.1111/j.1365-2842.2009.02042.x; Sculley DV, 2003, CLIN SCI, V105, P167, DOI 10.1042/CS20030031; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Sischo L, 2011, J DENT RES, V90, P1264, DOI 10.1177/0022034511399918; Slade GD, 1994, COMMUNITY DENT HLTH, P3; Urden Linda D, 2002, Lippincotts Case Manag, V7, P194, DOI 10.1097/00129234-200209000-00006; van der Weijden F, 2011, PERIODONTOL 2000, V55, P104, DOI 10.1111/j.1600-0757.2009.00337.x; Vanzeveren C, 2002, J ORAL REHABIL, V29, P232, DOI 10.1046/j.1365-2842.2002.00854.x; Veyrune J L, 2005, Gerodontology, V22, P3, DOI 10.1111/j.1741-2358.2004.00048.x; Wang TF, 2014, ARCH GERONTOL GERIAT, V58, P446, DOI 10.1016/j.archger.2014.01.002; Wong AHH, 2007, COMMUNITY DENT ORAL, V35, P64, DOI 10.1111/j.1600-0528.2007.00330.x; Wong MCM, 2002, COMMUNITY DENT ORAL, V30, P423, DOI 10.1034/j.1600-0528.2002.00013.x; Yang Po-Sheng, 2014, ScientificWorldJournal, V2014, P814671, DOI 10.1155/2014/814671; Zitzmann NU, 1999, INT J PROSTHODONT, V12, P307; Zlataric DK, 2003, J ORAL REHABIL, V30, P847, DOI 10.1046/j.1365-2842.2003.01039.x; Zlataric DK, 2002, J PERIODONTOL, V73, P137	50	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151605	10.1371/journal.pone.0151605	http://dx.doi.org/10.1371/journal.pone.0151605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986841	Green Published, gold			2022-12-27	WOS:000372580300094
J	Kim, DK; Kim, LHC; Raheem, AA; Shin, TY; Alabdulaali, I; Yoon, YE; Han, WK; Rha, KH				Kim, Dae Keun; Kim, Lawrence H. C.; Raheem, Ali Abdel; Shin, Tae Young; Alabdulaali, Ibrahim; Yoon, Young Eun; Han, Woong Kyu; Rha, Koon Ho			Comparison of Trifecta and Pentafecta Outcomes between T1a and T1b Renal Masses following Robot-Assisted Partial Nephrectomy (RAPN) with Minimum One Year Follow Up: Can RAPN for T1b Renal Masses Be Feasible?	PLOS ONE			English	Article							LAPAROSCOPIC PARTIAL NEPHRECTOMY; COMPLICATIONS; CLASSIFICATION; ISCHEMIA	Purpose/Objectives To investigate the feasibility of RAPN on T1b renal mass by assessment of Trifecta and Pentafecta rate between T1a and T1b renal mass. Materials/Methods We retrospectively reviewed the medical records of 277 cases of RPN performed from 2006 to 2015. Sixty patients with clinically T1b renal masses (> 4cm and <= 7 cm) were identified, and from 180 patients with clinically T1a renal mass, 60 patients were matched with T1b renal mass by propensity score. Tumor complexity was investigated according to R.E.N.A.L nephrometry score. "Pentafecta" was defined as achievement of Trifecta (negative surgical margin, no postoperative complications and warm ischemia time of <= 25 m inutes) with addition of over 90% estimated GFR preservation and no chronic kidney disease stage upgrading at 1 year postoperative period. Propensity score matching was performed by OneToManyMTCH. Logistic regression models were used to identify the variables which predict the Trifecta, and Pentafecta ac. Results Preoperative variables (age, sex, body mass index, ASA score) were similar between T1a and T1b after propensity score matching. The median R.E.N.A.L. nephrometry score was 8 vs 9 for T1a and T1b respectively (p<0.001). The median warm ischemia time was 20.1 min vs 26.2 min (p<0.001). Positive surgical margin rate was 5% vs 6.6% (p = 0.729) and overall complication rate of 13.3%. vs 15% (p = 0.793). The rate of achievement of Trifecta rate were 65.3% vs 43.3%(p = 0.017) and Pentafecta rate were 38.3% vs 26.7%(p = 0.172). For achievement of Pentafecta, R.E.N.A.L nephrometry score (HR 0.80; 95% CI (0.67-0.97); p = 0.031) was significant predictor of achieving Pentafecta. Subanalyis to assess the component of R.E.N.A.L nephrometry score, L component (location relative to the polar lines, HR 0.63; 95% CI (0.38-1.03); P = 0.064) was relatively important component for Pentafecta achievement. Conclusions The rate of Pentafecta after RAPN was comparable between T1a and T1b renal masses. RAPN is a feasible modality with excellent long term outcome for patients with larger renal mass (cT1b).	[Kim, Dae Keun] CHA Univ, CHA Med Sch, CHA Seoul Stn Med Ctr, Dept Urol, Seoul, South Korea; [Kim, Dae Keun] Hanyang Univ, Grad Sch, Sch Med, Dept Urol, Seoul 133791, South Korea; [Kim, Lawrence H. C.] Royal Prince Alfred Hosp, Dept Urol, Missenden Rd, Sydney, NSW, Australia; [Raheem, Ali Abdel] Tanta Univ, Dept Urol, Tanta, Egypt; [Shin, Tae Young] Hallym Univ, Coll Med, Chuncheon Sacred Hosp, Dept Urol, Chunchon, South Korea; [Kim, Lawrence H. C.; Raheem, Ali Abdel; Alabdulaali, Ibrahim; Yoon, Young Eun; Han, Woong Kyu; Rha, Koon Ho] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea	Pochon Cha University; Hanyang University; University of Sydney; Egyptian Knowledge Bank (EKB); Tanta University; Hallym University; Yonsei University; Yonsei University Health System	Rha, KH (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea.	khrha@yuhs.ac	김, 대근/X-8040-2019	김, 대근/0000-0003-3237-6304; Rha, Koon Ho/0000-0001-8588-7584; Yoon, Young Eun/0000-0001-8059-6649; Han, Woong Kyu/0000-0002-2527-4046	National Research Foundation of Korea grant - Korean Government (MEST) [NRF-2015R1A2A2A04003460]	National Research Foundation of Korea grant - Korean Government (MEST)	This work was supported by the National Research Foundation of Korea grant funded by the Korean Government (MEST) (NRF-2015R1A2A2A04003460). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumarzouk OM, 2012, EUR UROL, V62, P1023, DOI 10.1016/j.eururo.2012.06.038; Borghesi M, 2013, WORLD J UROL, V31, P499, DOI 10.1007/s00345-013-1095-2; Carneiro A, 2015, WORLD J UROL, V33, P2039, DOI 10.1007/s00345-015-1552-1; Choi JE, 2015, EUR UROL, V67, P891, DOI 10.1016/j.eururo.2014.12.028; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Gupta GN, 2013, UROL ONCOL-SEMIN ORI, V31, P51, DOI 10.1016/j.urolonc.2010.10.008; Hung AJ, 2013, J UROLOGY, V189, P36, DOI 10.1016/j.juro.2012.09.042; Khalifeh A, 2013, J UROLOGY, V189, P1236, DOI 10.1016/j.juro.2012.10.021; Kim DK, 2015, CURR UROL REP, V16, DOI 10.1007/s11934-015-0552-4; Komninos C, 2014, UROLOGY, V84, P1367, DOI 10.1016/j.urology.2014.08.012; Komninos C, 2014, EUR UROL, V66, P512, DOI 10.1016/j.eururo.2013.10.058; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Lista G, 2015, UROLOGY, V85, P589, DOI 10.1016/j.urology.2014.09.068; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Maddox M, 2015, CLIN GENITOURIN CANC, V13, P94, DOI 10.1016/j.clgc.2014.07.011; Petros F, 2012, J ENDOUROL, V26, P642, DOI 10.1089/end.2011.0340; Porpiglia F, 2013, BJU INT, V112, P1125, DOI 10.1111/bju.12317; Takagi T, 2014, UROLOGY, V84, P1128, DOI 10.1016/j.urology.2014.07.008; Takagi T, 2014, J UROLOGY, V192, P30, DOI 10.1016/j.juro.2013.12.035; Zargar H, 2015, BJU INT, V116, P407, DOI 10.1111/bju.12933	22	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151738	10.1371/journal.pone.0151738	http://dx.doi.org/10.1371/journal.pone.0151738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987069	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300120
J	Gilmour, S; Miyagawa, S; Kasuga, F; Shibuya, K				Gilmour, Stuart; Miyagawa, Shoji; Kasuga, Fumiko; Shibuya, Kenji			Current Measures on Radioactive Contamination in Japan: A Policy Situation Analysis	PLOS ONE			English	Article							INTERNAL RADIATION-EXPOSURE; POWER-PLANT DISASTER; NUCLEAR ACCIDENT; FUKUSHIMA; CHERNOBYL	Background The Great East Japan Earthquake on 11th March 2011 and the subsequent Fukushima Daiichi nuclear power plant disaster caused radioactive contamination in the surrounding environment. In the immediate aftermath of the accident the Government of Japan placed strict measures on radio-contamination of food, and enhanced radio-contamination monitoring activities. Japan is a pilot country in the WHO Foodborne Disease Burden Epidemiology Reference Group (FERG), and through this initiative has an opportunity to report on policy affecting chemicals and toxins in the food distribution network. Nuclear accidents are extremely rare, and a policy situation analysis of the Japanese government's response to the Fukushima Dai-ichi nuclear accident is a responsibility of Japanese scientists. This study aims to assess Japan government policies to reduce radio-contamination risk and to identify strategies to strengthen food policies to ensure the best possible response to possible future radiation accidents. Methods and Findings We conducted a hand search of all publicly available policy documents issued by the Cabinet Office, the Food Safety Commission, the Ministry of Health, Labor and Welfare (MHLW), the Ministry of Agriculture, Forestry and Fishery (MAFF) and prefectural governments concerning food safety standards and changes to radiation and contamination standards since March 11th, 2011. We extracted information on food shipment and sales restrictions, allowable radio-contamination limits, monitoring activities and monitoring results. The standard for allowable radioactive cesium (Cs-134 and Cs-137) of 100 Bq/Kg in general food, 50 Bq/Kg in infant formula and all milk products, and 10 Bq/Kg in drinking water was enforced from April 2012 under the Food Sanitation Law, although a provisional standard on radio-contamination had been applied since the nuclear accident. Restrictions on the commercial sale and distribution of specific meat, vegetable and fish products were released for areas at risk of radioactive contamination. Monitoring of radioactive materials in food products in the prefectures has been mainly conducted before shipment to restrict the distribution of radio-contaminated foods. Between March 2011 and March 2012, 133,832 tests of non-commercial and commercial products were conducted, and 1,204 tests (0.9%) were found to violate the provisional standards. Since April 2012, 278,275 tests were conducted, and 2,372 tests (0.9%) were found to violate the revised standards. MHLW assessment of representative market baskets of foodstuffs at 15 locations throughout Japan between February and March 2014 found very low estimated dietary intake of radioactive cesium (0.0007-0.019 mSv/year), as did assessments of the contents of an average day's food. Monitoring of fisheries products in coastal areas affected by the nuclear accident found very limited and declining radio-contamination of live fish outside of Fukushima prefecture. Fisheries monitoring is of limited geographical scope and covers only certain fishes. Conclusions Area-specific bans on production and distribution have been effective in preventing radioactive contamination in the Japanese food market. Currently there is no major concern about radioactive cesium concentrations in retail foodstuffs in Japan, and very low levels of contamination at the production and wholesale stage. However, because the residue limits and food safety policies were revised on an ad hoc, emergency basis after the nuclear accident, the monitoring procedure needs to be reviewed based on objective and scientifically rational criteria. A transparent and objective scientific framework is needed for prioritizing foodstuffs for inspection and revising Prefecture-specific restrictions. Monitoring of fishes and other seafood products in the wild should be regularized and the information made more publicly accessible, and monitoring activities expanded to identify foodstuffs that are no longer a food safety risk. Consultation with producers and consumers should be more formalized to ensure their concerns are incorporated into regular policy reviews in an appropriate and transparent manner. However, despite the limited available knowledge on best practice in food control and enforcement of provisional radio-contamination limits after the accident, current Japanese policy is sufficient to protect the Japanese public from major risk of radio-contamination from the commercial food market.	[Gilmour, Stuart] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Miyagawa, Shoji] Minist Hlth Labour & Welf, Hlth Bur, TB & Infect Dis Control Div, Infect Dis Informat Surveillance Off, Tokyo, Japan; [Kasuga, Fumiko] Natl Inst Hlth Sci, Div Safety Informat Drug Food & Chem, Tokyo, Japan	University of Tokyo; National Institute of Health Sciences - Japan	Gilmour, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan.	sgilmour@m.u-tokyo.ac.jp		Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labour and Welfare scientific research grant [H26-shokuhin-shitei-006]; Japan Society for the Promotion of Science [25253051]	Ministry of Health, Labour and Welfare scientific research grant; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Ministry of Health, Labour and Welfare scientific research grant (H26-shokuhin-shitei-006) and a Japan Society for the Promotion of Science grant-in-aid for scientific research (Number 25253051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSPAUGH LR, 1988, SCIENCE, V242, P1513, DOI 10.1126/science.3201240; Bevelacqua JJ, 2012, J ENVIRON RADIOACTIV, V105, P6, DOI 10.1016/j.jenvrad.2011.10.008; Brumfiel G, 2011, NATURE, V471, P273, DOI 10.1038/471273a; Center for Food Safety and Applied Nutrition, 2004, SUPP DOC GUID LEV RA; Consumer Affairs Agency, 2011, FOOD RAD Q A; Department of Food Safety, 2013, RAD MAT FOODS CURR S; Department of Food safety, 2013, MEAS ENS FOOD SAF; Department of Food Safety, 2013, REP ACT RAD FOOD MAT; [Investigation Committee on the Accident at Fukushima Nuclear Power Stations of Tokyo Electric Power Company Office C], 2012, FIN REP INV COMM; Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459; Leppanen AP, 2011, HEALTH PHYS, V100, P468, DOI 10.1097/HP.0b013e3181f2b52c; NAIIC, 2012, OFF REP FUK NUCL ACC; Orita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114407; Saenko V, 2011, CLIN ONCOL-UK, V23, P234, DOI 10.1016/j.clon.2011.01.502; Schwantes JM, 2012, ENVIRON SCI TECHNOL, V46, P8621, DOI 10.1021/es300556m; Shibuya K, 2014, LANCET, V383, P1883, DOI 10.1016/S0140-6736(14)60909-0; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Steinhauser G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057760; Sugimoto A, 2014, ENVIRON HEALTH PERSP, V122, P587, DOI 10.1289/ehp.1306848; Taira Y, 2014, ENVIRON SCI TECHNOL, V48, P4556, DOI 10.1021/es404534y; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2013, JAMA PEDIATR, V167, P1169, DOI 10.1001/jamapediatrics.2013.2311; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Wong DLF, 2010, OVERVIEW PROPOSED CO; Working Group for assessment of the effect of radioactive nuclides in food on health, 2011, WORK GROUP ASS EFF R; World Health Organization, 2013, HLTH RISK ASS NUCL A	28	13	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152040	10.1371/journal.pone.0152040	http://dx.doi.org/10.1371/journal.pone.0152040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007509	Green Submitted, gold, Green Published			2022-12-27	WOS:000372701200090
J	Mutschelknaus, L; Peters, C; Winkler, K; Yentrapalli, R; Heider, T; Atkinson, MJ; Moertl, S				Mutschelknaus, Lisa; Peters, Carsten; Winkler, Klaudia; Yentrapalli, Ramesh; Heider, Theresa; Atkinson, Michael John; Moertl, Simone			Exosomes Derived from Squamous Head and Neck Cancer Promote Cell Survival after Ionizing Radiation	PLOS ONE			English	Article							MESSENGER-RNAS; MICROVESICLES; MICRORNAS; MICROENVIRONMENT; PROLIFERATION; MECHANISM; THERAPY	Exosomes are nanometer-sized extracellular vesicles that are believed to function as intercellular communicators. Here, we report that exosomes are able to modify the radiation response of the head and neck cancer cell lines BHY and FaDu. Exosomes were isolated from the conditioned medium of irradiated as well as non-irradiated head and neck cancer cells by serial centrifugation. Quantification using NanoSight technology indicated an increased exosome release from irradiated compared to non-irradiated cells 24 hours after treatment. To test whether the released exosomes influence the radiation response of other cells the exosomes were transferred to non-irradiated and irradiated recipient cells. We found an enhanced uptake of exosomes isolated from both irradiated and non-irradiated cells by irradiated recipient cells compared to non-irradiated recipient cells. Functional analyses by exosome transfer indicated that all exosomes (from non-irradiated and irradiated donor cells) increase the proliferation of non-irradiated recipient cells and the survival of irradiated recipient cells. The survival-promoting effects are more pronounced when exosomes isolated from irradiated compared to non-irradiated donor cells are transferred. A possible mechanism for the increased survival after irradiation could be the increase in DNA doublestrand break repair monitored at 6, 8 and 10 h after the transfer of exosomes isolated from irradiated cells. This is abrogated by the destabilization of the exosomes. Our results demonstrate that radiation influences both the abundance and action of exosomes on recipient cells. Exosomes transmit prosurvival effects by promoting the proliferation and radioresistance of head and neck cancer cells. Taken together, this study indicates a functional role of exosomes in the response of tumor cells to radiation exposure within a therapeutic dose range and encourages that exosomes are useful objects of study for a better understanding of tumor radiation response.	[Mutschelknaus, Lisa; Winkler, Klaudia; Yentrapalli, Ramesh; Heider, Theresa; Atkinson, Michael John; Moertl, Simone] Helmholtz Zentrum mUNCHEN, German Res Ctr Environm Hlth, Inst Radiat Biol, Neuherberg, Germany; [Peters, Carsten] Tech Univ Munich, Dept Chem, D-80290 Munich, Germany; [Atkinson, Michael John] Tech Univ Munich, Radiat Biol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Technical University of Munich	Moertl, S (corresponding author), Helmholtz Zentrum mUNCHEN, German Res Ctr Environm Hlth, Inst Radiat Biol, Neuherberg, Germany.	moertl@helmholtz-muenchen.de	Atkinson, Michael J/E-5537-2011; Moertl, Simone/M-7353-2014; Atkinson, Michael/AAU-5127-2020; Yentrapalli, Ramesh/N-3509-2019	Atkinson, Michael J/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Atkinson, Michael/0000-0003-3358-2089; Yentrapalli, Ramesh/0000-0001-6292-4792				Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arscott WT, 2013, TRANSL ONCOL, V6, P638, DOI 10.1593/tlo.13640; Battke C, 2011, CANCER IMMUNOL IMMUN, V60, P639, DOI 10.1007/s00262-011-0979-5; Chen WX, 2014, TUMOR BIOL, V35, P9649, DOI 10.1007/s13277-014-2242-0; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Dutta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097580; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Hazawa M, 2014, BIOCHEM BIOPH RES CO, V446, P1165, DOI 10.1016/j.bbrc.2014.03.067; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; King TL, 2012, AM J PHYSIOL-REG I, V302, pR1219, DOI 10.1152/ajpregu.00028.2012; Kraemer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077484; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raimondo S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0086-x; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Thery C, 2001, CURRENT PROTOCOLS IN; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Xiao H, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0064-8; Yang L, 2013, MOL MED REP, V8, P1272, DOI 10.3892/mmr.2013.1634	32	105	110	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152213	10.1371/journal.pone.0152213	http://dx.doi.org/10.1371/journal.pone.0152213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27006994	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200111
J	Doltra, A; Hartmann, A; Stawowy, P; Goubergrits, L; Kuehne, T; Wellnhofer, E; Gebker, R; Schneeweis, C; Schnackenburg, B; Esler, M; Fleck, E; Kelle, S				Doltra, Adelina; Hartmann, Arthur; Stawowy, Philipp; Goubergrits, Leonid; Kuehne, Titus; Wellnhofer, Ernst; Gebker, Rolf; Schneeweis, Christopher; Schnackenburg, Bernhard; Esler, Murray; Fleck, Eckart; Kelle, Sebastian			Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study	PLOS ONE			English	Article							TREATMENT-RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; VASCULAR-LESIONS; NERVE ABLATION; CATHETER; NONRESPONDERS; STENOSIS	Aim To study the effects of RD on renal artery wall function non-invasively using magnetic resonance. Methods and Results 32 patients undergoing RD were included. A 3.0 Tesla magnetic resonance of the renal arteries was performed before RD and after 6-month. We quantified the vessel sharpness of both renal arteries using a quantitative analysis tool (Soap-Bubble1). In 17 patients we assessed the maximal and minimal cross-sectional area of both arteries, peak velocity, mean flow, and renal artery distensibility. In a subset of patients wall shear stress was assessed with computational flow dynamics. Neither renal artery sharpness nor renal artery distensibility differed significantly. A significant increase in minimal and maximal areas (by 25.3%, p = 0.008, and 24.6%, p = 0.007, respectively), peak velocity (by 16.9%, p = 0.021), and mean flow (by 22.4%, p = 0.007) was observed after RD. Wall shear stress significantly decreased (by 25%, p = 0.029). These effects were observed in blood pressure responders and non-responders. Conclusions RD is not associated with adverse effects at renal artery level, and leads to an increase in cross-sectional areas, velocity and flow and a decrease in wall shear stress.	[Doltra, Adelina; Hartmann, Arthur; Stawowy, Philipp; Wellnhofer, Ernst; Gebker, Rolf; Schneeweis, Christopher; Fleck, Eckart; Kelle, Sebastian] Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany; [Goubergrits, Leonid; Kuehne, Titus] Charite, Biofluid Mech Lab, D-13353 Berlin, Germany; [Goubergrits, Leonid; Kuehne, Titus] Deutsch Herzzentrum Berlin, Dept Congenital Heart Dis & Paediat Cardiol, Berlin, Germany; [Kuehne, Titus; Gebker, Rolf; Kelle, Sebastian] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Schnackenburg, Bernhard] Philips Healthcare, Clin Sci, Hamburg, Germany; [Esler, Murray] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Centre for Cardiovascular Research; Philips; Philips Healthcare; Baker Heart and Diabetes Institute	Kelle, S (corresponding author), Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany.; Kelle, S (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	kelle@dhzb.de	Kelle, Sebastian/ABH-7348-2020; Goubergrits, Leonid/AAB-2332-2022	Goubergrits, Leonid/0000-0002-1961-3179; Kelle, Sebastian/0000-0001-8105-6599; Kuehne, Titus/0000-0003-1631-4824	European Society of Cardiology; Philips Healthcare	European Society of Cardiology; Philips Healthcare	AD was supported by a Research Grant from the European Society of Cardiology (2013). Philips Healthcare provided support in the form of salaries for authors (BS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Doltra A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001353; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Gatehouse PD, 2005, EUR RADIOL, V15, P2172, DOI 10.1007/s00330-005-2829-3; Goubergrits L, 2013, ANN BIOMED ENG, V41, P2575, DOI 10.1007/s10439-013-0879-2; Ierna S, 2013, INT J CARDIOL, V165, pE35, DOI 10.1016/j.ijcard.2012.10.056; Kaltenbach B, 2012, J AM COLL CARDIOL, V60, P2694, DOI 10.1016/j.jacc.2012.09.027; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lambert T, CATHETER CARDIOVASC, V81, pE255, DOI 10.1002/ccd.24753; Lambert T, 2015, AM J CARDIOL, V115, P1545, DOI 10.1016/j.amjcard.2015.02.055; Mahfoud F, 2014, EUR HEART J, V35, P2224, DOI 10.1093/eurheartj/ehu093; Mahfoud F, 2013, EUR HEART J, V34, P2149, DOI 10.1093/eurheartj/eht154; Mahfoud F, 2012, HYPERTENSION, V60, P419, DOI 10.1161/HYPERTENSIONAHA.112.193870; Oppo K, 1998, RADIOLOGY, V208, P453, DOI 10.1148/radiology.208.2.9680575; Prochnau D, 2013, INT J CARDIOL, V167, P588, DOI 10.1016/j.ijcard.2012.09.224; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sakakura K, 2014, J AM COLL CARDIOL, V64, P635, DOI 10.1016/j.jacc.2014.03.059; Schmid A, 2016, CARDIOVASC INTER RAD, V39, P426, DOI 10.1007/s00270-015-1192-2; Schubert S, 2014, INT J CARDIOL, V177, pE172, DOI 10.1016/j.ijcard.2014.08.112; Steigerwald K, 2012, J HYPERTENS, V30, P2230, DOI 10.1097/HJH.0b013e32835821e5; Templin C, 2013, EUR HEART J, V34, P2141, DOI 10.1093/eurheartj/eht141; Tsioufis C, 2014, EUROINTERVENTION, V9, P27, DOI [10.4244/EIJV919A175, 10.4244/EIJV9I9A175]; VANBORTEL LM, 1995, HYPERTENSION, V26, P531, DOI 10.1161/01.HYP.26.3.531; Versaci F, 2014, INT J CARDIOL, V175, P370, DOI 10.1016/j.ijcard.2014.04.252; Vonend O, 2012, LANCET, V380, P778, DOI 10.1016/S0140-6736(12)61145-3; Wellnhofer E, 2010, ATHEROSCLEROSIS, V213, P475, DOI 10.1016/j.atherosclerosis.2010.09.007; Zhang ZH, 2014, J CLIN HYPERTENS, V16, P599, DOI 10.1111/jch.12367	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150662	10.1371/journal.pone.0150662	http://dx.doi.org/10.1371/journal.pone.0150662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003912	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400018
J	Chandra, Y; Jiang, LC; Wang, CJ				Chandra, Yanto; Jiang, Li Crystal; Wang, Cheng-Jun			Mining Social Entrepreneurship Strategies Using Topic Modeling	PLOS ONE			English	Article							TAXONOMY; IMPACT	Despite the burgeoning research on social entrepreneurship (SE), SE strategies remain poorly understood. Drawing on extant research on the social activism and social change, empowerment and SE models, we explore, classify and validate the strategies used by 2,334 social entrepreneurs affiliated with the world's largest SE support organization, Ashoka. The results of the topic modeling of the social entrepreneurs' strategy profiles reveal that they employed a total of 39 change-making strategies that vary across resources (material versus symbolic strategies), specificity (general versus specific strategies), and mode of participation (mass versus elite participation strategies); they also vary across fields of practice and time. Finally, we identify six meta-SE strategies-a reduction from the 39 strategies-and identify four new meta-SE strategies (i.e., system reform, physical capital development, evidence-based practices, and prototyping) that have been overlooked in prior SE research. Our findings extend and deepen the research into SE strategies and offer a comprehensive model of SE strategies that advances theory, practice and policy making.	[Chandra, Yanto] City Univ Hong Kong, Dept Publ Policy, Hong Kong, Hong Kong, Peoples R China; [Chandra, Yanto] City Univ Hong Kong, Dept Management, Hong Kong, Hong Kong, Peoples R China; [Jiang, Li Crystal] City Univ Hong Kong, Dept Media & Commun, Hong Kong, Hong Kong, Peoples R China; [Wang, Cheng-Jun] Nanjing Univ, Sch Journalism & Commun, Computat Commun Collaboratory, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Cheng-Jun] City Univ Hong Kong, Dept Media & Commun, Web Min Lab, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong; City University of Hong Kong; Nanjing University; City University of Hong Kong	Chandra, Y (corresponding author), City Univ Hong Kong, Dept Publ Policy, Hong Kong, Hong Kong, Peoples R China.; Chandra, Y (corresponding author), City Univ Hong Kong, Dept Management, Hong Kong, Hong Kong, Peoples R China.	ychandra@cityu.edu.hk	Chandra, Yanto/N-6238-2014	Chandra, Yanto/0000-0003-1083-5813	City University of Hong Kong [DRSS 019 020/2013, 9610292]	City University of Hong Kong(City University of Hong Kong)	This work was supported by City University of Hong Kong DRSS 019 & 020/2013 to Yanto Chandra and City University of Hong Kong Internal Grant A/C 9610292 to Li Crystal Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH HE, 1994, ACAD MANAGE REV, V19, P645, DOI 10.2307/258740; Alvesson M, 2007, ACAD MANAGE REV, V32, P1265, DOI 10.5465/AMR.2007.26586822; Alvord S.H., 2004, J APPL BEHAV SCI, V40, P260, DOI [10.1177/0021886304266847, DOI 10.1177/0021886304266847, 10.1007/978-3-540-48543-8_10]; Austin J, 2006, ENTREP THEORY PRACT, V30, P1, DOI 10.1111/j.1540-6520.2006.00107.x; Bank G, US; Battilana J, 2010, ACAD MANAGE J, V53, P1419, DOI 10.5465/AMJ.2010.57318391; Blei DM, 2007, ANN APPL STAT, V1, P634, DOI 10.1214/07-AOAS136; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boltanski L., 2006, JUSTIFICATION EC WOR, P1; Borgatti SP, 2013, ANAL SOCIAL NETWORKS, P1; Bornstein David, 2007, CHANGE WORLD SOCIAL; Chandra Y., 2016, SOCIAL ENTREPRENEURS; Chetkovich CA, 2006, GROUND GRASSROOTS OR, P205; Choi N, 2014, J BUS VENTURING, V29, P363, DOI 10.1016/j.jbusvent.2013.05.001; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Corner PD, 2010, ENTREP THEORY PRACT, V34, P635, DOI 10.1111/j.1540-6520.2010.00382.x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dacin PA, 2010, ACAD MANAGE PERSPECT, V24, P37, DOI 10.5465/AMP.2010.52842950; Den Hond F, 2007, ACAD MANAGE REV, V32, P901, DOI 10.5465/AMR.2007.25275682; Desa G, 2012, ENTREP THEORY PRACT, V36, P727, DOI 10.1111/j.1540-6520.2010.00430.x; Dey P, 2010, J ENTERP COMMUNITIES, V4, P85, DOI 10.1108/17506201011029528; Drayton B, 2010, HARVARD BUS REV, V88, P56; Ebrahim A, 2014, CALIF MANAGE REV, V56, P118, DOI [10.1525/cmr.2014.56.3.118, 10.1525/cmr.2013.56.3.118]; Fariss CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138935; Feinerer I, 2008, SOFTW, V5, P1; Gioia DA, 2013, ORGAN RES METHODS, V16, P15, DOI 10.1177/1094428112452151; Grimmer J, 2010, POLIT ANAL, V18, P1, DOI [10.1093/pan/mpp034, 10.1093/pan/mpq027]; Grun B, 2011, J STAT SOFTW, V40, P1; Higgins MC, 2003, ORGAN SCI, V14, P244, DOI 10.1287/orsc.14.3.244.15160; Hillgren PA, 2011, CODESIGN, V7, P169, DOI 10.1080/15710882.2011.630474; Holt D, 2015, CALIF MANAGE REV, V57, P107, DOI 10.1525/cmr.2015.57.3.107; Kerlin JA, 2010, VOLUNTAS, V21, P162, DOI 10.1007/s11266-010-9126-8; Maathai W., 2004, GREEN BELT MOVEMENT, P117; Maathai W., 2015, GREENBELT MOVEMENT; Mair J, 2012, J BUS ETHICS, V111, P353, DOI 10.1007/s10551-012-1414-3; Mair J, 2009, J BUS VENTURING, V24, P419, DOI 10.1016/j.jbusvent.2008.04.006; Manning C, 1999, FDN STAT NATURAL LAN, P1; Meyskens M, 2010, ENTREP THEORY PRACT, V34, P661, DOI 10.1111/j.1540-6520.2010.00389.x; MILLER A, 1988, STRATEGIC MANAGE J, V9, P239, DOI 10.1002/smj.4250090304; Miller TL, 2012, ACAD MANAGE REV, V37, P616, DOI 10.5465/amr.2010.0456; MORRISON AJ, 1992, STRATEGIC MANAGE J, V13, P399, DOI 10.1002/smj.4250130602; Moss TW, 2011, ENTREP THEORY PRACT, V35, P805, DOI 10.1111/j.1540-6520.2010.00372.x; Nag R, 2012, ACAD MANAGE J, V55, P421, DOI 10.5465/amj.2008.0352; Pache AC, 2013, ACAD MANAGE J, V56, P972, DOI 10.5465/amj.2011.0405; Pons P, 2005, COMPUTER INFORM SCI, P974; Porter M. E., 1996, HARVARD BUSINESS REV; Quinn KM, 2010, AM J POLIT SCI, V54, P209, DOI 10.1111/j.1540-5907.2009.00427.x; Richardson L, 2012, BEAUTIFUL SOUP; Rousseau DM, 2006, ACAD MANAGE REV, V31, P256, DOI 10.5465/AMR.2006.20208679; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Santos FM, 2012, J BUS ETHICS, V111, P335, DOI 10.1007/s10551-012-1413-4; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Sonne L, 2012, TECHNOL FORECAST SOC, V79, P638, DOI 10.1016/j.techfore.2011.06.008; Steyvers M, 2007, HDB LATENT SEMANTIC; Terjesen S, 2016, PUBLIC ADMIN REV, V76, P230, DOI 10.1111/puar.12472; UN, 2012, GUARDIAN; WADDOCK SA, 1991, PUBLIC ADMIN REV, V51, P393, DOI 10.2307/976408; Weerawardena J, 2006, J WORLD BUS, V41, P21, DOI 10.1016/j.jwb.2005.09.001; Yiu DW, 2014, MANAGE ORGAN REV, V10, P55, DOI 10.1111/more.12043; Yunus M, 2010, LONG RANGE PLANN, V43, P308, DOI 10.1016/j.lrp.2009.12.005; Zahra SA, 2009, J BUS VENTURING, V24, P519, DOI 10.1016/j.jbusvent.2008.04.007; Zimmerman MA, 1998, REHABIL PSYCHOL, V43, P3, DOI 10.1037/0090-5550.43.1.3; Zott C, 2007, ADMIN SCI QUART, V52, P70, DOI 10.2189/asqu.52.1.70	64	21	21	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151342	10.1371/journal.pone.0151342	http://dx.doi.org/10.1371/journal.pone.0151342			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26998970	gold, Green Published			2022-12-27	WOS:000372694700033
J	Geng, HH; Li, R; Su, YM; Xiao, J; Pan, M; Cai, XX; Ji, XP				Geng, Hai-Hua; Li, Rui; Su, Ya-Min; Xiao, Jie; Pan, Min; Cai, Xing-Xing; Ji, Xiao-Ping			The Circular RNA Cdr1as Promotes Myocardial Infarction by Mediating the Regulation of miR-7a on Its Target Genes Expression	PLOS ONE			English	Article							INDUCED APOPTOSIS; TRANSCRIPTION; PATHWAY	Objectives Recent studies have demonstrated the role of Cdr1as (or CiRS-7), one of the well-identified circular RNAs (circRNAs), as a miR-7a/b sponge or inhibitor in brain tissues or islet cells. This study aimed to investigate the presence of Cdr1as/miR-7a pathway in cardiomyocytes, and explore the mechanism underlying the function of miR-7a in protecting against myocardial infarction (MI)-induced apoptosis. Methods Mouse MI injury model was established and evaluated by infarct size determination. Real-time PCR was performed to quantify the expression of Cdr1as and miR-7a in cardiomyocytes. Cell apoptosis was determined by caspase-3 activity analysis and flow cytometry assays with Annexin V/PI staining. Transfection of Cdr1as overexpressing plasmid and miR-7a mimic were conducted for gain-of-function studies. Luciferase reporter assay and western blot analysis were performed to verity potential miR-7a targets. Results Cdr1as and miR-7a were both upregulated in MI mice with increased cardiac infarct size, or cardiomyocytes under hypoxia treatment. Cdr1as overexpression in MCM cells promoted cell apoptosis, but was then reversed by miR-7a overexpression. The SP1 was identified as a new miR-7a target, in line with previously identified PARP, while miR-7a-induced decrease of cell apoptosis under hypoxia treatment was proven to be inhibited by PARP-SP1 overexpression. Moreover, Cdr1as overexpression in vivo increased cardiac infarct size with upregulated expression of PARP and SP1, while miR-7a overexpression reversed these changes. Conclusions Cdr1as also functioned as a powerful miR-7a sponge in myocardial cells, and showed regulation on the protective role of miR-7a in MI injury, involving the function of miR-7a targets, PARP and SP1.	[Geng, Hai-Hua; Li, Rui; Xiao, Jie; Ji, Xiao-Ping] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China; [Geng, Hai-Hua; Li, Rui; Xiao, Jie; Ji, Xiao-Ping] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China; [Su, Ya-Min; Pan, Min; Cai, Xing-Xing] Nantong Univ, Affiliated Hosp, Dept Cardiol, Nantong 226001, Jiangsu, Peoples R China	Shandong University; Shandong University; Nantong University	Ji, XP (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China.; Ji, XP (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China.	Jixping@163.com		Pan, Min/0000-0001-9508-4849				CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Cho HJ, 2012, MOL THER, V20, P1750, DOI 10.1038/mt.2012.109; Danan M, 2011, NUCLEIC ACIDS RES; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Fan F, 2013, CURR PHARM DESIGN, V19, P4865, DOI 10.2174/13816128113199990325; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kos A, 1986, HEPATITIS DELTA VIRU; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090096; Li LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145766; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Meloni M, 2013, MOL THER, V21, P1390, DOI 10.1038/mt.2013.89; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nicolas FE, 2011, METHODS MOL BIOL, V732, P139, DOI 10.1007/978-1-61779-083-6_11; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Read DE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-56; Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Saraste A, 1997, CIRCULATION, V95, P320; Steele Robert, 2010, Genes Cancer, V1, P381; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Wang Hong-Ju, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P345; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yang GD, 2012, J CELL PHYSIOL, V227, P3192, DOI 10.1002/jcp.24006; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339; Zhao YJ, 2009, CHINESE MED J-PEKING, V122, P1322, DOI 10.3760/cma.j.issn.0366-6999.2009.11.016	40	287	320	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151753	10.1371/journal.pone.0151753	http://dx.doi.org/10.1371/journal.pone.0151753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998750	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700060
J	Reacher, M; Verlander, NQ; Roddick, I; Trundle, C; Brown, N; Farrington, M; Jones, P				Reacher, Mark; Verlander, Neville Q.; Roddick, Iain; Trundle, Cheryl; Brown, Nicholas; Farrington, Mark; Jones, Philip			Excess Mortality Attributable to Clostridium difficile and Risk Factors for Infection in an Historic Cohort of Hospitalised Patients Followed Up in the United Kingdom Death Register	PLOS ONE			English	Article							DIARRHEA; DISEASE; MORBIDITY; BURDEN; EUROPE; RATES	Methods We compared time from hospital admission to death in a probability sample of 100 Clostridium difficile infected cases and a probability sample of 98 non-cases admitted to an English teaching hospital between 2005 and 2007 with follow up in the UK national death register using survival analysis. Results Clostridium difficile infection was associated with a 50% increased risk of death (Hazard Ratio 1.51 (95% CI: 1.05-2.19 p = 0.03) at between five to eight years in Cox Regression analysis adjusting for age, sex, Charlson comorbidity index, diagnosis of a malignant condition and insertion of a nasogastric tube during admission. Acquisition of Clostridium difficile infection was independently associated with an almost six fold higher odds of being admitted with a diagnosis of infection of any other type (OR 5.79 (2.19, 15.25) p<0.001). Conclusions Our results strongly support continued priority being given to improve prevention and treatment of Clostridium difficile infection in the English National Health Service particularly in patients admitted with an infection. Our results may be applicable to other health systems.	[Reacher, Mark; Roddick, Iain] Cambridge Inst Publ Hlth, Publ Hlth England, Natl Infect Serv, Field Epidemiol Serv, Cambridge, England; [Reacher, Mark; Trundle, Cheryl; Brown, Nicholas; Farrington, Mark] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Publ Hlth England, Cambridge, England; [Verlander, Neville Q.] Publ Hlth England, Natl Infect Serv, Stat Modelling & Econ Dept, Stat Unit, London, England; [Jones, Philip] Ipswich Hosp, Dept Med Microbiol, Ipswich, Suffolk, England	Public Health England; University of Cambridge; Addenbrooke's Hospital; Public Health England; University of Cambridge; Public Health England; Ipswich Hospital NHS Trust; Ipswich Hospital	Reacher, M (corresponding author), Cambridge Inst Publ Hlth, Publ Hlth England, Natl Infect Serv, Field Epidemiol Serv, Cambridge, England.; Reacher, M (corresponding author), Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Publ Hlth England, Cambridge, England.	mhr28@cam.ac.uk	Reacher, Mark/Y-6979-2018	Reacher, Mark/0000-0001-6871-7903; Brown, Nicholas/0000-0002-6657-300X				ALTMAN DG, 1999, PRACTICAL STAT MED R, P74; ARONSSON B, 1987, EUR J CLIN MICROBIOL, V6, P352, DOI 10.1007/BF02017639; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corporation Stata, STAT STAT SOFTW; Delaney JAC, 2007, EMERG INFECT DIS, V13, P761, DOI 10.3201/eid1305.061124; Department of Health, 2012, UPD GUID DIAGN REP C; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Greenland, 1998, MODERN EPIDEMIOLOGY, P47; HEARD SR, 1988, EPIDEMIOL INFECT, V100, P63, DOI 10.1017/S0950268800065560; Hota SS, 2012, EMERG INFECT DIS, V18, P305, DOI [10.3201/eid1802.101611, 10.3201/eid1802.111611]; Hughes GJ, 2013, J HOSP INFECT, V84, P227, DOI 10.1016/j.jhin.2012.12.018; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Karas JA, 2010, INFECT DIS REP; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; National Institute for Health and Care Excellence, 2014, FAEC MICR TRANSPL RE; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Public Health England, 2015, ANN EP COMM MAND MRS; Schmid D, 2014, J INFECT PUBLIC HEAL, V7, P133, DOI 10.1016/j.jiph.2013.07.010; Stolley PD, 1982, CASE CONTROL STUDIES, P69; Thielman NM, 2010, MANDELL DOUGLAS BENN, P1375; UK government Department for Communities and Local Government, 2014, ENGL IND DEPR; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Wilcox M, 2015, UPDATE GUIDANCE MANA; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0149983	10.1371/journal.pone.0149983	http://dx.doi.org/10.1371/journal.pone.0149983			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999613	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700010
J	Ribeiro, JMC; Martin-Martin, I; Arca, B; Calvo, E				Ribeiro, Jose M. C.; Martin-Martin, Ines; Arca, Bruno; Calvo, Eric			A Deep Insight into the Sialome of Male and Female Aedes aegypti Mosquitoes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; SALIVARY-GLAND TRANSCRIPTS; TRANSPOSABLE ELEMENTS; ANOPHELES-STEPHENSI; XANTHURENIC ACID; MALARIA VECTOR; SIALOKININ-I; GENE; VIRUS; SIALOTRANSCRIPTOME	Only adult female mosquitoes feed on blood, while both genders take sugar meals. Accordingly, several compounds associated with blood feeding (i.e. vasodilators, anti-clotting, anti-platelets) are found only in female glands, while enzymes associated with sugar feeding or antimicrobials (such as lysozyme) are found in the glands of both sexes. We performed de novo assembly of reads from adult Aedes aegypti female and male salivary gland libraries (285 and 90 million reads, respectively). By mapping back the reads to the assembled contigs, plus mapping the reads from a publicly available Ae. aegypti library from adult whole bodies, we identified 360 transcripts (including splice variants and alleles) overexpressed tenfold or more in the glands when compared to whole bodies. Moreover, among these, 207 were overexpressed fivefold or more in female vs. male salivary glands, 85 were near equally expressed and 68 were overexpressed in male glands. We call in particular the attention to C-type lectins, angiopoietins, female-specific Antigen 5, the 9.7 kDa, 12-14 kDa, 23.5 kDa, 62/34 kDa, 4.2 kDa, proline-rich peptide, SG8, 8.7 kDa family and SGS fragments: these polypeptides are all of unknown function, but due to their overexpression in female salivary glands and putative secretory nature they are expected to affect host physiology. We have also found many transposons (some of which novel) and several endogenous viral transcripts (probably acquired by horizontal transfer) which are overexpressed in the salivary glands and may play some role in tissue-specific gene regulation or represent a mechanism of virus interference. This work contributes to a near definitive catalog of male and female salivary gland transcripts from Ae. aegypti, which will help to direct further studies aiming at the functional characterization of the many transcripts with unknown function and the understanding of their role in vector-host interaction and pathogen transmission.	[Ribeiro, Jose M. C.; Martin-Martin, Ines; Calvo, Eric] NIAID, Lab Malaria & Vector Res, Sect Vector Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Arca, Bruno] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Sect, Piazzale Aldo Moro 5, I-00185 Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sapienza University Rome	Ribeiro, JMC (corresponding author), NIAID, Lab Malaria & Vector Res, Sect Vector Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jribeiro@nih.gov	Martin Martin, Ines/I-9358-2012; Calvo, Eric/ABB-4935-2021; Arca, Bruno/C-8383-2012	Martin Martin, Ines/0000-0002-0956-7324; Calvo, Eric/0000-0001-7880-2730; Ribeiro, Jose/0000-0002-9107-0818; Arca, Bruno/0000-0002-4029-0984	EU [228421]; MIUR (PRIN) [2010C2LKKJ_004]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	EU(European Commission); MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BA was supported by funds from the EU grant INFRAVEC (228421) and from MIUR (PRIN 2010-2011, SKINFLAM, 2010C2LKKJ_004); EC, IMM and JMCR by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.	Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Beerntsen BT, 1999, INSECT MOL BIOL, V8, P459, DOI 10.1046/j.1365-2583.1999.00141.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Calvo E, 2008, INSECT BIOCHEM MOLEC, V38, P499, DOI 10.1016/j.ibmb.2007.12.006; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; Chagas AC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-875; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Grossman GL, 1997, INSECT BIOCHEM MOLEC, V27, P769, DOI 10.1016/S0965-1748(97)00063-5; Hajnicka V, 2000, PARASITE IMMUNOL, V22, P201, DOI 10.1046/j.1365-3024.2000.00296.x; Hirai M, 2001, BIOCHEM BIOPH RES CO, V287, P859, DOI 10.1006/bbrc.2001.5675; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Jiang XF, 2015, GENOME BIOL EVOL, V7, P1914, DOI 10.1093/gbe/evv115; JONES LD, 1990, T ROY SOC TROP MED H, V84, P846, DOI 10.1016/0035-9203(90)90104-M; Juhn J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-1; Jurka J., 2011, REPBASE REPORTS, V11, P1039; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552; Korochkina S, 2006, CELL MICROBIOL, V8, P163, DOI 10.1111/j.1462-5822.2005.00611.x; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Marinotti O, 1996, COMP BIOCHEM PHYS B, V113, P675, DOI 10.1016/0305-0491(95)02035-7; MARINOTTI O, 1990, J INSECT PHYSIOL, V36, P545, DOI 10.1016/0022-1910(90)90021-7; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Nascimento EP, 2000, ARCH INSECT BIOCHEM, V43, P9, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;9::AID-ARCH2&gt;3.0.CO;2-2; Nuttall PA, 2009, FRONT BIOSCI-LANDMRK, V14, P2466, DOI 10.2741/3390; Peng Z, 2007, PROTEIN PEPTIDE LETT, V14, P975, DOI 10.2174/092986607782541088; PIMENTEL GE, 1990, COMP BIOCHEM PHYS B, V96, P549, DOI 10.1016/0305-0491(90)90054-W; R Core Team, 2021, R LANGUAGE ENV STAT; RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6; RIBEIRO JMC, 1992, J EXP BIOL, V165, P61; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P13, DOI 10.1016/S0965-1748(02)00078-4; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Ribeiro JMC, 2014, INSECT BIOCHEM MOLEC, V44, P23, DOI 10.1016/j.ibmb.2013.10.006; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; ROSSIGNOL PA, 1982, J INSECT PHYSIOL, V28, P579, DOI 10.1016/0022-1910(82)90054-3; ROSSIGNOL PA, 1986, COMP BIOCHEM PHYS B, V83, P819, DOI 10.1016/0305-0491(86)90153-7; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stark KR, 1995, EXP PARASITOL, V81, P321, DOI 10.1006/expr.1995.1123; Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10; Thangamani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012137; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warnes GR, 2015, GPLOTS VARIOUS R PRO, V2; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077	67	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151400	10.1371/journal.pone.0151400	http://dx.doi.org/10.1371/journal.pone.0151400			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999592	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700039
J	Du, ZQ; Xu, XM; Zhang, H; Wu, ZT; Liu, Y				Du, Ziqiang; Xu, Xiaoming; Zhang, Hong; Wu, Zhitao; Liu, Yong			Geographical Detector-Based Identification of the Impact of Major Determinants on Aeolian Desertification Risk	PLOS ONE			English	Article							NORTH CHINA; CLIMATE-CHANGE; RELATIVE ROLE; VEGETATION; COVER; DEGRADATION; DYNAMICS; PROVINCE; REGION; AREAS	Arid and semi-arid areas in North China are facing the challenge of a rising aeolian desertification risk (ADR) due to the intertwined effects of complex natural processes and intensified anthropogenic activities. An accurate quantitative assessment of the relationship between ADR and its determinants is beneficial for understanding the driving mechanisms of aeolian desertification and for controlling future desertification. Previous studies have failed to quantify the relative role of determinants driving ADR and have been limited in assessing their interactive impacts. In this study, a spatial variance analysis-based geographical detector methodology is used to quantify the effects of geological, physical, and human factors on the occurrence of ADR in an area characterized by mountains and hills in northern China. It is found that soil type, precipitation, and wind velocity are the major determinants of ADR, which implies that geological and physical elements (e.g., soil attribute) and climatic factors (e.g., precipitation and wind velocity) rather than human activities have played a greater role in the incidence of ADR. Particularly, the results show that the interaction of various determinants causes significant non-linearly enhanced impacts on the ADR. The findings of our study will assist local inhabitants and policy makers in developing measures for wind prevention and sand control to mitigate the effects of desertification in the region.	[Du, Ziqiang; Xu, Xiaoming; Wu, Zhitao; Liu, Yong] Shanxi Univ, Inst Loess Plateau, Taiyuan 030006, Shanxi, Peoples R China; [Zhang, Hong] Shanxi Univ, Coll Environm & Resource Sci, Taiyuan 030006, Peoples R China	Shanxi University; Shanxi University	Du, ZQ (corresponding author), Shanxi Univ, Inst Loess Plateau, Taiyuan 030006, Shanxi, Peoples R China.; Zhang, H (corresponding author), Shanxi Univ, Coll Environm & Resource Sci, Taiyuan 030006, Peoples R China.	duzq@sxu.edu.cn; zhanghong@sxu.edu.cn	Xu, Xiaoming/R-2155-2018	Xu, Xiaoming/0000-0003-1405-8089	Important Specialized Science and Technology Item of Shanxi Province [20121101011]; National Natural Science Foundation of China [41161066, 41401053, 41301609]; Foundation for Young Scientists of Shanxi Province [2015021172]	Important Specialized Science and Technology Item of Shanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Young Scientists of Shanxi Province	The work was supported by the Important Specialized Science and Technology Item of Shanxi Province (grant no. 20121101011), the National Natural Science Foundation of China (grant nos. 41161066, 41401053 and 41301609) and the Foundation for Young Scientists of Shanxi Province (grant no. 2015021172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Belushi A.S., 2003, THESIS JORDANIAN U J; Albalawi EK, 2013, J FOOD AGRIC ENVIRON, V11, P791; Asner GP, 2005, GLOBAL CHANGE BIOL, V11, P182, DOI 10.1111/j.1529-8817.2003.00880.x; Becerril-Pina R, 2015, J ARID ENVIRON, V120, P4, DOI 10.1016/j.jaridenv.2015.04.006; Bo T-L, 2013, AEOLIAN RES; Canora F., 2014, J MAPS, P1, DOI DOI 10.1080/17445647; Cao F, 2013, GISCI REMOTE SENS; Chen Y, 2005, LAND DEGRAD DEV, V16, P367, DOI 10.1002/ldr.667; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; Gutman G, 1998, INT J REMOTE SENS, V19, P1533, DOI 10.1080/014311698215333; Hein L, 2011, J ARID ENVIRON, V75, P1164, DOI 10.1016/j.jaridenv.2011.05.002; Hellden U, 2008, GLOBAL PLANET CHANGE, V64, P169, DOI 10.1016/j.gloplacha.2008.10.006; Higginbottom TP, 2014, REMOTE SENS-BASEL, V6, P9552, DOI 10.3390/rs6109552; HOLBEN BN, 1986, INT J REMOTE SENS, V7, P1417, DOI 10.1080/01431168608948945; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021427; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang S, 2006, J ARID ENVIRON, V67, P308, DOI 10.1016/j.jaridenv.2006.02.016; Ibanez J, 2008, ECOL MODEL, V213, P180, DOI 10.1016/j.ecolmodel.2007.11.017; Li JC, 2015, J ARID LAND, V7, P755, DOI 10.1007/s40333-015-0050-z; Li S, 2007, LAND DEGRAD DEV, V18, P473, DOI 10.1002/ldr.787; Li SG, 2000, AGR FOREST METEOROL, V102, P125, DOI 10.1016/S0168-1923(00)00101-5; [李振山 LI Zhenshan], 2006, [中国沙漠, Journal of Desert Research], V26, P687; Liu SL, 2015, ENVIRON EARTH SCI, V73, P7561, DOI 10.1007/s12665-014-3926-x; Liu Y, 2004, INT J REMOTE SENS, V25, P4177, DOI 10.1080/01431160410001680419; Ma YH, 2007, ENVIRON GEOL, V51, P999, DOI 10.1007/s00254-006-0369-z; Millington JDA, 2007, ECOSYSTEMS, V10, P562, DOI 10.1007/s10021-007-9020-4; Piao SL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021764; Veron SR, 2006, J ARID ENVIRON, V66, P751, DOI 10.1016/j.jaridenv.2006.01.021; Vieira RMSP, 2015, SOLID EARTH, V6, P347, DOI 10.5194/se-6-347-2015; Wang JF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002112; Wang JF, 2012, ENVIRON MODELL SOFTW, V33, P114, DOI 10.1016/j.envsoft.2012.01.015; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang XM, 2006, GLOBAL ENVIRON CHANG, V16, P48, DOI 10.1016/j.gloenvcha.2005.06.006; Wang XM, 2008, EARTH-SCI REV, V88, P188, DOI 10.1016/j.earscirev.2008.02.001; Wang XM, 2009, GLOBAL PLANET CHANGE, V67, P167, DOI 10.1016/j.gloplacha.2009.02.004; Xu DY, 2014, CATENA, V123, P11, DOI 10.1016/j.catena.2014.07.004; Xu DY, 2011, J GEOGR SCI, V21, P926, DOI 10.1007/s11442-011-0890-1; Xu EQ, 2014, SOLID EARTH, V5, P1329, DOI 10.5194/se-5-1329-2014; Xue ZJ, 2013, GLOBAL PLANET CHANGE, V107, P102, DOI 10.1016/j.gloplacha.2013.05.001; Yue YM, 2012, PROCEDIA ENVIRON SCI, V13, P847, DOI 10.1016/j.proenv.2012.01.078; Zhang J, 2014, J ARID ENVIRON, V108, P19, DOI 10.1016/j.jaridenv.2014.04.006; Zhou W, 2015, ECOL INDIC, V48, P560, DOI 10.1016/j.ecolind.2014.08.043	42	28	35	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151331	10.1371/journal.pone.0151331	http://dx.doi.org/10.1371/journal.pone.0151331			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987114	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300061
J	Han, XT; Niu, Y; Guo, XX; Hu, Y; Yan, W; He, MG				Han, Xiaotong; Niu, Yong; Guo, Xinxing; Hu, Yin; Yan, William; He, Mingguang			Age-Related Changes of Intraocular Pressure in Elderly People in Southern China: Lingtou Eye Cohort Study	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; LONGITUDINAL ANALYSIS; JAPANESE POPULATION; BARBADOS EYE; ASSOCIATIONS; GLAUCOMA; ADULTS; YOUNG	Purpose To study age-related changes of intraocular pressure (IOP) and assess the cohort effect in both cross-sectional and longitudinal settings among elderly Chinese adults. Methods Participants were enrolled from the Lingtou Eye Cohort Study with Chinese government officials aged 40 years and older at baseline and received physical check-up and ocular examinations from 2010 to 2012. IOP was measured using a non-contact tonometer according to standardized protocols, as well as systolic blood pressure (SBP), diastolic blood pressure (DBP) and body mass index (BMI). Participants who had attended IOP measurements in both 2010 and 2012 were included in this study. Cross-sectional association of IOP with age was assessed using multivariate liner regression analyses and based on the data of 2010. Longitudinal changes in IOP were assessed by paired t-test. Results A total of 3372 subjects were enrolled in the current analysis (2010 mean [SD] age, 61.9 [7.1] years; 60.2% men). The mean IOP in 2010 was 15.4 +/- 2.3 mmHg for women and 15.2 +/- 2.3 mmHg for men with an intersex difference (P = 0.029). Cross-sectional analysis showed that IOP was negatively associated with age (P = 0.003, beta = -0.033 for women and P<0.001, beta = -0.061 for men) adjusted for baseline SBP, DBP and BMI. Paired t-test suggested that IOP was higher in the year 2012 than 2010 in women (P = 0.006) but did not change significantly in men within 2 years (P = 0.345). In addition, the 2-year changes of IOP were not associated with age adjusted for baseline IOP in 2010 (P = 0.249). Conclusion Cross-sectional data suggests that IOP is lower in people with older age. Longitudinal data does not support such findings and thus the identified decreasing pattern with age in cross-sectional analysis is likely caused by cohort effects.	[Han, Xiaotong; Guo, Xinxing; Hu, Yin; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Niu, Yong] Guangzhou 11 Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Yan, William; He, Mingguang] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia	Sun Yat Sen University; Centre for Eye Research Australia; University of Melbourne	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.; He, MG (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia.	mingguang_he@yahoo.com	Guo, Xinxing/AAT-1652-2020; He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810; Han, Xiaotong/0000-0001-6836-3447	Fundamental Research Funds of the State Key Laboratory in Ophthalmology; National Natural Science Foundation of China [81125007]; Brien Holden Vision Institute	Fundamental Research Funds of the State Key Laboratory in Ophthalmology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Brien Holden Vision Institute	The study was supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, and the National Natural Science Foundation of China (81125007) and a research grant from the Brien Holden Vision Institute. The sponsors had no role in study design, data collection, analysis or decision to publish or prepare of the manuscript.; This study was supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, National Natural Science Foundation of China (81125007) and a research grant from the Brien Holden Vision Institute. The authors alone are responsible for the content writing of the paper.	AlMubrad TM, 2008, CLIN EXP OPTOM, V91, P524, DOI 10.1111/j.1444-0938.2008.00298.x; Astrom S, 2014, ACTA OPHTHALMOL, V92, P417, DOI 10.1111/aos.12232; Baek SU, 2015, EYE, V29, P625, DOI 10.1038/eye.2015.11; Carbonaro F, 2010, EYE, V24, P1165, DOI 10.1038/eye.2010.11; Elena Rochtchina, 2002, CLIN EXPT OPHTHALMOL, V2002, P173; Fogagnolo P, 2010, J GLAUCOMA, V19, P418, DOI 10.1097/IJG.0b013e3181aff432; Fogagnolo P, 2009, INVEST OPHTH VIS SCI, V50, P2209, DOI 10.1167/iovs.08-2889; Foster PJ, 2011, INVEST OPHTH VIS SCI, V52, P8179, DOI 10.1167/iovs.11-7853; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; Guedes Guilherme, 2011, Curr Aging Sci, V4, P110; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Hu Y, 2015, INVEST OPHTH VIS SCI, V56, P842, DOI 10.1167/iovs.14-15943; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; Lin HY, 2005, ARCH OPHTHALMOL-CHIC, V123, P381, DOI 10.1001/archopht.123.3.381; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P856, DOI 10.1001/archopht.121.6.856; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Ozel AB, 2014, HUM GENET, V133, P41, DOI 10.1007/s00439-013-1349-5; Preussner PR, 2009, GRAEF ARCH CLIN EXP, V247, P1671, DOI 10.1007/s00417-009-1166-7; Qureshi IA, 1997, CLIN PHYSIOL, V17, P247, DOI 10.1111/j.1365-2281.1997.tb00004.x; Smedowski A, 2014, INVEST OPHTH VIS SCI, V55, P666, DOI 10.1167/iovs.13-13172; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; Yoshida M, 2014, ENVIRON HEALTH PREV, V19, P100, DOI 10.1007/s12199-013-0359-1; Yoshida M, 2014, ACTA MED OKAYAMA, V68, P27; Zhao D, 2014, INVEST OPHTH VIS SCI, V55, P6244, DOI 10.1167/iovs.14-14151; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	31	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151766	10.1371/journal.pone.0151766	http://dx.doi.org/10.1371/journal.pone.0151766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986222	Green Published, gold			2022-12-27	WOS:000372580300126
J	Li, J; Yim, S; Pacheck, A; Sanchez, B; Rutkove, SB				Li, Jia; Yim, Sung; Pacheck, Adam; Sanchez, Benjamin; Rutkove, Seward B.			Electrical Impedance Myography to Detect the Effects of Electrical Muscle Stimulation in Wild Type and Mdx Mice	PLOS ONE			English	Article							ELECTROMYOSTIMULATION; STRENGTH; DUCHENNE; RELAXATION; CHILDREN	Objective Tools to better evaluate the impact of therapy on nerve and muscle disease are needed. Electrical impedance myography (EIM) is sensitive to neuromuscular disease progression as well as to therapeutic interventions including myostatin inhibition and antisense oligonucleotide-based treatments. Whether the technique identifies the impact of electrical muscle stimulation (EMS) is unknown. Methods Ten wild-type (wt) C57B6 mice and 10 dystrophin-deficient (mdx) mice underwent 2 weeks of 20 min/day EMS on left gastrocnemius and sham stimulation on the right gastrocnemius. Multifrequency EIM data and limb girth were obtained before and at the conclusion of the protocol. Muscle weight, in situ force measurements, and muscle fiber histology were also assessed at the conclusion of the study. Results At the time of sacrifice, muscle weight was greater on the EMS-treated side than on the sham-stimulated side (p = 0.018 for wt and p = 0.007 for mdx). Similarly, in wt animals, EIM parameters changed significantly compared to baseline (resistance (p = 0.009), reactance (p = 0.0003) and phase (p = 0.002); these changes were due in part to reductions in the EIM values on the EMS-treated side and elevations on the sham-simulated side. Mdx animals showed analogous but non-significant changes (p = 0.083, p = 0.064, and p = 0.57 for resistance, reactance and phase, respectively). Maximal isometric force trended higher on the stimulated side in wt animals only (p = 0.06). Myofiber sizes in wt animals were also larger on the stimulated side than on the sham-stimulated side (p = 0.034); no significant difference was found in the mdx mice (p = 0.79). Conclusion EIM is sensitive to stimulation-induced muscle alterations in wt animals; similar trends are also present in mdx mice. The mechanisms by which these EIM changes develop, however, remains uncertain. Possible explanations include longer-term trophic effects and shorter-term osmotic effects.	[Li, Jia; Yim, Sung; Pacheck, Adam; Sanchez, Benjamin; Rutkove, Seward B.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Rutkove, SB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	srutkove@bidmc.harvard.edu		Rutkove, Seward/0000-0002-6375-3312	National Institutes of Health [R01 NS055099]; Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded entirely by National Institutes of Health R01 NS055099 and the Spinal Muscular Atrophy Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahad MA, 2009, CLIN NEUROPHYSIOL, V120, P1534, DOI 10.1016/j.clinph.2009.05.017; Bartok C, 2004, J APPL PHYSIOL, V96, P161, DOI 10.1152/japplphysiol.00686.2002; Bezerra P, 2009, MUSCLE NERVE, V40, P430, DOI 10.1002/mus.21329; CABRIC M, 1987, INT J SPORTS MED, V8, P323, DOI 10.1055/s-2008-1025677; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Crameri RM, 2002, SCAND J MED SCI SPOR, V12, P316, DOI 10.1034/j.1600-0838.2002.20106.x; DANGAIN J, 1989, J NEUROL NEUROSUR PS, V52, P1382, DOI 10.1136/jnnp.52.12.1382; Doupe J, 1943, J NEUROL PSYCHIATRY, V6, P136, DOI 10.1136/jnnp.6.3-4.136; FISHER MJ, 1990, INVEST RADIOL, V25, P480, DOI 10.1097/00004424-199005000-00003; FLECKENSTEIN JL, 1993, J APPL PHYSIOL, V74, P2855, DOI 10.1152/jappl.1993.74.6.2855; Gruther W, 2010, J REHABIL MED, V42, P593, DOI 10.2340/16501977-0564; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Herrero JA, 2006, INT J SPORTS MED, V27, P533, DOI 10.1055/s-2005-865845; Hortobagyi T, 1999, MOTOR CONTROL, V3, P205, DOI 10.1123/mcj.3.2.205; Kern H, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00189; Langley JN, 1918, J PHYSIOL-LONDON, V52, P15; Li J, INT C EL IMP GAIN FL; Li John Zenghong, 2012, ISRN Otolaryngol, V2012, P708974, DOI 10.5402/2012/708974; LUTHERT P, 1980, J NEUROL NEUROSUR PS, V43, P803, DOI 10.1136/jnnp.43.9.803; Maffiuletti NA, 2000, INT J SPORTS MED, V21, P437, DOI 10.1055/s-2000-3837; Malatesta D, 2003, J STRENGTH COND RES, V17, P573; Munn J, 2004, J APPL PHYSIOL, V96, P1861, DOI 10.1152/japplphysiol.00541.2003; Narayanaswami P, 2012, MUSCLE NERVE, V46, P257, DOI 10.1002/mus.23307; Ogino M, 2002, AM J PHYS MED REHAB, V81, P446, DOI 10.1097/00002060-200206000-00009; Pacheck A, 2016, CLIN NEUROPHYSIOL, V127, P1886, DOI 10.1016/j.clinph.2015.11.046; PloutzSnyder LL, 1997, MAGNET RESON MED, V37, P676, DOI 10.1002/mrm.1910370509; Pool D, 2016, DEV MED CHILD NEUROL, V58, P492, DOI 10.1111/dmcn.12955; Pratt SJP, 2013, J PHYSIOL-LONDON, V591, P559, DOI 10.1113/jphysiol.2012.241679; Routsi C, 2010, CRIT CARE, V14, DOI 10.1186/cc8987; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Sanchez B, 2014, PHYS MED BIOL, V59, P2369, DOI 10.1088/0031-9155/59/10/2369; Sanchez B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140521; SCOTT OM, 1990, J NEUROL SCI, V95, P171, DOI 10.1016/0022-510X(90)90240-N; SCOTT OM, 1986, J NEUROL NEUROSUR PS, V49, P1427, DOI 10.1136/jnnp.49.12.1427; Singer K P, 1986, Aust J Physiother, V32, P31, DOI 10.1016/S0004-9514(14)60641-3; Song YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052230; VEBER B, 1989, ANESTHESIOLOGY, V70, P684, DOI 10.1097/00000542-198904000-00024; VRBOVA G, 1981, J NEUROL NEUROSUR PS, V44, P1002, DOI 10.1136/jnnp.44.11.1002; Wan Q, 2015, AM J PHYS MED REHABI, P1, DOI 10.1097/PHM; Zhou S, 2000, Exerc Sport Sci Rev, V28, P177; ZUPAN A, 1992, MUSCLE NERVE, V15, P362, DOI 10.1002/mus.880150316	41	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151415	10.1371/journal.pone.0151415	http://dx.doi.org/10.1371/journal.pone.0151415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986564	Green Published, gold			2022-12-27	WOS:000372580300068
J	Miler, K				Miler, Krzysztof			Moribund Ants Do Not Call for Help	PLOS ONE			English	Article							PRECISION RESCUE BEHAVIOR; DIVISION-OF-LABOR; LIFE EXPECTANCY; WORKERS; HYMENOPTERA	When an antlion captures a foraging ant, the victim's nestmates may display rescue behaviour. This study tested the hypothesis that the expression of rescue behaviour depends on the life expectancy of the captured ant. This hypothesis predicts that the expression of rescue behaviour will be less frequent when the captured ant has a lower life expectancy than when it has a higher life expectancy because such a response would be adaptive at the colony level. Indeed, significant differences were found in the frequency of rescue behaviours in response to antlion victims with differing life expectancies. In agreement with prediction, victims with lower life expectancies were rescued less frequently, and those rescues had a longer latency and shorter duration. There was also a qualitative difference in the behaviour of rescuers to victims from the low and high life expectancy groups. Several explanations for these findings are proposed.	[Miler, Krzysztof] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Miler, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	krzysztof.miler@uj.edu.pl	Miler, Krzysztof/CAJ-5113-2022	Miler, Krzysztof/0000-0001-7684-0629	Jagiellonian University [DS/BiNoZ/INoS/761/15]	Jagiellonian University	This research was funded by the Jagiellonian University (grant DS/BiNoZ/INoS/761/15). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beponis LM, 2014, ETHOLOGY, V120, P873, DOI 10.1111/eth.12257; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Czechowski W, 2002, ANN ZOOL, V52, P423; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Hollis KL, 2015, LEARN MOTIV, V50, P68, DOI 10.1016/j.lmot.2014.11.003; Hollis KL, 2013, ANIM BEHAV, V85, P537, DOI 10.1016/j.anbehav.2012.12.005; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; Moron D, 2008, ANIM BEHAV, V75, P345, DOI 10.1016/j.anbehav.2007.06.005; Moron D, 2012, AM NAT, V180, P744, DOI 10.1086/668009; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Nowbahari E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048516; Nowbahari Elise, 2010, Communicative & Integrative Biology, V3, P77; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Robinson EJH, 2009, INSECT SOC, V56, P1, DOI 10.1007/s00040-008-1035-0; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; Taylor K, 2013, EVOL PSYCHOL-US, V11, P665, DOI 10.1177/147470491301100312; Tofilski A, 2002, BEHAV ECOL SOCIOBIOL, V51, P234, DOI [10.1007/s00265-001-0429-z, 10.1007/S00265-001-0429-Z]; Tofilski A, 2009, INSECT SOC, V56, P359, DOI 10.1007/s00040-009-0031-3; Tofilski A, 2008, AM NAT, V172, pE239, DOI 10.1086/591688; Woyciechowski M, 1998, APIDOLOGIE, V29, P191, DOI 10.1051/apido:19980111; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6	22	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151925	10.1371/journal.pone.0151925	http://dx.doi.org/10.1371/journal.pone.0151925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986741	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300153
J	Wong, CM; Poulin, KL; Tong, G; Christou, C; Kennedy, MA; Falls, T; Bell, JC; Parks, RJ				Wong, Carmen M.; Poulin, Kathy L.; Tong, Grace; Christou, Carin; Kennedy, Michael A.; Falls, Theresa; Bell, John C.; Parks, Robin J.			Adenovirus-Mediated Expression of the p14 Fusion-Associated Small Transmembrane Protein Promotes Cancer Cell Fusion and Apoptosis In Vitro but Does Not Provide Therapeutic Efficacy in a Xenograft Mouse Model of Cancer	PLOS ONE			English	Article							FUSOGENIC MEMBRANE GLYCOPROTEIN; VESICULAR STOMATITIS-VIRUS; SYNCYTIUM FORMATION; PORE EXPANSION; GENE-THERAPY; REOVIRUS; VECTORS; RECOMBINATION; REPLICATION; GENERATION	Adenoviruses (Ads) are used in numerous preclinical and clinical studies for delivery of anticancer therapeutic genes. Unfortunately, Ad has a poor ability to distribute throughout a tumor mass after intratumoral injection, and infects cells primarily within the immediate area of the injection tract. Thus, Ad-encoded transgene expression is typically limited to only a small percentage of cells within the tumor. One method to increase the proportion of the tumor impacted by Ad is through expression of fusogenic proteins. Infection of a single cell with an Ad vector encoding a fusogenic protein should lead to syncytium formation with adjacent cells, effectively spreading the effect of Ad and Ad-encoded therapeutic transgenes to a greater percentage of the tumor mass. Moreover, syncytium formation can be cytotoxic, suggesting that such proteins may be effective sole therapeutics. We show that an early region 1 (E1)-deleted Ad expressing reptilian reovirus p14 fusion-associated small transmembrane (FAST) protein caused extensive cell fusion in the replication-permissive 293 cell line and at high multiplicity of infection in non-permissive human lung adenocarcinoma A549 cells in vitro. FAST protein expression in the A549 cancer cell line led to a loss of cellular metabolic activity and membrane integrity, which correlated with induction of apoptosis. However, in an A549 xenograft CD-1 nude mouse cancer model, Ad-mediated FAST gene delivery did not induce detectable cell fusion, reduce tumor burden nor enhance mouse survival compared to controls. Taken together, our results show that, although AdFAST can enhance cancer cell killing in vitro, it is not effective as a sole therapeutic in the A549 tumor model in vivo.	[Wong, Carmen M.; Poulin, Kathy L.; Tong, Grace; Christou, Carin; Kennedy, Michael A.; Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Wong, Carmen M.; Bell, John C.; Parks, Robin J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Parks, Robin J.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Falls, Theresa; Bell, John C.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Bell, John C.; Parks, Robin J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Parks, RJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada.; Parks, RJ (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	rparks@ohri.ca	Falls, Theresa/GWZ-9829-2022; Kennedy, Michael/M-2578-2019; Kennedy, Michael/ABE-6002-2021	Falls, Theresa/0000-0001-5995-9118; 	Canadian Institutes of Health Research (CIHR); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC); Queen Elizabeth II Graduate Scholarship in Science and Technology	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research Society (Canada); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	Research in the Parks laboratory is supported by grants from the Canadian Institutes of Health Research (CIHR), the Cancer Research Society (Canada), and the National Sciences and Engineering Research Council (NSERC). C.M.W. holds the Queen Elizabeth II Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman AR, 2002, CANCER RES, V62, P6566; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; Brown CW, 2009, J VIROL, V83, P552, DOI 10.1128/JVI.01921-08; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Ciechonska M, 2014, J VIROL, V88, P6528, DOI 10.1128/JVI.00314-14; Ciechonska M, 2014, J VIROL, V88, P6137, DOI 10.1128/JVI.00121-14; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Corcoran JA, 2011, J GEN VIROL, V92, P162, DOI 10.1099/vir.0.026013-0; Ebert O, 2004, CANCER RES, V64, P3265, DOI 10.1158/0008-5472.CAN-03-3753; Errington F, 2006, GENE THER, V13, P138, DOI 10.1038/sj.gt.3302609; Fu XP, 2003, MOL THER, V7, P748, DOI 10.1016/S1525-0016(03)00092-3; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Goulet BB, 2013, BIOCHEM CELL BIOL, V91, P252, DOI 10.1139/bcb-2012-0094; GRAHAM FL, 1987, J GEN VIROL, V68, P937, DOI 10.1099/0022-1317-68-3-937; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guedan S, 2012, GENE THER, V19, P1048, DOI 10.1038/gt.2011.184; Heise CC, 1999, CANCER GENE THER, V6, P499, DOI 10.1038/sj.cgt.7700071; Higuchi H, 2000, CANCER RES, V60, P6396; Hoffmann D, 2007, MOL CANCER THER, V6, P1942, DOI 10.1158/1535-7163.MCT-06-0790; Ilkow CS, 2015, NAT MED, V21, P530, DOI 10.1038/nm.3848; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; Le Boeuf F, 2010, MOL THER, V18, P888, DOI 10.1038/mt.2010.44; Li H, 2001, HUM GENE THER, V12, P2155, DOI 10.1089/10430340152710504; Lieber A, 1996, J VIROL, V70, P8944, DOI 10.1128/JVI.70.12.8944-8960.1996; McCart JA, 2001, CANCER RES, V61, P8751; PARKS RJ, 1994, VIRUS RES, V32, P283, DOI 10.1016/0168-1702(94)90078-7; Poulin KL, 2010, J VIROL, V84, P10074, DOI 10.1128/JVI.02665-09; Ross PJ, 2009, COLD SPRING HARB PRO, V2009; Saha B, 2014, VIRUSES-BASEL, V6, P3563, DOI 10.3390/v6093563; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000016; Sargent KL, 2004, J VIROL, V78, P5032, DOI 10.1128/JVI.78.10.5032-5037.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smith E, 2011, HUM GENE THER, V22, P1053, DOI 10.1089/hum.2010.227; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sugimoto J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01462; Top D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000331	40	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151516	10.1371/journal.pone.0151516	http://dx.doi.org/10.1371/journal.pone.0151516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986751	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300081
J	Matsudaira, K; Oka, H; Kikuchi, N; Haga, Y; Sawada, T; Tanaka, S				Matsudaira, Ko; Oka, Hiroyuki; Kikuchi, Norimasa; Haga, Yuri; Sawada, Takayuki; Tanaka, Sakae			Psychometric Properties of the Japanese Version of the STarT Back Tool in Patients with Low Back Pain	PLOS ONE			English	Article							PRIMARY-CARE; SCREENING TOOL; IMPACT BACK; MANAGEMENT	Background and Objective The STarT Back Tool uses prognostic indicators to classify patients with low back pain into three risk groups to guide early secondary prevention in primary care. The present study aimed to evaluate the psychometric properties of the Japanese version of the tool (STarT-J). Methods An online survey was conducted among Japanese patients with low back pain aged 20-64 years. Reliability was assessed by examining the internal consistency of the overall and psychosocial subscales using Cronbach's alpha coefficients. Spearman's correlation coefficients were used to evaluate the concurrent validity between the STarT-J total score/psychosocial subscore and standard reference questionnaires. Discriminant validity was evaluated by calculating the area under the curves (AUCs) for the total and psychosocial subscale scores against standard reference cases. Known-groups validity was assessed by examining the relationship between low back pain-related disability and STarT-J scores. Results The analysis included data for 2000 Japanese patients with low back pain; the mean (standard deviation [SD]) age was 47.7 (9.3) years, and 54.1% were male. The mean (SD) STarT-J score was 2.2 (2.1). The Cronbach's alpha coefficient was 0.75 for the overall scale and 0.66 for the psychosocial subscale. Spearman's correlation coefficients ranged from 0.30 to 0.59, demonstrating moderate to strong concurrent validity. The AUCs for the total score ranged from 0.65 to 0.83, mostly demonstrating acceptable discriminative ability. For known-groups validity, participants with more somatic symptoms had higher total scores. Those in higher STarT-J risk groups had experienced more low back pain-related absences. Conclusions The overall STarT-J scale was internally consistent and had acceptable concurrent, discriminant, and known-groups validity. The STarT-J can be used with Japanese patients with low back pain.	[Matsudaira, Ko; Oka, Hiroyuki] Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr,Bunkyo Ku, Tokyo 113, Japan; [Kikuchi, Norimasa; Haga, Yuri; Sawada, Takayuki] Clin Study Support Inc, Nagoya, Aichi, Japan; [Kikuchi, Norimasa; Sawada, Takayuki] Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi 48011, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Aichi Medical University; University of Tokyo	Matsudaira, K (corresponding author), Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr,Bunkyo Ku, Tokyo 113, Japan.	kohart801@gmail.com	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Clinical Study Support, Inc.	Clinical Study Support, Inc.	The authors received no specific funding for this work. Clinical Study Support, Inc. provided support in the form of salaries for authors NK, YH and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abedi M, MAN THER; Aebischer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132068; [Anonymous], 2013, J MUSCULOSKELET PAIN; Axen I, 2013, BEST PRACT RES CL RH, V27, P601, DOI 10.1016/j.berh.2013.10.004; Azimi P, 2014, J ORTHOP SCI, V19, P213, DOI 10.1007/s00776-013-0506-y; Bruyere O, 2014, SPINE, V39, pE123, DOI 10.1097/BRS.0000000000000062; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Cohen J.E., 1988, STAT POWER ANAL BEHA; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dunn KM, 2013, BEST PRACT RES CL RH, V27, P591, DOI 10.1016/j.berh.2013.09.007; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Foster NE, 2013, BEST PRACT RES CL RH, V27, P649, DOI 10.1016/j.berh.2013.10.005; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hasenbring M, 2001, SCHMERZ, V15, P442, DOI 10.1007/s004820100030; Higashi A, 1996, Nihon Shokakibyo Gakkai Zasshi, V93, P884; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hill JC, 2011, PHYS THER, V91, P712, DOI 10.2522/ptj.20100280; Kikuchi N, J ORTHOP SCI; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Main CJ, 2012, PHYSIOTHERAPY, V98, P110, DOI 10.1016/j.physio.2011.03.003; Matsudaira K., 2013, RINSHO SEIKEIGEKA, V48, P13; Matsudaira K, 2012, SEIKEI GEKA, V63, P149; Matsudaira K, 2014, J ORTHOP SCI, V19, P26, DOI 10.1007/s00776-013-0471-5; Matsuoka H., 2007, SHINSHIN IGAKU, V47, P95, DOI DOI 10.15064/jjpm.47.2_95; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pilz B, 2014, BRAZ J PHYS THER, V18, P453, DOI 10.1590/bjpt-rbf.2014.0028; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pincus T, 2013, BEST PRACT RES CL RH, V27, P625, DOI 10.1016/j.berh.2013.09.010; Sowden G, 2012, FAM PRACT, V29, P50, DOI 10.1093/fampra/cmr037; Suzukamo Y, 2001, QOL EVALUATION HDB C, P8; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	38	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152019	10.1371/journal.pone.0152019	http://dx.doi.org/10.1371/journal.pone.0152019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002823	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400065
J	Aamelfot, M; Christiansen, DH; Dale, OB; McBeath, A; Benestad, SL; Falk, K				Aamelfot, Maria; Christiansen, Debes H.; Dale, Ole Bendik; McBeath, Alastair; Benestad, Sylvie L.; Falk, Knut			Localised Infection of Atlantic Salmon Epithelial Cells by HPR0 Infectious Salmon Anaemia Virus	PLOS ONE			English	Article							TIME RT-PCR; HEMAGGLUTININ GENE; MONOCLONAL-ANTIBODY; ISAV; EXPRESSION; INTERFERON; TRANSCRIPT; RECEPTOR; ENCODES; DISEASE	Infectious salmon anaemia (ISA) is an important, systemic viral disease of farmed Atlantic salmon, Salmo salar L. Endothelial cells are the main target cells for highly virulent HPR-deleted ISA virus (ISAV) types. Here we examine the pathogenesis of non-virulent ISAV HPR0 infections, presenting evidence of an epithelial tropism for this virus type, including actual infection and replication in the epithelial cells. Whereas all HPR0 RT-qPCR positive gills prepared for cryosection tested positive by immunohistochemistry (IHC) and immunofluorescent labelling, only 21% of HPR0 RT-qPCR positive formalin-fixed paraffin-embedded gills were IHC positive, suggesting different methodological sensitivities. Only specific epithelial cell staining was observed and no staining was observed in endothelial cells of positive gills. Furthermore, using an ISAV segment 7 RT-PCR assay, we demonstrated splicing of HPR0, suggesting initial activation of the replication machinery in the epithelial gill cells. Immunological responses were investigated by the expression of interferon-related genes (e.g. Mx and gamma IP) and by ELISA for presence of anti-ISAV antibodies on samples taken sequentially over several months during an episode of transient HPR0 infection. All fish revealed a variable, but increased expression of the immunological markers in comparison to normal healthy fish. Taken together, we conclude that HPR0 causes a localized epithelial infection of Atlantic salmon.	[Aamelfot, Maria; Dale, Ole Bendik; Benestad, Sylvie L.; Falk, Knut] Norwegian Vet Inst, Oslo, Norway; [Christiansen, Debes H.] Food & Vet Author, Torshavn, Faroe Islands, Denmark; [McBeath, Alastair] Dept Agr & Fisheries Scotland, Marine Lab, Marine Scotland Sci, Aberdeen, Scotland	Norwegian Veterinary Institute; Marine Scotland Science (MSS)	Falk, K (corresponding author), Norwegian Vet Inst, Oslo, Norway.	knut.falk@vetinst.no	Dale, Ole Bendik/ABB-6276-2021; Falk, Knut/D-2952-2012	Falk, Knut/0000-0002-9830-3493	Norwegian Research Council [207024]; Norwegian Seafood Research Fund [901051]; European Community; Faroese Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Seafood Research Fund; European Community(European Commission); Faroese Research Council	This work was supported by The Norwegian Research Council (http://www.forskningsradet.no/prognett-havbruk/Forside/1226994216892) HAVBRUK project no. 207024, The Norwegian Seafood Research Fund (http://www.fhf.no) project no. 901051, The European Community's Seventh Framework Programme (FP7, 2007-2013), and The Faroese Research Council (http://www.gransking.fo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2014, J FISH DIS, V37, P291, DOI 10.1111/jfd.12225; Aamelfot M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0265-1; Aamelfot M, 2013, J ANAT, V222, P547, DOI 10.1111/joa.12033; Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Aspehaug V, 2004, VIRUS RES, V106, P51, DOI 10.1016/j.virusres.2004.06.001; Biering E, 2002, DIS AQUAT ORGAN, V49, P117, DOI 10.3354/dao049117; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Cook-Versloot M, 2004, B EUR ASSOC FISH PAT, V24, P203; Cunningham CO, 2002, BULL EUR ASSN FISH P, V22, P366; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Falk K, 1998, DIS AQUAT ORGAN, V34, P77, DOI 10.3354/dao034077; Fourrier M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142020; Hellebo A, 2004, J VIROL, V78, P3055, DOI 10.1128/JVI.78.6.3055-3062.2004; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Lauscher A, 2011, VACCINE, V29, P6392, DOI 10.1016/j.vaccine.2011.04.074; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Lyngstad TM, 2012, DIS AQUAT ORGAN, V101, P197, DOI 10.3354/dao02520; McBeath A, 2015, J FISH DIS, V38, P3, DOI 10.1111/jfd.12253; McBeath AJA, 2007, FISH SHELLFISH IMMUN, V22, P230, DOI 10.1016/j.fsi.2006.05.004; McBeath A, 2013, J VIROL METHODS, V187, P65, DOI 10.1016/j.jviromet.2012.09.007; McBeath AJA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0083-x; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Nylund A, 2003, DIS AQUAT ORGAN, V56, P11, DOI 10.3354/dao056011; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5	29	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151723	10.1371/journal.pone.0151723	http://dx.doi.org/10.1371/journal.pone.0151723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999815	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700058
J	Badenes, SM; Fernandes, TG; Cordeiro, CSM; Boucher, S; Kuninger, D; Vemuri, MC; Diogo, MM; Cabral, JMS				Badenes, Sara M.; Fernandes, Tiago G.; Cordeiro, Claudia S. M.; Boucher, Shayne; Kuninger, David; Vemuri, Mohan C.; Diogo, Maria Margarida; Cabral, Joaquim M. S.			Defined Essential 8 (TM) Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems	PLOS ONE			English	Article							TERM SELF-RENEWAL; SUSPENSION-CULTURE; IPS CELLS; ES CELLS; DIFFERENTIATION; BIOREACTORS; PROPAGATION; DERIVATION; SURFACES; LAMININ	Human induced pluripotent stem (hiPS) cell culture using Essential 8 (TM) xeno-free medium and the defined xeno-free matrix vitronectin was successfully implemented under adherent conditions. This matrix was able to support hiPS cell expansion either in coated plates or on polystyrene-coated microcarriers, while maintaining hiPS cell functionality and pluripotency. Importantly, scale-up of the microcarrier-based system was accomplished using a 50 mL spinner flask, under dynamic conditions. A three-level factorial design experiment was performed to identify optimal conditions in terms of a) initial cell density b) agitation speed, and c) to maximize cell yield in spinner flask cultures. A maximum cell yield of 3.5 is achieved by inoculating 55,000 cells/cm(2) of microcarrier surface area and using 44 rpm, which generates a cell density of 1.4x10(6) cells/mL after 10 days of culture. After dynamic culture, hiPS cells maintained their typical morphology upon re-plating, exhibited pluripotency-associated marker expression as well as tri-lineage differentiation capability, which was verified by inducing their spontaneous differentiation through embryoid body formation, and subsequent downstream differentiation to specific lineages such as neural and cardiac fates was successfully accomplished. In conclusion, a scalable, robust and cost-effective xeno-free culture system was successfully developed and implemented for the scale-up production of hiPS cells.	[Badenes, Sara M.; Fernandes, Tiago G.; Cordeiro, Claudia S. M.] Univ Lisbon, Dept Bioengn, P-1699 Lisbon, Portugal; [Badenes, Sara M.; Fernandes, Tiago G.; Cordeiro, Claudia S. M.] Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, P-1699 Lisbon, Portugal; [Boucher, Shayne; Kuninger, David; Vemuri, Mohan C.; Diogo, Maria Margarida; Cabral, Joaquim M. S.] Thermo Fisher Sci, Life Sci Solut, Cell Biol, Frederick, MD USA	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Thermo Fisher Scientific	Fernandes, TG (corresponding author), Univ Lisbon, Dept Bioengn, P-1699 Lisbon, Portugal.; Fernandes, TG (corresponding author), Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, P-1699 Lisbon, Portugal.	tfernandes@tecnico.ulisboa.pt	Cabral, Joaquim M S/G-2052-2010; Diogo, Margarida/ABF-4341-2020; Fernandes, Tiago G./C-3865-2009; Badenes, Sara/F-6897-2014	Cabral, Joaquim M S/0000-0002-2405-5845; Fernandes, Tiago G./0000-0002-4651-2832; Badenes, Sara/0000-0001-6507-536X; Diogo, Maria Margarida/0000-0002-6270-4455	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [SFRH/BPD/74449/2010, SFRH/BPD/86316/2012]; FCT [UID/BIO/04565/2013, MITP-TB/ECE/0013/2013]	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Sara M. Badenes and Tiago G. Fernandes acknowledge Fundacao para a Ciencia e Tecnologia (FCT, Portugal, http://www.fct.pt) for financial support (SFRH/BPD/74449/2010, SFRH/BPD/86316/2012, respectively). Funding was received by iBB - Institute for Bioengineering and Biosciences (UID/BIO/04565/2013) from FCT. This work was also partially funded by FCT through project CARDIOSTEM-Engineered cardiac tissues and stem cell-based therapies for cardiovascular applications (MITP-TB/ECE/0013/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Badenes Sara M, 2015, Methods Mol Biol, V1283, P23, DOI 10.1007/7651_2014_106; Barbosa HSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038963; Bardy J, 2013, TISSUE ENG PART C-ME, V19, P166, DOI [10.1089/ten.TEC.2012.0146, 10.1089/ten.tec.2012.0146]; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Carlson J, 2008, J AM ASSOC LAB ANIM, V47, P80; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen AKL, 2011, STEM CELL RES, V7, P97, DOI 10.1016/j.scr.2011.04.007; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen VC, 2012, STEM CELL RES, V8, P388, DOI 10.1016/j.scr.2012.02.001; Cormier JT, 2006, TISSUE ENG, V12, P3233, DOI 10.1089/ten.2006.12.3233; Fan YJ, 2015, STEM CELL REV REP, V11, P96, DOI 10.1007/s12015-014-9544-x; Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007; Heng BC, 2012, STEM CELLS DEV, V21, P1701, DOI 10.1089/scd.2011.0509; Hunt MM, 2014, TISSUE ENG PART C-ME, V20, P76, DOI [10.1089/ten.TEC.2013.0040, 10.1089/ten.tec.2013.0040]; Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880; Jing DH, 2010, CELL TRANSPLANT, V19, P1397, DOI 10.3727/096368910X513955; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Lam ATL, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt498; Lambshead Jack W, 2013, Cell Regen, V2, P7, DOI 10.1186/2045-9769-2-7; Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110; Li JA, 2010, BIOINTERPHASES, V5, pFA132, DOI 10.1116/1.3525804; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Marinho PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09834; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Miranda CC, 2015, BIOTECHNOL J, V10, P1612, DOI 10.1002/biot.201400846; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Nagata S., 1975, MIXING PRINCIPLES AP, P24; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Marinho PAN, 2013, TISSUE ENG PART C-ME, V19, P146, DOI [10.1089/ten.tec.2012.0141, 10.1089/ten.TEC.2012.0141]; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009; Serra M, 2011, PLOS ONE, V6; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; STATHOPOULOS NA, 1985, BIOTECHNOL BIOENG, V27, P1021, DOI 10.1002/bit.260270713; Storm MP, 2010, BIOTECHNOL BIOENG, V107, P683, DOI 10.1002/bit.22850; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2013, STEM CELL RES, V11, P1103, DOI 10.1016/j.scr.2013.07.011; Want AJ, 2012, REGEN MED, V7, P71, DOI [10.2217/RME.11.101, 10.2217/rme.11.101]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yamasaki S, 2014, PLOS ONE, V9	48	43	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151264	10.1371/journal.pone.0151264	http://dx.doi.org/10.1371/journal.pone.0151264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999816	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700028
J	Dawood, F; Loo, CK				Dawood, Farhan; Loo, Chu Kiong			View-Invariant Visuomotor Processing in Computational Mirror Neuron System for Humanoid	PLOS ONE			English	Article							SELF; IMITATION; MOTOR; ORGANIZATION; REPRESENTATIONS; RECOGNITION; PERCEPTION	Mirror neurons are visuo-motor neurons found in primates and thought to be significant for imitation learning. The proposition that mirror neurons result from associative learning while the neonate observes his own actions has received noteworthy empirical support. Selfexploration is regarded as a procedure by which infants become perceptually observant to their own body and engage in a perceptual communication with themselves. We assume that crude sense of self is the prerequisite for social interaction. However, the contribution of mirror neurons in encoding the perspective from which the motor acts of others are seen have not been addressed in relation to humanoid robots. In this paper we present a computational model for development of mirror neuron system for humanoid based on the hypothesis that infants acquire MNS by sensorimotor associative learning through self-exploration capable of sustaining early imitation skills. The purpose of our proposed model is to take into account the view-dependency of neurons as a probable outcome of the associative connectivity between motor and visual information. In our experiment, a humanoid robot stands in front of a mirror (represented through self-image using camera) in order to obtain the associative relationship between his own motor generated actions and his own visual body-image. In the learning process the network first forms mapping from each motor representation onto visual representation from the self-exploratory perspective. Afterwards, the representation of the motor commands is learned to be associated with all possible visual perspectives. The complete architecture was evaluated by simulation experiments performed on DARwIn-OP humanoid robot.	[Dawood, Farhan; Loo, Chu Kiong] Univ Malaya, Dept Artificial Intelligence, Kuala Lumpur, Malaysia	Universiti Malaya	Loo, CK (corresponding author), Univ Malaya, Dept Artificial Intelligence, Kuala Lumpur, Malaysia.	ckloo.um@um.edu.my	Loo, Chu Kiong/AAI-5093-2021; Dawood, Farhan/G-9105-2011; Loo, Chu Kiong/F-4360-2011	Loo, Chu Kiong/0000-0001-7867-2665; Dawood, Farhan/0000-0002-6968-1671; Loo, Chu Kiong/0000-0001-7867-2665	High Impact Research MoE from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/FCSIT/10]	High Impact Research MoE from the Ministry of Education Malaysia	This research is supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/FCSIT/10 from the Ministry of Education Malaysia.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; [Anonymous], [No title captured]; Arbib M. A., 2006, P 6 INT C EV LANG, P3; Arbib Michael A., 2008, MIND SOC, V7, P43, DOI DOI 10.1007/S11299-007-0041-7; ASCHERSLEBEN G, 2006, PSYCHOL SCI, V48, P405, DOI DOI 10.1111/J.1467-7687.2008.00736.X; BAHRICK LE, 1985, DEV PSYCHOL, V21, P963, DOI 10.1037/0012-1649.21.6.963; Barakova EI, 2007, LECT NOTES COMPUT SC, V4528, P389; Bekoff M, 2004, TRENDS ECOL EVOL, V19, P176, DOI 10.1016/j.tree.2003.12.010; Billard A., 2008, SPRINGER HDB ROBOTIC, P1371, DOI DOI 10.1007/978-3-540-30301-5_60; Bonaiuto J, 2010, BIOL CYBERN, V102, P341, DOI 10.1007/s00422-010-0371-0; Brand M, 2002, LECT NOTES COMPUT SC, V2350, P707; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Carlin JD, 2011, CURR BIOL, V21, P1817, DOI 10.1016/j.cub.2011.09.025; Carpenter G. A., 2010, ADAPTIVE RESONANCE T; Chaminade T, 2008, BRAIN RES BULL, V75, P775, DOI 10.1016/j.brainresbull.2008.01.016; Chersi F, 2012, IEEE T AUTON MENT DE, V4, P204, DOI 10.1109/TAMD.2012.2200250; Chin TJ, 2007, IEEE T IMAGE PROCESS, V16, P1662, DOI 10.1109/TIP.2007.896668; Cook R, 2014, BEHAV BRAIN SCI, V37, P177, DOI 10.1017/S0140525X13000903; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Craigherol L, 2007, PROG BRAIN RES, V164, P39, DOI 10.1016/S0079-6123(07)64003-5; Cuijpers RH, 2006, NEURAL NETWORKS, V19, P311, DOI 10.1016/j.neunet.2006.02.004; Dawood F, 2014, ROB INT INF STRUCT S, P1; Dawood F., 2013, NEUR NETW IJCNN 2013, P1; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franzius M, 2007, PLOS COMPUT BIOL, V3, P1605, DOI 10.1371/journal.pcbi.0030166; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gold K, 2009, ROBOT AUTON SYST, V57, P384, DOI 10.1016/j.robot.2008.07.006; Goodale M.A., 1990, VISION ACTION CONTRO, P163; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C.M., 2007, SENSORIMOTOR FDN HIG; Jellema T, 2006, NEUROPSYCHOLOGIA, V44, P1535, DOI 10.1016/j.neuropsychologia.2006.01.020; Keysers C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0175; Kulic Dana, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P3166, DOI 10.1109/ROBOT.2009.5152266; Kuniyoshi Y, 2003, IEEE INT CONF ROBOT, P3132; Levy A, 2000, IEEE T IMAGE PROCESS, V9, P1371, DOI 10.1109/83.855432; LEWIS M, 1989, CHILD DEV, V60, P146, DOI 10.1111/j.1467-8624.1989.tb02704.x; Liwicki S., 2012, P AS C COMP VIS, P162; Liwicki S, 2012, IEEE T NEUR NET LEAR, V23, P1624, DOI 10.1109/TNNLS.2012.2208654; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Marshall PJ, 2015, TRENDS COGN SCI, V19, P499, DOI 10.1016/j.tics.2015.06.012; Meier F, 2012, P 15 INT C ART INT S; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Nagai Y., 2011, P 2011 IEEE INT C DE, V2, P1, DOI [DOI 10.1109/DEVLRN.2011.6037335, 10.1109/DEVLRN.2011.6037335]; Nelissen K, 2011, J NEUROSCI, V31, P3743, DOI 10.1523/JNEUROSCI.4803-10.2011; Nicolescu M. N., 2003, PROC 2 INT JOINT C A, P241, DOI DOI 10.1145/860575.860614; Oztop E, 2002, BIOL CYBERN, V87, P116, DOI 10.1007/s00422-002-0318-1; Oztop E, 2006, NEURAL NETWORKS, V19, P254, DOI 10.1016/j.neunet.2006.02.002; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; Pfeifer R., 2006, BODY SHAPES WAY WE T; Piaget J., 2013, PLAY DREAMS IMITATIO, V25; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rizzolatti, 2005, MONKEY BRAIN HUMAN B, P213; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rochat P, 1998, BRIT J DEV PSYCHOL, V16, P139, DOI 10.1111/j.2044-835X.1998.tb00914.x; Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Saegusa R, 2014, IEEE T NEUR NET LEAR, V25, P183, DOI 10.1109/TNNLS.2013.2271793; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Slater A, 1998, EXP BRAIN RES, V123, P90, DOI 10.1007/s002210050548; Tani J, 2004, NEURAL NETWORKS, V17, P1273, DOI 10.1016/j.neunet.2004.05.007; Tessitore G, 2010, BIOL CYBERN, V103, P471, DOI 10.1007/s00422-010-0415-5; Thill S, 2011, COGN COMPUT, V3, P525, DOI 10.1007/s12559-011-9108-1; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; von Hofsten C, 2004, TRENDS COGN SCI, V8, P266, DOI 10.1016/j.tics.2004.04.002; Webots, COMM MOB ROB SIM SOF; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938	75	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152003	10.1371/journal.pone.0152003	http://dx.doi.org/10.1371/journal.pone.0152003			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998923	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700092
J	Lee, M; Ahn, J				Lee, Marvin; Ahn, Jaehong			Effects of Central Corneal Stromal Thickness and Epithelial Thickness on Intraocular Pressure Using Goldmann Applanation and Non-Contact Tonometers	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OCULAR HYPERTENSION; GLAUCOMA; AGE; REDUCTION; TRIAL	Purpose To investigate whether corneal thickness parameters measured by optical coherence tomography (OCT), such as central corneal thickness (CCT), central corneal stromal thickness (CCST), and central corneal epithelial thickness (CCET), influence the intraocular pressure (IOP) difference measured by Goldmann applanation tonometry (GAT) and non-contact tonometry (NCT). Methods In total, 50 eyes from 50 subjects without glaucomatous defects were included in this retrospective, cross-sectional study. We measured IOP using GAT and NCT and calculated the difference between the two methods. CCT was measured by a Cirrus HD-OCT device using anterior segment imaging. The basement membrane of the epithelium, which was seen as a high-reflection line in the OCT image, was taken as a reference line to measure CCST and CCET. Results The mean IOP measured by GAT and NCT was 16.7 +/- 3.0 and 18.1 +/- 3.8 mmHg, respectively. The mean IOP difference was 1.5 +/- 1.7 mmHg, and the IOP measured by NCT was 8.4% +/- 11.3% higher than that measured by GAT. The CCET and CCST were 57.9 +/- 5.6 and 501.7 +/- 33.8 mu m, respectively. CCT showed a positive correlation with both GAT IOP (r = 0.648, P < 0.001) and NCT IOP (r = 0.676, P < 0.001). Although CCST showed a significant correlation with GAT IOP and NCT IOP, CCET did not. The difference between GAT IOP and NCT IOP increased with CCT (r = 0.333, P = 0.018), and CCET was positively correlated with the IOP difference between GAT and NCT (r = 0.435, P = 0.002). Conclusions IOP increased with greater CCT, and CCST seemed to have a more important role than CCET. CCET also increased with greater CCT, and this may be a possible explanation for the increasing difference in IOP between GAT and NCT with increasing CCT.	[Lee, Marvin] DMC Bundang Jesaeng Gen Hosp, Dept Ophthalmol, Songnam, South Korea; [Ahn, Jaehong] Ajou Univ, Sch Med, Dept Ophthalmol, Suwon 441749, South Korea	Ajou University	Lee, M (corresponding author), DMC Bundang Jesaeng Gen Hosp, Dept Ophthalmol, Songnam, South Korea.	mvejhw@dmc.or.kr						Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Argus WA, 1995, OPHTHALMOLOGY, V102, P1810, DOI 10.1016/S0161-6420(95)30790-7; Broman AT, 2007, J GLAUCOMA, V16, P581, DOI 10.1097/IJG.0b013e3180640f40; Calabuig-Goena M, 2015, CURRENT EYE RES, P1; Desai SP, 2002, EYE, V16, P675, DOI 10.1038/sj.eye.6700129; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; GOLDMANN H, 1957, Ophthalmologica, V134, P221; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kuerten D, 2015, GRAEF ARCH CLIN EXP, V253, P1105, DOI 10.1007/s00417-015-2998-y; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; MOSELEY MJ, 1989, EYE, V3, P332, DOI 10.1038/eye.1989.48; Moseley MJ, 1993, EYE LOND 1, V7, P127; Nam SM, 2010, OPHTHALMOLOGY, V117, P2096, DOI 10.1016/j.ophtha.2010.03.002; Nomura H, 2002, CURR EYE RES, V24, P81, DOI 10.1076/ceyr.24.2.81.8161; Randleman JB, 2003, OPHTHALMOLOGY, V110, P267, DOI 10.1016/S0161-6420(02)01727-X; Regine F, 2006, OPHTHAL PHYSL OPT, V26, P33, DOI 10.1111/j.1475-1313.2005.00341.x; Stelzer R, 1973, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V189, P33, DOI 10.1007/BF00411123; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Yang YJ, 2014, INVEST OPHTH VIS SCI, V55, P5032, DOI 10.1167/iovs.13-13831; Zhang Yang, 2009, Zhonghua Yan Ke Za Zhi, V45, P713	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151868	10.1371/journal.pone.0151868	http://dx.doi.org/10.1371/journal.pone.0151868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998838	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700076
J	Lix, LM; Wu, XY; Hopman, W; Mayo, N; Sajobi, TT; Liu, JX; Prior, JC; Papaioannou, A; Josse, RG; Towheed, TE; Davison, KS; Sawatzky, R				Lix, Lisa M.; Wu, Xiuyun; Hopman, Wilma; Mayo, Nancy; Sajobi, Tolulope T.; Liu, Juxin; Prior, Jerilynn C.; Papaioannou, Alexandra; Josse, Robert G.; Towheed, Tanveer E.; Davison, K. Shawn; Sawatzky, Richard			Differential Item Functioning in the SF-36 Physical Functioning and Mental Health Sub-Scales: A Population-Based Investigation in the Canadian Multicentre Osteoporosis Study	PLOS ONE			English	Article							SCALING ASSUMPTIONS; DATA QUALITY; MIMIC-MODEL; TESTS; VALIDATION; RELIABILITY; VALIDITY; CAMOS	Background Self-reported health status measures, like the Short Form 36-item Health Survey (SF-36), can provide rich information about the overall health of a population and its components, such as physical, mental, and social health. However, differential item functioning (DIF), which arises when population sub-groups with the same underlying (i.e., latent) level of health have different measured item response probabilities, may compromise the comparability of these measures. The purpose of this study was to test for DIF on the SF-36 physical functioning (PF) and mental health (MH) sub-scale items in a Canadian population-based sample. Methods Study data were from the prospective Canadian Multicentre Osteoporosis Study (CaMos), which collected baseline data in 1996-1997. DIF was tested using a multiple indicators multiple causes (MIMIC) method. Confirmatory factor analysis defined the latent variable measurement model for the item responses and latent variable regression with demographic and health status covariates (i.e., sex, age group, body weight, self-perceived general health) produced estimates of the magnitude of DIF effects. Results The CaMos cohort consisted of 9423 respondents; 69.4% were female and 51.7% were less than 65 years. Eight of 10 items on the PF sub-scale and four of five items on the MH sub-scale exhibited DIF. Large DIF effects were observed on PF sub-scale items about vigorous and moderate activities, lifting and carrying groceries, walking one block, and bathing or dressing. On the MH sub-scale items, all DIF effects were small or moderate in size. Conclusions SF-36 PF and MH sub-scale scores were not comparable across population sub-groups defined by demographic and health status variables due to the effects of DIF, although the magnitude of this bias was not large for most items. We recommend testing and adjusting for DIF to ensure comparability of the SF-36 in population-based investigations.	[Lix, Lisa M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Wu, Xiuyun] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada; [Hopman, Wilma] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Mayo, Nancy] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada; [Sajobi, Tolulope T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Sajobi, Tolulope T.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Liu, Juxin] Univ Saskatchewan, Dept Math & Stat, Saskatoon, SK, Canada; [Prior, Jerilynn C.] Univ British Columbia, Med & Endocrinol, Vancouver, BC V5Z 1M9, Canada; [Papaioannou, Alexandra] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Josse, Robert G.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Towheed, Tanveer E.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Davison, K. Shawn] Univ Victoria, Fac Grad Studies, Victoria, BC, Canada; [Sawatzky, Richard] Trinity Western Univ, Sch Nursing, Langley, BC, Canada; [Sawatzky, Richard] Providence Hlth Care, Ctr Hlth Evaluat & Outcomes Sci, Langley, BC, Canada	University of Manitoba; Dalhousie University; Queens University - Canada; McGill University; University of Calgary; University of Calgary; University of Saskatchewan; University of British Columbia; McMaster University; University of Toronto; Queens University - Canada; University of Victoria; Trinity Western University	Lix, LM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada.	lisa.lix@umanitoba.ca	Sawatzky, Richard/C-5470-2009	Sawatzky, Richard/0000-0002-8042-190X; Liu, Juxin/0000-0001-6631-932X; Sajobi, Tolulope/0000-0002-5696-5552; Wu, Xiu Yun/0000-0001-6612-8259	Canadian Institutes of Health Research [122110]; Manitoba Research Chair - Research Manitoba; Dairy Farmers of Canada; Merck Canada; Eli Lilly Canada; Novartis Canada; Amgen Canada Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Research Chair - Research Manitoba; Dairy Farmers of Canada; Merck Canada(Merck & Company); Eli Lilly Canada(Eli Lilly); Novartis Canada(Novartis); Amgen Canada Inc.(Amgen)	This work was supported by funding from the Canadian Institutes of Health Research (Funding Reference #122110; website http://www.cihr-irsc.gc.ca/e/193.html) to LML. LML receives salary support from a Manitoba Research Chair funded by Research Manitoba (http://researchmanitoba.ca/). CaMos is currently supported by the Canadian Institutes of Health Research (website http://www.cihr-irsc.gc.ca/e/193.html) Amgen Canada Inc. (website www.amgen.ca), Dairy Farmers of Canada (website http://www.dairyfarmers.ca/), Merck Canada (website www.merck.ca), Eli Lilly Canada (website www.lily.ca), and Novartis Canada (website www.novartis.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052028; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1189, DOI 10.1016/S0895-4356(98)00111-5; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cole SR, 2000, J CLIN EPIDEMIOL, V53, P285, DOI 10.1016/S0895-4356(99)00151-1; Crins MHP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134094; Finch H, 2005, APPL PSYCH MEAS, V29, P278, DOI 10.1177/0146621605275728; Fleishman JA, 2003, MED CARE, V41, P75, DOI 10.1097/01.MLR.0000076052.42628.CF; Fleishman JA, 2002, J GERONTOL B-PSYCHOL, V57, pS275, DOI 10.1093/geronb/57.5.S275; Hays RD, 2007, MED CARE, V45, pS32, DOI 10.1097/01.mlr.0000246649.43232.82; Health Canada, 2013, CANADIAN GUIDELINES, V4645; Hopman WM, 2007, QUAL LIFE RES, V16, P1595, DOI 10.1007/s11136-007-9273-6; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jin Y, 2013, EDUC PSYCHOL MEAS, V73, P339, DOI 10.1177/0013164412462705; Kamata A, 2008, STRUCT EQU MODELING, V15, P136, DOI 10.1080/10705510701758406; Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934; Lix LM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-29; Lord F.M., 1980, APPL ITEM RESPONSE T; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1995, MED CARE, V33, P15, DOI 10.1097/00005650-199501000-00002; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Perkins AJ, 2006, QUAL LIFE RES, V15, P331, DOI 10.1007/s11136-005-1551-6; Pollard B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-346; Samejima F, 1969, PSYCHOMETRIKA, V17; SAS Institute Inc, 2013, SAS STAT 9 3 US GUID; Sawatzky R, 2012, QUAL LIFE RES, V21, P637, DOI 10.1007/s11136-011-9976-6; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Teresi JA, 2007, QUAL LIFE RES, V16, P33, DOI 10.1007/s11136-007-9184-6; Teresi JA, 2007, QUAL LIFE RES, V16, P43, DOI 10.1007/s11136-007-9186-4; Wang WC, 2012, EDUC PSYCHOL MEAS, V72, P687, DOI 10.1177/0013164411426157; Wang WC, 2009, EDUC PSYCHOL MEAS, V69, P713, DOI 10.1177/0013164409332228; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson EK, 1996, AUST NZ J PUBL HEAL, V20, P359, DOI 10.1111/j.1467-842X.1996.tb01046.x; Woods CM, 2011, APPL PSYCH MEAS, V35, P339, DOI 10.1177/0146621611405984; Woods CM, 2009, J PSYCHOPATHOL BEHAV, V31, P320, DOI 10.1007/s10862-008-9118-9; Woods CM, 2009, APPL PSYCH MEAS, V33, P42, DOI 10.1177/0146621607314044; Woods CM, 2009, MULTIVAR BEHAV RES, V44, P1, DOI 10.1080/00273170802620121; Yu YF, 2007, MED CARE, V45, P851, DOI 10.1097/MLR.0b013e318074ce4c; Zumbo BD, 1999, HDB THEORY METHODS D	43	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151519	10.1371/journal.pone.0151519	http://dx.doi.org/10.1371/journal.pone.0151519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26998611	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700044
J	Tang, HJ; Hsieh, CF; Chang, PC; Chen, JJ; Lin, YH; Lai, CC; Chao, CM; Chuang, YC				Tang, Hung-Jen; Hsieh, Cheng-Fang; Chang, Ping-Chin; Chen, Jyh-Jou; Lin, Yu-Hsiu; Lai, Chih-Cheng; Chao, Chien-Ming; Chuang, Yin-Ching			Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates	PLOS ONE			English	Article							NONSUSCEPTIBLE KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; UNITED-STATES; RISK-FACTORS; EPIDEMIOLOGY; TAIWAN; INFECTIONS; MULTICENTER; BACTEREMIA; PREVENTION	This study was conducted to investigate the clinical significance, manifestations, microbiological characteristics and outcomes of carbapenem-resistant Enterobacteriaceae (wCRE) isolates, and compare the clinical features of community-and healthcare-acquired CRE isolates. A total of 78 patients were identified to have CRE. Klebsiella pneumoniae was the most common pathogens (n = 42, 53.8%), followed by Enterobacter cloacae (n = 24, 30.8%), and Escherichia coli (n = 11, 14.1%). Most of the patients acquired CRE from healthcare settings (n = 55, 70.5%), and other cases got CRE from community settings (n = 23, 29.5%). Nine cases (11.5%) were classified as CRE colonization. Among the remaining 69 cases of CRE infections, pneumonia (n = 28, 40.6%) was the most common type of infections, followed by urinary tract infection (n = 24, 34.8%), and intra-abdominal infection (n = 16, 23.2%). The patients acquired CRE from community settings were more likely to be elderly, female, and had more urinary tract infections than from healthcare settings. In contrast, the patients acquired CRE from healthcare settings had more intra-abdominal infections, intra-abdominal surgery, and presence of indwelling device than from community settings. In conclusion, community-acquired CRE are not rare, and their associated clinical presentations are different from healthcare-acquired CRE.	[Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Hsieh, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Kaohsiung, Taiwan; [Hsieh, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Ping-Chin; Chen, Jyh-Jou; Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Yu-Hsiu] Chi Mei Med Ctr, Comm Infect Control, Tainan, Taiwan; [Lai, Chih-Cheng; Chao, Chien-Ming] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chao, Chien-Ming] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital	Chao, CM (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.; Chao, CM (corresponding author), Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan.	ccm870958@yahoo.com.tw	Hsieh, Cheng-Fang/AAD-6950-2019	Hsieh, Cheng-Fang/0000-0002-9101-0233				Bhargava A, 2014, INFECT CONT HOSP EP, V35, P398, DOI 10.1086/675614; Chang YY, 2015, J MICROBIOL IMMUNOL, V48, P219, DOI 10.1016/j.jmii.2014.05.010; CLSI, 2012, M100S22 CLSI; CLSI, 2018, METHODS DILUTION ANT; Freeman R, 2015, J ANTIMICROB CHEMOTH, V70, P1212, DOI 10.1093/jac/dku500; Guh AY, 2014, EXPERT REV ANTI-INFE, V12, P565, DOI 10.1586/14787210.2014.902306; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Kritsotakis EI, 2011, J ANTIMICROB CHEMOTH, V66, P1383, DOI 10.1093/jac/dkr116; Lai CC, 2013, J FORMOS MED ASSOC, V112, P492, DOI 10.1016/j.jfma.2012.09.021; Lazarovitch T, 2015, INFECT CONT HOSP EP, V36, P1283, DOI 10.1017/ice.2015.186; Lee CH, 2010, ANTIMICROB AGENTS CH, V54, P5395, DOI 10.1128/AAC.00083-10; Lee GC, 2013, ANN PHARMACOTHER, V47, P1115, DOI 10.1177/1060028013503120; Ling ML, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0066-3; Liu SW, 2012, J MICROBIOL IMMUNOL, V45, P113, DOI 10.1016/j.jmii.2011.09.026; Liu YF, 2008, J ANTIMICROB CHEMOTH, V61, P1020, DOI 10.1093/jac/dkn049; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Patel N, 2011, J ANTIMICROB CHEMOTH, V66, P1600, DOI 10.1093/jac/dkr156; Schechner V, 2011, INFECT CONT HOSP EP, V32, P497, DOI 10.1086/659762; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Tan CK, 2010, J INFECTION, V61, P34, DOI 10.1016/j.jinf.2010.04.007; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Thaden JT, 2014, INFECT CONT HOSP EP, V35, P978, DOI 10.1086/677157; Wang JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121668; Xu YL, 2015, J THORAC DIS, V7, P376, DOI 10.3978/j.issn.2072-1439.2014.12.33; Yamamoto M, 2014, CRIT CARE, V18, DOI 10.1186/cc13949; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11	26	32	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151897	10.1371/journal.pone.0151897	http://dx.doi.org/10.1371/journal.pone.0151897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999356	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700081
J	Trachsel, S; Sun, DP; SanVicente, FM; Zheng, HJ; Atlin, GN; Suarez, EA; Babu, R; Zhang, XC				Trachsel, Samuel; Sun, Dapeng; SanVicente, Felix M.; Zheng, Hongjian; Atlin, Gary N.; Suarez, Edgar Antonio; Babu, Raman; Zhang, Xuecai			Identification of QTL for Early Vigor and Stay-Green Conferring Tolerance to Drought in Two Connected Advanced Backcross Populations in Tropical Maize (Zea mays L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ANTHESIS-SILKING INTERVAL; GRAIN-YIELD; SECONDARY TRAITS; 8 CYCLES; STRESS; SELECTION; NITROGEN; IMPROVEMENT; ENVIRONMENTS	We aimed to identify quantitative trait loci (QTL) for secondary traits related to grain yield (GY) in two BC1F2:3 backcross populations (LPSpop and DTPpop) under well-watered (4 environments; WW) and drought stressed (6; DS) conditions to facilitate breeding efforts towards drought tolerant maize. GY reached 5.6 and 5.8 t/ha underWWin the LPSpop and the DTPpop, respectively. Under DS, grain yield was reduced by 65% (LPSpop) to 59% (DTPpop) relative to WW. GY was strongly associated with the normalized vegetative index (NDVI; r ranging from 0.61 to 0.96) across environmental conditions and with an early flowering under drought stressed conditions (r ranging from -0.18 to -0.25) indicative of the importance of early vigor and drought escape for GY. Out of the 105 detected QTL, 53 were overdominant indicative of strong heterosis. For 14 out of 18 detected vigor QTL, as well as for eight flowering time QTL the trait increasing allele was derived from CML491. Collocations of early vigor QTL with QTL for stay green (bin 2.02, WW, LPSpop; 2.07, DS, DTPpop), the number of ears per plant (bins 2.02, 2.05, WW, LPSpop; 5.02, DS, LPSpop) and GY (bin 2.07, WW, DTPpop; 5.04, WW, LPSpop), reinforce the importance of the observed correlations. LOD scores for early vigor QTL in these bins ranged from 2.2 to 11.25 explaining 4.6 (additivity: +0.28) to 19.9% (additivity: +0.49) of the observed phenotypic variance. A strong flowering QTL was detected in bin 2.06 across populations and environmental conditions explaining 26-31.3% of the observed phenotypic variation (LOD: 13-17; additivity: 0.1-0.6d). Improving drought tolerance while at the same time maintaining yield potential could be achieved by combining alleles conferring early vigor from the recurrent parent with alleles advancing flowering from the donor. Additionally bin 8.06 (DTPpop) harbored a QTL for GY under WW(additivity: 0.27 t/ha) and DS (additivity: 0.58 t/ha). R-2 ranged from 0 (DTPpop, WW) to 26.54% (LPSpop, DS) for NDVI, 18.6 (LPSpop, WW) to 42.45% (LPSpop, DS) for anthesis and from 0 (DTPpop, DS) to 24.83% (LPSpop, WW) for GY. Lines out-yielding the best check by 32.5% (DTPpop, WW) to 60% (DTPpop, DS) for all population-by-irrigation treatment combination (except LPSpop, WW) identified are immediately available for the use by breeders.	[Trachsel, Samuel; SanVicente, Felix M.; Atlin, Gary N.; Suarez, Edgar Antonio; Zhang, Xuecai] CIMMYT, Int Maize & Wheat Improvement Ctr, Int Apdo Postal 6-641, Mexico City 06600, DF, Mexico; [Babu, Raman] CIMMYT, ICRISAT Campus, Hyderabad 502324, Andhra Pradesh, India; [Sun, Dapeng; Zheng, Hongjian] SAAS, Shanghai 201106, Peoples R China	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Trachsel, S (corresponding author), CIMMYT, Int Maize & Wheat Improvement Ctr, Int Apdo Postal 6-641, Mexico City 06600, DF, Mexico.	s.trachsel@cgiar.org		ZHANG, XUECAI/0000-0001-5498-6387	CGIAR research program on climate change, agriculture and food security (CCAFS)	CGIAR research program on climate change, agriculture and food security (CCAFS)	This study was funded by the CGIAR research program on climate change, agriculture and food security (CCAFS).	Almeida GD, 2014, MOL BREEDING, V34, P701, DOI 10.1007/s11032-014-0068-5; Almeida GD, 2013, THEOR APPL GENET, V126, P583, DOI 10.1007/s00122-012-2003-7; Araus JL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00305; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Babu R, 2005, THEOR APPL GENET, V111, P888, DOI 10.1007/s00122-005-0011-6; Banziger M, 2002, FIELD CROP RES, V75, P223, DOI 10.1016/S0378-4290(02)00028-X; Banziger M., 2000, BREEDING DROUGHT NIT; Betran FJ, 2003, FIELD CROP RES, V83, P51, DOI 10.1016/S0378-4290(03)00061-3; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; BOLANOS J, 1993, FIELD CROP RES, V31, P253, DOI 10.1016/0378-4290(93)90065-U; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borrell A, 2001, ANN APPL BIOL, V138, P91, DOI 10.1111/j.1744-7348.2001.tb00088.x; Borrell AK, 2000, CROP SCI, V40, P1295, DOI 10.2135/cropsci2000.4051295x; Cai HG, 2012, PLANT BREEDING, V131, P502, DOI 10.1111/j.1439-0523.2012.01963.x; Cairns J, 2012, J INTEGR PLANT BIOL, V54, P14; Cairns JE, 2013, CROP SCI, V53, P1335, DOI 10.2135/cropsci2012.09.0545; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; *CIMMYT APPL MOL G, 2003, LAB PROT, P7; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cooper M, 1994, PLANT ADAPTATION CRO, P193; Dill CL, 1997, GENETICS, V147, P1367; Edmeades G.O., 1997, RECENT ADV BREEDING; Edmeades GO, 1999, CROP SCI, V39, P1306, DOI 10.2135/cropsci1999.3951306x; Edmeades GO, 2000, CSSA SPEC PUBL, P43; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fischer RAT, 2010, CROP SCI, V50, pS85, DOI 10.2135/cropsci2009.10.0564; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Frascaroli E, 2009, THEOR APPL GENET, V118, P993, DOI 10.1007/s00122-008-0956-3; Gasura E, 2013, CROP SCI, V53, P2295, DOI 10.2135/cropsci2013.01.0032; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Grieder C, 2014, PLANT SOIL, V377, P295, DOI 10.1007/s11104-013-1997-1; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hao Z, 2010, J INTEGR PLANT BIOL, V53, P641; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Messmer R, 2011, FIELD CROP RES, V124, P93, DOI 10.1016/j.fcr.2011.06.010; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; MILES CD, 1974, PLANT PHYSIOL, V53, P589, DOI 10.1104/pp.53.4.589; Monneveux P, 2006, CROP SCI, V46, P180, DOI 10.2135/cropsci2005.04-0034; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ribaut JM, 2010, CURR OPIN PLANT BIOL, V13, P213, DOI 10.1016/j.pbi.2009.12.011; Ribaut JM, 2007, J EXP BOT, V58, P351, DOI 10.1093/jxb/erl214; Ruta N, 2010, THEOR APPL GENET, V120, P621, DOI 10.1007/s00122-009-1180-5; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Trachsel S, 2010, MOL BREEDING, V25, P91, DOI 10.1007/s11032-009-9310-y; Trachsel S, 2016, CROP SCI IN PRESS; Trachsel S, 2009, THEOR APPL GENET, V119, P1413, DOI 10.1007/s00122-009-1144-9; Tuberosa R, 2003, PLANT SOIL, V255, P35, DOI 10.1023/A:1026146615248; Tuberosa R, 2002, PLANT MOL BIOL, V48, P697, DOI 10.1023/A:1014897607670; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Uribelarrea M, 2002, CROP SCI, V42, P1910, DOI 10.2135/cropsci2002.1910; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Wang LJ, 2013, J GENET GENOMICS, V40, P307, DOI 10.1016/j.jgg.2013.04.004; Weber VS, 2012, CROP SCI, V52, P1011, DOI 10.2135/cropsci2011.09.0486; Zhang X, 2015, HEREDITY, V114, P291, DOI 10.1038/hdy.2014.99	59	31	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0149636	10.1371/journal.pone.0149636	http://dx.doi.org/10.1371/journal.pone.0149636			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999525	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700009
J	Wang, M; Cribb, B; Clarke, AR; Hanan, J				Wang, Ming; Cribb, Bronwen; Clarke, Anthony R.; Hanan, Jim			A Generic Individual-Based Spatially Explicit Model as a Novel Tool for Investigating Insect-Plant Interactions: A Case Study of the Behavioural Ecology of Frugivorous Tephritidae	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA HUBNER; TRYONI FROGGATT DIPTERA; FRUIT-FLIES; PEST-MANAGEMENT; MOVEMENT; FLY; PATTERN; ARCHITECTURE; DYNAMICS; POPULATIONS	Computational modelling of mechanisms underlying processes in the real world can be of great value in understanding complex biological behaviours. Uptake in general biology and ecology has been rapid. However, it often requires specific data sets that are overly costly in time and resources to collect. The aim of the current study was to test whether a generic behavioural ecology model constructed using published data could give realistic outputs for individual species. An individual-based model was developed using the Pattern-Oriented Modelling (POM) strategy and protocol, based on behavioural rules associated with insect movement choices. Frugivorous Tephritidae (fruit flies) were chosen because of economic significance in global agriculture and the multiple published data sets available for a range of species. The Queensland fruit fly (Qfly), Bactrocera tryoni, was identified as a suitable individual species for testing. Plant canopies with modified architecture were used to run predictive simulations. A field study was then conducted to validate our model predictions on how plant architecture affects fruit flies' behaviours. Characteristics of plant architecture such as different shapes, e.g., closed-canopy and vase-shaped, affected fly movement patterns and time spent on host fruit. The number of visits to host fruit also differed between the edge and centre in closed-canopy plants. Compared to plant architecture, host fruit has less contribution to effects on flies' movement patterns. The results from this Dmodel, combined with our field study and published empirical data suggest that placing fly traps in the upper canopy at the edge should work best. Such a modelling approach allows rapid testing of ideas about organismal interactions with environmental substrates in silico rather than in vivo, to generate new perspectives. Using published data provides a saving in time and resources. Adjustments for specific questions can be achieved by refinement of parameters based on targeted experiments.	[Wang, Ming; Hanan, Jim] Univ Queensland, QAAFI, Brisbane, Qld, Australia; [Cribb, Bronwen] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Cribb, Bronwen] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Clarke, Anthony R.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Clarke, Anthony R.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland University of Technology (QUT)	Hanan, J (corresponding author), Univ Queensland, QAAFI, Brisbane, Qld, Australia.	j.hanan@uq.edu.au	Clarke, Anthony R/B-5143-2011; Hanan, Jim/A-3692-2010	Clarke, Anthony R/0000-0002-8165-3032; Hanan, Jim/0000-0002-0358-8693; Wang, Ming/0000-0003-1457-5713	Plant Biosecurity Cooperative Research Centre [CRC3066]	Plant Biosecurity Cooperative Research Centre	BC and ARC received funding support from the Plant Biosecurity Cooperative Research Centre (http://www.pbcrc.com.au/), through project CRC3066 "Creating a novel lure and kill device for Queensland fruit fly". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben J, 2014, J APPL ECOL, V51, P693, DOI 10.1111/1365-2664.12224; ALLAN P, 1993, AUST J EXP AGR, V33, P781, DOI 10.1071/EA9930781; ALUJA M, 1993, J CHEM ECOL, V19, P2671, DOI 10.1007/BF00980700; ALUJA M, 1989, ENVIRON ENTOMOL, V18, P1, DOI 10.1093/ee/18.1.1; Augusiak J, 2014, ECOL MODEL, V280, P117, DOI 10.1016/j.ecolmodel.2013.11.009; Balagawi S, 2014, J APPL ENTOMOL, V138, P510, DOI 10.1111/jen.12100; Balagawi S, 2012, AUST J ENTOMOL, V51, P279, DOI 10.1111/j.1440-6055.2012.00863.x; Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3; Campbell JE, 1996, AUST J EXP AGR, V36, P489, DOI 10.1071/EA9960489; Carter N, 2015, ECOL MODEL, V312, P347, DOI 10.1016/j.ecolmodel.2015.06.008; Casas J, 1997, BEHAV ECOL, V8, P37, DOI 10.1093/beheco/8.1.37; Clarke AR, 2011, ANN APPL BIOL, V158, P26, DOI 10.1111/j.1744-7348.2010.00448.x; Cribb BW, 2010, ARTHROPOD-PLANT INTE, V4, P165, DOI 10.1007/s11829-010-9097-0; Dalby-Ball G, 2000, AUST J ENTOMOL, V39, P201, DOI 10.1046/j.1440-6055.2000.00167.x; Dalby-Ball G, 2002, GEN APPL ENTOMOLOGY, V32, P29; Daniel Claudia, 2014, Insects, V5, P564, DOI 10.3390/insects5030564; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Dong YC, 2014, J PEST SCI, V87, P647, DOI 10.1007/s10340-014-0605-3; Dyer AG, 2014, ECOL MODEL, V277, P119, DOI 10.1016/j.ecolmodel.2014.01.009; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2015, ECOLOGICAL MODELLING; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Guttal V, 2012, ECOL LETT, V15, P1158, DOI 10.1111/j.1461-0248.2012.01840.x; Hanan J, 2002, COMPUT ELECTRON AGR, V35, P255, DOI 10.1016/S0168-1699(02)00022-4; HENDRICHS J, 1990, ANN ENTOMOL SOC AM, V83, P632, DOI 10.1093/aesa/83.3.632; HOLBROOK FR, 1969, J ECON ENTOMOL, V62, P962, DOI 10.1093/jee/62.4.962; Kaspi R, 1999, FUNCT ECOL, V13, P539, DOI 10.1046/j.1365-2435.1999.00344.x; Kubicek A, 2015, ECOL COMPLEX, V22, P178, DOI 10.1016/j.ecocom.2015.03.005; Lenth R., 2019, Journal of Statistical Software, V60, P1; LINDENMAYER A, 1968, J THEOR BIOL, V18, P280, DOI 10.1016/0022-5193(68)90079-9; Liu C, 2013, ECOL MODEL, V248, P92, DOI 10.1016/j.ecolmodel.2012.09.016; Martin KR, 2013, AUTOPHAGY, V9, P74, DOI 10.4161/auto.22532; Masoudi-Nejad A, 2015, SEMINARS CANC BIOL; Paini D. R., 2015, PLOS ONE, V10; Pe'er G, 2013, OIKOS, V122, P1483, DOI 10.1111/j.1600-0706.2013.00198.x; Perkins LE, 2010, B ENTOMOL RES, V100, P591, DOI 10.1017/S0007485309990654; Perkins LE, 2009, ARTHROPOD-PLANT INTE, V3, P173, DOI 10.1007/s11829-009-9069-4; Perkins LE, 2008, ARTHROPOD-PLANT INTE, V2, P197, DOI 10.1007/s11829-008-9047-2; PROKOPY RJ, 1984, AM SCI, V72, P41; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Raghu S, 2004, J INSECT BEHAV, V17, P179, DOI 10.1023/B:JOIR.0000028568.90719.2a; Railsback S.F., 2011, AGENT BASED INDIVIDU; ROBACKER DC, 1990, J ECON ENTOMOL, V83, P412, DOI 10.1093/jee/83.2.412; Simon S, 2007, PEST TECHNOL, V1, P33; Skirvin DJ, 2004, ECOL MODEL, V171, P301, DOI 10.1016/j.ecolmodel.2003.07.007; Verdeny-Vilalta O, 2015, OIKOS, V124, P337, DOI 10.1111/oik.01557; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; Wang M, 2015, MODSIM2015, P375; Wang Z, 2015, SEMINARS CANC BIOL; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wilensky U., NETLOGO; Wood KA, 2015, J APPL ECOLOGY; Yuan RC, 2005, HORTSCIENCE, V40, P2011, DOI 10.21273/HORTSCI.40.7.2011; Zurell D, 2014, OIKOS	57	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151777	10.1371/journal.pone.0151777	http://dx.doi.org/10.1371/journal.pone.0151777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999285	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700065
J	Otto, MC; Afshin, A; Micha, R; Khatibzadeh, S; Fahimi, S; Singh, G; Danaei, G; Sichieri, R; Monteiro, CA; Louzada, MLC; Ezzati, M; Mozaffarian, D				Otto, Marcia C. de Oliveira; Afshin, Ashkan; Micha, Renata; Khatibzadeh, Shahab; Fahimi, Saman; Singh, Gitanjali; Danaei, Goodarz; Sichieri, Rosely; Monteiro, Carlos A.; Louzada, Maria L. C.; Ezzati, Majid; Mozaffarian, Dariush		Global Burden Dis Injuries Risk; Nutr Chronic Dis Expert Grp	The Impact of Dietary and Metabolic Risk Factors on Cardiovascular Diseases and Type 2 Diabetes Mortality in Brazil	PLOS ONE			English	Article							HOUSEHOLD FOOD AVAILABILITY; SYSTEMATIC ANALYSIS; BURDEN; HEALTH; TRENDS; PREVALENCE	Background Trends in food availability and metabolic risk factors in Brazil suggest a shift toward unhealthy dietary patterns and increased cardiometabolic disease risk, yet little is known about the impact of dietary and metabolic risk factors on cardiometabolic mortality in Brazil. Methods Based on data from Global Burden of Disease (GBD) Study, we used comparative risk assessment to estimate the burden of 11 dietary and 4 metabolic risk factors on mortality due to cardiovascular diseases and diabetes in Brazil in 2010. Information on national diets and metabolic risks were obtained from the Brazilian Household Budget Survey, the Food and Agriculture Organization database, and large observational studies including Brazilian adults. Relative risks for each risk factor were obtained from meta-analyses of randomized trials or prospective cohort studies; and disease-specific mortality from the GBD 2010 database. We quantified uncertainty using probabilistic simulation analyses, incorporating uncertainty in dietary and metabolic data and relative risks by age and sex. Robustness of findings was evaluated by sensitivity to varying feasible optimal levels of each risk factor. Results In 2010, high systolic blood pressure (SBP) and suboptimal diet were the largest contributors to cardiometabolic deaths in Brazil, responsible for 214,263 deaths (95% uncertainty interval [UI]: 195,073 to 233,936) and 202,949 deaths (95% UI: 194,322 to 211,747), respectively. Among individual dietary factors, low intakes of fruits and whole grains and high intakes of sodium were the largest contributors to cardiometabolic deaths. For premature cardiometabolic deaths (before age 70 years, representing 40% of cardiometabolic deaths), the leading risk factors were suboptimal diet (104,169 deaths; 95% UI: 99,964 to 108,002), high SBP (98,923 deaths; 95% UI: 92,912 to 104,609) and high body-mass index (BMI) (42,643 deaths; 95% UI: 40,161 to 45,111). Conclusion suboptimal diet, high SBP, and high BMI are major causes of cardiometabolic death in Brazil, informing priorities for policy initiatives.	[Otto, Marcia C. de Oliveira] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Afshin, Ashkan; Micha, Renata; Singh, Gitanjali; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Khatibzadeh, Shahab; Fahimi, Saman; Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA; [Micha, Renata] Agr Univ Athens, Dept Food Sci & Human Nutr, GR-11855 Athens, Greece; [Sichieri, Rosely] Univ Estado Rio De Janeiro, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Monteiro, Carlos A.; Louzada, Maria L. C.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, London, England	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Agricultural University of Athens; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Imperial College London	Otto, MC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA.	marcia.c.otto@uth.tmc.edu	Pekcan, A Gulden/AAI-6040-2021; Mozaffarian, Dariush/ABC-2822-2020; Bjerregaard, Peter/ABD-8894-2020; Calleja, Neville/E-3895-2019; Louzada, Maria Laura C/G-1851-2012; Duarte, Graziela Biude Silva/Q-7728-2016; Fisberg, Regina Mara/Q-6494-2019; Fisberg, Regina M/C-4069-2012; Monteiro, Carlos Augusto/F-9892-2012; Castetbon, Katia/F-2686-2017; , Sahar/L-7112-2013; Veerman, Lennert/A-9973-2011; Thorsdottir, Inga/M-3260-2015; Nagalla, Balakrishna/GRR-4393-2022	Pekcan, A Gulden/0000-0002-2037-3037; Bjerregaard, Peter/0000-0001-7153-8447; Calleja, Neville/0000-0003-1800-2103; Fisberg, Regina Mara/0000-0002-4490-9035; Fisberg, Regina M/0000-0002-4490-9035; Monteiro, Carlos Augusto/0000-0002-3777-1533; , Sahar/0000-0003-0705-8013; Naska, Androniki/0000-0002-1610-1813; Orfanos, Philippos/0000-0002-9949-3137; Haerpfer, Christian/0000-0002-7350-9049; Waskiewicz, Anna/0000-0001-5091-2145; Farzadfar, Farshad/0000-0001-8288-4046; Veerman, Lennert/0000-0002-3206-8232; Thorsdottir, Inga/0000-0002-2946-287X; Nagalla, Balakrishna/0000-0002-5613-0942; Ding, Eric/0000-0002-5881-8097; Sibai, Abla/0000-0002-1851-5606	National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL085710]; Bunge LLC; Swiss Re; National Heart, Lung, and Blood Institute of the National Institutes of Health [R21 HL109924]; USAID; NIH [R01-HD38700]; Higher School of Economics and Pension Fund of Russia; University of North Carolina Population Center [5 R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109924, R01HL085710] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bunge LLC; Swiss Re; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); USAID(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher School of Economics and Pension Fund of Russia; University of North Carolina Population Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Otto was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL085710 and by unrestricted educational grants from Bunge LLC and from Swiss Re, which had no role in the study design, data collection and analysis, or data interpretation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Dr. Otto was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL085710 and by unrestricted educational grants from Bunge LLC and from Swiss Re. Dr. Mozaffarian was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R21 HL109924). Dr. Mozaffarian reports ad hoc honoraria or consulting from Bunge, Haas Avocado Board, Nutrition Impact, Amarin, Astra Zeneca, Boston Heart Diagnostics, GOED, and Life Sciences Research Organization; and scientific advisory boards, Unilever North America and Elysium Health.r This work was undertaken as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. The results in this paper are prepared independently of the final estimates of the Global Burden of Diseases, Injuries, and Risk Factors study. We thank the Russia Longitudinal Monitoring Survey Phase 2, funded by the USAID and NIH (R01-HD38700), Higher School of Economics and Pension Fund of Russia, and the University of North Carolina Population Center (5 R24 HD050924) (Source: "Russia Longitudinal Monitoring survey, RLMS-HSE"), conducted by HSE and ZAO "Demoscope" together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology RAS (RLMS-HSE sites: http//.www.cpc.unc.edu/projects/rlms, http://www.hse.ru/org/hse/rlms) for sharing data with us. We thank Barbara Bowman, MS, PhD, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA; Patricia Constante Jamie, PhD, School of Public Health, University of Sao Paulo, Sao Paolo, Brazil; Karen Lock, PhD, London School of Hygiene and Tropical Medicine, London, UK; and Joceline Pomerleau, PhD, London School of Hygiene and Tropical Medicine, London, UK for advising and guidance on initial search strategy. We thank Louise Dekker, MSc, Jenna Golan, MPH, Shadi Kalantarian, MD, MPH, Liesbeth Smit, PhD, and Georgina Waweru Harvard School of Public Health, Boston, MA, USA for assistance with data collection.	Afshin A, 2013, CIRCULATION S, V127, pAMP21; Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Bezerra IN, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-74; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Chor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382; Conde WL, 2014, AM J CLIN NUTR, V100, p1617S, DOI 10.3945/ajcn.114.084764; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; GBD study, 2008, GLOB BURD DIS INJ RI; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM 2008 20; James WPT, 2004, COMP QUANTIFICATION, P497; Khatibzadeh S., 2012, CIRCULATION, V125; Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336; Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088; Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lock K., 2004, COMP QUANTIFICATION, P597; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Ministerio da Saude Brasil, 2015, INF SAUD 2013; Ministry of Health B, 2011, STRAT ACT PLAN TACKL; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Schmidt MI, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-123; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	38	31	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151503	10.1371/journal.pone.0151503	http://dx.doi.org/10.1371/journal.pone.0151503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990765	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800069
J	Thiyagarajan, K; Vitali, F; Tolaini, V; Galeffi, P; Cantale, C; Vikram, P; Singh, S; De Rossi, P; Nobili, C; Procacci, S; Del Fiore, A; Antonini, A; Presenti, O; Brunori, A				Thiyagarajan, Karthikeyan; Vitali, Fabio; Tolaini, Valentina; Galeffi, Patrizia; Cantale, Cristina; Vikram, Prashant; Singh, Sukhwinder; De Rossi, Patrizia; Nobili, Chiara; Procacci, Silvia; Del Fiore, Antonella; Antonini, Alessandro; Presenti, Ombretta; Brunori, Andrea			Genomic Characterization of Phenylalanine Ammonia Lyase Gene in Buckwheat	PLOS ONE			English	Article							CANDIDATE GENES; FAGOPYRUM; EXPRESSION; DIVERSITY; SOFTWARE; PATHWAY; RUTIN	Phenylalanine Ammonia Lyase (PAL) gene which plays a key role in bio-synthesis of medicinally important compounds, Rutin/quercetin was sequence characterized for its efficient genomics application. These compounds possessing anti-diabetic and anti-cancer properties and are predominantly produced by Fagopyrum spp. In the present study, PAL gene was sequenced from three Fagopyrum spp. (F. tataricum, F. esculentum and F. dibotrys) and showed the presence of three SNPs and four insertion/deletions at intra and inter specific level. Among them, the potential SNP (position 949th bp G>C) with Parsimony Informative Site was selected and successfully utilised to individuate the zygosity/allelic variation of 16 F. tataricum varieties. Insertion mutations were identified in coding region, which resulted the change of a stretch of 39 amino acids on the putative protein. Our Study revealed that autogamous species (F. tataricum) has lower frequency of observed SNPs as compared to allogamous species (F. dibotrys and F. esculentum). The identified SNPs in F. tataricum didn't result to amino acid change, while in other two species it caused both conservative and non-conservative variations. Consistent pattern of SNPs across the species revealed their phylogenetic importance. We found two groups of F. tataricum and one of them was closely related with F. dibotrys. Sequence characterization information of PAL gene reported in present investigation can be utilized in genetic improvement of buckwheat in reference to its medicinal value.	[Thiyagarajan, Karthikeyan; Vitali, Fabio; Tolaini, Valentina; Galeffi, Patrizia; Cantale, Cristina; De Rossi, Patrizia; Nobili, Chiara; Procacci, Silvia; Del Fiore, Antonella; Antonini, Alessandro; Presenti, Ombretta; Brunori, Andrea] UTAGRI INN, Italian Natl Agcy New Technol Energy & Sustainabl, Via Anguillarese 301, I-00123 Rome, Italy; [Thiyagarajan, Karthikeyan] Biovers Int, I-00054 Maccarese, Fiumicino, Italy; [Vikram, Prashant; Singh, Sukhwinder] Int Ctr Maize & Wheat Improvement, Genet Resource Program, El Batan, Texcoco, Mexico	Italian National Agency New Technical Energy & Sustainable Economics Development; Alliance; Bioversity International; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Thiyagarajan, K; Brunori, A (corresponding author), UTAGRI INN, Italian Natl Agcy New Technol Energy & Sustainabl, Via Anguillarese 301, I-00123 Rome, Italy.; Thiyagarajan, K (corresponding author), Biovers Int, I-00054 Maccarese, Fiumicino, Italy.	pltbiotech_tkarthi@outlook.com; andrea.brunori@enea.it	Karthikeyan, Thiyagarajan/AAI-4439-2020	Vikram, Prashant/0000-0002-3740-6608; Del Fiore, Antonella/0000-0003-3728-8864; nobili, chiara/0000-0003-4784-8351; Galeffi, Patrizia/0000-0002-0101-1751; Presenti, Ombretta/0000-0001-6404-1598; Thiyagarajan, Karthikeyan/0000-0003-2864-9373	ENEA International Fellowship; ENEA International Fellowship, Italy	ENEA International Fellowship; ENEA International Fellowship, Italy	Funding for this work came from an ENEA International Fellowship (2012-14), http://www.enea.it/en/job-study/international-fellowship.; Authors duly acknowledge the financial support of ENEA International Fellowship, Italy. We also extend our sincere thanks to all researchers of Biotechnology and Agroindustry Division (formerly called UTAGRI), ENEA, Italy, for their time to time support and encouragement. Authors also wishes to express their sincere gratitude to Prof. Enrico Porceddu and Prof. Mario Enrico Pe for their constant encouragement and support.	Bagal UR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S3-S1; Beaty TH, 2005, GENETICS, V171, P259, DOI 10.1534/genetics.105.043075; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Cho KS, 2015, PLOS ONE, V10; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; de Jong F, 2015, PHYTOCHEMISTRY, V117, P90, DOI 10.1016/j.phytochem.2015.06.005; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Dillon SK, 2010, GENETICS, V185, P1477, DOI 10.1534/genetics.110.116582; Durendic-Brenesel M, 2013, BOSNIAN J BASIC MED, V13, P100; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; HUDSON RR, 1992, GENETICS, V132, P583; Kowalska I, 2007, J AGR FOOD CHEM, V55, P2645, DOI 10.1021/jf063635b; Kreft I., 2003, Fagopyrum, V20, P7; Kreft S, 1999, J AGR FOOD CHEM, V47, P4649, DOI 10.1021/jf990186p; Kumar S, 2001, GENETICS, V158, P1321; Kumar S, 2007, BIOINFORMATICS, V23, P1713, DOI 10.1093/bioinformatics/btm239; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CC, 2012, EXP DIABETES RES, DOI 10.1155/2012/375673; Li CL, 2012, PLANT MOL BIOL REP, V30, P1172, DOI 10.1007/s11105-012-0431-9; Li SQ, 2001, CRIT REV FOOD SCI, V41, P451, DOI 10.1080/20014091091887; Li XH, 2010, J AGR FOOD CHEM, V58, P12176, DOI 10.1021/jf103310g; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Z, 2001, J NUTR, V131, P1850, DOI 10.1093/jn/131.6.1850; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Ohnishi O, 1996, GENES GENET SYST, V71, P383, DOI 10.1266/ggs.71.383; Ohnishi O., 1998, Fagopyrum, V15, P18; Ohnishi O., 1995, P 6 INT S BUCKWHEAT, P175; Ohsawa R, 1995, EUPHYTICA, V86, P183; Peukert M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-97; R Core Team, 2018, R LANG ENV STAT COMP; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Steward A. N., 1930, CONTRIB GRAY HERB HA, V88, P1; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Vakhrusheva AA, 2011, J MOL EVOL, V72, P138, DOI 10.1007/s00239-010-9408-1; Verdu CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107103; Williams LE, 2013, GENOME BIOL EVOL, V5, P599, DOI 10.1093/gbe/evt033; Yamane K, 2003, AM J BOT, V90, P339, DOI 10.3732/ajb.90.3.339; Yasuda T, 2001, ADV BUCKWHEAT RES, P499; Yasui Y, 1998, GENES GENET SYST, V73, P201, DOI 10.1266/ggs.73.201; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	47	14	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151187	10.1371/journal.pone.0151187	http://dx.doi.org/10.1371/journal.pone.0151187			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990297	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800045
J	Dietze, KK; Schimmer, S; Kretzmer, F; Wang, JZ; Lin, Y; Huang, X; Wu, WM; Wang, BJ; Lu, MJ; Dittmer, U; Yang, DL; Liu, J				Dietze, Kirsten K.; Schimmer, Simone; Kretzmer, Freya; Wang, Junzhong; Lin, Yong; Huang, Xuan; Wu, Weimin; Wang, Baoju; Lu, Mengji; Dittmer, Ulf; Yang, Dongliang; Liu, Jia			Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE-RESPONSE; VIRAL CLEARANCE; INFECTION; EXPANSION; EXPRESSION; DEPLETION; LIVER; MICE; HBV	Regulatory T cells (Tregs) play an important role in counter-regulating effector T cell responses in many infectious diseases. However, they can also contribute to the development of T cell dysfunction and pathogen persistence in chronic infections. Tregs have been reported to suppress virus-specific T cell responses in hepatitis B virus (HBV) infection of human patients as well as in HBV animal models. However, the phenotype and expansion of Tregs has so far only been investigated in other infections, but not in HBV. We therefore performed hydrodynamic injections of HBV plasmids into mice and analyzed the Treg response in the spleen and liver. Absolute Treg numbers significantly increased in the liver but not the spleen after HBV injection. The cells were natural Tregs that surprisingly did not show any activation or proliferation in response to the infection. However, they were able to suppress effector T cell responses, as selective depletion of Tregs significantly increased HBV-specific CD8+ T cell responses and accelerated viral antigen clearance. The data implies that natural Tregs infiltrate the liver in HBV infection without further activation or expansion but are still able to interfere with T cell mediated viral clearance.	[Dietze, Kirsten K.; Schimmer, Simone; Kretzmer, Freya; Lin, Yong; Huang, Xuan; Wu, Weimin; Lu, Mengji; Dittmer, Ulf] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Wang, Junzhong; Wang, Baoju; Yang, Dongliang; Liu, Jia] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	University of Duisburg Essen; Huazhong University of Science & Technology	Liu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	jialiu77@hotmail.com	Lu, Mengji/ABF-9410-2020; Wang, Junzhong/AAS-9767-2021		Deutsche Forschungsgemeinschaft [TRR60, GK 1045]; National Nature Science Foundation of China (SG-JIRP) [81461130019]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Nature Science Foundation of China (SG-JIRP)(National Natural Science Foundation of China (NSFC))	This work was supported by the Deutsche Forschungsgemeinschaft (TRR60 and GK 1045, www.dfg.de/) and the National Nature Science Foundation of China (SG-JIRP, 81461130019, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; Belkaid Y, 2008, EUR J IMMUNOL, V38, P918, DOI 10.1002/eji.200738120; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2011, IMMUNOLOGY, V133, P426, DOI 10.1111/j.1365-2567.2011.03460.x; Chen X, 2010, J IMMUNOL, V185, P174, DOI 10.4049/jimmunol.0903548; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Chuai X, 2014, ANTIVIR RES, V101, P68, DOI 10.1016/j.antiviral.2013.10.019; Crispe I Nicholas, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0321s22; Dai K, 2015, IMMUNOLOGY, V144, P506, DOI 10.1111/imm.12400; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dietze KK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003798; Dietze KK, 2011, P NATL ACAD SCI USA, V108, P2420, DOI 10.1073/pnas.1015148108; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Dong XJ, 2013, LIVER INT, V33, P1517, DOI 10.1111/liv.12248; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; Franzese O, 2005, J VIROL, V79, P3322, DOI 10.1128/JVI.79.6.3322-3328.2005; Furuichi Y, 2005, WORLD J GASTROENTERO, V11, P3772, DOI 10.3748/wjg.v11.i24.3772; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; Joedicke JJ, 2014, J IMMUNOL, V193, P2952, DOI 10.4049/jimmunol.1400649; Joedicke Jara J., 2014, Virologica Sinica, V29, P48, DOI 10.1007/s12250-014-3396-z; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; JUNG MC, 1991, J HEPATOL, V13, P310, DOI 10.1016/0168-8278(91)90074-L; Kondo Y, 2006, WORLD J GASTROENTERO, V12, P4310, DOI 10.3748/wjg.v12.i27.4310; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Liu J., 2014, FRONT ENV SCI ENG, P1, DOI DOI 10.1371/J0URNAL.PPAT.1003856; Liu Jia, 2014, Virologica Sinica, V29, P10, DOI 10.1007/s12250-014-3410-5; Liu J, 2013, J IMMUNOL, V191, P6178, DOI 10.4049/jimmunol.1301262; Liu YM, 2015, INT J CLIN EXP MED, V8, P6735; Lu MJ, 1999, J VIROL, V73, P281, DOI 10.1128/JVI.73.1.281-289.1999; Manigold T, 2007, LANCET INFECT DIS, V7, P804, DOI 10.1016/S1473-3099(07)70289-X; Myers L, 2013, J IMMUNOL, V190, P5485, DOI 10.4049/jimmunol.1202951; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rowe JH, 2012, IMMUNOLOGY, V136, P1, DOI 10.1111/j.1365-2567.2011.03551.x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Stross L, 2012, HEPATOLOGY, V56, P873, DOI 10.1002/hep.25765; Sugita K, 2015, EXP DERMATOL, V24, P554, DOI 10.1111/exd.12711; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Wu J, 2014, J VIROL, V88, P10421, DOI 10.1128/JVI.00996-14; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yang GL, 2007, INT IMMUNOL, V19, P133, DOI 10.1093/intimm/dxl130; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524; Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547; Zelinskyy G, 2006, EUR J IMMUNOL, V36, P2658, DOI 10.1002/eji.200636059; Zelinskyy G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000406; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	59	19	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151717	10.1371/journal.pone.0151717	http://dx.doi.org/10.1371/journal.pone.0151717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986976	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300119
J	Dumitru, ML; Joergensen, GH				Dumitru, Magda L.; Joergensen, Gitte H.			Gestalt Reasoning with Conjunctions and Disjunctions	PLOS ONE			English	Article							GLOBAL PRECEDENCE; SIMILARITY; COMPREHENSION; ORGANIZATION; PERFORMANCE; PROXIMITY; ATTENTION; KNOWLEDGE; PARALLEL; PATTERNS	Reasoning, solving mathematical equations, or planning written and spoken sentences all must factor in stimuli perceptual properties. Indeed, thinking processes are inspired by and subsequently fitted to concrete objects and situations. It is therefore reasonable to expect that the mental representations evoked when people solve these seemingly abstract tasks should interact with the properties of the manipulated stimuli. Here, we investigated the mental representations evoked by conjunction and disjunction expressions in language-picture matching tasks. We hypothesised that, if these representations have been derived using key Gestalt principles, reasoners should use perceptual compatibility to gauge the goodness of fit between conjunction/disjunction descriptions (e.g., the purple and/or the green) and corresponding binary visual displays. Indeed, the results of three experimental studies demonstrate that reasoners associate conjunction descriptions with perceptually-dependent stimuli and disjunction descriptions with perceptually-independent stimuli, where visual dependency status follows the key Gestalt principles of common fate, proximity, and similarity.	[Dumitru, Magda L.] Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia; [Dumitru, Magda L.] METU, Dept Cognit Sci, Ankara, Turkey; [Joergensen, Gitte H.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Joergensen, Gitte H.] Univ Connecticut, Dept Psychol, Storrs, CT USA	Macquarie University; Middle East Technical University; University of York - UK; University of Connecticut	Dumitru, ML (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.; Dumitru, ML (corresponding author), METU, Dept Cognit Sci, Ankara, Turkey.	magda.dumitru@gmail.com			Marie Curie fellowship FP7-PEOPLE-IAPP [610986]	Marie Curie fellowship FP7-PEOPLE-IAPP	Magda L. Dumitru was supported by a Marie Curie fellowship FP7-PEOPLE-2013-IAPP (grant number 610986). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENAV MB, 1995, VISION RES, V35, P853, DOI 10.1016/0042-6989(94)00173-J; Boot I, 2010, Q J EXP PSYCHOL, V63, P942, DOI 10.1080/17470210903134351; BRAINE MDS, 1981, J EXP CHILD PSYCHOL, V31, P46, DOI 10.1016/0022-0965(81)90003-5; CAMPBELL JID, 1994, COGNITION, V53, P1, DOI 10.1016/0010-0277(94)90075-2; Carnap Rudolf, 1956, MEANING NECESSITY, V2nd, P205; Casasanto D, 2008, MEM COGNITION, V36, P1047, DOI 10.3758/MC.36.6.1047; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; Chen L, 1986, ESSAYS COGNITIVE SCI, P250; Chevallier C, 2008, Q J EXP PSYCHOL, V61, P1741, DOI 10.1080/17470210701712960; Craik Kenneth James Williams, 1943, NATURE EXPLANATION, P1; Dumitru ML, 2014, COGN PROCESS, V15, P397, DOI 10.1007/s10339-014-0604-6; Dumitru ML, 2013, CONSCIOUS COGN, V22, P562, DOI 10.1016/j.concog.2013.03.008; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; FODOR JD, 1975, LINGUIST INQ, V6, P515; GEE JP, 1983, COGNITIVE PSYCHOL, V15, P411, DOI 10.1016/0010-0285(83)90014-2; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Glenberg AM, 2000, J MEM LANG, V43, P379, DOI 10.1006/jmla.2000.2714; Han S., 1997, EFFECT GROUPING SIMI; Han SH, 1999, J EXP PSYCHOL HUMAN, V25, P1411, DOI 10.1037/0096-1523.25.5.1411; Han SH, 1999, PERCEPT PSYCHOPHYS, V61, P1287, DOI 10.3758/BF03206180; Han SH, 1999, PERCEPT PSYCHOPHYS, V61, P661, DOI 10.3758/BF03205537; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Johnson-Laird P. N., 1991, DEDUCTION ESSAYS COG; Johnson-Laird P.N., 1983, MENTAL MODELS COGNIT; Kaufman L., 1986, HDB PERCEPTION HUMAN, V2, P1; Kintsch W., 1974, REPRESENTATION MEANI; Knoeferle P., LANGUAGE LI IN PRESS; Knoeferle P, 2011, PSYCHOPHYSIOLOGY, V48, P495, DOI 10.1111/j.1469-8986.2010.01080.x; Koehler W, 1929, GESTALT PSYCHOL; Koffka K, 1922, PSYCHOL BULL, V19, P531, DOI 10.1037/h0072422; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George, 1987, CULTURAL MODELS LANG, P195; Lamy D, 2002, PERCEPT PSYCHOPHYS, V64, P52, DOI 10.3758/BF03194557; Landy D, 2007, J EXP PSYCHOL LEARN, V33, P720, DOI 10.1037/0278-7393.33.4.720; Mac Whinney B, 1999, CARN S COGN, P213; MAKI RH, 1981, J EXP PSYCHOL-HUM L, V7, P15; McNeil NM, 2005, CHILD DEV, V76, P883, DOI 10.1111/j.1467-8624.2005.00884.x; MILLER J, 1981, J EXP PSYCHOL HUMAN, V7, P1161, DOI 10.1037/0096-1523.7.6.1161; Montague R., 1974, FORMAL PHILOS SELECT; Morrison R.G., 2005, CAMBRIDGE HDB THINKI, P209, DOI DOI 10.1006/COGP.1998.0702; Myachykov A, 2008, J COGN SCI, V9, P31; Nakayama K., 1995, INVITATION COGNITIVE, P1; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nissen M.J., 1985, ATTENTION PERFORM, V11, P205; PARIS SG, 1973, J EXP CHILD PSYCHOL, V16, P278, DOI 10.1016/0022-0965(73)90167-7; Quattrone G. A., 1986, PSYCHOL INTERGROUP R, P25; Quinlan PT, 1998, PERCEPT PSYCHOPHYS, V60, P303, DOI 10.3758/BF03206039; R Core Team, 2021, R LANGUAGE ENV STAT; SAGI D, 1985, SCIENCE, V228, P1217, DOI 10.1126/science.4001937; Scheepers C, 2011, PSYCHOL SCI, V22, P1319, DOI 10.1177/0956797611416997; Spelke Elizabeth S., 1995, P165; STERNBERG RJ, 1979, J EXP CHILD PSYCHOL, V28, P469, DOI 10.1016/0022-0965(79)90076-6; Theeuwes Jan, 2005, P418, DOI 10.1016/B978-012375731-9/50073-2; Tomlin R. S., 1995, WORD ORDER DISCOURSE, P517, DOI [DOI 10.1075/TS1.30.18TOM, 10.1075/TSL.30.18TOM, DOI 10.1075/TSL.30.18TOM]; Tversky B., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P14; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; WILTON RN, 1979, Q J EXP PSYCHOL, V31, P133, DOI 10.1080/14640747908400713; Zhang JJ, 2005, Q J EXP PSYCHOL-A, V58, P817, DOI 10.1080/02724980443000340; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151774	10.1371/journal.pone.0151774	http://dx.doi.org/10.1371/journal.pone.0151774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986760	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300129
J	Shimo, T; Matsumoto, K; Takabatake, K; Aoyama, E; Takebe, Y; Ibaragi, S; Okui, T; Kurio, N; Takada, H; Obata, K; Pang, P; Iwamoto, M; Nagatsuka, H; Sasaki, A				Shimo, Tsuyoshi; Matsumoto, Kenichi; Takabatake, Kiyofumi; Aoyama, Eriko; Takebe, Yuichiro; Ibaragi, Soichiro; Okui, Tatsuo; Kurio, Naito; Takada, Hiroyuki; Obata, Kyoichi; Pang, Pai; Iwamoto, Masahiro; Nagatsuka, Hitoshi; Sasaki, Akira			The Role of Sonic Hedgehog Signaling in Osteoclastogenesis and Jaw Bone Destruction	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER; PROLIFERATION; INVASION; GROWTH; MICROENVIRONMENT; METASTASIS; INHIBITION; EXPRESSION; RECEPTORS	Sonic hedgehog (SHH) and its signaling have been identified in several human cancers, and increased levels of its expression appear to correlate with disease progression and metastasis. However, the role of SHH in bone destruction associated with oral squamous cell carcinomas is still unclear. In this study we analyzed SHH expression and the role played by SHH signaling in gingival carcinoma-induced jawbone destruction. From an analysis of surgically resected lower gingival squamous cell carcinoma mandible samples, we found that SHH was highly expressed in tumor cells that had invaded the bone matrix. On the other hand, the hedgehog receptor Patched and the signaling molecule Gli-2 were highly expressed in the osteoclasts and the progenitor cells. SHH stimulated osteoclast formation and pit formation in the presence of the receptor activator for nuclear factor-kappa B ligand (RANKL) in CD11b(+) mouse bone marrow cells. SHH upregulated phosphorylation of ERK1/2 and p38 MAPK, NFATc1, tartrate-resistant acid phosphatase (TRAP), and Cathepsin K expression in RAW264.7 cells. Our results suggest that tumor-derived SHH stimulated the osteoclast formation and bone resorption in the tumor jawbone microenvironment.	[Shimo, Tsuyoshi; Matsumoto, Kenichi; Ibaragi, Soichiro; Okui, Tatsuo; Kurio, Naito; Takada, Hiroyuki; Obata, Kyoichi; Pang, Pai; Sasaki, Akira] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan; [Takabatake, Kiyofumi; Takebe, Yuichiro; Nagatsuka, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan; [Aoyama, Eriko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan; [Iwamoto, Masahiro] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Iwamoto, Masahiro] Childrens Hosp Philadelphia, Res Inst, Div Orthoped Surg, Philadelphia, PA 19104 USA	Okayama University; Okayama University; Okayama University; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shimo, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan.	shimotsu@md.okayama-u.ac.jp	Shimo, Tsuyoshi/AAT-8358-2020	Shimo, Tsuyoshi/0000-0002-7811-2366	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18689049, 26293428]; Grants-in-Aid for Scientific Research [26293428] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-in-Aid for Young Scientists (A)(18689049 https://kaken.nii.ac.jp/d/p/18689049.ja.html) (to T.S.) and a Grant-in-Aid for Scientific Research (B) (26293428, https://kaken.nii.ac.jp/d/p/26293428.ja.html) (to T.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Atkinson PJ, 2009, J NEUROCHEM, V108, P1539, DOI 10.1111/j.1471-4159.2009.05900.x; Bilodeau EA, 2011, HEAD NECK PATHOL, V5, P216, DOI 10.1007/s12105-011-0264-0; Choi SW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-35; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Das S, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/298623; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ebrahimi A, 2011, CANCER-AM CANCER SOC, V117, P4460, DOI 10.1002/cncr.26032; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Fried D, 2014, HEAD NECK-J SCI SPEC, V36, P776, DOI 10.1002/hed.23367; Heller E, 2012, CANCER RES, V72, P897, DOI 10.1158/0008-5472.CAN-11-2681; Honami T, 2012, ORAL ONCOL, V48, P49, DOI 10.1016/j.oraloncology.2011.08.026; Horikiri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076785; Hurchla MA, 2012, ONCOIMMUNOLOGY, V1, P1411, DOI 10.4161/onci.21060; Ichiki T, 2011, NEUROPEPTIDES, V45, P239, DOI 10.1016/j.npep.2011.03.006; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Liu HY, 2014, EXP DERMATOL, V23, P896, DOI 10.1111/exd.12556; MAGGI CA, 1993, J AUTON PHARMACOL, V13, P23, DOI 10.1111/j.1474-8673.1993.tb00396.x; Nishimaki H, 2004, BIOCHEM BIOPH RES CO, V314, P313, DOI 10.1016/j.bbrc.2003.12.097; Nishimori H, 2012, J BIOL CHEM, V287, P20037, DOI 10.1074/jbc.M112.353094; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; Osawa H, 2006, BIOCHEM BIOPH RES CO, V344, P680, DOI 10.1016/j.bbrc.2006.03.188; Rougerie P, 2013, IMMUNOLOGICAL REV, V256; Shimo T, 2004, DEV DYNAM, V229, P607, DOI 10.1002/dvdy.20009; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Waning DL, 2014, CLIN CANCER RES, V20, P3071, DOI 10.1158/1078-0432.CCR-13-1590; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Yan M, 2011, ORAL ONCOL, V47, P504, DOI 10.1016/j.oraloncology.2011.03.027; Young B, 2006, DEV BIOL, V299, P272, DOI 10.1016/j.ydbio.2006.07.028; Zunich SM, 2012, MOL CANCER, P1130	34	16	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151731	10.1371/journal.pone.0151731	http://dx.doi.org/10.1371/journal.pone.0151731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007126	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200063
J	Dinkins, JB; Smith, KT; Beck, JL; Kirol, CP; Pratt, AC; Conover, MR				Dinkins, Jonathan B.; Smith, Kurt T.; Beck, Jeffrey L.; Kirol, Christopher P.; Pratt, Aaron C.; Conover, Michael R.			Microhabitat Conditions in Wyoming's Sage-Grouse Core Areas: Effects on Nest Site Selection and Success	PLOS ONE			English	Article							HABITAT; PREDATION; SAGEBRUSH; SURVIVAL; FITNESS	The purpose of our study was to identify microhabitat characteristics of greater sage-grouse (Centrocercus urophasianus) nest site selection and survival to determine the quality of sage-grouse habitat in 5 regions of central and southwest Wyoming associated with Wyoming's Core Area Policy. Wyoming's Core Area Policy was enacted in 2008 to reduce human disturbance near the greatest densities of sage-grouse. Our analyses aimed to assess sage-grouse nest selection and success at multiple micro-spatial scales. We obtained microhabitat data from 928 sage-grouse nest locations and 819 random microhabitat locations from 2008-2014. Nest success was estimated from 924 nests with survival data. Sage-grouse selected nests with greater sagebrush cover and height, visual obstruction, and number of small gaps between shrubs (gap size >= 0.5 m and <1.0 m), while selecting for less bare ground and rock. With the exception of more small gaps between shrubs, we did not find any differences in availability of these microhabitat characteristics between locations within and outside of Core Areas. In addition, we found little supporting evidence that sage-grouse were selecting different nest sites in Core Areas relative to areas outside of Core. The Kaplan-Meier nest success estimate for a 27-day incubation period was 42.0% (95% CI: 38.4-45.9%). Risk of nest failure was negatively associated with greater rock and more medium-sized gaps between shrubs (gap size >= 2.0 m and <3.0 m). Within our study areas, Wyoming's Core Areas did not have differing microhabitat quality compared to outside of Core Areas. The close proximity of our locations within and outside of Core Areas likely explained our lack of finding differences in microhabitat quality among locations within these landscapes. However, the Core Area Policy is most likely to conserve high quality habitat at larger spatial scales, which over decades may have cascading effects on microhabitat quality available between areas within and outside of Core Areas.	[Dinkins, Jonathan B.; Smith, Kurt T.; Beck, Jeffrey L.; Kirol, Christopher P.; Pratt, Aaron C.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Conover, Michael R.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	University of Wyoming; Utah System of Higher Education; Utah State University	Dinkins, JB (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA.	jdinkins@uwyo.edu			American Colloid Company; Anadarko Petroleum Corporation; Bates Hole Working Group; Bighorn Basin Working Group; South-Central Working Group; Southwest Working Group; Wind River/Sweetwater River Local Sage-Grouse Working Group; Jack H. Berryman Institute; Lincoln County Predator Management Board; Margaret and Sam Kelly Ornithological Research Fund; Predatory Animal District of Sweetwater County; School of Energy Resources and Wyoming Reclamation and Restoration Center at the University of Wyoming; Uinta County Predator Management Board; Utah Agricultural Experiment Station; Wyoming Animal Damage Management Board; Wyoming Sage-grouse Conservation Fund of the Wyoming Game and Fish Department; Wyoming Wildlife and Natural Resource Trust; State of Wyoming Legislature through the Wyoming Wildlife and Natural Resource Trust on behalf of the Wyoming Sage-Grouse Implementation Team	American Colloid Company; Anadarko Petroleum Corporation; Bates Hole Working Group; Bighorn Basin Working Group; South-Central Working Group; Southwest Working Group; Wind River/Sweetwater River Local Sage-Grouse Working Group; Jack H. Berryman Institute; Lincoln County Predator Management Board; Margaret and Sam Kelly Ornithological Research Fund; Predatory Animal District of Sweetwater County; School of Energy Resources and Wyoming Reclamation and Restoration Center at the University of Wyoming; Uinta County Predator Management Board; Utah Agricultural Experiment Station; Wyoming Animal Damage Management Board; Wyoming Sage-grouse Conservation Fund of the Wyoming Game and Fish Department; Wyoming Wildlife and Natural Resource Trust; State of Wyoming Legislature through the Wyoming Wildlife and Natural Resource Trust on behalf of the Wyoming Sage-Grouse Implementation Team	Research funding was provided by: American Colloid Company; Anadarko Petroleum Corporation; Bates Hole, Bighorn Basin, South-Central, Southwest, and Wind River/Sweetwater River Local Sage-Grouse Working Groups; Jack H. Berryman Institute; Lincoln County Predator Management Board; Margaret and Sam Kelly Ornithological Research Fund; Predatory Animal District of Sweetwater County; School of Energy Resources and Wyoming Reclamation and Restoration Center at the University of Wyoming; Uinta County Predator Management Board; Utah Agricultural Experiment Station; Wyoming Animal Damage Management Board; Wyoming Sage-grouse Conservation Fund of the Wyoming Game and Fish Department; Wyoming Wildlife and Natural Resource Trust. Funding for analysis and publication of this paper was provided by the State of Wyoming Legislature through the Wyoming Wildlife and Natural Resource Trust on behalf of the Wyoming Sage-Grouse Implementation Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2008, ISR J ECOL EVOL, V54, P389, DOI 10.1560/IJEE.54.3-4.389; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2014, RMRSGTR326 USDA FOR; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyd C.S., 2014, J RANGELAND APPL, V1, P58; Braun C. E., 1998, P W ASS STATE FISH W, V78, P139; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; Coates PS, 2010, J WILDLIFE MANAGE, V74, P240, DOI 10.2193/2009-047; Connelly J. W., 1994, W160R19 ID DEP FISH; Connelly JW, 2011, STUD AVIAN BIOL, P53; CONNELLY JW, 1991, J WILDLIFE MANAGE, V55, P521, DOI 10.2307/3808984; Connelly JW, 2003, U IDAHO EXPT STATION, V80; Conover MR, 2010, CONDOR, V112, P331, DOI 10.1525/cond.2010.090172; Conover MR, 2007, PREDATOR PREY DYNAMI; Copeland HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067261; COX DR, 1972, J R STAT SOC B, V34, P187; Dalke P.D., 1963, J WILDLIFE MANAGE, V27, P810; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dinkins JB, 2014, CAN J ZOOL, V92, P319, DOI 10.1139/cjz-2013-0263; Dinkins J. B., 2013, THESIS UTAH STATE U; Dinkins JB, 2014, CONDOR, V116, P629, DOI 10.1650/CONDOR-13-163.1; Doherty KE, 2014, WILDLIFE BIOL, V20, P320, DOI 10.2981/wlb.00004; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; ENG ROBERT L., 1955, JOUR WILDLIFE MANAGEMENT, V19, P267, DOI 10.2307/3796862; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; GRIFFITH B, 1988, WILDLIFE SOC B, V16, P206; Hagen CA, 2011, STUD AVIAN BIOL, P95; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Kaczor NW, 2008, THESIS S DAKOTA STAT; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kirol CP, 2015, ECOL APPL, V25, P968, DOI 10.1890/13-1152.1; Kirol CP, 2012, CONDOR, V114, P75, DOI 10.1525/cond.2012.110024; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1333, DOI 10.2193/2008-338; Manly B.F.J., 2002, RESOURCE SELECTION A; Memmott KL, 1998, J RANGE MANAGE, V51, P547, DOI 10.2307/4003374; Musil DD, 2011, STUD AVIAN BIOL, P119; Northwest GAP Analysis Project, 2008, LAND COV DAT GAP AN; Patterson R.L., 1952, SAGE GROUSE WYOMING; R Core Team, 2021, R LANGUAGE ENV STAT; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rodemaker EJ, 2006, MAPPING LAND COVER T; Schroeder M.A., 1999, Birds of North America, V425, P1; State of Wyoming. Office of Governor Freudenthal, 2008, STAT WYOM EX DEP EX; Therneau T.M., 2000, MODELING SURVIVAL DA; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WALLESTAD R, 1974, J WILDLIFE MANAGE, V38, P630, DOI 10.2307/3800029; Wambolt CL, 2006, WILDLIFE SOC B, V34, P440, DOI 10.2193/0091-7648(2006)34[440:EOMSAT]2.0.CO;2; Webb Stephen L., 2012, Ecological Processes, V1	56	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150798	10.1371/journal.pone.0150798	http://dx.doi.org/10.1371/journal.pone.0150798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002531	Green Published, gold			2022-12-27	WOS:000372697400020
J	Holloway, KA; Rosella, L; Henry, D				Holloway, Kathleen Anne; Rosella, Laura; Henry, David			The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INTEGRATED MANAGEMENT; BACTERIAL-RESISTANCE; CHILDHOOD ILLNESS; IMPROVE; COUNTRIES; EPIDEMIOLOGY; GUIDELINES; DRUG; CARE	Background Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries. Aims To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies. Materials and Methods Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing. Results Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of >= 20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys. Conclusions Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries.	[Holloway, Kathleen Anne] WHO, Dept Hlth Syst Dev, Reg Off SouthEast Asia, New Delhi, India; [Rosella, Laura; Henry, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	World Health Organization; University of Toronto	Holloway, KA (corresponding author), WHO, Dept Hlth Syst Dev, Reg Off SouthEast Asia, New Delhi, India.	kaholloway54@gmail.com	Henry, David/AAU-4650-2020; Henry, David/L-3895-2017	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242	WHO Geneva	WHO Geneva(World Health Organization)	WHO Geneva funded collection of primary data on medicines policies and creation of the WHO medicines use database. However, WHO had no role in study design, data collection and analysis of secondary data on medicines policies and use, the decision to publish, nor preparation of the manuscript.	Bavestrello L, 2002, REV MED CHILE, V130, P1265; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Holloway KA, 2011, WHOBEMPMIE201122; Holloway KA, 2009, TROP MED INT HEALTH, V14, P1; Holloway KA, 2015, PAEDIATR INT CHILD H, V35, P5, DOI 10.1179/2046905514Y.0000000115; Holloway KA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001724; Holloway Kathleen Anne, 2011, Expert Rev Clin Pharmacol, V4, P335, DOI 10.1586/ecp.11.14; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Institute of Medicine, 1998, MICROBIAL THREATS HL; Jaffer B., 2007, WHO NGO TECHN BRIEF; Levy SB, 2005, ADV DRUG DELIVER REV, V57, P1446, DOI 10.1016/j.addr.2005.04.001; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Logez S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-136; Lu CY, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-75; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Park S, 2005, HEALTH POLICY PLANN, V20, P302, DOI 10.1093/heapol/czi033; Parrino TA, 2005, PHARMACOTHERAPY, V25, P289, DOI 10.1592/phco.25.2.289.56951; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Ratanawijitrasin S, 2001, SOC SCI MED, V53, P831, DOI 10.1016/S0277-9536(00)00390-7; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; SCORE, 2004, RES SENS ISS EUR ROA; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; Sketris IS, 2009, J POPUL THER CLIN PH, V16, pE103; Teng C L, 2006, Med J Malaysia, V61, P323; Trap B, 2002, HEALTH POLICY PLANN, V17, P288, DOI 10.1093/heapol/17.3.288; Vang C, 2006, EUR J CLIN PHARMACOL, V62, P57, DOI 10.1007/s00228-005-0069-8; WHO, 2005, WHOPSM20051; WHO, 1985, RAT US DRUGS C EXP; WHO, 2001, WHOCSRDRS20012; World Health Organisation, 2002, WHO POL PERSP MED, V5; World Health Organization, 2015, A6820 WHO; World Health Organization, 2006, US IND MEAS COUNTR P; World Health Organization, 2007, WHOTCM20072; World Health Organization, 1993, INVESTIGATE DRUG USE; World Health Organization, 2009, MED US PRIM CAR DEV; World Health Organization, 2010, WHOEMPMPC20101	42	40	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152020	10.1371/journal.pone.0152020	http://dx.doi.org/10.1371/journal.pone.0152020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002977	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400066
J	Klebow, S; Hahn, M; Nikoalev, A; Wunderlich, FT; Hovelmeyer, N; Karbach, SH; Waisman, A				Klebow, Sabrina; Hahn, Matthias; Nikoalev, Alexei; Wunderlich, F. Thomas; Hoevelmeyer, Nadine; Karbach, Susanne H.; Waisman, Ari			IL-6 Signaling in Myelomonocytic Cells Is Not Crucial for the Development of IMQ-Induced Psoriasis	PLOS ONE			English	Article							DELTA-T-CELLS; SKIN INFLAMMATION; EPIDERMAL HYPERPLASIA; AUTOIMMUNE-DISEASES; PLAQUE-FORMATION; IMIQUIMOD; INTERLEUKIN-6; TOCILIZUMAB; RECEPTOR; MODEL	Psoriasis is an autoimmune skin disease that is associated with aberrant activity of immune cells and keratinocytes. In mice, topical application of TLR7/8 agonist IMQ leads to a skin disorder resembling human psoriasis. Recently, it was shown that the IL-23/IL-17 axis plays a deciding role in the pathogenesis of human psoriasis, as well as in the mouse model of IMQ-induced psoriasis-like skin disease. A consequence of IL-17A production in the skin includes increased expression and production of IL-6, resulting in the recruitment of neutrophils and other myelomonocytic cells to the site of inflammation. To further investigate and characterize the exact role of IL-6 signaling in myelomonocytic cells during experimental psoriasis, we generated mice lacking the IL-6 receptor alpha specifically in myelomonocytic cells (IL-6R alpha Delta(myel)). Surprisingly, disease susceptibility of these mice was not affected in this model. Our study shows that classical IL-6 signaling in myelomonocytic cells does not play an essential role for disease development of IMQ-induced psoriasis-like skin disease.	[Klebow, Sabrina; Hahn, Matthias; Nikoalev, Alexei; Hoevelmeyer, Nadine; Karbach, Susanne H.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Wunderlich, F. Thomas] Max Planck Inst Metab Res, Cologne, Germany; [Karbach, Susanne H.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Waisman, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany.	waisman@uni-mainz.de	Karbach, Susanne/X-8136-2019; Waisman, Ari/C-7383-2015; Karbach, Susanne/GPC-8804-2022	Waisman, Ari/0000-0003-4304-8234; Hovelmeyer, Nadine/0000-0002-1807-4556	German Research Foundation (DFG) [CRC/TRR 156 (TPC01), KA 4035/1-1]; Stiftung Mainzer Herz; program MAIFOR from the University of Mainz	German Research Foundation (DFG)(German Research Foundation (DFG)); Stiftung Mainzer Herz; program MAIFOR from the University of Mainz	Research was supported by the German Research Foundation (DFG) grants CRC/TRR 156 (TPC01) to AW and KA 4035/1-1 to SHK. SHK research was also supported by the Stiftung Mainzer Herz and the program MAIFOR from the University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Camporeale A, 2012, FRONT BIOSCI-LANDMRK, V17, P2306, DOI 10.2741/4054; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Croxford AL, 2014, J INVEST DERMATOL, V134, P728, DOI 10.1038/jid.2013.404; Danilenko DM, 2008, VET PATHOL, V45, P563, DOI 10.1354/vp.45-4-563; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Ho LJ, 2015, BIOCHEM PHARMACOL, V97, P16, DOI 10.1016/j.bcp.2015.06.009; Hughes M, 2013, RHEUMATOLOGY, V52, P1728, DOI 10.1093/rheumatology/kes432; Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Lindroos J, 2011, J INVEST DERMATOL, V131, P1110, DOI 10.1038/jid.2010.432; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Palmou-Fontana N, 2014, DERMATOLOGY, V228, P311, DOI 10.1159/000362266; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Roller A, 2012, J IMMUNOL, V189, P4612, DOI 10.4049/jimmunol.1103173; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Saggini A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/964069; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Toruniowa B, 1995, ANN NY ACAD SCI, V762, P432; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Waisman A, 2012, NEW ENGL J MED, V366, P1251, DOI 10.1056/NEJMe1201071; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Wendling D, 2012, J RHEUMATOL, V39, P657, DOI 10.3899/jrheum.111166; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151913	10.1371/journal.pone.0151913	http://dx.doi.org/10.1371/journal.pone.0151913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999594	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700084
J	Marcinkiewicz, MM; Baker, ST; Wu, JC; Hubert, TL; Wolfson, MR				Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.			A Novel Approach for Ovine Primary Alveolar Epithelial Type II Cell Isolation and Culture from Fresh and Cryopreserved Tissue Obtained from Premature and Juvenile Animals	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; AIR-LIQUID INTERFACE; DIFFERENTIATED FUNCTION; NATRIURETIC-PEPTIDE; RESPIRATORY-FAILURE; IN-VITRO; LUNG; MAINTENANCE; EXPRESSION; GENE	The in vivo ovine model provides a clinically relevant platform to study cardiopulmonary mechanisms and treatments of disease; however, a robust ovine primary alveolar epithelial type II (ATII) cell culture model is lacking. The objective of this study was to develop and optimize ovine lung tissue cryopreservation and primary ATII cell culture methodologies for the purposes of dissecting mechanisms at the cellular level to elucidate responses observed in vivo. To address this, we established in vitro submerged and air-liquid interface cultures of primary ovine ATII cells isolated from fresh or cryopreserved lung tissues obtained from mechanically ventilated sheep (128 days gestation-6 months of age). Presence, abundance, and mRNA expression of surfactant proteins was assessed by immunocytochemistry, Western Blot, and quantitative PCR respectively on the day of isolation, and throughout the 7 day cell culture study period. All biomarkers were significantly greater from cells isolated from fresh than cryopreserved tissue, and those cultured in air-liquid interface as compared to submerged culture conditions at all time points. Surfactant protein expression remained in the air-liquid interface culture system while that of cells cultured in the submerged system dissipated over time. Despite differences in biomarker magnitude between cells isolated from fresh and cryopreserved tissue, cells isolated from cryopreserved tissue remained metabolically active and demonstrated a similar response as cells from fresh tissue through 72 hr period of hyperoxia. These data demonstrate a cell culture methodology using fresh or cryopreserved tissue to support study of ovine primary ATII cell function and responses, to support expanded use of biobanked tissues, and to further understanding of mechanisms that contribute to in vivo function of the lung.	[Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.] Temple Univ, Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA; [Wolfson, Marla R.] Temple Univ, Katz Sch Med, Dept Physiol Pediat & Med, Philadelphia, PA 19122 USA; [Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.] Temple Univ, Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.] Temple Univ, Katz Sch Med, CENTRe Collaborat Environm & Neonatal Therapeut, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA.; Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, Dept Physiol Pediat & Med, Philadelphia, PA 19122 USA.; Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA.; Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, CENTRe Collaborat Environm & Neonatal Therapeut, Philadelphia, PA 19122 USA.	marla.wolfson@temple.edu			Department of Defense/Office of Naval Research [N000141210597/N000141210810]; Discovery Laboratories, Inc.	Department of Defense/Office of Naval Research(Office of Naval ResearchUnited States Department of Defense); Discovery Laboratories, Inc.	This work was supported by the Department of Defense/Office of Naval Research N000141210597/N000141210810 (MRW) and Discovery Laboratories, Inc. (MRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bjarnadottir H, 2005, J BIOTECHNOL, V117, P173, DOI 10.1016/j.jbiotec.2005.01.016; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; D'Angelis CA, 2008, PEDIATR RES, V63, P239, DOI 10.1203/PDR.0b013e318163a215; D'Angelis CA, 2006, HISTOCHEM CELL BIOL, V126, P317, DOI 10.1007/s00418-006-0159-4; DiVincenti L, 2014, J AM ASSOC LAB ANIM, V53, P439; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Gonzales LW, 2001, PEDIATR PATHOL MOL M, V20, P387, DOI 10.1080/15513810109168622; Grek CL, 2009, EXP LUNG RES, V35, P155, DOI 10.1080/01902140802495870; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lenz AG, 2014, AM J RESP CELL MOL, V51, P526, DOI 10.1165/rcmb.2013-0479OC; Lenz AG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/652632; LILEY HG, 1988, BIOCHIM BIOPHYS ACTA, V961, P86, DOI 10.1016/0005-2760(88)90133-6; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Mancia A, 2012, COMP BIOCHEM PHYS C, V155, P136, DOI 10.1016/j.cbpc.2011.04.002; Marquez-Curtis LA, 2015, CRYOBIOLOGY, V71, P181, DOI 10.1016/j.cryobiol.2015.07.003; Mason R J, 1983, Curr Probl Clin Biochem, V13, P24; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X; SHANNON JM, 1990, AM J RESP CELL MOL, V2, P183, DOI 10.1165/ajrcmb/2.2.183; Shannon JM, 2001, AM J RESP CELL MOL, V24, P235, DOI 10.1165/ajrcmb.24.3.4302; SHANNON JM, 1992, AM J PHYSIOL, V262, pL427, DOI 10.1152/ajplung.1992.262.4.L427; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; SPAIN CL, 1987, PEDIATR RES, V21, P5, DOI 10.1203/00006450-198701000-00002; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; SUWABE A, 1991, AM J RESP CELL MOL, V5, P80, DOI 10.1165/ajrcmb/5.1.80; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Wolfson MR, 2008, ASAIO J, V54, P256, DOI 10.1097/MAT.0b013e318168fef0; Wolfson MR, 2012, PEDIATR RES, V72, P375, DOI 10.1038/pr.2012.96; WOLFSON MR, 1988, J APPL PHYSIOL, V65, P1436, DOI 10.1152/jappl.1988.65.3.1436; Xu XS, 1998, AM J RESP CELL MOL, V18, P168, DOI 10.1165/ajrcmb.18.2.2824; Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146, DOI 10.1152/ajplung.2000.279.6.L1146	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152027	10.1371/journal.pone.0152027	http://dx.doi.org/10.1371/journal.pone.0152027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999050	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700094
J	Summa, A; Vannozzi, G; Bergamini, E; Iosa, M; Morelli, D; Cappozzo, A				Summa, Aurora; Vannozzi, Giuseppe; Bergamini, Elena; Iosa, Marco; Morelli, Daniela; Cappozzo, Aurelio			Multilevel Upper Body Movement Control during Gait in Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; WALKING; STABILITY; TRUNK; ACCELERATIONS; YOUNG; HEAD; DISPLACEMENT; RELIABILITY; FREQUENCY	Upper body movements during walking provide information about balance control and gait stability. Typically developing (TD) children normally present a progressive decrease of accelerations from the pelvis to the head, whereas children with cerebral palsy (CP) exhibit a general increase of upper body accelerations. However, the literature describing how they are transmitted from the pelvis to the head is lacking. This study proposes a multilevel motion sensor approach to characterize upper body accelerations and how they propagate from pelvis to head in children with CP, comparing with their TD peers. Two age-and gender-matched groups of 20 children performed a 10m walking test at self-selected speed while wearing three magneto-inertial sensors located at pelvis, sternum, and head levels. The root mean square value of the accelerations at each level was computed in a local anatomical frame and its variation from lower to upper levels was described using attenuation coefficients. Between-group differences were assessed performing an ANCOVA, while the mutual dependence between acceleration components and the relationship between biomechanical parameters and typical clinical scores were investigated using Regression Analysis and Spearman's Correlation, respectively (alpha = 0.05). New insights were obtained on how the CP group managed the transmission of accelerations through the upper body. Despite a significant reduction of the acceleration from pelvis to sternum, children with CP do not compensate for large accelerations, which are greater than in TD children. Furthermore, those with CP showed negative sternum-to-head attenuations, in agreement with the documented rigidity of the head-trunk system observed in this population. In addition, the estimated parameters proved to correlate with the scores used in daily clinical practice. The proposed multilevel approach was fruitful in highlighting CP-TD gait differences, supported the in-field quantitative gait assessment in children with CP and might prove beneficial to designing innovative intervention protocols based on pelvis stabilization.	[Summa, Aurora; Vannozzi, Giuseppe; Bergamini, Elena; Cappozzo, Aurelio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Piazza Lauro De Bosis 15, I-00135 Rome, Italy; [Iosa, Marco; Morelli, Daniela] Fdn Santa Lucia IRCCS, Via Ardeatina 306, I-00179 Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia	Vannozzi, G (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Piazza Lauro De Bosis 15, I-00135 Rome, Italy.	giuseppe.vannozzi@uniroma4.it	Vannozzi, Giuseppe/G-9897-2013; Bergamini, Elena/AAC-1555-2019; Morelli, Daniela/L-2114-2018; Iosa, Marco/B-9531-2012; Iosa, Marco/AAC-1693-2022	Vannozzi, Giuseppe/0000-0002-2359-6076; Bergamini, Elena/0000-0002-9055-3981; Morelli, Daniela/0000-0001-5797-7451; 	Italian Ministry of Economic Development; University of Rome "Foro Italico"	Italian Ministry of Economic Development(Ministry of Economic Development, Italy); University of Rome "Foro Italico"	The study was financially supported by the Italian Ministry of Economic Development (ICE-CRUI agreement, call 2010, SIVAM project) and by the University of Rome "Foro Italico" (PR_2013, DeMOS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1985, STAT METHODS MED RES; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Berthoz A, 1994, HEAD BODY COORDINATI; Berthoz A, 2015, DEV MED CHILD NEUROL, V57, P15, DOI 10.1111/dmcn.12690; Brandes M, 2006, GAIT POSTURE, V24, P482, DOI 10.1016/j.gaitpost.2005.12.006; Bruijn SM, 2013, RES DEV DISABIL, V34, P1689, DOI 10.1016/j.ridd.2013.02.011; Cappa P, 2008, GAIT POSTURE, V28, P615, DOI 10.1016/j.gaitpost.2008.04.013; CAPPOZZO A, 1981, J BIOMECH, V14, P411, DOI 10.1016/0021-9290(81)90059-2; CAPPOZZO A, 1982, J BIOMECH, V15, P599, DOI 10.1016/0021-9290(82)90071-9; Chambers Henry G, 2002, J Am Acad Orthop Surg, V10, P222; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Hanna SE, 2009, DEV MED CHILD NEUROL, V51, P295, DOI 10.1111/j.1469-8749.2008.03196.x; Heyrman L, 2013, GAIT POSTURE, V38, P770, DOI 10.1016/j.gaitpost.2013.03.019; Heyrman L, 2014, RES DEV DISABIL, V35, P2044, DOI 10.1016/j.ridd.2014.04.031; HOF AL, 1996, GAIT POSTURE, V4, P222; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Innman V, 1981, HUMAN WALKING; Iosa M, 2012, RES DEV DISABIL, V33, P129, DOI 10.1016/j.ridd.2011.08.031; Kang HG, 2009, GAIT POSTURE, V30, P260, DOI 10.1016/j.gaitpost.2009.05.003; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Masci I, 2013, GAIT POSTURE, V37, P570, DOI 10.1016/j.gaitpost.2012.09.017; Massaad F, 2004, DEV MED CHILD NEUROL, V46, P674, DOI 10.1017/s0012162204001136; Mazza C, 2010, GAIT POSTURE, V31, P429, DOI 10.1016/j.gaitpost.2010.01.012; Mazza C, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-30; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Romkes J, 2007, J PEDIATR ORTHOP B, V16, P175, DOI 10.1097/BPB.0b013e32801405bf; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V109, P8, DOI DOI 10.1111/J.1469-8749.2007.TB12610.X; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Saether R, 2014, RES DEV DISABIL, V35, P1773, DOI 10.1016/j.ridd.2014.02.011; Schweizer K, 2014, CLIN BIOMECH, V29, P387, DOI 10.1016/j.clinbiomech.2014.02.005; Vaughan CL, 2003, EXP BRAIN RES, V153, P123, DOI 10.1007/s00221-003-1635-x; Wang TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143967; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	35	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151792	10.1371/journal.pone.0151792	http://dx.doi.org/10.1371/journal.pone.0151792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999362	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700066
J	Vasconcelos, BHB; Souza, GS; Barroso, TGCP; Silveira, LCL; Sousa, RCM; Callegari, B; Xavier, MB				Vasconcelos, Beatriz Helena B.; Souza, Givago S.; Barroso, Tatiana G. C. P.; Silveira, Luiz Carlos L.; Sousa, Rita Catarina M.; Callegari, Bianca; Xavier, Marilia B.			Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection	PLOS ONE			English	Article							TROPICAL SPASTIC PARAPARESIS; HTLV-I; LEUKEMIA; FEATURES; RISK	Background The human T-Cell Lymphotropic Virus Type 1 (HTLV-1) is a retrovirus associated with neurological alterations; individuals with HTLV-1 infection may develop HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Frequent neurological complaints include foot numbness and leg weakness. In this study, we compared the distribution of the body weight on different areas of the foot in HTLV-1 patients with HAM/TSP, asymptomatic HTLV-1 patients, and healthy individuals. Methodology We studied 36 HTLV-1 infected patients, who were divided in two groups of 18 patients each based on whether or not they had been diagnosed with HAM/TSP, and 17 control subjects. The evaluation included an interview on the patient's clinical history and examinations of the patient's reflexes, foot skin tactile sensitivity, and risk of falling. The pressure distribution on different areas of the foot was measured with baropodometry, using a pressure platform, while the patients had their eyes open or closed. Main Findings The prevalence of neurological disturbances-altered reflexes and skin tactile sensitivity and increased risk of falling-was higher in HTLV-1 HAM/TSP patients than in HTLV-1 asymptomatic patients. The medium and maximum pressure values were higher in the forefoot than in the midfoot and hindfoot in both HTLV-1 groups. In addition, the pressure on the hindfoot was lower in HAM/TSP patients compared to control subjects. Conclusions The neurological disturbances associated with HTLV-1 infection gradually worsened from HTLV-1 asymptomatic patients to HAM/TSP patients. Baropodometry is a valuable tool to establish the extent of neurological damage in patients suffering from HTLV-1 infection.	[Vasconcelos, Beatriz Helena B.; Xavier, Marilia B.] Univ Estado Para, Belem, Para, Brazil; [Souza, Givago S.; Barroso, Tatiana G. C. P.; Silveira, Luiz Carlos L.; Sousa, Rita Catarina M.; Xavier, Marilia B.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Souza, Givago S.; Silveira, Luiz Carlos L.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Silveira, Luiz Carlos L.] Univ Ceuma, Sao Luis, Maranhao, Brazil; [Callegari, Bianca] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Ceuma; Universidade Federal do Para	Callegari, B (corresponding author), Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil.	callegaribi@uol.com.br	Callegari, Bianca/G-3605-2016; Souza, Givago/W-6393-2019	Callegari, Bianca/0000-0001-9151-3896; Souza, Givago/0000-0002-4525-3971	Para Amazon Research Support Foundation (FAPESPA) [180/2012]; CAPES/COFECUBE [819-14]; Brazilian National Council for Scientific and Technological Development (CNPq) [486545/2012-1]; CAPES	Para Amazon Research Support Foundation (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CAPES/COFECUBE; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the following grants: Para Amazon Research Support Foundation (FAPESPA) number180/2012; CAPES/COFECUBE research grant number 819-14 and Brazilian National Council for Scientific and Technological Development (CNPq) number 486545/2012-1. BHBV is the recipient of a CAPES fellowship for graduate students. LCLS is a CNPq research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaut V.A.C.O., 2014, PHYS THER RES, V4, P99; AYRES M., 2003, BIOESTAT3 0 APLICACO; BHIGJEE AI, 1990, BRAIN, V113, P1307, DOI 10.1093/brain/113.5.1307; Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013; Cunha EFD, 2013, BRAZ J MED HUM HLTH, V1, P19; DEARAUJO A, 1993, ACTA NEUROL SCAND, V88, P59; Dias GAS, 2015, SPINAL CORD, P1; Donaghue VM, 1997, ORTHOPAEDIC PHYSICAL, V6, P1509; Franzoi AC, 2007, SPINAL CORD, V45, P64, DOI 10.1038/sj.sc.3101919; Gotuzzo E, 2004, CLIN INFECT DIS, V39, P939, DOI 10.1086/423957; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; KITAOKA HB, 1995, FOOT ANKLE INT, V16, P492, DOI 10.1177/107110079501600806; Lannes P, 2006, REV NEUROSCI, V14, P153; Macedo MC, 2013, BRAZ J MED HUM HLTH, V1, DOI [10.17267/2317-3386bjmhh.v1i2.168, DOI 10.17267/2317-3386BJMHH.V1I2.168]; Monteiro VA, 1999, THESIS PONTIFICIA U; Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA; Osame M, 2002, J NEUROVIROL, V8, P359, DOI 10.1080/13550280260422668; OSAME M, 1986, LANCET, V1, P1031; Rosario JLP, 2014, J BODYW MOV THER, V18, P215, DOI 10.1016/j.jbmt.2013.05.016; Reiss DB, 2014, RETROVIROLOGY S1, V11, pP51; Ribas João Gabriel Ramos, 2002, Rev. Soc. Bras. Med. Trop., V35, P377, DOI 10.1590/S0037-86822002000400015; Santos Fred Luciano Neves, 2005, J. Bras. Patol. Med. Lab., V41, P105, DOI 10.1590/S1676-24442005000200008; Satou Y, 2013, REV MED VIROL, V23, P269, DOI 10.1002/rmv.1745; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Souza A, 2012, REV SOC BRAS MED TRO, V45, P545, DOI 10.1590/S0037-86822012000500002; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tipismana M, 2008, SUBACUTE PROGR HTLV; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; UNSONG O, 2008, NEUROL CLIN, V26, P781, DOI DOI 10.1016/J.NCL.2008.03.008; van Sickels N. J., 2013, HUNTERS TROPICAL MED, P375; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; VERNANT JC, 1987, ANN NEUROL, V21, P123, DOI 10.1002/ana.410210204; Vianna DL, 2006, Braz. J. Phys. Ther., V10, P339, DOI 10.1590/S1413-35552006000300014; WHO, 1989, WEEKLY EPIDEMIOLOGIC, P382; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389; Zunt JR, 1999, NEUROLOGY, V53, P386, DOI 10.1212/WNL.53.2.386	36	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151855	10.1371/journal.pone.0151855	http://dx.doi.org/10.1371/journal.pone.0151855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998608	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700074
J	Bedoya-Lopez, A; Estrada, K; Sanchez-Flores, A; Ramirez, OT; Altamirano, C; Segovia, L; Miranda-Rios, J; Trujillo-Roldan, MA; Valdez-Cruz, NA				Bedoya-Lopez, Andrea; Estrada, Karel; Sanchez-Flores, Alejandro; Ramirez, Octavio T.; Altamirano, Claudia; Segovia, Lorenzo; Miranda-Rios, Juan; Trujillo-Roldan, Mauricio A.; Valdez-Cruz, Norma A.			Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture	PLOS ONE			English	Article							CONNECTS FANCONI-ANEMIA; B-MYB; GENE-EXPRESSION; DOWN-REGULATION; DIFFERENTIAL EXPRESSION; ANTIBODY-PRODUCTION; INTERFERON-GAMMA; MAMMALIAN-CELLS; COLD SHOCK; RNA-SEQ	Recombinant proteins are widely used as biopharmaceuticals, but their production by mammalian cell culture is expensive. Hence, improvement of bioprocess productivity is greatly needed. A temperature downshift (TDS) from 37 degrees C to 28-34 degrees C is an effective strategy to expand the productive life period of cells and increase their productivity (q(p)). Here, TDS in Chinese hamster ovary (CHO) cell cultures, initially grown at 37 degrees C and switched to 30 degrees C during the exponential growth phase, resulted in a 1.6-fold increase in the qp of recombinant human tissue plasminogen activator (rh-tPA). The transcriptomic response using next-generation sequencing (NGS) was assessed to characterize the cellular behavior associated with TDS. A total of 416 (q > 0.8) and 3,472 (q > 0.9) differentially expressed transcripts, with more than a 1.6-fold change at 24 and 48 h post TDS, respectively, were observed in cultures with TDS compared to those at constant 37 degrees C. In agreement with the extended cell survival resulting from TDS, transcripts related to cell growth arrest that controlled cell proliferation without the activation of the DNA damage response, were differentially expressed. Most upregulated genes were related to energy metabolism in mitochondria, mitochondrial biogenesis, central metabolism, and avoidance of apoptotic cell death. The gene coding for rh-tPA was not differentially expressed, but fluctuations were detected in the transcripts encoding proteins involved in the secretory machinery, particularly in glycosylation. Through NGS the dynamic processes caused by TDS were assessed in this biological system.	[Bedoya-Lopez, Andrea; Miranda-Rios, Juan; Trujillo-Roldan, Mauricio A.; Valdez-Cruz, Norma A.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico; [Estrada, Karel; Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotecnol, Unidad Univ Apoyo Bioinformat, Cuernavaca 62191, Morelos, Mexico; [Ramirez, Octavio T.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Segovia, Lorenzo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Pontificia Universidad Catolica de Valparaiso; Universidad Nacional Autonoma de Mexico	Valdez-Cruz, NA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico.	adri@biomedicas.unam.mx	Miranda Ríos, Juan/ABB-7767-2021; Valdez-Cruz, Norma A./AAH-9584-2020; Trujillo-Roldán, Mauricio/B-3961-2014; Segovia, Lorenzo/A-5206-2008; Sanchez-Flores, Alejandro/L-9454-2016	Valdez-Cruz, Norma A./0000-0002-8581-1173; Trujillo-Roldán, Mauricio/0000-0002-7497-4452; Segovia, Lorenzo/0000-0002-4291-4711; Altamirano, Claudia/0000-0002-6389-086X; Bedoya, Andrea/0000-0001-7804-5055; Sanchez-Flores, Alejandro/0000-0003-0476-3139	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [220795, 104951-Z, 178528]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM) [IN-210013, IN-209113]; CONACYT-Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially financed by Consejo Nacional de Ciencia y Tecnologia (CONACyT, www.conacyt.mx/, projects 220795, 104951-Z, 178528), and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM, www.dgapa.unam.mx, projects IN-210013 and IN-209113). ABL, thanks the "Programa de Doctorado en Ciencias Biomedicas", UNAM, and the scholarship from CONACYT-Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Ahn WS, 2008, BIOTECHNOL BIOENG, V101, P1234, DOI 10.1002/bit.22006; Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Alexa A, 2010, TOPGO TOPGO ENRICHME; Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; Altamirano C, 2006, ELECT J BIOTECHNOL, V9; Andersen DC, 2000, BIOTECHNOL BIOENG, V70, P25, DOI 10.1002/1097-0290(20001005)70:1<25::AID-BIT4>3.0.CO;2-Q; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; ARSURA M, 1992, BLOOD, V79, P2708; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Bhaijee F, 2011, ANN DIAGN PATHOL, V15, P69, DOI 10.1016/j.anndiagpath.2010.12.001; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Doolan P, 2012, BIOTECHNOL J, V7, P516, DOI 10.1002/biot.201100255; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fadloun A, 2008, ONCOGENE, V27, P477, DOI 10.1038/sj.onc.1210657; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fomina-Yadlin D, 2015, J BIOTECHNOL, V212, P106, DOI 10.1016/j.jbiotec.2015.08.025; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Gawlitzek M, 2009, BIOTECHNOL BIOENG, V103, P1164, DOI 10.1002/bit.22348; Gettmann J, 2013, BMC P S6, V7, pP5; Gibson L, 1996, ONCOGENE, V13, P665; Gilles C, 1999, J CELL SCI, V112, P4615; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hammond S, 2012, BIOTECHNOL BIOENG, V109, P528, DOI 10.1002/bit.23322; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Ilmjarv S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku158; Irminger-Finger I, 1998, J CELL BIOL, V143, P1329, DOI 10.1083/jcb.143.5.1329; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Jagya N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087835; Kantardjieff A, 2010, J BIOTECHNOL, V145, P143, DOI 10.1016/j.jbiotec.2009.09.008; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Kumar N, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-42; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Latham KE, 1996, ONCOGENE, V13, P1161; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; Liu WL, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Matijasevic Z, 1998, ONCOL RES, V10, P605; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Sanchez-Mora RM, 2012, J MOL NEUROSCI, V47, P582, DOI 10.1007/s12031-011-9687-z; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933; Neutelings T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069687; Odet F, 2011, BIOL REPROD, V85, P556, DOI 10.1095/biolreprod.111.091546; Oguchi S, 2006, CYTOTECHNOLOGY, V52, P199, DOI 10.1007/s10616-007-9059-2; Ohnishi T, 1998, ONCOGENE, V16, P1507, DOI 10.1038/sj.onc.1201663; Oliveira-Ferrer L, 2014, BRIT J CANCER, V110, P753, DOI 10.1038/bjc.2013.774; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Pistoni M, 2010, EMBO J, V29, P1215, DOI 10.1038/emboj.2010.16; QUELLE DE, 1995, CELL, V83, P993; Reynolds MR, 2014, ONCOGENE, V33, P556, DOI 10.1038/onc.2012.635; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Rupp O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085568; Rutter JL, 2003, ONCOGENE, V22, P4444, DOI 10.1038/sj.onc.1206564; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sanchez-Flores A, 2014, CURR TOP MED CHEM, V14, P398, DOI 10.2174/1568026613666131204142353; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schmitt E, 2000, BIOCHEM BIOPH RES CO, V270, P868, DOI 10.1006/bbrc.2000.2537; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sou SN, 2015, BIOTECHNOL BIOENG, V112, P1165, DOI 10.1002/bit.25524; Stancic A, 2013, J EXP BIOL, V216, P4233, DOI 10.1242/jeb.089334; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Swiderek H, 2007, BIOTECHNOL BIOENG, V98, P616, DOI 10.1002/bit.21445; Tao KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021602; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; Vergara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144224; Vergara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093865; Vishwanathan N, 2015, BIOTECHNOL BIOENG, V112, P965, DOI 10.1002/bit.25513; Wuest DM, 2012, BIOTECHNOL ADV, V30, P629, DOI 10.1016/j.biotechadv.2011.10.010; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Xia ZP, 2012, ASIAN J ANDROL, V14, P884, DOI 10.1038/aja.2012.71; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yee JC, 2009, BIOTECHNOL BIOENG, V102, P246, DOI 10.1002/bit.22039; Yoon SK, 2006, J BIOTECHNOL, V122, P463, DOI 10.1016/j.jbiotec.2005.09.010; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Zhang HY, 2014, CARCINOGENESIS, V35, P1863, DOI 10.1093/carcin/bgu113; Zhang XP, 2012, PROTEIN CELL, V3, P790, DOI 10.1007/s13238-012-2069-7	116	40	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151529	10.1371/journal.pone.0151529	http://dx.doi.org/10.1371/journal.pone.0151529			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991106	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800072
J	Lal, D; Reinthaler, EM; Dejanovici, B; May, P; Thiele, H; Lehesjoki, AE; Schwarz, G; Riesch, E; Ikram, MA; van Duijn, CM; Uitterlinden, AG; Hofman, A; Steinbock, H; Gruber-Sedlmayr, U; Neophytou, B; Zara, F; Hahn, A; Gormley, P; Becker, F; Weber, YG; Cilio, MR; Kunz, WS; Krause, R; Zimprich, F; Lemke, JR; Nurnberg, P; Sander, T; Lerche, H; Neubauer, BA				Lal, Dennis; Reinthaler, Eva M.; Dejanovici, Borislav; May, Patrick; Thiele, Holger; Lehesjoki, Anna-Elina; Schwarz, Gunter; Riesch, Erik; Ikram, M. Arfan; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Hofman, Albert; Steinboeck, Hannelore; Gruber-Sedlmayr, Ursula; Neophytou, Birgit; Zara, Federico; Hahn, Andreas; Gormley, Padhraig; Becker, Felicitas; Weber, Yvonne G.; Cilio, Maria Roberta; Kunz, Wolfram S.; Krause, Roland; Zimprich, Fritz; Lemke, Johannes R.; Nuernberg, Peter; Sander, Thomas; Lerche, Holger; Neubauer, Bernd A.		Genetic Comm Italian League Agains; EuroEPINOMICS CoGIE Consortium	Evaluation of Presumably Disease Causing SCN1A Variants in a Cohort of Common Epilepsy Syndromes	PLOS ONE			English	Article							NEURONAL SODIUM-CHANNEL; SEVERE MYOCLONIC EPILEPSY; FEBRILE SEIZURES PLUS; GENERALIZED EPILEPSY; DRAVET SYNDROME; ITALIAN PATIENTS; MUTATION; PREVALENCE; PHENOTYPE; GENOTYPE	Objective The SCN1A gene, coding for the voltage-gated Na+ channel alpha subunit NaV1.1, is the clinically most relevant epilepsy gene. With the advent of high-throughput next-generation sequencing, clinical laboratories are generating an ever-increasing catalogue of SCN1A variants. Variants are more likely to be classified as pathogenic if they have already been identified previously in a patient with epilepsy. Here, we critically re-evaluate the pathogenicity of this class of variants in a cohort of patients with common epilepsy syndromes and subsequently ask whether a significant fraction of benign variants have been misclassified as pathogenic. Methods We screened a discovery cohort of 448 patients with a broad range of common genetic epilepsies and 734 controls for previously reported SCN1A mutations that were assumed to be disease causing. We re-evaluated the evidence for pathogenicity of the identified variants using in silico predictions, segregation, original reports, available functional data and assessment of allele frequencies in healthy individuals as well as in a follow up cohort of 777 patients. Results and Interpretation We identified 8 known missense mutations, previously reported as pathogenic, in a total of 17 unrelated epilepsy patients (17/448; 3.80%). Our re-evaluation indicates that 7 out of these 8 variants (p.R27T; p.R28C; p.R542Q; p.R604H; p.T1250M; p.E1308D; p.R1928G; NP_001159435.1) are not pathogenic. Only the p. T1174S mutation may be considered as a genetic risk factor for epilepsy of small effect size based on the enrichment in patients (P = 6.60 x 10(-4); OR = 0.32, fishers exact test), previous functional studies but incomplete penetrance. Thus, incorporation of previous studies in genetic counseling of SCN1A sequencing results is challenging and may produce incorrect conclusions.	[Lal, Dennis; Thiele, Holger; Nuernberg, Peter; Sander, Thomas] Univ Cologne, Cologne Ctr GenoM, D-50931 Cologne, Germany; [Lal, Dennis; Gormley, Padhraig] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Lal, Dennis; Gormley, Padhraig] Harvard Univ, Sch Med, Boston, MA USA; [Lal, Dennis; Gormley, Padhraig] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Lal, Dennis; Gormley, Padhraig; Nuernberg, Peter] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Reinthaler, Eva M.; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Dejanovici, Borislav; Schwarz, Gunter] Univ Cologne, Dept Chem, Inst Biochem, D-50931 Cologne, Germany; [May, Patrick; Krause, Roland] Univ Luxembourg, LCSB, Esch Sur Alzette, Luxembourg; [Lehesjoki, Anna-Elina] Folkhalsan Inst Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Mol Neurol, Res Programs Unit, Helsinki, Finland; [Riesch, Erik] CeGaT GmbH Ctr Genom & Transcript, Tubingen, Germany; [Ikram, M. Arfan; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Neurol, Radiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Hofman, Albert] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Gruber-Sedlmayr, Ursula] Med Univ Graz, Dept Pediat, Graz, Austria; [Neophytou, Birgit] St Anna Childrens Hosp, Dept Neuropediat, A-1090 Vienna, Austria; [Zara, Federico] Inst G Gaslini, Lab Neurogenet & Neurosci, Genoa, Italy; [Hahn, Andreas; Neubauer, Bernd A.] Univ Med Ctr Giessen & Marburg, Dept Neuropediat, Giessen, Germany; [Becker, Felicitas; Weber, Yvonne G.; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany; [Cilio, Maria Roberta] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Cilio, Maria Roberta] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany; [Lemke, Johannes R.] Univ Leipzig, Inst Human Genet, D-04109 Leipzig, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Medical University of Vienna; University of Cologne; University of Luxembourg; University of Helsinki; University of Helsinki; CeGaT; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Medical University of Graz; Saint Anna Children's Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; University Hospital of Giessen & Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Bonn; Leipzig University; University of Cologne	Lal, D (corresponding author), Univ Cologne, Cologne Ctr GenoM, D-50931 Cologne, Germany.; Lal, D (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA.; Lal, D (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Lal, D (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.	Dennis.Lal@uni-koeln.de	Gormley, Padhraig/L-1949-2018; Zimprich, Fritz/O-1406-2019; May, Patrick/N-1019-2019; Thiele, Holger/ABE-6792-2020; Ronen, Gabriel M/AAS-3048-2021; Muhle, Hiltrud/F-5715-2010; Zara, Federico/U-3477-2017; Schwarz, Guenter/ABE-9643-2021; Neubauer, Bernd/AAZ-9391-2020; Kunz, Wolfram/K-1232-2019; Baulac, Stéphanie/O-2099-2016; Cilio, Maria Roberta/AAY-6197-2021; May, Patrick/B-1238-2010; Nothnagel, Michael/L-7187-2019; Caglayan, Hande S/A-2368-2016; Ikram, M. Arfan/AAM-5225-2021; Zimprich, Fritz/W-1738-2017; MINETTI, Carlo/K-4666-2018	Gormley, Padhraig/0000-0002-8908-6968; Zimprich, Fritz/0000-0002-6998-5480; May, Patrick/0000-0001-8698-3770; Thiele, Holger/0000-0002-0169-998X; Ronen, Gabriel M/0000-0002-7467-0627; Zara, Federico/0000-0001-9744-5222; Schwarz, Guenter/0000-0002-2118-9338; Kunz, Wolfram/0000-0003-1113-3493; Baulac, Stéphanie/0000-0001-6430-4693; Cilio, Maria Roberta/0000-0003-2481-8053; May, Patrick/0000-0001-8698-3770; Nothnagel, Michael/0000-0001-8305-7114; Caglayan, Hande S/0000-0001-6402-3306; Zimprich, Fritz/0000-0002-6998-5480; Moller, Rikke S./0000-0002-9664-1448; Altmuller, Janine/0000-0003-4372-1521; Van Duijn, Cornelia/0000-0002-2374-9204; Balling, Rudi/0000-0003-2902-5650; Suls, Arvid/0000-0003-0328-198X; Palotie, Aarno/0000-0002-2527-5874; Krause, Roland/0000-0001-9938-7126; MINETTI, Carlo/0000-0002-0640-1804; Feucht, Martha/0000-0001-7691-8158	EuroEPINOMICS programme (DFG grant) within the EUROCORES framework of the European Science Foundation (ESF) [LE1030/11-1, BN416/5-1, NU50/8-1, SA434/5-1]; EuroEPINOMICS programme (FWF grant) within the EUROCORES framework of the European Science Foundation (ESF) [1643-B09]; Netherlands Organization of Scientific Research NOW Investments [175.010.2005.011, 911-03-012]; Netherlands Genomics Initiative (NGI)/NOW project (Netherlands Consortium for Healthy Ageing; NCHA) [050-060-810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Austrian Science Fund (FWF) [I 643] Funding Source: researchfish	EuroEPINOMICS programme (DFG grant) within the EUROCORES framework of the European Science Foundation (ESF); EuroEPINOMICS programme (FWF grant) within the EUROCORES framework of the European Science Foundation (ESF); Netherlands Organization of Scientific Research NOW Investments; Netherlands Genomics Initiative (NGI)/NOW project (Netherlands Consortium for Healthy Ageing; NCHA); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	HL BN PN TS F. Zimprich received grants by the EuroEPINOMICS programme (DFG grant numbers: HL: LE1030/11-1, BN: BN416/5-1, PN: NU50/8-1, TS: SA434/5-1, FWF grant number: F. Zimprich: 1643-B09) within the EUROCORES framework of the European Science Foundation (ESF). The generation and management of genomics data for the Rotterdam Study are supported by the Netherlands Organization of Scientific Research NOW Investments (nr. 175.010.2005.011, 911-03-012) and the Netherlands Genomics Initiative (NGI)/NOW project nr. 050-060-810 (Netherlands Consortium for Healthy Ageing; NCHA). The authors thank the members of the Genomics Lab and the ERGO support team for their help in sampling the data and in creating the database, the study participants, the staff of the Rotterdam Study and the participating general practitioners and pharmacists. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participants and their families for participating in this study. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at (http://exac. broadinstitute.org/). H.L., B.N., P.N., T.S. and F.Z. received grants by the EuroEPINOMICS programme (DFG grant numbers: HL: LE1030/11-1, BN: BN416/5-1, PN: NU50/8-1, TS: SA434/5-1, FWF grant number: FZ: 1643-B09) within the EUROCORES framework of the European Science Foundation (ESF). The generation and management of genomics data for the Rotterdam Study are supported by the Netherlands Organization of Scientific Research NOW Investments (nr. 175.010.2005.011, 911-03-012) and the Netherlands Genomics Initiative (NGI)/NOW project nr. 050-060-810 (Netherlands Consortium for Healthy Ageing; NCHA). We thank the members of the Genomics Lab and the ERGO support team for their help in sampling the data and in creating the database, the study participants, the staff of the Rotterdam Study and the participating general practitioners and pharmacists. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Catarino CB, 2011, BRAIN, V134, P2982, DOI 10.1093/brain/awr129; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Cestele S, 2013, EPILEPSIA, V54, P927, DOI 10.1111/epi.12123; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; Fendri-Kriaa N, 2009, EUR J NEUROL, V16, P697, DOI 10.1111/j.1468-1331.2009.02570.x; Frosk P, 2013, J CHILD NEUROL, V28, P389, DOI 10.1177/0883073812443309; Frousios K, 2013, GENOMICS, V102, P223, DOI 10.1016/j.ygeno.2013.06.005; Gargus JJ, 2007, PEDIATR NEUROL, V37, P407, DOI 10.1016/j.pediatrneurol.2007.06.016; Goldberg-Stern H, 2014, J CHILD NEUROL, V29, P221, DOI 10.1177/0883073813509016; Heron SE, 2010, J MED GENET, V47, P137, DOI 10.1136/jmg.2008.065912; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Javed A, 2014, NAT METHODS, V11, P935, DOI [10.1038/NMETH.3046, 10.1038/nmeth.3046]; Kasperaviciute D, 2013, BRAIN, V136, P3140, DOI 10.1093/brain/awt233; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lossin C, 2003, J NEUROSCI, V23, P11289; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Marini Carla, 2010, Expert Rev Clin Pharmacol, V3, P371, DOI 10.1586/ecp.10.20; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; Nicita F, 2010, J CHILD NEUROL, V25, P1369, DOI 10.1177/0883073810365737; Orrico A, 2009, CLIN GENET, V75, P579, DOI 10.1111/j.1399-0004.2009.01155.x; Parihar R, 2013, J HUM GENET, V58, P573, DOI 10.1038/jhg.2013.77; Passamonti C, 2015, EPILEPSY BEHAV, V43, P89, DOI 10.1016/j.yebeh.2014.11.009; Ragsdale DS, 2008, BRAIN RES REV, V58, P149, DOI 10.1016/j.brainresrev.2008.01.003; Reinthaler EM, 2014, EPILEPSIA, V55, pE89, DOI 10.1111/epi.12712; Rilstone JJ, 2012, EPILEPSIA, V53, P1421, DOI 10.1111/j.1528-1167.2012.03583.x; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; Wang JW, 2012, EPILEPSY RES, V102, P195, DOI 10.1016/j.eplepsyres.2012.06.006; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Yordanova I, 2011, NEUROSCI LETT, V494, P180, DOI 10.1016/j.neulet.2011.03.008; Zucca C, 2008, ARCH NEUROL-CHICAGO, V65, P489, DOI 10.1001/archneur.65.4.489	39	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150426	10.1371/journal.pone.0150426	http://dx.doi.org/10.1371/journal.pone.0150426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990884	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800030
J	Diaz-Balzac, CA; Lazaro-Pena, MI; Vazquez-Figueroa, LD; Diaz-Balzac, RJ; Garcia-Arraras, JE				Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.; Vazquez-Figueroa, Lionel D.; Diaz-Balzac, Roberto J.; Garcia-Arraras, Jose E.			Holothurian Nervous System Diversity Revealed by Neuroanatomical Analysis	PLOS ONE			English	Article							URCHIN TUBE FEET; STARFISH ASTERIAS-RUBENS; STRONGYLOCENTROTUS-PURPURATUS; HEPTAPEPTIDE GFSKLYFAMIDE; SALMFAMIDE NEUROPEPTIDES; GLABERRIMA ECHINODERMATA; SMOOTH-MUSCLE; IMMUNOREACTIVITY; LOCALIZATION; CELLS	The Echinodermata comprise an interesting branch in the phylogenetic tree of deuterostomes. Their radial symmetry which is reflected in their nervous system anatomy makes them a target of interest in the study of nervous system evolution. Until recently, the study of the echinoderm nervous system has been hindered by a shortage of neuronal markers. However, in recent years several markers of neuronal and fiber subpopulations have been described. These have been used to identify subpopulations of neurons and fibers, but an integrative study of the anatomical relationship of these subpopulations is wanting. We have now used eight commercial antibodies, together with three antibodies produced by our group to provide a comprehensive and integrated description and new details of the echinoderm neuroanatomy using the holothurian Holothuria glaberrima (Selenka, 1867) as our model system. Immunoreactivity of the markers used showed: (1) specific labeling patterns by markers in the radial nerve cords, which suggest the presence of specific nerve tracts in holothurians. (2) Nerves directly innervate most muscle fibers in the longitudinal muscles. (3) Similar to other deuterostomes (mainly vertebrates), their enteric nervous system is composed of a large and diverse repertoire of neurons and fiber phenotypes. Our results provide a first blueprint of the anatomical organization of cells and fibers that form the holothurian neural circuitry, and highlight the fact that the echinoderm nervous system shows unexpected diversity in cell and fiber types and their distribution in both central and peripheral nervous components.	[Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave,Ullmann Room 709, Bronx, NY 10461 USA; [Diaz-Balzac, Carlos A.; Lazaro-Pena, Maria I.; Vazquez-Figueroa, Lionel D.; Diaz-Balzac, Roberto J.; Garcia-Arraras, Jose E.] Univ Puerto Rico, Dept Biol, Univ Puerto Rico Rio Piedras Campus,POB 23360, San Juan, PR 00931 USA	Yeshiva University; Albert Einstein College of Medicine; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras	Garcia-Arraras, JE (corresponding author), Univ Puerto Rico, Dept Biol, Univ Puerto Rico Rio Piedras Campus,POB 23360, San Juan, PR 00931 USA.	jegarcia@hpcf.upr.edu		Lazaro-Pena, Maria I./0000-0002-3061-8835; Diaz-Balzac, Carlos A./0000-0002-4723-1282	NSF [IOS-1252679, IOS-0842870]; NIH [1R15NS081686-01, 1SC1GM084770-01, 1R03NS065275-01]; University of Puerto Rico-Rio Piedras (UPR-RP) MARC Program [5T34GM007821]; Albert Einstein College of Medicine MSTP training grant [T32GM007288]; National Institute of Child Health and Human Development (NICHD) [F31HD066967, 2R25GM061151, R25GM097635-01]; NIH-RCMI [RRO-3641-01]; University of Puerto Rico; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD066967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151, T32GM007288, T34GM007821, SC1GM084770, R25GM097635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS081686, R03NS065275] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico-Rio Piedras (UPR-RP) MARC Program; Albert Einstein College of Medicine MSTP training grant; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH-RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NSF (IOS-1252679 and IOS-0842870) and NIH (1R15NS081686-01, 1SC1GM084770-01 and 1R03NS065275-01). CADB was funded by the University of Puerto Rico-Rio Piedras (UPR-RP) MARC Program (5T34GM007821), the Albert Einstein College of Medicine MSTP training grant (T32GM007288) and the National Institute of Child Health and Human Development (NICHD) predoctoral fellowship (F31HD066967), MILP by the UPR-RP RISE Program (2R25GM061151) and LDVF by the NIH ENDURE Program (R25GM097635-01). We also acknowledge partial support from NIH-RCMI (RRO-3641-01) and the University of Puerto Rico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2011, J COMP NEUROL, V519, P3566, DOI 10.1002/cne.22724; Bullock T., 1965, STRUCTURE FUNCTION N; Burke RD, 2006, J COMP NEUROL, V496, P244, DOI 10.1002/cne.20939; COBB JLS, 1985, BIOL BULL, V168, P432, DOI 10.2307/1541523; COBB JLS, 1969, COMP BIOCHEM PHYSIOL, V28, P967, DOI 10.1016/0010-406X(69)92132-X; COBB JLS, 1966, PROC R SOC SER B-BIO, V164, P641, DOI 10.1098/rspb.1966.0053; COTTRELL G A, 1970, Comparative and General Pharmacology, V1, P73, DOI 10.1016/0010-4035(70)90011-X; Devlin C. Leah, 1999, Invertebrate Neuroscience, V4, P1, DOI 10.1007/s101580050001; DEVLIN CL, 1993, COMP BIOCHEM PHYS C, V106, P573, DOI 10.1016/0742-8413(93)90181-J; Diaz-Balzac CA, 2007, BIOL BULL-US, V213, P28, DOI 10.2307/25066616; Diaz-Balzac CA, 2014, INVERTEBR NEUROSCI, V14, P113, DOI 10.1007/s10158-014-0169-1; Diaz-Balzac CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032689; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P99, DOI 10.1007/s00435-010-0103-y; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P33, DOI 10.1007/s00435-009-0098-4; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DiazMiranda L, 1996, CELL TISSUE RES, V286, P385, DOI 10.1007/s004410050708; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; ELPHICK MR, 1991, PEPTIDES, V12, P455, DOI 10.1016/0196-9781(91)90083-2; Elphick MR, 1991, NEUROPEPTIDE STRUCTU; FAUQUET M, 1989, J HISTOCHEM CYTOCHEM, V37, P1197, DOI 10.1177/37.8.2569003; Flament-Durand J, 1980, Acta Psychiatr Belg, V80, P364; FLOREY E, 1959, J PHYSIOL-LONDON, V145, P66, DOI 10.1113/jphysiol.1959.sp006127; FLOREY E, 1975, COMP BIOCHEM PHYS C, V51, P5, DOI 10.1016/0306-4492(75)90031-3; Garcia-Arraras J.E., 1993, HDB ENDOCRINE RES TR, P207; Garcia-Arraras JE, 2001, J EXP BIOL, V204, P865; GARCIAARRARAS JE, 1991, NEUROSCI LETT, V132, P199, DOI 10.1016/0304-3940(91)90301-9; Hoekstra LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044220; Hyman LH, 1955, INVERTEBRATES ECHINO; Inoue M, 2002, ZOOL SCI, V19, P1217, DOI 10.2108/zsj.19.1217; Lesser MP, 2011, P ROY SOC B-BIOL SCI, V278, P3371, DOI 10.1098/rspb.2011.0336; Mashanov V.S, 2016, STRUCTURE EVOLUTION, P665; Mashanov VS, 2007, EVOL DEV, V9, P244, DOI 10.1111/j.1525-142X.2007.00157.x; Mashanov VS, 2010, GLIA, V58, P1581, DOI 10.1002/glia.21031; Mashanov VS, 2006, ZOOMORPHOLOGY, V125, P27, DOI 10.1007/s00435-005-0010-9; NEWMAN SJ, 1995, P ROY SOC B-BIOL SCI, V261, P139, DOI 10.1098/rspb.1995.0128; NEWMAN SJ, 1994, CELL TISSUE RES, V278, P177, DOI 10.1007/s004410050205; PENTREATH VW, 1972, BIOL REV, V47, P363, DOI 10.1111/j.1469-185X.1972.tb00977.x; PROTAS LL, 1980, GEN PHARMACOL, V11, P113, DOI 10.1016/0306-3623(80)90019-1; STUBBS TR, 1981, CELL TISSUE RES, V220, P373; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Ullrich-Luter EM, 2011, P NATL ACAD SCI USA, V108, P8367, DOI 10.1073/pnas.1018495108	42	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151129	10.1371/journal.pone.0151129	http://dx.doi.org/10.1371/journal.pone.0151129			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987052	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300048
J	Estrada, J; Ruiz-Herrero, T; Scholes, C; Wunderlich, Z; DePace, AH				Estrada, Javier; Ruiz-Herrero, Teresa; Scholes, Clarissa; Wunderlich, Zeba; DePace, Angela H.			SiteOut: An Online Tool to Design Binding Site-Free DNA Sequences	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ENHANCER; COMPLEX; SPECIFICITY; EXPRESSION; SHAPE	DNA-binding proteins control many fundamental biological processes such as transcription, recombination and replication. A major goal is to decipher the role that DNA sequence plays in orchestrating the binding and activity of such regulatory proteins. To address this goal, it is useful to rationally design DNA sequences with desired numbers, affinities and arrangements of protein binding sites. However, removing binding sites from DNA is computationally non-trivial since one risks creating new sites in the process of deleting or moving others. Here we present an online binding site removal tool, SiteOut, that enables users to design arbitrary DNA sequences that entirely lack binding sites for factors of interest. SiteOut can also be used to delete sites from a specific sequence, or to introduce site-free spacers between functional sequences without creating new sites at the junctions. In combination with commercial DNA synthesis services, SiteOut provides a powerful and flexible platform for synthetic projects that interrogate regulatory DNA.	[Estrada, Javier; Scholes, Clarissa; Wunderlich, Zeba; DePace, Angela H.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Ruiz-Herrero, Teresa] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wunderlich, Zeba] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92717 USA	Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Irvine	DePace, AH (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.	angela_depace@hms.harvard.edu	Wunderlich, Zeba/I-9530-2019	Wunderlich, Zeba/0000-0003-4491-5715; Estrada Diez, Francisco Javier/0000-0001-8918-2573; Estrada, Javier/0000-0003-3646-204X	NIH [U01GM103804-01A1, R00HD073191]; NSF CAREER Award [1452557]; Grinnell Fund for Biomedical Research; Department of Systems Biology at HMS; Ramon Areces Foundation; Harvard Graduate Society Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM103804, T32GM007598] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Grinnell Fund for Biomedical Research; Department of Systems Biology at HMS; Ramon Areces Foundation; Harvard Graduate Society Research Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the DePace lab is generously supported by NIH U01GM103804-01A1, NSF CAREER Award 1452557 and the Grinnell Fund for Biomedical Research. JE was supported by the Department of Systems Biology at HMS, TRH by the Ramon Areces Foundation, ZW by NIH grant R00HD073191, and CS by a Harvard Graduate Society Research Fellowship.	Akbari OS, 2008, DEVELOPMENT, V135, P123, DOI 10.1242/dev.010744; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Crocker J, 2015, LOW AFFINITY BINDING; Erceg J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004060; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Weingarten-Gabbay S, 2014, HUM GENET, V133, P701, DOI 10.1007/s00439-013-1413-1; Wolanski M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00735; Wunderlich Z, 2015, CELL REP, V12, P1740, DOI 10.1016/j.celrep.2015.08.021; Zhou TY, 2015, P NATL ACAD SCI USA, V112, P4654, DOI 10.1073/pnas.1422023112	16	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151740	10.1371/journal.pone.0151740	http://dx.doi.org/10.1371/journal.pone.0151740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987123	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300121
J	Holldobler, B				Hoelldobler, Bert			Queen Specific Exocrine Glands in Legionary Ants and Their Possible Function in Sexual Selection	PLOS ONE			English	Article							ARMY ANTS; HYMENOPTERA; REPRODUCTION; FORMICIDAE; PHYLOGENY	The colonies of army ants and some other legionary ant species have single, permanently wingless queens with massive post petioles and large gasters. Such highly modified queens are called dichthadiigynes. This paper presents the unusually rich exocrine gland endowment of dichthadiigynes, which is not found in queens of other ant species. It has been suggested these kinds of glands produce secretions that attract and maintain worker retinues around queens, especially during migration. However, large worker retinues also occur in non-legionary species whose queens do not have such an exuberance of exocrine glands. We argue and present evidence in support of our previously proposed hypothesis that the enormous outfit of exocrine glands found in dichthadiigynes is due to sexual selection mediated by workers as the main selecting agents.	[Hoelldobler, Bert] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ USA; [Hoelldobler, Bert] Univ Wurzburg, Biozentrum, Zool 2, D-97070 Wurzburg, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B (corresponding author), Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ USA.; Holldobler, B (corresponding author), Univ Wurzburg, Biozentrum, Zool 2, D-97070 Wurzburg, Germany.	Bert.Hoelldobler@asu.edu						[Anonymous], 1971, INSECT SOC; Berghoff SM, 2003, INSECT SOC, V50, P139, DOI 10.1007/s00040-003-0642-z; Berghoff SM, 2002, INSECT SOC, V49, P133, DOI 10.1007/s00040-002-8292-0; BOLTON B, 1990, J NAT HIST, V24, P1339, DOI 10.1080/00222939000770811; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Brady SG, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-93; Brady SG, 2005, SYST ENTOMOL, V30, P593, DOI 10.1111/j.1365-3113.2005.00290.x; Brady SG, 2003, P NATL ACAD SCI USA, V100, P6575, DOI 10.1073/pnas.1137809100; Brown W. L. jr., 1960, Bulletin of the Museum of Comparative Zoology Harvard, V122, P145; FLETCHER DJC, 1985, ANNU REV ENTOMOL, V30, P319, DOI 10.1146/annurev.en.30.010185.001535; FRANKS NR, 1987, BIOL J LINN SOC, V30, P229, DOI 10.1111/j.1095-8312.1987.tb00298.x; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; HOLLDOBLER B, 1994, INSECT SOC, V41, P63, DOI 10.1007/BF01240573; Holldobler B., 1982, Psyche (Cambridge), V89, P113, DOI 10.1155/1982/40397; HOLLDOBLER B, 1983, ANN ENTOMOL SOC AM, V76, P235, DOI 10.1093/aesa/76.2.235; HOLLDOBLER B, 1989, ZOOMORPHOLOGY, V108, P255, DOI 10.1007/BF00312158; Holldobler B., 1978, Psyche (Cambridge), V85, P285, DOI 10.1155/1978/23867; Holldobler B., 1990, pi; HOLLDOBLER B, 1982, NATURWISSENSCHAFTEN, V69, P90, DOI 10.1007/BF00441231; HOLLDOBLER B, 1985, FORTS ZOOL, V31, P237; Holldobler B., 2011, LEAFCUTTER ANTS CIVI; Holldobler B., 2009, THE SUPERORGANISM; Kronauer DJC, 2006, NATURWISSENSCHAFTEN, V93, P402, DOI 10.1007/s00114-006-0121-2; MASUKO K, 1990, INSECT SOC, V37, P31, DOI 10.1007/BF02223813; Nakata K, 1998, J INSECT BEHAV, V11, P869, DOI 10.1023/A:1020816227912; Passera Luc, 1984, ORGANISATION SOCIAL; PEETERS C, 1985, BEHAV ECOL SOCIOBIOL, V18, P29; Peeters C, 1991, QUEEN NUMBER SOCIALI, P235; RATHMAYER W, 1962, EXPERIENTIA, V18, P47, DOI 10.1007/BF02136658; Rettenmeyer C. W., 1963, Kansas University Science Bulletin, V44, P281; RETTENMEYER CW, 1978, ANN ENTOMOL SOC AM, V71, P519, DOI 10.1093/aesa/71.4.519; SCHNEIRL.TC, 1969, ANIM BEHAV, V17, P87, DOI 10.1016/0003-3472(69)90116-X; Schneirla T. C., 1971, ARMY ANTS STUDY SOCI; Whelden RM, 1963, J NY ENTOMOL SOC, V71, P246; WHELDEN ROY M., 1963, JOUR NEW YORK ENTOMOL SOC, V71, P158; WHELDEN ROY M., 1963, JOUR NEW YORK ENTOMOL SOC, V71, P14; WHELDEN ROY M., 1963, JOUR NEW YORK ENTOMOL SOC, V71, P90; Witte V, 2000, INSECT SOC, V47, P76, DOI 10.1007/s000400050012	38	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151604	10.1371/journal.pone.0151604	http://dx.doi.org/10.1371/journal.pone.0151604			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986740	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300093
J	Kruisselbrink, R; Kwizera, A; Crowther, M; Fox-Robichaud, A; O'Shea, T; Nakibuuka, J; Ssinabulya, I; Nalyazi, J; Bonner, A; Devji, T; Wong, J; Cook, D				Kruisselbrink, Rebecca; Kwizera, Arthur; Crowther, Mark; Fox-Robichaud, Alison; O'Shea, Timothy; Nakibuuka, Jane; Ssinabulya, Isaac; Nalyazi, Joan; Bonner, Ashley; Devji, Tahira; Wong, Jeffrey; Cook, Deborah			Modified Early Warning Score (MEWS) Identifies Critical Illness among Ward Patients in a Resource Restricted Setting in Kampala, Uganda: A Prospective Observational Study	PLOS ONE			English	Article							CRITICAL-CARE; SEVERE SEPSIS; LOW-INCOME; VIEWS; VALIDATION; MANAGEMENT; HOSPITALS; ADMISSION; PREDICTS; BURDEN	Introduction Providing optimal critical care in developing countries is limited by lack of recognition of critical illness and lack of essential resources. The Modified Early Warning Score (MEWS), based on physiological parameters, is validated in adult medical and surgical patients as a predictor of mortality. The objective of this study performed in Uganda was to determine the prevalence of critical illness on the wards as defined by the MEWS, to evaluate the MEWS as a predictor of death, and to describe additional risk factors for mortality. Methods We conducted a prospective observational study at Mulago National Referral Teaching Hospital in Uganda. We included medical and surgical ward patients over 18 years old, excluding patients discharged the day of enrolment, obstetrical patients, and patients who self-discharged prior to study completion. Over a 72-hour study period, we collected demographic and vital signs, and calculated MEWS; at 7-days we measured outcomes. Patients discharged prior to 7 days were assumed to be alive at study completion. Descriptive and inferential statistical analyses were performed. Results Of 452 patients, the median age was 40.5 (IQR 29-54) years, 53.3% were male, 24.3% were HIV positive, and 45.1% had medical diagnoses. MEWS ranged from 0 to 9, with higher scores representing hemodynamic instability. The median MEWS was 2 [IQR 1-3] and the median length of hospital stay was 9 days [IQR 4-24]. In-hospital mortality at 7-days was 5.5%; 41.4% of patients were discharged and 53.1% remained on the ward. Mortality was independently associated with medical admission (OR: 7.17; 95% CI: 2.064-24.930; p = 0.002) and the MEWS >= 5 (OR: 5.82; 95% CI: 2.420-13.987; p<0.0001) in the multivariable analysis. Conclusion There is a significant burden of critical illness at Mulago Hospital, Uganda. Implementation of the MEWS could provide a useful triage tool to identify patients at greatest risk of death. Future research should include refinement of MEWS for low-resource settings, and development of appropriate interventions for patients identified to be at high risk of death based on early warning scores.	[Kruisselbrink, Rebecca; Crowther, Mark; O'Shea, Timothy; Cook, Deborah] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kwizera, Arthur] Makerere Univ, Dept Anesthesia & Crit Care, Kampala, Uganda; [Fox-Robichaud, Alison] McMaster Univ, Dept Crit Care, Hamilton, ON, Canada; [Nakibuuka, Jane] Mulago Hosp, Dept Med, Kampala, Uganda; [Ssinabulya, Isaac; Nalyazi, Joan] Makerere Univ, Dept Med, Kampala, Uganda; [Bonner, Ashley] McMaster Univ, Dept Biostat, Hamilton, ON, Canada; [Devji, Tahira] McMaster Univ, Dept Hlth Res Methodol, Hamilton, ON, Canada; [Wong, Jeffrey] Univ Toronto, Dept Med, Toronto, ON, Canada	McMaster University; Makerere University; McMaster University; Mulago National Referral Hospital; Makerere University; McMaster University; McMaster University; University of Toronto	Kruisselbrink, R (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	rebecca.kruisselbrink@medportal.ca	Smith, Gary B/A-8235-2013	Ssinabulya, Isaac/0000-0001-6521-7778; Wong, Jeffrey Man Hay/0000-0001-9164-3383; Kwizera, Arthur/0000-0002-7025-0465	Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	The authors received no specific funding for this work. The oximeters used for the study were donated by ProResp, Inc. The funder played no role in the design, data collection, analysis, interpretation, or write-up of this study. Dr. Crowther is funded by the Heart and Stroke Foundation of Canada. Dr. Cook holds a Research Chair of the Canadian Institutes of Health Research.	Adhikari NKJ, 2011, CURR OPIN CRIT CARE, V17, P620, DOI 10.1097/MCC.0b013e32834cd39c; Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Bhagwanjee S, 2006, CRIT CARE CLIN, V22, P433, DOI 10.1016/j.ccc.2006.03.008; Bleyer AJ, 2011, RESUSCITATION, V82, P1387, DOI 10.1016/j.resuscitation.2011.06.033; Burch VC, 2008, EMERG MED J, V25, P674, DOI 10.1136/emj.2007.057661; Churpek MM, 2012, CRIT CARE MED, V40, P2102, DOI 10.1097/CCM.0b013e318250aa5a; Cuthbertson BH, 2008, RESUSCITATION, V77, P153, DOI 10.1016/j.resuscitation.2008.03.013; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Edwards SE, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.007; Fowler RA, 2008, CRIT CARE, V12, DOI 10.1186/cc6984; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Kellett J, 2013, RESUSCITATION, V84, P13, DOI 10.1016/j.resuscitation.2012.08.331; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Ludikhuize J, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.003; Opio MO, 2013, RESUSCITATION, V84, P743, DOI 10.1016/j.resuscitation.2013.02.007; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Romero-Brufau S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0999-1; Rylance J, 2009, T ROY SOC TROP MED H, V103, P790, DOI 10.1016/j.trstmh.2009.05.004; Subbe CP, 2010, RESUSCITATION, V81, P923, DOI 10.1016/j.resuscitation.2010.05.013; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Wheeler I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059830; WHO, 2014, GLOB HLTH OBS	28	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151408	10.1371/journal.pone.0151408	http://dx.doi.org/10.1371/journal.pone.0151408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986466	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300067
J	Duvvari, MR; van de Ven, JPH; Geerlings, MJ; Saksens, NTM; Bakker, B; Henkes, A; Neveling, K; del Rosario, M; Westra, D; van den Heuvel, LPWJ; Schick, T; Fauser, S; Boon, CJF; Hoyng, CB; de Jong, EK; den Hollander, AI				Duvvari, Maheswara R.; van de Ven, Johannes P. H.; Geerlings, Maartje J.; Saksens, Nicole T. M.; Bakker, Bjorn; Henkes, Arjen; Neveling, Kornelia; del Rosario, Marisol; Westra, Dineke; van den Heuvel, Lambertus P. W. J.; Schick, Tina; Fauser, Sascha; Boon, Camiel J. F.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.			Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration	PLOS ONE			English	Article							BASAL LAMINAR DRUSEN; EXTRACELLULAR-MATRIX; BRUCHS MEMBRANE; GRADING SYSTEM; HIGH-RISK; CFH GENE; DISEASE; MUTATION; RARE; CLASSIFICATION	Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly people worldwide. Cuticular drusen (CD) is a clinical subtype of AMD, which typically displays an earlier age at onset, and has a strong genetic component. Genetic studies support a role for rare sequence variants in CD susceptibility, and rare sequence variants in the CFH gene have been identified in 8.8% of CD cases. To further explore the role of rare variants in CD, we performed whole exome sequencing (WES) in 14 affected members of six families and 12 sporadic cases with CD. We detected rare sequence variants in CFH and FBLN5, which previously were shown to harbor rare variants in patients with CD. In addition, we detected heterozygous rare sequence variants in several genes encoding components of the extracellular matrix (ECM), including FBLN1, FBLN3/EFEMP1, FBLN5, FBLN6/HMCN1, FBN2, and COL15A1. Two rare pathogenic variants were identified in the COL15A1 gene: one in a sporadic case and another was found to segregate in a family with six affected individuals with CD. In addition, two rare pathogenic variants were identified in the FGL1 gene in three unrelated CD cases. These findings suggest that alterations in the ECM and in the coagulation pathway may play a role in the pathogenesis of CD. The identified candidate genes require further analyses in larger cohorts to confirm their role in the CD subtype of AMD. No evidence was found of rare sequence variants in a single gene that segregate with CD in the six families, suggesting that the disease is genetically heterogeneous.	[Duvvari, Maheswara R.; van de Ven, Johannes P. H.; Geerlings, Maartje J.; Saksens, Nicole T. M.; Bakker, Bjorn; Henkes, Arjen; Boon, Camiel J. F.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Henkes, Arjen; Neveling, Kornelia; del Rosario, Marisol; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Westra, Dineke; van den Heuvel, Lambertus P. W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Nephrol, NL-6525 ED Nijmegen, Netherlands; [Schick, Tina; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hollander, Anneke den/N-4911-2014; Geerlings, Maartje/P-3338-2019; van den Heuvel, Lambertus/AAM-1772-2021; de Jong, Eiko/P-3407-2015; Geerlings, Maartje/P-8309-2015; van den Heuvel, L.P.W.J./H-8044-2014; Bakker, Bjorn/E-2842-2016; Boon, CJF/P-7534-2014	Geerlings, Maartje/0000-0003-1164-3573; van den Heuvel, Lambertus/0000-0003-3917-6727; de Jong, Eiko/0000-0001-6520-0407; Geerlings, Maartje/0000-0003-1164-3573; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Boon, CJF/0000-0002-6737-7932	Netherlands Organization for Scientific Research (Vidi Innovational Research Award) [016.096.309]; Foundation Fighting Blindness USA [C-GE-0811-0548-RAD04]; European Research Council under the European Union's Seventh Framework Programme (FP) / ERC [310644]	Netherlands Organization for Scientific Research (Vidi Innovational Research Award); Foundation Fighting Blindness USA; European Research Council under the European Union's Seventh Framework Programme (FP) / ERC(European Research Council (ERC))	This study was supported by the Netherlands Organization for Scientific Research (Vidi Innovational Research Award 016.096.309) and the Foundation Fighting Blindness USA (grant C-GE-0811-0548-RAD04). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC grant agreement n. 310644 (MACULA).	BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Booij JC, 2010, THESIS; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Boon CJF, 2013, PROG RETIN EYE RES, V37, P90, DOI 10.1016/j.preteyeres.2013.08.003; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Duvvari MR, 2015, MOL VIS, V21, P285; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grassi MA, 2007, ARCH OPHTHALMOL-CHIC, V125, P93, DOI 10.1001/archopht.125.1.93; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Li DQ, 2000, J BIOL CHEM, V275, P22339, DOI 10.1074/jbc.M000519200; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Malek G, 2006, BRIT J OPHTHALMOL, V90, P1080, DOI 10.1136/bjo.2006.098715; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; Ratnapriya R, 2014, HUM MOL GENET; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Saksens NTM, 2014, INVEST OPHTH VIS SCI, V55, P7085, DOI 10.1167/iovs.14-14659; Saksens NT, 2016, JAMA OPHTHALMOL, P1; Sivaprasad S, 2005, CLIN EXP OPHTHALMOL, V33, P518, DOI 10.1111/j.1442-9071.2005.01074.x; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; van de Ven JPH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1038, DOI 10.1001/archophthalmol.2012.265; van de Ven JPH, 2012, MOL VIS, V18, P2271; van de Ven JPH, 2012, AM J OPHTHALMOL, V154, P560, DOI 10.1016/j.ajo.2012.03.012; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P681, DOI 10.1006/bbrc.1993.1678; Yu Y, 2014, HUM MOL GENET, V23, P5283, DOI 10.1093/hmg/ddu226; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	39	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152047	10.1371/journal.pone.0152047	http://dx.doi.org/10.1371/journal.pone.0152047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007659	gold, Green Published			2022-12-27	WOS:000372701200091
J	Moss, P; Whitnell, J; Wright, A				Moss, Penny; Whitnell, Jasmine; Wright, Anthony			Quantitative and Qualitative Responses to Topical Cold in Healthy Caucasians Show Variance between Individuals but High Test-Retest Reliability	PLOS ONE			English	Article							NEUROPATHIC PAIN SYMPTOMS; WHIPLASH INJURY; THRESHOLDS; SENSITIZATION; HYPERALGESIA; DISORDERS; HEAT; SEX	Increased sensitivity to cold may be a predictor of persistent pain, but cold pain threshold is often viewed as unreliable. This study aimed to determine the within-subject reliability and between-subject variance of cold response, measured comprehensively as cold pain threshold plus pain intensity and sensation quality at threshold. A test-retest design was used over three sessions, one day apart. Response to cold was assessed at four sites (thenar eminence, volar forearm, tibialis anterior, plantar foot). Cold pain threshold was measured using a Medoc thermode and standard method of limits. Intensity of pain at threshold was rated using a 10cm visual analogue scale. Quality of sensation at threshold was quantified with indices calculated from subjects' selection of descriptors from a standard McGill Pain Questionnaire. Within-subject reliability for each measure was calculated with intra-class correlation coefficients and between-subject variance was evaluated as group coefficient of variation percentage (CV%). Gender and site comparisons were also made. Forty-five healthy adults participated: 20 male, 25 female; mean age 29 (range 18-56) years. All measures at all four test sites showed high within-subject reliability: cold pain thresholds r = 0.92-0.95; pain rating r = 0.93-0.97; McGill pain quality indices r = 0.87-0.85. In contrast, all measures showed wide between-subject variance (CV% between 51.4% and 92.5%). Upper limb sites were consistently more sensitive than lower limb sites, but equally reliable. Females showed elevated cold pain thresholds, although similar pain intensity and quality to males. Females were also more reliable and showed lower variance for all measures. Thus, although there was clear population variation, response to cold for healthy individuals was found to be highly reliable, whether measured as pain threshold, pain intensity or sensation quality. A comprehensive approach to cold response testing therefore may add validity and improve acceptance of this potentially important pain measure.	[Moss, Penny; Whitnell, Jasmine; Wright, Anthony] Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Curtin University	Moss, P (corresponding author), Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia.	p.moss@curtin.edu.au						Ahmad S, 2014, PAIN MED, V15, P857, DOI 10.1111/pme.12374; Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; BOECKSTYNS MEH, 1989, PAIN, V38, P29, DOI 10.1016/0304-3959(89)90069-9; Burckhardt CS, 2003, ARTH RHEUMAT ARTH CA, V49, pS96, DOI [DOI 10.1002/ART.11440, 10.1002/art.11440]; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Goldsmith R, 2012, MANUAL THER, V17, P402, DOI 10.1016/j.math.2012.02.014; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Heldestad V, 2010, CLIN NEUROPHYSIOL, V121, P1878, DOI 10.1016/j.clinph.2010.03.055; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; Kelly KG, 2005, MUSCLE NERVE, V32, P179, DOI 10.1002/mus.20355; Knutti IA, 2014, NEUROSCI LETT, V579, P157, DOI 10.1016/j.neulet.2014.07.023; Law LAF, 2008, PAIN, V140, P254, DOI 10.1016/j.pain.2008.08.014; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Martin Vincent T, 2009, Gend Med, V6 Suppl 2, P168, DOI 10.1016/j.genm.2009.03.006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moloney NA, 2012, J REHABIL RES DEV, V49, P191, DOI 10.1682/JRRD.2011.03.0044; Moloney NA, 2011, MUSCLE NERVE, V44, P547, DOI 10.1002/mus.22121; Moss P, 2011, EUROP J PAIN S, V5, P128; Neziri AY, 2011, EUR J PAIN, V15, P376, DOI 10.1016/j.ejpain.2010.08.011; O'Sullivan P, 2014, MANUAL THER, V19, P311, DOI 10.1016/j.math.2014.03.006; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Rahim-Williams B, 2012, PAIN MED, V13, P522, DOI 10.1111/j.1526-4637.2012.01336.x; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rowell LN, 2011, EUR J PAIN, V15, P764, DOI 10.1016/j.ejpain.2010.11.016; Sand T, 2010, CEPHALALGIA, V30, P904, DOI 10.1177/0333102409356023; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; Steinmetz A, 2013, ARCH PHYS MED REHAB, V94, P2523, DOI 10.1016/j.apmr.2013.04.019; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Thorn BE, 2004, CLIN J PAIN, V20, P275, DOI 10.1097/00002508-200409000-00001; Wasner GL, 2008, CLIN NEUROPHYSIOL, V119, P2389, DOI 10.1016/j.clinph.2008.07.223; Wylde V, 2011, OSTEOARTHR CARTILAGE, V19, P655, DOI 10.1016/j.joca.2011.02.009	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151972	10.1371/journal.pone.0151972	http://dx.doi.org/10.1371/journal.pone.0151972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007696	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200079
J	Pouw, RB; Brouwer, MC; Geissler, J; van Herpen, LV; Zeerleder, SS; Wuillemin, WA; Wouters, D; Kuijpers, TW				Pouw, Richard B.; Brouwer, Mieke C.; Geissler, Judy; van Herpen, Laurens V.; Zeerleder, Sacha S.; Wuillemin, Walter A.; Wouters, Diana; Kuijpers, Taco W.			Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; MACULAR DEGENERATION; RISK; VARIANTS; AUTOANTIBODIES; SUSCEPTIBILITY; ASSOCIATION; HAPLOTYPE; REGION; FHR-3	The major human complement regulator in blood, complement factor H (FH), has several closely related proteins, called FH-related (FHR) proteins. As all FHRs lack relevant complement regulatory activity, their physiological role is not well understood. FHR protein 3 (FHR-3) has been suggested to compete with FH for binding to Neisseria meningitidis, thereby affecting complement-mediated clearance. Clearly, the in vivo outcome of such competition greatly depends on the FH and FHR-3 concentrations. While FH levels have been established, accurate FHR-3 levels were never unequivocally reported to date. Moreover, CFHR3 gene copy numbers commonly vary, which may impact the FHR-3 concentration. Hence, we generated five anti-FHR-3 mAbs to specifically measure FHR-3 in human healthy donors of which we determined the gene copy number variation at the CFH/CFHR locus. Finally, we examined the acute-phase response characteristics of FHR-3 in a small sepsis cohort. We determined FHR-3 levels to have a mean of 19 nM and that under normal conditions the copy number of CFHR3 correlates to a very large extent with the FHR-3 serum levels. On average, FHR-3 was 132-fold lower compared to the FH concentration in the same serum samples and FHR-3 did not behave as a major acute phase response protein.	[Pouw, Richard B.; Brouwer, Mieke C.; van Herpen, Laurens V.; Wouters, Diana] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Immunopathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Pouw, Richard B.; Kuijpers, Taco W.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands; [Geissler, Judy; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Zeerleder, Sacha S.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Wuillemin, Walter A.] Luzerner Kantonsspital, Div Hematol, Bern, Switzerland; [Wuillemin, Walter A.] Luzerner Kantonsspital, Cent Hematol Lab, Bern, Switzerland; [Wuillemin, Walter A.] Univ Bern, Bern, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Lucerne Cantonal Hospital; Lucerne Cantonal Hospital; University of Bern	Wouters, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Immunopathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.wouters@sanquin.nl	Pouw, Richard/AAE-1042-2020	Pouw, Richard/0000-0003-3469-8454	European Union's seventh Framework program under EC-GA [279185]	European Union's seventh Framework program under EC-GA	Research leading to these results has received funding from the European Union's seventh Framework program under EC-GA no. 279185 (EUCLIDS; www.euclids-project.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; Ansari M, 2013, HUM MOL GENET, V22, P4857, DOI 10.1093/hmg/ddt336; Bernabeu-Herrero ME, 2015, MOL IMMUNOL, V67, P276, DOI 10.1016/j.molimm.2015.06.021; Caesar JJE, 2014, ELIFE, V3, DOI 10.7554/eLife.04008; Caliezi C, 2002, CRIT CARE MED, P30; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Hakobyan S, 2010, KIDNEY INT, V78, P782, DOI 10.1038/ki.2010.275; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Holmes LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060352; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Jozsi M, 2015, TRENDS IMMUNOL, V36, P374, DOI 10.1016/j.it.2015.04.008; Kubista KE, 2011, MOL VIS, V17, P2080; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; McHarg S, 2015, MOL IMMUNOL, DOI [10.1016/j.imbio.2015.02.032, DOI 10.1016/J.IMBIO.2015.02.032]; Moore I, 2010, BLOOD, V115, P379, DOI 10.1182/blood-2009-05-221549; Schmid-Kubista KE, 2009, INVEST OPHTH VIS SCI, V50, P5070, DOI 10.1167/iovs.09-3975; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; SKERKA C, 1993, J BIOL CHEM, V268, P2904; Sofat R, 2013, J IMMUNOL METHODS, V390, P63, DOI 10.1016/j.jim.2013.01.009; Tortajada A, 2013, J CLIN INVEST, V123, P2434, DOI 10.1172/JCI68280; Zhu L., 2014, J INEQUAL APPL, V2014, P1, DOI DOI 10.1681/ASN.2014010096	27	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152164	10.1371/journal.pone.0152164	http://dx.doi.org/10.1371/journal.pone.0152164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007437	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200101
J	Solstad, RG; Li, C; Isaksson, J; Johansen, J; Svenson, J; Stensvag, K; Haug, T				Solstad, Runar Gjerp; Li, Chun; Isaksson, Johan; Johansen, Jostein; Svenson, Johan; Stensvag, Klara; Haug, Tor			Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; STRONGYLOCENTROTUS-PURPURATUS; MOLECULAR-BASIS; CELOMIC FLUID; HYAS-ARANEUS; SPIDER CRAB; PROTEIN; GREEN; ORGANIZATION; ECHINODERM	The global problem of microbial resistance to antibiotics has resulted in an urgent need to develop new antimicrobial agents. Natural antimicrobial peptides are considered promising candidates for drug development. Echinoderms, which rely on innate immunity factors in the defence against harmful microorganisms, are sources of novel antimicrobial peptides. This study aimed to isolate and characterise antimicrobial peptides from the Edible sea urchin Echinus esculentus. Using bioassay-guided purification and cDNA cloning, three antimicrobial peptides were characterised from the haemocytes of the sea urchin; two heterodimeric peptides and a cysteine-rich peptide. The peptides were named EeCentrocin 1 and 2 and EeStrongylocin 2, respectively, due to their apparent homology to the published centrocins and strongylocins isolated from the green sea urchin Strongylocentrotus droebachiensis. The two centrocin-like peptides EeCentrocin 1 and 2 are intramolecularly connected via a disulphide bond to form a heterodimeric structure, containing a cationic heavy chain of 30 and 32 amino acids and a light chain of 13 amino acids. Additionally, the light chain of EeCentrocin 2 seems to be N-terminally blocked by a pyroglutamic acid residue. The heavy chains of EeCentrocins 1 and 2 were synthesised and shown to be responsible for the antimicrobial activity of the natural peptides. EeStrongylocin 2 contains 6 cysteines engaged in 3 disulphide bonds. A fourth peptide (Ee4635) was also discovered but not fully characterised. Using mass spectrometric and NMR analyses, EeCentrocins 1 and 2, EeStrongylocin 2 and Ee4635 were all shown to contain post-translationally brominated Trp residues in the 6 position of the indole ring.	[Solstad, Runar Gjerp; Li, Chun; Stensvag, Klara; Haug, Tor] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway; [Isaksson, Johan; Johansen, Jostein; Svenson, Johan] UiT Arctic Univ Norway, Dept Chem, Fac Sci & Technol, Tromso, Norway; [Svenson, Johan] Mat & Surfaces SP Tech Res Inst Sweden, Dept Chem, Boras, Sweden	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; SP Technical Research Institute of Sweden	Solstad, RG; Haug, T (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway.	Runar.g.solstad@uit.no; Tor.haug@uit.no	Haug, Tor/I-8163-2019; Isaksson, Johan/G-9292-2016; Haug, Tor/J-2498-2017	Haug, Tor/0000-0003-1104-5813; Isaksson, Johan/0000-0001-6287-7594; Haug, Tor/0000-0003-1104-5813; Stensvag, Klara/0000-0002-4717-6711; Solstad, Runar Gjerp/0000-0003-3463-6034	Research Council of Norway [208546]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway (http://www.forskningsradet.no) project XBioPepS (grant number 208546) where TH and JS are partners and KS is the project leader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard KA, 2001, ADV EXP MED BIOL, V484, P55; Bjorn C, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-67; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chattopadhyay S, 2006, PROTEINS, V64, P524, DOI 10.1002/prot.20963; Chen TB, 2005, REGUL PEPTIDES, V128, P75, DOI 10.1016/j.regpep.2004.12.022; Craig AG, 1997, J BIOL CHEM, V272, P4689, DOI 10.1074/jbc.272.8.4689; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Haug T, 2002, J INVERTEBR PATHOL, V81, P94, DOI 10.1016/S0022-2011(02)00153-2; Haug T, 2002, FISH SHELLFISH IMMUN, V12, P371, DOI 10.1006/fsim.2001.0378; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; JOLLES J, 1975, EUR J BIOCHEM, V54, P19, DOI 10.1111/j.1432-1033.1975.tb04108.x; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Keller R, 2004, THE COMPUTER AIDED R; Li C, 2010, ISJ-INVERT SURVIV J, V7, P132; Li C, 2008, DEV COMP IMMUNOL, V32, P1430, DOI 10.1016/j.dci.2008.06.013; Li C, 2015, DEV COMP IMMUNOL, V49, P190, DOI 10.1016/j.dci.2014.11.002; Li C, 2010, DEV COMP IMMUNOL, V34, P959, DOI 10.1016/j.dci.2010.04.004; Li C, 2010, DEV COMP IMMUNOL, V34, P286, DOI 10.1016/j.dci.2009.10.006; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Maltseva A.L., 2004, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V4, P101; [Мальцева А.Л. Malzeva A.L.], 2007, [Вестник Санкт-Петербургского университета. Серия 3: Биология, Vestnik Sankt-Peterburgskogo universiteta. Seriya 3: Biologiya], P85; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Patiny L, 2013, J CHEM INF MODEL, V53, P1223, DOI 10.1021/ci300563h; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; Pereira DM, 2014, DYES PIGMENTS, V111, P124, DOI 10.1016/j.dyepig.2014.06.011; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saude ACM, 2014, INT J NANOMED, V9, P5055, DOI 10.2147/IJN.S66300; Saugar JM, 2006, ANTIMICROB AGENTS CH, V50, P1251, DOI 10.1128/AAC.50.4.1251-1256.2006; Schillaci D, 2010, J APPL MICROBIOL, V108, P17, DOI 10.1111/j.1365-2672.2009.04394.x; SERVICE M, 1984, COMP BIOCHEM PHYS B, V79, P161, DOI 10.1016/0305-0491(84)90008-7; SHIGENAGA T, 1990, J BIOL CHEM, V265, P21350; Shinnar AE, 2003, BIOORG CHEM, V31, P425, DOI 10.1016/S0045-2068(03)00080-4; Smith LC, 2006, ISJ-INVERT SURVIV J, V3, P25; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Sperstad SV, 2009, MOL IMMUNOL, V46, P2604, DOI 10.1016/j.molimm.2009.05.002; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Stabili L, 1996, COMP BIOCHEM PHYS B, V113, P639, DOI 10.1016/0305-0491(95)02080-2; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasiemski A, 2007, DEV COMP IMMUNOL, V31, P749, DOI 10.1016/j.dci.2006.11.003; Taylor SW, 2000, J BIOL CHEM, V275, P38417, DOI 10.1074/jbc.M006762200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tossi A, 2000, BIOPOLYMERS, V55, P4; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Wagner C, 2012, HDB MARINE NATURAL P, P977; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang KR, 2013, PEPTIDES, V39, P80, DOI 10.1016/j.peptides.2012.11.002; WARDLAW AC, 1978, J INVERTEBR PATHOL, V32, P25, DOI 10.1016/0022-2011(78)90170-2; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	71	28	29	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151820	10.1371/journal.pone.0151820	http://dx.doi.org/10.1371/journal.pone.0151820			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007817	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200068
J	Afema, JA; Byarugaba, DK; Shah, DH; Atukwase, E; Nambi, M; Sischo, WM				Afema, Josephine A.; Byarugaba, Denis K.; Shah, Devendra H.; Atukwase, Esther; Nambi, Maria; Sischo, William M.			Potential Sources and Transmission of Salmonella and Antimicrobial Resistance in Kampala, Uganda	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157-H7; TANDEM REPEAT ANALYSIS; VARIABLE-NUMBER; GLOBAL BURDEN; INFECTIONS; DISEASE; EPIDEMIOLOGY; SURVEILLANCE	In sub-Saharan Africa, non-typhoidal Salmonellae (NTS) cause invasive disease particularly in children and HIV infected adults, but the disease epidemiology is poorly understood. Between 2012 and 2013, we investigated NTS sources and transmission in Kampala. We detected Salmonella in 60% of the influent and 60% of the effluent samples from a wastewater treatment plant and 53.3% of the influent and 10% of the effluent samples from waste stabilization ponds that serve the human population; 40.9% of flush-water samples from ruminant slaughterhouses, 6.6% of the poultry fecal samples from live bird markets and 4% of the fecal samples from swine at slaughter; and in 54.2% of the water samples from a channel that drains storm-water and effluents from the city. We obtained 775 Salmonella isolates, identified 32 serovars, and determined resistance to 15 antimicrobials. We genotyped common serovars using multiple-locus variable number tandem repeats analysis or pulsed-field gel electrophoresis. In addition, we analyzed 49 archived NTS isolates from asymptomatic livestock and human clinical cases. Salmonella from ruminant and swine sources were mostly pan-susceptible (95%) while poultry isolates were generally more resistant. Salmonella Kentucky isolated from poultry exhibited extensive drug resistance characterized by resistance to 10 antimicrobials. Interestingly, similar genotypes of S. Kentucky but with less antimicrobial resistance (AMR) were found in poultry, human and environmental sources. The observed AMR patterns could be attributed to host or management factors associated with production. Alternatively, S. Kentucky may be prone to acquiring AMR. The factors driving AMR remain poorly understood and should be elucidated. Overall, shared genotypes and AMR phenotypes were found in NTS from human, livestock and environmental sources, suggesting zoonotic and environmental transmissions most likely occur. Information from this study could be used to control NTS transmission.	[Afema, Josephine A.; Sischo, William M.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Byarugaba, Denis K.; Atukwase, Esther; Nambi, Maria] Makerere Univ, Coll Vet Med & Anim Resources & Biosecur, Dept Biomol Resources & Biolab Sci, Kampala, Uganda; [Shah, Devendra H.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Makerere University; Washington State University	Afema, JA (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	jaafema@vetmed.wsu.edu	Shah, Devendra H./S-4965-2016	Shah, Devendra H./0000-0001-6365-7868; Byarugaba, Denis K./0000-0002-4175-5659; Azikuru Afema, Josephine/0000-0003-3630-1772	United States Department of Agriculture Formula [3924-1027]; USAID Higher Education for Development; North Dakota State University [2530-0407]	United States Department of Agriculture Formula(United States Department of Agriculture (USDA)); USAID Higher Education for Development(United States Agency for International Development (USAID)); North Dakota State University	This work was supported by United States Department of Agriculture Formula Funds 3924-1027 (WMS), USAID Higher Education for Development subcontract with North Dakota State University 2530-0407. The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Afema JA, 2015, ZOONOSES PUBLIC HLTH, V62, P506, DOI 10.1111/zph.12172; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berge ACB, 2006, J APPL MICROBIOL, V101, P1309, DOI 10.1111/j.1365-2672.2006.03031.x; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Boyer TC, 2012, ANTIBIOTIC RESISTANC; Byarugaba DK, 2004, INT J ANTIMICROB AG, V24, P105, DOI 10.1016/j.ijantimicag.2004.02.015; CDC, 2013, NAT ANT RES MON SYST; Cho S, 2007, FEMS MICROBIOL LETT, V275, P16, DOI 10.1111/j.1574-6968.2007.00875.x; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Dhanani AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137697; Elgroud R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352029; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Francisco A, 2012, BMC BIOINFORMATICS, P13; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; Grimont P.A.D., 2007, AESTHETICS COSMETIC, P9; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Hendriksen RS, 2013, J CLIN MICROBIOL, V51, P284, DOI 10.1128/JCM.02227-12; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Ikwap K, 2014, PREV VET MED, V115, P39, DOI 10.1016/j.prevetmed.2014.03.009; Kagambega A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-253; Kansiime F., 1999, WASTEWATER TREATMENT; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Kariuki S, 2002, FEMS IMMUNOL MED MIC, V33, P165, DOI 10.1111/j.1574-695X.2002.tb00587.x; Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585, DOI 10.3855/jidc.549; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Letema S, 2012, ENVIRON ENG SCI, V29, P291, DOI 10.1089/ees.2011.0063; Leung AKC, 2005, J NATL MED ASSOC, V97, P281; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Mahero M, 2013, CLIN MICROBIOL, V2, P128, DOI [10.4172/2327-5073.1000128, DOI 10.4172/2327-5073.1000128]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Matagi SV, 2002, ENVIRON MONIT ASSESS, V77, P121, DOI 10.1023/A:1015860820467; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; MORINIGO MA, 1993, J APPL BACTERIOL, V74, P330, DOI 10.1111/j.1365-2672.1993.tb03033.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rickert-Hartman R, 2014, EMERG INFECT DIS, V20, P910, DOI 10.3201/eid2005.131575; SANDERSON MW, 1995, J CLIN MICROBIOL, V33, P2616, DOI 10.1128/JCM.33.10.2616-2619.1995; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; UBOS, 2014, NATL POPULATION HOUS; Vincent V, 2007, FOODBORNE PATHOG DIS, V4, P375, DOI 10.1089/fpd.2007.0025; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yoshida C, 2007, J MICROBIOL METH, V70, P261, DOI 10.1016/j.mimet.2007.04.018	53	33	33	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152130	10.1371/journal.pone.0152130	http://dx.doi.org/10.1371/journal.pone.0152130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999788	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700102
J	Dietrich, M; Tjale, MA; Weyer, J; Kearney, T; Seamark, ECJ; Nel, LH; Monadjem, A; Markotter, W				Dietrich, Muriel; Tjale, Mabotse A.; Weyer, Jacqueline; Kearney, Teresa; Seamark, Ernest C. J.; Nel, Louis H.; Monadjem, Ara; Markotter, Wanda			Diversity of Bartonella and Rickettsia spp. in Bats and Their Blood-Feeding Ectoparasites from South Africa and Swaziland	PLOS ONE			English	Article							FLIES NYCTERIBIIDAE; RESERVOIR HOSTS; INFECTION; GRAHAMII; BORRELIA; PATIENT; DNA	In addition to several emerging viruses, bats have been reported to host multiple bacteria but their zoonotic threats remain poorly understood, especially in Africa where the diversity of bats is important. Here, we investigated the presence and diversity of Bartonella and Rickettsia spp. in bats and their ectoparasites (Diptera and Siphonaptera) collected across South Africa and Swaziland. We collected 384 blood samples and 14 ectoparasites across 29 different bat species and found positive samples in four insectivorous and two frugivorous bat species, as well as their Nycteribiidae flies. Phylogenetic analyses revealed diverse Bartonella genotypes and one main group of Rickettsia, distinct from those previously reported in bats and their ectoparasites, and for some closely related to human pathogens. Our results suggest a differential pattern of host specificity depending on bat species. Bartonella spp. identified in bat flies and blood were identical supporting that bat flies may serve as vectors. Our results represent the first report of bat-borne Bartonella and Rickettsia spp. in these countries and highlight the potential role of bats as reservoirs of human bacterial pathogens.	[Dietrich, Muriel; Tjale, Mabotse A.; Nel, Louis H.; Markotter, Wanda] Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa; [Weyer, Jacqueline] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Weyer, Jacqueline] Univ Pretoria, ZA-0002 Pretoria, South Africa; [Kearney, Teresa] Ditsong Natl Museum Nat Hist, Pretoria, South Africa; [Kearney, Teresa] Univ Witwatersrand, Johannesburg, South Africa; [Seamark, Ernest C. J.] AfricanBats, Kloofsig, South Africa; [Seamark, Ernest C. J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Monadjem, Ara] Univ Swaziland, Kwaluseni, Eswatini	University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Witwatersrand; University of Pretoria	Markotter, W (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa.	wanda.markotter@up.ac.za	Nel, Louis H/F-1001-2012; Monadjem, Ara/K-7279-2014	Nel, Louis H/0000-0001-8963-0153; Monadjem, Ara/0000-0003-1906-4023; Markotter, Wanda/0000-0002-7550-0080; Dietrich, Muriel/0000-0002-2665-7970; Kearney, Teresa/0000-0002-0050-4060; Seamark, Ernest C. J./0000-0001-9741-9147	National Research Foundation (NRF) of South Africa [78566, ABI3500, 91496, 92524]; Poliomyelitis Research Foundation (PRF) [12/14]; National Research Foundation, South Africa (NRF) [N00595]	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Poliomyelitis Research Foundation (PRF); National Research Foundation, South Africa (NRF)(National Research Foundation - South Africa)	This work is based on the research supported in part by a number of grants from the National Research Foundation (NRF) of South Africa (Grant UID: 78566 (NRF RISP grant for the ABI3500) and Grant UID 91496 and 92524) and the Poliomyelitis Research Foundation (PRF) (Grant number 12/14). MD's postdoctoral fellowship is funded by the National Research Foundation, South Africa (NRF - N00595).	ACR, 2014, AFR CHIR REP 2014; Anti P, 2015, EMERG INFECT DIS, V21, P1418, DOI 10.3201/eid2108.142015; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Billeter SA, 2012, PARASITOLOGY, V139, P324, DOI 10.1017/S0031182011002113; Brook CE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003532; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; D'Auria SRN, 2010, VECTOR-BORNE ZOONOT, V10, P459, DOI 10.1089/vbz.2009.0070; DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993; Dick CW, 2007, ECOL ENTOMOL, V32, P446, DOI 10.1111/j.1365-2311.2007.00836.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Judson SD, 2015, ZOONOSES PUBLIC HLTH, V62, P609, DOI 10.1111/zph.12188; Kamani J, 2014, VECTOR-BORNE ZOONOT, V14, P625, DOI 10.1089/vbz.2013.1541; Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Loftis AD, 2005, J MED ENTOMOL, V42, P473, DOI 10.1603/0022-2585(2005)042[0473:DORBAB]2.0.CO;2; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Oksi J, 2013, J CLIN MICROBIOL, V51, P2781, DOI 10.1128/JCM.00910-13; Anh PH, 2015, EMERG INFECT DIS, V21, P1266, DOI 10.3201/eid2107.141760; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pretorius AM, 2004, INT J SYST EVOL MICR, V54, P1959, DOI 10.1099/ijs.0.03033-0; Pretorius AM, 2004, EMERG INFECT DIS, V10, P125; Serratrice J, 2003, REV MED INTERNE, V24, P629, DOI 10.1016/S0248-8663(03)00224-8; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1966, DOI 10.3201/eid1812.111237; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Tortosa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075215; Trataris AN, 2012, P C SO AFR CTR INF D; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Wilkinson DA, 2016, APPL ENVIRON MICROB, V82, P1778, DOI 10.1128/AEM.03505-15; Wolfel R, 2008, INT J MED MICROBIOL, V298, P368, DOI 10.1016/j.ijmm.2007.11.009	33	32	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152077	10.1371/journal.pone.0152077	http://dx.doi.org/10.1371/journal.pone.0152077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999518	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700098
J	Marsaux, CFM; Celis-Morales, C; Hoonhout, J; Claassen, A; Goris, A; Forster, H; Fallaize, R; Macready, AL; Navas-Carretero, S; Kolossa, S; Walsh, MC; Lambrinou, CP; Manios, Y; Godlewska, M; Traczyk, I; Lovegrove, JA; Martinez, JA; Daniel, H; Gibney, M; Mathers, JC; Saris, WHM				Marsaux, Cyril F. M.; Celis-Morales, Carlos; Hoonhout, Jettie; Claassen, Arjan; Goris, Annelies; Forster, Hannah; Fallaize, Rosalind; Macready, Anna L.; Navas-Carretero, Santiago; Kolossa, Silvia; Walsh, Marianne C.; Lambrinou, Christina-Paulina; Manios, Yannis; Godlewska, Magdalena; Traczyk, Iwona; Lovegrove, Julie A.; Martinez, J. Alfredo; Daniel, Hannelore; Gibney, Mike; Mathers, John C.; Saris, Wim H. M.			Objectively Measured Physical Activity in European Adults: Cross-Sectional Findings from the Food4Me Study	PLOS ONE			English	Article							ENERGY-EXPENDITURE; AMERICAN-COLLEGE; PUBLIC-HEALTH; RECOMMENDATION; QUESTIONNAIRE; PREVALENCE; INACTIVITY; DISEASE; HUMANS	Background Comparisons of objectively measured physical activity (PA) between residents of European countries measured concurrently with the same protocol are lacking. We aimed to compare PA between the seven European countries involved in the Food4Me Study, using accelerometer data collected remotely via the Internet. Methods Of the 1607 participants recruited, 1287 (539 men and 748 women) provided at least 3 weekdays and 2 weekend days of valid accelerometer data (TracmorD) at baseline and were included in the present analyses. Results Men were significantly more active than women (physical activity level = 1.74 vs. 1.70, p < 0.001). Time spent in light PA and moderate PA differed significantly between countries but only for women. Adherence to the World Health Organization recommendation to accumulate at least 150 min of moderate-equivalent PA weekly was similar between countries for men (range: 54-65%) but differed significantly between countries for women (range: 26-49%). Prevalence estimates decreased substantially for men and women in all seven countries when PA guidelines were defined as achieving 30 min of moderate and vigorous PA per day. Conclusions We were able to obtain valid accelerometer data in real time via the Internet from 80% of participants. Although our estimates are higher compared with data from Sweden, Norway, Portugal and the US, there is room for improvement in PA for all countries involved in the Food4Me Study.	[Marsaux, Cyril F. M.; Saris, Wim H. M.] Maastricht Univ, Med Ctr MUMC, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, NL-6200 MD Maastricht, Netherlands; [Celis-Morales, Carlos; Mathers, John C.] Inst Cellular Med, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Hoonhout, Jettie] Philips Res, Experiences Res Dept, Eindhoven, Netherlands; [Claassen, Arjan] Philips Innovat Serv, Software Dept, Eindhoven, Netherlands; [Goris, Annelies] Philips Consumer Lifestyle, Personal Hlth Solut, Amsterdam, Netherlands; [Forster, Hannah; Walsh, Marianne C.; Gibney, Mike] Univ Coll Dublin, UCD Inst Food & Hlth, Dublin 4, Ireland; [Fallaize, Rosalind; Macready, Anna L.; Lovegrove, Julie A.] Univ Reading, Hugh Sinclair Unit Human Nutr, Reading, Berks, England; [Fallaize, Rosalind; Macready, Anna L.; Lovegrove, Julie A.] Univ Reading, Inst Cardiovasc & Metab Res, Reading, Berks, England; [Navas-Carretero, Santiago; Martinez, J. Alfredo] Univ Navarra, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, E-31080 Pamplona, Spain; [Navas-Carretero, Santiago; Martinez, J. Alfredo; Daniel, Hannelore] Inst Salud Carlos III, CIBER Fisiopat Obesidad & Nutr CIBERobn, Madrid, Spain; [Kolossa, Silvia] Tech Univ Munich, Biochem Unit, ZIEL Res Ctr Nutr & Food Sci, D-80290 Munich, Germany; [Lambrinou, Christina-Paulina; Manios, Yannis] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Godlewska, Magdalena; Traczyk, Iwona] Natl Food & Nutr Inst IZZ, Warsaw, Poland	Maastricht University; Maastricht University Medical Centre (MUMC); Newcastle University - UK; Philips; Philips Research; Philips; Philips; University College Dublin; University of Reading; University of Reading; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Technical University of Munich; Harokopio University Athens; Institute of Food & Nutrition	Marsaux, CFM (corresponding author), Maastricht Univ, Med Ctr MUMC, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, NL-6200 MD Maastricht, Netherlands.	c.marsaux@maastrichtuniversity.nl	Fallaize, Rosalind/AGF-6918-2022; Traczyk, Iwona/W-4177-2018; Manios, Yannis/AAM-8953-2021; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Navas-Carretero, Santiago/L-2918-2015; Celis-Morales, Carlos/AAJ-5103-2020	Fallaize, Rosalind/0000-0003-3734-6489; Traczyk, Iwona/0000-0001-7413-1212; Manios, Yannis/0000-0001-6486-114X; Navas-Carretero, Santiago/0000-0002-5163-2230; Macready, Anna/0000-0003-0368-9336; Mathers, John/0000-0003-3406-3002	European Union [265494]	European Union(European Commission)	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 265494 (http://cordis.europa.eu/project/rcn/98657_en.html). Food4Me is the acronym of the project "Personalised nutrition: an integrated analysis of opportunities and challenges" (http://www.food4me.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Black AE, 1996, EUR J CLIN NUTR, V50, P72; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bonomi AG, 2010, OBESITY, V18, P1845, DOI 10.1038/oby.2010.34; Celis-Morales C, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0476-0; Celis-Morales C, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0450-2; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dannecker KL, 2013, MED SCI SPORT EXER, V45, P2105, DOI 10.1249/MSS.0b013e318299d2eb; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; EU Working Group, 2008, EU PHYS ACT GUID REC; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hagstromer M, 2010, J PHYS ACT HEALTH, V7, P541, DOI 10.1123/jpah.7.4.541; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Kesse-Guyot E, 2013, J MED INTERNET RES, V15, P148, DOI 10.2196/jmir.2488; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Montoye HJ, 1996, MEASURING PHYS ACTIV; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Plasqui G, 2013, OBES REV, V14, P451, DOI 10.1111/obr.12021; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; R Core Team, 2021, R LANGUAGE ENV STAT; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Rousseeuw P., 2015, ROBUSTBASE BASIC ROB; Speakman JR, 2010, AM J CLIN NUTR, V92, P826, DOI 10.3945/ajcn.2009.28540; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Valenti G, 2014, INT J OBESITY, V38, P1011, DOI 10.1038/ijo.2013.195; Van Domelen DR, 2011, AM J PREV MED, V41, P136, DOI 10.1016/j.amepre.2011.03.019; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661	40	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150902	10.1371/journal.pone.0150902	http://dx.doi.org/10.1371/journal.pone.0150902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999053	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000372694700019
J	Nissink, JWM; Bista, M; Breed, J; Carter, N; Embrey, K; Read, J; Winter-Holt, JJ				Nissink, J. Willem M.; Bista, Michal; Breed, Jason; Carter, Nikki; Embrey, Kevin; Read, Jonathan; Winter-Holt, Jon J.			MTH1 Substrate Recognition-An Example of Specific Promiscuity	PLOS ONE			English	Article							HUMAN MUTT HOMOLOG; PROTEINS; CANCER; DNA; REPAIR; PK(A)	MTH1 (NUDT1) is an oncologic target involved in the prevention of DNA damage. We investigate the way MTH1 recognises its substrates and present substrate-bound structures of MTH1 for 8-oxo-dGTP and 8-oxo-rATP as examples of novel strong and weak binding substrate motifs. Investigation of a small set of purine-like fragments using 2D NMR resulted in identification of a fragment with weak potency. The protein-ligand X-Ray structure of this fragment provides insight into the role of water molecules in substrate selectivity. Wider fragment screening by NMR resulted in three new protein structures exhibiting alternative binding configurations to the key Asp-Asp recognition element of the protein. These inhibitor binding modes demonstrate that MTH1 employs an intricate yet promiscuous mechanism of substrate anchoring through its Asp-Asp pharmacophore. The structures suggest that water-mediated interactions convey selectivity towards oxidized substrates over their non-oxidised counterparts, in particular by stabilization of a water molecule in a hydrophobic environment through hydrogen bonding. These findings may be useful in the design of inhibitors of MTH1.	[Nissink, J. Willem M.; Winter-Holt, Jon J.] AstraZeneca, Chem Oncol Innovat Med & Early Dev Biotech Unit, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England; [Nissink, J. Willem M.; Winter-Holt, Jon J.] Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Bista, Michal; Breed, Jason; Carter, Nikki; Read, Jonathan] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England; [Embrey, Kevin] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England	AstraZeneca; AstraZeneca; AstraZeneca	Nissink, JWM (corresponding author), AstraZeneca, Chem Oncol Innovat Med & Early Dev Biotech Unit, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England.; Nissink, JWM (corresponding author), Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	willem.nissink@astrazeneca.com	Nissink, J. Willem M./C-1507-2010	Nissink, J. Willem M./0000-0003-2572-9140; Bista, Michal/0000-0001-9237-1199	AstraZeneca	AstraZeneca(AstraZeneca)	All authors were employees of Astrazeneca at the time of writing. AstraZeneca provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Duddy WJ, 2004, PROTEIN SCI, V13, P3051, DOI 10.1110/ps.04920904; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jang YH, 2002, CHEM RES TOXICOL, V15, P1023, DOI 10.1021/tx010146r; KAKUMA T, 1995, J BIOL CHEM, V270, P25942, DOI 10.1074/jbc.270.43.25942; Kamiya H, 2004, J MOL BIOL, V336, P843, DOI 10.1016/j.jmb.2003.12.060; Kamiya H, 2006, J BIOCHEM, V140, P843, DOI 10.1093/jb/mvj214; Kamiya H, 2010, MUTAT RES-GEN TOX EN, V703, P32, DOI 10.1016/j.mrgentox.2010.06.003; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Leatherbarrow RJ, 2008, GRAFIT, P605; Marian CM, 2007, J PHYS CHEM A, V111, P1545, DOI 10.1021/jp068620v; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Okochi E, 2002, JPN J CANCER RES, V93, P501, DOI 10.1111/j.1349-7006.2002.tb01284.x; Parker AR, 2003, J BIOL CHEM, V278, P47937, DOI 10.1074/jbc.M306598200; Parker AR, 2002, CANCER RES, V62, P7230; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; Sakai Y, 2002, J BIOL CHEM, V277, P8579, DOI 10.1074/jbc.M110566200; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; SEPIOL J, 1976, Z NATURFORSCH C, V31, P361; Streib M, 2014, ANGEW CHEM INT EDIT, V53, P305, DOI 10.1002/anie.201307849; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151154	10.1371/journal.pone.0151154	http://dx.doi.org/10.1371/journal.pone.0151154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999531	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700023
J	Nlend, AEN; Motaze, AN; Tetang, SM; Zeudja, C; Ngantcha, M; Tejiokem, M				Nlend, Anne Esther Njom; Motaze, Annie Nga; Tetang, Suzie Moyo; Zeudja, Cecile; Ngantcha, Marcus; Tejiokem, Mathurin			Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaounde, Cameroon	PLOS ONE			English	Article								Background Effects of antiretroviral therapy (ART) on birth outcomes remain controversial. Objective To assess the impact of antenatal exposure to ART on the occurrence of preterm birth (PTB) and low birth weight (LBW). Methods A cross-sectional study conducted at the Essos Hospital Center in Yaounde from 2008 to 2011 among HIV vertically exposed infants with two distinct maternal antiretroviral experiences: monotherapy group (Zidovudine, ZDV) and the combination ART group (cART). Mothers already receiving cART before pregnancy were ineligible. In both groups, events of PTB (<37 weeks) and LBW (<2,500g) were analyzed using univariate and multivariate logistic regression; with p<0.05 considered statistically significant. Results Of the 760 infants, 481 were born from cART-exposed mothers against 279 from maternal-ZDV. Median maternal CD4 count was 378 [interquartile range (IQR): 253-535] cells/mm(3). Median duration of ART at onset of delivery was 13 [IQR: 10-17] weeks. In the cART-group, 64.9% (312/481) of mothers were exposed to Zidovudine/Lamuvidine/Nevirapine and only 2% (9/481) were on protease inhibitor-based regimens. Events of PTB were not significantly higher in the cART-group compared to the ZDV-group (10.2% vs. 6.4% respectively, p = 0.08), while onsets of LBW were significantly found in the cART-group compared to ZDV-group (11.6% vs. 7.2% respectively, p = 0.05). Other factors (parity, maternal age at delivery or CD4 cell count) were not associated with PTB. Conclusion cART, initiated during pregnancy, would be an independent factor of LBW. In the era of option B+ (lifelong ART to all HIV-pregnant women), further studies would guide towards measures limiting onsets of LBW.	[Nlend, Anne Esther Njom; Motaze, Annie Nga; Tetang, Suzie Moyo; Zeudja, Cecile] Natl Social Insurance Fund Hosp, Essos Hosp Ctr, Dept Pediat, Yaounde, Cameroon; [Tejiokem, Mathurin] Ctr Pasteur Cameroon, Epidemiol & Publ Hlth Unit, Yaounde, Cameroon		Nlend, AEN (corresponding author), Natl Social Insurance Fund Hosp, Essos Hosp Ctr, Dept Pediat, Yaounde, Cameroon.	anne.njom@gmail.com	NLEND, ANNE ESTHER NJOM/AAZ-8748-2020		French "Fondation GlaxoSmithKline"	French "Fondation GlaxoSmithKline"	We are thankful to the French "Fondation GlaxoSmithKline" for the supportive grant for the follow up of this perinatal cohort.	Aaron E, 2012, INFECT DIS OBSTET GY; Ackerman W, 2013, J NIPPON MED SCH, V80, P90, DOI 10.1272/jnms.80.90; Alemu Mazengia F, 2013, INT J, V1, P31; [Anonymous], 2020, HIGH POSS COST COVID; Dos Reis HLB, 2015, REV INST MED TROP SP, V57, P111, DOI 10.1590/S0036-46652015000200003; Briand N, 2009, AIDS, V23, P1235, DOI 10.1097/QAD.0b013e32832be0df; Browne JL, 2015, JAIDS-J ACQ IMM DEF, V70, P91, DOI 10.1097/QAI.0000000000000686; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Darak S, 2013, AIDS PATIENT CARE ST, V27, P163, DOI 10.1089/apc.2012.0401; Dola CP, 2012, J PERINAT MED, V40, P51, DOI 10.1515/JPM.2011.111; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Public Health, 2009, REC US ANT DRUGS PRE; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Nielsen-Saines K, 2012, PEDIATRICS, V129, pE1525, DOI 10.1542/peds.2011-2340; Nlend AEN, 2012, J TROP PEDIATRICS, V58, P297, DOI 10.1093/tropej/fmr100; Olagbuji BN, 2010, ARCH GYNECOL OBSTET, V281, P991, DOI 10.1007/s00404-009-1186-x; Papp E, 2015, J INFECT DIS, V211, P10, DOI 10.1093/infdis/jiu393; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Phiri K, 2015, PEDIATR INFECT DIS J, V34, pE169, DOI 10.1097/INF.0000000000000712; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Senise JF, 2011, AIDS REV, V13, P198; Sibiude J, 2015, EXPERT OPIN DRUG SAF, V14, P643, DOI 10.1517/14740338.2015.1019462; Sturt AS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008440; Tchetgen EJT, 2015, EPIDEMIOLOGY, V26, P473, DOI 10.1097/EDE.0000000000000317; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Turner AN, 2013, JAIDS-J ACQ IMM DEF, V64, P392, DOI 10.1097/QAI.0b013e3182a2d13c; van der Merwe K, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-42; Watts DH, 2012, J INFECT DIS, V206, P1639, DOI 10.1093/infdis/jis581; World Health Organization, 2010, ANT DURGS TREAT PREG; Young S, 2012, PLOS ONE, V8	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150565	10.1371/journal.pone.0150565	http://dx.doi.org/10.1371/journal.pone.0150565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999744	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700012
J	Doblinger, J; Cometti, B; Trevisan, S; Griesinger, G				Doblinger, Jakob; Cometti, Barbara; Trevisan, Silvia; Griesinger, Georg			Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III Trials	PLOS ONE			English	Article							CORIFOLLITROPIN ALPHA; VAGINAL PROGESTERONE; DOUBLE-BLIND; LIVE BIRTH; NONINFERIORITY; PREGNANCY; HORMONE	Objective To summarize efficacy and safety data on a new progesterone compound which is available for subcutaneous administration as compared to vaginally administered progesterone for luteal phase support in patients undergoing IVF treatment. Design Data from two randomized phase III trials (07EU/Prg06 and 07USA/Prg05) performed according to GCP standards with a total sample size of 1435 per-protocol patients were meta-analyzed on an individual patient data level. Setting University affiliated reproductive medicine unit. Patients Subcutaneous progesterone was administered to a total of 714 subjects and vaginal progesterone was administered to a total of 721 subjects who underwent fresh embryo transfer after ovarian stimulation followed by IVF or ICSI. The subjects were between 18 and 42 years old and had a BMI <30kg/m(2). Interventions Subcutaneous progesterone 25 mg daily vs. either progesterone vaginal gel 90 mg daily (07EU/Prg06) or 100 mg intravaginal twice a day (07USA/Prg05) for luteal phase support in IVF patients. Main outcome measures Ongoing pregnancy rate beyond 10 gestational weeks, live birth rate and OHSS risk. Results The administration of subcutaneous progesterone versus intra-vaginal progesterone had no impact on ongoing pregnancy likelihood (OR = 0.865, 95% CI 0.694 to 1.077; P = n.s.), live birth likelihood (OR = 0.889, 95% CI 0.714 to 1.106; P = n.s.) or OHSS risk (OR = 0.995, 95% CI 0.565 to 1.754; P = n.s.) in regression analyses accounting for clustering of patients within trials, while adjusting for important confounders. Only female age and number of oocytes retrieved were significant predictors of live birth likelihood and OHSS risk. Conclusion No statistical significant or clinical significant differences exist between subcutaneous and vaginal progesterone for luteal phase support.	[Doblinger, Jakob] Paracelsus Med Univ, Dept Obstet & Gynecol, Salzburg, Austria; [Cometti, Barbara; Trevisan, Silvia] IBSA Inst Biochim SA, R&D Sci Affairs, Lugano, Switzerland; [Griesinger, Georg] Univ Hosp Schleswig Holstein, Dept Gynecol Endocrinol & Reprod Med, Campus Luebeck, Lubeck, Germany	Paracelsus Private Medical University; University of Kiel; Schleswig Holstein University Hospital	Griesinger, G (corresponding author), Univ Hosp Schleswig Holstein, Dept Gynecol Endocrinol & Reprod Med, Campus Luebeck, Lubeck, Germany.	georg.griesinger@uni-luebeck.de		Cometti, Barbara/0000-0002-0810-7676; Doblinger, Jakob/0000-0003-3534-4244; Griesinger, Georg/0000-0002-0606-5804	IBSA Institute Biochimique SA	IBSA Institute Biochimique SA	Support for this work was provided by IBSA Institute Biochimique SA http://www.ibsa.ch. The funder provided support in the form of salaries for author [GG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the Author Contributions section.	Al-Inany HG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001750.pub3; Baker VL, 2014, HUM REPROD, V29, P2212, DOI 10.1093/humrep/deu194; Boostanfar R, 2015, FERTIL STERIL, V104, P94, DOI 10.1016/j.fertnstert.2015.04.018; de Ziegler D, 2013, FERTIL STERIL, V100, P860, DOI 10.1016/j.fertnstert.2013.05.029; Devroey P, 2009, HUM REPROD, V24, P3063, DOI 10.1093/humrep/dep291; Doody KJ, 2009, FERTIL STERIL, V91, P1012, DOI 10.1016/j.fertnstert.2008.01.069; Griesinger G, 2011, HUM REPROD, V26, P1017, DOI 10.1093/humrep/der013; Iliodromiti S, 2014, HUM REPROD UPDATE, V20, P560, DOI 10.1093/humupd/dmu003; Kolibianakis EM, 2006, HUM REPROD UPDATE, V12, P651, DOI 10.1093/humupd/dml038; Lockwood G, 2014, FERTIL STERIL, V101, P112, DOI 10.1016/j.fertnstert.2013.09.010; Sator M, 2013, GYNECOL ENDOCRINOL, V29, P205, DOI 10.3109/09513590.2012.736560; van der Linden M, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009154.pub2, 10.1002/14651858.CD009154.pub3]	12	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151388	10.1371/journal.pone.0151388	http://dx.doi.org/10.1371/journal.pone.0151388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991890	Green Submitted, gold, Green Published			2022-12-27	WOS:000372582800058
J	Kordjazi, Z; Frusher, S; Buxton, C; Gardner, C; Bird, T				Kordjazi, Ziya; Frusher, Stewart; Buxton, Colin; Gardner, Caleb; Bird, Tomas			The Influence of Mark-Recapture Sampling Effort on Estimates of Rock Lobster Survival	PLOS ONE			English	Article							JASUS-EDWARDSII; WATER TEMPERATURE; SIZE; DENSITY; CATCHABILITY; CATCHES; AREA	Five annual capture-mark-recapture surveys on Jasus edwardsii were used to evaluate the effect of sample size and fishing effort on the precision of estimated survival probability. Datasets of different numbers of individual lobsters (ranging from 200 to 1,000 lobsters) were created by random subsampling from each annual survey. This process of random subsampling was also used to create 12 datasets of different levels of effort based on three levels of the number of traps (15, 30 and 50 traps per day) and four levels of the number of sampling-days (2, 4, 6 and 7 days). The most parsimonious Cormack-Jolly-Seber (CJS) model for estimating survival probability shifted from a constant model towards sex-dependent models with increasing sample size and effort. A sample of 500 lobsters or 50 traps used on four consecutive sampling-days was required for obtaining precise survival estimations for males and females, separately. Reduced sampling effort of 30 traps over four sampling days was sufficient if a survival estimate for both sexes combined was sufficient for management of the fishery.	[Kordjazi, Ziya; Frusher, Stewart; Buxton, Colin; Gardner, Caleb] Univ Tasmania, IMAS, Hobart, Tas, Australia; [Bird, Tomas] Univ Melbourne, ARC Ctr Excellence Environm Decis, Melbourne, Vic, Australia	University of Tasmania; University of Melbourne	Kordjazi, Z (corresponding author), Univ Tasmania, IMAS, Hobart, Tas, Australia.	ziya.kordjazi@utas.edu.au	Kordjazi, Ziya/AAA-6936-2022; Buxton, Colin/AAV-3489-2021; Gardner, Caleb/I-7086-2013	Kordjazi, Ziya/0000-0003-0734-946X; Buxton, Colin/0000-0002-3256-5220; Gardner, Caleb/0000-0003-0324-4337	Iranian Government scholarship from the Ministry of Science and Technology	Iranian Government scholarship from the Ministry of Science and Technology	ZK was supported by an Iranian Government scholarship from the Ministry of Science and Technology. This scholarship provided ZK with tuition fees and living costs and played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CA, 2000, CRUSTACEANA, V73, P425, DOI 10.1163/156854000504516; Barrett N, 2009, MAR FRESHWATER RES, V60, P417, DOI 10.1071/MF07154; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Burke VJ, 1995, HERPETOLOGICA, V51, P451; Burnham K. P., 1998, MODEL SELECTION INFE; Cilimburg AB, 2002, AUK, V119, P778, DOI 10.1642/0004-8038(2002)119[0778:EODOSP]2.0.CO;2; Comeau M, 2009, NEW ZEAL J MAR FRESH, V43, P401, DOI 10.1080/00288330909510009; Conner MM, 2015, T AM FISH SOC, V144, P34, DOI 10.1080/00028487.2014.963254; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Fiske IJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003080; Green BS, 2009, ICES J MAR SCI, V66, P656, DOI 10.1093/icesjms/fsp030; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kelly S, 1999, MAR FRESHWATER RES, V50, P409, DOI 10.1071/MF98126; Kordjazi Z, 2015, ICES J MAR SCI, V72, P244, DOI 10.1093/icesjms/fsv005; Laake J., 2012, PROGRAM MARK GENTLE; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindberg MS, 2007, J WILDLIFE MANAGE, V71, P1002, DOI 10.2193/2005-696; McKelvey KS, 2001, CAN J ZOOL, V79, P1754, DOI 10.1139/cjz-79-10-1754; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; PENNINGTON M, 1991, BIOMETRICS, V47, P717, DOI 10.2307/2532157; PENNINGTON M, 1994, BIOMETRICS, V50, P725, DOI 10.2307/2532786; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; ROBSON D. S., 1964, TRANS AMER FISH SOC, V93, P215, DOI 10.1577/1548-8659(1964)93[215:SSIPME]2.0.CO;2; Schorr RA, 2014, ACTA CHIROPTEROL, V16, P231, DOI 10.3161/150811014X683426; SEBER GAF, 1965, BIOMETRIKA, V52, P249; SOMERS KM, 1986, AM MIDL NAT, V116, P36, DOI 10.2307/2425935; Srisurichan S, 2005, NEW ZEAL J MAR FRESH, V39, P749, DOI 10.1080/00288330.2005.9517350; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS MJ, 1982, MAR BIOL, V71, P187, DOI 10.1007/BF00394628; Ziegler PE, 2004, MAR BIOL, V145, P179, DOI 10.1007/s00227-004-1298-6; Ziegler PE, 2003, FISH RES, V61, P107, DOI 10.1016/S0165-7836(02)00240-0; Zimmerman JKM, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011016	33	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151683	10.1371/journal.pone.0151683	http://dx.doi.org/10.1371/journal.pone.0151683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990561	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800087
J	Mazzorana, M; Hussain, R; Sorensen, T				Mazzorana, Marco; Hussain, Rohanah; Sorensen, Thomas			Ca-Dependent Folding of Human Calumenin	PLOS ONE			English	Article							EF-HAND PROTEIN; CALCIUM-BINDING; ENDOPLASMIC-RETICULUM; CA2+-BINDING PROTEIN; STRUCTURAL-CHANGES; CALSEQUESTRIN; PREDICTION; SKELETAL; WEB; COOPERATIVITY	Human calumenin (hCALU) is a six EF-hand protein belonging to the CREC family. As other members of the family, it is localized in the secretory pathway and regulates the activity of SERCA2a and of the ryanodine receptor in the endoplasmic reticulum (ER). We have studied the effects of Ca2+ binding to the protein and found it to attain a more compact structure upon ion binding. Circular Dichroism (CD) measurements suggest a major rearrangement of the protein secondary structure, which reversibly switches from disordered at low Ca2+ concentrations to predominantly alpha-helical when Ca2+ is added. SAXS experiments confirm the transition from an unfolded to a compact structure, which matches the structural prediction of a trilobal fold. Overall our experiments suggest that calumenin is a Ca2+ sensor, which folds into a compact structure, capable of interacting with its molecular partners, when Ca2+ concentration within the ER reaches the millimolar range.	[Mazzorana, Marco; Hussain, Rohanah; Sorensen, Thomas] Diamond Light Source Ltd, Div Life Sci, Harwell Sci & Innovat Campus, Didcot, Oxon, England	Diamond Light Source	Mazzorana, M; Sorensen, T (corresponding author), Diamond Light Source Ltd, Div Life Sci, Harwell Sci & Innovat Campus, Didcot, Oxon, England.	marco.mazzorana@diamond.ac.uk; thomas.sorensen@diamond.ac.uk	Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Mazzorana, Marco/0000-0001-9414-4547; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499	Diamond Light Source; OPPF	Diamond Light Source; OPPF	This work was supported by Diamond Light Source. The funder provided support in the form of salaries for authors [MM, RH, TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; The authors wish to thank the OPPF for their support with the cloning and expression of the protein and Dr. Gemma Harris for the assistance with SPR and SEC-MALS experimens. We owe a special acknowledgement to the staff of beamlines B21, I22 and B23 of Diamond Light Source, in particular Dr. Robert P. Rambo help with SAXS data collection and analysis and Dr. Giuliano Siligardi for the insightful suggestions and scientific discussion. We thank Diamond Light Source for beamtime on B23 (SM-10526), I22 (SM-3999) and B21 (SM-10528).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assenberg R, 2008, ACTA CRYSTALLOGR F, V64, P258, DOI 10.1107/S1744309108004557; Bal NC, 2011, BIOCHEM J, V435, P391, DOI 10.1042/BJ20101771; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Bitto E, 2009, PROTEINS, V76, P477, DOI 10.1002/prot.22362; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hidalgo C, 1996, BIOPHYS J, V71, P2130, DOI 10.1016/S0006-3495(96)79413-4; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Hussain R, 2015, J SYNCHROTRON RADIAT, V22, P465, DOI 10.1107/S1600577514028161; IIDA S, 1986, J BIOCHEM-TOKYO, V99, P1765, DOI 10.1093/oxfordjournals.jbchem.a135654; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kojetin DJ, 2006, NAT STRUCT MOL BIOL, V13, P641, DOI 10.1038/nsmb1112; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kumar A, 2013, MOL BIOSYST, V9, P1949, DOI 10.1039/c3mb25588c; Kursula P, 2014, ACTA CRYSTALLOGR D, V70, P24, DOI 10.1107/S1399004713024437; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; LINSE S, 1995, PROTEIN SCI, V4, P1038, DOI 10.1002/pro.5560040602; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Perez J, 2001, J MOL BIOL, V308, P721, DOI 10.1006/jmbi.2001.4611; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahoo SK, 2008, MOL CELLS, V26, P265; Sahoo SK, 2010, BMB REP, V43, P158, DOI 10.5483/BMBRep.2010.43.3.158; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki N, 2014, J BIOCHEM, V155, P281, DOI 10.1093/jb/mvu003; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Yabe D, 1998, GENOMICS, V49, P331, DOI 10.1006/geno.1998.5245; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151547	10.1371/journal.pone.0151547	http://dx.doi.org/10.1371/journal.pone.0151547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991433	gold, Green Submitted, Green Published			2022-12-27	WOS:000372582800074
J	Park, JH; Kim, HJ; Kwon, GY; Gwack, J; Park, YJ; Youn, SK; Kwon, JW; Yang, BG; Lee, MS; Jung, M; Lee, H; Jun, BY; Lim, HS				Park, Ji-Hyuk; Kim, Hwa Jung; Kwon, Geun-Yong; Gwack, Jin; Park, Young-Joon; Youn, Seung-Ki; Kwon, Jun-Wook; Yang, Byung-Guk; Lee, Moo-Song; Jung, Miran; Lee, Hanyi; Jun, Byung-Yool; Lim, Hyun-Sul			Humidifier Disinfectants Are a Cause of Lung Injury among Adults in South Korea: A Community-Based Case-Control Study	PLOS ONE			English	Article							CLUSTER	Backgrounds An outbreak of lung injury among South Korean adults was examined in a hospital-based case-control study, and the suspected cause was exposure to humidifier disinfectant (HD). However, a case-control study with community-dwelling controls was needed to validate the previous study's findings, and to confirm the exposure-response relationship between HD and lung injury. Methods Each case of lung injury was matched with four community-dwelling controls, according to age (+/- 3 years), sex, residence, and history of childbirth since 2006 (for women). Environmental risk factors, which included type and use of humidifier and HD, were investigated using a structured questionnaire during August 2011. The exposure to HD was calculated for both cases and controls, and the corresponding risks of lung injury were compared. Results Among 28 eligible cases, 16 patients agreed to participate, and 60 matched controls were considered eligible for this study. The cases were more likely to have been exposed to HD (odds ratio: 116.1, 95% confidence interval: 6.5-2,063.7). All cases were exposed to HDs containing polyhexamethyleneguanidine phosphate, and the risk of lung injury increased with the cumulative exposure, duration of exposure, and exposure per day. Conclusions This study revealed a statistically significant exposure-response relationship between HD and lung injury. Therefore, continuous monitoring and stricter evaluation of environmental chemicals' safety should be conducted.	[Park, Ji-Hyuk; Lim, Hyun-Sul] Dongguk Univ, Coll Med, Dept Prevent Med, Gyeongju Si, Gyeongsangbuk D, South Korea; [Park, Ji-Hyuk; Kwon, Geun-Yong; Gwack, Jin; Park, Young-Joon; Youn, Seung-Ki] Korea Ctr Dis Control & Prevent, Div Epidem Intelligence Serv, Cheongju, Chungcheongbuk, South Korea; [Kim, Hwa Jung; Lee, Moo-Song] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Kwon, Jun-Wook] Korea Ctr Dis Control & Prevent, Ctr Infect Dis Control, Cheongju, Chungcheongbuk, South Korea; [Yang, Byung-Guk] Minist Hlth & Welf, Bur Publ Hlth Policy, Sejong, South Korea; [Lee, Moo-Song] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Prevent Med, Seoul, South Korea; [Jung, Miran] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nursing, Seoul, South Korea; [Lee, Hanyi] Hanyang Univ, Dept Nursing, Seoul 133791, South Korea; [Jun, Byung-Yool] Korea Ctr Dis Control & Prevent, Cheongju, Chungcheongbuk, South Korea	Dongguk University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; University of Ulsan; Asan Medical Center; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Infectious Disease Control; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Hanyang University; Korea Centers for Disease Control & Prevention (KCDC)	Lim, HS (corresponding author), Dongguk Univ, Coll Med, Dept Prevent Med, Gyeongju Si, Gyeongsangbuk D, South Korea.; Jun, BY (corresponding author), Korea Ctr Dis Control & Prevent, Cheongju, Chungcheongbuk, South Korea.	drmdjun@hanmail.net; wisewine@dongguk.ac.kr	Lee, Hanyi/Z-5408-2019					Dassonville C, 2008, INDOOR AIR, V18, P480, DOI 10.1111/j.1600-0668.2008.00549.x; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Hong SB, 2014, THORAX, V69, P694, DOI 10.1136/thoraxjnl-2013-204135; 전종근, 2008, Clinical and Experimental Pediatrics, V51, P383; Jeon B.H., 2012, ENV HLTH TOXICOL, V27, DOI DOI 10.5620/EHT.2012.27.E2012002; Kim HJ, 2014, THORAX, V69, P703, DOI 10.1136/thoraxjnl-2013-204132; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P2498, DOI 10.1021/es300567j; The Korea Centers for Disease Control and Prevention, 2011, REC 6 PROD HUM DIS; The Korea Centers for Disease Control and Prevention, 2011, HUM DIS POSS CAUS LU; The Korean Society of Critical Care Medicine, 2012, PROSP SURV AD LUNG I; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064430	11	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151849	10.1371/journal.pone.0151849	http://dx.doi.org/10.1371/journal.pone.0151849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990641	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800108
J	Sweadner, KJ; Toro, C; Whitlow, CT; Snively, BM; Cook, JF; Ozelius, LJ; Markello, TC; Brashear, A				Sweadner, Kathleen J.; Toro, Camilo; Whitlow, Christopher T.; Snively, Beverly M.; Cook, Jared F.; Ozelius, Laurie J.; Markello, Thomas C.; Brashear, Allison			ATP1A3 Mutation in Adult Rapid-Onset Ataxia	PLOS ONE			English	Article							ALTERNATING HEMIPLEGIA; DYSTONIA-PARKINSONISM; CEREBELLAR-ATAXIA; CRYSTAL-STRUCTURE; PROTEIN; CHILDHOOD; CAPOS; DISORDERS; CHILDREN; SPECTRUM	A 21-year old male presented with ataxia and dysarthria that had appeared over a period of months. Exome sequencing identified a de novo missense variant in ATP1A3, the gene encoding the alpha 3 subunit of Na,K-ATPase. Several lines of evidence suggest that the variant is causative. ATP1A3 mutations can cause rapid-onset dystonia-parkinsonism (RDP) with a similar age and speed of onset, as well as severe diseases of infancy. The patient's ATP1A3 p.Gly316Ser mutation was validated in the laboratory by the impaired ability of the expressed protein to support the growth of cultured cells. In a crystal structure of Na,K-ATPase, the mutated amino acid was directly apposed to a different amino acid mutated in RDP. Clinical evaluation showed that the patient had many characteristics of RDP, however he had minimal fixed dystonia, a defining symptom of RDP. Successive magnetic resonance imaging (MRI) revealed progressive cerebellar atrophy, explaining the ataxia. The absence of dystonia in the presence of other RDP symptoms corroborates other evidence that the cerebellum contributes importantly to dystonia pathophysiology. We discuss the possibility that a second de novo variant, in ubiquilin 4 (UBQLN4), a ubiquitin pathway component, contributed to the cerebellar neurodegenerative phenotype and differentiated the disease from other manifestations of ATP1A3 mutations. We also show that a homozygous variant in GPRIN1 (G protein-regulated inducer of neurite outgrowth 1) deletes a motif with multiple copies and is unlikely to be causative.	[Sweadner, Kathleen J.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Sweadner, Kathleen J.] Harvard Univ, Sch Med, Boston, MA USA; [Toro, Camilo] NHGRI, NIH Undiagnosed Dis Program Common Fund, Off Director, NIH, Bethesda, MD 20892 USA; [Toro, Camilo] NHGRI, Off Clin Director, Bethesda, MD 20892 USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Snively, Beverly M.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Cook, Jared F.; Brashear, Allison] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA; [Ozelius, Laurie J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Markello, Thomas C.] NHGRI, NIH Undiagnosed Dis Program, Common Fund, Off Director,NIH, Bethesda, MD 20892 USA; [Markello, Thomas C.] NHGRI, Human Biochem Genet Sect, Med Genet Branch, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sweadner, KJ (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.; Sweadner, KJ (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	sweadner@helix.mgh.harvard.edu			Common Fund of the National Institutes of Health; National Institutes of Health (NIH) [5R01 NS058949]; National Institutes of Health (NIH) Undiagnosed Diseases Program [HSSN30221300096P, HSSN268201300238P]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058949] Funding Source: NIH RePORTER	Common Fund of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) Undiagnosed Diseases Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Undiagnosed Diseases Program is funded by the Common Fund of the National Institutes of Health. This study was supported by National Institutes of Health (NIH) grant 5R01 NS058949 to AB, and by the National Institutes of Health (NIH) Undiagnosed Diseases Program HSSN30221300096P to AB and HSSN268201300238P to KJS.	Adams DR, 2012, HUM MUTAT, V33, P599, DOI 10.1002/humu.22035; Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Argyelan M, 2009, J NEUROSCI, V29, P9740, DOI 10.1523/JNEUROSCI.2300-09.2009; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Brashear A, 2014, GENEREVIEWS; Brashear A, 2012, DEV MED CHILD NEUROL, V54, P1065, DOI 10.1111/j.1469-8749.2012.04421.x; Brashear A, 2012, NEUROLOGY, V79, P1168, DOI 10.1212/WNL.0b013e3182698d6c; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Cook JF, 2014, MOVEMENT DISORD, V29, P344, DOI 10.1002/mds.25790; Dard R, 2015, DEV MED CHILD NEUROL, V57, P1183, DOI 10.1111/dmcn.12927; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Fremont R, 2014, J NEUROSCI, V34, P11723, DOI 10.1523/JNEUROSCI.1409-14.2014; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Ge X, 2009, J BIOL CHEM, V284, P36521, DOI 10.1074/jbc.M109.024109; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaneko M, 2014, NAT GENET, V46, P144, DOI 10.1038/ng.2850; Krystkowiak P, 2007, MOVEMENT DISORD, V22, P685, DOI 10.1002/mds.21392; Lee DY, 2013, EMBO REP, V14, P373, DOI 10.1038/embor.2013.22; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li M, 2015, NEUROBIOL DIS, V77, P88, DOI 10.1016/j.nbd.2015.02.002; Marin I, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-63; McCall WV, 2002, J ECT, V18, P74, DOI 10.1097/00124509-200206000-00002; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Nakagawa O, 2005, GENE DEV, V19, P2066, DOI 10.1101/gad.1338705; Nicolaides P, 1996, J MED GENET, V33, P419, DOI 10.1136/jmg.33.5.419; Nijholt DAT, 2011, CURR MED CHEM, V18, P2459; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Oblak AL, 2014, ACTA NEUROPATHOL, V128, P81, DOI 10.1007/s00401-014-1279-x; Paciorkowski AR, 2015, EPILEPSIA, V56, P422, DOI 10.1111/epi.12914; Panagiotakaki E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0335-5; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Prudente CN, 2014, NEUROSCIENCE, V260, P23, DOI 10.1016/j.neuroscience.2013.11.062; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rosewich H, 2014, NEUROLOGY, V83, P861, DOI 10.1212/WNL.0000000000000735; Rosewich H, 2014, J NEUROL SCI, V341, P133, DOI 10.1016/j.jns.2014.03.034; Rosewich H, 2014, NEUROLOGY, V82, P945, DOI 10.1212/WNL.0000000000000212; Ryno LM, 2013, CURR OPIN CHEM BIOL, V17, P346, DOI 10.1016/j.cbpa.2013.04.009; Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027; Sasaki M, 2014, NEUROLOGY, V82, P482, DOI 10.1212/WNL.0000000000000102; Sasaki M, 2014, MOVEMENT DISORD, V29, P153, DOI 10.1002/mds.25659; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sweney MT, 2015, PEDIATR NEUROL, V52, P56, DOI 10.1016/j.pediatrneurol.2014.09.015; Thompson VB, 2011, EXPERT OPIN THER TAR, V15, P1387, DOI 10.1517/14728222.2011.641533; Ugwu F, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.002; Viollet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127045; Zhang Can, 2009, Discov Med, V8, P18	49	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151429	10.1371/journal.pone.0151429	http://dx.doi.org/10.1371/journal.pone.0151429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990090	gold, Green Submitted, Green Published			2022-12-27	WOS:000372582800063
J	Vescovini, R; Telera, AR; Pedrazzoni, M; Abbate, B; Rossetti, P; Verzicco, I; Arcangeletti, MC; Medici, MC; Calderaro, A; Volpi, R; Sansoni, P; Fagnoni, FF				Vescovini, Rosanna; Telera, Anna Rita; Pedrazzoni, Mario; Abbate, Barbara; Rossetti, Pietro; Verzicco, Ignazio; Arcangeletti, Maria Cristina; Medici, Maria Cristina; Calderaro, Adriana; Volpi, Riccardo; Sansoni, Paolo; Fagnoni, Francesco Fausto			Impact of Persistent Cytomegalovirus Infection on Dynamic Changes in Human Immune System Profile	PLOS ONE			English	Article							CD8(+) T-CELLS; SEROPOSITIVITY; SUBSETS; CD4(+); ACCUMULATION; COMPARTMENTS; RESPONSES; PATHOGEN; AGE	Human cytomegalovirus (HCMV) imprints the immune system after primary infection, however its effect during chronic infection still needs to be deciphered. In this study we report the variation of blood cell count along with anti-HCMV IgG and T cell responses to pp-65 and IE-1 antigens, that occurred after an interval of five years in a cohort of 25 seropositive healthy adults. We found increased anti-viral IgG antibody responses and intracellular ninterferon-gamma secreting CD8+ T cell responses to pp-65: a result consistent with memory inflation. With the only exception of shortage in naive CD8+ T cells most memory T cell subsets as well as total CD8+ T cells, T cells, lymphocytes, monocytes and leukocytes had increased. By contrast, none of the cell types tested were found to have increased in 14 subjects stably seronegative. Rather, in addition to a shortage in naive CD8+ T cells, also memory T cell subsets and most other cell types decreased, either in a statistically significant or non-significant manner. The trend of T cell pool representation with regard to CD4/CD8 ratio was in the opposing directions depending on HCMV serology. Globally, this study demonstrates different dynamic changes of most blood cell types depending on presence or absence of HCMV infection. Therefore, HCMV plays a continual role in modulating homeostasis of blood T cells and a broader expanding effect on other cell populations of lymphoid and myeloid origin.	[Vescovini, Rosanna; Telera, Anna Rita; Pedrazzoni, Mario; Abbate, Barbara; Rossetti, Pietro; Verzicco, Ignazio; Arcangeletti, Maria Cristina; Medici, Maria Cristina; Calderaro, Adriana; Volpi, Riccardo; Sansoni, Paolo] Univ Parma, Dept Clin & Expt Med, Via Gramsci 14, I-43126 Parma, Italy; [Fagnoni, Francesco Fausto] Hosp Parma, Immunohematol & Transfus Ctr, Via Gramsci 14, I-43126 Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma	Vescovini, R (corresponding author), Univ Parma, Dept Clin & Expt Med, Via Gramsci 14, I-43126 Parma, Italy.; Fagnoni, FF (corresponding author), Hosp Parma, Immunohematol & Transfus Ctr, Via Gramsci 14, I-43126 Parma, Italy.	rosanna.vescovini@unipr.it; ffagnoni@ao.pr.it	Volpi, Riccardo/J-3405-2018; Fagnoni, Francesco F/A-1642-2008	Volpi, Riccardo/0000-0001-8653-6217; rossetti, pietro/0000-0003-4539-1546	Fondazione Cassa di Risparmio di Parma e Piacenza; Regione Emilia Romagna, Programma di Ricerca Regione Universita, Area 1, Strategic Programmes	Fondazione Cassa di Risparmio di Parma e Piacenza; Regione Emilia Romagna, Programma di Ricerca Regione Universita, Area 1, Strategic Programmes	This work was supported by the Fondazione Cassa di Risparmio di Parma e Piacenza and in part by a grant from Regione Emilia Romagna, Programma di Ricerca Regione Universita 2010-2012, Area 1, Strategic Programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckh M, 2011, J CLIN INVEST, V121, P1673, DOI 10.1172/JCI45449; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; CHAKRAVARTI A, 1995, NAT MED, V1, P1240, DOI 10.1038/nm1295-1240; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Crough T, 2005, EUR J IMMUNOL, V35, P139, DOI 10.1002/eji.200425548; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Fagnoni FF, 2002, IMMUNOLOGY, V106, P27, DOI 10.1046/j.1365-2567.2002.01400.x; Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Jackson SE, 2014, J VIROL, V88, P10894, DOI 10.1128/JVI.01477-14; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Li HF, 2014, EXP GERONTOL, V54, P84, DOI 10.1016/j.exger.2014.01.010; Libri V, 2011, IMMUNOLOGY, V132, P326, DOI 10.1111/j.1365-2567.2010.03386.x; LIFSON JD, 1985, CLIN IMMUNOL IMMUNOP, V36, P151, DOI 10.1016/0090-1229(85)90116-3; Litjens NHR, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-2; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Lugli E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00390; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; Muntasell A, 2013, EUR J IMMUNOL, V43, P1133, DOI 10.1002/eji.201243117; O'Hara GA, 2012, TRENDS IMMUNOL, V33, P84, DOI 10.1016/j.it.2011.11.005; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Vescovini R, 2014, AGE, V36, P625, DOI 10.1007/s11357-013-9594-z; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wallace DL, 2011, IMMUNOLOGY, V132, P27, DOI 10.1111/j.1365-2567.2010.03334.x; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721	34	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151965	10.1371/journal.pone.0151965	http://dx.doi.org/10.1371/journal.pone.0151965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990192	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800124
J	Yang, QD; Zuo, HC; Li, WD				Yang, Qidong; Zuo, Hongchao; Li, Weidong			Land Surface Model and Particle Swarm Optimization Algorithm Based on the Model-Optimization Method for Improving Soil Moisture Simulation in a Semi-Arid Region	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; ENERGY-BALANCE; CLIMATE; CALIBRATION; CARBON; PARAMETERIZATION; TEMPERATURE; SENSITIVITY; ASIA	Improving the capability of land-surface process models to simulate soil moisture assists in better understanding the atmosphere-land interaction. In semi-arid regions, due to limited near-surface observational data and large errors in large-scale parameters obtained by the remote sensing method, there exist uncertainties in land surface parameters, which can cause large offsets between the simulated results of land-surface process models and the observational data for the soil moisture. In this study, observational data from the Semi-Arid Climate Observatory and Laboratory (SACOL) station in the semi-arid loess plateau of China were divided into three datasets: summer, autumn, and summer-autumn. By combing the particle swarm optimization (PSO) algorithm and the land-surface process model SHAW (Simultaneous Heat and Water), the soil and vegetation parameters that are related to the soil moisture but difficult to obtain by observations are optimized using three datasets. On this basis, the SHAW model was run with the optimized parameters to simulate the characteristics of the land-surface process in the semi-arid loess plateau. Simultaneously, the default SHAW model was run with the same atmospheric forcing as a comparison test. Simulation results revealed the following: parameters optimized by the particle swarm optimization algorithm in all simulation tests improved simulations of the soil moisture and latent heat flux; differences between simulated results and observational data are clearly reduced, but simulation tests involving the adoption of optimized parameters cannot simultaneously improve the simulation results for the net radiation, sensible heat flux, and soil temperature. Optimized soil and vegetation parameters based on different datasets have the same order of magnitude but are not identical; soil parameters only vary to a small degree, but the variation range of vegetation parameters is large.	[Yang, Qidong; Li, Weidong] Yunnan Univ, Dept Atmospher Sci, Kunming, Yunnan, Peoples R China; [Zuo, Hongchao] Lanzhou Univ, Coll Atmospher Sci, Lanzhou 730000, Gansu, Peoples R China	Yunnan University; Lanzhou University	Yang, QD (corresponding author), Yunnan Univ, Dept Atmospher Sci, Kunming, Yunnan, Peoples R China.	yangqd@ynu.edu.cn		Li, Weidong/0000-0003-3094-4347	National Basic Research Program of China '973' Program [2012CB956200]; Natural Science Foundation of China [41305103, 41275019, 41475009]; Natural Science Foundation of Yunnan Province [201301YD00003]	National Basic Research Program of China '973' Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work is supported by the by the National Basic Research Program of China '973' Program (Grant 2012CB956200), Natural Science Foundation of China (41305103, 41275019, 41475009) and Natural Science Foundation of Yunnan Province (201301YD00003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, 200010 NWRC; Chau KW, 2006, J HYDROL, V329, P363, DOI 10.1016/j.jhydrol.2006.02.025; Crow WT, 2003, J GEOPHYS RES, V108; Dirmeyer PA, 2000, J CLIMATE, V13, P2900, DOI 10.1175/1520-0442(2000)013<2900:UAGSWD>2.0.CO;2; Dirmeyer PA, 2006, B AM METEOROL SOC, V87, P1381, DOI 10.1175/BAMS-87-10-1381; DUAN QY, 1994, J HYDROL, V158, P265, DOI 10.1016/0022-1694(94)90057-4; Eberhart RC, 2001, IEEE C EVOL COMPUTAT, P81, DOI 10.1109/CEC.2001.934374; FLERCHINGER GN, 1989, T ASAE, V32, P565, DOI 10.13031/2013.31040; Flerchinger GN, 1998, J APPL METEOROL, V37, P449, DOI 10.1175/1520-0450(1998)037<0449:SSEFAR>2.0.CO;2; Flerchinger GN, 2004, J ARID ENVIRON, V59, P369, DOI 10.1016/j.jaridenv.2004.01.016; Fu CB, 2003, GLOBAL PLANET CHANGE, V37, P219, DOI 10.1016/S0921-8181(02)00207-2; Gedney N, 2003, J HYDROMETEOROL, V4, P1265, DOI 10.1175/1525-7541(2003)004<1265:TSOGCM>2.0.CO;2; Gill MK, 2006, WATER RESOURCES RES, V42; Gupta HV, 2009, J HYDROL, V377, P80, DOI 10.1016/j.jhydrol.2009.08.003; Gupta HV, 1999, J GEOPHYS RES-ATMOS, V104, P19491, DOI 10.1029/1999JD900154; HENDERSON-SELLERS A, 1995, B AM METEOROL SOC, V76, P489, DOI 10.1175/1520-0477(1995)076<0489:TPFIOL>2.0.CO;2; Hu ZY, 2014, J CLIMATE, V27, P1143, DOI 10.1175/JCLI-D-13-00064.1; Huang JP, 2008, ADV ATMOS SCI, V25, P906, DOI 10.1007/s00376-008-0906-7; Ines AV, 2008, WATER RESOURCES RES, V44; Jhorar RK, 2004, J HYDROL, V285, P233, DOI 10.1016/j.jhydrol.2003.09.003; Jones AR, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI270.1; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J., 2010, ENCY MACHINE LEARNIN, P760, DOI DOI 10.1007/978-0-387-30164-8_630; Koster R, 2015, J HYDROMETEOROLOGY; Koster RD, 2009, J CLIMATE, V22, P4322, DOI 10.1175/2009JCLI2832.1; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Li CF, 2015, GLOBAL CHANGE BIOL, V21, P1951, DOI 10.1111/gcb.12846; Li Q, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012530; Liang X, 1996, GLOBAL PLANET CHANGE, V13, P195, DOI 10.1016/0921-8181(95)00046-1; Liu ZY, 2010, J CLIMATE, V23, P1447, DOI 10.1175/2009JCLI3183.1; Mitchell SR, 2015, AGR FOREST METEOROL, V208, P108, DOI 10.1016/j.agrformet.2015.04.003; Narisma GT, 2007, ABRUPT CHANGES RAINF; Nijssen B, 2001, J CLIMATE, V14, P1790, DOI [10.1175/1520-0442(2001)014<1790:GREOSM>2.0.CO;2, 10.1175/1520-0442(2001)014&lt;1790:GREOSM&gt;2.0.CO;2]; PASTOR J, 1986, BIOGEOCHEMISTRY, V2, P3, DOI 10.1007/BF02186962; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; ROTH CH, 1992, J SOIL SCI, V43, P1, DOI 10.1111/j.1365-2389.1992.tb00115.x; Scheerlinck K, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008051; SELLERS PJ, 1989, J APPL METEOROL, V28, P727, DOI 10.1175/1520-0450(1989)028&lt;0727:CTSBMF&gt;2.0.CO;2; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Shao YP, 1996, GLOBAL PLANET CHANGE, V13, P11, DOI 10.1016/0921-8181(95)00038-0; [孙鹏森 SUN PengSen], 2006, [生态学报, Acta Ecologica Sinica], V26, P3826; Veihe A, 2000, HYDROL PROCESS, V14, P915, DOI [10.1002/(SICI)1099-1085(20000415)14:5<915::AID-HYP978>3.0.CO;2-4, 10.1002/(SICI)1099-1085(20000415)14:5&lt;915::AID-HYP978&gt;3.0.CO;2-4]; Verhoef A, 1999, INT J CLIMATOL, V19, P1267, DOI [10.1002/(SICI)1097-0088(199909)19:11<1267::AID-JOC418>3.0.CO;2-S, 10.1002/(SICI)1097-0088(199909)19:11&lt;1267::AID-JOC418&gt;3.0.CO;2-S]; Xiao X, 2011, HYDROL EARTH SYST SC, V8, P555; Xue Y, 1996, SENSITIVITY SIMULATE; Yapo PO, 1998, J HYDROL, V204, P83, DOI 10.1016/S0022-1694(97)00107-8; Zhang C, 2016, REMOTE SENS ENVIRON, V175, P271, DOI 10.1016/j.rse.2016.01.002; Zhang C, 2013, ECOL MODEL, V267, P158, DOI 10.1016/j.ecolmodel.2013.06.008; Zhang C, 2013, J ARID LAND, V5, P102, DOI 10.1007/s40333-013-0146-2; Zhang XS, 2009, HYDROL PROCESS, V23, P430, DOI 10.1002/hyp.7152	50	3	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151576	10.1371/journal.pone.0151576	http://dx.doi.org/10.1371/journal.pone.0151576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991786	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800077
J	Zanotta, N; Tornesello, ML; Annunziata, C; Stellato, G; Buonaguro, FM; Comar, M				Zanotta, Nunzia; Tornesello, Maria Lina; Annunziata, Clorinda; Stellato, Giovanni; Buonaguro, Franco Maria; Comar, Manola			Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation	PLOS ONE			English	Article							DENDRITIC CELLS; CANCER; TUMOR; RESPONSES; TYPE-16; ASSOCIATION; PERSISTENCE; ACTIVATION; RECEPTORS; PATHWAYS	Background The causal interpretation of cervical immune response to Human Papillomavirus (HPV) infection is complex and poorly characterized mainly due to the delicate balance that exists between viral infection, increase of inflammatory cytokines and host risk factors. This study aims to explore the significance of cervical immune mediators associated to cell survival, angiogenesis and interaction with immune response, in predicting the risk to develop HPV-related intraepithelial lesions. Methods A panel of 48 cytokines and growth factors were explored in a selected cohort of 168 immunocompetent women including 88 diagnosed with low (LSIL) or high (HSIL) squamous intraepithelial lesions of the cervix and 80 with normal cervical cytology (NIL). HPV genotyping was performed by Linear Array HPV test and the soluble concentration of 48 immune molecules was analyzed using the Bio-Plex platform. Results The prevalence of single HR-HPV infection was 30% in NIL and 100% in LSIL and HSIL women. The expression of 13 cytokines, including interleukins IL-6, IL-3, IL-12p40, IL-12p70, IL-16, IL-18, LIF, of chemokines CCL7 (MCP-3), CXCL9 (MIG), CXCL12 (SDF-1 alpha) and of the tropic factors VEGF, G-CSF, M-CSF were significantly associated with the presence of infection, with levels being higher in women with precancerous lesions compared to NIL HPV negative women. Only the growth factor GM-CSF was positively associated with the cytological abnormalities. Conclusions The ability of HR-HPV to escape from innate immune recognition and to orchestrate the production of specific inflammatory and growth factors, involved in early inflammatory response and in the cell-proliferating phase of intraepithelial damage, was documented in women before the development of cervical lesions.	[Zanotta, Nunzia; Comar, Manola] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Tornesello, Maria Lina; Annunziata, Clorinda; Buonaguro, Franco Maria] Ist Nazl Tumori IRCCS Fond Pascale, Mol Biol & Viral Oncol Div, Naples, Italy; [Stellato, Giovanni] Ist Nazl Tumori IRCCS Fond Pascale, Div Gynecol Oncol, Naples, Italy; [Comar, Manola] Univ Trieste, Dept Med Sci, Trieste, Italy	IRCCS Burlo Garofolo; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; University of Trieste	Comar, M (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.; Comar, M (corresponding author), Univ Trieste, Dept Med Sci, Trieste, Italy.	manola.comar@burlo.trieste.it	Zanotta, Nunzia/K-4539-2016; Buonaguro, Franco M./T-6028-2019; Comar, Manola/K-4613-2016; Tornesello, Maria Lina/A-1964-2008; Maria, Buonaguro Franco/AAF-4888-2019; Annunziata, Clorinda/K-3886-2018; COMAR, Manola/K-4613-2016	Zanotta, Nunzia/0000-0002-6458-1946; Buonaguro, Franco M./0000-0002-7491-7220; Comar, Manola/0000-0001-6310-3320; Tornesello, Maria Lina/0000-0002-3523-3264; Annunziata, Clorinda/0000-0002-9580-8330; COMAR, Manola/0000-0002-9487-861X	Italian Health Ministry IRCCS-"Burlo Garofolo," Trieste, Italy [09/12]	Italian Health Ministry IRCCS-"Burlo Garofolo," Trieste, Italy	The present study has been supported by a grant from Italian Health Ministry (Current research 09/12) IRCCS-"Burlo Garofolo," Trieste, Italy.	Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Arbyn M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092615; Azar KK, 2004, HUM PATHOL, V35, P1376, DOI 10.1016/j.humpath.2004.08.012; Bais AG, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/24147; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chang YH, 2010, CANCER-AM CANCER SOC, V116, P4800, DOI 10.1002/cncr.25224; Comar M, 2013, J CLIN VIROL, V58, P479, DOI 10.1016/j.jcv.2013.07.001; Conesa-Zamora P, 2002, NAT REV CANCER, V2, P59; Conesa-Zamora P, 2013, GYNECOL ONCOL, V131, P480, DOI 10.1016/j.ygyno.2013.08.025; Deligeoroglou Efthimios, 2013, Infect Dis Obstet Gynecol, V2013, P540850, DOI 10.1155/2013/540850; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; Hazelbag S, 2001, GYNECOL ONCOL, V83, P235, DOI 10.1006/gyno.2001.6378; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hubert P, 2005, J PATHOL, V206, P346, DOI 10.1002/path.1771; Hubert P, 1999, AM J PATHOL, V154, P775, DOI 10.1016/S0002-9440(10)65324-2; Hussain SK, 2013, INT J CANCER, V133, P201, DOI 10.1002/ijc.28000; Jaafar F, 2009, AM J PATHOL, V175, P1525, DOI 10.2353/ajpath.2009.090295; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lee SJ, 2015, VACCINE, V33, P1549, DOI 10.1016/j.vaccine.2015.02.019; Liu Y, 2011, CANCER GENE THER, V18, P407, DOI 10.1038/cgt.2011.8; Majka M, 2006, FOLIA HISTOCHEM CYTO, V44, P155; Miller LS, 2007, J INVEST DERMATOL, V127, P262, DOI 10.1038/sj.jid.5700559; Molling JW, 2007, INT J CANCER, V121, P1749, DOI 10.1002/ijc.22894; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Perea SE, 2000, INT J MOL MED, V5, P661; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Scott ME, 2009, INT J CANCER, V124, P1379, DOI 10.1002/ijc.24117; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Sheu BC, 2007, J OBSTET GYNAECOL RE, V33, P103, DOI 10.1111/j.1447-0756.2007.00492.x; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Strickler HD, 2014, VIRAL IMMUNOL, V27, P20, DOI 10.1089/vim.2013.0097; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002; Tornesello ML, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/519619; Torres-Poveda K, 2014, WORLD J CLIN ONCOL, V5, P753, DOI 10.5306/wjco.v5.i4.753; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walentowicz-Sadlecka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084629; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151851	10.1371/journal.pone.0151851	http://dx.doi.org/10.1371/journal.pone.0151851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990868	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800110
J	Pasquier, D; de la Combe-Chossiere, LB; Carlier, D; Darloy, F; Degrendel-Courtecuisse, AC; Dufour, C; Fares, M; Gilbeau, L; Liem, X; Martin, P; Meyer, P; Minne, JF; Olszyk, O; Rhliouch, H; Tokarski, M; Viot, C; Castelain, B; Lartigau, E				Pasquier, David; de la Combe-Chossiere, Laurence Boutaud; Carlier, Damien; Darloy, Franck; Degrendel-Courtecuisse, Anne Catherine; Dufour, Chantal; Fares, Mustapha; Gilbeau, Laurent; Liem, Xavier; Martin, Philippe; Meyer, Pascal; Minne, Jean Francois; Olszyk, Olimpia; Rhliouch, Hassan; Tokarski, Marc; Viot, Chloe; Castelain, Bernard; Lartigau, Eric			Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France	PLOS ONE			English	Article							CONFORMAL RADIATION-THERAPY; MAGNETIC-RESONANCE IMAGES; INTEROBSERVER VARIABILITY; CONSENSUS GUIDELINES; PROSTATE-CANCER; TARGET VOLUME; HEAD; SEGMENTATION; INTERVENTION; METHODOLOGY	Background Inter-observer delineation variation has been detailed for many years in almost every tumor location. Inadequate delineation can impair the chance of cure and/or increase toxicity. The aim of our original work was to prospectively improve the homogeneity of delineation among all of the senior radiation oncologists in the Nord-Pas de Calais region, irrespective of the conditions of practice. Methods All 11 centers were involved. The first studied cancer was prostate cancer. Three clinical cases were studied: a low-risk prostate cancer case (case 1), a high-risk prostate cancer case (pelvic nodes, case 2) and a case of post-operative biochemical elevated PSA (case 3). All of the involved physicians delineated characteristically the clinical target volume (CTV) and organs at risk. The volumes were compared using validated indexes: the volume ratio (VR), common and additional volumes (CV and AV), volume overlap (VO) and Dice similarity coefficient (DSC). A second delineation of the same three cases was performed after discussion of the slice results and the choice of shared guidelines to evaluate homogenization. A comparative analysis of the indexes before and after discussion was conducted using the Wilcoxon test for paired samples. A p-value less than 0.05 was considered to indicate statistical significance. Results The indexes were not improved in case 1, for which the inter-observer agreement was considered good after the first comparison (DSC = 0.83 +/- 0.06). In case 2, the second comparison showed homogenization of the CTV delineation with a significant improvement in CV (81.4 +/- 11.7 vs. 88.6 +/- 10.26, respectively, p = 0.048), VO (0.41 +/- 0.09 vs. 0.47 +/- 0.07, respectively; p = 0.009) and DSC (0.58 +/- 0.09 vs. 0.63 +/- 0.07, respectively; p = 0.0098). In case 3, VR and AV were significantly improved: VR: 1.71(+/- 0.6) vs. 1.34(+/- 0.46), respectively, p = 0.0034; AV: 46.58(+/- 14.50) vs. 38.08(+/- 15.10), respectively, p = 0.0024. DSC was not improved, but it was already superior to 0.6 in the first comparison. Conclusion Our prospective work showed that a collaborative discussion about clinical cases and the choice of shared guidelines within an established framework improved the homogeneity of CTV delineation among the senior radiation oncologists in our region.	[Pasquier, David; Liem, Xavier; Castelain, Bernard; Lartigau, Eric] Univ Lille, Ctr Oscar Lambret, Acad Radiat Oncol Dept, Lille, France; [Pasquier, David; Lartigau, Eric] UMR CNRS 9189, CRISTAL, Lille, France; [de la Combe-Chossiere, Laurence Boutaud] Inst Andree Dutreix, Dunkerque, France; [Carlier, Damien; Darloy, Franck] Ctr Leonard Vinci, Dechy, France; [Degrendel-Courtecuisse, Anne Catherine] Ctr Joliot Curie, Boulogne Sur Mer, France; [Dufour, Chantal; Minne, Jean Francois] Ctr Cancerol Dentellieres, Valenciennes, France; [Fares, Mustapha] Ctr Pierre Curie, Bethune, France; [Gilbeau, Laurent; Meyer, Pascal] Ctr Gray, Maubeuge, France; [Martin, Philippe] Ctr Bourgogne Clin Bois, Lille, France; [Olszyk, Olimpia] Ctr Galilee, Lille, France; [Rhliouch, Hassan] Ctr Marie Curie, Arras, France; [Tokarski, Marc] Ctr Cancerol Artois, Lens, France; [Viot, Chloe] Reseau Onco Nord Pas de Calais, Loos, France	UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Centrale Lille; Universite de Lille	Pasquier, D (corresponding author), Univ Lille, Ctr Oscar Lambret, Acad Radiat Oncol Dept, Lille, France.; Pasquier, D (corresponding author), UMR CNRS 9189, CRISTAL, Lille, France.	pasquier@o-lambret.fr	lartigau, eric/GSI-5327-2022; Pasquier, David/O-8004-2014	Pasquier, David/0000-0001-6019-7309	Ligue Contre le Cancer, Reseau Regional de Cancerologie [04]; Region Nord Pas de Calais, Reseau Regional de Cancerologie [1200 1826]; Fonds europeen de developpement regional FEDER, Reseau Regional de Cancerologie [38420]; Agence Regionale de Sante, Reseau Regional de Cancerologie [03]	Ligue Contre le Cancer, Reseau Regional de Cancerologie; Region Nord Pas de Calais, Reseau Regional de Cancerologie(Region Hauts-de-France); Fonds europeen de developpement regional FEDER, Reseau Regional de Cancerologie; Agence Regionale de Sante, Reseau Regional de Cancerologie	This work was supported by Ligue Contre le Cancer (http://www.ligue-cancer.net/), Grant number 04, Reseau Regional de Cancerologie; Region Nord Pas de Calais (http://www. nordpasdecalais.fr/jcms/c_5001/accueil), Grant number 1200 1826, Reseau Regional de Cancerologie; Fonds europeen de developpement regional FEDER (http://www.europe-en-france.gouv.fr/Configuration-Generale-Pages-secondaires/FEDER), Grant number 38420, Reseau Regional de Cancerologie; and Agence Regionale de Sante (http://www.ars.nordpasdecalais.sante.fr/Internet.nordpasdecalais.0.html), Grant number 03, Reseau Regional de Cancerologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allozi R, 2010, RADIOTHER ONCOL, V97, P572, DOI 10.1016/j.radonc.2010.06.009; Bekelman JE, 2009, INT J RADIAT ONCOL, V73, P416, DOI 10.1016/j.ijrobp.2008.04.028; Boehmer D, 2006, RADIOTHER ONCOL, V79, P259, DOI 10.1016/j.radonc.2006.05.012; Brouwer CL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-32; BUENO G, 2001, P MED IM UND AN MIUA, P73; Cazzaniga LF, 1998, RADIOTHER ONCOL, V47, P293, DOI 10.1016/S0167-8140(98)00028-0; Chalana V, 1997, IEEE T MED IMAGING, V16, P642, DOI 10.1109/42.640755; Dawant BM, 1999, IEEE T MED IMAGING, V18, P909, DOI 10.1109/42.811271; Debois M, 1999, INT J RADIAT ONCOL, V45, P857, DOI 10.1016/S0360-3016(99)00288-6; Dewas S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-118; Fiorino C, 1998, RADIOTHER ONCOL, V47, P285, DOI 10.1016/S0167-8140(98)00021-8; Giraud P, 2002, RADIOTHER ONCOL, V62, P27, DOI 10.1016/S0167-8140(01)00444-3; Guo B, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0370-3; Guo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112187; Jager EA, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-014-0321-4; Kelemen A, 1999, IEEE T MED IMAGING, V18, P828, DOI 10.1109/42.811260; Lawton CAF, 2009, INT J RADIAT ONCOL, V74, P383, DOI 10.1016/j.ijrobp.2008.08.002; Lawton CAF, 2009, INT J RADIAT ONCOL, V74, P377, DOI 10.1016/j.ijrobp.2008.08.003; Ligier K, 2012, REV EPIDEMIOL SANTE, V60, P131, DOI 10.1016/j.respe.2011.10.006; Malone S, 2012, INT J RADIAT ONCOL, V84, P725, DOI 10.1016/j.ijrobp.2011.12.081; Michalski JM, 2010, INT J RADIAT ONCOL, V76, P361, DOI 10.1016/j.ijrobp.2009.02.006; Nyholm T, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-126; Ohri N, 2013, JNCI-J NATL CANCER I, V105, P387, DOI 10.1093/jnci/djt001; Pasquier D, 2007, INT J RADIAT ONCOL, V68, P592, DOI 10.1016/j.ijrobp.2007.02.005; Peters LJ, 2010, J CLIN ONCOL, V28, P2996, DOI 10.1200/JCO.2009.27.4498; Szumacher E, 2010, INT J RADIAT ONCOL, V76, P379, DOI 10.1016/j.ijrobp.2009.02.008	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150917	10.1371/journal.pone.0150917	http://dx.doi.org/10.1371/journal.pone.0150917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987121	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300037
J	Van Der Gucht, A; Zehou, O; Djelbani-Ahmed, S; Valeyrie-Allanore, L; Ortonne, N; Brugieres, P; Wolkenstein, P; Luciani, A; Rahmouni, A; Sbidian, E; Itti, E				Van Der Gucht, Axel; Zehou, Ouidad; Djelbani-Ahmed, Soraya; Valeyrie-Allanore, Laurence; Ortonne, Nicolas; Brugieres, Pierre; Wolkenstein, Pierre; Luciani, Alain; Rahmouni, Alain; Sbidian, Emilie; Itti, Emmanuel			Metabolic Tumour Burden Measured by F-18-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1	PLOS ONE			English	Article							NERVE SHEATH TUMORS; FDG PET; VOLUME; TOMOGRAPHY; GUIDELINES; MANAGEMENT; PHENOTYPE; MORTALITY; DIAGNOSIS; DEATH	Background To investigate the diagnostic and prognostic performances of F-18-FDG PET/CT measures of metabolic tumour burden in patients with neurofibromatosis type-1 (NF1), suspect of malignant transformation. Methods This retrospective study included 49 patients (15-60 years old, 30 women) with a diagnosis of NF1, followed in our Reference Centre for Rare Neuromuscular Diseases, who presented clinical signs of tumour progression (pain, neurological deficit, tumour growth). Quantitative metabolic parameters were measured on 149 tumoral targets, using semi-automatic software and the best cut off values to predict transformation was assessed by Receiver Operating Characteristics (ROC) analysis. Prognostic value of PET/CT metabolic parameters was assessed by Kaplan-Meier estimates of overall survival. Results Lesions were histologically documented in 40 patients: a sarcomatous transformation was found in 16, a dysplastic neurofibroma (NF) in 7, and a benign NF in 17; in the remaining 9 patients, a minimal follow-up of 12 mo (median 59 mo) confirmed the absence of transformation. The optimal cut off values for detection of malignant transformation were, in decreasing order of area under the ROC curves, a tumour-to-liver (T/L) ratio >2.5, SUVmax > 4.5, total lesion glycolysis (TLG) > 377, total metabolic tumour volume (TMTV) > 88 cm(3), and heterogeneity index (HIsuv) > 1.69. The best prognostic marker was the TLG: the 4-y estimates of survival were 97% [95% CI, 90% - 100%] in patients with TLG <= 377 vs. 27% [95% CI, 5% - 49%] in patients with TLG > 377 (P < 0.0001; chi(2) 27.85; hazard ratio 13.27 [95% CI, 3.72-47.35]). T/L ratio, SUVmax and TMTV demonstrated slightly lower performance to predict survival, with. 2 ranging 14.41-19.12. The HIsuv index was not predictive of survival. Conclusion Our study demonstrates that TLG and TMTV, as PET/CT measures of metabolic tumour burden, may be used clinically to identify sarcomatous transformation in patients with NF1 and predict overall survival, with a higher specificity for the TLG. Conventional measures such as the SUVmax, and T/L ratio also demonstrate high prognostic value.	[Van Der Gucht, Axel; Djelbani-Ahmed, Soraya; Itti, Emmanuel] Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, F-94010 Creteil, France; [Zehou, Ouidad; Valeyrie-Allanore, Laurence; Wolkenstein, Pierre; Sbidian, Emilie] Paris Est Univ, H Mondor Hosp, AP HP, Dept Dermatol, F-94010 Creteil, France; [Ortonne, Nicolas] Paris Est Univ, H Mondor Hosp, AP HP, Dept Pathol, F-94010 Creteil, France; [Brugieres, Pierre] Paris Est Univ, H Mondor Hosp, AP HP, Dept Neuroradiol, F-94010 Creteil, France; [Luciani, Alain; Rahmouni, Alain] Paris Est Univ, H Mondor Hosp, AP HP, Dept Med Imaging, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Van Der Gucht, A (corresponding author), Paris Est Univ, H Mondor Hosp, AP HP, Dept Nucl Med, F-94010 Creteil, France.	axel.vandergucht@gmail.com	Sbidian, Emilie/ABH-5714-2020; Luciani, Alain/U-1429-2018	Itti, Emmanuel/0000-0003-1578-4058; Van Der Gucht, Axel/0000-0002-2060-4210; Ortonne, Nicolas/0000-0003-0111-7422				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Benz MR, 2010, J NUCL MED, V51, P1174, DOI 10.2967/jnumed.109.074229; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Biehl KJ, 2006, J NUCL MED, V47, P1808; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Brenner W, 2006, EUR J NUCL MED MOL I, V33, P428, DOI 10.1007/s00259-005-0030-1; Chirindel A, 2015, J NUCL MED, V56, P379, DOI 10.2967/jnumed.114.142372; Choi ES, 2013, EUR J NUCL MED MOL I, V40, P1836, DOI 10.1007/s00259-013-2511-y; Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x; Combemale P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085954; Derlin T, 2013, CLIN NUCL MED, V38, pE19, DOI 10.1097/RLU.0b013e318266ce84; Doorn P F, 1995, Eur J Surg Oncol, V21, P78, DOI 10.1016/S0748-7983(05)80073-3; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2008, ANN ONCOL, V19, P390, DOI 10.1093/annonc/mdm450; Ferner RE, 2002, CANCER RES, V62, P1573; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Im HJ, 2012, EUR J NUCL MED MOL I, V39, P39, DOI 10.1007/s00259-011-1936-4; Kanoun S, 2014, EUR J NUCL MED MOL I, V41, P1735, DOI 10.1007/s00259-014-2783-x; Karabatsou K, 2009, NEUROSURGERY, V65, pA160, DOI 10.1227/01.NEU.0000337597.18599.D3; Khiewvan B, 2014, EUR J NUCL MED MOL I, V41, P1756, DOI 10.1007/s00259-014-2756-0; La TH, 2009, INT J RADIAT ONCOL, V74, P1335, DOI 10.1016/j.ijrobp.2008.10.060; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Matsumine A, 2009, J CANCER RES CLIN, V135, P891, DOI 10.1007/s00432-008-0523-y; Meignan M, 2014, EUR J NUCL MED MOL I, V41, P1113, DOI 10.1007/s00259-014-2705-y; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Salamon J, 2014, EUR RADIOL, V24, P405, DOI 10.1007/s00330-013-3020-x; Salamon J, 2013, EUR J NUCL MED MOL I, V40, P685, DOI 10.1007/s00259-012-2314-6; Sasanelli M, 2014, EUR J NUCL MED MOL I, V41, P2017, DOI 10.1007/s00259-014-2822-7; Sbidian E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-51; Sbidian E, 2010, J INVEST DERMATOL, V130, P2173, DOI 10.1038/jid.2010.100; Duong TA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-18; Tubiana M, 2009, RADIOLOGY, V251, P13, DOI 10.1148/radiol.2511080671; Valeyrie-Allanore L, 2008, BRIT J DERMATOL, V158, P1008, DOI 10.1111/j.1365-2133.2008.08494.x; Warbey VS, 2009, EUR J NUCL MED MOL I, V36, P751, DOI 10.1007/s00259-008-1038-0; Wasa J, 2010, AM J ROENTGENOL, V194, P1568, DOI 10.2214/AJR.09.2724; Zhang H, 2013, ACAD RADIOL, V20, P32, DOI 10.1016/j.acra.2012.07.002	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151809	10.1371/journal.pone.0151809	http://dx.doi.org/10.1371/journal.pone.0151809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987124	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300133
J	Wu, XX; Ebine, K; Ueda, T; Qiu, QS				Wu, Xuexia; Ebine, Kazuo; Ueda, Takashi; Qiu, Quan-Sheng			AtNHX5 and AtNHX6 Are Required for the Subcellular Localization of the SNARE Complex That Mediates the Trafficking of Seed Storage Proteins in Arabidopsis	PLOS ONE			English	Article							VACUOLAR SORTING RECEPTOR; GOLGI-APPARATUS; CATION/H+ ANTIPORTERS; NA+/H+ ANTIPORTERS; MEMBRANE-PROTEIN; EMERGING ROLES; ACID-RESIDUES; PLANT-GROWTH; H+-ATPASE; PH	The SNARE complex composed of VAMP727, SYP22, VTI11 and SYP51 is critical for protein trafficking and PSV biogenesis in Arabidopsis. This SNARE complex directs the fusion between the prevacuolar compartment (PVC) and the vacuole, and thus mediates protein trafficking to the vacuole. In this study, we examined the role of AtNHX5 and AtNHX6 in regulating this SNARE complex and its function in protein trafficking. We found that AtNHX5 and AtNHX6 were required for seed production, protein trafficking and PSV biogenesis. We further found that the nhx5 nhx6 syp22 triple mutant showed severe defects in seedling growth and seed development. The triple mutant had short siliques and reduced seed sets, but larger seeds. In addition, the triple mutant had numerous smaller protein storage vacuoles (PSVs) and accumulated precursors of the seed storage proteins in seeds. The PVC localization of SYP22 and VAMP727 was repressed in nhx5 nhx6, while a significant amount of SYP22 and VAMP727 was trapped in the Golgi or TGN in nhx5 nhx6. AtNHX5 and AtNHX6 were co-localized with SYP22 and VAMP727. Three conserved acidic residues, D164, E188, and D193 in AtNHX5 and D165, E189, and D194 in AtNHX6, were essential for the transport of the storage proteins, indicating the importance of exchange activity in protein transport. AtNHX5 or AtNHX6 did not interact physically with the SNARE complex. Taken together, AtNHX5 and AtNHX6 are required for the PVC localization of the SNARE complex and hence its function in protein transport. AtNHX5 and AtNHX6 may regulate the subcellular localization of the SNARE complex by their transport activity.	[Wu, Xuexia; Qiu, Quan-Sheng] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China; [Ebine, Kazuo; Ueda, Takashi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Ueda, Takashi] Japan Sci & Technol Agcy JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Lanzhou University; University of Tokyo; Japan Science & Technology Agency (JST)	Qiu, QS (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 73000, Gansu, Peoples R China.	qiuqsh@lzu.edu.cn	Ueda, Takashi/G-6984-2011	Ueda, Takashi/0000-0002-5190-892X; ebine, kazuo/0000-0003-3020-7208	National Basic Research Program of China (973 project) [2013CB429904]; National Natural Science Foundation of China (NSFC) [31070222, 31371438, 31571464]; Doctoral Fund of Ministry of Education of China (RFDP) [20130211110001]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k10]	National Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China (RFDP); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China (973 project, 2013CB429904 to QSQ), National Natural Science Foundation of China (NSFC, 31070222 to QSQ), National Natural Science Foundation of China (NSFC, 31371438 to QSQ), National Natural Science Foundation of China (NSFC, 31571464 to QSQ), Doctoral Fund of Ministry of Education of China (RFDP, 20130211110001 to QSQ), Fundamental Research Funds for the Central Universities (lzujbky-2013-k10 to QSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashnest JR, 2015, PLANT CELL PHYSIOL, V56, P2220, DOI 10.1093/pcp/pcv138; Bassham DC, 2000, CURR OPIN CELL BIOL, V12, P491, DOI 10.1016/S0955-0674(00)00121-6; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; BOSS WF, 1984, EUR J CELL BIOL, V34, P1; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chanroj S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00025; CHRISPEELS MJ, 1983, PLANTA, V158, P140, DOI 10.1007/BF00397707; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Dibrov P, 1998, BIOCHEMISTRY-US, V37, P8282, DOI 10.1021/bi9801457; Ebine K, 2008, PLANT CELL, V20, P3006, DOI 10.1105/tpc.107.057711; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fuji K, 2007, PLANT CELL, V19, P597, DOI 10.1105/tpc.106.045997; Hara-Nishimura I, 1998, PLANT CELL, V10, P825, DOI 10.1105/tpc.10.5.825; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Herman EM, 1999, PLANT CELL, V11, P601, DOI 10.1105/tpc.11.4.601; Hillmer S, 2001, J CELL BIOL, V152, P41, DOI 10.1083/jcb.152.1.41; Hinz G, 1999, PLANT CELL, V11, P1509, DOI 10.1105/tpc.11.8.1509; Hohl I, 1996, J CELL SCI, V109, P2539; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Kang H, 2012, PLANT CELL, V24, P5058, DOI 10.1105/tpc.112.103481; KIRSCH T, 1994, P NATL ACAD SCI USA, V91, P3403, DOI 10.1073/pnas.91.8.3403; Lee Y, 2013, PLANT PHYSIOL, V161, P121, DOI 10.1104/pp.112.210914; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Martiniere A, 2013, PLANT CELL, V25, P4028, DOI 10.1105/tpc.113.116897; Matsuoka K, 1997, PLANT CELL, V9, P533; MATSUOKA K, 1990, J BIOL CHEM, V265, P19750; Nishizawa K, 2003, PLANT J, V34, P647, DOI 10.1046/j.1365-313X.2003.01754.x; Ohtomo I, 2005, PLANT CELL PHYSIOL, V46, P1358, DOI 10.1093/pcp/pci146; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Otegui MS, 2008, TRAFFIC, V9, P1589, DOI 10.1111/j.1600-0854.2008.00787.x; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Park M, 2005, J CELL BIOL, V170, P757, DOI 10.1083/jcb.200504112; Park M, 2004, PLANT PHYSIOL, V134, P625, DOI 10.1104/pp.103.030635; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Qiu QS, 2012, J INTEGR PLANT BIOL, V54, P66, DOI 10.1111/j.1744-7909.2012.01097.x; Reguera M, 2015, PLANT CELL, V27, P1200, DOI 10.1105/tpc.114.135699; Reguera M, 2014, MOL PLANT, V7, P261, DOI 10.1093/mp/sst091; Richter S, 2009, TRAFFIC, V10, P819, DOI 10.1111/j.1600-0854.2009.00916.x; Robinson DG, 2005, TRAFFIC, V6, P615, DOI 10.1111/j.1600-0854.2005.00303.x; Schumacher K, 2014, CURR OPIN PLANT BIOL, V22, P71, DOI 10.1016/j.pbi.2014.09.005; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shimada T, 1997, PLANT CELL PHYSIOL, V38, P1414, DOI 10.1093/oxfordjournals.pcp.a029138; Shimada T, 2003, P NATL ACAD SCI USA, V100, P16095, DOI 10.1073/pnas.2530568100; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Sohn EJ, 2007, P NATL ACAD SCI USA, V104, P18801, DOI 10.1073/pnas.0708236104; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Uemura T, 2010, PLANT J, V64, P864, DOI 10.1111/j.1365-313X.2010.04372.x; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Wang LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118553; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zouhar J, 2010, PLANT J, V64, P577, DOI 10.1111/j.1365-313X.2010.04349.x	62	29	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151658	10.1371/journal.pone.0151658	http://dx.doi.org/10.1371/journal.pone.0151658			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986836	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300106
J	Zhao, YY; Wang, N; Liu, WH; Tao, WJ; Liu, LL; Shen, ZD				Zhao, Yan-Yan; Wang, Ning; Liu, Wan-Hui; Tao, Wen-Jie; Liu, Li-Li; Shen, Zhen-Duo			Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; BEVACIZUMAB; HETEROGENEITY; COMBINATION; BIODISTRIBUTION; ELECTROPHORESIS; SEPARATION; THERAPY; ASSAY	The similarity between a proposed biosimilar product and the reference product can be affected by many factors. This study is designed to examine whether any subtle difference in the distribution of the charge variants of an Avastin biosimilar can affect its in vitro potency and in vivo PK. Here, the acidic, basic and main peak fractions of a biosimilar product were isolated using high-performance cation-exchange chromatography and were subjected to various studies to compare their in vitro properties and in vivo PK profile. A serial of analytical methods, including size exclusion chromatography (SEC), imaged capillary isoelectric focusing (icIEF) capillary zone electrophoresis (CZE) and cation-exchange chromatography (CEX-HPLC) were also used to characterize the isolated charge variants. The kinetics constant was measured using a Biacore X100 system. The study indicates the biosimilar product has a high similarity with avastin in physicochemical properties. The potency in vitro and PK profile in rat of charge variants and biosimilar product are consistent with avastin.	[Zhao, Yan-Yan; Wang, Ning; Liu, Wan-Hui] Yantai Univ, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ,Sch Pharm, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Yantai 264005, Peoples R China; [Zhao, Yan-Yan; Liu, Wan-Hui; Tao, Wen-Jie; Liu, Li-Li; Shen, Zhen-Duo] Luye Pharma Grp Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai 264005, Peoples R China	Yantai University	Liu, WH (corresponding author), Yantai Univ, Key Lab Mol Pharmacol & Drug Evaluat, Minist Educ,Sch Pharm, Collaborat Innovat Ctr Adv Drug Delivery Syst & B, Yantai 264005, Peoples R China.; Liu, WH (corresponding author), Luye Pharma Grp Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai 264005, Peoples R China.	wanhuiliu@ytu.edu.cn	zhao, yan/GWC-9174-2022					Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; Breen ED, 2001, PHARMACEUT RES, V18, P1345, DOI 10.1023/A:1013054431517; Christiansen J, 2004, MOL CANCER THER, V3, P1493; Dhillon S, 2013, BIODRUGS, V27, P375, DOI 10.1007/s40259-013-0043-4; Dou P, 2008, J CHROMATOGR A, V1190, P372, DOI 10.1016/j.chroma.2008.03.001; Espinosa-de la Garza CE, 2013, ELECTROPHORESIS, V34, P1133, DOI 10.1002/elps.201200575; Falcao M, 2007, ACTA OPHTHALMOLOGICA, V85; Fekete S, 2013, TRAC-TREND ANAL CHEM, V42, P74, DOI 10.1016/j.trac.2012.09.012; Gangopadhyay A, 1996, NUCL MED BIOL, V23, P257, DOI 10.1016/0969-8051(95)02057-8; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Guelat B, 2012, J CHROMATOGR A, V1253, P32, DOI 10.1016/j.chroma.2012.06.081; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Heng S, 2015, ANAL BIOCHEM, V475, P14, DOI 10.1016/j.ab.2014.12.012; Hong G, 1999, J PHARM SCI, V88, P147, DOI 10.1021/js970335n; Inoue S, 2007, MOL THER, V15, P287, DOI 10.1038/sj.mt.6300035; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kaschak T, 2011, MABS-AUSTIN, V3, P577, DOI 10.4161/mabs.3.6.17959; Khawli LA, 2002, CANCER BIOTHER RADIO, V17, P359, DOI 10.1089/108497802760363150; Khawli LA, 2010, MABS-AUSTIN, V2, P613, DOI 10.4161/mabs.2.6.13333; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lau H, 2010, J CHROMATOGR B, V878, P868, DOI 10.1016/j.jchromb.2010.02.003; Linke T, 2012, J CHROMATOGR A, V1260, P120, DOI 10.1016/j.chroma.2012.08.061; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu YM, 2014, INVEST NEW DRUG, V32, P851, DOI 10.1007/s10637-014-0129-y; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; Michels D., 2011, BIOPROCESS INT, V9, P48; Moorhouse KG, 1997, J PHARMACEUT BIOMED, V16, P593, DOI 10.1016/S0731-7085(97)00178-7; Presta LG, 1997, CANCER RES, V57, P4593; Putnam WS, 2010, TRENDS BIOTECHNOL, V28, P509, DOI 10.1016/j.tibtech.2010.07.001; RODWELL JD, 1986, P NATL ACAD SCI USA, V83, P2632, DOI 10.1073/pnas.83.8.2632; Rustandi RR, 2014, ELECTROPHORESIS, V35, P1072, DOI 10.1002/elps.201300422; Sosic Z, 2008, ELECTROPHORESIS, V29, P4368, DOI 10.1002/elps.200800157; Suzuki H, 2013, MOL CLIN ONCOL, V1, P480, DOI 10.3892/mco.2013.82; Tangarone B, 2008, IBC 12 WELL CHAR BIO; Teshima G, 2011, J CHROMATOGR A, V1218, P2091, DOI 10.1016/j.chroma.2010.10.107; Tinsley J, 2015, J CLIN PHARMACOL, V55, P698, DOI 10.1002/jcph.468; Tsimberidou AM, 2014, J NATL COMPR CANC NE, V12, P194, DOI 10.6004/jnccn.2014.0020; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Wacker C, 2011, EUR J PHARM BIOPHARM, V79, P503, DOI 10.1016/j.ejpb.2011.06.010; Wang Yaning, 2004, Angiogenesis, V7, P335, DOI 10.1007/s10456-004-8272-2; Warnke C, 2013, MULT SCLER J, V19, P1137, DOI 10.1177/1352458513475489; Zhang T, 2011, J CHROMATOGR A, V1218, P5079, DOI 10.1016/j.chroma.2011.05.061; Zhao SS, 2014, ELECTROPHORESIS, V35, P96, DOI 10.1002/elps.201300372	45	20	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151874	10.1371/journal.pone.0151874	http://dx.doi.org/10.1371/journal.pone.0151874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987122	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300145
J	Nyberg, C; Karlsson, T; Hillered, L; Stridsberg, M; Engstrom, ER				Nyberg, Christoffer; Karlsson, Torbjorn; Hillered, Lars; Stridsberg, Mats; Engstrom, Elisabeth Ronne			The Early Endocrine Stress Response in Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							PITUITARY-ADRENAL-FUNCTION; ACUTE-PHASE; CHROMOGRANIN-A; CORTISOL; PLASMA; MECHANISMS; DYNAMICS; NEURONS; DISEASE; SPACE	Introduction In patients with severe illness, such as aneurysmal subarachnoid hemorrhage (SAH), a physiologic stress response is triggered. This includes activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. The aim of this study was to investigate the very early responses of these systems. Methods A porcine animal model of aneurysmal SAH was used. In this model, blood is injected slowly to the basal cisterns above the anterior skull base until the cerebral perfusion pressure is 0 mm Hg. Sampling was done from blood and urine at -10, +15, +75 and +135 minutes from time of induction of SAH. Analyses of adrenocorticotropic hormone (ACTH), cortisol, aldosterone, catecholamines and chromogranin-A were performed. Results Plasma ACTH, serum cortisol and plasma aldosterone increased in the samples following induction of SAH, and started to decline after 75 minutes. Urine cortisol also increased after SAH. Urine catecholamines and their metabolites were found to increase after SAH. Many samples were however below detection level, not allowing for statistical analysis. Plasma chromogranin-A peaked at 15 minutes after SAH, and thereafter decreased. Conclusions The endocrine stress response after aneurysmal SAH was found to start within 15 minutes in the HPA axis with early peak values of ACTH, cortisol and aldosterone. The fact that the concentrations of the HPA axis hormones decreased 135 minutes after SAH may suggest that a similar pattern exists in SAH patients, thus making it difficult to catch these early peak values. There were also indications of early activation of the sympathetic nervous system, but the small number of valid samples made interpretation difficult.	[Nyberg, Christoffer; Hillered, Lars; Engstrom, Elisabeth Ronne] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Karlsson, Torbjorn] Uppsala Univ, Dept Surg Sci, Sect Anesthesiol & Intens Care, Uppsala, Sweden; [Stridsberg, Mats] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Nyberg, C (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	christoffer.nyberg@neuro.uu.se			Uppsala University Hospital	Uppsala University Hospital	The study was supported financially by Uppsala University Hospital grants for clinical research.	Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; CRYER PE, 1991, AM J PHYSIOL, V260, pE243, DOI 10.1152/ajpendo.1991.260.2.E243; DILRAJ A, 1992, NEUROSURGERY, V31, P42, DOI 10.1227/00006123-199207000-00007; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Ebersberger A, 1997, J NEUROPHYSIOL, V77, P3122, DOI 10.1152/jn.1997.77.6.3122; Ebersberger A, 1999, PAIN, V81, P283, DOI 10.1016/S0304-3959(99)00017-2; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; Hansen-Schwartz J, 2004, NEUROCRIT CARE, V1, P235, DOI 10.1385/NCC:1:2:235; HJEMDAHL P, 1979, LIFE SCI, V25, P131, DOI 10.1016/0024-3205(79)90384-9; JENKINS JS, 1969, BRIT MED J, V4, P707, DOI 10.1136/bmj.4.5685.707; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; Lindgren C, 2013, ACTA ANAESTH SCAND, V57, P452, DOI 10.1111/aas.12014; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Naredi S, 2006, INTENS CARE MED, V32, P1955, DOI 10.1007/s00134-006-0408-y; Nyberg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099904; Poll EM, 2013, STRESS, V16, P153, DOI 10.3109/10253890.2012.697946; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Stridsberg M, 2000, J ENDOCRINOL, V165, P703, DOI 10.1677/joe.0.1650703; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Venkataraman S, 2007, REV ENDOCR METAB DIS, V8, P365, DOI 10.1007/s11154-007-9058-9; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151457	10.1371/journal.pone.0151457	http://dx.doi.org/10.1371/journal.pone.0151457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007694	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200055
J	Gupta, M; Angeli, F; Bosma, H; Rana, M; Prinja, S; Kumar, R; van Schayck, OCP				Gupta, Madhu; Angeli, Federica; Bosma, Hans; Rana, Monica; Prinja, Shankar; Kumar, Rajesh; van Schayck, Onno C. P.			Effectiveness of Multiple-Strategy Community Intervention in Reducing Geographical, Socioeconomic and Gender Based Inequalities in Maternal and Child Health Outcomes in Haryana, India	PLOS ONE			English	Article							PRIORITY	Objective The implemented multiple-strategy community intervention National Rural Health Mission (NRHM) between 2005 and 2012 aimed to reduce maternal and child health (MCH) inequalities across geographical, socioeconomic and gender categories in India. The objective of this study is to quantify the extent of reduction in these inequalities pre- and post-NRHM in Haryana, North India. Methods Data of district-level household surveys (DLHS) held before (2002-04), during (2007-08), and after (2012-13) the implementation of NRHM has been used. Geographical, socioeconomic and gender inequalities in maternal and child health were assessed by estimating the absolute differences in MCH indicators between urban and rural areas, between the most advantaged and least advantaged socioeconomic groups and between male and female children. Logistic regression analyses were done to observe significant differences in these inequalities between 2005 and 2012. Results There were significant improvements in all MCH indicators (p<0.05). The geographical and socioeconomic differences between urban and rural areas, and between rich and poor were significantly (p<0.05) reduced for pregnant women who had an institutional delivery (geographical difference declining from 22% to 7.6%; socioeconomic from 48.2% to 13%), post-natal care within 2 weeks of delivery (2.8% to 1.5%; 30.3% to 7%); and for children with full vaccination (10% to 3.5%, 48.3% to 14%) and who received oral rehydration solution (ORS) for diarrhea (11% to -2.2%; 41% to 5%). Inequalities between male and female children were significantly (p<0.05) reversed for full immunization (5.7% to -0.6%) and BCG immunization (1.9 to -0.9 points), and a significant (p<0.05) decrease was observed for oral polio vaccine (4.0% to 0%) and measles vaccine (4.2% to 0.1%). Conclusions The implemented multiple-strategy community intervention National Rural Health Mission (NRHM) between 2005 and 2012 might have resulted in significant reductions in geographical, socioeconomic and gender inequalities in MCH in Haryana, as causal relationships cannot be established with descriptive research.	[Gupta, Madhu; Rana, Monica; Prinja, Shankar; Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Dept Community Med, Chandigarh, India; [Angeli, Federica] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands; [Bosma, Hans] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Social Med, NL-6200 MD Maastricht, Netherlands; [van Schayck, Onno C. P.] Maastricht Univ, Sch Publ Hlth & Primary Care CAPHRI, Dept Family Practice, NL-6200 MD Maastricht, Netherlands	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Maastricht University; Maastricht University; Maastricht University	Gupta, M (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Dept Community Med, Chandigarh, India.	madhugupta21@gmail.com	Bosma, Hans/A-6184-2013	Angeli, Federica/0000-0003-4010-3103	National Rural Health Mission, Haryana	National Rural Health Mission, Haryana	The study was funded by the National Rural Health Mission, Haryana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, MAT NEWB CHILD SURV; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Colenbrander S, 2015, HEALTH POLICY PLANN, V30, P555, DOI 10.1093/heapol/czu030; Goldenberg RL, 2012, LANCET, V379, P1178, DOI 10.1016/S0140-6736(12)60474-7; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058573; Gupta M, 2016, EXTENT IMPLEME UNPUB; Gupta M, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.25987; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hosseinpoor AR, 2015, B WORLD HEALTH ORGAN, V93, P591, DOI 10.2471/BLT.15.162081; Hota P K, 2005, Indian J Public Health, V49, P107; *INT I POP SCI, 2002, DISTR LEV HOUS SURV; *INT I POP SCI, 2007, DISTR LEV HOUS FAC S; International Institute for Population Sciences, 2012, DISTR LEV HOUS FAC S; International Institute of Population Sciences, DISTR LEV HOUS SURV; Mackenbach JP, 2015, EUR J PUBLIC HEALTH, V25, P185, DOI 10.1093/eurpub/cku217; MCKEOWN T, 1972, POP STUD-J DEMOG, V26, P345, DOI 10.2307/2173815; Parkhurst JO, 2008, AIDS EDUC PREV, V20, P275, DOI 10.1521/aeap.2008.20.3.275; Pathak PK, 2011, SOC SCI MED, V73, P576, DOI 10.1016/j.socscimed.2011.06.024; Pathak PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013593; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Pradhan J, 2010, HLTH POLICY; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Prusty RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104598; Ram F, 2013, INDIAN J MED RES, V137, P721; Registrar General of India, SAMPL REG SYST; Registrar General of India, SPEC B MAT MORT IND; Sanneving L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19145; Schiffman J, 2010, SEMIN PERINATOL, V34, P462, DOI 10.1053/j.semperi.2010.09.008; School of Public Health, 2013, PGIMER CONC EV NAT R; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037037; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; World Health Organization, 2010, CONC FRAM ACT SOC DE	34	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150537	10.1371/journal.pone.0150537	http://dx.doi.org/10.1371/journal.pone.0150537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003589	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400015
J	Tawara, S; Tatsumi, T; Iio, S; Kobayashi, I; Shigekawa, M; Hikita, H; Sakamori, R; Hiramatsu, N; Miyoshi, E; Takehara, T				Tawara, Seiichi; Tatsumi, Tomohide; Iio, Sadaharu; Kobayashi, Ichizou; Shigekawa, Minoru; Hikita, Hayato; Sakamori, Ryotaro; Hiramatsu, Naoki; Miyoshi, Eiji; Takehara, Tetsuo			Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA DEVELOPMENT; SIMPLE NONINVASIVE INDEX; VIRUS-INFECTION; NONCIRRHOTIC PATIENTS; INTERFERON THERAPY; PANCREATIC-CANCER; ALPHA-FETOPROTEIN; VIRAL-HEPATITIS; CLINICAL-USE; CELL-LINES	Fucosylated haptoglobin (Fuc-Hpt) and Mac-2 binding protein (Mac-2 bp) are identified as cancer biomarkers, based on the results from a glyco-proteomic analysis. Recently, we reported that these glyco-biomarkers were associated with liver fibrosis and/ or ballooning hepatocytes in patients with nonalcoholic fatty liver disease (NAFLD). We evaluated the ability of these glycoproteins to estimate liver fibrosis in 317 patients with chronic hepatitis C. We measured the serum Fuc-Hpt and Mac-2 bp levels using a lectin-antibody ELISA and ELISA, respectively. The serum levels of both Fuc-Hpt and Mac-2 bp increased with the progression of liver fibrosis. The multivariate analysis revealed that Mac-2 bp was an independent factor associated with moderate liver fibrosis (F >= 2). In contrast, Fuc-Hpt was an independent factor associated with advanced liver fibrosis (F >= 3). In terms of evaluating liver fibrosis, the serum levels of these glycomarkers were correlated with well-known liver fibrosis indexes, such as the aspartate aminotransferase to platelet ratio index (APRI) and Fibrosis-4 (FIB4) index. An assay that combined the APRI or FIB4 index and the Fuc-Hpt or Mac-2 bp levels increased the AUC value for diagnosing hepatic fibrosis. Interestingly, the cumulative incidence of hepatocellular carcinoma (HCC) was significantly higher in the patients with elevated serum levels of Fuc-Hpt and Mac-2 bp. In conclusion, both Fuc-Hpt and Mac-2 bp could be useful glyco-biomarkers of liver fibrosis and predictors of HCC in patients with chronic hepatitis C.	[Tawara, Seiichi; Tatsumi, Tomohide; Shigekawa, Minoru; Hikita, Hayato; Sakamori, Ryotaro; Hiramatsu, Naoki; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Iio, Sadaharu] Hyogo Prefectural Nishinomiya Hosp, Dept Gastroenterol Med, Nishinomiya, Hyogo, Japan; [Kobayashi, Ichizou] Higashiosaka City Gen Hosp, Dept Gastroenterol Med, Higashiosaka, Osaka, Japan; [Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan	Osaka University; Osaka University	Tatsumi, T; Takehara, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	tatsumit@gh.med.osaka-u.ac.jp; takehara@gh.med.osaka-u.ac.jp	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X	Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Research Program on Hepatitis from the Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development, and this study was supported by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Asazawa H, 2015, CLIN CHEM LAB MED, V53, P95, DOI 10.1515/cclm-2014-0427; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; FREI A, 1984, HEPATOLOGY, V4, P830, DOI 10.1002/hep.1840040505; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hu JX, 2013, EXP THER MED, V5, P181, DOI 10.3892/etm.2012.768; Hu SX, 2009, J CLIN GASTROENTEROL, V43, P758, DOI 10.1097/MCG.0b013e31818be17c; Iacovazzi PA, 2008, IMMUNOPHARM IMMUNOT, V30, P687, DOI 10.1080/08923970802278177 ; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Inohara H, 1996, CANCER RES, V56, P4530; Kamada Y, 2013, PROTEOM CLIN APPL, V7, P648, DOI 10.1002/prca.201200137; Kamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066328; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; McCaughan GW, 2004, GUT, V53, P318, DOI 10.1136/gut.2003.026393; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Narisada M, 2008, BIOCHEM BIOPH RES CO, V377, P792, DOI 10.1016/j.bbrc.2008.10.061; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Ozaki Y, 2002, CANCER, V95, P1954, DOI 10.1002/cncr.10899; Oze T, 2011, J GASTROENTEROL, V46, P944, DOI 10.1007/s00535-011-0403-0; Patel K, 2003, J GASTROEN HEPATOL, V18, P253, DOI 10.1046/j.1440-1746.2003.02930.x; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Przybylo M, 2007, BBA-GEN SUBJECTS, V1770, P1427, DOI 10.1016/j.bbagen.2007.05.006; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tamaki N, 2014, J GASTROENTEROL, V49, P1495, DOI 10.1007/s00535-013-0914-y; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Toshima T, 2015, J GASTROENTEROL, V50, P76, DOI 10.1007/s00535-014-0946-y; Toyoda H, 2015, J GASTROEN HEPATOL, V30, P1183, DOI 10.1111/jgh.12915; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; YAMADA S, 1992, CLIN BIOCHEM, V25, P467, DOI 10.1016/0009-9120(92)90150-Q; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151828	10.1371/journal.pone.0151828	http://dx.doi.org/10.1371/journal.pone.0151828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002630	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400049
J	Bilgic, H; Hakki, EE; Pandey, A; Khan, MK; Akkaya, MS				Bilgic, Hatice; Hakki, Erdogan E.; Pandey, Anamika; Khan, Mohd Kamran; Akkaya, Mahinur S.			Ancient DNA from 8400 Year-Old Catalhoyuk Wheat: Implications for the Origin of Neolithic Agriculture	PLOS ONE			English	Article							DRAFT GENOME; NAKED WHEAT; DOMESTICATION; EXTRACTION; EVOLUTION; GRAINS; EMMER; POLYMORPHISMS; GEOGRAPHY; REVEALS	Human history was transformed with the advent of agriculture in the Fertile Crescent with wheat as one of the founding crops. Although the Fertile Crescent is renowned as the center of wheat domestication, archaeological studies have shown the crucial involvement of Catalhoyuk in this process. This site first gained attention during the 1961-65 excavations due to the recovery of primitive hexaploid wheat. However, despite the seeds being well preserved, a detailed archaeobotanical description of the samples is missing. In this article, we report on the DNA isolation, amplification and sequencing of ancient DNA of charred wheat grains from Catalhoyuk and other Turkish archaeological sites and the comparison of these wheat grains with contemporary wheat species including T. monococcum, T. dicoccum, T. dicoccoides, T. durum and T. aestivum at HMW glutenin protein loci. These ancient samples represent the oldest wheat sample sequenced to date and the first ancient wheat sample from the Middle East. Remarkably, the sequence analysis of the short DNA fragments preserved in seeds that are approximately 8400 years old showed that the Catalhoyuk wheat stock contained hexaploid wheat, which is similar to contemporary hexaploid wheat species including both naked (T. aestivum) and hulled (T. spelta) wheat. This suggests an early transitory state of hexaploid wheat agriculture from the Fertile Crescent towards Europe spanning present-day Turkey.	[Bilgic, Hatice; Pandey, Anamika; Khan, Mohd Kamran; Akkaya, Mahinur S.] Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey; [Bilgic, Hatice; Akkaya, Mahinur S.] Middle E Tech Univ, Biotechnol Program, TR-06531 Ankara, Turkey; [Hakki, Erdogan E.; Pandey, Anamika; Khan, Mohd Kamran] Selcuk Univ, Dept Soil Sci & Plant Nutr, Konya, Turkey	Middle East Technical University; Middle East Technical University; Selcuk University	Akkaya, MS (corresponding author), Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey.; Akkaya, MS (corresponding author), Middle E Tech Univ, Biotechnol Program, TR-06531 Ankara, Turkey.	akkayams@metu.edu.tr	HAKKI, ERDOGAN/AGU-8684-2022; Akkaya, Mahinur S./AAD-4088-2019; Akkaya, Mahinur/P-1163-2018; Pandey, Anamika/AAC-6411-2019; Khan, Mohd. Kamran/ABA-6003-2021	HAKKI, ERDOGAN/0000-0001-7147-7875; Akkaya, Mahinur/0000-0002-0454-5898; Pandey, Anamika/0000-0002-5022-8359; Khan, Mohd. Kamran/0000-0003-0437-4416	TUBITAK (The Scientific and Technical Research Council of Turkey) [TBAG 22045, 101T046]; United Nations Educational, Scientific and Cultural Organization (UNESCO)	TUBITAK (The Scientific and Technical Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); United Nations Educational, Scientific and Cultural Organization (UNESCO)	The present research work was funded by TUBITAK (The Scientific and Technical Research Council of Turkey) under project No. TBAG 22045 and 101T046. The authors thank United Nations Educational, Scientific and Cultural Organization (UNESCO) for providing a scholarship to HB for conducting second laboratory aDNA isolation at UMIST Biomolecular Sciences, Manchester, UK.	Allaby RC, 1999, GENOME, V42, P296, DOI 10.1139/gen-42-2-296; ALLABY RG, 1994, ANTIQUITY, V68, P126, DOI 10.1017/S0003598X00046263; Araus JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4953; Audic S, 1997, NAT BIOTECHNOL, V15, P855, DOI 10.1038/nbt0997-855; Blatter RHE, 2002, THEOR APPL GENET, V104, P329, DOI 10.1007/s001220100680; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Cooper A, 2000, SCIENCE, V289, P1139; Fernandez E, 2013, J ARCHAEOL SCI, V40, P659, DOI 10.1016/j.jas.2012.07.014; Fuller DQ, 2011, WORLD ARCHAEOL, V43, P628, DOI 10.1080/00438243.2011.624747; Gebel H.G.K., 2004, NEOLITHICS, V1, P28; Gokturk EH, 2002, RADIOCHIM ACTA, V90, P407, DOI 10.1524/ract.2002.90.7_2002.407; Gugerli F, 2005, NEW PHYTOL, V166, P409, DOI 10.1111/j.1469-8137.2005.01360.x; Hakki EE, 2000, MOL ECOL, V9, P2152, DOI 10.1046/j.1365-294X.2000.11143.x; HELBJEK H., 1964, Anatol. Stud., V14, P121, DOI 10.2307/3642467; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Heun M, 2012, J EXP BOT, V63, P4333, DOI 10.1093/jxb/ers162; Hillman G.C., 1996, J ASS ENV ARCHAEOL, V12, P195; Hodder I., 2013, BRIT I ANKARA MONOGR, V47; Hodder I., 2014, ARCHAEOLOGICAL THEOR; Hodder I., 2006, CATALHOYUK PERSPECTI; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Hu XG, 2012, GENET RESOUR CROP EV, V59, P491, DOI 10.1007/s10722-011-9698-1; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jiang QT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-73; Kim M, 2013, J ARCHAEOL SCI, V40, P517, DOI 10.1016/j.jas.2012.08.010; Larson G, 2015, SCIENCE, V347, P945, DOI 10.1126/science.aaa6113; Li CX, 2011, J ARCHAEOL SCI, V38, P115, DOI 10.1016/j.jas.2010.08.016; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mellaart J., 1967, CATAL HUYUK NEOLITHI; Nesbitt M, 1998, SCIENCE, V279, P1433; NEVO E, 1988, THEOR APPL GENET, V76, P737, DOI 10.1007/BF00303521; Newton MW, 1999, MELETEMATA STUDIES A; Ozkan H, 2005, THEOR APPL GENET, V110, P1052, DOI 10.1007/s00122-005-1925-8; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Ozkan H, 2011, GENET RESOUR CROP EV, V58, P11, DOI 10.1007/s10722-010-9581-5; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PLASCHKE J, 1995, THEOR APPL GENET, V91, P1001, DOI 10.1007/BF00223912; Poinar HN, 2003, INT CONGR SER, V1239, P575, DOI 10.1016/S0531-5131(02)00624-6; Riehl S, 2013, SCIENCE, V341, P65, DOI 10.1126/science.1236743; Rizzi E, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-21; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Schlumbaum A, 1998, J ARCHAEOL SCI, V25, P1111, DOI 10.1006/jasc.1998.0338; Smith O, 2015, SCIENCE, V347, P998, DOI 10.1126/science.1261278; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Weide A, 2015, J ARCHAEOL SCI, V57, P109, DOI 10.1016/j.jas.2015.01.013	49	22	23	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151974	10.1371/journal.pone.0151974	http://dx.doi.org/10.1371/journal.pone.0151974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DH3NW	26998604	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700089
J	Errahhali, ME; Errahhali, ME; Abda, N; Bellaoui, M				Errahhali, Manal Elidrissi; Errahhali, Mounia Elidrissi; Abda, Naima; Bellaoui, Mohammed			Exploring Geographic Variability in Cancer Prevalence in Eastern Morocco: A Retrospective Study over Eight Years	PLOS ONE			English	Article							SOUTH-WALES AUSTRALIA; MAMMOGRAPHY USE; PROSTATE-CANCER; TRENDS; CHINA	Background Malignant diseases have been believed to be more common in some areas of Eastern Morocco, but until now, cancer patterns have not been reported for this region. In this paper we present for the first time the cancer prevalence analysis in Eastern Morocco. Methods Cross-sectional study carried out among all patients diagnosed and/or treated with cancer at the Hassan II Regional Oncology Center (ROC) since it was established in October 2005 until December 2012. The ROC is the only hospital specialized in cancer care in Eastern Morocco. Results A total of 8,508 cases of cancer were registered among residents in Eastern Morocco, with a female to male ratio of 2.1. The mean age at diagnosis was 53.9 +/- 15.2 years (median age = 53 years). Thus, unlike in Western countries, cancer in Eastern Morocco afflicts younger population. The areas of Eastern Morocco did not differ significantly by mean age at diagnosis (p = 0.061). However, these regions differed significantly by sex ratio (p < 0.001). The highest sex ratio was observed in Figuig, with a female to male ratio of 3.1 (75.4% of the registered case were females), followed respectively by Taourirt, Oujda-Angad, Berkane, Nador-Driouch and Jerada. Clear variation in the distribution of cancer types between areas of Eastern Morocco was observed, both in males and females (p < 0.001). Furthermore, the areas of Eastern Morocco differed significantly by cancer prevalence (p < 0.001). The highest age-standardized five-year prevalence proportion was observed in Oujda-Angad with 420.2 per 100,000, followed respectively by Berkane (311.4), Jerada (287.8), Taourirt (269.3), Nador-Driouch (213.6) and Figuig (194.4). Trends in the five-year prevalence proportions decreased in Oujda-Angad, Berkane and Jerada throughout the study period, while an increasing trend was observed in Nador-Driouch, Taourirt and Figuig. Conclusions For the first time, our study presents the pattern and distribution of diagnosed cancers in Eastern Morocco. Our study illustrates substantial differences in cancer patterns between areas of Eastern Morocco. These findings are important for cancer control and highlight the need to develop program aiming at controlling and preventing the spread of major cancer sites in Eastern Morocco, particularly in areas with increased cancer prevalence rates.	[Errahhali, Manal Elidrissi; Errahhali, Mounia Elidrissi; Abda, Naima; Bellaoui, Mohammed] Univ Mohammed First, Fac Med & Pharm Oujda, Med Biol Unit, Oujda, Morocco	Mohammed First University of Oujda	Bellaoui, M (corresponding author), Univ Mohammed First, Fac Med & Pharm Oujda, Med Biol Unit, Oujda, Morocco.	bmbellaoui@gmail.com		Bellaoui, Mohammed/0000-0001-7508-4550; Abda, Naima/0000-0002-6702-4977				Baade PD, 2013, PROSTATE INT, V1, P47, DOI 10.12954/PI.12014; Bouchbika Z, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.31.2791; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Chen JG, 2006, INT J CANCER, V119, P1447, DOI 10.1002/ijc.21952; Corrarino JE, 2015, JNP-J NURSE PRACT, V11, P790, DOI 10.1016/j.nurpra.2015.05.016; Crocetti E, 2013, BRIT J CANCER, V109, P219, DOI 10.1038/bjc.2013.311; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; DPRF, 2014, SANT CHIFFR 2012; Ellison LF, 2012, HLTH REP, V23, pB1; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Engholm GFJ, 2015, NORDCAN CANC INCIDEN; Esteve J, 1994, IARC Sci Publ, P1; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; Guzzinati S, 2012, CANCER CAUSE CONTROL, V23, P1497, DOI 10.1007/s10552-012-0025-8; Han B, 2003, J AM GERIATR SOC, V51, P203, DOI 10.1046/j.1532-5415.2003.51059.x; HCP, 2012, MON REG E MOR 2012; IARC UK CR, 2014, WORLD CANC FACTSH; *INT AG RES CANC, 2012, GLOBOCAN 2012; John U, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1807-7; Kapp JM, 2009, BREAST CANCER RES TR, V113, P327, DOI 10.1007/s10549-008-9919-2; Lam JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146185; Lee DS, 2007, EXPERT OPIN THER TAR, V11, P757, DOI 10.1517/14728222.11.6.757; Linn Mary Morse, 2007, Urol Nurs, V27, P481; Maddams J, 2012, BRIT J CANCER, V107, P1195, DOI 10.1038/bjc.2012.366; Micheli A, 2002, ANN ONCOL, V13, P840, DOI 10.1093/annonc/mdf127; Missaoui N, 2010, INT J CANCER, V127, P2669, DOI 10.1002/ijc.25490; Nahar Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107675; Percy C., 1990, INT CLASSIFICATION D; Sahraoui S, 2013, INT RES J, V1, P35; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart B. W., 2003, World Cancer Report; Tazi MA, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.338; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P534, DOI 10.1016/j.canep.2015.05.007; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P29, DOI 10.1016/j.canep.2014.11.009; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151987	10.1371/journal.pone.0151987	http://dx.doi.org/10.1371/journal.pone.0151987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998751	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700090
J	Poupel, O; Moyat, M; Groizeleau, J; Antunes, LCS; Gribaldo, S; Msadek, T; Dubrac, S				Poupel, Olivier; Moyat, Mati; Groizeleau, Julie; Antunes, Luisa C. S.; Gribaldo, Simonetta; Msadek, Tarek; Dubrac, Sarah			Transcriptional Analysis and Subcellular Protein Localization Reveal Specific Features of the Essential WalKR System in Staphylococcus aureus	PLOS ONE			English	Article							YYCFG 2-COMPONENT SYSTEM; SENSOR HISTIDINE KINASE; SIGNAL-TRANSDUCTION PATHWAY; GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-PNEUMONIAE R6; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; RESPONSE-REGULATOR; ESCHERICHIA-COLI; CELL-DIVISION	The WalKR two-component system, controlling cell wall metabolism, is highly conserved among Bacilli and essential for cell viability. In Staphylococcus aureus, walR and walK are followed by three genes of unknown function: walH, walI and walJ. Sequence analysis and transcript mapping revealed a unique genetic structure for this locus in S. aureus: the last gene of the locus, walJ, is transcribed independently, whereas transcription of the tetra-cistronic walRKHI operon occurred from two independent promoters located upstream from walR. Protein topology analysis and protein-protein interactions in E. coli as well as subcellular localization in S. aureus allowed us to show that WalH and WalI are membrane-bound proteins, which associate with WalK to form a complex at the cell division septum. While these interactions suggest that WalH and WalI play a role in activity of the WalKR regulatory pathway, deletion of walH and/or walI did not have a major effect on genes whose expression is strongly dependent on WalKR or on associated phenotypes. No effect of WalH or WalI was seen on tightly controlled WalKR regulon genes such as sle1 or saouhsc_00773, which encodes a CHAP-domain amidase. Of the genes encoding the two major S. aureus autolysins, AtlA and Sle1, only transcription of atlA was increased in the Delta walH or Delta walI mutants. Likewise, bacterial autolysis was not increased in the absence of WalH and/or WalI and biofilm formation was lowered rather than increased. Our results suggest that contrary to their major role as WalK inhibitors in B. subtilis, the WalH and WalI proteins have evolved a different function in S. aureus, where they are more accessory. A phylogenomic analysis shows a striking conservation of the 5 gene wal cluster along the evolutionary history of Bacilli, supporting the key importance of this signal transduction system, and indicating that the walH and walI genes were lost in the ancestor of Streptococcaceae, leading to their atypical 3 wal gene cluster, walRKJ.	[Poupel, Olivier; Moyat, Mati; Groizeleau, Julie; Msadek, Tarek; Dubrac, Sarah] Inst Pasteur, Biol Gram Posit Pathogens, Dept Microbiol, Paris, France; [Poupel, Olivier; Moyat, Mati; Groizeleau, Julie; Msadek, Tarek; Dubrac, Sarah] CNRS, ERL3526, Paris, France; [Antunes, Luisa C. S.; Gribaldo, Simonetta] Inst Pasteur, Mol Biol Gene Extremophiles, Dept Microbiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Msadek, T; Dubrac, S (corresponding author), Inst Pasteur, Biol Gram Posit Pathogens, Dept Microbiol, Paris, France.; Msadek, T; Dubrac, S (corresponding author), CNRS, ERL3526, Paris, France.	tmsadek@pasteur.fr; sdubrac@pasteur.fr	gribaldo, simonetta/AAW-4377-2020	gribaldo, simonetta/0000-0002-7662-021X; Sarah, Dubrac/0000-0002-9810-5390; Moyat, Mati/0000-0002-9233-5320	Institut Pasteur Transversal Research Program [336]; Agence Nationale de la Recherche [ANR-09-MIEN-0010 GRABIRON, ANR-08-ALIA-0011 NABAB]	Institut Pasteur Transversal Research Program; Agence Nationale de la Recherche(French National Research Agency (ANR))	Support was provided by Institut Pasteur Transversal Research Program No. 336 [http://www.pasteur.fr]; Agence Nationale de la Recherche, Grant ANR-08-ALIA-0011 NABAB [http://www.agencenationale-recherche.fr/]; and Agence Nationale de la Recherche, Grant ANR-09-MIEN-0010 GRABIRON [http://www.agence-nationale-recherche.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, J MOL BIOL, V285, P1503, DOI 10.1006/jmbi.1998.2412; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; Beltrame CO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138924; Biller SJ, 2011, J BACTERIOL, V193, P896, DOI 10.1128/JB.00594-10; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Dautin N, 2000, J BACTERIOL, V182, P7060, DOI 10.1128/JB.182.24.7060-7066.2000; Delaune A, 2012, INFECT IMMUN, V80, P3438, DOI 10.1128/IAI.00195-12; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Dhiman A, 2015, BIOCHEM BIOPH RES CO, V459, P623, DOI 10.1016/j.bbrc.2015.02.159; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Fukuchi K, 2000, MICROBIOL-UK, V146, P1573, DOI 10.1099/00221287-146-7-1573; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Jansen A, 2007, INT J MED MICROBIOL, V297, P205, DOI 10.1016/j.ijmm.2007.02.002; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2009, J BACTERIOL, V191, P333, DOI 10.1128/JB.00331-08; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; McEvoy CRE, 2013, ANTIMICROB AGENTS CH, V57, P3240, DOI 10.1128/AAC.00279-13; Miller JH., 1972, EXPT MOL GENETICS; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; Ng WL, 2004, MICROBIOL-SGM, V150, P3096, DOI 10.1099/mic.0.27550-0; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Pontinen A, 2015, APPL ENVIRON MICROB, V81, P3994, DOI 10.1128/AEM.00626-15; RAYCHAUDHURI D, 1985, J BACTERIOL, V164, P1337, DOI 10.1128/JB.164.3.1337-1349.1985; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Shoji M, 2011, ANTIMICROB AGENTS CH, V55, P3870, DOI 10.1128/AAC.01563-10; Sleator RD, 2005, CLIN MICROBIOL INFEC, V11, P599, DOI 10.1111/j.1469-0691.2005.01176.x; Stack HM, 2005, APPL ENVIRON MICROB, V71, P4241, DOI 10.1128/AEM.71.8.4241-4247.2005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Szurmant H, 2006, PROTEIN SCI, V15, P929, DOI 10.1110/ps.052064406; Szurmant H, 2005, J BACTERIOL, V187, P5419, DOI 10.1128/JB.187.15.5419-5426.2005; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; Takahashi J, 2002, MICROBIOL IMMUNOL, V46, P601, DOI 10.1111/j.1348-0421.2002.tb02741.x; Turck M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030403; Vidaillac C, 2013, J INFECT DIS, V208, P67, DOI 10.1093/infdis/jit127; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wang LS, 2004, NUCLEIC ACIDS RES, V32, P3689, DOI 10.1093/nar/gkh694; Yang HJ, 2013, DNA REPAIR, V12, P334, DOI 10.1016/j.dnarep.2013.02.002; Yang HJ, 2011, DNA REPAIR, V10, P1121, DOI 10.1016/j.dnarep.2011.08.009; Yang HJ, 2011, MOL MICROBIOL, V79, P1276, DOI 10.1111/j.1365-2958.2011.07519.x	71	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151449	10.1371/journal.pone.0151449	http://dx.doi.org/10.1371/journal.pone.0151449			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999783	Green Published, gold			2022-12-27	WOS:000372694700042
J	Sabatelli, L				Sabatelli, Lorenzo			Relationship between the Uncompensated Price Elasticity and the Income Elasticity of Demand under Conditions of Additive Preferences	PLOS ONE			English	Article								Income and price elasticity of demand quantify the responsiveness of markets to changes in income and in prices, respectively. Under the assumptions of utility maximization and preference independence (additive preferences), mathematical relationships between income elasticity values and the uncompensated own and cross price elasticity of demand are here derived using the differential approach to demand analysis. Key parameters are: the elasticity of the marginal utility of income, and the average budget share. The proposed method can be used to forecast the direct and indirect impact of price changes and of financial instruments of policy using available estimates of the income elasticity of demand.	[Sabatelli, Lorenzo] GLOBMOD Hlth, Market Anal Unit, Barcelona, Spain		Sabatelli, L (corresponding author), GLOBMOD Hlth, Market Anal Unit, Barcelona, Spain.	Lorenzo.Sabatelli@globmod.com			GLOBMOD (GLOB MOD SL), a research and information technology company; Bill and Melinda Gates Foundation through the Disease Control Priorities Project (Department of Global Health of the University of Washington, Seattle)	GLOBMOD (GLOB MOD SL), a research and information technology company; Bill and Melinda Gates Foundation through the Disease Control Priorities Project (Department of Global Health of the University of Washington, Seattle)	This study was partly funded by GLOBMOD (GLOB MOD SL), a research and information technology company operating in the for-profit and not-for-profit health-economic and market research sectors. The funder provided support in the form of salary for the author [LS], but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The author received no additional funding, from any other source, for this work.; The author wishes to thank Prof. Dean T. Jamison (UCSF) for useful discussions. The author acknowledges partial financial support from the Bill and Melinda Gates Foundation through the Disease Control Priorities Project (Department of Global Health of the University of Washington, Seattle).	[Anonymous], 2003, INT EVIDENCE FOOD CO; Barnett WA, 2009, CONTRIB ECON ANAL, V288, P61, DOI 10.1108/S0573-8555(2009)0000288006; BARTEN AP, 1964, ECONOMETRICA, V32, P1, DOI 10.2307/1913731; Brown M. G., 2002, J AGR APPL EC, V34, P17; Cameron T.A., 2008, NEW PALGRAVE DICT EC; DEATON A, 1980, AM ECON REV, V70, P312; Deaton A, 2008, NEW PALGRAVE DICT EC; KNETSCH JL, 1984, Q J ECON, V99, P507, DOI 10.2307/1885962; Layard R, 2008, J PUBLIC ECON, V92, P1846, DOI 10.1016/j.jpubeco.2008.01.007; MANNING WG, 1987, AM ECON REV, V77, P251; Ringel JS, 2002, ELASTICITY DEMAND HL; Sabatelli L. A., 2013, VALUE HLTH, V16; Sabatelli L, 2013, LANCET, V381, P128; Santerre RE, 2006, SOUTH ECON J, V73, P233, DOI 10.2307/20111885; THEIL H, 1965, ECONOMETRICA, V33, P67, DOI 10.2307/1911889; Theil H, 1989, INT EVIDENCE CONSUMP	16	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151390	10.1371/journal.pone.0151390	http://dx.doi.org/10.1371/journal.pone.0151390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999511	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700038
J	Manera, V; Chapoulie, E; Bourgeois, J; Guerchouche, R; David, R; Ondrej, J; Drettakis, G; Robert, P				Manera, Valeria; Chapoulie, Emmanuelle; Bourgeois, Jeremy; Guerchouche, Rachid; David, Renaud; Ondrej, Jan; Drettakis, George; Robert, Philippe			A Feasibility Study with Image-Based Rendered Virtual Reality in Patients with Mild Cognitive Impairment and Dementia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; APATHY; ATTENTION; REHABILITATION; STIMULI; IMPACT	Virtual Reality (VR) has emerged as a promising tool in many domains of therapy and rehabilitation, and has recently attracted the attention of researchers and clinicians working with elderly people with MCI, Alzheimer's disease and related disorders. Here we present a study testing the feasibility of using highly realistic image-based rendered VR with patients with MCI and dementia. We designed an attentional task to train selective and sustained attention, and we tested a VR and a paper version of this task in a single-session within-subjects design. Results showed that participants with MCI and dementia reported to be highly satisfied and interested in the task, and they reported high feelings of security, low discomfort, anxiety and fatigue. In addition, participants reported a preference for the VR condition compared to the paper condition, even if the task was more difficult. Interestingly, apathetic participants showed a preference for the VR condition stronger than that of non-apathetic participants. These findings suggest that VR-based training can be considered as an interesting tool to improve adherence to cognitive training in elderly people with cognitive impairment.	[Manera, Valeria; Chapoulie, Emmanuelle; Bourgeois, Jeremy; David, Renaud; Robert, Philippe] Univ Nice Sophia Antipolis, IA, EA CoBTeK, F-06189 Nice, France; [Guerchouche, Rachid; Drettakis, George] Inst Natl Rech Informat & Automat, Sophia Antipolis, France; [David, Renaud; Robert, Philippe] CHU Nice, Ctr Mem Ressources & Rech, F-06202 Nice, France; [Ondrej, Jan] Disney Res Los Angeles, Los Angeles, CA USA; [Ondrej, Jan] Univ Dublin Trinity Coll, Dublin 2, Ireland	UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Trinity College Dublin	Manera, V (corresponding author), Univ Nice Sophia Antipolis, IA, EA CoBTeK, F-06189 Nice, France.	valeria.manera@unice.fr	Manera, Valeria/O-3498-2016; David, Renaud/ABG-4662-2020; Ondrej, Jan/N-1947-2016	Manera, Valeria/0000-0003-4490-4485; Ondrej, Jan/0000-0002-5409-1521	FP7 European Commission Seventh Framework Programme VERVE project; Innovation Alzheimer Association; Lions district Provence-Alpes Cote d'azur; Disney Research Los Angeles	FP7 European Commission Seventh Framework Programme VERVE project; Innovation Alzheimer Association; Lions district Provence-Alpes Cote d'azur; Disney Research Los Angeles	This study was supported by a grant from the FP7 European Commission Seventh Framework Programme VERVE project (Vanquishing fear and apathy through e-inclusion: http://www.verveconsortium.com/), by the Innovation Alzheimer Association, and by the Lions district Provence-Alpes Cote d'azur. The study has been realized in the ecological room of the Edmond et Lily Safra center at the Institut Claude Pompidou. Disney Research Los Angeles provided support in the form of salaries for authors [JO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aalten P, 2003, DEMENT GERIATR COGN, V15, P99, DOI 10.1159/000067972; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Benoit M, 2008, INT J GERIATR PSYCH, V23, P409, DOI 10.1002/gps.1895; Benoit M, 2015, NEUROPSYCH DIS TREAT, V11, P557, DOI 10.2147/NDT.S73179; Brickenkamp R, 1981, TEST DZ AINFUREKSANK; Chapoulie E, 2014, REMINISCENCE THERAPY; Chaurasia G, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2487228.2487238; Cohen-Mansfield J, 2011, J CLIN PSYCHIAT, V72, P480, DOI 10.4088/JCP.09m05694oli; Cohen-Mansfield J, 2010, PSYCHIAT RES, V177, P216, DOI 10.1016/j.psychres.2009.02.010; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galante E, 2007, G Ital Med Lav Ergon, V29, pB26; Garcia-Betances RI, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00080; Gates N, 2011, BMC GERIATR, V11; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; Halter C, 1973, MANUEL TEST ATTENTIO; Leone E., 2012, ADV AGING RES, V1, P13, DOI [https://doi.org/10.4236/aar.2012.12002, DOI 10.4236/AAR.2012.12002, 10.4236/aar.2012.12002]; Levinoff Elise J, 2005, Brain Cogn, V57, P127, DOI 10.1016/j.bandc.2004.08.058; Manera V, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00024; McCallum Simon, 2013, Serious Games Development and Applications. 4th International Conference, SGDA 2013. Proceedings: LNCS 8101, P15, DOI 10.1007/978-3-642-40790-1_2; Morgan DG, 1997, WESTERN J NURS RES, V19, P740, DOI 10.1177/019394599701900604; Mulin E, 2011, INT J GERIATR PSYCH, V26, P158, DOI 10.1002/gps.2508; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Sullivan C, 2011, GLASGOW MATH J, V53, P501, DOI 10.1017/S0017089511000097; ONeil M.E., 2011, SYSTEMATIC EVIDENCE; Optale G, 2010, NEUROREHAB NEURAL RE, V24, P348, DOI 10.1177/1545968309353328; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pettre J., 2009, SCA 09 P 2009 ACM SI, P189, DOI [10.1145/1599470.1599495, DOI 10.1145/1599470.1599495]; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Robert PH, 2008, AM J GERIAT PSYCHIAT, V16, P770, DOI 10.1097/JGP.0b013e31817e73db; Robert PH, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00054; Robert PH, 2010, CNS NEUROSCI THER, V16, P263, DOI 10.1111/j.1755-5949.2009.00132.x; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Shih-Ching Yeh, 2012, 2012 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2012), P23, DOI 10.1109/IECBES.2012.6498023; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Stavros Z, P 3 INT C PERV TECHN, P1, DOI [10.1145/18392941839319;2010, DOI 10.1145/18392941839319;2010]; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; van Zomeren AH, 1994, CLIN NEUROPSYCHOLOGY, P95; Weybright EH, 2010, THER RECREAT J, V44, P271; Yamaguchi H, 2011, INT PSYCHOGERIATR, V23, P674, DOI 10.1017/S1041610210001912; Zakzanis KK, 2009, MED SCI MONITOR, V15, pCR140; Zazzo R., 1972, MANUEL EXAMEN PSYCHO	46	86	89	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151487	10.1371/journal.pone.0151487	http://dx.doi.org/10.1371/journal.pone.0151487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26990298	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800065
J	Venancio, C; Ribeiro, R; Soares, A; Lopes, I				Venancio, Catia; Ribeiro, Rui; Soares, Amadeu; Lopes, Isabel			Multiple Stressor Differential Tolerances: Possible Implications at the Population Level	PLOS ONE			English	Article							DRIVEN GENETIC EROSION; DAPHNIA-LONGISPINA; CO-TOLERANCE; COPPER TOLERANCE; METALS; NICKEL; MINE; RESISTANCE; POLLUTION; ZINC	The probability of the most sensitive genotypes being eliminated from a population due to a contaminant pulse-genetic erosion-is negatively associated to the within-genotype variation. A sensitive genotype with a small phenotypic variation would be more prone to be lost-a critically sensitive genotype. Furthermore, natural populations inhabiting contaminated sites are usually exposed to several pollutants. Such co- or sequential exposure can have severe effects if at least some tolerant clonal lineages surviving one contaminant are sensitive to the others. Such an inverse relationship coupled with a low within-genotype variation potentially enhances genetic erosion. Accordingly, this study evaluated co-tolerance and the occurrence of clonal lineages critically sensitive to 48-hours lethal exposures of copper, zinc, cobalt, and chromium among eight clonal lineages of the cladocerans Daphnia longispina. Median lethal concentrations (LC50) of each metal were found to have the potential to provoke genetic erosion. Pairwise comparisons of LC50, from the eight clonal lineages, revealed neither negative nor positive correlations (r <= vertical bar 0.56 vertical bar; p >= 0.18), but inversely sensitive clonal lineages were found for all pairs of metals. Therefore, besides having the potential to eliminate critically sensitive clonal lineages in a first intermediately lethal pulse, all tested metals may provoke further losses of clonal lineages in an already genetically eroded population.	[Venancio, Catia; Soares, Amadeu; Lopes, Isabel] Univ Aveiro, Dept Biol, Campus Santiago, P-3810193 Aveiro, Portugal; [Venancio, Catia; Soares, Amadeu; Lopes, Isabel] Univ Aveiro, CESAM, Campus Santiago, P-3810193 Aveiro, Portugal; [Ribeiro, Rui] Univ Coimbra, Dept Life Sci, CFE, P-3000456 Coimbra, Portugal	Universidade de Aveiro; Universidade de Aveiro; Universidade de Coimbra	Venancio, C (corresponding author), Univ Aveiro, Dept Biol, Campus Santiago, P-3810193 Aveiro, Portugal.; Venancio, C (corresponding author), Univ Aveiro, CESAM, Campus Santiago, P-3810193 Aveiro, Portugal.	catiavenancio@gmail.com	Soares, Amadeu/A-8304-2008; Ribeiro, Rui/C-7788-2012; Venâncio, Cátia/AAJ-1445-2020; Venâncio, Cátia/AAF-6779-2021; Lopes, Isabel/C-2858-2009	Soares, Amadeu/0000-0003-0879-9470; Ribeiro, Rui/0000-0002-0883-1939; Venâncio, Cátia/0000-0002-6232-4081; Lopes, Isabel/0000-0002-9325-0329	Fundo Social Europeu - FSE; Programa Operacional Potencial Humano - POPH; national funds (OE) through Foundation for Science and Technology (FCT); Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) within the CESAM's strategic program [UID/AMB/50017/2013, PTDC/BIA-BIC/3488/2012]; FCT [SFRH/BD/81717/2011]	Fundo Social Europeu - FSE(European Social Fund (ESF)); Programa Operacional Potencial Humano - POPH; national funds (OE) through Foundation for Science and Technology (FCT); Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) within the CESAM's strategic program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially funded by Fundo Social Europeu - FSE and Programa Operacional Potencial Humano - POPH, and by national funds (OE) through Foundation for Science and Technology (FCT) and Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) (http://alfa.fct.mctes.pt), within the CESAM's strategic program (UID/AMB/50017/2013) and Generosi (PTDC/BIA-BIC/3488/2012). C. Venancio is grant holder from FCT (ref. SFRH/BD/81717/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially funded by Fundo Social Europeu-FSE and Programa Operacional Potencial Humano-POPH, and by national funds (OE) through Foundation for Science and Technology (FCT) and Ministerio da Ciencia, Tecnologia e Ensino Superior (MCTES) (http://alfa.fct.mctes.pt), within the CESAM's strategic program (UID/AMB/50017/2013) and Generosi (PTDC/BIA-BIC/3488/2012). C. Venancio is grant holder from FCT (ref. SFRH/BD/81717/2011).	Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; Agra AR, 2010, ENVIRON TOXICOL CHEM, V29, P939, DOI 10.1002/etc.97; American Society for Testing and Materials, 2002, ANN BOOK ASTM STAND; [Anonymous], 2004, DAPHN SP AC IMM TEST; Asselman J, 2015, ENVIRON TOXICOL CHEM, V34, P1056, DOI 10.1002/etc.2887; Baird DJ, 1989, P 1 EUR C EC LYNGB D, P144; BARIAUD A, 1984, B ENVIRON CONTAM TOX, V32, P597, DOI 10.1007/BF01607543; Belfiore NM, 2001, MUTAT RES-REV MUTAT, V489, P97, DOI 10.1016/S1383-5742(01)00065-5; Bourret V, 2008, AQUAT TOXICOL, V86, P76, DOI 10.1016/j.aquatox.2007.10.003; El-Deeb Bahig, 2009, American Journal of Biochemistry and Biotechnology, V5, P47, DOI 10.3844/ajbb.2009.47.53; GARNHAM GW, 1992, APPL MICROBIOL BIOT, V37, P270, DOI 10.1007/BF00178183; Gonnelli C, 2001, PHYSIOL PLANTARUM, V113, P507, DOI 10.1034/j.1399-3054.2001.1130409.x; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; HALL A, 1980, NEW PHYTOL, V85, P73, DOI 10.1111/j.1469-8137.1980.tb04449.x; Harris KD, 2012, GENETICS RES INT, DOI DOI 10.1155/2012/147892; Hoffman A.A., 1997, EXTREME ENV CHANGE E; Lopes I, 2005, ENVIRON TOXICOL CHEM, V24, P1414, DOI 10.1897/04-132R.1; Lopes I, 2004, ARCH ENVIRON CON TOX, V46, P43, DOI 10.1007/s00244-003-2143-5; Lopes I, 2009, ENVIRON TOXICOL CHEM, V28, P1912, DOI 10.1897/08-359.1; Martins N, 2007, ENVIRON TOXICOL CHEM, V26, P1904, DOI 10.1897/06-111R.1; Medina MH, 2007, CHEMOSPHERE, V67, P2105, DOI 10.1016/j.chemosphere.2006.12.024; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; Morgan AJ, 2007, ENVIRON SCI TECHNOL, V41, P1085, DOI 10.1021/es061992x; MUNZINGER A, 1992, AQUAT TOXICOL, V23, P203, DOI 10.1016/0166-445X(92)90053-P; Nowak C, 2009, ENVIRON POLLUT, V157, P881, DOI 10.1016/j.envpol.2008.11.005; Ribeiro R, 2013, ECOTOXICOLOGY, V22, P889, DOI 10.1007/s10646-013-1070-0; Ribeiro R, 2012, ENVIRON TOXICOL CHEM, V31, P977, DOI 10.1002/etc.1802; Rogalski MA, 2015, ECOLOGY, V96, P1166, DOI 10.1890/14-1663.1; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Saro L, 2012, ENVIRON TOXICOL CHEM, V31, P909, DOI 10.1002/etc.1762; Silva R.M., 2010, INTERDISCIPLINARY ST, P213; SIMKISS K, 1989, Reviews in Aquatic Sciences, V1, P173; Soldo D, 2000, AQUAT TOXICOL, V47, P181, DOI 10.1016/S0166-445X(99)00020-X; Tessier Andre, 1994, P197; Tilstone GH, 1997, PLANT SOIL, V191, P173, DOI 10.1023/A:1004234604143; Tilstone GH, 1997, HEREDITY, V79, P445, DOI 10.1038/hdy.1997.183; TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821, DOI 10.1128/AEM.47.4.821-824.1984; Ungherese G, 2010, ENVIRON POLLUT, V158, P1638, DOI 10.1016/j.envpol.2009.12.007; van Straalen NM, 2002, HUM ECOL RISK ASSESS, V8, P983, DOI 10.1080/1080-700291905783; Vandegehuchte MB, 2009, COMP BIOCHEM PHYS C, V150, P343, DOI 10.1016/j.cbpc.2009.05.014; Vandegehuchte MB, 2010, ENVIRON POLLUT, V158, P3323, DOI 10.1016/j.envpol.2010.07.023; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; VONFRENCKELLINSAM BAK, 1993, NEW PHYTOL, V125, P547, DOI 10.1111/j.1469-8137.1993.tb03902.x; Weider LJ, 1997, P ROY SOC B-BIOL SCI, V264, P1613, DOI 10.1098/rspb.1997.0225	45	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151847	10.1371/journal.pone.0151847	http://dx.doi.org/10.1371/journal.pone.0151847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990542	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800107
J	Zhai, H; Chen, L; Yang, YJ; Sun, HL; Pan, H; He, JC; Zhu, XZ; Sui, H; Wang, WB; Qiu, XH; Qiao, ZX; Yang, XX; Yang, JR; Yu, YM; Ban, B; He, CZ				Zhai, Hui; Chen, Lu; Yang, Yanjie; Sun, Hailian; Pan, Hui; He, Jincai; Zhu, Xiongzhao; Sui, Hong; Wang, Wenbo; Qiu, Xiaohui; Qiao, Zhengxue; Yang, Xiuxian; Yang, Jiarun; Yu, Yunmiao; Ban, Bo; He, Changzhi			Family and College Environmental Exposures Mediate the Relationship between Parental Education and Depression among College Students	PLOS ONE			English	Article							SYMPTOMS	Background Depression is a major health concern for college students due to its substantial morbidity and mortality. Although low parental education has been identified as a factor in depression in college students, the mechanisms through which parental educational achievement affects students' depression are not well understood. We tested whether adverse family and college environments mediate the relationship between parental educational level and depression among Chinese college students. Methods A total of 5180 respondents were selected using a cross-sectional survey. We examined the association of parental education, adverse family and college environments with depression in college students using the Adolescent Self-Rating Life Events Checklist, Beck Depression Inventory and socio-demographic questionnaires. Results Lower parental educational level is significantly correlated with depression in college students in our sample. Additionally, low family economic status, paternal or maternal unemployment, long periods spent apart from family, family conflicts, having been scolded and beaten by parents, poor or dissatisfying test performance, conflict with friends, heavy course load and failure in selection processes are also associated with parental education. Low family economic status, paternal or maternal unemployment, long periods spent apart from family, family conflicts, poor or dissatisfying test performance, conflict with friends and heavy course load mediated the relationship between parental education and depression in college students. Conclusions Adverse family and college environments could explain the influence of parental educational level on depression in college students.	[Zhai, Hui; Yang, Yanjie; Wang, Wenbo; Qiu, Xiaohui; Qiao, Zhengxue; Yang, Xiuxian; Yang, Jiarun; Yu, Yunmiao; He, Changzhi] Harbin Med Univ, Inst Publ Hlth, Dept Med Psychol, Harbin, Peoples R China; [Chen, Lu; Pan, Hui] Peking Union Med Coll Hosp, Dept Endocrinol, Beijing, Peoples R China; [Sun, Hailian] Harbin Med Univ, Affiliated Hosp 1, Dept Clin Psychol, Harbin, Peoples R China; [He, Jincai] Wenzhou Med Univ, Wenzhou Med Coll, Affiliated Hosp 1, Dept Internal Neurol, Wenzhou, Peoples R China; [Zhu, Xiongzhao] Cent S Univ, Xiangya Hosp 2, Dept Med Psychol, Changsha, Hunan, Peoples R China; [Sui, Hong] Harbin Med Univ, Inst Publ Hlth, Dept Epidemiol & Hlth Stat, Harbin, Peoples R China; [Ban, Bo] Jining Med Coll, Affiliated Hosp, Dept Endocrinol, Rizhao, Shandong, Peoples R China	Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harbin Medical University; Wenzhou Medical University; Central South University; Harbin Medical University; Jining Medical University	Yang, YJ (corresponding author), Harbin Med Univ, Inst Publ Hlth, Dept Med Psychol, Harbin, Peoples R China.; Sun, HL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Clin Psychol, Harbin, Peoples R China.	yanjie1965@163.com; Sunhailian1@163.com			National Natural Science Foundation of China [81473054, 81302484]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (81473054) to Prof. Yanjie Yang, the National Natural Science Foundation of China (81302484) to Zhengxue Qiao.	Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P8; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Eley TC, 2004, J AM ACAD CHILD PSY, V43, P298, DOI 10.1097/00004583-200403000-00011; Evans GW, 2002, ANN REV PUBLIC HLTH, V23; Fors S, 2009, J GERONTOL B-PSYCHOL, V64, P750, DOI 10.1093/geronb/gbp029; Furukawa TA, 2010, J PSYCHOSOM RES, V68, P581, DOI 10.1016/j.jpsychores.2009.05.003; GOODMAN E, 2003, ADOLESCENT HLTH, V0093; Jackson Benita, 2011, Race Soc Probl, V3, P119; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; Piko BF, 2007, EUR J PUBLIC HEALTH, V17, P353, DOI 10.1093/eurpub/ckl257; Wirback T, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0096-0; Wu WC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-116; Xu Ying, 2014, Nurse Educ Today, V34, pe7, DOI 10.1016/j.nedt.2013.10.017; Young CB, 2010, J AFFECT DISORDERS, V125, P1; Zisook S, 2009, J AFFECT DISORDERS, V117, P63, DOI 10.1016/j.jad.2009.01.002	15	12	12	14	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151759	10.1371/journal.pone.0151759	http://dx.doi.org/10.1371/journal.pone.0151759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991783	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800097
J	Bhalala, US; Hemani, M; Shah, M; Kim, B; Gu, B; Cruz, A; Arunachalam, P; Tian, E; Yu, C; Punnoose, J; Chen, S; Petrillo, C; Brown, A; Munoz, K; Kitchen, G; Lam, T; Bosemani, T; Huisman, TAGM; Allen, RH; Acharya, S				Bhalala, Utpal S.; Hemani, Malvi; Shah, Meehir; Kim, Barbara; Gu, Brian; Cruz, Angelo; Arunachalam, Priya; Tian, Elli; Yu, Christine; Punnoose, Joshua; Chen, Steven; Petrillo, Christopher; Brown, Alisa; Munoz, Karina; Kitchen, Grant; Lam, Taylor; Bosemani, Thangamadhan; Huisman, Thierry A. G. M.; Allen, Robert H.; Acharya, Soumyadipta			Defining Optimal Head-Tilt Position of Resuscitation in Neonates and Young Infants Using Magnetic Resonance Imaging Data	PLOS ONE			English	Article							UPPER AIRWAY; OBSTRUCTION; GUIDELINES	Head-tilt maneuver assists with achieving airway patency during resuscitation. However, the relationship between angle of head-tilt and airway patency has not been defined. Our objective was to define an optimal head-tilt position for airway patency in neonates (age: 0-28 days) and young infants (age: 29 days-4 months). We performed a retrospective study of head and neck magnetic resonance imaging (MRI) of neonates and infants to define the angle of head-tilt for airway patency. We excluded those with an artificial airway or an airway malformation. We defined head-tilt angle a priori as the angle between occipito-ophisthion line and ophisthion-C7 spinous process line on the sagittal MR images. We evaluated medical records for Hypoxic Ischemic Encephalopathy (HIE) and exposure to sedation during MRI. We analyzed MRI of head and neck regions of 63 children (53 neonates and 10 young infants). Of these 63 children, 17 had evidence of airway obstruction and 46 had a patent airway on MRI. Also, 16/63 had underlying HIE and 47/63 newborn infants had exposure to sedative medications during MRI. In spontaneously breathing and neurologically depressed newborn infants, the head-tilt angle (median +/- SD) associated with patent airway (125.3 degrees +/- 11.9 degrees) was significantly different from that of blocked airway (108.2 degrees +/- 17.1 degrees) (Mann Whitney U-test, p = 0.0045). The logistic regression analysis showed that the proportion of patent airways progressively increased with an increasing head-tilt angle, with >95% probability of a patent airway at head-tilt angle 144-150 degrees.	[Bhalala, Utpal S.; Shah, Meehir] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Hemani, Malvi; Kim, Barbara; Gu, Brian; Cruz, Angelo; Arunachalam, Priya; Tian, Elli; Yu, Christine; Punnoose, Joshua; Chen, Steven; Petrillo, Christopher; Brown, Alisa; Munoz, Karina; Kitchen, Grant; Lam, Taylor; Allen, Robert H.; Acharya, Soumyadipta] Johns Hopkins Univ, Dept Biomed Engn, Ctr Biomed Innovat & Design, Baltimore, MD USA; [Bosemani, Thangamadhan; Huisman, Thierry A. G. M.] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Div Pediat Radiol & Pediat Neuroradiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bhalala, US (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA.	ubhalal1@jhmi.edu	Huisman, Thierry/GYD-4734-2022		Johns Hopkins University PURA grant	Johns Hopkins University PURA grant	This work was supported by Johns Hopkins University PURA grant.	Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P839, DOI 10.1136/bmj.38979.379641.68; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; GREENE DG, 1961, JAMA-J AM MED ASSOC, V176, P570, DOI 10.1001/jama.1961.03040200006002; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Reber A, 1999, ANESTHESIOLOGY, V90, P1617, DOI 10.1097/00000542-199906000-00018; RUBEN H, 1960, LANCET, V1, P849; SAFAR P, 1959, J APPL PHYSIOL, V14, P760, DOI 10.1152/jappl.1959.14.5.760; SAFAR P, 1958, JAMA-J AM MED ASSOC, V167, P335, DOI 10.1001/jama.1958.72990200026008c; Tonkin SL, 1998, J ROY SOC MED, V91, P310, DOI 10.1177/014107689809100608; Upadhyay A, 2011, PRINCIPLES PEDIAT NE, P503; Von Ungern-Sternberg BS, 2005, PEDIATR ANESTH, V15, P181, DOI 10.1111/j.1460-9592.2004.01534.x; WILSON SL, 1980, J APPL PHYSIOL, V48, P500, DOI 10.1152/jappl.1980.48.3.500; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267	15	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151789	10.1371/journal.pone.0151789	http://dx.doi.org/10.1371/journal.pone.0151789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003759	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400044
J	Davis, J; Brazil, N				Davis, Jason; Brazil, Noli			Migration, Remittances and Nutrition Outcomes of Left-Behind Children: A National-Level Quantitative Assessment of Guatemala	PLOS ONE			English	Article							INTERNATIONAL REMITTANCES; MIGRANT REMITTANCES; US MIGRATION; WOMENS WORK; HOUSEHOLD; IMPACT; INEQUALITY; NETWORKS; GROWTH; EXPENDITURE	Historically, Guatemalans have suffered high rates of poverty and malnutrition while nearly ten percent of their population resides abroad. Many Guatemalan parents use economic migration, mainly international migration to the United States, as a means to improve the human capital prospects of their children. However, as this investigation shows, the timing of migration events in relation to left-behind children's ages has important, often negative and likely permanent, repercussions on the physical development of their children. To illustrate these dynamics, this investigation uses an instrumental variables framework to disentangle the countervailing effects of Guatemalan fathers' absences due to migration from concomitant remittances on left-behind children's growth outcomes. Based on national-level data collected in 2000, the investigation reveals that the international migration of a father in the previous year is correlated with a 22.1% lower length/height-for-age z-score for the average left-behind child aged <= 3. In contrast, the receipt of remittance income has no influence on the physical stature of a child, which may indicate that migrant fathers with young children are not able to achieve economic success soon enough during their ventures abroad to fully ameliorate the harmful effects caused by their absences.	[Davis, Jason] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Brazil, Noli] Univ So Calif, Spatial Sci Inst, Los Angeles, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of Southern California	Davis, J (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA.	jdavis36@live.unc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K99 HD079586, T32 HD007168, R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, P2CHD050924, R00HD079586, R24HD050924, K99HD079586] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research received support from a Pathway to Independence Award (K99 HD079586), a Population Research Training grant (T32 HD007168) and a Population Research Infrastructure Program grant (R24 HD050924), awarded to the Carolina Population Center by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). NICHD played no role in study design; data collection, analysis, and interpretation; manuscript preparation; or whether and where to publish this work.	Adams RH, 2006, J AFR ECON, V15, P396, DOI 10.1093/jafeco/ejl028; Adams RH, 2010, WORLD DEV, V38, P1626, DOI 10.1016/j.worlddev.2010.03.003; Anton JI, 2010, INT MIGR REV, V44, P269, DOI 10.1111/j.1747-7379.2010.00806.x; Baez J., 2008, DOES MORE MEAN BETTE; Beaton G, 1990, APPROPRIATE USES ANT; Becker G., 1974, EC FAMILY MARRIAGE C, P81, DOI DOI 10.1086/260166; BECKER GS, 1976, J POLIT ECON, V84, pS143, DOI 10.1086/260536; Bierbaum R.M., 2010, WORLD DEV REPORT 201; Buis ML, 2011, STATA J, V11, P315, DOI 10.1177/1536867X1101100211; Bureau of Labor Statistics. Occupational employment statistics, OCC EMPL STAT; Carletto C, 2011, FOOD POLICY, V36, P16, DOI 10.1016/j.foodpol.2010.08.002; CARLSON ED, 1985, DEMOGRAPHY, V22, P61, DOI 10.2307/2060986; Carrington WJ, 1996, AM ECON REV, V86, P909; Curran SR, 2003, DEMOGRAPHY, V40, P289, DOI 10.2307/3180802; Davis J., 2010, INT MIGRATION REMITT; Davis J, 2010, POPUL ENVIRON, V32, P216, DOI 10.1007/s11111-010-0128-7; de Brauw A, 2011, FOOD POLICY, V36, P88, DOI 10.1016/j.foodpol.2010.08.001; De Onis M, 2006, WHO CHILD GROWTH STA; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DELATORRE A, 1987, INT MIGR REV, V21, P728, DOI 10.2307/2546619; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frank R, 2005, SOC FORCES, V83, P919, DOI 10.1353/sof.2005.0031; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Goldstein S., 1983, MIGRATION FERTILITY; Gross R., 2000, SCN NEWS, V20, P20; Hallman K, 2006, MULTIPLE DISADVANTAG; Hamilton ER, 2009, POPUL RES POLICY REV, V28, P123, DOI 10.1007/s11113-008-9097-2; Hildebrandt N, 2005, ECONOMIA, V6, P257, DOI 10.1353/eco.2006.0009; IOM, 2004, ENC NAC IMP REM FAM; IOM, 2011, ENC REM 2010 NIN AD; IOM, 2003, ENC NAC EM INT GUAT; Kanaiaupuni SM, 1999, DEMOGRAPHY, V36, P339, DOI 10.2307/2648057; LESLIE J, 1988, WORLD DEV, V16, P1341, DOI 10.1016/0305-750X(88)90209-4; LEVINE NE, 1988, ETHNOLOGY, V27, P231, DOI 10.2307/3773519; LUCAS REB, 1985, J POLIT ECON, V93, P901, DOI 10.1086/261341; Marini A, 2003, MALNUTRITION POVERTY; MARTORELL R, 1995, J NUTR, V125, pS1060; McKay D., 2007, MOBILITIES, V2, P175, DOI DOI 10.1080/17450100701381532; Mckenzie D, 2007, J DEV ECON, V84, P1, DOI 10.1016/j.jdeveco.2006.11.003; McKenzie D, 2010, REV ECON STAT, V92, P811, DOI 10.1162/REST_a_00032; McKenzie D, 2010, J EUR ECON ASSOC, V8, P913; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; Menjivar C, 2007, SOC SCI QUART, V88, P1243, DOI 10.1111/j.1540-6237.2007.00501.x; Milman A, 2005, J NUTR, V135, P1415, DOI 10.1093/jn/135.6.1415; Mohapatra S., 2011, OUTLOOK REMITTANCE F; Munshi K, 2003, Q J ECON, V118, P549, DOI 10.1162/003355303321675455; Nobles JE, 2007, EFFECTS MEXICAN MIGR; Osili UO, 2004, ECON DEV CULT CHANGE, V52, P821, DOI 10.1086/420903; Ponce J, 2011, INT MIGR REV, V45, P727, DOI 10.1111/j.1747-7379.2011.00864.x; POPKIN BM, 1980, ECOL FOOD NUTR, V9, P1, DOI 10.1080/03670244.1980.9990579; Roodman D, 2009, 168 CTR GLOB DEV, V168, P1; Schmeer K, 2009, SOC SCI MED, V69, P1281, DOI 10.1016/j.socscimed.2009.07.030; STARK O, 1988, ECON DEV CULT CHANGE, V36, P465, DOI 10.1086/451670; STEPHEN EH, 1992, INT MIGR REV, V26, P67, DOI 10.2307/2546937; Stephen L., 2005, GENDER CLASS ETHNICI; Stillman S, 2012, ECON INQ, V50, P62, DOI 10.1111/j.1465-7295.2009.00284.x; Stoll D., 2012, MIGRATION FEVER MICR; Taylor JE, 1996, J DEV STUD, V32, P899, DOI 10.1080/00220389608422445; Toyama N, 2001, J TROP PEDIATRICS, V47, P179, DOI 10.1093/tropej/47.3.179; TUCKER K, 1988, SOC SCI MED, V26, P605, DOI 10.1016/0277-9536(88)90024-X; United Nations Children's Fund, 2007, PROGR CHILDR WORLD F; Vanwey LK, 2004, DEMOGRAPHY, V41, P739, DOI 10.1353/dem.2004.0039; WHO, 2006, WHO CHILD GROWTH STA; Woodruff C, 2007, J DEV ECON, V82, P509, DOI 10.1016/j.jdeveco.2006.03.006; World Health Organization, GROWTH REF 5 19 YEAR; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Yang D, 2007, WORLD BANK ECON REV, V21, P219, DOI 10.1093/wber/lhm003	67	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152089	10.1371/journal.pone.0152089	http://dx.doi.org/10.1371/journal.pone.0152089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002528	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400076
J	Fernandes, CS; Batalha, MA; Bichuette, ME				Fernandes, Camile Sorbo; Batalha, Marco Antonio; Bichuette, Maria Elina			Does the Cave Environment Reduce Functional Diversity?	PLOS ONE			English	Article							TERRESTRIAL ISOPODS CRUSTACEA; ONISCIDEA; HABITATS; BRAZIL; RULES	Caves are not colonised by all taxa present in the surface species pool, due to absence of light and the tendency to food limitation when compared to surface communities. Under strong species sorting during colonisation and later by the restrictive environmental filter, traits that are not adaptive in subterranean habitats may be filtered out. We tested whether cave communities were assembled by the restrictive regime propitiated by permanent darkness or by competitive exclusion due to resource scarcity. When compared to surface communities, the restrictive subterranean regime would lead to lower functional diversity and phenotypic clustering inside the caves, and the opposite should be expected in the case of competitive exclusion. Using isopods (Oniscidea) as model taxa, we measured several niche descriptors of taxa from surface and cave habitats, used a multivariate measure of functional diversity, and compared their widths. We found phenotypic overdispersion and higher functional diversity in cave taxa when compared to surface taxa. On the one hand, the dry climate outside of caves hampered the survival of several taxa and their ecological strategies, not viable under severe desiccation risk, culminating in the clustering of functional traits. In contrast, this restriction does not occur inside of caves, where isopods find favourable conditions under lower predation pressures and more amenable environmental parameters that allow occupation and subsequent diversification. Our results showed that, at least for some taxa, caves may not be such a harsh environment as previously thought. The high functional diversity we found inside caves adds an additional reason for the conservation of these sensitive environments.	[Fernandes, Camile Sorbo; Bichuette, Maria Elina] Univ Fed Sao Carlos, Dept Ecol & Evolutionary Biol, POB 676, BR-13565905 Sao Carlos, SP, Brazil; [Batalha, Marco Antonio] Univ Fed Sao Carlos, Dept Bot, POB 676, BR-13565905 Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Fernandes, CS (corresponding author), Univ Fed Sao Carlos, Dept Ecol & Evolutionary Biol, POB 676, BR-13565905 Sao Carlos, SP, Brazil.	camilesorbofernandes@yahoo.com.br	Bichuette, Maria Elina/C-5262-2013; Batalha, Marco A/C-9113-2012; Batalha, Marco Antonio/P-1102-2019	Bichuette, Maria Elina/0000-0002-9515-4832; Batalha, Marco A/0000-0002-8236-8022; Batalha, Marco Antonio/0000-0002-8236-8022	Coordination for the Improvement of Higher Education Personnel (CAPES); Postgraduate Program on Ecology and Natural Resources from Federal University of Sao Carlos (PPG-ERN UFSCar); Fapesp [2008/05678-7, 2010/08459-4, 2008/57949-4]; Brazilian National Council for Scientific and Technological Development (CNPq); CNPq [573802/2008-4]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Postgraduate Program on Ecology and Natural Resources from Federal University of Sao Carlos (PPG-ERN UFSCar); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author (CSF) was supported by a PhD fellowship granted by the Coordination for the Improvement of Higher Education Personnel (CAPES: http://www.capes.gov.br/). The field samples were supported by the Postgraduate Program on Ecology and Natural Resources from Federal University of Sao Carlos (PPG-ERN UFSCar: http://www.ppgern.ufscar.br/) and by Fapesp (http://www.fapesp.br/) numbers 2008/05678-7; 2010/08459-4.; We are grateful to the Brazilian National Council for Scientific and Technological Development (CNPq), for the productivity fellowship granted to the second author; to Dr AMPM Dias, coordinator of the National Institute of Science and Technology of the Hymenoptera Parasitoids from Brazilian Southeast Region (INCT Hympar Sudeste, Fapesp grant 2008/57949-4 and CNPq grant 573802/2008-4), for the scanning electron microscope; to Dr LBDR Fernandes, biologist at the Department of Ecology and Evolutionary Biology of the Federal University of Sao Carlos, for taking the scanning electron microscope images; to Dr E Trajano, for the donation of some specimens; to Dr. Ivanklin S. Campos-Filho and Dr. Paula B. Araujo for the help in our taxonomic doubts and for receiving the material for identification and description. To BS Brito, JE Gallao, N Hattori, FD Passos, D Pedroso, B Rantin, PP Rizzato, D Sansone, RC Santos, RH Santos, T Scatolini, L Senna-Horta, LB Simoes, JS Souza, E Trajano, DM Von-Schimonsky, T Zepon, for the help in field; and to JE Gallao and PP Rizzato, for comments on the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Barr TC, 1968, EVOLUTIONARY BIOL, V2, P72; Bichuette ME, 2013, AN 32 C BRAS ESP SOC, P95; Bichuette ME, 2004, RES ENC BRAS EST CAR, P20; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Campos IS, 2014, ZOOL J LINN SOC-LOND, V172, P360, DOI 10.1111/zoj12172; Cardoso P, 2012, INT J SPELEOL, V41, P83, DOI 10.5038/1827-806X.41.1.9; Christiansen K., 1962, Memoires Spelunca, VNo. 2, P76; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2010, J CRUSTACEAN BIOL, V30, P68, DOI 10.1651/09-3156.1; Diamond J.M, 1975, ECOLOGY EVOLUTION CO; Fiser C, 2012, BIOL LETTERS, V8, P578, DOI 10.1098/rsbl.2012.0125; Gallao JE, 2012, NAT CONSERVACAO, V10, P83, DOI 10.4322/natcon.2012.014; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Haddad A, 2007, TECNICAS MICROSCOPIA, V3rd; Holdich D.M., 1984, Symposia of the Zoological Society of London, P9; HOLDICH DM, 1974, J ZOOL, V172, P469; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; HOWARTH FG, 1993, AM NAT, V142, pS65, DOI 10.1086/285523; Howarth FG, 2012, ENCY CAVES, P230; Hutchinson G.E., 1959, AM NAT, V93, P342; Jongman RHG, 1995, DATA ANAL COMMUNITY; Karmann I, 1979, ESPELEO TEMA, V14, P43; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Langecker TG, 2000, ECOSYSTEMS WORLD 30, P17; Maire E, 2015, GLOBAL ECOL BIOGEOGR, V24, P728, DOI 10.1111/geb.12299; Moura VM, 2008, O CARSTE, V20, P76; Palacios-Vargas JG, 2013, TECNICAS ATUAIS ESTU; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Pipan T, 2012, BIOL J LINN SOC, V107, P1, DOI 10.1111/j.1095-8312.2012.01964.x; POULSON TL, 1969, SCIENCE, V165, P971; Quadros AF, 2008, REV BRAS ZOOL, V25, P58, DOI 10.1590/S0101-81752008000100009; R Core Team, 2020, R LANG ENV STAT COMP; Schmalfuss H., 1984, Symposia of the Zoological Society of London, P49; SCHMALFUSS H, 1978, ZOOMORPHOLOGIE, V91, P263, DOI 10.1007/BF00999815; Simoes Luiza Bertelli, 2013, Subterranean Biology, V11, P55, DOI 10.3897/subtbiol.11.5981; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Taiti S, 2003, ENCY CAVES KARST SCI, P547; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; TRAJANO E, 2012, ESPELEO TEMA, V23, P13; TRAJANO E., 2012, ENCY CAVES, P295, DOI DOI 10.1016/B978-0-12-383832-2.00040-2; Trajano E, 2003, O CARSTE, V15, P114; Trajano E., 2012, ENCY CAVES, P275, DOI DOI 10.1016/B978-0-12-383832-2.00035-9; Trajano Eleonora, 2009, Subterranean Biology, V7, P1; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Wilkens H, 2011, HEREDITY, V106, P707, DOI 10.1038/hdy.2010.105; Zimmer M, 2002, BIOL REV, V77, P455, DOI 10.1017/S1464793102005912	53	27	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151958	10.1371/journal.pone.0151958	http://dx.doi.org/10.1371/journal.pone.0151958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003837	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400059
J	Stressler, T; Ewert, J; Merz, M; Funk, J; Claaen, W; Lutz-Wahl, S; Schmidt, H; Kuhn, A; Fischer, L				Stressler, Timo; Ewert, Jacob; Merz, Michael; Funk, Joshua; Claaen, Wolfgang; Lutz-Wahl, Sabine; Schmidt, Herbert; Kuhn, Andreas; Fischer, Lutz			A Novel Glutamyl (Aspartyl)-Specific Aminopeptidase A from Lactobacillus delbrueckii with Promising Properties for Application	PLOS ONE			English	Article							PURIFICATION; HYDROLYSIS	Lactic acid bacteria (LAB) are auxotrophic for a number of amino acids. Thus, LAB have one of the strongest proteolytic systems to acquit their amino acid requirements. One of the intracellular exopeptidases present in LAB is the glutamyl (aspartyl) specific aminopeptidase (PepA; EC 3.4.11.7). Most of the PepA enzymes characterized yet, belonged to Lactococcus lactis sp., but no PepA from a Lactobacillus sp. has been characterized so far. In this study, we cloned a putative pepA gene from Lb. delbrueckii ssp. lactis DSM 20072 and characterized it after purification. For comparison, we also cloned, purified and characterized PepA from Lc. lactis ssp. lactis DSM 20481. Due to the low homology between both enzymes (30%), differences between the biochemical characteristics were very likely. This was confirmed, for example, by the more acidic optimum pH value of 6.0 for Lb-PepA compared to pH 8.0 for Lc-PepA. In addition, although the optimum temperature is quite similar for both enzymes (Lb-PepA: 60 degrees C; Lc-PepA: 65 degrees C), the temperature stability after three days, 20 degrees C below the optimum temperature, was higher for Lb-PepA (60% residual activity) than for Lc-PepA (2% residual activity). EDTA inhibited both enzymes and the strongest activation was found for CoCl2, indicating that both enzymes are metallopeptidases. In contrast to Lc-PepA, disulfide bond-reducing agents such as dithiothreitol did not inhibit Lb-PepA. Finally, Lb-PepA was not product-inhibited by L-Glu, whereas Lc-PepA showed an inhibition.	[Stressler, Timo; Ewert, Jacob; Merz, Michael; Claaen, Wolfgang; Lutz-Wahl, Sabine; Fischer, Lutz] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol & Enzyme Sci, Stuttgart, Germany; [Funk, Joshua; Schmidt, Herbert] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Microbiol & Hyg, Stuttgart, Germany; [Kuhn, Andreas] Univ Hohenheim, Inst Microbiol, Stuttgart, Germany	University Hohenheim; University Hohenheim; University Hohenheim	Stressler, T (corresponding author), Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol & Enzyme Sci, Stuttgart, Germany.	t.stressler@uni-hohenheim.de		Merz, Michael/0000-0002-1975-8175; Schmidt, Herbert/0000-0001-6046-4198				Aaslyng MD, 1998, J AGR FOOD CHEM, V46, P5225, DOI 10.1021/jf9806816; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bacon CL, 1994, INT DAIRY J, V4, P503, DOI 10.1016/0958-6946(94)90022-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brena Beatriz M., 2006, V22, P15; Caplice E, 1999, INT J FOOD MICROBIOL, V50, P131, DOI 10.1016/S0168-1605(99)00082-3; Carr FJ, 2002, CRIT REV MICROBIOL, V28, P281, DOI 10.1080/1040-840291046759; EXTERKATE FA, 1987, APPL ENVIRON MICROB, V53, P577, DOI 10.1128/AEM.53.3.577-583.1987; Girono L, 2000, TRENDS BIOTECHNOL, V18, P339, DOI 10.1016/S0167-7799(00)01472-4; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; IANSON KJA, 1995, MICROBIOL-UK, V141, P2873, DOI 10.1099/13500872-141-11-2873; Kim D, 2010, BIOCHEM BIOPH RES CO, V391, P431, DOI 10.1016/j.bbrc.2009.11.075; Kleerebezem M, 2003, CURR OPIN BIOTECH, V14, P232, DOI 10.1016/S0958-1669(03)00033-8; Kunji ERS, 1996, ANTON LEEUW INT J G, V70, P187, DOI 10.1007/BF00395933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mayo B., 2010, BIOTECHNOLOGY LACTIC, P3, DOI DOI 10.1002/9780813820866.CH1; Merz M., 2015, EUR FOOD RES TECHNOL, V241, P1; Merz M, 2016, J SCI FOOD AGR, V96, P3358, DOI 10.1002/jsfa.7515; Merz M, 2015, BIOCHEM ENG J, V99, P114, DOI 10.1016/j.bej.2015.03.019; Merza M, 2015, J MOL CATAL B-ENZYM, V122, P218, DOI 10.1016/j.molcatb.2015.09.010; NIKKILA P, 1995, J GEN APPL MICROBIOL, V41, P327, DOI 10.2323/jgam.41.327; NIVEN GW, 1991, J GEN MICROBIOL, V137, P1207, DOI 10.1099/00221287-137-5-1207; Rios GM, 2004, J MEMBRANE SCI, V242, P189, DOI 10.1016/j.memsci.2003.06.004; Rombouts I, 2009, J CHROMATOGR A, V1216, P5557, DOI 10.1016/j.chroma.2009.05.066; SALES MGR, 1995, AM J CLIN NUTR, V62, P87, DOI 10.1093/ajcn/62.1.87; Sambrook J., 2001, MOL CLONING LAB MANU; Schlichtherle-Cerny H, 2002, J AGR FOOD CHEM, V50, P1515, DOI 10.1021/jf010989o; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stressler T, 2014, J MOL CATAL B-ENZYM, V108, P103, DOI 10.1016/j.molcatb.2014.07.006; Stressler T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070055; Stressler T, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-39; TAN PST, 1991, APPL ENVIRON MICROB, V57, P3593, DOI 10.1128/AEM.57.12.3593-3599.1991	33	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152139	10.1371/journal.pone.0152139	http://dx.doi.org/10.1371/journal.pone.0152139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003449	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400084
J	Wu, PS; Feldman, AS; Rosas-Salazar, C; James, K; Escobar, G; Gebretsadik, T; Li, SX; Carroll, KN; Walsh, E; Mitchel, E; Das, S; Kumar, R; Yu, C; Dupont, WD; Hartert, TV				Wu, Pingsheng; Feldman, Amy S.; Rosas-Salazar, Christian; James, Kristina; Escobar, Gabriel; Gebretsadik, Tebeb; Li, Sherian Xu; Carroll, Kecia N.; Walsh, Eileen; Mitchel, Edward; Das, Suman; Kumar, Rajesh; Yu, Chang; Dupont, William D.; Hartert, Tina V.			Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma	PLOS ONE			English	Article							LONG-TERM IMPACTS; GUT MICROBIOTA; CESAREAN-SECTION; INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; VIRUS-INFECTION; EXPOSURE; CHILDREN; DELIVERY; OLIGOSACCHARIDES	Background Environmental exposures that occur in utero and during early life may contribute to the development of childhood asthma through alteration of the human microbiome. The objectives of this study were to estimate the cumulative effect and relative importance of environmental exposures on the risk of childhood asthma. Methods We conducted a population-based birth cohort study of mother-child dyads who were born between 1995 and 2003 and were continuously enrolled in the PRIMA (Prevention of RSV: Impact on Morbidity and Asthma) cohort. The individual and cumulative impact of maternal urinary tract infections (UTI) during pregnancy, maternal colonization with group B streptococcus (GBS), mode of delivery, infant antibiotic use, and older siblings at home, on the risk of childhood asthma were estimated using logistic regression. Dose-response effect on childhood asthma risk was assessed for continuous risk factors: number of maternal UTIs during pregnancy, courses of infant antibiotics, and number of older siblings at home. We further assessed and compared the relative importance of these exposures on the asthma risk. In a subgroup of children for whom maternal antibiotic use during pregnancy information was available, the effect of maternal antibiotic use on the risk of childhood asthma was estimated. Results Among 136,098 singleton birth infants, 13.29% developed asthma. In both univariate and adjusted analyses, maternal UTI during pregnancy (odds ratio [OR] 1.2, 95% confidence interval [CI] 1.18, 1.25; adjusted OR [AOR] 1.04, 95% CI 1.02, 1.07 for every additional UTI) and infant antibiotic use (OR 1.21, 95% CI 1.20, 1.22; AOR 1.16, 95% CI 1.15, 1.17 for every additional course) were associated with an increased risk of childhood asthma, while having older siblings at home (OR 0.92, 95% CI 0.91, 0.93; AOR 0.85, 95% CI 0.84, 0.87 for each additional sibling) was associated with a decreased risk of childhood asthma, in a dose-dependent manner. Compared with vaginal delivery, C-section delivery increased odds of childhood asthma by 34% (OR 1.34, 95% CI 1.29, 1.39) in the univariate analysis and 11% after adjusting for other environmental exposures and covariates (AOR 1.11, 95% CI 1.06, 1.15). Maternal GBS was associated with a significant increased risk of childhood asthma in the univariate analysis (OR 1.27, 95% CI 1.19, 1.35), but not in the adjusted analysis (AOR 1.03, 95% CI 0.96, 1.10). In the subgroup analysis of children whose maternal antibiotic use information was available, maternal antibiotic use was associated with an increased risk of childhood asthma in a similar dose-dependent manner in the univariate and adjusted analyses (OR 1.13, 95% CI 1.12, 1.15; AOR 1.06, 95% CI 1.05, 1.08 for every additional course). Compared with infants with the lowest number of exposures (no UTI during pregnancy, vaginal delivery, at least five older siblings at home, no antibiotics during infancy), infants with the highest number of exposures (at least three UTIs during pregnancy, C-section delivery, no older siblings, eight or more courses of antibiotics during infancy) had a 7.77 fold increased odds of developing asthma (AOR: 7.77, 95% CI: 6.25, 9.65). Lastly, infant antibiotic use had the greatest impact on asthma risk compared with maternal UTI during pregnancy, mode of delivery and having older siblings at home. Conclusion Early-life exposures, maternal UTI during pregnancy (maternal antibiotic use), mode of delivery, infant antibiotic use, and having older siblings at home, are associated with an increased risk of childhood asthma in a cumulative manner, and for those continuous variables, a dose-dependent relationship. Compared with in utero exposures, exposures occurring during infancy have a greater impact on the risk of developing childhood asthma.	[Wu, Pingsheng; Feldman, Amy S.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA; [Wu, Pingsheng; Feldman, Amy S.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Ctr Asthma & Environm Sci Res, Nashville, TN 37212 USA; [Wu, Pingsheng; Gebretsadik, Tebeb; Yu, Chang; Dupont, William D.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Rosas-Salazar, Christian; Carroll, Kecia N.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [James, Kristina] Peninsula Allergy & Asthma Ctr, Soldotna, AK USA; [Escobar, Gabriel] Kaiser Permanente Med Care Program, Oakland, CA USA; [Escobar, Gabriel; Li, Sherian Xu; Walsh, Eileen] Kaiser Permanente No Calif, Div Res, Perinatal Res Unit, Oakland, CA USA; [Mitchel, Edward] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Das, Suman] J Craig Venter Inst, Rockville, MD USA; [Kumar, Rajesh] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Kumar, Rajesh] Northwestern Univ, Chicago, IL 60611 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Kaiser Permanente; Kaiser Permanente; Vanderbilt University; J. Craig Venter Institute; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University	Wu, PS (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA.; Wu, PS (corresponding author), Vanderbilt Univ, Sch Med, Ctr Asthma & Environm Sci Res, Nashville, TN 37212 USA.; Wu, PS (corresponding author), Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA.	pingsheng.wu@vanderbilt.edu	Das, Suman/ABB-7273-2020; Rosas-Salazar, Christian/AAC-8571-2021	Das, Suman/0000-0003-2496-9724; Rosas-Salazar, Christian/0000-0001-6644-5780; Kumar, Rajesh/0000-0002-1962-7108	Agency for Healthcare Research and Quality [R01 HS018454]; NIH [K24 AI 077930]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110819, K24AI077930] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Agency for Healthcare Research and Quality [R01 HS018454; to TVH] and NIH [K24 AI 077930; to TVH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barile D, 2013, CURR OPIN BIOTECH, V24, P214, DOI 10.1016/j.copbio.2013.01.008; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Colombo DF, 2006, AM J OBSTET GYNECOL, V194, P466, DOI 10.1016/j.ajog.2005.07.098; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Escobar GJ, 2013, J PEDIATR INFECT DIS, V2, P205, DOI 10.1093/jpids/pit007; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hanson LA, 2003, ANN ALLERG ASTHMA IM, V90, P59, DOI 10.1016/S1081-1206(10)61662-6; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2013, CURR ALLERGY ASTHMA; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Huang Yvonne J, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS48, DOI 10.1513/AnnalsATS.201306-187MG; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Isolauri E, 2012, GASTROENTEROL CLIN N, V41, P747, DOI 10.1016/j.gtc.2012.08.007; Isolauri E, 2012, J PAEDIATR CHILD H, V48, P1, DOI 10.1111/j.1440-1754.2012.02489.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; Malveaux FJ, 2009, PEDIATRICS, V123, pS129, DOI 10.1542/peds.2008-2233B; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Moeller AH, 2013, GUT MICROBES, V4, P403, DOI 10.4161/gmic.26039; Myles I, 2013, J IMMUNOL, V190; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; R Core Team, 2013, R LANG ENV STAT COMP; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Roduit C, 2009, THORAX, V64, P107, DOI 10.1136/thx.2008.100875; Shilts MH, 2015, MICROB ECOL; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tollanes MC, 2008, J PEDIATR-US, V153, P112, DOI 10.1016/j.jpeds.2008.01.029; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Valles Y, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/j.1469-0691.2012.03876.x; Wakefield DB, 2006, PEDIATR PULM, V41, P962, DOI 10.1002/ppul.20476; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC	59	45	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151705	10.1371/journal.pone.0151705	http://dx.doi.org/10.1371/journal.pone.0151705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002979	gold, Green Submitted, Green Published			2022-12-27	WOS:000372697400038
J	Maestri, R; Patterson, BD				Maestri, Renan; Patterson, Bruce D.			Patterns of Species Richness and Turnover for the South American Rodent Fauna	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; SPATIAL-ANALYSIS; BETA-DIVERSITY; DIVERSIFICATION; PHYLOGENY; MAMMALS; CONSERVATISM; BIOGEOGRAPHY; RANGES; RATES	Understanding the spatial distribution of species sheds light on the group's biogeographical history, offers clues to the drivers of diversity, and helps to guide conservation strategies. Here, we compile geographic range information for South America's diverse rodents, whose 14 families comprise similar to 50% of the continent's mammalian species. The South American rodent fauna is dominated by independent and temporally staggered radiations of caviomorph and sigmodontine groups. We mapped species richness and turnover of all rodents and the principal clades to identify the main predictors of diversity patterns. Species richness was highest in the Andes, with a secondary hotspot in Atlantic Forest and some regions of considerable richness in Amazonia. Differences in richness were evident between the caviomorphs and sigmodontines, the former showing the greatest richness in tropical forests whereas the latter show-and largely determine-the all-rodent pattern. Elevation was the main predictor of sigmodontine richness, whereas temperature was the principal variable correlated with richness of caviomorphs. Across clades, species turnover was highest along the Andes and was best explained by elevational relief. In South America, the effects of the familiar latitudinal gradient in species richness are mixed with a strong longitudinal effect, triggered by the importance of elevation and the position of the Andes. Both latitudinal and elevational effects help explain the complicated distribution of rodent diversity across the continent. The continent's restricted-range species-those seemingly most vulnerable to localized disturbance-are mostly distributed along the Andes and in Atlantic Forest, with the greatest concentration in Ecuador. Both the Andes and Atlantic Forest are known hotspots for other faunal and floral components. Contrasting patterns of the older caviomorph and younger sigmodontine radiations underscore the interplay of both historical and ecological factors in determining present-day diversity patterns.	[Maestri, Renan] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, BR-91501970 Porto Alegre, RS, Brazil; [Patterson, Bruce D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA	Universidade Federal do Rio Grande do Sul; Field Museum of Natural History (Chicago)	Maestri, R (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, BR-91501970 Porto Alegre, RS, Brazil.	renanmaestri@gmail.com	Maestri, Renan/L-2637-2015; Patterson, Bruce D/O-5068-2019	Maestri, Renan/0000-0001-9134-2943; Patterson, Bruce D/0000-0002-2249-7260	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES foundation) [4087/14-3]; Barbara E. Brown Fund for Mammal Research (FMNH)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES foundation)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Barbara E. Brown Fund for Mammal Research (FMNH)	RM thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES foundation) for the sandwich fellowship, process number 4087/14-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Primary thanks are due the systematists and biogeographers who are responsible for refining species limits and geographic ranges in South America. We also thank Jessica Mohlman for her work compiling species ranges from the accounts in [27], funded by the Barbara E. Brown Fund for Mammal Research (FMNH).	Amori G, 2013, MAMMALIA, V77, P1, DOI 10.1515/mammalia-2012-0050; [Anonymous], 2012, BONES CLONES BIOMES; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Barton K., 2013, MUMIN MULTI MODEL IN; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Begon M, 2006, ECOLOGY INDIVIDUALS, V4th; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; GRAVES GR, 1988, AUK, V105, P47, DOI 10.1093/auk/105.1.47; Gross J., 2003, R NEWS, V3, P13; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; IUCN, 2010, IUCN REDL THREAT SPE; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; Kerkhoff AJ, 2014, P NATL ACAD SCI USA, V111, P8125, DOI 10.1073/pnas.1308932111; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Leite RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100687; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Lessa EP, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00039; Lopez-Gonzalez C, 2015, ECOGRAPHY, V38, P261, DOI 10.1111/ecog.00813; Mares M.A., 1982, Pymatuning Laboratory of Ecology Special Publications, V6, P393; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Ojeda R.A., 2013, ENCY BIODIVERSITY, P582, DOI [10.1016/B978-0-12-384719-5.00353-1, DOI 10.1016/B978-0-12-384719-5.00353-1]; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parada A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0440-z; Parada A, 2013, MOL PHYLOGENET EVOL, V66, P960, DOI 10.1016/j.ympev.2012.12.001; Patterson BD, 1999, J MAMMAL, V80, P345, DOI 10.2307/1383284; Patterson Bruce D., 2000, Diversity and Distributions, V6, P145, DOI 10.1046/j.1472-4642.2000.00080.x; Patterson BD, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00044; Patterson Bruce D., 2012, P351; Patton J.L., 1990, P355; Patton J.L., 2015, MAMMALS S AM, V2; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; R Core Team, 2016, R FDN STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Pereira MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069245; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rowe DL, 2010, J BIOGEOGR, V37, P305, DOI 10.1111/j.1365-2699.2009.02190.x; Ruggiero A, 2004, ECOGRAPHY, V27, P401, DOI 10.1111/j.0906-7590.2004.03801.x; RUGGIERO A, 1994, J BIOGEOGR, V21, P545, DOI 10.2307/2845657; Ruggiero A, 1998, J BIOGEOGR, V25, P1093, DOI 10.1046/j.1365-2699.1998.00253.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Sokal RR, 1998, BIOL J LINN SOC, V65, P41, DOI 10.1111/j.1095-8312.1998.tb00350.x; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Stevens RD, 2013, BIOTROPICA, V45, P764, DOI 10.1111/btp.12056; Tamma K, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0289-1; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Tognelli MF, 2004, ECOGRAPHY, V27, P427, DOI 10.1111/j.0906-7590.2004.03732.x; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Upham NS., 2015, BIOL CAVIOMORPH RODE, P63; Vilela JF, 2014, J ZOOL SYST EVOL RES, V52, P249, DOI 10.1111/jzs.12057; Voss RS, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)421<0001:ANSOTR>2.0.CO;2; Vucetich MG, 2015, BIOL CAVIOMORPH RODE, P11; Willig MR, 2016, J TROP ECOL, V32, P421, DOI 10.1017/S0266467415000589; Willig MR, 2003, BAT ECOLOGY, P580; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	72	41	56	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151895	10.1371/journal.pone.0151895	http://dx.doi.org/10.1371/journal.pone.0151895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999278	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700080
J	Ayehu, A; Kassaw, T; Hailu, G				Ayehu, Atitegeb; Kassaw, Teketo; Hailu, Getachew			Level of Young People Sexual and Reproductive Health Service Utilization and Its Associated Factors among Young People in Awabel District, Northwest Ethiopia	PLOS ONE			English	Article							ADOLESCENTS	Background Currently in Ethiopia, young people's sexual and reproductive health services are limited and there is a growing issue of confidentiality and affordability of these health services. Moreover, the available services provided are not sensitive to the special needs of young people. Therefore, this study was aimed to assess young people's sexual and reproductive health service utilization and its associated factors in Awabel district, Northwest Ethiopia. Methods A community based cross-sectional study was conducted among 781 randomly selected young people using a pre-tested structured questionnaires in Awabel district, Northwest Ethiopia. Data were entered into Epi data version 3.1 and analyzed using SPSS version 16.0 software. Results The mean age of respondents were 17.80 (+2.65) years. About 41% of young people had utilized sexual and reproductive health services. Young people from families of higher family expenditure, lived with mothers, participated in peer education and lived near to a Health Center were more likely to utilize sexual and reproductive health services. Furthermore, those who had a parental discussion on sexual and reproductive health (AOR (95% C.I): 2.23 (1.43, 3.46)) and ever had sexual intercourse (AOR (95% C.I): 1.88 (1.30, 2.71)) were more likely to utilize the service than their counterparts. On the other hand, those young people lived with their father and had a primary level of educational attainment was less likely to utilize the service. Conclusion Utilization of sexual and reproductive health services is low which needs a great attention where; if not intervened, young people might engage in risky sexual activities. Therefore, it needs a concerted effort from all the concerned bodies to improve their service utilization and thereby reduce the burden of young people's disease and disabilities associated with sexual and reproductive health.	[Ayehu, Atitegeb] Debre Markos Univ, Students Clin, Debre Markos, Ethiopia; [Kassaw, Teketo; Hailu, Getachew] Debre Markos Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Debre Markos, Ethiopia	University of Gondar	Kassaw, T (corresponding author), Debre Markos Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Debre Markos, Ethiopia.	kteketo@yahoo.com		Hailu, Getachew/0000-0002-7794-9500; TEGEGNE, Teketo/0000-0002-9137-3632				Abajobir AA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-138; Abebe M., 2014, OPEN J EPIDEMIOL, V04, P69, DOI [10.4236/ojepi.2014.42012, DOI 10.4236/OJEPI.2014.42012]; [Anonymous], 2007, NAT AD YOUTH REPR HL; Biddlecom Ann E, 2007, Afr J Reprod Health, V11, P99, DOI 10.2307/25549734; Central Statistical Agency of Ethiopia, 2007, POPULATION HOUSING C; de Visser RO, 2013, SEX HEALTH, V10, P553, DOI 10.1071/SH13034; East Gojam Zone Health Department, E GOJ ZON HLTH DEP A; Feleke SA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-294; Godia P, 2010, NAIROBI MOH, V8, P4; Kennedy EC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-770; Kennedy EC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-455; Lesedi C, 2011, SE ASIAN J TROP MED, V42, P1; Melaku YA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-252; Motuma A, 2012, HARAR B HLTH SCI, V4, P15; Noble J, 1996, WORLDS YOUTH 1996; PATH (Program for Appropriate Technology in Health), 1999, OUTLOOK, V17; Population Reference Bureau and Center for Population Options, 1994, WORLDS YOUTH 1994 SP; Ringheim K, 2010, IMPROVING REPROD HLT; The World Bank Group, 2011, WHY INVEST CHILDREN; Tilahun M, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-19; United Nations, MILL DEV GOALS REP 2; Zaw PPT, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-458	22	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151613	10.1371/journal.pone.0151613	http://dx.doi.org/10.1371/journal.pone.0151613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992006	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800079
J	Oxlade, O; Sugarman, J; Alvarez, GG; Pai, M; Schwartzman, K				Oxlade, Olivia; Sugarman, Jordan; Alvarez, Gonzalo G.; Pai, Madhukar; Schwartzman, Kevin			Xpert (R) MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation	PLOS ONE			English	Article							HYPOTHETICAL TRIAL; GENEXPERT MTB/RIF; XPERT MTB/RIF; SPUTUM	Background Tuberculosis (TB) remains a significant health problem in the Canadian Arctic. Substantial health system delays in TB diagnosis can occur, in part due to the lack of capacity for onsite microbiologic testing. A study recently evaluated the yield and impact of a rapid automated PCR test (Xpert (R) MTB/RIF) for the diagnosis of TB in Iqaluit (Nunavut). We conducted an economic analysis to evaluate the expected cost relative to the expected reduction in time to treatment initiation, with the addition of Xpert (R) MTB/RIF to the current diagnostic and treatment algorithms used in this setting. Methods A decision analysis model compared current microbiologic testing to a scenario where Xpert (R) MTB/RIF was added to the current diagnostic algorithm for active TB, and incorporated costs and clinical endpoints from the Iqaluit study. Several sensitivity analyses that considered alternative use were also considered. We estimated days to TB diagnosis and treatment initiation, health system costs, and the incremental cost per treatment day gained for each individual evaluated for possible TB. Results With the addition of Xpert (R) MTB/RIF, costs increased while days to TB treatment initiation were reduced. The incremental cost per treatment day gained (per individual investigated for TB) was $164 (95% uncertainty range $85, $452). In a sensitivity analysis that considered hospital discharge after a single negative Xpert (R) MTB/RIF, the Xpert (R) MTB/RIF scenario was cost saving. Interpretation Adding Xpert (R) MTB/RIF to the current diagnostic algorithm for TB in Nunavut appears to reduce time to diagnosis and treatment at reasonable cost. It may be especially well suited to overcome some of the other logistical barriers that are unique to this and other remote communities.	[Oxlade, Olivia; Sugarman, Jordan; Pai, Madhukar; Schwartzman, Kevin] McGill Univ, Dept Epidemiol, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Oxlade, Olivia; Pai, Madhukar; Schwartzman, Kevin] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Alvarez, Gonzalo G.] Ottawa Hosp Res Inst, Clin Epidemiol, Ottawa, ON, Canada; [Alvarez, Gonzalo G.] Univ Ottawa, Dept Med, Div Respirol, Ottawa, ON, Canada	McGill University; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Schwartzman, K (corresponding author), McGill Univ, Dept Epidemiol, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.; Schwartzman, K (corresponding author), McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada.	kevin.schwartzman@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Alvarez, Gonzalo G/0000-0003-1562-5305	Canadian Institutes of Health Research [MOP 89918, AOH 126659]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Support was provided by the Canadian Institutes of Health Research MOP 89918 to MP GA & AOH 126659 to KS OO JS [www.cihr.irsc.gc.ca]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GG, 2015, CHEST, V148, P767, DOI 10.1378/chest.14-2948; [Anonymous], 2013, PAT COST EST; [Anonymous], 2008, NUNAVUT NURSES SALAR; Bank of Canada, INFL CALC; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chaisson LH, 2014, CLIN INFECT DIS, V59, P1353, DOI 10.1093/cid/ciu620; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Davis JL, 2014, AM J RESP CRIT CARE, V189, P1551, DOI 10.1164/rccm.201311-1974OC; Goverment of Canada, 2011, CAN CENS; Koppaka R, 2004, TOMANS TUBERCULOSIS, P51; Langley I, 2014, LANCET GLOB HEALTH, V2, pE581, DOI 10.1016/S2214-109X(14)70291-8; McGuire M, 2015, Can Commun Dis Rep, V41, P8, DOI 10.14745/ccdr.v41is2a02; Menzies D., 2014, CANADIAN TUBERCULOSI, V7th; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Public Health Agency of Canada, 2002, 2002 2010 TUB CAN RE; References Public Health Agency of Canada, 2012, TUB CAN 2012 PRER; Schoch OD, 2007, AM J RESP CRIT CARE, V175, P80, DOI 10.1164/rccm.200608-1092OC; Sohn H, 2014, CLIN INFECT DIS; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Sugarman J, 2014, INT J TUBERC LUNG D, V18, P1223, DOI 10.5588/ijtld.14.0163; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2013, TUB DIAGN XPERT MTB	24	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150119	10.1371/journal.pone.0150119	http://dx.doi.org/10.1371/journal.pone.0150119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990299	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800025
J	Zhang, HX; Zheng, YT; Liu, LS; Fu, Q; Li, J; Huang, QS; Liu, HJ; Deng, RH; Wang, CX				Zhang, Huanxi; Zheng, Yitao; Liu, Longshan; Fu, Qian; Li, Jun; Huang, Qingshan; Liu, Huijiao; Deng, Ronghai; Wang, Changxi			Steroid Avoidance or Withdrawal Regimens in Paediatric Kidney Transplantation: A Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; FREE IMMUNOSUPPRESSION; CALCINEURIN INHIBITOR; ACUTE REJECTION; GROWTH; RECIPIENTS; RISK; MULTICENTER; INCREASES; CHILDREN	Background We combined the outcomes of all randomised controlled trials to investigate the safety and efficacy of steroid avoidance or withdrawal (SAW) regimens in paediatric kidney transplantation compared with steroid-based (SB) regimens. Methods A systematic literature search of PubMed, Embase, Cochrane Library, the trials registry and BIOSIS previews was performed. A change in the height standardised Z-score from baseline (Delta HSDS) and acute rejection were the primary endpoints. Results Eight reports from 5 randomised controlled trials were included, with a total of 528 patients. Sufficient evidence of a significant increase in the Delta HSDS was observed in the SAW group (mean difference (MD) = 0.38, 95% confidence interval (CI) 0.07-0.68, P = 0.01), particularly within the first year post-withdrawal (MD = 0.22, 95% CI 0.10-0.35, P = 0.0003) and in the prepubertal recipients (MD = 0.60, 95% CI 0.21-0.98, P = 0.002). There was no significant difference in the risk of acute rejection between the groups (relative risk = 1.04, 95% CI 0.80-1.36, P = 0.77). Conclusions The SAW regimen is justified in select paediatric renal allograft recipients because it provides significant benefits in post-transplant growth within the first year post-withdrawal with minimal effects on the risk of acute rejection, graft function, and graft and patient survival within 3 years post-withdrawal. These select paediatric recipients should have the following characteristics: prepubertal; Caucasian; with primary disease not related to immunological factors; de novo kidney transplant recipient; with low panel reactive antibody.	[Zhang, Huanxi; Zheng, Yitao; Liu, Longshan; Fu, Qian; Li, Jun; Deng, Ronghai; Wang, Changxi] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Qingshan] Sun Yat Sen Univ, Med Informat Inst, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Huijiao] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Deng, RH; Wang, CX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China.	mddrh81@163.com; wangchx@mail.sysu.edu.cn	Liu, Longshan/GWD-0798-2022		Guangdong Provincial Key Laboratory on Organ Donation and Transplant Immunology [2013A061401007]; National Nature Science Foundation of China [81270836, 81300623]; Science and Technology Planning Project of Guangdong Province, China [2014B020212006, 2013B051000020]; Science and Technology Program of Guangzhou, China [2014Y2-00114, 201400000003]	Guangdong Provincial Key Laboratory on Organ Donation and Transplant Immunology; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; Science and Technology Program of Guangzhou, China	This work was supported by the Guangdong Provincial Key Laboratory on Organ Donation and Transplant Immunology (2013A061401007), National Nature Science Foundation of China (No. 81270836, No. 81300623), Science and Technology Planning Project of Guangdong Province, China (2014B020212006, 2013B051000020), and Science and Technology Program of Guangzhou, China (2014Y2-00114, 201400000003). The author who received this funding is CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Benfield MR, 2010, AM J TRANSPLANT, V10, P81, DOI 10.1111/j.1600-6143.2009.02767.x; Borenstein M, 2008, INTRO METAANALYSIS; Castellini Greta, 2014, Trials, V15, P512, DOI 10.1186/1745-6215-15-512; Chavers BM, 2012, PEDIATR TRANSPLANT, V16, P704, DOI 10.1111/j.1399-3046.2012.01714.x; Delucchi A, 2011, PEDIATR TRANSPLANT, V15, P51; Franke D, 2015, CLIN J AM SOC NEPHRO, V10, P127, DOI 10.2215/CJN.02180314; Grenda R, 2010, AM J TRANSPLANT, V10, P828, DOI 10.1111/j.1600-6143.2010.03047.x; Grenda R, 2011, PEDIATR TRANSPLANT, V15, P32, DOI 10.1111/j.1399-3046.2010.01440.x; Grenda R, 2010, PEDIATR TRANSPLANT, V14, P961, DOI 10.1111/j.1399-3046.2010.01403.x; Grenda R, 2010, PEDIATR NEPHROL, V25, P747, DOI 10.1007/s00467-009-1318-3; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hocker B, 2010, NEPHROL DIAL TRANSPL, V25, P617, DOI 10.1093/ndt/gfp506; Hocker B, 2009, TRANSPLANTATION, V87, P934, DOI 10.1097/TP.0b013e31819b6d4a; HRICIK DE, 1993, J AM SOC NEPHROL, V4, P1300; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1910, DOI 10.1681/ASN.V11101910; Keus F, 2009, AM J GASTROENTEROL, V104, P546, DOI 10.1038/ajg.2008.22; Knight SR, 2010, TRANSPLANTATION, V89, P1, DOI 10.1097/TP.0b013e3181c518cc; Langer RM, 2013, PEDIATR TRANSPLANT, V17, P80; Mericq V, 2013, HORM RES PAEDIAT, V79, P88, DOI 10.1159/000347024; Pascual J, 2005, TRANSPL P, V37, P3746, DOI 10.1016/j.transproceed.2005.09.177; Pascual J, 2004, TRANSPLANTATION, V78, P1548, DOI 10.1097/01.TP.0000140969.43761.1F; Pascual J, 2012, NEPHROL DIAL TRANSPL, V27, P825, DOI 10.1093/ndt/gfr374; Penninga L, 2013, COCHRANE DB SYST REV, V5, pD8817; Sarwal MM, 2012, AM J TRANSPLANT, V12, P2719, DOI 10.1111/j.1600-6143.2012.04145.x; Sarwal M, 2008, AM J TRANSPLANT, V8, P192; Schunemann HJ, 2011, COCHRANE HDB SYSTEMA; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Sutherland S, 2009, TRANSPLANTATION, V87, P1744, DOI 10.1097/TP.0b013e3181a5df60; Tan JY, 2006, TRANSPL P, V38, P2054, DOI 10.1016/j.transproceed.2006.06.039; Tanner J.M., 1989, FETUS MAN PHYS GROWT, DOI 10.1002/ajhb.1310030224; Thorlund K., 2011, USER MANUAL TRIAL SE; Webb NJA, 2015, TRANSPLANTATION, V99, P1178, DOI 10.1097/TP.0000000000000498; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013	35	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0146523	10.1371/journal.pone.0146523	http://dx.doi.org/10.1371/journal.pone.0146523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991793	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800017
J	Liu, JP; Tang, ZH; Zhang, J; Chen, Q; Xu, PF; Liu, WZ				Liu, Jinping; Tang, Zhaohui; Zhang, Jin; Chen, Qing; Xu, Pengfei; Liu, Wenzhong			Visual Perception-Based Statistical Modeling of Complex Grain Image for Product Quality Monitoring and Supervision on Assembly Production Line	PLOS ONE			English	Article							COMPUTER-VISION; MACHINE VISION; TEXTURAL FEATURES; CLASSIFICATION; INSPECTION; WAVELET; RECOGNITION; ALGORITHM; DESIGN; SYSTEM	Computer vision as a fast, low-cost, noncontact, and online monitoring technology has been an important tool to inspect product quality, particularly on a large-scale assembly production line. However, the current industrial vision system is far from satisfactory in the intelligent perception of complex grain images, comprising a large number of local homogeneous fragmentations or patches without distinct foreground and background. We attempt to solve this problem based on the statistical modeling of spatial structures of grain images. We present a physical explanation in advance to indicate that the spatial structures of the complex grain images are subject to a representative Weibull distribution according to the theory of sequential fragmentation, which is well known in the continued comminution of ore grinding. To delineate the spatial structure of the grain image, we present a method of multi-scale and omnidirectional Gaussian derivative filtering. Then, a product quality classifier based on sparse multikernel-least squares support vector machine is proposed to solve the low-confidence classification problem of imbalanced data distribution. The proposed method is applied on the assembly line of a food-processing enterprise to classify (or identify) automatically the production quality of rice. The experiments on the real application case, compared with the commonly used methods, illustrate the validity of our method.	[Liu, Jinping; Xu, Pengfei] Hunan Normal Univ, Coll Math & Comp Sci, Changsha, Hunan, Peoples R China; [Liu, Jinping; Xu, Pengfei] Minist Educ China, Key Lab High Performance Comp & Stochast Informat, Changsha, Hunan, Peoples R China; [Liu, Jinping; Tang, Zhaohui; Zhang, Jin; Chen, Qing] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Liu, Wenzhong] Huazhong Univ Sci & Technol, Sch Automat, Wuhan 430074, Peoples R China	Hunan Normal University; Ministry of Education, China; Central South University; Huazhong University of Science & Technology	Tang, ZH (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	ljp202518@163.com	Liu, Jinping/AAM-7723-2021; Chen, QH/GXH-3158-2022	Liu, Jinping/0000-0002-8669-882X; 	National Natural Science Foundation of China [61501183, 61571199, 61472134, 61272337]; Young Teacher Foundation of Hunan Normal University [11405]; Science and Technology Planning Project of Hunan Province of China [2013FJ4051]; Scientific Research Foundation of Educational Commission of Hunan Province of China [13B065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teacher Foundation of Hunan Normal University; Science and Technology Planning Project of Hunan Province of China; Scientific Research Foundation of Educational Commission of Hunan Province of China	This work is supported by the National Natural Science Foundation of China (Nos. 61501183, 61571199, 61472134, and 61272337), http://www.nsfc.gov.cn, and is partly supported by the Young Teacher Foundation of Hunan Normal University under Grant Number 11405, Science and Technology Planning Project of Hunan Province of China under Grant Number 2013FJ4051, and Scientific Research Foundation of Educational Commission of Hunan Province of China under Grant Number 13B065.	Arce SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02266; Aujol JF, 2006, INT J COMPUT VISION, V67, P111, DOI 10.1007/s11263-006-4331-z; Brosnan T, 2002, COMPUT ELECTRON AGR, V36, P193, DOI 10.1016/S0168-1699(02)00101-1; Brosnan T, 2004, J FOOD ENG, V61, P3, DOI 10.1016/S0260-8774(03)00183-3; BROWN WK, 1989, J ASTROPHYS ASTRON, V10, P89, DOI 10.1007/BF02714980; BROWN WK, 1995, J APPL PHYS, V78, P2758, DOI 10.1063/1.360073; Cho CS, 2005, IEEE T IND ELECTRON, V52, P1073, DOI 10.1109/TIE.2005.851648; Choudhary R, 2008, BIOSYST ENG, V99, P330, DOI 10.1016/j.biosystemseng.2007.11.013; Cocchi M, 2005, ANAL CHIM ACTA, V544, P100, DOI 10.1016/j.aca.2005.02.075; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Fujii K, 2003, PSYCHOL RES-PSYCH FO, V67, P197, DOI 10.1007/s00426-002-0113-6; Gao LX, 2010, SENSORS-BASEL, V10, P4602, DOI 10.3390/s100504602; Geusebroek JM, 2005, INT J COMPUT VISION, V62, P7, DOI 10.1007/s11263-005-4632-7; Ghahramani Z, 2015, NATURE, V521, P452, DOI 10.1038/nature14541; Golnabi H, 2007, ROBOT CIM-INT MANUF, V23, P630, DOI 10.1016/j.rcim.2007.02.005; Guo ZH, 2010, PATTERN RECOGN, V43, P706, DOI 10.1016/j.patcog.2009.08.017; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He MF, 2013, MINER ENG, V53, P203, DOI 10.1016/j.mineng.2013.08.011; Huang W, 2011, SENSORS-BASEL, V11, P506, DOI 10.3390/s110100506; Jackman P, 2013, TRENDS FOOD SCI TECH, V29, P35, DOI 10.1016/j.tifs.2012.08.008; Kassim AA, 2007, IMAGE VISION COMPUT, V25, P1080, DOI 10.1016/j.imavis.2006.05.024; KOHONEN T, 1990, INT JOINT C NEUR NET, V1, P545; Kumar A, 2008, IEEE T IND ELECTRON, V55, P348, DOI 10.1109/TIE.1930.896476; Kurtulmus F, 2015, EXPERT SYST APPL, V42, P1880, DOI 10.1016/j.eswa.2014.10.003; Liu JP, 2013, INT J COMPUT INT SYS, V6, P969, DOI 10.1080/18756891.2013.809938; Liu JP, 2013, MINER ENG, V45, P128, DOI 10.1016/j.mineng.2013.02.003; Liu Jinping, 2010, Chinese Journal of Scientific Instrument, V31, P1769; Majumdar S, 2000, T ASAE, V43, P1681, DOI 10.13031/2013.3068; Maropoulos PG, 2014, INT J ADV MANUF TECH, V70, P621, DOI 10.1007/s00170-013-5283-4; Materka A, 1998, TEXTURE ANAL METHODS, P9; Molleda J, 2014, IEEE IND APPL MAG, V20, P35, DOI 10.1109/MIAS.2013.2288385; Povlow BR, 1993, TEXTURE CLASSIFICATI, P642; Rahman A., 2012, INT J COMPUTATIONAL, V2, P27; Simi M, 2013, IEEE-ASME T MECH, V18, P1140, DOI 10.1109/TMECH.2012.2198830; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; TSUGAWA S, 1994, IEEE T IND ELECTRON, V41, P398, DOI 10.1109/41.303790; Wilde M, 2014, IEEE T HUM-MACH SYST, V44, P200, DOI 10.1109/THMS.2013.2295298; Xian GM, 2010, EXPERT SYST APPL, V37, P6737, DOI 10.1016/j.eswa.2010.02.067; Xie Y, 2014, OPT LASER ENG, V52, P218, DOI 10.1016/j.optlaseng.2013.06.006; Yadav BK, 2001, COMPUT ELECTRON AGR, V33, P19, DOI 10.1016/S0168-1699(01)00169-7; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zeng XY, 2005, IEEE T NEURAL NETWOR, V16, P1541, DOI 10.1109/TNN.2005.852239; Zhang BH, 2014, FOOD RES INT, V62, P326, DOI 10.1016/j.foodres.2014.03.012; Zhang Y, 2010, PATTERN RECOGN LETT, V31, P2033, DOI 10.1016/j.patrec.2010.05.030	47	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0146484	10.1371/journal.pone.0146484	http://dx.doi.org/10.1371/journal.pone.0146484			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986726	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300009
J	Werbrouck, E; Van Gansbeke, D; Vanreusel, A; De Troch, M				Werbrouck, Eva; Van Gansbeke, Dirk; Vanreusel, Ann; De Troch, Marleen			Temperature Affects the Use of Storage Fatty Acids as Energy Source in a Benthic Copepod (Platychelipus littoralis, Harpacticoida)	PLOS ONE			English	Article							BIOCHEMICAL-COMPOSITION; SELECTIVE MOBILIZATION; MICROBIAL BIOMASS; STARVATION; LIPIDS; METABOLISM; ZOOPLANKTON; DYNAMICS; RESERVES; DAPHNIA	The utilization of storage lipids and their associated fatty acids (FA) is an important means for organisms to cope with periods of food shortage, however, little is known about the dynamics and FA mobilization in benthic copepods (order Harpacticoida). Furthermore, lipid depletion and FA mobilization may depend on the ambient temperature. Therefore, we subjected the temperate copepod Platychelipus littoralis to several intervals (3, 6 and 14 days) of food deprivation, under two temperatures in the range of the normal habitat temperature (4, 15 degrees C) and under an elevated temperature (24 degrees C), and studied the changes in FA composition of storage and membrane lipids. Although bulk depletion of storage FA occurred after a few days of food deprivation under 4 degrees C and 15 degrees C, copepod survival remained high during the experiment, suggesting the catabolization of other energy sources. Ambient temperature affected both the degree of FA depletion and the FA mobilization. In particular, storage FA were more exhausted and FA mobilization was more selective under 15 degrees C compared with 4 degrees C. In contrast, depletion of storage FA was limited under an elevated temperature, potentially due to a switch to partial anaerobiosis. Food deprivation induced selective DHA retention in the copepod's membrane, under all temperatures. However, prolonged exposure to heat and nutritional stress eventually depleted DHA in the membranes, and potentially induced high copepod mortality. Storage lipids clearly played an important role in the short-term response of the copepod P. littoralis to food deprivation. However, under elevated temperature, the use of storage FA as an energy source is compromised.	[Werbrouck, Eva; Van Gansbeke, Dirk; Vanreusel, Ann; De Troch, Marleen] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium	Ghent University	Werbrouck, E (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium.	eva.werbrouck@ugent.be	De Troch, Marleen/AAB-9809-2019	De Troch, Marleen/0000-0002-6800-0299	Ghent University [BOF-GOA 01GA1911W]; Research Foundation of Flanders [31523814, FWO12/ASP/319]	Ghent University(Ghent University); Research Foundation of Flanders(FWO)	EW is a fellow with the Research Foundation of Flanders (no. FWO12/ASP/319; http://www.fwo.be/en/). This research was further financed by Ghent University (BOF-GOA 01GA1911W). The FA analyses were supported by the Research Foundation of Flanders in the form of a research grant (31523814 - Fatty acids as dietary tracers in benthic food webs) awarded to MDT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir S, 2008, J EXP MAR BIOL ECOL, V354, P1, DOI 10.1016/j.jembe.2007.08.024; Abele D, 2002, J EXP BIOL, V205, P1831; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; Arts MT, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P71; Azovsky AI, 2005, MAR BIOL, V148, P327, DOI 10.1007/s00227-005-0086-2; BAMSTEDT U, 1978, SARSIA, V63, P225, DOI 10.1080/00364827.1978.10411344; BLANCHARD GF, 1990, MAR ECOL PROG SER, V68, P101, DOI 10.3354/meps068101; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CASTELLINI MA, 1992, EXPERIENTIA, V48, P575, DOI 10.1007/BF01920242; Chapkin RS, 2002, LIPIDS, V37, P193, DOI 10.1007/s11745-002-0880-8; Christie W., 1989, GAS CHROMATOGRAPHY L; Clarke KR, 2006, PRIMER V6 USER MANUA; Cnudde C., 2013, TROPHIC ECOLOGY INTE; Cnudde C, 2015, MAR ECOL PROG SER, V524, P225, DOI 10.3354/meps11161; Combe JP, 2005, REMOTE SENS ENVIRON, V98, P371, DOI 10.1016/j.rse.2005.07.010; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; De Troch M, 2012, MAR ECOL PROG SER, V465, P53, DOI 10.3354/meps09920; EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6; ELENDT BP, 1990, J CRUSTACEAN BIOL, V10, P79, DOI 10.2307/1548671; Evjemo JO, 2001, AQUACULTURE, V193, P65, DOI 10.1016/S0044-8486(00)00470-1; FINDLAY RH, 1989, APPL ENVIRON MICROB, V55, P2888, DOI 10.1128/AEM.55.11.2888-2893.1989; Garcia-Esquivel Z, 2002, COMP BIOCHEM PHYS A, V133, P63, DOI 10.1016/S1095-6433(02)00112-5; GIERE O, 1993, MEIOBENTHOLOGY MICRO; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Hagen W, 2001, ZOOL-ANAL COMPLEX SY, V104, P313, DOI 10.1078/0944-2006-00037; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Helland S, 2003, MAR BIOL, V143, P297, DOI 10.1007/s00227-003-1092-x; Hervant F, 1999, J EXP BIOL, V202, P3587; HICKS GRF, 1983, OCEANOGR MAR BIOL, V21, P67; Hulbert AJ, 2014, J COMP PHYSIOL B, V184, P149, DOI 10.1007/s00360-013-0786-8; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Jesus B, 2005, ESTUAR COAST SHELF S, V65, P30, DOI 10.1016/j.ecss.2005.05.005; Johnston DJ, 2004, COMP BIOCHEM PHYS B, V138, P137, DOI 10.1016/j.cbpc.2004.02.013; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; Koussoroplis AM, 2014, LIMNOL OCEANOGR, V59, P947, DOI 10.4319/lo.2014.59.3.0947; Lang K, 1948, MONOGRPAHIE HARPACTI, V2; LEE RF, 1970, J LIPID RES, V11, P237; LEE RF, 1975, COMP BIOCHEM PHYS B, V52, P265, DOI 10.1016/0305-0491(75)90063-2; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; MAYZAUD P, 1976, MAR BIOL, V37, P47, DOI 10.1007/BF00386778; Mezek T, 2010, AQUAT ECOL, V44, P397, DOI 10.1007/s10452-009-9299-7; NILSSON P, 1987, MAR ECOL PROG SER, V39, P267, DOI 10.3354/meps039267; Olsen Y, 2014, AQUACULTURE, V428, P203, DOI 10.1016/j.aquaculture.2014.03.002; Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Pond DW, 2012, J PLANKTON RES, V34, P443, DOI 10.1093/plankt/fbs027; RACLOT T, 1995, J LIPID RES, V36, P2164; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; Rychek EA, 2005, LIPIDS, V40, P599, DOI 10.1007/s11745-005-1421-1; Sahan E, 2007, AQUAT MICROB ECOL, V47, P253, DOI 10.3354/ame047253; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Schlechtriem C, 2008, J GREAT LAKES RES, V34, P143, DOI 10.3394/0380-1330(2008)34[143:EOLFOT]2.0.CO;2; Schlechtriem C, 2006, LIPIDS, V41, P397, DOI 10.1007/s11745-006-5111-9; Schulte PM, 2015, J EXP BIOL, V218, P1856, DOI 10.1242/jeb.118851; Shields RJ, 1999, J NUTR, V129, P1186, DOI 10.1093/jn/129.6.1186; Sokolova IM, 2008, CLIM RES, V37, P181, DOI 10.3354/cr00764; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Stuart JA, 1998, AM J PHYSIOL-REG I, V275, pR1977, DOI 10.1152/ajpregu.1998.275.6.R1977; Suderman K, 1998, MAR ECOL PROG SER, V164, P245, DOI 10.3354/meps164245; TESSIER AJ, 1983, LIMNOL OCEANOGR, V28, P667, DOI 10.4319/lo.1983.28.4.0667; TYLER S, 1984, J EXP ZOOL, V232, P1, DOI 10.1002/jez.1402320102; van Dooremalen C, 2010, J INSECT PHYSIOL, V56, P178, DOI 10.1016/j.jinsphys.2009.10.002; VANDENBERGHE W, 1981, MAR ECOL PROG SER, V4, P213, DOI 10.3354/meps004213; Veit-Kohler G, 2010, MAR BIOL, V157, P1819, DOI 10.1007/s00227-010-1454-0; VIRTUE P, 1993, MAR BIOL, V117, P441; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Williams JL, 2004, MAR BIOL, V144, P335, DOI 10.1007/s00227-003-1189-2; Wyckmans M, 2007, J EXP MAR BIOL ECOL, V345, P119, DOI 10.1016/j.jembe.2007.02.002	75	21	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151779	10.1371/journal.pone.0151779	http://dx.doi.org/10.1371/journal.pone.0151779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986852	Green Published, gold			2022-12-27	WOS:000372580300130
J	Yu, WY; Wardrop, NA; Bain, RES; Lin, YZ; Zhang, C; Wright, JA				Yu, Weiyu; Wardrop, Nicola A.; Bain, Robert E. S.; Lin, Yanzhao; Zhang, Ce; Wright, Jim A.			A Global Perspective on Drinking-Water and Sanitation Classification: An Evaluation of Census Content	PLOS ONE			English	Article								Following the recent expiry of the United Nations' 2015 Millennium Development Goals (MDGs), new international development agenda covering 2030 water, sanitation and hygiene (WASH) targets have been proposed, which imply new demands on data sources for monitoring relevant progress. This study evaluates drinking-water and sanitation classification systems from national census questionnaire content, based upon the most recent international policy changes, to examine national population census's ability to capture drinking-water and sanitation availability, safety, accessibility, and sustainability. In total, 247 censuses from 83 low income and lower-middle income countries were assessed using a scoring system, intended to assess harmonised water supply and sanitation classification systems for each census relative to the typology needed to monitor the proposed post-2015 indicators of WASH targets. The results signal a lack of international harmonisation and standardisation in census categorisation systems, especially concerning safety, accessibility, and sustainability of services in current census content. This suggests further refinements and harmonisation of future census content may be necessary to reflect ambitions for post-2015 monitoring.	[Yu, Weiyu; Wardrop, Nicola A.; Zhang, Ce; Wright, Jim A.] Univ Southampton, Geog & Environm, Southampton, Hants, England; [Bain, Robert E. S.] United Nations Childrens Fund, New York, NY USA; [Lin, Yanzhao] Yunnan Univ, Resource Environm & Earth Sci, Kunming City, Yunnan Province, Peoples R China	University of Southampton; UNICEF; Yunnan University	Yu, WY; Wright, JA (corresponding author), Univ Southampton, Geog & Environm, Southampton, Hants, England.	yurhcp@126.com; J.A.Wright@soton.ac.uk	Yu, Weiyu/AAV-4385-2020; Zhang, Ce/J-4906-2019; Wright, Jim/C-7881-2013	Zhang, Ce/0000-0001-5100-3584; Wright, Jim/0000-0002-8842-2181	Medical Research Council, UK [MR/J012343/1]; MRC [MR/J012343/1] Funding Source: UKRI; Medical Research Council [MR/J012343/1] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NAW was funded by the Medical Research Council, UK (project MR/J012343/1), web address: http://www.mrc.ac.uk/. No other individuals employed or contracted by the funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, INT PUBL US MICR SER; [Anonymous], 2015, JMP GREEN PAP GLOB M; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Esteve A, 2003, HIST METHOD, V36, P66, DOI 10.1080/01615440309601216; Flores O B, 2015, SOC INDIC RES, V2, P1; Gunther I, 2010, POLICY RES WORKING P, V5275; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Morning A, 2008, POPUL RES POLICY REV, V27, P239, DOI 10.1007/s11113-007-9062-5; Romilly G, 2015, FINANCING FUTURE INT; Stoler J, 2012, J WATER SANIT HYG DE, V2, P223, DOI 10.2166/washdev.2012.104; United Nations Department of Economic and Social Affairs, 2010, HDB POP HOUS CENS ED; United Nations General Assembly, 2010, HUM RIGHT WAT SAN A, P3; United Nations General Assembly, 2014, REP OP WORK GROUP GE; Van Koppen B, 2006, MULTIPLE USE WATERS; WHO Regional Office for Europe, 2014, WHO EXP M METH TOOLS, P12; WHO UNICEF, 2011, REP 1 CONS POST 2015; WHO/UNICEF, 2006, COR QUEST DRINK WAT; WHO UNICEF, 2014, WHO UNICEF JMP TASK; WHO UNICEF, 2012, JMP WORK GROUP EQ NO; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; WHO UNICEF, 2015, PROGR WAT SAN 2015 U; WHO UNICEF, 2012, REP 2 CONS POST 2015; World Bank, 2014, ANN REP REG; World Bank, 2014, UPD INC CLASS; World Health Organization United Nations Children's Fund, IMPR UN WAT SAN FAC; Yu WY, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0113-3	26	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151645	10.1371/journal.pone.0151645	http://dx.doi.org/10.1371/journal.pone.0151645			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986472	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000372580300103
J	Lu, MC; Chang, SC; Huang, KY; Koo, M; Lai, NS				Lu, Ming-Chi; Chang, Shou-Chih; Huang, Kuang-Yung; Koo, Malcolm; Lai, Ning-Sheng			Higher Risk of Thyroid Disorders in Young Patients with Type 1 Diabetes: A 12-Year Nationwide, Population-Based, Retrospective Cohort Study	PLOS ONE			English	Article							JOINT GENETIC SUSCEPTIBILITY; AUTOIMMUNE-THYROIDITIS; CHINESE CHILDREN; ADOLESCENTS; DISEASE; HYPOTHYROIDISM; EPIDEMIOLOGY; GENDER; AGE	Background The association between type 1 diabetes and thyroid autoimmunity has been studied in various populations, but seldom on Taiwanese children and adolescents. Therefore, the aim of this study was to examine the incidence of autoimmune thyroid disorders in Taiwanese children and adolescent patients with type 1 diabetes, based on data from a nationwide, population-based, health claims database. Methods Using Taiwan's National Health Insurance Research Database, we identified 3,652 patients with type 1 diabetes between 2000 and 2012. A comparison cohort was assembled, which consisted of five patients without type 1 diabetes, based on frequency matching for sex and 3-year age interval, for each patient with type 1 diabetes. Both groups were followed until diagnosis of thyroid disorders or the end of the follow-up period. Poisson regression models were used to calculate incidence rate ratios for the thyroid disorders between the type 1 diabetes cohort and the comparison cohort. Results Simple and unspecified goiter (International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM] code 240), thyrotoxicosis (ICD-9-CM code 242), unspecified hypothyroidism (ICD-9-CM code 244.9), and thyroiditis (ICD-9-CM code 245) showed significantly higher incidences in the type 1 diabetes cohort compared with the control cohort, with incidence rate ratios of 2.74, 6.95, 6.54, 16.07, respectively. Conclusions Findings from this nationwide, population-based cohort study showed that the incidences of autoimmune thyroid disorders were significantly higher in Taiwanese children and adolescents with type 1 diabetes compared with those without the disease.	[Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi 62247, Taiwan; [Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien 97004, Taiwan; [Chang, Shou-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Pediat, Chiayi 62247, Taiwan; [Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi 62247, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 3G3, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Lai, NS (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi 62247, Taiwan.; Lai, NS (corresponding author), Tzu Chi Univ, Sch Med, Hualien 97004, Taiwan.; Koo, M (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi 62247, Taiwan.; Koo, M (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 3G3, Canada.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Administration NHR, 2016, NAT HLTH INS RES DAT; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Bando Y, 2002, EXP CLIN ENDOCR DIAB, V110, P408, DOI 10.1055/s-2002-36427; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Chuang LM, 1996, CLIN ENDOCRINOL, V45, P631, DOI 10.1046/j.1365-2265.1996.00857.x; Riquetto ADC, 2015, DIABETES RES CLIN PR, V110, pE9, DOI 10.1016/j.diabres.2015.07.003; Danne T, 2007, ARCH DIS CHILD, V92, P1015, DOI 10.1136/adc.2006.094904; Denzer C, 2013, EUR J ENDOCRINOL, V168, P601, DOI 10.1530/EJE-12-0703; Fortunato RS, 2014, J ENDOCRINOL, V221, pR31, DOI 10.1530/JOE-13-0588; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; Franzese A, 2000, DIABETES CARE, V23, P1201, DOI 10.2337/diacare.23.8.1201; Goodwin G, 2006, DIABETES CARE, V29, P1397, DOI 10.2337/dc06-0098; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Johnson JL., 2006, DIABETES SPECTRUM, V19, P148, DOI [10.2337/diaspect.19.3.148, DOI 10.2337/DIASPECT.19.3.148]; Kakleas K, 2015, AUTOIMMUN REV, V14, P781, DOI 10.1016/j.autrev.2015.05.002; Kordonouri O, 2005, ARCH DIS CHILD, V90, P411, DOI 10.1136/adc.2004.056424; Kordonouri O, 2002, DIABETES CARE, V25, P1346, DOI 10.2337/diacare.25.8.1346; Lin WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086172; Nandi-Munshi D, 2015, PEDIATR NEUROL, V52, P373, DOI 10.1016/j.pediatrneurol.2014.12.005; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Omar MA, 2014, ALEX J MED, V50, P77, DOI 10.1016/j.ajme.2013.09.001; Park Yong Soo, 2000, Korean Journal of Internal Medicine, V15, P202; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Piatkowska Ewa, 2011, Pediatr Endocrinol Diabetes Metab, V17, P173; Triolo TM, 2011, DIABETES CARE, V34, P1211, DOI 10.2337/dc10-1756; TSAI WY, 1993, DIABETES CARE, V16, P1314, DOI 10.2337/diacare.16.9.1314; Villano MJB, 2009, J CLIN ENDOCR METAB, V94, P1458, DOI 10.1210/jc.2008-2193; WONG GWK, 1993, DIABETES CARE, V16, P1315, DOI 10.2337/diacare.16.9.1315	29	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152168	10.1371/journal.pone.0152168	http://dx.doi.org/10.1371/journal.pone.0152168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007574	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200102
J	Pinter, D; Beckmann, C; Koini, M; Pirker, E; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C				Pinter, Daniela; Beckmann, Christian; Koini, Marisa; Pirker, Eva; Filippini, Nicola; Pichler, Alexander; Fuchs, Siegrid; Fazekas, Franz; Enzinger, Christian			Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; WORKING-MEMORY; FMRI; ACTIVATION; NETWORK; ASSOCIATION; DYSFUNCTION; IMPAIRMENT; PATTERNS; MOTOR	Given increasing efforts to use resting-state fMRI (rfMRI) as a biomarker of disease progression in multiple sclerosis (MS) we here explored the reproducibility of longitudinal rfMRI over three months in patients with clinically and radiologically stable MS. To pursue this aim, two approaches were applied in nine rfMRI networks: First, the intraclass correlation coefficient (ICC 3,1) was assessed for the mean functional connectivity maps across the entire network and a region of interest (ROI). Second, the ratio of overlap between Z-thresholded connectivity maps for each network was assessed. We quantified between-session functional reproducibility of rfMRI for 20 patients with stable MS and 14 healthy controls (HC). Nine rfMRI networks (RSNs) were examined at baseline and after 3 months of followup: three visual RSNs, the default-mode network, sensorimotor-, auditory-, executive control, and the left and right fronto-parietal RSN. ROI analyses were constrained to thresholded overlap masks for each individual (Z>0) at baseline and follow-up. In both stable MS and HC mean functional connectivity across the entire network did not reach acceptable ICCs for several networks (ICC<0.40) but we found a high reproducibility of ROI ICCs and of the ratio of overlap. ROI ICCs of all nine networks were between 0.98 and 0.99 for HC and ranged from 0.88 to 0.99 in patients with MS, respectively. The ratio of overlap for all networks was similar for both groups, ranging from 0.60 to 0.75. Our findings attest to a high reproducibility of rfMRI networks not only in HC but also in patients with stable MS when applying ROI analysis. This supports the utility of rfMRI to monitor functional changes related to disease progression or therapeutic interventions in MS.	[Pinter, Daniela; Koini, Marisa; Pirker, Eva; Pichler, Alexander; Fuchs, Siegrid; Fazekas, Franz; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Beckmann, Christian] Radboud Univ Nijmegen, Donders Inst, Cognit Neurosci Dept, NL-6525 ED Nijmegen, Netherlands; [Beckmann, Christian] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Filippini, Nicola] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct MRI Brain, Oxford, England; [Enzinger, Christian] Med Univ Graz, Dept Radiol, Div Neuroradiol, Graz, Austria	Medical University of Graz; Radboud University Nijmegen; Radboud University Nijmegen; University of Oxford; Medical University of Graz	Pinter, D (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	daniela.pinter@medunigraz.at	Filippini, Nicola/H-6869-2013; Filippini, Nicola/Q-5250-2019; Beckmann, Christian F./E-6374-2012	Filippini, Nicola/0000-0003-1513-5269; Filippini, Nicola/0000-0003-1513-5269; Beckmann, Christian F./0000-0002-3373-3193; Pinter, Daniela/0000-0003-3138-5225	Biogen Idec.; HDH Wills Charitable Trust; UK Wellcome Trust; Dutch Organisation for Scientific Research NOW	Biogen Idec.(Biogen); HDH Wills Charitable Trust; UK Wellcome Trust(Wellcome Trust); Dutch Organisation for Scientific Research NOW	This study was supported by an unrestricted research grant provided by Biogen Idec. The sponsor had no influence on the design, data collection, analysis and interpretation of the results. NF is funded by the HDH Wills 1965 Charitable Trust. CFB acknowledges funding from the UK Wellcome Trust and the Dutch Organisation for Scientific Research NOW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2006, NEUROIMAGE, V29, P1000, DOI 10.1016/j.neuroimage.2005.08.010; Bosnell R, 2008, NEUROIMAGE, V42, P603, DOI 10.1016/j.neuroimage.2008.05.005; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Clement F, 2009, HUM BRAIN MAPP, V30, P4033, DOI 10.1002/hbm.20827; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cruz-Gomez AJ, 2013, MULT SCLER, V2013, DOI 10.1177/; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eaton KP, 2008, NEUROIMAGE, V41, P311, DOI 10.1016/j.neuroimage.2008.02.033; Enzinger C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00056; Enzinger C, 2012, NEUROLOGY, V79, P1416, DOI 10.1212/WNL.0b013e31826d600d; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Forsyth JK, 2014, NEUROIMAGE, V97, P41, DOI 10.1016/j.neuroimage.2014.04.027; Griffanti L, 2016, NEUROIMAGE, V124, P704, DOI 10.1016/j.neuroimage.2015.09.021; H?rting, 2000, WECHSLER GEDACHTNIST; Janssen AL, 2013, NEUROPSYCHOLOGIA, P1, DOI [10.1016/j.neuropsychologia.2013.08.010, DOI 10.1016/J.NEUROPSYCHOL0GIA.2013.08.010]; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jovicich J, 2016, NEUROIMAGE, V124, P442, DOI 10.1016/j.neuroimage.2015.07.010; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Lee JN, 2010, NEUROIMAGE, V49, P1282, DOI 10.1016/j.neuroimage.2009.09.072; Loitfelder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093715; Marshall I, 2004, RADIOLOGY, V233, P868, DOI 10.1148/radiol.2333031782; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Plummer DL., 1992, REV NEU RORADIOL, V5, P489, DOI 10.1177/197140099200500413; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Raemaekers M, 2007, NEUROIMAGE, V36, P532, DOI 10.1016/j.neuroimage.2007.03.061; Rao S, 1990, MANUAL BRIEF REPEATA; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; Sacco R, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/857807; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	47	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152158	10.1371/journal.pone.0152158	http://dx.doi.org/10.1371/journal.pone.0152158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007237	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200100
J	Chu, LY; Wang, YF; Cheng, HH; Kuo, CC; Wu, KK				Chu, Ling-Yun; Wang, Yi-Fu; Cheng, Huei-Hsuan; Kuo, Cheng-Chin; Wu, Kenneth K.			Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation	PLOS ONE			English	Article							VE-CADHERIN; TRYPTOPHAN-HYDROXYLASE; VASCULAR-PERMEABILITY; TNF-ALPHA; TYROSINE PHOSPHORYLATION; MONOLAYER PERMEABILITY; ADHERENS JUNCTIONS; CELL PERMEABILITY; EXPRESSION; KINASE	The endothelial junction is tightly controlled to restrict the passage of blood cells and solutes. Disruption of endothelial barrier function by bacterial endotoxins, cytokines or growth factors results in inflammation and vascular damage leading to vascular diseases. We have identified 5-methoxytryptophan (5-MTP) as an anti-inflammatory factor by metabolomic analysis of conditioned medium of human fibroblasts. Here we postulated that endothelial cells release 5-MTP to protect the barrier function. Conditioned medium of human umbilical vein endothelial cells (HUVECs) prevented endothelial hyperpermeability and VE-cadherin downregulation induced by VEGF, LPS and cytokines. We analyzed the metabolomic profile of HUVEC conditioned medium and detected 5-MTP but not melatonin, serotonin or their catabolites, which was confirmed by enzyme-linked immunosorbent assay. Addition of synthetic pure 5-MTP preserved VE-cadherin and maintained barrier function despite challenge with pro-inflammatory mediators. Tryptophan hydroxylase-1, an enzyme required for 5-MTP biosynthesis, was downregulated in HUVECs by pro-inflammatory mediators and it was accompanied by reduction of 5-MTP. 5-MTP protected VE-cadherin and prevented endothelial hyperpermeability by blocking p38 MAPK activation. A chemical inhibitor of p38 MAPK, SB202190, exhibited a similar protective effect as 5-MTP. To determine whether 5-MTP prevents vascular hyperpermeability in vivo, we evaluated the effect of 5-MTP administration on LPS-induced murine microvascular permeability with Evans blue. 5-MTP significantly prevented Evans blue dye leakage. Our findings indicate that 5-MTP is a new class of endothelium-derived molecules which protects endothelial barrier function by blocking p38 MAPK.	[Chu, Ling-Yun; Cheng, Huei-Hsuan; Kuo, Cheng-Chin; Wu, Kenneth K.] China Med Univ Hosp, Metabol Med Res Ctr, Taichung, Taiwan; [Wang, Yi-Fu; Kuo, Cheng-Chin; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Wang, Yi-Fu] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Cheng, Huei-Hsuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kuo, Cheng-Chin; Wu, Kenneth K.] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; National Tsing Hua University; National Tsing Hua University	Wu, KK (corresponding author), China Med Univ Hosp, Metabol Med Res Ctr, Taichung, Taiwan.; Wu, KK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.; Wu, KK (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Wu, KK (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.; Wu, KK (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	kkgo@nhri.org.tw			Ministry of Science and Technology of Taiwan [MOST 103-2321-B-400-005, 103-2321-B-039-003]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan grants MOST 103-2321-B-400-005 (to CCK), and 103-2321-B-039003 (to KKW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Cash CD, 1998, GEN PHARMACOL, V30, P569, DOI 10.1016/S0306-3623(97)00308-X; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088507; Cheng HH, 2012, P NATL ACAD SCI USA, V109, P13231, DOI 10.1073/pnas.1209919109; Chu LY, 2015, PROSTAG OTH LIPID M, V118, P19, DOI 10.1016/j.prostaglandins.2015.04.006; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; DARMON MC, 1988, J NEUROCHEM, V51, P312, DOI 10.1111/j.1471-4159.1988.tb04871.x; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c; Deng WG, 2002, FASEB J, V16, P1286, DOI 10.1096/fj.01-0844fje; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; Dong FY, 2014, BIOCHEM BIOPH RES CO, V450, P447, DOI 10.1016/j.bbrc.2014.05.140; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Liu TG, 2012, J CELL PHYSIOL, V227, P1438, DOI 10.1002/jcp.22859; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Min JK, 2005, J IMMUNOL, V175, P531, DOI 10.4049/jimmunol.175.1.531; Ni W, 2008, BRIT J PHARMACOL, V154, P663, DOI 10.1038/bjp.2008.111; Niwa K, 2001, FREE RADICAL RES, V35, P519, DOI 10.1080/10715760100301531; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Rahman MS, 2009, NEUROSCIENCE, V158, P751, DOI 10.1016/j.neuroscience.2008.10.029; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wu KK, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-17; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Yuan XC, 2011, J PINEAL RES, V51, P220, DOI 10.1111/j.1600-079X.2011.00882.x	42	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152166	10.1371/journal.pone.0152166	http://dx.doi.org/10.1371/journal.pone.0152166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002329	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400089
J	Morioka, MS; Kitazume, M; Osaki, K; Wood, J; Tanaka, Y				Morioka, Masaki Suimye; Kitazume, Miwako; Osaki, Ken; Wood, Jonathan; Tanaka, Yujiro			Filling in the Gap of Human Chromosome 4: Single Molecule Real Time Sequencing of Macrosatellite Repeats in the Facioscapulohumeral Muscular Dystrophy Locus	PLOS ONE			English	Article							HUMAN GENOME; D4Z4; DNA	A majority of facioscapulohumeral muscular dystrophy (FSHD) is caused by contraction of macrosatellite repeats called D4Z4 that are located in the subtelomeric region of human chromosome 4q35. Sequencing the FSHD locus has been technically challenging due to its long size and nearly identical nature of repeat elements. Here we report sequencing and partial assembly of a BAC clone carrying an entire FSHD locus by a single molecule real time (SMRT) sequencing technology which could produce long reads up to about 18 kb containing D4Z4 repeats. De novo assembly by Hierarchical Genome Assembly Process 1 (HGAP.1) yielded a contig of 41 kb containing all but a part of the most distal D4Z4 element. The validity of the sequence model was confirmed by an independent approach employing anchored multiple sequence alignment by Kalign using reads containing unique flanking sequences. Our data will provide a basis for further optimization of sequencing and assembly conditions of D4Z4.	[Morioka, Masaki Suimye] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan; [Kitazume, Miwako; Osaki, Ken] Tomy Digital Biol, Bunkyo Ku, SF Bldg 7F,1-4-6 Nezu, Tokyo 1130031, Japan; [Wood, Jonathan] Wellcome Trust Sanger Inst, Genome Reference Consortium, Genome Reference Informat T135, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Tanaka, Yujiro] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Genome Struct & Regulat, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan; [Tanaka, Yujiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU); Wellcome Trust Sanger Institute; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Genome Struct & Regulat, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.; Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.	yujirotanaka@gmail.com			Ministry of Health, Labour, and Welfare in Japan [H24-Neuro, Muscle-General-004]; Ministry of Education, Culture, Sports, Science Technology [26460408]	Ministry of Health, Labour, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a grant from the Ministry of Health, Labour, and Welfare in Japan (www.mhlw.go.jp) to YT (H24-Neuro, Muscle-General-004), and a grant from the Ministry of Education, Culture, Sports, Science & Technology (www.mext.go.jp) in Japan to YT (26460408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Rossi M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-8; Schaap M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-143; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26	20	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151963	10.1371/journal.pone.0151963	http://dx.doi.org/10.1371/journal.pone.0151963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002334	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400061
J	Chen, XY; Chen, KL; He, JL; Yao, K				Chen, Xinyi; Chen, Kailin; He, Jiliang; Yao, Ke			Comparing the Curative Effects between Femtosecond Laser-Assisted Cataract Surgery and Conventional Phacoemulsification Surgery: A Meta-Analysis	PLOS ONE			English	Article							ENDOTHELIAL-CELL LOSS; OPTICAL COHERENCE TOMOGRAPHY; LENS FRAGMENTATION; CAPSULOTOMY; POWER; TIME; MICROINCISION; PARAMETERS; INCISION; OUTCOMES	Purpose To compare the outcomes of femtosecond laser-assisted cataract surgery (FLACS) with those of conventional phacoemulsification surgery (CPS) for age-related cataracts. Methods A comprehensive literature search of PubMed, EMBASE, and the Cochrane Controlled Trials Register was conducted to identify randomized controlled trials (RCT) and comparative cohort studies comparing FLACS with CPS. Endothelial cell loss percentage (ECL%), central corneal thickness (CCT), corrected and uncorrected distant visual acuity (CDVA and UDVA), and mean absolute error (MAE) of refraction were used as primary outcomes. Secondary outcomes included surgically induced astigmatism (SIA), mean effective phacoemulsification time (EPT), phacoemulsification power and circularity of the capsulorhexis. Results Nine RCTs and fifteen cohort studies including 4,903 eyes (2,861 in the FLACS group and 2,072 in the CPS group) were identified. There were significant differences between the two groups in ECL% at one week, about one month and three months postoperatively, in CCT at one day, about one month postoperatively and at the final follow-up, in CDVA at one week postoperatively, and in UDVA at the final follow-up. Significant differences were also observed in MAE, EPT, phacoemulsification power, and the circularity of capsulorhexis. However, no significant differences were observed in CDVA at one week postoperatively or in surgically induced astigmatism. Conclusions Compared to CPS, FLACS is a safer and more effective method for reducing endothelial cell loss and postoperative central corneal thickening as well as achieving better and faster visual rehabilitation and refractive outcomes. However, there is no difference in final CDVA and surgically induced astigmatism between the two groups.	[Chen, Xinyi; Chen, Kailin; Yao, Ke] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [He, Jiliang] Zhejiang Univ, Sch Med, Inst Environm Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Chen, Xinyi/0000-0002-1858-5671; Yao, Ke/0000-0002-6764-7365	Key Program of National Natural Science Foundation of China [81130018]; Zhejiang Key Laboratory Fund of China [2011E10006]; Project of National Clinical Key Discipline of Chinese Ministry of Health	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Key Laboratory Fund of China; Project of National Clinical Key Discipline of Chinese Ministry of Health	This study was supported by Key Program of National Natural Science Foundation of China (No. 81130018); Zhejiang Key Laboratory Fund of China (2011E10006) and Project of National Clinical Key Discipline of Chinese Ministry of Health.	Abell RG, 2014, J CATARACT REFR SURG, V40, P1777, DOI 10.1016/j.jcrs.2014.05.031; Abell RG, 2013, J CATARACT REFR SURG, V39, P1321, DOI 10.1016/j.jcrs.2013.06.009; Abell RG, 2013, OPHTHALMOLOGY, V120, P942, DOI 10.1016/j.ophtha.2012.11.045; Chee SP, 2015, AM J OPHTHALMOL, V159, P714, DOI 10.1016/j.ajo.2015.01.016; Chen C, 2015, EUR J OPHTHALMOL, V25, P119, DOI 10.5301/ejo.5000521; Chen M, 2015, INT J OPHTHALMOL-CHI, V8, P201, DOI 10.3980/j.issn.2222-3959.2015.01.34; Chen XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13123; Cho Yang Kyeung, 2010, Korean J Ophthalmol, V24, P10, DOI 10.3341/kjo.2010.24.1.10; Conrad-Hengerer I, 2014, J REFRACT SURG, V30, P516, DOI 10.3928/1081597X-20140624-01; Conrad-Hengerer I, 2014, J REFRACT SURG, V30, P222, DOI 10.3928/1081597X-20140321-01; Conrad-Hengerer I, 2013, J CATARACT REFR SURG, V39, P1307, DOI 10.1016/j.jcrs.2013.05.033; Conrad-Hengerer I, 2012, J REFRACT SURG, V28, P879, DOI 10.3928/1081597X-20121116-02; Crema AS, 2007, J CATARACT REFR SURG, V33, P1014, DOI 10.1016/j.jcrs.2007.02.035; Daya SM, 2014, J CATARACT REFR SURG, V40, P37, DOI 10.1016/j.jcrs.2013.07.040; Dick HB, 1996, J CATARACT REFR SURG, V22, P63; Ecsedy M, 2011, J REFRACT SURG, V27, P717, DOI 10.3928/1081597X-20110825-01; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Filkom T, 2012, J REFRACT SURG, V28, P540, DOI 10.3928/1081597X-20120703-04; Glasser DB, 2012, AM J OPHTHALMOL, V154, P217, DOI 10.1016/j.ajo.2012.03.024; Hayashi K, 1996, J CATARACT REFR SURG, V22, P1079, DOI 10.1016/S0886-3350(96)80121-0; HAYASHI K, 1994, OPHTHALMIC SURG LAS, V25, P510; He LM, 2011, CURR OPIN OPHTHALMOL, V22, P43, DOI 10.1097/ICU.0b013e3283414f76; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Ho JW, 2015, CURR OPIN OPHTHALMOL, V26, P22, DOI 10.1097/ICU.0000000000000121; Kranitz K, 2012, J REFRACT SURG, V28, P259, DOI 10.3928/1081597X-20120309-01; Kranitz K, 2011, J REFRACT SURG, V27, P558, DOI 10.3928/1081597X-20110623-03; Krarup T, 2014, ACTA OPHTHALMOL, V92, P617, DOI 10.1111/aos.12406; Lawless M, 2012, J REFRACT SURG, V28, P859, DOI 10.3928/1081597X-20121115-02; Lipner M, 2015, EYE WORLD; Mastropasqua L, 2014, J CATARACT REFR SURG, V40, P2035, DOI 10.1016/j.jcrs.2014.05.032; Mastropasqua L, 2014, J REFRACT SURG, V30, P27, DOI 10.3928/1081597X-20131217-03; Nagy ZZ, 2014, J REFRACT SURG, V30, P522, DOI 10.3928/1081597X-20140711-04; Nagy ZZ, 2012, J CATARACT REFR SURG, V38, P941, DOI 10.1016/j.jcrs.2012.02.031; Nagy ZZ, 2011, J REFRACT SURG, V27, P564, DOI 10.3928/1081597X-20110607-01; Nordan LT, 2003, J REFRACT SURG, V19, P8; Norrby S, 2008, J CATARACT REFR SURG, V34, P368, DOI 10.1016/j.jcrs.2007.10.031; Packer M, 2014, AM J OPHTHALMOL, V157, P1323, DOI 10.1016/j.ajo.2014.02.025; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Ranka M, 2015, SURV OPHTHALMOL, V60, P356, DOI 10.1016/j.survophthal.2015.02.001; Reddy KP, 2013, J CATARACT REFR SURG, V39, P1297, DOI 10.1016/j.jcrs.2013.05.035; Roberts TV, 2013, CLIN EXP OPHTHALMOL, V41, P180, DOI 10.1111/j.1442-9071.2012.02851.x; Schargus M, 2015, J REFRACT SURG, V31, P146, DOI 10.3928/1081597X-20150220-01; Schultz T, 2015, EUR J OPHTHALMOL, V25, P112, DOI 10.5301/ejo.5000484; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tabin G, 2008, CURR OPIN OPHTHALMOL, V19, P55, DOI 10.1097/ICU.0b013e3282f154bd; Takacs AI, 2012, J REFRACT SURG, V28, P387, DOI 10.3928/1081597X-20120508-02; Uy HS, 2012, CURR OPIN OPHTHALMOL, V23, P33, DOI 10.1097/ICU.0b013e32834cd622; Walkow T, 2000, J CATARACT REFR SURG, V26, P727, DOI 10.1016/S0886-3350(99)00462-9; ZETTERSTROM C, 1995, J CATARACT REFR SURG, V21, P55, DOI 10.1016/S0886-3350(13)80480-4	50	34	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152088	10.1371/journal.pone.0152088	http://dx.doi.org/10.1371/journal.pone.0152088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999612	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700099
J	Kawahara, M; Hasegawa, N; Takaku, H				Kawahara, Mamoru; Hasegawa, Nozomi; Takaku, Hiroshi			Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BACILLUS-CALMETTE-GUERIN; HUMAN NK CELLS; INTERFERON-GAMMA; ADAPTIVE IMMUNITY; IFN-GAMMA; T-CELLS; TUBERCULOSIS; INNATE; RESISTANCE	Several lines of evidence have recently suggested that natural killer (NK) cells develop immunological memory against viral infections. However, there is no apparent evidence that NK cells acquire specific memory against Mycobacterium bovis bacillus Calmette-Guerin (BCG), the only currently licensed vaccine for preventing tuberculosis. In the present study, we investigated whether murine splenic NK cells can be activated by BCG in a dendritic cell (DC)-independent or -dependent manner, and furthermore examined whether these NK cells acquire specific memory following BCG vaccination. NK cells isolated from spleens of BCG-immunized mice produced interferon (IFN). through direct BCG stimulation in the absence of antigen-presenting cells; however, NK cells from control animals similarly directly responded to BCG, and the response level was not statistically significant between the immunized and the naive NK cells. When purified NK cells that had been exposed to BCG were cocultured with RAW murine macrophages infected with BCG, the antibacterial activity of the macrophages was strongly enhanced; however, its level was similar to that by naive NK cells, which had not been exposed to BCG. When splenocytes harvested from BCG-immunized mice were stimulated with purified protein derivative (PPD) derived from Mycobacterium tuberculosis, a specific IFN. response was clearly observed, mainly attributed to NK cells and memory CD4(+) T cells. To investigate whether these NK cells as well as the T cells are activated by cell-cell interaction with DCs presenting mycobacterial antigens, NK cells isolated from BCG-immunized mice were cocultured with splenocytes harvested from naive mice in the presence of PPD stimulation. However, no IFN. response was found in the NK cells. These results suggest that murine splenic NK cells do not develop BCG-specific immunological memory in either a DC-independent or -dependent manner.	[Kawahara, Mamoru] Japan BCG Lab, Dept Res & Dev, Tokyo, Japan; [Kawahara, Mamoru; Hasegawa, Nozomi; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan	Chiba Institute of Technology; Chiba Institute of Technology	Kawahara, M (corresponding author), Japan BCG Lab, Dept Res & Dev, Tokyo, Japan.; Kawahara, M (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan.	kawahara@bcg.gr.jp			Supporting Program for Creating University Ventures from the Japan Science and Technology Agency; Research and Development Program for New Bioindustry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan	Supporting Program for Creating University Ventures from the Japan Science and Technology Agency; Research and Development Program for New Bioindustry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported in part by a grant from the Supporting Program for Creating University Ventures from the Japan Science and Technology Agency (www.jst.go.jp/) (HT) and a grant from the Research and Development Program for New Bioindustry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan (www.maff.go.jp/) (HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Abdul-Careem MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032821; Akazawa T, 2004, CANCER RES, V64, P757, DOI 10.1158/0008-5472.CAN-03-1518; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Cook KD, 2014, CRIT REV IMMUNOL, V34, P359, DOI 10.1615/CritRevImmunol.2014010604; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DENIS M, 1991, J LEUKOCYTE BIOL, V49, P380, DOI 10.1002/jlb.49.4.380; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Korbel DS, 2004, INT J PARASITOL, V34, P1517, DOI 10.1016/j.ijpara.2004.10.006; Marcenaro E, 2008, INT IMMUNOL, V20, P1155, DOI 10.1093/intimm/dxn073; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Portevin D, 2012, CELL MICROBIOL, V14, P1734, DOI 10.1111/j.1462-5822.2012.01834.x; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Schaible UE, 1998, J IMMUNOL, V160, P1290; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Via LE, 1998, J CELL SCI, V111, P897	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152051	10.1371/journal.pone.0152051	http://dx.doi.org/10.1371/journal.pone.0152051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999357	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700096
J	Bae, A; Park, D; Ahn, YY; Park, J				Bae, Arram; Park, Doheum; Ahn, Yong-Yeol; Park, Juyong			The Multi-Scale Network Landscape of Collaboration	PLOS ONE			English	Article							COMMUNITY STRUCTURE; COMPLEX	Propelled by the increasing availability of large-scale high-quality data, advanced data modeling and analysis techniques are enabling many novel and significant scientific understanding of a wide range of complex social, natural, and technological systems. These developments also provide opportunities for studying cultural systems and phenomena-which can be said to refer to all products of human creativity and way of life. An important characteristic of a cultural product is that it does not exist in isolation from others, but forms an intricate web of connections on many levels. In the creation and dissemination of cultural products and artworks in particular, collaboration and communication of ideas play an essential role, which can be captured in the heterogeneous network of the creators and practitioners of art. In this paper we propose novel methods to analyze and uncover meaningful patterns from such a network using the network of western classical musicians constructed from a large-scale comprehensive Compact Disc recordings data. We characterize the complex patterns in the network landscape of collaboration between musicians across multiple scales ranging from the macroscopic to the mesoscopic and microscopic that represent the diversity of cultural styles and the individuality of the artists.	[Bae, Arram; Park, Doheum; Park, Juyong] Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Daejeon, South Korea; [Ahn, Yong-Yeol] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA	Korea Advanced Institute of Science & Technology (KAIST); Indiana University System; Indiana University Bloomington	Park, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Daejeon, South Korea.	juyongp@kaist.ac.kr	Park, Juyong/I-2290-2012; Ahn, Yong-Yeol/C-6334-2011	Ahn, Yong-Yeol/0000-0002-4352-4301	National Research Foundation of Korea [NRF-20100004910, NRF-2013S1A3A2055285]; BK21 Postgraduate Program for Content Science; Institute for Information & Communications Technology Promotion (IITP) - Korea government (MSIP) [R0184-15-1037]	National Research Foundation of Korea(National Research Foundation of Korea); BK21 Postgraduate Program for Content Science; Institute for Information & Communications Technology Promotion (IITP) - Korea government (MSIP)	This work was supported by National Research Foundation of Korea (NRF-20100004910 and NRF-2013S1A3A2055285) (http://www.nrf.re.kr/nrf_eng_cms/), BK21 Postgraduate Program for Content Science (https://bkplus.nrf.re.kr/index.jsp), and Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (MSIP) (R0184-15-1037) (http://english.msip.go.kr/english/main/main.do).	Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], 2008, NATURE, V455, P1, DOI 10.1038/455001a; [Anonymous], COMPLEX NETWORKS; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Jeh G., 2002, P 8 ACM SIGKDD INT C, P538; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Klingenstein S, 2014, P NATL ACAD SCI USA, V111, P9419, DOI 10.1073/pnas.1405984111; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Page L., 1999, PAGERANK CITATION RA, P1999; Pan J-Y, 2004, P 10 ACM SIGKDD INT, P653, DOI 10.1145/1014052.1014135; Park D, 2014, COMPLEX NETWORKS, P1; Park D, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0039-z; Park J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026112; Park J, 2007, INT J BIFURCAT CHAOS, V17, P2281, DOI 10.1142/S0218127407018385; Park JY, 2007, P NATL ACAD SCI USA, V104, P17916, DOI 10.1073/pnas.0705081104; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Ross Alex, 2007, REST IS NOISE LISTEN; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schich M, 2012, LEONARDO, V45, P77; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Silva DDE, 2004, PHYSICA A, V332, P559, DOI 10.1016/j.physa.2003.09.059; Struble JW, 1995, HIST AM CLASSICAL MU; Taruskin R., 2009, MUSIC 19 CENTURY OXF; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	38	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151784	10.1371/journal.pone.0151784	http://dx.doi.org/10.1371/journal.pone.0151784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990088	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800103
J	Kim, JY; Goo, YK; Zo, YG; Ji, SY; Trimarsanto, H; To, S; Clark, TG; Price, RN; Auburn, S				Kim, Jung-Yeon; Goo, Youn-Kyoung; Zo, Young-Gun; Ji, So-Young; Trimarsanto, Hidayat; To, Sheren; Clark, Taane G.; Price, Ric N.; Auburn, Sarah			Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; MICROSATELLITE DIVERSITY; TRANSMISSION DYNAMICS; MALARIA PARASITES; NATURAL-SELECTION; INFECTIONS; MARKERS; FALCIPARUM; SPECTRUM	Background Vivax malaria was successfully eliminated from the Republic of Korea (ROK) in the late 1970s but re-emerged in 1993. Two decades later as the ROK enters the final stages of malaria elimination, dedicated surveillance of the local P. vivax population is critical. We apply a population genetic approach to gauge P. vivax transmission dynamics in the ROK between 2010 and 2012. Methodology/Principal Findings P. vivax positive blood samples from 98 autochthonous cases were collected from patients attending health centers in the ROK in 2010 (n = 27), 2011 (n = 48) and 2012 (n = 23). Parasite genotyping was undertaken at 9 tandem repeat markers. Although not reaching significance, a trend of increasing population diversity was observed from 2010 (H-E = 0.50 +/- 0.11) to 2011 (H-E = 0.56 +/- 0.08) and 2012 (H-E = 0.60 +/- 0.06). Conversely, linkage disequilibrium declined during the same period: I-AS = 0.15 in 2010 (P = 0.010), 0.09 in 2011 (P = 0.010) and 0.05 in 2012 (P = 0.010). In combination with data from other ROK studies undertaken between 1994 and 2007, our results are consistent with increasing parasite divergence since re-emergence. Polyclonal infections were rare (3% infections) suggesting that local out-crossing alone was unlikely to explain the increased divergence. Cases introduced from an external reservoir may therefore have contributed to the increased diversity. Aside from one isolate, all infections carried a short MS20 allele (142 or 149 bp), not observed in other studies in tropical endemic countries despite high diversity, inferring that these regions are unlikely reservoirs. Conclusions Whilst a number of factors may explain the observed population genetic trends, the available evidence suggests that an external geographic reservoir with moderate diversity sustains the majority of P. vivax infection in the ROK, with important implications for malaria elimination.	[Kim, Jung-Yeon; Goo, Youn-Kyoung; Ji, So-Young] Osong Hlth Technol Adm, Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, 2 Ro, Osong, South Korea; [Goo, Youn-Kyoung] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu 700422, South Korea; [Zo, Young-Gun] Sungkyunkwan Univ, Sch Med, Dept Mol Parasitol, Suwon 440746, Gyeonggi Do, South Korea; [Zo, Young-Gun] Samsung Biomed Res Inst, Ctr Mol Med, Suwon 440746, Gyeonggi Do, South Korea; [Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jl MH Thamrin 8, Jakarta 10340, Indonesia; [To, Sheren; Price, Ric N.; Auburn, Sarah] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0810, Australia; [To, Sheren; Price, Ric N.; Auburn, Sarah] Charles Darwin Univ, Darwin, NT 0810, Australia; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University; Sungkyunkwan University (SKKU); Samsung; Eijkman Institute; Agency for the Assessment & Application of Technology (BPPT); Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Kim, JY (corresponding author), Osong Hlth Technol Adm, Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, 2 Ro, Osong, South Korea.; Auburn, S (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0810, Australia.; Auburn, S (corresponding author), Charles Darwin Univ, Darwin, NT 0810, Australia.	jykim-malaria@nih.go.kr; Sarah.Auburn@menzies.edu.au	Clark, Taane G./AAM-2570-2020; Auburn, Sarah/N-2266-2013	Clark, Taane G./0000-0001-8985-9265; Auburn, Sarah/0000-0002-4638-536X; Price, Richard/0000-0003-2000-2874; Trimarsanto, Hidayat/0000-0003-2436-8283	APMEN Small Project Grant [107-05]; Wellcome Trust [091625]; APMEN; Medical Research Council UK [MR/K000551/1, MR/M01360X/1]; MRC [MR/K000551/1, MR/M01360X/1] Funding Source: UKRI; Medical Research Council [MR/M01360X/1, MR/K000551/1] Funding Source: researchfish	APMEN Small Project Grant; Wellcome Trust(Wellcome TrustEuropean Commission); APMEN; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been an output of the Asia Pacific Malaria Elimination Network (APMEN). The study was funded by an APMEN Small Project Grant awarded to JYK (No. 107-05). SA, HT and RNP are funded by the Wellcome Trust [Wellcome Trust Senior Research Fellow in Clinical Science (091625) awarded to RNP]. SA is also part-funded by APMEN. TGC is funded by the Medical Research Council UK (Grant no. MR/K000551/1 and MR/M01360X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Chai In-Ho, 1994, Korean Journal of Parasitology, V32, P195, DOI 10.3347/kjp.1994.32.3.195; Cho Shin-Hyeong, 2002, Korean Journal of Parasitology, V40, P139, DOI 10.3347/kjp.2002.40.3.139; Choi YK, 2010, AM J TROP MED HYG, V82, P426, DOI 10.4269/ajtmh.2010.09-0245; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Ferreira MU, 2014, TRENDS PARASITOL, V30, P465, DOI 10.1016/j.pt.2014.08.003; Getachew S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140780; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Goo YK, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0803-3; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Han ET, 2011, PARASITOL RES, V109, P1571, DOI 10.1007/s00436-011-2413-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Havryliuk T, 2009, MEM I OSWALDO CRUZ, V104, P67, DOI 10.1590/S0074-02762009000100011; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Honma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-257; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Iwagami M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002522; Iwagami M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001592; Iwagami M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-184; Jennison C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003634; Ju HL, 2013, ACTA TROP, V125, P67, DOI 10.1016/j.actatropica.2012.09.016; Kang Jung-Mi, 2012, Malar J, V11, P206, DOI 10.1186/1475-2875-11-206; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Kim JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039645; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Lee SW, 2009, AM J TROP MED HYG, V81, P600, DOI 10.4269/ajtmh.2009.09-0102; Liu YB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-262; Menegon M, 2014, INFECT GENET EVOL, V27, P244, DOI 10.1016/j.meegid.2014.07.029; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park JW, 2009, KOREAN J PARASITOL, V47, pS39, DOI 10.3347/kjp.2009.47.S.S39; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Pritchard JK, 2000, GENETICS, V155, P945; Rezende AM, 2009, AM J TROP MED HYG, V80, P729, DOI 10.4269/ajtmh.2009.80.729; Rodrigues PT, 2014, AM J TROP MED HYG, V90, P1102, DOI 10.4269/ajtmh.13-0588; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schousboe ML, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-392; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; Tibayrenc M, 2014, ADV PARASIT, V84, P253, DOI 10.1016/B978-0-12-800099-1.00005-3; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; WHO, 2013, WORLD MALARIA REPORT 2013, P1	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151514	10.1371/journal.pone.0151514	http://dx.doi.org/10.1371/journal.pone.0151514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990869	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000372582800070
J	Mader, L; Rueegg, CS; Vetsch, J; Rischewski, J; Ansari, M; Kuehni, CE; Michel, G				Mader, Luzius; Rueegg, Corina S.; Vetsch, Janine; Rischewski, Johannes; Ansari, Marc; Kuehni, Claudia E.; Michel, Gisela		SPOG	Employment Situation of Parents of Long-Term Childhood Cancer Survivors	PLOS ONE			English	Article							GENERAL-POPULATION; ECONOMIC-IMPACT; FAMILIES; SIBLINGS; REGISTRY; CHILDREN; HEALTH; INCOME; COSTS	Background Taking care of children diagnosed with cancer affects parents' professional life. The impact in the long-term however, is not clear. We aimed to compare the employment situation of parents of long-term childhood cancer survivors with control parents of the general population, and to identify clinical and socio-demographic factors associated with parental employment. Methods As part of the Swiss Childhood Cancer Survivor Study, we sent a questionnaire to parents of survivors aged 5-15 years, who survived >= 5 years after diagnosis. Information on control parents of the general population came from the Swiss Health Survey (restricted to men and women with >= 1 child aged 5-15 years). Employment was categorized as not employed, part-time, and full-time employed. We used generalized ordered logistic regression to determine associations with clinical and socio-demographic factors. Clinical data was available from the Swiss Childhood Cancer Registry. Results We included 394 parent-couples of survivors and 3'341 control parents (1'731 mothers; 1'610 fathers). Mothers of survivors were more often not employed (29% versus 22%; p(trend) = 0.007). However, no differences between mothers were found in multivariable analysis. Fathers of survivors were more often employed full-time (93% versus 87%; p(trend) = 0.002), which remained significant in multivariable analysis. Among parents of survivors, mothers with tertiary education (OR = 2.40, CI: 1.14-5.07) were more likely to be employed. Having a migration background (OR = 3.63, CI: 1.71-7.71) increased the likelihood of being full-time employed in mothers of survivors. Less likely to be employed were mothers of survivors diagnosed with lymphoma (OR = 0.31, CI: 0.13-0.73) and >2 children (OR = 0.48, CI: 0.30-0.75); and fathers of survivors who had had a relapse (OR = 0.13, CI: 0.04-0.36). Conclusion Employment situation of parents of long-term survivors reflected the more traditional parenting roles. Specific support for parents with low education, additional children, and whose child had a more severe cancer disease could improve their long-term employment situation.	[Mader, Luzius; Rueegg, Corina S.; Vetsch, Janine; Michel, Gisela] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [Rischewski, Johannes] Cantonal Hosp Lucerne, Childrens Hosp, Dept Oncol Hematol, Luzern, Switzerland; [Ansari, Marc] Univ Hosp Geneva, Dept Pediat, Unit Oncol Hematol, Geneva, Switzerland; [Kuehni, Claudia E.; Michel, Gisela] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Lucerne; Lucerne Cantonal Hospital; University of Geneva; University of Bern	Michel, G (corresponding author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.	gisela.michel@unilu.ch	Michel, Gisela/G-1081-2018; Rueegg, Corina Silvia/H-7128-2019; ANSARI, Marc/V-3334-2017	Michel, Gisela/0000-0002-9589-0928; Rueegg, Corina Silvia/0000-0003-3720-4659; ansari, marc/0000-0002-9649-6498; Kuehni, Claudia E./0000-0001-8957-2002; Leibundgut, Kurt/0000-0003-2514-6041; Tinner, Eva Maria/0000-0001-5843-8097	Swiss National Science Foundation [100019_153268/1]; Ambizione Grant [PZ00P3121682/1, PZ00P3-141722]; Swiss Cancer League [KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ambizione Grant; Swiss Cancer League	This study was supported by the Swiss National Science Foundation (www.snf.ch): Grant No. 100019_153268/1; Ambizione Grant to GM: PZ00P3121682/1 and PZ00P3-141722. The Swiss Childhood Cancer Survivor Study was funded by the Swiss Cancer League (www.krebsliga.ch): KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011. The University of Lucerne research committee (FoKo) supports the open access publication (www.unilu.ch/en/research/university-of-lucerne-funding/research-committee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderfer MA, 2010, PSYCHO-ONCOLOGY, V19, P789, DOI 10.1002/pon.1638; Bona K, 2014, J PAIN SYMPTOM MANAG, V47, P594, DOI 10.1016/j.jpainsymman.2013.04.003; Bundesamt fuar Statistik, 2013, SCHWEIZ GES 2012 KUR; Bundesamt fur Statistik, 2013, SCHWEIZ GES 2012 UB; Bundesamt fur Statistik, 2015, ARB 2015; Dussel V, 2011, J CLIN ONCOL, V29, P1007, DOI 10.1200/JCO.2009.27.8960; Eiser C, 2007, CHILD CARE HLTH DEV, V33, P455, DOI 10.1111/j.1365-2214.2006.00710.x; Germann U., 2005, EIDGENOSSISCHE VOLKS; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Heath JA, 2006, PEDIATR HEMAT ONCOL, V23, P439, DOI 10.1080/08880010600692526; Hoven E, 2013, ACTA ONCOL, V52, P1076, DOI 10.3109/0284186X.2012.760846; Kuehni CE, 2012, INT J EPIDEMIOL, V41, P1553, DOI 10.1093/ije/dyr142; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Lau S, 2014, PEDIATR BLOOD CANCER, V61, P2277, DOI 10.1002/pbc.25195; Lieberherr R., 2010, GESUNDHEIT GESUNDHEI; Limburg H, 2008, PEDIATR BLOOD CANCER, V51, P93, DOI 10.1002/pbc.21448; Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129; Michel G, 2007, SWISS MED WKLY, V137, P502; Miedema B, 2008, CURR ONCOL, V15, P173; Mostert S, 2008, J PEDIAT HEMATOL ONC, V30, P738, DOI 10.1097/MPH.0b013e31817e4aad; Okada H, 2014, CANC NURS, P1; Robison LL, 2009, J CLIN ONCOL; Rueegg CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034930; Schindler M, 2014, BETREUUNGSAUFWAND EL; StataCorp, 2017, STAT SURV DAT REF MA; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Syse A, 2011, CANCER EPIDEMIOL, V35, P298, DOI 10.1016/j.canep.2010.08.002; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; Wakefield CE, 2014, J PSYCHOSOC ONCOL, V32, P602, DOI 10.1080/07347332.2014.936653; Wengenroth L, 2014, PEDIATR BLOOD CANCER, V61, P538, DOI 10.1002/pbc.24821	30	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151966	10.1371/journal.pone.0151966	http://dx.doi.org/10.1371/journal.pone.0151966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990301	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000372582800125
J	Park, KS; Park, J; Choi, SH; Ann, SH; Singh, GB; Shin, ES; Lee, JS; Chung, HC				Park, Kyung Sun; Park, Jongha; Choi, Seong Hoon; Ann, Seo Hee; Singh, Gillian Balbir; Shin, Eun-Seok; Lee, Jong Soo; Chung, Hyun Chul			Serum Phosphorus Concentration and Coronary Artery Calcification in Subjects without Renal Dysfunction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; PARATHYROID-HORMONE; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; CALCIUM; PHOSPHATE; RISK; ASSOCIATION	Serum phosphorus (P) concentration is associated with coronary artery calcification (CAC) as well as cardiovascular events in patients with chronic kidney disease. It has been suggested that this relationship is extended to subjects without renal dysfunction, but further explorations in diverse races and regions are still needed. We performed a cross-sectional study of 2,509 Korean subjects (Far Eastern Asian) with an estimated glomerular filtration rate of >= 60 ml/min/1.73m(2) and who underwent coronary computerized tomography. Serum P concentration was divided into pre-determined 4 categories: <= 3.2, 3.2< to <= 3.6, 3.6< to <= 4.0 and >4.0 mg/dL. Agatston score (AS), an index of CAC, was divided into 3 categories: 0, 0< to <= 100, and >100. A multinomial logit model (baseline outcome: AS = 0) was applied to estimate the odds ratio (OR) for each serum P category (reference: <= 3.2mg/dL). Mean age of subjects was 53.5 +/- 9.1 years and 36.9% were female. In the adjusted model, serum P concentration of 3.6< to <= 4.0 mg/dL and >4.0 mg/dL showed high ORs for AS of > 100 [OR: 1.58, 95% confidence interval (CI): 1.04-2.40 and OR: 2.11, 95% CI: 1.34-3.32, respectively]. A unit (mg/dL) increase in serum P concentration was associated with 50% increase in risk of AS > 100 (OR: 1.50, 95% CI: 1.16-1.94). A higher serum P concentration, even within a normal range, may be associated with a higher CAC in subjects with normal renal function.	[Park, Kyung Sun; Park, Jongha; Ann, Seo Hee; Singh, Gillian Balbir; Shin, Eun-Seok; Lee, Jong Soo; Chung, Hyun Chul] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 680749, South Korea; [Choi, Seong Hoon] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Radiol, Ulsan 680749, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Chung, HC (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan 680749, South Korea.	hcjungmd@uuh.ulsan.kr			Ulsan University Hospital (Biomedical Research Centre Promotion Fund) [UUH-08-01]	Ulsan University Hospital (Biomedical Research Centre Promotion Fund)	This work was funded by Ulsan University Hospital (Biomedical Research Centre Promotion Fund, UUH-08-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Ulsan University Hospital (Biomedical Research Centre Promotion Fund, UUH-08-01).	Adeney KL, 2009, J AM SOC NEPHROL, V20, P381, DOI 10.1681/ASN.2008040349; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alluri K, 2015, ATHEROSCLEROSIS, V239, P109, DOI 10.1016/j.atherosclerosis.2014.12.040; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bringhurst F, 2015, HARRISONS PRINCIPLES; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Cancela AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036883; Chen NX, 2002, KIDNEY INT, V62, P1724, DOI 10.1046/j.1523-1755.2002.00625.x; Criqui MH, 2014, JAMA-J AM MED ASSOC, V311, P271, DOI 10.1001/jama.2013.282535; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Giachelli CM, 2003, J AM SOC NEPHROL, V14, pS300, DOI 10.1097/01.ASN.0000081663.52165.66; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kwak SM, 2014, ARTERIOSCL THROM VAS, V34, P1763, DOI 10.1161/ATVBAHA.114.303440; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu L, 2014, RENAL FAILURE, V36, P1244, DOI 10.3109/0886022X.2014.938544; Nakayama M, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-22; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Park KS, 2011, AM J CLIN NUTR, V94, P1465, DOI 10.3945/ajcn.110.001974; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Stevens LA, 2004, J AM SOC NEPHROL, V15, P770, DOI 10.1097/01.ASN.0000113243.24155.2F; Streja E, 2014, BONE, V61, P201, DOI 10.1016/j.bone.2014.01.016; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Wang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133938	36	17	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151007	10.1371/journal.pone.0151007	http://dx.doi.org/10.1371/journal.pone.0151007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992166	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800041
J	Pintor, AFV; Schwarzkopf, L; Krockenberger, AK				Pintor, Anna F. V.; Schwarzkopf, Lin; Krockenberger, Andrew K.			Extensive Acclimation in Ectotherms Conceals Interspecific Variation in Thermal Tolerance Limits	PLOS ONE			English	Article							TEMPERATURE-ACCLIMATION; LOCOMOTOR PERFORMANCE; CLIMATIC VARIABILITY; BODY-TEMPERATURE; LIZARDS; RANGE; MODEL; METABOLISM; RESPONSES; GRADIENT	Species' tolerance limits determine their capacity to tolerate climatic extremes and limit their potential distributions. Interspecific variation in thermal tolerances is often proposed to indicate climatic vulnerability and is, therefore, the subject of many recent meta-studies on differential capacities of species from climatically different habitats to deal with climate change. Most studies on thermal tolerances do not acclimate animals or use inconsistent, and insufficient, acclimation times, limiting our knowledge of the shape, duration and extent of acclimation responses. Consequently patterns in thermal tolerances observed in meta-analyses, based on data from the literature are based on inconsistent, partial acclimation and true trends may be obscured. In this study we describe time-course of complete acclimation of critical thermal minima in the tropical ectotherm Carlia longipes and compare it to the average acclimation response of other reptiles, estimated from published data, to assess how much acclimation time may contribute to observed differences in thermal limits. Carlia longipes decreased their lower critical thermal limits by 2.4 degrees C and completed 95% of acclimation in 17 weeks. Wild populations did not mirror this acclimation process over the winter. Other reptiles appear to decrease cold tolerance more quickly (95% in 7 weeks) and to a greater extent, with an estimated average acclimation response of 6.1 degrees C. However, without data on tolerances after longer acclimation times available, our capacity to estimate final acclimation state is very limited. Based on the subset of data available for meta-analysis, much of the variation in cold tolerance observed in the literature can be attributed to acclimation time. Our results indicate that (i) acclimation responses can be slow and substantial, even in tropical species, and (ii) interspecific differences in acclimation speed and extent may obscure trends assessed in some meta-studies. Cold tolerances of wild animals are representative of cumulative responses to recent environments, while lengthy acclimation is necessary for controlled comparisons of physiological tolerances. Measures of inconsistent, intermediate acclimation states, as reported by many studies, represent neither the realised nor the potential tolerance in that population, are very likely underestimates of species' physiological capacities and may consequently be of limited value.	[Pintor, Anna F. V.; Krockenberger, Andrew K.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Cairns, Qld 4878, Australia; [Schwarzkopf, Lin] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Pintor, AFV (corresponding author), James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Cairns, Qld 4878, Australia.	Anna.Pintor@my.jcu.edu.au	Schwarzkopf, Lin/C-1242-2012	Schwarzkopf, Lin/0000-0002-1009-670X; Krockenberger, Andrew/0000-0003-2872-9939	James Cook University; Centre for Tropical Biodiversity and Climate Change; National Climate Change Adaptation Research Facility; Skyrail Rainforest Foundation	James Cook University; Centre for Tropical Biodiversity and Climate Change; National Climate Change Adaptation Research Facility; Skyrail Rainforest Foundation	Funding was provided by James Cook University (http://www.jcu.edu.au/; AFVP), the Centre for Tropical Biodiversity and Climate Change (https://research.jcu.edu.au/ctbcc; AKK), the National Climate Change Adaptation Research Facility (https://www.nccarf.edu.au/; AFVP), and the Skyrail Rainforest Foundation (http://www.skyrailfoundation.org/; AFVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; ALEKSIUK M, 1976, COPEIA, P170, DOI 10.2307/1443787; Andersson M, 2010, AUSTRAL ECOL, V35, P294, DOI 10.1111/j.1442-9993.2009.02035.x; Andrews RM, 2012, BIOL J LINN SOC, V106, P851, DOI 10.1111/j.1095-8312.2012.01901.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2014, R LANG ENV STAT COMP; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BELEHRADEK J, 1957, ANNU REV PHYSIOL, V19, P59, DOI 10.1146/annurev.ph.19.030157.000423; BLEM CR, 1990, COMP BIOCHEM PHYS A, V97, P259, DOI 10.1016/0300-9629(90)90182-R; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; BRATTSTROM BAYARD H., 1962, PHYSIOL ZOOL, V35, P148; Buckley LB, 2015, FUNCTIONAL ECOLOGY, DOI [10.1111/365-2435, DOI 10.1111/365-2435]; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Clusella-Trullas S, 2014, J COMP PHYSIOL B, V184, P5, DOI 10.1007/s00360-013-0776-x; Corn M.J., 1971, J Herpet, V5, P17, DOI 10.2307/1562838; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; GOLDSTEIN H, 1986, BIOMETRIKA, V73, P43; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Holt RD, 2003, EVOL ECOL RES, V5, P159; Huey R. B., 1990, STRESS PROTEINS BIOL; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUTCHISON V H, 1970, Herpetologica, V26, P1; Hutchison V. H., 1961, Physiological Zoology, V84, P92; HUTCHISON VH, 1979, AM ZOOL, V19, P367; KATTAN GH, 1989, PHYSIOL ZOOL, V62, P593, DOI 10.1086/physzool.62.2.30156187; KAUFMANN JS, 1989, PHYSIOL ZOOL, V62, P1047, DOI 10.1086/physzool.62.5.30156195; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; LAYNE JR, 1982, J THERM BIOL, V7, P139, DOI 10.1016/0306-4565(82)90002-X; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; MURRISH DE, 1968, COMP BIOCHEM PHYSIOL, V27, P329, DOI 10.1016/0010-406X(68)90775-5; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Pintor AFV, 2015, ECOL MONOGR, V85, P643, DOI 10.1890/14-1510.1; Ramlov H, 2000, HUM REPROD, V15, P26, DOI 10.1093/humrep/15.suppl_5.26; SHINE R, 1979, AM NAT, V113, P905, DOI 10.1086/283444; Shine R, 1999, J EVOLUTION BIOL, V12, P918, DOI 10.1046/j.1420-9101.1999.00093.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; TSUJI JS, 1988, PHYSIOL ZOOL, V61, P241, DOI 10.1086/physzool.61.3.30161237; Vickers M, 2011, AM NAT, V177, P452, DOI 10.1086/658150; WHEELER PE, 1986, J THERM BIOL, V11, P161, DOI 10.1016/0306-4565(86)90041-0; Xu XF, 2006, COMP BIOCHEM PHYS A, V143, P118, DOI 10.1016/j.cbpa.2005.11.004; Yang J, 2008, J COMP PHYSIOL B, V178, P343, DOI 10.1007/s00360-007-0227-7	52	36	36	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150408	10.1371/journal.pone.0150408	http://dx.doi.org/10.1371/journal.pone.0150408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990769	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000372582800029
J	Felton, AM; Felton, A; Raubenheimer, D; Simpson, SJ; Krizsan, SJ; Hedwall, PO; Stolter, C				Felton, Annika M.; Felton, Adam; Raubenheimer, David; Simpson, Stephen J.; Krizsan, Sophie J.; Hedwall, Per-Ola; Stolter, Caroline			The Nutritional Balancing Act of a Large Herbivore: An Experiment with Captive Moose (Alces alces L)	PLOS ONE			English	Article							GENERALIST HERBIVORE; MAMMALIAN HERBIVORES; GEOMETRIC ANALYSIS; FOOD SELECTION; ENERGY-INTAKE; MACRONUTRIENT SELECTION; DIET SELECTION; SIZE SELECTION; PROTEIN; WINTER	The nutrient balancing hypothesis proposes that, when sufficient food is available, the primary goal of animal diet selection is to obtain a nutritionally balanced diet. This hypothesis can be tested using the Geometric Framework for nutrition (GF). The GF enables researchers to study patterns of nutrient intake (e.g. macronutrients; protein, carbohydrates, fat), interactions between the different nutrients, and how an animal resolves the potential conflict between over-eating one or more nutrients and under-eating others during periods of dietary imbalance. Using the moose (Alces alces L.), a model species in the development of herbivore foraging theory, we conducted a feeding experiment guided by the GF, combining continuous observations of six captive moose with analysis of the macronutritional composition of foods. We identified the moose's self-selected macronutrient target by allowing them to compose a diet by mixing two nutritionally complementary pellet types plus limited access to Salix browse. Such periods of free choice were intermixed with periods when they were restricted to one of the two pellet types plus Salix browse. Our observations of food intake by moose given free choice lend support to the nutrient balancing hypothesis, as the moose combined the foods in specific proportions that provided a particular ratio and amount of macronutrients. When restricted to either of two diets comprising a single pellet type, the moose i) maintained a relatively stable intake of non-protein energy while allowing protein intakes to vary with food composition, and ii) increased their intake of the food item that most closely resembled the self-selected macronutrient intake from the free choice periods, namely Salix browse. We place our results in the context of the nutritional strategy of the moose, ruminant physiology and the categorization of food quality.	[Felton, Annika M.; Felton, Adam; Hedwall, Per-Ola] Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden; [Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Krizsan, Sophie J.] Swedish Univ Agr Sci, Dept Agr Res Northern Sweden, S-90183 Umea, Sweden; [Stolter, Caroline] Univ Hamburg, Dept Anim Ecol & Conservat, Bioctr Grindel, Hamburg, Germany	Swedish University of Agricultural Sciences; University of Sydney; University of Sydney; University of Sydney; Swedish University of Agricultural Sciences; University of Hamburg	Felton, AM (corresponding author), Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Alnarp, Sweden.	annika.felton@slu.se	Hedwall, Per-Ola/ABG-2195-2020	Hedwall, Per-Ola/0000-0002-0120-7420; Simpson, Stephen J./0000-0003-0256-7687; , Sophie/0000-0002-9424-3884; Raubenheimer, David/0000-0001-9050-1447	Stiftelsen Skogssallskapet [1011-79/150-7 HJHIL]; Magnus Bergwalls Stiftelse; Fonden for Skogsvetenskaplig Forskning - Swedish University of Agricultural Sciences	Stiftelsen Skogssallskapet; Magnus Bergwalls Stiftelse; Fonden for Skogsvetenskaplig Forskning - Swedish University of Agricultural Sciences	The work was supported by grants from Stiftelsen Skogssallskapet, nb 1011-79/150-7 HJHIL (https://www.skogssallskapet.se/om-oss/organisation/stiftelsen.html), Magnus Bergwalls Stiftelse (http://www.magnbergvallsstiftelse.nu/), and Fonden for Skogsvetenskaplig Forskning - Swedish University of Agricultural Sciences (https://internt.slu.se/Documents/internwebben/s-fak/Stipendier_medarbetare/Lilla-fonden-sv-en_2015.pdf). All were granted to AMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen MS, 1997, J DAIRY SCI, V80, P1447, DOI 10.3168/jds.S0022-0302(97)76074-0; [Anonymous], 1989, REC DIET ALL; Asher GW, 2011, LIVEST SCI, V140, P8, DOI 10.1016/j.livsci.2011.02.002; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; Beck JL, 2005, WEST N AM NATURALIST, V65, P516; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P76, DOI 10.1016/0040-5809(78)90006-0; BELOVSKY GE, 1986, OECOLOGIA, V70, P35, DOI 10.1007/BF00377109; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Bengtsson S., 1983, 22 SLL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom R., 1987, Swedish Wildlife Research Supplement, V1, P213; Berteaux D, 1998, OECOLOGIA, V115, P84, DOI 10.1007/s004420050494; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; Cederlund G., 1980, SWEDISH WILDLIFE RES, V11, P171; Chai WH, 1998, ANIM FEED SCI TECH, V74, P281, DOI 10.1016/S0377-8401(98)00187-4; Clauss M, 2002, ZOO BIOL, V21, P499, DOI 10.1002/zoo.10059; Clauss M., 2003, ZOO ANIMAL NUTR, VII, P27; Clauss M, 2009, J MORPHOL, V270, P929, DOI 10.1002/jmor.10729; Cone JW, 1996, ANIM FEED SCI TECH, V61, P113, DOI 10.1016/0377-8401(96)00950-9; DANELL K, 1991, ECOLOGY, V72, P1624, DOI 10.2307/1940962; Development Core Team R, 2013, R LANG ENV STAT COMP; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; Ellsworth E, 2013, WILDLIFE RES, V40, P349, DOI 10.1071/WR13106; Erlenbach JA, 2014, J MAMMAL, V95, P160, DOI 10.1644/13-MAMM-A-161; Felton AM, 2008, INT J PRIMATOL, V29, P379, DOI 10.1007/s10764-008-9241-1; Felton AM, 2009, INT J PRIMATOL, V30, P675, DOI 10.1007/s10764-009-9367-9; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; GROSS JE, 1993, OIKOS, V68, P75, DOI 10.2307/3545311; Hewson-Hughes AK, 2013, BEHAV ECOL, V24, P293, DOI 10.1093/beheco/ars168; Hewson-Hughes AK, 2011, J EXP BIOL, V214, P1039, DOI 10.1242/jeb.049429; HJELJORD O, 1982, J WILDLIFE MANAGE, V46, P333, DOI 10.2307/3808644; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Irwin MT, 2014, AM J PHYS ANTHROPOL, V153, P78, DOI 10.1002/ajpa.22412; Johnson CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070383; Keunen JE, 2002, J DAIRY SCI, V85, P3304, DOI 10.3168/jds.S0022-0302(02)74419-6; Krizsan S. J., 2013, Proceedings of the 4th Nordic Feed Science Conference, Uppsala, Sweden, 12-13 June 2013, P118; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; LUNDBERG P, 1990, HOLARCTIC ECOL, V13, P177; Mansson J, 2007, SCAND J FOREST RES, V22, P407, DOI 10.1080/02827580701515023; Mansson J, 2009, FOREST ECOL MANAG, V258, P2450, DOI 10.1016/j.foreco.2009.08.025; Mayntz D, 2009, ANIM BEHAV, V77, P349, DOI 10.1016/j.anbehav.2008.09.036; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; *MERCK CO INC, 2005, MERCK VET MAN; Milner JM, 2014, J WILDLIFE MANAGE, V78, P1322, DOI 10.1002/jwmg.798; Moen R, 1998, ECOSYSTEMS, V1, P52, DOI 10.1007/s100219900005; Moen R, 1997, ECOLOGY, V78, P505; Muller DWH, 2011, P ROY SOC B-BIOL SCI, V278, P2076, DOI 10.1098/rspb.2010.2275; NCFA, 1976, DET FOOD FEED ACC KJ, V6; Ohlson M, 2001, OIKOS, V94, P442, DOI 10.1034/j.1600-0706.2001.940307.x; OLDEMEYER JL, 1977, J WILDLIFE MANAGE, V41, P533, DOI 10.2307/3800528; PALO RT, 1992, OIKOS, V65, P450, DOI 10.2307/3545562; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PARSONS AJ, 1994, J ANIM ECOL, V63, P465, DOI 10.2307/5563; Persson IL, 2000, ANN ZOOL FENN, V37, P251; Plantinga EA, 2011, BRIT J NUTR, V106, pS35, DOI 10.1017/S0007114511002285; PROVENZA FD, 1995, J RANGE MANAGE, V48, P2, DOI 10.2307/4002498; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Raubenheimer David, 2006, Notornis, V53, P100; Raubenheimer D, 2012, PHILOS T R SOC B, V367, P1628, DOI 10.1098/rstb.2012.0007; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; REGELIN WL, 1985, J WILDLIFE MANAGE, V49, P388, DOI 10.2307/3801539; Robbins CT, 2007, OIKOS, V116, P1675, DOI 10.1111/j.0030-1299.2007.16140.x; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Schwartz C. C., 1988, Alces, V24, P178; SCHWARTZ CC, 1987, J WILDLIFE MANAGE, V51, P352, DOI 10.2307/3801015; SCHWARTZ CC, 1988, J WILDLIFE MANAGE, V52, P26, DOI 10.2307/3801052; SHAHIDI F, 1992, J AM OIL CHEM SOC, V69, P917, DOI 10.1007/BF02636344; Shipley LA, 1999, OIKOS, V84, P55, DOI 10.2307/3546866; Shipley LA, 1998, CAN J ZOOL, V76, P1722, DOI 10.1139/cjz-76-9-1722; Shochat E, 1997, ZOO BIOL, V16, P479, DOI 10.1002/(SICI)1098-2361(1997)16:6<479::AID-ZOO2>3.0.CO;2-7; Simpson R. J., 2012, NATURE NUTR UNIFYING; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; SMHI, 2013, KLIM ARS MAN; SOPPELA P, 1992, ACTA PHYSIOL SCAND, V145, P65, DOI 10.1111/j.1748-1716.1992.tb09337.x; SPALINGER DE, 1992, AM NAT, V140, P325, DOI 10.1086/285415; Stolter C, 2005, CAN J ZOOL, V83, P807, DOI [10.1139/z05-077, 10.1139/Z05-077]; THONNEY ML, 1976, J ANIM SCI, V43, P692, DOI 10.2527/jas1976.433692x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; vanWieren SE, 1996, FOREST ECOL MANAG, V88, P149, DOI 10.1016/S0378-1127(96)03877-7; Villalba JJ, 2005, J CHEM ECOL, V31, P123, DOI 10.1007/s10886-005-0979-z; VIVAS HJ, 1991, J ANIM ECOL, V60, P395, DOI 10.2307/5286; Wam HK, 2010, EUR J WILDLIFE RES, V56, P745, DOI 10.1007/s10344-010-0370-4; Wam HK, 2010, RANGELAND ECOL MANAG, V63, P387, DOI 10.2111/REM-D-09-00039.1; Weber ML, 1998, CAN J ZOOL, V76, P1141, DOI 10.1139/cjz-76-6-1141; Webster JR, 2000, ANIM SCI, V70, P547, DOI 10.1017/S1357729800051894; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908	91	30	32	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150870	10.1371/journal.pone.0150870	http://dx.doi.org/10.1371/journal.pone.0150870			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986618	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300032
J	de Moura-Tonello, SCG; Porta, A; Marchi, A; Fagundes, AD; Francisco, CD; Rehder-Santos, P; Milan-Mattos, JC; Simoes, RP; Gois, MD; Catai, AM				Garcia de Moura-Tonello, Silvia Cristina; Porta, Alberto; Marchi, Andrea; Fagundes, Alessandra de Almeida; Francisco, Cristina de Oliveira; Rehder-Santos, Patricia; Milan-Mattos, Juliana Cristina; Simoes, Rodrigo Polaquini; Gois, Mariana de Oliveira; Catai, Aparecida Maria			Cardiovascular Variability Analysis and Baroreflex Estimation in Patients with Type 2 Diabetes in Absence of Any Manifest Neuropathy	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ARTERIAL-PRESSURE; SPECTRAL-ANALYSIS; SENSITIVITY; SYSTEM; DOMAIN; PERIOD; TIME	Introduction Indexes derived from spontaneous heart period (HP) and systolic arterial pressure (SAP) fluctuations can detect autonomic dysfunction in individuals with type 2 diabetes mellitus (DM) associated to cardiovascular autonomic neuropathy (CAN) or other neuropathies. It is unknown whether HP and SAP variability indexes are sensitive enough to detect the autonomic dysfunction in DM patients without CAN and other neuropathies. Methods We evaluated 68 males aged between 40 and 65 years. The group was composed by DM type 2 DM with no manifest neuropathy (n = 34) and healthy (H) subjects (n = 34). The protocol consisted of 15 minutes of recording of HP and SAP variabilities at rest in supine position (REST) and after active standing (STAND). The HP power in the high frequency band (HF, from 0.15 to 0.5 Hz), the SAP power in the low frequency band (LF, from 0.04 to 0.15 Hz) and BRS estimated via spectral approach and sequence method were computed. Results The HF power of HP was lower in DM patients than in H subjects, while the two groups exhibited comparable HF power of HP during STAND. The LF power of SAP was similar in DM and H groups at REST and increased during STAND in both groups. BRSs estimated in the HF band and via baroreflex sequence method were lower in DM than in H and they decreased further during STAND in both populations. Conclusion Results suggest that vagal control of heart rate and cardiac baroreflex control was impaired in type 2 DM, while sympathetic control directed to vessels, sympathetic and baroreflex response to STAND were preserved. Cardiovascular variability indexes are sensitive enough to typify the early, peculiar signs of autonomic dysfunction in type-2 DM patients well before CAN becomes manifest.	[Garcia de Moura-Tonello, Silvia Cristina; Fagundes, Alessandra de Almeida; Francisco, Cristina de Oliveira; Rehder-Santos, Patricia; Milan-Mattos, Juliana Cristina; Simoes, Rodrigo Polaquini; Gois, Mariana de Oliveira; Catai, Aparecida Maria] Univ Fed Sao Carlos, Dept Phys Therapy, BR-13560 Sao Carlos, Brazil; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Marchi, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy	Universidade Federal de Sao Carlos; University of Milan; IRCCS Policlinico San Donato; Polytechnic University of Milan	Catai, AM (corresponding author), Univ Fed Sao Carlos, Dept Phys Therapy, BR-13560 Sao Carlos, Brazil.	mcatai@ufscar.br	Catai, Aparecida Maria/G-4612-2012; Rehder-Santos, Patricia/M-8642-2019; Simões, Rodrigo/B-7133-2013; Marchi, Andrea/J-7205-2016	Rehder-Santos, Patricia/0000-0001-5838-6936; Marchi, Andrea/0000-0001-5846-4164	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUXPE-CSF-PVE) [23038.007721/2013-4]; CAPES [99999.007781/2014-08]; Sao Paulo Foundation for Research Support/ Brasil (FAPESP) [2010/52070-4, 2013/07953-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUXPE-CSF-PVE)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Foundation for Research Support/ Brasil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	The research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, AUXPE-CSF-PVE, #23038.007721/2013-4) to Aparecida M. Catai and Alberto Porta, CAPES (#99999.007781/2014-08) to Silvia Cristina Garcia Moura-Tonello and Sao Paulo Foundation for Research Support/ Brasil (FAPESP, #2010/52070-4 and #2013/07953-3) to Aparecida M. Catai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Camm AJ, 1996, CIRCULATION, V93, P1043; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P352, DOI 10.1007/BF02441589; Ducher M, 1999, DIABETES CARE, V22, P388, DOI 10.2337/diacare.22.3.388; EWING DJ, 1981, LANCET, V1, P183; Frattola A, 1997, DIABETOLOGIA, V40, P1470, DOI 10.1007/s001250050851; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Javorka M, 2005, CLIN PHYSIOL FUNCT I, V25, P270, DOI 10.1111/j.1475-097X.2005.00623.x; Kaminska Anna, 2008, Endokrynol Pol, V59, P398; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Matsushima R, 2004, CLIN AUTON RES, V14, P376, DOI 10.1007/s10286-004-0182-2; Middlekauff HR, 2014, J AM COLL CARDIOL, V64, P1740, DOI 10.1016/j.jacc.2014.06.1201; Moura-Tonello SCG, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-13; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nollo G, 2005, AM J PHYSIOL-HEART C, V288, pH1777, DOI 10.1152/ajpheart.00594.2004; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pereira JG, 2008, REV ESPACO SAUDE, V10, P7; Perseguini NM, 2011, BRAZ J MED BIOL RES, V44, P29, DOI 10.1590/S0100-879X2011000100005; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 1998, MED BIOL ENG COMPUT, V36, P35, DOI 10.1007/BF02522855; Porta A, 2002, BIOL CYBERN, V86, P241, DOI 10.1007/s00422-001-0292-z; Porta A, 2013, J APPL PHYSIOL, V115, P1032, DOI 10.1152/japplphysiol.00537.2013; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; Robertson D, 2012, AUTON NEUROSCI-BASIC, V172, P1, DOI 10.1016/j.autneu.2012.10.010; Rowaiye OO, 2013, CARDIOL J, V20, P453, DOI 10.5603/CJ.2013.0130; Ruiz J, 2005, HYPERTENSION, V46, P162, DOI 10.1161/01.HYP.0000169053.14440.7d; Sanya EO, 2003, EUR J CLIN INVEST, V33, P582, DOI 10.1046/j.1365-2362.2003.01170.x; Svacinova J, 2013, PHYSIOL RES, V62, P605, DOI 10.33549/physiolres.932510; Tank J, 2001, AM J MED SCI, V322, P24, DOI 10.1097/00000441-200107000-00005; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949; Vinik AI, 2013, ENDOCRIN METAB CLIN, V42, P747, DOI 10.1016/j.ecl.2013.06.001; Vinik AI, 2001, CLEV CLIN J MED, V68, P928, DOI 10.3949/ccjm.68.11.928; Ziegler D, 2001, CLIN AUTON RES, V11, P369, DOI 10.1007/BF02292769	38	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0148903	10.1371/journal.pone.0148903	http://dx.doi.org/10.1371/journal.pone.0148903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987126	Green Published, gold			2022-12-27	WOS:000372580300013
J	Matuszewski, DJ; Wahlby, C; Puigvert, JC; Sintorn, IM				Matuszewski, Damian J.; Wahlby, Carolina; Puigvert, Jordi Carreras; Sintorn, Ida-Maria			PopulationProfiler: A Tool for Population Analysis and Visualization of Image-Based Cell Screening Data	PLOS ONE			English	Article								Image-based screening typically produces quantitative measurements of cell appearance. Large-scale screens involving tens of thousands of images, each containing hundreds of cells described by hundreds of measurements, result in overwhelming amounts of data. Reducing per-cell measurements to the averages across the image(s) for each treatment leads to loss of potentially valuable information on population variability. We present PopulationProfiler-a new software tool that reduces per-cell measurements to population statistics. The software imports measurements from a simple text file, visualizes population distributions in a compact and comprehensive way, and can create gates for subpopulation classes based on control samples. We validate the tool by showing how PopulationProfiler can be used to analyze the effect of drugs that disturb the cell cycle, and compare the results to those obtained with flow cytometry.	[Matuszewski, Damian J.; Wahlby, Carolina; Sintorn, Ida-Maria] Sci Life Lab, Uppsala, Sweden; [Puigvert, Jordi Carreras] Sci Life Lab, Stockholm, Sweden; [Matuszewski, Damian J.; Wahlby, Carolina; Sintorn, Ida-Maria] Uppsala Univ, Dept Informat Technol, Ctr Image Anal, Uppsala, Sweden; [Puigvert, Jordi Carreras] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Stockholm, Sweden	Uppsala University; Karolinska Institutet	Matuszewski, DJ (corresponding author), Sci Life Lab, Uppsala, Sweden.; Matuszewski, DJ (corresponding author), Uppsala Univ, Dept Informat Technol, Ctr Image Anal, Uppsala, Sweden.	damian.matuszewski@it.uu.se	Sintorn, Ida-Maria/AAA-4900-2020	Sintorn, Ida-Maria/0000-0002-8307-7411; Wahlby, Carolina/0000-0002-4139-7003	Science for Life Laboratory Sweden and Swedish Research Council [2012-4968, 2014-6075]	Science for Life Laboratory Sweden and Swedish Research Council	This work was financially supported by Science for Life Laboratory Sweden and Swedish Research Council (Vetenskapsradet http://www.vr.se/) grants 2012-4968 to CW and 2014-6075 to IMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickle M, 2010, ANAL BIOANAL CHEM, V398, P219, DOI 10.1007/s00216-010-3788-3; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063583; Gough AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102678; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Ljosa V, 2013, J BIOMOL SCREEN, V18, P1321, DOI 10.1177/1087057113503553; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604	7	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151554	10.1371/journal.pone.0151554	http://dx.doi.org/10.1371/journal.pone.0151554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987120	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300085
J	Miller, ME; Rosten, P; Lemieux, ME; Lai, C; Humphries, RK				Miller, Michelle Erin; Rosten, Patty; Lemieux, Madeleine E.; Lai, Courteney; Humphries, R. Keith			Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion	PLOS ONE			English	Article							DEFINITIVE HEMATOPOIESIS; EXPRESSION; LEUKEMIA; RENEWAL; GENES; ROLES; MSI2; HOX	Meis1 is recognized as an important transcriptional regulator in hematopoietic development and is strongly implicated in the pathogenesis of leukemia, both as a Hox transcription factor co-factor and independently. Despite the emerging recognition of Meis1's importance in the context of both normal and leukemic hematopoiesis, there is not yet a full understanding of Meis1's functions and the relevant pathways and genes mediating its functions. Recently, several conditional mouse models for Meis1 have been established. These models highlight a critical role for Meis1 in adult mouse hematopoietic stemcells (HSCs) and implicate reactive oxygen species (ROS) as a mediator of Meis1 function in this compartment. There are, however, several reported differences between these studies in terms of downstream progenitor populations impacted and effectors of function. In this study, we describe further characterization of a conditional knockout model based on mice carrying a loxP-flanked exon 8 of Meis1 which we crossed onto the inducible Cre localization/expression strains, B6; 129-Gt(ROSA) 26Sortm1(Cre/ERT) Nat/J or B6. Cg-Tg(Mx1-Cre) 1Cgn/J. Findings obtained from these two inducible Meis1 knockout models confirm and extend previous reports of the essential role of Meis1 in adult HSC maintenance and expansion and provide new evidence that highlights key roles of Meis1 in both megakaryopoiesis and erythropoiesis. Gene expression analyses point to a number of candidate genes involved in Meis1's role in hematopoiesis. Our data additionally support recent evidence of a role of Meis1 in ROS regulation.	[Miller, Michelle Erin; Rosten, Patty; Lai, Courteney; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Lemieux, Madeleine E.] Bioinfo, Plantagenet, ON, Canada; [Humphries, R. Keith] Univ British Columbia, Dept Med, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Humphries, RK (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.; Humphries, RK (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	khumphri@bccrc.ca		Humphries, Richard/0000-0003-0540-7005	Michael Smith Foundation of Health Research [ST-JGS-747(06-1)BM]; Terry Fox Foundation [18006, 122869]	Michael Smith Foundation of Health Research(Michael Smith Foundation for Health Research); Terry Fox Foundation	MEM received a Trainee Award (ST-JGS-747(06-1)BM) from the Michael Smith Foundation of Health Research, http://www.msfhr.org/.KH received Terry Fox New Frontiers Program Project Grants (18006 & 122869) from the Terry Fox Foundation, http://www.terryfox.org/. Funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioinfo provided support in the form of salaries for author MEL, and MEL and Bioinfo provided microarray analysis information processing and statistical analysis pro bono and were not remunerated for the service. Bioinfo did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Argiropoulos B, 2010, BLOOD, V115, P4071, DOI 10.1182/blood-2009-06-225573; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOCKAMP EO, 1995, BLOOD, V86, P1502, DOI 10.1182/blood.V86.4.1502.bloodjournal8641502; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Cai M, 2012, BLOOD; Capron C, 2011, EXP HEMATOL, V39, P629, DOI 10.1016/j.exphem.2011.02.014; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.253; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Cvejic A, 2011, HAEMATOL-HEMATOL J, V96, P190, DOI 10.3324/haematol.2010.027698; de Andres-Aguayo L, 2012, CURR OPIN HEMATOL, V19, P268, DOI 10.1097/MOH.0b013e328353c778; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; KRYSTAL G, 1994, J EXP MED, V180, P851, DOI 10.1084/jem.180.3.851; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Lieu YK, 2009, P NATL ACAD SCI USA, V106, P21689, DOI 10.1073/pnas.0907623106; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; PAWLIUK R, 1994, BLOOD, V84, P2868, DOI 10.1182/blood.V84.9.2868.bloodjournal8492868; Roychoudhury J, 2015, BLOOD, V125, P2544, DOI 10.1182/blood-2014-09-599258; Sardina JL, 2012, CRIT REV ONCOL HEMAT, V81, P257, DOI 10.1016/j.critrevonc.2011.03.005; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Wang GG, 2006, MOL CELL BIOL, V26, P3902, DOI 10.1128/MCB.26.10.3902-3916.2006; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151584	10.1371/journal.pone.0151584	http://dx.doi.org/10.1371/journal.pone.0151584			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986211	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300090
J	Stucchi, N; Scocchia, L; Carlini, A				Stucchi, Natale; Scocchia, Lisa; Carlini, Alessandro			When Geometry Constrains Vision: Systematic Misperceptions within Geometrical Configurations	PLOS ONE			English	Article							SACCADIC LOCALIZATION; VISUAL-PERCEPTION; SPATIAL-RESOLUTION; GESTALT PSYCHOLOGY; EYE-MOVEMENTS; VECTOR-FIELD; SHAPE; TARGETS; ATTENTION; ACCURACY	How accurate are we in reproducing a point within a simple shape? This is the empirical question we addressed in this work. Participants were presented with a tiny disk embedded in an empty circle (Experiment 1 and 3) or in a square (Experiment 2). Shortly afterwards the disk vanished and they had to reproduce the previously seen disk position within the empty shape by means of the mouse cursor, as accurately as possible. Several loci inside each shape were tested. We found that the space delimited by a circle and by a square is not homogeneous and the observed distortion appears to be consistent across observers and specific for the two tested shapes. However, a common pattern can be identified when reproducing geometrical loci enclosed in a shape: errors are shifted toward the periphery in the region around the center and toward the center in the region nearby the edges. The error absolute value declines progressively as we approach an equilibrium contour line between the center and the outline of the shape where the error is null. These results suggest that enclosing an empty space within a shape imposes an organization to it and warps its metrics: not only the perceived loci inside a shape are not the same as the geometrical loci, but they are misperceived in a systematic way that is functional to the correct identification of the center of the shape. Eye movements recordings (Experiment 3) are consistent with this interpretation of the data.	[Stucchi, Natale; Scocchia, Lisa] Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1, I-20126 Milan, Italy; [Stucchi, Natale; Scocchia, Lisa] NeuroMi Milan Ctr Neurosci, Milan, Italy; [Carlini, Alessandro] Univ Burgundy, CNRS, Lab Res Learning & Dev LEAD, UMR 5022, Dijon, France	University of Milano-Bicocca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne	Scocchia, L (corresponding author), Univ Milano Bicocca, Dept Psychol, Piazza Ateneo Nuovo 1, I-20126 Milan, Italy.; Scocchia, L (corresponding author), NeuroMi Milan Ctr Neurosci, Milan, Italy.	lisa.scocchia@unimib.it	Carlini, Alessandro/GXF-8404-2022	Stucchi, Natale/0000-0002-7695-4068				Arnheim R., 1982, POWER CTR; Arnheim R, 1988, POWER CTR STUDY COMP, P239; Arnheim R., 1969, VISUAL THINKING, P345; Arnheim R, 1974, ART VISUAL PERCEPTIO, P508; ATTNEAVE F, 1955, Am J Psychol, V68, P209, DOI 10.2307/1418892; ATTNEAVE F, 1955, Am J Psychol, V68, P69, DOI 10.2307/1418390; BENJAFIELD J, 1980, CAN J PSYCHOL, V34, P253, DOI 10.1037/h0081053; BLUM H, 1973, J THEOR BIOL, V38, P205, DOI 10.1016/0022-5193(73)90175-6; BLUM H, 1974, ANN NY ACAD SCI, V231, P19, DOI 10.1111/j.1749-6632.1974.tb20549.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JF, 1937, AM J PSYCHOL, V49, P543, DOI 10.2307/1416380; Chalupa LM, 2004, VISUAL NEUROSCIENCES, V2; Chalupa LM, 2004, VISUAL NEUROSCIENCES, V1; Findlay J. M., 2003, ACTIVE VISION PSYCHO; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; FINDLAY JM, 2003, ACTIVE VISION PSYCHO, P220; HATFIELD G, 1985, PSYCHOL BULL, V97, P155, DOI 10.1037/0033-2909.97.2.155; HE P, 1991, J OPT SOC AM A, V8, P440, DOI 10.1364/JOSAA.8.000440; Kanizsa G., 1979, ORG VISION; Kleiner M, 2014, PSYCHTOOLBOX 3; Kohler W., 1920, SOURCE BOOK GESTALT; Kohler W, 1940, DYNAMICS PSYCHOL LIV; Kohler W, 1930, YALE REV, V19, P560; KOWLER E, 1995, VISION RES, V35, P1741, DOI 10.1016/0042-6989(94)00255-K; LASHLEY KS, 1951, PSYCHOL REV, V58, P123, DOI 10.1037/h0056603; McGowan JW, 1998, VISION RES, V38, P895, DOI 10.1016/S0042-6989(97)00232-0; Melcher D, 1999, VISION RES, V39, P2929, DOI 10.1016/S0042-6989(99)00029-2; Orbison WD, 1939, AM J PSYCHOL, V52, P31, DOI 10.2307/1416658; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PSOTKA J, 1978, J EXP PSYCHOL HUMAN, V4, P101, DOI 10.1037/0096-1523.4.1.101; Sickles WR, 1942, J EXP PSYCHOL, V30, P84, DOI 10.1037/h0057731; SPERRY RW, 1955, J COMP PHYSIOL PSYCH, V48, P463, DOI 10.1037/h0046231; STADLER M, 1991, PSYCHOL RES-PSYCH FO, V53, P102, DOI 10.1007/BF01371818; Stucchi N, 2010, PERCEPTION, V39, P1026, DOI 10.1068/p6665; Vishwanath D, 2003, VISION RES, V43, P1637, DOI 10.1016/S0042-6989(03)00168-8; Vishwanath D, 2004, J VISION, V4, P445, DOI 10.1167/4.6.4; Vishwanath D, 2000, VISION RES, V40, P2797, DOI 10.1016/S0042-6989(00)00118-8; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Wardak C, 2011, NEUROPSYCHOLOGIA, V49, P535, DOI 10.1016/j.neuropsychologia.2010.12.008; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]; Wertheimer M, 1938, LAWS ORG PERCEPTUAL; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wertheimer Max, 1925, PHILOS Z FORSCHUNG A, V1, P39; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Yeshurun Y, 2008, PERCEPT PSYCHOPHYS, V70, P104, DOI 10.3758/PP.70.1.104; YOKOSE Z, 1965, JPN PSYCHOL RES, V7, P101, DOI 10.4992/psycholres1954.7.101; Yokose Z, 1957, PSYCHOLOGIA, V1, P17	48	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151488	10.1371/journal.pone.0151488	http://dx.doi.org/10.1371/journal.pone.0151488			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986214	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300078
J	Kulkarni, H; Mamtani, M; Peralta, J; Almeida, M; Dyer, TD; Goring, HH; Johnson, MP; Duggirala, R; Mahaney, MC; Olvera, RL; Almasy, L; Glahn, DC; Williams-Blangero, S; Curran, JE; Blangero, J				Kulkarni, Hemant; Mamtani, Manju; Peralta, Juan; Almeida, Marcio; Dyer, Thomas D.; Goring, Harald H.; Johnson, Matthew P.; Duggirala, Ravindranath; Mahaney, Michael C.; Olvera, Rene L.; Almasy, Laura; Glahn, David C.; Williams-Blangero, Sarah; Curran, Joanne E.; Blangero, John			Soluble Forms of Intercellular and Vascular Cell Adhesion Molecules Independently Predict Progression to Type 2 Diabetes in Mexican American Families	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; E-SELECTIN; ELEVATED CONCENTRATIONS; SERUM CONCENTRATIONS; CIRCULATING LEVELS; OXIDATIVE STRESS; INFLAMMATION; MARKERS	Objective While the role of type 2 diabetes (T2D) in inducing endothelial dysfunction is fairly well-established the etiological role of endothelial dysfunction in the onset of T2D is still a matter of debate. In the light of conflicting evidence in this regard, we conducted a prospective study to determine the association of circulating levels of soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vessel cell adhesion molecule 1 (sVCAM-1) with incident T2D. Methods Data from this study came from 1,269 Mexican Americans of whom 821 initially T2D-free individuals were longitudinally followed up in the San Antonio Family Heart Study. These individuals were followed for 9752.95 person-years for development of T2D. Prospective association of sICAM-1 and sVCAM-1 with incident T2D was studied using Kaplan-Meier survival plots and mixed effects Cox proportional hazards modeling to account for related-ness among study participants. Incremental value of adhesion molecule biomarkers was studied using integrated discrimination improvement (IDI) and net reclassification improvement (NRI) indexes. Results Decreasing median values for serum concentrations of sICAM-1 and sVCAM-1 were observed in the following groups in this order: individuals with T2D at baseline, individuals who developed T2D during follow-up, individuals with prediabetes at baseline and normal glucose tolerant (NGT) individuals who remained T2D-free during follow-up. Top quartiles for sICAM-1 and sVCAM-1 were strongly and significantly associated with homeostatic model of assessment-insulin resistance (HOMA-IR). Mixed effects Cox proportional hazards modeling revealed that after correcting for important clinical confounders, high sICAM-1 and sVCAM-1 concentrations were associated with 2.52 and 1.99 times faster progression to T2D as compared to low concentrations, respectively. Individuals with high concentrations for both sICAM-1 and sVCAM-1 progressed to T2D 3.42 times faster than those with low values for both sICAM-1 and sVCAM-1. The results were similar in women in reproductive age group and the remainder of the cohort. Inclusion of sICAM-1 and sVCAM-1 in predictive models significantly improved reclassification and discrimination. The majority of these results were seen even when the analyses were restricted to NGT individuals. Conclusion Serum concentrations of sICAM-1 and sVCAM-1 independently and additively predict future T2D and represent important candidate biomarkers of T2D.	[Kulkarni, Hemant; Mamtani, Manju; Peralta, Juan; Almeida, Marcio; Dyer, Thomas D.; Goring, Harald H.; Johnson, Matthew P.; Duggirala, Ravindranath; Mahaney, Michael C.; Almasy, Laura; Williams-Blangero, Sarah; Curran, Joanne E.; Blangero, John] Univ Texas Brownsville, Rio Grande Valley Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA; [Olvera, Rene L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Glahn, David C.] Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Health San Antonio; Yale University; Hartford Hospital	Kulkarni, H (corresponding author), Univ Texas Brownsville, Rio Grande Valley Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA.	hemant.kulkarni@utrgv.edu	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021; Kulkarni, Hemant/AEM-5750-2022	Blangero, John/0000-0001-6250-5723; Peralta, Juan Manuel/0000-0002-8811-5579; Curran, Joanne/0000-0002-6898-155X	National Institutes of Health (NIH) [R01 DK082610, R01 HL045522, R01 MH078143, R01 MH078111, R01 MH083824]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078111, R01MH078143, R01MH083824] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health (NIH) grants R01 DK082610, R01 HL045522, R01 MH078143, R01 MH078111 and R01 MH083824. The funders had no role in the conduct, interpretation and publication of the results.	Adela R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/490842; Albertini JP, 1998, DIABETES CARE, V21, P1008, DOI 10.2337/diacare.21.6.1008; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Balsan GA, 2015, REV ASSOC MED BRAS, V61, P72, DOI 10.1590/1806-9282.61.01.072; Begic I, 2012, MED GLAS, V9, P32; Berezin AE, 2016, DIABETES METAB SYND, V10, pS154, DOI 10.1016/j.dsx.2015.09.016; Bonello N, 2002, HUM REPROD, V17, P2272, DOI 10.1093/humrep/17.9.2272; Boulbou MS, 2005, INT J CARDIOL, V98, P39, DOI 10.1016/j.ijcard.2003.07.037; Carbone F, 2015, CURR DRUG TARGETS, V16, P295, DOI 10.2174/1389450115666141109213439; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Chen NG, 1999, J CLIN ENDOCR METAB, V84, P3485, DOI 10.1210/jc.84.10.3485; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI DOI 10.1161/JAHA.112.000869; Matheus ASD, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/653789; Del Turco S, 2013, CURR PHARM DESIGN, V19, P2420, DOI 10.2174/1381612811319130010; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Fagard RH, 2009, PRIM CARE DIABETES, V3, P205, DOI 10.1016/j.pcd.2009.09.003; Fasching P, 1996, J CLIN ENDOCR METAB, V81, P4313, DOI 10.1210/jc.81.12.4313; Gardner AW, 2015, J VASC SURG, V61, P1249, DOI 10.1016/j.jvs.2014.02.045; Gibbons Gary H, 2004, J Clin Hypertens (Greenwich), V6, P11, DOI 10.1111/j.1524-6175.2004.03562.x; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Houghton JL, 2002, J AM COLL CARDIOL, V39, P1314, DOI 10.1016/S0735-1097(02)01781-3; Kent JW, 2007, ATHEROSCLEROSIS, V195, P367, DOI 10.1016/j.atherosclerosis.2006.10.005; Kent JW, 2004, DIABETES, V53, P2691, DOI 10.2337/diabetes.53.10.2691; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Marfella R, 2000, CIRCULATION, V101, P2247, DOI 10.1161/01.CIR.101.19.2247; Matsumoto K, 2002, ATHEROSCLEROSIS, V161, P243, DOI 10.1016/S0021-9150(01)00757-2; Matsumoto K, 2002, DIABETIC MED, V19, P822, DOI 10.1046/j.1464-5491.2002.00799.x; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Morris AA, 2012, METAB SYNDR RELAT D, V10, P252, DOI 10.1089/met.2011.0117; Nowak M, 2008, CLIN EXP MED, V8, P159, DOI 10.1007/s10238-008-0173-z; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polovina MM, 2014, POSTGRAD MED, V126, P38, DOI 10.3810/pgm.2014.03.2739; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rossi R, 2005, DIABETES CARE, V28, P702, DOI 10.2337/diacare.28.3.702; Saku K, 1999, JPN CIRC J, V63, P19, DOI 10.1253/jcj.63.19; Somigliana E, 1996, HUM REPROD, V11, P1190; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59; Therneau T, 2012, COXME MIXED EFFECTS; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Vigano P, 2000, OBSTET GYNECOL, V95, P115, DOI 10.1016/S0029-7844(99)00465-2; Voruganti VS, 2008, J MOL MED, V86, P303, DOI 10.1007/s00109-007-0273-3; Wallen NH, 1999, EUR HEART J, V20, P1039; Wei XM, 2015, DIABETES RES CLIN PR, V107, P9, DOI 10.1016/j.diabres.2014.09.019; Weyer C, 2002, ATHEROSCLEROSIS, V161, P233, DOI 10.1016/S0021-9150(01)00626-8; Zeitler H, 1997, Eur J Med Res, V2, P389; Zhao JH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S127	54	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151177	10.1371/journal.pone.0151177	http://dx.doi.org/10.1371/journal.pone.0151177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007680	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200043
J	Levy-Tzedek, S; Maidenbaum, S; Amedi, A; Lackner, J				Levy-Tzedek, S.; Maidenbaum, S.; Amedi, A.; Lackner, J.			Aging and Sensory Substitution in a Virtual Navigation Task	PLOS ONE			English	Article							AGE-DIFFERENCES; SPATIAL MEMORY; COGNITION; LOCALIZATION; ENVIRONMENT; BEHAVIOR; EYECANE; SYSTEMS; DEVICE	Virtual environments are becoming ubiquitous, and used in a variety of contexts-from entertainment to training and rehabilitation. Recently, technology for making them more accessible to blind or visually impaired users has been developed, by using sound to represent visual information. The ability of older individuals to interpret these cues has not yet been studied. In this experiment, we studied the effects of age and sensory modality (visual or auditory) on navigation through a virtual maze. We added a layer of complexity by conducting the experiment in a rotating room, in order to test the effect of the spatial bias induced by the rotation on performance. Results from 29 participants showed that with the auditory cues, it took participants a longer time to complete the mazes, they took a longer path length through the maze, they paused more, and had more collisions with the walls, compared to navigation with the visual cues. The older group took a longer time to complete the mazes, they paused more, and had more collisions with the walls, compared to the younger group. There was no effect of room rotation on the performance, nor were there any significant interactions among age, feedback modality and room rotation. We conclude that there is a decline in performance with age, and that while navigation with auditory cues is possible even at an old age, it presents more challenges than visual navigation.	[Levy-Tzedek, S.] Ben Gurion Univ Negev, Dept Phys Therapy, Recanati Sch Community Hlth Profess, IL-84105 Beer Sheva, Israel; [Levy-Tzedek, S.] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Maidenbaum, S.; Amedi, A.] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Amedi, A.] Hebrew Univ Jerusalem, Fac Humanities, Dept Cognit Sci, Jerusalem, Israel; [Amedi, A.] Univ Paris 06, Inst Vis, Univ Sorbonne, Paris, France; [Lackner, J.] Brandeis Univ, Dept Physiol, Ashton Graybiel Spatial Orientat Lab, Waltham, MA USA	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; UDICE-French Research Universities; Sorbonne Universite; Brandeis University	Levy-Tzedek, S (corresponding author), Ben Gurion Univ Negev, Dept Phys Therapy, Recanati Sch Community Hlth Profess, IL-84105 Beer Sheva, Israel.; Levy-Tzedek, S (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.	Shelly@bgu.ac.il	Maidenbaum, Shachar/K-4277-2019; Levy-Tzedek, Shelly/E-8612-2017	Maidenbaum, Shachar/0000-0002-2078-3896; Amedi, Amir/0000-0001-5042-2533	Brandeis-Leir foundation; Brandeis-Bronfman foundation; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center of the Ben-Gurion University of the Negev; Promobilia Foundation	Brandeis-Leir foundation; Brandeis-Bronfman foundation; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center of the Ben-Gurion University of the Negev; Promobilia Foundation	The Brandeis-Leir foundation (SL, AA, JL) and the Brandeis-Bronfman foundation (SL, JL) provided funding for this experiment. The research was partially supported by the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center of the Ben-Gurion University of the Negev (SL). The support of the Promobilia Foundation is gratefully acknowledged (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Boot WR, 2011, FRONT PSYCHOL, P2; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Carriot J, 2011, EXP BRAIN RES, V209, P415, DOI 10.1007/s00221-011-2567-5; Dehaene S, 2010, NEUROIMAGE, V49, P1837, DOI 10.1016/j.neuroimage.2009.09.024; Goeke C, 2015, SCI REPORTS, P5; Hartshorne Joshua K, 2015, PSYCHOL SCI; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Iaria G, 2009, BEHAV BRAIN RES, V196, P187, DOI 10.1016/j.bbr.2008.08.040; Kimura T, 2007, ANTHROPOL SCI, V115, P67, DOI 10.1537/ase.060309; Lackner JR, 2010, EXP BRAIN RES, V202, P513, DOI 10.1007/s00221-009-2149-y; Lahav O, 2008, VIRTUAL REHABILITATI, V2008; Levy-Tzedek S, 2012, RESTOR NEUROL NEUROS, V30, P313, DOI 10.3233/RNN-2012-110219; Levy-Tzedek S, 2012, SCI REPORTS, P2; Levy-Tzedek S, 2014, FRONTIERS NEUROSCIEN, P8; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Liu YC, 2001, ERGONOMICS, V44, P425, DOI 10.1080/00140130010011369; Loomis JM, 2012, ATTEN PERCEPT PSYCHO, V74, P1260, DOI 10.3758/s13414-012-0311-2; Mahmood O, 2009, BEHAV BRAIN RES, V205, P88, DOI 10.1016/j.bbr.2009.08.001; Maidenbaum S, 2014, MULTISENS RES, V27, P379, DOI 10.1163/22134808-00002463; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; Maidenbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072555; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; Moffat SD, 2006, NEUROBIOL AGING, V27, P965, DOI 10.1016/j.neurobiolaging.2005.05.011; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Ouda L, 2015, CELL TISSUE RES, P1; Park D. C., 2000, BASIC MECH ACCOUNTIN; Proulx MJ, 2016, RESTOR NEUROL NEUROS, V34, P29, DOI 10.3233/RNN-150541; Rodgers M Kirk, 2012, Neurobiol Aging, V33, DOI 10.1016/j.neurobiolaging.2010.07.021; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; SHULL PETER B., 2015, J NEUROENG REHABIL, V12, P1, DOI DOI 10.1186/S12984-015-0055-Z; Smith K, 2012, UNIVERSAL ACCESS INF, V11, P387, DOI 10.1007/s10209-011-0254-8; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; Stenfelt S, 2009, SCAND J PSYCHOL, V50, P385, DOI 10.1111/j.1467-9450.2009.00748.x; Westin T., 2010, ADV GAME ACCESSIBILI, P400; White GR., 2008, P 3 INT C DIG INT ME; Wilkniss SM, 1997, PSYCHOL AGING, V12, P372, DOI 10.1037/0882-7974.12.2.372; Yan JH, 1998, EXP AGING RES, V24, P155	42	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151593	10.1371/journal.pone.0151593	http://dx.doi.org/10.1371/journal.pone.0151593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007812	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200056
J	Nistal-Villan, E; Poutou, J; Rodriguez-Garcia, E; Bunuales, M; Carte-Abad, B; Prieto, J; Gonzalez-Aseguinolaza, G; Hernandez-Alcoceba, R; Larrea, E				Nistal-Villan, Estanislao; Poutou, Joanna; Rodriguez-Garcia, Estefania; Bunuales, Maria; Carte-Abad, Beatriz; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria; Hernandez-Alcoceba, Ruben; Larrea, Esther			A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling	PLOS ONE			English	Article							FEVER VIRUS-INFECTION; HAMSTER MESOCRICETUS-AURATUS; EXPRESSION; GENE; MICE; SYSTEM; ALPHA; CELLS; ACTIVATION; MONOCYTES	Development of reporter systems for in vivo examination of IFN-beta induction or signaling of type I interferon (IFN-I) pathways is of great interest in order to characterize biological responses to different inducers such as viral infections. Several reporter mice have been developed to monitor the induction of both pathways in response to different agonists. However, alternative strategies that do not require transgenic mice breeding have to date not been reported. In addition, detection of these pathways in vivo in animal species other than mice has not yet been addressed. Herein we describe a simple method based on the use of an adeno-associated viral vector (AAV8-3xIRF-ISRE-Luc) containing an IFN-beta induction and signaling-sensitive promoter sequence controlling the expression of the reporter gene luciferase. This vector is valid for monitoring IFN-I responses in vivo elicited by diverse stimuli in different organs. Intravenous administration of the vector in C57BL/6 mice and Syrian hamsters was able to detect activation of the IFN pathway in the liver upon systemic treatment with different pro-inflammatory agents and infection with Newcastle disease virus (NDV). In addition, intranasal instillation of AAV8-3xIRF-ISRE-Luc showed a rapid and transient IFN-I response in the respiratory tract of mice infected with the influenza A/PR8/34 virus lacking the NS1 protein. In comparison, this response was delayed and exacerbated in mice infected with influenza A/PR/8 wild type virus. In conclusion, the AAV8-3xIRF-ISRE-Luc vector offers the possibility of detecting IFN-I activation in response to different stimuli and in different animal models with no need for reporter transgenic animals.	[Nistal-Villan, Estanislao; Poutou, Joanna; Rodriguez-Garcia, Estefania; Bunuales, Maria; Carte-Abad, Beatriz; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria; Hernandez-Alcoceba, Ruben] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Regulat Gene Express Program, E-31080 Pamplona, Spain; [Larrea, Esther] Univ Navarra, Inst Salud Trop, E-31080 Pamplona, Spain; [Nistal-Villan, Estanislao; Poutou, Joanna; Rodriguez-Garcia, Estefania; Bunuales, Maria; Carte-Abad, Beatriz; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria; Hernandez-Alcoceba, Ruben; Larrea, Esther] IdiSNA Navarra Inst Hlth Res, Pamplona, Spain; [Nistal-Villan, Estanislao] Univ CEU San Pablo, Microbiol Sect, Dept Pharmaceut & Hlth Sci, Fac Pharm, Campus Monteprincipe, Madrid, Spain	University of Navarra; University of Navarra; San Pablo CEU University	Hernandez-Alcoceba, R (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Regulat Gene Express Program, E-31080 Pamplona, Spain.; Larrea, E (corresponding author), Univ Navarra, Inst Salud Trop, E-31080 Pamplona, Spain.; Hernandez-Alcoceba, R; Larrea, E (corresponding author), IdiSNA Navarra Inst Hlth Res, Pamplona, Spain.	rubenh@unav.es; elarrea@unav.es	Gonzalez-Aseguinolaza, Gloria/H-9928-2015; Nistal-Villán, Estanislao/AAM-8029-2020; Buñuales, María/P-2146-2019; Larrea, Esther/L-7586-2014; Nistal-Villan, Estanislao/GWM-7994-2022	Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Nistal-Villán, Estanislao/0000-0003-2458-8833; Buñuales, María/0000-0002-9588-9214; Larrea, Esther/0000-0002-1443-6513; Poutou Paumier, Yoanna/0000-0002-7830-6371; Prieto, Jesus/0000-0002-1091-9593; Rodriguez Garcia, Estefania/0000-0002-0578-6212	Spanish Department of Science [SAF2012-39504, SAF2012-39578]; Spanish MINECO fellowship [JCI-2011-09179]; ISCIII; FEDER [PI11/01534]; European Marie-Curie [IRG-2010-277172]	Spanish Department of Science(Spanish Government); Spanish MINECO fellowship; ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); European Marie-Curie(European Commission)	This work was funded by grants SAF2012-39504 (to RH) and SAF2012-39578 (to GG) from the Spanish Department of Science; Spanish MINECO fellowship JCI-2011-09179 and by the ISCIII, cofounded by FEDER, grant number PI11/01534 and the European Marie-Curie IRG-2010-277172 (to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda F, 2011, CANCER RES, V71, P3214, DOI 10.1158/0008-5472.CAN-10-3259; Berraondo P, 2009, EUR J PHARM SCI, V37, P418, DOI 10.1016/j.ejps.2009.03.013; Bunuales M, 2012, HUM GENE THER, V23, P1258, DOI 10.1089/hum.2012.043; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; Fioravanti J, 2011, HEPATOLOGY, V53, P1864, DOI 10.1002/hep.24306; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; GrageGriebenow E, 1996, J LEUKOCYTE BIOL, V60, P389, DOI 10.1002/jlb.60.3.389; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Iankov ID, 2006, J VIROL, V80, P8530, DOI 10.1128/JVI.00593-06; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jia WZ, 2008, MOL IMMUNOL, V45, P2419, DOI 10.1016/j.molimm.2007.11.011; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kumar R, 2012, APPL BIOCHEM BIOTECH, V167, P2005, DOI 10.1007/s12010-012-9700-1; Larrea E, 2006, GUT, V55, P1188, DOI 10.1136/gut.2005.070060; Larrea E, 2014, GUT, V63, P665, DOI 10.1136/gutjnl-2012-304377; Li GY, 2008, INT J CLIN EXP PATHO, V1, P169; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; Nistal-Villan E, 2015, J INNATE IMMUN, V7, P466, DOI 10.1159/000375262; Paessler S, 2004, J INFECT DIS, V189, P2072, DOI 10.1086/383246; Paneda A, 2011, HUM GENE THER, V22, P999, DOI 10.1089/hum.2010.190; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Poupiot J, 2011, METHODS MOL BIOL, V709, P63, DOI 10.1007/978-1-61737-982-6_4; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Sbrana E, 2006, AM J TROP MED HYG, V74, P1084, DOI 10.4269/ajtmh.2006.74.1084; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Simmons DJ, 1997, J BIOMED MATER RES, V34, P393, DOI 10.1002/(SICI)1097-4636(19970305)34:3<393::AID-JBM14>3.0.CO;2-H; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Unzu C, 2011, MOL THER, V19, P243, DOI 10.1038/mt.2010.210; Vanrell L, 2011, MOL THER, V19, P1245, DOI 10.1038/mt.2011.37	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152031	10.1371/journal.pone.0152031	http://dx.doi.org/10.1371/journal.pone.0152031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007218	Green Published, gold			2022-12-27	WOS:000372701200088
J	Bigorgne, AE; John, B; Ebrahimkhani, MR; Shimizu-Albergine, M; Campbell, JS; Crispe, IN				Bigorgne, Amelie E.; John, Beena; Ebrahimkhani, Mohammad R.; Shimizu-Albergine, Masami; Campbell, Jean S.; Crispe, Ian N.			TLR4-Dependent Secretion by Hepatic Stellate Cells of the Neutrophil-Chemoattractant CXCL1 Mediates Liver Response to Gut Microbiota	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOTHELIAL-CELLS; INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; TLR4; INFILTRATION; CHEMOKINE; FIBROSIS; MICE	Background & Aims The gut microbiota significantly influences hepatic immunity. Little is known on the precise mechanism by which liver cells mediate recognition of gut microbes at steady state. Here we tested the hypothesis that a specific liver cell population was the sensor and we aimed at deciphering the mechanism by which the activation of TLR4 pathway would mediate liver response to gut microbiota. Methods Using microarrays, we compared total liver gene expression in WT versus TLR4 deficient mice. We performed in situ localization of the major candidate protein, CXCL1. With an innovative technique based on cell sorting, we harvested enriched fractions of KCs, LSECs and HSCs from the same liver. The cytokine secretion profile was quantified in response to low levels of LPS (1ng/mL). Chemotactic activity of stellate cell-derived CXCL1 was assayed in vitro on neutrophils upon TLR4 activation. Results TLR4 deficient liver had reduced levels of one unique chemokine, CXCL1 and subsequent decreased of neutrophil counts. Depletion of gut microbiota mimicked TLR4 deficient phenotype, i.e., decreased neutrophils counts in the liver. All liver cells were responsive to low levels of LPS, but hepatic stellate cells were the major source of chemotactic levels of CXCL1. Neutrophil migration towards secretory hepatic stellate cells required the TLR4 dependent secretion of CXCL1. Conclusions Showing the specific activation of TLR4 and the secretion of one major functional chemokine-CXCL1, the homolog of human IL-8-, we elucidate a new mechanism in which Hepatic Stellate Cells play a central role in the recognition of gut microbes by the liver at steady state.	[Bigorgne, Amelie E.; John, Beena; Ebrahimkhani, Mohammad R.; Crispe, Ian N.] Seattle Biomed Res Inst, 307 North Westlake Ave, Seattle, WA 98109 USA; [Shimizu-Albergine, Masami; Campbell, Jean S.; Crispe, Ian N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [John, Beena] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Ebrahimkhani, Mohammad R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Shimizu-Albergine, Masami] Univ Washington, Dept Pharmacol, Med Ctr, Seattle, WA 98195 USA; [Crispe, Ian N.] Univ Washington, Dept Pathol, Med Ctr, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Pennsylvania; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bigorgne, AE (corresponding author), Seattle Biomed Res Inst, 307 North Westlake Ave, Seattle, WA 98109 USA.	amelie.bigorgne@inserm.fr		Campbell, Jean/0000-0002-9187-2204; Ebrahimkhani, Mo R./0000-0001-5753-6779	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R01AI072049]; INC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072049] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); INC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health Grant #1R01AI072049. INC received the funding.	Bigorgne A.E., 2010, GASTROENTEROL RES PR, V2010; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Dunham RM, 2013, J IMMUNOL, V190, P2009, DOI 10.4049/jimmunol.1201937; Henao-Mejia J, 2013, ADV IMMUNOL, V117, P73, DOI 10.1016/B978-0-12-410524-9.00003-7; John B, 2005, J IMMUNOL, V175, P1643, DOI 10.4049/jimmunol.175.3.1643; John B, 2007, HEPATOLOGY, V45, P178, DOI 10.1002/hep.21446; Knolle PA, 2001, TRENDS IMMUNOL, V22, P432, DOI 10.1016/S1471-4906(01)01957-3; Le Roy T, 2012, GUT, V0, P1; Lisbonne M, 2011, EUR J IMMUNOL, V41, P1720, DOI 10.1002/eji.201041006; Lu YZ, 2012, LAB INVEST, V92, P783, DOI 10.1038/labinvest.2012.11; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Maher JJ, 1998, AM J PHYSIOL-GASTR L, V275, pG847, DOI 10.1152/ajpgi.1998.275.4.G847; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Mosher B, 2001, J SURG RES, V99, P201, DOI 10.1006/jsre.2001.6217; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Quigley EMM, 2013, J HEPATOL, V58, P1020, DOI 10.1016/j.jhep.2012.11.023; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; SHIRATORI Y, 1994, BIOCHEM BIOPH RES CO, V203, P1398, DOI 10.1006/bbrc.1994.2340; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Tillack K, 2012, J IMMUNOL, V188, P3150, DOI 10.4049/jimmunol.1103414; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; Wang FL, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-284; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	30	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151063	10.1371/journal.pone.0151063	http://dx.doi.org/10.1371/journal.pone.0151063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002851	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400023
J	Hanzlicek, GA; Raghavan, RK; Ganta, RR; Anderson, GA				Hanzlicek, Gregg A.; Raghavan, Ram K.; Ganta, Roman R.; Anderson, Gary A.			Bayesian Space-Time Patterns and Climatic Determinants of Bovine Anaplasmosis	PLOS ONE			English	Article							LONE STAR TICK; MODEL; DISEASE; MAXIMUM; RISK	The space-time pattern and environmental drivers (land cover, climate) of bovine anaplasmosis in the Midwestern state of Kansas was retrospectively evaluated using Bayesian hierarchical spatio-temporal models and publicly available, remotely-sensed environmental covariate information. Cases of bovine anaplasmosis positively diagnosed at Kansas State Veterinary Diagnostic Laboratory (n = 478) between years 2005-2013 were used to construct the models, which included random effects for space, time and space-time interaction effects with defined priors, and fixed-effect covariates selected a priori using an univariate screening procedure. The Bayesian posterior median and 95% credible intervals for the space-time interaction term in the best-fitting covariate model indicated a steady progression of bovine anaplasmosis over time and geographic area in the state. Posterior median estimates and 95% credible intervals derived for covariates in the final covariate model indicated land surface temperature (minimum), relative humidity and diurnal temperature range to be important risk factors for bovine anaplasmosis in the study. The model performance measured using the Area Under the Curve (AUC) value indicated a good performance for the covariate model (>0.7). The relevance of climatological factors for bovine anaplasmosis is discussed.	[Hanzlicek, Gregg A.; Raghavan, Ram K.; Anderson, Gary A.] Kansas State Univ, Coll Vet Med, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA; [Hanzlicek, Gregg A.; Raghavan, Ram K.; Anderson, Gary A.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Raghavan, Ram K.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA.; Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.; Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA.	rkraghavan@vet.k-state.edu		Raghavan, Ram/0000-0002-2657-3398				[Anonymous], 2013, BAYESIAN DIS MAPPING; Beckham TR., 2015, VECTOR-BORNE ZOONOT, V15, P453; Berger KA, 2013, INT J REMOTE SENS, V34, P73, DOI 10.1080/01431161.2012.705447; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Cressie N., 1992, TERRA NOVA, V4, P613, DOI DOI 10.1111/J.1365-3121.1992.TB00605.X; Fan Jerome, 2006, CJEM, V8, P19; Goodin DouglasG., 2004, CLIMATE WEATHER ATLA; HAIR JA, 1975, J MED ENTOMOL, V12, P37, DOI 10.1093/jmedent/12.1.37; Hayhoe K, 2015, CLIMATE CHANGE MIDWE; Jonsson NN, 2000, VET J, V160, P87; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Knorr-Held L, 1998, STAT MED, V17, P2045, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2045::AID-SIM943>3.0.CO;2-P; KOCAN KM, 1981, AM J VET RES, V42, P15; Kocan KM, 2010, CURRENT CHALLENGES M; Land Processes Distributed Active Archive Center, MODIS OV; McGarigal K., 2012, TECH REP; Potgieter F. T., 2004, Infectious diseases of livestock, Volume One, P594; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P205, DOI 10.1089/vbz.2015.1837; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Raghavan RK, 2014, VECTOR-BORNE ZOONOT, V14, P486, DOI 10.1089/vbz.2013.1496; Rodgers SE, 2007, J MED ENTOMOL, V44, P372, DOI 10.1603/0022-2585(2007)44[372:DOETSA]2.0.CO;2; Rynkiewicz EC, 2014, EXP APPL ACAROL, V64, P109, DOI 10.1007/s10493-014-9798-7; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schoof J., 2013, CLIMATE CHANGE MIDWE, V146, P146; SCHWARTZ MD, 1995, ANN ASSOC AM GEOGR, V85, P553, DOI 10.1111/j.1467-8306.1995.tb01812.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Springer YP, 2015, AM J TROP MED HYG, V93, P875, DOI 10.4269/ajtmh.15-0330; Suss J, 2008, J TRAVEL MED, V15, P39, DOI 10.1111/j.1708-8305.2007.00176.x; White JW, 2008, AGR FOREST METEOROL, V148, P1574, DOI 10.1016/j.agrformet.2008.05.017; White JW, 2011, AGRON J, V103, P1242, DOI 10.2134/agronj2011.0038; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Yoder JA, 2012, INT J ACAROL, V38, P334, DOI 10.1080/01647954.2011.647073	35	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151924	10.1371/journal.pone.0151924	http://dx.doi.org/10.1371/journal.pone.0151924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003596	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400057
J	Itonaga, M; Matsuzaki, I; Warigaya, K; Tamura, T; Shimizu, Y; Fujimoto, M; Kojima, F; Ichinose, M; Murata, S				Itonaga, Masahiro; Matsuzaki, Ibu; Warigaya, Kenji; Tamura, Takaaki; Shimizu, Yuki; Fujimoto, Masakazu; Kojima, Fumiyoshi; Ichinose, Masao; Murata, Shin-ichi			Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							K-RAS MUTATIONS; POLYMERASE-CHAIN-REACTION; COLORECTAL-CANCER; SENSITIVE DETECTION; PANCREATIC-CANCER; LUNG-CANCER; PCR; ASSAY; DNA; FLUORESCENCE	Detecting point mutation of human cancer cells quickly and accurately is gaining in importance for pathological diagnosis and choice of therapeutic approach. In the present study, we present novel methodology, peptide nucleic acid-locked nucleic acid mediated loop-mediated isothermal amplification (PNA-LNA mediated LAMP), for rapid detection of KRAS mutation using advantages of both artificial DNA and LAMP. PNA-LNA mediated LAMP reactions occurred under isothermal temperature conditions of with 4 primary primers set for the target regions on the KRAS gene, clamping PNA probe that was complimentary to the wild type sequence and LNA primers complementary to the mutated sequences. PNA-LNA mediated LAMP was applied for cDNA from 4 kinds of pancreatic carcinoma cell lines with or without KRAS point mutation. The amplified DNA products were verified by naked-eye as well as a real-time PCR equipment. By PNA-LNA mediated LAMP, amplification of wild type KRAS DNA was blocked by clamping PNA probe, whereas, mutant type KRAS DNA was significantly amplified within 50 min. Mutant alleles could be detected in samples which diluted until 0.1% of mutant-to-wild type ratio. On the other hand, mutant alleles could be reproducibly with a mutant-to-wild type ratio of 30% by direct sequencing and of 1% by PNA-clamping PCR. The limit of detection (LOD) of PNA-LNA mediated LAMP was much lower than the other conventional methods. Competition of LNA clamping primers complementary to two different subtypes (G12D and G12V) of mutant KRAS gene indicated different amplification time depend on subtypes of mutant cDNA. PNA-LNA mediated LAMP is a simple, rapid, specific and sensitive methodology for the detection of KRAS mutation.	[Itonaga, Masahiro; Matsuzaki, Ibu; Warigaya, Kenji; Tamura, Takaaki; Shimizu, Yuki; Fujimoto, Masakazu; Kojima, Fumiyoshi; Murata, Shin-ichi] Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan; [Itonaga, Masahiro; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Murata, S (corresponding author), Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan.	smurata@wakayama-med.ac.jp	Itonaga, Masahiro/AAK-6905-2021; Ichinose, Masao/HAB-1645-2022					Anderson SM, 2011, EXPERT REV MOL DIAGN, V11, P635, DOI [10.1586/erm.11.42, 10.1586/ERM.11.42]; Anker P, 1997, GASTROENTEROLOGY, V112, P1114, DOI 10.1016/S0016-5085(97)70121-5; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-227; Bournet B, 2009, ENDOSCOPY, V41, P552, DOI 10.1055/s-0029-1214717; DEMERS DB, 1995, NUCLEIC ACIDS RES, V23, P3050, DOI 10.1093/nar/23.15.3050; Dieterle CP, 2004, CLIN CANCER RES, V10, P641, DOI 10.1158/1078-0432.CCR-1355-02; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; HANVEY JC, 1992, SCIENCE, V258, P1481, DOI 10.1126/science.1279811; Hirsch FR, 2001, CLIN CANCER RES, V7, P5; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kyger EM, 1998, ANAL BIOCHEM, V260, P142, DOI 10.1006/abio.1998.2687; Li JY, 2013, J VIROL METHODS, V193, P583, DOI 10.1016/j.jviromet.2013.07.059; Minnucci G, 2012, HAEMATOL-HEMATOL J, V97, P1394, DOI 10.3324/haematol.2011.056184; MOTOJIMA K, 1991, AM J GASTROENTEROL, V86, P1784; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Pan L, 2015, PEST MANAG SCI, V71, P123, DOI 10.1002/ps.3777; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Srivastava S, 2001, CLIN CANCER RES, V7, P1118; Sun XY, 2002, NAT BIOTECHNOL, V20, P186, DOI 10.1038/nbt0202-186; Taback B, 2004, INT J CANCER, V111, P409, DOI 10.1002/ijc.20268; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; Wen Pan J-YW, 2011, J ANIMAL VET ADV, V10; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Yoneda A, 2014, J SURG RES, V187, pE1, DOI 10.1016/j.jss.2013.01.001	32	40	44	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151654	10.1371/journal.pone.0151654	http://dx.doi.org/10.1371/journal.pone.0151654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999437	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700052
J	Ramachandran, G; Tennant, SM; Boyd, MA; Wang, JY; Tulapurkar, ME; Pasetti, MF; Levine, MM; Simon, R				Ramachandran, Girish; Tennant, Sharon M.; Boyd, Mary A.; Wang, Jin Y.; Tulapurkar, Mohan E.; Pasetti, Marcela F.; Levine, Myron M.; Simon, Raphael			Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INVASIVE NONTYPHOIDAL SALMONELLA; ELECTRON CRYOMICROSCOPY; CONJUGATE VACCINE; ATOMIC MODEL; INFECTION; PROTECTION; FEVER; VIRULENCE; MACROPHAGES	Non-typhoidal Salmonella (NTS) serovars Typhimurium and Enteritidis are major causes of invasive bacterial infections in children under 5 years old in sub-Saharan Africa, with case fatality rates of similar to 20%. There are no licensed NTS vaccines for humans. Vaccines that induce antibodies against a Salmonella Typhi surface antigen, Vi polysaccharide, significantly protect humans against typhoid fever, establishing that immune responses to Salmonella surface antigens can be protective. Flagella proteins, abundant surface antigens in Salmonella serovars that cause human disease, are also powerful immunogens, but the functional capacity of elicited anti-flagellar antibodies and their role in facilitating bacterial clearance has been unclear. We examined the ability of anti-flagellar antibodies to mediate microbial killing by immune system components in-vitro and assessed their role in protecting mice against invasive Salmonella infection. Polyclonal (hyperimmune sera) and monoclonal antibodies raised against phase 1 flagellin proteins of S. Enteritidis and S. Typhimurium facilitated bacterial uptake and killing of the homologous serovar pathogen by phagocytes. Polyclonal anti-flagellar antibodies accompanied by complement also achieved direct bacterial killing. Serum bactericidal activity was restricted to Salmonella serovars expressing the same flagellin used as immunogen. Notably, individual anti-flagellin monoclonal antibodies with complement were not bactericidal, but this biological activity was restored when different monoclonal anti-flagellin antibodies were combined. Passive transfer immunization with a monoclonal IgG antibody specific for phase 1 flagellin from S. Typhimurium protected mice against lethal challenge with a representative African invasive S. Typhimurium strain. These findings have relevance for the use of flagellin proteins in NTS vaccines, and confirm the role of anti-flagellin antibodies as mediators of protective immunity.	[Ramachandran, Girish; Tennant, Sharon M.; Boyd, Mary A.; Wang, Jin Y.; Pasetti, Marcela F.; Levine, Myron M.; Simon, Raphael] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Ramachandran, Girish; Tennant, Sharon M.; Wang, Jin Y.; Tulapurkar, Mohan E.; Levine, Myron M.; Simon, Raphael] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Boyd, Mary A.; Pasetti, Marcela F.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Tulapurkar, Mohan E.] Univ Maryland, Sch Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA; [Boyd, Mary A.] US FDA, Silver Spring, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Simon, R (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.; Simon, R (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	rsimon@medicine.umaryland.edu	tulapurkar, mohan/F-1926-2015	tulapurkar, mohan/0000-0002-2476-5417; Pasetti, Marcela/0000-0003-0894-4009	Middle Atlantic RCE Program, NIAID/NIH [2 U54 AI057168]; UK Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	Middle Atlantic RCE Program, NIAID/NIH; UK Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Middle Atlantic RCE Program, NIAID/NIH 2 U54 AI057168 and a Strategic Translation Grant from the UK Wellcome Trust (MML PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2006, J IMMUNOL, V177, P3983, DOI 10.4049/jimmunol.177.6.3983; ANDERSON TR, 1987, INFECT IMMUN, V55, P3204, DOI 10.1128/IAI.55.12.3204-3206.1987; Ault A, 2013, VACCINE, V31, P5879, DOI 10.1016/j.vaccine.2013.09.041; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Boyd MA, 2014, CLIN VACCINE IMMUNOL, V21, P712, DOI 10.1128/CVI.00115-14; CARSIOTIS M, 1984, INFECT IMMUN, V46, P814, DOI 10.1128/IAI.46.3.814-818.1984; Casadevall A, 1998, TRENDS MICROBIOL, V6, P102, DOI 10.1016/S0966-842X(98)01208-6; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; FELIX A, 1951, J HYG-CAMBRIDGE, V49, P92, DOI 10.1017/S0022172400015394; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Hiriart Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-640; Ikeda JS, 2001, INFECT IMMUN, V69, P3021, DOI 10.1128/IAI.69.5.3021-3030.2001; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; KLUGMAN KP, 1987, LANCET, V2, P1165; LEVINE MM, 1978, AM J TROP MED HYG, V27, P795, DOI 10.4269/ajtmh.1978.27.795; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Lindberg A., 1984, METHOD MICROBIOL, V15, P1, DOI DOI 10.1016/S0580-9517(08)70457-4; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mohan VK, 2015, CLIN INFECT DIS, V61, P393, DOI 10.1093/cid/civ295; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Simon R, 2014, PROTEIN EXPRES PURIF, V102, P1, DOI 10.1016/j.pep.2014.07.005; Simon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064680; Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SVENSON SB, 1979, INFECT IMMUN, V25, P863, DOI 10.1128/IAI.25.3.863-872.1979; Tapia MD, 2015, CLIN INFECT DIS, V61, pS332, DOI 10.1093/cid/civ729; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; WATSON DC, 1992, INFECT IMMUN, V60, P4679, DOI 10.1128/IAI.60.11.4679-4686.1992; WEINSTEIN DL, 1984, INFECT IMMUN, V46, P819, DOI 10.1128/IAI.46.3.819-825.1984; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yonekura K, 2005, STRUCTURE, V13, P407, DOI 10.1016/j.str.2005.02.003	37	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151875	10.1371/journal.pone.0151875	http://dx.doi.org/10.1371/journal.pone.0151875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998925	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700077
J	Wang, QH; Zhao, ZJ; Zhang, XX; Li, XL; Zhu, M; Li, PP; Yang, ZQ; Wang, Y; Yan, GY; Shang, H; Cao, YM; Fan, Q; Cui, LW				Wang, Qinghui; Zhao, Zhenjun; Zhang, Xuexing; Li, Xuelian; Zhu, Min; Li, Peipei; Yang, Zhaoqing; Wang, Ying; Yan, Guiyun; Shang, Hong; Cao, Yaming; Fan, Qi; Cui, Liwang			Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; BLOOD-STAGE ANTIGENS; SERUM ANTIBODIES; VACCINE CANDIDATE; CLINICAL MALARIA; 19-KILODALTON DOMAIN; ENDEMIC AREA; REDUCED RISK; IGG ISOTYPE; PROTECTION	Understanding naturally acquired immunity to infections caused by Plasmodia in different malaria endemicity settings is needed for better vaccine designs and for exploring antibody responses as a proxy marker of malaria transmission intensity. This study investigated the sero-epidemiology of malaria along the international border between China and Myanmar, where malaria elimination action plans are in place. This study recruited 233 P. vivax and 156 P. falciparum infected subjects with acute malaria at the malaria clinics and hospitals. In addition, 93 and 67 healthy individuals from the same endemic region or from non-endemic region, respectively, were used as controls. Acute malaria infections were identified by microscopy. Anti-recombinant PfMSP1(19) and PvMSP1(19) antibody levels were measured by ELISA. Antibody responses to respective MSP1(19) were detected in 50.9% and 78.2% patients with acute P. vivax and P. falciparum infections, respectively. There were cross-reacting antibodies in Plasmodium patients against these two recombinant proteins, though we could not exclude the possibility of submicroscopic mixed-species infections. IgG1, IgG3 and IgG4 were the major subclasses. Interestingly, 43.2% of the healthy endemic population also had antibodies against PfMSP1(19), whereas only 3.9% of this population had antibodies against PvMSP1(19). Higher antibody levels were correlated with age and parasite density, but not with season, gender or malaria history. Both total IgG and individual IgG subclasses underwent substantial declines during the convalescent period in three months. This study demonstrated that individuals in a hypoendemic area with coexistence of P. vivax and P. falciparum can mount rapid antibody responses against both PfMSP1(19) and PvMSP1(19). The significantly higher proportion of responders to PfMSP119 in the healthy endemic population indicates higher prevalence of P. falciparum in the recent past. Specific antibodies against PvMSP1(19) could serve as a marker of recent exposure to P. vivax in epidemiological studies.	[Wang, Qinghui; Zhang, Xuexing; Cao, Yaming] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110001, Liaoning, Peoples R China; [Zhao, Zhenjun; Li, Peipei; Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Li, Xuelian] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning, Peoples R China; [Zhu, Min] China Med Univ, Sch Humanities & Social Sci, Shenyang 110001, Liaoning, Peoples R China; [Yang, Zhaoqing] Kunming Med Univ, Dept Pathogen Biol & Immunol, Kunming, Peoples R China; [Wang, Ying] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Shenyang 110001, Liaoning, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA	China Medical University; China Medical University; China Medical University; Kunming Medical University; Army Medical University; University of California System; University of California Irvine; China Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, YM (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110001, Liaoning, Peoples R China.; Fan, Q (corresponding author), Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China.; Cui, LW (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.	ymcao@mail.cmu.edu.cn; qifan10001@163.com; luc2@psu.edu			National Institutes of Health, USA [U19AI089672, R01 AI099611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099611, U19AI089672] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants U19AI089672 to LC and R01 AI099611 to YC from the National Institutes of Health, USA.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Achary KG, 2014, PARASITE IMMUNOL, V36, P485, DOI 10.1111/pim.12121; Afridi S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-308; Ak Mucide, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P685; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Branch OH, 2000, J INFECT DIS, V181, P1746, DOI 10.1086/315424; Chuangchaiya S, 2010, CLIN EXP IMMUNOL, V160, P233, DOI 10.1111/j.1365-2249.2009.04075.x; COOPER JA, 1993, PARASITOL TODAY, V9, P50, DOI 10.1016/0169-4758(93)90031-A; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; DALY TM, 1993, INFECT IMMUN, V61, P2462, DOI 10.1128/IAI.61.6.2462-2467.1993; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dutta S, 2005, INFECT IMMUN, V73, P5936, DOI 10.1128/IAI.73.9.5936-5944.2005; EGAN AF, 1995, INFECT IMMUN, V63, P456, DOI 10.1128/IAI.63.2.456-466.1995; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; Ferreira AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105828; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; FREEMAN RR, 1983, J EXP MED, V158, P1647, DOI 10.1084/jem.158.5.1647; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Ladeia-Andrade S, 2007, MEM I OSWALDO CRUZ, V102, P943, DOI 10.1590/S0074-02762007000800009; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Li NN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-361; Lourembam SD, 2012, VACCINE, V30, P767, DOI 10.1016/j.vaccine.2011.11.069; Mazumdar S, 2010, INFECT IMMUN, V78, P872, DOI 10.1128/IAI.00427-09; Mehrizi AA, 2011, ACTA TROP, V119, P84, DOI 10.1016/j.actatropica.2011.04.012; Mehrizi AA, 2009, ACTA TROP, V112, P1, DOI 10.1016/j.actatropica.2009.05.016; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x; Nagao Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-113; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006; Noland GS, 2008, INFECT IMMUN, V76, P5721, DOI 10.1128/IAI.00591-08; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Omosun YO, 2005, ACTA TROP, V95, P233, DOI 10.1016/j.actatropica.2005.06.019; Pan D, 2010, ACTA TROP, V116, P200, DOI 10.1016/j.actatropica.2010.08.004; Park JW, 2001, CLIN DIAGN LAB IMMUN, V8, P14, DOI 10.1128/CDLI.8.1.14-20.2001; Pitabut Nada, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Riccio EKP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-326; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Rzepczyk CM, 1997, INFECT IMMUN, V65, P1098, DOI 10.1128/IAI.65.3.1098-1100.1997; Sachdeva S, 2004, INFECT IMMUN, V72, P5775, DOI 10.1128/IAI.72.10.5775-5782.2004; Shi YP, 1996, INFECT IMMUN, V64, P2716, DOI 10.1128/IAI.64.7.2716-2723.1996; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; Soares IS, 1999, MOL MED, V5, P459; Soares IS, 1999, ACTA TROP, V72, P13, DOI 10.1016/S0001-706X(98)00078-3; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Torres KJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-173; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; Versiani FG, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/965841; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027705; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Yeom JS, 2008, J PARASITOL, V94, P1410, DOI 10.1645/GE-1484.1; Zakeri S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-257; Zeyrek FY, 2008, AM J TROP MED HYG, V78, P729, DOI 10.4269/ajtmh.2008.78.729	77	17	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151900	10.1371/journal.pone.0151900	http://dx.doi.org/10.1371/journal.pone.0151900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999435	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700082
J	Reigstad, I; Smeland, HYH; Skogstrand, T; Sortland, K; Schmid, MC; Reed, RK; Stuhr, L				Reigstad, Inga; Smeland, Hilde Y. H.; Skogstrand, Trude; Sortland, Kristina; Schmid, Marei Caroline; Reed, Rolf K.; Stuhr, Linda			Stromal Integrin alpha 11 beta 1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; EXTRACELLULAR-MATRIX; COLLAGEN RECEPTOR; CELL; FIBROBLASTS; EXPRESSION; BINDING	Purpose It has been implied that the collagen binding integrin alpha 11 beta 1 plays a role in carcinogenesis. As still relatively little is known about how the stromal integrin alpha 11 beta 1 affects different aspects of tumor development, we wanted to examine the direct effects on primary tumor growth, fibrosis, tumor interstitial fluid pressure (PIF) and metastasis in murine 4T1 mammary and RM11 prostate tumors, using an in vivo SCID integrin alpha 11-deficient mouse model. Methods Tumor growth was measured using a caliper, PIF by the wick-in-needle technique, activated fibroblasts by alpha-SMA immunofluorescence staining and fibrosis by transmission electron microscopy and picrosirius-red staining. Metastases were evaluated using hematoxylin and eosin stained sections. Results RM11 tumor growth was significantly reduced in the SCID integrin alpha 11-deficient (alpha 11-KO) compared to in SCID integrin alpha 11 wild type (WT) mice, whereas there was no similar effect in the 4T1 tumor model. The 4T1 model demonstrated an alteration in collagen fibril diameter in the integrin alpha 11-KO mice compared to WT, which was not found in the RM11 model. There were no significant differences in the amount of activated fibroblasts, total collagen content, collagen organization or PIF in the tumors in integrin alpha 11-deficient mice compared to WT mice. There was also no difference in lung metastases between the two groups. Conclusion Deficiency of stromal integrin alpha 11 beta 1 showed different effects on tumor growth and collagen fibril diameter depending on tumor type, but no effect on tumor PIF or development of lung metastasis.	[Reigstad, Inga; Smeland, Hilde Y. H.; Skogstrand, Trude; Sortland, Kristina; Schmid, Marei Caroline; Reed, Rolf K.; Stuhr, Linda] Univ Bergen, Dept Biomed, Bergen, Norway; [Reigstad, Inga; Skogstrand, Trude; Sortland, Kristina] Haukeland Hosp, Matrix Biol Grp, N-5021 Bergen, Norway; [Smeland, Hilde Y. H.; Schmid, Marei Caroline; Reed, Rolf K.] Univ Bergen, Ctr Canc Biomarkers, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Reigstad, I (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.; Reigstad, I (corresponding author), Haukeland Hosp, Matrix Biol Grp, N-5021 Bergen, Norway.	inga.reigstad@uib.no	Reed, Rolf K./B-9422-2017	Reed, Rolf K./0000-0002-2633-6595	Research Council of Norway [223250/F50]; Helse-Vest, NO [911708, 911966]	Research Council of Norway(Research Council of Norway); Helse-Vest, NO	This work was supported by The Research Council of Norway, grants 223250/F50 to Center of Cancer Biomarkers, University of Bergen; Helse-Vest, NO, grant number 911708-Inga Reigstad; and Helse-Vest, NO, grant number 911966-Rolf K. Reed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fernando RI, 2010, J CLIN INVEST, V120, P533, DOI 10.1172/JCI38379; Friman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034082; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Ishii G, 2016, ADV DRUG DELIVER REV, V99, P186, DOI 10.1016/j.addr.2015.07.007; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; Lu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103173; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Navab R, 2016, ONCOGENE, V35, P1899, DOI 10.1038/onc.2015.254; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Schulz JN, 2015, J INVEST DERMATOL, V135, P1435, DOI 10.1038/jid.2015.24; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; THOMPSON TC, 1993, MOL CARCINOGEN, V7, P165, DOI 10.1002/mc.2940070307; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; van Dijk M, 2013, EXP CELL RES, V319, P1663, DOI 10.1016/j.yexcr.2013.02.006; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Vuoristo M, 2007, MELANOMA RES, V17, P215, DOI 10.1097/CMR.0b013e328270b935; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Westcott JM, 2015, J CLIN INVEST, V125, P1927, DOI 10.1172/JCI77767; WIIG H, 1986, ANN BIOMED ENG, V14, P139, DOI 10.1007/BF02584264; Zeltz C, 2014, ADV EXP MED BIOL, V819, P73, DOI 10.1007/978-94-017-9153-3_5; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104	37	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151663	10.1371/journal.pone.0151663	http://dx.doi.org/10.1371/journal.pone.0151663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990302	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800085
J	Hill, J; Hoyt, J; Achieng, F; Ouma, P; L'lanziva, A; Kariuki, S; Desai, M; Webster, J				Hill, Jenny; Hoyt, Jenna; Achieng, Florence; Ouma, Peter; L'lanziva, Anne; Kariuki, Simon; Desai, Meghna; Webster, Jayne			User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SULFADOXINE-PYRIMETHAMINE; EFFICACY; WOMEN; METAANALYSIS; THERAPY; MICROSCOPY; MUTATION; TRIAL; GHANA	Background The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) alongside long-lasting insecticide-treated nets (LLIN) and case management for reducing the risks associated with malaria in pregnancy in areas of moderate-to-high transmission in sub-Saharan Africa. Due to increasing Plasmodium falciparum resistance to SP, the search for alternative drugs or strategies to control malaria in pregnancy is a priority. We assessed the acceptability among pregnant women and health providers of intermittent screening and treatment (ISTp) and IPTp with dihydroartemisinin-piperaquine (DP) as alternative strategies in the context of an un-blinded clinical trial. Methods Qualitative data were collected through ten focus group discussions with women participating in a randomized controlled trial to evaluate ISTp or IPTp with DP (multi-day regimen) versus IPTp with SP (single dose) in western Kenya. Individual in-depth interviews were conducted with 26 health providers working in the trial facilities and trial staff. Results Women appreciated the advantages of being tested with a rapid diagnostic test (RDT) at every ANC visit (although a few women disliked finger pricks) and accepted that they would not receive any antimalarial when tested RDT-negative. There were differences in women's experiences of the efficacy of antimalarials between the trial arms, with more women in the IPTp-SP arm reporting they had experienced malaria episodes. Side effects were experienced among women taking DP and SP. Although women and trial staff reported adherence to the full DP regimen within the trial, health providers were not confident that women would adhere to multi-day regimens in non-trial settings. Health providers recognized the advantages of ISTp in reducing unnecessary exposure to drugs, but lacked confidence in the reliability of RDTs compared to microscopy. Conclusions Our findings indicate that, within a trial context, ISTp-DP and IPTp-DP were generally acceptable among both users and providers and were regarded as potentially valuable alternatives to IPTp-SP. Several challenges were identified the most important of which was concerns with achieving adherence to DP in non-trial settings, requiring operational feasibility studies in routine health systems. Policy adoption of ISTp with RDTs would require a major shift in thinking among health providers due to lack of confidence in RDTs.	[Hill, Jenny; Hoyt, Jenna] Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Achieng, Florence; Ouma, Peter; L'lanziva, Anne; Kariuki, Simon] Ctr Dis Control, Res & Publ Hlth Collaborat, Kenya Med Res Inst, Kisumu, Kenya; [Desai, Meghna] Ctr Dis Control & Prevent, Atlanta, GA USA; [Webster, Jayne] Univ London London Sch Hyg & Trop Med, Dis Control Dept, Keppel St, London WC1E 7HT, England	Liverpool School of Tropical Medicine; University of Liverpool; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine	Hill, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	jenny.hill@lstmed.ac.uk	Kariuki, Simon/AFT-6596-2022; Hill, Jenny/C-3839-2017	Hill, Jenny/0000-0003-1588-485X; Webster, Jayne/0000-0002-0498-8883	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation; United States President's Malaria Initiative; U.S. Agency for International Development; U.S. Centers for Disease Control and Prevention (CDC); CDC; Kenya Medical Research Institute (KEMRI)	Malaria in Pregnancy (MiP) Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); United States President's Malaria Initiative(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); U.S. Agency for International Development(United States Agency for International Development (USAID)); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Kenya Medical Research Institute (KEMRI)	This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, UK, and was made possible through support provided by the United States President's Malaria Initiative, U.S. Agency for International Development and U.S. Centers for Disease Control and Prevention (CDC), under the terms of an Interagency Agreement with CDC and through a Cooperative Agreement between the CDC and the Kenya Medical Research Institute (KEMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2015, PROVIDER US IN PRESS; Banek K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-7; Bernard H. R., 2017, RES METHODS ANTHR; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Chatio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116856; Chico RM, 2015, TROP MED INT HEALTH, V20, P1621, DOI 10.1111/tmi.12595; Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4; Diggle E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-502; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Gutman J, 2015, J INFECT DIS, V211, P1997, DOI 10.1093/infdis/jiu836; Hill J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001688; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Kalanda GC, 2006, TROP MED INT HEALTH, V11, P569, DOI 10.1111/j.1365-3156.2006.01608.x; Kattenberg JH, 2012, AM J TROP MED HYG, V87, P251, DOI 10.4269/ajtmh.2012.12-0125; Kattenberg JH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-321; Lagarde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023588; Myint HY, 2007, T ROY SOC TROP MED H, V101, P858, DOI 10.1016/j.trstmh.2007.05.018; Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002; Paintain LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024035; Pell C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-432; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2015, PLOS ONE IN PRESS; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065437; Webster J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067520; World Health Organisation, EV BUS STRAT HLTH SY	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150259	10.1371/journal.pone.0150259	http://dx.doi.org/10.1371/journal.pone.0150259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986471	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000372580300019
J	Jang, ES; Jeong, SH; Kim, JW; Choi, YS; Leissner, P; Brechot, C				Jang, Eun Sun; Jeong, Sook-Hyang; Kim, Jin-Wook; Choi, Yun Suk; Leissner, Philippe; Brechot, Christian			Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma	PLOS ONE			English	Article							DES-GAMMA-CARBOXYPROTHROMBIN; CHRONIC HEPATITIS; BIOMARKERS; SERUM; CANCER; MARKER; AFP; RECOMMENDATIONS; METAANALYSIS; CIRRHOSIS	Background & Aims Alpha-fetoprotein (AFP) is the most widely used serum biomarker for hepatocellular carcinoma (HCC), despite its limitations. As complementary biomarkers, protein induced by vitamin K absence (PIVKA-II), osteopontin (OPN), and Dickkopf-1 (DKK-1) have been proposed. This study aimed to perform a head-to-head comparison of the diagnostic performance of AFP, PIVKA-II, OPN and DKK-1 as single or in combination to seek the best biomarker or panel, and to investigate the clinical factors affecting their performance. Methods Using 401 stored plasma samples obtained from 208 HCC patients and 193 liver cirrhosis control patients, plasma AFP, PIVKA-II, OPN and DKK-1 levels were measured by ELISA, and receiver operating characteristic curve analyses were performed for each biomarker and for every combination of two to four markers. Results Of the four biomarkers, AFP showed the highest area under the curve (0.786). The sensitivity and specificity for each single biomarker was 62% and 90.2% (AFP>20 ng/mL), 51.0% and 91.2% (PIVKA-II>10 ng/mL), 46.2% and 80.3% (OPN>100 ng/mL), and 50.0% and 80.8% (DKK-1>500 pg/mL), respectively. Among the combinations of two biomarkers, AFP>20 ng/mL or DKK-1>500 pg/mL showed the best diagnostic performance (sensitivity 78.4%, specificity 72.5%). Triple or quadruple combination did not improve the diagnostic performance further. The patient's age, etiology and tumor invasiveness of HCC affected the performance of each marker. Conclusions AFP was the most useful single biomarker for HCC diagnosis, and the combined measurement of AFP and DKK-1 could maximize the diagnostic yield. Clinical decision should be based on the consideration of various factors affecting the diagnostic performance of each biomarker. Efforts to seek novel HCC biomarkers should be continued.	[Jang, Eun Sun; Jeong, Sook-Hyang; Kim, Jin-Wook; Choi, Yun Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul 151, South Korea; [Leissner, Philippe] bioMerieux, Med Diagnost Discovery Dept, Marcy Letoile, France; [Brechot, Christian] Merieux Inst, Lyon, France	Seoul National University (SNU); Seoul National University Hospital; bioMerieux	Jeong, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seoul 151, South Korea.	jsh@snubh.org	BRECHOT, Christian/S-2011-2018	Kim, Jin-Wook/0000-0003-0934-3344	bioMerieux	bioMerieux	This study was supported by grant from bioMerieux. The funder provided support in the form of salaries for authors [PL and CB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2003, ONCOLOGY-BASEL, V65, P95, DOI 10.1159/000072332; Beale G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-200; BOYKO EJ, 1994, MED DECIS MAKING, V14, P175, DOI 10.1177/0272989X9401400210; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chaiteerakij R, 2015, CLIN GASTROENTEROL H, V13, P237, DOI 10.1016/j.cgh.2013.10.038; Chung MY, 2003, CLIN MOL HEPATOL, V9, P116; Durazo FA, 2008, J GASTROEN HEPATOL, V23, P1541, DOI 10.1111/j.1440-1746.2008.05395.x; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Ge TX, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0367-z; Keselman HJ, 1999, PSYCHOL METHODS, V4, P58, DOI 10.1037/1082-989X.4.1.58; Kim GA, 2015, LIVER INT, V35, P232, DOI 10.1111/liv.12516; Kim J, 2006, AM J GASTROENTEROL, V101, P2051, DOI 10.1111/j.1572-0241.2006.00679.x; Lee JM, 2014, DIGEST DIS, V32, P764, DOI 10.1159/000368020; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Putz-Bankuti C, 2010, Z GASTROENTEROL, V48, pP20; SATO Y, 1994, J SURG ONCOL, V55, P265, DOI 10.1002/jso.2930550414; Shang SF, 2012, HEPATOLOGY, V55, P483, DOI 10.1002/hep.24703; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Shim JJ, 2014, J GASTROEN HEPATOL, V29, P1699, DOI 10.1111/jgh.12612; Volk Michael L., 2007, Cancer Biomarkers, V3, P79; Wang MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S3-S9; Yang H, 2013, INT J BIOL MARKER, V28, P286, DOI [10.5301/JBM.5000015, 10.5301/jbm.5000015]; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zhang J, 2014, INT J BIOL MARKER, V29, pE403, DOI 10.5301/jbm.5000101; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x	30	59	61	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151069	10.1371/journal.pone.0151069	http://dx.doi.org/10.1371/journal.pone.0151069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986465	Green Submitted, gold, Green Published			2022-12-27	WOS:000372580300043
J	Almaatouq, A; Radaelli, L; Pentland, A; Shmueli, E				Almaatouq, Abdullah; Radaelli, Laura; Pentland, Alex; Shmueli, Erez			Are You Your Friends' Friend? Poor Perception of Friendship Ties Limits the Ability to Promote Behavioral Change	PLOS ONE			English	Article							SOCIAL NETWORK; SMOKING-CESSATION; PEER-SUPPORT; ADJUSTMENT; CHILDREN; OBESITY; BUDDIES; SPREAD	Persuasion is at the core of norm creation, emergence of collective action, and solutions to 'tragedy of the commons' problems. In this paper, we show that the directionality of friendship ties affect the extent to which individuals can influence the behavior of each other. Moreover, we find that people are typically poor at perceiving the directionality of their friendship ties and that this can significantly limit their ability to engage in cooperative arrangements. This could lead to failures in establishing compatible norms, acting together, finding compromise solutions, and persuading others to act. We then suggest strategies to overcome this limitation by using two topological characteristics of the perceived friendship network. The findings of this paper have significant consequences for designing interventions that seek to harness social influence for collective action.	[Almaatouq, Abdullah] MIT, Ctr Computat Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Almaatouq, Abdullah; Radaelli, Laura; Pentland, Alex; Shmueli, Erez] MIT, Media Lab, Cambridge, MA 02139 USA; [Radaelli, Laura; Shmueli, Erez] Tel Aviv Univ, Dept Ind Engn, IL-69978 Tel Aviv, Israel; [Pentland, Alex] MIT, IDSS, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tel Aviv University; Massachusetts Institute of Technology (MIT)	Almaatouq, A (corresponding author), MIT, Ctr Computat Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Almaatouq, A (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	amaatouq@mit.edu	Almaatouq, Abdullah/ABB-4234-2021	Almaatouq, Abdullah/0000-0002-8467-9123; Radaelli, Laura/0000-0002-7277-801X				Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Aral S, 2014, MANAGE SCI, V60, P1352, DOI 10.1287/mnsc.2014.1936; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Ball B., 2013, NETWORK SCI, V1, P16, DOI DOI 10.1017/NWS.2012.4; BUHRMESTER D, 1990, CHILD DEV, V61, P1101, DOI 10.1111/j.1467-8624.1990.tb02844.x; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; CHEN XY, 1992, INT J BEHAV DEV, V15, P259, DOI 10.1177/016502549201500206; Cho Y, 2012, TECHNOL FORECAST SOC, V79, P97, DOI 10.1016/j.techfore.2011.06.003; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Davis K, 1945, AM SOCIOL REV, V10, P242, DOI 10.2307/2085643; de Montjoye YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05277; Dong W., 2012, PROCEEDINGS OF THE 2, P266; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; EDER D, 1978, AM SOCIOL REV, V43, P237, DOI 10.2307/2094701; Ellenbogen S, 1997, J ADOLESCENCE, V20, P355, DOI 10.1006/jado.1997.0092; Ford P, 2013, INT J ENV RES PUB HE, V10, P5507, DOI 10.3390/ijerph10115507; Fowler J., 2009, BRIT MED J, V338, P23, DOI DOI 10.1136/BMJ.A2338; GERSHMAN ES, 1983, MERRILL PALMER QUART, V29, P169; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gray M, 2000, COMP POLIT STUD, V33, P1091, DOI 10.1177/0010414000033009001; Hartup W W, 1993, New Dir Child Dev, P3, DOI 10.1002/cd.23219936003; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Klein J, 2006, MEN MASC, V9, P53, DOI 10.1177/1097184X04271387; Laursen B, 1993, NEW DIR CHILD ADOLES, V1993, P3; Lazega E, 2001, SOCIAL CAPITAL THEOR, V185, P208; Madan A, 2010, WIREL HLTH, V2010, P104, DOI DOI 10.1145/1921081.1921094; Madan A, 2012, IEEE PERVAS COMPUT, V11, P36, DOI 10.1109/MPRV.2011.79; Mani A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01735; Margetts Helen, 2012, SOCIAL INFLUENCE COL; Marwell G., 1993, CRITICAL MASS COLLEC; May S, 2000, TOB CONTROL, V9, P415, DOI 10.1136/tc.9.4.415; Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Rotheram-Borus MJ, 2012, DIABETES EDUCATOR, V38, P357, DOI 10.1177/0145721712444617; Shmueli E, 2014, SENSING UNDERSTANDIN; Stanton-Salazar RD, 2005, YOUTH SOC, V36, P379, DOI 10.1177/0044118X04267814; Stock S, 2007, PEDIATRICS, V120, pe1059, DOI 10.1542/peds.2006-3003; Tur-Kaspa H., 1999, EUROPEAN J SPECIAL N, V14, P37, DOI [DOI 10.1080/0885625990140104, 10.1080/0885625990140104]; Uzzi B, 1997, ADMIN SCI QUART, V42, P35, DOI 10.2307/2393808; Vaquera E, 2008, SOC SCI RES, V37, P55, DOI 10.1016/j.ssresearch.2006.11.002; Wen Dong, 2012, Social Computing, Behavioral-Cultural Modeling and Prediction. Proceedings of the 5th International Conference, SBP 2012, P172, DOI 10.1007/978-3-642-29047-3_21; WenzGross M, 1997, EXCEPT CHILDREN, V63, P183, DOI 10.1177/001440299706300203; Whyte William Foote, 2012, STREET CORNER SOC SO	52	38	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151588	10.1371/journal.pone.0151588	http://dx.doi.org/10.1371/journal.pone.0151588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002530	Green Submitted, gold, Green Published			2022-12-27	WOS:000372697400034
J	Yang, YJ; Chen, LH; Li, N; Zhang, QF				Yang, Yuanjun; Chen, Lihua; Li, Ning; Zhang, Qiufen			Effect of Root Moisture Content and Diameter on Root Tensile Properties	PLOS ONE			English	Article							STRENGTH; REINFORCEMENT; RESISTANCE; CELLULOSE; WATER; SHAPE	The stabilization of slopes by vegetation has been a topical issue for many years. Root mechanical characteristics significantly influence soil reinforcement; therefore it is necessary to research into the indicators of root tensile properties. In this study, we explored the influence of root moisture content on tensile resistance and strength with different root diameters and for different tree species. Betula platyphylla, Quercus mongolica, Pinus tabulae-formis, and Larix gmelinii, the most popular tree species used for slope stabilization in the rocky mountainous areas of northern China, were used in this study. A tensile test was conducted after root samples were grouped by diameter and moisture content. The results showedthat: 1) root moisture content had a significant influence on tensile properties; 2) slightly loss of root moisture content could enhance tensile strength, but too much loss of water resulted in weaker capacity for root elongation, and consequently reduced tensile strength; 3) root diameter had a strong positive correlation with tensile resistance; and 4) the roots of Betula platyphylla had the best tensile properties when both diameter and moisture content being controlled. These findings improve our understanding of root tensile properties with root size and moisture, and could be useful for slope stabilization using vegetation.	[Yang, Yuanjun; Chen, Lihua; Li, Ning; Zhang, Qiufen] Beijing Forest Univ, Sch Water & Soil Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University	Chen, LH (corresponding author), Beijing Forest Univ, Sch Water & Soil Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	chenlihua_bjfu@163.com			National Science and Technology Pillar Program [2015BAD07B03]	National Science and Technology Pillar Program	This study is funded by the National Science and Technology Pillar Program (NO. 2015BAD07B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischetti GB, 2005, PLANT SOIL, V278, P11, DOI 10.1007/s11104-005-0605-4; Chen LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093066; Cofie P, 2001, SOIL TILL RES, V63, P51, DOI 10.1016/S0167-1987(01)00225-2; De Baets S, 2008, PLANT SOIL, V305, P207, DOI 10.1007/s11104-008-9553-0; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; Gray DH, 1996, BIOTECHNICAL SOIL BI; Gu XL, 2014, FRONT STRUCT CIV ENG, V8, P308, DOI 10.1007/s11709-014-0266-6; Gyssels G, 2005, PROG PHYS GEOG, V29, P189, DOI 10.1191/0309133305pp443ra; Hales TC, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001168; Huang QG, 2006, CHINESE J APPL ECOLO, V13, P519, DOI 10.13287/j.1001-9332.2002.0123; [姜志强 Jiang Zhiqiang], 2004, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V23, P2133; Liu XiuPing, 2006, Journal of Beijing Forestry University, V28, P67; Lu ChunJuan, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P69; [吕春娟 Lv Chunjuan], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P17; Lv CJ, 2012, THESIS BEIJING FORES; Mao Z, 2014, PLANT SOIL, V381, P249, DOI 10.1007/s11104-014-2116-7; Nilaweera N.S., 1999, B ENG GEOL ENVIRON, V57, P337, DOI [10.1007/s100640050056, DOI 10.1007/S100640050056]; Osman N, 2006, ECOL ENG, V28, P90, DOI 10.1016/j.ecoleng.2006.04.004; Roering JJ, 2003, CAN GEOTECH J, V40, P237, DOI 10.1139/T02-113; Schroeder WL, 1984, WORKSH SLOP STAB PRO, P43; Sidle RC, 2001, HYDROL PROCESS, V15, P1675, DOI 10.1002/hyp.233; Simon A, 2002, EARTH SURF PROC LAND, V27, P527, DOI 10.1002/esp.325; Stokes A., 2002, Plant roots: the hidden half, P175; Stokes A, 2008, SLOPE STABILITY EROS, P65, DOI [DOI 10.1007/978-1-4020-6676-4_4, 10.1007/978-1-4020-6676-4_4]; Stokes A, 2007, DEV PLANT SOIL SCI, V103, P165; Tokyay M, 1997, CEMENT CONCRETE RES, V27, P1281, DOI 10.1016/S0008-8846(97)00104-X; TURMANINA V. I., 1965, BYUL MOSKOV OBSHCHEST ISPYTATE LEI PRIRODY OTD BIOL, V70, P36; Vergani C, 2012, ECOL ENG, V46, P43, DOI 10.1016/j.ecoleng.2012.04.036; [王萍花 WANG Pinghua], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P154; Watson Alex J., 2004, New Zealand Journal of Forestry Science, V34, P344; WU TH, 1976, 5 OH STAT U DEP CIV, P94; Zhang CB, 2014, GEOMORPHOLOGY, V206, P196, DOI 10.1016/j.geomorph.2013.09.024; Zhang CB, 2010, ECOL ENG, V36, P19, DOI 10.1016/j.ecoleng.2009.09.005; Zhang CB, 2014, J ARID LAND, V6, P601, DOI 10.1007/s40333-014-0004-x; Zhang CB, 2012, TREES-STRUCT FUNCT, V26, P1577, DOI 10.1007/s00468-012-0732-5; Zhu HaiLi, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P40; Zhu QingKe, 2002, Journal of Beijing Forestry University, V24, P64	37	39	41	13	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151791	10.1371/journal.pone.0151791	http://dx.doi.org/10.1371/journal.pone.0151791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003872	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400045
J	Kumar, S; Lanckacker, E; Dentener, M; Bracke, K; Provoost, S; De Grove, K; Brusselle, G; Wouters, E; Maes, T; Joos, G				Kumar, Smitha; Lanckacker, Ellen; Dentener, Mieke; Bracke, Ken; Provoost, Sharen; De Grove, Katrien; Brusselle, Guy; Wouters, Emiel; Maes, Tania; Joos, Guy			Aggravation of Allergic Airway Inflammation by Cigarette Smoke in Mice Is CD44-Dependent	PLOS ONE			English	Article							HYALURONAN-BINDING PROTEINS; INDUCED MURINE MODEL; DENDRITIC CELL; LUNG INFLAMMATION; CD44 ISOFORMS; ASTHMA; SENSITIZATION; ACTIVATION; EXPRESSION; DEPOSITION	Background Although epidemiological studies reveal that cigarette smoke (CS) facilitates the development and exacerbation of allergic asthma, these studies offer limited information on the mechanisms involved. The transmembrane glycoprotein CD44 is involved in cell adhesion and acts as a receptor for hyaluronic acid and osteopontin. We aimed to investigate the role of CD44 in a murine model of CS-facilitated allergic airway inflammation. Methods Wild type (WT) and CD44 knock-out (KO) mice were exposed simultaneously to house dust mite (HDM) extract and CS. Inflammatory cells, hyaluronic acid (HA) and osteopontin (OPN) levels were measured in bronchoalveolar lavage fluid (BALF). Proinflammatory mediators, goblet cell metaplasia and peribronchial eosinophilia were assessed in lung tissue. T-helper (Th) 1, Th2 and Th17 cytokine production was evaluated in mediastinal lymph node cultures. Results In WT mice, combined HDM/CS exposure increased the number of inflammatory cells and the levels of HA and OPN in BALF and Th2 cytokine production in mediastinal lymph nodes compared to control groups exposed to phosphate buffered saline (PBS)/CS, HDM/Air or PBS/Air. Furthermore, HDM/CS exposure significantly increased goblet cell metaplasia, peribronchial eosinophilia and inflammatory mediators in the lung. CD44 KO mice exposed to HDM/CS had significantly fewer inflammatory cells in BALF, an attenuated Th2 cytokine production, as well as decreased goblet cells and peribronchial eosinophils compared to WT mice. In contrast, the levels of inflammatory mediators were similar or higher than in WT mice. Conclusion We demonstrate for the first time that the aggravation of pulmonary inflammation upon combined exposure to allergen and an environmental pollutant is CD44-dependent. Data from this murine model of concomitant exposure to CS and HDM might be of importance for smoking allergic asthmatics.	[Kumar, Smitha; Lanckacker, Ellen; Bracke, Ken; Provoost, Sharen; De Grove, Katrien; Brusselle, Guy; Maes, Tania; Joos, Guy] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Dentener, Mieke; Wouters, Emiel] Univ Hosp Maastricht, Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Resp Med, Maastricht, Netherlands	Ghent University; Ghent University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC)	Maes, T (corresponding author), Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium.	Tania.Maes@Ugent.be	Wouters, Emiel/ABD-6200-2021; Maes, Tania/M-8675-2016; Bracke, Ken R/GSN-7630-2022	Maes, Tania/0000-0002-3037-6928; Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505	Concerted Research Initiative of the Ghent University [BOF/GOA 01251504]; Interuniversity Attraction Poles (IUAP)-Belgian Science Policy [P6/35, P7/30]; Fund for Scientific Research Flanders-Belgium (FWO Vlaanderen) [G.0329.11N]	Concerted Research Initiative of the Ghent University; Interuniversity Attraction Poles (IUAP)-Belgian Science Policy; Fund for Scientific Research Flanders-Belgium (FWO Vlaanderen)(FWO)	This study was funded by Concerted Research Initiative of the Ghent University Project BOF/GOA 01251504, Interuniversity Attraction Poles (IUAP)-Belgian Science Policy P6/35 and P7/30 and Fund for Scientific Research Flanders-Belgium (FWO Vlaanderen; Research Project G.0329.11N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Bracke KR, 2010, AM J RESP CELL MOL, V42, P753, DOI 10.1165/rcmb.2008-0424OC; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Haegel-Kronenberger H, 1998, J IMMUNOL, V161, P3902; Hillas G, 2013, CYTOKINE, V61, P251, DOI 10.1016/j.cyto.2012.10.002; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Katoh S, 2011, EUR J IMMUNOL, V41, P3198, DOI 10.1002/eji.201141521; Klagas I, 2009, EUR RESPIR J, V34, P616, DOI 10.1183/09031936.00070808; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Lackie PM, 1997, AM J RESP CELL MOL, V16, P14, DOI 10.1165/ajrcmb.16.1.8998074; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moerloose KB, 2005, AM J RESP CRIT CARE, V172, P168, DOI 10.1164/rccm.200409-1174OC; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Salvi SS, 2001, AM J RESP CRIT CARE, V164, P1343, DOI 10.1164/ajrccm.164.8.2103080; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Scott DA, 2000, BIOMARKERS, V5, P240, DOI 10.1080/135475000230406; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Stapleton M, 2011, J AM BOARD FAM MED, V24, P313, DOI 10.3122/jabfm.2011.03.100180; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Thomson NC, 2009, CURR OPIN PULM MED, V15, P39, DOI 10.1097/MCP.0b013e32831da894; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Uchakina ON, 2013, CLIN IMMUNOL, V146, P56, DOI 10.1016/j.clim.2012.11.002; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; van der Windt GJW, 2010, AM J PATHOL, V177, P2483, DOI 10.2353/ajpath.2010.100562; Van Hove CL, 2009, INT ARCH ALLERGY IMM, V149, P195, DOI 10.1159/000199715; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen K, 2003, AM J RESP CELL MOL, V29, P405, DOI 10.1165/rcmb.2003-0008OC; Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151113	10.1371/journal.pone.0151113	http://dx.doi.org/10.1371/journal.pone.0151113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999446	Green Submitted, gold, Green Published			2022-12-27	WOS:000372694700022
J	Kim, W; Park, H; Seo, S				Kim, Woonsu; Park, Hyesun; Seo, Seongwon			Global Metabolic Reconstruction and Metabolic Gene Evolution in the Cattle Genome	PLOS ONE			English	Article							MEAT QUALITY TRAITS; SEGMENTAL DUPLICATIONS; BISPHOSPHOGLYCERATE MUTASE; SUPEROXIDE-DISMUTASE; PLACENTAL EXPRESSION; BOVINE; GENERATION; SEQUENCE; DATABASE; GROWTH	The sequence of cattle genome provided a valuable opportunity to systematically link genetic and metabolic traits of cattle. The objectives of this study were 1) to reconstruct genome-scale cattle-specific metabolic pathways based on the most recent and updated cattle genome build and 2) to identify duplicated metabolic genes in the cattle genome for better understanding of metabolic adaptations in cattle. A bioinformatic pipeline of an organism for amalgamating genomic annotations from multiple sources was updated. Using this, an amalgamated cattle genome database based on UMD_3.1, was created. The amalgamated cattle genome database is composed of a total of 33,292 genes: 19,123 consensus genes between NCBI and Ensembl databases, 8,410 and 5,493 genes only found in NCBI or Ensembl, respectively, and 266 genes from NCBI scaffolds. A metabolic reconstruction of the cattle genome and cattle pathway genome database (PGDB) was also developed using Pathway Tools, followed by an intensive manual curation. The manual curation filled or revised 68 pathway holes, deleted 36 metabolic pathways, and added 23 metabolic pathways. Consequently, the curated cattle PGDB contains 304 metabolic pathways, 2,460 reactions including 2,371 enzymatic reactions, and 4,012 enzymes. Furthermore, this study identified eight duplicated genes in 12 metabolic pathways in the cattle genome compared to human and mouse. Some of these duplicated genes are related with specific hormone biosynthesis and detoxifications. The updated genome-scale metabolic reconstruction is a useful tool for understanding biology and metabolic characteristics in cattle. There has been significant improvements in the quality of cattle genome annotations and the MetaCyc database. The duplicated metabolic genes in the cattle genome compared to human and mouse implies evolutionary changes in the cattle genome and provides a useful information for further research on understanding metabolic adaptations of cattle.	[Kim, Woonsu; Park, Hyesun; Seo, Seongwon] Chungnam Natl Univ, Dept Anim Biosyst Sci, Daejeon, South Korea	Chungnam National University	Seo, S (corresponding author), Chungnam Natl Univ, Dept Anim Biosyst Sci, Daejeon, South Korea.	swseo@cnu.kr	Seo, Seongwon/E-9687-2013	Seo, Seongwon/0000-0002-4131-0545	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2010-0022865]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This research was supported by Basic Science Research Program (NRF-2010-0022865) through the National Research Foundation of Korea (NRF) funded by the Ministry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BEITZ DC, 1985, J ANIM SCI, V61, P1; Boeke JD, 1991, CURR OPIN CELL BIOL, V3, P502, DOI 10.1016/0955-0674(91)90079-E; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Craft CM, 1999, MOL BRAIN RES, V65, P44, DOI 10.1016/S0169-328X(98)00336-2; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dunner S, 2013, LIVEST SCI, V154, P34, DOI 10.1016/j.livsci.2013.02.020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gu M, 2009, PLACENTA, V30, P919, DOI 10.1016/j.placenta.2009.08.005; Guillemin N, 2011, J PROTEOMICS, V75, P352, DOI 10.1016/j.jprot.2011.07.026; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Hough MA, 2003, STRUCTURE, V11, P937, DOI 10.1016/S0969-2126(03)00155-2; Hoyer JD, 2004, AM J HEMATOL, V75, P205, DOI 10.1002/ajh.20014; Hubisz MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017034; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2011, ARCH TOXICOL, V85, P1015, DOI 10.1007/s00204-011-0705-2; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kim JJ, 2003, J ANIM SCI, V81, P1933; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Mulquiney PJ, 1999, BIOCHEM J, V342, P567, DOI 10.1042/0264-6021:3420567; Oltjen JW, 1996, J ANIM SCI, V74, P1406; Pavlicek J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-154; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Pritlove DC, 2006, PLACENTA, V27, P924, DOI 10.1016/j.placenta.2005.08.010; RECNY MA, 1982, J BIOL CHEM, V257, P2878; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheer Maurice, 2011, Nucleic Acids Res, V39, pD670, DOI 10.1093/nar/gkq1089; Schomerus C, 2004, J NEUROENDOCRINOL, V16, P741, DOI 10.1111/j.1365-2826.2004.01228.x; Seo S, 2013, ANIMAL, V7, P172, DOI 10.1017/S1751731111002588; Seo S, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-33; Sevane N, 2014, MOL BIOL REP, V41, P4721, DOI 10.1007/s11033-014-3343-y; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Wang YL, 2004, J BIOL CHEM, V279, P39132, DOI 10.1074/jbc.M405982200; WILLIAMS F, 1961, J BIOL CHEM, V236, pPC36; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	51	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150974	10.1371/journal.pone.0150974	http://dx.doi.org/10.1371/journal.pone.0150974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992093	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800040
J	Townsend, ML; Riepsamen, A; Georgiou, C; Flood, VM; Caputi, P; Wright, IM; Davis, WS; Jones, A; Larkin, TA; Williamson, MJ; Grenyer, BFS				Townsend, Michelle L.; Riepsamen, Angelique; Georgiou, Christos; Flood, Victoria M.; Caputi, Peter; Wright, Ian M.; Davis, Warren S.; Jones, Alison; Larkin, Theresa A.; Williamson, Moira J.; Grenyer, Brin F. S.			Longitudinal Intergenerational Birth Cohort Designs: A Systematic Review of Australian and New Zealand Studies	PLOS ONE			English	Review							DENTIN LEAD LEVELS; LIFE STRESS; DEVELOPMENTAL ORIGINS; MATER-UNIVERSITY; MENTAL-HEALTH; ORAL-HEALTH; GROWING-UP; CHILDHOOD; PREGNANCY; RISK	Background The longitudinal birth cohort design has yielded a substantial contribution to knowledge of child health and development. The last full review in New Zealand and Australia in 2004 identified 13 studies. Since then, birth cohort designs continue to be an important tool in understanding how intrauterine, infant and childhood development affect long-term health and well-being. This updated review in a defined geographical area was conducted to better understand the factors associated with successful quality and productivity, and greater scientific and policy contribution and scope. Methods We adopted the preferred reporting items for systematic reviews and meta-analyses (PRISMA) approach, searching PubMed, Scopus, Cinahl, Medline, Science Direct and Pro-Quest between 1963 and 2013. Experts were consulted regarding further studies. Five inclusion criteria were used: (1) have longitudinally tracked a birth cohort, (2) have collected data on the child and at least one parent or caregiver (3) be based in Australia or New Zealand, (4) be empirical in design, and (5) have been published in English. Results 10665 records were initially retrieved from which 23 birth cohort studies met the selection criteria. Together these studies recruited 91,196 participants, with 38,600 mothers, 14,206 fathers and 38,390 live births. Seventeen studies were located in Australia and six in New Zealand. Research questions initially focused on the perinatal period, but as studies matured, longer-term effects and outcomes were examined. Conclusions This review demonstrates the significant yield from this effort both in terms of scientific discovery and social policy impact. Further opportunities have been recognised with cross-study collaboration and pooling of data between established and newer studies and international studies to investigate global health determinants.	[Townsend, Michelle L.; Georgiou, Christos; Caputi, Peter; Wright, Ian M.; Jones, Alison; Larkin, Theresa A.; Grenyer, Brin F. S.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Townsend, Michelle L.; Caputi, Peter; Grenyer, Brin F. S.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Riepsamen, Angelique] Univ New S Wales, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW, Australia; [Georgiou, Christos] Eastern Hlth, Melbourne, Vic, Australia; [Georgiou, Christos] Monash Univ, Fac Med Nursing & Hlth Serv, Eastern Hlth Clin Sch, Melbourne, Vic 3004, Australia; [Georgiou, Christos; Larkin, Theresa A.] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Flood, Victoria M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Flood, Victoria M.] St Vincents Hosp, Darlinghurst, NSW 2010, Australia; [Wright, Ian M.; Davis, Warren S.] NSW Hlth, Illawarra Shoalhaven Local Hlth Dist, Sydney, NSW, Australia; [Williamson, Moira J.] Cent Queensland Univ, Sch Nursing & Midwifery, Rockhampton, Qld 4702, Australia	University of Wollongong; University of Wollongong; University of New South Wales Sydney; Monash University; University of Wollongong; University of Sydney; St Vincents Hospital Sydney; Central Queensland University	Grenyer, BFS (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.; Grenyer, BFS (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.	grenyer@uow.edu.au	Townsend, Michelle L/M-9667-2017; Flood, Victoria M/A-8732-2016; Grenyer, Brin FS/AAB-6452-2020; Williamson, Moira/AAK-1100-2020	Townsend, Michelle L/0000-0001-8921-781X; Flood, Victoria M/0000-0001-5310-7221; Grenyer, Brin FS/0000-0003-1501-4336; Riepsamen, Angelique/0000-0002-7633-6294; Williamson, Moira/0000-0002-8504-5851; Wright, Ian/0000-0001-5337-0134; Larkin, Theresa/0000-0001-5916-7276	Global Challenges Program; Illawarra Health and Medical Research Institute, at the University of Wollongong	Global Challenges Program; Illawarra Health and Medical Research Institute, at the University of Wollongong	This study was funded by the Global Challenges Program and the Illawarra Health and Medical Research Institute, at the University of Wollongong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison L H, 1993, Paediatr Perinat Epidemiol, V7, P318, DOI 10.1111/j.1365-3016.1993.tb00407.x; Ambrosini GL, 2009, PUBLIC HEALTH NUTR, V12, P1807, DOI 10.1017/S1368980008004618; [Anonymous], 2013, SUBST DUN; Arora A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-28; BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; Bagshaw ATM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055208; Barker D. J. P., 1994, MOTHERS BABIES DIS L; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Behjati S, 2007, MED HYPOTHESES, V68, P998, DOI 10.1016/j.mehy.2006.10.010; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; BOULTON TJC, 1995, ACTA PAEDIATR, V84, P146, DOI 10.1111/j.1651-2227.1995.tb13597.x; Boulton TJC, 1995, ACTA PAEDIAT INT J P, V84; Brennan PA, 2011, BIOL PSYCHOL, V87, P99, DOI 10.1016/j.biopsycho.2011.02.013; Cameron CM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1080; Cameron CM, 2012, MATERN CHILD HLTH J, V16, P1896, DOI 10.1007/s10995-011-0940-4; Campbell Alasdair, 2011, J Glob Health, V1, P46; CARMICHAEL A, 1983, AUST PAEDIATR J, V19, P68; Carver A, 2005, AM J HEALTH PROMOT, V20, P139, DOI 10.4278/0890-1171-20.2.139; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2008, ARCH GEN PSYCHIAT, V65, P203, DOI 10.1001/archgenpsychiatry.2007.24; Centre for Overweigh and Obesity, 2011, DET RES SYDN; Centre for Traumatic Stress Studies, 2013, WHAT IS BIRTH NOW ST; Coe CL, 2008, CURR DIR PSYCHOL SCI, V17, P36, DOI 10.1111/j.1467-8721.2008.00544.x; Comino E, 2010, AUST NZ J PUBL HEAL, V34, pS9, DOI 10.1111/j.1753-6405.2010.00546.x; Conn JA, 2009, PUBLIC HEALTH NUTR, V12, P2448, DOI 10.1017/S1368980009005552; Copeland WE, 2013, J CHILD PSYCHOL PSYC, V54, P791, DOI 10.1111/jcpp.12062; Crane J, 2012, PEDIAT ALLERG IMM-UK, V23, P59, DOI 10.1111/j.1399-3038.2011.01227.x; Curran PJ, 2008, DEV PSYCHOL, V44, P365, DOI 10.1037/0012-1649.44.2.365; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P1480, DOI 10.1016/j.jaci.2011.03.014; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; Danese A, 2011, MOL PSYCHIATR, V16, P244, DOI 10.1038/mp.2010.5; de Silva-Sanigorski AM, 2010, BMC PUBLIC HLTH, V10; de Silva-Sanigorski Andrea M, 2011, BMC Public Health, V11, P505, DOI 10.1186/1471-2458-11-505; Doolan I, 2013, CHILD ABUSE NEGL; DOUGLAS RM, 1994, INT J EPIDEMIOL, V23, P818, DOI 10.1093/ije/23.4.818; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; Ellis JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026679; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Epton MJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-26; Fergusson DM, 2012, BRIT J PSYCHIAT, V200, P116, DOI 10.1192/bjp.bp.111.093328; Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993; FERGUSSON DM, 1988, J CHILD PSYCHOL PSYC, V29, P811, DOI 10.1111/j.1469-7610.1988.tb00755.x; FERGUSSON DM, 1993, J CHILD PSYCHOL PSYC, V34, P215, DOI 10.1111/j.1469-7610.1993.tb00980.x; Fergusson DM, 2003, J ABNORM CHILD PSYCH, V31, P605, DOI 10.1023/A:1026258106540; Fergusson DM, 2001, AUST NZ J PSYCHIAT, V35, P287, DOI 10.1046/j.1440-1614.2001.00902.x; Fergusson DM, 2013, CHRISTCHURCH EXPERIE, P79; Foley DL, 2009, AM J EPIDEMIOL, V169, P389, DOI 10.1093/aje/kwn380; FRY R, 1993, J PSYCHOSOM RES, V37, P89, DOI 10.1016/0022-3999(93)90075-Q; Garnett SP, 2001, INT J OBESITY, V25, P1667, DOI 10.1038/sj.ijo.0801821; Godfrey K M, 2001, Public Health Nutr, V4, P611; Golding J, 2010, POSTGRAD MED J, V86, P387, DOI 10.1136/pgmj.2009.178954rep; Gortmaker SL, 1997, DEV PSYCHOBIOL, V31, P107; Gray M, 2005, FAMILY MATTERS, P4; Guardamagna O, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-73; Hardy LL, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-24; Hure AJ, 2012, J EPIDEMIOL, V22, P267, DOI 10.2188/jea.JE20110079; Institute IHaMR, 2014, ILL BORN CROSS GEN H; JORDAN TE, 1988, J ROY SOC HEALTH, V108, P166, DOI 10.1177/146642408810800508; Jorm AF, 2003, PSYCHOSOM MED, V65, P662, DOI 10.1097/01.PSY.0000077506.29218.60; KEEPING JD, 1989, BRIT J OBSTET GYNAEC, V96, P289, DOI 10.1111/j.1471-0528.1989.tb02388.x; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Kemp A, 2013, PEDIAT ALLERGY IMMUN, V3, P12085; Kent AL, 2012, J PAEDIATR CHILD H, V48, P730, DOI 10.1111/j.1440-1754.2012.02541.x; Knight JA, 2009, J BIOETHIC INQ, V6, P467, DOI 10.1007/s11673-009-9186-x; Koong D, 1997, OBSTET GYNECOL, V89, P654, DOI 10.1016/S0029-7844(97)81435-4; LANGLEY J, 1979, AUST PAEDIATR J, V15, P255; Lawlor DA, 2005, J EPIDEMIOL COMMUN H, V59, P279, DOI 10.1136/jech.2004.025262; Lawlor DA, 2009, INT J EPIDEMIOL, V38, P897, DOI 10.1093/ije/dyp240; Lawrance M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-31; Li JH, 2013, J PEDIATR-US, V162, P483, DOI 10.1016/j.jpeds.2012.09.007; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loke YJ, 2013, TWIN RES HUM GENET, V16, P13, DOI 10.1017/thg.2012.114; Mackerras DEM, 2010, NUTR DIET, V67, P171, DOI 10.1111/j.1747-0080.2010.01451.x; Mackey DA, 2012, CORNEA, V31, P162, DOI 10.1097/ICO.0b013e318226155f; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Magarey AM, 1999, ACTA PAEDIATR, V88, P1204, DOI 10.1080/080352599750030293; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Martin AJ, 2002, PEDIATRICS, V109, P1061, DOI 10.1542/peds.109.6.1061; McClay J, 2000, AM J MED GENET, V96, P554; McClure EB, 2001, J ABNORM CHILD PSYCH, V29, P1, DOI 10.1023/A:1005260311313; McFarlane AC, 2013, NEUROTOXICOLOGY, V39, P11, DOI 10.1016/j.neuro.2013.08.003; McKnight CM, 2012, MED J AUSTRALIA, V197, P608, DOI 10.5694/mja12.10698; McMichael A, 1991, INT J ENVIRON HEAL R, V1, P192; MCMICHAEL AJ, 1992, NEUROTOXICOL TERATOL, V14, P321, DOI 10.1016/0892-0362(92)90038-C; MCMICHAEL AJ, 1986, J EPIDEMIOL COMMUN H, V40, P18, DOI 10.1136/jech.40.1.18; Mill J, 2006, ARCH GEN PSYCHIAT, V63, P462, DOI 10.1001/archpsyc.63.4.462; Milne BJ, 2009, AM J MED GENET B, V150B, P41, DOI 10.1002/ajmg.b.30764; Moffitt T. E., 2001, SEX DIFFERENCES ANTI; Mook-Kanamori DO, 2011, J CLIN ENDOCR METAB, V96, pE810, DOI 10.1210/jc.2010-2316; Morton SMB., 2012, GROWING NZ LONGITUDI; Morton SMB., 2010, GROWING NZ LONGITUDI; Morton SMB, 2013, INT J EPIDEMIOL, V42, P65, DOI 10.1093/ije/dyr206; Motte E, 2010, ARCH PEDIATRIE, V17, P60, DOI 10.1016/j.arcped.2009.10.014; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; National Drug and Alcohol Research Centre, 2010, TRIPL B BUMPS BAB SY; Newcombe R, 2007, TWIN RES HUM GENET, V10, P581, DOI 10.1375/twin.10.4.581; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Nicholson JM, 2004, J PAEDIATR CHILD H, V40, P87, DOI 10.1111/j.1440-1754.2004.00327.x; Olesen SC, 2010, FAMILY MATTERS, P43; Paracchini S, 2011, GENES BRAIN BEHAV, V10, P158, DOI 10.1111/j.1601-183X.2010.00651.x; Paterson J, 2006, NZ MED J, V119; Paterson J, 2008, INT J EPIDEMIOL, V37, P273, DOI 10.1093/ije/dym171; Peres MA, 2011, AUST NZ J PUBL HEAL, V35, P549, DOI 10.1111/j.1753-6405.2011.00736.x; Prichard Z, 2002, AM J MED GENET, V114, P169, DOI 10.1002/ajmg.10181; Research Centre for Primary Health Care and Equity, 2012, GUD STUD SYDN; Robinson M, 2013, AUST PSYCHOL, V48, P239, DOI 10.1111/ap.12022; Robinson M, 2011, DEV PSYCHOPATHOL, V23, P507, DOI 10.1017/S0954579411000241; Rosenman S, 2006, AUST NZ J PSYCHIAT, V40, P482, DOI 10.1080/j.1440-1614.2006.01826.x; Rumbold AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-583; Rutter M, 2004, JAMA-J AM MED ASSOC, V291, P2007, DOI 10.1001/jama.291.16.2007; Saffery R, 2012, INT J EPIDEMIOL, V41, P55, DOI 10.1093/ije/dyr140; Sanson A, 2013, FUTURE DIRECTION OPP; Sayers S, AUSTR ABORIGINAL BIR, DOI [10.1186/1472-698X-9-23, DOI 10.1186/1472-698X-9-23]; Sayers Susan M, 2003, BMC Int Health Hum Rights, V3, P1, DOI 10.1186/1472-698X-3-1; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Shonkoff JP, 2011, PEDIATRICS; Shulruf B, 2007, EVAL HEALTH PROF, V30, P207, DOI 10.1177/0163278707304030; Silva P A, 1990, Paediatr Perinat Epidemiol, V4, P76, DOI 10.1111/j.1365-3016.1990.tb00621.x; SILVA PA, 1984, J DEV BEHAV PEDIATR, V5, P1; Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.2223/JPED.1728, 10.1590/S0021-75572007000800004]; Sinclair K D, 2007, Soc Reprod Fertil Suppl, V64, P425; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sutton A J, 1998, Health Technol Assess, V2, P1; Tam CS, 2006, J CLIN ENDOCR METAB, V91, P4369, DOI 10.1210/jc.2006-0953; Tikellis G, 2012, INT J OBESITY, V36, P496, DOI 10.1038/ijo.2011.261; van Eekelen JAM, 2011, AUST J PSYCHOL, V63, P6, DOI 10.1111/j.1742-9536.2011.00002.x; Vimpani G, 2002, CHILDRENS HLTH DEV; VOLPE RA, 1992, ENVIRON GEOCHEM HLTH, V14, P133, DOI 10.1007/BF01783488; Warrington NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053897; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Yazar S, 2013, OPHTHALMIC GENET; Yin J, 2012, EUR J CLIN NUTR, V66, P1329, DOI 10.1038/ejcn.2012.122	133	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150491	10.1371/journal.pone.0150491	http://dx.doi.org/10.1371/journal.pone.0150491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991330	Green Published, gold			2022-12-27	WOS:000372582800033
J	Arba, MA; Darebo, TD; Koyira, MM				Arba, Mihiretu Alemayehu; Darebo, Tadele Dana; Koyira, Mengistu Meskele			Institutional Delivery Service Utilization among Women from Rural Districts of Wolaita and Dawro Zones, Southern Ethiopia; a Community Based Cross-Sectional Study	PLOS ONE			English	Article							CARE	Introduction The highest number of maternal deaths occur during labour, delivery and the first day after delivery highlighting the critical need for good quality care during this period. Therefore, for the strategies of institutional delivery to be effective, it is essential to understand the factors that influence individual and household factors to utilize skilled birth attendance and institutions for delivery. This study was aimed to assess factors affecting the utilization of institutional delivery service of women in rural districts of Wolaita and Dawro Zones. Methods A community based cross-sectional study was done among mothers who gave birth within the past one year preceding the survey in Wolaita and Dawro Zones, from February 01 -April 30, 2015 by using a three stage sampling technique. Initially, 6 districts were selected randomly from the total of 17 eligible districts. Then, 2 kebele from each district was selected randomly cumulating a total of 12 clusters. Finally, study participants were selected from each cluster by using systematic sampling technique. Accordingly, 957 mothers were included in the survey. Data was collected by using a pretested interviewer administered structured questionnaire. The questionnaire was prepared by including socio-demographic variables and variables of maternal health service utilization factors. Data was entered using Epi-data version 1.4.4.0 and exported to SPSS version 20 for analysis. Bivariate and multiple logistic regressions were applied to identify candidate and predictor variables respectively. Result Only 38% of study participants delivered the index child at health facility. Husband's educational status, wealth index, average distance from nearest health facility, wanted pregnancy, agreement to follow post-natal care, problem faced during delivery, birth order, preference of health professional for ante-natal care and maternity care were predictors of institutional delivery. Conclusion The use of institutional delivery service is low in the study community. Even though antenatal care service is high; nearly two in every three mothers delivered their index child out of health facility. Improving socio-economic status of mothers as well as availing modern health facilities to the nearest locality will have a good impact to improve institutional delivery service utilization. Similarly, education is also a tool to improve awareness of mothers and their husbands for the improvement of health care service utilization.	[Arba, Mihiretu Alemayehu; Darebo, Tadele Dana; Koyira, Mengistu Meskele] Wolaita Sodo Univ, Coll Hlth Sci & Med, Sch Publ Hlth, POB 138, Wolaita Sodo, Ethiopia		Arba, MA (corresponding author), Wolaita Sodo Univ, Coll Hlth Sci & Med, Sch Publ Hlth, POB 138, Wolaita Sodo, Ethiopia.	mihiretua@gmail.com		Alemayehu, Mihiretu/0000-0002-2459-7476	Wolaita Sodo University	Wolaita Sodo University	This research is funded by Wolaita Sodo University. The institution supported by providing transportation service and allocating budget for data collection.; Our gratitude goes to Wolaita Sodo University for its financial support. We would also like to extend our whole-hearted gratitude to the respective Woreda administrative bodies for their assistance. Last but not least, data collectors and study participants deserve our special thanks.	Aliy J, 2012, ETHIOP J HEALTH DEV, V26, P265; Bolam A, 1998, HEALTH POLICY PLANN, V13, P152, DOI 10.1093/heapol/13.2.152; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Chimankar DA, 2011, STUD ETHNO-MED, V5, P209, DOI 10.1080/09735070.2011.11886411; Daniel O, 2014, INT J GYNECOL OBSTET, V2, P63, DOI DOI 10.11648/j.jgo.20140204.20140214; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Federal Democratic Republic of Ethiopia, 2008, SUMM STAT REP 2007 P; Gedefaw A., 2013, ETHIOPIA SCI J PUBLI, V1, P18; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lule E., 2005, ACHIEVING MILLENNIUM; Magadi M, CHOICE DELIVERY CARE; Melaku YA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0418-7; Nigeria Demographic and Health Survey, 2008, DIR EST MAT MORT, P237; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; United Nations, 2008, MILL DEV GOALS REP; WHO, 2004, MAT MORT 2000; WHO, 1994, MOTH BAB PACK IMPL S; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; YarZever I, 2013, EUR J BIOL MED SCI R, V1, P1; Zere E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-34	22	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151082	10.1371/journal.pone.0151082	http://dx.doi.org/10.1371/journal.pone.0151082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986563	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300044
J	Pang, QX; Gao, LL; Hu, WJ; An, Y; Deng, HK; Zhang, YC; Sun, XW; Zhu, GZ; Liu, BH; Zhao, BS				Pang, Qiuxiang; Gao, Lili; Hu, Wenjing; An, Yang; Deng, Hongkuan; Zhang, Yichao; Sun, Xiaowen; Zhu, Guangzhong; Liu, Baohua; Zhao, Bosheng			De Novo Transcriptome Analysis Provides Insights into Immune Related Genes and the RIG-I-Like Receptor Signaling Pathway in the Freshwater Planarian (Dugesia japonica)	PLOS ONE			English	Article							NF-KAPPA-B; MOLECULAR CHARACTERIZATION; FUNCTIONAL GENOMICS; ADAPTER PROTEIN; INNATE IMMUNITY; CDNA CLONING; SYSTEM; REGENERATION; HOMOLOG; BETA	Background The freshwater planarian Dugesia japonica (D. japonica) possesses extraordinary ability to regenerate lost organs or body parts. Interestingly, in the process of regeneration, there is little wound infection, suggesting that D. japonica has a formidable innate immune system. The importance of immune system prompted us to search for immune-related genes and RIG-I-like receptor signaling pathways. Results Transcriptome sequencing of D. japonica was performed on an IlluminaHiSeq2000 platform. A total of 27,180 transcripts were obtained by Trinity assembler. CEGMA analysis and mapping of all trimmed reads back to the assembly result showed that our transcriptome assembly covered most of the whole transcriptome. 23,888 out of 27,180 transcripts contained ORF (open reading fragment), and were highly similar to those in Schistosoma mansoni using BLASTX analysis. 8,079 transcripts (29.7%) and 8,668 (31.9%) were annotated by Blast2GO and KEGG respectively. A DYNLRB-like gene was cloned to verify its roles in the immune response. Finally, the expression patterns of 4 genes (RIG-I, TRAF3, TRAF6, P38) in the RIG-I-like receptor signaling pathway were detected, and the results showed they are very likely to be involved in planarian immune response. Conclusion RNA-Seq analysis based on the next-generation sequencing technology was an efficient approach to discover critical genes and to understand their corresponding biological functions. Through GO and KEGG analysis, several critical and conserved signaling pathways and genes related to RIG-I-like receptor signaling pathway were identified. Four candidate genes were selected to identify their expression dynamics in the process of pathogen stimulation. These annotated transcripts of D. japonica provide a useful resource for subsequent investigation of other important pathways.	[Pang, Qiuxiang; Gao, Lili; Hu, Wenjing; Deng, Hongkuan; Zhang, Yichao; Sun, Xiaowen; Zhu, Guangzhong; Zhao, Bosheng] Shandong Univ Technol, Sch Life Sci, Lab Dev & Evolutionary Biol, Zibo 255049, Peoples R China; [Pang, Qiuxiang; Gao, Lili; Hu, Wenjing; Deng, Hongkuan; Liu, Baohua] Shandong Univ Technol, Sch Life Sci, Antiaging & Regenerat Med Res Inst, Zibo 255049, Peoples R China; [An, Yang] Immolife Biotech Co Ltd, Nanjing 210000, Jiangsu, Peoples R China; [Liu, Baohua] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China	Shandong University of Technology; Shandong University of Technology; Shenzhen University	Zhao, BS (corresponding author), Shandong Univ Technol, Sch Life Sci, Lab Dev & Evolutionary Biol, Zibo 255049, Peoples R China.; Liu, BH (corresponding author), Shandong Univ Technol, Sch Life Sci, Antiaging & Regenerat Med Res Inst, Zibo 255049, Peoples R China.; Liu, BH (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.	ppliew@szu.edu.cn; zhaobosheng@sdut.edu.cn	Liu, Baohua/AAH-3685-2020	Liu, Baohua/0000-0002-1599-8059	National Natural Science Foundation of China [31172074, 30700071, 31572263]; Shandong Provincial Natural Science Foundation [ZR2010CL002]; Educational Commission of Shandong Province for University Excellent Teacher of International Cooperation Training Project, Young Teacher Support Program in Shandong University of Technology; Immolife-biotech Co. Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Educational Commission of Shandong Province for University Excellent Teacher of International Cooperation Training Project, Young Teacher Support Program in Shandong University of Technology; Immolife-biotech Co. Ltd.	This work was supported by the National Natural Science Foundation of China (Grant Numbers 31172074, 30700071, 31572263), the Shandong Provincial Natural Science Foundation (Grant Number ZR2010CL002), the Educational Commission of Shandong Province for University Excellent Teacher of International Cooperation Training Project, Young Teacher Support Program in Shandong University of Technology and the Immolife-biotech Co. Ltd. The funder from Immolife-biotech Co. Ltd. only provided support in the form of salaries for Yang An, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abnave P, 2014, CELL HOST MICROBE, V16, P338, DOI 10.1016/j.chom.2014.08.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Baguna J., 1988, Progress in Zoology, V36, P65; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P205, DOI 10.1016/S0145-305X(00)00057-4; Bowman AB, 1999, J CELL BIOL, V146, P165; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Feng H, 2011, FISH SHELLFISH IMMUN, V30, P1159, DOI 10.1016/j.fsi.2011.03.002; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Forsthoefel DJ, 2009, CURR OPIN GENET DEV, V19, P412, DOI 10.1016/j.gde.2009.05.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Huang BY, 2014, MOL BIOL REP, V41, P6481, DOI 10.1007/s11033-014-3531-9; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jin QY, 2012, MOL CELL ENDOCRINOL, V348, P233, DOI 10.1016/j.mce.2011.08.029; Johansson MW, 1999, DEV COMP IMMUNOL, V23, P303, DOI 10.1016/S0145-305X(99)00013-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Lan JF, 2013, DEV COMP IMMUNOL, V41, P608, DOI 10.1016/j.dci.2013.07.004; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li FH, 2013, FISH SHELLFISH IMMUN, V34, P973, DOI 10.1016/j.fsi.2012.08.023; Li YW, 2014, DEV COMP IMMUNOL, V44, P217, DOI 10.1016/j.dci.2013.12.011; Liang YJ, 2011, FISH SHELLFISH IMMUN, V31, P963, DOI 10.1016/j.fsi.2011.08.014; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo T, 2006, DEV COMP IMMUNOL, V30, P607, DOI 10.1016/j.dci.2005.10.004; Mao M, 1996, P NATL ACAD SCI USA, V93, P5910, DOI 10.1073/pnas.93.12.5910; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mialhe E, 1995, MOL MAR BIOL BIOTECH, V4, P275; Mikkelsen SS, 2009, J BIOL CHEM, V284, P10774, DOI 10.1074/jbc.M807272200; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Nie L, 2015, DEV COMP IMMUNOL, V48, P95, DOI 10.1016/j.dci.2014.09.008; Pang QX, 2010, COMP BIOCHEM PHYS B, V157, P54, DOI 10.1016/j.cbpb.2010.05.002; Peiris TH, 2014, SEMIN IMMUNOL, V26, P295, DOI 10.1016/j.smim.2014.06.005; Petersen CP, 2014, CELL HOST MICROBE, V16, P271, DOI 10.1016/j.chom.2014.08.016; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Salo E, 2006, BIOESSAYS, V28, P546, DOI 10.1002/bies.20416; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SODERHALL K, 1994, ANN NY ACAD SCI, V712, P155, DOI 10.1111/j.1749-6632.1994.tb33570.x; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Tseng IT, 2004, FISH SHELLFISH IMMUN, V17, P325, DOI 10.1016/j.fsi.2004.04.010; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang JL, 2011, NAT PRODUCT BIOPROSP, V1, P1, DOI 10.1007/s13659-011-0003-y; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Young JAT, 2004, P NATL ACAD SCI USA, V101, P12781, DOI 10.1073/pnas.0404890101; Zeng A, 2013, J CELL BIOL, V201, P409, DOI 10.1083/jcb.201207172; Zhai YJ, 2015, DEV COMP IMMUNOL, V49, P1, DOI 10.1016/j.dci.2014.11.006; Zhang Y, 2014, FISH SHELLFISH IMMUN, V40, P466, DOI 10.1016/j.fsi.2014.07.029	63	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151597	10.1371/journal.pone.0151597	http://dx.doi.org/10.1371/journal.pone.0151597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986572	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300092
J	Moch, M; Windoffer, R; Schwarz, N; Pohl, R; Omenzetter, A; Schnakenberg, U; Herb, F; Chaisaowong, K; Merhof, D; Ramms, L; Fabris, G; Hoffmann, B; Merkel, R; Leube, RE				Moch, Marcin; Windoffer, Reinhard; Schwarz, Nicole; Pohl, Raphaela; Omenzetter, Andreas; Schnakenberg, Uwe; Herb, Fabian; Chaisaowong, Kraisorn; Merhof, Dorit; Ramms, Lena; Fabris, Gloria; Hoffmann, Bernd; Merkel, Rudolf; Leube, Rudolf E.			Effects of Plectin Depletion on Keratin Network Dynamics and Organization	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; ALPHA-6-BETA-4 INTEGRIN; CROSS-TALK; IN-VITRO; CYTOSKELETON; HEMIDESMOSOMES; MIGRATION; BINDING; CELLS; ACTIN	The keratin intermediate filament cytoskeleton protects epithelial cells against various types of stress and is involved in fundamental cellular processes such as signaling, differentiation and organelle trafficking. These functions rely on the cell type-specific arrangement and plasticity of the keratin system. It has been suggested that these properties are regulated by a complex cycle of assembly and disassembly. The exact mechanisms responsible for the underlying molecular processes, however, have not been clarified. Accumulating evidence implicates the cytolinker plectin in various aspects of the keratin cycle, i.e., by acting as a stabilizing anchor at hemidesmosomal adhesion sites and the nucleus, by affecting keratin bundling and branching and by linkage of keratins to actin filament and microtubule dynamics. In the present study we tested these hypotheses. To this end, plectin was downregulated by shRNA in vulvar carcinoma-derived A431 cells. As expected, integrin beta 4-and BPAG-1-positive hemidesmosomal structures were strongly reduced and cytosolic actin stress fibers were increased. In addition, integrins alpha 3 and beta 1 were reduced. The experiments furthermore showed that loss of plectin led to a reduction in keratin filament branch length but did not alter overall mechanical properties as assessed by indentation analyses using atomic force microscopy and by displacement analyses of cytoplasmic superparamagnetic beads using magnetic tweezers. An increase in keratin movement was observed in plectin-depleted cells as was the case in control cells lacking hemidesmosome-like structures. Yet, keratin turnover was not significantly affected. We conclude that plectin alone is not needed for keratin assembly and disassembly and that other mechanisms exist to guarantee proper keratin cycling under steady state conditions in cultured single cells.	[Moch, Marcin; Windoffer, Reinhard; Schwarz, Nicole; Pohl, Raphaela; Leube, Rudolf E.] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany; [Omenzetter, Andreas; Schnakenberg, Uwe] Rhein Westfal TH Aachen, Inst Mat Elect Engn 1, Aachen, Germany; [Herb, Fabian; Chaisaowong, Kraisorn; Merhof, Dorit] Rhein Westfal TH Aachen, Inst Imaging & Comp Vis, Aachen, Germany; [Ramms, Lena; Fabris, Gloria; Hoffmann, Bernd; Merkel, Rudolf] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Chaisaowong, Kraisorn] King Mongkuts Univ Technol North Bangkok, Bangkok, Thailand	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; King Mongkuts University of Technology North Bangkok	Leube, RE (corresponding author), Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany.	rleube@ukaachen.de	Merhof, Dorit/AAV-7892-2021; Schwarz, Nicole/ABC-8096-2020; Moch, Marcin/GWC-7292-2022; Merkel, Rudolf/G-3647-2013	Moch, Marcin/0000-0003-2143-5292; Merkel, Rudolf/0000-0003-3178-3282; Schnakenberg, Uwe/0000-0002-2251-0605; Windoffer, Reinhard/0000-0003-1403-5880; Leube, Rudolf/0000-0002-5519-7379; Schwarz, Nicole/0000-0001-7888-6970; Hoffmann, Bernd/0000-0002-3803-8835	German Research Foundation [LE 566/18-1, LE 566/22-1, WI 1731/8-1]; Excellence Initiative of the German federal government; Excellence Initiative of the German state government; RWTH ERS Boost-Fund [OPBF071]; IZKF, Uniklinik RWTH Aachen University; EU [642866]	German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German federal government; Excellence Initiative of the German state government; RWTH ERS Boost-Fund; IZKF, Uniklinik RWTH Aachen University; EU(European Commission)	Funded by 1. German Research Foundation, http://www.dfg.de/en/, LE 566/18-1, RE, 2. German Research Foundation, http://www.dfg.de/en/, LE 566/22-1, REL, 3. German Research Foundation, http://www.dfg.de/en/, WI 1731/8-1, RW, 4. Excellence Initiative of the German federal and state governments, http://www.dfg.de/en/research_funding/programmes/excellence_initiative/, RWTH ERS Boost-Fund 2013 OPBF071, US, 5. IZKF, Uniklinik RWTH Aachen University, http://www.medizin.rwth-aachen.de/cms/Medizin/Die_Fakultaet/Einrichtungen/similar to dgun/IZKF_Aachen/?lidx=1, Boost Fund, REF and RW, 6. IZKF, Uniklinik RWTH Aachen University, http://www.medizin.rwth-aachen.de/cms/Medizin/Die_Fakultaet/Einrichtungen/similar to dgun/IZKF_ Aachen/?lidx=1, TP1, REL and RW, and 7. EU # 2020-MSCA-ITN InCeM, http://ec.europa.eu/programmes/horizon2020/en/h2020-section/mariesklodowska-curie-actions, 642866, REL, RW. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Boczonadi V, 2007, EXP CELL RES, V313, P3579, DOI 10.1016/j.yexcr.2007.07.005; Bonakdar N, 2015, EXP CELL RES, V331, P331, DOI 10.1016/j.yexcr.2014.10.001; Bouameur JE, 2014, J INVEST DERMATOL, V134, P2776, DOI 10.1038/jid.2014.255; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; CHOU CF, 1993, J CELL SCI, V105, P433; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Feng X, 2015, J CELL BIOL, V209, P59, DOI 10.1083/jcb.201408079; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Herberich Gerlind, 2014, MULTIDIMENSIONAL IMA; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; HERTLE MD, 1991, DEVELOPMENT, V112, P193; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; Iwatsuki H, 2010, ACTA HISTOCHEM CYTOC, V43, P19, DOI 10.1267/ahc.10009; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Leube Rudolf E, 2011, Bioarchitecture, V1, P39; Long HA, 2006, J CELL SCI, V119, P5147, DOI 10.1242/jcs.03304; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Moch M, 2013, P NATL ACAD SCI USA, V110, P10664, DOI 10.1073/pnas.1306020110; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Nievers MG, 2000, J CELL SCI, V113, P963; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Sailer M, 2010, MICROSC MICROANAL, V16, P462, DOI 10.1017/S1431927610093657; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Szabo S, 2015, J HEPATOL, V62, P1357, DOI 10.1016/j.jhep.2015.01.007; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Walko G, 2015, CELL TISSUE RES, V360, P363, DOI 10.1007/s00441-014-2061-z; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Windoffer R, 1999, J CELL SCI, V112, P4521; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	55	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0149106	10.1371/journal.pone.0149106	http://dx.doi.org/10.1371/journal.pone.0149106			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007410	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200017
J	Wong, RSY; Ismail, NA				Wong, Rowena Syn Yin; Ismail, Noor Azina			An Application of Bayesian Approach in Modeling Risk of Death in an Intensive Care Unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; APACHE IV; REGRESSION; VALIDATION; ADMISSION; PATIENT; SAPS-3	Background and Objectives There are not many studies that attempt to model intensive care unit (ICU) risk of death in developing countries, especially in South East Asia. The aim of this study was to propose and describe application of a Bayesian approach in modeling in-ICU deaths in a Malaysian ICU. Methods This was a prospective study in a mixed medical-surgery ICU in a multidisciplinary tertiary referral hospital in Malaysia. Data collection included variables that were defined in Acute Physiology and Chronic Health Evaluation IV (APACHE IV) model. Bayesian Markov Chain Monte Carlo (MCMC) simulation approach was applied in the development of four multivariate logistic regression predictive models for the ICU, where the main outcome measure was in-ICU mortality risk. The performance of the models were assessed through overall model fit, discrimination and calibration measures. Results from the Bayesian models were also compared against results obtained using frequentist maximum likelihood method. Results The study involved 1,286 consecutive ICU admissions between January 1, 2009 and June 30, 2010, of which 1,111 met the inclusion criteria. Patients who were admitted to the ICU were generally younger, predominantly male, with low co-morbidity load and mostly under mechanical ventilation. The overall in-ICU mortality rate was 18.5% and the overall mean Acute Physiology Score (APS) was 68.5. All four models exhibited good discrimination, with area under receiver operating characteristic curve (AUC) values approximately 0.8. Calibration was acceptable (Hosmer-Lemeshow p-values > 0.05) for all models, except for model M3. Model M1 was identified as the model with the best overall performance in this study. Conclusion Four prediction models were proposed, where the best model was chosen based on its overall performance in this study. This study has also demonstrated the promising potential of the Bayesian MCMC approach as an alternative in the analysis and modeling of in-ICU mortality outcomes.	[Wong, Rowena Syn Yin; Ismail, Noor Azina] Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia	Universiti Malaya	Ismail, NA (corresponding author), Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia.	nazina@um.edu.my	ISMAIL, NOOR AZINA/B-5341-2010	ISMAIL, NOOR AZINA/0000-0001-8032-2162	University of Malaya [RG138/09HTM]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya (www.um.edu.my) Grant RG138/09HTM Assessment of Performance of the Scoring Systems at an Interdisciplinary ICU, received by NAI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrick EJ, 1997, AM STAT, V51, P211, DOI 10.2307/2684890; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Chen MH, 1999, J ROY STAT SOC B, V61, P223, DOI 10.1111/1467-9868.00173; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Congdon P, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0470092394; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KAY R, 1987, BIOMETRIKA, V74, P495, DOI 10.1093/biomet/74.3.495; Kazembe LN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-6; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Letchuman GR, 2010, MED J MALAYSIA, V65, P180; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nazaimoon WMW, 2013, DIABETIC MED, V30, P825, DOI 10.1111/dme.12161; SCHWARTZ S, 1981, CRIT CARE MED, V9, P625, DOI 10.1097/00003246-198109000-00001; Siegelaar SE, 2011, CRIT CARE, V15, DOI 10.1186/cc10440; Siegelaar SE, 2010, CRIT CARE, V14, DOI 10.1186/cc8881; Souza Aparecida D. P., 2004, Pesqui. Oper., V24, P253, DOI 10.1590/S0101-74382004000200003; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Tong JMG, MALAYSIAN REGISTRY I; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8866; Vogenberg FR, 2009, AM HEALTH DRUG BENEF, V2, P218; Wong RSY, 2015, ANN ACAD MED SINGAP, V44, P127; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	30	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151949	10.1371/journal.pone.0151949	http://dx.doi.org/10.1371/journal.pone.0151949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007413	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200077
J	Berisha, S; Han, J; Shahid, M; Han, YC; Witschey, WRT				Berisha, Sebastian; Han, Joyce; Shahid, Mohammed; Han, Yuchi; Witschey, Walter R. T.			Measurement of Myocardial T-1 rho with a Motion Corrected, Parametric Mapping Sequence in Humans	PLOS ONE			English	Article							TISSUE CHARACTERIZATION; INVERSION-RECOVERY; IN-VIVO; INFARCTION; TIME; T-1; COMPENSATION; ARTIFACTS; ECHO; B-0	Purpose To develop a robust T-1 rho magnetic resonance imaging (MRI) sequence for assessment of myocardial disease in humans. Materials and Methods We developed a breath-held T-1 rho mapping method using a single-shot, T-1 rho-prepared balanced steady-state free-precession (bSSFP) sequence. The magnetization trajectory was simulated to identify sources of T-1 rho error. To limit motion artifacts, an optical flow-based image registration method was used to align T-1 rho images. The reproducibility and accuracy of these methods was assessed in phantoms and 10 healthy subjects. Results are shown in 1 patient with pre-ventricular contractions (PVCs), 1 patient with chronic myocardial infarction (MI) and 2 patients with hypertrophic cardiomyopathy (HCM). Results In phantoms, the mean bias was 1.0 +/- 2.7 msec (100 msec phantom) and 0.9 +/- 0.9 msec (60 msec phantom) at 60 bpm and 2.2 +/- 3.2 msec (100 msec) and 1.4 +/- 0.9 msec (60 msec) at 80 bpm. The coefficient of variation (COV) was 2.2 (100 msec) and 1.3 (60 msec) at 60 bpm and 2.6 (100 msec) and 1.4 (60 msec) at 80 bpm. Motion correction improved the alignment of T-1 rho images in subjects, as determined by the increase in Dice Score Coefficient (DSC) from 0.76 to 0.88. T-1 rho reproducibility was high (COV < 0.05, intra-class correlation coefficient (ICC) = 0.85-0.97). Mean myocardial T-1 rho value in healthy subjects was 63.5 +/- 4.6 msec. There was good correspondence between late-gadolinium enhanced (LGE) MRI and increased T-1 rho relaxation times in patients. Conclusion Single-shot, motion corrected, spin echo, spin lock MRI permits 2D T-1 rho mapping in a breath-hold with good accuracy and precision.	[Berisha, Sebastian; Shahid, Mohammed; Witschey, Walter R. T.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Han, Joyce; Han, Yuchi] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Witschey, WRT (corresponding author), Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.	witschey@mail.med.upenn.edu	Han, Q. Joyce/GLR-1652-2022	Han, Q. Joyce/0000-0001-7089-1767	National Institutes of Health [NHLBI R00-HL108157]; Mr. and Mrs. Thomas B. McCabe Fund; National Center for Research Resources [UL1RR024134]; National Center for Advancing Translational Sciences [UL1TR000003]; Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL108157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mr. and Mrs. Thomas B. McCabe Fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health NHLBI R00-HL108157 and the Mr. and Mrs. Thomas B. McCabe Fund. The project described was supported by the National Center for Research Resources, Grant UL1RR024134, and is now at the National Center for Advancing Translational Sciences, Grant UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported in part by the Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics (http://www.itmat.upenn.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya M, 2014, MAGN RESON MED; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; Bruce D, IJCAI 81 P 7 INT JOI; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Chen WT, 2011, MAGN RESON IMAGING, V29, P608, DOI 10.1016/j.mri.2011.02.002; Dixon WT, 1996, MAGNET RESON MED, V36, P90, DOI 10.1002/mrm.1910360116; Fleiss JL, 1999, DESIGN ANAL CLIN EXP; Han JQ, 2015, J CARDIOVASC MAGN S1, V17, pP22; Han Q, 2014, J CARDIOVASC MAGN S1, V16, pP70; Han Y, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-013-9248-7; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huber S, 2006, J MAGN RESON IMAGING, V24, P1040, DOI 10.1002/jmri.20720; Liu C, 2009, PIXELS EXPLORING NEW; Murase K, 2011, MAGN RESON IMAGING, V29, P126, DOI 10.1016/j.mri.2010.07.003; Musthafa HSN, 2013, MAGN RESON MED, V69, P1389, DOI 10.1002/mrm.24382; Muthupillai R, 2004, RADIOLOGY, V232, P606, DOI 10.1148/radiol.2322030334; Roujol S, 2014, MAGN RESON MED, P1; Scheffler K, 2001, MAGNET RESON MED, V45, P720, DOI 10.1002/mrm.1097; van Oorschot JWM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0104-y; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-53; Wang C, 2015, J CARDIOL, P00090; Wang DJJ, 2010, ESTIMATION PERFUSION, V1295, P1289; Witschey WRT, 2008, J MAGN RESON IMAGING, V28, P744, DOI 10.1002/jmri.21444; Witschey WRT, 2007, MAGN RESON MED, V57, P2, DOI 10.1002/mrm.21134; Witschey WRT, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-37; Witschey WRT, 2010, MAGN RESON MED, V64, P1454, DOI 10.1002/mrm.22543; Witschey WRT, 2007, J MAGN RESON, V186, P75, DOI 10.1016/j.jmr.2007.01.015; Xue H, 2013, MAGN RESON MED, V69, P1408, DOI 10.1002/mrm.24385; Xue H, 2012, MAGN RESON MED, V67, P1644, DOI 10.1002/mrm.23153	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151144	10.1371/journal.pone.0151144	http://dx.doi.org/10.1371/journal.pone.0151144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003184	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400025
J	Karimi, S; Ahl, D; Vagesjo, E; Holm, L; Phillipson, M; Jonsson, H; Roos, S				Karimi, Shokoufeh; Ahl, David; Vagesjo, Evelina; Holm, Lena; Phillipson, Mia; Jonsson, Hans; Roos, Stefan			In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; HOST-RANGE; PROBIOTIC LACTOBACILLI; CHROMOPHORE MATURATION; PROMISCUOUS PLASMID; GENE-EXPRESSION; GUT MICROBIOTA; STABILITY; EVOLUTION	Lactobacillus reuteri is a symbiont that inhabits the gastrointestinal (GI) tract of mammals, and several strains are used as probiotics. After introduction of probiotic strains in a complex ecosystem like the GI tract, keeping track of them is a challenge. The main objectives of this study were to introduce reporter proteins that would enable in vivo and in vitro detection of L. reuteri and increase knowledge about its interactions with the host. We describe for the first time cloning of codon-optimized reporter genes encoding click beetle red luciferase (CBRluc) and red fluorescent protein mCherry in L. reuteri strains ATCC PTA 6475 and R2LC. The plasmid persistence of mCherry-expressing lactobacilli was evaluated by both flow cytometry (FCM) and conventional plate count (PC), and the plasmid loss rates measured by FCM were lower overall than those determined by PC. Neutralization of pH and longer induction duration significantly improved the mCherry signal. The persistency, dose-dependent signal intensity and localization of the recombinant bacteria in the GI tract of mice were studied with an in vivo imaging system (IVIS), which allowed us to detect fluorescence from 6475-CBRluc-mCherry given at a dose of 1x10(10) CFU and luminescence signals at doses ranging from 1x10(5) to 1x10(10) CFU. Both 6475-CBRluc-mCherry and R2LC-CBRluc were localized in the colon 1 and 2 h after ingestion, but the majority of the latter were still found in the stomach, possibly reflecting niche specificity for R2LC. Finally, an in vitro experiment showed that mCherry-producing R2LC adhered efficiently to the intra cellular junctions of cultured IPEC-J2 cells. In conclusion, the two reporter genes CBRluc and mCherry were shown to be suitable markers for biophotonic imaging (BPI) of L. reuteri and may provide useful tools for future studies of in vivo and in vitro interactions between the bacteria and the host.	[Karimi, Shokoufeh; Jonsson, Hans; Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, Uppsala, Sweden; [Ahl, David; Vagesjo, Evelina; Holm, Lena; Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Karimi, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, Uppsala, Sweden.	shokoufeh.karimi@slu.se		Phillipson, Mia/0000-0002-2387-0266; Roos, Stefan/0000-0002-1606-1794	Biogaia AB	Biogaia AB	This work was funded by Biogaia AB, www.biogaia.se. The company has only financially sponsored the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2009, J PEDIATR GASTR NUTR, V49, P349, DOI 10.1097/MPG.0b013e31818f091b; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bahl ML, 2004, FEMS MICROBIOL LETT, V232, P45, DOI 10.1016/S0378-1097(04)00015-1; Bingle LEH, 2001, CURR OPIN MICROBIOL, V4, P194, DOI 10.1016/S1369-5274(00)00188-0; Bonot S, 2010, APPL ENVIRON MICROB, V76, P378, DOI 10.1128/AEM.01125-09; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Bourgois JJ, 2001, J BIOENERG BIOMEMBR, V33, P353, DOI 10.1023/A:1010615508916; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; BRON S, 1988, PLASMID, V19, P231, DOI 10.1016/0147-619X(88)90041-8; Casas Ivan A., 2000, Microbial Ecology in Health and Disease, V12, P247; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cooper TF, 2000, P NATL ACAD SCI USA, V97, P12643, DOI 10.1073/pnas.220077897; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; De Gelder L, 2008, GENETICS, V178, P2179, DOI 10.1534/genetics.107.084475; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Deane SM, 2004, J BACTERIOL, V186, P2123, DOI 10.1128/JB.186.7.2123-2133.2004; Dinleyici EC, 2014, ACTA PAEDIATR, V103, pe300, DOI 10.1111/apa.12617; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; FABIA R, 1993, SCAND J GASTROENTERO, V28, P155, DOI 10.3109/00365529309096063; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Francavilla R, 2014, J CLIN GASTROENTEROL, V48, P407, DOI 10.1097/MCG.0000000000000007; Gheysens O, 2009, METHODS, V48, P139, DOI 10.1016/j.ymeth.2009.03.013; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hsieh FC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-35; Hughes JM, 2012, MBIO, V3, DOI 10.1128/mBio.00077-12; Hummel S, 2012, APPL ENVIRON MICROB, V78, P1140, DOI 10.1128/AEM.06983-11; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Indrio F, 2014, JAMA PEDIATR, V168, P228, DOI 10.1001/jamapediatrics.2013.4367; KIEWIET R, 1993, APPL ENVIRON MICROB, V59, P358, DOI 10.1128/AEM.59.2.358-364.1993; Landete JM, 2015, APPL MICROBIOL BIOT, V99, P6865, DOI 10.1007/s00253-015-6770-3; Lau BTC, 2013, PLASMID, V70, P353, DOI 10.1016/j.plasmid.2013.07.007; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee MS, 2012, FOOD SCI BIOTECHNOL, V21, P917, DOI 10.1007/s10068-012-0120-3; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; LENSKI RE, 1987, J BACTERIOL, V169, P5314, DOI 10.1128/jb.169.11.5314-5316.1987; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Loftie-Eaton W, 2014, APPL ENVIRON MICROB, V80, P5439, DOI 10.1128/AEM.00793-14; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; Miyawaki A, 2003, CURR OPIN CHEM BIOL, V7, P557, DOI 10.1016/S1367-5931(03)00097-8; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; MOLIN G, 1992, ANTON LEEUW INT J G, V61, P167, DOI 10.1007/BF00584223; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; NOACK D, 1981, MOL GEN GENET, V184, P121, DOI 10.1007/BF00271207; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; PALOHEIMO M, 1992, APPL MICROBIOL BIOT, V36, P584; Perez-Burgos A, 2015, J PHYSIOL-LONDON, V593, P3943, DOI 10.1113/JP270229; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Rhee KJ, 2011, GUT MICROBES, V2, P34, DOI 10.4161/gmic.2.1.14882; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; Ruiz PA, 2005, IMMUNOLOGY, V115, P441, DOI 10.1111/j.1365-2567.2005.02176.x; Schreiber O, 2009, AM J PHYSIOL-GASTR L, V296, pG534, DOI 10.1152/ajpgi.90470.2008; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Sota M, 2010, ISME J, V4, P1568, DOI 10.1038/ismej.2010.72; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Tannock GW, 1992, LACTIC ACID BACTERIA, P21; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Yang FJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0372-1	75	29	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151969	10.1371/journal.pone.0151969	http://dx.doi.org/10.1371/journal.pone.0151969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002525	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400062
J	Mlodzianoski, MJ; Curthoys, NM; Gunewardene, MS; Carter, S; Hess, ST				Mlodzianoski, Michael J.; Curthoys, Nikki M.; Gunewardene, Mudalige S.; Carter, Sean; Hess, Samuel T.			Super-Resolution Imaging of Molecular Emission Spectra and Single Molecule Spectral Fluctuations	PLOS ONE			English	Article							PHOTOACTIVATION LOCALIZATION MICROSCOPY; OPTICAL RECONSTRUCTION MICROSCOPY; FLUORESCENCE MICROSCOPY; ROOM-TEMPERATURE; LIVING CELLS; LIVE CELLS; RESOLUTION; NANOSCOPY; SPECTROSCOPY; PROBES	Localization microscopy can image nanoscale cellular details. To address biological questions, the ability to distinguish multiple molecular species simultaneously is invaluable. Here, we present a new version of fluorescence photoactivation localization microscopy (FPALM) which detects the emission spectrum of each localized molecule, and can quantify changes in emission spectrum of individual molecules over time. This information can allow for a dramatic increase in the number of different species simultaneously imaged in a sample, and can create super-resolution maps showing how single molecule emission spectra vary with position and time in a sample.	[Mlodzianoski, Michael J.; Curthoys, Nikki M.; Gunewardene, Mudalige S.; Carter, Sean; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA	University of Maine System; University of Maine Orono	Hess, ST (corresponding author), Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA.	sam.hess@umit.maine.edu	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Mlodzianoski, Michael/0000-0002-3510-9167	National Institutes of Health (NIH) Career Award [K25-AI65459]; NIH [R15-GM094713]; National Science Foundation Major Research Instrumentation [CHE-0722759]; Maine Technology Institute MTAF [1106, 2061]; University of Maine Vice President for Research; Maine Economic Improvement Fund; NIH Career Award [K25-AI65459, NIH R15-GM094713]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116002, R15GM094713] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Career Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); Maine Technology Institute MTAF; University of Maine Vice President for Research; Maine Economic Improvement Fund; NIH Career Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) Career Award K25-AI65459 supported STH; NIH R15-GM094713 supported MJM and NMC; National Science Foundation Major Research Instrumentation CHE-0722759 supported MSG and STH; Maine Technology Institute MTAF 1106 and 2061 supported STH; University of Maine Vice President for Research supported STH; and Maine Economic Improvement Fund supported STH.; We thank G. Bernhardt for manufacturing our mirror dichroic, T. Tripp, D. Breton, M. Parent, and B. Hopler for machining, P. Andresen for programming assistance, M. Mason, and R.D. Astumian for useful discussions. This work was funded by NIH Career Award K25-AI65459, NIH R15-GM094713, NSF MRI CHE-0722759, Maine Technology Institute MTAF 1106 and 2061, UMaine V.P. for Research, and the Maine Economic Improvement Fund (MEIF). S.T.H. holds patents (US Patents "3D biplane microscopy" 7772569/7880149, "Microscopy Imaging Techniques" 8217992, and "Microscopy system and method for creating three dimensional images using probe molecules" 8994807) in super-resolution microscopy. *This work has been previously presented, in part, at the 57th Annual Meeting of the Biophysical Society (Philadelphia, PA, 2013), and the annual meeting of the American Society for Cell Biology (Philadelphia, PA, 2014).	AMBROSE WP, 1991, NATURE, V349, P225, DOI 10.1038/349225a0; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bossi M, 2008, NANO LETT, V8, P2463, DOI 10.1021/nl801471d; Cutler PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064320; Empedocles SA, 1996, PHYS REV LETT, V77, P3873, DOI 10.1103/PhysRevLett.77.3873; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Gould TJ, 2008, NAT METHODS, V5, P1027, DOI 10.1038/nmeth.1271; Gudheti MV, 2013, BIOPHYS J, V104, P2182, DOI 10.1016/j.bpj.2013.03.054; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kim D, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/9/094011; Lu HP, 1997, NATURE, V385, P143, DOI 10.1038/385143a0; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Mlodzianoski M, 2013, BIOPHYS J, V104, p666A, DOI 10.1016/j.bpj.2012.11.3679; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Testa I, 2010, BIOPHYS J, V99, P2686, DOI 10.1016/j.bpj.2010.08.012; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; TRAUTMAN JK, 1994, NATURE, V369, P40, DOI 10.1038/369040a0; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]	33	47	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0147506	10.1371/journal.pone.0147506	http://dx.doi.org/10.1371/journal.pone.0147506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002724	Green Published, gold			2022-12-27	WOS:000372697400008
J	Wijesekera, TP; Saurabh, S; Dauwalder, B				Wijesekera, Thilini P.; Saurabh, Sumit; Dauwalder, Brigitte			Juvenile Hormone Is Required in Adult Males for Drosophila Courtship	PLOS ONE			English	Article							BINDING-PROTEIN; NEURAL CIRCUITRY; LIGAND-BINDING; MANDUCA-SEXTA; TAKEOUT GENE; FAT-BODY; MELANOGASTER; BEHAVIOR; FRUITLESS; HEMOLYMPH	Juvenile Hormone (JH) has a prominent role in the regulation of insect development. Much less is known about its roles in adults, although functions in reproductive maturation have been described. In adult females, JH has been shown to regulate egg maturation and mating. To examine a role for JH in male reproductive behavior we created males with reduced levels of Juvenile Hormone Acid O-Methyl Transferase (JHAMT) and tested them for courtship. JHAMT regulates the last step of JH biosynthesis in the Corpora Allata (CA), the organ of JH synthesis. Males with reduced levels of JHAMT showed a reduction in courtship that could be rescued by application of Methoprene, a JH analog, shortly before the courtship assays were performed. In agreement with this, reducing JHAMT conditionally in mature flies led to courtship defects that were rescuable by Methoprene. The same result was also observed when the CA were conditionally ablated by the expression of a cellular toxin. Our findings demonstrate that JH plays an important physiological role in the regulation of male mating behavior.	[Wijesekera, Thilini P.; Saurabh, Sumit; Dauwalder, Brigitte] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Wijesekera, Thilini P.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Wijesekera, Thilini P.] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dauwalder, B (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX USA.	bdauwalder@uh.edu	Saurabh, Sumit/ABD-8993-2020	Sumit Saurabh, Sumit/0000-0001-7661-1914	National Science Foundation [IOS-0919697]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation (nsf.gov) Grant number IOS-0919697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Argue KJ, 2013, HORM BEHAV, V64, P589, DOI 10.1016/j.yhbeh.2013.08.018; BELLEN HJ, 1992, DEVELOPMENT, V114, P787; Bilen J, 2013, P NATL ACAD SCI USA, V110, P18321, DOI 10.1073/pnas.1318119110; BOWNES M, 1983, J EMBRYOL EXP MORPH, V75, P241; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; DAI JD, 1991, DEV BIOL, V144, P309, DOI 10.1016/0012-1606(91)90424-2; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dubrovsky EB, 2002, INSECT BIOCHEM MOLEC, V32, P1555, DOI 10.1016/S0965-1748(02)00076-0; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GLINKA AV, 1995, INSECT BIOCHEM MOLEC, V25, P775, DOI 10.1016/0965-1748(94)00098-3; GOODMAN W, 1978, MOL CELL ENDOCRINOL, V11, P225, DOI 10.1016/0303-7207(78)90010-2; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Li YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028269; Manoli DS, 2005, NATURE; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; NOWOCK J, 1975, GEN COMP ENDOCR, V27, P230, DOI 10.1016/0016-6480(75)90238-5; OZYHAR A, 1987, EUR J BIOCHEM, V162, P675, DOI 10.1111/j.1432-1033.1987.tb10690.x; POSTLETHWAIT JH, 1974, BIOL BULL-US, V147, P119, DOI 10.2307/1540573; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; RINGO J, 1992, BEHAV GENET, V22, P469, DOI 10.1007/BF01066616; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; SHTORCH A, 1995, ARCH INSECT BIOCHEM, V30, P195, DOI 10.1002/arch.940300209; SLITER TJ, 1987, INSECT BIOCHEM, V17, P161, DOI 10.1016/0020-1790(87)90156-9; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TOMPKINS L, 1990, J NEUROGENET, V6, P221, DOI 10.3109/01677069009107112; TROWELL SC, 1992, COMP BIOCHEM PHYS B, V103, P795, DOI 10.1016/0305-0491(92)90196-X; Truman JW, 2007, INSECT BIOCHEM MOLEC, V37, P761, DOI 10.1016/j.ibmb.2007.05.011; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007; WOJTASEK H, 1995, BIOCHEMISTRY-US, V34, P5234, DOI 10.1021/bi00015a037; Yamamoto R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-85; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	42	34	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151912	10.1371/journal.pone.0151912	http://dx.doi.org/10.1371/journal.pone.0151912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003411	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400055
J	Nanda, N; Dhawan, DK; Bhatia, A; Mahmood, A; Mahmood, S				Nanda, Neha; Dhawan, Devinder K.; Bhatia, Alka; Mahmood, Akhtar; Mahmood, Safrun			Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach	PLOS ONE			English	Article							NF-KAPPA-B; COLORECTAL-CANCER CELLS; HUMAN BREAST-CANCER; METABOLIC-ACTIVATION; TUMOR BURDEN; COLON-CANCER; MATRIX-METALLOPROTEINASE-9; MODEL; MICE; PROGRESSION	Background Doxycycline (DOX) exhibits anti-inflammatory, anti-tumor, and pro-apoptotic activity and is being tested in clinical trials as a chemotherapeutic agent for several cancers, including colon cancer. Materials & Methods In the current study, the chemotherapeutic activity of doxycycline was tested in a rat model of colon carcinogenesis, induced by colon specific cancer promoter, 1,2, dimethylhydrazine (DMH) as well as study the effect of DOX-alone on a separate group of rats. Results Doxycycline administration in DMH-treated rats (DMH-DOX) unexpectedly increased tumor multiplicity, stimulated progression of colonic tumor growth from adenomas to carcinomas and revealed metastasis in small intestine as determined by macroscopic and histopathological analysis. DOX-alone treatment showed markedly enhanced chronic inflammation and reactive hyperplasia, which was dependent upon the dose of doxycycline administered. Moreover, immunohistochemical analysis revealed evidence of inflammation and anti-apoptotic action of DOX by deregulation of various biomarkers. Conclusion These results suggest that doxycycline caused chronic inflammation in colon, small intestine injury, enhanced the efficacy of DMH in tumor progression and provided a mechanistic link between doxycycline-induced chronic inflammation and tumorigenesis. Ongoing studies thus may need to focus on the molecular mechanisms of doxycycline action, which lead to its inflammatory and tumorigenic effects.	[Nanda, Neha; Bhatia, Alka; Mahmood, Safrun] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India; [Nanda, Neha; Dhawan, Devinder K.] Panjab Univ, Dept Biophys, Chandigarh 160014, India; [Mahmood, Akhtar] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University; Panjab University	Mahmood, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India.; Dhawan, DK (corresponding author), Panjab Univ, Dept Biophys, Chandigarh 160014, India.	dhawan@pu.ac.in; mahmoodpgi@gmail.com			Indian Council of Medical Research (ICMR), New Delhi, India, [3/1/3/JRF-2009/MPD-74]	Indian Council of Medical Research (ICMR), New Delhi, India,(Indian Council of Medical Research (ICMR))	The authors would like to thank Indian Council of Medical Research (ICMR), New Delhi, India, (Reference No-3/1/3/JRF-2009/MPD-74) for financial support to the research work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya P, 2009, HUM REPROD, V24, P1900, DOI 10.1093/humrep/dep106; American Cancer Society, 2014, COL CANC FACTS FIG 2; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Chadha VD, 2007, MOL CELL BIOCHEM, V304, P101, DOI 10.1007/s11010-007-9490-x; Chen XW, 2005, INT J CANCER, V116, P52, DOI 10.1002/ijc.20997; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Dance-Barnes ST, 2009, CARCINOGENESIS, V30, P1016, DOI 10.1093/carcin/bgp082; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Duivenvoorden WCM, 2007, BRIT J CANCER, V96, P1526, DOI 10.1038/sj.bjc.6603740; Duivenvoorden WCM, 2002, CANCER RES, V62, P1588; Dursun D, 2001, AM J OPHTHALMOL, V132, P8, DOI 10.1016/S0002-9394(01)00913-8; Fainaru O, 2008, FASEB J, V22, P3728, DOI 10.1096/fj.08-110494; FIALA ES, 1987, J CANCER RES CLIN, V113, P145, DOI 10.1007/BF00391436; Fife R S, 1998, Adv Dent Res, V12, P94; Fischer A. H., 2008, CSH PROTOC, V3; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kovacs Z, 2011, NEUROCHEM INT, V59, P563, DOI 10.1016/j.neuint.2011.06.016; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu XD, 2008, J IMMUNOL, V181, P449, DOI 10.4049/jimmunol.181.1.449; Loughery J., 2013, BIODISCOVERY, V8, pe8946, DOI [10.7750/BioDiscovery.2013.8.1, DOI 10.7750/BI0DISC0VERY.2013.8.1]; Malhotra P, 2013, TUMOR BIOL, V34, P1901, DOI 10.1007/s13277-013-0734-y; Megaraj V, 2014, CHEM RES TOXICOL, V27, P656, DOI 10.1021/tx4004769; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mouratidis PXE, 2007, INT J CANCER, V120, P743, DOI 10.1002/ijc.22303; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Onoda T, 2004, J LAB CLIN MED, V143, P207, DOI 10.1016/j.lab.2003.12.012; Panico A, 2015, MEDCHEMCOMM, V6, P823, DOI 10.1039/c4md00556b; Pettan-Brewer C, 2012, AM J CANCER RES, V2, P168; Pozzi A, 2002, ONCOGENE, V21, P272, DOI 10.1038/sj.onc.1205045; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Sagar J, 2010, CLIN MED INSIGHTS-TH, V2, P133; Sagar J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-31; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Shostak K, 2015, TRENDS MOL MED, V21, P385, DOI 10.1016/j.molmed.2015.04.001; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Sun BC, 2007, EXP BIOL MED, V232, P1300, DOI 10.3181/0705-RM-145; Tahan Veysel, 2008, Cases J, V1, P144, DOI 10.1186/1757-1626-1-144; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Veeramachaneni N., 2003, J SURG RES, V114, P251; Walker SR, 2014, CANCERS, V6, P958, DOI 10.3390/cancers6020958; Wang F, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0274-0; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	51	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151539	10.1371/journal.pone.0151539	http://dx.doi.org/10.1371/journal.pone.0151539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998758	Green Published, gold			2022-12-27	WOS:000372694700045
J	Slancarova, J; Bartonova, A; Zapletal, M; Kotilinek, M; Fric, ZF; Micevski, N; Kati, V; Konvicka, M				Slancarova, Jana; Bartonova, Alena; Zapletal, Michal; Kotilinek, Milan; Fric, Zdenek Faltynek; Micevski, Nikola; Kati, Vasiliki; Konvicka, Martin			Life History Traits Reflect Changes in Mediterranean Butterfly Communities Due to Forest Encroachment	PLOS ONE			English	Article							AGRICULTURAL LAND ABANDONMENT; PLANT-COMMUNITIES; SPECIES RICHNESS; LANDSCAPE; CLIMATE; EUROPE; DIVERSITY; RESPONSES; HABITAT; LEPIDOPTERA	The biodiversity of the Southern Balkans, part of the Mediterranean global biodiversity hotspot, is threatened by land use intensification and abandonment, the latter causing forest encroachment of formerly open habitats. We investigated the impact of forest encroachment on butterfly species richness, community species composition and the representation of life history traits by repeated seasonal visits of 150 one-hectare sites in five separate regions in three countries-Greece, Bulgaria, and the Republic of Macedonia (FYROM-the Former Yugoslav Republic of Macedonia)-10 replicates for each habitat type of grasslands, open formations and scrub forest within each region. Grasslands and open formations sites hosted in average more species and more red-listed species than scrub forest, while no pattern was found for numbers of Mediterranean species. As shown by ordination analyses, each of the three habitat types hosted distinct butterfly communities, with Mediterranean species inclining either towards grasslands or open formations. Analysing the representation of life history traits revealed that successional development from grasslands and open formations towards scrub forest shifts the community composition towards species overwintering in earlier stages, having fewer generations per year, and inhabiting large European or Eurosiberian (e. g. northern) ranges; it decreases the representation of Mediterranean endemics. The loss of grasslands and semi-open formations due to forest encroachment thus threatens exactly the species that should be the focus of conservation attention in the Mediterranean region, and innovative conservation actions to prevent ongoing forest encroachment are badly needed.	[Slancarova, Jana; Bartonova, Alena; Zapletal, Michal; Kotilinek, Milan; Konvicka, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Slancarova, Jana; Bartonova, Alena; Zapletal, Michal; Fric, Zdenek Faltynek; Konvicka, Martin] CAS, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic; [Micevski, Nikola] Macedonian Entomol Soc ENTOMAK, Skopje, North Macedonia; [Kati, Vasiliki] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Patras	Slancarova, J; Konvicka, M (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Slancarova, J; Konvicka, M (corresponding author), CAS, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic.	slancaro@mail.com; konva333@gmail.com	Liparova, Jana/H-7748-2012; Kati, Vassiliki I/AAB-9418-2020; Konvicka, Martin/H-1446-2014; Bartonova, Alena Suchackova/ABH-7498-2020; FALTYNEK, FRIC ZDENEK/H-1468-2014	Kati, Vassiliki I/0000-0003-3357-4556; Bartonova, Alena Suchackova/0000-0001-6298-2466; FALTYNEK, FRIC ZDENEK/0000-0002-3611-8022	University of South Bohemia [114/2012/P, 168/2013/P]; Institute of Entomology: The Xerxes Society; Explorer Club; Biology Centre CAS, Institute of Vertebrate Biology [CZ.1.07/2.4.00/17.0138]; University of South Bohemia, University of South Bohemia [144/2010/P]; Biology Centre CAS, Institute of Entomology [14-33733S]; Grant Agency of the Czech Republic	University of South Bohemia; Institute of Entomology: The Xerxes Society; Explorer Club; Biology Centre CAS, Institute of Vertebrate Biology; University of South Bohemia, University of South Bohemia; Biology Centre CAS, Institute of Entomology; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by University of South Bohemia: 114/2012/P, 168/2013/P, (https://gaju.jcu.cz/) to JS; Biology Centre CAS, Institute of Entomology: The Xerxes Society 2012 (http://www.xerces.org/joan-dewind-award/) to JS; Explorer Club 2013 (https://explorersclub.org/expeditions/funding/2013_grant_awardees) to JS; Biology Centre CAS, Institute of Vertebrate Biology: CZ.1.07/2.4.00/17.0138 (http://www.ivb.cz/institute.html) to JS; University of South Bohemia: 144/2010/P, University of South Bohemia (http://gaju.jcu.cz/) to MK; and Biology Centre CAS, Institute of Entomology: 14-33733S, The Grant Agency of the Czech Republic (www.gacr.cz) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FAUNA EUROPAEA VERSI; Bartonova A, 2014, EUR J ENTOMOL, V111, P543, DOI 10.14411/eje.2014.060; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Borschig C, 2013, BASIC APPL ECOL, V14, P547, DOI 10.1016/j.baae.2013.09.002; Bunce RGH, 1998, ENVIRON CONSERV, V25, P219, DOI 10.1017/S0376892998000277; Carnicer J, 2013, GLOBAL ECOL BIOGEOGR, V22, P6, DOI 10.1111/j.1466-8238.2012.00762.x; Cizek L, 2006, ECOL ENTOMOL, V31, P337, DOI 10.1111/j.1365-2311.2006.00783.x; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Coreau A, 2007, LANDSCAPE ECOL, V22, P747, DOI 10.1007/s10980-006-9074-2; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Dennis RLH, 2004, ECOL ENTOMOL, V29, P12, DOI 10.1111/j.1365-2311.2004.00572.x; Dobson M, 1998, MAMMAL REV, V28, P77, DOI 10.1046/j.1365-2907.1998.00027.x; Dover JW, 2011, J INSECT CONSERV, V15, P523, DOI 10.1007/s10841-010-9331-1; Dover JW, 2010, J INSECT CONSERV, V14, P413, DOI 10.1007/s10841-010-9267-5; Farris E, 2010, J NAT CONSERV, V18, P258, DOI 10.1016/j.jnc.2009.11.003; GARCIABARROS E, 1988, ECOL ENTOMOL, V13, P391, DOI 10.1111/j.1365-2311.1988.tb00371.x; Grill A, 2005, BIODIVERS CONSERV, V14, P1281, DOI 10.1007/s10531-004-1661-4; Grill A, 2003, BIOL CONSERV, V114, P427, DOI 10.1016/S0006-3207(03)00070-3; Grove AT., 2003, NATURE MEDITERRANEAN; Hadjigeorgiou I, 2005, LIVEST PROD SCI, V96, P51, DOI 10.1016/j.livprodsci.2005.05.016; Kadlec T, 2012, J INSECT CONSERV, V16, P275, DOI 10.1007/s10841-011-9414-7; Kati V, 2004, BIOL CONSERV, V115, P33, DOI 10.1016/S0006-3207(03)00091-0; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Konvicka M, 1999, J INSECT CONSERV, V3, P211, DOI 10.1023/A:1009641618795; Leingartner A, 2014, OECOLOGIA, V175, P613, DOI 10.1007/s00442-014-2917-7; Lopez-Villalta JS, 2010, B INSECTOL, V63, P161; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ohwaki A, 2007, BIODIVERS CONSERV, V16, P1521, DOI 10.1007/s10531-006-9042-9; Pamperis LN, 1997, BUTTERFLIES GREECE; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Sanchez-Rodriguez J. F., 1995, Journal of the Lepidopterists' Society, V49, P192; Schoville SD, 2009, MOL ECOL, V18, P3471, DOI 10.1111/j.1365-294X.2009.04287.x; Settele J, 2009, ECOLOGY BUTTERFLIES, P315; Sirami C, 2007, DIVERS DISTRIB, V13, P42, DOI 10.1111/j.1472-4642.2006.00297.x; Slamova I, 2013, INSECT CONSERV DIVER, V6, P243, DOI 10.1111/j.1752-4598.2012.00212.x; Slancarova J, 2015, J INSECT CONSERV, V19, P823, DOI 10.1007/s10841-015-9801-6; Stefanescu C, 2004, J BIOGEOGR, V31, P905, DOI 10.1111/j.1365-2699.2004.01088.x; Stefanescu C, 2005, BIOL CONSERV, V126, P234, DOI 10.1016/j.biocon.2005.05.010; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stefanescu C, 2011, J INSECT CONSERV, V15, P83, DOI 10.1007/s10841-010-9325-z; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; Steiner Roland, 2000, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V606, P1; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Tansley A.G., 1926, AIMS METHODS STUDY V; Ter Braak C.J.F., 2013, CANOCO 5 WINDOWS REL; The R Core Team, 2012, R VERS 2 15 2; Tolman T, 2009, COLLINS BUTTERFLY GU; van der Leeuw S. E., 2004, DYNAMICS MEDITERRANE, P121; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Van Swaay C., 2013, 112013136 EUR ENV AG, DOI [10.2800/89760, DOI 10.2800/89760]; van Swaay Chris, 2010, pi; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Zakkak S, 2014, J INSECT CONSERV, V18, P599, DOI 10.1007/s10841-014-9663-3; Zakkak S, 2014, J NAT CONSERV, V22, P157, DOI 10.1016/j.jnc.2013.11.001; Zografou K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087245; Zografou K, 2009, J INSECT CONSERV, V13, P505, DOI 10.1007/s10841-008-9198-6	62	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152026	10.1371/journal.pone.0152026	http://dx.doi.org/10.1371/journal.pone.0152026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999008	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700093
J	Lim, HD; Kim, MH; Lee, CY; Namgung, U				Lim, Hee-Don; Kim, Min-Hee; Lee, Chan-Yong; Namgung, Uk			Anti-Inflammatory Effects of Acupuncture Stimulation via the Vagus Nerve	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SOLITARY TRACT; BRAIN-STEM; ENDOTOXEMIA; NUCLEUS; NEURONS; PATHWAY; ELECTROACUPUNCTURE; ACTIVATION; RECEPTORS	Although acupuncture therapy is widely used in traditional Asian medicine for the treatment of diverse internal organ disorders, its underlying biological mechanisms are largely unknown. Here, we investigated the functional involvement of acupuncture stimulation (AS) in the regulation of inflammatory responses. TNF-alpha production in mouse serum, which was induced by lipopolysaccharide (LPS) administration, was decreased by manual acupuncture (MAC) at the zusanli acupoint (stomach36, ST36). In the spleen, TNF-alpha mRNA and protein levels were also downregulated by MAC and were recovered by using a splenic neurectomy and a vagotomy. c-Fos, which was induced in the nucleus tractus solitarius (NTS) and dorsal motor nucleus of the vagus nerve (DMV) by LPS and electroacupuncture (EAC), was further increased by focal administration of the AMPA receptor blocker CNQX and the purinergic receptor antagonist PPADS. TNF-alpha levels in the spleen were decreased by CNQX and PPADS treatments, implying the involvement of inhibitory neuronal activity in the DVC. In unanesthetized animals, both MAC and EAC generated c-Fos induction in the DVC neurons. However, MAC, but not EAC, was effective in decreasing splenic TNF-alpha production. These results suggest that the therapeutic effects of acupuncture may be mediated through vagal modulation of inflammatory responses in internal organs.	[Lim, Hee-Don; Kim, Min-Hee; Namgung, Uk] Daejeon Univ, Dept Oriental Med, Daejeon, South Korea; [Lee, Chan-Yong] Daejeon Univ, Dept Microbiol & Biotechnol, Daejeon, South Korea	Daejeon University; Daejeon University	Namgung, U (corresponding author), Daejeon Univ, Dept Oriental Med, Daejeon, South Korea.	unamgung@dju.kr			Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013056735]; Ministry of Education [2013011219]	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Ministry of Education	This work was supported by grants from the Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2013056735) and by the Ministry of Education (2013011219), URL: www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2013056735) and by the Ministry of Education (2013011219).	Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Burnstock G, 2014, SCIENCE, V346, pS23; Cailotto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087785; Cano G, 2001, J COMP NEUROL, V439, P1, DOI 10.1002/cne.1331; Chang IA, 2013, J ACUPUNCT MERIDIAN, V6, P89, DOI 10.1016/j.jams.2012.12.004; Chang IA, 2012, FASEB J, V26, P2401, DOI 10.1096/fj.11-199018; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hermann GE, 2008, NEUROSCIENTIST, V14, P53, DOI 10.1177/1073858407305725; Illes P, 2012, NEUROSCIENTIST, V18, P422, DOI 10.1177/1073858411418524; Iwa M, 2006, AM J PHYSIOL-GASTR L, V290, pG285, DOI 10.1152/ajpgi.00068.2005; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Kavoussi B, 2007, INTEGR CANCER THER, V6, P251, DOI 10.1177/1534735407305892; Kim MH, 2012, J ACUPUNCT MERIDIAN, V5, P148, DOI [10.1016/j.jams.2012.05.002/, 10.1016/j.jams.2012.05.002]; Kim SY, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1086; Langevin HM, 2001, FASEB J, V15, P2275, DOI 10.1096/fj.01-0015hyp; Leake R., 1999, INTEGR MED, V1, P107; LUX G, 1994, GUT, V35, P1026, DOI 10.1136/gut.35.8.1026; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; McDougal DH, 2011, J NEUROSCI, V31, P14037, DOI 10.1523/JNEUROSCI.2855-11.2011; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; Nishijo K, 1997, NEUROSCI LETT, V227, P165, DOI 10.1016/S0304-3940(97)00337-6; Noguchi E, 2010, AUTON NEUROSCI-BASIC, V156, P15, DOI 10.1016/j.autneu.2010.06.010; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Potts JT, 2006, EXP PHYSIOL, V91, P59, DOI 10.1113/expphysiol.2005.032227; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Taniguchi T, 2005, MINI-REV MED CHEM, V5, P241, DOI 10.2174/1389557053175407; Toney GM, 2000, J APPL PHYSIOL, V88, P2062, DOI 10.1152/jappl.2000.88.6.2062; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Xu GY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01354.x; Yang FL, 2007, SHOCK, V28, P309, DOI 10.1097/shk.0b013e31803dd04d; Yin JY, 2010, AUTON NEUROSCI-BASIC, V157, P31, DOI 10.1016/j.autneu.2010.03.007; Zagon A, 2001, EUR J NEUROSCI, V13, P781, DOI 10.1046/j.0953-816x.2000.01445.x	41	75	88	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151882	10.1371/journal.pone.0151882	http://dx.doi.org/10.1371/journal.pone.0151882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991319	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800113
J	Teymoortash, A; Pfestroff, A; Wittig, A; Franke, N; Hoch, S; Harnisch, S; Schade-Brittinger, C; Hoeffken, H; Engenhart-Cabillic, R; Brugger, M; Strauch, K				Teymoortash, Afshin; Pfestroff, Andreas; Wittig, Andrea; Franke, Nora; Hoch, Stephan; Harnisch, Susanne; Schade-Brittinger, Carmen; Hoeffken, Helmut; Engenhart-Cabillic, Rita; Brugger, Markus; Strauch, Konstantin			Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radiotherapy in Patients with Head and Neck Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blinded Phase I Clinical Trial	PLOS ONE			English	Article							RADIATION-INDUCED XEROSTOMIA; SALIVARY HYPOFUNCTION; PAROTID-GLAND; MANAGEMENT; RECEPTOR; TESTS; FLOW	This prospective, randomized, placebo-controlled, double-blinded phase I clinical trial investigates safety and efficacy of botulinum toxin (BoNT) to preserve gland function after radiotherapy in patients with head and neck cancer. Twelve patients with advanced head and neck cancer were injected with BoNT into the submandibular glands prior to primary radiochemotherapy. Six patients received BoNT/A and 6 patients BoNT/A and B, half of each subgroup into their left and the other half into their right gland. As an internal control, sodium chloride was injected into the respective contralateral gland (placebo). For the evaluation of the salivary gland function, technetium pertechnetate salivary gland scintigraphy was performed before and after the end of radiotherapy. BoNT/A and B were well tolerated. Analysis of the scintigraphic data revealed no statistically significant difference between BoNT and placebo regarding the scintigraphic uptake difference (pBoNT/A = 0.84 and pBoNT/A-B = 0.56 for BoNT/A vs. placebo and BoNT/A-B vs. placebo, respectively). We also found no significant difference in treatment between BoNT and placebo in terms of salivary excretion fraction (pBoNT/A = 0.44; pBoNT/A-B = 0.44). This study demonstrates that BoNT can be safely combined with radiochemotherapy. Dosing and timing of BoNT injection should be further investigated for efficacy analysis.	[Teymoortash, Afshin; Franke, Nora; Hoch, Stephan] Univ Marburg, Dept Otolaryngol Head & Neck Surg, Marburg, Germany; [Pfestroff, Andreas; Hoeffken, Helmut] Univ Marburg, Dept Nucl Med, Marburg, Germany; [Wittig, Andrea; Engenhart-Cabillic, Rita] Univ Marburg, Dept Radiotherapy & Radiooncol, Marburg, Germany; [Harnisch, Susanne; Schade-Brittinger, Carmen] Univ Marburg, Ctr Clin Trials, Marburg, Germany; [Brugger, Markus; Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany; [Brugger, Markus; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Strauch, Konstantin] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg	Teymoortash, A (corresponding author), Univ Marburg, Dept Otolaryngol Head & Neck Surg, Marburg, Germany.	teymoort@med.uni-marburg.de			Von-Behring-Rontgen Foundation, Marburg, Germany [57-0011]; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	Von-Behring-Rontgen Foundation, Marburg, Germany; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ	This study was financially supported by the Von-Behring-Rontgen Foundation, Marburg, Germany, Grant No. 57-0011. Furthermore, this work was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ.	ABOK K, 1984, VIRCHOWS ARCH B, V45, P443, DOI 10.1007/BF02889885; Bansal M, 2004, QUAL LIFE RES, V13, P481, DOI 10.1023/B:QURE.0000018491.80646.bc; Baujat B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002026.pub2; Cannon DM, 2008, INT J RADIAT ONCOL, V70, P660, DOI 10.1016/j.ijrobp.2007.09.018; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Dirix P, 2010, LANCET ONCOL, V11, P85, DOI 10.1016/S1470-2045(09)70231-1; Ellies M, 2002, LARYNGOSCOPE, V112, P82, DOI 10.1097/00005537-200201000-00015; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jahn R, 2006, SCIENCE, V312, P540, DOI 10.1126/science.1127236; Jankovic J, 2004, J NEUROL NEUROSUR PS, V75, P951, DOI 10.1136/jnnp.2003.034702; Lipp A, 2003, NEUROLOGY, V61, P1279, DOI 10.1212/WNL.61.9.1279; Lovelace TL, 2014, OR SURG OR MED OR PA, V117, P595, DOI 10.1016/j.oooo.2014.01.229; Nagler RM, 2003, IN VIVO, V17, P369; Pfestroff A, 2010, IN VIVO, V24, P681; R Core Team, 2012, R LANG ENV STAT COMP; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Shiboski CH, 2007, ORAL SURG ORAL MED O, V103, pS66, DOI 10.1016/j.tripleo.2006.11.013; Teymoortash A, 2007, BRIT J PHARMACOL, V152, P161, DOI 10.1038/sj.bjp.0707375; Teymoortash A, 2009, ORAL ONCOL, V45, P737, DOI 10.1016/j.oraloncology.2008.11.014; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wei L, 2001, DRUG INF J, V35, P1201, DOI 10.1177/009286150103500417; Welz H, 2009, ONCOLOGY-BASEL, V76, P405, DOI 10.1159/000215927	26	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151316	10.1371/journal.pone.0151316	http://dx.doi.org/10.1371/journal.pone.0151316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991494	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800055
J	Chen, WD; Zhu, YL; Cui, FC; Liu, LY; Sun, ZY; Chen, JZ; Li, YQ				Chen, Wenduo; Zhu, Youliang; Cui, Fengchao; Liu, Lunyang; Sun, Zhaoyan; Chen, Jizhong; Li, Yunqi			GPU-Accelerated Molecular Dynamics Simulation to Study Liquid Crystal Phase Transition Using Coarse-Grained Gay-Berne Anisotropic Potential	PLOS ONE			English	Article							GRAPHICS PROCESSING UNITS; SURFACE-INITIATED POLYMERIZATION; MAIN-CHAIN; COMPUTER-SIMULATION; FLEXIBLE MOLECULES; MONTE-CARLO; MODEL; POLYMERS; SPACERS; POLYDISPERSITY	Gay-Berne (GB) potential is regarded as an accurate model in the simulation of anisotropic particles, especially for liquid crystal (LC) mesogens. However, its computational complexity leads to an extremely time-consuming process for large systems. Here, we developed a GPU-accelerated molecular dynamics (MD) simulation with coarse-grained GB potential implemented in GALAMOST package to investigate the LC phase transitions for mesogens in small molecules, main-chain or side-chain polymers. For identical mesogens in three different molecules, on cooling from fully isotropic melts, the small molecules form a single-domain smectic-B phase, while the main-chain LC polymers prefer a single-domain nematic phase as a result of connective restraints in neighboring mesogens. The phase transition of side-chain LC polymers undergoes a two-step process: nucleation of nematic islands and formation of multi-domain nematic texture. The particular behavior originates in the fact that the rotational orientation of the mesogenes is hindered by the polymer backbones. Both the global distribution and the local orientation of mesogens are critical for the phase transition of anisotropic particles. Furthermore, compared with the MD simulation in LAMMPS, our GPU-accelerated code is about 4 times faster than the GPU version of LAMMPS and at least 200 times faster than the CPU version of LAMMPS. This study clearly shows that GPU-accelerated MD simulation with GB potential in GALAMOST can efficiently handle systems with anisotropic particles and interactions, and accurately explore phase differences originated from molecular structures.	[Chen, Wenduo; Cui, Fengchao; Liu, Lunyang; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, 5625 Renmin St, Changchun 130022, Peoples R China; [Chen, Wenduo; Cui, Fengchao; Liu, Lunyang; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, 5625 Renmin St, Changchun 130022, Peoples R China; [Zhu, Youliang; Sun, Zhaoyan; Chen, Jizhong] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, 5625 Renmin St, Changchun 130022, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS	Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, 5625 Renmin St, Changchun 130022, Peoples R China.; Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, 5625 Renmin St, Changchun 130022, Peoples R China.; Chen, JZ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, 5625 Renmin St, Changchun 130022, Peoples R China.	jzchen@ciac.ac.cn; yunqi@ciac.ac.cn	Zhu, You-Liang/AAS-2299-2020; Li, Yunqi/C-8372-2016	Zhu, You-Liang/0000-0002-9561-0770; Li, Yunqi/0000-0002-5190-3037; liu, lunyang/0000-0003-2506-883X; Chen, Wenduo/0000-0002-4828-4706	National Natural Science Foundation of China [21404105, 21374117, 21404102, 21474111]; One Hundred Talents Program of Chinese Academy of Sciences; National Program on Key Basic Research Project (973 Program) [2015CB655302]; China Postdoctoral Science Foundation [2014M551200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	WC was supported by National Natural Science Foundation of China (21404105, http://www.nsfc.gov.cn/). YL was supported by National Natural Science Foundation of China (21374117), One Hundred Talents Program of Chinese Academy of Sciences (http://www.cas.cn/) and National Program on Key Basic Research Project (973 Program 2015CB655302 http://www.most.gov.cn/). YZ was supported by National Natural Science Foundation of China (21404102) and China Postdoctoral Science Foundation (2014M551200, http://jj.chinapostdoctor.org.cn/V1/Program1). ZS was supported by National Natural Science Foundation of China (21474111).	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Allen MP, 1996, J PHYS-CONDENS MAT, V8, P9433, DOI 10.1088/0953-8984/8/47/041; Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Berardi R, 2004, J CHEM PHYS, V121, P9123, DOI 10.1063/1.1790453; BLUMSTEIN A, 1982, J POLYM SCI POL PHYS, V20, P877, DOI 10.1002/pol.1982.180200510; Boamfa MI, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.025501; Boamfa MI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.050701; Bose TK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265701; Brown WM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3058435; Busselez R, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4896052; Care CM, 2005, REP PROG PHYS, V68, P2665, DOI 10.1088/0034-4885/68/11/R04; Chen XF, 2010, CHEM SOC REV, V39, P3072, DOI 10.1039/b814540g; Cuetos A, 2002, J CHEM PHYS, V117, P2934, DOI 10.1063/1.1491872; de Miguel E, 2002, J CHEM PHYS, V117, P6313, DOI 10.1063/1.1504430; DEMIGUEL E, 1991, MOL PHYS, V74, P405, DOI 10.1080/00268979100102321; Dewar A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011704; DICKE HR, 1985, ANGEW MAKROMOL CHEM, V131, P95, DOI 10.1002/apmc.1985.051310107; Ebrahimi D, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4870932; Friedrichs MS, 2009, J COMPUT CHEM, V30, P864, DOI 10.1002/jcc.21209; GAY JG, 1981, J CHEM PHYS, V74, P3316, DOI 10.1063/1.441483; Gemunden P, 2015, SOFT MATTER, V11, P532, DOI 10.1039/c4sm02075h; Gopinadhan M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.078301; Heinemann T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4902824; Ilnytskyi J, 2001, COMPUT PHYS COMMUN, V134, P23, DOI 10.1016/S0010-4655(00)00187-9; Ilnytskyi JM, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2712438; Ilnytskyi JM, 2002, COMPUT PHYS COMMUN, V148, P43, DOI 10.1016/S0010-4655(02)00467-8; Juszynska-Galazka E, 2014, J PHYS CHEM B, V118, P14982, DOI 10.1021/jp510584w; Karimi-Varzaneh HA, 2011, J COMPUT CHEM, V32, P1475, DOI 10.1002/jcc.21717; Koga M, 2013, MACROMOL CHEM PHYS, V214, P2295, DOI 10.1002/macp.201300353; Li YQ, 2004, J CHEM PHYS, V121, P1133, DOI 10.1063/1.1758938; Li YQ, 2013, J PHYS CHEM B, V117, P2615, DOI 10.1021/jp309135m; Li ZW, 2013, RSC ADV, V3, P813, DOI 10.1039/c2ra22108j; Liu AJ, 2015, SOFT MATTER, V11, P2326, DOI 10.1039/c4sm02344g; Liu H, 2012, ACS MACRO LETT, V1, P1249, DOI 10.1021/mz3003374; Liu YJ, 2014, J AM CHEM SOC, V136, P2602, DOI 10.1021/ja412172f; LUCKHURST GR, 1993, MOL PHYS, V80, P233, DOI 10.1080/00268979300102241; Lyulin AV, 1998, MACROMOLECULES, V31, P4626, DOI 10.1021/ma971105y; Martinez-Felipe A, 2013, IND ENG CHEM RES, V52, P8714, DOI 10.1021/ie303130e; McBride C, 1999, MOL PHYS, V97, P511, DOI 10.1080/00268979909482851; Milano G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3142103; Nielsen SO, 2004, J PHYS-CONDENS MAT, V16, pR481, DOI 10.1088/0953-8984/16/15/R03; Peroukidis SD, 2015, SOFT MATTER, V11, P5999, DOI 10.1039/c5sm00903k; Persson RAX, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4729745; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pujolle-Robic C, 2001, NATURE, V409, P167, DOI 10.1038/35051537; Qi WK, 2012, POLYMER, V53, P634, DOI 10.1016/j.polymer.2011.11.049; Rovigatti L, 2015, SOFT MATTER, V11, P692, DOI 10.1039/c4sm02218a; Sasaki H, 2015, J PHYS CHEM B, V119, P4531, DOI 10.1021/jp512710r; Satoh K, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818418; Shen HJ, 2014, J CHEM THEORY COMPUT, V10, P731, DOI 10.1021/ct400974z; Shibaev VP, 2014, POLYM SCI SER A+, V56, P727, DOI 10.1134/S0965545X14060091; SHILOV S, 1993, MAKROMOL CHEM-THEOR, V2, P21; Skacej G, 2011, SOFT MATTER, V7, P9983, DOI 10.1039/c1sm05709j; Stimson LM, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1948376; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Sunarso A, 2010, J COMPUT PHYS, V229, P5486, DOI 10.1016/j.jcp.2010.03.047; Nguyen TD, 2014, NANOSCALE, V6, P3083, DOI 10.1039/c3nr05413f; Nguyen TD, 2011, COMPUT PHYS COMMUN, V182, P2307, DOI 10.1016/j.cpc.2011.06.005; van Meel JA, 2008, MOL SIMULAT, V34, P259, DOI 10.1080/08927020701744295; Vanzo D, 2012, SOFT MATTER, V8, P11790, DOI 10.1039/c2sm27114a; Vita F, 2014, ACS MACRO LETT, V3, P91, DOI 10.1021/mz400518x; Ware TH, 2015, SCIENCE, V347, P982, DOI 10.1126/science.1261019; Wilson MR, 2007, CHEM SOC REV, V36, P1881, DOI 10.1039/b612799c; Wilson MR, 1997, J CHEM PHYS, V107, P8654, DOI 10.1063/1.475017; Withers IM, 2003, J CHEM PHYS, V119, P10209, DOI 10.1063/1.1615768; Workineh ZG, 2014, POLYMERS-BASEL, V6, P2082, DOI 10.3390/polym6082082; Wu Z. N., 2014, ANGEW CHEM, V126, P12392, DOI DOI 10.1002/ange.201407390; Xie SJ, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4908047; Xie SJ, 2014, J CHEM PHYS, V140; Xue YH, 2013, PHYS CHEM CHEM PHYS, V15, P15356, DOI 10.1039/c3cp51960k; Yang G, 2012, MACROMOLECULES, V45, P3590, DOI 10.1021/ma2027879; Yang KD, 2014, SOFT MATER, V12, P185, DOI 10.1080/1539445X.2013.858359; Zhou ZX, 2015, J AM CHEM SOC, V137, P2179, DOI 10.1021/ja512179x; Zhu YL, 2013, J COMPUT CHEM, V34, P2197, DOI 10.1002/jcc.23365	74	7	7	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151704	10.1371/journal.pone.0151704	http://dx.doi.org/10.1371/journal.pone.0151704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986851	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300118
J	Chevalier, J; Chamoux, C; Hammes, F; Chicoye, A				Chevalier, Julie; Chamoux, Catherine; Hammes, Florence; Chicoye, Annie			Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; PLACEBO-CONTROLLED PHASE-3; NATURAL-HISTORY; ORAL BG-12; FRANCE	Objectives The paper aimed to estimate the incremental cost-effectiveness ratio (ICER) at the public published price for delayed-release dimethyl fumarate versus relevant Multiple Sclerosis disease-modifying therapies available in France in June 2015. Methods The economic model was adapted to the French setting in accordance with the Haute Autorite de Sante guidelines using a model previously developed for NICE. A cohort of Relapsing Remitting Multiple Sclerosis patients was simulated over a 30-year time horizon. Twenty one health states were taken into account: Kurtzke Expanded Disability Status Scale (EDSS) 0-9 for Relapsing Remitting Multiple Sclerosis patients, EDSS 0-9 for Secondary Progressive Multiple Sclerosis patients, and death. Estimates of relative treatment efficacy were determined using a mixed-treatment comparison. Probabilities of events were derived from the dimethyl fumarate pivotal clinical trials and the London Ontario Dataset. Costs and utilities were extracted from the published literature from both the payer and societal perspectives. Univariate and probabilistic sensitivity analyses were performed to assess the robustness of the model results. Results From both perspectives, dimethyl fumarate and interferon beta-1a (IFN beta-1a) 44mcg were the two optimal treatments, as the other treatments (IFN beta-1a 30mcg, IFN beta-1b 250mcg, teriflunomide, glatiramer acetate, fingolimod) were dominated on the efficiency frontier. From the societal perspective, dimethyl fumarate versus IFN beta-1a 44mcg incurred an incremental cost of (sic)3,684 and an incremental quality-adjusted life year (QALY) of 0.281, corresponding to an ICER of (sic)13,110/QALY. Conclusions Despite reference threshold for France, dimethyl fumarate can be considered as a cost-effective option as it is on the efficiency frontier.	[Chevalier, Julie; Chicoye, Annie] Mapi Grp, Real World Strategy & Analyt, Paris, France; [Chamoux, Catherine; Hammes, Florence] Biogen France SAS, Econ Sante & Affaires Gouvernement, Nanterre, France; [Chicoye, Annie] ESSEC Business Sch, Inst Hlth Econ & Management, Cergy Pontoise, France	ESSEC Business School	Chevalier, J (corresponding author), Mapi Grp, Real World Strategy & Analyt, Paris, France.	jchevalier@mapigroup.com			Biogen France SAS	Biogen France SAS	Biogen France SAS financed the study, no other current funding sources were received for this study. Julie Chevalier and Annie Chicoye are employed by Mapi Group. Mapi Group provided support in the form of salaries for authors JC and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Catherine Chamoux and Florence Hammes are employed by Biogen France SAS. Biogen France SAS provided support in the form of salaries for authors CC and FH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, ENDORSE ETUDE 109MS3; [Anonymous], 2012, DEFINE ETUDE 109MS30; [Anonymous], 2012, CONFIRM ETUDE 109MS3; [Anonymous], 2014, NICE TECHNOLOGY APPR; Biogen, 2015, UPD SYST REV MIX TRE; Briggs A, 2006, DECISION MODELING HL; Chevalier J, 2013, EUR J HEALTH ECON, V14, P57, DOI 10.1007/s10198-011-0351-x; Confavreux Christian, 2006, Rev Prat, V56, P1313; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; [H. A. d. S HAS], 2012, METH GUID CHOIC METH; Hutchinson M, 2014, CURR MED RES OPIN, V30, P613, DOI 10.1185/03007995.2013.863755; INED [Internet], TABL DE MORT; Kobelt G, 2009, MULT SCLER J, V15, P741, DOI 10.1177/1352458509102771; Kremenchutzky M, 2006, BRAIN, V129, P584, DOI 10.1093/brain/awh721; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leroy E, 2007, MULT SCLER J, V13, P865, DOI 10.1177/1352458507077410; Phillips JT, 2013, 65 AM AC NEUR ANN M; TYSEDMUS, 2012, TYSEDMUS OBSERVATION; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; Zuvich RL, 2009, SEMIN IMMUNOL, V21, P328, DOI 10.1016/j.smim.2009.08.003	23	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150703	10.1371/journal.pone.0150703	http://dx.doi.org/10.1371/journal.pone.0150703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987055	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300024
J	Vivarelli, F; Canistro, D; Sapone, A; De Nicola, GR; Marquillas, CB; Iori, R; Antonazzo, IC; Gentilini, F; Paolini, M				Vivarelli, Fabio; Canistro, Donatella; Sapone, Andrea; De Nicola, Gina Rosalinda; Marquillas, Clara Babot; Iori, Renato; Antonazzo, Ippazio Cosimo; Gentilini, Fabio; Paolini, Moreno			Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders	PLOS ONE			English	Article							HIGH-FAT DIET; DRUG-METABOLIZING-ENZYMES; TUSCAN BLACK CABBAGE; OXIDATIVE STRESS; NUTRITIONAL ANTIOXIDANTS; ACYLATED ANTHOCYANINS; ENDOTHELIAL-CELLS; SENSITIVE ASSAY; DOWN-REGULATION; SHORT-TERM	Background Obesity is recognized as a leading global health problem, correlated with an increased risk for several chronic diseases. One strategy for weight control management includes the use of vegetables rich in bioactive compounds to counteract weight gain, improve the antioxidant status and stimulate lipid catabolism. Aim of the Study The aim of this study was to investigate the role of Raphanus sativus Sango sprout juice (SSJ), a Brassica extraordinarily rich in anthocyanins (AC) and isothiocyanates (ITCs), in a non-genetic model of obesity (high fat diet-HFD induced). Methods Control groups were fed with HFD or regular diet (RD). After a 10-week period, animals were assigned to experimental units and treated by gavage for 28 days as follows: HFD and RD control groups (rats fed HFD or RD and treated with vehicle only) and HFD-treated groups (rats fed HFD and treated with 15, 75 or 150 mg/kg b.w. of SSJ). Body weight and food consumption were recorded and serum lipid profile was measured (total cholesterol, triglycerides, and non-esterified fatty acids). Hepatic phase-I, phase-II as well as antioxidant enzymatic activities were assessed. Results SSJ lowered total cholesterol level, food intake and liver weight compared with HFD rodents. SSJ at medium dose proved effective in reducing body-weight (similar to 19 g reduction). SSJ was effective in up-regulating the antioxidant enzymes catalase, NAD(P)H:quinone reductase, oxidised glutathione reductase and superoxide dismutase, which reached or exceeded RD levels, as well as the phase II metabolic enzyme UDP-glucuronosyl transferase (up to about 43%). HFD up-regulated almost every cytochrome P450 isoform tested, and a mild down-regulation to baseline was observed after SSJ intervention. Conclusion This work reveals, for the first time, the antioxidant, hypolipidemic and antiobesity potential of SSJ, suggesting its use as an efficient new functional food/nutraceutical product.	[Vivarelli, Fabio; Canistro, Donatella; Sapone, Andrea; Marquillas, Clara Babot; Antonazzo, Ippazio Cosimo; Paolini, Moreno] Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy; [De Nicola, Gina Rosalinda; Iori, Renato] Ctr Ric Colture Ind CRA CIN, Consiglio Ric Agr Anal Econ Agr, Bologna, Italy; [Gentilini, Fabio] Univ Bologna, Dept Vet Med Sci, Alma Mater Studiorum, Bologna, Italy	University of Bologna; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Bologna	Vivarelli, F; Canistro, D (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy.	fabio.vivarelli3@unibo.it; donatella.canistro@unibo.it	De Nicola, Gina Rosalinda/AAC-9218-2021; Stefanadis, Christodoulos/ABH-2232-2020	De Nicola, Gina Rosalinda/0000-0002-2916-8662; Stefanadis, Christodoulos/0000-0001-5974-6454; Vivarelli, Fabio/0000-0002-8734-0985; Antonazzo, Ippazio Cosimo/0000-0001-8046-4574; CANISTRO, DONATELLA/0000-0002-6378-1698	Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	All sources of financial and material support were provided by a grant from the Italian Ministry of Education, University and Research.	Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; AITIO A, 1978, ANAL BIOCHEM, V85, P488, DOI 10.1016/0003-2697(78)90245-2; Anwar S, 2014, TOXICOL LETT, V226, P206, DOI 10.1016/j.toxlet.2014.01.048; Arima H, 2010, INTERNAL MED, V49, P2043, DOI 10.2169/internalmedicine.49.3918; Badshah H, 2013, NEUROPEPTIDES, V47, P347, DOI 10.1016/j.npep.2013.06.001; Bailey Y. L., 1967, TECHNIQUES PROTEIN C; Barillari J, 2007, J AGR FOOD CHEM, V55, P5505, DOI 10.1021/jf070558r; BAST A, 1986, TRENDS PHARMACOL SCI, V7, P266, DOI 10.1016/0165-6147(86)90349-4; BAUER C, 1994, TERATOGEN CARCIN MUT, V14, P13, DOI 10.1002/tcm.1770140103; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Box P, 1978, STAT EXPT; Bruce M., 1967, METHOD ENZYMOL, V10, P551; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Canistro D, 2004, MUTAT RES-FUND MOL M, V545, P23, DOI 10.1016/j.mrfmmm.2003.08.001; Canistro D, 2009, FOOD CHEM TOXICOL, V47, P454, DOI 10.1016/j.fct.2008.11.040; Canistro D, 2012, FOOD CHEM TOXICOL, V50, P2612, DOI 10.1016/j.fct.2012.05.030; Choi KM, 2012, OBESITY, V20, P1365, DOI 10.1038/oby.2011.388; Cimino F, 2013, GENES NUTR, V8, P391, DOI 10.1007/s12263-012-0324-4; Crujeiras AB, 2013, FREE RADICAL RES, V47, P243, DOI 10.3109/10715762.2013.772604; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; De Nicola GR, 2013, FOOD CHEM, V141, P297, DOI 10.1016/j.foodchem.2013.02.102; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; Derosa G, 2012, EXPERT OPIN DRUG SAF, V11, P459, DOI 10.1517/14740338.2012.675326; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; ERNSTER L, 1962, BIOCHIM BIOPHYS ACTA, V58, P171, DOI 10.1016/0006-3002(62)90997-6; Finer N, 2013, ENCY HUMAN NUTR, P404; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fisher CD, 2009, DRUG METAB DISPOS, V37, P2087, DOI 10.1124/dmd.109.027466; Fontaine KR, 2012, INT J OBESITY, V36, P1121, DOI 10.1038/ijo.2011.194; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Gonzalez-Castejon M, 2011, PHARMACOL RES, V64, P438, DOI 10.1016/j.phrs.2011.07.004; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Gupta D, 2012, EXPERT REV CARDIOVAS, V10, P379, DOI [10.1586/ERC.12.4, 10.1586/erc.12.4]; HABIG WH, 1974, J BIOL CHEM, V249, P7130; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Ho JN, 2012, BIOSCI BIOTECH BIOCH, V76, P1068, DOI 10.1271/bbb.110666; Huang HL, 2007, OBES SURG, V17, P1457, DOI 10.1007/s11695-008-9423-0; Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kim KH, 2011, ANNU REV FOOD SCI T, V2, P237, DOI 10.1146/annurev-food-022510-133656; Kolotkin RL, 2012, OBESITY, V20, P2325, DOI 10.1038/oby.2012.104; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Lee YM, 2006, NUTRITION, V22, P956, DOI 10.1016/j.nut.2005.12.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9; Marinou K, 2010, INT J CARDIOL, V138, P3, DOI 10.1016/j.ijcard.2009.03.135; Matera R, 2015, FOOD CHEM, V166, P397, DOI 10.1016/j.foodchem.2014.06.056; Matera R, 2012, FOOD CHEM, V133, P563, DOI 10.1016/j.foodchem.2012.01.050; Matsuda M, 2014, HORM MOL BIOL CLIN I, V19, P75, DOI 10.1515/hmbci-2014-0001; MAZEL P, 1971, FUNDAMENTALS DRUG ME, P546; Melega S, 2013, BRIT J NUTR, V110, P988, DOI 10.1017/S0007114513000068; Melega S, 2013, MUTAT RES-GEN TOX EN, V751, P45, DOI 10.1016/j.mrgentox.2012.10.013; MISRA HP, 1972, J BIOL CHEM, V247, P3170; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; PAOLINI M, 1991, CARCINOGENESIS, V12, P759, DOI 10.1093/carcin/12.5.759; Paolini M, 1996, J INVEST MED, V44, P470; Puccinelli E, 2013, XENOBIOTICA, V43, P686, DOI 10.3109/00498254.2012.756558; Raunio H, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00123; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; Salamone F, 2012, WORLD J GASTROENTERO, V18, P3862, DOI 10.3748/wjg.v18.i29.3862; Sankhari JM, 2012, J SCI FOOD AGR, V92, P1688, DOI 10.1002/jsfa.5532; Sapone A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/790987; Sheweita SA, 2000, CURR DRUG METAB, V1, P107, DOI 10.2174/1389200003339117; Singla P, 2010, WORLD J DIABETES, V1, P76, DOI 10.4239/wjd.v1.i3.76; Sancho RAS, 2012, FOOD RES INT, V46, P378, DOI 10.1016/j.foodres.2011.11.021; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; Tsai AG, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-191; Valgimigli L, 2009, ENVIRON MOL MUTAGEN, V50, P222, DOI 10.1002/em.20468; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; WHO, 1998, WHO OB PREV MAN GLOB; Wu T, 2014, INT J FOOD SCI NUTR, V65, P351, DOI 10.3109/09637486.2013.854749; Wu T, 2013, FOOD FUNCT, V4, P1654, DOI 10.1039/c3fo60251f; Wu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077585; Xiao Z, 2012, J NUTR, V142, p1377S, DOI 10.3945/jn.111.152041	77	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150913	10.1371/journal.pone.0150913	http://dx.doi.org/10.1371/journal.pone.0150913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987061	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300036
J	Bossu, J; Beauchene, J; Estevez, Y; Duplais, C; Clair, B				Bossu, Julie; Beauchene, Jacques; Estevez, Yannick; Duplais, Christophe; Clair, Bruno			New Insights on Wood Dimensional Stability Influenced by Secondary Metabolites: The Case of a Fast-Growing Tropical Species Bagassa guianensis Aubl.	PLOS ONE			English	Article							MICROFIBRIL ANGLE; EXTRACTIVES; SHRINKAGE; HEARTWOOD; GRAVITY; STRESS; FIBER	Challenging evaluation of tropical forest biodiversity requires the reporting of taxonomic diversity but also the systematic characterization of wood properties in order to discover new promising species for timber industry. Among wood properties, the dimensional stability is regarded as a major technological characteristic to validate whether a wood species is adapted to commercial uses. Cell structure and organization are known to influence the drying shrinkage making wood density and microfibrils angle markers of choice to predict wood dimensional stability. On the contrary the role of wood extractive content remains unclear. This work focuses on the fast-growing tropical species Bagassa guianensis and we report herein a correlation between heartwood drying shrinkage and extractive content. Chemical extractions and shrinkage experiments were performed on separate wood twin samples to better evaluate correctly how secondary metabolites influence the wood shrinkage behaviour. Extractive content were qualitatively and quantitatively analysed using HPLC and NMR spectroscopy. We found that B guianensis heartwood has a homogeneous low shrinkage along its radius that could not be explained only by its basic density. In fact the low drying shrinkage is correlated to the high extractive content and a corrected model to improve the prediction of wood dimensional stability is presented. Additionally NMR experiments conducted on sapwood and heartwood extracts demonstrate that secondary metabolites biosynthesis occurs in sapwood thus revealing B. guianensis as a Juglans-Type heartwood formation. This work demonstrates that B. guianensis, a fast-growing species associated with high durability and high dimensional stability, is a good candidate for lumber production and commercial purposes.	[Bossu, Julie; Beauchene, Jacques; Estevez, Yannick; Duplais, Christophe; Clair, Bruno] Univ Guyane, Univ Antilles, INRA, CNRS,UMR EcoFoG,AgroParisTech,Cirad, F-97310 Kourou, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE	Bossu, J (corresponding author), Univ Guyane, Univ Antilles, INRA, CNRS,UMR EcoFoG,AgroParisTech,Cirad, F-97310 Kourou, France.	juliebossu@hotmail.fr	Clair, Bruno/B-7503-2013; BEAUCHENE, Jacques/AAN-4909-2020; Duplais, Christophe/E-3668-2017	Clair, Bruno/0000-0002-4093-9034; BEAUCHENE, Jacques/0000-0003-4578-3670; Duplais, Christophe/0000-0003-0926-9885	Investissement d'Avenir Grant of the ANR [CEBA: ANR-10-LABX-25-01]; CNRS-INSIS; European Social Fund (FSE); Labex CEBA award; INSIS award; European Social Founds award	Investissement d'Avenir Grant of the ANR(French National Research Agency (ANR)); CNRS-INSIS; European Social Fund (FSE)(European Social Fund (ESF)); Labex CEBA award; INSIS award; European Social Founds award	This work was supported by Investissement d'Avenir Grant of the ANR (CEBA: ANR-10-LABX-25-01). JB received a doctoral fellowship from the CNRS-INSIS and the European Social Fund (FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Eric Nicolini (CIRAD-AMAP) and Onoefe NGwete (CIRAD-ECOFOG) for their help in trees identification and field work. This research project has been financially supported by the Labex CEBA, INSIS and European Social Founds awards.	Abe H, 2005, IAWA J, V26, P161, DOI 10.1163/22941932-90000108; Adamopoulos S, 2002, HOLZ ROH WERKST, V60, P377, DOI 10.1007/s00107-002-0329-6; Barnett JR, 2004, BIOL REV, V79, P461, DOI 10.1017/S1464793103006377; CHAFE SC, 1986, WOOD SCI TECHNOL, V20, P293, DOI 10.1007/BF00351583; Clair B, 2003, HOLZFORSCHUNG, V57, P189, DOI 10.1515/HF.2003.028; Clair B, 2012, HOLZFORSCHUNG, V66, P349, DOI [10.1515/hf.2011.159, 10.1515/HF.2011.159]; Cote W.A., 1968, PRINCIPLES WOOD SCI, DOI [10.1007/978-3-642-87928-9_5, 10.1007/978-3-642-87928-9_1, DOI 10.1007/978-3-642-87928-9_1]; De Filippis L, 1998, TREES-STRUCT FUNCT, V12, P377; de Moura LF, 2006, WOOD FIBER SCI, V38, P166; Dejardin A, 2010, CR BIOL, V333, P325, DOI 10.1016/j.crvi.2010.01.010; Donaldson L, 2008, IAWA J, V29, P345, DOI 10.1163/22941932-90000192; Flores O, 2006, ACTA OECOL, V29, P141, DOI 10.1016/j.actao.2005.08.007; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; Groemping U, 2006, RELATIVE IMPORTANCE, V17, P27; HARRIS JM, 1965, HOLZFORSCHUNG, V19, P144, DOI 10.1515/hfsg.1965.19.5.144; Hernandez RE, 2007, WOOD MATER SCI ENG, V2, P45, DOI 10.1080/17480270701538425; Kampe A, 2013, PLANT CELL MONOGR, V20, P71, DOI 10.1007/978-3-642-36491-4_3; Koponen S, 1998, SIGNIFICANCE MICROFI, P348; KRYLA JM, 1980, WOOD SCI, V13, P18; MANTANIS GI, 1994, WOOD SCI TECHNOL, V28, P119, DOI 10.1007/BF00192691; Nakada R, 2012, TREE PHYSIOL, V32, P1497, DOI 10.1093/treephys/tps108; Newlin JA, 1919, REPORT FOREST SERVIC, V676, P60; R Core Team, 2021, R LANGUAGE ENV STAT; Royer M, 2012, INT BIODETER BIODEGR, V70, P55, DOI 10.1016/j.ibiod.2011.10.016; Royer M, 2010, PHYTOCHEMISTRY, V71, P1708, DOI 10.1016/j.phytochem.2010.06.020; Stamm A.J., 1942, T AM SOC MECH ENG, V64, P379; Stamm AJ, 1935, IND ENG CHEM, V27, P401, DOI 10.1021/ie50304a011; Stamm AJ, 1952, WOOD CHEM, V2, P691; Taylor F. W., 1974, Weed Science, V6, P396; Walker JCF, 1993, PRIMARY WOOD PROCESS, P95; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; Yamamoto H, 2001, WOOD SCI TECHNOL, V35, P167, DOI 10.1007/s002260000074; Yin JP, 2015, WOOD SCI TECHNOL, V49, P987, DOI 10.1007/s00226-015-0741-9	33	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150777	10.1371/journal.pone.0150777	http://dx.doi.org/10.1371/journal.pone.0150777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007687	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200031
J	Romera-Cardenas, G; Thomas, LM; Lopez-Cobo, S; Garcia-Cuesta, EM; Long, EO; Reyburn, HT				Romera-Cardenas, Gema; Thomas, L. Michael; Lopez-Cobo, Sheila; Garcia-Cuesta, Eva M.; Long, Eric O.; Reyburn, Hugh T.			Ionomycin Treatment Renders NK Cells Hyporesponsive	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MHC CLASS-I; COMPLEX CLASS-I; SELF-TOLERANCE; T-CELLS; TRANSCRIPTIONAL ANALYSIS; MEDIATED CYTOTOXICITY; FUNCTIONAL-ANALYSIS; SIGNALING PATHWAYS; VIRAL-INFECTION	Natural killer cells are cytotoxic lymphocytes important in immune responses to cancer and multiple pathogens. However, chronic activation of NK cells can induce a hyporesponsive state. The molecular basis of the mechanisms underlying the generation and maintenance of this hyporesponsive condition are unknown, thus an easy and reproducible mechanism able to induce hyporesponsiveness on human NK cells would be very useful to gain understanding of this process. Human NK cells treated with ionomycin lose their ability to degranulate and secrete IFN-gamma in response to a variety of stimuli, but IL-2 stimulation can compensate these defects. Apart from reductions in the expression of CD11a/CD18, no great changes were observed in the activating and inhibitory receptors expressed by these NK cells, however their transcriptional signature is different to that described for other hyporesponsive lymphocytes.	[Romera-Cardenas, Gema; Lopez-Cobo, Sheila; Garcia-Cuesta, Eva M.; Reyburn, Hugh T.] CSIC, CNB, Madrid, Spain; [Thomas, L. Michael; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Romera-Cardenas, Gema] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Reyburn, HT (corresponding author), CSIC, CNB, Madrid, Spain.	htreyburn@cnb.csic.es	García-Cuesta, Eva M./J-6600-2017; Long, Eric O/G-5475-2011; Reyburn, Hugh T/B-4338-2009	García-Cuesta, Eva M./0000-0003-2311-4353; Long, Eric O/0000-0002-7793-3728; Reyburn, Hugh T/0000-0003-2855-1595	Fondo de Investigacion Sanitaria [PI11/00298, PI08/1701]; MINECO [SAF2014-58752-R]; CSIC; EMBO Short term fellowship; National Institutes of Health, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000525] Funding Source: NIH RePORTER	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); MINECO(Spanish Government); CSIC; EMBO Short term fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Fondo de Investigacion Sanitaria (PI11/00298 and PI08/1701), MINECO (SAF2014-58752-R) (to HTR), a JAE Predoc studentship from the CSIC and an EMBO Short term fellowship (to GRC) and the Intramural Research Program at the National Institutes of Health, National Institute of Allergy and Infectious Disease (to LMT and EOL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS SI, 1986, CELL IMMUNOL, V101, P558, DOI 10.1016/0008-8749(86)90166-8; Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Babor F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00027; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Brown ACN, 2012, BLOOD, V120, P3729, DOI 10.1182/blood-2012-05-429977; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Burshtyn DN, 2010, METHODS MOL BIOL, V612, P89, DOI 10.1007/978-1-60761-362-6_7; Calabia-Linares C, 2011, J CELL SCI, V124, P820, DOI 10.1242/jcs.078832; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Crozat K, 2011, BLOOD, V117, P2874, DOI 10.1182/blood-2010-10-315457; Dybkaer K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-230; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; FINEGOLD I, 1967, J IMMUNOL, V99, P839; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Jewett A, 1996, J IMMUNOL, V156, P907; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; JONDAL M, 1975, INT J CANCER, V15, P596, DOI 10.1002/ijc.2910150409; Kim HS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002754; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; KLEIN E, 1968, CANCER RES, V28, P1300; LANIER LL, 1991, J IMMUNOL, V146, P4421; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Mazumdar B, 2013, EUR J IMMUNOL, V43, P1345, DOI 10.1002/eji.201243215; Montelli TCB, 2001, ARQ NEURO-PSIQUIAT, V59, P6, DOI 10.1590/S0004-282X2001000100003; Morlino G, 2014, MOL CELL BIOL, V34, P1412, DOI 10.1128/MCB.01177-13; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Peracoli MTS, 1999, ARQ NEURO-PSIQUIAT, V57, P539, DOI 10.1590/S0004-282X1999000400001; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; PLAUT M, 1973, J IMMUNOL, V111, P389; Pradeu T, 2013, NAT REV IMMUNOL, V13, P764, DOI 10.1038/nri3521; Prinz PU, 2014, INT J CANCER, V135, P1832, DOI 10.1002/ijc.28837; PROSS HF, 1976, INT J CANCER, V18, P593, DOI 10.1002/ijc.2910180508; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reiners KS, 2013, MOL THER, V21, P895, DOI 10.1038/mt.2013.14; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Sarkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064835; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; SLEZAK SE, 1989, J IMMUNOL METHODS, V117, P205, DOI 10.1016/0022-1759(89)90142-7; Thomas LM, 2013, J IMMUNOL, V191, P3981, DOI 10.4049/jimmunol.1301159; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Yoon JC, 2011, J VIROL, V85, P12557, DOI 10.1128/JVI.00838-11; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	61	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150998	10.1371/journal.pone.0150998	http://dx.doi.org/10.1371/journal.pone.0150998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007115	gold, Green Submitted, Green Published			2022-12-27	WOS:000372701200039
J	Souza, RS; Diaz-Albiter, HM; Dillon, VM; Dillon, RJ; Genta, FA				Souza, Raquel Santos; Diaz-Albiter, Hector Manuel; Dillon, Vivian Maureen; Dillon, Rod J.; Genta, Fernando Ariel			Digestion of Yeasts and Beta-1,3-Glucanases in Mosquito Larvae: Physiological and Biochemical Considerations	PLOS ONE			English	Article							AEDES-AEGYPTI; ANOPHELES-GAMBIAE; ENZYMES; DIPTERA; GUT; EXPRESSION; FOOD; COMPARTMENTALIZATION; BIOSYNTHESIS; MICROBIOTA	Aedes aegypti larvae ingest several kinds of microorganisms. In spite of studies regarding mosquito digestion, little is known about the nutritional utilization of ingested cells by larvae. We investigated the effects of using yeasts as the sole nutrient source for A. aegypti larvae. We also assessed the role of beta-1,3-glucanases in digestion of live yeast cells. Beta-1,3-glucanases are enzymes which hydrolyze the cell wall beta-1,3-glucan polyssacharide. Larvae were fed with cat food (controls), live or autoclaved Saccharomyces cerevisiae cells and larval weight, time for pupation and adult emergence, larval and pupal mortality were measured. The presence of S. cerevisiae cells inside the larval gut was demonstrated by light microscopy. Beta-1,3-glucanase was measured in dissected larval samples. Viability assays were performed with live yeast cells and larval gut homogenates, with or without addition of competing beta-1,3-glucan. A. aegypti larvae fed with yeast cells were heavier at the 4th instar and showed complete development with normal mortality rates. Yeast cells were efficiently ingested by larvae and quickly killed (10% death in 2h, 100% in 48h). Larvae showed beta-1,3-glucanase in head, gut and rest of body. Gut beta-1,3-glucanase was not derived from ingested yeast cells. Gut and rest of body activity was not affected by the yeast diet, but head homogenates showed a lower activity in animals fed with autoclaved S. cerevisiae cells. The enzymatic lysis of live S. cerevisiae cells was demonstrated using gut homogenates, and this activity was abolished when excess beta-1,3-glucan was added to assays. These results show that live yeast cells are efficiently ingested and hydrolyzed by A. aegypti larvae, which are able to fully-develop on a diet based exclusively on these organisms. Beta-1,3-glucanase seems to be essential for yeast lytic activity of A. aegypti larvae, which possess significant amounts of these enzyme in all parts investigated.	[Souza, Raquel Santos; Diaz-Albiter, Hector Manuel; Genta, Fernando Ariel] Fiocruz MS, Inst Oswaldo Cruz, Lab Insect Biochem & Physiol, 4365 Brasil Av,Leonidas Deane Bldg,Room 207, BR-21040360 Rio De Janeiro, Brazil; [Dillon, Vivian Maureen] Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Dillon, Rod J.] Univ Lancaster, Div Biomed & Life Sci, Furness Bldg, Lancaster LA1 4YG, England; [Dillon, Rod J.; Genta, Fernando Ariel] Natl Inst Sci & Technol Mol Entomol, Ctr Hlth Sci, 373 Carlos Chagas Filho Av,Bldg D,Room 5, BR-21941590 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; University of Liverpool; Lancaster University	Genta, FA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Insect Biochem & Physiol, 4365 Brasil Av,Leonidas Deane Bldg,Room 207, BR-21040360 Rio De Janeiro, Brazil.; Genta, FA (corresponding author), Natl Inst Sci & Technol Mol Entomol, Ctr Hlth Sci, 373 Carlos Chagas Filho Av,Bldg D,Room 5, BR-21941590 Rio De Janeiro, Brazil.	genta@ioc.fiocruz.br	Genta, Fernando/F-1791-2011	Genta, Fernando/0000-0001-9558-1116; Diaz-Albiter, Hector/0000-0003-2937-0569	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.760/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573959/2008-0, 400607/2012-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1273/2011]; Science Without Borders Program by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Young Talent Fellowship) [400584/2012-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Parasitology program) [1273/2011]; National Institute of Science and Technology for Molecular Entomology (CNPq) [573959/2008-0]; Science Without Borders Program (Special Visitant Researcher Fellowship, CNPq) [400607/2012-3]; FIOCRUZ; CAPES; CNPq; FAPERJ	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Science Without Borders Program by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Young Talent Fellowship)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Parasitology program); National Institute of Science and Technology for Molecular Entomology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science Without Borders Program (Special Visitant Researcher Fellowship, CNPq); FIOCRUZ; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	FAG was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/), grant number E-26/110.760/2013, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), grant number 573959/2008-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/), grant number 1273/2011. RJD was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), grant number 400607/2012-3. HMD was funded by funded by the Science Without Borders Program by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Young Talent Fellowship, http://www.cnpq.br/), grant number 400584/2012-3). RSS was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Parasitology program, http://www.capes.gov.br/), grant number 1273/2011. RJD, VMD and FAG are staff members from their respective departments, and were funded by the National Institute of Science and Technology for Molecular Entomology (CNPq grant number 573959/2008-0) and by Science Without Borders Program (Special Visitant Researcher Fellowship, CNPq number 400607/2012-3). FAG was funded by FIOCRUZ, CAPES, CNPq and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, FRONT PHYSIOL, DOI DOI 10.3389/fphys.2014.00276; Ashburner M., 1989, DROSOPHILA LAB HDB; AVISSAR YJ, 1994, J AM MOSQUITO CONTR, V10, P45; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragatto I, 2010, INSECT BIOCHEM MOLEC, V40, P861, DOI 10.1016/j.ibmb.2010.08.006; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023; Chen XG, 2008, ADV GENET, V64, P19, DOI 10.1016/S0065-2660(08)00802-X; Clements N., 2000, BIOL MOSQUITOES; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ferreira AHP, 2001, INSECT BIOCHEM MOLEC, V31, P1065, DOI 10.1016/S0965-1748(01)00054-6; Genta FA, 2003, INSECT BIOCHEM MOLEC, V33, P1085, DOI 10.1016/S0965-1748(03)00121-8; Genta FA, 2007, BBA-PROTEINS PROTEOM, V1774, P1079, DOI 10.1016/j.bbapap.2007.07.006; Genta FA, 2009, INSECT BIOCHEM MOLEC, V39, P861, DOI 10.1016/j.ibmb.2009.10.003; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; HO BC, 1992, J MED ENTOMOL, V29, P960, DOI 10.1093/jmedent/29.6.960; Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009; Kay B, 1999, CURR OPIN INFECT DIS, V12, P425, DOI 10.1097/00001432-199910000-00003; KHAWALED K, 1992, J INVERTEBR PATHOL, V59, P186, DOI 10.1016/0022-2011(92)90031-X; Lucena SA, 2013, ANAL BIOCHEM, V434, P39, DOI 10.1016/j.ab.2012.10.032; Lucena SA, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-51; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021; MERRITT RW, 1990, J AM MOSQUITO CONTR, V6, P35; Moraes CS, 2012, J INSECT PHYSIOL, V58, P1136, DOI 10.1016/j.jinsphys.2012.05.015; Muniaraj M, 2012, TROP BIOMED, V29, P646; Nathan MB, 2007, RECENT EPIDEMIOLOGIC, P30; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Oviedo MN, 2008, INSECT MOL BIOL, V17, P61, DOI 10.1111/j.1365-2583.2008.00779.x; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Paz S., 2015, PHILOS T R SOC LON B, V370, DOI DOI 10.1098/RSTB.2013.0561.20130561; ROMBOUTS FM, 1976, EUR J BIOCHEM, V63, P121, DOI 10.1111/j.1432-1033.1976.tb10214.x; Ruiz-Herrera J, 1991, Antonie Van Leeuwenhoek, V60, P72; Sandven P, 1999, J CLIN MICROBIOL, V37, P3731, DOI 10.1128/JCM.37.11.3731-3732.1999; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares TS, 2011, GENE, V489, P70, DOI 10.1016/j.gene.2011.08.018; Souza-Neto JA, 2003, COMP BIOCHEM PHYS A, V136, P717, DOI 10.1016/S1095-6433(03)00224-1; Steyn A, 2016, MICROBIAL E IN PRESS; Takken W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-345; Terra, 2005, COMPREHENSIVE MOL IN, P171, DOI [10.1016/B0-44-451924-6/00053-3, DOI 10.1016/B0-44-451924-6/00053-3]; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Timmermann SE, 1996, ENTOMOL EXP APPL, V80, P173, DOI 10.1007/BF00194752; Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x; Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194; WALKER ED, 1988, J MED ENTOMOL, V25, P551, DOI 10.1093/jmedent/25.6.551; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Yahouedo GA, 2014, ACTA TROP, V132, pS96, DOI 10.1016/j.actatropica.2013.11.014	52	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151403	10.1371/journal.pone.0151403	http://dx.doi.org/10.1371/journal.pone.0151403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007411	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000372701200053
J	Kumar, S; Rathkolb, B; Kemter, E; Sabrautzki, S; Michel, D; Adler, T; Becker, L; Beckers, J; Busch, DH; Garrett, L; Hans, W; Holter, SM; Horsch, M; Klingenspor, M; Klopstock, T; Racz, I; Rozman, J; Panesso, ILV; Vernaleken, A; Zimmer, A; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Wolf, E; Aigner, B				Kumar, Sudhir; Rathkolb, Birgit; Kemter, Elisabeth; Sabrautzki, Sibylle; Michel, Dian; Adler, Thure; Becker, Lore; Beckers, Johannes; Busch, Dirk H.; Garrett, Lillian; Hans, Wolfgang; Hoelter, Sabine M.; Horsch, Marion; Klingenspor, Martin; Klopstock, Thomas; Racz, Ildiko; Rozman, Jan; Panesso, Ingrid Liliana Vargas; Vernaleken, Alexandra; Zimmer, Andreas; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Wolf, Eckhard; Aigner, Bernhard			Generation and Standardized, Systemic Phenotypic Analysis of Pou3f3(L423P) Mutant Mice	PLOS ONE			English	Article							MOUSE MUTAGENESIS PROJECT; KIDNEY-DISEASE; CRUCIAL ROLES; MUTATION; GENES; EXPRESSION; UROMODULIN; MODELS; BRN-1	Increased levels of blood plasma urea were used as phenotypic parameter for establishing novel mouse models for kidney diseases on the genetic background of C3H inbred mice in the phenotype-driven Munich ENU mouse mutagenesis project. The phenotypically recessive mutant line HST011 was established and further analyzed. The causative mutation was detected in the POU domain, class 3 transcription factor 3 (Pou3f3) gene, which leads to the amino acid exchange Pou3f3(L423P) thereby affecting the conserved homeobox domain of the protein. Pou3f3 homozygous knockout mice are published and show perinatal death. Line Pou3f3(L423P) is a viable mouse model harboring a homozygous Pou3f3 mutation. Standardized, systemic phenotypic analysis of homozygous mutants was carried out in the German Mouse Clinic. Main phenotypic changes were low body weight and a state of low energy stores, kidney dysfunction and secondary effects thereof including low bone mineralization, multiple behavioral and neurological defects including locomotor, vestibular, auditory and nociceptive impairments, as well as multiple subtle changes in immunological parameters. Genome-wide transcriptome profiling analysis of kidney and brain of Pou3f3(L423P) homozygous mutants identified significantly regulated genes as compared to wild-type controls.	[Kumar, Sudhir; Rathkolb, Birgit; Kemter, Elisabeth; Wolf, Eckhard; Aigner, Bernhard] Ludwig Maximilians Univ Munchen, Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Kumar, Sudhir; Rathkolb, Birgit; Kemter, Elisabeth; Wolf, Eckhard; Aigner, Bernhard] Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, D-81377 Munich, Germany; [Sabrautzki, Sibylle; Michel, Dian; Adler, Thure; Becker, Lore; Beckers, Johannes; Hans, Wolfgang; Horsch, Marion; Rozman, Jan; Panesso, Ingrid Liliana Vargas; Vernaleken, Alexandra; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, German Mouse Clin, Inst Expt Genet, D-85764 Neuherberg, Germany; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Garrett, Lillian; Hoelter, Sabine M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Klingenspor, Martin; Rozman, Jan] Tech Univ Munich, Else Kroner Fresenius Ctr, Mol Nutr Med, D-85350 Freising Weihenstephan, Germany; [Klopstock, Thomas; Panesso, Ingrid Liliana Vargas; Vernaleken, Alexandra] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Klopstock, Thomas; Panesso, Ingrid Liliana Vargas; de Angelis, Martin Hrabe] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Campus Grosshadern, D-81377 Munich, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, D-53105 Bonn, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; University of Bonn	Aigner, B (corresponding author), Ludwig Maximilians Univ Munchen, Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany.; Aigner, B (corresponding author), Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, D-81377 Munich, Germany.	b.aigner@gen.vetmed.uni-muenchen.de	Zimmer, Andreas/B-8357-2009; Hölter, Sabine M./N-5868-2014; Klingenspor, Martin/D-6930-2011; Wolf, Eckhard/AAT-7500-2021; Becker, Lore/AAJ-1203-2020; Klingenspor, Martin/K-5033-2019; Rozman, Jan/A-2540-2010; Beckers, Johannes/K-7237-2012; de Angelis, Martin Hrabe/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014	Hölter, Sabine M./0000-0003-4878-5241; Klingenspor, Martin/0000-0002-4502-6664; Wolf, Eckhard/0000-0002-0430-9510; Becker, Lore/0000-0002-6890-4984; Rozman, Jan/0000-0002-8035-8904; Beckers, Johannes/0000-0001-7874-3822; de Angelis, Martin Hrabe/0000-0002-7898-2353; Garrett, Lillian/0000-0003-4880-7076; Kemter, Elisabeth/0000-0001-7785-7502; Aigner, Bernhard/0000-0003-1644-2711	German Federal Ministry of Education and Research; German Center for Vertigo and Balance Disorders [01 EO 0901]; GMC (NGFN-Plus grants) [01GS0850, 01GS0851, 01GS0853, 01GS0854, 01GS0869, 01KX1012]; Initiative and Networking Fund of the Helmholtz Association [HA-215]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; GMC (NGFN-Plus grants); Initiative and Networking Fund of the Helmholtz Association	This work has been funded by the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD), the German Center for Vertigo and Balance Disorders (grant 01 EO 0901) and to the GMC (NGFN-Plus grants No. 01GS0850, 01GS0851, 01GS0853, 01GS0854, 01GS0869; Infrafrontier grant 01KX1012), and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society (HA-215).	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dheedene A, 2014, MOL SYNDROMOL, V5, P32, DOI 10.1159/000356060; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; HRABE DE ANGELIS M, 2007, MOUSE BIOMEDICAL RES, P225; Kemter E, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0068-0; Kemter E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078337; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mutai H, 2009, DEV NEUROBIOL, V69, P913, DOI 10.1002/dneu.20746; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Rathkolb B, 2000, MAMM GENOME, V11, P543, DOI 10.1007/s003350010104; Rozman J, 2014, MAMM GENOME, V25, P497, DOI 10.1007/s00335-014-9532-0; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Sumiyama K, 1996, J MOL EVOL, V43, P170, DOI 10.1007/PL00006075; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150472	10.1371/journal.pone.0150472	http://dx.doi.org/10.1371/journal.pone.0150472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003440	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400014
J	Livingstone, IAT; Tarbert, CM; Giardini, ME; Bastawrous, A; Middleton, D; Hamilton, R				Livingstone, I. A. T.; Tarbert, C. M.; Giardini, M. E.; Bastawrous, A.; Middleton, D.; Hamilton, R.			Photometric Compliance of Tablet Screens and Retro-Illuminated Acuity Charts As Visual Acuity Measurement Devices	PLOS ONE			English	Article							CONTRAST SENSITIVITY	Mobile technology is increasingly used to measure visual acuity. Standards for chart-based acuity tests specify photometric requirements for luminance, optotype contrast and luminance uniformity. Manufacturers provide some photometric data but little is known about tablet performance for visual acuity testing. This study photometrically characterised seven tablet computers (iPad, Apple inc.) and three ETDRS (Early Treatment Diabetic Retinopathy Study) visual acuity charts with room lights on and off, and compared findings with visual acuity measurement standards. Tablet screen luminance and contrast were measured using nine points across a black and white checkerboard test screen at five arbitrary brightness levels. ETDRS optotypes and adjacent white background luminance and contrast were measured. All seven tablets (room lights off) exceeded the most stringent requirement for mean luminance(>= 120 cd/m(2)) providing the nominal brightness setting was above 50%. All exceeded contrast requirement (Weber >= 90%) regardless of brightness setting, and five were marginally below the required luminance uniformity threshold (L-min/L-max >= 80%). Re-assessing three tablets with room lights on made little difference to mean luminance or contrast, and improved luminance uniformity to exceed the threshold. The three EDTRS charts (room lights off) had adequate mean luminance (>= 120 cd/m(2)) and Weber contrast (>= 90%), but all three charts failed to meet the luminance uniformity standard (L-min/L-max >= 80%). Two charts were operating beyond manufacturer's recommended lamp replacement schedule. With room lights on, chart mean luminance and Weber contrast increased, but two charts still had inadequate luminance uniformity. Tablet computers showed less inter-device variability, higher contrast, and better luminance uniformity than charts in both lights-on and lights-off environments, providing brightness setting was >50%. Overall, iPad tablets matched or marginally out-performed ETDRS charts in terms of photometric compliance with high contrast acuity standards.	[Livingstone, I. A. T.] NHS Greater Glasgow & Clyde, Dept Ophthalmol, Glasgow, Lanark, Scotland; [Livingstone, I. A. T.] NHS Greater Glasgow & Clyde, Glasgow Ctr Ophthalm Res, Glasgow, Lanark, Scotland; [Livingstone, I. A. T.; Hamilton, R.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Tarbert, C. M.; Middleton, D.; Hamilton, R.] NHS Greater Glasgow & Clyde, Dept Clin Phys, Glasgow, Lanark, Scotland; [Giardini, M. E.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Bastawrous, A.] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Eye Hlth, London WC1, England	University of Glasgow; University of Strathclyde; University of London; London School of Hygiene & Tropical Medicine	Livingstone, IAT (corresponding author), NHS Greater Glasgow & Clyde, Dept Ophthalmol, Glasgow, Lanark, Scotland.; Livingstone, IAT (corresponding author), NHS Greater Glasgow & Clyde, Glasgow Ctr Ophthalm Res, Glasgow, Lanark, Scotland.; Livingstone, IAT (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	iain.livingstone@nhs.net	Hamilton, Ruth/H-4253-2011; Giardini, Mario/C-3552-2008	Hamilton, Ruth/0000-0002-0855-9533; Giardini, Mario/0000-0003-4849-9683; Middleton, Duncan/0000-0003-2909-0049	Queen Elizabeth Diamond Jubilee Trust; MRC [G1001934] Funding Source: UKRI; Medical Research Council [G1001934] Funding Source: researchfish; Fight for Sight [1310/11] Funding Source: researchfish	Queen Elizabeth Diamond Jubilee Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	IL was funded in part by the Queen Elizabeth Diamond Jubilee Trust. URL: http://jubileetribute.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Physicists in Medicine Task Group 18, 2005, 03 AAPM IM INF SUBC; [Anonymous], PERS HLTH CAR 2020 F; Aslam TM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0239; Bastawrous A, 2012, EYE, V26, P343, DOI 10.1038/eye.2012.6; Bastawrous A, 2015, JAMA OPHTHALMOLOGY; Black JM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002730; British Standards Institution, 2003, 427412003 BS; Buhren J, 2006, OPTOMETRY VISION SCI, V83, P290, DOI 10.1097/01.opx.0000216100.93302.2d; Dorr M, 2013, INVEST OPHTH VIS SCI, V54, P7266, DOI 10.1167/iovs.13-11743; HAUSER B, 1992, KLIN MONATSBL AUGENH, V200, P105, DOI 10.1055/s-2008-1045721; Health C for D and R, MOB MED APPL; International Committee for Display Metrology, 2013, INF DISPL MEAS STAND; International Council of Ophthalmology, RES VIS AC MEAS STAN; Johnson CA, 1995, OPTOMETRY VISION SCI, V72, P864, DOI 10.1097/00006324-199512000-00004; Kollbaum PS, 2014, OPTOMETRY VISION SCI, V91, P291, DOI 10.1097/OPX.0000000000000158; Lin TP, 2015, J PARKINSON DIS, V5, P125, DOI 10.3233/JPD-140470; Livingstone IAT, 2014, IEEE ENG MED BIO, P2189, DOI 10.1109/EMBC.2014.6944052; Norgett Y, 2014, J VISION, V14, DOI 10.1167/14.12.23; research2guidance, 2013, MOB HLTH MARK TRENDS, V3; Ruamviboonsuk Paisan, 2012, J Med Assoc Thai, V95 Suppl 3, pS109; SHEEDY JE, 1984, AM J OPTOM PHYS OPT, V61, P595; Tahir HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095074; Tsui Irena, 2014, J Diabetes Sci Technol, V8, P845, DOI 10.1177/1932296814529637; World Health Organization, UN EYE HLTH GLOB ACT; Zhang ZT, 2013, J TELEMED TELECARE, V19, P55, DOI 10.1177/1357633X12474964	25	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150676	10.1371/journal.pone.0150676	http://dx.doi.org/10.1371/journal.pone.0150676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002333	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000372697400019
J	Langie, SAS; Szic, KSV; Declerck, K; Traen, S; Koppen, G; Van Camp, G; Schoeters, G; Vanden Berghe, W; De Boever, P				Langie, Sabine A. S.; Szic, Katarzyna Szarc vel; Declerck, Ken; Traen, Sophie; Koppen, Gudrun; Van Camp, Guy; Schoeters, Greet; Vanden Berghe, Wim; De Boever, Patrick			Whole-Genome Saliva and Blood DNA Methylation Profiling in Individuals with a Respiratory Allergy	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; GROWTH-FACTOR; T-CELLS; EXPOSURE; DIAGNOSTICS; PATTERNS; SAMPLES; TISSUE; BETA	The etiology of respiratory allergies (RA) can be partly explained by DNA methylation changes caused by adverse environmental and lifestyle factors experienced early in life. Longitudinal, prospective studies can aid in the unravelment of the epigenetic mechanisms involved in the disease development. High compliance rates can be expected in these studies when data is collected using non-invasive and convenient procedures. Saliva is an attractive biofluid to analyze changes in DNA methylation patterns. We investigated in a pilot study the differential methylation in saliva of RA (n = 5) compared to healthy controls (n = 5) using the Illumina Methylation 450K BeadChip platform. We evaluated the results against the results obtained in mononuclear blood cells from the same individuals. Differences in methylation patterns from saliva and mononuclear blood cells were clearly distinguishable (P-Adj<0.001 and vertical bar Delta beta vertical bar 0.2), though the methylation status of about 96% of the cg-sites was comparable between peripheral blood mononuclear cells and saliva. When comparing RA cases with healthy controls, the number of differentially methylated sites (DMS) in saliva and blood were 485 and 437 (P<0.05 and vertical bar Delta beta vertical bar>0.1), respectively, of which 216 were in common. The methylation levels of these sites were significantly correlated between blood and saliva. The absolute levels of methylation in blood and saliva were confirmed for 3 selected DMS in the PM20D1, STK32C, and FGFR2 genes using pyrosequencing analysis. The differential methylation could only be confirmed for DMS in PM20D1 and STK32C genes in saliva. We show that saliva can be used for genome-wide methylation analysis and that it is possible to identify DMS when comparing RA cases and healthy controls. The results were replicated in blood cells of the same individuals and confirmed by pyrosequencing analysis. This study provides proof-of-concept for the applicability of saliva-based whole-genome methylation analysis in the field of respiratory allergy.	[Langie, Sabine A. S.; Szic, Katarzyna Szarc vel; Traen, Sophie; Koppen, Gudrun; Schoeters, Greet; De Boever, Patrick] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium; [Szic, Katarzyna Szarc vel; Declerck, Ken; Vanden Berghe, Wim] Univ Antwerp, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Szic, Katarzyna Szarc vel; Declerck, Ken; Schoeters, Greet; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Van Camp, Guy] Univ Antwerp, Ctr Med Genet, Lab Canc Res & Clin Oncol, Edegem, Belgium; [Schoeters, Greet] Univ Southern Denmark, Inst Publ Hlth, Dept Environm Med, Odense, Denmark; [De Boever, Patrick] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium	VITO; University of Antwerp; University of Antwerp; University of Antwerp; University of Southern Denmark; Hasselt University	Langie, SAS (corresponding author), Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium.	sabine.langie@vito.be	Berghe, Wim Vanden/S-6425-2018; De Boever, Patrick/AAA-8387-2019; Vanden Berghe, Wim/HGE-4696-2022; Langie, Sabine A/Q-2917-2017; Van Camp, Guy/F-3386-2013; Koppen, Gudrun/Q-4011-2018	Berghe, Wim Vanden/0000-0003-0161-7355; De Boever, Patrick/0000-0002-5197-8215; Langie, Sabine A/0000-0003-3288-7331; Van Camp, Guy/0000-0001-5105-9000; Schoeters, Greta/0000-0002-6556-4814; Declerck, Ken/0000-0001-8104-8054	AXA Research Fund; Cefic-LRI Innovative Science Award	AXA Research Fund(AXA Research Fund); Cefic-LRI Innovative Science Award	SL is the beneficiary of a post-doctoral grant from the AXA Research Fund and the Cefic-LRI Innovative Science Award 2013.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-27; Birnboim HC, 2008, PDWP011; Bolstad B, 2005, BIOINFORMATICS COMPU; Bonne NJ, 2012, GENOME MED, V4, DOI 10.1186/gm383; Brunst KJ, 2013, J ALLERGY CLIN IMMUN, V131, P592, DOI 10.1016/j.jaci.2012.10.042; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Delaleu N, 2015, ARTHRITIS RHEUMATOL, V67, P1084, DOI 10.1002/art.39015; Everson TM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0213-8; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Gaffin JM, 2014, CLIN EXP ALLERGY, V44, P681, DOI 10.1111/cea.12219; Gomez-Uriz AM, 2015, HUM MOL GENET, V24, P1432, DOI 10.1093/hmg/ddu559; Goode MR, 2014, JOVE-J VIS EXP, DOI 10.3791/51697; Gunawardhana LP, 2014, PEDIATR PULM, V49, P852, DOI 10.1002/ppul.22930; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Koni AC, 2011, INT J OBESITY, V35, pS113, DOI 10.1038/ijo.2011.43; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Little FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084449; Lowe R, 2013, EPIGENETICS-US, V8, P445, DOI 10.4161/epi.24362; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Michel S, 2013, ALLERGY, V68, P355, DOI 10.1111/all.12097; Nie S, 2014, LAB CHIP, V14, P1087, DOI 10.1039/c3lc51303c; Njau F, 2009, MICROBES INFECT, V11, P1002, DOI 10.1016/j.micinf.2009.07.006; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Park HK, 2008, ALLERGY, V63, P447, DOI 10.1111/j.1398-9995.2007.01593.x; Pascual M, 2011, EPIGENETICS-US, V6, P1131, DOI 10.4161/epi.6.9.16061; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Qin HJ, 2011, P NATL ACAD SCI USA, V108, P2016, DOI 10.1073/pnas.1019082108; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Schafer CA, 2014, MONOGR ORAL SCI, V24, P88, DOI 10.1159/000358791; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Sebastian T, 2014, CLIN CHIM ACTA, V429, P198, DOI 10.1016/j.cca.2013.12.009; Shah S, 2015, ANN ALLERG ASTHMA IM, V114, P63, DOI 10.1016/j.anai.2014.09.012; Shikhagaie MM, 2014, CLIN EXP ALLERGY, V44, P184, DOI 10.1111/cea.12176; Sly PD, 2011, CURR OPIN ALLERGY CL, V11, P24, DOI 10.1097/ACI.0b013e328342309d; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suderman M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-13; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thompson TM, 2013, BEHAV GENET, V43, P168, DOI 10.1007/s10519-012-9579-1; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; World Health Organization, 2007, GLOB SURV PREV CONTR; Wren ME, 2015, CLIN THER, V37, P529, DOI 10.1016/j.clinthera.2015.02.022; Wu HC, 2014, EPIGENETICS-US, V9, P929, DOI 10.4161/epi.28902; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13	53	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151109	10.1371/journal.pone.0151109	http://dx.doi.org/10.1371/journal.pone.0151109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999364	Green Published, gold			2022-12-27	WOS:000372694700021
J	Song, J; Tanida, M; Shibamoto, T; Zhang, T; Wang, MF; Kuda, Y; Kurata, Y				Song, Jie; Tanida, Mamoru; Shibamoto, Toshishige; Zhang, Tao; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka			The Role of Lumbar Sympathetic Nerves in Regulation of Blood Flow to Skeletal Muscle during Anaphylactic Hypotension in Anesthetized Rats	PLOS ONE			English	Article							NITRIC-OXIDE; VASOCONSTRICTION; SHOCK; ANTAGONISTS; INHIBITION; MECHANISMS; RESPONSES; SYSTEM	During hypovolemic shock, skeletal muscle blood flow could be redistributed to vital organs via vasoconstriction in part evoked by activation of the innervating sympathetic nerve activity. However, it is not well known whether this mechanism operates during anaphylactic shock. We determined the femoral artery blood flow (FBF) and lumbar sympathetic nerve activity (LSNA) mainly regulating the hindquater muscle blood flow during anaphylactic hypotension in anesthetized rats. Anesthetized Sprague-Dawley rats were randomly allocated to the following groups (n = 7/group): (1) non-sensitized, (2) anaphylaxis, (3) anaphylaxis-lumbar sympathectomy (LS) and (4) anaphylaxis-sinoaortic denervation (SAD) groups. Anaphylaxis was induced by an intravenous injection of the ovalbumin antigen to the sensitized rats. The systemic arterial pressure (SAP), heart rate (HR), central venous pressure (CVP), FBF and LSNA were continuously measured. In the anaphylaxis group, LSNA and HR increased, while SAP and FBF decreased after antigen injection. In the anaphylaxis-SAD group, LSNA did not significantly change during the early phase, but the responses of SAP and FBF were similar to those in the anaphylaxis group. In the anaphylaxis-LS group, both FBF and SAP decreased similarly to the anaphylaxis group during anaphylactic hypotension. These results indicated that LSNA increased via baroreceptor reflex, but this sympathoexcitation or LS did not affect antigen-induced decreases in FBF or SAP. Lumbar sympathetic nerves are not involved in regulation of the blood flow to the hindlimb or systemic blood pressure during anaphylactic hypotension in anesthetized rats.	[Song, Jie; Tanida, Mamoru; Shibamoto, Toshishige; Zhang, Tao; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan; [Song, Jie] China Japan Friendship Hosp, Dept Anesthesiol, Beijing 100029, Peoples R China; [Zhang, Tao] China Med Univ, Affiliated Hosp 4, Dept Colorectal & Hernia Surg, Shenyang 110032, Peoples R China; [Wang, Mofei] China Med Univ, Affiliated Hosp 4, Dept Diabet Surg, Shenyang 110032, Peoples R China	Kanazawa Medical University; China-Japan Friendship Hospital; China Medical University; China Medical University	Tanida, M; Shibamoto, T (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan.	mtanida@kanazawa-med.ac.jp; shibamo@kanazawa-med.ac.jp			Kanazawa Medical University [S2013-1]; Mishima Kaiun Memorial Foundation [11]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16K09767] Funding Source: KAKEN	Kanazawa Medical University; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by grants from Grant for Promoted Research from Kanazawa Medical University (MT, S2013-1, http://www.kanazawa-med.ac.jp/kenkyu/publication.html), from Mishima Kaiun Memorial Foundation (MT, No11, http://www.mishima-kaiun.or.jp/assist/2147.html) and from Takeda Science Foundation (MT, http://www.takeda-sci.or.jp/business/doc/2013_list.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, EUROPEAN RESPIRATORY; BARON R, 1988, J COMP NEUROL, V275, P460, DOI 10.1002/cne.902750310; BAYORH MA, 1985, PROSTA LEUKOTR MED, V17, P229, DOI 10.1016/0262-1746(85)90110-6; BRANTIGAN JW, 1974, J APPL PHYSIOL, V37, P117, DOI 10.1152/jappl.1974.37.1.117; Coney AM, 2003, J PHYSIOL-LONDON, V549, P613, DOI 10.1113/jphysiol.2003.042267; Dewachter P, 2005, ANESTHESIOLOGY, V103, P40, DOI 10.1097/00000542-200507000-00010; Hui YQ, 2004, CIRCULATION, V110, P3360, DOI 10.1161/01.CIR.0000147775.50954.AA; Jendzjowsky NG, 2013, J APPL PHYSIOL, V115, P97, DOI 10.1152/japplphysiol.00250.2013; KAPIN MA, 1985, AM J PHYSIOL, V249, pH430, DOI 10.1152/ajpheart.1985.249.2.H430; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; MATHISON R, 1992, BRIT J PHARMACOL, V106, P263, DOI 10.1111/j.1476-5381.1992.tb14326.x; Miki K, 2004, J PHYSIOL-LONDON, V557, P261, DOI 10.1113/jphysiol.2003.055525; MITSUHATA H, 1995, J CLIN IMMUNOL, V15, P277, DOI 10.1007/BF01541317; Moreira TS, 2011, BRAZ J MED BIOL RES, V44, P883, DOI 10.1590/S0100-879X2011000900009; OFFNER B, 1994, J APPL PHYSIOL, V77, P173, DOI 10.1152/jappl.1994.77.1.173; Potas JR, 2004, AUTON NEUROSCI-BASIC, V112, P25, DOI 10.1016/j.autneu.2004.03.004; Shibamoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1436, DOI 10.1152/ajpheart.00368.2005; SMEDEGARD G, 1979, ACTA PHYSIOL SCAND, V106, P191, DOI 10.1111/j.1748-1716.1979.tb06389.x; Sun LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113945; Thomas GD, 1998, J PHYSIOL-LONDON, V506, P817, DOI 10.1111/j.1469-7793.1998.817bv.x; VATNER SF, 1974, J CLIN INVEST, V54, P225, DOI 10.1172/JCI107757; Wang MF, 2015, EXP LUNG RES, V41, P324, DOI 10.3109/01902148.2015.1032448; Wang M, 2014, EUR J PHARMACOL, V731, P38, DOI 10.1016/j.ejphar.2014.03.012; Wang MF, 2013, AM J PHYSIOL-REG I, V305, pR900, DOI 10.1152/ajpregu.00120.2013; Zhang W, 2013, IN VIVO, V27, P485; Zhang W, 2012, AM J PHYSIOL-REG I, V302, pR1191, DOI 10.1152/ajpregu.00695.2011; Zhang W, 2011, ANESTHESIOLOGY, V114, P614, DOI 10.1097/ALN.0b013e31820b8d34	27	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150882	10.1371/journal.pone.0150882	http://dx.doi.org/10.1371/journal.pone.0150882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998924	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700017
J	Clemente, NS; Ugarte-Gil, C; Solorzano, N; Maguina, C; Moore, D				Clemente, Nuria Sanchez; Ugarte-Gil, Cesar; Solorzano, Nelson; Maguina, Ciro; Moore, David			An Outbreak of Bartonella bacilliformis in an Endemic Andean Community	PLOS ONE			English	Article							EPIDEMIOLOGY	Background Bartonellosis affects small Andean communities in Peru, Colombia and Ecuador. Research in this area has been limited. Methods Retrospective review of 191 cases of bartonellosis managed in Caraz District Hospital, Peru, during the last outbreak (2003). Results The majority of cases (65%) were 14 years old and younger. There was a peak in acute cases after the rainy season; chronic cases presented more constantly throughout the year. The sensitivity of blood smear against blood culture in acute disease was 25%. The most commonly used treatment for chronic disease was rifampicin; chloramphenicol was used to treat most acute cases. Complications arose in 6.8% and there were no deaths. Conclusions Diagnostic and treatment algorithms for acute and chronic bartonellosis have been developed without a strong evidence base. Preparation of ready-to-go operational research protocols for future outbreaks would strengthen the evidence base for diagnostic and treatment strategies and enhance opportunities for control.	[Clemente, Nuria Sanchez; Moore, David] London Sch Hyg & Trop Med, London WC1, England; [Ugarte-Gil, Cesar; Maguina, Ciro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Solorzano, Nelson] Hosp San Juan Dios, Caraz, Peru	University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Clemente, NS (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	nuriasanchezclemente@gmail.com	Ugarte-Gil, Cesar/E-6074-2013; Clemente, Nuria Sanchez/AAL-4309-2020	Ugarte-Gil, Cesar/0000-0002-2833-9087; 	London School of Hygiene and Tropical Medicine; Wellcome Trust [092691/Z10/Z]	London School of Hygiene and Tropical Medicine; Wellcome Trust(Wellcome TrustEuropean Commission)	NSC received a travel stipend from the London School of Hygiene and Tropical Medicine. DM received support from the support of the Wellcome Trust (grant 092691/Z10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DM acknowledges the support of the Wellcome Trust (grant 092691/Z10/Z)	Angelakis E, 2008, J ANTIMICROB CHEMOTH, V61, P1252, DOI 10.1093/jac/dkn094; [Anonymous], 1992, REV MED HEREDIANA; [Anonymous], 1996, REV NEUROPSIQUIATR; [Anonymous], 1998, REV MED HEREDIANA; Blazes DL, 2013, EMERG INFECT DIS, V19, P1111, DOI 10.3201/eid1907.121718; BREÑA CHÁVEZ Judith Patricia, 2006, Rev Med Hered, V17, P122; Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054; Chinga-Alayo E, 2004, T ROY SOC TROP MED H, V98, P116, DOI 10.1016/S0035-9203(03)00017-8; Clemente NS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001819; Direccion Regional de Salud Ancash (Peru), 2015, B EP SEM, P38; GRAY GC, 1990, AM J TROP MED HYG, V42, P215, DOI 10.4269/ajtmh.1990.42.215; Maguina Ciro, 1997, Rev Gastroenterol Peru, V17, P31; Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006; Maguiña Vargas Ciro, 2008, Acta méd. peruana, V25, P30; Maguina Vargas C., 1998, BARTONELLOSIS ENFERM, P89; Maguiña Vargas Ciro, 2008, Rev Med Hered, V19, P36; Ministerio de Salud, 1998, DOCTR NORM PROC CONT; Minnick MF, 2003, ANTIMICROBIAL AGENTS, V47; Peru Ministerio de Salud, 2006, NORM TECN SAL AT BAR; SCHULTZ MG, 1968, AM J TROP MED HYG, V17, P503, DOI 10.4269/ajtmh.1968.17.503; Tarazona F Augusto, 2006, Rev. perú. med. exp. salud publica, V23, P188	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150525	10.1371/journal.pone.0150525	http://dx.doi.org/10.1371/journal.pone.0150525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991495	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000372582800035
J	Hall, A; Kingsford, M				Hall, April; Kingsford, Michael			Predators Exacerbate Competitive Interactions and Dominance Hierarchies between Two Coral Reef Fishes	PLOS ONE			English	Article							HABITAT DEGRADATION; DENSITY-DEPENDENCE; INTERSPECIFIC COMPETITION; POPULATION REGULATION; SELECTIVE MORTALITY; HUMBUG DAMSELFISH; HIGH DIVERSITY; PREY REFUGES; SIZE; RECRUITMENT	Predation and competition are critical processes influencing the ecology of organisms, and can play an integral role in shaping coral reef fish communities. This study compared the relative and interacting effects of competition and predation on two competing species of coral reef fish, Pomacentrus amboinensis and P. moluccensis (Pomacentridae), using a multifactorial experiment. Fish were subjected to the sight and smell of a known predator (Pseudochromis fuscus), the presence of the heterospecific competitor (i.e., P. amboinensis vs. P. moluccensis), or a combination of the two for a period of 19 days. The sub-lethal effects of predator/competitor treatments were compared with controls; a combination of otolith microstructure analysis and observations were used to determine otolith growth patterns and behaviour. We predicted that the stress of competition and/or predation would result in strong sub-lethal impacts, and act synergistically on growth and behavioural patterns. We found strong evidence to support this prediction, but only for P. amboinensis, which suffered reductions in growth in both predator and competitor treatments, with the largest reductions occurring when subjected to both predation and competition concurrently. There was strong evidence of asymmetrical competition between the two damselfish species, with P. moluccensis as the dominant competitor, displaying strong aggressive behaviour towards P. amboinensis. Growth reductions for P. amboinensis in predator/competitor treatments appeared to come about primarily due to increases in shelter seeking behaviour, which significantly reduced the foraging rates of individuals compared with controls. These data highlight the importance of predator/competitor synergisms in influencing key behaviours and demographic parameters for juvenile coral reef fishes.	[Hall, April] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; James Cook Univ, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Hall, A (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	april.hall3110@gmail.com	Kingsford, Michael J/C-2015-2008	Kingsford, Michael J/0000-0003-1704-6198; Hall, April/0000-0003-3672-2761	ARC Centre of Excellence for Coral Reef Studies grant	ARC Centre of Excellence for Coral Reef Studies grant(Australian Research Council)	All funding was from an ARC Centre of Excellence for Coral Reef Studies grant to Michael Kingsford.	Baumann H, 2011, HELGOLAND MAR RES, V65, P425, DOI 10.1007/s10152-011-0255-2; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Boaden AE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00292.1; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; Bosiger YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034535; Bostrom-Einarsson L, 2014, ECOLOGY, V95, P3056; Bostrom-Einarsson L, 2013, J EXP MAR BIOL ECOL, V448, P85, DOI 10.1016/j.jembe.2013.06.017; CALEY MJ, 1993, MAR BIOL, V117, P33, DOI 10.1007/BF00346423; Cappuccino Naomi, 1995, P3, DOI 10.1016/B978-012159270-7/50002-6; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; COATES D, 1980, J ANIM ECOL, V49, P335, DOI 10.2307/4292; Cohen J.E., 1988, STAT POWER ANAL BEHA; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Connell SD, 1998, MAR ECOL PROG SER, V169, P251, DOI 10.3354/meps169251; Connell SD, 1996, MAR BIOL, V126, P347, DOI 10.1007/BF00347459; Cooke SJ, 2003, CAN J ZOOL, V81, P699, DOI 10.1139/Z03-044; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Figueira WF, 2008, OECOLOGIA, V156, P215, DOI 10.1007/s00442-008-0985-2; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Green BS, 2009, REV-METHODS TECHNOL, V11, P1, DOI 10.1007/978-1-4020-5775-5_1; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; HAMBRIGHT KD, 1991, ARCH HYDROBIOL, V121, P389; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hixon M.A., 2002, CORAL REEF FISHES DY; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Hixon MA, 2012, ECOL MONOGR, V82, P467, DOI 10.1890/11-1525.1; Holbrook SJ, 2003, OECOLOGIA, V135, P532, DOI 10.1007/s00442-003-1220-9; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2011, ANIM BEHAV, V81, P543, DOI 10.1016/j.anbehav.2010.11.019; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Jones Geoffrey P., 2002, P221, DOI 10.1016/B978-012615185-5/50013-X; JONES GP, 1988, J EXP MAR BIOL ECOL, V123, P115, DOI 10.1016/0022-0981(88)90164-5; Killen SS, 2006, MAR ECOL PROG SER, V321, P255, DOI 10.3354/meps321255; Kingsford MJ, 2011, CORAL REEFS, V30, P203, DOI 10.1007/s00338-010-0692-4; Lonnstedt OM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02259; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; McCormick MI, 1998, AUST J ECOL, V23, P258, DOI 10.1111/j.1442-9993.1998.tb00729.x; Mitchell MD, 2013, FUNCT ECOL, V27, P299, DOI 10.1111/1365-2435.12043; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Morales-Nin B, 2000, FISH RES, V46, P53, DOI 10.1016/S0165-7836(00)00133-8; PITCHER CR, 1988, CORAL REEFS, V7, P105, DOI 10.1007/BF00300969; Rizzari JR, 2014, OIKOS, V123, P829, DOI 10.1111/oik.01318; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; SALE PF, 1988, CORAL REEFS, V7, P117, DOI 10.1007/BF00300971; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Sogard SM, 1997, B MAR SCI, V60, P1129; Villegas-Hernandez H, 2008, AQUAT BIOL, V1, P249, DOI 10.3354/ab00026; Walsh SM, 2012, J FISH BIOL, V80, P519, DOI 10.1111/j.1095-8649.2011.03209.x; Webster MS, 2004, ECOLOGY, V85, P986, DOI 10.1890/02-0576; Webster MS, 2000, MAR ECOL PROG SER, V196, P187, DOI 10.3354/meps196187; Webster MS, 2002, OECOLOGIA, V131, P52, DOI 10.1007/s00442-001-0860-x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; WOOTTON JT, 1992, ECOLOGY, V73, P981, DOI 10.2307/1940174	71	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151778	10.1371/journal.pone.0151778	http://dx.doi.org/10.1371/journal.pone.0151778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992169	gold, Green Published, Green Accepted			2022-12-27	WOS:000372582800101
J	Melese, M; Jerene, D; Alem, G; Seid, J; Belachew, F; Kassie, Y; Habte, D; Negash, S; Ayana, G; Girma, B; Haile, YK; Hiruy, N; Suarez, PG				Melese, Muluken; Jerene, Degu; Alem, Genetu; Seid, Jemal; Belachew, Feleke; Kassie, Yewulsew; Habte, Dereje; Negash, Solomon; Ayana, Gonfa; Girma, Belaineh; Haile, Yared K.; Hiruy, Nebiyu; Suarez, Pedro G.			Decentralization of Acid Fast Bacilli(AFB) External Quality Assurance Using Blind Rechecking for Sputum Smear Microscopy in Ethiopia	PLOS ONE			English	Article							ASSESSMENT GUIDELINES; TUBERCULOSIS; LABORATORIES; ENSURE	Introduction Ethiopia achieved a rapid expansion of TB microscopic centers for acid fast bacilli (AFB). However, external quality assurance (EQA) services were, until recently, limited to few regional and sub-regional laboratories. In this paper, we describe the decentralization experience and the result of EQA using random blinded rechecking. Materials and Methods The routine EQA quarterly report was compiled and analyzed. A positive result by the microscopic center while the EQA center reported negative result is categorized as false positive (FP). A negative result by the microscopic center while the EQA center reported positive is considered false negative (FN). The reading of EQA centers was considered a gold standard to compute the sensitivity, specificity, positive predictive (PPV) and negative predictive values (NPV) of the readings of microscopic centers. Results We decentralized sputum smear AFB EQA from 4 Regional Laboratories (RRLs) to 82 EQA centers and enrolled 956 health facilities in EQA schemes. Enrollment of HFs in EQA was gradual because it required training and mentoring laboratory professionals, institutionalizing internal QA measures, equipping all HFs to perform diagnosis, and establishing more EQA centers. From 2012 to 2014 (Phase I), the FP rate declined from 0.6% to 0.2% and FN fell from as high as 7.6% to 1.6% in supported health facilities (HFs). In HFs that joined in Phase II, FN rates ranged from 5.6 to 7.3%. The proportion of HFs without errors has increased from 77.9% to 90.5% in Phase I HFs and from 82.9% to 86.9% in Phase II HFs. Overall sensitivity and specificity were 95.0% and 99.7%, respectively. PPV and NPV were 93.3% and 99.7%, respectively. Conclusion Decentralizing blinded rechecking of sputum smear microscopy is feasible in low-income settings. While a comprehensive laboratory improvement strategy enhanced the quality of microscopy, laboratory professionals' capacity in slide reading and smear quality requires continued support.	[Melese, Muluken; Jerene, Degu; Seid, Jemal; Kassie, Yewulsew; Habte, Dereje; Negash, Solomon; Girma, Belaineh; Hiruy, Nebiyu] Management Sci Hlth, Help Ethiopia Address Low Performance TB HEAL TB, Addis Ababa, Ethiopia; [Alem, Genetu] Amhara Reg Hlth Bur, Bahir Dar, Ethiopia; [Belachew, Feleke] Oromia Reg Reference Lab, Addis Ababa, Ethiopia; [Ayana, Gonfa] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Haile, Yared K.] USAID, Addis Ababa, Ethiopia; [Suarez, Pedro G.] Management Sci Hlth, Ctr Hlth Serv, Arlington, VA USA	United States Agency for International Development (USAID)	Melese, M (corresponding author), Management Sci Hlth, Help Ethiopia Address Low Performance TB HEAL TB, Addis Ababa, Ethiopia.	mmelese@msh.org	Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761; Habte, Dereje/0000-0002-4720-4188	United States Agency for International Development(USAID) through HEAL TB [AID-663-A-11-00011]	United States Agency for International Development(USAID) through HEAL TB(United States Agency for International Development (USAID))	United States Agency for International Development(USAID) supported this work through HEAL TB, under cooperative agreement number AID-663-A-11-00011. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government.	Chiang CY, 2005, J FORMOS MED ASSOC, V104, P502; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Ethiopian Health and Nutrition Research Institute Federal Ministry of Health, 2009, GUID QUAL ASS SMEAR; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; Jekel JF, 2007, EPIDEMIOLOGY BIOSTAT; Kumar V, 2009, INT J TUBERC LUNG D, V13, P1183; Kusznierz GF, 2004, INT J TUBERC LUNG D, V8, P1234; Manyazewal T, 2013, DIAGN MICR INFEC DIS, V75, P55, DOI 10.1016/j.diagmicrobio.2012.09.020; Martinez A, 2005, INT J TUBERC LUNG D, V9, P301; Martinez-Guarneros A, 2003, INT J TUBERC LUNG D, V7, P516; Mundy CJF, 2002, INT J TUBERC LUNG D, V6, P47; Otero L, 2011, INT J TUBERC LUNG D, V15, P211; Patel Nilesh D, 2012, Indian J Tuberc, V59, P12; Ridderhof JC, 2007, B WORLD HEALTH ORGAN, V85, P354, DOI 10.2471/BLT.06.039081; Selvakumar N, 2003, INT J TUBERC LUNG D, V7, P1077; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P355; Van Deun A, 1998, INT J TUBERC LUNG D, V2, P756; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; World Health Organization, 2002, KNCV INT UN TUB LUNG; World Health Organization, 2006, WHOHTMTB2006368; World Health Organization (WHO), 1998, WHO TUB HDB; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606; Yip CW, 2012, INT J TUBERC LUNG D, V16, P398, DOI 10.5588/ijtld.11.0330	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151366	10.1371/journal.pone.0151366	http://dx.doi.org/10.1371/journal.pone.0151366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991651	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800056
J	DeGennaro, CM; Savir, Y; Springer, M				DeGennaro, Christine M.; Savir, Yonatan; Springer, Michael			Identifying Metabolic Subpopulations from Population Level Mass Spectrometry	PLOS ONE			English	Article							FLUX ANALYSIS; CELL METABOLISM; STEM-CELLS; EXPRESSION; MODEL; RATIO	Metabolism underlies many important cellular decisions, such as the decisions to proliferate and differentiate, and defects in metabolic signaling can lead to disease and aging. In addition, metabolic heterogeneity can have biological consequences, such as differences in outcomes and drug susceptibilities in cancer and antibiotic treatments. Many approaches exist for characterizing the metabolic state of a population of cells, but technologies for measuring metabolism at the single cell level are in the preliminary stages and are limited. Here, we describe novel analysis methodologies that can be applied to established experimental methods to measure metabolic variability within a population. We use mass spectrometry to analyze amino acid composition in cells grown in a mixture of C-12- and C-13-labeled sugars; these measurements allow us to quantify the variability in sugar usage and thereby infer information about the behavior of cells within the population. The methodologies described here can be applied to a large range of metabolites and macromolecules and therefore have the potential for broad applications.	[DeGennaro, Christine M.; Springer, Michael] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Savir, Yonatan] Technion Israel Inst Technol, Fac Med, Dept Physiol Biophys & Syst Biol, IL-31096 Haifa, Israel	Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Springer, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	michael_springer@hms.harvard.edu		DeGennaro, Christine/0000-0001-7318-9949	National Science Foundations Grant [1349248]; National Institutes of Health [P50 GM107618]; Milton Fellowship; Novartis Postdoctoral Fellowship; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107618] Funding Source: NIH RePORTER	National Science Foundations Grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milton Fellowship; Novartis Postdoctoral Fellowship; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Science Foundations Grant 1349248 and the National Institutes of Health P50 GM107618 (M.S.), the Milton Fellowship and Novartis Postdoctoral Fellowship (C.M.D.), and the Human Frontier Science Program (Y.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ahlqvist KJ, 2015, BBA-BIOENERGETICS, V1847, P1380, DOI 10.1016/j.bbabio.2015.05.014; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bigger JW, 1944, LANCET, V2, P497; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Canelas AB, 2008, BIOTECHNOL BIOENG, V100, P734, DOI 10.1002/bit.21813; Christensen B, 1999, METAB ENG, V1, P282, DOI 10.1006/mben.1999.0117; Escalante-Chong R, 2015, P NATL ACAD SCI USA, V112, P1636, DOI 10.1073/pnas.1418058112; Gebreselassie NA, 2015, METAB ENG, V31, P132, DOI 10.1016/j.ymben.2015.07.005; Ghosh A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003827; Heinemann M, 2011, CURR OPIN BIOTECH, V22, P26, DOI 10.1016/j.copbio.2010.09.008; Justus CR, 2015, INT J MOL SCI, V16, P11055, DOI 10.3390/ijms160511055; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kotte O, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20135022; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Nargund S, 2014, MOL BIOSYST, V10, P1496, DOI 10.1039/c3mb70348g; NURSE P, 1974, J BACTERIOL, V117, P1108, DOI 10.1128/JB.117.3.1108-1116.1974; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; SZYPERSKI T, 1995, EUR J BIOCHEM, V232, P433, DOI 10.1111/j.1432-1033.1995.433zz.x; van Dijk G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00173; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Vasdekis AE, 2015, METAB ENG, V27, P115, DOI 10.1016/j.ymben.2014.09.007; Venturelli OS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002042; Wang J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002041; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Zamboni N, 2011, CURR OPIN BIOTECH, V22, P103, DOI 10.1016/j.copbio.2010.08.009; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151659	10.1371/journal.pone.0151659	http://dx.doi.org/10.1371/journal.pone.0151659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986964	Green Published, gold			2022-12-27	WOS:000372580300107
J	Deminice, R; Ribeiro, DF; Frajacomo, FTT				Deminice, Rafael; Ribeiro, Diogo Farias; Trevisan Frajacomo, Fernando Tadeu			The Effects of Acute Exercise and Exercise Training on Plasma Homocysteine: A Meta-Analysis	PLOS ONE			English	Article							ACUTE PHYSICAL-EXERCISE; AMINO-ACID-METABOLISM; OXIDATIVE STRESS; CREATINE SUPPLEMENTATION; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION; BLOOD-LIPIDS; NITRIC-OXIDE; YOUNG-WOMEN; ALL-CAUSE	Background Although studies have demonstrated that physical exercise alters homocysteine levels in the blood, meta-analyses of the effects of acute exercise and exercise training on homocysteine blood concentration have not been performed, especially regarding the duration and intensity of exercise, which could affect homocysteine levels differently. Objective The aim of this meta-analysis was to ascertain the effects of acute exercise and exercise training on homocysteine levels in the blood. Method A review was conducted according to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses using the online databases PubMed, SPORTDiscus, and SciELO to identify relevant studies published through June 2015. Review Manager was used to calculate the effect size of acute exercise and exercise training using the change in Hcy plasmaserum concentration from baseline to post-acute exercise and trained vs. sedentary control groups, respectively. Weighted mean differences were calculated using random effect models. Results Given the abundance of studies, acute exercise trials were divided into two subgroups according to exercise volume and intensity, whereas the effects of exercise training were analyzed together. Overall, 22 studies with a total of 520 participants indicated increased plasma homocysteine concentration after acute exercise (1.18 mu mol/L, 95% CI: 0.71 to 1.65, p < .01). Results of a subgroup analysis indicated that either long-term exercise of low-to-moderate intensity (1.39 mu mol/L, 95% CI: 0.9 to 1.89, p < .01) or short-term exercise of high intensity (0.83 mu mol/L, 95% CI: 0.19 to 1.40, p < .01) elevated homocysteine levels in the blood. Increased homocysteine induced by exercise was significantly associated with volume of exercise, but not intensity. By contrast, resistance training reduced plasma homocysteine concentration (-1.53 mu mol/L, 95% CI: -2.77 to -0.28, p = .02), though aerobic training did not. The cumulative results of the seven studies with a total of 230 participants in exercise training analysis did not demonstrate a significant impact on homocysteine levels in the blood (-0.56 mu mol/L, 95% CI: -1.61 to 0.50, p = .23). Conclusions Current evidence demonstrates that acute exercise increases homocysteine levels in the blood independent of exercise duration and intensity. Resistance, but not aerobic training decreases plasma homocysteine levels.	[Deminice, Rafael; Ribeiro, Diogo Farias; Trevisan Frajacomo, Fernando Tadeu] Univ Estadual Londrina, Dept Phys Educ, Londrina, PR, Brazil	Universidade Estadual de Londrina	Deminice, R (corresponding author), Univ Estadual Londrina, Dept Phys Educ, Londrina, PR, Brazil.	deminice@ig.com.br	Frajacomo, Fernando/U-7735-2019; Deminice, Rafael/AAB-7871-2020; Frajacomo, Fernando/I-4633-2016; Deminice, Rafael/AAG-4868-2019	Frajacomo, Fernando/0000-0002-3872-7067; Frajacomo, Fernando/0000-0002-3872-7067; Deminice, Rafael/0000-0002-9246-1079				Ali A, 1998, AM J CARDIOL, V82, P1543, DOI 10.1016/S0002-9149(98)00710-3; Antunes HKM, 2015, DEMENT GER COGN D EX, V5, P13, DOI 10.1159/000369160; Benedini S, 2010, SPORT SCI HLTH, V6, P35, DOI [10.1007/s11332-010-0094-6, DOI 10.1007/S11332-010-0094-6]; Bereket-Yucel S, 2015, J SPORT MED PHYS FIT, V55, P313; Bizheh N, 2011, IRAN J BASIC MED SCI, V14, P568; Boreham CAG, 2005, BRIT J SPORT MED, V39, P590, DOI 10.1136/bjsm.2002.001131; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Chambers JC, 1999, CIRCULATION, V99, P1156, DOI 10.1161/01.CIR.99.9.1156; Chen CY, 2005, ANN NUTR METAB, V49, P33, DOI 10.1159/000084175; Choi JK, 2014, KOREAN J PHYSIOL PHA, V18, P163, DOI 10.4196/kjpp.2014.18.2.163; De Cree C, 1999, SCAND J MED SCI SPOR, V9, P272; De Cree C, 2000, INT J SPORTS MED, V21, P256, DOI 10.1055/s-2000-8884; Silva ADE, 2014, AMINO ACIDS, V46, P1795, DOI 10.1007/s00726-014-1741-z; Deminice R, 2013, NUTRITION, V29, P1127, DOI 10.1016/j.nut.2013.03.003; Deminice R, 2011, EUR J APPL PHYSIOL, V111, P2663, DOI 10.1007/s00421-011-1891-6; Duncan GE, 2004, PREV MED, V39, P894, DOI 10.1016/j.ypmed.2004.03.012; Eberhardt RT, 2000, J CLIN INVEST, V106, P483, DOI 10.1172/JCI8342; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Galvao DA, 2011, J UROLOGY, V186, P1291, DOI 10.1016/j.juro.2011.05.055; Gaume V, 2005, ANN NUTR METAB, V49, P125, DOI 10.1159/000085536; Gelecek N, 2007, ANN NUTR METAB, V51, P53, DOI 10.1159/000100821; Guzel NA, 2012, CHINESE J PHYSIOL, V55, P202, DOI 10.4077/CJP.2012.AMM122; Hammouda Omar, 2013, Asian J Sports Med, V4, P23; Hammouda Omar, 2012, Asian J Sports Med, V3, P239, DOI 10.5812/asjsm.34544; Hayward Reid, 2003, Pathophysiology, V9, P207, DOI 10.1016/S0928-4680(03)00023-3; Herrmann M, 2003, CLIN CHEM LAB MED, V41, P1518, DOI 10.1515/CCLM.2003.233; Herrmann M, 2003, CLIN CHEM LAB MED, V41, P1525, DOI 10.1515/CCLM.2003.234; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Iglesias-Gutierrez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051185; Jakovljevic Biljana, 2015, Mater Sociomed, V27, P95, DOI 10.5455/msm.2015.27.95-98; Joubert LM, 2006, INT J SPORT NUTR EXE, V16, P341, DOI 10.1123/ijsnem.16.4.341; Konig D, 2003, ANN NUTR METAB, V47, P114, DOI 10.1159/000070032; Kumudini N, 2014, NEUROSCI LETT, V568, P1, DOI 10.1016/j.neulet.2014.03.044; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Maroto-Sanchez B, 2013, NUTR HOSP, V28, P325, DOI 10.3305/nh.2013.28.2.6300; McAnulty LS, 2011, APPL PHYSIOL NUTR ME, V36, P976, DOI [10.1139/H11-120, 10.1139/h11-120]; McAnulty SR, 2005, J NUTR BIOCHEM, V16, P530, DOI 10.1016/j.jnutbio.2005.02.001; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Morita H, 2001, CIRCULATION, V103, P133; Murawska-Cialowicz E, 2014, CENTRAL EUROPEAN J S, V8, P5; Neuman JC, 2013, NUTR RES, V33, P487, DOI 10.1016/j.nutres.2013.04.008; O'Dochartaigh C, 2004, CLIN SCI, V106, P413, DOI 10.1042/CS20030383; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Randeva HS, 2002, J CLIN ENDOCR METAB, V87, P4496, DOI 10.1210/jc.2001-012056; Real JT, 2005, NUTR METAB CARDIOVAS, V15, P134, DOI 10.1016/j.numecd.2004.05.004; Rennie MJ, 2000, ANNU REV NUTR, V20, P457, DOI 10.1146/annurev.nutr.20.1.457; Saboorisarein M, 2012, INT J CARD RES, P01; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Shen L, 2015, J ALZHEIMERS DIS, V46, P777, DOI 10.3233/JAD-150140; Shi ZH, 2015, STROKE, V46, P2419, DOI 10.1161/STROKEAHA.115.009136; Sotgia S, 2007, CLIN NUTR, V26, P444, DOI 10.1016/j.clnu.2007.05.003; Steenge GR, 2001, ARCH INTERN MED, V161, P1455, DOI 10.1001/archinte.161.11.1455; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Subasi SS, 2009, TURK J BIOCHEM, V34, P9; Suliman M, 2007, NEPHROL DIAL TRANSPL, V22, P209, DOI 10.1093/ndt/gfl510; van Hall G, 1999, CLIN SCI, V97, P557, DOI 10.1042/CS19980422; Venta R, 2009, MED SCI SPORT EXER, V41, P1645, DOI 10.1249/MSS.0b013e31819e02f2; Vincent HK, 2006, OBESITY, V14, P1921, DOI 10.1038/oby.2006.224; Vincent Kevin R, 2003, Prev Cardiol, V6, P197, DOI 10.1111/j.1520-037X.2003.01723.x; Virtanen JK, 2005, J INTERN MED, V257, P255, DOI 10.1111/j.1365-2796.2005.01450.x; Wright M, 1998, J SPORT MED PHYS FIT, V38, P262; Zinellu A, 2007, SCAND J MED SCI SPOR, V17, P452, DOI 10.1111/j.1600-0838.2006.00542.x	68	36	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151653	10.1371/journal.pone.0151653	http://dx.doi.org/10.1371/journal.pone.0151653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986570	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300104
J	O'Brien-Simpson, NM; Pantarat, N; Attard, TJ; Walsh, KA; Reynolds, EC				O'Brien-Simpson, Neil M.; Pantarat, Namfon; Attard, Troy J.; Walsh, Katrina A.; Reynolds, Eric C.			A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PEPTIDES; SUSCEPTIBILITY; METHICILLIN; MECHANISM; GROWTH; TIME; MRSA	We describe a microbial flow cytometry method that quantifies within 3 hours antimicrobial peptide (AMP) activity, termed Minimum Membrane Disruptive Concentration (MDC). Increasing peptide concentration positively correlates with the extent of bacterial membrane disruption and the calculated MDC is equivalent to its MBC. The activity of AMPs representing three different membranolytic modes of action could be determined for a range of Gram positive and negative bacteria, including the ESKAPE pathogens, E. coli and MRSA. By using the MDC50 concentration of the parent AMP, the method provides high-throughput, quantitative screening of AMP analogues. A unique feature of the MDC assay is that it directly measures peptide/bacteria interactions and lysed cell numbers rather than bacteria survival as with MIC and MBC assays. With the threat of multi-drug resistant bacteria, this high-throughput MDC assay has the potential to aid in the development of novel antimicrobials that target bacteria with improved efficacy.	[O'Brien-Simpson, Neil M.; Pantarat, Namfon; Attard, Troy J.; Walsh, Katrina A.; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu	O'Brien-Simpson, Neil/B-2901-2009	O'Brien-Simpson, Neil/0000-0001-8462-5603; FCCN, Bogus/0000-0001-6282-8004; Walsh, Katrina/0000-0002-0927-2008	Australian Government, Department of Industry, Innovation and Science; Australian National Health and Medical Research Council Project [1008106]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National Health and Medical Research Council Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Government, Department of Industry, Innovation and Science and the Australian National Health and Medical Research Council Project (Grant 1008106).	Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Bartlett KH, 2004, INT J ANTIMICROB AG, V23, P606, DOI 10.1016/j.ijantimicag.2004.02.018; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Butler T, 2001, J ANTIMICROB CHEMOTH, V48, P903, DOI 10.1093/jac/48.6.903; Casey JT, 2004, J MICROBIOL METH, V58, P327, DOI 10.1016/j.mimet.2004.04.017; CDC, 2000, MMWR-MORBID MORTAL W, V49, P149; Chia CSB, 2011, BIOPOLYMERS, V96, P147, DOI 10.1002/bip.21438; Coombs G, 2007, ANTIMICROBIALS 2007; Fernandez DI, 2009, BBA-BIOMEMBRANES, V1788, P1630, DOI 10.1016/j.bbamem.2008.10.007; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Freire JM, 2015, BBA-BIOMEMBRANES, V1848, P554, DOI 10.1016/j.bbamem.2014.11.001; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Huang TH, 2015, ANAL CHEM, V87, P1941, DOI 10.1021/ac504241x; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kollef MH, 2006, CURR OPIN INFECT DIS, V19, P161, DOI 10.1097/01.qco.0000216627.13445.e2; Kredics L, 2013, CHEM BIODIVERS, V10, P744, DOI 10.1002/cbdv.201200390; Kusuma CM, 2005, ANTIMICROB AGENTS CH, V49, P3256, DOI 10.1128/AAC.49.8.3256-3263.2005; Lambert RJW, 2000, J APPL MICROBIOL, V88, P784, DOI 10.1046/j.1365-2672.2000.01017.x; Lee H, 2015, BBA-BIOMEMBRANES, V1848, P634, DOI 10.1016/j.bbamem.2014.11.016; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lozano-Chiu M, 1999, J CLIN MICROBIOL, V37, P2755, DOI 10.1128/JCM.37.9.2755-2759.1999; Maisetta G, 2013, FEBS J, V280, P2842, DOI 10.1111/febs.12288; Matsuzaki K., 2008, BIOCHIM BIOPHYS ACTA, V8, P8; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Motyl M, 2005, CURR PROTOC PHARM; Ohkushi D, 2013, J INFECT CHEMOTHER, V19, P871, DOI 10.1007/s10156-013-0584-y; Pan JJ, 2009, J MEMBRANE BIOL, V231, P11, DOI 10.1007/s00232-009-9199-8; Raventos D, 2005, COMB CHEM HIGH T SCR, V8, P219, DOI 10.2174/1386207053764549; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; ROZGONYI F, 1990, ACTA MICROBIOL HUNG, V37, P179; Sani MA, 2013, ANTIMICROB AGENTS CH, V57, P3593, DOI 10.1128/AAC.00195-13; Tieleman DP, 1999, BIOPHYS J, V76, P1757, DOI 10.1016/S0006-3495(99)77337-6; Tiwari V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00512; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Wayne PA., 2009, M07A7 CLSI; World Health Organization, 2014, ANT RES GLOB REP SUR; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021	38	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151694	10.1371/journal.pone.0151694	http://dx.doi.org/10.1371/journal.pone.0151694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986223	Green Published, gold			2022-12-27	WOS:000372580300114
J	Shang, FQ; Zhang, J; Li, Z; Zhang, J; Yin, YJ; Wang, YQ; Marin, TL; Gongol, B; Xiao, H; Zhang, YY; Chen, Z; Shyy, JYJ; Lei, T				Shang, Fenqing; Zhang, Jiao; Li, Zhao; Zhang, Jin; Yin, Yanjun; Wang, Yaqiong; Marin, Traci L.; Gongol, Brendan; Xiao, Han; Zhang, You-yi; Chen, Zhen; Shyy, John Y-J; Lei, Ting			Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ANGIOTENSIN RECEPTOR ANTAGONIST; IMPROVES ENDOTHELIAL FUNCTION; POLY(ADP-RIBOSE) POLYMERASE; ESSENTIAL-HYPERTENSION; OXIDATIVE STRESS; CELL-DEATH; INHIBITION; DYSFUNCTION; EXPRESSION	Hyperglycemia and hypertension impair endothelial function in part through oxidative stress-activated poly (ADP-ribose) polymerase 1 (PARP1). Biguanides and angiotensin II receptor blockers (ARBs) such as metformin and telmisartan have a vascular protective effect. We used cultured vascular endothelial cells (ECs), diabetic and hypertensive rodent models, and AMPKa2-knockout mice to investigate whether metformin and telmisartan have a beneficial effect on the endothelium via AMP-activated protein kinase (AMPK) phosphorylation of PARP1 and thus inhibition of PARP1 activity. The results showed that metformin and telmisartan, but not glipizide and metoprolol, activated AMPK, which phosphorylated PARP1 Ser-177 in cultured ECs and the vascular wall of rodent models. Experiments using phosphorylated/de-phosphorylated PARP1 mutants show that AMPK phosphorylation of PARP1 leads to decreased PARP1 activity and attenuated protein poly (ADP-ribosyl)ation (PARylation), but increased endothelial nitric oxide synthase (eNOS) activity and silent mating type information regulation 2 homolog 1 (SIRT1) expression. Taken together, the data presented here suggest biguanides and ARBs have a beneficial effect on the vasculature by the cascade of AMPK phosphorylation of PARP1 to inhibit PARP1 activity and protein PARylation in ECs, thereby mitigating endothelial dysfunction.	[Shang, Fenqing; Zhang, Jiao; Li, Zhao; Zhang, Jin; Yin, Yanjun; Wang, Yaqiong; Shyy, John Y-J; Lei, Ting] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710049, Peoples R China; [Zhang, Jiao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiol, Xian 710049, Peoples R China; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Allied Hlth, Dept Cardiopulm Sci, Loma Linda, CA 92350 USA; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Allied Hlth, Dept Anat, Loma Linda, CA 92350 USA; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Med, Dept Cardiopulm Sci, Loma Linda, CA USA; [Marin, Traci L.; Gongol, Brendan] Loma Linda Univ, Sch Med, Dept Anat, Loma Linda, CA USA; [Xiao, Han; Zhang, You-yi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing 100871, Peoples R China; [Chen, Zhen] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Lei, Ting] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Pathol, Sch Basic Med Sci, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University; Peking University; University of California System; University of California San Diego; Xi'an Jiaotong University	Lei, T (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Cardiovasc Res Ctr, Xian 710049, Peoples R China.; Lei, T (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Pathol, Sch Basic Med Sci, Xian 710049, Peoples R China.	leiting@mail.xjtu.edu.cn	Xiao, Han/T-5032-2019	Bouman-Chen, Zhen/0000-0002-3291-1090	NSFC [81270349, 81300067]; US National Institutes of Health [HL89940, HL108735, HL122368]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089940, R01HL108735, R00HL122368, K99HL122368] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NSFC 81270349, NSFC 81300067, US National Institutes of Health grants HL89940, HL108735, and US National Institutes of Health grant HL122368.	Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; Andreone TL, 2003, J IMMUNOL, V170, P2113, DOI 10.4049/jimmunol.170.4.2113; Asmar R, 2002, J RENIN-ANGIO-ALDO S, V3, P176, DOI 10.3317/jraas.2002.038; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bellien J, 2007, CLIN SCI, V112, P393, DOI 10.1042/CS20060236; Benndorf RA, 2007, J CARDIOVASC PHARM, V50, P367, DOI 10.1097/FJC.0b013e31811dfbe7; Boyle JG, 2011, DIABETOLOGIA, V54, P1799, DOI 10.1007/s00125-011-2126-4; Cheang WS, 2014, ARTERIOSCL THROM VAS, V34, P830, DOI 10.1161/ATVBAHA.113.301938; Choi SK, 2012, HYPERTENSION, V59, P1060, DOI 10.1161/HYPERTENSIONAHA.111.190140; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; De Acular LGK, 2006, DIABETES CARE, V29, P1083, DOI 10.2337/dc05-2146; Deji N, 2012, BIOCHEM BIOPH RES CO, V418, P559, DOI 10.1016/j.bbrc.2012.01.070; Diamanti-Kandarakis E, 2012, NAT REV ENDOCRINOL, V8, P328, DOI 10.1038/nrendo.2012.69; Dorenkamp M, 2005, EUR J PHARMACOL, V520, P179, DOI 10.1016/j.ejphar.2005.07.020; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Gongol B, 2013, P NATL ACAD SCI USA, V110, P3161, DOI 10.1073/pnas.1222051110; Hans CP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007430; Higashi Y, 2000, J AM COLL CARDIOL, V35, P284, DOI 10.1016/S0735-1097(99)00561-6; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hong J, 2013, DIABETES CARE, V36, P1304, DOI 10.2337/dc12-0719; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kishi T, 2012, J HYPERTENS, V30, P1646, DOI 10.1097/HJH.0b013e328355860e; Libby P, 2003, DIABETES METAB, V29, pS117, DOI 10.1016/S1262-3636(03)72796-7; Mather KJ, 2001, J AM COLL CARDIOL, V37, P1344, DOI 10.1016/S0735-1097(01)01129-9; Mathews MT, 2008, ARTERIOSCL THROM VAS, V28, P711, DOI 10.1161/ATVBAHA.107.156406; Matsumura T, 2011, ARTERIOSCL THROM VAS, V31, P1268, DOI 10.1161/ATVBAHA.110.222067; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Paradisi G, 2001, CIRCULATION, V103, P1410, DOI 10.1161/01.CIR.103.10.1410; Qin WD, 2013, BBA-MOL CELL RES, V1833, P59, DOI 10.1016/j.bbamcr.2012.10.013; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Romualdi D, 2008, HUM REPROD, V23, P2127, DOI 10.1093/humrep/den230; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Satoh M, 2010, HYPERTENS RES, V33, P135, DOI 10.1038/hr.2009.190; Scalera F, 2008, HYPERTENSION, V51, P696, DOI 10.1161/HYPERTENSIONAHA.107.104570; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Schiffrin EL, 2002, J HYPERTENS, V20, P71, DOI 10.1097/00004872-200201000-00011; Sharma V, 2008, AM J PHYSIOL-HEART C, V294, pH1609, DOI 10.1152/ajpheart.00949.2007; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; von Lukowicz T, 2008, CARDIOVASC RES, V78, P158, DOI 10.1093/cvr/cvm110; Yuen CY, 2011, CARDIOVASC RES, V90, P122, DOI 10.1093/cvr/cvq392; Zhang S, 2007, CELL DEATH DIFFER, V14, P1001, DOI 10.1038/sj.cdd.4402088	49	33	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151845	10.1371/journal.pone.0151845	http://dx.doi.org/10.1371/journal.pone.0151845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986624	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300140
J	Takahashi, R; Mabuchi, S; Kawano, M; Sasano, T; Matsumoto, Y; Kuroda, H; Kozasa, K; Hashimoto, K; Sawada, K; Kimura, T				Takahashi, Ryoko; Mabuchi, Seiji; Kawano, Mahiru; Sasano, Tomoyuki; Matsumoto, Yuri; Kuroda, Hiromasa; Kozasa, Katsumi; Hashimoto, Kae; Sawada, Kenjiro; Kimura, Tadashi			Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary	PLOS ONE			English	Article							IRINOTECAN HYDROCHLORIDE CPT-11; NUCLEOTIDE-EXCISION-REPAIR; PHASE-I; THERAPEUTIC TARGET; SOLID TUMORS; CANCER; TRABECTEDIN; CISPLATIN; RESISTANT; TOPOTECAN	Objective The objective of this study was to evaluate the antitumor effects of lurbinectedin as a single agent or in combination with existing anticancer agents for clear cell carcinoma (CCC) of the ovary, which is regarded as an aggressive, chemoresistant, histological subtype. Methods Using human ovarian CCC cell lines, the antitumor effects of lurbinectedin, SN-38, doxorubicin, cisplatin, and paclitaxel as single agents were assessed using the MTS assay. Then, the antitumor effects of combination therapies involving lurbinectedin and 1 of the other 4 agents were evaluated using isobologram analysis to examine whether these combinations displayed synergistic effects. The antitumor activity of each treatment was also examined using cisplatin-resistant and paclitaxel-resistant CCC sublines. Finally, we determined the effects of mTORC1 inhibition on the antitumor activity of lurbinectedin-based chemotherapy. Results Lurbinectedin exhibited significant antitumor activity toward chemosensitive and chemoresistant CCC cells in vitro. An examination of mouse CCC cell xenografts revealed that lurbinectedin significantly inhibits tumor growth. Among the tested combinations, lurbinectedin plus SN-38 resulted in a significant synergistic effect. This combination also had strong synergistic effects on both the cisplatin-resistant and paclitaxel-resistant CCC cell lines. Everolimus significantly enhanced the antitumor activity of lurbinectedin-based chemotherapies. Conclusions Lurbinectedin, a new agent that targets active transcription, exhibits antitumor activity in CCC when used as a single agent and has synergistic antitumor effects when combined with irinotecan. Our results indicate that lurbinectedin is a promising agent for treating ovarian CCC, both as a first-line treatment and as a salvage treatment for recurrent lesions that develop after platinum-based or paclitaxel treatment.	[Takahashi, Ryoko; Mabuchi, Seiji; Kawano, Mahiru; Sasano, Tomoyuki; Matsumoto, Yuri; Kuroda, Hiromasa; Kozasa, Katsumi; Hashimoto, Kae; Sawada, Kenjiro; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University	Mabuchi, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	smabuchi@gyne.med.osaka-u.ac.jp	Mabuchi, Seiji/AAX-1986-2020	Sasano, Tomoyuki/0000-0003-3754-475X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23592446]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-aid for General Scientific Research no. 23592446 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamias A, 2010, CANCER-AM CANCER SOC, V116, P1462, DOI 10.1002/cncr.24915; Carter NJ, 2007, DRUGS, V67, P2257, DOI 10.2165/00003495-200767150-00009; Crotzer DR, 2007, GYNECOL ONCOL, V105, P404, DOI 10.1016/j.ygyno.2006.12.024; Elez ME, 2014, CLIN CANCER RES, V20, P2205, DOI 10.1158/1078-0432.CCR-13-1880; Erba E, 2000, BRIT J CANCER, V82, P1732; Hisamatsu T, 2013, MOL CANCER THER, V12, P1367, DOI 10.1158/1535-7163.MCT-12-1185; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Itamochi H, 2002, JPN J CANCER RES, V93, P723, DOI 10.1111/j.1349-7006.2002.tb01312.x; Kawano M, 2014, INT J GYNECOL CANCER, V24, P829, DOI 10.1097/IGC.0000000000000143; Leal JFM, 2010, BRIT J PHARMACOL, V161, P1099, DOI 10.1111/j.1476-5381.2010.00945.x; Mabuchi S, 2011, CLIN CANCER RES, V17, P4462, DOI 10.1158/1078-0432.CCR-10-2987; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Mathijssen RHJ, 2002, CURR CANCER DRUG TAR, V2, P103, DOI 10.2174/1568009023333890; Molina JR, 2008, CLIN CANCER RES, V14, P7900, DOI 10.1158/1078-0432.CCR-08-0415; Monk BJ, 2010, J CLIN ONCOL, V28, P3107, DOI 10.1200/JCO.2009.25.4037; NIIMI S, 1992, CANCER RES, V52, P328; Nozawa S, 1988, Hum Cell, V1, P426; NOZAWA S, 1991, JPN J CANCER RES, V82, P854, DOI 10.1111/j.1349-7006.1991.tb02713.x; Okamoto A, 2014, 2014 ASCO ANN M J S, V32, p5s; Palanisamy S., 2015, EXPERT OPIN DRUG DEL, V27, P1; Pitot HC, 2000, CLIN CANCER RES, V6, P2236; Poveda A, 2014, J CLIN ONCOL, V32, p5s; Romano M, 2013, INT J CANCER, V133, P2024, DOI 10.1002/ijc.28213; Sasano T, 2015, MOL CANCER RES, V13, P795, DOI 10.1158/1541-7786.MCR-14-0314; Soares DG, 2011, MOL CANCER THER, V10, P1481, DOI 10.1158/1535-7163.MCT-11-0252; Sugiyama T, 1998, CANCER LETT, V128, P211, DOI 10.1016/S0304-3835(98)00065-2; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Taamma A, 2001, J CLIN ONCOL, V19, P1256, DOI 10.1200/JCO.2001.19.5.1256; Takakura S, 2007, INT SURG, V92, P202; Takano M, 2015, 2015 ASCO ANN M J S, V33; Takebayashi Y, 2001, NAT MED, V7, P961, DOI 10.1038/91008; Tomioka Y., 1998, J KURUME MED ASS, V61, P323; Vidal A, 2012, CLIN CANCER RES, V18, P5399, DOI 10.1158/1078-0432.CCR-12-1513; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; Zhang N, 2013, INT J ONCOL, V42, P2053, DOI 10.3892/ijo.2013.1906	35	20	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151050	10.1371/journal.pone.0151050	http://dx.doi.org/10.1371/journal.pone.0151050			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986199	gold, Green Published			2022-12-27	WOS:000372580300042
J	Terragni, R; Morselli-Labate, AM; Vignoli, M; Bottero, E; Brunetti, B; Saunders, JH				Terragni, Rossella; Morselli-Labate, Antonio M.; Vignoli, Massimo; Bottero, Enrico; Brunetti, Barbara; Saunders, Jimmy H.			Is Serum Total LDH Evaluation Able to Differentiate between Alimentary Lymphoma and Inflammatory Bowel Disease in a Real World Clinical Setting?	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE ACTIVITY; GASTROINTESTINAL INFLAMMATION; MUSCULARIS PROPRIA; CELL LYMPHOMA; FELINE; CLASSIFICATION; CATS; DIAGNOSIS; BIOPSY; DOGS	Context An increase in enzyme lactate dehydrogenase (LDH) in serum is a negative prognostic factor for survival in cats affected by lymphoma. Measuring LDH at the time of diagnosis has been studied for differentiating neoplastic disease from non-neoplastic disease in dogs. Inflammatory bowel disease (IBD) and alimentary lymphoma are common diseases in cats. Objective The aim of this study was to determine whether elevation of total LDH occurred in cats with alimentary lymphoma and non-neoplastic gastrointestinal disease, such as IBD, and to evaluate whether this enzyme is useful in supporting the differential diagnosis of these specific diseases. Materials and Methods A prospective non-randomized controlled study was carried-out in a real world setting of three Italian private veterinary clinics. Seventy-one client-owned cats with a history of chronic gastrointestinal symptoms were enrolled; 33 cats were histologically diagnosed as having alimentary lymphoma and 38 cats as having IBD. Serum samples of total LDH analysis were measured. Results Gender (P = 0.016) and age (P = 0.046) were found to be significant factors influencing the differentiation of serum total LDH between cats with alimentary lymphoma and those with IBD. Despite low diagnostic accuracy in the overall population (63%), a cut-off value of serum total LDH ranging from 0.85- to 1.04-times the upper reference limit showed good capability (accuracy >80%) of differentiating these two conditions in neutered males and cats younger than 8 years of age (AUC: 0.805, 0.833; sensitivities: 76.9%, 83.3%; specificities: 80.0%, 76.5%; PPV: 76.9%, 55.6%; NPV: 80.0%, 92.9%; respectively). Conclusions Although our study showed that gender and age are significant factors in differentiating serum total LDH between cats with alimentary lymphoma and those with IBD, this test had poor diagnostic accuracy in differentiating between these two conditions in the overall population.	[Terragni, Rossella] Petcare Vet Assoc, Marzabotto, BO, Italy; [Morselli-Labate, Antonio M.] Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Bologna, Italy; [Brunetti, Barbara] Univ Bologna, Alma Mater Studiorum, Dept Vet Med Sci, Bologna, Italy; [Vignoli, Massimo] Univ Teramo, Fac Vet Med, Piano Daccio, TE, Italy; [Bottero, Enrico] Argentina Polyclin, Arma Di Taggia, IM, Italy; [Saunders, Jimmy H.] Univ Ghent, Fac Vet Med, Med Imaging, B-9000 Ghent, Belgium	University of Bologna; University of Bologna; University of Teramo; Ghent University	Terragni, R (corresponding author), Petcare Vet Assoc, Marzabotto, BO, Italy.	terragni.rossella@gmail.com	Vignoli, Massimo/R-5134-2019; Brunetti, Barbara/AAK-1860-2021	Vignoli, Massimo/0000-0002-4981-4051; BRUNETTI, BARBARA/0000-0002-2694-905X				Augoff K, 2015, CANCER LETT, V358, P1, DOI 10.1016/j.canlet.2014.12.035; Barrs V, 2012, J FELINE MED SURG, V14, P182, DOI 10.1177/1098612X12439265; Bilir C, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0497-y; Chino J, 2013, J VET MED SCI, V75, P701, DOI 10.1292/jvms.12-0246; Daniaux LA, 2014, J FELINE MED SURG, V16, P89, DOI 10.1177/1098612X13498596; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Grover S, 2005, COMP CONT EDUC PRACT, V27, P741; Gustafson TL, 2014, J AM ANIM HOSP ASSOC, V50, P46, DOI 10.5326/JAAHA-MS-5989; Hadden AG, 2008, J VET INTERN MED, V22, P153, DOI 10.1111/j.1939-1676.2007.0031.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Guzman-de la Garza FJ, 2013, CLINICS, V68, P1034, DOI 10.6061/clinics/2013(07)23; Jergens AE, 2014, VET PATHOL, V51, P946, DOI 10.1177/0300985813511123; Jergens AE, 2012, J FELINE MED SURG, V14, P445, DOI 10.1177/1098612X12451548; Jung SH, 2015, ACTA HAEMATOL-BASEL, V133, P10, DOI 10.1159/000360068; Marconato L, 2009, VET COMP ONCOL, V7, P236, DOI 10.1111/j.1476-5829.2009.00196.x; Marconato L, 2010, JAVMA-J AM VET MED A, V236, P969, DOI 10.2460/javma.236.9.969; Patel S, 2015, J CANCER RES THER, V11, P119, DOI 10.4103/0973-1482.138193; PEZZILLI R, 1995, DIGEST DIS SCI, V40, P2341, DOI 10.1007/BF02063235; Rissetto K, 2011, J AM ANIM HOSP ASSOC, V47, P28, DOI 10.5326/JAAHA-MS-5554; Russell KJ, 2012, J FELINE MED SURG, V14, P910, DOI 10.1177/1098612X12454861; Santagostino SF, 2015, VET PATHOL, V52, P250, DOI 10.1177/0300985814537529; Scott KD, 2011, J VET INTERN MED, V25, P1253, DOI 10.1111/j.1939-1676.2011.00831.x; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Washabau RJ, 2010, J VET INTERN MED, V24, P10, DOI 10.1111/j.1939-1676.2009.0443.x; Washizu T, 2002, VET RES COMMUN, V26, P341, DOI 10.1023/A:1016278409138; Wu XZ, 2010, WORLD J GASTROENTERO, V16, P4084, DOI 10.3748/wjg.v16.i32.4084; Zhao Z, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/140913; Zwingenberger AL, 2010, J VET INTERN MED, V24, P289, DOI 10.1111/j.1939-1676.2009.0457.x	28	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151641	10.1371/journal.pone.0151641	http://dx.doi.org/10.1371/journal.pone.0151641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986208	Green Published, gold			2022-12-27	WOS:000372580300102
J	Wray, CM; Bishop, SR				Wray, Christopher M.; Bishop, Steven R.			A Financial Market Model Incorporating Herd Behaviour	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; ASSET RETURNS; CRASHES; ECONOPHYSICS; INFORMATION	Herd behaviour in financial markets is a recurring phenomenon that exacerbates asset price volatility, and is considered a possible contributor to market fragility. While numerous studies investigate herd behaviour in financial markets, it is often considered without reference to the pricing of financial instruments or other market dynamics. Here, a trader interaction model based upon informational cascades in the presence of information thresholds is used to construct a new model of asset price returns that allows for both quiescent and herd-like regimes. Agent interaction is modelled using a stochastic pulse-coupled network, parametrised by information thresholds and a network coupling probability. Agents may possess either one or two information thresholds that, in each case, determine the number of distinct states an agent may occupy before trading takes place. In the case where agents possess two thresholds (labelled as the finite state-space model, corresponding to agents' accumulating information over a bounded state-space), and where coupling strength is maximal, an asymptotic expression for the cascade-size probability is derived and shown to follow a power law when a critical value of network coupling probability is attained. For a range of model parameters, a mixture of negative binomial distributions is used to approximate the cascade-size distribution. This approximation is subsequently used to express the volatility of model price returns in terms of the model parameter which controls the network coupling probability. In the case where agents possess a single pulse-coupling threshold (labelled as the semi-infinite state-space model corresponding to agents' accumulating information over an unbounded state-space), numerical evidence is presented that demonstrates volatility clustering and long-memory patterns in the volatility of asset returns. Finally, output from the model is compared to both the distribution of historical stock returns and the market price of an equity index option.	[Wray, Christopher M.; Bishop, Steven R.] UCL, Dept Math, London, England	University of London; University College London	Wray, CM (corresponding author), UCL, Dept Math, London, England.	Chris.Wray@ucl.ac.uk			Engineering and Physical Sciences Research Council [EP/K039830/1]; European Commission [641191]; EPSRC [EP/K039830/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council grant number EP/K039830/1 (Christopher M. Wray). This work was also supported by the European Commission grant number 641191 (CIMPLEX) (Steven R. Bishop). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano S., 2007, LONG MEMORY EC, P345; Almgren R., 2003, APPL MATH FINANCE, V10, P1, DOI [10.1080/135048602100056, DOI 10.1080/135048602100056]; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Bacry E, 2008, J ECON DYN CONTROL, V32, P156, DOI 10.1016/j.jedc.2007.01.024; Bacry E, 2001, PHYSICA A, V299, P84, DOI 10.1016/S0378-4371(01)00284-9; Bacry E, 2012, QUANT FINANC, V13, P1; Baillie RT, 1996, J ECONOMETRICS, V73, P5, DOI 10.1016/0304-4076(95)01732-1; BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Barndorff-Nielsen OE, 2001, J R STAT SOC B, V63, P167, DOI 10.1111/1467-9868.00282; Bikhchandani S, 2001, IMF STAFF PAPERS, V47, P279; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Bouchaud JP, 2013, J STAT PHYS, V151, P567, DOI 10.1007/s10955-012-0687-3; Bouchaud JP, 2002, PHYSICA A, V313, P238, DOI 10.1016/S0378-4371(02)01039-7; BOUCHAUD JP, 1994, J PHYS I, V4, P863; Bouchaud JP., 2009, THEORY FINANCIAL RIS; Brogaard J, 2014, REV FINANC STUD, V27, P2267, DOI 10.1093/rfs/hhu032; Calvet L, 2002, REV ECON STAT, V84, P381, DOI 10.1162/003465302320259420; Cella C, 2013, REV FINANC STUD, V26, P1607, DOI 10.1093/rfs/hht023; Chakraborti A, 2011, QUANT FINANC, V11, P1013, DOI 10.1080/14697688.2010.539249; Chicheportiche R, 2014, PHYSICA A, V410, P174, DOI 10.1016/j.physa.2014.05.007; Cincotti S, 2012, EUR PHYS J-SPEC TOP, V214, P361, DOI 10.1140/epjst/e2012-01699-6; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cont R, 2000, MACROECON DYN, V4, P170; Cont R., 2007, LONG MEMORY EC, P289, DOI [10.1007/978-3-540-34625-8_10, DOI 10.1007/978-3-540-34625-8_10]; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Corral A, 2012, CRITICALITY SELF ORG; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Devenow A, 1996, EUR ECON REV, V40, P603, DOI 10.1016/0014-2921(95)00073-9; Di Matteo T, 2007, QUANT FINANC, V7, P21, DOI 10.1080/14697680600969727; Ding ZX, 1996, J ECONOMETRICS, V73, P185, DOI 10.1016/0304-4076(95)01737-2; Drmota M., 2009, RANDOM TREES; Easley D, 2011, J PORTFOLIO MANAGE, V37, P118, DOI 10.3905/jpm.2011.37.2.118; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; Ellis CJ, 2011, ECON J, V121, P763, DOI 10.1111/j.1468-0297.2010.02401.x; Feller W., 1968, INTRO PROBABILITY TH, V1; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gontis V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102201; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Grimmett G. R., 1999, PERCOLATION; HILTON P, 1991, MATH INTELL, V13, P64, DOI 10.1007/BF03024089; Hull J. C., 2011, OPTIONS FUTURES OTHE; Kani I., 1994, RISK, V7, P32; Khandani A., 2007, J INVESTMENT MANAGEM, V5, P5; Kim Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036115; King MR, 2009, J FINANC STABIL, V5, P283, DOI 10.1016/j.jfs.2009.02.002; Knuth DE, 1998, SORTING SEARCHING, V3; Kononovicius A, 2014, PHYSICA A, V405, P80, DOI 10.1016/j.physa.2014.03.003; LeBaron BD, 2001, QUANT FINANCE, V1, P621, DOI DOI 10.1088/1469-7688/1/6/304; Levy M, 2008, J ECON DYN CONTROL, V32, P137, DOI 10.1016/j.jedc.2007.01.023; Levy P, 1925, CALCUL PROBABILITES; Lillo F, 2003, NATURE, V421, P129, DOI 10.1038/421129a; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Menkhoff L, 2010, J BANK FINANC, V34, P2573, DOI 10.1016/j.jbankfin.2010.04.014; Pan J, 2002, J FINANC ECON, V63, P3, DOI 10.1016/S0304-405X(01)00088-5; Park A, 2012, EUR ECON REV, V56, P1020, DOI 10.1016/j.euroecorev.2012.04.006; Petersen AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036114; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Redner S, 2001, GUIDE 1 PASSAGE PROC; Rennison J, 2015, FINANCIAL TIMES; Sornette D, 2011, COMPUTER TRADING CRA; Sornette D, 2006, PHYSICA A, V370, P704, DOI 10.1016/j.physa.2006.02.022; Sprenger TO, 2014, EUR FINANC MANAG, V20, P926, DOI 10.1111/j.1468-036X.2013.12007.x; Stanley HE, 2002, P NATL ACAD SCI USA, V99, P2561, DOI 10.1073/pnas.022582899; Stanley RP, 2012, CAM ST AD M, V49, P1; Tedeschi G, 2012, J ECON BEHAV ORGAN, V81, P82, DOI 10.1016/j.jebo.2011.09.006; Watson H.W., 1875, J ANTHR I GREAT BRIT, V4, P138, DOI DOI 10.2307/2841222; Williams A, 2015, FINANCIAL TIMES; Wray CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06355; Xue Y, 2012, J BANK FINANC, V36, P760, DOI 10.1016/j.jbankfin.2011.09.008; Yalamova R, 2011, J BEHAV FINANC, V12, P169, DOI 10.1080/15427560.2011.602484; Zhang X, 2011, PREDICTING STOCK MAR	75	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151790	10.1371/journal.pone.0151790	http://dx.doi.org/10.1371/journal.pone.0151790			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007236	Green Published, Green Submitted, gold			2022-12-27	WOS:000372701200064
J	Asare, EO; Tompkins, AM; Bomblies, A				Asare, Ernest Ohene; Tompkins, Adrian Mark; Bomblies, Arne			A Regional Model for Malaria Vector Developmental Habitats Evaluated Using Explicit, Pond-Resolving Surface Hydrology Simulations	PLOS ONE			English	Article							ANOPHELES-GAMBIAE-S.S.; SPATIAL-DISTRIBUTION; MOSQUITO LARVAE; ENVIRONMENTAL-FACTORS; CRUST FORMATION; SANDY SOILS; EL-NINO; TRANSMISSION; CLIMATE; DYNAMICS	Dynamical malaria models can relate precipitation to the availability of vector breeding sites using simple models of surface hydrology. Here, a revised scheme is developed for the VECTRI malaria model, which is evaluated alongside the default scheme using a two year simulation by HYDREMATS, a 10 metre resolution, village-scale model that explicitly simulates individual ponds. Despite the simplicity of the two VECTRI surface hydrology parametrization schemes, they can reproduce the sub-seasonal evolution of fractional water coverage. Calibration of the model parameters is required to simulate the mean pond fraction correctly. The default VECTRI model tended to overestimate water fraction in periods subject to light rainfall events and underestimate it during periods of intense rainfall. This systematic error was improved in the revised scheme by including the a parametrization for surface run-off, such that light rainfall below the initial abstraction threshold does not contribute to ponds. After calibration of the pond model, the VECTRI model was able to simulate vector densities that compared well to the detailed agent based model contained in HYDREMATS without further parameter adjustment. Substituting local rain-gauge data with satellite-retrieved precipitation gave a reasonable approximation, raising the prospects for regional malaria simulations even in data sparse regions. However, further improvements could be made if a method can be derived to calibrate the key hydrology parameters of the pond model in each grid cell location, possibly also incorporating slope and soil texture.	[Asare, Ernest Ohene] Kwame Nkrumah Univ Sci & Technol, Dept Phys, Kumasi, Ghana; [Asare, Ernest Ohene; Tompkins, Adrian Mark] Abdus Salam Int Ctr Theoret Phys ICTP, Trieste, Italy; [Bomblies, Arne] Univ Vermont, Sch Engn, 33 Colchester Ave, Burlington, VT 05405 USA	Kwame Nkrumah University Science & Technology; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Vermont	Asare, EO (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Phys, Kumasi, Ghana.; Asare, EO (corresponding author), Abdus Salam Int Ctr Theoret Phys ICTP, Trieste, Italy.	eoheneasare@gmail.com	Tompkins, Adrian M/N-6472-2013	Tompkins, Adrian M/0000-0003-0975-6691; Asare, Ernest/0000-0003-4078-8755	Italian government's funds-in-trust programme; ICTP PhD Sandwich Training and Educational Programme (STEP); European Union [266327]; QWeCI (Quantifying Weather and Climate Impacts on health in developing countries) [243964]	Italian government's funds-in-trust programme; ICTP PhD Sandwich Training and Educational Programme (STEP); European Union(European Commission); QWeCI (Quantifying Weather and Climate Impacts on health in developing countries)	EOA was funded by two International Centre of Theoretical Physics (ICTP) programme, namely the Italian government's funds-in-trust programme and the ICTP PhD Sandwich Training and Educational Programme (STEP). The study was also partly funded by two European Union Seventh Framework Programmes projects: HEALTHY FUTURES under the grant agreement number 266327 and QWeCI (Quantifying Weather and Climate Impacts on health in developing countries) under the grant agreement number 243964.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Asare EO, 2015, GEOSPATIAL HLT UNPUB; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bomblies A, 2012, CLIMATIC CHANGE, V112, P673, DOI 10.1007/s10584-011-0230-6; Bomblies A, 2009, ECOHEALTH, V6, P426, DOI 10.1007/s10393-010-0274-5; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Desconnets JC, 1997, J HYDROL, V188, P155; Favreau G, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006785; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Garmendia A, 2010, LIMNETICA, V29, P145; Gianotti RL, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007567; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hayashi M, 2000, J HYDROL, V237, P74, DOI 10.1016/S0022-1694(00)00300-0; Herman A, 1997, INT J REMOTE SENS, V18, P2147, DOI 10.1080/014311697217800; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; HOOGMOED WB, 1984, SOIL TILL RES, V4, P5, DOI 10.1016/0167-1987(84)90013-8; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; IDSO SB, 1981, WATER RESOUR BULL, V17, P46; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Leduc C, 2001, J HYDROL, V243, P43, DOI 10.1016/S0022-1694(00)00403-0; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; LOVE T, 2004, AM MET SOC C APPL CL; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-28; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Martin-Rosales W, 2003, CR GEOSCI, V335, P461, DOI 10.1016/S1631-0713(03)00059-2; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Minakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032725; Minke AG, 2010, WETLANDS, V30, P541, DOI 10.1007/s13157-010-0044-8; Molineaux L, 1980, RES EPIDEMIOLOGY CON; Montosi E, 2012, HYDROL EARTH SYST SC, V16, P2759, DOI 10.5194/hess-16-2759-2012; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; POLLARD D, 1995, GLOBAL PLANET CHANGE, V10, P129, DOI 10.1016/0921-8181(94)00023-7; Ramier D, 2009, J HYDROL, V375, P204, DOI 10.1016/j.jhydrol.2008.12.002; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Shaman J, 2002, EMERG INFECT DIS, V8, P6; Soti V, 2010, HYDROL EARTH SYST SC, V14, P1449, DOI 10.5194/hess-14-1449-2010; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; STROOSNIJDER L, 1984, SOIL TILL RES, V4, P321, DOI 10.1016/0167-1987(84)90032-1; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65; USDA S, 1972, NAT ENG HDB; Yamana TK, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009744	59	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150626	10.1371/journal.pone.0150626	http://dx.doi.org/10.1371/journal.pone.0150626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003834	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400017
J	He, JJ; Ma, J; Elsheikha, HM; Song, HQ; Zhou, DH; Zhu, XQ				He, Jun-Jun; Ma, Jun; Elsheikha, Hany M.; Song, Hui-Qun; Zhou, Dong-Hui; Zhu, Xing-Quan			Proteomic Profiling of Mouse Liver following Acute Toxoplasma gondii Infection	PLOS ONE			English	Article							IFN-GAMMA; MURINE MACROPHAGES; GENE-EXPRESSION; HOST-RESISTANCE; SUPPRESSION; MODULATION; INDUCTION; IMMUNITY; FIBROBLASTS; ACTIVATION	Toxoplasma gondii remains a global public health problem. However, its pathophysiology is still not-completely understood particularly the impact of infection on host liver metabolism. We performed iTRAQ-based proteomic analysis to evaluate early liver protein responses in BALB/c mice following infection with T. gondii PYS strain (genotype ToxoDB#9) infection. Our data revealed modification of protein expression in key metabolic pathways, as indicated by the upregulation of immune response and downregulation of mitochondrial respiratory chain, and the metabolism of fatty acids, lipids and xenobiotics. T. gondii seems to hijack host PPAR signaling pathway to downregulate the metabolism of fatty acids, lipids and energy in the liver. The metabolism of over 400 substances was affected by the downregulation of genes involved in xenobiotic metabolism. The top 10 transcription factors used by upregulated genes were Stat2, Stat1, Irf2, Irf1, Sp2, Egr1, Stat3, Klf4, Elf1 and Gabpa, while the top 10 transcription factors of downregulated genes were Hnf4A, Ewsr1, Fli1, Hnf4g, Nr2f1, Pparg, Rxra, Hnf1A, Foxa1 and Foxo1. These findings indicate global reprogramming of the metabolism of the mouse liver after acute T. gondii infection. Functional characterization of the altered proteins may enhance understanding of the host responses to T. gondii infection and lead to the identification of new therapeutic targets.	[He, Jun-Jun; Ma, Jun; Song, Hui-Qun; Zhou, Dong-Hui; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China; [Ma, Jun] Hunan Agr Univ, Coll Vet Med, Changsha 410128, Hunan, Peoples R China; [Elsheikha, Hany M.] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Hunan Agricultural University; University of Nottingham	Zhou, DH; Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China.	zhoudonghui@caas.cn; xingquanzhu1@hotmail.com	Elsheikha, Hany/G-7573-2011	Elsheikha, Hany/0000-0003-3303-930X	National Natural Science Foundation of China [31230073]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups)	Project support was provided by the National Natural Science Foundation of China (Grant No. 31230073) and the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atmaca HT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-135; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BergCandolfi M, 1996, INT J PARASITOL, V26, P1321, DOI 10.1016/S0020-7519(96)00111-7; BergCandolfi M, 1996, XENOBIOTICA, V26, P381, DOI 10.3109/00498259609046717; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; He J., 2015, 2015 IEEE International Magnetics Conference (INTERMAG), DOI 10.1109/INTMAG.2015.7157342; Iaccheri B, 2008, CLIN THER, V30, P2069, DOI 10.1016/j.clinthera.2008.10.021; Jiang HH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-227; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kyriakides M, 2016, ARCH TOXICOL, P1; Lang C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002483; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Luder CGK, 2001, EUR J IMMUNOL, V31, P1475, DOI 10.1002/1521-4141(200105)31:5&lt;1475::AID-IMMU1475&gt;3.0.CO;2-C; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahmoud ME, 2015, CELL MICROBIOL, V17, P1069, DOI 10.1111/cmi.12423; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Melzer T, 2008, INFECT IMMUN, V76, P4883, DOI 10.1128/IAI.01288-07; Menendez MT, 2015, MBIO, V6, DOI 10.1128/mBio.00462-15; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; PERITI P, 1993, DRUG SAFETY, V9, P346, DOI 10.2165/00002018-199309050-00004; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; SCOTT JP, 1988, MED TOXICOL ADV DRUG, V3, P107, DOI 10.1007/BF03259936; Shapira S, 2002, J INFECT DIS, V185, pS66, DOI 10.1086/338000; Shapira Y, 2012, EXP MOL PATHOL, V93, P386, DOI 10.1016/j.yexmp.2012.09.012; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Stutz A, 2012, IMMUNOBIOLOGY, V217, P28, DOI 10.1016/j.imbio.2011.08.008; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; TIWARI I, 1982, POSTGRAD MED J, V58, P299, DOI 10.1136/pgmj.58.679.299; Tymoshenko S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004261; Ustun S, 2004, WORLD J GASTROENTERO, V10, P452; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WEITBERG AB, 1979, NEW ENGL J MED, V300, P1093, DOI 10.1056/NEJM197905103001907; Wendum D, 2002, J CLIN PATHOL, V55, P637, DOI 10.1136/jcp.55.8.637; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zeng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006787; Zhou CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139635; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z; Zhou DH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-96	57	36	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152022	10.1371/journal.pone.0152022	http://dx.doi.org/10.1371/journal.pone.0152022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003162	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400067
J	Steward, T; Pico-Perez, M; Mata, F; Martinez-Zalacain, I; Cano, M; Contreras-Rodriguez, O; Fernandez-Aranda, F; Yucel, M; Soriano-Mas, C; Verdejo-Garcia, A				Steward, Trevor; Pico-Perez, Maria; Mata, Fernanda; Martinez-Zalacain, Ignacio; Cano, Marta; Contreras-Rodriguez, Oren; Fernandez-Aranda, Fernando; Yucel, Murat; Soriano-Mas, Carles; Verdejo-Garcia, Antonio			Emotion Regulation and Excess Weight: Impaired Affective Processing Characterized by Dysfunctional Insula Activation and Connectivity	PLOS ONE			English	Article							DECISION-MAKING; COGNITIVE REAPPRAISAL; ANTERIOR INSULA; NEGATIVE AFFECT; NEURAL BASES; SUPPRESSION; ADOLESCENTS; OBESITY; FMRI; METAANALYSIS	Emotion-regulation strategies are understood to influence food intake. This study examined the neurophysiological underpinnings of negative emotion processing and emotion regulation in individuals with excess weight compared to normal-weight controls. Fifteen participants with excess-weight (body mass index >25) and sixteen normal-weight controls (body mass index 18-25) performed an emotion-regulation task during functional magnetic resonance imaging. Participants were exposed to 24 negative affective or neutral pictures that they were instructed to Observe (neutral pictures), Maintain (sustain the emotion elicited by negative pictures) or Regulate (down-regulate the emotion provoked by negative pictures through previously trained reappraisal techniques). When instructed to regulate negative emotions by means of cognitive reappraisal, participants with excess weight displayed persistently heightened activation in the right anterior insula. Decreased responsivity was also found in right anterior insula, the orbitofrontal cortex and cerebellum during negative emotion experience in participants with excess weight. Psycho-physiological interaction analyses showed that excess-weight participants had decreased negative functional coupling between the right anterior insula and the right dlPFC, and the bilateral dmPFC during cognitive reappraisal. Our findings support contentions that excess weight is linked to an abnormal pattern of neural activation and connectivity during the experience and regulation of negative emotions, with the insula playing a key role in these alterations. We posit that ineffective regulation of emotional states contributes to the acquisition and preservation of excess weight.	[Steward, Trevor; Pico-Perez, Maria; Martinez-Zalacain, Ignacio; Cano, Marta; Contreras-Rodriguez, Oren; Fernandez-Aranda, Fernando; Soriano-Mas, Carles] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Steward, Trevor; Pico-Perez, Maria; Cano, Marta; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Mata, Fernanda; Yucel, Murat; Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Mata, Fernanda; Yucel, Murat; Verdejo-Garcia, Antonio] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia; [Contreras-Rodriguez, Oren; Soriano-Mas, Carles] Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Barcelona, Spain; [Soriano-Mas, Carles] Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, E-08193 Barcelona, Spain; [Steward, Trevor; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Monash University; Monash University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Soriano-Mas, C (corresponding author), Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain.; Soriano-Mas, C (corresponding author), Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Barcelona, Spain.; Soriano-Mas, C (corresponding author), Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, E-08193 Barcelona, Spain.	csoriano@idibell.cat	Verdejo-Garcia, Antonio/AAV-1147-2021; Yücel, Murat/AAY-8124-2020; Fernandez-Aranda, Fernando/L-9762-2014; Picó-Pérez, Maria/AAE-1174-2020; Yucel, Murat/I-3004-2014; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Soriano-Mas, Carles/E-4028-2019; Steward, Trevor/K-7469-2015	Verdejo-Garcia, Antonio/0000-0001-8874-9339; Yücel, Murat/0000-0002-4705-452X; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Picó-Pérez, Maria/0000-0002-1573-2445; Yucel, Murat/0000-0002-4705-452X; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Soriano-Mas, Carles/0000-0003-4574-6597; Steward, Trevor/0000-0003-3116-8175; Cano, Marta/0000-0003-0675-9483; Martinez-Zalacain, Ignacio/0000-0002-4036-0284	Monash Biomedical Imaging (MBI), Monash University, Melbourne (Australia); Carlos III Health Institute (Spain) [PI13/01958, CIBER-CB06/03/0034]; FEDER funds; Agency of University and Research Funding Management of the Catalan Government (AGAUR) [2014SGR1672]; Carlos III Health Institute [FIS PI14/00290]; FI grant from the AGAUR [2015 FI_B 00839]; National Health and Medical Research Council Research Fellowship [APP1021973]; Spanish Ministry for Education, Culture and Sport [FPU13/02141]; Miguel Servet contract from the Carlos III Health Institute [CP10/00604]; Sara Borrell postdoctoral fellowship from the Carlos III Health Institute [CD14/00246]	Monash Biomedical Imaging (MBI), Monash University, Melbourne (Australia); Carlos III Health Institute (Spain)(Instituto de Salud Carlos III); FEDER funds(European Commission); Agency of University and Research Funding Management of the Catalan Government (AGAUR); Carlos III Health Institute(Instituto de Salud Carlos III); FI grant from the AGAUR; National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry for Education, Culture and Sport(Spanish Government); Miguel Servet contract from the Carlos III Health Institute; Sara Borrell postdoctoral fellowship from the Carlos III Health Institute	This study was supported in part by grants from the Monash Biomedical Imaging (MBI), Monash University, Melbourne (Australia) (MBI Platform Access Grant 2013), Carlos III Health Institute (Spain) (PI13/01958 and CIBER-CB06/03/0034), FEDER funds, and the Agency of University and Research Funding Management of the Catalan Government (AGAUR; 2014SGR1672). TS is supported by grants from the Carlos III Health Institute (FIS PI14/00290 and CIBERobn) and co-funded by FEDER funds -a way to build Europe. CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and CIBER Salud Mental (CIBERsam) are both initiatives of ISCIII. MPP is supported by a FI grant from the AGAUR (2015 FI_B 00839). MY is supported by a National Health and Medical Research Council Research Fellowship (#APP1021973). MC is supported by a grant from the Spanish Ministry for Education, Culture and Sport (FPU13/02141). CSM is funded by a Miguel Servet contract from the Carlos III Health Institute (CP10/00604). OCR is currently funded by a Sara Borrell postdoctoral fellowship (Grant No. CD14/00246) from the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albein-Urios N, 2014, ADDICT BIOL, V19, P415, DOI 10.1111/j.1369-1600.2012.00497.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104; Brett M., 2002, NEUROIMAGE, V16, P497; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Burger KS, 2014, OBESITY, V22, P441, DOI 10.1002/oby.20563; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; de Weijer BA, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-37; Delgado-Rico E, 2013, OBESITY, V21, P1662, DOI 10.1002/oby.20375; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Friedman KE, 2005, OBES RES, V13, P907, DOI 10.1038/oby.2005.105; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hemmingsson E, 2014, OBES REV, V15, P769, DOI 10.1111/obr.12197; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Lang PJ., 2001, INT AFFECTIVE PICTUR; Lavender JM, 2015, EUR EAT DISORD REV, V23, P246, DOI 10.1002/erv.2351; Lawrence EJ, 2014, NEUROIMAGE, V88, P113, DOI 10.1016/j.neuroimage.2013.10.069; Leehr EJ, 2016, EUR EAT DISORD REV, V24, P169, DOI 10.1002/erv.2421; Leehr EJ, 2015, NEUROSCI BIOBEHAV R, V49, P125, DOI 10.1016/j.neubiorev.2014.12.008; Lowe MR, 2006, APPETITE, V47, P83, DOI 10.1016/j.appet.2006.03.160; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mark AL, 2006, CLIN EXP PHARMACOL P, V33, P857, DOI 10.1111/j.1440-1681.2006.04454.x; Mata F, 2015, APPETITE, V93, P24, DOI 10.1016/j.appet.2015.03.024; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Meule A, 2015, EUR EAT DISORD REV, V23, P193, DOI 10.1002/erv.2355; Muller A, 2014, EUR EAT DISORD REV, V22, P260, DOI 10.1002/erv.2294; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Perlman G, 2012, J AFFECT DISORDERS, V29, P997; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Raspopow K, 2013, APPETITE, V62, P143, DOI 10.1016/j.appet.2012.11.031; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Roberts C, 2007, OBESITY, V15, P3045, DOI 10.1038/oby.2007.363; Rudenga KJ, 2013, INT J OBESITY, V37, P309, DOI 10.1038/ijo.2012.39; Siep N, 2012, NEUROIMAGE, V60, P213, DOI 10.1016/j.neuroimage.2011.12.067; Singh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00925; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Svaldi J, 2012, APPETITE, V59, P256, DOI 10.1016/j.appet.2012.04.016; Tchanturia K, 2014, EUR EAT DISORD REV, V22, P200, DOI 10.1002/erv.2287; Vandewalle J, 2014, INT J OBESITY, V38, P525, DOI 10.1038/ijo.2013.233; Verdejo-Garcia A, 2015, HUM BRAIN MAPP, V36, P226, DOI 10.1002/hbm.22625; Vink M, 2014, NEUROIMAGE, V91, P70, DOI 10.1016/j.neuroimage.2014.01.035; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wagner A, 2006, PSYCHIAT RES-NEUROIM, V147, P57, DOI 10.1016/j.pscychresns.2005.11.005; Yokum S, 2013, INT J OBESITY, V37, P1565, DOI 10.1038/ijo.2013.39; Yuan JJ, 2015, SCI CHINA LIFE SCI, V58, P480, DOI 10.1007/s11427-014-4739-6; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	65	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152150	10.1371/journal.pone.0152150	http://dx.doi.org/10.1371/journal.pone.0152150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003840	Green Published, gold			2022-12-27	WOS:000372697400087
J	Souza, FBD; Porfirio, GJM; Andriolo, BNG; de Albuquerque, JV; Trevisani, VFM				do Valle Souza, Francine Bertolais; Martiniano Porfirio, Gustavo Jose; Gomes Andriolo, Brenda Nazare; de Albuquerque, Julia Vajda; Moca Trevisani, Virginia Fernandes			Rituximab Effectiveness and Safety for Treating Primary Sjogren's Syndrome (pSS): Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DOUBLE-BLIND; CLASSIFICATION; IMPROVEMENT; EFFICACY; LYMPHOMA; RISK	Background Primary Sjogren's Syndrome (pSS) is a systemic autoimmune disease that involves the exocrine glands and internal organs. pSS leads to destruction and loss of secretory function due to intense lymphoplasmacytic infiltration. Therapeutic options include mainly symptomatic and supportive measures, and traditional immunosuppressant drugs have shown no effectiveness in randomized trials. Rituximab (RTX) is a chimeric antibody anti-CD20 that leads to B cell depletion by diverse mechanisms. There is evidence that this drug may be effective for treating pSS. The objective of this systematic review was to evaluate Rituximab effectiveness and safety for treating pSS. Methods and Findings We conducted a systematic review of RCTs published until December 2015, with no language restriction. We registered a protocol on Plataforma Brasil (40654814.6.0000.5505) and developed search strategies for the following scientific databases: MEDLINE, EMBASE, CENTRAL and LILACS. We included adults with established pSS diagnosis and considered the use of Rituximab as intervention and the use of other drugs or placebo as control. Four studies met our eligibility criteria: three with low risk of bias and one with uncertain risk of bias. The total number of participants was 276 (145 RTX, 131 placebo). We assessed the risk of bias of each included study and evaluated the following as primary outcomes: lacrimal gland function, salivary gland function, fatigue improvement and adverse events. We found no significant differences between the groups in the Schirmer test at week 24 meta-analysis (MD 3.59, 95% CI -2.89 to 10.07). Only one study evaluated the lissamine green test and reported a statistically significant difference between the groups at week 24 (MD -2.00, 95% CI -3.52 to -0.48). There was a significant difference between the groups regarding salivary flow rate (MD 0.09, 95% CI 0.02 to 0.16) and improvement in fatigue VAS at weeks 6 (RR 3.98, 95% CI 1.61 to 9.82) and week 16 (RR 3.08, 95% CI 1.21 to 7.80). Conclusions According to moderate quality evidence, the treatment with a single RTX course in patients with SSp presents discrete effect for improving lacrimal gland function. Low-quality evidence indicates the potential of this drug for improving salivary flow. According to low quality evidence, no differences were observed in the evaluation after 24 weeks regarding fatigue reduction (30% VAS), serious adverse events occurrence, quality of life improvement and disease activity. With a very low level of evidence, there was no improvement in oral dryness VAS evaluation.	[do Valle Souza, Francine Bertolais; Martiniano Porfirio, Gustavo Jose; Gomes Andriolo, Brenda Nazare; de Albuquerque, Julia Vajda; Moca Trevisani, Virginia Fernandes] Sao Paulo Fed Univ UNIFESP, Dept Evidence Based Med, Sao Paulo, Brazil; [Moca Trevisani, Virginia Fernandes] Santo Amaro Univ UNISA, Dept Rheumatol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Santo Amaro (UNISA)	Souza, FBD (corresponding author), Sao Paulo Fed Univ UNIFESP, Dept Evidence Based Med, Sao Paulo, Brazil.	francinebertolais@usp.br	Andriolo, Brenda/AAP-5738-2021; Porfírio, Gustavo/A-2763-2013; trevisani, Virginia Fernandes Moça/I-1137-2013; Trevisani, Virginia/AAI-5225-2020	Porfírio, Gustavo/0000-0003-0650-902X; trevisani, Virginia Fernandes Moça/0000-0002-7180-6285; Trevisani, Virginia/0000-0002-7180-6285; Vajda de Albuquerque, Julia/0000-0003-1385-8658				Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Alamanos Y, 2006, RHEUMATOLOGY, V45, P187, DOI 10.1093/rheumatology/kei107; BOWMAN S, 2015, ARTHRITIS RHEUMA S10, V67; Carubbi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4359; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2007, ARTHRIT RHEUM-ARTHR, V57, P310, DOI 10.1002/art.22536; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; Drosos A A, 1986, Scand J Rheumatol Suppl, V61, P246; Gottenberg JE, 2014, JAMA-J AM MED ASSOC, V312, P249, DOI 10.1001/jama.2014.7682; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; MASON A M S, 1973, Seminars in Arthritis and Rheumatism, V2, P301; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Meiners PM, 2011, EXPERT OPIN BIOL TH, V11, P1381, DOI 10.1517/14712598.2011.605352; MOUTSOPOULOS H M, 1991, Current Opinion in Rheumatology, V3, P815, DOI 10.1097/00002281-199110000-00011; Novljan MP, 2004, ANN RHEUM DIS, V63, P874, DOI 10.1136/ard.2003.014027; Price EJ, 1998, J RHEUMATOL, V25, P896; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Retamozo S, 2012, IMMUNOLOGICAL TESTS, P401; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Skopouli FN, 1996, CLIN EXP RHEUMATOL, V14, P555; Szodoray P, 2004, SCAND J IMMUNOL, V59, P592, DOI 10.1111/j.0300-9475.2004.01432.x; Thanou-Stavraki A, 2008, SEMIN ARTHRITIS RHEU, V37, P273, DOI 10.1016/j.semarthrit.2007.06.002; Tzioufas AG, 2012, J AUTOIMMUN, V39, P1, DOI 10.1016/j.jaut.2012.01.006; Tzioufas AG, 2012, PATHOGENETIC ASPECTS, P33; Van Woerkom JM, 2007, ANN RHEUM DIS, V66, P1026, DOI 10.1136/ard.2006.060905; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Voulgarelis M, 2012, MEDICINE, V91, P1, DOI 10.1097/MD.0b013e31824125e4; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337	33	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150749	10.1371/journal.pone.0150749	http://dx.doi.org/10.1371/journal.pone.0150749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998607	Green Submitted, gold, Green Published			2022-12-27	WOS:000372694700014
J	Fais, A; Lewis, TP; Zitterbart, DP; Alvarez, O; Tejedor, A; Soto, NA				Fais, Andrea; Lewis, Tim P.; Zitterbart, Daniel P.; Alvarez, Omar; Tejedor, Ana; Soto, Natacha Aguilar			Abundance and Distribution of Sperm Whales in the Canary Islands: Can Sperm Whales in the Archipelago Sustain the Current Level of Ship-Strike Mortalities?	PLOS ONE			English	Article							DETECTION PROBABILITIES; ECOLOGICAL TRAPS; ACOUSTIC SURVEYS; COLLISIONS; MITOCHONDRIAL; CETACEANS; HABITAT	Sperm whales are present in the Canary Islands year-round, suggesting that the archipelago is an important area for this species in the North Atlantic. However, the area experiences one of the highest reported rates of sperm whale ship-strike in the world. Here we investigate if the number of sperm whales found in the archipelago can sustain the current rate of ship-strike mortality. The results of this study may also have implications for offshore areas where concentrations of sperm whales may coincide with high densities of ship traffic, but where ship-strikes may be undocumented. The absolute abundance of sperm whales in an area of 52933 km(2), covering the territorial waters of the Canary Islands, was estimated from 2668 km of acoustic line-transect survey using Distance sampling analysis. Data on sperm whale diving and acoustic behaviour, obtained from bio-logging, were used to calculate g(0) = 0.92, this is less than one because of occasional extended periods when whales do not echolocate. This resulted in an absolute abundance estimate of 224 sperm whales (95% log-normal CI 120-418) within the survey area. The recruitment capability of this number of whales, some 2.5 whales per year, is likely to be exceeded by the current ship-strike mortality rate. Furthermore, we found areas of higher whale density within the archipelago, many coincident with those previously described, suggesting that these are important habitats for females and immature animals inhabiting the archipelago. Some of these areas are crossed by active shipping lanes increasing the risk of ship-strikes. Given the philopatry in female sperm whales, replacement of impacted whales might be limited. Therefore, the application of mitigation measures to reduce the ship-strike mortality rate seems essential for the conservation of sperm whales in the Canary Islands.	[Fais, Andrea; Lewis, Tim P.; Alvarez, Omar; Soto, Natacha Aguilar] Univ La Laguna, Dept Anim Biol Geol & Edaphol, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Tenerife, Canary Islands, Spain; [Zitterbart, Daniel P.] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Ocean Acoust Lab, Bremerhaven, Germany; [Zitterbart, Daniel P.] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Alvarez, Omar] CIMA Canarias, Avda Majuelos 115, Tenerife 38107, Canary Islands, Spain; [Tejedor, Ana] KAI Marine Serv, Nalon 16, Madrid 28240, Spain; [Soto, Natacha Aguilar] Univ St Andrews, Scottish Oceans Inst, CREEM, St Andrews, Fife, Scotland; [Fais, Andrea] Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Germany	Universidad de la Laguna; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Woods Hole Oceanographic Institution; University of St Andrews; University of Veterinary Medicine Hannover, Foundation	Fais, A (corresponding author), Univ La Laguna, Dept Anim Biol Geol & Edaphol, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Tenerife, Canary Islands, Spain.; Fais, A (corresponding author), Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Germany.	andrea.fais@tiho-hannover.de	De Soto, Natacha Aguilar/D-3002-2011	De Soto, Natacha Aguilar/0000-0001-9818-3527; Zitterbart, Daniel/0000-0001-9429-4350	Canary Islands Government; Spanish Ministry of the Environment; Spanish Ministry of the Defence; Fundacion Biodiversidad-MAGRAMA via the LIFE-INDEMARES project	Canary Islands Government; Spanish Ministry of the Environment(Spanish Government); Spanish Ministry of the Defence; Fundacion Biodiversidad-MAGRAMA via the LIFE-INDEMARES project	Funding was provided through an agreement between the Canary Islands Government and the Spanish Ministries of the Environment and Defence. Additional survey effort on the Amanay, Banquete and Concepcion seamounts was funded by the Fundacion Biodiversidad-MAGRAMA via the LIFE-INDEMARES project. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. One of the authors (OA) is employed by a commercial company, CIMA Canarias, nevertheless this commercial affiliation only provided financial support in the form of author's salaries and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Soto N, 2000, J CETACEAN RES MANAG; Alexander A, MOL ECOL UNPUB; Andre M, 1997, THESIS U LAS PALMAS; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Barlow J, 2013, J ACOUST SOC AM, V134, P2486, DOI 10.1121/1.4816573; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Borchers DL, 2013, BIOMETRICS, V69, P703, DOI 10.1111/biom.12049; Buckland S.T., 2001, pi; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Conn PB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00004.1; Constantine R, 2015, BIOL CONSERV, V186, P149, DOI 10.1016/j.biocon.2015.03.008; Cooney R., 2004, PRECAUTIONARY PRINCI; Cooney R., 2005, BIODIVERSITY PRECAUT; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Diaz-Delgado J, 2015, THESIS U LAS PALMAS; Donovan TM, 2001, ECOL APPL, V11, P871; Douglas AB, 2008, J MAR BIOL ASSOC UK, V88, P1121, DOI 10.1017/S0025315408000295; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Faerber MM, 2010, MAR MAMMAL SCI, V26, P602, DOI 10.1111/j.1748-7692.2010.00370.x; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Gero Shane, 2007, Journal of Cetacean Research and Management, V9, P143; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gero S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1113; Gillespie D, 1996, EUROPEAN RES CETATEC, V10, P87; Gillespie Douglas, 1997, Report of the International Whaling Commission, V47, P897; Gordon JCD, 1987, BEHAV ECOLOGY SPERM; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Jensen A.S., 2003, LARGE WHALE SHIP STR; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Leaper R., 2003, IWC SCI COMM M UNPUB; Leaper Russell, 2000, Journal of Cetacean Research and Management, V2, P187; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; Ritter Fabian, 2012, Journal of Cetacean Research and Management, V12, P119; Ritter Fabian, 2010, Journal of Cetacean Research and Management, V11, P139; Rodriguez MC, 2005, J MARIT RES, V2, P81; Silber GK, 2012, MAR POLICY, V36, P1221, DOI 10.1016/j.marpol.2012.03.008; Silber GK, 2010, J EXP MAR BIOL ECOL, V391, P10, DOI 10.1016/j.jembe.2010.05.013; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tejedor A., 2012, MITIGACION IMPACTOS; Thomas L., 2006, DISTANCE 6 0 RELEASE; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Vanderlaan ASM, 2007, MAR MAMMAL SCI, V23, P144, DOI 10.1111/j.1748-7692.2006.00098.x; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Whitehead H., 2003, SPERM WHALES SOCIAL; Whitehead H, 2008, MAR ECOL PROG SER, V361, P291, DOI 10.3354/meps07412; Williams R., 2011, CONSERV LETT, V2011, P1, DOI [DOI 10.1111/J.1755-263X.2010.00151.X, 10.1111/j.1755-263X.2010.00151.x]; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510	55	23	26	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150660	10.1371/journal.pone.0150660	http://dx.doi.org/10.1371/journal.pone.0150660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999791	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700013
J	Norby, FL; Adamsson Eryd, S; Niemeijer, MN; Rose, LM; Smith, AV; Yin, XY; Agarwal, SK; Arking, DE; Chasman, DL; Chen, LY; Eijgelsheim, M; Engstrom, G; Franco, OH; Heeringa, J; Hindy, G; Hofman, A; Lutsey, PL; Magnani, JW; McManus, DD; Orho-Melander, M; Pankow, JS; Rukh, G; Schulz, CA; Uitterlinden, AG; Albert, CM; Benjamin, EJ; Gudnason, V; Smith, JG; Stricker, BHC; Alonso, A				Norby, Faye L.; Adamsson Eryd, Samuel; Niemeijer, Maartje N.; Rose, Lynda M.; Smith, Albert V.; Yin, Xiaoyan; Agarwal, Sunil K.; Arking, Dan E.; Chasman, Daniel L.; Chen, Lin Y.; Eijgelsheim, Mark; Engstrom, Gunnar; Franco, Oscar H.; Heeringa, Jan; Hindy, George; Hofman, Albert; Lutsey, Pamela L.; Magnani, Jared W.; McManus, David D.; Orho-Melander, Marju; Pankow, James S.; Rukh, Gull; Schulz, Christina-Alexandra; Uitterlinden, Andre G.; Albert, Christine M.; Benjamin, Emelia J.; Gudnason, Vilmundur; Smith, J. Gustav; Stricker, Bruno H. C.; Alonso, Alvaro			Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; LOCI; DESIGN; PREVALENCE; WHITES; COHORT; TRENDS; IMPACT	Background Several studies have shown associations between blood lipid levels and the risk of atrial fibrillation (AF). To test the potential effect of blood lipids with AF risk, we assessed whether previously developed lipid gene scores, used as instrumental variables, are associated with the incidence of AF in 7 large cohorts. Methods We analyzed 64,901 individuals of European ancestry without previous AF at baseline and with lipid gene scores. Lipid-specific gene scores, based on loci significantly associated with lipid levels, were calculated. Additionally, non-pleiotropic gene scores for high-density lipoprotein cholesterol (HDLc) and low-density lipoprotein cholesterol (LDLc) were calculated using SNPs that were only associated with the specific lipid fraction. Cox models were used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) of AF per 1-standard deviation (SD) increase of each lipid gene score. Results During a mean follow-up of 12.0 years, 5434 (8.4%) incident AF cases were identified. After meta-analysis, the HDLc, LDLc, total cholesterol, and triglyceride gene scores were not associated with incidence of AF. Multivariable-adjusted HR (95% CI) were 1.01 (0.981.03); 0.98 (0.96-1.01); 0.98 (0.95-1.02); 0.99 (0.97-1.02), respectively. Similarly, non-pleiotropic HDLc and LDLc gene scores showed no association with incident AF: HR (95% CI) = 1.00 (0.97-1.03); 1.01 (0.99-1.04). Conclusions In this large cohort study of individuals of European ancestry, gene scores for lipid fractions were not associated with incident AF.	[Norby, Faye L.; Lutsey, Pamela L.; Pankow, James S.; Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Adamsson Eryd, Samuel; Engstrom, Gunnar; Hindy, George; Orho-Melander, Marju; Rukh, Gull; Schulz, Christina-Alexandra; Smith, J. Gustav] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Niemeijer, Maartje N.; Eijgelsheim, Mark; Franco, Oscar H.; Heeringa, Jan; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. C.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Rose, Lynda M.; Chasman, Daniel L.; Albert, Christine M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Res Inst, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Yin, Xiaoyan] Boston Univ, Sch Med, Dept Biostat, Cardiol Sect, Boston, MA 02118 USA; [Yin, Xiaoyan] Boston Univ, Sch Med, Dept Biostat, Prevent Med Sect, Boston, MA 02118 USA; [Agarwal, Sunil K.] Mt Sinai Heart Ctr, Icahn Sch Med, New York, NY USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Cardiac Arrhythmia Ctr, Cardiovasc Div,Dept Med, Minneapolis, MN 55455 USA; [Eijgelsheim, Mark; Uitterlinden, Andre G.; Stricker, Bruno H. C.] Univ Med Ctr, Erasmus Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA; [Magnani, Jared W.; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Albert, Christine M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Smith, J. Gustav] Lund Univ, Dept Cardiol, Lund, Sweden; [Stricker, Bruno H. C.] Inspectorate Hlth Care, Utrecht, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; Lund University; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icelandic Heart Association; University of Iceland; Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Lund University	Norby, FL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.	flopez@umn.edu	Alonso, Alvaro/A-4917-2010; Gudnason, Vilmundur/AAE-7126-2019; Franco, Óscar H/ABE-2305-2020; Benjamin, Emelia/E-7103-2011; Norby, Faye/FNA-7255-2022; Smith, Albert Vernon/K-5150-2015	Alonso, Alvaro/0000-0002-2225-8323; Gudnason, Vilmundur/0000-0001-5696-0084; Franco, Óscar H/0000-0002-4606-4929; Benjamin, Emelia/0000-0003-4076-2336; Norby, Faye/0000-0002-1975-0405; Lutsey, Pamela/0000-0002-1572-1340; Smith, Albert Vernon/0000-0003-1942-5845; Albert, Christine/0000-0002-2081-1121; Hindy, George/0000-0002-7257-9299; Chen, Lin/0000-0002-0700-814X; Pankow, James/0000-0001-7076-483X	National Institutes of Health [N01-AG-12100]; NIA Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute [HHSN268201 100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN2682 01100010C, HHSN268201100011C, HHSN26820110 0012C, RC1HL 099452, RC1HL101056, HL 043851, HL 69757, HL099355]; American Heart Association [09SDG2280087]; National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Malmo city council; Swedish Cancer Society; Swedish Medical Research Council; Swedish Dairy association; Albert Pahlsson foundation; Gunnar Nilsson foundation; Swedish Heart-Lung foundation; Swedish Research Council; Crafoord foundation; Swedish National Health Service; Skane University Hospital; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; Ministry of Health Welfare and Sport; European Commission (DG XII); Municipality of Rotterdam; National Cancer Institute [CA 047988]; Donald W. Reynolds Foundation; Amgen; Harris Family Foundation; Watkin's Foundation;  [2R01 HL092577];  [1RO1 HL076784];  [1R01 AG028321];  [6R01-NS 17950];  [KL2RR031981];  [HL-093613]; NATIONAL CANCER INSTITUTE [R01CA047988, UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL101056, RC1HL099355, R21HL093613, RC1HL099452, U19HL069757, R01HL116690, U01HL069757, R01HL043851, R01HL076784, R01HL092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321, N01AG012100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Malmo city council; Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Dairy association; Albert Pahlsson foundation; Gunnar Nilsson foundation; Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord foundation; Swedish National Health Service; Skane University Hospital; Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Welfare and Sport; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Amgen(Amgen); Harris Family Foundation; Watkin's Foundation; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AGES: The Age, Gene/Environment Susceptibility Reykjavik Study has been funded by National Institutes of Health contract N01-AG-12100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). ARIC: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201 100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN2682 01100010C, HHSN268201100011C, and HHSN26820110 0012C). This work was additionally funded by grants RC1HL 099452 and RC1HL101056 from National Heart, Lung, and Blood Institute and 09SDG2280087 from the American Heart Association. FHS: Framingham Heart Study research was conducted using data and resources from the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine based on analyses by Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Other support came from 2R01 HL092577, 1RO1 HL076784, 1R01 AG028321 (Benjamin), 6R01-NS 17950, And KL2RR031981 (McManus). MDCS: The Malmo Diet and Cancer study was made possible by grants from the Malmo city council, the Swedish Cancer Society, the Swedish Medical Research Council, the Swedish Dairy association, and the Albert Pahlsson and Gunnar Nilsson foundations. J. Gustav Smith was supported by the Swedish Heart-Lung foundation, the Swedish Research Council, the Crafoord foundation, governmental funding of clinical research within the Swedish National Health Service, and Skane University Hospital. RS: The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is supported by the Erasmus MC and Erasmus University Rotterdam; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science; the Ministry of Health Welfare and Sport; the European Commission (DG XII); and the Municipality of Rotterdam. WGHS: The Women's Genome Health Study is supported by HL 043851, HL 69757, HL099355 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation with collaborative scientific support and funding for genotyping provided by Amgen. AF endpoint confirmation was supported by HL-093613 and a grant from the Harris Family Foundation and Watkin's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2014, J AM HEART ASS, P3; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Balse E, 2009, P NATL ACAD SCI USA, V106, P14681, DOI 10.1073/pnas.0902809106; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Duntas LH, 2012, MED CLIN N AM, V96, P269, DOI 10.1016/j.mcna.2012.01.012; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Iguchi Y, 2010, AM J CARDIOL, V106, P1129, DOI 10.1016/j.amjcard.2010.06.030; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lewis SJ, 2010, CIRC-CARDIOVASC GENE, V3, P109, DOI 10.1161/CIRCGENETICS.109.880955; Lopez FL, 2012, CIRC-ARRHYTHMIA ELEC, V5, P155, DOI 10.1161/CIRCEP.111.966804; Lubitz SA, 2014, J AM COLL CARDIOL, V63, P1200, DOI 10.1016/j.jacc.2013.12.015; Lutsey PL, 2012, CIRC-CARDIOVASC GENE, V5, P73, DOI 10.1161/CIRCGENETICS.111.959619; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Mora S, 2014, CIRC-ARRHYTHMIA ELEC, V7, P612, DOI 10.1161/CIRCEP.113.001378; Psaty BM, 1997, CIRCULATION, V96, P2455; Rasmussen-Torvik LJ, 2010, GENET EPIDEMIOL, V34, P665, DOI 10.1002/gepi.20525; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sanoski CA, 2010, AM J HEALTH-SYST PH, V67, pS11, DOI 10.2146/ajhp100148; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Smith JG, 2014, JAMA; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watanabe H, 2011, CIRC J, V75, P2767, DOI 10.1253/circj.CJ-11-0780; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151932	10.1371/journal.pone.0151932	http://dx.doi.org/10.1371/journal.pone.0151932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999784	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700087
J	Rizk, SM; Shahin, NN; Shaker, OG				Rizk, Sherine M.; Shahin, Nancy N.; Shaker, Olfat G.			Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; PROGNOSTIC VALUE; POOR-PROGNOSIS; EXPRESSION; SIRTUINS; DEACETYLASE; METASTASIS; PROMOTER; DBC1	Background Breast cancer is reported to cause the highest mortality among female cancer patients. Previous studies have explored the association of silent mating-type information regulator 2 homolog 1 (SIRT1) gene expression with prognosis in breast cancer. However, no studies exist, so far, on the role of SIRT1 gene polymorphism in breast cancer risk or prognosis. The present study aimed to assess the association between SIRT1 gene polymorphisms and breast cancer in Egyptians. Methods The study comprised 980 Egyptian females divided into a breast cancer group (541 patients) and a healthy control group (439 subjects). SIRT1 gene single nucleotide polymorphisms (SNPs) rs3758391, rs3740051 and rs12778366 were genotyped using real-time polymerase chain reaction (RT-PCR). Allelic and genotypic frequencies were determined in both groups and association with breast cancer and clinicopathological characteristics was assessed. Results Breast cancer patients exhibited elevated serum SIRT1 levels which varied among different tumor grades. SIRT1 rs3758391 and rs12778366 TT genotypes were more frequent, exhibited higher SIRT1 levels than CC and CT genotypes and were associated with histologic grade and lymph node status. SIRT1 rs12778366 TT genotype also correlated with negative estrogen receptor (ER) and progesterone receptor (PR) statuses. The T allele frequency for both SNPs was higher in breast cancer patients than in normal subjects. Combined GG and AG genotypes of rs3740051 were more frequent, showed higher serum SIRT1 levels than the AA genotype, and were associated with ER and PR expression. Furthermore, inheritance of the G allele was associated with breast cancer. Conclusions Our findings reveal that rs3758391 and rs12778366 polymorphisms of SIRT1 gene are associated with breast cancer risk and prognosis in the Egyptian population.	[Rizk, Sherine M.; Shahin, Nancy N.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Shahin, NN (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	nancy.shahin@pharma.cu.edu.eg	O, Shaker/Y-6125-2019; Shaker, Olfat G/S-2010-2017; Issa, Randa @M.T/E-7144-2019; Shahin, Nancy Nabil/I-5318-2019	O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234; Shahin, Nancy Nabil/0000-0002-9746-5335				BABSON AL, 1966, CLIN CHEM, V12, P482; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Byler S, 2014, ANTICANCER RES, V34, P1071; Cao YW, 2015, INT J CLIN EXP MED, V8, P616; Cao YW, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0097-2; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen WY, 2013, CURR OPIN HEMATOL, V20, P308, DOI 10.1097/MOH.0b013e328360ab64; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; Chong ZZ, 2012, FUTUR CARDIOL, V8, P89, DOI [10.2217/FCA.11.76, 10.2217/fca.11.76]; Clark-Knowles KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082106; Consiglio CR, 2014, MOL BIOL REP, V41, P4233, DOI 10.1007/s11033-014-3294-3; Cruz M, 2010, DIABETES-METAB RES, V26, P261, DOI 10.1002/dmrr.1082; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Figarska SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058636; Gabay O, 2012, JOINT BONE SPINE, V79, P570, DOI 10.1016/j.jbspin.2012.04.005; Genestie C, 1998, ANTICANCER RES, V18, P571; Hamdy SI, 2002, BRIT J CLIN PHARMACO, V53, P596, DOI 10.1046/j.1365-2125.2002.01604.x; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hu YY, 2015, J ATHEROSCLER THROMB, V22, P165, DOI 10.5551/jat.24844; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jendrassik L, 1938, BIOCHEM Z, V297, P81; Kilic U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090428; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Li Kai, 2011, N Am J Med Sci (Boston), V4, P104; Lim CS, 2007, CELL BIOL INT, V31, P636, DOI 10.1016/j.cellbi.2006.11.003; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Maeda S, 2011, CLIN EXP NEPHROL, V15, P381, DOI 10.1007/s10157-011-0418-0; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; Naqvi A, 2010, HUM MOL GENET, V19, P4123, DOI 10.1093/hmg/ddq331; Ozcelik T, 2010, NAT GENET, V42, P641, DOI 10.1038/ng0810-641; Rai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048621; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Rizk SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114560; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Shahin MHA, 2011, PHARMACOGENET GENOM, V21, P130, DOI 10.1097/FPC.0b013e3283436b86; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sung JY, 2010, CANCER SCI, V101, P1738, DOI 10.1111/j.1349-7006.2010.01573.x; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Teo YY, 2010, CURR OPIN LIPIDOL, V21, P104, DOI 10.1097/MOL.0b013e3283369e5b; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Zhang T, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-351	51	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151901	10.1371/journal.pone.0151901	http://dx.doi.org/10.1371/journal.pone.0151901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999517	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700083
J	Wang, AJ; Li, Y; Zhang, M; Chen, Q				Wang, Aijun; Li, You; Zhang, Ming; Chen, Qi			The Role of Parieto-Occipital Junction in the Interaction between Dorsal and Ventral Streams in Disparity-Defined Near and Far Space Processing	PLOS ONE			English	Article							AREA V6; SOMATOSENSORY CELLS; STEREOSCOPIC DEPTH; FMRI REVEALS; MACAQUE; CORTEX; BRAIN; SENSITIVITY; NEURONS; SIZE	Neuropsychological and functional MRI data suggest that two functionally and anatomically dissociable streams of visual processing exist: a ventral perception-related stream and a dorsal action-related stream. However, relatively little is known about how the two streams interact in the intact brain during the production of adaptive behavior. Using functional MRI and a virtual three-dimensional paradigm, we aimed at examining whether the parieto-occipital junction (POJ) acts as an interface for the integration and processing of information between the dorsal and ventral streams in the near and far space processing. Virtual reality three-dimensional near and far space was defined by manipulating binocular disparity, with -68.76 arcmin crossed disparity for near space and +68.76 arcmin uncrossed disparity for near space. Our results showed that the POJ and bilateral superior occipital gyrus (SOG) showed relative increased activity when responded to targets presented in the near space than in the far space, which was independent of the retinotopic and perceived sizes of target. Furthermore, the POJ showed the enhanced functional connectivity with both the dorsal and ventral streams during the far space processing irrespective of target sizes, supporting that the POJ acts as an interface between the dorsal and ventral streams in disparity-defined near and far space processing. In contrast, the bilateral SOG showed the enhanced functional connectivity only with the ventral stream if retinotopic sizes of targets in the near and far spaces were matched, which suggested there was a functional dissociation between the POJ and bilateral SOG.	[Wang, Aijun; Li, You; Chen, Qi] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China; [Wang, Aijun; Li, You; Chen, Qi] S China Normal Univ, Sch Psychol, Guangzhou 510631, Guangdong, Peoples R China; [Chen, Qi] S China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Guangdong, Peoples R China; [Chen, Qi] Guangdong 999 Brain Hosp, Epilepsy Ctr, Guangzhou 510510, Guangdong, Peoples R China; [Wang, Aijun; Zhang, Ming] Soochow Univ, Dept Psychol, Suzhou 215123, Peoples R China	South China Normal University; South China Normal University; South China Normal University; Soochow University - China	Chen, Q (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China.; Chen, Q (corresponding author), S China Normal Univ, Sch Psychol, Guangzhou 510631, Guangdong, Peoples R China.; Chen, Q (corresponding author), S China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Guangdong, Peoples R China.; Chen, Q (corresponding author), Guangdong 999 Brain Hosp, Epilepsy Ctr, Guangzhou 510510, Guangdong, Peoples R China.	qi.chen27@gmail.com			Natural Science Foundation of China [31371127, 31371025]; Program for New Century Excellent Talents in the University of China [NCET-12-0645]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities [14ZZ1202]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University of China(Program for New Century Excellent Talents in University (NCET)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from Natural Science Foundation of China (31371127, 31371025). QC is supported by the Program for New Century Excellent Talents in the University of China (NCET-12-0645) and by the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014). AW is supported by the Fundamental Research Funds for the Central Universities (14ZZ1202).	Astafiev SV, 2003, J NEUROSCI, V23, P4689; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; Bremmer F, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00008; Breveglieri R, 2006, J NEUROSCI, V26, P3679, DOI 10.1523/JNEUROSCI.4637-05.2006; Breveglieri R, 2002, NEUROREPORT, V13, P2113, DOI 10.1097/00001756-200211150-00024; Cacola P., 2013, J IMAGERY RES SPORT, V8, P55, DOI [10.1515/jirspa-2013-0003, DOI 10.1515/JIRSPA-2013-0003]; Cardin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047685; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Chen Q, 2012, J COGNITIVE NEUROSCI, V24, P2223, DOI 10.1162/jocn_a_00260; Chen Q, 2012, J NEUROSCI, V32, P13352, DOI 10.1523/JNEUROSCI.1772-12.2012; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Galletti C, 2005, EUR J NEUROSCI, V21, P959, DOI 10.1111/j.1460-9568.2005.03911.x; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Iriki A, 1996, NEUROREPORT, V7, P2325; Legrand D, 2007, CONSCIOUS COGN, V16, P687, DOI 10.1016/j.concog.2007.06.003; Liu Q, 2009, NEUROREPORT, V20, P809, DOI 10.1097/WNR.0b013e32832be7c0; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; MENNEMEIER M, 1992, BRAIN, V115, P37, DOI 10.1093/brain/115.1.37; Milner A. D., 1995, VISUAL BRAIN ACTION; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Patten ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140696; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Pitzalis S, 2013, NEUROIMAGE, V82, P517, DOI 10.1016/j.neuroimage.2013.06.026; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Rossit S, 2013, CORTEX, V49, P2525, DOI 10.1016/j.cortex.2012.12.014; ROY JP, 1990, NATURE, V348, P160, DOI 10.1038/348160a0; ROY JP, 1992, J NEUROSCI, V12, P2478; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vuilleumier P, 1998, ANN NEUROL, V43, P406, DOI 10.1002/ana.410430324; Weiss PH, 2003, NEUROIMAGE, V18, P837, DOI 10.1016/S1053-8119(03)00018-1; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; ZEKI S, 1986, J PHYSIOL-LONDON, V381, pP62	58	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151838	10.1371/journal.pone.0151838	http://dx.doi.org/10.1371/journal.pone.0151838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999674	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700070
J	Ilczyszyn, WM; Sabat, AJ; Akkerboom, V; Szkarlat, A; Klepacka, J; Sowa-Sierant, I; Wasik, B; Kosecka-Strojek, M; Buda, A; Miedzobrodzki, J; Friedrich, AW				Ilczyszyn, Weronika M.; Sabat, Artur J.; Akkerboom, Viktoria; Szkarlat, Anna; Klepacka, Joanna; Sowa-Sierant, Iwona; Wasik, Barbara; Kosecka-Strojek, Maja; Buda, Aneta; Miedzobrodzki, Jacek; Friedrich, Alexander W.			Clonal Structure and Characterization of Staphylococcus aureus Strains from Invasive Infections in Paediatric Patients from South Poland: Association between Age, spa Types, Clonal Complexes, and Genetic Markers	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; NEONATOLOGY SURVEILLANCE NETWORK; LOW-LEVEL RESISTANCE; INTENSIVE-CARE-UNIT; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; NASAL CARRIAGE; CHILDREN; COMMUNITY; EPIDEMIOLOGY	The aim of current study was to examine clonal structure and genetic profile of invasive Staphylococcus aureus isolates recovered from infants and children treated at the Jagiellonian University Children's Hospital of Krakow, Poland. The 107 invasive S. aureus isolates, collected between February 2012 and August 2014, were analysed retrospectively. Antimicrobial susceptibility testing, spa typing and DNA microarray analysis were performed to determine clonal distribution, diversity and gene content in regard to patients characteristics. In total, 107 isolates were recovered from 88 patients with clinical symptoms of invasive bacterial infection. The final set of 92 non-duplicate samples included 38 MRSA isolates. Additionally, a set of 54 S. aureus isolates collected during epidemiological screening was genotyped and analysed. There were 72 healthcare-associated (HCA) and 20 community-onset (CO) infection events caused by 33 and 5 MRSA isolates, respectively. The majority of isolates were affiliated with the major European clonal complexes CC5 (t003, spa-CC 002), CC45 (spa-CC 015), CC7 or CC15 (t084, t091, spa-CC 084). Two epidemic clones (CC5-MRSA-II or CC45-MRSA-IV) dominated among MRSA isolates, while MSSA population contained 15 different CCs. The epidemiological screening isolates belonged to similar genetic lineages as those collected from invasive infection cases. The HCA infection events, spa types t003, t2642 or CC5 were significantly associated with infections occurring in neonates and children under 5 years of age. Moreover, carriage of several genetic markers, including erm(A), sea (N315), egc-cluster, chp was significantly higher in isolates obtained from children in this age group. The spa types t091 and t008 were underrepresented among patients aged 5 years or younger, whereas spa type t008, CC8 and presence of splE was associated with infection in children aged 10 years or older. The HCA-MRSA strains were most frequently found in children under 5 years, although the majority of invasive infections was associated with MSSA strains. Moreover, an association between age group of children from the study population and a specific strain genotype (spa type, clonal complex or genetic content) was observed among the patients.	[Ilczyszyn, Weronika M.; Kosecka-Strojek, Maja; Buda, Aneta; Miedzobrodzki, Jacek] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sabat, Artur J.; Akkerboom, Viktoria; Friedrich, Alexander W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Szkarlat, Anna; Klepacka, Joanna; Sowa-Sierant, Iwona; Wasik, Barbara] Jagiellonian Univ, Childrens Univ Hosp, Dept Clin Microbiol, Krakow, Poland	Jagiellonian University; University of Groningen; Jagiellonian University	Miedzobrodzki, J (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	jacek.miedzobrodzki@uj.edu.pl	Kosecka-Strojek, Maja/W-2624-2018; Międzobrodzki, Jacek/U-4353-2018; Friedrich, Alex/ABG-9823-2020	Kosecka-Strojek, Maja/0000-0001-8337-6975; Międzobrodzki, Jacek/0000-0003-4252-880X; 	Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow, Leading National Research Center (KNOW) - Ministry of Science and Higher Education in Poland	Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow, Leading National Research Center (KNOW) - Ministry of Science and Higher Education in Poland	This work was funded by the Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow, which is a part of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education in Poland.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Anantha Ram Venkatesh, 2014, CMAJ Open, V2, pE352, DOI 10.9778/cmajo.20140018; Argudin MA, 2012, APPL ENVIRON MICROB, V78, P2930, DOI 10.1128/AEM.07487-11; Ascher SB, 2012, EARLY HUM DEV, V88, pS92, DOI 10.1016/S0378-3782(12)70025-7; Barrado L, 2014, J INFECTION, V68, P195, DOI 10.1016/j.jinf.2013.10.001; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Bonnal C, 2015, MED MALADIES INFECT, V45, P84, DOI 10.1016/j.medmal.2015.01.002; Britton PN, 2013, J PAEDIATR CHILD H, V49, P754, DOI 10.1111/jpc.12255; Calderwood MS, 2014, J INFECT DIS, V209, P571, DOI 10.1093/infdis/jit501; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072811; Chung JW, 2014, DIAGN MICR INFEC DIS, V79, P119, DOI 10.1016/j.diagmicrobio.2014.03.009; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Deurenberg RH, 2009, DIAGN MICR INFEC DIS, V65, P116, DOI 10.1016/j.diagmicrobio.2009.07.007; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Garcia C, 2016, EUR J CLIN MICROBIOL, V35, P89, DOI 10.1007/s10096-015-2512-9; Ghasemian Abdolmajid, 2015, Iran J Pathol, V10, P258; Gomes RT, 2013, BRAZ J INFECT DIS, V17, P573, DOI 10.1016/j.bjid.2013.02.010; Gradel KO, 2014, CLIN EPIDEMIOL, V6, P301, DOI 10.2147/CLEP.S66998; Grundmann H, 2014, EURO SURVEILL B EUR, V19; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hamer DH, 2015, PEDIATR INFECT DIS J, V34, pE1, DOI 10.1097/INF.0000000000000549; Helbin WM, 2012, POSTEP MIKROBIOL, V51, P291; Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kupferschmidt K, 2012, SCIENCE, V338, P1019, DOI 10.1126/science.338.6110.1019; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Li HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053341; Li SP, 2015, APMIS, V123, P28, DOI 10.1111/apm.12304; Li T, 2013, EPIDEMIOL INFECT, V141, P2158, DOI 10.1017/S0950268812002919; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Luthander J, 2013, ACTA PAEDIATR, V102, P182, DOI 10.1111/apa.12077; Luxner J, 2014, DIAGN MICR INFEC DIS, V78, P153, DOI 10.1016/j.diagmicrobio.2013.10.010; McNeil JC, 2014, INFECT DRUG RESIST, V7, P117, DOI 10.2147/IDR.S39639; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097833; Nakao A, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-14; Netsvyetayeva I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-128; Nowrouzian FL, 2015, EUR J CLIN MICROBIOL, V34, P1443, DOI 10.1007/s10096-015-2371-4; Park DA, 2013, INFECT CHEMOTHER, V45, P202, DOI 10.3947/ic.2013.45.2.202; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Polin RA, 2012, PEDIATRICS, V129, P1104, DOI 10.1542/peds.2012-0147; Post V, 2014, INT J MED MICROBIOL, V304, P565, DOI 10.1016/j.ijmm.2014.03.003; Powers ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003871; Qiao YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0582-4; Rasmussen G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114276; Rasmussen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077477; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Rello J, 2010, INFECT DIS CRITICAL; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Rojo A, 2014, EUR J CLIN MICROBIOL, V33, P651, DOI 10.1007/s10096-013-2000-z; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Romaniszyn D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0890-3; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Ruffing U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052487; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Satta Giovanni, 2013, BMC Res Notes, V6, P398, DOI 10.1186/1756-0500-6-398; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Schulte B, 2013, J CLIN MICROBIOL, V51, P212, DOI 10.1128/JCM.01967-12; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vanderkooi OG, 2011, PAED CHILD HEALT-CAN, V16, P276, DOI 10.1093/pch/16.5.276; Vergnano S, 2011, PEDIATR INFECT DIS J, V30, P850, DOI 10.1097/INF.0b013e318224546d; Verkaik NJ, 2010, CLIN MICROBIOL INFEC, V16, P1312, DOI 10.1111/j.1469-0691.2009.03073.x; Wannet WJB, 2004, J CLIN MICROBIOL, V42, P3077, DOI 10.1128/JCM.42.7.3077-3082.2004; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279; Wisniewska K, 2012, FOLIA MICROBIOL, V57, P243, DOI 10.1007/s12223-012-0148-z; Witte Wolfgang, 1997, Clin Microbiol Infect, V3, P414, DOI 10.1111/j.1469-0691.1997.tb00277.x; Wojkowska-Mach J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-339; Yu FY, 2012, DIAGN MICR INFEC DIS, V74, P363, DOI 10.1016/j.diagmicrobio.2012.08.015	81	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151937	10.1371/journal.pone.0151937	http://dx.doi.org/10.1371/journal.pone.0151937			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992009	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800119
J	Mohammad, GH; Damink, SWMO; Malago, M; Dhar, DK; Pereira, SP				Mohammad, Goran Hamid; Damink, S. W. M. Olde; Malago, Massimo; Dhar, Dipok Kumar; Pereira, Stephen P.			Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome	PLOS ONE			English	Article							TUMOR M2-PYRUVATE KINASE; INFILTRATING LYMPHOCYTES; NUCLEAR TRANSLOCATION; AEROBIC GLYCOLYSIS; PROGNOSTIC-FACTOR; CELL CARCINOMA; PKM2 PROMOTES; MARKER; PHOSPHORYLATION; PROGRESSION	Pancreatic cancer has a 5-year survival rate of less than 4%. Despite advances in diagnostic technology, pancreatic cancer continues to be diagnosed at a late and incurable stage. Accurate biomarkers for early diagnosis and to predict treatment response are urgently needed. Since alteration of glucose metabolism is one of the hallmarks of cancer cells, we proposed that pyruvate kinase type M2 (M2PK) and lactate dehydrogenase A (LDHA) enzymes could represent novel diagnostic markers and potential therapeutic targets in pancreatic cancer. In 266 tissue sections from normal pancreas, pancreatic cystic neoplasms, pancreatic intraepithelial neoplasia (PanIN) and cancer, we evaluated the expression of PKM2, LDHA, Ki-67 and CD8+ by immunohistochemistry and correlated these markers with clinicopathological characteristics and patient survival. PKM2 and LDHA expression was also assessed by Western blot in 10 human pancreatic cancer cell lines. PKM2 expression increased progressively from cyst through PanIN to cancer, whereas LDHA was overexpressed throughout the carcinogenic process. All but one cell line showed high expression of both proteins. Patients with strong PKM2 and LDHA expression had significantly worse survival than those with weak PKM2 and/or LDHA expression (7.0 months vs. 27.9 months, respectively, p = 0.003, log rank test). The expression of both PKM2 and LDHA correlated directly with Ki-67 expression, and inversely with intratumoral CD8+ cell count. PKM2 was significantly overexpressed in poorly differentiated tumours and both PKM2 and LDHA were overexpressed in larger tumours. Multivariable analysis showed that combined expression of PKM2 and LDHA was an independent poor prognostic marker for survival. In conclusion, our results demonstrate a high expression pattern of two major glycolytic enzymes during pancreatic carcinogenesis, with increased expression in aggressive tumours and a significant adverse effect on survival.	[Mohammad, Goran Hamid; Damink, S. W. M. Olde; Malago, Massimo; Dhar, Dipok Kumar; Pereira, Stephen P.] UCL, Royal Free Hosp Campus, UCL Inst Liver & Digest Hlth, London, England; [Mohammad, Goran Hamid] Univ Sulaimani, Sch Sci, Dept Chem, Sulaimanyah, Kurdistan Regio, Iraq; [Damink, S. W. M. Olde] Maastricht Univ, Med Ctr, Dept Surg, NL-6200 MD Maastricht, Netherlands; [Dhar, Dipok Kumar] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia	University of London; University College London; University of Sulimanyah; Maastricht University; King Faisal Specialist Hospital & Research Center	Pereira, SP (corresponding author), UCL, Royal Free Hosp Campus, UCL Inst Liver & Digest Hlth, London, England.	stephen.pereira@ucl.ac.uk	Pereira, Stephen P/C-5639-2009; Mohammad, Goran/C-6819-2019; Damink, Steven WM Olde/U-7919-2019	Pereira, Stephen P/0000-0003-0821-1809; Mohammad, Goran/0000-0003-4822-1497; Damink, Steven WM Olde/0000-0002-5202-9345	Pancreatic Cancer Research Fund; Jason Boas Foundation; NIH [P01 CA084203]; UCLH/UCL Comprehensive Biomedical Centre from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; NATIONAL CANCER INSTITUTE [P01CA084203] Funding Source: NIH RePORTER	Pancreatic Cancer Research Fund; Jason Boas Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLH/UCL Comprehensive Biomedical Centre from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Pancreatic Cancer Research Fund, The Jason Boas Foundation, NIH grant P01 CA084203 and the UCLH/UCL Comprehensive Biomedical Centre, which receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACT FIG 2014; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Ashida A, 2006, INT J ONCOL, V28, P1345; Azoitei N, Z GASTROENTEROL, V51, pK55; Billiard J, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-19; Cancer Research UK, 2014, PANCR CANC STAT; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Crane CA, 2014, P NATL ACAD SCI USA, V111, P12823, DOI 10.1073/pnas.1413933111; Dhar DK, 2013, CANCER-AM CANCER SOC, V119, P575, DOI 10.1002/cncr.27611; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Feng JK, 2015, MOL MED REP, V11, P2111, DOI 10.3892/mmr.2014.2990; Fiume L, 2014, FUTURE MED CHEM, V6, P429, DOI [10.4155/FMC.13.206, 10.4155/fmc.13.206]; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goonetilleke KS, 2007, PANCREAS, V34, P318, DOI 10.1097/MPA.0b013e31802ee9c7; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; He TL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0633-8; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Ikeguchi M, 2004, EJSO-EUR J SURG ONC, V30, P53, DOI 10.1016/j.ejso.2003.10.001; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Joergensen MT, 2010, PANCREAS, V39, P243, DOI 10.1097/MPA.0b013e3181bae8ab; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kachel P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1135-y; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Kumar Y, 2007, PANCREAS, V35, P114, DOI 10.1097/mpa.0b013e3180537237; Kumar Y, 2010, TUMOR BIOL, V31, P69, DOI 10.1007/s13277-009-0010-3; Le A, 2012, CLIN CANCER RES, V18, P4285, DOI 10.1158/1078-0432.CCR-12-0041; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li J, 2014, CLIN TRANSL ONCOL, V16, P200, DOI 10.1007/s12094-013-1063-8; Li YG, 2009, DIGEST LIVER DIS, V41, P605, DOI 10.1016/j.dld.2008.11.010; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu WR, 2015, ONCOTARGET, V6, P846, DOI 10.18632/oncotarget.2749; Lockney Natalie A, 2015, J Gastrointest Cancer, V46, P390, DOI 10.1007/s12029-015-9764-6; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Nakano O, 2001, CANCER RES, V61, P5132; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Parra-Bonilla G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075984; Rajeshkumar N V., 2015, CANCER RES, P713; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shi M, 2014, CLIN CANCER RES, V20, P4370, DOI 10.1158/1078-0432.CCR-14-0186; Singh SR, 2015, CANCER LETT, V356, P147, DOI 10.1016/j.canlet.2014.06.002; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Sun X, 2015, TUMOR BIOL, P1; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wang Y, 2015, CANC BIOL T IN PRESS; Warner SL, 2014, FUTURE MED CHEM, V6, P1167, DOI [10.4155/FMC.14.70, 10.4155/fmc.14.70]; Wong N, 2015, CANCER LETT, V356, P184, DOI 10.1016/j.canlet.2014.01.031; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Xue JJ, 2014, EUR J MED CHEM, V80, P1, DOI 10.1016/j.ejmech.2014.04.035; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yu Y, 2001, BIOCHEM PHARMACOL, V62, P81, DOI 10.1016/S0006-2952(01)00636-0; Yu YP, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-78; Zhang XL, 2013, PATHOL RES PRACT, V209, P510, DOI 10.1016/j.prp.2013.06.005; Zhao D, 2013, ONCOTARGET, V4, P802, DOI 10.18632/oncotarget.1007; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066	66	57	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151635	10.1371/journal.pone.0151635	http://dx.doi.org/10.1371/journal.pone.0151635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26989901	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800082
J	Park, SH; Lee, SI; Ricke, SC				Park, Si Hong; Lee, Sang In; Ricke, Steven C.			Microbial Populations in Naked Neck Chicken Ceca Raised on Pasture Flock Fed with Commercial Yeast Cell Wall Prebiotics via an Illumina MiSeq Platform	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; SACCHAROMYCES-CEREVISIAE; POULTRY PRODUCTION; BROILER-CHICKENS; GASTROINTESTINAL-TRACT; MUCOSA DEVELOPMENT; FED DIETS; PERFORMANCE; IDENTIFICATION; MICROFLORA	Prebiotics are non-digestible carbohydrate dietary supplements that selectively stimulate the growth of one or more beneficial bacteria in the gastrointestinal tract of the host. These bacteria can inhibit colonization of pathogenic bacteria by producing antimicrobial substances such as short chain fatty acids (SCFAs) and competing for niches with pathogens within the gut. Pasture flock chickens are generally raised outdoors with fresh grass, sunlight and air, which represents different environmental growth conditions compared to conventionally raised chickens. The purpose of this study was to evaluate the difference in microbial populations from naked neck chicken ceca fed with commercial prebiotics derived from brewer's yeast cell wall via an Illumina MiSeq platform. A total of 147 day-of-hatch naked neck chickens were distributed into 3 groups consisted of 1) C: control (no prebiotic), 2) T1: Biolex (R) MB40 with 0.2%, and 3) T2: Leiber (R) ExCel with 0.2%, consistently supplemented prebiotics during the experimental period. At 8 weeks, a total of 15 birds from each group were randomly selected and ceca removed for DNA extraction. The Illumina Miseq platform based on V4 region of 16S rRNA gene was applied for microbiome analysis. Both treatments exhibited limited impact on the microbial populations at the phylum level, with no significant differences in the OTU number of Bacteroidetes among groups and an increase of Proteobacteria OTUs for the T1 (Biolex (R) MB40) group. In addition there was a significant increase of genus Faecalibacterium OTU, phylum Firmicutes. According to the development of next generation sequencing (NGS), microbiome analysis based on 16S rRNA gene proved to be informative on the prebiotic impact on poultry gut microbiota in pasture-raised naked neck birds.	[Park, Si Hong; Lee, Sang In; Ricke, Steven C.] Univ Arkansas, Dept Food Sci, Ctr Food Safety, Fayetteville, AR 72704 USA; [Lee, Sang In; Ricke, Steven C.] Univ Arkansas, Cellular & Mol Biol Grad Program, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Ricke, SC (corresponding author), Univ Arkansas, Dept Food Sci, Ctr Food Safety, Fayetteville, AR 72704 USA.; Ricke, SC (corresponding author), Univ Arkansas, Cellular & Mol Biol Grad Program, Fayetteville, AR 72701 USA.	sricke@uark.edu			Leiber GmbH, Hafenstrasse, Germany	Leiber GmbH, Hafenstrasse, Germany	Research funding was awarded to author SCR and from Leiber GmbH (http://www.leibergmbh.de/), Hafenstrasse, Germany. Leiber GmbH played a role in initial phases of the project and the editing of the publication but had no additional role in final study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMS/USDA, 2008, NAT ORG PROGR; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chon JW, 2012, POULTRY SCI, V91, P2382, DOI 10.3382/ps.2011-01980; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; Diaz-Sanchez S, 2013, POULTRY SCI, V92, P562, DOI 10.3382/ps.2012-02741; Ding GZ, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-24; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fanatico AC, 2009, J APPL POULTRY RES, V18, P355, DOI 10.3382/japr.2008-00123; Fanatico AC, 2005, POULTRY SCI, V84, P1785, DOI 10.1093/ps/84.11.1785; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Hanning I, 2012, POULTRY SCI, V91, P3295, DOI 10.3382/ps.2012-02557; Hooge D. M., 2004, International Journal of Poultry Science, V3, P163; Jones FT, 2003, POULTRY SCI, V82, P613, DOI 10.1093/ps/82.4.613; Jozefiak D, 2008, J ANIM FEED SCI, V17, P392, DOI 10.22358/jafs/66633/2008; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Line J. E., 2005, International Journal of Poultry Science, V4, P81; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Meng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089862; Morales-Lopez R, 2009, POULTRY SCI, V88, P601, DOI 10.3382/ps.2008-00298; Newman K., 1994, Biotechnology in the feed industry. Proceedings of Alltech's 10th Annual Symposium, P167; Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190; Oakley BB, 2012, FEMS MICROBIOL ECOL, V79, P327, DOI 10.1111/j.1574-6941.2011.01219.x; Park S., 2014, J PROB HLTH, V2, P122; Park SH, 2013, POULTRY SCI, V92, P546, DOI 10.3382/ps.2012-02734; Park SH, 2013, FOOD BIOSCI, V1, P66, DOI DOI 10.1016/J.FBIO.2013.02.003; Park SH, 2011, FEMS MICROBIOL LETT, V316, P7, DOI 10.1111/j.1574-6968.2010.02188.x; Pelícia K, 2004, Rev. Bras. Cienc. Avic., V6, P163, DOI 10.1590/S1516-635X2004000300006; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rastall RA, 2015, CURR OPIN BIOTECH, V32, P42, DOI 10.1016/j.copbio.2014.11.002; Ricke SC, 2015, POULTRY SCI, V94, P1411, DOI 10.3382/ps/pev049; Ricke SC, 1999, CRIT REV MICROBIOL, V25, P19, DOI 10.1080/10408419991299176; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Santin E, 2001, J APPL POULTRY RES, V10, P236, DOI 10.1093/japr/10.3.236; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Shakouri MD, 2009, J ANIM PHYSIOL AN N, V93, P647, DOI 10.1111/j.1439-0396.2008.00852.x; Shaufi MAM, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0051-7; Sirri F, 2011, ANIMAL, V5, P312, DOI 10.1017/S175173111000176X; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley VG, 2004, POULTRY SCI, V83, P39, DOI 10.1093/ps/83.1.39; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tillman GE, 2011, FEMS MICROBIOL ECOL, V77, P395, DOI 10.1111/j.1574-6941.2011.01119.x; Van Loo EJ, 2012, ANNU REV FOOD SCI T, V3, P203, DOI 10.1146/annurev-food-022811-101158; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yeoman Carl J., 2012, Animal Health Research Reviews, V13, P89, DOI 10.1017/S1466252312000138; Yu H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-182; Zhang AW, 2005, POULTRY SCI, V84, P1015, DOI 10.1093/ps/84.7.1015; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	57	48	51	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151944	10.1371/journal.pone.0151944	http://dx.doi.org/10.1371/journal.pone.0151944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992104	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800120
J	Roser-Renouf, C; Maibach, EW; Li, J				Roser-Renouf, Connie; Maibach, Edward W.; Li, Jennifer			Adapting to the Changing Climate: An Assessment of Local Health Department Preparations for Climate Change-Related Health Threats, 2008-2012	PLOS ONE			English	Article							PUBLIC-HEALTH; PREPAREDNESS; METAANALYSIS; MITIGATION; PERCEPTION; BEHAVIOR; BARRIERS	Background Climate change poses a major public health threat. A survey of U.S. local health department directors in 2008 found widespread recognition of the threat, but limited adaptive capacity, due to perceived lack of expertise and other resources. Methods We assessed changes between 2008 and 2012 in local public health departments' preparedness for the public health threats of climate change, in light of increasing national polarization on the issue, and widespread funding cutbacks for public health. A geographically representative online survey of directors of local public health departments was conducted in 2011-2012 (N = 174; response rate = 50%), and compared to the 2008 telephone survey results (N = 133; response rate = 61%). Results Significant polarization had occurred: more respondents in 2012 were certain that the threat of local climate change impacts does/does not exist, and fewer were unsure. Roughly 10% said it is not a threat, compared to 1% in 2008. Adaptation capacity decreased in several areas: perceived departmental expertise in climate change risk assessment; departmental prioritization of adaptation; and the number of adaptation-related programs and services departments provided. In 2008, directors' perceptions of local impacts predicted the number of adaptation-related programs and services their departments offered, but in 2012, funding predicted programming and directors' impact perceptions did not. This suggests that budgets were constraining directors' ability to respond to local climate change-related health threats. Results also suggest that departmental expertise may mitigate funding constraints. Strategies for overcoming these obstacles to local public health departments' preparations for climate change are discussed.	[Roser-Renouf, Connie; Maibach, Edward W.] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Li, Jennifer] Natl Assoc Cty & City Hlth Officials, Washington, DC USA	George Mason University	Roser-Renouf, C (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.	croserre@gmu.edu	Maibach, Edward/A-7102-2009	Maibach, Edward/0000-0003-3409-9187	Centers for Disease Control and Prevention to the National Association for City & County Health Officials; NACCHO [2011-101305]	Centers for Disease Control and Prevention to the National Association for City & County Health Officials(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NACCHO	This research was funded by a grant from the Centers for Disease Control and Prevention to the National Association for City & County Health Officials, and was sub-contracted to Edward Maibach & Connie Roser-Renouf at the Center for Climate Change Communication at George Mason University. The sub-contract number was NACCHO contract #2011-101305.	American Public Health Association (APHA), 2011, CLIM CHANG MAST PUBL; American Public Health Association (APHA), 2014, CLIM HLTH INF; Association of State and Territorial Health Officials (ASTHO), 2009, TAK PULS CHANG NAT F; Balbus J, 2008, PREPARING PUBLIC HLT; Bedsworth L, 2009, ENVIRON HEALTH PERSP, V117, P617, DOI 10.1289/ehp.0800114; Bell E, 2011, AM J PUBLIC HEALTH, V101, P804, DOI 10.2105/AJPH.2010.202820; Bierbaum R, CLIMATE CHANGE IMPAC, P670; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Carr JL, 2012, J PUBLIC HEALTH MAN, V18, pE24, DOI 10.1097/PHH.0b013e31823dea74; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Ebi KL, 2009, ENVIRON HEALTH PERSP, V117, P857, DOI 10.1289/ehp.0800088; Frumkin H, 2015, CLIMATE CHANGE PUBLI, P231; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Hess JJ, 2014, RESPIR MED SER, V7, P341, DOI 10.1007/978-1-4614-8417-2_20; Huang CR, 2011, AM J PREV MED, V40, P183, DOI 10.1016/j.amepre.2010.10.025; Johnson TD, 2012, NATIONS HLTH, V42, pE17; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kintisch E., 2012, SCI INSIDER; Leiserowitz A, 2015, CLIMATE CHANGE AM CA; Luber G, CLIMATE CHANGE IMPAC, P220; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Maibach EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002838; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Media Matters for America, 2015, STUD BROADC NETW COV; Milwaukee Metropolitan Area HeatTask Force, 2014, EXC HEAT EVENT COORD; NACCHO, 2014, 2 NACCHO; National Association of County and City Health Officials (NACCHO), 2014, LOC HLTH DEP BUDG CU; National Association of County and City Health Officials (NACCHO), 2012, LOC HLTH DEP JOB LOS; Polivka BJ, 2012, ENVIRON HEALTH PERSP, V120, P321, DOI 10.1289/ehp.1104025; Sarfaty M, 2016, J ALLER CL IMM-PRACT, V4, P333, DOI 10.1016/j.jaip.2015.09.018; Sarfaty M, 2015, ANN AM THORAC SOC, V12, P274, DOI 10.1513/AnnalsATS.201410-460BC; Sarfaty M, 2014, INT J ENV RES PUB HE, V11, P12473, DOI 10.3390/ijerph111212473; Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA306, DOI 10.1289/ehp.117-a306; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Syal SS, 2011, MITIG ADAPT STRAT GL, V16, P911, DOI 10.1007/s11027-011-9302-1; United States Global Research Change Program (USGCRP), 2014, NAT CLIM ASS; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Vynn S, 2009, CLIMATE LEADERSHIP I; Weed DL, 2004, J MED PHILOS, V29, P313, DOI 10.1080/03605310490500527; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	43	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151558	10.1371/journal.pone.0151558	http://dx.doi.org/10.1371/journal.pone.0151558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991658	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800076
J	Xue, BH; Li, Y; He, YL; Wei, RY; Sun, RZ; Yin, Z; Bou, G; Liu, ZH				Xue, Binghua; Li, Yan; He, Yilong; Wei, Renyue; Sun, Ruizhen; Yin, Zhi; Bou, Gerelchimeg; Liu, Zhonghua			Porcine Pluripotent Stem Cells Derived from IVF Embryos Contribute to Chimeric Development In Vivo	PLOS ONE			English	Article							CULTURE-CONDITIONS; VITRO DIFFERENTIATION; SELF-RENEWAL; BLASTOCYSTS; PIG; LINES; MASS; ESTABLISHMENT; EXPRESSION; NAIVE	Although the pig is considered an important model of human disease and an ideal animal for the preclinical testing of cell transplantation, the utility of this model has been hampered by a lack of genuine porcine embryonic stem cells. Here, we derived a porcine pluripotent stem cell (pPSC) line from day 5.5 blastocysts in a newly developed culture system based on MXV medium and a 5% oxygen atmosphere. The pPSCs had been passaged more than 75 times over two years, and the morphology of the colony was similar to that of human embryonic stemcells. Characterization and assessment showed that the pPSCs were alkaline phosphatase (AKP) positive, possessed normal karyotypes and expressed classic pluripotent markers, including OCT4, SOX2 and NANOG. In vitro differentiation through embryonic body formation and in vivo differentiation via teratoma formation in nude mice demonstrated that the pPSCs could differentiate into cells of the three germ layers. The pPSCs transfected with fuw-DsRed (pPSC-FDs) could be passaged with a stable expression of both DsRed and pluripotent markers. Notably, when pPSC-FDs were used as donor cells for somatic nuclear transfer, 11.52% of the reconstructed embryos developed into blastocysts, which was not significantly different from that of the reconstructed embryos derived from porcine embryonic fibroblasts. When pPSC-FDs were injected into day 4.5 blastocysts, they became involved in the in vitro embryonic development and contributed to the viscera of foetuses at day 50 of pregnancy as well as the developed placenta after the chimeric blastocysts were transferred into recipients. These findings indicated that the pPSCs were porcine pluripotent cells; that this would be a useful cell line for porcine genetic engineering and a valuable cell line for clarifying the molecular mechanism of pluripotency regulation in pigs.	[Xue, Binghua; Li, Yan; He, Yilong; Wei, Renyue; Yin, Zhi; Bou, Gerelchimeg; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Sun, Ruizhen] Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China	Northeast Agricultural University - China; Harbin Medical University	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China.	liuzhonghua@neau.edu.cn			National Natural Science Foundation of China [31371457]; High Technology Research and Development Program of China (863 Program) [2012AA020601]; National Basic Research Program of China (Program 973) [2011CBA01000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (Program 973)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grant number 31371457), the High Technology Research and Development Program of China (863 Program) (grant number 2012AA020601) and the National Basic Research Program of China (Program 973) (grant number 2011CBA01000).	ANDERSON GB, 1994, THERIOGENOLOGY, V42, P204, DOI 10.1016/0093-691X(94)90676-A; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Blomberg LA, 2008, MOL REPROD DEV, V75, P450, DOI 10.1002/mrd.20780; Brevini TAL, 2008, REPROD DOMEST ANIM, V43, P193, DOI 10.1111/j.1439-0531.2008.01161.x; Brevini TAL, 2007, THERIOGENOLOGY, V68, pS206, DOI 10.1016/j.theriogenology.2007.05.043; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Chen LR, 1999, THERIOGENOLOGY, V52, P195, DOI 10.1016/S0093-691X(99)00122-3; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Choi KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072184; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dodsworth BT, 2015, STEM CELLS, V33, P3181, DOI 10.1002/stem.2085; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; EVANS MJ, 1990, THERIOGENOLOGY, V33, P125, DOI 10.1016/0093-691X(90)90603-Q; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Hall VJ, 2014, STEM CELLS DEV, V23, P2030, DOI 10.1089/scd.2013.0502; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; HOCHEREAUDEREVIERS MT, 1993, REPROD NUTR DEV, V33, P475, DOI 10.1051/rnd:19930508; Jung SK, 2014, J VET SCI, V15, P519, DOI 10.4142/jvs.2014.15.4.519; KASHIWAZAKI N, 1992, VET REC, V130, P186, DOI 10.1136/vr.130.9.186; Kim HS, 2007, ZYGOTE, V15, P55, DOI 10.1017/S0967199406003972; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li M, 2004, J REPROD DEVELOP, V50, P237, DOI 10.1262/jrd.50.237; Li M, 2004, ZYGOTE, V12, P43, DOI 10.1017/S0967199404002679; Li M, 2003, MOL REPROD DEV, V65, P429, DOI 10.1002/mrd.10301; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Moore K, 1997, IN VITRO CELL DEV-AN, V33, P62; Moore K, 1996, MOL REPROD DEV, V45, P139, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;139::AID-MRD5&gt;3.0.CO;2-U; MUMMERY CL, 1993, BIOCHEM BIOPH RES CO, V191, P188, DOI 10.1006/bbrc.1993.1201; Nagashima H, 2004, BIOL REPROD, V70, P702, DOI 10.1095/biolreprod.103.022681; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; NOTARIANNI E, 1990, J REPROD FERTIL, P51; ONISHI A, 1994, BIOL REPROD, V51, P1069, DOI 10.1095/biolreprod51.6.1069; Park Ji-Yeun, 2013, Evid Based Complement Alternat Med, V2013, P982095, DOI 10.1155/2013/982095; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P865, DOI 10.1016/0093-691X(90)90558-B; Rui R, 2006, THERIOGENOLOGY, V65, P713, DOI 10.1016/j.theriogenology.2005.04.033; Samuelson Linda C, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4483; Son HY, 2009, ASIAN AUSTRAL J ANIM, V22, P26, DOI 10.5713/ajas.2009.80343; Stroband H W, 1990, J Reprod Fertil Suppl, V40, P261; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; TALBOT NC, 1993, IN VITRO CELL DEV-AN, V29A, P543; Tan GY, 2012, ZYGOTE, V20, P347, DOI 10.1017/S096719941100030X; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Vassiliev I, 2010, J REPROD DEVELOP, V56, P546, DOI 10.1262/jrd.09-197A; Vassiliev I, 2010, CELL REPROGRAM, V12, P223, DOI 10.1089/cell.2009.0053; Wang JY, 2013, STEM CELL REV REP, V9, P700, DOI 10.1007/s12015-013-9439-2; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yang JR, 2009, CLONING STEM CELLS, V11, P235, DOI 10.1089/clo.2008.0050; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	56	36	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151737	10.1371/journal.pone.0151737	http://dx.doi.org/10.1371/journal.pone.0151737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991423	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800094
J	Deng, J; Sun, PS; Zhao, FX; Han, XH; Yang, GH; Feng, YZ; Ren, GX				Deng, Jian; Sun, Pingsheng; Zhao, Fazhu; Han, Xinhui; Yang, Gaihe; Feng, Yongzhong; Ren, Guangxin			Soil C, N, P and Its Stratification Ratio Affected by Artificial Vegetation in Subsoil, Loess Plateau China	PLOS ONE			English	Article							DRY COMBUSTION METHODS; ORGANIC-CARBON; LAND-USE; SAMPLING DEPTH; AFFORESTATION; DYNAMICS; MATTER; NITROGEN; FOREST; SEQUESTRATION	Artificial vegetation restoration can induce variations in accumulation and distribution of soil carbon (C), nitrogen (N) and phosphorus (P). However, little is known about variations in soil C, N and P nutrient fraction stratification following artificial vegetation in Loess Plateau China. Based on the hypothesis that re-vegetated can improve soil quality and stratification ratios (SR) can be used as an indicator to evaluate soil quality. This study measured contents and storages of soil organic carbon (SOC), total nitrogen (TN), total phosphorus (TP) and their SRs in topsoil (0-20 cm) and subsoil (20-60 cm) in three 30-year re-vegetated lands that had been converted from arable land (Robinia pseudoacacia L., Caragana Korshinskii Kom. and abandoned cropland with low interferences and few management measures) and one slope cropland (SC) as a control for three soil profiles(0-20 cm, 20-40 cm and 40-60 cm) from June 2009 to June 2013. The results showed that the contents and storages of SOC, TN and TP in re-vegetated land were significantly higher than those in the SC in both topsoil and subsoil. The storages of SOC, TN and TP in the topsoil (0-20 cm) of the re-vegetated lands increased by 16.2%-26.4%, 12.7%-28.4% and 16.5%-20.9%, respectively, and increased by smaller but significant amounts in subsoil from 2009 to 2013. The SRs for SOC, TN and TP in the re-vegetated lands were mostly >2 (either for 0-20: 2040 cm or 0-20: 40-60 cm) and greater than that in the SC. The SRs showed an increasing trend with increasing restoration age. The results also showed that the land use type and soil depth were the most influential factors for the SRs and storages, and the SRs of SOC and TN had significantly positive correlations with their storages. The SRs were concluded to be a good indicator for evaluating the soil quality, which can be significantly enhanced through vegetation restoration. Moreover, vegetation restoration can significantly enhance SOC, TN and TP accumulation in both topsoil and subsoil.	[Deng, Jian; Sun, Pingsheng; Zhao, Fazhu; Han, Xinhui; Yang, Gaihe; Feng, Yongzhong; Ren, Guangxin] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Deng, Jian; Sun, Pingsheng; Yang, Gaihe; Feng, Yongzhong; Ren, Guangxin] Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Yang, GH (corresponding author), Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012; Deng, Jian/E-2988-2014	Feng, Yongzhong/0000-0002-5202-4368; Deng, Jian/0000-0002-0841-7084	Special Fund for forest-scientific Research in the Public Interest [201304312]; National Natural Science Foundation of China [41301601]; Science and Technology Coordinating Innovative Engineering project of Shaanxi province [2015KTCL02-07]	Special Fund for forest-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Coordinating Innovative Engineering project of Shaanxi province	The study was financially supported by Special Fund for forest-scientific Research in the Public Interest (No. 201304312) (http://www.forestry.gov.cn), National Natural Science Foundation of China (No. 41301601) (http://www.nsfc.gov.cn/) and the Science and Technology Coordinating Innovative Engineering project of Shaanxi province (No. 2015KTCL02-07)(http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; An SS, 2010, CATENA, V81, P226, DOI 10.1016/j.catena.2010.04.002; [Anonymous], 2015, PRIMER 7 USER MANUAL; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; Cannell MGR, 1999, FORESTRY, V72, P237, DOI 10.1093/forestry/72.3.237; Chang RY, 2012, CATENA, V95, P145, DOI 10.1016/j.catena.2012.02.012; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Sa JCDM, 2013, SOIL SCI SOC AM J, V77, P2094, DOI 10.2136/sssaj2013.01.0007; Ellert BH, 1995, CAN J SOIL SCI, V75, P529, DOI 10.4141/cjss95-075; Feng X, 2013, SCI REPORTS, V3; Francaviglia R, 2014, AGR ECOSYST ENVIRON, V183, P86, DOI 10.1016/j.agee.2013.10.026; Franzluebbers AJ, 2002, SOIL TILL RES, V66, P95, DOI 10.1016/S0167-1987(02)00018-1; Fu BJ, 2000, CATENA, V39, P69, DOI 10.1016/S0341-8162(99)00084-3; Grieve IC, 2001, CATENA, V42, P361, DOI 10.1016/S0341-8162(00)00147-8; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Hok L, 2015, AGR ECOSYST ENVIRON, V214, P54, DOI 10.1016/j.agee.2015.08.013; Jia GM, 2005, FOREST ECOL MANAG, V217, P117, DOI 10.1016/j.foreco.2005.05.055; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Klute A., 1986, METHODS SOIL ANAL 1; Korkanc SY, 2014, CATENA, V123, P62, DOI 10.1016/j.catena.2014.07.009; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lima AMN, 2006, FOREST ECOL MANAG, V235, P219, DOI 10.1016/j.foreco.2006.08.331; Liu GB, 1999, AMBIO, V28, P663; Macdonald CA, 2009, SOIL BIOL BIOCHEM, V41, P1642, DOI 10.1016/j.soilbio.2009.05.003; Mikhailova EA, 2003, COMMUN SOIL SCI PLAN, V34, P1853, DOI 10.1081/CSS-120023220; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Peregrina F, 2014, J PLANT NUTR SOIL SC, V177, P548, DOI 10.1002/jpln.201300371; Qiu LP, 2010, PLANT SOIL, V332, P207, DOI 10.1007/s11104-010-0286-5; Raiesi F, 2012, PLANT SOIL, V351, P161, DOI 10.1007/s11104-011-0941-5; Ruiz-Navarro A, 2009, GEODERMA, V153, P353, DOI 10.1016/j.geoderma.2009.08.024; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; SMECK NE, 1985, GEODERMA, V36, P185, DOI 10.1016/0016-7061(85)90001-1; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tfaily MM, 2014, J GEOPHYS RES-BIOGEO, V119, P661, DOI 10.1002/2013JG002492; Tivet F, 2012, SOIL SCI SOC AM J, V76, P1048, DOI 10.2136/sssaj2011.0328; VandenBygaart AJ, 2011, SOIL SCI SOC AM J, V75, P226, DOI 10.2136/sssaj2010.0099; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Wang YF, 2010, QUATERNARY RES, V73, P70, DOI 10.1016/j.yqres.2008.11.006; Xue Sha, 2009, Scientia Agricultura Sinica, V42, P1458; Zhang CB, 2014, J ARID LAND, V6, P601, DOI 10.1007/s40333-014-0004-x; Zhang DJ, 2014, PLANT SOIL, V376, P307, DOI 10.1007/s11104-013-1954-z; Zhao FZ, 2015, ECOL ENG, V74, P415, DOI 10.1016/j.ecoleng.2014.11.010; Zhao FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099657; Zhao FZ, 2013, SOIL SCI, V178, P550, DOI 10.1097/SS.0000000000000018; Zheng ZC, 2012, WATER SCI ENG, V5, P191, DOI 10.3882/j.issn.1674-2370.2012.02.007	51	36	40	9	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151446	10.1371/journal.pone.0151446	http://dx.doi.org/10.1371/journal.pone.0151446			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987057	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300072
J	Severo, ETD; Calonego, FW; Sansigolo, CA; Bond, B				Durgante Severo, Elias Taylor; Calonego, Fred Willians; Sansigolo, Claudio Angeli; Bond, Brian			Changes in the Chemical Composition and Decay Resistance of Thermally-Modified Hevea brasiliensis Wood	PLOS ONE			English	Article							NATURAL DURABILITY; MATURE WOODS; JUVENILE; EUCALYPTUS; HEARTWOOD; BEECH	In this study the effect of thermal treatment on the equilibrium moisture content, chemical composition and biological resistance to decay fungi of juvenile and mature Hevea brasiliensis wood (rubber wood) was evaluated. Samples were taken from a 53-year-old rubber wood plantation located in Tabapua, Sao Paulo, Brazil. The samples were thermally-modified at 180 degrees C, 200 degrees C and 220 degrees C. Results indicate that the thermal modification caused: (1) a significant increase in the extractive content and proportional increase in the lignin content at 220 degrees C; (2) a significant decrease in the equilibrium moisture content, holocelluloses, arabinose, galactose and xylose content, but no change in glucose content; and (3) a significant increase in wood decay resistance against both Pycnoporus sanguineus (L.) Murrill and Gloeophyllum trabeum (Pers.) Murrill decay fungi. The greatest decay resistance was achieved from treatment at 220 degrees C which resulted in a change in wood decay resistance class from moderately resistant to resistant. Finally, this study also demonstrated that the influence of thermal treatment in mature wood was lower than in juvenile wood.	[Durgante Severo, Elias Taylor; Calonego, Fred Willians; Sansigolo, Claudio Angeli] Sao Paulo State Univ, UNESP, Fac Agr Sci, Dept Forest Sci, Sao Paulo, Brazil; [Durgante Severo, Elias Taylor; Bond, Brian] Virginia Tech, Brooks Forest Prod Ctr, Dept Sustainable Biomat, Blacksburg, VA USA; [Durgante Severo, Elias Taylor] Fazenda Expt Lageado, Fac Agr Sci, Dept Forest Sci, POB 237, BR-18603970 Botucatu, SP, Brazil; [Bond, Brian] Virginia Polytech Inst & State Univ, Brooks Forest Prod Ctr, 1650 Ramble Rd, Blacksburg, VA 24061 USA	Universidade Estadual Paulista; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Severo, ETD (corresponding author), Sao Paulo State Univ, UNESP, Fac Agr Sci, Dept Forest Sci, Sao Paulo, Brazil.; Severo, ETD (corresponding author), Virginia Tech, Brooks Forest Prod Ctr, Dept Sustainable Biomat, Blacksburg, VA USA.; Severo, ETD (corresponding author), Fazenda Expt Lageado, Fac Agr Sci, Dept Forest Sci, POB 237, BR-18603970 Botucatu, SP, Brazil.	severo@fca.unesp.br	Severo, Elias T. D./H-5210-2013	Bond, Brian/0000-0001-6712-8250; Calonego, Fred Willians/0000-0002-1597-5586	Research Assistance Foundation from Sao Paulo (FAPESP), Brazil [2013/15372-0]	Research Assistance Foundation from Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors thank the Research Assistance Foundation from Sao Paulo (FAPESP), Brazil, for financial support through grant numbers 2013/15372-0.; The authors thank the Research Assistance Foundation from Sao Paulo (FAPESP), Brazil, for financial support through grant numbers 2013/15372-0.	American Society for Testing and Materials, 2008, D2017 ASTM; [Anonymous], 1999, 222OM98 TAPPI; [Anonymous], 2007, D1413 ASTM, DOI 10.31520/D1413-073; [Anonymous], 1999, 264CM97 TAPPI; Bachle H, 2010, WOOD SCI TECHNOL, V44, P421, DOI 10.1007/s00226-010-0361-3; Bhuiyan MTR, 2000, J WOOD SCI, V46, P431, DOI 10.1007/BF00765800; Brito JO, 2008, BIORESOURCE TECHNOL, V99, P8545, DOI 10.1016/j.biortech.2008.03.069; Calonego FW, 2012, EUR J WOOD WOOD PROD, V70, P453, DOI 10.1007/s00107-011-0568-5; Calonego FW, 2010, BIORESOURCE TECHNOL, V101, P9391, DOI 10.1016/j.biortech.2010.06.119; Esteves B, 2008, HOLZFORSCHUNG, V62, P344, DOI 10.1515/HF.2008.057; Ferreira A, 2011, EUR J WOOD WOOD PROD, V69, P659, DOI 10.1007/s00107-010-0510-2; Goldschmid O., 1971, LIGNINS OCCURRENCE F, P241; Hakkou M, 2006, POLYM DEGRAD STABIL, V91, P393, DOI 10.1016/j.polymdegradstab.2005.04.042; Haupt M, 2003, HOLZ ROH WERKST, V61, P473, DOI 10.1007/s00107-003-0428-z; Homan W, 2000, P WORLD C TIMB ENG B; HONG LT, 1994, RUBBERWOOD PROCESSIN, P37; Hong LT, 1995, 20 INT UN FOR RES OR; KADIR AA, 1989, HOLZFORSCHUNG, V43, P173, DOI 10.1515/hfsg.1989.43.3.173; Kopitovic S., 1989, Drevarsky Vyskum, P13; Latorraca JVF, 2011, AN ACAD BRAS CIENC, V83, P1059, DOI 10.1590/S0001-37652011005000016; Lenth CA, 2001, WOOD FIBER SCI, V33, P104; Metsa-Kortelainen S, WATER; Severo ETD, 2013, EUR J WOOD WOOD PROD, V71, P815, DOI 10.1007/s00107-013-0731-2; Severo ETD, 2012, EUR J WOOD WOOD PROD, V70, P741, DOI 10.1007/s00107-012-0611-1; Severo ETD, 2009, PI0902388A2 INPI; Shanks RA, 2011, J THERM ANAL CALORIM, V106, P93, DOI 10.1007/s10973-011-1620-8; SULLIVAN J, 1994, J CHROMATOGR A, V671, P339, DOI 10.1016/0021-9673(94)80259-9; Teoh YP, 2011, J WOOD SCI, V57, P255, DOI 10.1007/s10086-011-1173-2; Vernois M, 2001, REV HEAT TREATMENTS; Waskett P, 2001, OPPORTUNITIES UK GRO, P83; Weiland JJ, 2003, HOLZ ROH WERKST, V61, P216, DOI 10.1007/s00107-003-0364-y; Wikberg H, 2004, CARBOHYD POLYM, V58, P461, DOI 10.1016/j.carbpol.2004.08.008	32	26	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151353	10.1371/journal.pone.0151353	http://dx.doi.org/10.1371/journal.pone.0151353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986200	gold, Green Published, Green Submitted			2022-12-27	WOS:000372580300066
J	Kessans, SA; Linhart, MD; Meador, LR; Kilbourne, J; Hogue, BG; Fromme, P; Matoba, N; Mor, TS				Kessans, Sarah A.; Linhart, Mark D.; Meador, Lydia R.; Kilbourne, Jacquelyn; Hogue, Brenda G.; Fromme, Petra; Matoba, Nobuyuki; Mor, Tsafrir S.			Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles	PLOS ONE			English	Article							PROXIMAL EXTERNAL REGION; NEUTRALIZING MONOCLONAL-ANTIBODIES; TRANSCYTOSIS-BLOCKING ABS; T-CELL RESPONSES; IMMUNE-RESPONSES; EPITHELIAL TRANSCYTOSIS; TRANSMEMBRANE DOMAIN; VACCINE CANDIDATE; ORAL IMMUNIZATION; GLYCOPROTEIN GP41	It is widely anticipated that a prophylactic vaccine may be needed to control the HIV/AIDS epidemic worldwide. Despite over two decades of research, a vaccine against HIV-1 remains elusive, although a recent clinical trial has shown promising results. Recent studies have focused on highly conserved domains within HIV-1 such as the membrane proximal external region (MPER) of the envelope glycoprotein, gp41. MPER has been shown to play critical roles in mucosal transmission of HIV-1, though this peptide is poorly immunogenic on its own. Here we provide evidence that plant-produced HIV-1 enveloped virus-like particles (VLPs) consisting of Gag and a deconstructed form of gp41 comprising the MPER, transmembrane, and cytoplasmic domains (Dgp41) provides an effective platform to display MPER for use as an HIV vaccine candidate. Prime-boost strategies combining systemic and mucosal priming with systemic boosting using two different vaccine candidates (VLPs and CTB-MPR-a fusion of MPER and the B-subunit of cholera toxin) were investigated in BALB/c mice. Serum antibody responses against both the Gag and gp41 antigens were elicited when systemically primed with VLPs. These responses could be recalled following systemic boosting with VLPs. In addition, mucosal priming with VLPs allowed for a boosting response against Gag and gp41 when boosted with either candidate. Importantly, the VLPs also induced Gag-specific CD4 and CD8 T-cell responses. This report on the immunogenicity of plant-based Gag/Dgp41 VLPs may represent an important milestone on the road towards a broadly efficacious and inexpensive subunit vaccine against HIV-1.	[Kessans, Sarah A.; Linhart, Mark D.; Meador, Lydia R.; Hogue, Brenda G.; Matoba, Nobuyuki; Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Kessans, Sarah A.; Linhart, Mark D.; Meador, Lydia R.; Kilbourne, Jacquelyn; Hogue, Brenda G.; Matoba, Nobuyuki; Mor, Tsafrir S.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Hogue, Brenda G.; Fromme, Petra] Arizona State Univ, Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ USA; [Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Kessans, Sarah A.] Univ Canterbury, Dept Chem, Biomol Interact Ctr, Christchurch 1, New Zealand; [Matoba, Nobuyuki] Owensboro Canc Res Program, Owensboro, KY USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Matoba, Nobuyuki] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Louisville; University of Louisville	Mor, TS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.; Mor, TS (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ USA.	tsafrir.mor@asu.edu		Hogue, Brenda/0000-0002-4545-9208; Matoba, Nobuyuki/0000-0001-7231-3004; Fromme, Petra/0000-0003-0953-4909	National Institutes of Health, National Institute of Allergy and Infectious diseases [U19 AI062150]; Center for Membrane Proteins in Infectious Diseases (MPID); Protein Structure Initiative (PSI: Biology) of the National Institute of General Medicine Science; National Institutes of Health [1U54 GM094625]; National Institutes of Health, the National Institute of Allergy and Infectious Diseases [R03 AI073157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062150, R03AI073157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094625] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Membrane Proteins in Infectious Diseases (MPID); Protein Structure Initiative (PSI: Biology) of the National Institute of General Medicine Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by the National Institutes of Health, National Institute of Allergy and Infectious diseases (U19 AI062150 to TM); by the Center for Membrane Proteins in Infectious Diseases (MPID), which is funded by the Protein Structure Initiative (PSI: Biology) of the National Institute of General Medicine Science, the National Institutes of Health (1U54 GM094625 to PF, BGH, and TSM); and the National Institutes of Health, the National Institute of Allergy and Infectious Diseases and R03 AI073157 to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Balasubramaniam M, 2011, PHYSIOLOGY, V26, P236, DOI 10.1152/physiol.00051.2010; Benjelloun F, 2013, AIDS, V27, P1992, DOI 10.1097/QAD.0b013e3283632ea1; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Bouvin-Pley M, 2014, J VIROL, V88, P13910, DOI 10.1128/JVI.02083-14; Broliden K, 2001, IMMUNOL LETT, V79, P29, DOI 10.1016/S0165-2478(01)00263-2; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Doan LX, 2005, REV MED VIROL, V15, P75, DOI 10.1002/rmv.449; Durrani Z, 1998, J IMMUNOL METHODS, V220, P93, DOI 10.1016/S0022-1759(98)00145-8; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gong Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136507; Gong Z, 2014, PROTEIN SCI, V23, P1607, DOI 10.1002/pro.2540; Gonzalez-Rabade N, 2011, PLANT BIOTECHNOL J, V9, P629, DOI 10.1111/j.1467-7652.2011.00609.x; Guetard D, 2008, VACCINE, V26, P4477, DOI 10.1016/j.vaccine.2008.06.059; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Haynes BF, 2014, SCIENCE, V344, P588, DOI 10.1126/science.1254990; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Ivankin A, 2012, BBA-BIOMEMBRANES, V1818, P2521, DOI 10.1016/j.bbamem.2012.06.002; Kaul R, 2001, AIDS, V15, P431, DOI 10.1097/00002030-200102160-00026; Kessans SA, 2013, PLANT BIOTECHNOL J, V11, P681, DOI 10.1111/pbi.12058; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910; Kuehn BM, 2015, JAMA-J AM MED ASSOC, V313, P1000, DOI 10.1001/jama.2015.0942; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Leary S, 2013, AVMA GUIDELINES EUTH; Leroux-Roels G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055438; Lindh I, 2008, APMIS, V116, P985, DOI 10.1111/j.1600-0463.2008.00900.x; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Matoba N, 2004, P NATL ACAD SCI USA, V101, P13584, DOI 10.1073/pnas.0405297101; Matoba N, 2009, PLANT BIOTECHNOL J, V7, P129, DOI 10.1111/j.1467-7652.2008.00381.x; Matoba N, 2008, CURR HIV RES, V6, P218, DOI 10.2174/157016208784324994; Matoba N, 2006, VACCINE, V24, P5047, DOI 10.1016/j.vaccine.2006.03.045; Matoba N, 2011, VACCINE, V29, P5584, DOI 10.1016/j.vaccine.2011.06.007; McCarthy M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5488; McInerney TL, 1999, VACCINE, V17, P1359, DOI 10.1016/S0264-410X(98)00388-0; McLain L, 1996, VACCINE, V14, P799, DOI 10.1016/0264-410X(95)00229-T; Meyers A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-53; Montefiori DC, 2001, J VIROL, V75, P5879, DOI 10.1128/JVI.75.13.5879-5890.2001; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Mor TS, 2001, BIOTECHNOL BIOENG, V75, P259, DOI 10.1002/bit.10012; Ofek G, 2014, J VIROL, V88, P2426, DOI 10.1128/JVI.02837-13; Pastori C, 2012, VIROLOGY, V431, P1, DOI 10.1016/j.virol.2012.05.005; Perez-Filgueira DM, 2004, J VIROL METHODS, V121, P201, DOI 10.1016/j.jviromet.2004.06.022; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Rybicki EP, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0205-0; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Sagar M, 2012, J INFECT DIS, V205, P1248, DOI 10.1093/infdis/jis183; Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053; Scotti N, 2009, PLANTA, V229, P1109, DOI 10.1007/s00425-009-0898-2; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Thanavala Y, 2005, P NATL ACAD SCI USA, V102, P3378, DOI 10.1073/pnas.0409899102; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Tudor D, 2011, AIDS, V25, P751, DOI 10.1097/QAD.0b013e32834507bd; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Verkoczy L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004073; Verkoczy L, 2013, J IMMUNOL, V191, P2538, DOI 10.4049/jimmunol.1300971; Wang J, 2011, VACCINE, V29, P8542, DOI 10.1016/j.vaccine.2011.09.032; Williamson AL, 2016, EXPERT REV VACCINES, V15, P585, DOI 10.1586/14760584.2016.1129904; Zhang XR, 2006, PLANT BIOTECHNOL J, V4, P419, DOI 10.1111/j.1467-7652.2006.00191.x; Zhang YF, 2014, SCI CHINA LIFE SCI, V57, P987, DOI 10.1007/s11427-014-4746-7; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zimran A, 2015, BLOOD CELL MOL DIS, V54, P9, DOI 10.1016/j.bcmd.2014.10.002; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	75	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151842	10.1371/journal.pone.0151842	http://dx.doi.org/10.1371/journal.pone.0151842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986483	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300139
J	Kluge, M; Campos, FS; Tavares, M; de Amorim, DB; Valdez, FP; Giongo, A; Roehe, PM; Franco, AC				Kluge, Mariana; Campos, Fabricio Souza; Tavares, Mauricio; de Amorim, Derek Blaese; Valdez, Fernanda Pedone; Giongo, Adriana; Roehe, Paulo Michel; Franco, Ana Claudia			Metagenomic Survey of Viral Diversity Obtained from Feces of Subantarctic and South American Fur Seals	PLOS ONE			English	Article							GROUP-C ROTAVIRUS; CROSS-SPECIES TRANSMISSION; HEPATITIS-E VIRUS; VESICULAR EXANTHEMA; DIARRHEIC DOGS; FECAL VIROME; LION VIRUS; CHILDREN; PICOBIRNAVIRUS; PARVOVIRUS	The Brazilian South coast seasonally hosts numerous marine species, observed particularly during winter months. Some animals, including fur seals, are found dead or debilitated along the shore and may harbor potential pathogens within their microbiota. In the present study, a metagenomic approach was performed to evaluate the viral diversity in feces of fur seals found deceased along the coast of the state of Rio Grande do Sul. The fecal virome of two fur seal species was characterized: the South American fur seal (Arctocephalus australis) and the Subantarctic fur seal (Arctocephalus tropicalis). Fecal samples from 10 specimens (A. australis, n = 5; A. tropicalis, n = 5) were collected and viral particles were purified, extracted and amplified with a random PCR. The products were sequenced through Ion Torrent and Illumina platforms and assembled reads were submitted to BLASTx searches. Both viromes were dominated by bacteriophages and included a number of potentially novel virus genomes. Sequences of picobirnaviruses, picornaviruses and a hepevirus-like were identified in A. australis. A rotavirus related to group C, a novel member of the Sakobuvirus and a sapovirus very similar to California sea lion sapovirus 1 were found in A. tropicalis. Additionally, sequences of members of the Anelloviridae and Parvoviridae families were detected in both fur seal species. This is the first metagenomic study to screen the fecal virome of fur seals, contributing to a better understanding of the complexity of the viral community present in the intestinal microbiota of these animals.	[Kluge, Mariana; Campos, Fabricio Souza; Roehe, Paulo Michel; Franco, Ana Claudia] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Virol Lab, Porto Alegre, RS, Brazil; [Tavares, Mauricio; de Amorim, Derek Blaese] Univ Fed Rio Grande do Sul, CECLIMAR Ctr Coastal Limnol & Marine Studies, Imbe, RS, Brazil; [Valdez, Fernanda Pedone] PUCRS Pontif Catholic Univ Rio Grande do Sul, Genom & Mol Biol Lab, Porto Alegre, RS, Brazil; [Giongo, Adriana] PUCRS Pontif Catholic Univ Rio Grande do Sul, IPR Inst Petr & Nat Resources, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Franco, AC (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Microbiol Immunol & Parasitol, Virol Lab, Porto Alegre, RS, Brazil.	anafranco.ufrgs@gmail.com	ROEHE, PAULO MICHEL/K-1208-2012; Campos, Fabricio S/D-8819-2014; Tavares, Maurício/D-6801-2015; Giongo, Adriana/P-8718-2015; Franco, Ana Cláudia AC/N-4373-2015	ROEHE, PAULO MICHEL/0000-0002-2370-7661; Campos, Fabricio S/0000-0002-5948-472X; Tavares, Maurício/0000-0003-3618-9928; Giongo, Adriana/0000-0002-1412-7040; Kluge, Mariana/0000-0001-7500-2041; Franco, Ana/0000-0001-7747-5125	National Council for the Improvement of Higher Education (CAPES); National Council for Scientific and Technological Development (CNPq); Study and Project Funding Agency (FINEP)	National Council for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Study and Project Funding Agency (FINEP)	The research leading to these results has received funding from the National Council for the Improvement of Higher Education (CAPES-http://www.capes.gov.br/), the National Council for Scientific and Technological Development (CNPq-http://www.cnpq.br/), and the Study and Project Funding Agency (FINEP-http://www.finep.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2015, ARCH VIROL, V160, P1837, DOI 10.1007/s00705-015-2425-z; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allison AB, 2013, J VIROL, V87, P2342, DOI 10.1128/JVI.02428-12; Allison AB, 2012, J VIROL, V86, P865, DOI 10.1128/JVI.06187-11; Arbiza J., 2012, NEW APPROACHES STUDY, V2, P151, DOI DOI 10.5772/54214; Attoui H., 2011, VIRUS TAXONOMY, P541; Barry AF, 2011, INFECT GENET EVOL, V11, P1811, DOI 10.1016/j.meegid.2011.06.020; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Bester M.N., 1987, NOAA Technical Report NMFS, V51, P57; Bhattacharya R, 2007, INFECT GENET EVOL, V7, P229, DOI 10.1016/j.meegid.2006.09.005; Biagini P, 2011, VIRUS TAXONOMY CLASS, P326; Bihl F, 2010, J ANTIMICROB CHEMOTH, V65, P817, DOI 10.1093/jac/dkq085; Bodewes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079259; Burek KA, 2005, J WILDLIFE DIS, V41, P512, DOI 10.7589/0090-3558-41.3.512; Clarke I, 2011, VIRUS TAXONOMY CLASS, P977; Coria-Galindo E, 2009, J WILDLIFE DIS, V45, P722, DOI 10.7589/0090-3558-45.3.722; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; de Bruyn PJN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003757; de Oliveira Amanda, 2011, Latin American Journal of Aquatic Mammals, V9, P145; Delmas B., 2011, VIRUS TAXONOMY, P535; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Esona MD, 2008, J CLIN VIROL, V42, P221, DOI 10.1016/j.jcv.2008.02.002; Fahsbender E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09637; Ferreira JM, 2008, POLAR BIOL, V31, P303, DOI 10.1007/s00300-007-0358-z; Gabbay YB, 1999, J DIARRHOEAL DIS RES, V17, P69; Ganesh Balasubramanian, 2014, VirusDisease, V25, P223, DOI 10.1007/s13337-014-0207-y; GELBERG HB, 1982, VET PATHOL, V19, P413, DOI 10.1177/030098588201900407; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; Giordano MO, 2008, J INFECTION, V56, P371, DOI 10.1016/j.jinf.2008.02.017; Gulland F. M. D., 2001, CRC HDB MARINE MAMMA; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; Ikeda Y, 2002, EMERG INFECT DIS, V8, P341, DOI 10.3201/eid0804.010228; Kapoor A, 2008, J VIROL, V82, P311, DOI 10.1128/JVI.01240-07; Karlsson EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5791; Katz Helena, 2012, ISRN Zoology, P1; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kerley G., 1987, STATUS BIOL ECOLOGY, P61; Kim YJ, 1999, J CLIN MICROBIOL, V37, P1484, DOI 10.1128/JCM.37.5.1484-1488.1999; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Malik YS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780752; Carruyo-Nunez GM, 2014, REV CIENT-FAC CIEN V, V24, P125; Marvil P, 1999, J GEN VIROL, V80, P653, DOI 10.1099/0022-1317-80-3-653; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Mawatari T, 2004, J VET MED SCI, V66, P887, DOI 10.1292/jvms.66.887; Meng XJ, 2010, J VIRAL HEPATITIS, V17, P153, DOI 10.1111/j.1365-2893.2009.01257.x; Moura J.F., 2007, LATIN AM J AQUATIC M, V6, p103 , DOI DOI 10.5597/LAJAM00114; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Ng TFF, 2011, J GEN VIROL, V92, P1318, DOI 10.1099/vir.0.029678-0; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ogden KM, 2012, VIROLOGY, V431, P50, DOI 10.1016/j.virol.2012.05.011; Pinedo MC, 1990, G ORLA SER ZOOL, V15, P37; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sikorski A, 2013, GENOME ANNOUNC, V1, DOI [10.1099/vir.0.052654-0.17, DOI 10.1099/VIR.0.052654-0.17]; Simoes-Lopes PC, 1995, BIOCIENCIAS, V3, P173; SMITH AW, 1973, NATURE, V244, P108, DOI 10.1038/244108a0; Smith DB, 2014, J GEN VIROL, V95, P2223, DOI 10.1099/vir.0.068429-0; Soma T, 2015, MICROBIOL IMMUNOL, V59, P123, DOI 10.1111/1348-0421.12223; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; The Pirbright Institute, 2015, PIC PAG; Tijssen P., 2011, VIRUS TAXONOMY, P405; Phan TG, 2015, VIRUS GENES, V50, P134, DOI 10.1007/s11262-014-1123-3; Vaz-Ferreira R, 1982, FAO FISHERIES SERIES, V5, P497; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Wang QH, 2006, J CLIN MICROBIOL, V44, P2057, DOI 10.1128/JCM.02634-05; Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020; Woo PCY, 2012, J VIROL, V86, P6377, DOI 10.1128/JVI.00686-12; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Zhang W, 2014, J GEN VIROL, V95, P2553, DOI 10.1099/vir.0.069674-0	77	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151921	10.1371/journal.pone.0151921	http://dx.doi.org/10.1371/journal.pone.0151921			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986573	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300152
J	Kobayashi, M; Yamato, E; Tanabe, K; Tashiro, F; Miyazaki, S; Miyazaki, J				Kobayashi, Masaki; Yamato, Eiji; Tanabe, Koji; Tashiro, Fumi; Miyazaki, Satsuki; Miyazaki, Jun-ichi			Functional Analysis of Novel Candidate Regulators of Insulin Secretion in the MIN6 Mouse Pancreatic beta Cell Line	PLOS ONE			English	Article							GENE-EXPRESSION; MEMBRANE DEPOLARIZATION; MOLECULAR DETERMINANTS; GUANYLATE-CYCLASE; LENTIVIRUS VECTOR; RAT ISLETS; PROTEIN; RELEASE; IDENTIFICATION; SECRETAGOGIN	Elucidating the regulation of glucose-stimulated insulin secretion (GSIS) in pancreatic beta cells is important for understanding and treating diabetes. The pancreatic beta cell line, MIN6, retains GSIS but gradually loses it in long-term culture. The MIN6 subclone, MIN6c4, exhibits well-regulated GSIS even after prolonged culture. We previously used DNA microarray analysis to compare gene expression in the parental MIN6 cells and MIN6c4 cells and identified several differentially regulated genes that may be involved in maintaining GSIS. Here we investigated the potential roles of six of these genes in GSIS: Tmem59l (Transmembrane protein 59 like), Scgn (Secretagogin), Gucy2c (Guanylate cyclase 2c), Slc29a4 (Solute carrier family 29, member 4), Cdhr1 (Cadherin-related family member 1), and Celsr2 (Cadherin EGF LAG seven-pass G-type receptor 2). These genes were knocked down in MIN6c4 cells using lentivirus vectors expressing gene-specific short hairpin RNAs (shRNAs), and the effects of the knockdown on insulin expression and secretion were analyzed. Suppression of Tmem59l, Scgn, and Gucy2c expression resulted in significantly decreased glucose- and/ or KCl-stimulated insulin secretion from MIN6c4 cells, while the suppression of Slc29a4 expression resulted in increased insulin secretion. Tmem59l overexpression rescued the phenotype of the Tmem59l knockdown MIN6c4 cells, and immunostaining analysis indicated that the TMEM59L protein colocalized with insulin and GM130, a Golgi complex marker, in MIN6 cells. Collectively, our findings suggested that the proteins encoded by Tmem59l, Scgn, Gucy2c, and Slc29a4 play important roles in regulating GSIS. Detailed studies of these proteins and their functions are expected to provide new insights into the molecular mechanisms involved in insulin secretion.	[Kobayashi, Masaki; Tanabe, Koji; Tashiro, Fumi; Miyazaki, Satsuki; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Dept Stem Cell Regulat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Yamato, Eiji] Mukogawa Womens Univ, Dept Nutr & Food Sci, 6-46 Ikebiraki Cho, Nishinomiya, Hyogo 6638558, Japan	Osaka University; Mukogawa Women's University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Dept Stem Cell Regulat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590; Yamato, Eiji/0000-0002-9075-6869; masaki, kobayashi/0000-0002-0985-0322				Aoki M, 2014, BIOCHEM BIOPH RES CO, V445, P357, DOI 10.1016/j.bbrc.2014.01.193; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Belz M, 2014, AM J PHYSIOL-ENDOC M, V306, pE697, DOI 10.1152/ajpendo.00362.2013; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Bolz H, 2005, MOL VIS, V11, P929; Cortijo C, 2012, CELL REP, V2, P1593, DOI 10.1016/j.celrep.2012.10.016; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elson GCA, 1999, BIOCHEM BIOPH RES CO, V264, P55, DOI 10.1006/bbrc.1999.1481; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; GRODSKY GM, 1966, DIABETES, V15, P910, DOI 10.2337/diab.15.12.910; GYLFE E, 1978, J ENDOCRINOL, V78, P239, DOI 10.1677/joe.0.0780239; Hasegawa K, 2013, FASEB J, V27, P2301, DOI 10.1096/fj.12-226092; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; HERCHUELZ A, 1980, ENDOCRINOLOGY, V107, P491, DOI 10.1210/endo-107-2-491; KITA T, 1994, AM J PHYSIOL, V266, pF342, DOI 10.1152/ajprenal.1994.266.2.F342; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Nakajima D, 2001, MOL BRAIN RES, V94, P85; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Ohtani M, 2013, GEN COMP ENDOCR, V187, P86, DOI 10.1016/j.ygcen.2013.02.011; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; PFEIFER MA, 1981, AM J MED, V70, P579, DOI 10.1016/0002-9343(81)90579-9; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Russell MA, 2010, ISLETS, V2, P374, DOI 10.4161/isl.2.6.13917; Salehi A, 2009, LIFE SCI, V85, P470, DOI 10.1016/j.lfs.2009.08.001; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; Ullrich S, 2010, J BIOL CHEM, V285, P20664, DOI 10.1074/jbc.M109.055608; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; YAMATO E, 1994, BIOCHEM BIOPH RES CO, V199, P327, DOI 10.1006/bbrc.1994.1232; Yamato E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061211; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhou MY, 2007, J BIOL CHEM, V282, P3188, DOI 10.1074/jbc.M609421200	44	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151927	10.1371/journal.pone.0151927	http://dx.doi.org/10.1371/journal.pone.0151927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986842	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300154
J	Mayorga-Vega, D; Bocanegra-Parrilla, R; Ornelas, M; Viciana, J				Mayorga-Vega, Daniel; Bocanegra-Parrilla, Raul; Ornelas, Martha; Viciana, Jesus			Criterion-Related Validity of the Distance- and Time-Based Walk/Run Field Tests for Estimating Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MAXIMAL OXYGEN INTAKE; BLOOD LACTATE CONCENTRATIONS; 3-KILOMETER RUNNING PERFORMANCE; 20-M SHUTTLE RUN; MILE RUN; CARDIOVASCULAR FITNESS; AEROBIC CAPACITY; 12-MINUTE RUN; CORRELATION-COEFFICIENTS; METABOLIC DETERMINANTS	Objectives The main purpose of the present meta-analysis was to examine the criterion-related validity of the distance- and time-based walk/run tests for estimating cardiorespiratory fitness among apparently healthy children and adults. Materials and Methods Relevant studies were searched from seven electronic bibliographic databases up to August 2015 and through other sources. The Hunter-Schmidt's psychometric meta-analysis approach was conducted to estimate the population criterion-related validity of the following walk/run tests: 5,000 m, 3 miles, 2 miles, 3,000 m, 1.5 miles, 1 mile, 1,000 m, 1/2 mile, 600 m, 600 yd, 1/4 mile, 15 min, 12 min, 9 min, and 6 min. Results From the 123 included studies, a total of 200 correlation values were analyzed. The overall results showed that the criterion-related validity of the walk/run tests for estimating maximum oxygen uptake ranged from low to moderate (r(p) = 0.42-0.79), with the 1.5 mile (r(p) = 0.79, 0.73-0.85) and 12 min walk/run tests (r(p) = 0.78, 0.72-0.83) having the higher criterion-related validity for distance- and time-based field tests, respectively. The present meta-analysis also showed that sex, age and maximum oxygen uptake level do not seem to affect the criterion-related validity of the walk/run tests. Conclusions When the evaluation of an individual's maximum oxygen uptake attained during a laboratory test is not feasible, the 1.5 mile and 12 min walk/run tests represent useful alternatives for estimating cardiorespiratory fitness. As in the assessment with any physical fitness field test, evaluators must be aware that the performance score of the walk/run field tests is simply an estimation and not a direct measure of cardiorespiratory fitness.	[Mayorga-Vega, Daniel; Bocanegra-Parrilla, Raul; Viciana, Jesus] Univ Granada, Dept Phys Educ & Sport, Granada, Spain; [Ornelas, Martha] Autonomous Univ Chihuahua, Fac Sci Phys Culture, Chihuahua, Mexico	University of Granada	Mayorga-Vega, D (corresponding author), Univ Granada, Dept Phys Educ & Sport, Granada, Spain.	dmayorgavega@gmail.com	Mayorga-Vega, Daniel/AAB-1857-2019; Mayorga-Vega, Daniel/AAT-8872-2021; Viciana, Jesus/AAA-6684-2019	Mayorga-Vega, Daniel/0000-0002-4494-4113; Viciana, Jesus/0000-0002-5424-118X	Spanish Ministry of Education, Culture and Sport [AP2010-5905]	Spanish Ministry of Education, Culture and Sport(Spanish Government)	Daniel Mayorga-Vega is an FPU [Formacion del Profesorado Universitario] fellow; research was supported by the Spanish Ministry of Education, Culture and Sport (AP2010-5905). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarwaey OA, 2003, MED SCI SPORT EXER, V35, P480, DOI 10.1249/01.MSS.0000053723.16531.D0; Anderson GS, 1992, PEDIAT EXERC SCI, V4, P312, DOI DOI 10.1123/PES.4.4.312; Arabas JL, 1996, AM J HLTH ED, V29, P11; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Babineau C, 1997, INT J SPORTS MED, V18, P13, DOI 10.1055/s-2007-972588; Baldwin DL, 1983, THESIS U WISCONSIN L; Bandyopadhyay A, 2015, BIOL SPORT, V32, P59, DOI 10.5604/20831862.1127283; Bandyopadhyay Amit, 2014, Indian J Physiol Pharmacol, V58, P184; Baumgartner T., 2015, MEASUREMENT EVALUATI, V9th ed.; Bergmann G. G., 2015, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V174, P15; Bergmann GG., 2014, REV BRAS ATIVIDADE F, V19, P64, DOI DOI 10.12820/RBAFS.V.19N1P64; Blair SN, 2009, BRIT J SPORT MED, V43, P1; BORGHOLS E A M, 1981, Geneeskunde en Sport, V14, P74; BRANDON LJ, 1992, J SPORT MED PHYS FIT, V32, P1; Buono MJ., 1991, PEDIAT EXERC SCI, V3, P250, DOI DOI 10.1123/PES.3.3.250; BURGER SC, 1990, S AFR MED J, V78, P327; BURKE EJ, 1976, RES QUART, V47, P95, DOI 10.1080/10671315.1976.10615345; Burns RD., 2014, THESIS U UTAH UTAH; Burns RD, 2015, PEDIATR EXERC SCI, V27, P404, DOI 10.1123/pes.2014-0175; Burns RD, 2016, J SPORT SCI, V34, P18, DOI 10.1080/02640414.2015.1031163; Cadenas-Sanchez C, 2014, NUTR HOSP, V30, P1333, DOI 10.3305/nh.2014.30.6.7859; Calders P, 2008, EUR J PEDIATR, V167, P563, DOI 10.1007/s00431-007-0553-5; Casajus JA, 2007, J SCI MED SPORT, V10, P382, DOI 10.1016/j.jsams.2006.08.004; Castro-Pineiro J, 2011, NUTR HOSP, V26, P572, DOI [10.1590/S0212-16112011000300021, 10.3305/nh.2011.26.3.4597]; Castro-Pinero J, 2010, BRIT J SPORT MED, V44, P934, DOI 10.1136/bjsm.2009.058321; Castro-Pinero J, 2009, INT J SPORTS MED, V30, P366, DOI 10.1055/s-0028-1105934; Castro-Pinero J, 2009, MED SCI SPORTS EXERC, V41, pS121, DOI [10.1249/01.mss.0000353656.17328.b5, DOI 10.1249/01.MSS.0000353656.17328.B5]; Castro-Pinero J, 2009, J SPORT SCI, V27, P405, DOI 10.1080/02640410802603889; Chiou LA, 1991, ASIAN J PHYS ED, V14, P32; CISAR CJ, 1986, J SPORT MED PHYS FIT, V26, P234; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONLEY DS, 1991, MED SCI SPORT EXER, V23, P766; Coolbaugh Crystal L, 2014, PLoS One, V9, pe97704, DOI 10.1371/journal.pone.0097704; Cooper H. M., 2009, HDB RES SYNTHESIS ME; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; Council of Europe Committee for the Development of Sport, 1988, EUR HDB EUROFIT TEST; Cunningham L. N., 1994, Medicine and Science in Sports and Exercise, V26, pS209, DOI 10.1249/00005768-199405001-01178; CURETON KJ, 1977, RES QUART, V48, P270, DOI 10.1080/10671315.1977.10615420; CURETON KJ, 1995, MED SCI SPORT EXER, V27, P445; Cureton KJ, 1997, MED SCI SPORT EXER, V29, P259, DOI 10.1097/00005768-199702000-00015; Dal Pupo J, 2013, RES SPORTS MED, V21, P124, DOI 10.1080/15438627.2012.757225; Damitz S. R., 1994, Medicine and Science in Sports and Exercise, V26, pS209, DOI 10.1249/00005768-199405001-01177; DASILVA S G, 1992, Medicine and Science in Sports and Exercise, V24, pS102, DOI 10.1249/00005768-199205001-00610; de Almeida JA, 2010, REV BRAS MED ESPORTE, V16, P57, DOI 10.1590/S1517-86922010000100011; Diaz FJ, 2000, REV INVEST CLIN, V52, P44; DOROCIAK JJ, 1983, J SPORT MED PHYS FIT, V23, P322; Dorociak JJ, 1981, THESIS U S CAROLINA; Drinkard B, 2001, PHYS THER, V81, P1889, DOI 10.1093/ptj/81.12.1889; Epperson C. E., 1999, Medicine and Science in Sports and Exercise, V31, pS104, DOI 10.1097/00005768-199905001-00370; FAY L, 1989, MED SCI SPORT EXER, V21, P319; Ferfila N, 2014, SPORT REV TEORETICNA, V62, P201; Fernhall B., 1988, ADAPTED PHYS ACTIVIT, V5, P49, DOI DOI 10.1123/apaq.5.1.49; Field AP, 2005, PSYCHOL METHODS, V10, P444, DOI 10.1037/1082-989X.10.4.444; Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037//1082-989X.6.2.161; Fontana KE, 1983, REV BRASILEIRA CIENC, V4, P78; FOSTER C, 1978, EUR J APPL PHYSIOL O, V39, P73, DOI 10.1007/BF00421711; Garzon MJC, 2005, MED CLIN-BARCELONA, V124, P146; George JD, 2001, MED SCI SPORT EXER, V33, pS45, DOI 10.1097/00005768-200105001-00261; GEORGE JD, 1993, MED SCI SPORT EXER, V25, P401; GETCHELL LH, 1977, RES QUART, V48, P61, DOI 10.1080/10671315.1977.10762151; GHOSH AK, 1987, INDIAN J MED RES, V85, P680; Grant JA, 1999, J STRENGTH COND RES, V13, P346; Grant S, 1997, J SPORT SCI, V15, P403, DOI 10.1080/026404197367191; GUTIN B, 1976, RES QUART, V47, P536, DOI 10.1080/10671315.1976.10615408; Gutin B, 1975, J Hum Ergol (Tokyo), V4, P27; Haines DA, 1993, AUST J SCI MED SPORT, V25, P35; Hamlin MJ, 2014, J HUM KINET, V40, P83, DOI 10.2478/hukin-2014-0010; Hamlin MJ, 2013, P BRIT ASS SPORT EX; HERGENROEDER AC, 1989, AM J DIS CHILD, V143, P673, DOI 10.1001/archpedi.1989.02150180051019; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Howald H, 1975, Schweiz Z Sportmed, V23, P57; Ingham SA, 2008, MED SCI SPORT EXER, V40, P345, DOI 10.1249/mss.0b013e31815a83dc; ISHIKO T, 1967, CAN MED ASSOC J, V96, P746; JACKSON A, 1990, RES Q EXERCISE SPORT, V61, P233, DOI 10.1080/02701367.1990.10608684; JACKSON AS, 1976, RES QUART, V47, P86, DOI 10.1080/10671315.1976.10615344; JESSUP GT, 1974, AM J PHYS MED REHAB, V53, P200; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Katch FI, 1973, RES QUART, V44, P301, DOI DOI 10.1080/10671188.1973.10615208; 서성혁, 2010, [The Korean Journal of Measurement and Evaluation in Physical Education and Sports Science, 한국체육측정평가학회지], V12, P25; Kirk SM, 2014, MED SCI SPORT EXER, V46, P116, DOI 10.1249/01.mss.0000493518.64624.dd; Kitagawa K, 1976, P INT C PHYS ACT SCI, P553; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; KRAHENBUHL GS, 1983, MED SCI SPORT EXER, V15, P486; KRAHENBUHL GS, 1977, MED SCI SPORT EXER, V9, P37; KUMAGAI S, 1982, EUR J APPL PHYSIOL O, V49, P13, DOI 10.1007/BF00428959; Larsen GE, 2002, RES Q EXERCISE SPORT, V73, P66, DOI 10.1080/02701367.2002.10608993; Lawrenz W, 2012, DEUT Z SPORTMED, V63, P102, DOI 10.5960/dzsm.2012.012; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Li LW, 1985, ASIAN J PHYS ED, V14, P46; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Mahon AD, 1996, INT J SPORTS MED, V17, P580, DOI 10.1055/s-2007-972898; Marsh HW, 1993, AUST J SCI MED SPORT, V25, P73; MASSICOTTE DR, 1985, J SPORT MED PHYS FIT, V25, P10; Mayhew J L, 1975, J Sports Med Phys Fitness, V15, P342; Mayorga-Vega D, 2014, J HUM SPORT EXERC, V9, P188, DOI 10.4100/jhse.2014.91.18; Mayorga-Vega D, 2015, J SPORT SCI MED, V14, P536; Mayorga-Vega D, 2014, J SPORT SCI MED, V13, P1; MCCORMACK WP, 1991, MED SCI SPORT EXER, V23, P611; McCreight GA, 1982, THESIS U BRIT COLUMB; Mello RP, 1984, T385 ARM RES I ENV M; Meredith MD., 2010, FITNESSGRAM ACTIVITY; Midgley AW, 2008, SPORTS MED, V38, P441, DOI 10.2165/00007256-200838060-00001; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; MYLES WS, 1980, ERGONOMICS, V23, P543, DOI 10.1080/00140138008924768; Nevill AM, 2008, J SPORT MED PHYS FIT, V48, P138; O'Gorman D, 2000, J STRENGTH COND RES, V14, P62, DOI 10.1519/1533-4287(2000)014<0062:VOFTFE>2.0.CO;2; ONG TC, 1986, ERGONOMICS, V29, P273, DOI 10.1080/00140138608968264; Paludo AC, 2014, REV BRAS MED ESPORTE, V20, P176, DOI 10.1590/1517-86922014200301564; Paludo Ana Carolina, 2012, Rev. bras. cineantropom. desempenho hum., V14, P401, DOI 10.5007/1980-0037.2012v14n4p401; Penry JT, 2008, THESIS OREGON STATE; Pescatello LS, 2014, ACSMS GUIDELINES EXE; Plowman S. A., 1999, MEAS PHYS EDUC EXERC, V3, P63, DOI [DOI 10.1207/, 10.1207/s15327841mpee0302_1, DOI 10.1207/S15327841MPEE0302_1]; Pomerants T, 2004, THESIS U TARTU TARTU; Quinart S, 2014, J SCI MED SPORT, V17, P521, DOI 10.1016/j.jsams.2013.07.010; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Ramsbottom R, 1992, J SPORT SCI, V10, P119, DOI 10.1080/02640419208729914; Ramsbottom R, 1987, Br J Sports Med, V21, P9; Ramsbottom R, 1989, J SPORT SCI, V7, P9, DOI 10.1080/02640418908729818; RASCH PJ, 1974, J SPORT MED PHYS FIT, V14, P32; Redkva PE, 2012, J EXERC PHYSL, V15, P107; Riddoch CJ, 1990, NO IR HLTH FITN SURV; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Rowland T, 1999, ARCH PEDIAT ADOL MED, V153, P845, DOI 10.1001/archpedi.153.8.845; ROWLAND TW, 1993, MED SCI SPORT EXER, V25, P689; Ruiz JR, 2009, BRIT J SPORT MED, V43, P909, DOI 10.1136/bjsm.2008.056499; Ruiz JR, 2015, NUTR HOSP, V31, P875, DOI 10.3305/nh.2015.31.2.7789; SAFRIT MJ, 1988, CAN J SPORT SCI, V13, P188; Schmidt F.L., 2015, METHODS META ANAL CO; SCOTT BK, 1994, INT J SPORTS MED, V15, P504, DOI 10.1055/s-2007-1021095; Slattery KM, 2006, J STRENGTH COND RES, V20, P47; Sloniger MA, 1997, CAN J APPL PHYSIOL, V22, P337, DOI 10.1139/h97-022; Soong PX, 2005, MED SCI SPORT EXER, V37, pS17, DOI 10.1097/00005768-200505001-00116; SPARLING PB, 1983, MED SCI SPORT EXER, V15, P218; Sporis G, 2013, J SPORT HUM PERFORM, V1, P15; Sporis Goran, 2014, Coll Antropol, V38 Suppl 2, P165; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stratton E, 2009, INT J SPORTS MED, V30, P40, DOI 10.1055/s-2008-1038761; Sucec A. A., 1999, Medicine and Science in Sports and Exercise, V31, pS379, DOI 10.1097/00005768-199905001-01933; SUCEC AA, 1982, INT J SPORTS MED, V3, P66; Swisher A, 1998, CARDIOPULMONARY PHYS, V9, P3, DOI [10.1097/01823246-199809030-00002, DOI 10.1097/01823246-199809030-00002]; TANAKA K, 1981, Japanese Journal of Physical Fitness and Sports Medicine, V30, P94; TANAKA K, 1990, EUR J APPL PHYSIOL O, V59, P443, DOI 10.1007/BF02388626; TANAKA K, 1988, Annals of Physiological Anthropology, V7, P31; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; TURLEY KR, 1994, PEDIATR EXERC SCI, V6, P178; Unnithan VB, 1995, INT J SPORTS MED, V16, P528, DOI 10.1055/s-2007-973049; VANMECHELEN W, 1986, EUR J APPL PHYSIOL O, V55, P503, DOI 10.1007/BF00421645; Vehrs P. R., 1996, Medicine and Science in Sports and Exercise, V28, pS182; VODAK PA, 1975, RES QUART, V46, P230, DOI 10.1080/10671315.1975.10615327; von Haaren B, 2011, DEUT Z SPORTMED, V62, P351; Walker LA, 2009, MED SCI SPORTS EXERC, V41, pS101, DOI [10.1249/01.MSS.0000354868.79967.47, DOI 10.1249/01.MSS.0000354868.79967.47]; [王国军 Wang Guojun], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P1265; Weiglein L, 2011, MIL MED, V176, P669, DOI 10.7205/MILMED-D-10-00444; WELTMAN A, 1990, INT J SPORTS MED, V11, P373, DOI 10.1055/s-2007-1024821; WELTMAN A, 1987, INT J SPORTS MED, V8, P401, DOI 10.1055/s-2008-1025694; WELTMAN J, 1989, INT J SPORTS MED, V10, P207, DOI 10.1055/s-2007-1024902; WEYAND PG, 1994, MED SCI SPORT EXER, V26, P1174; Wiley J F, 1972, Res Q, V43, P89; Yoshida T, 1976, P INT C PHYS ACT SCI, P541	161	51	53	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151671	10.1371/journal.pone.0151671	http://dx.doi.org/10.1371/journal.pone.0151671			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987118	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300109
J	Sang, W; Yu, L; He, L; Ma, WH; Zhu, ZH; Zhu, F; Wang, XP; Lei, CL				Sang, Wen; Yu, Lin; He, Li; Ma, Wei-Hua; Zhu, Zhi-Hui; Zhu, Fen; Wang, Xiao-Ping; Lei, Chao-Liang			UVB Radiation Delays Tribolium castaneum Metamorphosis by Influencing Ecdysteroid Metabolism	PLOS ONE			English	Article							ULTRAVIOLET-B RADIATION; RED FLOUR BEETLE; MOLECULAR INSIGHTS; MOLTING HORMONE; MANDUCA-SEXTA; RANA-PIPIENS; BOMBYX-MORI; P450 ENZYME; DNA-REPAIR; DROSOPHILA	Ultraviolet B (UVB) radiation is an important environmental factor. It is generally known that UVB exhibits high genotoxicity due to causing DNA damage, potentially leading to skin carcinogenesis and aging in mammals. However, little is known about the effects of UVB on the development and metamorphosis of insects, which are the most abundant terrestrial animals. In the present study, we performed dose-response analyses of the effects UVB irradiation on Tribolium castaneum metamorphosis, assessed the function of the T. castaneum prothoracicotropic hormone gene (Trcptth), and analyzed ecdysteroid pathway gene expression profile and ecdysterone titers post-UVB irradiation. The results showed that UVB not only caused death of T. castaneum larvae, but also delayed larval-pupal metamorphosis and reduced the size and emergence rate of pupae. In addition, we verified the function of Trcptth, which is responsible for regulating metamorphosis. It was also found that the expression profiles of Trcptth as well as ecdysteroidogenesis and response genes were influenced by UVB radiation. Therefore, a disturbance pulse of ecdysteroid may be involved in delaying development under exposure to irradiation. To our knowledge, this is the first report indicating that UVB can influence the metamorphosis of insects. This study will contribute to a better understanding of the impact of UVB on signaling mechanisms in insect metamorphosis.	[Sang, Wen; He, Li; Ma, Wei-Hua; Zhu, Zhi-Hui; Zhu, Fen; Wang, Xiao-Ping; Lei, Chao-Liang] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Yu, Lin] Huazhong Agr Univ, Key Lab Plant Pathol Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lei, CL (corresponding author), Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	ioir@mail.hzau.edu.cn		MA, WEIHUA/0000-0001-9521-2038	National Natural Science Foundation of China [31171856]; China Scholarship Council; graduate student Science and Technology Project of HuaZhong Agriculture University [2012YB16]; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation [2012YB16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); graduate student Science and Technology Project of HuaZhong Agriculture University; Huazhong Agricultural University Scientific & Technological Self-innovation Foundation	This work was supported by the National Natural Science Foundation of China, (No. 31171856), http://www.nsfc.gov.cn/ and the China Scholarship Council and graduate student Science and Technology Project of HuaZhong Agriculture University, (2012YB16), http://yjs.hzau.edu.cn/.; This research was supported by the National Natural Science Foundation of China (No. 31171856), China Scholarship Council and Huazhong Agricultural University Scientific & Technological Self-innovation Foundation (2012YB16). We would like to thank Dr. Hong-yu Zhang for providing the Pub-nls-EGFP vector.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Amare A, 2007, PEPTIDES, V28, P1282, DOI 10.1016/j.peptides.2007.04.014; Bacher S, 2005, FUNCT ECOL, V19, P263, DOI 10.1111/j.1365-2435.2005.00954.x; Belden LK, 2002, OECOLOGIA, V130, P551, DOI 10.1007/s00442-001-0843-y; Broehan G, 2010, INSECT BIOCHEM MOLEC, V40, P274, DOI 10.1016/j.ibmb.2009.10.009; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Croteau MC, 2008, PHYSIOL BIOCHEM ZOOL, V81, P743, DOI 10.1086/591949; Croteau MC, 2008, J TOXICOL ENV HEAL A, V71, P134, DOI 10.1080/15287390701613330; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Emanuele E, 2014, J DRUGS DERMATOL, V13, P274; Gelman DB, 2002, J INSECT PHYSIOL, V48, P63, DOI 10.1016/S0022-1910(01)00146-9; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Grant KP, 1995, CAN J ZOOL, V73, P2292, DOI 10.1139/z95-271; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Hackney JF, 2012, PLOS ONE, P7; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Higgins GM, 1926, J EXP ZOOL, V46, P333, DOI 10.1002/jez.1400460305; Ilijin L, 2014, TURK J BIOL, V38, P157, DOI 10.3906/biy-1306-75; ISHIBASHI J, 1994, BIOCHEMISTRY-US, V33, P5912, DOI 10.1021/bi00185a031; Jackowska M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-24; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kingan TG, 2000, J EXP BIOL, V203, P3011; Kong Y, 2014, INSECT MOL BIOL, V23, P632, DOI 10.1111/imb.12115; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Niwa YS, 2014, GENES GENET SYST, V89, P27, DOI 10.1266/ggs.89.27; Nowotarski SL, 2015, CANCER GROWTH METAST, P17, DOI 10.4137/CGM.S21219; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Peric-Mataruga Vesna, 2006, Archives of Biological Sciences, V58, P1; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Potter KA, 2013, PHYSIOL ENTOMOL, V38, P246, DOI 10.1111/phen.12030; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Sang W, 2015, ENVIRON ENTOMOL, V44, P418, DOI 10.1093/ee/nvv010; Sang W, 2012, J INSECT PHYSIOL, V58, P830, DOI 10.1016/j.jinsphys.2012.03.007; Shah P, 2015, PHOTOCHEM PHOTOBIOL, V91, P254, DOI 10.1111/php.12406; Tauchman SJ, 2007, INSECT BIOCHEM MOLEC, V37, P847, DOI 10.1016/j.ibmb.2007.05.015; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	44	10	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151831	10.1371/journal.pone.0151831	http://dx.doi.org/10.1371/journal.pone.0151831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986217	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300138
J	Stanley, RJ; Thomas, GMH				Stanley, Rob J.; Thomas, Geraint M. H.			Activation of G Proteins by Guanine Nucleotide Exchange Factors Relies on GTPase Activity	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; LIVING CELLS; GAPS; KINETICS; CANCER; RCC1; GEFS; RAN	G proteins are an important family of signalling molecules controlled by guanine nucleotide exchange and GTPase activity in what is commonly called an 'activation/inactivation cycle'. The molecular mechanism by which guanine nucleotide exchange factors (GEFs) catalyse the activation of monomeric G proteins is well-established, however the complete reversibility of this mechanism is often overlooked. Here, we use a theoretical approach to prove that GEFs are unable to positively control G protein systems at steady-state in the absence of GTPase activity. Instead, positive regulation of G proteins must be seen as a product of the competition between guanine nucleotide exchange and GTPase activity-emphasising a central role for GTPase activity beyond merely signal termination. We conclude that a more accurate description of the regulation of G proteins via these processes is as a 'balance/imbalance' mechanism. This result has implications for the understanding of intracellular signalling processes, and for experimental strategies that rely on modulating G protein systems.	[Stanley, Rob J.; Thomas, Geraint M. H.] UCL, CoMPLEX, London, England; [Stanley, Rob J.; Thomas, Geraint M. H.] UCL, Dept Cell & Dev Biol, London, England	University of London; University College London; University of London; University College London	Thomas, GMH (corresponding author), UCL, CoMPLEX, London, England.; Thomas, GMH (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	g.thomas@ucl.ac.uk		Stanley, Rob/0000-0002-4396-1122	British Heart Foundation [SP/08/004]	British Heart Foundation(British Heart Foundation)	British Heart Foundation SP/08/004 (https://www.bhf.org.uk) funded RS's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alberts B, 2013, ESSENTIAL CELL BIOL; Barren B, 2007, J NEUROSCI RES, V85, P3505, DOI 10.1002/jnr.21414; Baynes J.W., 2014, MED BIOCH; Berg JM, 2010, BIOCHEMISTRY; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bolsover S. R., 2011, CELL BIOL SHORT COUR; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Chang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045651; Dong JH, 2007, GENE, V396, P116, DOI 10.1016/j.gene.2007.03.001; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Goody RS, 2014, FEBS J, V281, P593, DOI 10.1111/febs.12551; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; Gunawardena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036321; Hancock J., 2010, CELL SIGNALLING; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Loirand G, 2013, PHYSIOL REV, V93, P1659, DOI 10.1152/physrev.00021.2012; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Michaelis L, 1913, BIOCHEM Z, V49, P333; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Nelson D.L, 2013, LEHNINGER PRINCIPLES, V6th; Northup John K, 2012, Cell Logist, V2, P140; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oliveira AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052874; Peyker A, 2005, CHEMBIOCHEM, V6, P78, DOI 10.1002/cbic.200400280; Randazzo P. A., 2013, CELLULAR LOGISTICS, V3, pe27609, DOI [10.4161/cl.27609, DOI 10.4161/CL.27609]; Seixas E, 2013, TRAFFIC, V14, P871, DOI 10.1111/tra.12072; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Voet D., 2010, BIOCHEMISTRY; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	43	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151861	10.1371/journal.pone.0151861	http://dx.doi.org/10.1371/journal.pone.0151861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986850	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300142
J	Brasileiro, SV; Orsini, MRCA; Cavalcante, JA; Bartholomeu, D; Montiel, JM; Costa, PSS; Costa, LR				Brasileiro, Sarah V.; Orsini, Mara R. C. A.; Cavalcante, Julianna A.; Bartholomeu, Daniel; Montiel, Jose M.; Costa, Paulo S. S.; Costa, Luciane R.			Controversies Regarding the Psychometric Properties of the Brief COPE: The Case of the Brazilian-Portuguese Version "COPE Breve"	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; COPING STRATEGIES; CULTURAL-ADAPTATION; SAMPLE-SIZE; STRESS; DIMENSIONALITY; VALIDATION; MODELS	The Brief Coping Orientation to Problems Experienced (COPE) inventory investigates the different ways in which people respond to stressful situations. Knowledge is lacking regarding the coping strategies and styles of people in developing countries, including Brazil. This study aimed to adapt and validate the Brief COPE to Brazilian Portuguese (named COPE Breve) by focusing on dispositional coping. For the cross-cultural adaptation, the original Brief COPE in English (28 items grouped into 14 subscales) was adapted according to a universalistic approach, following these steps: translation, synthesis, back-translation, analysis by an expert panel, and pretest with 30 participants. Then, 237 adults from the community health service responded to the COPE Breve. Psychometric analyses included reliability and exploratory factor analysis. Most of the 14 subscales from the original Brief COPE exhibited problems related to internal consistency. A Velicer's minimum average partial test (MAP) was performed and pointed out 3 factors. Exploratory factor analysis produced a revised 20-item version with a 3-factor solution: religion and positive reframing, distraction and external support. The psychometric properties of the COPE Breve with three factors were appropriate. Limitations of this study as well as suggestions for future studies are presented. The COPE Breve should be used in Brazilian clinics and investigations, but divergences in its psychometrics should be further explored in other contexts.	[Brasileiro, Sarah V.] Univ Fed Goias, Programa Posgrad Ciencias Saude, Goiania, Go, Brazil; [Orsini, Mara R. C. A.] Univ Fed Goias, Fac Educ, Dept Psicol, Goiania, Go, Brazil; [Bartholomeu, Daniel] Univ Fed Goias, Programa Posgrad Odontol, Goiania, Go, Brazil; [Bartholomeu, Daniel] Ctr Univ Fundacao Inst Ensino Osasco UniFIEO, Programa Posgrad Psicol Educ, Sao Paulo, Brazil; [Montiel, Jose M.] UniFIEO, Programa Posgrad Psicol Educ, Sao Paulo, Brazil; [Costa, Paulo S. S.] Univ Fed Goias, Fac Med, Dept Pediat, Goiania, Go, Brazil; [Costa, Luciane R.] Univ Fed Goias, Fac Odontol, Dept Saude Oral, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Centro Universitario Fieo; Universidade Federal de Goias; Universidade Federal de Goias	Costa, LR (corresponding author), Univ Fed Goias, Fac Odontol, Dept Saude Oral, Goiania, Go, Brazil.	lsucasas@ufg.br	Costa, Paulo S/L-5460-2016; Bartholomeu, Daniel/C-5269-2012; Costa, Luciane Rezende/H-1732-2012; Montiel, José Maria/I-3951-2013	Costa, Paulo S/0000-0001-9370-9139; Bartholomeu, Daniel/0000-0001-8524-7843; Costa, Luciane Rezende/0000-0001-7637-0049; Montiel, José Maria/0000-0003-0182-4581	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasil)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	SVB and JAC received Master of Science Scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brasil). PSSC and LRC received researcher scholarships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyal NR, 2011, J BURN CARE RES, V32, P392, DOI 10.1097/BCR.0b013e318217f97a; AUERBACH SM, 1989, J CONSULT CLIN PSYCH, V57, P388, DOI 10.1037/0022-006X.57.3.388; Ayers TS, 1996, J PERS, V64, P923, DOI 10.1111/j.1467-6494.1996.tb00949.x; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; CARVER CS, 1994, J PERS SOC PSYCHOL, V66, P184, DOI 10.1037/0022-3514.66.1.184; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cattell RB., 1966, HDB MULTIVARIATE EXP, P174; DeVellis RF, 2016, SCALE DEV THEORY APP; Doron J, 2014, J PERS ASSESS, V96, P567, DOI 10.1080/00223891.2014.886255; FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hooper MW, 2013, ADDICT BEHAV, V38, P2736, DOI 10.1016/j.addbeh.2013.07.005; Hur YM, 2012, BEHAV GENET, V42, P541, DOI 10.1007/s10519-012-9541-2; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Kapsou M, 2010, J HEALTH PSYCHOL, V15, P215, DOI 10.1177/1359105309346516; Kim Y, 2002, PERS INDIV DIFFER, V32, P1377, DOI 10.1016/S0191-8869(01)00128-3; Kimemia M, 2011, INT J ADV COUNS, V33, P149, DOI 10.1007/s10447-011-9122-8; Krageloh CU, 2011, RELIGIONS, V2, P216, DOI 10.3390/rel2030216; Krageloh CU, 2012, J RELIG HEALTH, V51, P1137, DOI 10.1007/s10943-010-9416-x; Lazarus R.S., 1984, EMOTION ADAPTATION; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Maroco J., 2014, PSICOL SA DE DOEN AS, V15, P300, DOI [DOI 10.15309/14PSD150201, 10.15309/14psd150201]; Mejorada R., 2013, PSICOL SALUD, V23, P55, DOI [10.25009/pys.v23i1.515, DOI 10.25009/PYS.V23I1.515]; Mohanraj R, 2015, AIDS BEHAV, V19, P341, DOI 10.1007/s10461-014-0872-2; Montel S, 2012, AMYOTROPH LATERAL SC, V13, P599, DOI 10.3109/17482968.2012.711835; Monzani D, 2015, EUR J PSYCHOL, V11, P295, DOI 10.5964/ejop.v11i2.935; Moran C, 2014, UNIV PSYCHOL, V13, P4; Moran C, 2010, UNIV PSYCHOL, V9, P543, DOI 10.11144/Javeriana.upsy9-2.capv; Muller L, 2003, ENCEPHALE, V29, P507; Perczek R, 2000, J PERS ASSESS, V74, P63, DOI 10.1207/S15327752JPA740105; Pett MA, 2003, MAKING SENSE FACTOR, DOI DOI 10.4135/9781412984898; Pozzi Gino, 2015, Brain Behav, V5, pe00351, DOI 10.1002/brb3.351; Ribeiro J.L. Pais, 2004, Psic., Saúde & Doenças, V5, P3; Ruiz RJ, 2015, WESTERN J NURS RES, V37, P257, DOI 10.1177/0193945914527176; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Su XY, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0074-9; TANAKA JS, 1987, CHILD DEV, V58, P134, DOI 10.1111/j.1467-8624.1987.tb03495.x; Thompson B, 2004, EXPLORATORY CONFIRMA	42	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152233	10.1371/journal.pone.0152233	http://dx.doi.org/10.1371/journal.pone.0152233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007646	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200115
J	Gillett, AK; Ploeg, R; O'Donoghue, PJ; Chapman, PA; Webb, RI; Flint, M; Mills, PC				Gillett, Amber K.; Ploeg, Richard; O'Donoghue, Peter J.; Chapman, Phoebe A.; Webb, Richard I.; Flint, Mark; Mills, Paul C.			Ultrastructural and Molecular Characterisation of an Heterosporis-Like Microsporidian in Australian Sea Snakes (Hydrophiinae)	PLOS ONE			English	Article							N. SP MICROSPORIDIA; INTESTINAL MICROSPORIDIOSIS; ENTEROCYTOZOON-SALMONIS; PLISTOPHORA-ANGUILLARUM; TETRAMICRA-BREVIFILUM; EASTERN AUSTRALIA; FISH; PARASITE; INFECTION; MUSCLE	Four sea snakes (two Hydrophis major, one Hydrophis platurus, one Hydrophis elegans) were found washed ashore on different beaches in the Sunshine Coast region and Fraser Island in Queensland, Australia between 2007-2013. Each snake had multiple granulomas and locally extensive regions of pallor evident in the hypaxial and intercostal musculature along the body. Lesions in two individuals were also associated with vertebral and rib fractures. Histological examination revealed granulomas scattered throughout skeletal muscle, subcutaneous adipose tissue and fractured bone. These were composed of dense aggregates of microsporidian spores surrounded by a mantle of macrophages. Sequences (ssrRNA) were obtained from lesions in three sea snakes and all revealed 99% similarity with Heterosporis anguillarum from the Japanese eel (Anguillarum japonica). However, ultrastructural characteristics of the organism were not consistent with those of previous descriptions. Electron microscopic examination of skeletal muscle revealed large cysts (not xenomas) bound by walls of fibrillar material (Heterosporis-like sporophorocyst walls were not detected). The cysts contained numerous mature microsporidian spores arranged in small clusters, sometimes apparently within sporophorous vesicles. The microspores were monomorphic, oval and measured 2.5-3.0 mu m by 1.6-1.8 mu m. They contained isofilar polar filaments with 11 (infrequently 9-12) coils arranged in two ranks. This is the first published report of a microsporidian infection in hydrophiid sea snakes. This discovery shows microsporidia with molecular affinities to Heterosporis anguillarum but ultrastructural characters most consistent with the genus Pleistophora (but no hitherto described species). Further studies are required to determine whether the microsporidian presented here belongs to the genus Heterosporis, or to a polymorphic species group as suggested by the recognition of a robust Pleistophora/Heterosporis clade by molecular studies. The gross and histological pathology associated with these infections are described.	[Gillett, Amber K.; Chapman, Phoebe A.; Flint, Mark; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Vet MARTI, Gatton, Qld, Australia; [Gillett, Amber K.] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Ploeg, Richard] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia; [O'Donoghue, Peter J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Flint, Mark] Univ Florida, Sch Forest Resources & Conservat, Florida Aquariums Ctr Conservat, Apollo Beach, FL USA	University of Queensland; University of Melbourne; University of Queensland; University of Queensland; State University System of Florida; University of Florida	Gillett, AK (corresponding author), Univ Queensland, Sch Vet Sci, Vet MARTI, Gatton, Qld, Australia.; Gillett, AK (corresponding author), Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia.	amber.gillett@uqconnect.edu.au	O'Donoghue, Peter/G-1043-2011; Chapman, Phoebe/E-5044-2016	O'Donoghue, Peter/0000-0001-8715-1394; Chapman, Phoebe/0000-0002-3303-9134	University of Queensland, The School of Veterinary Science Donor/Bequest Research fund [BEQPMI2014]	University of Queensland, The School of Veterinary Science Donor/Bequest Research fund	This work was supported by The University of Queensland, The School of Veterinary Science Donor/Bequest Research fund BEQPMI2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghaffar F, 2009, PARASITOL RES, V106, P39, DOI 10.1007/s00436-009-1633-4; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Al-Quraishy S, 2012, PARASITOLOGY, V139, P454, DOI 10.1017/S0031182011001971; Baquero E, 2005, J EUKARYOT MICROBIOL, V52, P476, DOI 10.1111/j.1550-7408.2005.00054.x; Canning E. U., 1981, Parasitological topics -- a presentation volume to P.C.C. Garnham, F.R.S. on the occasion of his 80th birthday, 1981., P57; CANNING EU, 1980, J FISH DIS, V3, P317, DOI 10.1111/j.1365-2761.1980.tb00402.x; CANNING EU, 1979, PROTISTOLOGICA, V15, P317; Casal G, 2010, J PARASITOL, V96, P1155, DOI 10.1645/GE-2182.1; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; CHILMONCZYK S, 1991, J PROTOZOOL, V38, P264, DOI 10.1111/j.1550-7408.1991.tb04440.x; CHUPP GL, 1993, CLIN INFECT DIS, V16, P15, DOI 10.1093/clinids/16.1.15; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DesportesLivage I, 1996, J EUKARYOT MICROBIOL, V43, P49, DOI 10.1111/j.1550-7408.1996.tb02472.x; Diamant A, 2010, DIS AQUAT ORGAN, V91, P137, DOI 10.3354/dao02256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FETCHO JR, 1986, J COMP NEUROL, V249, P551, DOI 10.1002/cne.902490409; FIGUERAS A, 1992, DIS AQUAT ORGAN, V14, P127, DOI 10.3354/dao014127; Gardiner CH, 1988, ATLAS PROTOZOAN PARA, V651; Garg P, 2013, CORNEA, V32, pS33, DOI 10.1097/ICO.0b013e3182a2c91f; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Gillett AK, 2014, J ZOO WILDLIFE MED, V45, P755, DOI 10.1638/2013-0265.1; Guyenot E., 1922, Revue Suisse de Zoologie, V30, P1; Hall T., 2005, BIOEDIT BIOL SEQUENC; HASHIMOTO K, 1976, B JPN SOC SCI FISH, V42, P411; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hoshina T, 1951, J TOKYO U FISH, V38, P35; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Jacobson ER, 1998, J ZOO WILDLIFE MED, V29, P315; Joh SJ, 2007, J VET SCI, V8, P147, DOI 10.4142/jvs.2007.8.2.147; Karpov SA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00112; Koudela B, 1998, FOLIA PARASIT, V45, P149; Ladds PW, 2009, PATHOLOGY AUSTR NATI, P261; Limpus CJ, 1975, BIOL SEA SNAKES, P173; LIU SK, 1971, J AM VET MED ASSOC, V159, P1578; Lom J, 2002, SYST PARASITOL, V53, P81, DOI 10.1023/A:1020422209539; Lom J, 2000, DIS AQUAT ORGAN, V43, P225, DOI 10.3354/dao043225; LOM J, 1967, J PROTOZOOL, V14, P141, DOI 10.1111/j.1550-7408.1967.tb01459.x; LOM JII, 1963, ACTA PROTOZOOLOGICA, V1, P81; Maillo PA, 1998, PARASITOL RES, V84, P208, DOI 10.1007/s004360050384; MAURAND J, 1988, J FISH DIS, V11, P251, DOI 10.1111/j.1365-2761.1988.tb00546.x; McCosker J., 1975, BIOL SEA SNAKES, V75, P217; McGourty KR, 2007, J PARASITOL, V93, P655, DOI 10.1645/GE-994R.1; Nagpal A, 2013, TRANSPL INFECT DIS, V15, P526, DOI 10.1111/tid.12119; NARASIMHAMURTI CC, 1982, ACTA PROTOZOOL, V21, P127; O'donoghue P., 2010, MICROSPORIDIA 2010 A; ORENSTEIN JM, 1990, HUM PATHOL, V21, P475; Pekkarinen M, 2002, DIS AQUAT ORGAN, V48, P133, DOI 10.3354/dao048133; Pfaller JB, 2012, INTEGR COMP BIOL, V52, P296, DOI 10.1093/icb/ics038; Phelps NBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132027; PUTZ RE, 1965, J PROTOZOOL, V12, P228, DOI 10.1111/j.1550-7408.1965.tb01842.x; Rambaut A, 2014, TRACER VERSION V1 6; Rasmussen AR, 2014, ZOOTAXA, V3869, P351, DOI 10.11646/zootaxa.3869.4.1; Reece R, TARONGA ZOO, P227; Richter B, 2014, J COMP PATHOL, V150, P332, DOI 10.1016/j.jcpa.2013.07.009; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanders JL, 2010, DIS AQUAT ORGAN, V91, P47, DOI 10.3354/dao02245; Schottelius J, 2000, MEM I OSWALDO CRUZ, V95, P133, DOI 10.1590/S0074-02762000000700022; Shaw RW, 1997, J PARASITOL, V83, P296, DOI 10.2307/3284459; SHIELDS JD, 1992, J CRUSTACEAN BIOL, V12, P94, DOI 10.2307/1548723; Small HJ, 2014, DIS AQUAT ORGAN, V110, P213, DOI 10.3354/dao02754; Stentiford GD, 2013, INT J PARASITOL, V43, P339, DOI 10.1016/j.ijpara.2012.11.010; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; TSUI WH, 1988, B I ZOOL ACAD SINICA, V27, P159; Vagelli A, 2005, J PARASITOL, V91, P152, DOI 10.1645/GE-388R; Vavra J, 2013, ADV PARASIT, V82, P253, DOI 10.1016/B978-0-12-407706-5.00004-6; Videira M, 2015, PARASITOL RES, V114, P2435, DOI 10.1007/s00436-015-4438-7; Vossbrinck CR, 2005, FOLIA PARASIT, V52, P131, DOI 10.14411/fp.2005.017; Wassenberg TJ, 2001, BIOL CONSERV, V100, P271, DOI 10.1016/S0006-3207(01)00031-3; Xiang H, 2014, CAN J MICROBIOL, V60, P557, DOI 10.1139/cjm-2014-0209	70	4	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150724	10.1371/journal.pone.0150724	http://dx.doi.org/10.1371/journal.pone.0150724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007116	Green Published, gold			2022-12-27	WOS:000372701200027
J	Arunrut, N; Kampeera, J; Sirithammajak, S; Sanguanrut, P; Proespraiwong, P; Suebsing, R; Kiatpathomchai, W				Arunrut, Narong; Kampeera, Jantana; Sirithammajak, Sarawut; Sanguanrut, Piyachat; Proespraiwong, Porranee; Suebsing, Rungkarn; Kiatpathomchai, Wansika			Sensitive Visual Detection of AHPND Bacteria Using Loop-Mediated Isothermal Amplification Combined with DNA-Functionalized Gold Nanoparticles as Probes	PLOS ONE			English	Article							NECROSIS DISEASE AHPND; SPOT SYNDROME VIRUS; VIBRIO-PARAHAEMOLYTICUS; SHRIMP; NANOGOLD; PLASMID; AGENT	Acute hepatopancreatic necrosis disease (AHPND) is a component cause of early mortality syndrome (EMS) of shrimp. In 2013, the causative agent was found to be unique isolates of Vibrio parahaemolyticus (VPAHPND) that contained a 69 kbp plasmid (pAP1) carrying binary Pir-like toxin genes Pir(vp)A and Pir(vp)B. In Thailand, AHPND was first recognized in 2012, prior to knowledge of the causative agent, and it subsequently led to a precipitous drop in shrimp production. After VPAHPND was characterized, a major focus of the AHPND control strategy was to monitor broodstock shrimp and post larvae for freedom from VPAHPND by nucleic acid amplification methods, most of which required use of expensive and sophisticated equipment not readily available in a shrimp farm setting. Here, we describe a simpler but equally sensitive approach for detection of VPAHPND based on loop-mediated isothermal amplification (LAMP) combined with unaided visual reading of positive amplification products using a DNA-functionalized, ssDNA-labled nanogold probe (AuNP). The target for the special set of six LAMP primers used was the VPAHPND Pir(vp)A gene. The LAMP reaction was carried out at 65 degrees C for 45 min followed by addition of the red AuNP solution and further incubation at 65 degrees C for 5 min, allowing any Pir(vp)A gene amplicons present to hybridize with the probe. Hybridization protected the AuNP against aggregation, so that the solution color remained red upon subsequent salt addition (positive test result) while unprotected AuNP aggregated and underwent a color change from red to blue and eventually precipitated (negative result). The total assay time was approximately 50 min. The detection limit (100 CFU) was comparable to that of other commonly-used methods for nested PCR detection of VPAHPND and 100-times more sensitive than 1-step PCR detection methods (104 CFU) that used amplicon detection by electrophoresis or spectrophotometry. There was no cross reaction with DNA templates derived from non-AHPND bacteria commonly found in shrimp ponds (including other Vibrio species). The new method significantly reduced the time, difficulty and cost for molecular detection of VPAHPND in shrimp hatchery and farm settings.	[Arunrut, Narong; Kampeera, Jantana; Sirithammajak, Sarawut; Suebsing, Rungkarn; Kiatpathomchai, Wansika] NSTDA, BIOTEC, Bioengn & Sensing Technol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand; [Sanguanrut, Piyachat] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol CENTE, Rama 6 Rd, Bangkok 10400, Thailand; [Proespraiwong, Porranee] Charoen Pokphand Foods Pul CO LTD, Aquat Anim Hlth Res Ctr, Samutsakorn 74000, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Kiatpathomchai, W (corresponding author), NSTDA, BIOTEC, Bioengn & Sensing Technol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand.	wansika@biotec.or.th	Suebsing, Rungkarn/AAL-7161-2021; Kiatpathomchai, Wansika/F-1625-2011		National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by grants from National Research Council of Thailand.	Arunrut N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108047; Arunrut N, 2013, J VIROL METHODS, V193, P542, DOI 10.1016/j.jviromet.2013.07.017; Arunrut N, 2011, J VIROL METHODS, V171, P21, DOI 10.1016/j.jviromet.2010.09.022; Dangtip S, 2015, AQUACULT REP, V2, P158, DOI 10.1016/j.aqrep.2015.10.002; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Han JE, 2015, DIS AQUAT ORGAN, V113, P33, DOI 10.3354/dao02830; He YQ, 2011, BIOSENS BIOELECTRON, V26, P2018, DOI 10.1016/j.bios.2010.08.079; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Jaroenram W, 2012, J VIROL METHODS, V186, P36, DOI 10.1016/j.jviromet.2012.08.013; Jaroenrama W, 2009, MOL CELL PROBE, V23, P65, DOI 10.1016/j.mcp.2008.12.003; Jiang Y, 2013, J AM CHEM SOC, V135, P7430, DOI 10.1021/ja4023978; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kaewphinit T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/926230; Kiatpathomchai W, 2008, J VIROL METHODS, V153, P214, DOI 10.1016/j.jviromet.2008.06.025; Koiwai K, 2016, J FISH DIS, V39, P603, DOI 10.1111/jfd.12387; Leano E.M., 2012, GLOB AQUACULT, P38; Lee CT, 2015, P NATL ACAD SCI USA, V112, P10798, DOI 10.1073/pnas.1503129112; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nimitphak T, 2010, MOL CELL PROBE, V24, P1, DOI 10.1016/j.mcp.2009.09.004; Prompamorn P, 2011, LETT APPL MICROBIOL, V52, P344, DOI 10.1111/j.1472-765X.2011.03007.x; Seetang-Nun Y, 2013, MOL CELL PROBE, V27, P71, DOI 10.1016/j.mcp.2012.11.005; Sirikharin R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126987; Suebsing R, 2013, J APPL MICROBIOL, V114, P1254, DOI 10.1111/jam.12160; Thitamadee S, 2016, AQUACULTURE, V452, P69, DOI 10.1016/j.aquaculture.2015.10.028; Tinwongger S, 2014, FISH PATHOL, V49, P159, DOI 10.3147/jsfp.49.159; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Yamazaki W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-94; Yang YT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00816-14; Yongkiettrakul S, 2014, PARASITOL INT, V63, P777, DOI 10.1016/j.parint.2014.06.004	31	52	54	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151769	10.1371/journal.pone.0151769	http://dx.doi.org/10.1371/journal.pone.0151769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003504	Green Published, gold, Green Submitted			2022-12-27	WOS:000372697400042
J	Garriga, J; Palmer, JRB; Oltra, A; Bartumeus, F				Garriga, Joan; Palmer, John R. B.; Oltra, Aitana; Bartumeus, Frederic			Expectation-Maximization Binary Clustering for Behavioural Annotation	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; MOVEMENT ECOLOGY PARADIGM; STATE-SPACE MODELS; ANIMAL MOVEMENT; MAXIMUM-LIKELIHOOD; POSITIONAL ENTROPY; INCOMPLETE DATA; RANDOM-WALKS; LEVY WALKS; TELEMETRY	The growing capacity to process and store animal tracks has spurred the development of new methods to segment animal trajectories into elementary units of movement. Key challenges for movement trajectory segmentation are to (i) minimize the need of supervision, (ii) reduce computational costs, (iii) minimize the need of prior assumptions (e.g. simple parametrizations), and (iv) capture biologically meaningful semantics, useful across a broad range of species. We introduce the Expectation-Maximization binary Clustering (EMbC), a general purpose, unsupervised approach to multivariate data clustering. The EMbC is a variant of the Expectation-Maximization Clustering (EMC), a clustering algorithm based on the maximum likelihood estimation of a Gaussian mixture model. This is an iterative algorithm with a closed form step solution and hence a reasonable computational cost. The method looks for a good compromise between statistical soundness and ease and generality of use (by minimizing prior assumptions and favouring the semantic interpretation of the final clustering). Here we focus on the suitability of the EMbC algorithm for behavioural annotation of movement data. We show and discuss the EMbC outputs in both simulated trajectories and empirical movement trajectories including different species and different tracking methodologies. We use synthetic trajectories to assess the performance of EMbC compared to classic EMC and Hidden Markov Models. Empirical trajectories allow us to explore the robustness of the EMbC to data loss and data inaccuracies, and assess the relationship between EMbC output and expert label assignments. Additionally, we suggest a smoothing procedure to account for temporal correlations among labels, and a proper visualization of the output for movement trajectories. Our algorithm is available as an R-package with a set of complementary functions to ease the analysis.	[Garriga, Joan; Oltra, Aitana; Bartumeus, Frederic] ICREA Movement Ecol Lab CEAB CSIC, Cala St Francesc 14, Blanes 17300, Spain; [Palmer, John R. B.; Bartumeus, Frederic] Ctr Ecol Res & Forestry Applicat CREAF, Barcelona 08193, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); ICREA; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Barcelona	Bartumeus, F (corresponding author), ICREA Movement Ecol Lab CEAB CSIC, Cala St Francesc 14, Blanes 17300, Spain.; Bartumeus, F (corresponding author), Ctr Ecol Res & Forestry Applicat CREAF, Barcelona 08193, Spain.	fbartu@ceab.csic.es	Palmer, John R.B./N-8620-2014; Bartumeus, Frederic/D-1911-2010	Palmer, John R.B./0000-0002-2648-7860; Bartumeus, Frederic/0000-0001-6908-3797	MINECO [BFU2010-22337, CGL2010-11600-E]; Human Frontier Science Program [RGY0084/2011]; Consejo Superior de Investigaciones Cientificas (CSIC) Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI); ICREA Funding Source: Custom	MINECO(Spanish Government); Human Frontier Science Program(Human Frontier Science Program); Consejo Superior de Investigaciones Cientificas (CSIC) Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI); ICREA(ICREA)	This work was supported by Spanish Ministry of Science and Innovation (currently MINECO) (grants BFU2010-22337 and CGL2010-11600-E) and the Human Frontier Science Program (grant RGY0084/2011). The authors acknowledge support of the publication fee by the Consejo Superior de Investigaciones Cientificas (CSIC) Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	[Anonymous], 1978, STAT EXPT INTRO DESI; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Bilmes JA, 1998, TR97021 UC BERK COMP; Bom RA, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-6; BOX GEP, 1976, J AM STAT ASSOC, V71, P791, DOI 10.2307/2286841; Charles C, 2014, CAN J FISH AQUAT SCI, V71, P1817, DOI 10.1139/cjfas-2013-0572; Chen WC, 2012, QUICK GUID EMCLUSTER; Chen WC, 2012, EMCLUSTER EM ALGORIT; Dalziel BD, 2008, AM NAT, V172, P248, DOI 10.1086/589448; Dean B, 2013, J ROYAL SOC INTERFAC, V10; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Freeman R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0279; Freeman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009236; Fronhofer EA, 2013, OIKOS, V122, P857, DOI 10.1111/j.1600-0706.2012.21021.x; Giuggioli L, 2010, J ANIM ECOL, V79, P906, DOI 10.1111/j.1365-2656.2010.01682.x; Gloaguen P, 2015, ENVIRONMETRICS, V26, P17, DOI 10.1002/env.2319; Guilford T, 2004, JOURNAL OF THEORETIC, V227, P25, DOI [10.1016/j.jtbi.2003.07.003, DOI 10.1016/J.JTBI.2003.07.003]; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Gupta MR, 2010, FOUND TRENDS SIGNAL, V4, P223, DOI 10.1561/2000000034; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; Kim J.Y., 2007, SPEECH SCI, V14, P163; Knell AS, 2012, THEOR ECOL-NETH, V5, P325, DOI 10.1007/s12080-011-0130-4; Kranstauber B., 2013, MOVE VISUALIZING ANA; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; McLachlan GJ, 2008, WILEY SER PROBAB ST, P365; McLachlan GJ, 2004, PAPERS; Metzner C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8516; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Ovaskainen O, 2008, THEOR POPUL BIOL, V73, P198, DOI 10.1016/j.tpb.2007.11.002; Resheff YS, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0027-0; Reynolds AM, 2012, ECOLOGY, V93, P1228, DOI 10.1890/11-1815.1; Roberts S, 2004, J THEOR BIOL, V227, P39, DOI 10.1016/j.jtbi.2003.07.002; Safi K, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-4; Shamoun-Baranes J, 2012, BIOL LETTERS, V8, P6, DOI 10.1098/rsbl.2011.0764; Tariquzzaman MD, 2012, INT J INNOVATIVE COM, V8; Thiebault A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1013, DOI 10.1007/s00265-013-1546-1; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Van Der Maaten Laurens, 2009, ARTIF INTELL, P384; van Gils JA, 2015, J ANIM ECOL, V84, P554, DOI 10.1111/1365-2656.12301; Visser I, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i07	54	84	84	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151984	10.1371/journal.pone.0151984	http://dx.doi.org/10.1371/journal.pone.0151984			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002631	Green Published, Green Submitted, gold			2022-12-27	WOS:000372697400063
J	Imanaka, M; Ando, M; Kitamura, T; Kawamura, T				Imanaka, Mie; Ando, Masahiko; Kitamura, Tetsuhisa; Kawamura, Takashi			Impact of Registered Dietitian Expertise in Health Guidance for Weight Loss	PLOS ONE			English	Article							OBESE ADULTS; STUDENTS; PROGRAM; SUPPORT; MAINTENANCE; OVERWEIGHT; EDUCATION; SKILLS; RISK; OSCE	Background & Objectives Expertise of registered dietitians (RDs) is important for health guidance but has been poorly evaluated. We evaluated the kind of RD expertise that would improve their skills. Design, Setting, Participants, Measurements This study was a post-hoc analysis of our randomized controlled trial, which compared the weight change between participants using the web-based self-disclosure health support and those using the email health support. Healthy men and women aged 35-64 years with a body mass index (BMI) of > = 24.5 kg/m(2) were recruited for this study. We evaluated the relationship of RD expertise indicators including the duration of working as an RD, the experience of health counseling, and membership in the Japan Dietetic Association (JDA) with the weight loss of study participants. The primary endpoint was the change in body weight. Comparison of changes in body weight by the RD expertise indicators was evaluated using analysis of covariance. Results A total of 175 participants were eligible for analyses. Changes in body weight were significantly greater when they were supported by the RDs in the routine counseling group than when supported by the RDs in the non-routine counseling group (-1.8 kg versus -0.4 kg, fully adjusted P = 0.0089). Duration of working as an RD and JDA membership did not significantly affect changes in body weight. Conclusions Among some indices of RD experience, the experience of providing routine experience of health counseling was associated with weight loss.	[Imanaka, Mie] Kyoto Koka Womens Univ, Dept Hlth & Nutr, Kyoto, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Kitamura, Tetsuhisa] Osaka Univ, Grad Sch Med, Div Environm Med & Populat Sci, Dept Social & Environm Med, Suita, Osaka, Japan; [Kawamura, Takashi] Kyoto Univ Hlth Serv, Kyoto, Japan	Nagoya University; Osaka University; Kyoto University	Ando, M (corresponding author), Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan.	mando@med.nagoya-u.ac.jp	Kitamura, Tetsuhisa/AAA-2555-2020	Kitamura, Tetsuhisa/0000-0003-0107-0580				Anderson JW, 2011, POSTGRAD MED, V123, P205, DOI 10.3810/pgm.2011.09.2476; BENNER P, 1982, AM J NURS, V82, P402, DOI 10.2307/3462928; Brady J, 2012, CAN J DIET PRACT RES, V73, P117, DOI 10.3148/73.3.2012.117; Byham-Gray LD, 2005, J AM DIET ASSOC, V105, P1574, DOI 10.1016/j.jada.2005.07.007; Cant RP, 2008, J HUM NUTR DIET, V21, P502, DOI 10.1111/j.1365-277X.2008.00883.x; Chan M, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0343-0; Collins CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-669; Dalle Grave R, 2010, DIABET METAB SYND OB, V3, P373, DOI 10.2147/DMSOTT.S13860; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Harvey-Berino J, 2004, OBES RES, V12, P320, DOI 10.1038/oby.2004.40; Imafuku Yuji, 2007, Rinsho Byori, V55, P1097; Imanaka M, 2013, J MED INTERNET RES, V15, P289, DOI 10.2196/jmir.2405; Jahangiri L, 2013, EUR J DENT EDUC, V17, P10, DOI 10.1111/eje.12012; Japan Diabetes Society, 2001, FOOD EXCH LIST DIAB; Ministry of Health Labour and Welfare Health Service Bureau, PROGR STAND SPEC HLT, P69; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Patricio MF, 2013, MED TEACH, V35, P503, DOI 10.3109/0142159X.2013.774330; Schulz AJ, 2003, EVAL PROGRAM PLANN, V26, P249, DOI 10.1016/S0149-7189(03)00029-6; Tabak N, 1996, WESTERN J NURS RES, V18, P534, DOI 10.1177/019394599601800505; Tate DF, 2006, ARCH INTERN MED, V166, P1620, DOI 10.1001/archinte.166.15.1620; Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Templeton C L, 1991, Diabetes Educ, V17, P355, DOI 10.1177/014572179101700505; Van Wieren A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25139; Zakowski LJ, 2002, ACAD MED, V77, P1030, DOI 10.1097/00001888-200210000-00019	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151456	10.1371/journal.pone.0151456	http://dx.doi.org/10.1371/journal.pone.0151456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003943	Green Published, gold			2022-12-27	WOS:000372697400032
J	Keinath, AT				Keinath, Alexander Thomas			The Preferred Directions of Conjunctive Grid X Head Direction Cells in the Medial Entorhinal Cortex Are Periodically Organized	PLOS ONE			English	Article							REPRESENTATION; MODEL; MAP	The discovery of speed-modulated grid, head direction, and conjunctive grid x head direction cells in the medial entorhinal cortex has led to the hypothesis that path integration, the updating of one's spatial representation based on movement, may be carried out within this region. This hypothesis has been formalized by many computational models, including a class known as attractor network models. While many of these models propose specific mechanisms by which path integration might occur, predictions of these specific mechanisms have not been tested. Here I derive and test a key prediction of one attractor network path integration mechanism. Specifically, I first demonstrate that this mechanism predicts a periodic distribution of conjunctive cell preferred directions in order to minimize drift. Next, I test whether conjunctive cell preferred directions are in fact periodically organized. Results indicate that conjunctive cells are preferentially tuned to increments of 36 degrees, consistent with drift minimization in this path integration mechanism. By contrast, no periodicity was observed in the preferred directions of either pure grid or pure head direction cells. These results provide the first neural evidence of a nonuniform structure in the directional preferences of any head direction representation found in the brain.	[Keinath, Alexander Thomas] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	University of Pennsylvania	Keinath, AT (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	akeinath@sas.upenn.edu			National Science Foundation Integrative Graduate Education and Research Traineeship [0966142]	National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF))	This work was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship #0966142 (ATK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Blair HT, 1998, NEURON, V21, P1387, DOI 10.1016/S0896-6273(00)80657-1; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess CP, 2014, J NEUROSCI, V34, P6224, DOI 10.1523/JNEUROSCI.2540-12.2014; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2014, CURR BIOL, V24, P252, DOI 10.1016/j.cub.2013.12.002; Grossberg S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0524; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; Pilly PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060599; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Si BL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003558; Stackman RW, 1998, J NEUROSCI, V18, P9020; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; Widloski J, 2014, NEURON, V83, P481, DOI 10.1016/j.neuron.2014.06.018; Yoon KJ, 2013, NAT NEUROSCI, V16, P1077, DOI 10.1038/nn.3450	26	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152041	10.1371/journal.pone.0152041	http://dx.doi.org/10.1371/journal.pone.0152041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003407	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400069
J	Khatri-Chhetri, N; Khatri-Chhetri, R; Chung, CS; Chern, RS; Chien, CH				Khatri-Chhetri, Nabin; Khatri-Chhetri, Rupak; Chung, Cheng-Shu; Chern, Rey-Shyong; Chien, Chi-Hsien			The Spatial Relationship and Surface Projection of Canine Sciatic Nerve and Sacrotuberous Ligament: A Perineal Hernia Repair Perspective	PLOS ONE			English	Article							BRACHIAL-PLEXUS; DOG; TRANSPOSITION; HERNIORRHAPHY; MUSCLE	Sciatic nerve entrapment can occur as post-operative complication of perineal hernia repair when sacrotuberous ligament is incorporated during hernia deficit closure. This results in sciatic sensory loss and paralysis of the hind leg. This study investigated the spatial relationship of sciatic nerve and sacrotuberous ligament and their surface topographic projection of 68 cadavers (29 Beagles and 39 Taiwanese mongrels) with various heights (25-56 cm). By gross dissection, the sacrotuberous ligament and sciatic nerve were exposed and their distance in between was measured along four parts (A, B, C, D) of sacrotuberous ligament. The present study revealed that the C was the section of sacrotuberous ligament where the sciatic nerve and the sacrotuberous ligament are closest to each other. Furthermore, a positive correlation was observed between C and height of the dogs. From the present study, we found that the C in smaller dogs has the shortest distance between the sciatic nerve and the sacrotuberous ligament, and thus the most vulnerable to sciatic nerve entrapment, and needs to be avoided or approached cautiously during perineal hernia repair.	[Khatri-Chhetri, Nabin; Khatri-Chhetri, Rupak; Chung, Cheng-Shu; Chern, Rey-Shyong; Chien, Chi-Hsien] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan; [Khatri-Chhetri, Nabin; Chung, Cheng-Shu; Chien, Chi-Hsien] Natl Pingtung Univ Sci & Technol, Anim Hosp, Dept Small Anim Surg & Acupuncture, Pingtung 91201, Taiwan; [Chern, Rey-Shyong] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Anat, Pingtung 91201, Taiwan; [Chien, Chi-Hsien] Asia Univ, Lab Small Anim Surg & Acupuncture, Dept Vet Med Postbaccalaureate, Taichung, Taiwan	National Pingtung University Science & Technology; National Pingtung University Science & Technology; National Pingtung University Science & Technology; Asia University Taiwan	Chien, CH (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan.; Chien, CH (corresponding author), Natl Pingtung Univ Sci & Technol, Anim Hosp, Dept Small Anim Surg & Acupuncture, Pingtung 91201, Taiwan.; Chien, CH (corresponding author), Asia Univ, Lab Small Anim Surg & Acupuncture, Dept Vet Med Postbaccalaureate, Taichung, Taiwan.	chdvmm@gmail.com						Andrews CM, 2008, VET SURG, V37, P254, DOI 10.1111/j.1532-950X.2008.00374.x; BELLENGER CR, 1980, AUST VET J, V56, P434, DOI 10.1111/j.1751-0813.1980.tb02637.x; Bongartz A, 2005, VET SURG, V34, P405, DOI 10.1111/j.1532-950X.2005.00062.x; Brissot HN, 2004, VET SURG, V33, P412, DOI 10.1111/j.1532-950X.2004.04060.x; Budras KD, 2007, ANATOMY DOG ILLUSTRA, V5, P72; BURROWS CF, 1973, J SMALL ANIM PRACT, V14, P315, DOI 10.1111/j.1748-5827.1973.tb06466.x; Campoy L, 2008, VET ANAESTH ANALG, V35, P348, DOI 10.1111/j.1467-2995.2007.00390.x; Carrier DR, 2005, GENOME RES, V15, P1825, DOI 10.1101/gr.3800005; de Lahunta A., 2009, VET NEUROANATOMY CLI, P77; DESAI R, 1982, J AM ANIM HOSP ASSOC, V18, P195; DORN AS, 1982, J AM ANIM HOSP ASSOC, V18, P624; Evans HE, 2013, MILLERS ANATOMY DOG, P327; Evans HE, 2013, MILLERS ANATOMY DOG, P650; Forterre F, 2007, VET SURG, V36, P464, DOI 10.1111/j.1532-950X.2007.00293.x; HAYES HM, 1978, J AM ANIM HOSP ASSOC, V14, P703; HOSGOOD G, 1995, J AM ANIM HOSP ASSOC, V31, P331, DOI 10.5326/15473317-31-4-331; 윤헌영, 2010, [Journal of Veterinary Clinics, 한국임상수의학회지], V27, P584; Jeusette I, 2010, RES VET SCI, V88, P227, DOI 10.1016/j.rvsc.2009.07.009; Lorenz MD, 2011, HDB VET NEUROLOGY, P94, DOI [10.1016/B978-1- 4377- 0651-2.10005- 0, DOI 10.1016/B978-1-4377-0651-2.10005-0]; Mahler SP, 2008, VET ANAESTH ANALG, V35, P80, DOI 10.1111/j.1467-2995.2007.00356.x; Pratummintra K, 2013, J VET MED SCI, V75, P337, DOI 10.1292/jvms.11-0478; Radlinsky MG, 2013, SMALL ANIMAL SURG, P568; SJOLLEMA BE, 1989, VET QUART, V11, P18, DOI 10.1080/01652176.1989.9694191; SPREULL JSA, 1980, J SMALL ANIM PRACT, V21, P265, DOI 10.1111/j.1748-5827.1980.tb01247.x; Stoll MR, 2002, VET SURG, V31, P379, DOI 10.1053/jvet.2002.33596; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; Szabo S, 2007, J AM ANIM HOSP ASSOC, V43, P136, DOI 10.5326/0430136; Vnuk D, 2006, VET MED-CZECH, V51, P111, DOI 10.17221/5528-VETMED; WEAVER AD, 1981, J SMALL ANIM PRACT, V22, P749, DOI 10.1111/j.1748-5827.1981.tb00582.x; Zink MC, 2013, CANINE SPORTS MEDICINE AND REHABILITATION, P1	30	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152078	10.1371/journal.pone.0152078	http://dx.doi.org/10.1371/journal.pone.0152078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003911	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400074
J	Chandler, JF; Burn, D; Berggren, P; Sweet, MJ				Chandler, Josie F.; Burn, Deborah; Berggren, Per; Sweet, Michael J.			Influence of Resource Availability on the Foraging Strategies of the Triangle Butterflyfish Chaetodon triangulum in the Maldives	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-FEEDING BUTTERFLYFISHES; TERRITORY SIZE; CORALLIVOROUS BUTTERFLYFISHES; SPECIALIZATION; FISH; CONSUMPTION; SELECTIVITY; AUSTRIACUS	Obligate coral feeders such as many members of the Chaetodontidae family (also known as butterflyfish) often show strong preferences for particular coral species. This is thought to have evolved through natural selection as an energy-maximising strategy. Although some species remain as highly specialised feeders throughout their lifetime, many corallivores show a degree of dietary versatility when food abundance is limited; a strategy described by the optimal foraging theory. This study aimed to examine if, within-reef differences in the feeding regime and territory size of the Triangle Butterflyfish Chaetodon triangulum occurred, as a function of resource availability. Results showed that the dietary specialisation of C. triangulum was significant in both areas of low and high coral cover (chi L2(2) = 2.52 x 102, P<0.001 and chi L2(2) = 3.78 x 102, P<0.001 respectively). Resource selection functions (RSFs), calculated for the two main sites of contrasting coral assemblage, showed that in the resource-rich environments, only two Genera (Acropora and Pocillopora) were preferentially selected for, with the majority of other corals being actively 'avoided'. Conversely, in territories of lower coral coverage, C. triangulum was being less selective in its prey choice and consuming corals in a more even distribution with respect to their availability. Interestingly, coral cover appeared to show no significant effect on feeding rate, however it was a primary determinant of territory size. The findings of the study agree with the predictions of the optimal foraging theory, in that where food supply is scarce, dietary specialisation is minimised and territory size increased. This results in maximising energy intake. This study represents the first scientific evidence that C. triangulum is an obligate corallivore and, as with many other butterflyfish, is therefore dependent on healthy scleractinian corals for survival.	[Chandler, Josie F.; Burn, Deborah; Berggren, Per] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sweet, Michael J.] Univ Derby, Environm Sustainabil Res Ctr, Derby DE22 1GB, England	Newcastle University - UK; University of Derby	Chandler, JF (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.f.chandler@outlook.com	Sweet, Michael/E-9661-2012	Sweet, Michael/0000-0003-4983-8333; Burn, Deborah/0000-0002-9581-2954				Allen G.R., 1998, GUIDE ANGELFISHES BU; Alwany M, 2003, MAR ECOL-P S Z N I, V24, P165, DOI 10.1046/j.1439-0485.2003.03833.x; Berumen M.L., 2001, INQUIRY U ARKANSAS U, V2; Berumen M.L., 2006, P 10 INT COR REEF S, P644; Berumen ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P989, DOI 10.1007/s00265-007-0526-8; Brooker RM, 2013, CORAL REEFS, V32, P613, DOI 10.1007/s00338-013-1057-6; Brooker RM, 2013, OECOLOGIA, V172, P409, DOI 10.1007/s00442-012-2521-7; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Cole AJ, 2011, CORAL REEFS, V30, P85, DOI 10.1007/s00338-010-0674-6; Cole AJ, 2009, J EXP MAR BIOL ECOL, V373, P11, DOI 10.1016/j.jembe.2009.02.016; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Couce E, 2013, GLOBAL CHANGE BIOL, V19, P3592, DOI [10.1111/gcb.12335, 10]; Gassner P, 2012, BIODIV SCI, V6; Gregson MA, 2008, CORAL REEFS, V27, P583, DOI 10.1007/s00338-008-0366-7; HARMELINVIVIEN ML, 1989, ENVIRON BIOL FISH, V25, P101, DOI 10.1007/BF00002204; Hughes R.N., 1980, Oceanography and Marine Biology an Annual Review, V18, P423; IRONS D K, 1989, Environmental Biology of Fishes, V25, P187, DOI 10.1007/BF00002211; JONES GP, 1986, OECOLOGIA, V68, P549, DOI 10.1007/BF00378770; Lawton RJ, 2012, OIKOS, V121, P191, DOI 10.1111/j.1600-0706.2011.19409.x; MacArthur RH, 1966, AM NAT, V4, P100; Manly B., 1993, RESOURCE SELECTION A; Manly B.F.J., 2002, RESOURCE SELECTION A; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Michael SW, 2004, ANGELFISHES BUTTERFL; Pisapia C, 2012, P 12 INT COR REEF S; Pratchett M.S., 2007, RAFFLES B ZOOL, V14, P155; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; REESE E S, 1975, Zeitschrift fuer Tierpsychologie, V37, P37; Righton D, 1998, J EXP MAR BIOL ECOL, V226, P183, DOI 10.1016/S0022-0981(97)00235-9; ROBERTS CM, 1992, ENVIRON BIOL FISH, V34, P79, DOI 10.1007/BF00004786; STARCK WALTER A., 1966, ICHTHYOL AQUARIUM J, V38, P313; TRICAS TC, 1989, ANIM BEHAV, V37, P830, DOI 10.1016/0003-3472(89)90067-5; Veron J. E., 2000, CORALS WORLD, V1; Whiteman EA, 2004, BIOL REV, V79, P351, DOI 10.1017/S1464793103006304	34	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151923	10.1371/journal.pone.0151923	http://dx.doi.org/10.1371/journal.pone.0151923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999662	gold, Green Published, Green Submitted			2022-12-27	WOS:000372694700085
J	Kok, FM; Groen, Y; Becke, M; Fuermaier, ABM; Tucha, O				Kok, Francien M.; Groen, Yvonne; Becke, Miriam; Fuermaier, Anselm B. M.; Tucha, Oliver			Self-Reported Empathy in Adult Women with Autism Spectrum Disorders - A Systematic Mini Review	PLOS ONE			English	Review							HIGH-FUNCTIONING AUTISM; SEX-DIFFERENCES; FETAL TESTOSTERONE; GENDER-DIFFERENCES; ASPERGER-SYNDROME; CHILDHOOD-AUTISM; QUOTIENT EQ; CHILDREN; GIRLS; FEMALES	Introduction There is limited research on Autism Spectrum Disorders (ASD) in females. Although the empathy construct has been examined thoroughly in autism, little attention has been paid to empathy in adult women with this condition or to gender differences within the disorder. Objective Self-reported empathy in adult women with ASD was examined and compared to that of typically developed men and women as well as to men with this condition. Methods Online databases were searched for articles investigating self-reported empathy among adult women with ASD. Only six studies comparing women to men were identified. Results All studies found women with an ASD to report lower levels of empathy than typically developed women, and typically developed men, but similar levels to men with this condition. Conclusion The self-reported empathic ability of women diagnosed with ASD resembles that of their male counterparts most closely; they show a hypermasculinisation in empathy. This is particularly surprising considering the large gender difference in empathy in the general population. Discussion One of the limitations of this review is that the current diagnostic criteria for ASD are oriented towards male-specific behaviour and fail to integrate gender specific characteristics. Hence, women diagnosed with ASD are likely to be at the male end of the continuum. The suggested hypermasculinisation of women on the spectrum, as evident from this review, may therefore be exaggerated due to a selection bias.	[Kok, Francien M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; Univ Groningen, Fac Behav & Social Sci, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen	Kok, FM (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	f.m.kok@rug.nl	Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840; Groen, Yvonne/0000-0002-7242-0317				aan het Rot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098436; Althaus M, 2015, NEUROPSYCHOLOGIA, V79, P53, DOI 10.1016/j.neuropsychologia.2015.10.025; Andersson GW, 2013, RES DEV DISABIL, V34, P413, DOI 10.1016/j.ridd.2012.08.025; [Anonymous], 2013, DIAGNOSTIC STAT MANU, V5; Attwood T., 2015, COMPLETE GUIDE ASPER; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 2011, TXB AUTISM SPECTRUM, P39; Baron-Cohen S, 2007, ESSENTIAL DIFFERENCE; Baron-Cohen S, 2014, PLOS ONE; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Basow Susan A, 1992, GENDER STEREOTYPES R; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.1111/j.1467-8624.1982.tb01331.x; Carter AS, 2007, J AUTISM DEV DISORD, V37, P86, DOI 10.1007/s10803-006-0331-7; Centers for Disease Control and Prevention (CDC), 2010, PREV AUT SPECTR DIS; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Cheslack-Postava K, 2012, SOC SCI MED, V74, P1667, DOI 10.1016/j.socscimed.2011.06.013; Chevallier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031107; Davis M. H., 1980, THESIS U TEXAS AUSTI; Dworzynski K, 2012, J AM ACAD CHILD PSY, V51, P788, DOI 10.1016/j.jaac.2012.05.018; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Frazier TW, 2014, J AM ACAD CHILD PSY, V53, P329, DOI 10.1016/j.jaac.2013.12.004; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Gould J., 2011, GOOD AUTISM PRACTICE, V12, P34; Groen Y, 2015, J AUTISM DEV DISORD, V45, P2848, DOI 10.1007/s10803-015-2448-z; Hadjikhani N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.113; Halladay AK, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0019-y; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Hiller RM, 2014, J ABNORM CHILD PSYCH, V42, P1381, DOI 10.1007/s10802-014-9881-x; Holtmann M, 2007, DEV MED CHILD NEUROL, V49, P361, DOI 10.1111/j.1469-8749.2007.00361.x; Honda H, 2005, DEV MED CHILD NEUROL, V47, P10, DOI 10.1017/S0012162205000034; Idring S, 2015, J AUTISM DEV DISORD, V45, P1766, DOI 10.1007/s10803-014-2336-y; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Karniol R, 1998, SEX ROLES, V39, P45, DOI 10.1023/A:1018825732154; Kirkovski M, 2013, J AUTISM DEV DISORD, V43, P2584, DOI 10.1007/s10803-013-1811-1; Knickmeyer R, 2006, HORM BEHAV, V49, P282, DOI 10.1016/j.yhbeh.2005.08.010; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Knickmeyer RC, 2006, J CHILD NEUROL, V21, P825, DOI 10.1177/08830738060210101601; Kopp S, 2011, RES DEV DISABIL, V32, P2875, DOI 10.1016/j.ridd.2011.05.017; Kumazaki H, 2015, RES AUTISM SPECT DIS, V13-14, P1, DOI 10.1016/j.rasd.2014.12.011; Lai MC, 2015, J AM ACAD CHILD PSY, V54, P11, DOI 10.1016/j.jaac.2014.10.003; Lai MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020835; Lutchmaya S, 2002, INFANT BEHAV DEV, V25, P327, DOI 10.1016/S0163-6383(02)00094-2; Mandic-Maravic V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10418; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; Milne E, 2006, J AUTISM DEV DISORD, V36, P225, DOI 10.1007/s10803-005-0052-3; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; PAULHUS DL, 1991, J PERS SOC PSYCHOL, V60, P307, DOI 10.1037/0022-3514.60.2.307; Posserud B, 2008, AUTISM, V12, P99, DOI 10.1177/1362361307085268; Rivet TT, 2011, RES AUTISM SPECT DIS, V5, P957, DOI 10.1016/j.rasd.2010.12.003; Robinson EB, 2013, P NATL ACAD SCI USA, V110, P5258, DOI 10.1073/pnas.1211070110; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Rynkiewicz A, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0073-0; Scheeren AM, 2012, J AUTISM DEV DISORD, V42, P2046, DOI 10.1007/s10803-012-1451-x; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Stacy ME, 2014, AUTISM, V18, P965, DOI 10.1177/1362361313505719; Sucksmith E, 2013, NEUROPSYCHOLOGIA, V51, P98, DOI 10.1016/j.neuropsychologia.2012.11.013; Szatmari P, 2012, AM J MED GENET B, V159B, P5, DOI 10.1002/ajmg.b.31238; Tsakanikos E, 2011, RES AUTISM SPECT DIS, V5, P803, DOI 10.1016/j.rasd.2010.09.009; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728; Wakabayashi A, 2007, J AUTISM DEV DISORD, V37, P1823, DOI 10.1007/s10803-006-0316-6; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Williams JG, 2008, J AUTISM DEV DISORD, V38, P1731, DOI 10.1007/s10803-008-0558-6	74	3	3	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151568	10.1371/journal.pone.0151568	http://dx.doi.org/10.1371/journal.pone.0151568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26998928	Green Published, Green Submitted, gold			2022-12-27	WOS:000372694700047
J	Stern, WM; Desikan, M; Hoad, D; Jaffer, F; Strigaro, G; Sander, JW; Rothwell, JC; Sisodiya, SM				Stern, William M.; Desikan, Mahalekshmi; Hoad, Damon; Jaffer, Fatima; Strigaro, Gionata; Sander, Josemir W.; Rothwell, John C.; Sisodiya, Sanjay M.			Spontaneously Fluctuating Motor Cortex Excitability in Alternating Hemiplegia of Childhood: A Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							DE-NOVO MUTATIONS; CLINICAL-MANIFESTATIONS; ATP1A3; ATPASE; MECHANISMS; POTASSIUM; ALPHA	Background Alternating hemiplegia of childhood is a very rare and serious neurodevelopmental syndrome; its genetic basis has recently been established. Its characteristic features include typically-unprovoked episodes of hemiplegia and other transient or more persistent neurological abnormalities. Methods We used transcranial magnetic stimulation to assess the effect of the condition on motor cortex neurophysiology both during and between attacks of hemiplegia. Nine people with alternating hemiplegia of childhood were recruited; eight were successfully tested using transcranial magnetic stimulation to study motor cortex excitability, using single and paired pulse paradigms. For comparison, data from ten people with epilepsy but not alternating hemiplegia, and ten healthy controls, were used. Results YOne person with alternating hemiplegia tested during the onset of a hemiplegic attack showed progressively diminishing motor cortex excitability until no response could be evoked; a second person tested during a prolonged bilateral hemiplegic attack showed unusually low excitability. Three people tested between attacks showed asymptomatic variation in cortical excitability, not seen in controls. Paired pulse paradigms, which probe intracortical inhibitory and excitatory circuits, gave results similar to controls. Conclusions We report symptomatic and asymptomatic fluctuations in motor cortex excitability in people with alternating hemiplegia of childhood, not seen in controls. We propose that such fluctuations underlie hemiplegic attacks, and speculate that the asymptomatic fluctuation we detected may be useful as a biomarker for disease activity.	[Stern, William M.; Sander, Josemir W.; Sisodiya, Sanjay M.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR Univ Coll London Hosp Biomed Res Ctr, London WC1N 3BG, England; [Stern, William M.; Sander, Josemir W.; Sisodiya, Sanjay M.] Epilepsy Soc, Gerrards Cross SL9 0RJ, Bucks, England; [Desikan, Mahalekshmi; Hoad, Damon; Rothwell, John C.] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Jaffer, Fatima] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Strigaro, Gionata] Univ Piemonte Orientale, Neurol Sect, Dept Translat Med, Novara, Italy; [Sander, Josemir W.] Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of Eastern Piedmont Amedeo Avogadro	Sisodiya, SM (corresponding author), UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR Univ Coll London Hosp Biomed Res Ctr, London WC1N 3BG, England.; Sisodiya, SM (corresponding author), Epilepsy Soc, Gerrards Cross SL9 0RJ, Bucks, England.	s.sisodiya@ucl.ac.uk	Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661; Jaffer, Fatima/0000-0001-6336-2752	Epilepsy Society (UK); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Marvin Weil Epilepsy Research Fund	Epilepsy Society (UK); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Marvin Weil Epilepsy Research Fund	The study was funded by Epilepsy Society (UK) and undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. JWS is supported by the Marvin Weil Epilepsy Research Fund.	Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; AMINIAN A, 1993, ANN NEUROL, V33, P43, DOI 10.1002/ana.410330108; Bauer PR, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714300010; Boroojerdi B, 2001, CLIN NEUROPHYSIOL, V112, P931, DOI 10.1016/S1388-2457(01)00523-5; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Cantello R, 2002, BRAIN RES REV, V38, P309, DOI 10.1016/S0165-0173(01)00158-8; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Edwards IJ, 2013, J NEUROSCI, V33, P9913, DOI 10.1523/JNEUROSCI.5584-12.2013; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hoei-Hansen CE, 2014, EUR J PAEDIATR NEURO, V18, P50, DOI 10.1016/j.ejpn.2013.08.007; Hunanyan AS, 2015, EPILEPSIA, V56, P82, DOI 10.1111/epi.12878; Ishii A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056120; Jaffer F, 2015, BRAIN; Kale N, 2014, NEUROLOGY S, V82, pP4191; Kirshenbaum GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060141; Koenderink JB, 2003, J BIOL CHEM, V278, P51213, DOI 10.1074/jbc.M306384200; Li M, 2015, NEUROBIOL DIS; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Panagiotakaki E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0335-5; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P11, DOI 10.1113/jphysiol.2008.162461; Sasaki M, 2014, NEUROLOGY, V82, P482, DOI 10.1212/WNL.0000000000000102; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Viollet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127045; Vollono C, 2014, EUR J NEUROL OF 0717; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; ZUPANC ML, 1991, PEDIATR NEUROL, V7, P35, DOI 10.1016/0887-8994(91)90103-R	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151667	10.1371/journal.pone.0151667	http://dx.doi.org/10.1371/journal.pone.0151667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999520	Green Published, gold, Green Submitted			2022-12-27	WOS:000372694700053
J	Alt, Y; Grimm, A; Schlegel, L; Grambihler, A; Kittner, JM; Wiltink, J; Galle, PR; Woerns, MA; Schattenberg, JM				Alt, Yvonne; Grimm, Anna; Schlegel, Liesa; Grambihler, Annette; Kittner, Jens M.; Wiltink, Joerg; Galle, Peter R.; Woerns, Marcus A.; Schattenberg, Joern M.			The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease	PLOS ONE			English	Article							CYTOKERATIN 18; SERUM; FIBROSIS; PREDICTORS; APOPTOSIS; PROGNOSIS; CIRRHOSIS; BIOPSY	Background Patients with chronic liver disease often suffer from unspecific symptoms and report severe impairment in the quality of life. The underlying mechanisms are multifactorial and include disease-specific but also liver related causes. The current analysis evaluated the association of hepatocellular apoptosis in non-viral chronic liver disease and health-related quality of life (HRQL). Furthermore we examined factors, which influence patient's physical and mental well-being. Methods A total of 150 patients with non-infectious chronic liver disease were included between January 2014 and June 2015. The German version of the Chronic Liver Disease Questionnaire (CLDQ-D), a liver disease specific instrument to assess HRQL, was employed. Hepatocellular apoptosis was determined by measuring Cytokeratin 18 (CK18, M30 Apoptosense ELISA). Results Female gender (5.24 vs. 5.54, p = 0.04), diabetes mellitus type II (4.75 vs. 5.46, p<0.001) and daily drug intake (5.24 vs. 6.01, p = 0.003) were associated with a significant impairment in HRQL. HRQL was not significantly different between the examined liver diseases. Levels of CK18 were the highest in patients with NASH compared to all other disease entities (p<0.001). Interestingly, CK18 exhibited significant correlations with obesity (p<0.001) and hyperlipidemia (p<0.001). In patients with cirrhosis levels of CK18 correlated with the MELD score (r = 0.18, p = 0.03) and were significantly higher compared to patients without existing cirrhosis (265.5 U/l vs. 186.9 U/l, p = 0.047). Additionally, CK18 showed a significant correlation with the presence and the degree of hepatic fibrosis (p = 0.003) and inflammation (p<0.001) in liver histology. Finally, there was a small negative association between CLDQ and CK18 (r = -0.16, p = 0.048). Conclusion Different parameters are influencing HRQL and CK18 levels in chronic non-viral liver disease and the amount of hepatocellular apoptosis correlates with the impairment in HRQL in chronic non-viral liver diseases. These findings support the role of liver-protective therapies for the improvement of the quality of life in chronic liver disease.	[Alt, Yvonne; Grimm, Anna; Schlegel, Liesa; Grambihler, Annette; Kittner, Jens M.; Galle, Peter R.; Woerns, Marcus A.; Schattenberg, Joern M.] Johannes Gutenberg Univ Mainz, Dept Med, Univ Med Ctr, D-55122 Mainz, Germany; [Wiltink, Joerg] Johannes Gutenberg Univ Mainz, Dept Psychosomat Med & Psychotherapy, Univ Med Ctr, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Schattenberg, JM (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med, Univ Med Ctr, D-55122 Mainz, Germany.	joern.schattenberg@unimedizin-mainz.de	Schattenberg, Jörn M./C-1301-2013; Galle, Peter/ABE-2872-2021; Galle, Peter R/T-5292-2018	Schattenberg, Jörn M./0000-0002-4224-4703; Galle, Peter/0000-0001-8294-0992; Galle, Peter R/0000-0001-8294-0992	Johannes-Gutenberg University Mainz; German liver foundation; Deutsche Diabetes Gesellschaft; Johannes Gutenberg University Mainz	Johannes-Gutenberg University Mainz; German liver foundation; Deutsche Diabetes Gesellschaft; Johannes Gutenberg University Mainz	YA received support of intramural funds of the Johannes-Gutenberg University Mainz and from German liver foundation; JMS received funding from the Deutsche Diabetes Gesellschaft and support of intramural funds of the Johannes Gutenberg University Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Afendy A, 2009, ALIMENT PHARM THER, V30, P469, DOI 10.1111/j.1365-2036.2009.04061.x; Aida Y, 2014, INT J CLIN EXP MED, V7, P4191; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkhouri N, 2011, EXPERT REV GASTROENT, V5, P201, DOI [10.1586/EGH.11.6, 10.1586/egh.11.6]; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Bianchi L, 2001, J HEPATOL, V35, P290, DOI 10.1016/S0168-8278(01)00155-6; Canbay A, 2014, Z GASTROENTEROL, V52, P290, DOI 10.1055/s-0033-1356138; Cordoba J, 2003, J HEPATOL, V39, P231, DOI 10.1016/S0168-8278(03)00189-2; David K, 2009, HEPATOLOGY, V49, P1904, DOI 10.1002/hep.22868; de Souza NP, 2015, BRAZ J INFECT DIS, V19, P590, DOI 10.1016/j.bjid.2015.08.003; Denk G, 2014, HEPATOL RES, V44, P1286, DOI 10.1111/hepr.12304; Dvorak K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111551; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Gough SCL, 2009, DIABETES METAB SYNDR, V2, P179, DOI 10.2147/DMSO.S7088; Gutteling JJ, 2007, NETH J MED, V65, P227; Hauser W, 2004, CLIN GASTROENTEROL H, V2, P157, DOI 10.1016/S1542-3565(03)00315-X; Hauser W, 2004, EUR J GASTROEN HEPAT, V16, P599, DOI 10.1097/01.meg.000108324.52416.18; Jara M, 2014, CLIN TRANSPLANT, V28, P1331, DOI 10.1111/ctr.12426; Joka D, 2012, HEPATOLOGY, V55, P455, DOI 10.1002/hep.24734; Kronenberger B, 2005, J VIRAL HEPATITIS, V12, P307, DOI 10.1111/j.1365-2893.2005.00594.x; Les I, 2010, EUR J GASTROEN HEPAT, V22, P221, DOI 10.1097/MEG.0b013e3283319975; Marchesini G, 2001, GASTROENTEROLOGY, V120, P170, DOI 10.1053/gast.2001.21193; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Saab S, 2005, LIVER TRANSPLANT, V11, P218, DOI 10.1002/lt.20345; Schulz KH, 2008, QUAL LIFE RES, V17, P575, DOI 10.1007/s11136-008-9332-7; Sekiguchi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131658; Suk KT, 2015, WORLD J HEPATOL, V7, P607, DOI 10.4254/wjh.v7.i3.607; Yagmur E, 2007, CLIN BIOCHEM, V40, P651, DOI 10.1016/j.clinbiochem.2006.12.010; Yang ZH, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.15(5)2015.25328; Yilmaz Y, 2007, WORLD J GASTROENTERO, V13, P837, DOI 10.3748/wjg.v13.i6.837; Younossi ZM, 2001, AM J GASTROENTEROL, V96, P2199, DOI 10.1016/S0002-9270(01)02519-9; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zuberi Bader Faiyaz, 2007, J Ayub Med Coll Abbottabad, V19, P7	34	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151200	10.1371/journal.pone.0151200	http://dx.doi.org/10.1371/journal.pone.0151200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990427	Green Published, gold, Green Submitted			2022-12-27	WOS:000372582800046
J	Asghar, MS; Becerra, L; Larsson, HBW; Borsook, D; Ashina, M				Asghar, Mohammad Sohail; Becerra, Lino; Larsson, Henrik B. W.; Borsook, David; Ashina, Messoud			Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CENTRAL-NERVOUS-SYSTEM; EVOKED DISCHARGE FREQUENCY; ANTERIOR CINGULATE CORTEX; HUMAN CEREBRAL-ARTERIES; DYNAMIC-RANGE NEURONS; STEM ACTIVATION; BINDING-SITES; DORSAL-HORN; SPINAL-CORD	Background Intravenous infusion of calcitonin-gene-related-peptide (CGRP) provokes headache and migraine in humans. Mechanisms underlying CGRP-induced headache are not fully clarified and it is unknown to what extent CGRP modulates nociceptive processing in the brain. To elucidate this we recorded blood-oxygenation-level-dependent (BOLD) signals in the brain by functional MRI after infusion of CGRP in a double-blind placebo-controlled crossover study of 27 healthy volunteers. BOLD-signals were recorded in response to noxious heat stimuli in the V1-area of the trigeminal nerve. In addition, we measured BOLD-signals after injection of sumatriptan (5-HT1B/1D antagonist). Results Brain activation to noxious heat stimuli following CGRP infusion compared to baseline resulted in increased BOLD-signal in insula and brainstem, and decreased BOLD-signal in the caudate nuclei, thalamus and cingulate cortex. Sumatriptan injection reversed these changes. Conclusion The changes in BOLD-signals in the brain after CGRP infusion suggests that systemic CGRP modulates nociceptive transmission in the trigeminal pain pathways in response to noxious heat stimuli.	[Asghar, Mohammad Sohail; Ashina, Messoud] Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark; [Asghar, Mohammad Sohail; Ashina, Messoud] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark; [Becerra, Lino; Borsook, David] Boston Childrens Hosp, PAIN Grp, Boston, MA 02453 USA; [Becerra, Lino; Borsook, David] Harvard Univ, Sch Med, Ctr Pain & Brain, Boston, MA 02453 USA; [Larsson, Henrik B. W.] Univ Copenhagen, Glostrup Hosp, Fac Hlth & Med Sci, Funct Imaging Unit,Dept Diagnost, DK-2600 Glostrup, Denmark	University of Copenhagen; University of Copenhagen; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Copenhagen	Ashina, M (corresponding author), Univ Copenhagen, Glostrup Hosp, Danish Headache Ctr, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark.; Ashina, M (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Neurol, Fac Hlth & Med Sci, DK-2600 Glostrup, Denmark.	ashina@dadlnet.dk	Ashina, Messoud/AFU-1246-2022	Ashina, Messoud/0000-0003-0951-5804	University of Copenhagen; Lundbeck Foundation Center for Neurovascular Signaling (LUCENS); Research Foundation of the Capital Region of Denmark; Danish Council for Independent Research-Medical Sciences (FSS) [271-08-0446]; Novo Nordisk Foundation; Cool Sorption Foundation; Danish Headache Foundation; Alex Klees Smerteforskningslegat; Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat; Merck Co., Inc. [33936]; Else Torps and Flemming Jensens legat; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	University of Copenhagen; Lundbeck Foundation Center for Neurovascular Signaling (LUCENS)(Lundbeck Corporation); Research Foundation of the Capital Region of Denmark; Danish Council for Independent Research-Medical Sciences (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Cool Sorption Foundation; Danish Headache Foundation; Alex Klees Smerteforskningslegat; Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat; Merck Co., Inc.(Merck & Company); Else Torps and Flemming Jensens legat; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors were independently responsible for the study design, data analysis and manuscript. The study was sponsored by University of Copenhagen, Lundbeck Foundation Center for Neurovascular Signaling (LUCENS), the Research Foundation of the Capital Region of Denmark, Danish Council for Independent Research-Medical Sciences (FSS; grant 271-08-0446), the Novo Nordisk Foundation, Cool Sorption Foundation, Danish Headache Foundation, Alex Klees Smerteforskningslegat, Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat and Else Torps and Flemming Jensens legat. The Investigator Initiated Studies Program of Merck & Co., Inc., provided funding towards this study (research grant 33936). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The corresponding author had full access to all the study data and had the final responsibility to submit for publication.	Afridi SK, 2005, ARCH NEUROL-CHICAGO, V62, P1270, DOI 10.1001/archneur.62.8.1270; Allman JM, 2011, ANN NY ACAD SCI, V1225, P59, DOI 10.1111/j.1749-6632.2011.06011.x; Amin FM, 2013, CEPHALALGIA, V33, P1009, DOI 10.1177/0333102413483374; Amin FM, 2013, LANCET NEUROL, V12, P454, DOI 10.1016/S1474-4422(13)70067-X; Asghar MS, 2010, NEUROLOGY, V75, P1520, DOI 10.1212/WNL.0b013e3181f9626a; Asghar MS, 2012, J HEADACHE PAIN, V13, P159, DOI 10.1007/s10194-011-0415-4; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Ashina M, 2000, PAIN, V86, P133, DOI 10.1016/S0304-3959(00)00232-3; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bahra A, 2001, LANCET, V357, P1016, DOI 10.1016/S0140-6736(00)04250-1; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Borsook D, 2004, J NEUROBIOL, V61, P107, DOI 10.1002/neu.20085; Brain SD, 1996, GEN PHARMACOL, V27, P607, DOI 10.1016/0306-3623(95)00125-5; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chatchaisak D, 2013, J CHEM NEUROANAT, V47, P50, DOI 10.1016/j.jchemneu.2012.09.005; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; de Leeuw R, 2006, ORAL SURG ORAL MED O, V102, P750, DOI 10.1016/j.tripleo.2005.12.018; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; EDVINSSON L, 1987, ANN NEUROL, V21, P431, DOI 10.1002/ana.410210503; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Eftekhari S, 2013, J PAIN, V14, P1289, DOI 10.1016/j.jpain.2013.03.010; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Fan J, 2011, NEUROIMAGE, V54, P2539, DOI 10.1016/j.neuroimage.2010.10.007; FOWLER PA, 1991, EUR NEUROL, V31, P291, DOI 10.1159/000116756; GOADSBY PJ, 1988, ANN NEUROL, V23, P193, DOI 10.1002/ana.410230214; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; IADAROLA MJ, 1995, PAIN, V63, P55, DOI 10.1016/0304-3959(95)00015-K; INAGAKI S, 1986, BRAIN RES, V374, P287, DOI 10.1016/0006-8993(86)90423-3; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; JansenOlesen I, 1996, CEPHALALGIA, V16, P310, DOI 10.1046/j.1468-2982.1996.1605310.x; Klein TA, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00014, 10.3389/fnins.2013.00113]; Kramer HH, 2007, PAIN, V133, P72, DOI 10.1016/j.pain.2007.03.001; KRUGER L, 1988, BRAIN RES, V463, P223, DOI 10.1016/0006-8993(88)90395-2; LACEY LF, 1995, EUR J CLIN PHARMACOL, V47, P543; Lassen LH, 2008, J HEADACHE PAIN, V9, P151, DOI 10.1007/s10194-008-0036-8; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Levy D, 2005, ANN NEUROL, V58, P698, DOI 10.1002/ana.20619; Li DG, 2008, J PAIN, V9, P1155, DOI 10.1016/j.jpain.2008.06.011; LINEBERRY CG, 1975, BRAIN RES, V98, P110, DOI 10.1016/0006-8993(75)90513-2; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; MAO JR, 1992, BRAIN RES, V574, P157, DOI 10.1016/0006-8993(92)90812-N; MASON RT, 1984, NATURE, V308, P653, DOI 10.1038/308653a0; May A, 1998, PAIN, V74, P61, DOI 10.1016/S0304-3959(97)00144-9; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; MCCULLOCH J, 1986, P NATL ACAD SCI USA, V83, P5731, DOI 10.1073/pnas.83.15.5731; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MORECRAFT RJ, 1992, J COMP NEUROL, V322, P471, DOI 10.1002/cne.903220403; Morelli N, 2013, CEPHALALGIA, V33, P416, DOI 10.1177/0333102412474505; Naliboff BD, 2001, PSYCHOSOM MED, V63, P365, DOI 10.1097/00006842-200105000-00006; Naliboff BD, 2006, GASTROENTEROLOGY, V131, P352, DOI 10.1053/j.gastro.2006.05.014; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; PEDERSENBJERGAARD U, 1991, PEPTIDES, V12, P333, DOI 10.1016/0196-9781(91)90022-H; Pendse G, 2009, NEUROIMAGE, V47, P231, DOI 10.1016/j.neuroimage.2009.02.035; Petersen KA, 2005, CLIN PHARMACOL THER, V77, P202, DOI 10.1016/j.clpt.2004.10.001; Petersen KA, 2005, CEPHALALGIA, V25, P139, DOI 10.1111/j.1468-2982.2004.00830.x; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploner M, 1999, PAIN, V81, P211, DOI 10.1016/S0304-3959(99)00012-3; Reinert A, 1998, EXP BRAIN RES, V121, P174, DOI 10.1007/s002210050449; ROSEN SD, 1994, LANCET, V344, P147, DOI 10.1016/S0140-6736(94)92755-3; SEXTON PM, 1991, MOL NEUROBIOL, V5, P251, DOI 10.1007/BF02935550; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Starr CJ, 2009, J NEUROSCI, V29, P2684, DOI 10.1523/JNEUROSCI.5173-08.2009; STOVER JD, 1992, SOMATOSENS MOT RES, V9, P107, DOI 10.3109/08990229209144766; Sun RQ, 2004, J NEUROPHYSIOL, V92, P320, DOI 10.1152/jn.00086.2004; Sun RQ, 2003, PAIN, V104, P201, DOI 10.1016/S0304-3959(03)00008-3; Thomsen LL, 1996, CEPHALALGIA, V16, P169, DOI 10.1046/j.1468-2982.1996.1603169.x; TSAI SH, 1988, J COMP NEUROL, V271, P435, DOI 10.1002/cne.902710310; TSCHOPP FA, 1985, P NATL ACAD SCI USA, V82, P248, DOI 10.1073/pnas.82.1.248; Upadhyay J, 2008, MAGN RESON MED, V60, P1037, DOI 10.1002/mrm.21682; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Visser WH, 1996, HEADACHE, V36, P471, DOI 10.1046/j.1526-4610.1996.3608471.x; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wang Y, 2013, EXP BRAIN RES, V226, P15, DOI 10.1007/s00221-013-3405-8; Weigelt A, 2010, PAIN, V149, P529, DOI 10.1016/j.pain.2010.03.027; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Wunderlich Arthur P, 2011, Open Neuroimag J, V5, P1, DOI 10.2174/1874440001105010001; YOSHIDA A, 1991, J COMP NEUROL, V307, P609, DOI 10.1002/cne.903070408; Yu LC, 1999, REGUL PEPTIDES, V83, P21, DOI 10.1016/S0167-0115(99)00046-4; Yu Y, 2002, REGUL PEPTIDES, V103, P23, DOI 10.1016/S0167-0115(01)00326-3; Zambreanu L, 2005, PAIN, V114, P397, DOI 10.1016/j.pain.2005.01.005	93	26	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150334	10.1371/journal.pone.0150334	http://dx.doi.org/10.1371/journal.pone.0150334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990646	gold, Green Submitted, Green Published			2022-12-27	WOS:000372582800028
J	Asselah, T; Thompson, AJ; Flisiak, R; Romero-Gomez, M; Messinger, D; Bakalos, G; Shiffman, ML				Asselah, Tarik; Thompson, Alex J.; Flisiak, Robert; Romero-Gomez, Manuel; Messinger, Diethelm; Bakalos, Georgios; Shiffman, Mitchell L.			A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2 alpha/Ribavirin	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; PEGYLATED INTERFERON; RIBAVIRIN; ALPHA-2A; SOFOSBUVIR; IMPACT; 40KD	Background Access to direct-acting antiviral agents (DAAs) is restricted in some settings; thus, the European Association for the Study of the Liver recommends dual peginterferon/ribavirin (PegIFN/RBV) therapy wherever DAAs are unavailable. HCV genotype (GT) 3 infection is now the most difficult genotype to eradicate and PegIFN/RBV remains an effective option. The goal of this study was to devise a simple predictive score to identify GT3 patients with a high probability of achieving a sustained virologic response (SVR) with PegIFN alfa-2a/RBV therapy. Methods Relationships between baseline characteristics and SVR were explored by multiple logistic regression models and used to develop a simple scoring system to predict SVR using data from 1239 treatment-naive GT3 patients who received PegIFN alfa-2a/RBV for 24 weeks in two large observational cohort studies. Results The score was validated using a database of 473 patients. Scores were assigned for six factors as follows: age (years) (<= 40: 2 points; >40 but <= 55: 1); bodyweight (kg) (<70: 2; >= 70 but <90: 1); no cirrhosis/transition to cirrhosis (2); ALT <= 2.5 x ULN (1); platelets (10(9)/L) (>200: 2; >= 100 but <200: 1); HCV RNA (<400,000 IU/mL: 1). The points are summed to arrive at a score ranging from 0-10 where higher scores indicate higher chances of SVR; 141, 123, 203, 249, 232, and 218 patients had total scores of 0-4, 5, 6, 7, 8, and 9-10, respectively, among whom SVR rates were 45%, 62%, 72%, 76%, 84%, and 89%. Among 622 patients who had scores of 6-10 and HCV RNA <50 IU/mL by treatment week 4 the SVR rate was 86% (532/622). Conclusions A simple baseline scoring system involving age, bodyweight, cirrhosis status, ALT level, platelet count and HCV RNA level can be used to identify treatment-naive Caucasian patients with HCV GT3 infection with a high probability of SVR with PegIFN alfa-2a/RBV therapy.	[Asselah, Tarik] Univ Paris Diderot, Hop Beaujon, AP HP, Serv Hepatol,CRI,Inserm,UMR 1149, Paris, France; [Thompson, Alex J.] Univ Melbourne, Dept Gastroenterol, St Vincents Hosp, Melbourne, Vic, Australia; [Flisiak, Robert] Med Univ Bialystok, Dept Infect Dis & Hepatol, PL-15540 Bialystok, Poland; [Romero-Gomez, Manuel] Univ Seville, UCM Digest Dis, Valme Univ Hosp, Seville, Spain; [Romero-Gomez, Manuel] Univ Seville, CIBERehd, Valme Univ Hosp, Seville, Spain; [Messinger, Diethelm] PROMETRIS GmbH, Biostat, D-68219 Mannheim, Germany; [Bakalos, Georgios] F Hoffmann La Roche Ltd, Global Prod Dev Med Affairs, CH-4074 Basel, Switzerland; [Shiffman, Mitchell L.] Richmond & Newport News, Bon Secours Hlth Syst, Liver Inst Virginia, Richmond, VA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; St Vincent's Hospital Melbourne; University of Melbourne; Medical University of Bialystok; Hospital Valme; University of Sevilla; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Valme; University of Sevilla; Roche Holding	Asselah, T (corresponding author), Univ Paris Diderot, Hop Beaujon, AP HP, Serv Hepatol,CRI,Inserm,UMR 1149, Paris, France.	tarik.asselah@bjn.aphp.fr	Romero-Gomez, Manuel/L-8030-2014; Flisiak, Robert/S-5356-2018	Romero-Gomez, Manuel/0000-0001-8494-8947; Bakalos, Georgios/0000-0003-1862-632X; Flisiak, Robert/0000-0003-3394-1635	F. Hoffmann-La Roche Ltd.; PROMETRIS GmbH; F. Hoffmann-La Roche Ltd, Basel, Switzerland	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); PROMETRIS GmbH; F. Hoffmann-La Roche Ltd, Basel, Switzerland(Hoffmann-La Roche)	These studies were funded by F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche participated in the design and conduct of the study, in the analysis and interpretation of the data, and in the preparation and review of the manuscript before submission. Third-party medical writing assistance, provided by Blair Jarvis MSc, ELS, of Health Interactions, but not editorial content development sufficient to meet International Committee of Medical Journal Editors (ICMJE) authorship criteria, was provided by Health Interactions and funded by F. Hoffmann-La Roche Ltd. F. Hoffmann-La Roche Ltd provided support in the form of salaries for authors [GB]. PROMETRIS GmbH is the clinical research organization contracted by F. Hoffmann-La Roche Ltd to provide data management and statistical services. PROMETRIS GmbH provided support in the form of salaries for authors [DM], participated in the design and conduct of the study, in the analysis and interpretation of the data, and in the preparation and review of the manuscript before submission. The specific roles of these authors are articulated in the 'author contributions' section.; Support for third-party writing assistance for this manuscript, provided by Debbie Briggs PhD and Blair Jarvis Msc, ELS of Health Interactions, was funded by F. Hoffmann-La Roche Ltd, Basel, Switzerland.	Ampuero J, 2014, ALIMENT PHARM THER, V39, P686, DOI 10.1111/apt.12646; Bochud PY, 2009, J HEPATOL, V51, P655, DOI 10.1016/j.jhep.2009.05.016; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Dalgard O, 2004, HEPATOLOGY, V40, P1260, DOI 10.1002/hep.20467; Dalgard O, 2008, HEPATOLOGY, V47, P35, DOI 10.1002/hep.21975; Diago M, 2010, HEPATOLOGY, V51, P1897, DOI 10.1002/hep.23531; Ferenci P, 2014, LIVER INT, V34, P1550, DOI 10.1111/liv.12439; Firdaus R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099126; Foster GR, 2015, J HEPATOL, V62, pS259, DOI 10.1016/S0168-8278(15)30151-3; Foster GR, 2012, J HEPATOL, V56, pS437, DOI 10.1016/S0168-8278(12)61122-2; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heidrich B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108751; Jayasekera CR, 2014, NEW ENGL J MED, V370, P1869, DOI 10.1056/NEJMp1400160; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Moghaddam A, 2011, HEPATOLOGY, V53, P746, DOI 10.1002/hep.24154; Nkontchou G, 2011, J VIRAL HEPATITIS, V18, pE516, DOI 10.1111/j.1365-2893.2011.01441.x; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; World Health Organization, GUID SCREEN CAR TREA; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zeuzem S, 2009, ANTIVIR THER, V14, P143	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150569	10.1371/journal.pone.0150569	http://dx.doi.org/10.1371/journal.pone.0150569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991780	gold, Green Published			2022-12-27	WOS:000372582800037
J	Azary, S; Ganguly, A; Bunin, GR; Lombardi, C; Park, AS; Ritz, B; Heck, JE				Azary, Saeedeh; Ganguly, Arupa; Bunin, Greta R.; Lombardi, Christina; Park, Andrew S.; Ritz, Beate; Heck, Julia E.			Sporadic Retinoblastoma and Parental Smoking and Alcohol Consumption before and after Conception: A Report from the Children's Oncology Group	PLOS ONE			English	Article							CIGARETTE-SMOKING; SOCIOECONOMIC-STATUS; CHILDHOOD-CANCER; TOBACCO-SMOKE; DNA ADDUCTS; RISK; MUTATIONS; EXPRESSION; PREGNANCY; EXPOSURE	Background Retinoblastoma is the most frequent tumor of the eye in children and very little is known about the etiology of non-familial (sporadic) retinoblastoma. In this study we examined whether parental tobacco smoking or alcohol consumption (pre- or post-conception) contribute to the two phenotypes (bilateral or unilateral) of sporadic retinoblastoma. Methods Two large multicenter case-control studies identified 488 cases through eye referral centers in the United States and Canada or through the Children's Oncology Group. Controls (n = 424) were selected from among friends and relatives of cases and matched by age. Risk factor information was obtained via telephone interview. We employed multivariable logistic regression to estimate the effects of parental tobacco smoking and alcohol consumption on retinoblastoma. Findings Maternal smoking before and during pregnancy contributed to unilateral retinoblastoma risk in the child: year before pregnancy conditional Odds Ratio (OR), 8.9; 95% confidence interval (CI) 1.5-51, and unconditional OR, 2.4; 95% CI, 1.3-4.7; month before or during pregnancy, conditional OR, 3.3; 95% CI, 0.5-20.8, and unconditional OR, 2.8; 95% CI, 1.1-7.0. No association was found for maternal or paternal alcohol consumption. Conclusion The results of this study indicate that maternal active smoking during pregnancy may be a risk factor for sporadic retinoblastoma. Our study supports a role for tobacco exposures in embryonal tumors.	[Azary, Saeedeh; Lombardi, Christina; Park, Andrew S.; Ritz, Beate; Heck, Julia E.] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Ganguly, Arupa] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Bunin, Greta R.] Childrens Hosp Philadelphia, Div Oncol, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Heck, JE (corresponding author), Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA.	jeheck@ucla.edu	Heck, Julia E/B-5230-2009	Heck, Julia E/0000-0001-8713-8413	NIH/NCI [RO1 - CA118580]; NIH/NIEHS [R03ES021643, R21ES019986]; ARRA supplement [CA-118580-03S1]; Jonsson Cancer Center Foundation/UCLA; NATIONAL CANCER INSTITUTE [R01CA118580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES021643, R21ES019986] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ARRA supplement; Jonsson Cancer Center Foundation/UCLA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from NIH/NCI (RO1 - CA118580), NIH/NIEHS (R03ES021643, R21ES019986), and ARRA supplement (CA-118580-03S1). Dr. Azary was supported by a grant from the Jonsson Cancer Center Foundation/UCLA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaku I, 2013, JAMA-J AM MED ASSOC, V309, P539, DOI 10.1001/jama.2012.114523; Bonanomi MTBC, 2009, CLINICS, V64, P427, DOI 10.1590/S1807-59322009000500010; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; BUNIN GR, 1989, CANCER RES, V49, P5730; Bunin GR, 2012, ENVIRON MOL MUTAGEN, V53, P451, DOI 10.1002/em.21705; Bunin GR, 2011, PAEDIATR PERINAT EP, V25, P402, DOI 10.1111/j.1365-3016.2011.01210.x; Bunin GR, 2011, INT J CANCER, V128, P2393, DOI 10.1002/ijc.25565; Canturk S, 2010, BRIT J OPHTHALMOL, V94, P1432, DOI 10.1136/bjo.2009.168062; Casswell S, 2003, ADDICTION, V98, P601, DOI 10.1046/j.1360-0443.2003.00331.x; Centers for Disease Control and Prevention, 2011, PRAMSTAT SYST; DELLARCO VL, 1988, MUTAT RES, V195, P1, DOI 10.1016/0165-1110(88)90013-9; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dietz PM, 2011, AM J EPIDEMIOL, V173, P355, DOI 10.1093/aje/kwq381; Dryja TP, 1997, HUM GENET, V100, P446, DOI 10.1007/s004390050531; EVERSON RB, 1986, SCIENCE, V231, P54, DOI 10.1126/science.3941892; Finette BA, 1998, NAT MED, V4, P1144, DOI 10.1038/2640; Foix-L'Helias L, 2012, HUM REPROD, V27, P2186, DOI 10.1093/humrep/des149; GOODRICH DW, 1990, CANCER SURV, V9, P529; HANSEN C, 1993, ENVIRON HEALTH PERSP, V99, P229, DOI 10.2307/3431488; Heck JE, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1773-0; Heck JE, 2012, CANCER CAUSE CONTROL, V23, P1567, DOI 10.1007/s10552-012-0034-7; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; HOAR RM, 1982, ENVIRON HEALTH PERSP, V44, P31, DOI 10.2307/3429473; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; Kaste SC, 1997, J CLIN ONCOL, V15, P1183, DOI 10.1200/JCO.1997.15.3.1183; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lombardi C, 2015, CANCER CAUSE CONTROL, V26, P387, DOI 10.1007/s10552-014-0514-z; Navarro AM, 1999, TOB CONTROL, V8, P182, DOI 10.1136/tc.8.2.182; OBE G, 1979, MUTAT RES, V65, P229, DOI 10.1016/0165-1110(79)90004-6; Orjuela MA, 2005, CANCER EPIDEM BIOMAR, V14, P1433, DOI 10.1158/1055-9965.EPI-04-0427; Pang D, 2003, BRIT J CANCER, V88, P373, DOI 10.1038/sj.bjc.6600774; Pickett KE, 2003, OBSTET GYNECOL, V101, P140, DOI 10.1016/S0029-7844(02)02370-0; Potts RJ, 1999, MUTAT RES-FUND MOL M, V423, P103, DOI 10.1016/S0027-5107(98)00242-5; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Shu XO, 1996, JNCI-J NATL CANCER I, V88, P24, DOI 10.1093/jnci/88.1.24; Stavrou EP, 2009, CANCER CAUSE CONTROL, V20, P1551, DOI 10.1007/s10552-009-9400-5; Viczian AS, 2006, DEV DYNAM, V235, P1133, DOI 10.1002/dvdy.20708; Windsor RA, 2000, AM J OBSTET GYNECOL, V182, P68, DOI 10.1016/S0002-9378(00)70492-3; Yang QH, 2000, CANCER EPIDEM BIOMAR, V9, P967; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279	42	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151728	10.1371/journal.pone.0151728	http://dx.doi.org/10.1371/journal.pone.0151728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991078	gold, Green Published			2022-12-27	WOS:000372582800092
J	Li, R; Pu, X; Chang, JY; Ye, YQ; Komaki, R; Minna, JD; Roth, JA; Han, BH; Wu, XF				Li, Rong; Pu, Xia; Chang, Joe Y.; Ye, Yuanqing; Komaki, Ritsuko; Minna, John D.; Roth, Jack A.; Han, Baohui; Wu, Xifeng			MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; STEM-CELLS; LARGE-SCALE; MICRORNA; RISK; SURVIVAL; DATABASE; MODIFY; SITES	Severe radiation-induced toxicities limit treatment efficacy and compromise outcomes of lung cancer. We aimed to identify microRNA-related genetic variations as biomarkers for the prediction of radiotherapy-induced acute toxicities. We genotyped 233 SNPs (161 in microRNA binding site and 72 in processing gene) and analyzed their associations with pneumonitis and esophagitis in 167 stage III NSCLC patients received definitive radiation therapy. Sixteen and 11 SNPs were associated with esophagitis and pneumonitis, respectively. After multiple comparison correction, RPS6KB2:rs10274, SMO:rs1061280, SMO:rs1061285 remained significantly associated with esophagitis, while processing gene DGCR8:rs720014, DGCR8:rs3757, DGCR8:rs1633445 remained significantly associated with pneumonitis. Patients with the AA genotype of RPS6KB2: rs10274 had an 81% reduced risk of developing esophagitis (OR: 0.19, 95% CI: 0.07-0.51, p = 0.001, q = 0.06). Patients with the AG+GG genotype of SMO: rs1061280 had an 81% reduced risk of developing esophagitis (OR: 0.19, 95% CI: 0.07-0.53, p = 0.001, q = 0.06). Patients with the GG+GA genotype of DGCR8: rs720014 had a 3.54-fold increased risk of pneumonitis (OR: 3.54, 95% CI: 1.65-7.61, p < 0.05, q < 0.1). Significantly cumulative effects of the top SNPs were observed for both toxicities (P-trend < 0.001). Using bioinformatics tools, we found that the genotype of rs10274 was associated with altered expression of the RPS6KB2 gene. Gene-based analysis showed DGCR8 (p = 0.010) and GEMIN4 (p = 0.039) were the top genes associated with the risk of developing pneumonitis. Our results provide strong evidence that microRNA-related genetic variations contribute to the development of radiotherapy-induced acute esophagitis and pneumonitis and could thus serve as biomarkers to help accurately predict radiotherapy-induced toxicity in NSCLC patients.	[Li, Rong; Pu, Xia; Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Li, Rong; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, W Huaihai Rd 241, Shanghai 200030, Peoples R China; [Chang, Joe Y.; Komaki, Ritsuko] Univ Texas MD Anderson Canc Ctr, Radiat Dept, Houston, TX 77030 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Wu, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org		Li, Rong/0000-0003-3971-1670	U.S. NIH [R01-CA111646, P50CA070907, R01-CA127615, CPRIT RP130502]; Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA111646, P50CA070907] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by U.S. NIH grants R01-CA111646 (X. Wu), P50CA070907 (J.D. Minna, J.A. Roth, and X. Wu), R01-CA127615 (X. Wu), and CPRIT RP130502 (X. Wu). Additional support was provided by the Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center (X. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Cellini F, 2014, MOLECULES, V19, P5379, DOI 10.3390/molecules19045379; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P4205, DOI 10.1002/cncr.28338; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fachal L, 2012, RADIOTHER ONCOL, V105, P321, DOI 10.1016/j.radonc.2012.09.013; Gomez-Cabello D, 2013, AGING CELL, V12, P923, DOI 10.1111/acel.12117; Gong M, 2012, PROTEIN SCI, V21, P797, DOI 10.1002/pro.2062; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hildebrandt MAT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012402; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Jacob NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057603; Ke HL, 2013, CARCINOGENESIS, V34, P1006, DOI 10.1093/carcin/bgt006; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Li J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5051; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Madani I, 2007, J THORAC ONCOL, V2, P864, DOI 10.1097/JTO.0b013e318145b2c6; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Masson-Cote L, 2011, INT J RADIAT ONCOL, V80, P686, DOI 10.1016/j.ijrobp.2010.02.010; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Pelczar P, 2013, GASTROENTEROLOGY, V144, P134, DOI 10.1053/j.gastro.2012.09.061; Price A, 2012, NAT REV CLIN ONCOL, V9, P591, DOI 10.1038/nrclinonc.2012.135; Pu X, 2013, CANCER RES, V73, P1867, DOI 10.1158/0008-5472.CAN-12-0873; Pu X, 2012, CLIN CANCER RES, V18, P5983, DOI 10.1158/1078-0432.CCR-12-0774; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka T, 2013, NAT CELL BIOL, V15, P511, DOI 10.1038/ncb2719; Topkan E, 2009, LUNG CANCER, V63, P393, DOI 10.1016/j.lungcan.2008.06.015; Uyterlinde W, 2013, CLIN LUNG CANCER, V14, P541, DOI 10.1016/j.cllc.2013.04.001; Werner-Wasik M, 2010, INT J RADIAT ONCOL, V76, pS86, DOI 10.1016/j.ijrobp.2009.05.070; Wilker EH, 2010, ENVIRON HEALTH PERSP, V118, P943, DOI 10.1289/ehp.0901440; Wu XF, 2009, CANCER PREV RES, V2, P617, DOI 10.1158/1940-6207.CAPR-09-0025; Xue JX, 2013, MOL THER, V21, P456, DOI 10.1038/mt.2012.183; Yanaihara N, 2013, CLIN CHEM, V59, P1811, DOI 10.1373/clinchem.2012.198176; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yazbeck VY, 2013, CANCER J, V19, P231, DOI 10.1097/PPO.0b013e31829453fb; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574	42	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150467	10.1371/journal.pone.0150467	http://dx.doi.org/10.1371/journal.pone.0150467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991123	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800032
J	Ma, DX; Duan, W; Li, YK; Wang, ZM; Li, SL; Gong, NQ; Chen, G; Chen, ZS; Wan, CD; Yang, J				Ma, Dongxia; Duan, Wu; Li, Yakun; Wang, Zhimin; Li, Shanglin; Gong, Nianqiao; Chen, Gang; Chen, Zhishui; Wan, Chidan; Yang, Jun			PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLOIMMUNE RESPONSES; PROGRAMMED DEATH-1; PANCREATIC-ISLETS; CO-TRANSPLANTATION; TISSUE EXPRESSION; GRAFT-SURVIVAL; AUTOIMMUNE; REJECTION; STIMULATION	Background Islet transplantation may potentially cure type 1 diabetes mellitus (T1DM). However, immune rejection, especially that induced by the alloreactive T-cell response, remains a restraining factor for the long-term survival of grafted islets. Programmed death ligand-1 (PD-L1) is a negative costimulatory molecule. PD-L1 deficiency within the donor heart accelerates allograft rejection. Here, we investigate whether PD-L1 deficiency in donor islets reduces allograft survival time. Methods Glucose Stimulation Assays were performed to evaluate whether PD-L1 deficiency has detrimental effects on islet function. Islets isolated from PDL1-deficient mice or wild-type (WT) mice (C57BL/6j) were implanted beneath the renal capsule of streptozotocin (STZ)-induced diabetic BALB/c mice. Blood glucose levels and graft survival time after transplantation were monitored. Moreover, we analyzed the residual islets, infiltrating immune cells and alloreactive cells from the recipients. Results PD-L1 deficiency within islets does not affect islet function. However, islet PD-L1 deficiency increased allograft rejection and was associated with enhanced inflammatory cell infiltration and recipient T-cell alloreactivity. Conclusions This is the first report to demonstrate that PD-L1 deficiency accelerated islet allograft rejection and regulated recipient alloimmune responses.	[Ma, Dongxia; Li, Yakun; Wang, Zhimin; Li, Shanglin; Gong, Nianqiao; Chen, Gang; Chen, Zhishui; Yang, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Organ Transplantat,Minist Hlth, Inst Organ Transplantat,Tongji Hosp,Minist Educ, Wuhan 430074, Hubei Province, Peoples R China; [Duan, Wu] Huazhong Univ Sci & Technol, Dept Endocrinol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Wan, Chidan] Huazhong Univ Sci & Technol, Dept Hepatobiliary Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Organ Transplantat,Minist Hlth, Inst Organ Transplantat,Tongji Hosp,Minist Educ, Wuhan 430074, Hubei Province, Peoples R China.; Wan, CD (corresponding author), Huazhong Univ Sci & Technol, Dept Hepatobiliary Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	chidanwan@163.com; jy@tjh.tjmu.edu.cn	Gong, Nianqiao/ABD-9276-2021		National Natural Science Foundation of China [81373169, 81172827]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81373169 & No. 81172827). JY obtained the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; DiNorcia J, 2015, JAMA SURG, V150, P1066, DOI 10.1001/jamasurg.2015.1853; Dudler J, 2006, TRANSPLANTATION, V82, P1733, DOI 10.1097/01.tp.0000250757.69384.79; El Khatib MM, 2015, GENE THER, V22, P430, DOI 10.1038/gt.2015.18; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Gao WD, 2003, TRANSPLANTATION, V76, P994, DOI 10.1097/01.TP.0000085010.39567.FB; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Grapensparr L, 2015, J CLIN ENDOCR METAB, V100, pE583, DOI 10.1210/jc.2014-4070; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Huang SH, 2010, DIABETOLOGIA, V53, P2389, DOI 10.1007/s00125-010-1858-x; Jeffery LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131539; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Krogstrup NV, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007941; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee G, 2015, J SURG RES, V197, P419, DOI 10.1016/j.jss.2015.02.061; Li T, 2015, TRANSPL P, V47, P165, DOI 10.1016/j.transproceed.2014.10.043; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Luan Xi-Ying, 2009, Zhonghua Xue Ye Xue Za Zhi, V30, P689; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Ozkaynak E, 2002, J IMMUNOL, V169, P6546, DOI 10.4049/jimmunol.169.11.6546; Plege-Fleck A, 2014, XENOTRANSPLANTATION, V21, P533, DOI 10.1111/xen.12121; Sakata N, 2008, PANCREAS, V36, P417, DOI 10.1097/MPA.0b013e31815ccad2; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Shoji K, 2015, PEDIATR INFECT DIS J, V34, P1063, DOI 10.1097/INF.0000000000000811; Takemoto N, 2015, TRANSPLANTATION, V99, P942, DOI 10.1097/TP.0000000000000579; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Wang XJ, 2009, TRANSPLANTATION, V87, P482, DOI 10.1097/TP.0b013e318195e5fa; Xu DM, 2012, DIABETOLOGIA, V55, P1091, DOI 10.1007/s00125-011-2433-9; Yamada A, 2001, J IMMUNOL, V167, P140, DOI 10.4049/jimmunol.167.1.140; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yang J, 2008, CIRCULATION, V117, P660, DOI 10.1161/CIRCULATIONAHA.107.741025	40	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0152087	10.1371/journal.pone.0152087	http://dx.doi.org/10.1371/journal.pone.0152087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990974	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800131
J	Freeland-Riggert, BT; Cairns, SH; Poulton, BC; Riggert, CM				Freeland-Riggert, Brandye T.; Cairns, Stefan H.; Poulton, Barry C.; Riggert, Christopher M.			Differences Found in the Macroinvertebrate Community Composition in the Presence or Absence of the Invasive Alien Crayfish, Orconectes hylas	PLOS ONE			English	Article							RED SWAMP CRAYFISH; PROCAMBARUS-CLARKII; PACIFASTACUS-LENIUSCULUS; OMNIVOROUS CRAYFISH; FEEDING PREFERENCES; QUADRUNCUS CREASER; NONNATIVE CRAYFISH; IMPERILED CRAYFISH; PERUNCUS CREASER; LIFE-HISTORIES	Introductions of alien species into aquatic ecosystems have been well documented, including invasions of crayfish species; however, little is known about the effects of these introductions on macroinvertebrate communities. The woodland crayfish (Orconectes hylas (Faxon)) has been introduced into the St. Francis River watershed in southeast Missouri and has displaced populations of native crayfish. The effects of O. hylas on macroinvertebrate community composition were investigated in a fourth-order Ozark stream at two locations, one with the presence of O. hylas and one without. Significant differences between sites and across four sampling periods and two habitats were found in five categories of benthic macroinvertebrate metrics: species richness, percent/composition, dominance/diversity, functional feeding groups, and biotic indices. In most seasons and habitat combinations, the invaded site had significantly higher relative abundance of riffle beetles (Coleoptera: Elmidae), and significantly lower Missouri biotic index values, total taxa richness, and both richness and relative abundance of midges (Diptera: Chironomidae). Overall study results indicate that some macroinvertebrate community differences due to the O. hylas invasion were not consistent between seasons and habitats, suggesting that further research on spatial and temporal habitat use and feeding ecology of Ozark crayfish species is needed to improve our understanding of the effects of these invasions on aquatic communities.	[Freeland-Riggert, Brandye T.; Cairns, Stefan H.] Univ Cent Missouri, Dept Biol & Agr, Warrensburg, MO USA; [Poulton, Barry C.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA; [Riggert, Christopher M.] Missouri Dept Conservat, Jefferson City, MO USA; [Freeland-Riggert, Brandye T.] Missouri Dept Nat Resources, POB 176, Jefferson City, MO USA	University Central Missouri; United States Department of the Interior; United States Geological Survey	Freeland-Riggert, BT (corresponding author), Univ Cent Missouri, Dept Biol & Agr, Warrensburg, MO USA.; Freeland-Riggert, BT (corresponding author), Missouri Dept Nat Resources, POB 176, Jefferson City, MO USA.	Brandye.Freeland-Riggert@dnr.mo.gov			University of Central Missouri	University of Central Missouri	The authors received no specific funding for this work. At the time of the study Brandye T. Freeland-Riggert was currently not employed by USGS as a federal employee nor was the study funded though the University of Central Missouri where Brandye T. Freeland-Riggert was a biology graduate student.	ABRAHAMSSON SA, 1966, OIKOS, V17, P96, DOI 10.2307/3564784; Alcorlo P, 2004, CRUSTACEANA, V77, P435, DOI 10.1163/1568540041643283; Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; ANDERSON NH, 1979, J FISH RES BOARD CAN, V36, P335, DOI 10.1139/f79-052; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; [Anonymous], 1960, INT C ENTOMOLOGY 2; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Bondar GA, 2005, CANADIAN J FISHERIES, V62, P2632; BROWN HP, 1987, ANNU REV ENTOMOL, V32, P253, DOI 10.1146/annurev.ento.32.1.253; Chucholl C, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011082; Clements WH, 2004, ECOL APPL, V14, P954, DOI 10.1890/03-5009; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; Crawford L, 2006, AQUAT CONSERV, V16, P611, DOI 10.1002/aqc.761; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; DeShon J. D., 1995, BIOL ASSESSMENT CRIT, P217, DOI DOI 10.1080/0964056022000013039; Distefano R.J., 2011, Freshwater Crayfish, V18, P37; DiStefano RJ, MANAGEMENT IN PRESS; DiStefano Robert, 2002, Freshwater Crayfish, V13, P439; DiStefano RJ, 2008, J CRUSTACEAN BIOL, V28, P417, DOI 10.1651/0278-0372(2008)028[0417:COICPQ]2.0.CO;2; DiStefano RJ, 2008, J CRUSTACEAN BIOL, V28, P189, DOI 10.1651/06-2822R.1; DiStefano RJ, 2009, FISHERIES, V34, P586, DOI 10.1577/1548-8446-34.12.586; Dorn NJ, 2004, OECOLOGIA, V140, P150, DOI 10.1007/s00442-004-1548-9; Edmunds G.F., 1976, MAYFLIES N CENTRAL A; Elliott JM, 2000, ECOL ENTOMOL, V25, P26, DOI 10.1046/j.1365-2311.2000.00229.x; Englund G, 2000, FRESHWATER BIOL, V43, P75, DOI 10.1046/j.1365-2427.2000.00524.x; France R, 1996, OECOLOGIA, V107, P239, DOI 10.1007/BF00327908; Freeland-Riggert BT, 2014, THESIS U CENTRAL MIS; Gamradt SC, 1997, CONSERV BIOL, V11, P793, DOI 10.1046/j.1523-1739.1997.96230.x; Gherardi F, 2000, AQUAT SCI, V62, P179, DOI 10.1007/PL00001330; Gherardi F, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P258; Gherardi F, 2007, BFPP-CONNAISS GEST P, P7, DOI 10.1051/kmae:2007014; Goddard J.S., 1988, P145; Guan RZ, 1998, AQUACULTURE, V169, P177, DOI 10.1016/S0044-8486(98)00377-9; HANSON JM, 1990, FRESHWATER BIOL, V24, P69, DOI 10.1111/j.1365-2427.1990.tb00308.x; Hayslip G, EPA910992013; HILL AM, 1994, ECOLOGY, V75, P2118, DOI 10.2307/1941615; HILSENHOFF W L, 1988, Journal of the North American Benthological Society, V7, P65, DOI 10.2307/1467832; Hobbs HH, 2001, CRUSTACEANA, V74, P635, DOI 10.1163/156854001750377911; Holdich DM, 1999, CRUSTACEAN ISS, V11, P31; Hollows JW, 2002, NEW ZEAL J MAR FRESH, V36, P129, DOI 10.1080/00288330.2002.9517076; Houghton DC, 1998, GREAT LAKES ENTOMOL, V31, P13; Huryn AD, 2000, ANNU REV ENTOMOL, V45, P83, DOI 10.1146/annurev.ento.45.1.83; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; Ilheu M., 1993, Freshwater Crayfish, V9, P359; JACKSON JK, 1995, J N AM BENTHOL SOC, V14, P115, DOI 10.2307/1467728; Jacobsen D, 2003, FRESHWATER BIOL, V48, P2025, DOI 10.1046/j.1365-2427.2003.01140.x; Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x; Jacobson RB, 2004, DS94 USGS US DEP INT; Jones P.D., 1983, Freshwater Crayfish, V5, P192; KERANS BL, 1994, ECOL APPL, V4, P768, DOI 10.2307/1942007; KLEMM DJ, 1990, EPA600490030; Klose K, 2012, FRESHWATER BIOL, V57, P526, DOI 10.1111/j.1365-2427.2011.02721.x; Kreps TA, 2012, CAN J FISH AQUAT SCI, V69, P1164, DOI [10.1139/f2012-052, 10.1139/F2012-052]; Kuhlmann ML, 2007, NORTHEAST NAT, V14, P507, DOI 10.1656/1092-6194(2007)14[507:IOTUSR]2.0.CO;2; LODGE DM, 1994, ECOLOGY, V75, P1265, DOI 10.2307/1937452; Lodge DM, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:NCTNAF>2.0.CO;2; Lodge DM, 1998, AUST J ECOL, V23, P53, DOI 10.1111/j.1442-9993.1998.tb00705.x; McCarthy JM, 2006, FRESHWATER BIOL, V51, P224, DOI 10.1111/j.1365-2427.2005.01485.x; MCCLAIN WR, 1992, AQUACULTURE, V101, P251, DOI 10.1016/0044-8486(92)90029-K; MDC, 2015, MISS SPEC COMM CONS; MDNR, 2010, SEM MACR STREAM BIOA; MDNR, 2003, BIOL ASS STUD BIG CR; MDNR, 2010, FLOW MEAS OP CHANN S; MDNR, 2010, STREAM HAB ASS PROJ; MDNR, 2000, BIOL ASS REP BIG CRE; MDNR, 2010, TAX LEV MACR ID MDNR; Merritt R. W., 2008, INTRO AQUATIC INSECT; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Muck JA, 2002, AM MIDL NAT, V147, P338, DOI 10.1674/0003-0031(2002)147[0338:RBOTCO]2.0.CO;2; Muenz TK, 2004, THESIS U GEORGIA ATH; Nigh T.A., 2002, ATLAS MISSOURI ECORE; Nystrom P, 1996, FRESHWATER BIOL, V36, P631, DOI 10.1046/j.1365-2427.1996.d01-528.x; Nystrom P, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P192; Nystrom P, 1998, HYDROBIOLOGIA, V368, P201, DOI 10.1023/A:1003266603371; Occhipinti-Ambrogi A, 2004, MAR POLLUT BULL, V49, P688, DOI 10.1016/j.marpolbul.2004.08.011; Oliveira J, 1998, AQUAC RES, V29, P123, DOI 10.1046/j.1365-2109.1998.00936.x; OLSEN TM, 1991, CAN J FISH AQUAT SCI, V48, P1853, DOI 10.1139/f91-219; Parkyn SM, 2001, FRESHWATER BIOL, V46, P641, DOI 10.1046/j.1365-2427.2001.00702.x; Pennak RW, 1989, FRESHWATER INVERTEBR; Pflieger WL, 1996, CRAYFISHES MISSOURI; Poulton BC, 2010, ENVIRON MONIT ASSESS, V163, P619, DOI 10.1007/s10661-009-0864-2; Poulton BC, 2007, 20075108 US DEP INT; Rabalais MR, 2006, AM MIDL NAT, V155, P295, DOI 10.1674/0003-0031(2006)155[295:IOAICS]2.0.CO;2; Rahm EJ, 2005, CRUSTACEANA, V78, P437, DOI 10.1163/1568540054473585; Riggert CM, 1999, AM MIDL NAT, V142, P348, DOI 10.1674/0003-0031(1999)142[0348:DASAOT]2.0.CO;2; Rodriguez CF, 2005, BIOL INVASIONS, V7, P75, DOI 10.1007/s10530-004-9636-7; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schwiebert EG, 2007, NUMPHS, VI; Stark B.P, 2008, INTRO AQUATIC INSECT, V4th, P311; Stenroth P, 2003, FRESHWATER BIOL, V48, P466, DOI 10.1046/j.1365-2427.2003.01020.x; STEWART KW, 1973, ANN ENTOMOL SOC AM, V66, P959, DOI 10.1093/aesa/66.5.959; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Taugbol T, 1999, CRUSTACEAN ISS, V11, P271; Taylor CA, 2007, FISHERIES, V32, P372, DOI 10.1577/1548-8446(2007)32[372:AROTCS]2.0.CO;2; THORP JH, 2001, ECOLOGY CLASSIFICATI; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Westhoff JT, 2012, HYDROBIOLOGIA, V683, P43, DOI 10.1007/s10750-011-0939-2; Whitledge GW, 1996, FRESHW CRAYFISH, V11, P159; Zar JH, 1974, BIOSTATISTICAL ANAL	103	1	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150199	10.1371/journal.pone.0150199	http://dx.doi.org/10.1371/journal.pone.0150199			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986207	Green Published, gold			2022-12-27	WOS:000372580300018
J	Mombach, KD; Brito, CLD; Padoin, AV; Casagrande, DS; Mottin, CC				Mombach, Karin Daniele; de Souza Brito, Cesar Luis; Padoin, Alexandre Vontobel; Casagrande, Daniela Schaan; Mottin, Claudio Cora			Emotional and Affective Temperaments in Smoking Candidates for Bariatric Surgery	PLOS ONE			English	Article							NICOTINE DEPENDENCE; PERSONALITY-TRAITS; CIGARETTE-SMOKING; INTEGRATIVE MODEL; BIPOLAR SPECTRUM; ANGER TRAITS; RISK-FACTORS; TOBACCO USE; FOLLOW-UP; DISORDERS	Introduction The prevalence of smoking habits in severe obesity is higher than in the general population. There is some evidence that smokers have different temperaments compared to non-smokers. The aim of this study is to evaluate the associations between smoking status (smokers, ex-smokers and non-smokers) and temperament characteristics in bariatric surgery candidates. Methods We analyzed data on temperament of 420 bariatric surgery candidates, as assessed by the AFECTS scale, in an exploratory cross-sectional survey of bariatric surgery candidates who have been grouped into smokers, ex-smokers and non-smokers. Results We detected significant statistical differences in temperament related to the smoking status in this population after controlling the current use of psychiatric medication. Smokers had higher anxiety and lower control than non-smokers. Ex-smokers with BMI >50 kg/m(2) presented higher coping and control characteristics than smokers. Conclusions Smoking in bariatric surgery candidates was associated with lower control and higher anxious temperament, when controlled by current use of psychiatric medication. Smokers with BMI >50 kg/m(2) presented lower coping and control than ex-smokers. Assessment of temperament in bariatric surgery candidates may help in decisions about smoking cessation treatment and prevention of smoking relapse after surgery.	[Mombach, Karin Daniele; Padoin, Alexandre Vontobel; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Postgrad Program Med & Hlth Sci, Clin Sugery, Porto Alegre, RS, Brazil; [Mombach, Karin Daniele; de Souza Brito, Cesar Luis; Padoin, Alexandre Vontobel; Casagrande, Daniela Schaan; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Obes & Metab Syndrome Ctr, Porto Alegre, RS, Brazil; [de Souza Brito, Cesar Luis; Padoin, Alexandre Vontobel; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Fac Med, Porto, Portugal	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade do Porto	Mombach, KD (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Med, Postgrad Program Med & Hlth Sci, Clin Sugery, Porto Alegre, RS, Brazil.; Mombach, KD (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Obes & Metab Syndrome Ctr, Porto Alegre, RS, Brazil.	karindm@gmail.com	Padoin, Alexandre V/M-7660-2013; de Souza Brito, Cesar Luis/AAG-9984-2019	Padoin, Alexandre V/0000-0002-9754-4818; de Souza Brito, Cesar Luis/0000-0002-2509-7270	Brazilian Government - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP)	Brazilian Government - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This study was supported by the Brazilian Government - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); and Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P45, DOI 10.1016/j.jad.2003.10.012; Alciati A, 2007, J AFFECT DISORDERS, V101, P131, DOI 10.1016/j.jad.2006.11.008; Amann B, 2009, J AFFECT DISORDERS, V118, P155, DOI 10.1016/j.jad.2009.01.020; Bisol LW, 2010, J AFFECT DISORDERS, V127, P89, DOI 10.1016/j.jad.2010.04.016; Blackburn GL, 2009, OBESITY, V17, P842, DOI 10.1038/oby.2008.578; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chatkin R, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-61; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cosci F, 2009, ADDICT BEHAV, V34, P28, DOI 10.1016/j.addbeh.2008.08.003; Etter JF, 2003, NICOTINE TOB RES, V5, P401, DOI 10.1080/1462220031000094240; Eysenck HJ, 1997, J PERS SOC PSYCHOL, V73, P1224, DOI 10.1037/0022-3514.73.6.1224; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finks JF, 2011, ANN SURG, V254, P633, DOI 10.1097/SLA.0b013e318230058c; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Gurpegui M, 2007, PROG NEURO-PSYCHOPH, V31, P997, DOI 10.1016/j.pnpbp.2007.02.006; Hall W, 2002, TOB CONTROL, V11, P119, DOI 10.1136/tc.11.2.119; HEATH AC, 1995, BEHAV GENET, V25, P103, DOI 10.1007/BF02196921; Hintsanen M, 2012, J PSYCHOSOM RES, V73, P391, DOI 10.1016/j.jpsychores.2012.08.012; Kalarchian MA, 2007, AM J PSYCHIAT, V164, P328, DOI 10.1176/appi.ajp.164.2.328; Kang Eunjeong, 2010, J Prev Med Public Health, V43, P193, DOI 10.3961/jpmph.2010.43.3.193; Katzow JJ, 2003, BIPOLAR DISORD, V5, P436, DOI 10.1046/j.1399-5618.2003.00068.x; Koster A, 2008, AM J CLIN NUTR, V88, P1206, DOI 10.3945/ajcn.2008.26298; Lara DR, 2006, J AFFECT DISORDERS, V94, P89, DOI 10.1016/j.jad.2006.03.021; Lara DR, 2006, J AFFECT DISORDERS, V94, P67, DOI 10.1016/j.jad.2006.02.025; Lara DR, 2012, J AFFECT DISORDERS, V140, P14, DOI 10.1016/j.jad.2011.08.036; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Levine MD, 2007, ADDICT BEHAV, V32, P2365, DOI 10.1016/j.addbeh.2007.02.002; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Livingston EH, 2006, J AM COLL SURGEONS, V203, P625, DOI 10.1016/j.jamcollsurg.2006.07.006; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; Nguyen NT, 2003, J AM COLL SURGEONS, V197, P548, DOI 10.1016/S1072-7515(03)00648-3; Osler M, 2001, GENET EPIDEMIOL, V21, P193, DOI 10.1002/gepi.1028; Pelissolo A, 2000, PSYCHIAT RES, V94, P67, DOI 10.1016/S0165-1781(00)00127-X; Pompili M, 2009, J ADDICT DIS, V28, P13, DOI 10.1080/10550880802544757; Rezvanfard M, 2010, ARCH IRAN MED, V13, P395, DOI 010135/AIM.006; Rihmer Z, 2010, CURR OPIN PSYCHIATR, V23, P12, DOI 10.1097/YCO.0b013e32833299d4; Ryden A, 2004, INT J OBESITY, V28, P1485, DOI 10.1038/sj.ijo.0802768; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sullivan S, 2007, INT J OBESITY, V31, P669, DOI 10.1038/sj.ijo.0803464; Tindle HA, 2010, AM J MED, V123, P1036, DOI 10.1016/j.amjmed.2010.06.016; Unseld M, 2012, J AFFECT DISORDERS, V141, P324, DOI 10.1016/j.jad.2012.03.028; von Zerssen D, 1998, J AFFECT DISORDERS, V51, P1; Zhang W, 2005, OBES SURG, V15, P43, DOI 10.1381/0960892052993422	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150722	10.1371/journal.pone.0150722	http://dx.doi.org/10.1371/journal.pone.0150722			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26987115	Green Published, gold			2022-12-27	WOS:000372580300025
J	Nguyen, MU; Kwong, J; Chang, J; Gillet, VG; Lee, RM; Johnson, KG				Nguyen, Margaret U.; Kwong, Jereen; Chang, Julia; Gillet, Victoria G.; Lee, Rachel M.; Johnson, Karl Gregory			The Extracellular and Cytoplasmic Domains of Syndecan Cooperate Postsynaptically to Promote Synapse Growth at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; CELL-SURFACE; DENDRITIC SPINES; MYOBLAST FUSION; RECEPTOR; PATHWAY; PROTEIN; PHOSPHATASE; EXPRESSION; NEUROFIBROMIN	The heparan sulfate proteoglycan (HSPG) Syndecan (Sdc) is a crucial regulator of synapse development and growth in both vertebrates and invertebrates. In Drosophila, Sdc binds via its extracellular heparan sulfate (HS) sidechains to the receptor protein tyrosine phosphatase LAR to promote the morphological growth of the neuromuscular junction (NMJ). To date, however, little else is known about the molecular mechanisms by which Sdc functions to promote synapse growth. Here we show that all detectable Sdc found at the NMJ is provided by the muscle, strongly suggesting a post-synaptic role for Sdc. We also show that both the cytoplasmic and extracellular domains of Sdc are required to promote synapse growth or to rescue Sdc loss of function. We report the results of a yeast two-hybrid screen using the cytoplasmic domains of Sdc as bait, and identify several novel candidate binding partners for the cytoplasmic domains of Sdc. Together, these studies provide new insight into the mechanism of Sdc function at the NMJ, and provide enticing future directions for further exploring how Sdc promotes synapse growth.	[Kwong, Jereen; Chang, Julia; Johnson, Karl Gregory] Pomona Coll, Program Mol Biol, Claremont, CA 91711 USA; [Nguyen, Margaret U.; Gillet, Victoria G.; Lee, Rachel M.; Johnson, Karl Gregory] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA	Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Johnson, KG (corresponding author), Pomona Coll, Program Mol Biol, Claremont, CA 91711 USA.; Johnson, KG (corresponding author), Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA.	karl.johnson@pomona.edu		Johnson, Karl/0000-0003-3931-5985	National Science Foundation - Research at Undergraduate Institutions [0841551]; Division of Integrative Organismal Systems - Neural Systems Cluster [0841551]; National Institutes of Health Academic Research Enhancement Award [1R15NS065433-01]; National Institute of Neurological Disorders and Stroke [1R15NS065433-01]; Pomona College Summer Undergraduate Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS065433] Funding Source: NIH RePORTER	National Science Foundation - Research at Undergraduate Institutions; Division of Integrative Organismal Systems - Neural Systems Cluster; National Institutes of Health Academic Research Enhancement Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Pomona College Summer Undergraduate Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Science Foundation - Research at Undergraduate Institutions; Division of Integrative Organismal Systems - Neural Systems Cluster. The recipient was KGJ and the grant number was 0841551 (http://www.nsf.gov/div/index.jsp?div=IOS). This work was also funded by the National Institutes of Health Academic Research Enhancement Award; National Institute of Neurological Disorders and Stroke. The recipient was KGJ and the grant number was 1R15NS065433-01. Additional funding came from the Pomona College Summer Undergraduate Research Program. Recipients of these funds were MUN, JK, JC and VGG (http://www.pomona.edu/research).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; De Renzis S, 2006, DEV CELL, V10, P257, DOI 10.1016/j.devcel.2006.01.011; de Wit J, 2013, NEURON, V79, P696, DOI 10.1016/j.neuron.2013.06.049; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; GRINBLAT Y, 1989, NUCLEIC ACIDS RES, V17, P7303, DOI 10.1093/nar/17.18.7303; Guo YQ, 2000, J CELL SCI, V113, P3499; Hernandez G, 2004, PROTEOMICS, V4, P316, DOI 10.1002/pmic.200300555; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kamimura K, 2013, J CELL BIOL, V200, P219, DOI 10.1083/jcb.201207036; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Klass CM, 2000, J CELL SCI, V113, P493; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martin PT, 2002, GLYCOBIOLOGY, V12, p1R, DOI 10.1093/glycob/12.1.1R; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Okina E, 2012, INT J BIOCHEM CELL B, V44, P2161, DOI 10.1016/j.biocel.2012.08.017; Schulz JG, 2011, EMBO REP, V12, P1039, DOI 10.1038/embor.2011.153; Siddiqui TJ, 2013, NEURON, V79, P680, DOI 10.1016/j.neuron.2013.06.029; Smart AD, 2011, DEV NEUROBIOL, V71, P608, DOI 10.1002/dneu.20854; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Swan LE, 2004, GENE DEV, V18, P223, DOI 10.1101/gad.287604; Volta M, 2010, BIOCHEM BIOPH RES CO, V391, P1216, DOI 10.1016/j.bbrc.2009.12.043; Zhang Y, 2000, J CELL SCI, V113, P3103	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151621	10.1371/journal.pone.0151621	http://dx.doi.org/10.1371/journal.pone.0151621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987116	Green Published, gold			2022-12-27	WOS:000372580300097
J	Roques, L; Bonnefon, O				Roques, Lionel; Bonnefon, Olivier			Modelling Population Dynamics in Realistic Landscapes with Linear Elements: A Mechanistic-Statistical Reaction-Diffusion Approach	PLOS ONE			English	Article							AEDES-ALBOPICTUS; ESTABLISHMENT; MOVEMENTS; MOSQUITO	We propose and develop a general approach based on reaction-diffusion equations for modelling a species dynamics in a realistic two-dimensional (2D) landscape crossed by linear one-dimensional (1D) corridors, such as roads, hedgerows or rivers. Our approach is based on a hybrid "2D/1D model", i.e, a system of 2D and 1D reaction-diffusion equations with homogeneous coefficients, in which each equation describes the population dynamics in a given 2D or 1D element of the landscape. Using the example of the range expansion of the tiger mosquito Aedes albopictus in France and its main highways as 1D corridors, we show that the model can be fitted to realistic observation data. We develop a mechanistic-statistical approach, based on the coupling between a model of population dynamics and a probabilistic model of the observation process. This allows us to bridge the gap between the data (3 levels of infestation, at the scale of a French department) and the output of the model (population densities at each point of the landscape), and to estimate the model parameter values using a maximum-likelihood approach. Using classical model comparison criteria, we obtain a better fit and a better predictive power with the 2D/1D model than with a standard homogeneous reaction-diffusion model. This shows the potential importance of taking into account the effect of the corridors (highways in the present case) on species dynamics. With regard to the particular case of A. albopictus, the conclusion that highways played an important role in species range expansion in mainland France is consistent with recent findings from the literature.	[Roques, Lionel; Bonnefon, Olivier] INRA, UR BioSP 546, F-84914 Avignon, France	INRAE	Roques, L (corresponding author), INRA, UR BioSP 546, F-84914 Avignon, France.	lionel.roques@avignon.inra.fr		olivier, bonnefon/0000-0002-0462-4836	French Agence Nationale pour la Recherche [ANR-12-AGRO-0006]; European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant [321186]	French Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Research Council under the European Union's Seventh Framework Programme (FP) / ERC Grant(European Research Council (ERC))	This work was supported by French Agence Nationale pour la Recherche, within the ANR-12-AGRO-0006 PEERLESS (http://www.agence-nationale-recherche.fr/?Projet=ANR-12-AGRO-0006) and European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 321186 - ReaDi (http://erc.europa.eu/projects-and-results/erc-funded-projects/readi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard D, 2012, MATH GEOSCI, V44, P545, DOI 10.1007/s11004-012-9396-3; Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Berestycki H, 2013, J MATH BIOL, V66, P743, DOI 10.1007/s00285-012-0604-z; Berliner LM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002865; Bertuzzo E, 2009, J ROYAL SOC INTERFAC; Bianchi FJJA, 2003, ENVIRON ENTOMOL, V32, P1290, DOI 10.1603/0046-225X-32.6.1290; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Caminade C, 2012, J R SOC INTERFACE; Cantrell R.S., 2003, SPATIAL ECOLOGY VIA; Flacio E., 2006, SOVE15TH EUROPEAN M, P57; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; FRIED I, 1972, AIAA J, V10, P219, DOI 10.2514/3.6561; Garcia AF, 2000, ANN APPL BIOL, V137, P89, DOI 10.1111/j.1744-7348.2000.tb00040.x; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Grindrod P., 1996, THEORY APPL REACTION; Haddad NM, 2003, ECOLOGY, V84, P609, DOI 10.1890/0012-9658(2003)084[0609:CUBDT]2.0.CO;2; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Hecht F, 2012, J NUMER MATH, V20, P251, DOI 10.1515/jnum-2012-0013; Klaus F., 2015, J LANDSCAPE ECOLOGY, V8, P22, DOI [10.1515/jlecol-2015-0001, DOI 10.1515/JLECOL-2015-0001]; McKenzie HW, 2012, INTERFACE FOCUS, V2, P205, DOI 10.1098/rsfs.2011.0086; Murray J.D., 2002, INTERDISCIPLINARY AP, V17; Ovaskainen O, 2008, ECOLOGY, V89, P542, DOI 10.1890/07-0443.1; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Preisler HK, 2004, ENVIRONMETRICS, V15, P643, DOI 10.1002/env.636; Robinet C, 2012, BIOL INVASIONS, V14, P1557, DOI 10.1007/s10530-011-9979-9; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Roques A, 2015, PROCESSIONARY MOTHS; Roques L., 2013, MODELES REACTION DIF; Roques L, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2014.0349; Roques L, 2011, J THEOR BIOL, V274, P43, DOI 10.1016/j.jtbi.2011.01.006; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shigesada N., 1997, OXFORD SERIES ECOLOG; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Soubeyrand S, 2014, POPUL ECOL, V56, P427, DOI 10.1007/s10144-013-0415-0; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1; Turchin Peter, 1998; Wikle CK, 2003, INT STAT REV, V71, P181, DOI 10.1111/j.1751-5823.2003.tb00192.x; Wilks D. S, 2011, STAT METHODS ATMOSPH, V100	45	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151217	10.1371/journal.pone.0151217	http://dx.doi.org/10.1371/journal.pone.0151217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986201	gold, Green Submitted, Green Published			2022-12-27	WOS:000372580300054
J	Gisladottir, A; Luque-Fernandez, MA; Harlow, BL; Gudmundsdottir, B; Jonsdottir, E; Bjarnadottir, RI; Hauksdottir, A; Aspelund, T; Cnattingius, S; Valdimarsdottir, UA				Gisladottir, Agnes; Luque-Fernandez, Miguel Angel; Harlow, Bernard L.; Gudmundsdottir, Berglind; Jonsdottir, Eyrun; Bjarnadottir, Ragnheidur I.; Hauksdottir, Arna; Aspelund, Thor; Cnattingius, Sven; Valdimarsdottir, Unnur A.			Obstetric Outcomes of Mothers Previously Exposed to Sexual Violence	PLOS ONE			English	Article							CHILDHOOD ABUSE; LIFETIME DIAGNOSIS; PRIMIPAROUS WOMEN; NULLIPAROUS WOMEN; FEAR; CHILDBIRTH; BIRTH; RISK; PREGNANCY; HEALTH	Background There is a scarcity of data on the association of sexual violence and women's subsequent obstetric outcomes. Our aim was to investigate whether women exposed to sexual violence as teenagers (12-19 years of age) or adults present with different obstetric outcomes than women with no record of such violence. Methods We linked detailed prospectively collected information on women attending a Rape Trauma Service (RTS) to the Icelandic Medical Birth Registry (IBR). Women who attended the RTS in 1993-2010 and delivered (on average 5.8 years later) at least one singleton infant in Iceland through 2012 formed our exposed cohort (n = 1068). For each exposed woman's delivery, nine deliveries by women with no RTS attendance were randomly selected from the IBR (n = 9126) matched on age, parity, and year and season of delivery. Information on smoking and Body mass index (BMI) was available for a sub-sample (n = 792 exposed and n = 1416 non-exposed women). Poisson regression models were used to estimate Relative Risks (RR) with 95% confidence intervals (CI). Results Compared with non-exposed women, exposed women presented with increased risks of maternal distress during labor and delivery (RR 1.68, 95% CI 1.01-2.79), prolonged first stage of labor (RR 1.40, 95% CI 1.03-1.88), antepartum bleeding (RR 1.95, 95% CI 1.22-3.07) and emergency instrumental delivery (RR 1.16, 95% CI 1.00-1.34). Slightly higher risks were seen for women assaulted as teenagers. Overall, we did not observe differences between the groups regarding the risk of elective cesarean section (RR 0.86, 95% CI 0.61-1.21), except for a reduced risk among those assaulted as teenagers (RR 0.56, 95% CI 0.34-0.93). Adjusting for maternal smoking and BMI in a sub-sample did not substantially affect point estimates. Conclusion Our prospective data suggest that women with a history of sexual assault, particularly as teenagers, are at increased risks of some adverse obstetric outcomes.	[Gisladottir, Agnes; Hauksdottir, Arna; Aspelund, Thor; Valdimarsdottir, Unnur A.] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Luque-Fernandez, Miguel Angel] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Luque-Fernandez, Miguel Angel; Valdimarsdottir, Unnur A.] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Harlow, Bernard L.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Gudmundsdottir, Berglind; Jonsdottir, Eyrun] Natl Univ Hosp Iceland, Landspitali, Rape Trauma Serv, Reykjavik, Iceland; [Gudmundsdottir, Berglind; Jonsdottir, Eyrun] Natl Univ Hosp Iceland, Landspitali, Ctr Trauma, Reykjavik, Iceland; [Gudmundsdottir, Berglind] Univ Iceland, Dept Psychol, Reykjavik, Iceland; [Bjarnadottir, Ragnheidur I.] Natl Univ Hosp Iceland, Landspitali, Dept Obstet & Gynecol, Reykjavik, Iceland; [Aspelund, Thor] Iceland Heart Assoc, Kopavogur, Iceland; [Cnattingius, Sven] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Valdimarsdottir, Unnur A.] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden	University of Iceland; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Icelandic Heart Association; Karolinska Institutet; Karolinska Institutet	Gisladottir, A (corresponding author), Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland.	agnesg@hi.is	Aspelund, Thor/K-7022-2019; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015; FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; Aspelund, Thor/C-5983-2008	Aspelund, Thor/0000-0002-7998-5433; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Aspelund, Thor/0000-0002-7998-5433; Valdimarsdottir, Unnur/0000-0001-5382-946X; Hauksdottir, Arna/0000-0002-4253-1059; Harlow, Bernard/0000-0002-6735-8862; Gudmundsdottir, Berglind/0000-0002-4145-7723	Icelandic Research Fund for Graduate Students [RAN090310-0736]; Landspitali University Hospital Research Fund	Icelandic Research Fund for Graduate Students; Landspitali University Hospital Research Fund	This work was supported by The Icelandic Research Fund for Graduate Students, RAN090310-0736, www.rannis.is (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by the Landspitali University Hospital Research Fund, http://www.landspitali.is/visindi-og-menntun/visindastarfsemi/visindasjodur-lsh/ (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SS, 2012, BJOG-INT J OBSTET GY, V119, P1238, DOI 10.1111/j.1471-0528.2012.03433.x; Alehagen S, 2001, INT J BEHAV MED, V8, P50, DOI 10.1207/S15327558IJBM0801_04; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Eberhard-Gran M, 2008, J PSYCHOSOM OBST GYN, V29, P258, DOI 10.1080/01674820802075998; Elvander C, 2013, BIRTH-ISS PERINAT C, V40, P289, DOI 10.1111/birt.12065; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finnbogadottir H, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-14; Garcia-Moreno C, 2015, LANCET, V385, P1685, DOI 10.1016/S0140-6736(14)61830-4; Gisladottir A, 2014, ACTA OBSTET GYN SCAN, V93, P351, DOI 10.1111/aogs.12331; Gisladottir A, 2012, ACTA OBSTET GYN SCAN, V91, P134, DOI 10.1111/j.1600-0412.2011.01283.x; Halvorsen L, 2013, BIRTH-ISS PERINAT C, V40, P182, DOI 10.1111/birt.12054; Heimstad R, 2006, ACTA OBSTET GYN SCAN, V85, P435, DOI 10.1080/00016340500432507; Henriksen L, 2014, BJOG-INT J OBSTET GY, V121, P1237, DOI 10.1111/1471-0528.12923; Henriksen L, 2013, BIRTH-ISS PERINAT C, V40, P281, DOI 10.1111/birt.12063; Hodnett ED, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000012.pub4; Jonas S, 2011, PSYCHOL MED, V41, P709, DOI 10.1017/S003329171000111X; Karlsdottir E, 2010, RANNSOKN OFBELDI GEG; Laursen M, 2009, BJOG-INT J OBSTET GY, V116, P1350, DOI 10.1111/j.1471-0528.2009.02250.x; Leeners B, 2013, J PERINAT MED, V41, P365, DOI 10.1515/jpm-2011-0086; Leeners B, 2010, J PSYCHOSOM RES, V69, P503, DOI 10.1016/j.jpsychores.2010.04.017; Lindert J, 2014, INT J PUBLIC HEALTH, V59, P359, DOI 10.1007/s00038-013-0519-5; Lukasse M, 2010, BJOG-INT J OBSTET GY, V117, P1153, DOI 10.1111/j.1471-0528.2010.02627.x; Lukasse M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-83; Lukasse M, 2009, BIRTH-ISS PERINAT C, V36, P190, DOI 10.1111/j.1523-536X.2009.00323.x; Masho SW, 2007, J WOMENS HEALTH, V16, P262, DOI 10.1089/jwh.2006.M076; Nelson EC, 2006, PSYCHOL MED, V36, P1473, DOI 10.1017/S0033291706008397; Nerum H, 2013, BJOG-INT J OBSTET GY, V120, P487, DOI 10.1111/1471-0528.12053; Nerum H, 2010, BJOG-INT J OBSTET GY, V117, P288, DOI 10.1111/j.1471-0528.2009.02454.x; Noll JG, 2007, PEDIATRICS, V120, pE61, DOI 10.1542/peds.2006-3058; Norman SM, 2012, OBSTET GYNECOL, V120, P130, DOI 10.1097/AOG.0b013e318259589c; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Riley EH, 2010, J EPIDEMIOL COMMUN H, V64, P413, DOI 10.1136/jech.2009.095109; Rouhe H, 2013, BJOG-INT J OBSTET GY, V120, P75, DOI 10.1111/1471-0528.12011; Schei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087579; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Suglia SF, 2015, AM J PREV MED, V48, P205, DOI 10.1016/j.amepre.2014.09.013; Van der Hulst LAM, 2006, J PSYCHOSOM OBST GYN, V27, P59, DOI 10.1080/01674820500305788; Walsh K, 2012, CLIN PSYCHOL-SCI PR, V19, P260, DOI 10.1111/cpsp.12004	38	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150726	10.1371/journal.pone.0150726	http://dx.doi.org/10.1371/journal.pone.0150726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007230	Green Published, Green Accepted, gold			2022-12-27	WOS:000372701200028
J	Jordan, CA; Schank, CJ; Urquhart, GR; Dans, AJ				Jordan, Christopher A.; Schank, Cody J.; Urquhart, Gerald R.; Dans, Armando J.			Terrestrial Mammal Occupancy in the Context of Widespread Forest Loss and a Proposed Interoceanic Canal in Nicaragua's Decreasingly Remote South Caribbean Region	PLOS ONE			English	Article								Central America is experiencing rapid forest loss and habitat degradation both inside and outside of protected areas. Despite increasing deforestation, the Caribbean region of Nicaragua plays an important role in the survival or extinction of large mammal populations in Central America given that it still retains core areas of habitat for large mammal species. The proposed interoceanic canal project that would bisect the southern half of this Caribbean region represents a new threat that, combined with an advancing agricultural frontier, could affect populations of large mammal species such as jaguars, white-lipped peccaries, and Baird's tapirs. We used occupancy models to examine the relative occupancy probabilities for an assemblage of terrestrial mammals in the south Caribbean region of Nicaragua to identify current core areas for our study species and conduct a preliminary evaluation of the potential impacts of the proposed interoceanic canal. We modeled a community level distribution of eight species with varying levels of sensitivity to human encroachment and a range of habitat associations. Our model results reveal three priority areas for terrestrial mammal conservation in our study area. The mapped predictions show that the only remaining area of suitable habitat for large mammals in the path of the proposed interoceanic canal is a relatively thin strip of forest that runs along the Caribbean Coast. In light of these findings, we propose five recommendations that will help ensure the conservation of this area of the proposed canal route as suitable habitat for our study species.	[Jordan, Christopher A.; Schank, Cody J.; Dans, Armando J.] Global Wildlife Conservat, Austin, TX USA; [Jordan, Christopher A.] Panthera, New York, NY USA; [Schank, Cody J.] Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA; [Jordan, Christopher A.; Urquhart, Gerald R.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Urquhart, Gerald R.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	University of Texas System; University of Texas Austin; Michigan State University; Michigan State University	Jordan, CA (corresponding author), Global Wildlife Conservat, Austin, TX USA.; Jordan, CA (corresponding author), Panthera, New York, NY USA.; Jordan, CA (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	cjordan@globalwildlife.org			National Science Foundation Coupled Natural and Human System Program [CNH-0815966]; National Science Foundation Graduate Research Fellowship [2010081992]; Disney Worldwide Conservation Fund; Global Forest Watch Small Grants Program [00530]; Liz Claiborne and Art Ortenberg Jaguar Research Grant; Tapir Specialist Group Conservation Fund; Donald. D. Harrington Fellowship from the Graduate School at the University of Texas at Austin; Department of Geography and the Environment at the University of Texas at Austin; Tinker Field Research Grant from the Teresa Lozano Long Institue of Latin American Studies at the University of Texas at Austin	National Science Foundation Coupled Natural and Human System Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Disney Worldwide Conservation Fund; Global Forest Watch Small Grants Program; Liz Claiborne and Art Ortenberg Jaguar Research Grant; Tapir Specialist Group Conservation Fund; Donald. D. Harrington Fellowship from the Graduate School at the University of Texas at Austin; Department of Geography and the Environment at the University of Texas at Austin; Tinker Field Research Grant from the Teresa Lozano Long Institue of Latin American Studies at the University of Texas at Austin	This work was supported by the National Science Foundation Coupled Natural and Human System Program (CNH-0815966), www.nsf.gov, to GRU; the National Science Foundation Graduate Research Fellowship (2010081992) 2010-2012, http://www.nsf.gov/, to CAJ; the Disney Worldwide Conservation Fund, 2012, 2013, https://thewaltdisneycompany.com/content/conservation-funding, to GRU; the Global Forest Watch Small Grants Program (00530), 2015, https://gfw.fluidreview.com/, to CAJ; the Liz Claiborne and Art Ortenberg Jaguar Research Grant, 2013, http://www.panthera.org/node/785, to CAJ; the Tapir Specialist Group Conservation Fund. 2012. http://www.tapirs.org/tsgcf/index.html, to CAJ; the Donald. D. Harrington Fellowship from the Graduate School at the University of Texas at Austin, http://www.utexas.edu/ogs/funding/fellowships/harrington/CJS; the Robert E. Veselka Fellowship from the Department of Geography and the Environment at the University of Texas at Austin, http://www.utexas.edu/cola/depts/geography/events/16493, to CJS; and The Tinker Field Research Grant from the Teresa Lozano Long Institue of Latin American Studies at the University of Texas at Austin, http://www.utexas.edu/cola/insts/llilas/student-programs/funding-opportunities/graduate-funding/field-research.php, to CJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambientalistas Jovenes, 2013, LIST ROJ ESP ALT RIE; [Anonymous], ESTUD AMBIENT; [Anonymous], NATURAL RESERVES NO; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Christie, 2000, TAKING CARE WHAT WE; Condit R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002208; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Holland M.B., 2012, CLIMATE CONSERVATION, P56, DOI DOI 10.5822/978-1-61091-203-7_5; Hong Kong Nicaraguan Canal Development Group (HKND), ENV SOC IMP ASS; Hong Kong Nicaraguan Canal Development Group (HKND), 2014, NIC CAN PROJ OV; Huete-Perez JA, 2015, ENVIRON SCI TECHNOL, V49, P3989, DOI 10.1021/acs.est.5b00215; IUCN, 2013, IUCN RED LIST THREAT; Jordan C.A., 2015, THESIS MICHIGAN STAT; Jordan Christopher A., 2013, Tapir Conservation, V22, P14; Kilpatrick K, 2015, CANAL WILL DESTROY W; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; NASA, 2015, THIS DAT SET WAS PRO; Petracca LS, 2014, J NAT CONSERV, V22, P436, DOI 10.1016/j.jnc.2014.04.002; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Royle J. A., 2008, HIERARCHICAL MODELIN; Schank Cody, 2015, Tapir Conservation, V23, P15; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; Vreugdenhil D, 2002, MAP ECOSYSTEMAS CENT; Zipkin E, HIERARCHICAL APPROAC	28	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151372	10.1371/journal.pone.0151372	http://dx.doi.org/10.1371/journal.pone.0151372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007122	Green Published, gold, Green Submitted			2022-12-27	WOS:000372701200051
J	Le Clef, N; Verhulst, A; D'Haese, PC; Vervaet, BA				Le Clef, Nathalie; Verhulst, Anja; D'Haese, Patrick C.; Vervaet, Benjamin A.			Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ISCHEMIA/REPERFUSION-INJURY; COLD ISCHEMIA; POSTISCHEMIC ACUTE; MOLECULE-1 KIM-1; ANGIOTENSIN-II; MOUSE MODEL; RAT MODEL; FAILURE; DISEASE	Acute kidney injury (AKI) is an underestimated, yet important risk factor for development of chronic kidney disease (CKD). Even after initial total recovery of renal function, some patients develop progressive and persistent deterioration of renal function and these patients are more likely to progress to end-stage renal disease (ESRD). Animal models are indispensable for unravelling the mechanisms underlying this progression towards CKD and ESRD and for the development of new therapeutic strategies in its prevention or treatment. Ischemia (i.e. hypoperfusion after surgery, bleeding, dehydration, shock, or sepsis) is a major aetiology in human AKI, yet unilateral ischemia-reperfusion is a rarely used animal model for research on CKD and fibrosis. Here, we demonstrate in C57Bl/6J mice, by both histology and gene expression, that unilateral ischemia-reperfusion without contralateral nephrectomy is a very robust model to study the progression from acute renal injury to longterm tubulo-interstitial fibrosis, i.e. the histopathological hallmark of CKD. Furthermore, we report that the extent of renal fibrosis, in terms of Col I, TGF beta, CCN2 and CCN3 expression and collagen I immunostaining, increases with increasing body temperature during ischemia and ischemia-time. Thus, varying these two main determinants of ischemic injury allows tuning the extent of the long-term fibrotic outcome in this model. Finally, in order to cover the whole practical finesse of ischemia-reperfusion and allow model and data transfer, we provide a referenced overview on crucial technical issues (incl. anaesthesia, analgesia, and pre- and post-operative care) with the specific aim of putting starters in the right direction of implementing ischemia in their research and stimulate them, as well as the community, to have a critical view on ischemic literature data.	[Le Clef, Nathalie; Verhulst, Anja; D'Haese, Patrick C.; Vervaet, Benjamin A.] Univ Antwerp, Lab Pathophysiol, Dept Biomed Sci, B-2020 Antwerp, Belgium	University of Antwerp	D'Haese, PC (corresponding author), Univ Antwerp, Lab Pathophysiol, Dept Biomed Sci, B-2020 Antwerp, Belgium.	Patrick.Dhaese@uantwerpen.be	Vervaet, Benjamin/AAU-4679-2020	Vervaet, Benjamin/0000-0002-8589-5469	Agency for Innovation by Science and Technology in Flanders [111389]	Agency for Innovation by Science and Technology in Flanders	NLC was funded by a PhD grant of the Agency for Innovation by Science and Technology in Flanders (http://www.iwt.be/), grant number 111389. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2013, ACTA HISTOCHEM CYTOC, V46, P161, DOI 10.1267/ahc.13022; Alpers CE, 2014, DRUG DISCOV TODAY, V11, P1, DOI DOI 10.1016/J.DDM0D.2014.12.003; Ascon M, 2009, KIDNEY INT, V75, P526, DOI 10.1038/ki.2008.602; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; Basile DP, 1998, AM J PHYSIOL-RENAL, V275, pF894, DOI 10.1152/ajprenal.1998.275.6.F894; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Burne MJ, 2000, TRANSPLANTATION, V69, P1023; Campbell D, 2015, J CLIN HYPERTENS, V17, P514, DOI 10.1111/jch.12560; Carattino MD, 1999, IMMUNOPHARMACOLOGY, V43, P241, DOI 10.1016/S0162-3109(99)00095-8; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; CRADDOCK GN, 1976, ARCH SURG-CHICAGO, V111, P582; del Moral RMG, 2013, SCI WORLD J, DOI 10.1155/2013/486574; Delbridge MS, 2007, TRANSPL P, V39, P2983, DOI 10.1016/j.transproceed.2007.04.028; Dhaun N, 2013, KIDNEY INT, V84, P637, DOI 10.1038/ki.2013.158; Downey P, 2001, J ENDOUROL, V15, P209, DOI 10.1089/089277901750134647; Ertugrul A., 1999, International Urology and Nephrology, V31, P611, DOI 10.1023/A:1007100303378; Feitoza CQ, 2008, MOL MED, V14, P724, DOI 10.2119/2008-00064.Feitoza; Fish R, 2011, ANESTHESIA ANALGESIA; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Guarnieri M, 2012, LAB ANIMAL, V41, P337, DOI 10.1038/laban.152; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Haisch C, 1997, TRANSPLANT P, V29, P3424, DOI 10.1016/S0041-1345(97)00963-9; Hankenson FC, 2013, CRITICAL CARE MANAGE; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Horbelt M, 2007, AM J PHYSIOL-RENAL, V293, pF688, DOI 10.1152/ajprenal.00452.2006; Holderied A., 2014, DRUG DISCOV TODAY, V11, P19, DOI [10.1016/j.ddmod.2014.06.004, DOI 10.1016/J.DDMOD.2014.06.004]; Hosgood SA, 2013, J SURG RES, V182, P153, DOI 10.1016/j.jss.2012.08.001; Hosgood SA, 2012, J SURG RES, V174, pE85, DOI 10.1016/j.jss.2011.10.024; Humphreys BD, 2014, KIDNEY INT, V86, P481, DOI 10.1038/ki.2013.368; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Jani A, 2004, AM J TRANSPLANT, V4, P1246, DOI 10.1111/j.1600-6143.2004.00498.x; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Karipineni F, 2014, INT J SURG, V12, P551, DOI 10.1016/j.ijsu.2014.04.002; Kashiwagi E, 2014, EXP TOXICOL PATHOL, V66, P301, DOI 10.1016/j.etp.2014.04.007; Kassab S, 2001, FUND CLIN PHARMACOL, V15, P379, DOI 10.1046/j.1472-8206.2001.xs052.x; Kennedy SE, 2008, NEPHROLOGY, V13, P390, DOI 10.1111/j.1440-1797.2008.00979.x; Kim J, 2014, KIDNEY INT; Kimura M, 1999, AM J PATHOL, V155, P1371, DOI 10.1016/S0002-9440(10)65239-X; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kohn D. F., 1997, ANESTHESIA ANALGESIA; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Kwak W, 2011, BIOCHEM BIOPH RES CO, V406, P7, DOI 10.1016/j.bbrc.2011.01.085; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lech M, 2013, KIDNEY INT, V83, P647, DOI 10.1038/ki.2012.463; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Lim Beom Jin, 2014, Drug Discov Today Dis Models, V11, P45; Ling H, 2015, INFLAMMATION; MALIS CD, 1983, AM J PHYSIOL, V245, pF735, DOI 10.1152/ajprenal.1983.245.6.F735; MANGINO MJ, 1991, AM J PHYSIOL, V261, pF841, DOI 10.1152/ajprenal.1991.261.5.F841; Massberg S, 1998, TRANSPL P, V30, P4217, DOI 10.1016/S0041-1345(98)01397-9; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nakagawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136994; Nguan CYC, 2014, AM J PHYSIOL-RENAL, V306, pF724, DOI 10.1152/ajprenal.00410.2013; Oxburgh Leif, 2012, Methods Mol Biol, V886, P363, DOI 10.1007/978-1-61779-851-1_32; Pang P, 2015, KIDNEY INT, V87, P771, DOI 10.1038/ki.2014.364; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; PELKEY TJ, 1992, J VASC SURG, V15, P619, DOI 10.1016/0741-5214(92)90006-T; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Singh AP, 2012, PHARMACOL REP, V64, P31, DOI 10.1016/S1734-1140(12)70728-4; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Skrypnyk NI, 2013, JOVE-J VIS EXP, DOI 10.3791/50495; Spurgeon-Pechman KR, 2007, AM J PHYSIOL-RENAL, V293, pF269, DOI 10.1152/ajprenal.00279.2006; Stokman G, 2005, J AM SOC NEPHROL, V16, P1684, DOI 10.1681/ASN.2004080678; Stubenitsky BM, 2001, TRANSPLANT INT, V14, P256, DOI 10.1111/j.1432-2277.2001.tb00054.x; Tilney NL, 2003, TRANSPLANT REV, V17, P140, DOI [10.1016/S0955-470X(03)00040-5, DOI 10.1016/S0955-470X(03)00040-5]; Tokuyama H, 2002, HYPERTENSION, V40, P34, DOI 10.1161/01.HYP.0000022060.13995.ED; Tsuji Y., 1993, International Urology and Nephrology, V25, P83, DOI 10.1007/BF02552259; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; van Zutphen LFM, 1993, PRINCIPLES LAB ANIMA; Wang YL, 2013, TRANSPL P, V45, P3198, DOI 10.1016/j.transproceed.2013.07.061; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; ZAGER RA, 1989, CIRC RES, V65, P1263, DOI 10.1161/01.RES.65.5.1263; Zager RA, 2013, KIDNEY INT, V84, P703, DOI 10.1038/ki.2013.157; Zager RA, 2011, AM J PHYSIOL-RENAL, V301, pF1334, DOI 10.1152/ajprenal.00431.2011; Zager RA, 2009, AM J PHYSIOL-RENAL, V297, pF961, DOI 10.1152/ajprenal.00381.2009; Zager RA, 2009, AM J PHYSIOL-RENAL, V296, pF362, DOI 10.1152/ajprenal.90645.2008	87	92	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152153	10.1371/journal.pone.0152153	http://dx.doi.org/10.1371/journal.pone.0152153			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007127	gold, Green Published, Green Submitted			2022-12-27	WOS:000372701200099
J	Zhang, L; Butler, CA; Khan, HSG; Dashper, SG; Seers, CA; Veith, PD; Zhang, JG; Reynolds, EC				Zhang, Lianyi; Butler, Catherine A.; Khan, Hasnah S. G.; Dashper, Stuart G.; Seers, Christine A.; Veith, Paul D.; Zhang, Jian-Guo; Reynolds, Eric C.			Characterisation of the Porphyromonas gingivalis Manganese Transport Regulator Orthologue	PLOS ONE			English	Article							METALLOREGULATORY PROTEIN MNTR; SECONDARY STRUCTURE ANALYSES; METAL-ION-ACTIVATION; BACILLUS-SUBTILIS; RESPONSE REGULATOR; DIPHTHERIA; IRON; PATHOGENESIS; MECHANISM; REPRESSOR	PgMntR is a predicted member of the DtxR family of transcriptional repressors responsive to manganese in the anaerobic periodontal pathogen Porphyromonas gingivalis. Our bioinformatic analyses predicted that PgMntR had divalent metal binding site(s) with elements of both manganous and ferrous ion specificity and that PgMntR has unusual twin C-terminal FeoA domains. We produced recombinant PgMntR and four variants to probe the specificity of metal binding and its impact on protein structure and DNA binding. PgMntR dimerised in the absence of a divalent transition metal cation. PgMntR bound three Mn(II) per monomer with an overall dissociation constant K-d 2.0 x 10(-11) M at pH 7.5. PgMntR also bound two Fe (II) with distinct binding affinities, K-d1 2.5 x 10(-10) M and K-d2 <= 6.0 x 10(-8) M at pH 6.8. Two of the metal binding sites may form a binuclear centre with two bound Mn2+ being bridged by Cys108 but this centre provided only one site for Fe2+. Binding of Fe2+ or Mn2+ did not have a marked effect on the PgMntR secondary structure. Apo-PgMntR had a distinct affinity for the promoter region of the gene encoding the only known P. gingivalis manganese transporter, FB2. Mn2+ increased the DNA binding affinity of PgMntR whilst Fe2+ destabilised the protein-DNA complex in vitro. PgMntR did not bind the promoter DNA of the gene encoding the characterised iron transporter FB1. The C-terminal FeoA domain was shown to be essential for PgMntR structure/function, as its removal caused the introduction of an intramolecular disulfide bond and abolished the binding of Mn2+ and DNA. These data indicate that PgMntR is a novel member of the DtxR family that may function as a transcriptional repressor switch to specifically regulate manganese transport and homeostasis in an iron-dependent manner.	[Zhang, Lianyi; Butler, Catherine A.; Khan, Hasnah S. G.; Dashper, Stuart G.; Seers, Christine A.; Veith, Paul D.; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia; [Zhang, Jian-Guo] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Zhang, Jian-Guo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu.au	Zhang, Lianyi/H-7491-2014	Khan, Hasnah/0000-0001-9807-438X; Butler, Catherine/0000-0001-6371-3954; Dashper, Stuart/0000-0003-0106-8691; Veith, Paul/0000-0002-7344-1662	Australian Government, Department of Industry, Innovation and Science	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Funding provided by Australian Government, Department of Industry, Innovation and Science.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Butler CA, 2015, J ORAL BIOSCI, V57, P91, DOI 10.1016/j.job.2014.12.003; Butler CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111168; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Cugini C, 2013, J ORAL MICROBIOL, P5, DOI [10.3402/jom.v5i0.19804, DOI 10.3402/JOM.V5I0.19804]; D'Aquino JA, 2005, P NATL ACAD SCI USA, V102, P18408, DOI 10.1073/pnas.0500908102; Dashper SG, 2005, J BIOL CHEM, V280, P28095, DOI 10.1074/jbc.M503896200; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Desai KK, 2013, BIOCHEMISTRY-US, V52, P2518, DOI 10.1021/bi4002375; DeWitt MA, 2007, J MOL BIOL, V365, P1257, DOI 10.1016/j.jmb.2006.10.080; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Golynskiy M, 2007, J BIOL INORG CHEM, V12, P699, DOI 10.1007/s00775-007-0216-z; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Golynskiy MV, 2005, BIOCHEMISTRY-US, V44, P3380, DOI 10.1021/bi0480741; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; He J, 2006, INFECT IMMUN, V74, P4214, DOI 10.1128/IAI.00014-06; Henry LG, 2012, FUTURE MICROBIOL, V7, P497, DOI [10.2217/FMB.12.17, 10.2217/fmb.12.17]; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kliegman JI, 2006, BIOCHEMISTRY-US, V45, P3493, DOI 10.1021/bi0524215; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Lewis JP, 2010, PERIODONTOL, V52, P94, DOI [http://dx.doi.org/10.1111/j.1600-0757.2009.00329.x, DOI 10.1111/J.1600-0757.2009.00329.X]; Lieser SA, 2003, BIOCHEMISTRY-US, V42, P12634, DOI 10.1021/bi0350248; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Parker D, 2005, J BACTERIOL, V187, P366, DOI 10.1128/JB.187.1.366-375.2005; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Posey JE, 1999, P NATL ACAD SCI USA, V96, P10887, DOI 10.1073/pnas.96.19.10887; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Schmitt MP, 2002, J BACTERIOL, V184, P6882, DOI 10.1128/JB.184.24.6882-6892.2002; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; Van Holde K.E., 2006, PRINCIPLES PHYS BIOC; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zaharik ML, 2004, FRONT BIOSCI-LANDMRK, V9, P1035, DOI 10.2741/1317; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	59	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151407	10.1371/journal.pone.0151407	http://dx.doi.org/10.1371/journal.pone.0151407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007570	Green Submitted, Green Published, gold			2022-12-27	WOS:000372701200054
J	Doboro, FA; Njiro, S; Sibeko-Matjila, K; Van Vuuren, M				Doboro, Fulufhelo Amanda; Njiro, Stephen; Sibeko-Matjila, Kgomotso; Van Vuuren, Moritz			Molecular Analysis of South African Ovine Herpesvirus 2 Strains Based on Selected Glycoprotein and Tegument Genes	PLOS ONE			English	Article							MALIGNANT CATARRHAL FEVER; KAPOSIS-SARCOMA; SHEEP; OUTBREAK; PHYLOGENIES; DIVERSITY; INFECTION; GENOTYPES; VIRUS; PCR	Ovine herpesvirus 2 (OvHV-2), is the causative agent of sheep-associated malignant catarrhal fever (SA-MCF), a generally fatal disease of cattle and other captive wild ruminants. Information on the OvHV-2 strains circulating in South Africa (SA) and other African countries with regard to genetic structure and diversity, and pattern of distribution is not available. This study aimed to characterize the OvHV-2 strains circulating in SA using selected genes encoding glycoproteins and tegument proteins. To establish the genetic diversity of OvHV-2 strains, four genes, Ov 7, Ov 8 ex2, ORF 27 and ORF 73 were selected for analysis by PCR and DNA sequencing. Nucleotide and amino acid multiple sequence analyses revealed two genotypes for ORF 27 and ORF 73, and three genotypes for Ov 7 and Ov 8 ex2, randomly distributed throughout the regions. Ov 7 and ORF 27 nucleotide sequence analysis revealed variations that distinguished SA genotypes from those of reference OvHV-2 strains. Epitope mapping analysis showed that mutations identified from the investigated genes are not likely to affect the functions of the gene products, particularly those responsible for antibody binding activities associated with B-cell epitopes. Knowledge of the extent of genetic diversity existing among OvHV-2 strains has provided an understanding on the distribution patterns of OvHV-2 strains or genotypes across the regions of South Africa. This can facilitate the management of SA-MCF in SA, in terms of introduction of control measures or safe practices to monitor and control OvHV-2 infection. The products encoded by the Ov 7, Ov 8 ex2 and ORF 27 genes are recommended for evaluation of their coded proteins as possible antigens in the development of an OvHV-2 specific serodiagnostic assay.	[Doboro, Fulufhelo Amanda] Agr Res Council, Mol Epidemiol & Diagnost Programme, Onderstepoort Vet Inst, Onderstepoort, South Africa; [Njiro, Stephen] Agr Res Council, Food Feed & Vet Publ Hlth Programme, Onderstepoort Vet Inst, Onderstepoort, South Africa; [Sibeko-Matjila, Kgomotso; Van Vuuren, Moritz] Univ Pretoria, Fac Vet Sci, ZA-0002 Pretoria, South Africa	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Doboro, FA (corresponding author), Agr Res Council, Mol Epidemiol & Diagnost Programme, Onderstepoort Vet Inst, Onderstepoort, South Africa.	DoboroA@arc.agric.za	Sibeko-Matjila, Kgomotso/X-6565-2019; Sibeko-Matjila, Kgomotso/O-6028-2014; Sibeko-Matjila, Kgomotso/O-3691-2019	Sibeko-Matjila, Kgomotso/0000-0003-1139-7333; Sibeko-Matjila, Kgomotso/0000-0003-1139-7333; 	Department of Science and Technology (DST); Meat Industry Trust (MIT)	Department of Science and Technology (DST)(Department of Science & Technology (India)); Meat Industry Trust (MIT)	This work was supported by Department of Science and Technology (DST) for research funding; Meat Industry Trust (MIT) for payment of the University tuitions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Bastawecy IM, 2012, LIFE SCI J, V9, P798; BAXTER SIF, 1993, ARCH VIROL, V132, P145, DOI 10.1007/BF01309849; Bell SA, 2006, VET MICROBIOL, V116, P249, DOI 10.1016/j.vetmic.2006.05.002; Brault SA, 2010, VET IMMUNOL IMMUNOP, V137, P136, DOI 10.1016/j.vetimm.2010.05.010; Collery P, 1996, VET REC, V139, P16, DOI 10.1136/vr.139.1.16; Coulter LJ, 2001, J COMP PATHOL, V124, P2, DOI 10.1053/jcpa.2000.0524; de KOCK GILLES, 1950, S AFRICAN JOUR SCI, V46, P176; Dunowska M, 2001, J GEN VIROL, V82, P2785, DOI 10.1099/0022-1317-82-11-2785; Egyed L, 1996, J CLIN MICROBIOL, V34, P1091, DOI 10.1128/JCM.34.5.1091-1095.1996; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FOSTER PD, 1983, VET REC, V113, P477, DOI 10.1136/vr.113.20.477; Gao SJ, 1999, J INFECT DIS, V180, P1466, DOI 10.1086/315098; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greenblatt RJ, 2005, J VIROL, V79, P1125, DOI 10.1128/JVI.79.2.1125-1132.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Honiball EJ, 2008, REV MALIGNANT CATARR; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; LI H, 1995, J CLIN MICROBIOL, V33, P2048, DOI 10.1128/JCM.33.8.2048-2053.1995; Li H, 2011, VET MICROBIOL, V150, P270, DOI 10.1016/j.vetmic.2011.02.016; Liang L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006916; Liu Y, 2013, ECOL EVOL, V3, P4683, DOI 10.1002/ece3.856; Loken T, 1998, VET REC, V143, P464, DOI 10.1136/vr.143.17.464; Muller-Doblies UU, 1998, J CLIN MICROBIOL, V36, P2970; National Research Council, 1981, WAT BUFF NEW PROSP U, P111; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Toole D, 2002, J VET DIAGN INVEST, V14, P183, DOI 10.1177/104063870201400301; Pier G, 2004, IMMUNOLOGY INFECT IM, V1; Pier G, 2004, INFECT IMMUNITY, V1; PIERCY S. E., 1952, BRIT VET JOUR, V108, P35; Plowright W., 1990, Virus infections of ruminants., P123; Plowright W, 1964, THESIS U PRETORIA S, P336; Reid H W, 2004, INFECT DIS LIVESTOCK; ROSSITER PB, 1981, J COMP PATHOL, V91, P303, DOI 10.1016/0021-9975(81)90036-0; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taus NS, 2007, J GEN VIROL, V88, P40, DOI 10.1099/vir.0.82285-0; Thorsteinsdottir L, 2013, RES VET SCI, V94, P170, DOI 10.1016/j.rvsc.2012.07.011; Tustin RC, 2001, COMMUNICATION; Wright H, 2003, RES VET SCI, V75, P163, DOI 10.1016/S0034-5288(03)00043-2; Zhang YJ, 2001, J INFECT DIS, V183, P125, DOI 10.1086/317650; ZUCKERKANDL EMILE, 1965, P97	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0147019	10.1371/journal.pone.0147019	http://dx.doi.org/10.1371/journal.pone.0147019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002629	gold, Green Published, Green Submitted			2022-12-27	WOS:000372697400007
J	Allegri, M; Bianchi, MG; Chiu, M; Varet, J; Costa, AL; Ortelli, S; Blosi, M; Bussolati, O; Poland, CA; Bergamaschi, E				Allegri, Manfredi; Bianchi, Massimiliano G.; Chiu, Martina; Varet, Julia; Costa, Anna L.; Ortelli, Simona; Blosi, Magda; Bussolati, Ovidio; Poland, Craig A.; Bergamaschi, Enrico			Shape-Related Toxicity of Titanium Dioxide Nanofibres	PLOS ONE			English	Article							CARBON NANOTUBES; OXIDATIVE STRESS; IN-VITRO; NANOPARTICLES; ASBESTOS; PERMEABILITY; EXPOSURE; TIO2; INHALATION; DEPOSITION	Titanium dioxide (TiO2) nanofibres are a novel fibrous nanomaterial with increasing applications in a variety of fields. While the biological effects of TiO2 nanoparticles have been extensively studied, the toxicological characterization of TiO2 nanofibres is far from being complete. In this study, we evaluated the toxicity of commercially available anatase TiO2 nanofibres using TiO2 nanoparticles (NP) and crocidolite asbestos as non-fibrous or fibrous benchmark materials. The evaluated endpoints were cell viability, haemolysis, macrophage activation, trans-epithelial electrical resistance (an indicator of the epithelial barrier competence), ROS production and oxidative stress as well as the morphology of exposed cells. The results showed that TiO2 nanofibres caused a cell-specific, dose-dependent decrease of cell viability, with larger effects on alveolar epithelial cells than on macrophages. The observed effects were comparable to those of crocidolite, while TiO2 NP did not decrease cell viability. TiO2 nanofibres were also found endowed with a marked haemolytic activity, at levels significantly higher than those observed with TiO2 nanoparticles or crocidolite. Moreover, TiO2 nanofibres and crocidolite, but not TiO2 nanoparticles, caused a significant decrease of the trans-epithelial electrical resistance of airway cell monolayers. SEM images demonstrated that the interaction with nanofibres and crocidolite caused cell shape perturbation with the longest fibres incompletely or not phagocytosed. The expression of several pro-inflammatory markers, such as NO production and the induction of Nos2 and Ptgs2, was significantly increased by TiO2 nanofibres, as well as by TiO2 nanoparticles and crocidolite. This study indicates that TiO2 nanofibres had significant toxic effects and, for most endpoints with the exception of pro-inflammatory changes, are more bio-active than TiO2 nanoparticles, showing the relevance of shape in determining the toxicity of nanomaterials. Given that several toxic effects of TiO2 nanofibres appear comparable to those observed with crocidolite, the possibility that they exert length dependent toxicity in vivo seems worthy of further investigation.	[Allegri, Manfredi; Chiu, Martina; Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci SBiBiT, I-43100 Parma, Italy; [Bianchi, Massimiliano G.; Bergamaschi, Enrico] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Varet, Julia; Poland, Craig A.] Inst Occupat Med, Edinburgh EH8 9SV, Midlothian, Scotland; [Costa, Anna L.; Ortelli, Simona; Blosi, Magda] Inst Sci & Technol Ceram ISTEC CNR, Faenza, Italy; [Poland, Craig A.] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, ELEGI,Colt Labs,MRC, Edinburgh, Midlothian, Scotland	University of Parma; University of Parma; University Hospital of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR); University of Edinburgh	Bussolati, O (corresponding author), Univ Parma, Dept Biomed Biotechnol & Translat Sci SBiBiT, I-43100 Parma, Italy.; Poland, CA (corresponding author), Inst Occupat Med, Edinburgh EH8 9SV, Midlothian, Scotland.; Poland, CA (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, ELEGI,Colt Labs,MRC, Edinburgh, Midlothian, Scotland.	ovidio.bussolati@unipr.it; craig.poland@iom-world.org	Chiu, Martina/ABF-5811-2020; Chiu, Martina/I-7792-2016; Costa, Anna Luisa/AFF-8479-2022; Ortelli, Simona/G-6374-2018; Costa, Anna Luisa/AAF-1024-2022; Poland, Craig/AAM-8237-2020; Costa, Anna/A-8534-2012	Chiu, Martina/0000-0002-5655-9984; Chiu, Martina/0000-0002-5655-9984; Ortelli, Simona/0000-0002-0868-3315; Costa, Anna Luisa/0000-0003-1407-6498; Costa, Anna/0000-0003-1407-6498; BLOSI, MAGDA/0000-0001-8841-247X; BIANCHI, Massimiliano/0000-0002-4179-6573; Poland, Craig/0000-0002-5345-1249	EU [280716]	EU(European Commission)	This work was supported by EU FP7 SANOWORK (Grant n. 280716, http://sanowork.eu/) to EB and ALC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANJILVEL S, 1995, FUND APPL TOXICOL, V28, P41, DOI 10.1006/faat.1995.1144; Baisch BL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-5; Banga A, 2012, CELL PHYSIOL BIOCHEM, V29, P197, DOI 10.1159/000337601; Belade E, 2015, ARCH TOXICOL, V89, P1543, DOI 10.1007/s00204-014-1324-5; Bergstrand H, 1990, Agents Actions Suppl, V30, P199; Bianchi MG, 2015, TOXICOL RES-UK, V4, P385, DOI 10.1039/c4tx00193a; Bonner JC, 2013, ENVIRON HEALTH PERSP, V121, P676, DOI 10.1289/ehp.1205693; Brown DM, 2007, CARBON, V45, P1743, DOI 10.1016/j.carbon.2007.05.011; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074; Cho WS, 2012, TOXICOL SCI, V126, P469, DOI 10.1093/toxsci/kfs006; Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810; Clouter A, 2001, TOXICOL SCI, V63, P90, DOI 10.1093/toxsci/63.1.90; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Donaldson K, 2004, MUTAT RES-FUND MOL M, V553, P5, DOI 10.1016/j.mrfmmm.2004.06.011; Donaldson K, 2013, CURR OPIN BIOTECH, V24, P724, DOI 10.1016/j.copbio.2013.05.003; Donaldson K, 2013, ACCOUNTS CHEM RES, V46, P723, DOI 10.1021/ar300092y; Donaldson K, 2011, NANOMEDICINE-UK, V6, P143, DOI 10.2217/NNM.10.139; Donaldson K, 2009, CRIT REV TOXICOL, V39, P487, DOI 10.1080/10408440902911861; Farcal L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127174; FINKBEINER WE, 1993, AM J RESP CELL MOL, V9, P547, DOI 10.1165/ajrcmb/9.5.547; Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502; Gardner SY, 1997, EXP LUNG RES, V23, P1, DOI 10.3109/01902149709046044; GROSS TJ, 1994, AM J PHYSIOL, V266, pL287, DOI 10.1152/ajplung.1994.266.3.L287; Hamilton RF, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-35; Hurbankova M, 2013, CENT EUR J PUBL HEAL, V21, P165, DOI 10.21101/cejph.a3881; Jensen H, 2006, J EXP NANOSCI, V1, P355, DOI 10.1080/17458080600752482; JONES AD, 1993, ANN OCCUP HYG, V37, P211, DOI 10.1093/annhyg/37.2.211; Kim D, 2005, COLLOID SURFACE B, V40, P83, DOI 10.1016/j.colsurfb.2004.05.007; Kohyama N, 1996, AM J IND MED, V30, P515, DOI 10.1002/(SICI)1097-0274(199611)30:5<515::AID-AJIM1>3.0.CO;2-S; Li Y, 2014, REDOX BIOL, V2, P485, DOI 10.1016/j.redox.2014.01.023; Lim SJ, 2004, J CONTROL RELEASE, V100, P53, DOI 10.1016/j.jconrel.2004.07.032; Liu CH, 2012, J MATER RES, V27, P2265, DOI 10.1557/jmr.2012.154; Lu SL, 2009, ENVIRON HEALTH PERSP, V117, P241, DOI 10.1289/ehp.11811; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Murphy FA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-8; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pavan C, 2013, CHEM RES TOXICOL, V26, P1188, DOI 10.1021/tx400105f; Peterson MW, 1998, AM J PHYSIOL-LUNG C, V275, pL262, DOI 10.1152/ajplung.1998.275.2.L262; PETERSON MW, 1993, AM J PHYSIOL, V265, pL308, DOI 10.1152/ajplung.1993.265.3.L308; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollastri S, 2014, J HAZARD MATER, V276, P469, DOI 10.1016/j.jhazmat.2014.05.060; Ramkumar KM, 2012, EUR J PHARM BIOPHARM, V81, P324, DOI 10.1016/j.ejpb.2012.02.013; RIVM, 2002, 650010030 RIVA; Rotoli BM, 2009, HUM EXP TOXICOL, V28, P361, DOI 10.1177/0960327109105159; Rotoli BM, 2008, TOXICOL LETT, V178, P95, DOI 10.1016/j.toxlet.2008.02.007; Rotoli BM, 2012, J NANOPART RES, P14; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Salem LB, 2009, J CONTROL RELEASE, V136, P110, DOI 10.1016/j.jconrel.2009.01.019; Schinwald A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-47; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Silva RM, 2013, J TOXICOL ENV HEAL A, V76, P953, DOI 10.1080/15287394.2013.826567; Singh DP, 2010, SCI ADV MATER, V2, P295, DOI 10.1166/sam.2010.1095; Siu MT, 2013, TOXICOL APPL PHARM, V273, P508, DOI 10.1016/j.taap.2013.09.020; Sweeney S, 2015, INT J NANOMED, V10, P3115, DOI 10.2147/IJN.S77867; Taylor EL, 2004, BRIT J PHARMACOL, V143, P179, DOI 10.1038/sj.bjp.0705909; Wei MD, 2004, CHEM PHYS LETT, V400, P231, DOI 10.1016/j.cplett.2004.10.114; WHO, 1997, DET AIRB FIBR NUMB C	60	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151365	10.1371/journal.pone.0151365	http://dx.doi.org/10.1371/journal.pone.0151365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999274	gold, Green Submitted, Green Published			2022-12-27	WOS:000372694700035
J	Chow, LN; Schreiner, P; Ng, BYY; Lo, B; Hughes, MR; Scott, RW; Gusti, V; Lecour, S; Simonson, E; Manisali, I; Barta, I; McNagny, KM; Crawford, J; Webb, M; Underhill, TM				Chow, Leola N.; Schreiner, Petra; Ng, Betina Y. Y.; Lo, Bernard; Hughes, Michael R.; Scott, R. Wilder; Gusti, Vionarica; Lecour, Samantha; Simonson, Eric; Manisali, Irina; Barta, Ingrid; McNagny, Kelly M.; Crawford, Jason; Webb, Murray; Underhill, T. Michael			Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice	PLOS ONE			English	Article							STEM-CELL MIGRATION; CHEMOKINE RECEPTOR; LIVER FIBROSIS; STELLATE CELLS; LUNG INJURY; CIRCULATING FIBROCYTES; CXCR4; PIRFENIDONE; PHARMACOKINETICS; HEMATOPOIESIS	Modulation of chemokine CXCL12 and its receptor CXCR4 has been implicated in attenuation of bleomycin (BLM)-induced pulmonary fibrosis and carbon tetrachloride (CCl4)-induced hepatic injury. In pulmonary fibrosis, published reports suggest that collagen production in the injured lung is derived from fibrocytes recruited from the circulation in response to release of pulmonary CXCL12. Conversely, in hepatic fibrosis, resident hepatic stellate cells (HSC), the key cell type in progression of fibrosis, upregulate CXCR4 expression in response to activation. Further, CXCL12 induces HSC proliferation and subsequent production of collagen I. In the current study, we evaluated AMD070, an orally bioavailable inhibitor of CXCL12/CXCR4 in alleviating BLM-induced pulmonary and CCl4-induced hepatic fibrosis in mice. Similar to other CXCR4 antagonists, treatment with AMD070 significantly increased leukocyte mobilization. However, in these two models of fibrosis, AMD070 had a negligible impact on extracellular matrix deposition. Interestingly, our results indicated that CXCL12/CXCR4 signaling has a role in improving mortality associated with BLM induced pulmonary injury, likely through dampening an early inflammatory response and/or vascular leakage. Together, these findings indicate that the CXCL12-CXCR4 signaling axis is not an effective target for reducing fibrosis.	[Chow, Leola N.; Gusti, Vionarica; Lecour, Samantha; Simonson, Eric; Manisali, Irina] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Schreiner, Petra; Ng, Betina Y. Y.; Lo, Bernard; Hughes, Michael R.; Scott, R. Wilder; Barta, Ingrid; McNagny, Kelly M.; Crawford, Jason; Webb, Murray; Underhill, T. Michael] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Chow, LN (corresponding author), Ctr Drug Res & Dev, Vancouver, BC, Canada.; Underhill, TM (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	lchow@cdrd.ca; tunderhi@brc.ubc.ca	McNagny, Kelly/P-5239-2014; Hughes, Michael/N-6039-2015	McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Gusti, Vionarica/0000-0001-9663-8428; Crawford, Jason/0000-0002-5512-9018	Centre for Drug Research and Development; Canadian Institutes of Health Research [MOP-106484]	Centre for Drug Research and Development; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Innovation Funds from The Centre for Drug Research and Development and Canadian Institutes of Health Research grant (MOP-106484) to MU. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Cao YJ, 2008, ANTIMICROB AGENTS CH, V52, P1630, DOI 10.1128/AAC.01460-07; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Crawford JB, 2008, ORG PROCESS RES DEV, V12, P823, DOI 10.1021/op8000993; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Dranse HJ, 2011, J CELL SCI, V124, P2723, DOI 10.1242/jcs.084699; Egan JJ, 1999, LANCET, V354, P1839, DOI 10.1016/S0140-6736(99)00347-5; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hamada N, 2005, J IMMUNOL, V175, P1224, DOI 10.4049/jimmunol.175.2.1224; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kleaveland KR, 2014, J IMMUNOL, V193, P5229, DOI 10.4049/jimmunol.1400753; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Lapidot T, 2001, ANN NY ACAD SCI, V938, P83, DOI 10.1111/j.1749-6632.2001.tb03577.x; Li F, 2012, EUR RESP SOC ANN C 2; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Makino H, 2013, J MED INVESTIG, V60, P127, DOI 10.2152/jmi.60.127; Mark AL, 2010, ANN SURG, V252, P591, DOI 10.1097/SLA.0b013e3181f4e479; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Mosi RM, 2012, BIOCHEM PHARMACOL, V83, P472, DOI 10.1016/j.bcp.2011.11.020; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nicod LP, 1999, LANCET, V354, P268, DOI 10.1016/S0140-6736(99)00178-6; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Ramachandran P, 2012, QJM-INT J MED, V105, P813, DOI 10.1093/qjmed/hcs069; Saiman Y, 2015, HEPATOL RES, V45, P794, DOI 10.1111/hepr.12411; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Skerlj RT, 2010, J MED CHEM, V53, P3376, DOI 10.1021/jm100073m; Song JS, 2010, EXP MOL MED, V42, P465, DOI 10.3858/emm.2010.42.6.048; Spagnolo P, 2015, DRUG DISCOV TODAY, V20, P514, DOI 10.1016/j.drudis.2015.01.001; Stone ND, 2007, ANTIMICROB AGENTS CH, V51, P2351, DOI 10.1128/AAC.00013-07; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Wang XD, 1999, NUTR REV, V57, P51, DOI 10.1111/j.1753-4887.1999.tb01778.x; Watanabe M, 2008, J IMMUNOL, V181, P6670, DOI 10.4049/jimmunol.181.9.6670; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	35	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151765	10.1371/journal.pone.0151765	http://dx.doi.org/10.1371/journal.pone.0151765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998906	Green Submitted, Green Published, gold			2022-12-27	WOS:000372694700062
J	Zhou, ZJ; Zhang, H; Lai, JG; Diao, DM; Li, WH; Dang, CX; Song, YC				Zhou, Zhangjian; Zhang, Hao; Lai, Jianguo; Diao, Dongmei; Li, Wenhan; Dang, Chengxue; Song, Yongchun			Relationships between p14(ARF) Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CPG ISLAND; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; ABERRANT METHYLATION; DNA METHYLATION; P14 METHYLATION; HIGH-FREQUENCY; COLON-CANCER; HYPERMETHYLATION	We conducted a meta-analysis to explore the relationships between p14(ARF) gene methylation and clinicopathological features of colorectal cancer (CRC). Databases, including Pubmed, Embase and Cochrane Library, were searched and, finally, a total of 18 eligible researches encompassing 1988 CRC patients were selected. Combined odds ratios (ORs) with 95% confidence intervals (95% CIs) were evaluated under a fixed effects model for absence of heterogeneity. Significant associations were observed between p14(ARF) gene methylation and tumor location (OR = 2.35, 95% CI: 1.55-3.55, P = 0.001), microsatellite instability (MSI) status (OR = 3.28, 95% CI: 2.12-5.07, P<0.0001). However, there were no significant associations between p14(ARF) gene methylation and tumor stage, tumor differentiation. We concluded that p14(ARF) gene methylation may be significantly associated with tumor location, and MSI status of CRC.	[Zhou, Zhangjian; Zhang, Hao; Lai, Jianguo; Diao, Dongmei; Li, Wenhan; Dang, Chengxue; Song, Yongchun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Div Surg Oncol, 277 W Yanta Rd, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University	Song, YC (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Div Surg Oncol, 277 W Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	dr.syc@163.com	diao, dongmei/HGD-6807-2022	Zhou, Zhangjian/0000-0002-2341-6338				Ahuja N, 1997, CANCER RES, V57, P3370; Atalay C., 2013, Experimental Oncology, V35, P246; Bai AHC, 2004, INT J CANCER, V112, P846, DOI 10.1002/ijc.20485; Bogaert J, 2014, ANN GASTROENTEROL, V27, P9; Boland CR, 1998, CANCER RES, V58, P5248; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Chaar I, 2014, TUMOR BIOL, V35, P1439, DOI 10.1007/s13277-013-1198-9; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Distler P, 1997, DIGEST DIS, V15, P302, DOI 10.1159/000171605; Dominguez G, 2003, MUTAT RES-FUND MOL M, V530, P9, DOI 10.1016/S0027-5107(03)00133-7; Esteller M, 2000, CANCER RES, V60, P129; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Hasegawa A, 2004, ANTICANCER RES, V24, P2047; Hibi K, 2002, JPN J CANCER RES, V93, P883, DOI 10.1111/j.1349-7006.2002.tb01333.x; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Iacopetta B, 2006, INT J CANCER, V119, P2272, DOI 10.1002/ijc.22237; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jia Y, 2013, CHIN J CANCER, V32, P21, DOI 10.5732/cjc.011.10245; Kang C, 2014, WORLD J GASTROENTERO, V20, P6433, DOI 10.3748/wjg.v20.i21.6433; Kang MY, 2008, CANCER-AM CANCER SOC, V112, P1699, DOI 10.1002/cncr.23335; Kim JC, 2010, ANN SURG ONCOL, V17, P1767, DOI 10.1245/s10434-009-0901-y; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; Kondo I, 2008, DIS COLON RECTUM, V51, P1395, DOI 10.1007/s10350-008-9382-5; Lee M, 2006, PATHOL RES PRACT, V202, P415, DOI 10.1016/j.prp.2005.11.011; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; MCMICHAEL AJ, 1985, JNCI-J NATL CANCER I, V75, P185; MCMICHAEL AJ, 1983, AM J EPIDEMIOL, V118, P620, DOI 10.1093/oxfordjournals.aje.a113672; Naghibalhossaini F, 2011, PATHOL ONCOL RES, V17, P819, DOI 10.1007/s12253-011-9388-5; Nazemalhosseini Mojarad Ehsan, 2013, Gastroenterol Hepatol Bed Bench, V6, P120; Nilsson TK, 2013, INT J ONCOL, V42, P127, DOI 10.3892/ijo.2012.1682; Nyiraneza C, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-9; Nyiraneza C, 2011, HUM PATHOL, V42, P1897, DOI 10.1016/j.humpath.2010.06.021; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Samowitz WS, 2007, J MOL DIAGN, V9, P281, DOI 10.2353/jmoldx.2007.070031; Samowitz WS, 2001, AM J PATHOL, V158, P1517, DOI 10.1016/S0002-9440(10)64102-8; Shen L, 2003, GASTROENTEROLOGY, V124, P626, DOI 10.1053/gast.2003.50102; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thibodeau SN, 1996, CANCER RES, V56, P4836; Wiencke JK, 1999, CANCER EPIDEM BIOMAR, V8, P501; Yamamoto H, 2002, GENE CHROMOSOME CANC, V33, P322, DOI 10.1002/gcc.10010; YANG AS, 1995, NUCLEIC ACIDS RES, V23, P1380, DOI 10.1093/nar/23.8.1380; Zheng SC, 2000, CARCINOGENESIS, V21, P2057, DOI 10.1093/carcin/21.11.2057; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152050	10.1371/journal.pone.0152050	http://dx.doi.org/10.1371/journal.pone.0152050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999279	Green Submitted, gold, Green Published			2022-12-27	WOS:000372694700095
J	Barsotti, NS; Almeida, RR; Costa, PR; Barros, MT; Kalil, J; Kokron, CM				Barsotti, Nathalia Silveira; Almeida, Rafael Ribeiro; Costa, Priscilla Ramos; Barros, Myrthes Toledo; Kalil, Jorge; Kokron, Cristina Maria			IL-10-Producing Regulatory B Cells Are Decreased in Patients with Common Variable Immunodeficiency	PLOS ONE			English	Article							T-CELLS; B10 CELLS; IN-VITRO; AUTOIMMUNITY; DISEASE; FREQUENCY; INFLAMMATION; COMPARTMENT; ACTIVATION; EXPRESSION	Common variable immunodeficiency (CVID) is the most prevalent symptomatic primary immunodeficiency in adults. CVID patients often present changes in the frequency and function of B lymphocytes, reduced number of Treg cells, chronic immune activation, recurrent infections, high incidence of autoimmunity and increased risk for malignancies. We hypothesized that the frequency of B10 cells would be diminished in CVID patients because these cells play an important role in the development of Treg cells and in the control of T cell activation and autoimmunity. Therefore, we evaluated the frequency of B10 cells in CVID patients and correlated it with different clinical and immunological characteristics of this disease. Forty-two CVID patients and 17 healthy controls were recruited for this study. Cryo-preserved PBMCs were used for analysis of T cell activation, frequency of Treg cells and characterization of B10 cells by flow cytometry. IL-10 production by sorted B cells culture and plasma sCD14 were determined by ELISA. We found that CVID patients presented decreased frequency of IL-10-producing CD24(hi)CD38(hi) B cells in different cell culture conditions and decreased frequency of IL-10-producing CD24(hi)CD27(+) B cells stimulated with CpG+PIB. Moreover, we found that CVID patients presented lower secretion of IL-10 by sorting-purified B cells when compared to healthy controls. The frequency of B10 cells had no correlation with autoimmunity, immune activation and Treg cells in CVID patients. This work suggests that CVID patients have a compromised regulatory B cell compartment which is not correlated with clinical and immunological characteristics presented by these individuals.	[Barsotti, Nathalia Silveira; Almeida, Rafael Ribeiro; Costa, Priscilla Ramos; Kalil, Jorge; Kokron, Cristina Maria] Univ Sao Paulo, Sch Med, Dept Med, Lab Clin Immunol & Allergy LIM60,Div Clin Immunol, Sao Paulo, Brazil; [Barros, Myrthes Toledo; Kalil, Jorge; Kokron, Cristina Maria] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Kalil, Jorge] Univ Sao Paulo, Sch Med, InCor, Inst Heart, Sao Paulo, Brazil; [Barros, Myrthes Toledo; Kokron, Cristina Maria] HC FMUSP, Clin Immunol & Allergy Div, Primary Immunodeficiency Outpatient Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Barsotti, NS (corresponding author), Univ Sao Paulo, Sch Med, Dept Med, Lab Clin Immunol & Allergy LIM60,Div Clin Immunol, Sao Paulo, Brazil.	nathalia.btt@usp.br	Kokron, Cristina M/D-3140-2012; Almeida, Rafael Ribeiro/F-8014-2014; KALIL, JORGE/C-8029-2012	Kokron, Cristina M/0000-0002-9080-0305; Almeida, Rafael Ribeiro/0000-0003-3984-7527; Silveira Barsotti, Nathalia/0000-0003-3513-5258; KALIL, JORGE/0000-0001-8415-4274				Agarwal S, 2009, CURR ALLERGY ASTHM R, V9, P347, DOI 10.1007/s11882-009-0051-0; Arumugakani G, 2010, J CLIN IMMUNOL, V30, P292, DOI 10.1007/s10875-009-9351-3; Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brouet JC, 2000, EUR J IMMUNOL, V30, P2516, DOI 10.1002/1521-4141(200009)30:9<2516::AID-IMMU2516>3.0.CO;2-Z; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Goode I, 2014, TRANSPL P, V46, P3, DOI 10.1016/j.transproceed.2013.08.075; Hel Z, 2014, J CLIN IMMUNOL, V34, P971, DOI 10.1007/s10875-014-0099-z; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Kofod-Olsen E, 2016, CLIN IMMUNOL, V162, P49, DOI 10.1016/j.clim.2015.11.003; Kokron CM, 2004, AN ACAD BRAS CIENC, V76, P707, DOI 10.1590/S0001-37652004000400007; Kondratenko I, 1997, CLIN EXP IMMUNOL, V108, P9, DOI 10.1046/j.1365-2249.1997.d01-993.x; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Li XJ, 2012, BLOOD, V120, P3318, DOI 10.1182/blood-2012-05-432575; Litzman J, 2012, CLIN EXP IMMUNOL, V170, P321, DOI 10.1111/j.1365-2249.2012.04655.x; Lopes-da-Silva S, 2008, J CLIN IMMUNOL, V28, pS46, DOI 10.1007/s10875-008-9172-9; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Melo KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006269; Mouillot G, 2010, J CLIN IMMUNOL, V30, P746, DOI 10.1007/s10875-010-9424-3; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Vlkova M, 2015, CLIN IMMUNOL, V160, P292, DOI 10.1016/j.clim.2015.06.013; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang M, 2013, CELL MOL IMMUNOL, V10, P122, DOI 10.1038/cmi.2012.60; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zha BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049835	37	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151761	10.1371/journal.pone.0151761	http://dx.doi.org/10.1371/journal.pone.0151761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991898	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800098
J	Crocetti, E; Moscatelli, S; Van der Graaff, J; Keijsers, L; van Lier, P; Koot, HM; Rubini, M; Meeus, W; Branje, S				Crocetti, Elisabetta; Moscatelli, Silvia; Van der Graaff, Jolien; Keijsers, Loes; van Lier, Pol; Koot, Hans M.; Rubini, Monica; Meeus, Wim; Branje, Susan			The Dynamic Interplay among Maternal Empathy, Quality of Mother-Adolescent Relationship, and Adolescent Antisocial Behaviors: New Insights from a Six-Wave Longitudinal Multi-Informant Study	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; CHILD; SUPPORT; PERCEPTIONS; FRIENDS; ASSOCIATIONS; AUTONOMY; PARENTS; LINKS	Adolescents' behavior is often a matter of concern, given their increased likelihood of enacting antisocial behaviors, which cause disruptions in the social order and are potentially harmful for the adolescents themselves and for the people around them. In this six-wave longitudinal study we sought to examine the interplay among maternal empathy, multiple indicators of mother-adolescent relationship quality (i.e., balanced relatedness, conflict, and support), and adolescent antisocial behaviors rated both by adolescents and their mothers. Participants for the current study were 497 Dutch adolescents (56.9% males) followed from age 13 to 18, and their mothers. A series of cross-lagged panel models revealed reciprocal associations between maternal empathy and mother-adolescent relationship quality and between mother-adolescent relationship quality and adolescent antisocial behaviors. Interestingly, we also found some indirect effects of adolescent antisocial behaviors on maternal empathy mediated by mother-adolescent relationship quality. Overall, this study further highlights a process of reciprocal influences within mother-adolescent dyads.	[Crocetti, Elisabetta; Van der Graaff, Jolien; Keijsers, Loes; Meeus, Wim; Branje, Susan] Univ Utrecht, Res Ctr Adolescent Dev, Utrecht, Netherlands; [Moscatelli, Silvia; Rubini, Monica] Univ Bologna, Dept Psychol, Bologna, Italy; [van Lier, Pol; Koot, Hans M.] Vrije Univ Amsterdam, Dept Clin Dev Psychol, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Meeus, Wim] Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands	Utrecht University; University of Bologna; Vrije Universiteit Amsterdam; Tilburg University	Crocetti, E (corresponding author), Univ Utrecht, Res Ctr Adolescent Dev, Utrecht, Netherlands.	e.crocetti@uu.nl	Crocetti, Elisabetta/D-5373-2014; Moscatelli, Silvia/CAG-2033-2022	Crocetti, Elisabetta/0000-0002-2681-5684; Moscatelli, Silvia/0000-0002-0666-2211; Branje, Susan/0000-0002-9999-5313; Koot, Hans/0000-0002-9643-2363	Netherlands Organisation for Scientific Research [GB-MAGW 480-03-005, GB-MAGW 480-08-006, 024.001.003]; Stichting Achmea Slachtoffer en Samenleving (SASS); VU University Amsterdam; Utrecht University; NWO [431-14-014]; Italian Ministry of Research and Education, University and Research FIRB [RBFR128CR6_004]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Stichting Achmea Slachtoffer en Samenleving (SASS); VU University Amsterdam; Utrecht University; NWO(Netherlands Organization for Scientific Research (NWO)); Italian Ministry of Research and Education, University and Research FIRB	Data of the Research on Adolescent Development and Relationships (RADAR) were used for this study. RADAR has been financially supported by main grants from the Netherlands Organisation for Scientific Research (GB-MAGW 480-03-005, GB-MAGW 480-08-006), and Stichting Achmea Slachtoffer en Samenleving (SASS), a grant from the Netherlands Organization for Scientific Research to the Consortium Individual Development (CID; 024.001.003), and various other grants from the Netherlands Organization for Scientific Research, the VU University Amsterdam, and Utrecht University. EC received support for preparing this article by a grant from NWO (431-14-014) assigned to SB. SM and MR received support for working on this article by a grant from the Italian Ministry of Research and Education, University and Research FIRB 2012 (Protocollo RBFR128CR6_004) assigned to SM.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Adachi P, 2015, EUR J DEV PSYCHOL, V12, P116, DOI 10.1080/17405629.2014.963549; [Anonymous], 1991, MANUAL CHILD BEHAV C; Arim RG, 2011, J YOUTH ADOLESCENCE, V40, P207, DOI 10.1007/s10964-009-9493-x; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Bandura Albert, 1977, SOCIAL LEARNING THEO; Barnett MA, 1987, EMPATHY ITS DEV, P142; BELL RQ, 1968, PSYCHOL REV, V75, P81, DOI 10.1037/h0025583; BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836; Bornstein M. H., 2009, T MODEL DEV CHILDREN, P139, DOI [10.1037/11877-000, DOI 10.1037/11877-008]; Branje S. J. T., 2008, WHAT CAN PARENTS DO, P135; Branje S, 2013, ROUTL COMMUN SER, P271; Branje SJT, 2010, J ABNORM CHILD PSYCH, V38, P751, DOI 10.1007/s10802-010-9401-6; Byrne B.M., 2012, STRUCTURAL EQUATION; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2007, STRUCTURAL EQUATION, V9, P233; Damon W, 1997, J MORAL EDUC, V26, P117, DOI 10.1080/0305724970260201; Davis M., 1996, EMPATHY SOCIAL PSYCH; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Goede IHA, 2009, J YOUTH ADOLESCENCE, V38, P75, DOI 10.1007/s10964-008-9286-7; Decety J, 2014, PERSPECT PSYCHOL SCI, V9, P525, DOI 10.1177/1745691614545130; DIX T, 1991, PSYCHOL BULL, V110, P3, DOI 10.1037/0033-2909.110.1.3; ECCLES JS, 1991, J SOC ISSUES, V47, P53, DOI 10.1111/j.1540-4560.1991.tb01834.x; Feshbach N.D., 1987, EMPATHY ITS DEV, P271; Feshbach ND, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P85; FURMAN W, 1985, DEV PSYCHOL, V21, P1016, DOI 10.1037/0012-1649.21.6.1016; Gondoli DM, 1997, DEV PSYCHOL, V33, P861, DOI 10.1037/0012-1649.33.5.861; Hall S.G, 1904, ADOLESCENCE; Havighurst RJ, 1952, DEV TASKS ED; Hawk ST, 2013, J PERS ASSESS, V95, P96, DOI 10.1080/00223891.2012.696080; Helsen M, 2000, J YOUTH ADOLESCENCE, V29, P319, DOI 10.1023/A:1005147708827; Hoeve M, 2012, J ABNORM CHILD PSYCH, V40, P771, DOI 10.1007/s10802-011-9608-1; Hoeve M, 2009, J ABNORM CHILD PSYCH, V37, P749, DOI 10.1007/s10802-009-9310-8; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Huh D, 2006, J ADOLESCENT RES, V21, P185, DOI 10.1177/0743558405285462; Keijsers L, 2011, J ABNORM PSYCHOL, V120, P878, DOI 10.1037/a0024588; Keijsers L, 2010, J RES ADOLESCENCE, V20, P88, DOI 10.1111/j.1532-7795.2009.00631.x; Kerr M., 2003, HDB PSYCHOL, DOI [https://doi.org/10.1002/0471264385.wei0616, DOI 10.1002/0471264385.WEI0616]; Laible DJ, 2004, J ADOLESCENT RES, V19, P759, DOI 10.1177/0743558403260094; Laursen B, 1998, CHILD DEV, V69, P817, DOI 10.2307/1132206; Laursen B., 2009, HDB ADOLESCENT PSYCH, DOI DOI 10.1002/9780470479193.ADLPSY002002; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lollis S, 1997, J SOC PERS RELAT, V14, P441, DOI 10.1177/0265407597144002; LYTTON H, 1990, DEV PSYCHOL, V26, P683, DOI 10.1037/0012-1649.26.5.683; Miklikowska M, 2011, DEV PSYCHOL, V47, P1342, DOI 10.1037/a0024726; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Muthen B., 2010, MPLUS USERS GUIDE; PATTERSON GR, 1984, CHILD DEV, V55, P1299, DOI 10.2307/1129999; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Shulman S, 1997, J YOUTH ADOLESCENCE, V26, P597, DOI 10.1023/A:1024586006966; Soenens B, 2007, PERS SOC PSYCHOL B, V33, P299, DOI 10.1177/0146167206296300; Stern JA, 2015, ATTACH HUM DEV, V17, P1, DOI 10.1080/14616734.2014.969749; STICE E, 1995, DEV PSYCHOL, V31, P322, DOI 10.1037/0012-1649.31.2.322; Trumpeter NN, 2008, J GENET PSYCHOL, V169, P51, DOI 10.3200/GNTP.169.1.51-71; Van der Giessen D, 2014, SOC DEV, V23, P537, DOI 10.1111/sode.12061; van Lier PAC, 2008, RADAR STUDY DESIGN D; van Lissa CJ, 2014, DEV PSYCHOL, V50, P1219, DOI 10.1037/a0035050; Verhulst F.C., 1996, HANDLEIDING CBCL4 18; Verhulst F. C., 1997, HANDLEIDING YOUTH SE; Werner LLAA, 2016, J ABNORM CHILD PSYCH, V44, P1121, DOI 10.1007/s10802-015-0106-8	60	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150009	10.1371/journal.pone.0150009	http://dx.doi.org/10.1371/journal.pone.0150009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26990191	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800024
J	Samad, MS; Bakken, LR; Nadeem, S; Clough, TJ; de Klein, CAM; Richards, KG; Lanigan, GJ; Morales, SE				Samad, Md Sainur; Bakken, Lars R.; Nadeem, Shahid; Clough, Timothy J.; de Klein, Cecile A. M.; Richards, Karl G.; Lanigan, Gary J.; Morales, Sergio E.			High-Resolution Denitrification Kinetics in Pasture Soils Link N2O Emissions to pH, and Denitrification to C Mineralization	PLOS ONE			English	Article							NITROUS-OXIDE; PRODUCT RATIO; NO; ACIDIFICATION; COMMUNITIES	Denitrification in pasture soils is mediated by microbial and physicochemical processes leading to nitrogen loss through the emission of N2O and N-2. It is known that N2O reduction to N-2 is impaired by low soil pH yet controversy remains as inconsistent use of soil pH measurement methods by researchers, and differences in analytical methods between studies, undermine direct comparison of results. In addition, the link between denitrification and N2O emissions in response to carbon (C) mineralization and pH in different pasture soils is still not well described. We hypothesized that potential denitrification rate and aerobic respiration rate would be positively associated with soils. This relationship was predicted to be more robust when a high resolution analysis is performed as opposed to a single time point comparison. We tested this by characterizing 13 different temperate pasture soils from northern and southern hemispheres sites (Ireland and New Zealand) using a fully automated-high-resolution GC detection system that allowed us to detect a wide range of gas emissions simultaneously. We also compared the impact of using different extractants for determining pH on our conclusions. In all pH measurements, soil pH was strongly and negatively associated with both N2O production index (IN2O) and N2O/(N2O+N-2) product ratio. Furthermore, emission kinetics across all soils revealed that the denitrification rates under anoxic conditions (NO+N2O+N-2 mu mol N/h/vial) were significantly associated with C mineralization (CO2 mu mol/h/vial) measured both under oxic (r(2) = 0.62, p = 0.0015) and anoxic (r(2) = 0.89, p<0.0001) conditions.	[Samad, Md Sainur; Morales, Sergio E.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Bakken, Lars R.; Nadeem, Shahid] Norwegian Univ Life Sci, Dept Environm Sci, As, Norway; [Clough, Timothy J.] Lincoln Univ, Dept Soil & Phys Sci, Lincoln, New Zealand; [de Klein, Cecile A. M.] AgRes Invermay, Mosgiel, New Zealand; [Richards, Karl G.; Lanigan, Gary J.] TEAGASC, Environm Res Ctr, Johnstown Castle, Wexford, Ireland	University of Otago; Norwegian University of Life Sciences; Lincoln University - New Zealand; AgResearch - New Zealand; Teagasc	Morales, SE (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.	sergio.morales@otago.ac.nz	Bakken, Lars/AAO-2099-2020; Morales, Sergio/O-5680-2019; Clough, Timothy/Q-4982-2018; Lanigan, Gary J/C-6864-2012; Richards, Karl G./A-5606-2010; Richards, Karl/ABF-1109-2020	Morales, Sergio/0000-0002-5862-0726; Clough, Timothy/0000-0002-5978-5274; Lanigan, Gary J/0000-0003-0813-3097; Richards, Karl G./0000-0002-3703-3450; Richards, Karl/0000-0002-3703-3450; Samad, Md Sainur/0000-0003-1409-7985	New Zealand Government through the New Zealand Fund for Global Partnerships in Livestock Emissions Research [16084]; University of Otago	New Zealand Government through the New Zealand Fund for Global Partnerships in Livestock Emissions Research; University of Otago	This work was funded by the New Zealand Government through the New Zealand Fund for Global Partnerships in Livestock Emissions Research to support the objectives of the Livestock Research Group of the Global Research Alliance on Agricultural Greenhouse Gases (Agreement number: 16084) awarded to SEM and the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bergaust L, 2010, APPL ENVIRON MICROB, V76, P6387, DOI 10.1128/AEM.00608-10; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Cuhel J, 2011, AGR ECOSYST ENVIRON, V141, P230, DOI 10.1016/j.agee.2011.02.016; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; Gawlik BM, 2003, SCI TOTAL ENVIRON, V312, P33, DOI 10.1016/S0048-9697(03)00194-3; ISO, 2005, 10390 ISO, P7; Jahangir MMR, 2012, AGR ECOSYST ENVIRON, V147, P13, DOI 10.1016/j.agee.2011.04.015; Lampe C, 2006, SOIL BIOL BIOCHEM, V38, P2602, DOI 10.1016/j.soilbio.2006.03.016; Lesschen JP, 2011, ENVIRON POLLUT, V159, P3215, DOI 10.1016/j.envpol.2011.04.001; Liu BB, 2014, MBIO, V5, DOI 10.1128/mBio.01383-14; Liu BB, 2010, FEMS MICROBIOL ECOL, V72, P407, DOI 10.1111/j.1574-6941.2010.00856.x; Molstad L, 2007, J MICROBIOL METH, V71, P202, DOI 10.1016/j.mimet.2007.08.011; Morales SE, 2015, SOIL BIOL BIOCHEM, V82, P87, DOI 10.1016/j.soilbio.2014.12.018; Morkved PT, 2007, SOIL BIOL BIOCHEM, V39, P2048, DOI 10.1016/j.soilbio.2007.03.006; Mosier AR, 1998, BIOL FERT SOILS, V27, P221, DOI 10.1007/s003740050424; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Ostrom NE, 2010, SOIL BIOL BIOCHEM, V42, P499, DOI 10.1016/j.soilbio.2009.12.003; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; PAUSTIAN K, 2004, R141 CAST; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; Raut N, 2012, SOIL BIOL BIOCHEM, V55, P104, DOI 10.1016/j.soilbio.2012.06.011; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Regaert D., 2015, Journal of Soil Science and Environmental Management, V6, P178; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saggar S, 2013, SCI TOTAL ENVIRON, V465, P173, DOI 10.1016/j.scitotenv.2012.11.050; Senbayram M, 2012, AGR ECOSYST ENVIRON, V147, P4, DOI 10.1016/j.agee.2011.06.022; Simek M, 2002, EUR J SOIL SCI, V53, P345, DOI 10.1046/j.1365-2389.2002.00461.x; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110	30	54	54	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151713	10.1371/journal.pone.0151713	http://dx.doi.org/10.1371/journal.pone.0151713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990862	Green Published, Green Submitted, gold			2022-12-27	WOS:000372582800090
J	Scholes, S; Bridges, S; Fat, LN; Mindell, JS				Scholes, Shaun; Bridges, Sally; Fat, Linda Ng; Mindell, Jennifer S.			Comparison of the Physical Activity and Sedentary Behaviour Assessment Questionnaire and the Short-Form International Physical Activity Questionnaire: An Analysis of Health Survey for England Data	PLOS ONE			English	Article							CRITERION-RELATED VALIDITY; RISK-FACTORS; IPAQ; RELIABILITY; ADULTS; TIME; AGE; COEFFICIENT; AGREEMENT	Background The Physical Activity and Sedentary Behaviour Assessment Questionnaire (PASBAQ), used within the Health Survey for England (HSE) at 5-yearly intervals, is not included annually due to funding and interview-length constraints. Policy-makers and data-users are keen to consider shorter instruments such as the Short-form International Physical Activity Questionnaire (IPAQ) for the annual survey. Both questionnaires were administered in HSE 2012, enabling comparative assessment in a random sample of 1252 adults. Methods Relative agreement using prevalence-adjusted bias-adjusted Kappa (PABAK) statistics was estimated for: sufficient aerobic activity (moderate-to-vigorous physical activity [MVPA] >= 150minutes/week); inactivity (MVPA<30minutes/week); and excessive sitting (>= 540minutes/weekday). Cross-sectional associations with health outcomes were compared across tertiles of MVPA and tertiles of sitting time using logistic regression with tests for linear trend. Results Compared with PASBAQ data, IPAQ-assessed estimates of sufficient aerobic activity and inactivity were higher and lower, respectively; estimates of excessive sitting were higher. Demographic patterns in prevalence were similar. Agreement using PABAK statistics was fair-to-moderate for sufficient aerobic activity (0.32-0.49), moderate-to-substantial for inactivity (0.42-0.74), and moderate-to-substantial for excessive sitting (0.49-0.75). As with the PASBAQ, IPAQ-assessed MVPA and sitting each showed graded associations with mental well-being (women: P for trend = 0.003 and 0.004, respectively) and obesity (women: P for trend = 0.007 and 0.014, respectively). Conclusions Capturing habitual physical activity and sedentary behaviour through brief questionnaires is complex. Differences in prevalence estimates can reflect differences in questionnaire structure and content rather than differences in reported behaviour. Treating all IPAQ-assessed walking as moderate-intensity contributed to the differences in prevalence estimates. PASBAQ data will be used for population surveillance every 4 to 5 years. The current version of the Short-form IPAQ was included in HSE 2013-14 to enable more frequent assessment of physical activity and sedentary behaviour; a modified version with different item-ordering and additional questions on walking-pace and effort was included in HSE 2015.	[Scholes, Shaun; Fat, Linda Ng; Mindell, Jennifer S.] UCL, Res Dept Epidemiol & Publ Hlth, Hlth & Social Surveys Res Grp, 1-19 Torrington Pl, London WC1E 6BT, England; [Bridges, Sally] NatCen Social Res, 35 Northampton Sq, London EC1V 0AX, England	University of London; University College London	Scholes, S (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, Hlth & Social Surveys Res Grp, 1-19 Torrington Pl, London WC1E 6BT, England.	s.scholes@ucl.ac.uk	Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Bridges, Sally/0000-0002-9378-0055; Scholes, Shaun/0000-0002-7865-5264	Health and Social Care Information Centre	Health and Social Care Information Centre	The Health Survey for England 2012 was funded by the Health and Social Care Information Centre. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2006, MED SCI SPORT EXER, V38, P1584, DOI 10.1249/01.mss.0000229457.73333.9a; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Bauman Adrian, 2006, Promot Educ, V13, P92, DOI 10.1177/10253823060130020103; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Becares L, 2009, HLTH SURVEY ENGLAND, V1, P221; Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008; Bell JA, 2014, DIABETOLOGIA, V57, P2048, DOI 10.1007/s00125-014-3323-8; Brown W, 2004, AUST NZ J PUBL HEAL, V28, P128, DOI 10.1111/j.1467-842X.2004.tb00925.x; Chief Medical Officer, 2004, LEAST 5 WEEK EV IMP; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Department for Culture Media and Sport Strategy Unit, 2002, GAME PLAN STRAT DEL; Department of Health, 2011, START ACT STAY ACT; Dyrstad SM, 2014, MED SCI SPORT EXER, V46, P99, DOI 10.1249/MSS.0b013e3182a0595f; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Everage NJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/389853; Flight L, 2015, PHARM STAT, V14, P74, DOI 10.1002/pst.1659; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; International Physical Activity Questionnaire, 2004, GUID DAT PROC AN INT; Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; Knott C, 2012, HLTH SURVEY ENGLAND, P63; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Littman AJ, 2004, EPIDEMIOLOGY, V15, P105, DOI 10.1097/01.ede.0000091604.32542.97; Lordan G, 2015, RISK ANAL, V35, P2069, DOI 10.1111/risa.12417; Macniven R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-41; Maddison R, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-62; Matthews CE, 2005, MED SCI SPORT EXER, V37, P986, DOI 10.1249/01.mss.0000171615.76521.69; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Neave A., 2014, RESPONSES HLTH SURVE; Pols MA, 1998, EUR J EPIDEMIOL, V14, P63, DOI 10.1023/A:1007427831179; Sabia S, 2014, AM J EPIDEMIOL, V179, P781, DOI 10.1093/aje/kwt330; Sadarangani KP, 2014, DIABETES CARE, V37, P1016, DOI 10.2337/dc13-1816; Scholes S., 2012, HLTH SURV ENGL, V1, P1; Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; SPARC, 2004, NZ PHYS ACT QUEST; Stamatakis E, 2007, AM J PREV MED, V32, P320, DOI 10.1016/j.amepre.2006.12.020; Stamatakis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073753; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Stranges S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005878; Szklo M., 2007, EPIDEMIOLOGY BASICS; Taylor-Piliae RE, 2006, AM J EPIDEMIOL, V164, P598, DOI 10.1093/aje/kwj248; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; The Health and Social Care Information Centre, 2014, HLTH SURV ENGL 2012; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Troiano RP, 2012, J PHYS ACT HEALTH, V9, pS68, DOI 10.1123/jpah.9.s1.s68; UKactive, 2014, TURN TID IN; Wanner M, 2014, BRIT J SPORT MED, V48, P1570, DOI 10.1136/bjsports-2012-092122; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Warrens MJ, 2013, J PROBAB STAT, V2013, DOI 10.1155/2013/325831; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Weston L., 2014, HLTH SURVEY ENGLAND, V1, P1; World Health Organization, 2011, GLOB REC PHYS ACT HL	63	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151647	10.1371/journal.pone.0151647	http://dx.doi.org/10.1371/journal.pone.0151647			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26990093	gold, Green Published			2022-12-27	WOS:000372582800083
J	Schwarz, R; Tanzler, D; Ihling, CH; Sinz, A				Schwarz, Rico; Taenzler, Dirk; Ihling, Christian H.; Sinz, Andrea			Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor beta/delta upon Ligand Binding	PLOS ONE			English	Article							CHEMICAL CROSS-LINKING; MASS-SPECTROMETRY; PPAR-GAMMA; PROTEIN STRUCTURES; ALPHA; IDENTIFICATION; HETERODIMER; CONSTRAINTS; SELECTIVITY; SIMULATION	Peroxisome proliferator-activated receptors (PPARs) have been intensively studied as drug targets to treat type 2 diabetes, lipid disorders, and metabolic syndrome. This study is part of our ongoing efforts to map conformational changes in PPARs in solution by a combination of chemical cross-linking and mass spectrometry (MS). To our best knowledge, we performed the first studies addressing solution structures of full-length PPAR-beta/delta. We monitored the conformations of the ligand-binding domain (LBD) as well as full-length PPAR-beta/delta upon binding of two agonists. (Photo-) cross-linking relied on (i) a variety of externally introduced amine-and carboxyl-reactive linkers and (ii) the incorporation of the photo-reactive amino acid p-benzoylphenylalanine (Bpa) into PPAR-beta/delta by genetic engineering. The distances derived from cross-linking experiments allowed us to monitor conformational changes in PPAR-beta/delta upon ligand binding. The cross-linking/MS approach proved highly advantageous to study nuclear receptors, such as PPARs, and revealed the interplay between DBD (DNA-binding domain) and LDB in PPAR-beta/delta. Our results indicate the stabilization of a specific conformation through ligand binding in PPAR-beta/delta LBD as well as fulllength PPAR-beta/delta. Moreover, our results suggest a close distance between the N-and C-terminal regions of full-length PPAR-beta/delta in the presence of GW1516. Chemical cross-linking/MS allowed us gaining detailed insights into conformational changes that are induced in PPARs when activating ligands are present. Thus, cross-linking/MS should be added to the arsenal of structural methods available for studying nuclear receptors.	[Schwarz, Rico; Taenzler, Dirk; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Sinz, A (corresponding author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06120 Halle, Germany.	andrea.sinz@pharmazie.uni-halle.de			DFG [Si 867/14-1, Si 867/15-1, Si 867/16-1]; EU (COST Action) [1403]	DFG(German Research Foundation (DFG)); EU (COST Action)(European Cooperation in Science and Technology (COST)European Commission)	This study was supported by the DFG (projects Si 867/14-1, 15-1, and 16-1) and the EU (COST Action 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AS acknowledges financial support by the DFG (projects Si 867/14-1, 15-1, and 16-1) and the EU (COST Action 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2015, NUCLEIC ACIDS RES, V43, P5033, DOI 10.1093/nar/gkv331; Arlt C M., 2015, INTEGRATED WOR UNPUB; Batista FAH, 2012, PLOS ONE, V7; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; Chon SH, 2015, EXP DERMATOL, V24, P290, DOI 10.1111/exd.12658; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fabris D, 2010, J MASS SPECTROM, V45, P841, DOI 10.1002/jms.1762; Giordano Attianese Greta M P, 2015, Nucl Recept Signal, V13, pe001, DOI 10.1621/nrs.13001; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Krauth F, 2009, RAPID COMMUN MASS SP, V23, P2811, DOI 10.1002/rcm.4188; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leitner A, 2014, P NATL ACAD SCI USA, V111, P9455, DOI 10.1073/pnas.1320298111; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Li JE, 2015, AM J CHINESE MED, V43, P879, DOI 10.1142/S0192415X15500512; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Michalik L, 2007, J BIOL CHEM, V282, P9666, DOI 10.1074/jbc.M610523200; Montagner A, 2015, EUR J DERMATOL, V25, P4, DOI 10.1684/ejd.2014.2505; Muller MQ, 2010, ANAL CHEM, V82, P6958, DOI 10.1021/ac101241t; Muller MQ, 2009, J MED CHEM, V52, P2875, DOI 10.1021/jm9000665; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Rastinejad F, 2015, TRENDS BIOCHEM SCI, V40, P16, DOI 10.1016/j.tibs.2014.10.011; Rau O, 2008, ARCH PHARM, V341, P191, DOI 10.1002/ardp.200700209; Schwarz R, 2013, J MED CHEM, V56, P4252, DOI 10.1021/jm400446b; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Sinz A, 2014, EXPERT REV PROTEOMIC, V11, P733, DOI 10.1586/14789450.2014.960852; Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Toral M, 2015, J HYPERTENS, V33, P1831, DOI 10.1097/HJH.0000000000000634; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	44	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151412	10.1371/journal.pone.0151412	http://dx.doi.org/10.1371/journal.pone.0151412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992147	gold, Green Published, Green Submitted			2022-12-27	WOS:000372582800061
J	Aprile-Garcia, F; Metzger, MW; Paez-Pereda, M; Stadler, H; Acuna, M; Liberman, AC; Senin, SA; Gerez, J; Hoijman, E; Refojo, D; Mitkovski, M; Panhuysen, M; Stuhmer, W; Holsboer, F; Deussing, JM; Arzt, E				Aprile-Garcia, Fernando; Metzger, Michael W.; Paez-Pereda, Marcelo; Stadler, Herbert; Acuna, Matias; Liberman, Ana C.; Senin, Sergio A.; Gerez, Juan; Hoijman, Esteban; Refojo, Damian; Mitkovski, Miso; Panhuysen, Markus; Stuehmer, Walter; Holsboer, Florian; Deussing, Jan M.; Arzt, Eduardo			Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MAJOR DEPRESSIVE DISORDER; RESONANCE ENERGY-TRANSFER; HUMAN P2X(7) RECEPTOR; PURINERGIC RECEPTOR; P2RX7 GENE; MICROGLIAL CELLS; IMMUNE-SYSTEM; OF-FUNCTION; TNF-ALPHA	The P2X7 receptor is a member of the P2X family of ligand-gated ion channels. A single-nucleotide polymorphism leading to a glutamine (Gln) by arginine (Arg) substitution at codon 460 of the purinergic P2X7 receptor (P2X7R) has been associated with mood disorders. No change in function (loss or gain) has been described for this SNP so far. Here we show that although the P2X7R-Gln460Arg variant per se is not compromised in its function, co-expression of wild-type P2X7R with P2X7R-Gln460Arg impairs receptor function with respect to calcium influx, channel currents and intracellular signaling in vitro. Moreover, co-immunoprecipitation and FRET studies show that the P2X7R-Gln460Arg variant physically interacts with P2X7R-WT. Specific silencing of either the normal or polymorphic variant rescues the heterozygous loss of function phenotype and restores normal function. The described loss of function due to co-expression, unique for mutations in the P2RX7 gene so far, explains the mechanism by which the P2X7R-Gln460Arg variant affects the normal function of the channel and may represent a mechanism of action for other mutations.	[Aprile-Garcia, Fernando; Acuna, Matias; Liberman, Ana C.; Senin, Sergio A.; Gerez, Juan; Arzt, Eduardo] Max Planck Gesell, CONICET, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst, Buenos Aires, DF, Argentina; [Aprile-Garcia, Fernando; Arzt, Eduardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina; [Metzger, Michael W.; Paez-Pereda, Marcelo; Refojo, Damian; Holsboer, Florian; Deussing, Jan M.; Arzt, Eduardo] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Stadler, Herbert; Panhuysen, Markus] Affectis Pharmaceut, D-44227 Dortmund, Germany; [Hoijman, Esteban] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopias Avanzadas, Buenos Aires, DF, Argentina; [Mitkovski, Miso; Stuehmer, Walter] Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany; [Holsboer, Florian] HMNC Brain Hlth, Munich, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; University of Buenos Aires; Max Planck Society; University of Buenos Aires; Max Planck Society	Arzt, E (corresponding author), Max Planck Gesell, CONICET, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst, Buenos Aires, DF, Argentina.; Arzt, E (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina.; Arzt, E (corresponding author), Max Planck Inst Psychiat, D-80804 Munich, Germany.	earzt@ibioba-mpsp-conicet.gov.ar	Stuehmer, Walter/A-2176-2009; Hoijman, Esteban/AAI-8735-2020; Deussing, Jan M/ABB-5993-2021	Stuehmer, Walter/0000-0002-0642-7764; Hoijman, Esteban/0000-0003-1927-1989; Deussing, Jan/0000-0002-9329-5252; Aprile-Garcia, Fernando/0000-0002-5133-0857; Mitkovski, Miso/0000-0001-9195-2434; Refojo, Damian/0000-0002-9798-6413	Affectis Pharmaceuticals AG; University of Buenos Aires (UBA); CONICET; FOCEMMercosur [COF 03/11]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; German Federal Ministry of Education and Research [FKZ 01ZX1314H]; program for medical genome research within the framework of the NGFN-Plus [FKZ:01GS08151]; Volkswagen Stiftung	Affectis Pharmaceuticals AG; University of Buenos Aires (UBA)(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FOCEMMercosur; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); program for medical genome research within the framework of the NGFN-Plus; Volkswagen Stiftung(Volkswagen)	This work was partially supported by grants from Affectis Pharmaceuticals AG (http://www.affectis.com/), the University of Buenos Aires (UBA) (http://www.uba.ar/), the CONICET (http://www.conicet.gov.ar/), FOCEMMercosur (COF 03/11) (http://www.mercosur.int/innovaportal/v/385/2/innova.front/fondo_para_la_convergencia_estructural_del_mercosur_focem) and Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (http://www.agencia.mincyt.gob.ar/) (E.A); by the German Federal Ministry of Education and Research (https://www.bmbf.de/en), within the framework of the e:Med research and funding concept (IntegraMent: Integrated Understanding of Causes and Mechanisms in Mental Disorders; FKZ 01ZX1314H), by the program for medical genome research within the framework of the NGFN-Plus (FKZ:01GS08151) (http://www.ngfn.de/en) (J.D.) and by the Volkswagen Stiftung (D.R.) (https://www.volkswagenstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio LS, 2011, BRIT J PHARMACOL, V163, P1069, DOI 10.1111/j.1476-5381.2011.01303.x; Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Bulanova E, 2005, J IMMUNOL, V174, P3880, DOI 10.4049/jimmunol.174.7.3880; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Gendron FP, 2003, J NEUROCHEM, V87, P344, DOI 10.1046/j.1471-4159.2003.01995.x; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Green EK, 2009, AM J MED GENET B, V150B, P1063, DOI 10.1002/ajmg.b.30931; Grigoroiu-Serbanescu M, 2009, AM J MED GENET B, V150B, P1017, DOI 10.1002/ajmg.b.30952; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Halmai Z, 2013, J AFFECT DISORDERS, V150, P104, DOI 10.1016/j.jad.2013.02.033; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jones KA, 2013, MOL CELL NEUROSCI, V53, P52, DOI 10.1016/j.mcn.2012.10.002; Kataoka A, 2009, J NEUROCHEM, V108, P115, DOI 10.1111/j.1471-4159.2008.05744.x; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003; Lodge NJ, 2008, CURR OPIN DRUG DISC, V11, P633; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; McQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6; Mingam R, 2008, BRAIN BEHAV IMMUN, V22, P234, DOI 10.1016/j.bbi.2007.08.007; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Murakami K, 2003, NEUROSCIENCE, V117, P37, DOI 10.1016/S0306-4522(02)00804-7; Nagy G, 2008, PROG NEURO-PSYCHOPH, V32, P1884, DOI 10.1016/j.pnpbp.2008.08.021; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; Ohlendorff SD, 2007, PHARMACOGENET GENOM, V17, P555, DOI 10.1097/FPC.0b013e3280951625; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Perez-Flores G, 2015, BIOCHEM BIOPH RES CO, V467, P484, DOI 10.1016/j.bbrc.2015.10.025; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sluyter Ronald, 2011, Recent Pat DNA Gene Seq, V5, P41; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Sperlagh B, 2014, TRENDS PHARMACOL SCI, V35, P537, DOI 10.1016/j.tips.2014.08.002; Suadicani SO, 2009, ASN NEURO, V1, DOI 10.1042/AN20090001; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Viikki M, 2011, NEUROSCI LETT, V493, P127, DOI 10.1016/j.neulet.2011.02.023; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Young MT, 2008, J BIOL CHEM, V283, P26241, DOI 10.1074/jbc.M804458200	61	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151862	10.1371/journal.pone.0151862	http://dx.doi.org/10.1371/journal.pone.0151862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986975	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300143
J	Chowanadisai, W; Messerli, SM; Miller, DH; Medina, JE; Hamilton, JW; Messerli, MA; Brodsky, AS				Chowanadisai, Winyoo; Messerli, Shanta M.; Miller, Daniel H.; Medina, Jamie E.; Hamilton, Joshua W.; Messerli, Mark A.; Brodsky, Alexander S.			Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors	PLOS ONE			English	Article							CANCER CELL-LINES; MESENCHYMAL TRANSITION; GENE-EXPRESSION; DNA METHYLATION; YAP; CARBOPLATIN; EMT	The majority of ovarian tumors eventually recur in a drug resistant form. Using cisplatin sensitive and resistant cell lines assembled into 3D spheroids we profiled gene expression and identified candidate mechanisms and biological pathways associated with cisplatin resistance. OVCAR-8 human ovarian carcinoma cells were exposed to sub-lethal concentrations of cisplatin to create a matched cisplatin-resistant cell line, OVCAR-8R. Genome-wide gene expression profiling of sensitive and resistant ovarian cancer spheroids identified 3,331 significantly differentially expressed probesets coding for 3,139 distinct protein-coding genes (Fc > 2, FDR < 0.05) (S2 Table). Despite significant expression changes in some transporters including MDR1, cisplatin resistance was not associated with differences in intracellular cisplatin concentration. Cisplatin resistant cells were significantly enriched for a mesenchymal gene expression signature. OVCAR-8R resistance derived gene sets were significantly more biased to patients with shorter survival. From the most differentially expressed genes, we derived a 17-gene expression signature that identifies ovarian cancer patients with shorter overall survival in three independent datasets. We propose that the use of cisplatin resistant cell lines in 3D spheroid models is a viable approach to gain insight into resistance mechanisms relevant to ovarian tumors in patients. Our data support the emerging concept that ovarian cancers can acquire drug resistance through an epithelial-to-mesenchymal transition.	[Chowanadisai, Winyoo] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA; [Chowanadisai, Winyoo; Messerli, Shanta M.; Medina, Jamie E.; Hamilton, Joshua W.; Messerli, Mark A.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Miller, Daniel H.; Brodsky, Alexander S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Miller, Daniel H.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Medina, Jamie E.] Bridgewater State Univ, Dept Biol Sci, Bridgewater, MA 02325 USA; [Hamilton, Joshua W.] Univ Minnesota, Swenson Coll Sci & Engn, Duluth, MN 55804 USA; [Messerli, Mark A.] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Brodsky, Alexander S.] Brown Univ, Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Brodsky, Alexander S.] Brown Univ, Alpert Med Sch, Providence, RI 02903 USA; [Brodsky, Alexander S.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Marine Biological Laboratory - Woods Hole; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts System of Public Higher Education; Bridgewater State College; University of Minnesota System; University of Minnesota Duluth; South Dakota State University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Messerli, MA (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Brodsky, AS (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Messerli, MA (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.; Brodsky, AS (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pathol & Lab Med, Providence, RI 02903 USA.; Brodsky, AS (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02903 USA.; Brodsky, AS (corresponding author), Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA.	mark.messerli@sdstate.edu; alex_brodsky@brown.edu		/0000-0002-4866-1145	National Institutes of Health (NIH) NCRR [P41 RR001395-27S1]; National Science Foundation (NSF) [DBI-1005378]; Office of Research at Oklahoma State University; Mary Kay Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Research at Oklahoma State University; Mary Kay Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by the National Institutes of Health (NIH) NCRR supplement grant P41 RR001395-27S1 (JWH), National Science Foundation (NSF) DBI-1005378 "REU Site: Biological Discovery in Woods Hole", faculty startup funds from the Office of Research at Oklahoma State University (WC), and the Mary Kay Foundation (ASB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Joel Commisso at the Interdisciplinary Center for Plasma Mass Spectrometry at the University of California, Davis, for his technical expertise. We thank Milton C. Gum for his advice regarding dataset analyses. This work was funded by the NIH NCRR supplement grant P41 RR001395-27S1 (J.W.H.), NSF DBI-1005378 "REU Site: Biological Discovery in Woods Hole", faculty startup funds from the Office of Research at Oklahoma State University (W.C.), and the Mary Kay Foundation (A.S.B.).	Baldwin LA, 2012, OBSTET GYNECOL, V120, P612, DOI 10.1097/AOG.0b013e318264f794; Beck A, 2013, DRYAD DIGITAL REPOSI; Beck AH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002875; Bentink S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030269; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Debernardis D, 1997, CANCER RES, V57, P870; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamazawa S, 2000, ONCOLOGY-BASEL, V59, P329, DOI 10.1159/000012191; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Ke WF, 2011, MED ONCOL, V28, pS135, DOI 10.1007/s12032-010-9747-1; Lee KW, 2015, CLIN CANCER RES, V21, P357, DOI 10.1158/1078-0432.CCR-14-1374; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Ma L, 2010, ACTA BIOCH BIOPH SIN, V42, P593, DOI 10.1093/abbs/gmq067; Marchini S, 2013, EUR J CANCER, V49, P520, DOI 10.1016/j.ejca.2012.06.026; Mitra AK, 2015, GYNECOL ONCOL, V138, P372, DOI 10.1016/j.ygyno.2015.05.040; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Nevedomskaya E, 2016, J PROTEOME RES, V15, P280, DOI 10.1021/acs.jproteome.5b00793; Overbeck TR, 2013, ONCOLOGY-BASEL, V84, P362, DOI 10.1159/000348884; Rago AP, 2009, TISSUE ENG PT A, V15, P387, DOI 10.1089/ten.tea.2008.0107; Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Song IS, 2004, MOL CANCER THER, V3, P1543; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058226; Wang LJ, 2012, MOL CELL BIOCHEM, V363, P257, DOI 10.1007/s11010-011-1178-6; Ween MP, 2015, CRIT REV ONCOL HEMAT, V96, P220, DOI 10.1016/j.critrevonc.2015.05.012; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205	48	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151089	10.1371/journal.pone.0151089	http://dx.doi.org/10.1371/journal.pone.0151089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986722	Green Published, gold			2022-12-27	WOS:000372580300045
J	Fleddermann, M; Rauh-Pfeiffer, A; Demmelmair, H; Holdt, L; Teupser, D; Koletzko, B				Fleddermann, M.; Rauh-Pfeiffer, A.; Demmelmair, H.; Holdt, L.; Teupser, D.; Koletzko, B.			Effects of a Follow-On Formula Containing Isomaltulose (Palatinose (TM)) on Metabolic Response, Acceptance, Tolerance and Safety in Infants: A Randomized-Controlled Trial	PLOS ONE			English	Article							ENDOCRINE RESPONSES; BLOOD-GLUCOSE; LOWER PROTEIN; MILK FORMULA; LATER LIFE; C-PEPTIDE; BREAST; AGE; INSULIN; OBESITY	Effects of the dietary glycaemic load on postprandial blood glucose and insulin response might be of importance for fat deposition and risk of obesity. We aimed to investigate the metabolic effects, acceptance and tolerance of a follow-on formula containing the low glycaemic and low insulinaemic carbohydrate isomaltulose replacing high glycaemic maltodextrin. Healthy term infants aged 4 to 8 completed months (n = 50) were randomized to receive the intervention follow-on formula (IF, 2.1g isomaltulose (Palatinose (TM))/100mL) or an isocaloric conventional formula (CF) providing 2.1g maltodextrin/100mL for four weeks. Plasma insulinaemia 60min after start of feeding (primary outcome) was not statistically different, while glycaemia adjusted for age and time for drinking/volume of meal 60min after start of feeding was 122(105,140) mg/dL in IF (median, interquartile range) and 111 (100,123) in CF (p = 0.01). Urinary c-peptide: creatinine ratio did not differ (IF: 81.5(44.7, 96.0) vs. CF: 56.8(37.5, 129), p = 0.43). Urinary c-peptide: creatinine ratio was correlated total intake of energy (R = 0.31, p = 0.045), protein (R = 0.42, p = 0.006) and fat (R = 0.40, p = 0.01) but not with carbohydrate intake (R = 0.22, p = 0.16). Both formulae were well accepted without differences in time of crying, flatulence, stool characteristics and the occurrence of adverse events. The expected lower postprandial plasma insulin and blood glucose level due to replacement of high glycaemic maltodextrin by low glycaemic isomaltulose were not observed in the single time-point blood analysis. In infants aged 4 to 8 completed months fed a liquid formula, peak blood glucose might be reached earlier than 60min after start of feeding. Non-invasive urinary c-peptide measurements may be a suitable marker of nutritional intake during the previous four days in infants.	[Fleddermann, M.; Rauh-Pfeiffer, A.; Demmelmair, H.; Koletzko, B.] Univ Munich, Dr von Hauner Childrens Hosp, Med Ctr, Munich, Germany; [Holdt, L.; Teupser, D.] Univ Munich, Med Ctr, Inst Lab Med, Munich, Germany	University of Munich; University of Munich	Koletzko, B (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Med Ctr, Munich, Germany.	office.koletzko@med.uni-muenchen.de			BENEO GmbH (Mannheim, Germany), a member of the Suedzucker Group; European Union's Seventh Framework Programme (FP7), project EarlyNutrition [289346]	BENEO GmbH (Mannheim, Germany), a member of the Suedzucker Group; European Union's Seventh Framework Programme (FP7), project EarlyNutrition	The study was financially supported by BENEO GmbH (Mannheim, Germany), a member of the Suedzucker Group. BENEO supplied the respective formulas and reserves the exclusive right to use the results and data for possible Health Claim requests. Further, the research leading to these results was part of the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no 289346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; [Anonymous], 2010, MERC MERC ULTR INS E; [Anonymous], 2006, WHO CHILD GROWTH STA; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Besser REJ, 2011, DIABETES CARE, V34, P607, DOI 10.2337/dc10-2114; Blaak EE, 2012, OBES REV, V13, P923, DOI 10.1111/j.1467-789X.2012.01011.x; Bowman P, 2012, DIABETIC MED, V29, P90, DOI 10.1111/j.1464-5491.2011.03428.x; Dodd H, 2011, AM J CLIN NUTR, V94, P992, DOI 10.3945/ajcn.111.012138; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Foterek K, 2014, J PEDIATR GASTR NUTR, V58, P361, DOI 10.1097/MPG.0000000000000202; Haschke F, 2000, J PEDIATR GASTR NUTR, V31, pS14, DOI 10.1097/00005176-200007001-00003; Holub I, 2010, BRIT J NUTR, V103, P1730, DOI 10.1017/S0007114509993874; Jansen H, 2011, DIABETES CARE, V34, P403, DOI 10.2337/dc10-1100; Keyhani-Nejad F, 2014, DIABETOLOGIA, V28, P28; Konig D, 2012, NUTRITION, V28, P651, DOI 10.1016/j.nut.2011.09.019; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Lina BAR, 2002, FOOD CHEM TOXICOL, V40, P1375, DOI 10.1016/S0278-6915(02)00105-9; LUCAS A, 1980, LANCET, V1, P1267; LUCAS A, 1981, ACTA PAEDIATR SCAND, V70, P195, DOI 10.1111/j.1651-2227.1981.tb05541.x; Madsen AL, 2010, DIABETIC MED, V27, P1350, DOI 10.1111/j.1464-5491.2010.03134.x; Maeda A, 2013, J DIABETES INVEST, V4, P281, DOI 10.1111/jdi.12045; Oram RA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003193; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Regnault TRH, 2013, CLIN EXP PHARMACOL P, V40, P824, DOI 10.1111/1440-1681.12162; SALMENPERA L, 1988, J PEDIATR GASTR NUTR, V7, P651, DOI 10.1097/00005176-198809000-00005; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Socha P, 2011, AM J CLIN NUTR, V94, p1776S, DOI 10.3945/ajcn.110.000596; Suzuki S, 2014, WORLD J DIABETES, V5, P198, DOI 10.4239/wjd.v5.i2.198; Tonouchi H, 2011, BRIT J NUTR, V105, P10, DOI 10.1017/S0007114510003193; Tori AJ, 2007, J PEDIATR GASTR NUTR, V45, P194, DOI 10.1097/MPG.0b013e31804c98cc; van Can JGP, 2009, BRIT J NUTR, V102, P1408, DOI 10.1017/S0007114509990687; Varma V, 2015, METABOLOMICS, V11, P529, DOI 10.1007/s11306-014-0716-0; WALLENSTEEN M, 1991, ACTA PAEDIATR SCAND, V80, P143, DOI 10.1111/j.1651-2227.1991.tb11824.x; Weber M, 2014, AM J CLIN NUTR, V99, P1041, DOI 10.3945/ajcn.113.064071; Wright CJ, 2015, EUR J CLIN NUTR, V25, P29; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, P17	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151614	10.1371/journal.pone.0151614	http://dx.doi.org/10.1371/journal.pone.0151614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987056	Green Submitted, Green Published, gold			2022-12-27	WOS:000372580300096
J	Khalid, O; Vera, MU; Gordts, PL; Ellinwood, NM; Schwartz, PH; Dickson, PI; Esko, JD; Wang, RY				Khalid, Omar; Vera, Moin U.; Gordts, Philip L.; Ellinwood, N. Matthew; Schwartz, Philip H.; Dickson, Patricia I.; Esko, Jeffrey D.; Wang, Raymond Y.			Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I	PLOS ONE			English	Article							ENZYME-REPLACEMENT THERAPY; EMBRYONIC STEM-CELLS; BONE-MARROW-TRANSPLANTATION; CORONARY-HEART-DISEASE; TOLL-LIKE RECEPTOR-4; HURLER-SYNDROME; APOLIPOPROTEIN-J; HEPARAN-SULFATE; MOUSE MODEL; MICROGLIAL ACTIVATION	Background Cardiovascular disease, a progressive manifestation of alpha-L-iduronidase deficiency or mucopolysaccharidosis type I, continues in patients both untreated and treated with hematopoietic stem cell transplantation or intravenous enzyme replacement. Few studies have examined the effects of alpha-L-iduronidase deficiency and subsequent glycosaminoglycan storage upon arterial gene expression to understand the pathogenesis of cardiovascular disease. Methods Gene expression in carotid artery, ascending, and descending aortas from four non-tolerized, non-enzyme treated 19 month-old mucopolysaccharidosis type I dogs was compared with expression in corresponding vascular segments from three normal, age-matched dogs. Data were analyzed using R and whole genome network correlation analysis, a bias-free method of categorizing expression level and significance into discrete modules. Genes were further categorized based on module-trait relationships. Expression of clusterin, a protein implicated in other etiologies of cardiovascular disease, was assessed in canine and murine mucopolysaccharidosis type I aortas via Western blot and in situ immunohistochemistry. Results Gene families with more than two-fold, significant increased expression involved lysosomal function, proteasome function, and immune regulation. Significantly downregulated genes were related to cellular adhesion, cytoskeletal elements, and calcium regulation. Clusterin gene overexpression (9-fold) and protein overexpression (1.3 to 1.62-fold) was confirmed and located specifically in arterial plaques of mucopolysaccharidosis-affected dogs and mice. Conclusions Overexpression of lysosomal and proteasomal-related genes are expected responses to cellular stress induced by lysosomal storage in mucopolysaccharidosis type I. Upregulation of immunity-related genes implicates the potential involvement of glycosaminoglycan-induced inflammation in the pathogenesis of mucopolysaccharidosis-related arterial disease, for which clusterin represents a potential biomarker.	[Khalid, Omar; Schwartz, Philip H.] CHOC Res Inst, Natl Human Neural Stem Cell Resource, Orange, CA USA; [Vera, Moin U.; Dickson, Patricia I.] Harbor UCLA, Los Angeles Biomed Res Inst, Div Med Genet, Torrance, CA USA; [Gordts, Philip L.; Esko, Jeffrey D.; Wang, Raymond Y.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Ellinwood, N. Matthew] Iowa State Univ, Coll Agr & Life Sci, Ames, IA USA; [Schwartz, Philip H.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Wang, Raymond Y.] CHOC Childrens Hosp, Div Metab Disorders, Orange, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California San Diego; Iowa State University; University of California System; University of California Irvine	Wang, RY (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.; Wang, RY (corresponding author), CHOC Childrens Hosp, Div Metab Disorders, Orange, CA USA.	rawang@choc.org	Wang, Raymond Yu Jeang/H-8870-2019; Wang, Raymond Yu Jeang/CAJ-3535-2022; Ellinwood, Norman/AAX-7005-2021; Ellinwood, Matthew/R-6419-2018	Wang, Raymond Yu Jeang/0000-0001-6494-7613; Gordts, Philip/0000-0001-7224-4328; Ellinwood, Matthew/0000-0002-1701-5052	National Institutes of Health (NIH) [T01NS05242-11]; Children's Hospital of Orange County Pediatric Subspecialty Faculty; MPSI Research Foundation; Children's Hospital of Orange County; European Community FP7 Award [PIOF-GA-2010-273994]; Lysosomal Disease Network [U54-NS065768]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085381, U54NS065768] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Orange County Pediatric Subspecialty Faculty; MPSI Research Foundation; Children's Hospital of Orange County; European Community FP7 Award; Lysosomal Disease Network; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant T01NS05242-11 (NME), Children's Hospital of Orange County Pediatric Subspecialty Faculty and the MPSI Research Foundation (RYW), Children's Hospital of Orange County (OK and PHS), European Community FP7 Award, PIOF-GA-2010-273994 (PG), and the Lysosomal Disease Network U54-NS065768 (MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenhoven M, 2015, BLOOD, V125, P2164, DOI 10.1182/blood-2014-11-608075; Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Baldo G, 2011, MOL GENET METAB, V104, P608, DOI 10.1016/j.ymgme.2011.08.018; Braunlin E, 2006, PEDIATR RES, V59, P27, DOI 10.1203/01.pdr.0000190579.24054.39; Braunlin E, 2014, CARDIOVASC PATHOL, V23, P145, DOI 10.1016/j.carpath.2014.01.001; Braunlin EA, 2006, AM J CARDIOL, V98, P416, DOI 10.1016/j.amjcard.2006.02.047; BROSIUS FC, 1981, AM J CARDIOL, V47, P649, DOI 10.1016/0002-9149(81)90550-6; Bruyere J, 2015, J MOL BIOL, V427, P775, DOI 10.1016/j.jmb.2014.09.012; CHEITLIN MD, 1975, JAMA-J AM MED ASSOC, V231, P951, DOI 10.1001/jama.231.9.951; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; DIEMER V, 1992, J BIOL CHEM, V267, P5257; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Esko J, 2015, MOL GENET METAB, V114, pS42, DOI 10.1016/j.ymgme.2014.12.080; FACTOR SM, 1978, VIRCHOWS ARCH A, V379, P1, DOI 10.1007/BF00432778; Fesslova V, 2009, CARDIOL YOUNG, V19, P170, DOI 10.1017/S1047951109003576; Frohbergh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100882; GOMPF RE, 1990, AM J VET RES, V51, P2054; Hamada N, 2011, J ATHEROSCLER THROMB, V18, P209, DOI 10.5551/jat.5819; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii T, 2001, ATHEROSCLEROSIS, V158, P215, DOI 10.1016/S0021-9150(01)00416-6; Ishikawa Y, 1998, ARTERIOSCL THROM VAS, V18, P665, DOI 10.1161/01.ATV.18.4.665; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Jordan MC, 2005, MOL GENET METAB, V86, P233, DOI 10.1016/j.ymgme.2005.05.003; JORDANSTARCK TC, 1994, J LIPID RES, V35, P194; Kakkis ED, 1996, BIOCHEM MOL MED, V58, P156, DOI 10.1006/bmme.1996.0044; Kampmann C, 2014, J INHERIT METAB DIS, V37, P269, DOI 10.1007/s10545-013-9649-4; Kelly AS, 2013, J INHERIT METAB DIS, V36, P221, DOI 10.1007/s10545-011-9438-x; Khalid O, 2014, GENOM DATA, V2, P127, DOI 10.1016/j.gdata.2014.06.011; Khalid O, 2014, STEM CELL RES, V12, P791, DOI 10.1016/j.scr.2014.03.009; Killedar S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-39; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kim JJ, 2014, STEM CELLS, V32, P1468, DOI 10.1002/stem.1675; Kim JJ, 2012, J BIOL CHEM, V287, P41103, DOI 10.1074/jbc.M112.416545; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leal GN, 2010, CARDIOL YOUNG, V20, P254, DOI 10.1017/S104795110999062X; Lin HY, 2005, J INHERIT METAB DIS, V28, P1146, DOI 10.1007/s10545-005-0211-x; Liu YL, 2005, MOL THER, V11, P35, DOI 10.1016/j.ymthe.2004.08.027; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lyons JA, 2011, LAB INVEST, V91, P665, DOI 10.1038/labinvest.2011.7; Martins C, 2015, BRAIN, V138, P336, DOI 10.1093/brain/awu355; MENON KP, 1992, GENOMICS, V14, P763, DOI 10.1016/S0888-7543(05)80182-X; Metcalf JA, 2010, MOL GENET METAB, V99, P396, DOI 10.1016/j.ymgme.2009.12.003; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Nemes A, 2008, HEART VESSELS, V23, P108, DOI 10.1007/s00380-007-1013-x; Neufeld EF, 2013, ONLINE METABOLIC MOL; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Parente MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032419; Poulakou MV, 2008, IN VIVO, V22, P537; RENTERIA VG, 1976, AM J CARDIOL, V38, P487, DOI 10.1016/0002-9149(76)90468-9; Sandhoff K., 2011, COLD SPRING HARB PER, V3, P3; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schuchman EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054459; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHULL RM, 1984, AM J PATHOL, V114, P487; Sifuentes M, 2007, MOL GENET METAB, V90, P171, DOI 10.1016/j.ymgme.2006.08.007; Simonaro CM, 2015, MOL GENET METAB, V114, pS106, DOI 10.1016/j.ymgme.2014.12.241; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Trougakos IP, 2002, EXP GERONTOL, V37, P1175, DOI 10.1016/S0531-5565(02)00139-0; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wang RY, 2015, MOL GENET METAB, V114, pS123, DOI 10.1016/j.ymgme.2014.12.284; Wang RY, 2014, MOL GENET METAB, V112, P286, DOI 10.1016/j.ymgme.2014.05.015; Wang RY, 2014, MOL GENET METAB, V111, P128, DOI 10.1016/j.ymgme.2013.11.001; Wang RY, 2011, MOL GENET METAB, V104, P592, DOI 10.1016/j.ymgme.2011.09.004; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Woloszynek JC, 2004, BIOCHEM J, V379, P461, DOI 10.1042/BJ20031048; Wraith JE, 2006, J INHERIT METAB DIS, V29, P442, DOI 10.1007/s10545-006-0239-6; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046; Yano S, 2009, J INHERIT METAB DIS, V32, pS53, DOI 10.1007/s10545-009-1057-4; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; YLAHERTTUALA S, 1987, ARTERIOSCLEROSIS, V7, P333, DOI 10.1161/01.ATV.7.4.333	76	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0150850	10.1371/journal.pone.0150850	http://dx.doi.org/10.1371/journal.pone.0150850			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26986213	Green Published, Green Submitted, gold			2022-12-27	WOS:000372580300030
J	Nair, SC; Jacobs, JWG; Bakker, MF; Jahangier, ZN; Bijlsma, JWJ; van Laar, JM; Lafeber, FPJG; Welsing, PMJ				Nair, Sandhya C.; Jacobs, Johannes W. G.; Bakker, Marije F.; Jahangier, Z. Nazira; Bijlsma, Johannes W. J.; van Laar, Jacobs M.; Lafeber, Floris P. J. G.; Welsing, Paco M. J.		Utrecht Arthritis Cohort Study Grp	Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; EARLY RHEUMATOID-ARTHRITIS; EULAR RECOMMENDATIONS; DISEASE; MANAGEMENT; THERAPY; VALIDATION; STRATEGIES; EFFICACY; PREDICT	Objective To determine the optimal methotrexate dose in individual patients and to explore whether this optimal dose and the level of disease activity at that dose could be predicted. Methods Data from CAMERA II trial comparing MTX and MTX with 10 mg of prednisone both in a tight control treatment strategy in early RA was used. For each patient a curve for disease activity over time was fitted and the MTX dose after which further step-up did not result in relevant improvement in disease activity anymore was determined the 'lowest optimally effective MTX dose (LOED)'. The association of demographic and clinical characteristics at baseline with this LOED and with the level of disease activity reached at LOED was studied. Results In 204 (100 MTX and 104 MTX with prednisone) out of 236 patients LOED could be defined. 10 mg/wk was the most prevalent LOED in patients treated with MTX and prednisone and 10 mg/wk, 20 mg/wk and 30 mg/wk in the MTX strategy. Although the specific LOED could not reliably be predicted, higher baseline disease activity, height and lower weight were associated with higher LOEDs (i.e at least 15 mg/wk). A score was presented to decide on a starting dose of 10 mg/wk or (at least) 15 mg/wk. The level of disease activity at LOED could not be reliably predicted. Conclusion A starting dose of 10 mg/wk might be a good choice for most patients and is frequently already the optimal dose. However, a subgroup of patient can be determined who would require higher MTX doses.	[Nair, Sandhya C.; Jacobs, Johannes W. G.; Bakker, Marije F.; Bijlsma, Johannes W. J.; van Laar, Jacobs M.; Lafeber, Floris P. J. G.; Welsing, Paco M. J.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Jahangier, Z. Nazira] Tergooi Hosp, Dept Rheumatol, Hilversum, Netherlands	Utrecht University; Utrecht University Medical Center	Nair, SC (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	sandyn26@gmail.com			ReumaFonds [LLP-9] Funding Source: researchfish	ReumaFonds		Bakker MF, 2007, ANN RHEUM DIS, V66, P56, DOI 10.1136/ard.2007.078360; Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Bijlsma JWJ, 2007, ANN RHEUM DIS, V66, P1409, DOI 10.1136/ard.2007.076463; Boers M, 2003, ARTHRITIS RHEUM, V48, P1771, DOI 10.1002/art.11156; Combe B, 2007, ANN RHEUM DIS, V66, P34, DOI 10.1136/ard.2005.044354; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Hider SL, 2009, ANN RHEUM DIS, V68, P57, DOI 10.1136/ard.2008.088237; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv3, DOI 10.1093/rheumatology/kes083; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Maradit-Kremers H, 2006, J RHEUMATOL, V33, P248; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantalaiho V, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3060; Saevarsdottir S, 2011, ANN RHEUM DIS, V70, P469, DOI 10.1136/ard.2010.139212; Schipper LG, 2010, RHEUMATOLOGY, V49, P2154, DOI 10.1093/rheumatology/keq195; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2013, ANN RHEUM DIS; Van der Goes MC, 2012, OSTEOPOROS INT; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Visser K, 2009, ANN RHEUM DIS, V68, P1086, DOI 10.1136/ard.2008.094474; Wessels JAM, 2007, ARTHRITIS RHEUM-US, V56, P1765, DOI 10.1002/art.22640	22	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0148791	10.1371/journal.pone.0148791	http://dx.doi.org/10.1371/journal.pone.0148791			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1YG	26987073	Green Published, gold, Green Submitted			2022-12-27	WOS:000372580300012
J	Nyamtema, AS; Mwakatundu, N; Dominico, S; Mohamed, H; Pemba, S; Rumanyika, R; Kairuki, C; Kassiga, I; Shayo, A; Issa, O; Nzabuhakwa, C; Lyimo, C; van Roosmalen, J				Nyamtema, Angelo S.; Mwakatundu, Nguke; Dominico, Sunday; Mohamed, Hamed; Pemba, Senga; Rumanyika, Richard; Kairuki, Clementina; Kassiga, Irene; Shayo, Allan; Issa, Omary; Nzabuhakwa, Calist; Lyimo, Chagi; van Roosmalen, Jos			Enhancing Maternal and Perinatal Health in Under-Served Remote Areas in Sub-Saharan Africa: A Tanzanian Model	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; NONPHYSICIAN CLINICIAN; SERVICES	Background In Tanzania, maternal mortality ratio (MMR), unmet need for emergency obstetric care and health inequities across the country are in a critical state, particularly in rural areas. This study was established to determine the feasibility and impact of decentralizing comprehensive emergency obstetric and neonatal care (CEmONC) services in underserved rural areas using associate clinicians. Methods Ten health centres (HCs) were upgraded by constructing and equipping maternity blocks, operating rooms, laboratories, staff houses and installing solar panels, standby generators and water supply systems. Twenty-three assistant medical officers (advanced level associate clinicians), and forty-four nurse-midwives and clinical officers (associate clinicians) were trained in CEmONC and anaesthesia respectively. CEmONC services were launched between 2009 and 2012. Monthly supportive supervision and clinical audits of adverse pregnancy outcomes were introduced in 2011 in these HCs and their respective district hospitals. Findings After launching CEmONC services from 2009 to 2014 institutional deliveries increased in all upgraded rural HCs. Mean numbers of monthly deliveries increased by 151% and obstetric referrals decreased from 9% to 3% (p = 0.03) in HCs. A total of 43,846 deliveries and 2,890 caesarean sections (CS) were performed in these HCs making the mean proportion of all births in EmONC facilities of 128% and mean population-based CS rate of 9%. There were 190 maternal deaths and 1,198 intrapartum and very early neonatal deaths (IVEND) in all health facilities. Generally, health centres had statistically significantly lower maternal mortality ratios and IVEND rates than district hospitals (p < 0.00 and < 0.02 respectively). Of all deaths (maternal and IVEND) 84% to 96% were considered avoidable. Conclusions These findings strongly indicate that remotely located health centres in resource limited settings hold a great potential to increase accessibility to CEmONC services and to improve maternal and perinatal health.	[Nyamtema, Angelo S.; Mwakatundu, Nguke; Dominico, Sunday; Mohamed, Hamed; Pemba, Senga; Rumanyika, Richard; Kairuki, Clementina; Kassiga, Irene; Shayo, Allan; Issa, Omary; Nzabuhakwa, Calist; Lyimo, Chagi; van Roosmalen, Jos] World Lung Fdn, Maternal Hlth Project, Dar Es Salaam, Tanzania; [Nyamtema, Angelo S.; Pemba, Senga; Shayo, Allan] Tanzanian Training Ctr Int Hlth, Ifakara, Tanzania; [Nyamtema, Angelo S.; Pemba, Senga] St Francis Univ, Coll Hlth & Allied Sci, Ifakara, Tanzania; [Rumanyika, Richard] Catholic Univ Hlth & Allied Sci, Dept Obstet & Gynaecol, Mwanza, Tanzania; [Kairuki, Clementina] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Kassiga, Irene] St Francis Referral Hosp, Dept Obstet & Gynaecol, Ifakara, Tanzania; [van Roosmalen, Jos] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Nyamtema, AS (corresponding author), World Lung Fdn, Maternal Hlth Project, Dar Es Salaam, Tanzania.; Nyamtema, AS (corresponding author), Tanzanian Training Ctr Int Hlth, Ifakara, Tanzania.; Nyamtema, AS (corresponding author), St Francis Univ, Coll Hlth & Allied Sci, Ifakara, Tanzania.	nyamtema_angelo@yahoo.co.uk	Richardson, Mary/M-9299-2016		Bloomberg Philanthropies; WorldLung Foundation-Maternal Health Project; Foundation H&B Agerup through the WorldLung Foundation-Maternal Health Project	Bloomberg Philanthropies; WorldLung Foundation-Maternal Health Project; Foundation H&B Agerup through the WorldLung Foundation-Maternal Health Project	This project was co-funded by Bloomberg Philanthropies and Foundation H&B Agerup through the WorldLung Foundation-Maternal Health Project whose URL is http://www.worldlungfoundation.org which was the implementer. The URL for Bloomberg Philanthropies is http://www.bloomberg.org and for Foundation H&B Agerup is www.fondationhbagerup.org. NM received the fund on behalf of The WorldLung Foundation-Maternal Health Project which had full control of all primary data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005052; Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Bankana B, 2003, INT J GYNECOL OBSTET, V83, P112, DOI 10.1016/S0020-7292(03)00187-5; CDC, 2014, RED MAT MORT TANZ SE; Dangal G., 2014, NEPAL J OBSTET GYNEC, V17, P8; Djan JO, 1997, INT J GYNECOL OBSTET, V59, pS83, DOI 10.1016/S0020-7292(97)00151-3; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Joint Learning Initiative, 2004, HUM RES HLTH OV CRIS, P13; Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kwesigabo G, 2012, J PUBLIC HEALTH POL, V33, pS35, DOI 10.1057/jphp.2012.55; Ministry of Health and Social Welfare (MoHSW), TANZ SERV AV READ AS; Ministry of Health & Social Welfare, 2008, NORM DIAGN TRAT CHAG, P1; Mucunguzi S, 2014, AFR J REPROD HEALTH, V18, P87; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; National Academy of Engineering Public Information on Noise Control, 2010, TANZ DEM HLTH SURV, P131; National Bureau of Statistics, 2012 TANZ POP HOUS C; Nyamtema AS, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-28; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Remme JHF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001000; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sabitu K, 1997, INT J GYNECOL OBSTET, V59, pS99, DOI 10.1016/S0020-7292(97)00153-7; Sudhof L, 2013, TROP MED INT HEALTH, V18, P18, DOI 10.1111/tmi.12016; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNICEF WHO, 2014, WORLD BANK UN POP DI; WHO, 2009, MON EM OBST CAR; WHO, 1994, WHOFHEMSM9411; WHO, 2000, OP RES REPR HLTH; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization, 2014, WORLD HLTH STAT 2013; World Health Organization, 2008, MIDL HLTH WORK STAT; World Health Organization, 2012, WHO REC OPT HLTH WOR	36	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2016	11	3							e0151419	10.1371/journal.pone.0151419	http://dx.doi.org/10.1371/journal.pone.0151419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1YG	26986725	Green Published, gold			2022-12-27	WOS:000372580300069
J	Wang, TH; Hsia, SM; Wu, CH; Ko, SY; Chen, MY; Shih, YH; Shieh, TM; Chuang, LC; Wu, CY				Wang, Tong-Hong; Hsia, Shih-Min; Wu, Chi-Hao; Ko, Shun-Yao; Chen, Michael Yuanchien; Shih, Yin-Hua; Shieh, Tzong-Ming; Chuang, Li-Chuan; Wu, Ching-Yi			Evaluation of the Antibacterial Potential of Liquid and Vapor Phase Phenolic Essential Oil Compounds against Oral Microorganisms	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; IN-VITRO; BETA-THUJAPLICIN; ANTIMICROBIAL ACTIVITY; CARVACROL; THYMOL; HINOKITIOL; BACTERIAL; COMPONENTS; MECHANISM	The aim of the present study was to determine the antibacterial activities of the phenolic essential oil ( EO) compounds hinokitiol, carvacrol, thymol, and menthol against oral pathogens. Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia. coli were used in this study. The minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), bacterial growth curves, temperature and pH stabilities, and synergistic effects of the liquid and vapor EO compounds were tested. The MIC/MBC of the EO compounds, ranging from the strongest to weakest, were hinokitiol (40-60 mu g/mL/40-100 mu g/mL), thymol (100-200 mu g/mL/200-400 mu g/mL), carvacrol (200-400 mu g/mL/200-600 mu g/mL), and menthol (500-more than 2500 mu g/mL/1000-more than 2500 mu g/mL). The antibacterial activities of the four EO phenolic compound based on the agar diffusion test and bacterial growth curves showed that the four EO phenolic compounds were stable under different temperatures for 24 h, but the thymol activity decreased when the temperature was higher than 80 degrees C. The combination of liquid carvacrol with thymol did not show any synergistic effects. The activities of the vaporous carvacrol and thymol were inhibited by the presence of water. Continual violent shaking during culture enhanced the activity of menthol. Both liquid and vaporous hinokitiol were stable at different temperatures and pH conditions. The combination of vaporous hinokitiol with zinc oxide did not show synergistic effects. These results showed that the liquid and vapor phases of hinokitiol have strong anti-oral bacteria abilities. Hinokitiol has the potential to be applied in oral health care products, dental materials, and infection controls to exert antimicrobial activity.	[Wang, Tong-Hong] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Wang, Tong-Hong] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Wang, Tong-Hong] Chang Gung Univ Sci & Technol, Grad Inst Hlth Ind Technol, Taoyuan, Taiwan; [Hsia, Shih-Min; Wu, Chi-Hao] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Ko, Shun-Yao] Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan; [Ko, Shun-Yao] Chang Jung Christian Univ, Innovate Res Ctr Med, Tainan, Taiwan; [Chen, Michael Yuanchien] China Med Univ Hosp, Dept Oral & Maxillofacial Surg, Taichung, Taiwan; [Chen, Michael Yuanchien] China Med Univ, Sch Dent, Coll Med, Taichung, Taiwan; [Shih, Yin-Hua] China Med Univ Hosp, Mind Body Interface Lab, Taichung, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Coll Hlth Care, Taichung, Taiwan; [Chuang, Li-Chuan] Chang Gung Mem Hosp Linkou, Dept Pediat Dent, Taoyuan, Taiwan; [Chuang, Li-Chuan] Chang Gung Univ, Grad Inst Craniofacial & Dent Sci, Coll Med, Taoyuan, Taiwan; [Wu, Ching-Yi] Natl Yang Ming Univ, Inst Oral Biol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Taipei Medical University; Chang Jung Christian University; Chang Jung Christian University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Shieh, TM (corresponding author), China Med Univ, Dept Dent Hyg, Coll Hlth Care, Taichung, Taiwan.	tmshieh@mail.cmu.edu.tw	Hsia, Shih-Min/AAL-2026-2020; hao, yingbin/I-8600-2017; Abbas, Aqleem/M-9403-2016	hao, yingbin/0000-0001-9211-0554; Abbas, Aqleem/0000-0001-9174-9700; Wu, Ching-Yi/0000-0002-2004-4874; Kang, Zhensheng/0000-0001-5575-0122	China Medical University [CMU103-S-38]; Taipei Medical University [03C0720007A, 104-6202-015-111]; National Science Council, Taiwan [MOST104-2320-B-182A-009-, NSC 102-2314-B-039-015-MY3]	China Medical University(China Medical University); Taipei Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from China Medical University (CMU103-S-38), Taipei Medical University (03C0720007A, 104-6202-015-111), and the National Science Council, Taiwan (MOST104-2320-B-182A-009- and NSC 102-2314-B-039-015-MY3).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from China Medical University (CMU103-S-38), Taipei Medical University (03C0720007A, 104-6202-015-111), and the National Science Council, Taiwan (MOST 104-2320-B-182A-009- and NSC 102-2314-B-039-015-MY3).	Abdullah GZ, 2011, INT J NANOMED, V6, P387, DOI 10.2147/IJN.S14667; Aguiar GP, 2013, NAT PROD RES, V27, P1668, DOI 10.1080/14786419.2012.751595; Akiyama H, 1998, J DERMATOL SCI, V17, P67, DOI 10.1016/S0923-1811(97)00070-4; Alam M, 2013, NANOMED-NANOTECHNOL, V9, P247, DOI 10.1016/j.nano.2012.07.004; Arima Y, 2003, J ANTIMICROB CHEMOTH, V51, P113, DOI 10.1093/jac/dkg037; Bardaji DKR, 2016, NAT PROD RES, V30, P1178, DOI 10.1080/14786419.2015.1043630; Barret MC, 2001, INORG CHEM, V40, P4384, DOI 10.1021/ic0100368; Bebermeyer Richard D, 2005, Tex Dent J, V122, P1022; Botelho MA, 2007, BRAZ J MED BIOL RES, V40, P349, DOI 10.1590/S0100-879X2007000300010; Burt SA, 2005, J FOOD PROTECT, V68, P919, DOI 10.4315/0362-028X-68.5.919; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chami N, 2005, ORAL MICROBIOL IMMUN, V20, P106, DOI 10.1111/j.1399-302X.2004.00202.x; Ciandrini E, 2014, CLIN ORAL INVEST, V18, P2001, DOI 10.1007/s00784-013-1179-9; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Du WX, 2008, J AGR FOOD CHEM, V56, P3082, DOI 10.1021/jf703629s; Ebihara S, 2011, J PHARMACOL SCI, V115, P99, DOI 10.1254/jphs.10R05CP; Ema M, 2004, FOOD CHEM TOXICOL, V42, P465, DOI 10.1016/j.fct.2003.10.009; Farazuddin M, 2014, INT J NANOMED, V9, P1139, DOI 10.2147/IJN.S34668; Flamee S, 2015, EUR ARCH PAEDIATR DE, V16, P449, DOI 10.1007/s40368-015-0192-x; Freires IA, 2015, MOLECULES, V20, P7329, DOI 10.3390/molecules20047329; Guarda A, 2011, INT J FOOD MICROBIOL, V146, P144, DOI 10.1016/j.ijfoodmicro.2011.02.011; Holowachuk SA, 2003, J MICROBIOL METH, V55, P441, DOI 10.1016/S0167-7012(03)00190-8; Iha K, 2013, OR SURG OR MED OR PA, V116, P433, DOI 10.1016/j.oooo.2013.05.021; Imai Norio, 2006, Journal of Toxicological Sciences, V31, P357, DOI 10.2131/jts.31.357; Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565; Jung SY, 2012, DRUG DEV IND PHARM, V38, P635, DOI 10.3109/03639045.2011.621432; Kavoosi G, 2013, J FOOD SCI, V78, pE244, DOI 10.1111/1750-3841.12015; Labib GS, 2015, DRUG DES DEV THER, V9, P3349, DOI 10.2147/DDDT.S85356; Langeveld WT, 2014, CRIT REV MICROBIOL, V40, P76, DOI 10.3109/1040841X.2013.763219; Li H, 2014, INT J CLIN EXP PATHO, V7, P7389; Lindenmuller IH, 2011, CURR PROBL DERMATOL, V40, P107, DOI 10.1159/000321060; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; Lopez P, 2007, J AGR FOOD CHEM, V55, P4348, DOI 10.1021/jf063295u; Low SB, 2014, AM J VET RES, V75, P653, DOI 10.2460/ajvr.75.7.653; Maisanaba S, 2015, MUTAT RES-GEN TOX EN, V784, P37, DOI 10.1016/j.mrgentox.2015.05.005; Marcos-Arias C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-119; Maroof A, 2010, BIOSCIENCE REP, V30, P223, DOI 10.1042/BSR20090068; Miyake M, 2007, J ORAL MAXIL SURG, V65, P2159, DOI 10.1016/j.joms.2007.04.026; Morita Yasilihiro, 2007, Biocontrol Science, V12, P101; Nafisi S, 2004, BIOPOLYMERS, V74, P345, DOI 10.1002/bip.20080; Bitu VDN, 2014, NAT PROD RES, V28, P399, DOI 10.1080/14786419.2013.867343; Nunez L, 2012, BRAZ J MICROBIOL, V43, P1255, DOI 10.1590/S1517-83822012000400003; Okuyama Yusuke, 2012, Nihon Rinsho, V70, P1362; Rahim ZHA, 2014, JCPSP-J COLL PHYSICI, V24, P796, DOI 11.2014/JCPSP.796801; Rodrigues Celia Regina Martins Delgado, 2008, J Clin Dent, V19, P18; Rodriguez-Garcia I, 2016, CRIT REV FOOD SCI, V56, P1717, DOI 10.1080/10408398.2013.800832; Sarrami N, 2002, BRIT DENT J, V193, P257, DOI 10.1038/sj.bdj.4801539; Seo HS, 2015, INT J FOOD MICROBIOL, V215, P95, DOI 10.1016/j.ijfoodmicro.2015.08.021; Shen Q, 2011, AAPS PHARMSCITECH, V12, P1044, DOI 10.1208/s12249-011-9672-4; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; Shih YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094941; Shih YH, 2013, MICROBIOL RES, V168, P254, DOI 10.1016/j.micres.2012.12.007; Tan CQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/525218; TRAUB WH, 1995, J ANTIMICROB CHEMOTH, V35, P149, DOI 10.1093/jac/35.1.149; Ursino MG, 2011, REGUL TOXICOL PHARM, V60, P93, DOI 10.1016/j.yrtph.2011.02.010; Wang CM, 2016, J NAT MED-TOKYO, V70, P563, DOI 10.1007/s11418-016-0978-0; Williams C, 2001, BEST PRACT RES CL GA, V15, P511, DOI 10.1053/bega.2001.0191; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Zhou SY, 2013, J FOOD SCI, V78, pM725, DOI 10.1111/1750-3841.12098	59	383	395	16	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2016	11	9							e0163147	10.1371/journal.pone.0163147	http://dx.doi.org/10.1371/journal.pone.0163147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX2BH	27681039	Green Submitted, Green Published, gold			2022-12-27	WOS:000384171400032
J	Hao, YB; Wang, T; Wang, K; Wang, XJ; Fu, YP; Huang, LL; Kang, ZS				Hao, Yingbin; Wang, Ting; Wang, Kang; Wang, Xiaojie; Fu, Yanping; Huang, Lili; Kang, Zhensheng			Transcriptome Analysis Provides Insights into the Mechanisms Underlying Wheat Plant Resistance to Stripe Rust at the Adult Plant Stage	PLOS ONE			English	Article							F-SP TRITICI; PUCCINIA-STRIIFORMIS; GENE-EXPRESSION; DISEASE RESISTANCE; SALICYLIC-ACID; DEFENSE RESPONSES; BROAD-SPECTRUM; BIOSYNTHESIS; METABOLISM; ANNOTATION	Stripe rust (or yellow rust), which is caused by Puccinia striiformis f. sp. tritici (Pst), is one of the most devastating wheat diseases worldwide. The wheat cultivar Xingzi 9104 (XZ) is an elite wheat germplasm that possesses adult plant resistance (APR), which is non-race-specific and durable. Thus, to better understand the mechanism underlying APR, we performed transcriptome sequencing of wheat seedlings and adult plants without Pst infection, and a total of 157,689 unigenes were obtained as a reference. In total, 2,666, 783 and 2,587 differentially expressed genes (DEGs) were found to be up-or down-regulated after Pst infection at 24, 48 and 120 hours post-inoculation (hpi), respectively, based on a comparison of Pst- and mock-infected plants. Among these unigenes, the temporal pattern of the up-regulated unigenes exhibited transient expression patterns during Pst infection, as determined through a Gene Ontology (GO) enrichment analysis. In addition, a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that many biological processes, including phenylpropanoid biosynthesis, reactive oxygen species, photosynthesis and thiamine metabolism, which mainly control the mechanisms of lignification, reactive oxygen species and sugar, respectively, are involved in APR. In particular, the continuous accumulation of reactive oxygen species may potentially contribute to the ability of the adult plant to inhibit fungal growth and development. To validate the bioinformatics results, 6 candidate genes were selected for further functional identification using the virus-induced gene silencing (VIGS) system, and 4 candidate genes likely contribute to plant resistance against Pst infection. Our study provides new information concerning the transcriptional changes that occur during the Pst-wheat interaction at the adult stage and will help further our understanding of the detailed mechanisms underlying APR to Pst.	[Hao, Yingbin; Wang, Ting; Wang, Kang; Wang, Xiaojie; Fu, Yanping; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Hao, Yingbin; Wang, Ting; Wang, Kang; Wang, Xiaojie; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China; [Fu, Yanping] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Wang, XJ; Kang, ZS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.; Wang, XJ; Kang, ZS (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China.	wangxiaojie@nwsuaf.edu.cn; kangzs@nwsuaf.edu.cn	Hsia, Shih-Min/AAL-2026-2020; hao, yingbin/I-8600-2017; Abbas, Aqleem/M-9403-2016	hao, yingbin/0000-0001-9211-0554; Abbas, Aqleem/0000-0001-9174-9700; Wu, Ching-Yi/0000-0002-2004-4874; Kang, Zhensheng/0000-0001-5575-0122				Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Asensi-Fabado MA, 2010, TRENDS PLANT SCI, V15, P582, DOI 10.1016/j.tplants.2010.07.003; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Cheng YL, 2015, ENVIRON MICROBIOL, V17, P2601, DOI 10.1111/1462-2920.12719; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Coram TE, 2008, MOL PLANT PATHOL, V9, P479, DOI [10.1111/j.1364-3703.2008.00476.x, 10.1111/J.1364-3703.2008.00476.X]; Coram TE, 2008, MOL PLANT PATHOL, V9, P157, DOI 10.1111/J.1364-3703.2007.00453.X; Coura Jose Rodrigues, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P415, DOI 10.1590/S0036-46651995000500006; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Croft MT, 2006, EUKARYOT CELL, V5, P1175, DOI 10.1128/EC.00097-06; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duan XY, 2013, MOL PLANT PATHOL, V14, P728, DOI 10.1111/mpp.12044; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Feng H, 2013, BIOCHIM BIOPHYS ACTA, V1839, P1; FUKUDA H, 1982, PLANTA, V155, P423, DOI 10.1007/BF00394471; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; hang XZ, 1986, LIAONING AGR SCI, V3, P26; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hua J, 2013, CURR OPIN PLANT BIOL, V16, P406, DOI 10.1016/j.pbi.2013.06.017; Huang XL, 2013, PHYSIOL MOL PLANT P, V81, P26, DOI 10.1016/j.pmpp.2012.10.004; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; LINE RF, 1995, PLANT DIS, V79, P1254; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Liu HongMei, 2006, Acta Agronomica Sinica, V32, P1742; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; MARES DJ, 1977, PHYSIOL PLANT PATHOL, V10, P257, DOI 10.1016/0048-4059(77)90030-3; Metraux JP, 2002, TRENDS PLANT SCI, V7, P332, DOI 10.1016/S1360-1385(02)02313-0; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pont C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r119; Rapala-Kozik M, 2008, J EXP BOT, V59, P4133, DOI 10.1093/jxb/ern253; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; van de Mortel M, 2007, MOL PLANT MICROBE IN, V20, P887, DOI 10.1094/MPMI-20-8-0887; Voegele RT, 2006, FEMS MICROBIOL LETT, V259, P165, DOI 10.1111/j.1574-6968.2006.00248.x; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang GN, 2006, PLANT MOL BIOL, V60, P437, DOI 10.1007/s11103-005-4770-x; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Zaninotto F, 2006, PLANT PHYSIOL, V141, P379, DOI 10.1104/pp.106.078857; Zhang HC, 2012, PLANT CELL REP, V31, P2121, DOI 10.1007/s00299-012-1322-0; Zhang SJ, 2014, J BIOTECHNOL, V189, P48, DOI 10.1016/j.jbiotec.2014.08.032; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	68	383	395	16	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150717	10.1371/journal.pone.0150717	http://dx.doi.org/10.1371/journal.pone.0150717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	27681039	Green Submitted, Green Published, gold			2022-12-27	WOS:000372582800038
J	Ramu, R; Shirahatti, PS; Swamy, SN; Zameer, F; Dhananjaya, BL; Prasad, MNN				Ramu, Ramith; Shirahatti, Prithvi S.; Swamy, Nanjunda S.; Zameer, Farhan; Dhananjaya, Bhadrapura Lakkappa; Prasad, Nagendra M. N.			Assessment of In Vivo Antidiabetic Properties of Umbelliferone and Lupeol Constituents of Banana (Musa sp var. Nanjangud Rasa Bale) Flower in Hyperglycaemic Rodent Model	PLOS ONE			English	Article							ANTIOXIDANT; GLYCOGEN	Banana is an extensively cultivated plant worldwide, mainly for its fruit, while its ancillary product, the banana flower is consumed as a vegetable and is highly recommended for diabetics in the traditional Indian medicine system. This study is based on an investigation of the in vivo antihyperglycaemic activity of Umbelliferone (C1) and Lupeol (C2) isolated from the ethanol extract of banana flower (EF) in alloxan induced diabetic rat model. Diabetic rats which were administered with C1, C2 and EF (100 and 200 mg/kg b. wt.) for 4 weeks showed deterioration in fasting hyperglycaemia and reversal of abnormalities in serum/urine protein, urea and creatinine, when compared to the diabetic control group of rats. The diabetic group of rats fed with EF, C1 and C2 (100 mg/kg b. wt.) once daily, for a period of 28 days resulted in a significant reduction of diabetic symptoms viz., polyphagia, polydipsia, polyuria and urine sugar together with an improved body weight. HbA1c extent was reduced whereas levels of insulin and Hb were increased. Both the extract and compounds wielded positive impacts in diabetic rats by reversal of altered activities of hepatic marker enzymes viz., aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP); glycolytic enzyme (hexokinase); shunt enzyme (glucose-6-phosphate dehydrogenase); gluconeogenic enzymes (glucose-6-phosphatase, fructose-1,6-bisphosphatase, lactate dehydrogenase) and pyruvate kinase. The characteristic diabetic complications such as hypercholesterolemia and hypertriacylglycerolemia also significantly reverted to normal in the serum/liver of diabetic rats. Besides these, the treatment increased the activities of enzymatic and nonenzymatic antioxidants in the serum and liver. The histological observations revealed a marked regeneration of the beta-cells in the drug treated diabetic rats. In conclusion, the present study illustrates that EF, C1 and C2 enhances the glycolytic activities, besides increasing the hepatic glucose utilization in diabetic rats by stimulating insulin secretion from the remnant beta-cells along with potential enzymatic and non-enzymatic antioxidant activities.	[Ramu, Ramith] Sri Dharmasthala Manjunatheshwara Coll Post Grad, Dept Biotechnol, Dakshina Kannada 574240, Karnataka, India; [Ramu, Ramith; Shirahatti, Prithvi S.; Swamy, Nanjunda S.; Prasad, Nagendra M. N.] Sri Jayachamarajendra Coll Engn, Dept Biotechnol, JSS Tech Inst Campus, Mysore 570006, Karnataka, India; [Zameer, Farhan] Pooja Bhagavat Mem Mahajana PG Ctr, Dept Studies Biotechnol Microbiol & Biochem, Mahajana Life Sci Res Ctr, Mysore 570016, Karnataka, India; [Dhananjaya, Bhadrapura Lakkappa] Jain Univ, Ctr Emerging Technol, Toxinol Toxicol & Drug Discovery Unit, Jain Global Campus, Kanakapura Taluk 562112, Karnataka, India	Sri Jayachamarajendra College of Engineering; Jain University	Prasad, MNN (corresponding author), Sri Jayachamarajendra Coll Engn, Dept Biotechnol, JSS Tech Inst Campus, Mysore 570006, Karnataka, India.; Dhananjaya, BL (corresponding author), Jain Univ, Ctr Emerging Technol, Toxinol Toxicol & Drug Discovery Unit, Jain Global Campus, Kanakapura Taluk 562112, Karnataka, India.	chandu_greeshma@rediffmail.com; npmicro8@yahoo.com	Zameer, Farhan/AAU-8054-2021; RAMU, RAMITH/AAY-3039-2020	RAMU, Dr. RAMITH/0000-0003-2776-5815; Zameer, Dr. Farhan/0000-0002-4868-1111; SHIVANANJU, NANJUNDA SWAMY/0000-0002-5494-9428				BAKER H, 1980, NUTR REP INT, V21, P531; Bhaskar JJ, 2012, J AGR FOOD CHEM, V60, P427, DOI 10.1021/jf204539v; CORNBLATH M, 1963, J BIOL CHEM, V238, P1592; David LD, 1932, J BIOL CHEM, V98, P719; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fugen A, 2002, CELL BIOCHEM FUNCT, V20, P297; Indradevi S., 2012, Journal of King Saud University Science, V24, P171, DOI 10.1016/j.jksus.2010.12.007; Kavishankar GB, 2014, PHYTOMEDICINE, V21, P1026, DOI 10.1016/j.phymed.2014.04.033; KEMP A, 1954, BIOCHEM J, V56, P646, DOI 10.1042/bj0560646; King A, 2016, BIOCHEM PHARMACOL, V99, P1, DOI 10.1016/j.bcp.2015.08.108; King J., 1965, PRACTICAL CLIN ENZYM, P363; LELOIR LF, 1962, METHOD ENZYMOL, V5, P145, DOI 10.1016/S0076-6879(62)05196-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna GL, 1968, MANUAL HISTOLOGICAL; Mahboob M., 2005, SMJ Singapore Medical Journal, V46, P322; Mahendran G, 2014, PHYTOMEDICINE, V21, P1237, DOI 10.1016/j.phymed.2014.06.011; Maithili V, 2011, INDIAN J PHARMACOL, V43, P455, DOI 10.4103/0253-7613.83121; Makni M, 2011, J DIABETES COMPLICAT, V25, P339, DOI 10.1016/j.jdiacomp.2010.09.001; Makni M, 2010, FOOD CHEM TOXICOL, V48, P2407, DOI 10.1016/j.fct.2010.05.079; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murali R, 2013, BIOCHIMIE, V95, P1848, DOI 10.1016/j.biochi.2013.06.013; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; NAYAK SS, 1981, CLIN CHIM ACTA, V109, P267; OECD Guidelines for the Testing of Chemicals, 2001, 423 OECD, V423; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oi K, 1997, BIOCHEM MOL MED, V62, P70, DOI 10.1006/bmme.1997.2622; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; POGSON CI, 1967, NATURE, V216, P156, DOI 10.1038/216156a0; Prabakaran D, 2012, J FUNCT FOODS, V4, P776, DOI 10.1016/j.jff.2012.05.005; Rahimi R, 2005, BIOMED PHARMACOTHER, V59, P365, DOI 10.1016/j.biopha.2005.07.002; Ramachandran V, 2014, PHYTOMEDICINE, V21, P225, DOI 10.1016/j.phymed.2013.08.027; Ramesh B, 2006, J MED FOOD, V9, P562, DOI 10.1089/jmf.2006.9.562; Ramith R., 2014, S AFRICAN J BOT, V95, P54; Rangachari B, 2011, EUR J PHARMACOL, V667, P410; Rao USM, 2011, AFR J TRADIT COMPLEM, V8, P210; Rohilla A., 2012, INT J RES PHARM BIOM, V3, P819; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shobana S, 2010, BRIT J NUTR, V104, P1787, DOI 10.1017/S0007114510002977; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Stadler K, 2003, FREE RADICAL BIO MED, V35, P1240, DOI 10.1016/S0891-5849(03)00499-4; Sundaram R, 2014, PHYTOMEDICINE, V21, P793, DOI 10.1016/j.phymed.2014.01.007; Sundaram R, 2013, PHYTOMEDICINE, V20, P577, DOI 10.1016/j.phymed.2013.01.006; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tabatabaei-Malazy O, 2013, J MED HYPOTHESES IDE, V7, P25, DOI 10.1016/j.jmhi.2012.12.002; Vessal M, 2003, COMP BIOCHEM PHYS C, V135, P357, DOI 10.1016/S1532-0456(03)00140-6	48	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151135	10.1371/journal.pone.0151135	http://dx.doi.org/10.1371/journal.pone.0151135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003006	Green Submitted, Green Published, gold			2022-12-27	WOS:000372697400024
